TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205095_s_at	30	0.333333	0.0778404	-	0.780538	0.420137	0.520323	1.68 [0.47 - 5.96]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212383_at	30	0.2	0.0106928	0.169789	1.72349	0.165122	0.780137	2.18 [0.73 - 6.56]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1752579	165	0.830303	0.000434764	0.0125726	0.97043	0.0136485	0.567247	1.76 [1.12 - 2.77]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1752579	165	0.830303	0.000137687	0.00463866	1.31577	0.017012	0.783798	2.19 [1.15 - 4.17]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205095_s_at	163	0.546012	0.00261689	0.0563996	-0.610828	0.00434643	-1.64989	0.19 [0.06 - 0.60]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212383_at	163	0.730061	0.00348421	0.0710415	-0.71424	0.016351	-0.614807	0.54 [0.33 - 0.89]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212383_at	79	0.734177	0.00539666	0.10049	-1.08757	0.139671	-0.410692	0.66 [0.38 - 1.14]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205095_s_at	79	0.78481	0.0208423	0.275847	-0.973602	0.125715	-0.71816	0.49 [0.19 - 1.22]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212383_at	58	0.810345	0.0457471	0.465437	-0.739274	0.479633	-0.221831	0.80 [0.43 - 1.48]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205095_s_at	58	0.293103	0.0391269	0.421683	-0.625279	0.336392	-0.183051	0.83 [0.57 - 1.21]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212383_at	34	0.352941	0.164037	-	0.568384	0.520668	-0.314519	0.73 [0.28 - 1.91]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205095_s_at	34	0.117647	0.00252273	0.0547463	-1.74956	0.0957872	-0.562082	0.57 [0.29 - 1.10]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205095_s_at	158	0.462025	0.0105965	0.168642	0.605762	0.0511381	0.773569	2.17 [1.00 - 4.72]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212383_at	158	0.898734	0.0471596	0.47429	0.64102	0.220535	0.436197	1.55 [0.77 - 3.11]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212383_at	53	0.169811	0.142959	-	0.866155	0.248429	0.71383	2.04 [0.61 - 6.86]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205095_s_at	53	0.528302	0.00835444	0.140897	0.901492	0.634062	0.203571	1.23 [0.53 - 2.83]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212383_at	53	0.698113	0.244067	-	0.415618	0.361944	0.544136	1.72 [0.53 - 5.55]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205095_s_at	53	0.528302	0.00570084	0.104894	1.01702	0.448174	0.346581	1.41 [0.58 - 3.46]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205095_s_at	180	0.733333	0.09177	-	0.378772	0.706116	0.0397317	1.04 [0.85 - 1.28]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212383_at	180	0.772222	0.0225868	0.291802	0.549266	0.122899	0.371095	1.45 [0.90 - 2.32]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212383_at	559	0.892665	0.0743007	-	-0.735256	0.915282	-0.0329154	0.97 [0.53 - 1.77]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205095_s_at	559	0.790698	0.0895657	-	-0.561255	0.541753	-0.067045	0.94 [0.75 - 1.16]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212383_at	77	0.545455	0.000176715	0.00577	-1.04218	0.0057584	-0.572083	0.56 [0.38 - 0.85]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205095_s_at	77	0.480519	0.0132984	0.199623	-0.654597	0.0249518	-0.263132	0.77 [0.61 - 0.97]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212383_at	70	0.171429	0.0390141	0.420903	-0.684196	0.414328	-0.371039	0.69 [0.28 - 1.68]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205095_s_at	70	0.357143	0.0235675	0.300541	-0.619065	0.584895	-0.670618	0.51 [0.05 - 5.67]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39326_at	50	0.64	0.0786684	-	-0.703753	0.364723	-0.263433	0.77 [0.43 - 1.36]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205095_s_at	74	0.22973	0.000237692	0.00746821	-1.12024	0.001483	-0.625546	0.53 [0.36 - 0.79]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212383_at	74	0.135135	0.00928192	0.152629	-0.951121	0.379286	-0.332247	0.72 [0.34 - 1.50]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212383_at	67	0.791045	0.0093124	0.153008	1.59026	0.247966	2.09951	8.16 [0.23 - 287.54]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205095_s_at	67	0.895522	1.65518e-07	1.02717e-05	2.67716	0.0088623	3.86275	47.60 [2.64 - 858.68]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205095_s_at	115	0.130435	0.133281	-	15.2391	0.906723	0.0857306	1.09 [0.26 - 4.57]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212383_at	115	0.504348	0.0281422	0.339342	-1.32913	0.774322	-0.199304	0.82 [0.21 - 3.20]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39326_at	158	0.101266	0.0263389	0.324414	-0.801213	0.705443	-0.0754242	0.93 [0.63 - 1.37]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39326_at	76	0.157895	0.289865	-	-0.681965	0.761428	0.135942	1.15 [0.48 - 2.76]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212383_at	204	0.308824	0.00681484	0.120499	-0.413562	0.0648812	-0.366491	0.69 [0.47 - 1.02]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205095_s_at	204	0.784314	0.0347989	0.390846	-0.35578	0.364236	-0.047783	0.95 [0.86 - 1.06]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212383_at	87	0.287356	0.00860076	0.14405	-0.961542	0.295333	-0.434322	0.65 [0.29 - 1.46]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205095_s_at	87	0.678161	0.309348	-	-0.440497	0.520179	-0.416892	0.66 [0.18 - 2.35]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212383_at	87	0.287356	0.00860076	0.14405	-0.961542	0.295333	-0.434322	0.65 [0.29 - 1.46]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205095_s_at	87	0.678161	0.309348	-	-0.440497	0.520179	-0.416892	0.66 [0.18 - 2.35]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212383_at	77	0.480519	0.064676	-	1.35476	0.503095	0.454477	1.58 [0.42 - 5.96]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205095_s_at	77	0.766234	0.278687	-	-1.08769	0.804683	-0.22711	0.80 [0.13 - 4.82]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212383_at	77	0.480519	0.0476455	0.477299	1.22633	0.327133	0.57276	1.77 [0.56 - 5.58]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205095_s_at	77	0.38961	0.231878	-	0.768086	0.910146	0.0901981	1.09 [0.23 - 5.24]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205095_s_at	136	0.794118	0.309558	-	-0.744391	0.89257	0.0384358	1.04 [0.59 - 1.82]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212383_at	136	0.125	0.128393	-	-0.771859	0.273093	-0.677415	0.51 [0.15 - 1.71]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205095_s_at	200	0.33	0.0965073	-	0.554664	0.428887	0.191598	1.21 [0.75 - 1.95]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212383_at	200	0.875	0.0863011	-	0.628535	0.632605	0.305797	1.36 [0.39 - 4.76]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20876	60	0.116667	0.0182629	0.251214	-1.12083	0.09651	-0.67085	0.51 [0.23 - 1.13]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20876	60	0.75	0.215804	-	0.495626	0.695673	0.164645	1.18 [0.52 - 2.69]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205095_s_at	286	0.199301	0.00852546	0.143089	-0.566522	0.13575	-0.221377	0.80 [0.60 - 1.07]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212383_at	286	0.29021	0.0540568	-	-0.389701	0.21208	-0.465107	0.63 [0.30 - 1.30]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205095_s_at	159	0.603774	0.0534005	-	0.602697	0.901429	0.0295693	1.03 [0.65 - 1.64]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212383_at	159	0.465409	0.0238057	0.30264	0.761755	0.575557	0.324101	1.38 [0.44 - 4.30]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205095_s_at	159	0.603774	0.00558414	0.103212	1.01785	0.365326	0.26226	1.30 [0.74 - 2.29]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212383_at	159	0.861635	0.022396	0.290083	0.812949	0.64131	0.277225	1.32 [0.41 - 4.24]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212383_at	159	0.861635	0.109262	-	0.681764	0.681316	0.281601	1.33 [0.35 - 5.08]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205095_s_at	159	0.578616	0.00281898	0.0599024	0.941969	0.511994	0.159263	1.17 [0.73 - 1.89]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205095_s_at	54	0.703704	0.0663921	-	1.16644	0.565186	0.421767	1.52 [0.36 - 6.42]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212383_at	54	0.425926	0.267071	-	0.863948	0.660408	0.278609	1.32 [0.38 - 4.58]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212383_at	117	0.709402	0.0085035	0.142808	0.817916	0.112546	0.537502	1.71 [0.88 - 3.32]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212383_at	117	0.794872	0.134104	-	0.621727	0.208881	0.53075	1.70 [0.74 - 3.89]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205095_s_at	117	0.102564	0.0166274	0.234877	15.2193	0.200227	0.517936	1.68 [0.76 - 3.71]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205095_s_at	117	0.102564	0.0472361	0.474765	15.2133	0.170339	0.64271	1.90 [0.76 - 4.77]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205095_s_at	117	0.102564	0.0166274	0.234877	15.2193	0.200227	0.517936	1.68 [0.76 - 3.71]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205095_s_at	117	0.102564	0.17314	-	1.29734	0.748499	0.174917	1.19 [0.41 - 3.47]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212383_at	117	0.794872	0.0236026	0.300851	0.868446	0.127435	0.603086	1.83 [0.84 - 3.97]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212383_at	117	0.709402	0.0085035	0.142808	0.817916	0.112546	0.537502	1.71 [0.88 - 3.32]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212383_at	236	0.118644	0.00261635	0.0563902	-0.922266	0.738821	0.229125	1.26 [0.33 - 4.84]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205095_s_at	236	0.139831	0.0125956	0.19179	-0.773396	0.566672	-0.128018	0.88 [0.57 - 1.36]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212383_at	249	0.859438	0.0389109	0.420188	0.551071	0.0877784	0.859571	2.36 [0.88 - 6.34]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205095_s_at	249	0.875502	0.143239	-	-0.568499	0.992813	-0.00156785	1.00 [0.71 - 1.40]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212383_at	62	0.774194	0.153755	-	-0.893491	0.643951	-0.108488	0.90 [0.57 - 1.42]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205095_s_at	125	0.592	0.00198444	0.0450057	-0.987651	0.150647	-1.22386	0.29 [0.06 - 1.56]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205095_s_at	54	0.111111	0.0109647	0.173009	-1.61786	0.692854	-0.095888	0.91 [0.56 - 1.46]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212383_at	125	0.896	0.0151597	0.219688	1.07181	0.705142	0.255801	1.29 [0.34 - 4.86]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212383_at	125	0.896	0.0632088	-	0.70699	0.655708	-0.233567	0.79 [0.28 - 2.21]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212383_at	54	0.111111	0.0886087	-	-1.08532	0.69992	-0.109669	0.90 [0.51 - 1.57]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205095_s_at	62	0.112903	0.099098	-	-1.02458	0.704838	-0.0753023	0.93 [0.63 - 1.37]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205095_s_at	125	0.128	0.0477141	0.477723	15.2181	0.993716	-0.0086706	0.99 [0.11 - 8.58]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212383_at	198	0.338384	0.0890353	-	0.521351	0.422636	0.234462	1.26 [0.71 - 2.24]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205095_s_at	198	0.626263	0.0454033	0.463257	0.421108	0.460376	0.0613013	1.06 [0.90 - 1.25]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205095_s_at	198	0.848485	0.139931	-	0.458216	0.251457	0.120598	1.13 [0.92 - 1.39]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212383_at	198	0.29798	0.0391984	0.422177	0.530446	0.228683	0.276349	1.32 [0.84 - 2.07]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205095_s_at	198	0.848485	0.139195	-	0.465117	0.425821	0.08719	1.09 [0.88 - 1.35]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212383_at	198	0.29798	0.0281042	0.339032	0.698333	0.152549	0.398981	1.49 [0.86 - 2.57]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205095_s_at	62	0.725806	0.114452	-	-1.50355	0.509832	-0.882752	0.41 [0.03 - 5.71]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212383_at	51	0.117647	0.010189	0.163751	-2.01724	0.480636	-1.08309	0.34 [0.02 - 6.87]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212383_at	62	0.16129	0.00100456	0.0255826	-1.72727	0.0178477	-2.35925	0.09 [0.01 - 0.67]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205095_s_at	51	0.137255	0.359758	-	15.2489	0.324268	2.05018	7.77 [0.13 - 457.93]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212383_at	177	0.107345	0.118671	-	0.897109	0.32824	0.57812	1.78 [0.56 - 5.68]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205095_s_at	177	0.412429	0.123902	-	-0.412833	0.874134	-0.0965246	0.91 [0.28 - 3.00]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212383_at	177	0.107345	0.137272	-	0.676517	0.379795	0.451247	1.57 [0.57 - 4.30]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205095_s_at	177	0.412429	0.156322	-	-0.331436	0.972281	-0.0184031	0.98 [0.35 - 2.77]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212383_at	145	0.606897	0.0377522	0.412093	-0.759968	0.582866	-0.395607	0.67 [0.16 - 2.76]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205095_s_at	145	0.496552	0.31009	-	-0.340055	0.524025	-0.466087	0.63 [0.15 - 2.63]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212383_at	226	0.230089	0.0270668	0.330495	1.0028	0.682381	0.209689	1.23 [0.45 - 3.37]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205095_s_at	226	0.80531	0.105257	-	-0.74667	0.18941	-0.13599	0.87 [0.71 - 1.07]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212383_at	55	0.618182	0.138228	-	-0.7491	0.309869	-0.743422	0.48 [0.11 - 2.00]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205095_s_at	55	0.127273	0.0104993	0.167481	-1.24889	0.0378766	-1.65766	0.19 [0.04 - 0.91]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212383_at	55	0.890909	0.110191	-	-15.2092	0.228367	-1.00685	0.37 [0.07 - 1.88]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212383_at	49	0.632653	0.10862	-	-1.17577	0.13391	-1.30187	0.27 [0.05 - 1.49]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205095_s_at	55	0.127273	0.0043607	0.0849513	-1.60492	0.00310643	-2.73739	0.06 [0.01 - 0.40]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205095_s_at	49	0.142857	3.40322e-05	0.00134534	-2.1562	0.011081	-2.42898	0.09 [0.01 - 0.57]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	770377_1	34	0.117647	0.259658	-	1.10176	0.989705	-0.00451424	1.00 [0.50 - 1.98]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	770377	34	0.117647	0.259658	-	1.10176	0.989705	-0.00451424	1.00 [0.50 - 1.98]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212383_at	63	0.492063	0.198969	-	0.440342	0.718021	0.0766284	1.08 [0.71 - 1.64]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205095_s_at	63	0.349206	0.0024274	0.0530582	-1.00167	0.41616	-0.417841	0.66 [0.24 - 1.80]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4885084_3p_a_at	28	0.857143	0.256052	-	0.728628	0.554449	0.395927	1.49 [0.40 - 5.52]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.267871.1.S1_3p_at	28	0.821429	0.259185	-	0.659267	0.801651	-0.106994	0.90 [0.39 - 2.07]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205095_s_at	82	0.890244	0.0189476	0.257882	1.04103	0.762892	0.159592	1.17 [0.42 - 3.31]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212383_at	82	0.121951	0.00696175	0.1225	-1.05504	0.335847	-0.505662	0.60 [0.22 - 1.69]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	39326_at	84	0.72619	0.00217209	0.048461	-1.20332	0.0518274	-0.496558	0.61 [0.37 - 1.00]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205095_s_at	79	0.696203	0.0772676	-	-0.504812	0.604954	-0.202083	0.82 [0.38 - 1.76]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212383_at	79	0.126582	0.16995	-	-0.496377	0.307506	-0.350763	0.70 [0.36 - 1.38]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	Z71460_at	86	0.104651	0.0836583	-	-0.93377	0.13236	-1.08412	0.34 [0.08 - 1.39]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205095_s_at	104	0.163462	0.0228817	0.294446	1.50714	0.169551	0.809778	2.25 [0.71 - 7.14]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212383_at	104	0.115385	0.00185662	0.0426113	-1.17879	0.14972	-0.866074	0.42 [0.13 - 1.37]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P333733	117	0.273504	0.0153951	0.222159	-0.70467	0.21195	-0.395813	0.67 [0.36 - 1.25]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205095_s_at	204	0.534314	0.0204202	0.271904	0.871343	0.170569	0.357519	1.43 [0.86 - 2.38]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205095_s_at	204	0.534314	0.00136154	0.0329757	0.884594	0.021257	0.474409	1.61 [1.07 - 2.41]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212383_at	204	0.289216	0.131573	-	-0.555036	0.479904	-0.501386	0.61 [0.15 - 2.43]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212383_at	204	0.303922	0.197664	-	-0.361494	0.847675	-0.100285	0.90 [0.33 - 2.52]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212383_at	178	0.522472	0.0558448	-	-0.378145	0.645019	-0.171305	0.84 [0.41 - 1.75]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205095_s_at	178	0.438202	0.338075	-	-0.189144	0.70239	-0.118219	0.89 [0.48 - 1.63]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300004090	41	0.731707	0.117977	-	0.675483	0.366533	0.364975	1.44 [0.65 - 3.18]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212383_at	111	0.297297	0.0232504	0.297732	-0.616205	0.0787322	-0.670298	0.51 [0.24 - 1.08]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205095_s_at	111	0.36036	0.0140687	0.208042	-0.644965	0.434859	-0.121516	0.89 [0.65 - 1.20]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205095_s_at	90	0.855556	0.0350688	0.392825	0.824712	0.956188	0.0359516	1.04 [0.29 - 3.74]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205095_s_at	90	0.855556	0.0975673	-	0.747165	0.956164	0.0410962	1.04 [0.24 - 4.51]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212383_at	90	0.111111	0.000115817	0.00398533	-1.38416	0.887343	-0.0901798	0.91 [0.26 - 3.18]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212383_at	90	0.133333	0.00792298	0.135303	-1.1103	0.953675	-0.0417732	0.96 [0.23 - 3.93]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1345	50	0.22	0.07237	-	1.65061	0.187587	0.92594	2.52 [0.64 - 10.01]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	461	50	0.52	0.302096	-	0.507539	0.361728	0.541643	1.72 [0.54 - 5.50]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205095_s_at	138	0.289855	0.0380743	0.414356	-0.512777	0.518824	-0.144424	0.87 [0.56 - 1.34]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212383_at	138	0.811594	0.0604643	-	-0.661594	0.378431	-0.139974	0.87 [0.64 - 1.19]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205095_s_at	129	0.821705	0.00901841	0.149335	0.724556	0.315505	0.201767	1.22 [0.83 - 1.81]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212383_at	129	0.170543	0.312185	-	0.336431	0.744914	0.182203	1.20 [0.40 - 3.60]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22390	56	0.464286	0.0173653	0.242321	-0.809611	0.0392836	-0.870666	0.42 [0.18 - 0.96]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36725	56	0.446429	0.00101246	0.0257512	-1.1882	0.0105235	-1.03217	0.36 [0.16 - 0.79]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10618	56	0.125	0.00611494	0.110787	-1.1586	0.0991336	-0.903963	0.40 [0.14 - 1.19]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22390	56	0.464286	0.0182975	0.251552	-0.843471	0.0180753	-1.06504	0.34 [0.14 - 0.83]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10618	56	0.517857	0.00220634	0.0490844	-1.30418	0.0279528	-1.47669	0.23 [0.06 - 0.85]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36725	56	0.446429	0.000367387	0.01088	-1.27277	0.0127804	-0.939015	0.39 [0.19 - 0.82]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212383_at	278	0.208633	0.0546622	-	0.501126	0.779454	0.0749613	1.08 [0.64 - 1.82]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205095_s_at	278	0.899281	0.0311055	0.362931	-0.821713	0.100357	-0.398109	0.67 [0.42 - 1.08]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212383_at	133	0.18797	0.252487	-	0.360767	0.942636	0.0145348	1.01 [0.68 - 1.51]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205095_s_at	133	0.661654	0.000945509	0.0243142	0.785811	0.000471511	1.34885	3.85 [1.81 - 8.21]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14070	81	0.444444	0.078962	-	0.986793	0.297494	0.393187	1.48 [0.71 - 3.10]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212383_at	185	0.740541	0.0432048	0.449088	0.375508	0.131152	0.300794	1.35 [0.91 - 2.00]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205095_s_at	185	0.113514	0.105989	-	0.392423	0.438016	0.163802	1.18 [0.78 - 1.78]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212383_at	185	0.740541	0.068861	-	0.367699	0.203637	0.277264	1.32 [0.86 - 2.02]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205095_s_at	185	0.816216	0.17679	-	-0.334104	0.796778	0.0603826	1.06 [0.67 - 1.68]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P333733	110	0.781818	0.321422	-	0.263873	0.839815	0.0415535	1.04 [0.70 - 1.56]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P333733	110	0.109091	0.235228	-	0.563658	0.630901	0.127449	1.14 [0.68 - 1.91]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205095_s_at	80	0.85	0.01062	0.168922	1.18576	0.0471784	0.423176	1.53 [1.01 - 2.32]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212383_at	80	0.25	0.133498	-	1.06943	0.973669	-0.0197151	0.98 [0.30 - 3.16]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_3888	281	0.309609	0.00652769	0.11655	-0.395959	0.123586	-0.30145	0.74 [0.50 - 1.09]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212383_at	38	0.868421	0.0148297	0.216198	1.39548	0.318769	0.510501	1.67 [0.61 - 4.55]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205095_s_at	38	0.763158	0.013025	0.196594	1.31378	0.156179	0.66388	1.94 [0.78 - 4.86]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212383_at	140	0.557143	0.0234804	0.299771	0.650569	0.0703638	1.13678	3.12 [0.91 - 10.68]
GENE	ATP6V0A1	ATPase, H+ transporting, lysosomal V0 subunit a1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205095_s_at	140	0.671429	0.158276	-	0.414906	0.359478	0.653423	1.92 [0.48 - 7.78]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205703_at	30	0.6	0.0376994	0.411721	0.860397	0.730142	0.195561	1.22 [0.40 - 3.69]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205704_s_at	30	0.3	0.012954	0.195803	-1.08209	0.60754	0.422707	1.53 [0.30 - 7.66]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	217603_at	30	0.666667	0.0300376	0.35456	0.906629	0.406037	0.615756	1.85 [0.43 - 7.91]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1686106	165	0.115152	0.0118159	0.182922	-0.73907	0.497526	-0.625369	0.54 [0.09 - 3.26]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1700380	165	0.878788	0.00871231	0.145469	-1.67968	0.389217	-0.207157	0.81 [0.51 - 1.30]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1700380	165	0.581818	0.0563412	-	0.668054	0.411652	0.331698	1.39 [0.63 - 3.08]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1686106	165	0.254545	0.256884	-	-0.418702	0.695066	-0.519437	0.59 [0.04 - 7.99]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205704_s_at	163	0.705521	0.0868784	-	-0.391357	0.79477	-0.0456348	0.96 [0.68 - 1.35]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	217603_at	163	0.656442	0.0854776	-	-0.375186	0.942193	-0.0475255	0.95 [0.26 - 3.45]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205703_at	163	0.429448	0.0247948	0.311258	0.457303	0.275791	0.474411	1.61 [0.68 - 3.77]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	235255_at	163	0.779141	0.295312	-	-0.259893	0.816681	0.0942376	1.10 [0.50 - 2.44]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1555114_at	79	0.139241	0.0490711	0.486022	-0.751047	0.417801	0.25329	1.29 [0.70 - 2.38]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205703_at	79	0.556962	0.0494456	0.488288	-0.589044	0.558228	-0.513591	0.60 [0.11 - 3.34]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	235255_at	79	0.367089	0.212305	-	0.395546	0.664326	0.154198	1.17 [0.58 - 2.34]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	217603_at	79	0.101266	0.0987536	-	-0.708414	0.818106	-0.128473	0.88 [0.29 - 2.63]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205704_s_at	79	0.848101	0.00489735	0.0931099	0.972129	0.415021	0.20205	1.22 [0.75 - 1.99]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205703_at	58	0.189655	0.0538549	-	-0.655649	0.724593	-0.0632225	0.94 [0.66 - 1.33]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205704_s_at	58	0.87931	0.136171	-	-0.697777	0.951798	0.0109301	1.01 [0.71 - 1.44]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217603_at	58	0.275862	0.0142608	0.210116	-0.726934	0.989294	-0.00393194	1.00 [0.56 - 1.77]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	217603_at	34	0.705882	0.0104214	0.166548	-1.24858	0.0551421	-0.670711	0.51 [0.26 - 1.01]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205703_at	34	0.764706	0.0776144	-	0.741331	0.387845	0.189064	1.21 [0.79 - 1.86]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205704_s_at	34	0.117647	0.0934228	-	1.21663	0.69552	0.147343	1.16 [0.55 - 2.42]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	217603_at	158	0.898734	0.050445	-	0.63238	0.138838	0.920023	2.51 [0.74 - 8.49]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205703_at	158	0.303797	0.112096	-	0.436296	0.797112	0.173264	1.19 [0.32 - 4.46]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205704_s_at	158	0.816456	0.00581014	0.106461	-1.05397	0.460447	-0.266285	0.77 [0.38 - 1.55]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205704_s_at	53	0.150943	0.102976	-	-0.734826	0.661191	-0.342125	0.71 [0.15 - 3.28]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205703_at	53	0.792453	0.281429	-	-0.480473	0.861434	-0.036266	0.96 [0.64 - 1.45]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	217603_at	53	0.679245	0.0444992	0.45748	0.738595	0.190977	0.504112	1.66 [0.78 - 3.52]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205704_s_at	53	0.150943	0.253173	-	-0.511996	0.529632	-0.447066	0.64 [0.16 - 2.58]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205703_at	53	0.792453	0.280187	-	-0.525558	0.90077	0.0276648	1.03 [0.67 - 1.59]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	217603_at	53	0.679245	0.0751062	-	0.621184	0.359319	0.326087	1.39 [0.69 - 2.78]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205703_at	180	0.827778	0.00767142	0.131999	0.669567	0.633148	0.0555347	1.06 [0.84 - 1.33]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205704_s_at	180	0.3	0.0431601	0.448796	-0.436713	0.0866032	-0.518642	0.60 [0.33 - 1.08]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	217603_at	180	0.25	0.219553	-	0.31695	0.579901	0.125431	1.13 [0.73 - 1.77]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	235255_at	180	0.8	0.220886	-	-0.321888	0.636064	-0.0581262	0.94 [0.74 - 1.20]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1555114_at	559	0.844365	0.0800722	-	-0.51577	0.904705	0.0165732	1.02 [0.78 - 1.33]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205703_at	559	0.431127	0.00613908	0.111127	-0.544634	0.0404196	-0.246694	0.78 [0.62 - 0.99]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	235255_at	559	0.175313	0.0817839	-	0.497852	0.246095	0.159052	1.17 [0.90 - 1.53]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	217603_at	559	0.531306	0.0984757	-	-0.334085	0.39834	-0.16601	0.85 [0.58 - 1.25]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205704_s_at	559	0.617174	0.00649569	0.116107	0.541331	0.0547842	0.436249	1.55 [0.99 - 2.41]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	217603_at	77	0.428571	0.187318	-	0.346321	0.731872	0.0991863	1.10 [0.63 - 1.95]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205703_at	77	0.896104	0.133717	-	-0.689457	0.955003	0.0090694	1.01 [0.74 - 1.38]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205704_s_at	77	0.844156	2.16598e-05	0.000897316	1.39655	0.00535369	0.774084	2.17 [1.26 - 3.74]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	235255_at	77	0.103896	0.0865296	-	0.8011	0.510659	0.275042	1.32 [0.58 - 2.99]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	235255_at	70	0.557143	0.141722	-	-0.398503	0.821539	-0.198379	0.82 [0.15 - 4.60]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	217603_at	70	0.828571	0.130651	-	-0.549645	0.534781	-0.496069	0.61 [0.13 - 2.92]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205704_s_at	70	0.514286	0.0665467	-	-0.484327	0.563576	-0.191844	0.83 [0.43 - 1.58]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1555114_at	70	0.171429	0.000696539	0.0187876	-1.0859	0.269884	-1.02672	0.36 [0.06 - 2.22]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205703_at	70	0.142857	0.00149418	0.0356194	-1.12207	0.554628	-0.661476	0.52 [0.06 - 4.63]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37801_at	50	0.78	0.0531772	-	-0.856841	0.216787	-1.8309	0.16 [0.01 - 2.93]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205703_at	74	0.108108	3.54984e-05	0.00139702	-1.55171	0.052071	-0.402003	0.67 [0.45 - 1.00]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205704_s_at	74	0.756757	0.0761409	-	0.575146	0.325645	0.226237	1.25 [0.80 - 1.97]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	217603_at	74	0.162162	0.0167174	0.235791	-0.842485	0.119721	-0.733634	0.48 [0.19 - 1.21]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	235255_at	74	0.121622	0.00752344	0.130041	-0.986868	0.198005	-0.520132	0.59 [0.27 - 1.31]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205703_at	67	0.522388	0.337472	-	0.649253	0.743898	-1.05846	0.35 [0.00 - 198.69]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1555114_at	67	0.835821	0.154163	-	0.973298	0.552666	2.05393	7.80 [0.01 - 6862.48]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	235255_at	67	0.895522	0.0043319	0.0845064	2.13383	0.289699	1.71694	5.57 [0.23 - 133.66]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	217603_at	67	0.865672	0.0108096	0.171176	1.56974	0.444791	0.615157	1.85 [0.38 - 8.96]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205704_s_at	67	0.895522	0.0124044	0.189633	1.85726	0.819547	0.347783	1.42 [0.07 - 28.10]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	217603_at	115	0.895652	0.166436	-	0.869518	0.986382	0.0198695	1.02 [0.10 - 9.99]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1555114_at	115	0.2	0.0518817	-	15.3863	0.265473	0.510169	1.67 [0.68 - 4.09]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205704_s_at	115	0.486957	0.0331134	0.3783	1.29464	0.410859	0.580464	1.79 [0.45 - 7.13]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	235255_at	115	0.417391	0.0131641	0.198138	-1.36337	0.105096	-1.35812	0.26 [0.05 - 1.33]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205703_at	115	0.434783	0.0788753	-	-0.945346	0.502532	-0.375974	0.69 [0.23 - 2.06]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37801_at	158	0.78481	5.17981e-06	0.0002458	1.24788	0.0152897	1.58191	4.86 [1.35 - 17.47]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37801_at	76	0.671053	0.134064	-	-0.947908	0.84931	-0.195053	0.82 [0.11 - 6.15]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	235255_at	204	0.245098	0.0570855	-	0.309702	0.242198	0.136743	1.15 [0.91 - 1.44]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	217603_at	204	0.313726	0.122631	-	-0.234856	0.528788	-0.0642015	0.94 [0.77 - 1.15]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205704_s_at	204	0.666667	0.00547625	0.101648	0.41372	0.026955	0.397045	1.49 [1.05 - 2.11]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205703_at	204	0.818627	0.0130158	0.196491	-0.470565	0.12219	-0.10816	0.90 [0.78 - 1.03]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1555114_at	204	0.102941	0.0705331	-	-0.416557	0.642019	-0.0354375	0.97 [0.83 - 1.12]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	235255_at	87	0.747126	0.0853696	-	0.669275	0.441576	0.44544	1.56 [0.50 - 4.85]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	235255_at	87	0.747126	0.0853696	-	0.669275	0.441576	0.44544	1.56 [0.50 - 4.85]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205703_at	87	0.16092	0.0410455	0.434765	1.82081	0.672064	0.538165	1.71 [0.14 - 20.70]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	217603_at	87	0.275862	0.0200789	0.268692	-0.86272	0.454749	-0.724095	0.48 [0.07 - 3.24]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205704_s_at	87	0.137931	0.0454895	0.463804	-0.848455	0.356922	-0.397585	0.67 [0.29 - 1.57]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	217603_at	87	0.275862	0.0200789	0.268692	-0.86272	0.454749	-0.724095	0.48 [0.07 - 3.24]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1555114_at	87	0.735632	0.0338885	0.384109	0.800701	0.085015	1.83044	6.24 [0.78 - 50.07]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1555114_at	87	0.735632	0.0338885	0.384109	0.800701	0.085015	1.83044	6.24 [0.78 - 50.07]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205703_at	87	0.16092	0.0410455	0.434765	1.82081	0.672064	0.538165	1.71 [0.14 - 20.70]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205704_s_at	87	0.137931	0.0454895	0.463804	-0.848455	0.356922	-0.397585	0.67 [0.29 - 1.57]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	235255_at	77	0.103896	0.000103883	0.0036218	-1.92111	0.311004	-0.977164	0.38 [0.06 - 2.49]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205704_s_at	77	0.844156	0.00118462	0.0293665	1.80167	0.0740995	1.23431	3.44 [0.89 - 13.31]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	235255_at	77	0.103896	0.010983	0.173225	-1.59409	0.852389	0.198188	1.22 [0.15 - 9.83]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	217603_at	77	0.675325	0.00152617	0.0362498	1.70158	0.00421441	2.27905	9.77 [2.05 - 46.53]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205703_at	77	0.285714	0.0351808	0.393645	15.6039	0.3158	1.76301	5.83 [0.19 - 182.68]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205704_s_at	77	0.844156	0.0114703	0.178927	1.34232	0.321812	0.608553	1.84 [0.55 - 6.13]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555114_at	77	0.779221	0.190486	-	-1.27461	0.107209	1.43324	4.19 [0.73 - 23.98]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205703_at	77	0.285714	0.0147847	0.215721	15.6212	0.274068	1.68606	5.40 [0.26 - 110.77]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	217603_at	77	0.727273	3.2384e-05	0.00128693	2.55661	0.000887538	3.07456	21.64 [3.53 - 132.62]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555114_at	77	0.454545	0.0792954	-	1.29547	0.0236244	1.91037	6.76 [1.29 - 35.33]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205704_s_at	136	0.889706	0.141704	-	-15.1882	0.643194	-0.143725	0.87 [0.47 - 1.59]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	217603_at	136	0.183824	0.123191	-	-0.744627	0.665458	-0.162174	0.85 [0.41 - 1.77]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205703_at	136	0.117647	0.142798	-	-0.80416	0.838601	0.0508704	1.05 [0.64 - 1.72]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205703_at	200	0.895	0.0467378	0.471663	0.757187	0.796065	0.0491203	1.05 [0.72 - 1.52]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205704_s_at	200	0.105	0.0638374	-	-0.707686	0.776185	0.101232	1.11 [0.55 - 2.22]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	217603_at	200	0.815	0.166431	-	-0.644106	0.598361	-0.145113	0.86 [0.50 - 1.48]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7438	60	0.883333	0.117542	-	-1.46216	0.882848	-0.227096	0.80 [0.04 - 16.34]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7438	60	0.733333	0.090445	-	-0.886338	0.273424	-1.83836	0.16 [0.01 - 4.27]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205703_at	286	0.192308	0.0415007	0.437819	-0.455697	0.270611	-0.131745	0.88 [0.69 - 1.11]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205704_s_at	286	0.758741	0.106903	-	0.346855	0.988998	0.0029882	1.00 [0.66 - 1.53]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	217603_at	286	0.132867	0.0115557	0.179918	-0.607983	0.0977598	-0.257196	0.77 [0.57 - 1.05]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205703_at	159	0.672956	0.2568	-	0.363725	0.71854	0.0785966	1.08 [0.71 - 1.66]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205704_s_at	159	0.628931	0.214617	-	0.392198	0.82874	-0.0716393	0.93 [0.49 - 1.78]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205703_at	159	0.446541	0.107273	-	0.63577	0.329929	0.248236	1.28 [0.78 - 2.11]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217603_at	159	0.301887	0.0209907	0.277225	0.982231	0.259022	0.513276	1.67 [0.69 - 4.07]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205704_s_at	159	0.440252	0.0131588	0.198079	0.852425	0.638009	0.175027	1.19 [0.57 - 2.47]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205704_s_at	159	0.899371	0.0896462	-	0.812799	0.716097	-0.136874	0.87 [0.42 - 1.82]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205703_at	159	0.389937	0.0486441	0.483426	0.705382	0.13685	0.323882	1.38 [0.90 - 2.12]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217603_at	159	0.371069	0.0147207	0.21504	0.93059	0.0652341	0.879079	2.41 [0.95 - 6.13]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	217603_at	159	0.597484	0.0796971	-	0.643449	0.238025	0.641206	1.90 [0.65 - 5.51]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235255_at	159	0.320755	0.0689226	-	0.867754	0.443997	-0.19897	0.82 [0.49 - 1.36]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235255_at	159	0.308176	0.0875818	-	0.663991	0.502747	-0.147285	0.86 [0.56 - 1.33]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235255_at	159	0.320755	0.00859183	0.143936	1.10746	0.467714	0.15359	1.17 [0.77 - 1.76]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205703_at	54	0.277778	0.0809855	-	1.70286	0.4553	-0.902367	0.41 [0.04 - 4.33]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205704_s_at	54	0.5	0.0728879	-	1.34634	0.337872	0.81925	2.27 [0.42 - 12.12]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	217603_at	54	0.166667	0.178946	-	15.3444	0.461705	-1.05299	0.35 [0.02 - 5.76]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217603_at	117	0.153846	0.0500584	-	1.32334	0.998027	0.00194517	1.00 [0.21 - 4.68]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217603_at	117	0.897436	0.0362419	0.40134	-15.237	0.633285	-0.455021	0.63 [0.10 - 4.11]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205703_at	117	0.683761	0.126939	-	0.489791	0.566962	0.343443	1.41 [0.44 - 4.57]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217603_at	117	0.153846	0.0702753	-	1.65027	0.896319	0.123924	1.13 [0.18 - 7.30]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205703_at	117	0.683761	0.03715	0.407833	0.772199	0.454574	0.479407	1.62 [0.46 - 5.67]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	217603_at	117	0.153846	0.0500584	-	1.32334	0.998027	0.00194517	1.00 [0.21 - 4.68]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205703_at	117	0.683761	0.126939	-	0.489791	0.566962	0.343443	1.41 [0.44 - 4.57]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205703_at	117	0.401709	0.0957406	-	0.724083	0.688723	0.302781	1.35 [0.31 - 5.95]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205704_s_at	117	0.521368	0.0288327	0.34494	-0.858168	0.147583	-0.715305	0.49 [0.19 - 1.29]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205704_s_at	117	0.410256	0.0486188	0.483272	-0.621535	0.875156	0.056906	1.06 [0.52 - 2.15]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205704_s_at	117	0.410256	0.0486188	0.483272	-0.621535	0.875156	0.056906	1.06 [0.52 - 2.15]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205704_s_at	117	0.410256	0.0520427	-	-0.751144	0.198598	-0.651633	0.52 [0.19 - 1.41]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205704_s_at	236	0.228814	0.294572	-	-0.316154	0.615188	-0.16802	0.85 [0.44 - 1.63]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	217603_at	236	0.724576	0.0263427	0.324445	-0.789032	0.598462	-0.134796	0.87 [0.53 - 1.44]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205703_at	236	0.122881	0.156355	-	-0.489446	0.876161	-0.027149	0.97 [0.69 - 1.37]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	235255_at	236	0.279661	0.00397421	0.078914	-0.765915	0.128762	-0.324896	0.72 [0.48 - 1.10]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	217603_at	249	0.554217	0.00435165	0.0848115	-0.630753	0.457268	-0.145621	0.86 [0.59 - 1.27]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205703_at	249	0.128514	0.19023	-	-0.36831	0.544469	-0.0832079	0.92 [0.70 - 1.20]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205704_s_at	249	0.13253	0.205758	-	0.463822	0.532081	0.171471	1.19 [0.69 - 2.03]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	235255_at	249	0.257028	0.0269328	0.32938	-0.492523	0.196507	-0.219571	0.80 [0.58 - 1.12]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205704_s_at	125	0.136	0.185797	-	-0.546662	0.632934	0.182538	1.20 [0.57 - 2.54]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205704_s_at	54	0.166667	0.0176877	0.245535	-1.41597	0.739769	-0.0993404	0.91 [0.50 - 1.63]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217603_at	125	0.296	0.282039	-	0.52952	0.4745	0.245306	1.28 [0.65 - 2.50]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217603_at	125	0.152	0.173543	-	-0.505946	0.953988	-0.0153595	0.98 [0.58 - 1.66]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205703_at	62	0.306452	0.0724979	-	1.2679	0.754471	-0.15107	0.86 [0.33 - 2.22]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205703_at	125	0.608	0.15294	-	-0.590504	0.742195	-0.269725	0.76 [0.15 - 3.81]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217603_at	54	0.111111	0.159349	-	-1.0815	0.797753	-0.0767424	0.93 [0.51 - 1.67]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205704_s_at	62	0.887097	0.13034	-	-1.45069	0.746458	-0.0798254	0.92 [0.57 - 1.50]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205703_at	125	0.808	0.0230056	0.295553	-0.98546	0.284575	-0.691278	0.50 [0.14 - 1.78]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205703_at	54	0.462963	0.193549	-	0.85284	0.71612	-0.21375	0.81 [0.26 - 2.56]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	217603_at	62	0.854839	0.247146	-	-0.859019	0.737548	-0.0826651	0.92 [0.57 - 1.49]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205704_s_at	125	0.136	0.011684	0.181402	-1.06866	0.973886	-0.0165086	0.98 [0.37 - 2.64]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217603_at	198	0.732323	0.0117701	0.182394	-0.880563	0.19627	-0.249981	0.78 [0.53 - 1.14]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217603_at	198	0.70202	0.0227657	0.293407	-0.776016	0.402227	-0.170489	0.84 [0.57 - 1.26]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205703_at	198	0.126263	0.110307	-	0.804494	0.433765	0.07047	1.07 [0.90 - 1.28]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205704_s_at	198	0.454545	0.0076891	0.132232	-0.556595	0.406105	-0.147698	0.86 [0.61 - 1.22]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205703_at	198	0.636364	0.12558	-	0.413421	0.496474	0.064298	1.07 [0.89 - 1.28]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	217603_at	198	0.737374	0.00894892	0.148461	-0.729503	0.467632	-0.119239	0.89 [0.64 - 1.22]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205704_s_at	198	0.454545	0.0317533	0.367942	-0.544365	0.929046	-0.0195362	0.98 [0.64 - 1.51]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205704_s_at	198	0.40404	0.0351672	0.393546	-0.558828	0.899322	-0.0289856	0.97 [0.62 - 1.52]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205703_at	198	0.893939	0.0621743	-	-0.834785	0.977574	-0.00206109	1.00 [0.86 - 1.15]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205704_s_at	62	0.83871	0.109459	-	-15.316	0.912489	-0.0680487	0.93 [0.28 - 3.14]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	217603_at	51	0.843137	0.00432859	0.0844552	2.16053	0.222249	2.35577	10.55 [0.24 - 463.44]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	217603_at	62	0.83871	0.0633513	-	1.08495	0.631666	0.626688	1.87 [0.14 - 24.26]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205703_at	51	0.117647	0.0310139	0.362219	-1.74498	0.105048	-6.24768	0.00 [0.00 - 3.70]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205703_at	62	0.806452	0.427496	-	0.523764	0.982844	-0.0412471	0.96 [0.02 - 41.20]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205704_s_at	51	0.627451	0.0687946	-	-15.8542	0.701926	-0.351306	0.70 [0.12 - 4.25]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	217603_at	177	0.898305	0.0324881	0.373565	-1.19036	0.422483	-0.506582	0.60 [0.17 - 2.08]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	235255_at	145	0.22069	0.00555273	0.102758	-0.92246	0.028604	-1.53871	0.21 [0.05 - 0.85]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205704_s_at	177	0.418079	0.0381511	0.414895	0.511092	0.482013	0.189698	1.21 [0.71 - 2.05]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205703_at	177	0.723164	0.0401574	0.428753	-0.733711	0.382369	-0.793715	0.45 [0.08 - 2.68]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	217603_at	145	0.889655	0.126805	-	-1.06784	0.37494	-0.807689	0.45 [0.07 - 2.66]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205704_s_at	145	0.717241	0.0169056	0.237698	-1.10932	0.238693	-0.42871	0.65 [0.32 - 1.33]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1555114_at	177	0.355932	0.0343312	0.387396	0.55904	0.388991	0.512503	1.67 [0.52 - 5.36]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1555114_at	177	0.423729	0.147152	-	0.408464	0.84996	0.128096	1.14 [0.30 - 4.29]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205703_at	177	0.723164	0.0731523	-	-0.527445	0.378323	-0.693477	0.50 [0.11 - 2.34]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1555114_at	145	0.17931	0.107033	-	0.937625	0.449799	0.614959	1.85 [0.38 - 9.11]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205703_at	145	0.834483	0.118167	-	-0.911538	0.724058	0.385587	1.47 [0.17 - 12.51]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	235255_at	177	0.59887	0.088281	-	-0.494283	0.630602	-0.268901	0.76 [0.26 - 2.29]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	217603_at	177	0.898305	0.05291	-	-1.3018	0.702637	-0.275125	0.76 [0.18 - 3.12]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	235255_at	177	0.237288	0.0588249	-	-0.46842	0.459607	-0.359235	0.70 [0.27 - 1.81]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205704_s_at	177	0.700565	0.130478	-	-0.49049	0.998567	-0.000551491	1.00 [0.55 - 1.82]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	217603_at	226	0.106195	0.00623794	0.112516	-0.978162	0.215873	-0.192984	0.82 [0.61 - 1.12]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205704_s_at	226	0.20354	0.0365179	0.403323	-0.636885	0.26094	-0.303261	0.74 [0.44 - 1.25]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1555114_at	226	0.110619	0.0170245	0.238898	2.04528	0.958651	0.00618983	1.01 [0.80 - 1.27]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205703_at	226	0.738938	0.080005	-	-0.641346	0.584228	-0.0676925	0.93 [0.73 - 1.19]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	235255_at	226	0.327434	0.0665047	-	0.639397	0.403286	0.120642	1.13 [0.85 - 1.50]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	235255_at	55	0.472727	0.257024	-	0.583866	0.836755	-0.189083	0.83 [0.14 - 5.00]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	217603_at	55	0.181818	0.0200894	0.268792	-1.17913	0.165342	-1.51564	0.22 [0.03 - 1.87]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	235255_at	49	0.693878	0.069205	-	-1.69021	0.444424	-0.887549	0.41 [0.04 - 4.00]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	217603_at	49	0.142857	0.0180938	0.249551	-1.38863	0.111201	-2.2662	0.10 [0.01 - 1.69]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1555114_at	55	0.563636	0.0516277	-	0.866921	0.313633	0.917685	2.50 [0.42 - 14.92]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205704_s_at	55	0.818182	0.00374114	0.0752016	1.36974	0.270321	0.777474	2.18 [0.55 - 8.67]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205703_at	55	0.781818	0.216004	-	0.595546	0.931753	0.112417	1.12 [0.09 - 14.66]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205704_s_at	49	0.204082	0.062028	-	-1.10329	0.76496	-0.261351	0.77 [0.14 - 4.27]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205703_at	55	0.236364	0.135504	-	-0.694889	0.807124	-0.344986	0.71 [0.04 - 11.30]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	235255_at	55	0.2	0.208155	-	0.907815	0.948255	0.0534215	1.05 [0.21 - 5.30]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205703_at	49	0.183673	0.186478	-	-0.790423	0.645137	-0.741606	0.48 [0.02 - 11.19]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1555114_at	55	0.381818	0.00521646	0.0978483	1.80331	0.0657796	1.92778	6.87 [0.88 - 53.59]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	217603_at	55	0.145455	0.000295691	0.00902271	-1.64165	0.0273293	-2.54558	0.08 [0.01 - 0.75]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1555114_at	49	0.591837	0.0646029	-	1.04718	0.234308	1.61502	5.03 [0.35 - 71.99]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205704_s_at	55	0.818182	0.126399	-	0.732447	0.519349	0.398042	1.49 [0.44 - 5.00]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	813858	34	0.323529	0.0913386	-	0.910629	0.41915	0.959385	2.61 [0.25 - 26.76]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205704_s_at	63	0.650794	0.000130124	0.0044145	1.24003	0.00166518	0.8901	2.44 [1.40 - 4.24]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1555114_at	63	0.126984	0.00317521	0.0659374	-1.23357	0.341106	-1.70243	0.18 [0.01 - 6.07]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205703_at	63	0.190476	0.000375349	0.0110825	-1.244	0.0342255	-25.5944	0.00 [0.00 - 0.15]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	235255_at	63	0.396825	0.0947576	-	-0.559362	0.816721	0.682093	1.98 [0.01 - 632.99]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	217603_at	63	0.492063	0.336435	-	0.327497	0.629832	0.128037	1.14 [0.68 - 1.91]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.183161.0.A1_3p_at	28	0.678571	0.0728861	-	0.980124	0.575264	0.269202	1.31 [0.51 - 3.36]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.12627.2.S1_3p_at	28	0.107143	0.12219	-	-1.16158	0.454187	-2.24052	0.11 [0.00 - 37.59]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6912717_3p_at	28	0.785714	0.0507993	-	-1.79412	0.19675	-7.28715	0.00 [0.00 - 43.70]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.256986.0.A1_3p_at	28	0.535714	0.147293	-	-0.81081	0.730453	-0.260961	0.77 [0.17 - 3.40]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.12627.0.A1_3p_at	28	0.25	0.248585	-	-0.696066	0.781884	0.294729	1.34 [0.17 - 10.82]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.256986.0.A1_3p_x_at	28	0.75	0.0340761	0.385505	-1.92321	0.171535	-3.64953	0.03 [0.00 - 4.86]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205704_s_at	82	0.52439	0.147166	-	0.489393	0.616816	0.323854	1.38 [0.39 - 4.92]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	217603_at	82	0.439024	0.0164426	0.232993	-0.808994	0.248337	-0.535545	0.59 [0.24 - 1.45]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205703_at	82	0.231707	0.0049609	0.09406	-0.956521	0.668772	-0.134681	0.87 [0.47 - 1.62]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37801_at	84	0.202381	0.386602	-	-0.286478	0.811355	-0.168508	0.84 [0.21 - 3.37]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205704_s_at	79	0.848101	0.000825297	0.0216843	1.08013	0.377308	0.574322	1.78 [0.50 - 6.36]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	217603_at	79	0.898734	0.0931992	-	0.675769	0.741511	0.128109	1.14 [0.53 - 2.43]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205703_at	79	0.113924	0.230024	-	-0.434129	0.916611	0.0467846	1.05 [0.44 - 2.52]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205703_at	104	0.788462	0.0908549	-	0.571562	0.995431	0.00313611	1.00 [0.34 - 2.93]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205704_s_at	104	0.519231	0.290072	-	-0.342743	0.990696	0.00914668	1.01 [0.22 - 4.69]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	217603_at	104	0.798077	0.110641	-	0.576305	0.778807	0.161958	1.18 [0.38 - 3.64]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P87513	117	0.769231	0.000479463	0.0136712	0.998347	0.012985	0.885945	2.43 [1.21 - 4.88]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1555114_at	204	0.666667	0.150001	-	0.524702	0.908555	0.0521146	1.05 [0.43 - 2.56]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1555114_at	204	0.632353	0.110057	-	0.434451	0.371432	0.309983	1.36 [0.69 - 2.69]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	235255_at	204	0.186275	0.0124776	0.19046	-0.914934	0.22231	-0.609296	0.54 [0.20 - 1.45]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	217603_at	204	0.122549	0.0047784	0.0913226	-1.1089	0.0155098	-1.2986	0.27 [0.10 - 0.78]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	235255_at	204	0.102941	0.127639	-	-0.549593	0.616713	-0.206772	0.81 [0.36 - 1.83]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	217603_at	204	0.514706	0.0316368	0.367045	-0.603456	0.0703738	-0.770141	0.46 [0.20 - 1.07]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205704_s_at	204	0.843137	3.73172e-05	0.00146079	1.44393	0.00333412	2.51149	12.32 [2.30 - 65.93]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205704_s_at	204	0.857843	8.10423e-06	0.00036927	1.27495	0.00117831	2.06812	7.91 [2.27 - 27.59]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205703_at	204	0.872549	0.122961	-	-1.44137	0.705276	-0.122179	0.88 [0.47 - 1.67]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205703_at	204	0.186275	0.038004	0.413864	-0.621093	0.207626	-0.301247	0.74 [0.46 - 1.18]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205704_s_at	178	0.134831	0.28577	-	0.33927	0.710447	0.136763	1.15 [0.56 - 2.36]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	217603_at	178	0.5	0.0113138	0.177104	0.498795	0.127944	0.625765	1.87 [0.84 - 4.18]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205703_at	178	0.404494	0.282603	-	0.218184	0.840822	0.0533846	1.05 [0.63 - 1.78]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	217603_at	111	0.684685	0.242039	-	-0.336568	0.718836	-0.0891194	0.91 [0.56 - 1.49]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1555114_at	111	0.576577	0.068746	-	0.473548	0.737088	0.049689	1.05 [0.79 - 1.40]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205704_s_at	111	0.828829	0.165912	-	-0.590191	0.521798	-0.139717	0.87 [0.57 - 1.33]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	235255_at	111	0.162162	0.0327965	0.375907	-0.681786	0.778551	-0.0511004	0.95 [0.67 - 1.36]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205703_at	111	0.414414	0.0761567	-	-0.465052	0.288971	-0.214387	0.81 [0.54 - 1.20]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205704_s_at	90	0.177778	0.00607256	0.110189	2.26558	0.546768	0.281584	1.33 [0.53 - 3.31]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205704_s_at	90	0.177778	0.0204747	0.272416	2.00599	0.63706	0.252506	1.29 [0.45 - 3.67]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	217603_at	90	0.111111	0.0368962	0.406027	1.84478	0.729855	0.235101	1.27 [0.33 - 4.80]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	217603_at	90	0.122222	0.0216335	0.28315	15.275	0.239523	0.894122	2.45 [0.55 - 10.85]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205703_at	90	0.455556	0.322118	-	-0.32094	0.727641	0.327975	1.39 [0.22 - 8.79]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205703_at	90	0.211111	0.251101	-	0.608709	0.524762	0.659293	1.93 [0.25 - 14.75]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3216	50	0.14	0.0620551	-	15.3027	0.692718	0.123898	1.13 [0.61 - 2.09]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	217603_at	138	0.101449	0.00516813	0.0971358	-0.843568	0.975816	0.102009	1.11 [0.00 - 810.38]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1555114_at	138	0.173913	0.014006	0.207363	-0.663783	0.337978	-1.1574	0.31 [0.03 - 3.35]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205704_s_at	138	0.217391	0.141529	-	0.467909	0.588967	0.072232	1.07 [0.83 - 1.40]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	235255_at	138	0.15942	0.012975	0.196038	-0.684307	0.989152	0.0258421	1.03 [0.02 - 42.58]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205703_at	138	0.246377	0.0210497	0.277773	-0.576257	0.115709	-11.0553	0.00 [0.00 - 15.17]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205703_at	129	0.131783	0.107748	-	0.677919	0.700505	0.072505	1.08 [0.74 - 1.56]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205704_s_at	129	0.147287	0.0740892	-	-0.571277	0.363093	-0.304262	0.74 [0.38 - 1.42]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	217603_at	129	0.844961	0.0124829	0.190521	0.742777	0.0550752	0.689669	1.99 [0.99 - 4.03]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39556	56	0.232143	0.0656214	-	0.877995	0.432168	0.310187	1.36 [0.63 - 2.96]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39556	56	0.232143	0.0108687	0.171875	1.43686	0.0718582	0.739279	2.09 [0.94 - 4.68]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205704_s_at	278	0.726619	0.0516578	-	-0.437495	0.912322	0.0171038	1.02 [0.75 - 1.38]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205703_at	278	0.323741	0.091654	-	-0.3342	0.80785	-0.169846	0.84 [0.21 - 3.32]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1555114_at	278	0.244604	0.0213903	0.280917	0.559829	0.325689	0.516426	1.68 [0.60 - 4.69]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	235255_at	278	0.701439	0.0387771	0.41926	-0.455462	0.298608	-0.284316	0.75 [0.44 - 1.29]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	217603_at	278	0.532374	0.0239573	0.30397	-0.442272	0.333145	-0.277038	0.76 [0.43 - 1.33]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	217603_at	133	0.766917	0.000472358	0.0134978	0.923932	0.323586	0.958352	2.61 [0.39 - 17.48]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205703_at	133	0.857143	0.00260889	0.0562597	0.858591	0.01274	3.24799	25.74 [2.00 - 331.51]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205704_s_at	133	0.81203	0.0720638	-	-0.627508	0.35357	-0.218554	0.80 [0.51 - 1.28]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15874	81	0.160494	0.278536	-	1.07035	0.639144	0.300687	1.35 [0.38 - 4.75]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217603_at	185	0.405405	0.0225383	0.291365	-0.404645	0.958154	0.0106821	1.01 [0.68 - 1.51]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205703_at	185	0.708108	0.0796755	-	0.311408	0.469714	0.2074	1.23 [0.70 - 2.16]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205704_s_at	185	0.52973	0.0395254	0.424428	0.361571	0.123804	0.28866	1.33 [0.92 - 1.93]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205703_at	185	0.686486	0.0487858	0.484289	0.367186	0.369718	0.281304	1.32 [0.72 - 2.45]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	217603_at	185	0.410811	0.010124	0.162965	-0.421358	0.479666	-0.133086	0.88 [0.61 - 1.27]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205704_s_at	185	0.513514	0.0842482	-	0.28024	0.218098	0.217997	1.24 [0.88 - 1.76]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P87513	110	0.236364	0.0270786	0.330592	0.652395	0.0594094	0.406351	1.50 [0.98 - 2.29]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P87513	110	0.563636	0.0190032	0.258419	0.706092	0.0142206	0.647604	1.91 [1.14 - 3.21]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205703_at	80	0.65	0.096955	-	0.715025	0.264065	0.186813	1.21 [0.87 - 1.67]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205704_s_at	80	0.225	0.0341683	0.386189	-0.935563	0.314058	-0.247283	0.78 [0.48 - 1.26]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	217603_at	80	0.5375	0.00165231	0.0387093	1.59247	0.0567475	0.652795	1.92 [0.98 - 3.76]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	217603_at	38	0.5	0.0504524	-	-0.92369	0.654494	-0.349258	0.71 [0.15 - 3.26]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1555114_at	38	0.131579	0.0785475	-	-0.996427	0.745134	0.122477	1.13 [0.54 - 2.37]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205704_s_at	38	0.421053	0.00455222	0.0878916	1.56729	0.0116683	1.32401	3.76 [1.34 - 10.52]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	235255_at	38	0.894737	0.000284631	0.00873022	2.01467	0.0322035	1.12034	3.07 [1.10 - 8.55]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205703_at	38	0.710526	0.0933525	-	-0.931341	0.538848	0.199829	1.22 [0.65 - 2.31]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205704_s_at	140	0.228571	0.0337393	0.382996	0.899476	0.0113163	1.05633	2.88 [1.27 - 6.51]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	217603_at	140	0.164286	0.141415	-	-0.486454	0.394165	-0.632403	0.53 [0.12 - 2.28]
GENE	ATP6V0A2	ATPase, H+ transporting, lysosomal V0 subunit a2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205703_at	140	0.128571	0.0150353	0.218376	-0.846268	0.0156249	-2.82092	0.06 [0.01 - 0.59]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	220197_at	30	0.433333	0.0341327	0.385925	0.917975	0.4671	0.483217	1.62 [0.44 - 5.96]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1735801	165	0.509091	0.135862	-	0.360374	0.799003	-0.0918143	0.91 [0.45 - 1.85]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1735801	165	0.515152	0.0526204	-	0.696509	0.539506	-0.354632	0.70 [0.23 - 2.18]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	220197_at	163	0.895706	0.104419	-	-0.626518	0.989589	0.007515	1.01 [0.33 - 3.12]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	220197_at	79	0.810127	0.176148	-	-0.549749	0.392955	-0.743528	0.48 [0.09 - 2.62]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	220197_at	58	0.362069	0.0336389	0.382246	0.606759	0.109171	0.243121	1.28 [0.95 - 1.72]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	220197_at	34	0.441176	0.000716888	0.0192515	1.37112	0.0204692	0.610102	1.84 [1.10 - 3.08]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	220197_at	158	0.234177	0.00799722	0.136272	0.845749	0.0421426	1.67912	5.36 [1.06 - 27.08]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	220197_at	53	0.716981	0.0343621	0.387625	0.773341	0.670677	0.0852371	1.09 [0.74 - 1.61]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	220197_at	53	0.716981	0.150336	-	0.512316	0.755767	0.0570823	1.06 [0.74 - 1.52]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	220197_at	180	0.261111	0.0291071	0.347147	-0.494006	0.615026	-0.0505385	0.95 [0.78 - 1.16]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	220197_at	559	0.776386	0.10477	-	-0.439388	0.24434	-0.149875	0.86 [0.67 - 1.11]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	220197_at	77	0.480519	0.173499	-	-0.348636	0.733082	0.0515282	1.05 [0.78 - 1.42]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	220197_at	70	0.285714	0.00403104	0.0798109	-0.804427	0.188723	-0.746081	0.47 [0.16 - 1.44]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	220197_at	74	0.108108	0.225672	-	0.624305	0.774465	0.0589646	1.06 [0.71 - 1.59]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	220197_at	67	0.895522	0.163159	-	1.0693	0.598577	0.53123	1.70 [0.24 - 12.29]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	220197_at	115	0.426087	0.101365	-	1.02377	0.955891	-0.0211391	0.98 [0.46 - 2.07]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	220197_at	204	0.563725	0.00309887	0.0646583	0.420085	0.224789	0.0624938	1.06 [0.96 - 1.18]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	220197_at	87	0.896552	0.143016	-	0.776129	0.356315	0.180498	1.20 [0.82 - 1.76]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	220197_at	87	0.896552	0.143016	-	0.776129	0.356315	0.180498	1.20 [0.82 - 1.76]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	220197_at	77	0.441558	0.101894	-	1.03173	0.473166	0.178339	1.20 [0.73 - 1.95]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	220197_at	77	0.337662	0.100982	-	1.56498	0.40226	0.228225	1.26 [0.74 - 2.14]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	220197_at	136	0.654412	0.237887	-	0.527241	0.971393	0.00729236	1.01 [0.68 - 1.50]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	220197_at	200	0.895	0.0011308	0.0282481	1.0769	0.969914	0.00595739	1.01 [0.74 - 1.37]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5759	60	0.783333	0.00513791	0.0966894	1.07564	0.863634	0.015099	1.02 [0.85 - 1.21]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5759	60	0.85	0.000153506	0.0051021	1.51966	0.273877	0.111297	1.12 [0.92 - 1.36]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	220197_at	286	0.853147	0.0229461	0.295022	-0.772331	0.108818	-0.188625	0.83 [0.66 - 1.04]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220197_at	159	0.144654	0.241149	-	-0.459329	0.848518	-0.0555683	0.95 [0.53 - 1.67]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220197_at	159	0.811321	0.235359	-	-0.560222	0.981924	-0.00635622	0.99 [0.57 - 1.72]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220197_at	159	0.72956	0.371634	-	0.347374	0.812818	0.079647	1.08 [0.56 - 2.09]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	220197_at	54	0.425926	0.0322918	0.372069	-1.56418	0.582976	-0.37462	0.69 [0.18 - 2.62]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220197_at	117	0.358974	0.156037	-	-0.44839	0.643239	-0.0987256	0.91 [0.60 - 1.38]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220197_at	117	0.863248	0.115647	-	-1.46738	0.323168	-0.299523	0.74 [0.41 - 1.34]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220197_at	117	0.358974	0.156037	-	-0.44839	0.643239	-0.0987256	0.91 [0.60 - 1.38]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220197_at	117	0.230769	0.0232575	0.297795	-0.852924	0.209451	-0.395586	0.67 [0.36 - 1.25]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	220197_at	236	0.779661	0.164087	-	0.419094	0.866948	0.0343461	1.03 [0.69 - 1.55]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	220197_at	249	0.542169	0.0444995	0.457482	-0.440366	0.798612	0.040966	1.04 [0.76 - 1.43]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220197_at	125	0.616	0.0632268	-	-0.792054	0.300019	-0.640697	0.53 [0.16 - 1.77]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220197_at	125	0.504	0.0211145	0.278373	-0.670762	0.224525	-0.536768	0.58 [0.25 - 1.39]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220197_at	54	0.518519	0.268388	-	-0.67533	0.537925	-0.244913	0.78 [0.36 - 1.71]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220197_at	62	0.564516	0.211	-	-0.624186	0.636691	-0.151191	0.86 [0.46 - 1.61]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220197_at	198	0.328283	0.0956749	-	0.385054	0.298854	0.0755301	1.08 [0.94 - 1.24]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220197_at	198	0.338384	0.0149314	0.217277	0.72733	0.159369	0.128915	1.14 [0.95 - 1.36]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220197_at	198	0.338384	0.0266275	0.326834	0.689049	0.211827	0.119584	1.13 [0.93 - 1.36]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	220197_at	51	0.54902	0.0931515	-	1.6768	0.326136	1.8895	6.62 [0.15 - 287.46]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	220197_at	62	0.370968	0.0264282	0.325164	1.97961	0.395146	1.08709	2.97 [0.24 - 36.34]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	220197_at	177	0.666667	0.0389278	0.420305	-0.591446	0.140267	-0.856716	0.42 [0.14 - 1.33]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	220197_at	145	0.862069	0.116253	-	-1.08892	0.148358	-1.24033	0.29 [0.05 - 1.56]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	220197_at	177	0.124294	0.125221	-	-0.517337	0.189673	-0.8883	0.41 [0.11 - 1.55]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	220197_at	226	0.39823	0.0494059	0.488048	0.599683	0.568566	-0.0665157	0.94 [0.74 - 1.18]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	220197_at	55	0.363636	0.164338	-	0.797992	0.831385	0.336607	1.40 [0.06 - 31.03]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	220197_at	49	0.122449	0.0483196	0.481443	-1.14645	0.344171	-1.78958	0.17 [0.00 - 6.81]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	220197_at	55	0.109091	0.165846	-	-0.756846	0.847616	-0.289396	0.75 [0.04 - 14.33]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	774064	34	0.764706	0.0723672	-	0.85599	0.62903	0.267068	1.31 [0.44 - 3.86]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	220197_at	63	0.857143	0.0227965	0.293683	0.952219	0.0860384	0.177217	1.19 [0.98 - 1.46]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g10190665_3p_at	28	0.607143	0.03983	0.426517	-1.32371	0.229856	-3.62305	0.03 [0.00 - 9.88]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	220197_at	82	0.390244	0.0865076	-	0.631944	0.390482	0.287139	1.33 [0.69 - 2.57]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	220197_at	79	0.493671	0.0307362	0.360053	0.563317	0.269282	0.308349	1.36 [0.79 - 2.35]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	220197_at	104	0.153846	0.031564	0.366483	-0.856099	0.99477	0.00359318	1.00 [0.34 - 2.94]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P215111	117	0.683761	0.00175068	0.0406001	0.875353	0.0797006	0.100547	1.11 [0.99 - 1.24]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	220197_at	204	0.166667	0.0774858	-	-0.714652	0.494269	-0.09486	0.91 [0.69 - 1.19]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	220197_at	204	0.240196	0.011438	0.178552	-0.706376	0.0678782	-0.185378	0.83 [0.68 - 1.01]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	220197_at	178	0.342697	0.0231184	0.296558	-0.45434	0.671645	0.087321	1.09 [0.73 - 1.63]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	220197_at	111	0.324324	0.14496	-	0.445163	0.402889	0.111224	1.12 [0.86 - 1.45]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	220197_at	90	0.844444	0.0514391	-	0.825105	0.405877	0.332575	1.39 [0.64 - 3.06]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	220197_at	90	0.155556	0.0108356	0.171484	-0.911987	0.203369	0.428127	1.53 [0.79 - 2.97]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	220197_at	138	0.826087	0.0716164	-	0.501502	0.558968	0.0655969	1.07 [0.86 - 1.33]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	220197_at	129	0.713178	0.0318299	0.368531	0.552476	0.458889	0.162461	1.18 [0.77 - 1.81]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17333	56	0.125	0.0933677	-	-0.816229	0.95454	-0.00609264	0.99 [0.81 - 1.23]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32726	56	0.857143	0.105689	-	-0.957435	0.757705	-0.0338898	0.97 [0.78 - 1.20]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17333	56	0.107143	0.105047	-	-0.866899	0.750763	-0.0360448	0.96 [0.77 - 1.20]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43737	56	0.25	0.0583345	-	0.890054	0.869941	-0.0211342	0.98 [0.76 - 1.26]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32726	56	0.857143	0.108154	-	-0.938471	0.804402	-0.0259466	0.97 [0.79 - 1.20]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43737	56	0.25	0.0318245	0.36849	1.22578	0.7708	-0.0400226	0.96 [0.73 - 1.26]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	220197_at	278	0.521583	0.000799905	0.02112	0.65241	0.113469	0.256147	1.29 [0.94 - 1.77]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	220197_at	133	0.857143	0.00294078	0.0619851	0.883435	0.0352624	3.50031	33.13 [1.27 - 861.77]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3845	81	0.111111	0.175261	-	-0.85923	0.291193	-0.230942	0.79 [0.52 - 1.22]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16059	81	0.111111	0.111081	-	15.2568	0.39502	0.272547	1.31 [0.70 - 2.46]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	220197_at	185	0.291892	0.145957	-	0.28321	0.296023	0.289584	1.34 [0.78 - 2.30]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	220197_at	185	0.264865	0.0980742	-	0.303115	0.326156	0.253874	1.29 [0.78 - 2.14]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P215111	110	0.781818	0.0706206	-	-0.54281	0.6518	-0.0399121	0.96 [0.81 - 1.14]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P215111	110	0.781818	0.0758548	-	-0.818909	0.613115	-0.0577128	0.94 [0.75 - 1.18]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	220197_at	80	0.825	0.186857	-	-0.815078	0.53696	-0.111488	0.89 [0.63 - 1.27]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:774064	59	0.20339	0.0663935	-	1.68191	0.720431	-0.149037	0.86 [0.38 - 1.95]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	220197_at	38	0.736842	0.12756	-	0.803883	0.248606	0.243801	1.28 [0.84 - 1.93]
GENE	ATP6V0A4	ATPase, H+ transporting, lysosomal V0 subunit a4	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	220197_at	140	0.892857	0.114771	-	-1.08615	0.581108	-0.559509	0.57 [0.08 - 4.17]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	200078_s_at	30	0.7	0.0429415	0.447364	0.835879	0.704958	0.154667	1.17 [0.52 - 2.60]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1721391	165	0.775758	0.0110993	0.174593	0.656006	0.0779321	0.434024	1.54 [0.95 - 2.50]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1721391	165	0.775758	0.000541536	0.0151689	1.16924	0.00749626	1.0497	2.86 [1.32 - 6.17]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	200078_s_at	163	0.644172	0.237718	-	-0.249504	0.811628	-0.0403563	0.96 [0.69 - 1.34]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	200078_s_at	79	0.151899	0.16952	-	0.641309	0.600627	0.129191	1.14 [0.70 - 1.85]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200078_s_at	58	0.724138	0.0123347	0.188844	0.747753	0.0825623	0.572798	1.77 [0.93 - 3.39]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200078_s_at	34	0.558824	0.243984	-	-0.455709	0.908481	-0.0366975	0.96 [0.52 - 1.80]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	200078_s_at	158	0.689873	0.00695859	0.122457	-0.763571	0.204463	-0.345805	0.71 [0.41 - 1.21]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	200078_s_at	53	0.264151	0.0209892	0.277212	-0.822257	0.0610481	-1.76703	0.17 [0.03 - 1.09]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	200078_s_at	53	0.169811	0.00296959	0.0624746	-1.20585	0.0243879	-2.35794	0.09 [0.01 - 0.74]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	200078_s_at	180	0.133333	0.0746647	-	0.651516	0.597858	0.20793	1.23 [0.57 - 2.67]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	200078_s_at	180	0.111111	0.375654	-	-0.297367	0.794403	0.0925138	1.10 [0.55 - 2.20]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	200078_s_at	559	0.497317	0.111968	-	0.319737	0.764784	0.0845295	1.09 [0.63 - 1.89]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	200078_s_at	77	0.103896	0.0150657	0.218696	-0.924738	0.449585	-0.187255	0.83 [0.51 - 1.35]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	200078_s_at	77	0.779221	0.0015486	0.0366902	0.915987	0.655766	0.121391	1.13 [0.66 - 1.93]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	200078_s_at	70	0.7	0.0899675	-	-0.50884	0.264341	-0.307175	0.74 [0.43 - 1.26]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36167_at	50	0.4	0.0193421	0.26168	0.85739	0.0509789	0.323663	1.38 [1.00 - 1.91]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	200078_s_at	74	0.567568	0.000180727	0.00588413	1.06749	0.00254959	1.60897	5.00 [1.76 - 14.21]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	200078_s_at	74	0.432432	2.37208e-05	0.000973645	1.31408	0.00237744	1.44278	4.23 [1.67 - 10.73]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	200078_s_at	67	0.701493	0.332451	-	0.643237	0.923003	-0.092108	0.91 [0.14 - 5.90]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	200078_s_at	115	0.469565	0.162014	-	-0.759064	0.380597	-0.713466	0.49 [0.10 - 2.41]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36167_at	158	0.487342	0.210425	-	-0.354765	0.568104	-0.251234	0.78 [0.33 - 1.84]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36167_at	76	0.671053	0.0201794	0.269641	-2.03638	0.425481	-0.700607	0.50 [0.09 - 2.78]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	200078_s_at	204	0.897059	0.0328105	0.376013	-0.487986	0.628736	-0.0868202	0.92 [0.64 - 1.30]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	200078_s_at	87	0.873563	0.0131363	0.19783	1.0963	0.167404	0.622437	1.86 [0.77 - 4.51]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	200078_s_at	87	0.873563	0.0131363	0.19783	1.0963	0.167404	0.622437	1.86 [0.77 - 4.51]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	200078_s_at	77	0.688312	0.0435089	0.451073	-1.83434	0.159378	-0.808794	0.45 [0.14 - 1.37]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	200078_s_at	77	0.688312	0.0237928	0.302526	-15.6839	0.0895471	-1.11459	0.33 [0.09 - 1.19]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	200078_s_at	136	0.897059	0.101945	-	0.893731	0.971688	-0.0193441	0.98 [0.34 - 2.85]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	200078_s_at	200	0.365	0.0497826	0.490318	0.647736	0.257122	0.503318	1.65 [0.69 - 3.95]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4825	60	0.133333	0.21922	-	0.873272	0.753719	0.0971007	1.10 [0.60 - 2.02]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4825	60	0.166667	0.071037	-	-0.742313	0.546957	-0.188556	0.83 [0.45 - 1.53]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	200078_s_at	286	0.398601	0.0177022	0.245679	0.488634	0.200009	0.354293	1.43 [0.83 - 2.45]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200078_s_at	159	0.805031	0.000150663	0.00501933	1.17439	0.000588713	1.35558	3.88 [1.79 - 8.40]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200078_s_at	159	0.805031	0.000476297	0.013594	1.23835	0.00355842	1.28685	3.62 [1.52 - 8.60]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200078_s_at	159	0.421384	0.000307621	0.00933631	1.39103	0.0140081	0.951714	2.59 [1.21 - 5.53]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	200078_s_at	159	0.628931	0.0018032	0.0416003	0.962387	0.0302025	0.742445	2.10 [1.07 - 4.11]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	200078_s_at	159	0.754717	6.4552e-06	0.000300325	1.33549	0.00197797	1.0962	2.99 [1.49 - 5.99]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	200078_s_at	159	0.754717	1.02365e-05	0.000456351	1.50552	0.00742563	1.0515	2.86 [1.33 - 6.18]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	200078_s_at	54	0.888889	0.0156037	0.224339	1.75356	0.216361	0.813421	2.26 [0.62 - 8.19]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200078_s_at	117	0.837607	0.0634787	-	0.696332	0.512552	0.19849	1.22 [0.67 - 2.21]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200078_s_at	117	0.128205	0.114738	-	-0.713009	0.977674	-0.00995364	0.99 [0.49 - 1.99]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200078_s_at	117	0.837607	0.0634787	-	0.696332	0.512552	0.19849	1.22 [0.67 - 2.21]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200078_s_at	117	0.128205	0.078404	-	-0.804436	0.388139	-0.326352	0.72 [0.34 - 1.51]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	200078_s_at	236	0.224576	0.0475713	0.476841	0.781966	0.0464618	0.710565	2.04 [1.01 - 4.10]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	200078_s_at	236	0.45339	0.0149534	0.21751	0.696547	0.0437621	0.650853	1.92 [1.02 - 3.61]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	200078_s_at	249	0.413655	0.00497361	0.0942496	0.644666	0.0155837	0.691207	2.00 [1.14 - 3.50]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	200078_s_at	249	0.236948	0.0127954	0.194033	0.731475	0.0265962	0.587383	1.80 [1.07 - 3.02]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200078_s_at	62	0.887097	0.0109483	0.172816	1.38394	0.118162	0.537126	1.71 [0.87 - 3.36]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200078_s_at	125	0.16	0.0978896	-	1.53291	0.731268	0.132026	1.14 [0.54 - 2.42]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200078_s_at	125	0.264	0.10442	-	0.656897	0.898209	0.0381006	1.04 [0.58 - 1.86]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200078_s_at	54	0.888889	0.0163613	0.232162	1.51678	0.131969	0.668994	1.95 [0.82 - 4.66]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200078_s_at	198	0.484848	0.137946	-	0.380469	0.568737	0.11233	1.12 [0.76 - 1.65]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200078_s_at	198	0.484848	0.0989963	-	0.448039	0.544234	0.123263	1.13 [0.76 - 1.68]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200078_s_at	198	0.484848	0.0689282	-	0.385065	0.280555	0.173028	1.19 [0.87 - 1.63]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	200078_s_at	51	0.117647	0.0440145	0.454354	-1.64706	0.442088	-0.598145	0.55 [0.12 - 2.53]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	200078_s_at	62	0.548387	0.186216	-	0.757302	0.821199	0.121488	1.13 [0.39 - 3.24]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	200078_s_at	177	0.847458	0.0269927	0.329879	0.651251	0.363454	0.293265	1.34 [0.71 - 2.52]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	200078_s_at	145	0.282759	0.0480625	0.479867	-0.652357	0.549462	-0.286773	0.75 [0.29 - 1.92]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	200078_s_at	177	0.847458	0.0140754	0.208115	0.788625	0.289937	0.391679	1.48 [0.72 - 3.06]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	200078_s_at	226	0.230089	0.0253802	0.316287	-0.648757	0.29788	-0.423527	0.65 [0.29 - 1.45]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	200078_s_at	55	0.109091	0.0212901	0.279994	-1.39889	0.290103	-0.489376	0.61 [0.25 - 1.52]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	200078_s_at	49	0.122449	2.42258e-05	0.000992232	-2.29105	0.172323	-0.57344	0.56 [0.25 - 1.28]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	200078_s_at	55	0.127273	0.0421852	0.442377	-1.00933	0.529193	-0.255211	0.77 [0.35 - 1.72]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	200078_s_at	63	0.698413	0.0182612	0.251197	0.803517	0.0961817	0.317346	1.37 [0.95 - 2.00]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	200078_s_at	28	0.678571	0.351221	-	0.503892	0.971432	-0.027214	0.97 [0.22 - 4.32]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13543437_3p_s_at	28	0.321429	0.135669	-	0.963211	0.35663	0.148796	1.16 [0.85 - 1.59]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	200078_s_at	82	0.390244	0.0248391	0.31164	-0.745228	0.301897	-0.708377	0.49 [0.13 - 1.89]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36167_at	84	0.440476	0.077836	-	0.532313	0.212476	0.542707	1.72 [0.73 - 4.04]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	200078_s_at	79	0.810127	0.0832667	-	-0.621032	0.55482	-0.264464	0.77 [0.32 - 1.85]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D89052_at	86	0.848837	0.22047	-	0.667617	0.630125	0.267989	1.31 [0.44 - 3.89]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	200078_s_at	104	0.105769	0.108815	-	1.48218	0.869991	-0.106441	0.90 [0.25 - 3.22]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P137814	117	0.786325	0.00211726	0.0474585	0.895436	0.0562272	0.739896	2.10 [0.98 - 4.48]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	200078_s_at	204	0.887255	5.17142e-05	0.00195369	1.44274	0.00136711	1.69906	5.47 [1.93 - 15.48]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	200078_s_at	204	0.647059	5.53989e-05	0.00207693	1.06047	0.00015187	1.50187	4.49 [2.06 - 9.77]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	200078_s_at	178	0.651685	0.10744	-	-0.348021	0.948716	-0.026559	0.97 [0.43 - 2.19]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200001442	41	0.731707	0.245787	-	-0.629755	0.815712	-0.09423	0.91 [0.41 - 2.01]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	200078_s_at	111	0.279279	0.0141944	0.209401	0.806613	0.108359	0.473331	1.61 [0.90 - 2.86]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	200078_s_at	90	0.311111	0.124203	-	0.602939	0.953576	0.0183362	1.02 [0.55 - 1.89]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	200078_s_at	90	0.322222	0.0579714	-	0.901773	0.938257	0.0279081	1.03 [0.51 - 2.08]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1829	50	0.66	0.386236	-	0.423435	0.639382	0.442609	1.56 [0.24 - 9.91]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	200078_s_at	138	0.869565	0.000348569	0.0103986	1.03597	0.0107288	0.62094	1.86 [1.15 - 3.00]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	200078_s_at	129	0.837209	0.204876	-	0.391312	0.623226	-0.227673	0.80 [0.32 - 1.98]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9875	56	0.714286	0.113095	-	0.586231	0.693221	0.114715	1.12 [0.63 - 1.98]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26935	56	0.642857	0.00786235	0.13451	0.980703	0.56783	0.188831	1.21 [0.63 - 2.31]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9875	56	0.714286	0.0691641	-	0.707252	0.628562	0.156267	1.17 [0.62 - 2.20]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32237	56	0.714286	0.164124	-	0.529083	0.893055	0.0513144	1.05 [0.50 - 2.22]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26935	56	0.642857	0.0283696	0.341193	0.764751	0.586341	0.163641	1.18 [0.65 - 2.12]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32237	56	0.714286	0.138974	-	0.59524	0.608527	0.204743	1.23 [0.56 - 2.69]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	200078_s_at	278	0.776978	0.0189274	0.257686	-0.582152	0.152981	-0.227542	0.80 [0.58 - 1.09]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	200078_s_at	133	0.684211	0.265935	-	-0.285696	0.90111	0.0177066	1.02 [0.77 - 1.35]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6470	81	0.271605	0.152428	-	1.0402	0.831213	0.111618	1.12 [0.40 - 3.12]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2925	81	0.271605	0.024201	0.306102	2.03166	0.717368	0.217802	1.24 [0.38 - 4.04]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4219	81	0.62963	0.243904	-	-0.735937	0.9979	0.00141171	1.00 [0.35 - 2.87]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200078_s_at	185	0.47027	0.0277867	0.336435	-0.393374	0.309835	-0.0988088	0.91 [0.75 - 1.10]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200078_s_at	185	0.47027	0.0512001	-	-0.321762	0.181272	-0.118173	0.89 [0.75 - 1.06]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P137814	110	0.163636	0.113921	-	0.554624	0.441367	0.136859	1.15 [0.81 - 1.62]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P137814	110	0.336364	0.309472	-	-0.314692	0.996582	-0.00101008	1.00 [0.63 - 1.59]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	200078_s_at	80	0.7625	0.068363	-	-1.27127	0.784208	-0.140136	0.87 [0.32 - 2.37]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_2960	281	0.857651	0.0920245	-	-0.353718	0.518952	-0.105289	0.90 [0.65 - 1.24]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	200078_s_at	38	0.815789	0.000139263	0.00468516	1.77444	0.00120213	2.52216	12.46 [2.71 - 57.32]
GENE	ATP6V0B	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	200078_s_at	140	0.628571	6.12098e-05	0.00226925	1.12234	0.00244048	0.898953	2.46 [1.37 - 4.39]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	200954_at	30	0.866667	0.189288	-	0.754529	0.424942	0.468883	1.60 [0.51 - 5.06]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	36994_at	30	0.3	0.237489	-	0.555733	0.431079	0.493519	1.64 [0.48 - 5.60]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1789005	165	0.733333	0.0278278	0.336772	-0.685991	0.536707	0.12153	1.13 [0.77 - 1.66]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1789005	165	0.733333	0.235347	-	-0.531283	0.949108	-0.0183722	0.98 [0.56 - 1.73]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	36994_at	163	0.687117	0.0593369	-	-0.425384	0.566422	-0.112639	0.89 [0.61 - 1.31]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	200954_at	163	0.613497	0.0170597	0.239253	-0.5	0.229544	-0.208613	0.81 [0.58 - 1.14]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	200954_at	79	0.898734	0.0415871	0.438397	-1.36715	0.191444	-0.302992	0.74 [0.47 - 1.16]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	36994_at	79	0.860759	0.0270242	0.330141	-1.24322	0.310066	-0.312261	0.73 [0.40 - 1.34]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200954_at	58	0.87931	0.16134	-	0.608354	0.716369	0.0673192	1.07 [0.74 - 1.54]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	36994_at	58	0.758621	0.0307552	0.360201	0.681339	0.193962	0.412446	1.51 [0.81 - 2.81]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200954_at	34	0.676471	0.000324071	0.00976562	1.43554	0.144862	0.500425	1.65 [0.84 - 3.23]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	36994_at	34	0.617647	0.0254967	0.317282	-0.952103	0.128059	-0.660914	0.52 [0.22 - 1.21]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	200954_at	158	0.898734	0.0800246	-	0.566681	0.402892	0.263013	1.30 [0.70 - 2.41]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	36994_at	158	0.139241	0.191167	-	0.510566	0.735376	0.0957409	1.10 [0.63 - 1.92]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	36994_at	53	0.320755	0.0414145	0.437242	0.902338	0.581217	0.292768	1.34 [0.47 - 3.79]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	200954_at	53	0.113208	0.155963	-	0.99338	0.7144	0.148062	1.16 [0.52 - 2.56]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	36994_at	53	0.415094	0.145336	-	0.518649	0.839192	0.104275	1.11 [0.41 - 3.04]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	200954_at	53	0.264151	0.101209	-	0.78392	0.734918	0.143183	1.15 [0.50 - 2.64]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	200954_at	180	0.777778	0.111846	-	0.389328	0.817875	0.0702151	1.07 [0.59 - 1.95]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	36994_at	180	0.494444	0.149805	-	0.301861	0.761187	0.125439	1.13 [0.50 - 2.55]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	200954_at	559	0.318426	0.0457839	0.465669	0.443288	0.363475	0.243997	1.28 [0.75 - 2.16]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	36994_at	559	0.47585	0.18131	-	-0.275531	0.466444	-0.246419	0.78 [0.40 - 1.52]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	200954_at	77	0.428571	0.135271	-	0.385858	0.56271	-0.094943	0.91 [0.66 - 1.25]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	36994_at	77	0.480519	0.00388171	0.0774474	-0.753866	0.116862	-0.328518	0.72 [0.48 - 1.09]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	200954_at	70	0.871429	0.026277	0.323893	-1.01228	0.13081	-0.911185	0.40 [0.12 - 1.31]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	36994_at	70	0.857143	0.0438032	0.452985	-0.857682	0.186103	-0.697899	0.50 [0.18 - 1.40]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36994_at	50	0.54	0.0552824	-	-0.714808	0.533447	-0.168522	0.84 [0.50 - 1.44]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	200954_at	74	0.743243	0.0611216	-	0.567375	0.371569	0.411927	1.51 [0.61 - 3.73]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	36994_at	74	0.567568	0.00631916	0.113652	0.774748	0.124991	0.943662	2.57 [0.77 - 8.58]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	200954_at	67	0.567164	0.00401393	0.0795412	2.42254	0.0203188	4.36734	78.83 [1.97 - 3153.71]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	36994_at	67	0.656716	0.0187014	0.255496	1.51796	0.0316274	4.47689	87.96 [1.48 - 5218.07]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	200954_at	115	0.826087	0.279876	-	-1.07023	0.915171	0.0779003	1.08 [0.26 - 4.53]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	36994_at	115	0.191304	0.0587113	-	15.367	0.458455	0.600904	1.82 [0.37 - 8.93]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36994_at	158	0.651899	0.235935	-	-0.366254	0.836651	-0.0964633	0.91 [0.36 - 2.27]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36994_at	76	0.684211	0.0254523	0.316904	-1.9784	0.195526	-0.809663	0.45 [0.13 - 1.52]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	36994_at	204	0.485294	0.0175897	0.244561	-0.335836	0.302301	-0.209621	0.81 [0.54 - 1.21]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	200954_at	204	0.563725	0.0493639	0.487794	-0.281957	0.367263	-0.186659	0.83 [0.55 - 1.24]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	36994_at	87	0.344828	0.0406036	0.431782	0.972278	0.497423	0.268563	1.31 [0.60 - 2.84]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	200954_at	87	0.896552	0.0490955	0.48617	0.878963	0.336178	0.347729	1.42 [0.70 - 2.88]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	200954_at	87	0.896552	0.0490955	0.48617	0.878963	0.336178	0.347729	1.42 [0.70 - 2.88]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	36994_at	87	0.344828	0.0406036	0.431782	0.972278	0.497423	0.268563	1.31 [0.60 - 2.84]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	200954_at	77	0.155844	0.100262	-	15.3048	0.252088	0.809784	2.25 [0.56 - 8.99]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	36994_at	77	0.623377	0.152097	-	0.894659	0.480922	0.596526	1.82 [0.35 - 9.54]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	200954_at	77	0.311688	0.13018	-	1.46236	0.434332	0.605861	1.83 [0.40 - 8.37]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	36994_at	77	0.623377	0.0641316	-	1.01252	0.250173	0.90194	2.46 [0.53 - 11.46]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	36994_at	136	0.514706	0.306226	-	0.462546	0.662975	-0.244888	0.78 [0.26 - 2.35]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	200954_at	136	0.779412	0.122261	-	0.713246	0.642946	-0.163762	0.85 [0.42 - 1.70]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	200954_at	200	0.12	0.20918	-	-0.487654	0.861368	-0.0837013	0.92 [0.36 - 2.35]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	36994_at	200	0.275	0.016857	0.237207	-0.70381	0.241129	-0.759418	0.47 [0.13 - 1.67]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	200954_at	286	0.685315	0.0824099	-	0.344482	0.284916	0.275427	1.32 [0.80 - 2.18]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	36994_at	286	0.195804	0.111712	-	-0.355871	0.710718	0.103746	1.11 [0.64 - 1.92]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200954_at	159	0.666667	0.00709742	0.124337	0.828414	0.320346	0.375855	1.46 [0.69 - 3.06]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	36994_at	159	0.220126	0.0446249	0.458287	1.01466	0.520176	0.281469	1.33 [0.56 - 3.12]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200954_at	159	0.515723	0.0499181	0.491132	0.748635	0.619896	0.223769	1.25 [0.52 - 3.03]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	36994_at	159	0.679245	0.00334505	0.0687571	0.898213	0.0702026	0.773919	2.17 [0.94 - 5.01]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	36994_at	159	0.679245	0.0144806	0.212477	0.88035	0.135533	0.75146	2.12 [0.79 - 5.69]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200954_at	159	0.515723	0.101268	-	0.5232	0.997475	0.00124226	1.00 [0.46 - 2.16]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	36994_at	54	0.62963	0.0730347	-	1.23041	0.183212	1.25495	3.51 [0.55 - 22.27]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	200954_at	54	0.314815	0.0710243	-	1.73936	0.087147	1.61873	5.05 [0.79 - 32.25]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200954_at	117	0.888889	0.00717201	0.125343	1.08148	0.136632	0.576651	1.78 [0.83 - 3.80]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200954_at	117	0.25641	0.0180614	0.249232	1.34296	0.0881219	0.785338	2.19 [0.89 - 5.41]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200954_at	117	0.888889	0.00717201	0.125343	1.08148	0.136632	0.576651	1.78 [0.83 - 3.80]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200954_at	117	0.247863	0.10995	-	0.844095	0.545033	0.288851	1.33 [0.52 - 3.40]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	36994_at	117	0.649573	0.00495254	0.0939351	1.02441	0.0623932	0.877888	2.41 [0.96 - 6.06]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	36994_at	117	0.649573	0.00829688	0.140156	0.818513	0.0751078	0.713711	2.04 [0.93 - 4.48]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	36994_at	117	0.649573	0.00829688	0.140156	0.818513	0.0751078	0.713711	2.04 [0.93 - 4.48]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	36994_at	117	0.897436	0.158759	-	0.75559	0.391483	0.412667	1.51 [0.59 - 3.88]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	36994_at	236	0.741525	0.00309457	0.0645859	0.793689	0.0684312	0.85646	2.35 [0.94 - 5.92]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	200954_at	236	0.741525	0.00101007	0.0257002	0.881092	0.0743234	0.618009	1.86 [0.94 - 3.66]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	200954_at	249	0.891566	0.000354638	0.0105544	0.95573	0.0857984	0.486209	1.63 [0.93 - 2.83]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	36994_at	249	0.714859	0.000344173	0.0102856	0.753938	0.0450994	0.759474	2.14 [1.02 - 4.49]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	36994_at	125	0.848	0.0696402	-	0.596794	0.912695	0.0344842	1.04 [0.56 - 1.92]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	36994_at	54	0.888889	0.00602581	0.109528	1.54122	0.981221	-0.00848858	0.99 [0.49 - 2.01]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200954_at	62	0.887097	0.0070652	0.123902	1.33426	0.924679	-0.0278564	0.97 [0.55 - 1.73]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200954_at	125	0.864	0.0823744	-	0.742944	0.387697	0.350754	1.42 [0.64 - 3.15]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	36994_at	62	0.854839	0.0850407	-	0.890431	0.802526	-0.0729292	0.93 [0.52 - 1.65]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200954_at	125	0.2	0.0853396	-	0.876677	0.817236	0.074701	1.08 [0.57 - 2.03]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200954_at	54	0.888889	0.00602581	0.109528	1.54122	0.929747	0.0321221	1.03 [0.51 - 2.11]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	36994_at	125	0.848	0.12497	-	0.659948	0.494461	0.271667	1.31 [0.60 - 2.86]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200954_at	198	0.848485	0.00557427	0.103069	0.789123	0.064069	0.455922	1.58 [0.97 - 2.56]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	36994_at	198	0.191919	0.000630326	0.0172612	1.27817	0.00437276	0.605037	1.83 [1.21 - 2.78]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200954_at	198	0.848485	0.0127995	0.194078	0.734702	0.0966251	0.428246	1.53 [0.93 - 2.54]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	36994_at	198	0.777778	0.00188827	0.0432075	0.807943	0.00950375	0.677536	1.97 [1.18 - 3.29]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	36994_at	198	0.707071	0.00901561	0.149299	0.693866	0.0255805	0.60252	1.83 [1.08 - 3.10]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200954_at	198	0.333333	0.00748388	0.129515	0.669465	0.0248466	0.450848	1.57 [1.06 - 2.33]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	36994_at	62	0.451613	0.019905	0.267046	1.6228	0.282989	2.14867	8.57 [0.17 - 433.22]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	200954_at	51	0.627451	0.268093	-	0.972829	0.411849	1.46722	4.34 [0.13 - 144.24]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	200954_at	62	0.870968	0.0105903	0.168569	1.44044	0.146225	1.72458	5.61 [0.55 - 57.45]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	36994_at	51	0.529412	0.125719	-	1.55245	0.534667	1.97364	7.20 [0.01 - 3655.01]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	36994_at	177	0.80791	0.0407579	0.432826	0.612858	0.952761	0.0320925	1.03 [0.36 - 2.99]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	200954_at	145	0.289655	0.0431286	0.44859	0.8786	0.331487	0.59551	1.81 [0.55 - 6.03]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	200954_at	177	0.112994	0.0470561	0.473647	-0.684277	0.665904	0.22219	1.25 [0.46 - 3.42]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	36994_at	177	0.80791	0.0705226	-	0.488807	0.920864	0.0464361	1.05 [0.42 - 2.62]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	36994_at	145	0.248276	0.0215838	0.282694	1.15565	0.320038	0.643051	1.90 [0.54 - 6.76]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	200954_at	177	0.118644	0.0495519	0.488929	-0.594041	0.718053	0.160275	1.17 [0.49 - 2.80]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	36994_at	226	0.59292	0.165775	-	0.3905	0.883352	0.0612894	1.06 [0.47 - 2.41]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	200954_at	226	0.849558	0.172326	-	-0.697532	0.813874	-0.0837151	0.92 [0.46 - 1.85]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	36994_at	55	0.618182	0.0263653	0.324636	0.966277	0.397646	0.525987	1.69 [0.50 - 5.72]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	36994_at	55	0.454545	0.0303785	0.357248	1.13504	0.325195	0.690218	1.99 [0.50 - 7.89]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	36994_at	49	0.469388	0.0699587	-	1.14885	0.88628	0.111035	1.12 [0.24 - 5.12]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	200954_at	55	0.836364	0.0821005	-	0.869333	0.668521	0.330841	1.39 [0.31 - 6.33]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	200954_at	55	0.854545	0.10365	-	0.819975	0.60542	0.353136	1.42 [0.37 - 5.44]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	200954_at	49	0.857143	0.106925	-	1.03281	0.7653	-0.25579	0.77 [0.14 - 4.15]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	840768	34	0.117647	0.0392408	0.422469	15.3309	0.0710258	0.574497	1.78 [0.95 - 3.31]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	36994_at	63	0.142857	0.0852375	-	1.18529	0.247511	0.242407	1.27 [0.84 - 1.92]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	200954_at	63	0.888889	0.156528	-	0.632324	0.392868	0.221172	1.25 [0.75 - 2.07]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502312_3p_s_at	28	0.714286	0.0677657	-	0.992662	0.903491	0.0286592	1.03 [0.65 - 1.64]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	200954_3p_at	28	0.214286	0.027653	0.335337	-1.23725	0.461771	-4.79112	0.01 [0.00 - 2889.99]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502312_3p_x_at	28	0.642857	0.0516347	-	1.02102	0.597687	-0.30301	0.74 [0.24 - 2.28]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502312_3p_at	28	0.25	0.109278	-	-0.895441	0.992215	0.00326639	1.00 [0.52 - 1.93]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	36994_at	82	0.487805	0.0299241	0.353661	-0.749805	0.360763	-0.838115	0.43 [0.07 - 2.61]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	200954_at	82	0.280488	0.000494186	0.0140293	-1.15327	0.180605	-0.863292	0.42 [0.12 - 1.49]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	36994_at	84	0.452381	0.0119377	0.18432	-0.729927	0.286365	-0.588067	0.56 [0.19 - 1.64]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	36994_at	79	0.468354	0.0176678	0.245338	-0.621609	0.565427	-0.341607	0.71 [0.22 - 2.28]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	200954_at	79	0.607595	0.00824773	0.139521	-0.720507	0.316283	-0.454039	0.64 [0.26 - 1.54]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M62762_at	86	0.255814	0.0696253	-	-0.756897	0.924848	-0.0747964	0.93 [0.20 - 4.39]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	200954_at	104	0.134615	0.0062391	0.112532	-1.02689	0.190623	-0.834273	0.43 [0.12 - 1.51]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	36994_at	104	0.115385	0.00334643	0.0687798	-1.14727	0.0843187	-1.4587	0.23 [0.04 - 1.22]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P279220	117	0.333333	0.00486167	0.092575	-0.788173	0.058745	-0.476701	0.62 [0.38 - 1.02]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P54816	117	0.230769	0.210262	-	-0.394044	0.736513	0.091704	1.10 [0.64 - 1.87]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	200954_at	204	0.558824	0.00940687	0.154181	0.705166	0.0248475	0.870419	2.39 [1.12 - 5.11]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	36994_at	204	0.382353	8.52937e-05	0.00304386	2.32252	0.000555551	2.64072	14.02 [3.13 - 62.80]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	36994_at	204	0.215686	1.22621e-05	0.00053733	15.5013	6.45138e-05	2.17655	8.82 [3.03 - 25.64]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	200954_at	204	0.558824	0.00822835	0.139271	0.985015	0.0167868	1.30851	3.70 [1.27 - 10.82]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	36994_at	178	0.589888	0.0327039	0.375205	0.424022	0.13865	0.905991	2.47 [0.75 - 8.21]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	200954_at	178	0.893258	0.0542733	-	0.570707	0.234974	0.612109	1.84 [0.67 - 5.06]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	36994_at	111	0.540541	0.0896984	-	0.445347	0.250082	0.406793	1.50 [0.75 - 3.00]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	200954_at	111	0.171171	0.0352065	0.393832	0.882975	0.188335	0.48714	1.63 [0.79 - 3.36]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	36994_at	90	0.155556	0.00815904	0.138374	-0.985065	0.484561	-0.35205	0.70 [0.26 - 1.89]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	36994_at	90	0.155556	0.00496659	0.0941449	-1.11882	0.189717	-0.730247	0.48 [0.16 - 1.43]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	200954_at	90	0.111111	0.00135395	0.0328229	-1.21235	0.826798	0.0963134	1.10 [0.46 - 2.61]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	200954_at	90	0.111111	0.0479511	0.479182	-0.942404	0.860529	-0.0868704	0.92 [0.35 - 2.42]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	543	50	0.62	0.372405	-	-0.468325	0.873934	-0.0921226	0.91 [0.29 - 2.85]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	36994_at	138	0.724638	0.0299317	0.353721	0.538646	0.306181	0.291013	1.34 [0.77 - 2.34]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	200954_at	138	0.644928	0.00389177	0.0776074	0.686011	0.175095	0.385403	1.47 [0.84 - 2.57]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	200954_at	129	0.899225	0.252219	-	-0.524965	0.59064	0.211949	1.24 [0.57 - 2.68]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	36994_at	129	0.147287	0.150736	-	0.657899	0.654022	0.248541	1.28 [0.43 - 3.80]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23099	56	0.392857	0.287674	-	0.378167	0.87872	-0.0533532	0.95 [0.48 - 1.88]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23968	56	0.517857	0.288549	-	0.379093	0.818636	-0.0857114	0.92 [0.44 - 1.91]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7341	56	0.232143	0.22889	-	0.507239	0.98034	-0.00717038	0.99 [0.56 - 1.76]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23099	56	0.25	0.332912	-	0.4394	0.876463	-0.0595094	0.94 [0.44 - 2.00]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42668	56	0.321429	0.182087	-	0.512918	0.881698	-0.0550912	0.95 [0.46 - 1.96]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7341	56	0.607143	0.188124	-	-0.504465	0.675105	-0.136042	0.87 [0.46 - 1.65]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23968	56	0.517857	0.222904	-	0.416485	0.984901	0.00621187	1.01 [0.53 - 1.91]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42668	56	0.321429	0.262731	-	0.446054	0.896204	-0.0528414	0.95 [0.43 - 2.10]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	36994_at	278	0.647482	0.0685126	-	-0.371962	0.354626	-0.211331	0.81 [0.52 - 1.27]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	200954_at	278	0.877698	0.0578049	-	-0.618277	0.366059	-0.177941	0.84 [0.57 - 1.23]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	200954_at	133	0.744361	0.109912	-	-0.450421	0.378057	-0.248859	0.78 [0.45 - 1.36]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	36994_at	133	0.789474	0.387092	-	-0.249385	0.930232	0.0191072	1.02 [0.66 - 1.56]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200954_at	185	0.837838	0.00110463	0.0277004	0.701496	0.413095	0.136755	1.15 [0.83 - 1.59]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	36994_at	185	0.891892	0.194432	-	0.355706	0.981144	-0.00384377	1.00 [0.72 - 1.37]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200954_at	185	0.859459	0.000808435	0.0213099	0.786382	0.614522	0.0918585	1.10 [0.77 - 1.57]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	36994_at	185	0.318919	0.257712	-	0.199608	0.917228	0.0154864	1.02 [0.76 - 1.36]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P279220	110	0.881818	0.0300177	0.354403	0.846946	0.615784	0.186524	1.21 [0.58 - 2.50]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P54816	110	0.145455	0.162481	-	-0.445665	0.541037	0.180135	1.20 [0.67 - 2.13]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P279220	110	0.4	0.099759	-	0.393917	0.526673	0.17913	1.20 [0.69 - 2.08]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P54816	110	0.881818	0.00947203	0.154988	0.959038	0.511983	0.255438	1.29 [0.60 - 2.77]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	200954_at	80	0.4625	0.0153105	0.221272	1.17981	0.103624	0.758299	2.13 [0.86 - 5.32]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	36994_at	80	0.7	0.044698	0.458756	0.857285	0.261433	0.690387	1.99 [0.60 - 6.65]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_4198	281	0.281139	0.0456002	0.464507	0.327138	0.132132	0.57926	1.78 [0.84 - 3.79]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	36994_at	38	0.657895	0.0155236	0.223504	1.21819	0.0304627	1.72346	5.60 [1.18 - 26.69]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	200954_at	38	0.5	0.000451511	0.0129863	1.90379	0.0165834	1.56253	4.77 [1.33 - 17.13]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	36994_at	140	0.221429	0.0147499	0.21535	1.04024	0.497265	0.249999	1.28 [0.62 - 2.64]
GENE	ATP6V0C	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	200954_at	140	0.114286	0.0601634	-	1.07956	0.617688	0.180223	1.20 [0.59 - 2.43]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212041_at	30	0.4	0.0112566	0.176436	1.11342	0.14717	0.471817	1.60 [0.85 - 3.03]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1795826	165	0.733333	0.033256	0.379374	0.552874	0.856004	0.0321949	1.03 [0.73 - 1.46]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1795826	165	0.745455	6.95023e-05	0.00253976	1.31972	0.0408708	0.523937	1.69 [1.02 - 2.79]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212041_at	163	0.245399	0.00302214	0.0633649	-0.61806	0.0309138	-0.248207	0.78 [0.62 - 0.98]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212041_at	79	0.101266	0.0434863	0.450925	-0.806909	0.544319	-0.120459	0.89 [0.60 - 1.31]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212041_at	58	0.155172	0.11776	-	0.627746	0.241147	0.358755	1.43 [0.79 - 2.61]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212041_at	34	0.588235	0.207714	-	-0.527437	0.62944	-0.139362	0.87 [0.49 - 1.53]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212041_at	158	0.14557	0.0395501	0.424598	-0.59443	0.936276	-0.019208	0.98 [0.61 - 1.57]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212041_at	53	0.830189	0.0104222	0.166557	-1.67174	0.0247261	-1.41867	0.24 [0.07 - 0.83]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212041_at	53	0.792453	0.0070802	0.124105	-1.74762	0.015873	-1.52236	0.22 [0.06 - 0.75]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212041_at	180	0.322222	0.112952	-	-0.343429	0.408589	-0.261321	0.77 [0.41 - 1.43]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212041_at	559	0.282648	0.0554588	-	-0.38864	0.544269	-0.154706	0.86 [0.52 - 1.41]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212041_at	77	0.675325	0.00160176	0.0377286	-0.946132	0.00545427	-0.471288	0.62 [0.45 - 0.87]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212041_at	70	0.885714	0.0505942	-	-0.98286	0.179132	-0.360767	0.70 [0.41 - 1.18]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38686_at	50	0.72	0.126805	-	-0.67864	0.636529	-0.1083	0.90 [0.57 - 1.41]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212041_at	74	0.77027	0.0102711	0.164741	0.77334	0.319245	0.57429	1.78 [0.57 - 5.50]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212041_at	67	0.731343	0.147294	-	0.940283	0.796158	0.411358	1.51 [0.07 - 34.21]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212041_at	115	0.417391	0.0927939	-	1.04279	0.898566	0.097129	1.10 [0.25 - 4.91]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38686_at	158	0.778481	0.0394804	0.424119	-0.937656	0.490294	-0.286715	0.75 [0.33 - 1.70]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38686_at	76	0.302632	0.0474001	0.475782	1.80118	0.863987	0.130916	1.14 [0.25 - 5.10]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212041_at	204	0.142157	0.208695	-	0.253009	0.637267	0.065512	1.07 [0.81 - 1.40]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212041_at	87	0.252874	0.086901	-	-0.672999	0.656427	-0.162811	0.85 [0.41 - 1.74]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212041_at	87	0.252874	0.086901	-	-0.672999	0.656427	-0.162811	0.85 [0.41 - 1.74]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212041_at	77	0.805195	0.00888215	0.147619	1.5099	0.194837	0.878666	2.41 [0.64 - 9.09]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212041_at	77	0.74026	0.0012145	0.0299833	1.65395	0.109119	0.948167	2.58 [0.81 - 8.23]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212041_at	136	0.102941	0.00298242	0.0626923	-1.43899	0.00746215	-0.698083	0.50 [0.30 - 0.83]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212041_at	200	0.105	0.395477	-	-0.348596	0.924938	-0.0474926	0.95 [0.36 - 2.56]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21729	60	0.883333	0.0195188	0.263371	1.13204	0.198938	0.414658	1.51 [0.80 - 2.85]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21729	60	0.216667	0.0251997	0.314742	1.29991	0.073559	0.602785	1.83 [0.94 - 3.54]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212041_at	286	0.195804	0.00338478	0.0694116	-0.616092	0.268473	-0.203134	0.82 [0.57 - 1.17]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212041_at	159	0.773585	0.000497521	0.0141101	1.07713	0.00368936	1.19731	3.31 [1.48 - 7.43]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212041_at	159	0.773585	0.000573357	0.0159251	1.22275	0.00612828	1.33927	3.82 [1.46 - 9.94]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212041_at	159	0.72327	0.000557414	0.0155472	1.05109	0.00477573	1.17678	3.24 [1.43 - 7.35]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212041_at	54	0.888889	0.0156037	0.224339	1.75356	0.27428	0.565776	1.76 [0.64 - 4.86]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212041_at	117	0.846154	0.00919786	0.151581	0.960512	0.649777	0.120386	1.13 [0.67 - 1.90]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212041_at	117	0.846154	0.0662791	-	0.824376	0.809147	0.0741065	1.08 [0.59 - 1.96]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212041_at	117	0.846154	0.00919786	0.151581	0.960512	0.649777	0.120386	1.13 [0.67 - 1.90]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212041_at	117	0.350427	0.23583	-	-0.464657	0.474082	-0.224151	0.80 [0.43 - 1.48]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212041_at	236	0.148305	0.0140084	0.20739	1.59572	0.055939	0.803673	2.23 [0.98 - 5.09]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212041_at	249	0.172691	0.00244177	0.0533136	1.20644	0.00573703	0.898823	2.46 [1.30 - 4.65]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212041_at	62	0.870968	0.0592442	-	1.0503	0.606532	0.171139	1.19 [0.62 - 2.28]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212041_at	125	0.592	0.161217	-	0.534456	0.564014	0.188041	1.21 [0.64 - 2.29]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212041_at	125	0.504	0.178377	-	0.399812	0.622937	0.126001	1.13 [0.69 - 1.87]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212041_at	54	0.111111	0.00347311	0.0708602	-1.80727	0.598605	0.211069	1.23 [0.56 - 2.71]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212041_at	198	0.712121	6.74019e-05	0.00247165	0.988077	0.000264391	0.815392	2.26 [1.46 - 3.50]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212041_at	198	0.681818	0.00149015	0.0355398	0.82938	0.00308864	0.675682	1.97 [1.26 - 3.07]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212041_at	198	0.681818	2.69467e-06	0.000135313	0.973765	3.33459e-05	0.794661	2.21 [1.52 - 3.22]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212041_at	51	0.27451	0.0683678	-	-1.51656	0.316121	-0.999818	0.37 [0.05 - 2.60]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212041_at	62	0.516129	0.263685	-	-0.671952	0.54304	-0.37813	0.69 [0.20 - 2.32]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212041_at	177	0.129944	0.0854984	-	-0.561781	0.191065	-0.605636	0.55 [0.22 - 1.35]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212041_at	177	0.220339	0.176437	-	-0.349642	0.891544	-0.0541561	0.95 [0.43 - 2.06]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212041_at	145	0.551724	0.0116822	0.181381	-0.936735	0.119803	-0.879494	0.41 [0.14 - 1.26]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212041_at	226	0.207965	0.00633086	0.113815	-0.784841	0.0174832	-0.93999	0.39 [0.18 - 0.85]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212041_at	55	0.618182	0.195855	-	0.571597	0.655812	-0.146552	0.86 [0.45 - 1.65]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212041_at	55	0.109091	0.246638	-	-0.706049	0.371489	-0.316274	0.73 [0.36 - 1.46]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212041_at	49	0.122449	0.0263771	0.324735	-1.3902	0.166167	-0.456727	0.63 [0.33 - 1.21]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	384078	34	0.235294	0.00920261	0.151641	2.21034	0.179983	1.12753	3.09 [0.59 - 16.05]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212041_at	63	0.555556	0.0175687	0.244352	-0.827489	0.516866	-0.135162	0.87 [0.58 - 1.31]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.106876.0.A1_3p_at	28	0.214286	0.0219838	0.286347	-1.20862	0.211261	-27.4151	0.00 [0.00 - 5770607.97]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212041_at	82	0.378049	0.0270851	0.330646	-0.735177	0.162661	-0.611708	0.54 [0.23 - 1.28]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38686_at	84	0.321429	0.0864852	-	-0.506078	0.105224	-0.905932	0.40 [0.14 - 1.21]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212041_at	79	0.898734	0.0119792	0.184796	-1.38239	0.174622	-0.443918	0.64 [0.34 - 1.22]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X71490_at	86	0.546512	0.00988794	0.160096	-1.15953	0.171886	-0.694813	0.50 [0.18 - 1.35]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212041_at	104	0.788462	0.149444	-	-0.679779	0.889815	-0.0491621	0.95 [0.47 - 1.91]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P54636	117	0.299145	0.042221	0.442614	-0.587901	0.578394	-0.17026	0.84 [0.46 - 1.54]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212041_at	204	0.867647	0.145117	-	0.654701	0.93364	0.044867	1.05 [0.36 - 3.01]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212041_at	204	0.882353	0.0353412	0.394816	0.72338	0.0945984	0.644562	1.91 [0.89 - 4.06]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212041_at	178	0.848315	0.0161459	0.229952	-0.819505	0.358482	-0.314724	0.73 [0.37 - 1.43]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212041_at	111	0.891892	0.072402	-	-1.02098	0.929882	0.0235501	1.02 [0.61 - 1.73]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212041_at	90	0.4	0.126363	-	0.540866	0.650977	0.108372	1.11 [0.70 - 1.78]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212041_at	90	0.844444	0.174065	-	-0.96019	0.998268	-0.000597893	1.00 [0.58 - 1.71]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5098	50	0.6	0.286281	-	-0.561968	0.828193	-0.320929	0.73 [0.04 - 13.16]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212041_at	138	0.471014	0.126625	-	0.374079	0.626318	0.0686605	1.07 [0.81 - 1.41]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212041_at	129	0.860465	0.0777698	-	0.580284	0.677835	0.17975	1.20 [0.51 - 2.80]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37847	56	0.535714	0.0604739	-	0.635679	0.681073	0.1163	1.12 [0.65 - 1.96]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28591	56	0.160714	0.0247132	0.310553	1.49801	0.558367	0.134207	1.14 [0.73 - 1.79]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37847	56	0.482143	0.145527	-	0.518416	0.798066	0.0809493	1.08 [0.58 - 2.02]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28591	56	0.25	0.0471623	0.474307	1.01975	0.653528	0.114868	1.12 [0.68 - 1.85]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212041_at	278	0.780576	0.00879259	0.146487	-0.756224	0.0237459	-0.448433	0.64 [0.43 - 0.94]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212041_at	133	0.744361	0.267446	-	0.29799	0.998801	0.00021735	1.00 [0.75 - 1.33]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5483	81	0.703704	0.028398	0.341424	1.15429	0.199769	0.399834	1.49 [0.81 - 2.75]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14617	81	0.17284	0.0183303	0.251874	-1.26962	0.181761	-0.644711	0.52 [0.20 - 1.35]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212041_at	185	0.324324	0.120161	-	-0.282276	0.531244	-0.0579931	0.94 [0.79 - 1.13]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212041_at	185	0.324324	0.230985	-	-0.202439	0.764481	-0.0255055	0.97 [0.83 - 1.15]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P54636	110	0.818182	0.0240085	0.304419	0.7564	0.635385	0.128822	1.14 [0.67 - 1.94]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P54636	110	0.118182	0.140023	-	-0.467468	0.950719	-0.0131179	0.99 [0.65 - 1.50]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212041_at	80	0.2125	0.0293824	0.349352	1.92676	0.416187	0.349273	1.42 [0.61 - 3.29]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3909	281	0.505338	0.0879655	-	0.237382	0.466987	0.108855	1.12 [0.83 - 1.50]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212041_at	38	0.842105	0.0329761	0.377265	1.23527	0.144849	0.881639	2.41 [0.74 - 7.90]
GENE	ATP6V0D1	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212041_at	140	0.792857	0.104749	-	-0.695084	0.547896	-0.178301	0.84 [0.47 - 1.50]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1799889	165	0.381818	0.017991	0.248538	-0.565218	0.171757	-0.965611	0.38 [0.10 - 1.52]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1799889	165	0.642424	0.00906046	0.149862	-1.19861	0.066901	-2.06778	0.13 [0.01 - 1.15]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1553151_at	79	0.860759	0.0101951	0.163825	0.929041	0.715005	0.280231	1.32 [0.29 - 5.96]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1553153_at	79	0.227848	0.0630127	-	-0.600026	0.410466	-0.385726	0.68 [0.27 - 1.70]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1553155_x_at	79	0.898734	0.063487	-	0.747852	0.847391	0.0920003	1.10 [0.43 - 2.80]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1553151_at	559	0.846154	0.105817	-	-0.533081	0.968294	-0.0035417	1.00 [0.84 - 1.19]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1553153_at	559	0.853309	0.160819	-	0.338557	0.934061	0.0124757	1.01 [0.75 - 1.36]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1553155_x_at	559	0.447227	0.171169	-	-0.286364	0.461261	-0.168205	0.85 [0.54 - 1.32]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1553151_at	70	0.385714	0.0211082	0.278314	-0.619006	0.410306	-0.854952	0.43 [0.06 - 3.26]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1553153_at	70	0.342857	0.221444	-	-0.337719	0.768964	-0.498046	0.61 [0.02 - 16.87]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1553155_x_at	70	0.228571	0.0382791	0.415791	-0.617532	0.475805	-1.26793	0.28 [0.01 - 9.18]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1553155_x_at	67	0.492537	0.0419234	0.440638	-1.4963	0.476946	-1.75188	0.17 [0.00 - 21.67]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1553151_at	67	0.119403	0.0586837	-	-1.26249	0.21513	-4.0971	0.02 [0.00 - 10.82]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1553153_at	67	0.238806	0.0537572	-	-1.40229	0.969879	-0.0795851	0.92 [0.01 - 57.48]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1553155_x_at	115	0.591304	0.0619927	-	0.999599	0.0974131	2.04309	7.71 [0.69 - 86.40]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1553151_at	115	0.852174	0.123809	-	0.883631	0.596299	0.293892	1.34 [0.45 - 3.98]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1553153_at	115	0.886957	0.0269394	0.329436	1.2262	0.472507	0.836758	2.31 [0.24 - 22.64]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1553155_x_at	204	0.897059	0.0652259	-	-0.422081	0.505944	-0.0722908	0.93 [0.75 - 1.15]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1553151_at	204	0.308824	0.1751	-	-0.207767	0.615961	-0.0265328	0.97 [0.88 - 1.08]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1553153_at	204	0.235294	0.126734	-	-0.251517	0.52155	-0.0577316	0.94 [0.79 - 1.13]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1553155_x_at	87	0.229885	0.0858022	-	1.00705	0.921369	0.0552268	1.06 [0.35 - 3.16]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1553151_at	87	0.252874	0.0133235	0.1999	-0.928973	0.299904	-0.776973	0.46 [0.11 - 2.00]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1553151_at	87	0.252874	0.0133235	0.1999	-0.928973	0.299904	-0.776973	0.46 [0.11 - 2.00]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1553153_at	87	0.16092	0.240898	-	-0.534326	0.961956	-0.0259215	0.97 [0.34 - 2.83]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1553153_at	87	0.16092	0.240898	-	-0.534326	0.961956	-0.0259215	0.97 [0.34 - 2.83]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1553155_x_at	87	0.229885	0.0858022	-	1.00705	0.921369	0.0552268	1.06 [0.35 - 3.16]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553151_at	77	0.12987	0.235204	-	-0.763271	0.726838	-0.475413	0.62 [0.04 - 8.95]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553153_at	77	0.311688	0.144636	-	1.07106	0.811924	0.192858	1.21 [0.25 - 5.94]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553155_x_at	77	0.272727	0.016564	0.234232	15.6065	0.350251	0.858331	2.36 [0.39 - 14.29]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553155_x_at	77	0.272727	0.0376682	0.411501	15.5927	0.48001	0.75223	2.12 [0.26 - 17.11]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553151_at	77	0.12987	0.0736348	-	-1.16892	0.844989	-0.301586	0.74 [0.04 - 15.21]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553153_at	77	0.311688	0.110372	-	1.53043	0.548833	0.532581	1.70 [0.30 - 9.72]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1553151_at	177	0.858757	0.062763	-	-0.838701	0.131942	-0.577716	0.56 [0.26 - 1.19]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1553155_x_at	177	0.638418	0.0231181	0.296556	0.610258	0.69006	0.301607	1.35 [0.31 - 5.95]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1553151_at	177	0.163842	0.0204615	0.272292	-0.691114	0.195007	-0.574561	0.56 [0.24 - 1.34]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1553153_at	177	0.898305	0.132374	-	-0.861825	0.707414	-0.260968	0.77 [0.20 - 3.01]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1553153_at	177	0.898305	0.150151	-	-0.996489	0.822287	-0.179646	0.84 [0.17 - 4.01]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1553155_x_at	177	0.559322	0.0907753	-	0.396169	0.993438	-0.00548596	0.99 [0.27 - 3.68]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1553151_at	145	0.137931	0.131914	-	-0.600003	0.888875	0.0632466	1.07 [0.44 - 2.59]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1553153_at	145	0.172414	0.0534758	-	1.31046	0.589213	0.49666	1.64 [0.27 - 9.97]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1553155_x_at	145	0.57931	0.00651759	0.116411	0.903355	0.270789	0.931858	2.54 [0.48 - 13.33]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1553151_at	226	0.827434	0.0991887	-	0.525896	0.378628	0.10063	1.11 [0.88 - 1.38]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1553153_at	226	0.769912	0.0875815	-	0.513191	0.330727	0.229707	1.26 [0.79 - 2.00]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1553155_x_at	226	0.283186	0.0552905	-	-0.551578	0.512451	-0.175347	0.84 [0.50 - 1.42]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1553155_x_at	55	0.727273	0.104624	-	0.812325	0.179163	1.49746	4.47 [0.50 - 39.74]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1553151_at	55	0.890909	0.0244648	0.3084	1.36879	0.0280648	1.19394	3.30 [1.14 - 9.58]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1553153_at	55	0.109091	0.196683	-	-0.731821	0.845881	0.253736	1.29 [0.10 - 16.65]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1553155_x_at	49	0.102041	0.038815	0.419523	-1.28926	0.800708	0.452809	1.57 [0.05 - 52.91]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1553151_at	49	0.714286	0.0352159	0.393901	1.16489	0.210799	1.96211	7.11 [0.33 - 153.75]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1553153_at	49	0.142857	0.0792335	-	-1.03482	0.738007	-0.544253	0.58 [0.02 - 14.08]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1553151_at	55	0.890909	0.00460539	0.0887021	1.39131	0.0208414	1.02225	2.78 [1.17 - 6.61]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1553153_at	55	0.636364	0.141149	-	0.647601	0.402967	0.973841	2.65 [0.27 - 25.95]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1553155_x_at	55	0.745455	0.0135302	0.202175	1.06647	0.17752	1.28254	3.61 [0.56 - 23.26]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1553151_at	63	0.111111	0.000462602	0.0132589	-1.45712	0.0955692	-13.2064	0.00 [0.00 - 10.21]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1553153_at	63	0.253968	0.167435	-	-0.498499	0.509334	-0.115863	0.89 [0.63 - 1.26]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1553155_x_at	63	0.206349	0.0062078	0.112093	-0.975846	0.614183	-0.115741	0.89 [0.57 - 1.40]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.130017.1.S1_3p_s_at	28	0.321429	0.0691516	-	-1.03791	0.445014	-1.31567	0.27 [0.01 - 7.85]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.130017.1.S2_3p_s_at	28	0.75	0.132812	-	-1.11021	0.44415	-0.440225	0.64 [0.21 - 1.99]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1553155_x_at	204	0.284314	0.0114122	0.178251	-0.90098	0.397055	-0.228697	0.80 [0.47 - 1.35]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1553151_at	204	0.745098	0.15322	-	0.535099	0.582916	0.109636	1.12 [0.75 - 1.65]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1553153_at	204	0.176471	0.102732	-	1.133	0.741043	0.0813363	1.08 [0.67 - 1.76]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1553155_x_at	204	0.426471	0.0323645	0.372623	-0.576342	0.33367	-0.19167	0.83 [0.56 - 1.22]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1553151_at	204	0.867647	0.0202077	0.269907	0.744034	0.221054	0.182903	1.20 [0.90 - 1.61]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1553153_at	204	0.789216	0.165816	-	-0.524909	0.922697	0.0181148	1.02 [0.71 - 1.47]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300007693	41	0.560976	0.0977649	-	0.684942	0.296501	0.284789	1.33 [0.78 - 2.27]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1553155_x_at	111	0.765766	0.0787947	-	0.494608	0.702986	-0.100392	0.90 [0.54 - 1.52]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1553151_at	111	0.630631	0.1612	-	0.367499	0.59226	0.0551098	1.06 [0.86 - 1.29]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1553153_at	111	0.837838	0.364219	-	-0.344843	0.884676	-0.0450536	0.96 [0.52 - 1.76]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1553155_x_at	138	0.804348	0.0606092	-	0.512961	0.505994	0.120642	1.13 [0.79 - 1.61]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1553151_at	138	0.601449	0.0347056	0.39016	0.508207	0.0771762	0.389504	1.48 [0.96 - 2.27]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1553153_at	138	0.123188	0.0655094	-	0.83733	0.760696	0.0424509	1.04 [0.79 - 1.37]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17100	56	0.178571	0.270153	-	0.580715	0.608379	-0.0848088	0.92 [0.66 - 1.27]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33550	56	0.821429	0.01164	0.180893	1.17397	0.970006	0.00794398	1.01 [0.67 - 1.53]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12415	56	0.857143	0.19409	-	-0.765496	0.468863	-0.119402	0.89 [0.64 - 1.23]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17100	56	0.607143	0.247635	-	-0.437319	0.641554	-0.086807	0.92 [0.64 - 1.32]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12415	56	0.232143	0.320411	-	-0.379003	0.69401	-0.070684	0.93 [0.66 - 1.33]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33550	56	0.821429	0.0852295	-	0.783795	0.96605	0.00815671	1.01 [0.69 - 1.47]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1553155_x_at	278	0.546763	0.057265	-	-0.372525	0.911898	0.0627015	1.06 [0.35 - 3.23]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1553151_at	278	0.83813	0.0205304	0.272937	0.519538	0.33763	0.512479	1.67 [0.59 - 4.76]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1553153_at	278	0.615108	0.0300021	0.354279	-0.459485	0.869881	0.0651597	1.07 [0.49 - 2.33]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P121424	110	0.145455	0.232618	-	-0.443772	0.887408	0.0360783	1.04 [0.63 - 1.71]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P146146	110	0.518182	0.0220148	0.286629	-0.719784	0.363548	-0.162408	0.85 [0.60 - 1.21]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P121424	110	0.609091	0.153482	-	-0.350284	0.982958	0.0041448	1.00 [0.69 - 1.47]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P146146	110	0.627273	0.0707763	-	-0.451186	0.781684	-0.0365442	0.96 [0.74 - 1.25]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1553155_x_at	38	0.526316	0.0992358	-	-0.776422	0.628301	-0.154809	0.86 [0.46 - 1.60]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1553151_at	38	0.605263	0.0427562	0.446147	0.927769	0.320826	0.232974	1.26 [0.80 - 2.00]
GENE	ATP6V0D2	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1553153_at	38	0.526316	0.0992358	-	-0.776422	0.862415	-0.0472012	0.95 [0.56 - 1.63]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214150_x_at	30	0.5	0.0723791	-	-0.722295	0.141	-0.709901	0.49 [0.19 - 1.27]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	200096_s_at	30	0.166667	0.309848	-	-0.500047	0.619481	-0.196728	0.82 [0.38 - 1.79]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214244_s_at	30	0.266667	0.0112127	0.175923	-1.06687	0.112053	-1.36932	0.25 [0.05 - 1.38]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201171_at	30	0.466667	0.153732	-	-0.582435	0.329024	-0.59326	0.55 [0.17 - 1.82]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201172_x_at	30	0.466667	0.157094	-	-0.564941	0.318971	-0.429401	0.65 [0.28 - 1.51]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1715635	165	0.169697	0.178809	-	0.457525	0.513297	0.0779489	1.08 [0.86 - 1.37]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1715635	165	0.775758	0.176053	-	-0.708768	0.568228	0.107115	1.11 [0.77 - 1.61]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214244_s_at	163	0.895706	0.0722679	-	0.513888	0.593392	0.275334	1.32 [0.48 - 3.62]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201171_at	163	0.570552	0.105014	-	-0.32802	0.947481	0.0220951	1.02 [0.53 - 1.97]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201172_x_at	163	0.423313	0.376755	-	-0.174593	0.852039	0.0246306	1.02 [0.79 - 1.33]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214150_x_at	163	0.343558	0.367675	-	-0.182485	0.911422	0.0161608	1.02 [0.76 - 1.35]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	200096_s_at	163	0.441718	0.210059	-	0.251689	0.888039	0.0176428	1.02 [0.80 - 1.30]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201172_x_at	79	0.443038	0.0892236	-	0.505746	0.384124	0.156745	1.17 [0.82 - 1.66]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201171_at	79	0.189873	0.0170034	0.238686	1.07814	0.365313	0.306869	1.36 [0.70 - 2.64]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	200096_s_at	79	0.56962	0.0310638	0.362607	0.621668	0.481387	0.126649	1.14 [0.80 - 1.61]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214244_s_at	79	0.227848	0.0149704	0.217689	0.963073	0.311414	0.554748	1.74 [0.59 - 5.10]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214150_x_at	79	0.443038	0.0468667	0.472467	0.595865	0.202069	0.294969	1.34 [0.85 - 2.11]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214150_x_at	58	0.534483	0.21456	-	0.340897	0.664081	0.129773	1.14 [0.63 - 2.05]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200096_s_at	58	0.793103	0.00807402	0.137271	0.87145	0.240415	0.433764	1.54 [0.75 - 3.18]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214244_s_at	58	0.362069	0.175559	-	-0.386878	0.672955	-0.0755042	0.93 [0.65 - 1.32]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201171_at	58	0.5	0.403216	-	-0.234812	0.845244	0.0246863	1.02 [0.80 - 1.31]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201172_x_at	58	0.87931	0.000235211	0.00740052	1.45153	0.278232	0.487206	1.63 [0.67 - 3.93]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201172_x_at	34	0.323529	0.0177679	0.246331	1.08095	0.105971	0.524129	1.69 [0.89 - 3.19]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214150_x_at	34	0.529412	0.0698192	-	0.703392	0.499813	0.237809	1.27 [0.64 - 2.53]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	200096_s_at	34	0.294118	0.0714118	-	0.831889	0.377944	0.294891	1.34 [0.70 - 2.59]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214244_s_at	34	0.705882	0.0482101	0.480772	-0.828139	0.598565	-0.16168	0.85 [0.47 - 1.55]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201171_at	34	0.5	0.191631	-	0.496526	0.708611	0.0572822	1.06 [0.78 - 1.43]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201172_x_at	158	0.696203	0.0764079	-	-0.47621	0.819735	-0.0507486	0.95 [0.61 - 1.47]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214150_x_at	158	0.816456	0.0754125	-	-0.623531	0.483946	-0.177902	0.84 [0.51 - 1.38]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	200096_s_at	158	0.506329	0.199806	-	-0.299044	0.697076	-0.0796512	0.92 [0.62 - 1.38]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214244_s_at	158	0.303797	0.149308	-	0.396015	0.872698	-0.101311	0.90 [0.26 - 3.12]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201171_at	158	0.246835	0.0950154	-	0.504708	0.548436	-0.202445	0.82 [0.42 - 1.58]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201171_at	53	0.245283	0.0757694	-	0.922848	0.229898	0.356177	1.43 [0.80 - 2.55]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	200096_s_at	53	0.773585	0.102378	-	0.609361	0.86746	0.110519	1.12 [0.30 - 4.09]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201172_x_at	53	0.377358	0.237549	-	-0.433226	0.680724	0.341235	1.41 [0.28 - 7.15]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214244_s_at	53	0.603774	0.00518136	0.097331	0.936362	0.0378975	0.764414	2.15 [1.04 - 4.42]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201171_at	53	0.867925	0.0642031	-	0.773435	0.741749	0.082875	1.09 [0.66 - 1.78]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214150_x_at	53	0.207547	0.0217197	0.283939	-0.892943	0.842876	0.162492	1.18 [0.24 - 5.87]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	200096_s_at	53	0.207547	0.178837	-	-0.550062	0.952847	-0.0408998	0.96 [0.25 - 3.72]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201172_x_at	53	0.679245	0.233238	-	0.419342	0.652283	0.352672	1.42 [0.31 - 6.60]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214150_x_at	53	0.207547	0.0761226	-	-0.680163	0.717687	0.278901	1.32 [0.29 - 5.99]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214244_s_at	53	0.603774	0.000568361	0.0158069	1.21791	0.02866	0.90144	2.46 [1.10 - 5.52]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214150_x_at	180	0.75	0.00368266	0.0742611	0.653619	0.056456	0.581986	1.79 [0.98 - 3.25]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	200096_s_at	180	0.794444	0.144898	-	0.368975	0.948101	-0.0265646	0.97 [0.44 - 2.17]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214244_s_at	180	0.894444	0.158998	-	0.451913	0.451568	0.145395	1.16 [0.79 - 1.69]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201171_at	180	0.105556	0.0234865	0.299825	-0.632071	0.32583	-0.136343	0.87 [0.66 - 1.15]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201172_x_at	180	0.716667	0.00454094	0.0877194	0.64896	0.223353	0.614333	1.85 [0.69 - 4.97]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	200096_s_at	180	0.194444	0.0681759	-	0.540288	0.750326	0.103552	1.11 [0.59 - 2.10]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201172_x_at	559	0.109123	0.00503897	0.0952227	-0.715957	0.00309964	-1.04847	0.35 [0.17 - 0.70]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201171_at	559	0.284436	6.85539e-05	0.00250904	-0.780599	0.0143399	-0.327725	0.72 [0.55 - 0.94]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	200096_s_at	559	0.545617	0.00919207	0.151509	-0.528223	0.0203266	-0.690291	0.50 [0.28 - 0.90]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214244_s_at	559	0.73703	0.0152048	0.220163	-0.610197	0.127907	-0.27287	0.76 [0.54 - 1.08]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214150_x_at	559	0.141324	0.000113486	0.00391475	-0.890103	0.0019791	-0.987702	0.37 [0.20 - 0.70]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201172_x_at	77	0.246753	0.10927	-	0.489317	0.666501	0.195911	1.22 [0.50 - 2.97]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214150_x_at	77	0.168831	0.00258261	0.0557993	1.24763	0.124639	0.469075	1.60 [0.88 - 2.91]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	200096_s_at	77	0.246753	0.0141236	0.208636	0.78218	0.129921	0.521631	1.68 [0.86 - 3.31]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214244_s_at	77	0.428571	0.134998	-	0.388328	0.637862	-0.139369	0.87 [0.49 - 1.55]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201171_at	77	0.74026	0.0650426	-	-0.58583	0.387297	-0.168792	0.84 [0.58 - 1.24]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	200096_s_at	77	0.337662	0.0388424	0.419713	0.578508	0.300203	0.287195	1.33 [0.77 - 2.29]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201172_x_at	70	0.871429	0.0934298	-	-0.76853	0.441895	-0.262199	0.77 [0.39 - 1.50]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201171_at	70	0.157143	0.112379	-	-0.52703	0.162009	-0.55819	0.57 [0.26 - 1.25]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	200096_s_at	70	0.885714	0.218807	-	-0.57238	0.584871	-0.14891	0.86 [0.51 - 1.47]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214244_s_at	70	0.114286	0.00103127	0.0261518	-1.23512	0.296642	-0.573106	0.56 [0.19 - 1.65]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214150_x_at	70	0.828571	0.0236529	0.301294	-0.944448	0.482617	-0.361869	0.70 [0.25 - 1.91]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33875_at	50	0.78	0.0446237	0.458279	0.819131	0.951417	-0.0170111	0.98 [0.57 - 1.70]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	200096_s_at	74	0.337838	0.17815	-	-0.39568	0.710244	-0.183702	0.83 [0.32 - 2.19]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214244_s_at	74	0.891892	0.0615274	-	0.819862	0.714958	-0.0888182	0.92 [0.57 - 1.47]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201171_at	74	0.202703	0.0273115	0.332522	0.883737	0.0886937	0.295669	1.34 [0.96 - 1.89]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201172_x_at	74	0.891892	0.00248011	0.0539934	1.22293	0.170432	0.877525	2.40 [0.69 - 8.43]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214150_x_at	74	0.108108	0.193561	-	0.66786	0.476661	0.367559	1.44 [0.52 - 3.97]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	200096_s_at	74	0.864865	0.0896304	-	0.65491	0.746716	0.130385	1.14 [0.52 - 2.51]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201172_x_at	67	0.567164	0.0583428	-	1.27396	0.327526	1.91291	6.77 [0.15 - 311.75]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201171_at	67	0.164179	0.12435	-	-1.052	0.772434	-0.341386	0.71 [0.07 - 7.19]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	200096_s_at	67	0.701493	0.0605194	-	1.19031	0.656892	0.790658	2.20 [0.07 - 72.19]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214244_s_at	67	0.492537	0.345721	-	-0.655616	0.783787	-0.357842	0.70 [0.05 - 9.01]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214150_x_at	67	0.597015	0.0316807	0.367383	1.56195	0.341475	2.05893	7.84 [0.11 - 545.24]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201172_x_at	115	0.321739	0.16122	-	-0.737241	0.136541	-1.17592	0.31 [0.07 - 1.45]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201171_at	115	0.713043	0.00943193	0.154492	1.30619	0.251843	0.553294	1.74 [0.67 - 4.48]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	200096_s_at	115	0.521739	0.147645	-	-0.834718	0.245546	-0.841298	0.43 [0.10 - 1.78]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214244_s_at	115	0.895652	0.000514276	0.014515	1.71739	0.329133	0.677697	1.97 [0.50 - 7.68]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214150_x_at	115	0.356522	0.0205271	0.272907	-1.21991	0.0422268	-1.6175	0.20 [0.04 - 0.94]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33875_at	158	0.272152	0.0357962	0.398122	-0.602077	0.258029	-0.470098	0.62 [0.28 - 1.41]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33875_at	76	0.328947	0.0214267	0.281252	2.02015	0.388228	0.588484	1.80 [0.47 - 6.86]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201171_at	204	0.72549	0.00791447	0.135192	0.420976	0.294454	0.146291	1.16 [0.88 - 1.52]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	200096_s_at	204	0.848039	0.0790679	-	0.346993	0.4393	0.199752	1.22 [0.74 - 2.03]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214244_s_at	204	0.857843	0.0483142	0.48141	0.397963	0.849281	0.0424114	1.04 [0.67 - 1.62]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214150_x_at	204	0.411765	0.0717194	-	0.259161	0.253721	0.279394	1.32 [0.82 - 2.14]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201172_x_at	204	0.789216	0.0658868	-	0.321143	0.44288	0.212827	1.24 [0.72 - 2.13]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214150_x_at	87	0.735632	4.36067e-05	0.00167853	1.43531	0.0628598	1.95852	7.09 [0.90 - 55.82]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201171_at	87	0.310345	0.0526729	-	1.00445	0.266121	0.297233	1.35 [0.80 - 2.27]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201172_x_at	87	0.83908	0.00241887	0.0529065	1.20836	0.0553816	1.60546	4.98 [0.96 - 25.74]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	200096_s_at	87	0.781609	0.0103897	0.166167	0.975132	0.0812945	1.22394	3.40 [0.86 - 13.46]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214244_s_at	87	0.885057	0.0546606	-	0.921685	0.421024	0.282687	1.33 [0.67 - 2.64]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201171_at	87	0.310345	0.0526729	-	1.00445	0.266121	0.297233	1.35 [0.80 - 2.27]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214150_x_at	87	0.735632	4.36067e-05	0.00167853	1.43531	0.0628598	1.95852	7.09 [0.90 - 55.82]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	200096_s_at	87	0.781609	0.0103897	0.166167	0.975132	0.0812945	1.22394	3.40 [0.86 - 13.46]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214244_s_at	87	0.885057	0.0546606	-	0.921685	0.421024	0.282687	1.33 [0.67 - 2.64]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201172_x_at	87	0.83908	0.00241887	0.0529065	1.20836	0.0553816	1.60546	4.98 [0.96 - 25.74]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201171_at	77	0.298701	0.0226978	0.292798	-1.19717	0.280432	-0.454851	0.63 [0.28 - 1.45]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214150_x_at	77	0.246753	0.00449973	0.087089	-1.64459	0.222039	-1.7431	0.17 [0.01 - 2.87]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	200096_s_at	77	0.246753	0.0060293	0.109578	-1.41264	0.111001	-0.869366	0.42 [0.14 - 1.22]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214244_s_at	77	0.194805	0.00412782	0.0813308	-1.46397	0.161478	-0.728363	0.48 [0.17 - 1.34]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201172_x_at	77	0.220779	0.00125534	0.0308213	-1.82394	0.0849921	-1.32558	0.27 [0.06 - 1.20]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214150_x_at	77	0.246753	0.00645502	0.115544	-1.4015	0.276892	-1.35221	0.26 [0.02 - 2.96]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201171_at	77	0.298701	0.0228	0.293715	-1.36272	0.433968	-0.38549	0.68 [0.26 - 1.79]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201172_x_at	77	0.220779	0.00152467	0.0362203	-1.59887	0.0952838	-1.15273	0.32 [0.08 - 1.22]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	200096_s_at	77	0.311688	0.00442938	0.0860095	-1.73872	0.133234	-0.929794	0.39 [0.12 - 1.33]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214244_s_at	77	0.194805	0.00950523	0.155398	-1.4975	0.340345	-0.588847	0.55 [0.17 - 1.86]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214244_s_at	136	0.198529	0.119964	-	1.46482	0.567165	0.349276	1.42 [0.43 - 4.69]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201171_at	136	0.213235	0.0377733	0.412242	-0.959509	0.260426	-0.298037	0.74 [0.44 - 1.25]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201172_x_at	136	0.595588	0.349092	-	-0.453302	0.547792	0.478363	1.61 [0.34 - 7.68]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214150_x_at	136	0.882353	0.00252064	0.0547096	1.40165	0.0535536	1.20802	3.35 [0.98 - 11.41]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	200096_s_at	136	0.102941	0.0477188	0.477752	-1.07371	0.683831	-0.210585	0.81 [0.29 - 2.23]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	200096_s_at	200	0.12	0.0200485	0.268405	-0.811949	0.637806	-0.326528	0.72 [0.19 - 2.81]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214244_s_at	200	0.85	0.000170996	0.00560666	1.18106	0.198664	0.450557	1.57 [0.79 - 3.12]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201171_at	200	0.365	0.0867279	-	0.567485	0.6149	0.126301	1.13 [0.69 - 1.86]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201172_x_at	200	0.87	0.0296093	0.351162	0.794843	0.877686	0.141751	1.15 [0.19 - 7.01]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214150_x_at	200	0.895	0.0109012	0.17226	0.969069	0.62843	0.301152	1.35 [0.40 - 4.58]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5761	60	0.183333	0.0536435	-	1.31899	0.326406	0.729178	2.07 [0.48 - 8.89]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5761	60	0.483333	0.000398287	0.011662	1.44595	8.87871e-05	2.15583	8.64 [2.94 - 25.38]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	200096_s_at	286	0.84965	0.0629304	-	0.450237	0.244838	0.370736	1.45 [0.78 - 2.71]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214244_s_at	286	0.531469	0.0235663	0.30053	-0.445397	0.151133	-0.363275	0.70 [0.42 - 1.14]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201171_at	286	0.304196	0.081926	-	-0.346573	0.706629	-0.0544029	0.95 [0.71 - 1.26]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201172_x_at	286	0.888112	0.0235179	0.300102	0.579699	0.32824	0.441027	1.55 [0.64 - 3.76]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214150_x_at	286	0.625874	5.41175e-05	0.00203419	0.764656	0.0232104	0.674574	1.96 [1.10 - 3.51]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200096_s_at	159	0.710692	0.116487	-	0.507637	0.545361	0.315387	1.37 [0.49 - 3.81]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201171_at	159	0.389937	0.106212	-	-0.505617	0.661484	-0.100149	0.90 [0.58 - 1.42]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214150_x_at	159	0.27044	0.0366475	0.404251	1.2008	0.92103	-0.057369	0.94 [0.30 - 2.94]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200096_s_at	159	0.264151	0.0828341	-	0.903517	0.756456	0.188083	1.21 [0.37 - 3.96]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214244_s_at	159	0.295597	0.0455967	0.464484	-0.629498	0.204205	-0.431776	0.65 [0.33 - 1.26]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201172_x_at	159	0.465409	0.189369	-	0.425616	0.592419	-0.321159	0.73 [0.22 - 2.35]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201171_at	159	0.578616	0.148276	-	0.454026	0.400779	0.217113	1.24 [0.75 - 2.06]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214150_x_at	159	0.81761	0.0527258	-	-1.10614	0.580065	-0.26874	0.76 [0.30 - 1.98]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214244_s_at	159	0.496855	0.16891	-	0.520674	0.619211	-0.207034	0.81 [0.36 - 1.84]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201171_at	159	0.716981	0.269411	-	0.419907	0.642946	0.136928	1.15 [0.64 - 2.05]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	200096_s_at	159	0.264151	0.125381	-	0.627831	0.766337	-0.152718	0.86 [0.31 - 2.35]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201172_x_at	159	0.515723	0.13428	-	0.474983	0.816852	0.141348	1.15 [0.35 - 3.81]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201172_x_at	159	0.465409	0.0720887	-	0.707382	0.8168	0.16349	1.18 [0.30 - 4.70]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214244_s_at	159	0.496855	0.178442	-	0.431008	0.820941	-0.0829101	0.92 [0.45 - 1.89]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214150_x_at	159	0.81761	0.13764	-	-0.764158	0.728503	-0.168608	0.84 [0.33 - 2.19]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	200096_s_at	159	0.792453	0.0148277	0.216177	0.802418	0.255688	0.470326	1.60 [0.71 - 3.60]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	200096_s_at	159	0.742138	0.0270681	0.330505	0.811814	0.38039	0.41509	1.51 [0.60 - 3.83]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	200096_s_at	159	0.735849	0.109859	-	0.524698	0.756973	0.124655	1.13 [0.51 - 2.49]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214150_x_at	54	0.444444	0.143918	-	-0.99718	0.790731	0.367018	1.44 [0.10 - 21.71]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201172_x_at	54	0.148148	0.164175	-	15.3534	0.460662	0.641127	1.90 [0.35 - 10.43]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214244_s_at	54	0.444444	0.144834	-	-0.993362	0.572672	-0.775582	0.46 [0.03 - 6.81]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	200096_s_at	54	0.203704	0.117254	-	15.4089	0.452222	0.418823	1.52 [0.51 - 4.53]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214149_s_at	54	0.351852	0.0383167	0.416053	-1.40041	0.744566	-0.170076	0.84 [0.30 - 2.35]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201171_at	54	0.703704	0.065646	-	-1.77159	0.348582	-1.09372	0.33 [0.03 - 3.30]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201172_x_at	117	0.752137	0.0191419	0.259757	0.762718	0.590788	0.281234	1.32 [0.48 - 3.69]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201172_x_at	117	0.752137	0.0152474	0.22061	0.910563	0.906192	0.0691438	1.07 [0.34 - 3.38]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214150_x_at	117	0.760684	0.170064	-	-0.72461	0.786311	-0.227321	0.80 [0.15 - 4.12]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214150_x_at	117	0.401709	0.13319	-	0.516203	0.794887	0.181818	1.20 [0.30 - 4.72]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200096_s_at	117	0.649573	0.140404	-	0.469093	0.570934	0.16654	1.18 [0.66 - 2.10]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201172_x_at	117	0.111111	0.0402213	0.429187	-0.930651	0.24403	-0.598093	0.55 [0.20 - 1.50]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200096_s_at	117	0.65812	0.118434	-	0.584616	0.664891	0.149524	1.16 [0.59 - 2.28]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201172_x_at	117	0.752137	0.0191419	0.259757	0.762718	0.590788	0.281234	1.32 [0.48 - 3.69]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214150_x_at	117	0.401709	0.13319	-	0.516203	0.794887	0.181818	1.20 [0.30 - 4.72]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214150_x_at	117	0.418803	0.195393	-	0.54202	0.831615	-0.182759	0.83 [0.15 - 4.49]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200096_s_at	117	0.649573	0.140404	-	0.469093	0.570934	0.16654	1.18 [0.66 - 2.10]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214244_s_at	117	0.615385	0.203938	-	0.403903	0.770078	0.210237	1.23 [0.30 - 5.05]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214244_s_at	117	0.25641	0.114808	-	-0.601644	0.684704	0.340497	1.41 [0.27 - 7.27]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	200096_s_at	117	0.871795	0.158165	-	-1.33753	0.684717	-0.135962	0.87 [0.45 - 1.68]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201171_at	117	0.376068	0.171126	-	-0.511167	0.756148	-0.197801	0.82 [0.24 - 2.86]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201171_at	117	0.230769	0.271663	-	0.45502	0.912668	-0.0566548	0.94 [0.34 - 2.60]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214244_s_at	117	0.102564	0.0867831	-	-0.831306	0.812261	-0.2249	0.80 [0.12 - 5.11]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214244_s_at	117	0.615385	0.203938	-	0.403903	0.770078	0.210237	1.23 [0.30 - 5.05]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201171_at	117	0.230769	0.271663	-	0.45502	0.912668	-0.0566548	0.94 [0.34 - 2.60]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201171_at	117	0.128205	0.00277407	0.0591291	-1.19993	0.0482102	-1.61212	0.20 [0.04 - 0.99]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201171_at	236	0.648305	0.0391665	0.421956	-0.643785	0.153177	-0.218589	0.80 [0.60 - 1.08]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201172_x_at	236	0.805085	0.0344742	0.388454	0.632426	0.737585	-0.185202	0.83 [0.28 - 2.46]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214150_x_at	236	0.470339	0.0675471	-	0.503945	0.218402	0.702545	2.02 [0.66 - 6.18]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	200096_s_at	236	0.877119	0.0138959	0.206169	0.810921	0.850722	-0.0747243	0.93 [0.43 - 2.02]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214244_s_at	236	0.122881	0.0989223	-	-0.570339	0.731522	-0.086598	0.92 [0.56 - 1.50]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	200096_s_at	236	0.720339	0.289393	-	-0.344073	0.718973	-0.113203	0.89 [0.48 - 1.65]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201172_x_at	249	0.811245	0.0507005	-	0.485917	0.593425	0.237549	1.27 [0.53 - 3.03]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214150_x_at	249	0.779116	0.0720365	-	0.434407	0.0946315	0.73521	2.09 [0.88 - 4.94]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	200096_s_at	249	0.879518	0.00526304	0.0985334	0.755535	0.501939	0.215406	1.24 [0.66 - 2.33]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214244_s_at	249	0.116466	0.0096006	0.156574	-0.702227	0.220064	-0.232279	0.79 [0.55 - 1.15]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201171_at	249	0.321285	0.100248	-	-0.356872	0.419528	-0.103961	0.90 [0.70 - 1.16]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	200096_s_at	249	0.88755	0.0555391	-	0.552243	0.888677	0.035791	1.04 [0.63 - 1.71]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214244_s_at	125	0.688	0.0944629	-	0.482099	0.491731	0.344715	1.41 [0.53 - 3.77]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201171_at	125	0.16	0.0905244	-	0.975491	0.972486	0.0117903	1.01 [0.52 - 1.98]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214244_s_at	54	0.888889	0.104042	-	1.04317	0.953643	0.0235909	1.02 [0.46 - 2.27]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201171_at	54	0.592593	0.00880733	0.146674	1.48685	0.195904	1.28395	3.61 [0.52 - 25.27]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214150_x_at	62	0.435484	0.315975	-	-0.484789	0.666889	-0.173232	0.84 [0.38 - 1.85]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201172_x_at	125	0.896	0.0319909	0.369768	0.955404	0.944337	0.0369161	1.04 [0.37 - 2.92]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201172_x_at	125	0.896	0.0391799	0.422049	0.750067	0.889153	-0.0564138	0.95 [0.43 - 2.09]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200096_s_at	62	0.112903	0.0488847	0.48489	-1.08608	0.94448	-0.0311501	0.97 [0.40 - 2.33]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214150_x_at	125	0.896	0.0121246	0.186457	1.05156	0.25096	0.812938	2.25 [0.56 - 9.03]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200096_s_at	125	0.896	0.00611914	0.110846	1.13841	0.670086	0.140066	1.15 [0.60 - 2.19]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214244_s_at	62	0.887097	0.145026	-	0.815191	0.992515	-0.00311515	1.00 [0.52 - 1.91]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214150_x_at	125	0.464	0.0714909	-	0.544414	0.323428	0.521545	1.68 [0.60 - 4.74]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201172_x_at	54	0.740741	0.311305	-	0.591693	0.996117	-0.00199822	1.00 [0.45 - 2.23]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214150_x_at	54	0.759259	0.251999	-	0.668447	0.868087	-0.0805175	0.92 [0.36 - 2.39]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201171_at	62	0.629032	0.105607	-	0.756506	0.702776	0.333078	1.40 [0.25 - 7.72]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200096_s_at	125	0.8	0.00867384	0.144981	0.783563	0.803415	0.0637314	1.07 [0.65 - 1.76]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214244_s_at	125	0.424	0.04675	0.471739	0.849342	0.37743	0.547656	1.73 [0.51 - 5.83]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	200096_s_at	54	0.685185	0.150739	-	0.813175	0.851215	0.103497	1.11 [0.38 - 3.27]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201172_x_at	62	0.112903	0.00511784	0.0963924	-1.39949	0.712667	-0.124255	0.88 [0.46 - 1.71]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201171_at	125	0.68	0.163986	-	0.525917	0.613537	0.22037	1.25 [0.53 - 2.93]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201172_x_at	198	0.348485	0.145024	-	0.412194	0.947487	0.0193149	1.02 [0.57 - 1.81]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214244_s_at	198	0.323232	0.0744404	-	0.412812	0.86483	0.024969	1.03 [0.77 - 1.37]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201172_x_at	198	0.176768	0.242436	-	0.468595	0.878114	-0.0477024	0.95 [0.52 - 1.75]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214150_x_at	198	0.656566	0.0691825	-	-0.548528	0.701638	-0.110175	0.90 [0.51 - 1.57]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214150_x_at	198	0.171717	0.17809	-	-0.437435	0.756169	-0.0942409	0.91 [0.50 - 1.65]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200096_s_at	198	0.80303	0.100079	-	-0.649449	0.983467	-0.00529422	0.99 [0.60 - 1.64]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201171_at	198	0.212121	0.0134381	0.201163	0.729406	0.183891	0.154477	1.17 [0.93 - 1.47]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200096_s_at	198	0.131313	0.171871	-	0.695334	0.868955	-0.0438632	0.96 [0.57 - 1.61]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214244_s_at	198	0.419192	0.00613308	0.111043	0.754777	0.626344	0.0906408	1.09 [0.76 - 1.58]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201172_x_at	198	0.888889	0.0913359	-	0.492307	0.384983	0.213295	1.24 [0.76 - 2.00]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214244_s_at	198	0.419192	0.00543055	0.100984	0.804297	0.810445	0.0465159	1.05 [0.72 - 1.53]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201171_at	198	0.212121	0.0551547	-	0.717869	0.496612	0.0975842	1.10 [0.83 - 1.46]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214150_x_at	198	0.727273	0.0713284	-	-0.481764	0.88657	0.0342362	1.03 [0.65 - 1.66]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201171_at	198	0.212121	0.109212	-	0.605532	0.594522	0.0782323	1.08 [0.81 - 1.44]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	200096_s_at	198	0.10101	0.0895436	-	0.763984	0.581132	0.117813	1.13 [0.74 - 1.71]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214244_s_at	62	0.274194	0.0204882	0.272542	15.6133	0.0363193	1.16762	3.21 [1.08 - 9.59]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201171_at	62	0.854839	0.0335728	0.381751	1.22721	0.270712	0.278791	1.32 [0.80 - 2.17]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201172_x_at	51	0.784314	0.217208	-	-15.4333	0.238292	-1.19143	0.30 [0.04 - 2.20]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201172_x_at	62	0.532258	0.100139	-	-1.04783	0.778934	-0.22147	0.80 [0.17 - 3.76]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214150_x_at	51	0.54902	0.0944113	-	1.66998	0.746859	-1.04386	0.35 [0.00 - 199.26]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	200096_s_at	51	0.117647	0.0440145	0.454354	-1.64706	0.151283	-0.855262	0.43 [0.13 - 1.37]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214150_x_at	62	0.758065	0.037483	0.410194	-15.5046	0.35418	-2.01842	0.13 [0.00 - 9.50]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	200096_s_at	62	0.306452	0.269083	-	-0.636859	0.753231	-0.145234	0.86 [0.35 - 2.14]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214244_s_at	51	0.784314	0.000471579	0.0134787	2.85249	0.00222788	2.07387	7.96 [2.11 - 30.06]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201171_at	51	0.843137	0.00130086	0.0317491	2.36917	0.0659111	0.50506	1.66 [0.97 - 2.84]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201171_at	145	0.724138	0.0854397	-	-0.807799	0.626677	-0.254192	0.78 [0.28 - 2.16]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214150_x_at	177	0.175141	0.124432	-	0.656755	0.955148	0.0353939	1.04 [0.30 - 3.56]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	200096_s_at	177	0.384181	0.072209	-	0.450551	0.430688	0.324207	1.38 [0.62 - 3.10]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214244_s_at	177	0.677966	0.080827	-	-0.47988	0.31001	-0.388632	0.68 [0.32 - 1.44]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214150_x_at	177	0.576271	0.130445	-	0.3532	0.846295	0.106532	1.11 [0.38 - 3.27]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	200096_s_at	145	0.896552	0.291074	-	-0.750974	0.951743	0.0367806	1.04 [0.32 - 3.41]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201172_x_at	177	0.129944	0.173333	-	0.633752	0.640342	0.247648	1.28 [0.45 - 3.62]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214244_s_at	145	0.627586	0.0193831	0.262073	-0.951183	0.257163	-0.609126	0.54 [0.19 - 1.56]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201171_at	177	0.237288	0.0711167	-	0.649054	0.317592	0.40604	1.50 [0.68 - 3.33]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201172_x_at	177	0.463277	0.14276	-	0.349796	0.548852	0.276465	1.32 [0.53 - 3.26]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214150_x_at	145	0.889655	0.122441	-	-1.43935	0.660842	-0.353275	0.70 [0.14 - 3.40]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201171_at	177	0.887006	0.0256767	0.318816	0.721118	0.241173	0.412412	1.51 [0.76 - 3.01]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201172_x_at	145	0.124138	0.201559	-	-0.534064	0.854774	-0.125148	0.88 [0.23 - 3.37]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	200096_s_at	177	0.175141	0.148173	-	0.580797	0.567108	0.269786	1.31 [0.52 - 3.30]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214244_s_at	177	0.661017	0.0507166	-	-0.629949	0.148382	-0.635048	0.53 [0.22 - 1.25]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	200096_s_at	226	0.734513	0.0815498	-	-0.660136	0.922701	-0.0531986	0.95 [0.32 - 2.78]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214244_s_at	226	0.207965	0.400096	-	0.310326	0.605844	-0.10709	0.90 [0.60 - 1.35]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214150_x_at	226	0.327434	0.19093	-	0.430702	0.959218	0.0247896	1.03 [0.40 - 2.65]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201172_x_at	226	0.858407	0.26961	-	-0.568489	0.750721	-0.205881	0.81 [0.23 - 2.90]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201171_at	226	0.893805	0.122972	-	-1.06443	0.72601	-0.0593733	0.94 [0.68 - 1.31]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214150_x_at	55	0.127273	0.0509801	-	15.2877	0.117651	1.38594	4.00 [0.70 - 22.69]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	200096_s_at	55	0.781818	5.57584e-05	0.0020889	1.8424	0.00564651	1.81363	6.13 [1.70 - 22.15]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214244_s_at	55	0.727273	0.000156905	0.00520079	1.79485	0.00175039	1.52199	4.58 [1.77 - 11.88]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	200096_s_at	49	0.77551	0.0130883	0.197297	1.33736	0.155255	0.959892	2.61 [0.69 - 9.81]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214244_s_at	49	0.693878	0.0771619	-	0.981962	0.286297	0.609349	1.84 [0.60 - 5.64]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214150_x_at	55	0.890909	8.691e-06	0.000393445	2.29143	0.00457021	3.07502	21.65 [2.59 - 181.33]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201172_x_at	55	0.745455	0.00964565	0.157129	1.11455	0.0607689	1.21963	3.39 [0.95 - 12.11]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214150_x_at	49	0.897959	0.0250203	0.313202	1.39321	0.0392543	2.40252	11.05 [1.13 - 108.50]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201171_at	55	0.490909	0.0243963	0.307804	1.05262	0.137592	0.435887	1.55 [0.87 - 2.75]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201172_x_at	55	0.781818	9.2491e-05	0.00326944	1.79265	0.0030354	2.34848	10.47 [2.22 - 49.47]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201172_x_at	49	0.897959	0.0250203	0.313202	1.39321	0.106941	1.37595	3.96 [0.74 - 21.09]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201171_at	55	0.872727	0.000235165	0.00739926	1.85446	0.00168647	1.09606	2.99 [1.51 - 5.93]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	200096_s_at	55	0.690909	0.00159462	0.0375894	1.33697	0.0492632	1.01076	2.75 [1.00 - 7.53]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214244_s_at	55	0.181818	0.205016	-	0.913459	0.570999	0.25799	1.29 [0.53 - 3.16]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201171_at	49	0.897959	0.0185596	0.254115	1.45123	0.072583	0.693888	2.00 [0.94 - 4.27]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214150_x_at	63	0.285714	0.192262	-	0.544622	0.761633	-0.144937	0.87 [0.34 - 2.21]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201172_x_at	63	0.174603	0.115072	-	0.919771	0.322764	0.297639	1.35 [0.75 - 2.43]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201171_at	63	0.142857	0.00282084	0.0599342	-1.1661	0.481388	-0.508803	0.60 [0.15 - 2.48]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	200096_s_at	63	0.825397	0.356096	-	-0.442528	0.606109	0.143093	1.15 [0.67 - 1.99]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214244_s_at	63	0.761905	0.0505728	-	0.685218	0.897447	0.0646355	1.07 [0.40 - 2.85]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.24322.1.S1_3p_a_at	28	0.642857	0.0461444	0.467943	1.09726	0.219508	-0.177954	0.84 [0.63 - 1.11]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	200096_s_at	28	0.5	0.166464	-	-0.756427	0.542208	-0.529305	0.59 [0.11 - 3.23]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.24322.2.A1_3p_a_at	28	0.321429	0.0958476	-	-0.915974	0.897924	-0.0686179	0.93 [0.33 - 2.66]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502318_3p_x_at	28	0.535714	0.132029	-	0.855088	0.566849	0.105587	1.11 [0.77 - 1.60]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214244_s_at	82	0.878049	0.172306	-	-0.958535	0.938576	0.0299842	1.03 [0.48 - 2.21]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201171_at	82	0.731707	0.242486	-	-0.51914	0.642186	-0.146099	0.86 [0.47 - 1.60]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201172_x_at	82	0.378049	0.0673462	-	-0.614146	0.124863	-1.0111	0.36 [0.10 - 1.32]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214150_x_at	82	0.182927	0.00125166	0.030746	-1.13101	0.00655436	-1.69853	0.18 [0.05 - 0.62]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	200096_s_at	82	0.134146	0.00598075	0.10889	-1.06196	0.135636	-0.794425	0.45 [0.16 - 1.28]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33875_at	84	0.892857	0.108957	-	-0.927552	0.283089	-0.481013	0.62 [0.26 - 1.49]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214244_s_at	79	0.886076	0.162915	-	0.527769	0.940851	0.0267786	1.03 [0.51 - 2.08]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201171_at	79	0.658228	0.00460239	0.0886565	0.757242	0.795357	-0.0544229	0.95 [0.63 - 1.43]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201172_x_at	79	0.278481	0.131071	-	0.477291	0.770623	0.123569	1.13 [0.49 - 2.60]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214150_x_at	79	0.544304	0.209767	-	0.324579	0.841738	0.0872495	1.09 [0.46 - 2.57]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	200096_s_at	79	0.151899	0.169777	-	0.549197	0.703389	0.146246	1.16 [0.55 - 2.46]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214150_x_at	104	0.346154	0.026562	0.326286	-0.709728	0.296845	-0.555989	0.57 [0.20 - 1.63]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	200096_s_at	104	0.701923	0.134106	-	-0.573414	0.796808	-0.0975864	0.91 [0.43 - 1.91]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214244_s_at	104	0.884615	0.0638068	-	0.769573	0.929503	0.0421087	1.04 [0.41 - 2.65]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201171_at	104	0.894231	0.301686	-	0.451932	0.951013	-0.0191633	0.98 [0.53 - 1.81]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201172_x_at	104	0.653846	0.0905992	-	-0.618775	0.452194	-0.333253	0.72 [0.30 - 1.71]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P213840	117	0.615385	0.00273517	0.0584571	0.840515	0.720068	0.0988352	1.10 [0.64 - 1.90]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P12050	117	0.25641	0.00334799	0.0688056	-0.866293	0.151314	-0.27311	0.76 [0.52 - 1.11]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201172_x_at	204	0.289216	0.0250654	0.313589	0.797277	0.116538	0.99941	2.72 [0.78 - 9.46]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201171_at	204	0.29902	0.0781196	-	0.83943	0.776333	0.17588	1.19 [0.35 - 4.01]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201171_at	204	0.132353	0.103683	-	-0.563283	0.261393	-0.528536	0.59 [0.23 - 1.48]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	200096_s_at	204	0.215686	0.012297	0.188417	2.12457	0.265122	0.838169	2.31 [0.53 - 10.10]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214244_s_at	204	0.230392	0.0060232	0.109492	-0.985275	0.185215	-0.888663	0.41 [0.11 - 1.53]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	200096_s_at	204	0.20098	0.0193888	0.262127	1.04948	0.246407	0.635388	1.89 [0.64 - 5.53]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214244_s_at	204	0.259804	0.0304107	0.3575	-0.608034	0.0621606	-0.930484	0.39 [0.15 - 1.05]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214150_x_at	204	0.79902	0.00778877	0.133544	0.958371	0.391508	1.01837	2.77 [0.27 - 28.44]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214150_x_at	204	0.691176	0.0748862	-	0.4858	0.78555	0.240098	1.27 [0.23 - 7.17]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201172_x_at	204	0.833333	0.0455728	0.464333	0.777512	0.146366	1.26276	3.54 [0.64 - 19.43]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201171_at	178	0.269663	0.275882	-	-0.24406	0.769191	-0.0532641	0.95 [0.66 - 1.35]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201172_x_at	178	0.117978	0.146675	-	-0.43141	0.467289	-0.358301	0.70 [0.27 - 1.84]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214150_x_at	178	0.820225	0.218568	-	0.301215	0.50688	0.325535	1.38 [0.53 - 3.62]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	200096_s_at	178	0.140449	0.00390989	0.0778951	-0.742817	0.189251	-0.63803	0.53 [0.20 - 1.37]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214244_s_at	178	0.438202	0.0498266	0.490582	-0.386254	0.796949	-0.0659023	0.94 [0.57 - 1.55]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200003390	41	0.292683	0.094837	-	0.825269	0.639121	0.24621	1.28 [0.46 - 3.58]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201171_at	111	0.117117	0.105328	-	-0.58273	0.753722	-0.0411465	0.96 [0.74 - 1.24]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	200096_s_at	111	0.81982	0.0588722	-	-0.74394	0.651901	-0.148604	0.86 [0.45 - 1.64]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214244_s_at	111	0.81982	0.242286	-	0.37792	0.942255	0.018123	1.02 [0.62 - 1.66]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214150_x_at	111	0.216216	0.00489198	0.0930295	-0.781022	0.194483	-0.463264	0.63 [0.31 - 1.27]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201172_x_at	111	0.333333	0.161968	-	0.410021	0.54201	-0.245305	0.78 [0.36 - 1.72]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214244_s_at	90	0.833333	0.119133	-	-0.907197	0.700412	-0.235715	0.79 [0.24 - 2.62]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214244_s_at	90	0.255556	0.15592	-	-0.547826	0.95189	-0.0422914	0.96 [0.24 - 3.79]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201171_at	90	0.355556	0.0136671	0.203674	0.948335	0.174499	0.969616	2.64 [0.65 - 10.69]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201171_at	90	0.366667	0.00247969	0.0539861	1.49168	0.0495607	1.60758	4.99 [1.00 - 24.83]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201172_x_at	90	0.644444	0.0288189	0.344829	0.695796	0.807137	0.0977791	1.10 [0.50 - 2.42]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201172_x_at	90	0.7	0.0155878	0.224172	0.872131	0.977681	0.0124751	1.01 [0.42 - 2.43]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214150_x_at	90	0.666667	0.129642	-	0.493649	0.967636	-0.0147436	0.99 [0.48 - 2.01]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214150_x_at	90	0.888889	0.163713	-	0.673154	0.751118	-0.124818	0.88 [0.41 - 1.91]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	200096_s_at	90	0.744444	0.00800939	0.136431	0.855395	0.685373	0.140587	1.15 [0.58 - 2.27]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	200096_s_at	90	0.744444	0.0348886	0.391505	0.788257	0.642096	0.185033	1.20 [0.55 - 2.63]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201171_at	138	0.804348	0.000455502	0.0130845	0.895348	0.0454614	0.234828	1.26 [1.00 - 1.59]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	200096_s_at	138	0.594203	0.00528951	0.098922	0.662961	0.1238	0.286549	1.33 [0.92 - 1.92]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214244_s_at	138	0.862319	0.00134185	0.0325789	0.918211	0.0151	0.45976	1.58 [1.09 - 2.29]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214150_x_at	138	0.876812	0.0313274	0.364653	0.657547	0.710245	0.0987584	1.10 [0.66 - 1.86]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201172_x_at	138	0.623188	0.0172512	0.241178	0.575882	0.0845075	0.375014	1.46 [0.95 - 2.23]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214150_x_at	129	0.620155	0.132405	-	0.372268	0.92737	-0.0430939	0.96 [0.38 - 2.42]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	200096_s_at	129	0.426357	0.262473	-	-0.279976	0.726859	-0.172982	0.84 [0.32 - 2.22]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214244_s_at	129	0.465116	0.0857412	-	0.434461	0.611736	0.121714	1.13 [0.71 - 1.81]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201171_at	129	0.224806	0.142628	-	-0.424787	0.185688	-0.206622	0.81 [0.60 - 1.10]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201172_x_at	129	0.844961	0.0624561	-	-0.729911	0.754599	-0.194281	0.82 [0.24 - 2.78]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10852	56	0.892857	0.0359318	0.399103	1.03076	0.567953	-0.217726	0.80 [0.38 - 1.70]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10852	56	0.392857	0.0830685	-	-0.610014	0.694034	-0.1527	0.86 [0.40 - 1.84]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214150_x_at	278	0.884892	0.295333	-	0.279803	0.949873	0.0158999	1.02 [0.62 - 1.67]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201172_x_at	278	0.848921	0.196773	-	0.31186	0.8303	-0.0480096	0.95 [0.61 - 1.48]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201171_at	278	0.269784	0.331781	-	0.209435	0.815435	0.0348671	1.04 [0.77 - 1.39]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	200096_s_at	278	0.323741	0.125706	-	-0.306056	0.579941	-0.124616	0.88 [0.57 - 1.37]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214244_s_at	278	0.111511	0.16295	-	-0.393688	0.932505	0.0177907	1.02 [0.67 - 1.54]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201172_x_at	133	0.571429	0.0388318	0.41964	-0.508691	0.359311	-0.153245	0.86 [0.62 - 1.19]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214150_x_at	133	0.105263	0.286317	-	-0.36695	0.469438	-0.195076	0.82 [0.48 - 1.40]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	200096_s_at	133	0.646617	0.00550174	0.102019	-0.770377	0.166131	-0.208229	0.81 [0.60 - 1.09]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214244_s_at	133	0.721804	0.00236456	0.0519372	0.732596	0.00086729	0.702579	2.02 [1.34 - 3.05]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201171_at	133	0.368421	0.00738608	0.128212	0.735772	0.0190242	0.468074	1.60 [1.08 - 2.36]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15234	81	0.876543	0.0177518	0.246172	1.31036	0.679135	0.182724	1.20 [0.51 - 2.85]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	8605	81	0.111111	0.00590081	0.107754	-1.39884	0.83946	0.091303	1.10 [0.45 - 2.65]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200096_s_at	185	0.897297	0.00769869	0.132359	-0.942777	0.845937	-0.0196022	0.98 [0.80 - 1.19]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214244_s_at	185	0.827027	0.00136781	0.0331018	-0.826676	0.0547533	-0.538732	0.58 [0.34 - 1.01]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201172_x_at	185	0.810811	0.0576373	-	-0.390282	0.844549	-0.0208926	0.98 [0.79 - 1.21]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214150_x_at	185	0.848649	0.025211	0.314839	-0.583588	0.634249	0.0569492	1.06 [0.84 - 1.34]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201171_at	185	0.789189	0.199261	-	-0.257943	0.140897	-0.336001	0.71 [0.46 - 1.12]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201172_x_at	185	0.810811	0.0256197	0.31833	-0.523334	0.555166	-0.068054	0.93 [0.75 - 1.17]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	200096_s_at	185	0.897297	0.0627273	-	-0.50675	0.797009	0.0238512	1.02 [0.85 - 1.23]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214244_s_at	185	0.832432	0.00125217	0.0307565	-0.756067	0.0239258	-0.581579	0.56 [0.34 - 0.93]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201171_at	185	0.87027	0.0583681	-	-0.569951	0.0728382	-0.488888	0.61 [0.36 - 1.05]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214150_x_at	185	0.848649	0.0218599	0.285219	-0.532245	0.490348	0.0749525	1.08 [0.87 - 1.33]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P213840	110	0.372727	0.158729	-	-0.411826	0.745238	0.0786359	1.08 [0.67 - 1.74]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P12050	110	0.654545	0.130261	-	0.444042	0.493103	0.113969	1.12 [0.81 - 1.55]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P213840	110	0.109091	0.100068	-	0.682911	0.34546	0.17334	1.19 [0.83 - 1.70]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P12050	110	0.654545	0.194993	-	0.302128	0.587345	0.0730226	1.08 [0.83 - 1.40]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214150_x_at	80	0.2125	0.122203	-	1.45847	0.786724	0.105371	1.11 [0.52 - 2.38]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	200096_s_at	80	0.1375	0.070259	-	15.237	0.264201	0.451232	1.57 [0.71 - 3.47]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214244_s_at	80	0.25	0.148382	-	0.87684	0.795532	0.0608964	1.06 [0.67 - 1.68]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201171_at	80	0.85	0.33642	-	0.492253	0.776034	0.0415669	1.04 [0.78 - 1.39]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201172_x_at	80	0.7625	0.0812656	-	-1.05459	0.941584	0.0315996	1.03 [0.44 - 2.40]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_0963	281	0.565836	0.120096	-	0.218804	0.160349	0.150841	1.16 [0.94 - 1.44]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	200096_s_at	38	0.684211	0.0386891	0.418649	1.04827	0.617069	0.381138	1.46 [0.33 - 6.52]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214244_s_at	38	0.894737	0.0420464	0.441456	1.2434	0.89635	0.0505067	1.05 [0.49 - 2.25]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214150_x_at	38	0.210526	0.0822465	-	-0.811924	0.378242	-0.860568	0.42 [0.06 - 2.87]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201172_x_at	38	0.763158	0.0162851	0.231381	1.23376	0.930016	-0.07279	0.93 [0.18 - 4.72]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201171_at	38	0.894737	0.0420464	0.441456	1.2434	0.456769	0.168814	1.18 [0.76 - 1.85]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201171_at	140	0.357143	0.28859	-	0.34455	0.711855	0.142231	1.15 [0.54 - 2.45]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201172_x_at	140	0.585714	0.135269	-	-0.454611	0.553819	0.193015	1.21 [0.64 - 2.30]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214150_x_at	140	0.778571	0.0583013	-	0.572846	0.379789	0.351556	1.42 [0.65 - 3.11]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	200096_s_at	140	0.7	0.10938	-	-0.544505	0.819043	0.0537824	1.06 [0.67 - 1.67]
GENE	ATP6V0E1	ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214244_s_at	140	0.807143	0.138166	-	0.467303	0.569379	0.298573	1.35 [0.48 - 3.77]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201972_at	30	0.433333	0.00873028	0.145697	-1.08893	0.22964	-0.818793	0.44 [0.12 - 1.68]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201971_s_at	30	0.833333	0.0127731	0.193783	1.34147	0.455292	0.255674	1.29 [0.66 - 2.53]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1711516	165	0.848485	0.0287254	0.344074	0.671641	0.585483	0.0883525	1.09 [0.80 - 1.50]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1711516	165	0.709091	0.0617738	-	0.662345	0.472586	0.186525	1.21 [0.72 - 2.00]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201971_s_at	163	0.791411	0.0475895	0.476954	-0.532324	0.578078	-0.1334	0.88 [0.55 - 1.40]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201972_at	163	0.190184	0.164066	-	-0.322872	0.732466	-0.0585126	0.94 [0.67 - 1.32]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201971_s_at	79	0.265823	0.144886	-	-0.453228	0.607601	-0.123125	0.88 [0.55 - 1.41]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201972_at	79	0.189873	0.184551	-	0.53785	0.97653	0.00730978	1.01 [0.62 - 1.64]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201972_at	58	0.637931	0.0745365	-	0.503974	0.137504	0.416557	1.52 [0.88 - 2.63]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201971_s_at	58	0.258621	0.0035562	0.0722147	0.956775	0.0486849	0.327661	1.39 [1.00 - 1.92]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201971_s_at	34	0.676471	0.025015	0.313156	0.923251	0.510086	0.175363	1.19 [0.71 - 2.01]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201972_at	34	0.235294	0.00116116	0.0288802	1.81071	0.0406867	0.705302	2.02 [1.03 - 3.98]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201972_at	158	0.71519	0.0423519	0.44348	-0.554181	0.397183	-0.227362	0.80 [0.47 - 1.35]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201971_s_at	158	0.170886	0.0903327	-	-0.488516	0.939715	-0.0145371	0.99 [0.68 - 1.44]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201971_s_at	53	0.867925	0.219245	-	0.557236	0.666693	0.179072	1.20 [0.53 - 2.70]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201972_at	53	0.132075	0.00751832	0.129973	-1.122	0.150548	-0.727446	0.48 [0.18 - 1.30]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201971_s_at	53	0.283019	0.10096	-	0.684105	0.437412	0.300422	1.35 [0.63 - 2.88]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201972_at	53	0.132075	0.015805	0.226431	-1.00484	0.327858	-0.460202	0.63 [0.25 - 1.59]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201972_at	180	0.738889	0.0822307	-	0.389689	0.477969	0.181639	1.20 [0.73 - 1.98]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201971_s_at	180	0.75	0.0492906	0.487352	-0.499617	0.172703	-0.138109	0.87 [0.71 - 1.06]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201971_s_at	559	0.13059	0.0168387	0.237022	0.96846	0.439548	0.136026	1.15 [0.81 - 1.62]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201972_at	559	0.168157	0.177874	-	0.44642	0.91743	-0.0349317	0.97 [0.50 - 1.87]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201971_s_at	77	0.363636	0.0124473	0.190119	-0.666763	0.107612	-0.318985	0.73 [0.49 - 1.07]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201972_at	77	0.883117	0.0843413	-	-0.863038	0.302014	-0.479466	0.62 [0.25 - 1.54]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201971_s_at	70	0.342857	0.15829	-	0.40094	0.884523	0.0843596	1.09 [0.35 - 3.40]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201972_at	70	0.585714	0.0663594	-	-0.498937	0.419911	-0.288891	0.75 [0.37 - 1.51]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34890_at	50	0.62	0.00462894	0.0890604	-1.20698	0.896689	-0.0262408	0.97 [0.66 - 1.45]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34889_at	50	0.82	0.0311587	0.363345	0.865052	0.705438	0.120031	1.13 [0.61 - 2.10]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201971_s_at	74	0.121622	0.0906344	-	-0.655182	0.245532	-0.156368	0.86 [0.66 - 1.11]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201972_at	74	0.324324	0.0509699	-	-0.592416	0.623275	0.203713	1.23 [0.54 - 2.76]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201971_s_at	67	0.850746	9.06157e-08	5.856e-06	3.15356	0.00345685	3.10559	22.32 [2.78 - 179.00]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201972_at	67	0.791045	4.32237e-05	0.00166539	2.35386	0.00112035	3.83729	46.40 [4.61 - 466.61]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201971_s_at	115	0.895652	0.0118592	0.183419	1.37322	0.0305545	1.30083	3.67 [1.13 - 11.94]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201972_at	115	0.895652	0.00470929	0.0902789	1.51892	0.0878098	2.07522	7.97 [0.74 - 86.31]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34889_at	158	0.449367	0.0336146	0.382064	-0.612737	0.16126	-0.543045	0.58 [0.27 - 1.24]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34890_at	158	0.860759	0.0440193	0.454385	0.781765	0.744687	0.0601456	1.06 [0.74 - 1.53]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34889_at	76	0.131579	0.151336	-	15.2211	0.518306	0.435282	1.55 [0.41 - 5.79]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34890_at	76	0.631579	0.0671966	-	0.933373	0.14322	0.680243	1.97 [0.79 - 4.91]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201972_at	204	0.882353	0.190822	-	0.282638	0.40948	0.251872	1.29 [0.71 - 2.34]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201971_s_at	204	0.813725	0.116873	-	0.281918	0.799645	0.0241306	1.02 [0.85 - 1.23]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201972_at	87	0.252874	0.122396	-	0.812385	0.63271	0.304663	1.36 [0.39 - 4.73]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201971_s_at	87	0.793103	0.0372536	0.408569	0.865364	0.211912	0.320393	1.38 [0.83 - 2.28]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201972_at	87	0.252874	0.122396	-	0.812385	0.63271	0.304663	1.36 [0.39 - 4.73]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201971_s_at	87	0.793103	0.0372536	0.408569	0.865364	0.211912	0.320393	1.38 [0.83 - 2.28]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201972_at	77	0.545455	0.0143154	0.210703	-2.14774	0.195277	-1.16053	0.31 [0.05 - 1.81]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201971_s_at	77	0.194805	0.120201	-	15.3494	0.489503	0.200417	1.22 [0.69 - 2.16]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201972_at	77	0.545455	0.0204639	0.272314	-1.60551	0.137793	-1.16173	0.31 [0.07 - 1.45]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201971_s_at	77	0.103896	0.196072	-	15.1943	0.949257	0.0164703	1.02 [0.61 - 1.69]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201971_s_at	136	0.205882	0.0008058	0.0212513	-1.40267	0.0768763	-0.452452	0.64 [0.39 - 1.05]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201972_at	136	0.764706	0.0856098	-	0.799796	0.463522	0.432522	1.54 [0.48 - 4.90]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201971_s_at	200	0.2	0.000147991	0.00494134	-1.14737	0.0373948	-0.713881	0.49 [0.25 - 0.96]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201972_at	200	0.79	0.0136759	0.203771	0.758673	0.272268	0.705682	2.03 [0.57 - 7.14]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7826	60	0.783333	0.171179	-	-0.722326	0.764468	-0.0745767	0.93 [0.57 - 1.51]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20557	60	0.333333	0.0724739	-	-0.679427	0.992631	0.00283141	1.00 [0.55 - 1.83]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20557	60	0.366667	0.231206	-	0.497674	0.788926	0.0929575	1.10 [0.56 - 2.17]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7826	60	0.783333	0.0430338	0.447969	0.807245	0.500567	0.404134	1.50 [0.46 - 4.86]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201971_s_at	286	0.283217	0.0181132	0.249743	-0.470643	0.0572627	-0.175048	0.84 [0.70 - 1.01]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201972_at	286	0.241259	0.00637132	0.11438	0.723872	0.0309121	0.708359	2.03 [1.07 - 3.86]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201971_s_at	159	0.698113	0.036837	0.405605	0.658208	0.800743	0.0556046	1.06 [0.69 - 1.63]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201972_at	159	0.157233	0.176751	-	0.953465	0.901129	0.0820199	1.09 [0.30 - 3.96]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201971_s_at	159	0.289308	0.088661	-	-0.54298	0.999781	-5.86677e-05	1.00 [0.66 - 1.52]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201972_at	159	0.886792	0.147548	-	-1.00775	0.921902	-0.0552693	0.95 [0.31 - 2.86]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201971_s_at	159	0.698113	0.10561	-	0.602834	0.945871	-0.0168532	0.98 [0.60 - 1.60]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201972_at	159	0.647799	0.0553799	-	0.597838	0.622094	0.274959	1.32 [0.44 - 3.93]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201971_s_at	54	0.111111	0.00327397	0.0675813	-1.9918	0.534942	-0.263777	0.77 [0.33 - 1.77]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201972_at	54	0.518519	0.251417	-	-0.79566	0.859469	0.0956281	1.10 [0.38 - 3.17]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201971_s_at	117	0.196581	0.0190038	0.258425	-0.910177	0.062551	-0.489312	0.61 [0.37 - 1.03]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201971_s_at	117	0.897436	0.101277	-	-1.52808	0.530615	-0.103839	0.90 [0.65 - 1.25]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201972_at	117	0.786325	0.0695458	-	-0.849954	0.960955	0.0145909	1.01 [0.57 - 1.82]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201972_at	117	0.786325	0.260441	-	-0.599546	0.905363	0.0425746	1.04 [0.52 - 2.11]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201972_at	117	0.786325	0.0695458	-	-0.849954	0.960955	0.0145909	1.01 [0.57 - 1.82]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201972_at	117	0.786325	0.0168349	0.236983	-2.0562	0.53085	-0.232284	0.79 [0.38 - 1.64]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201971_s_at	117	0.897436	0.101277	-	-1.52808	0.530615	-0.103839	0.90 [0.65 - 1.25]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201971_s_at	117	0.897436	0.325197	-	-0.964288	0.818794	-0.0452138	0.96 [0.65 - 1.41]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201971_s_at	236	0.555085	0.105937	-	0.434049	0.519211	0.158123	1.17 [0.72 - 1.89]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201972_at	236	0.364407	0.0138079	0.20521	0.764998	0.0853623	0.897848	2.45 [0.88 - 6.83]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201972_at	249	0.738956	0.00345437	0.0705536	0.648419	0.0367035	0.866732	2.38 [1.05 - 5.37]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201971_s_at	249	0.64257	0.014725	0.215086	0.514271	0.346557	0.184737	1.20 [0.82 - 1.77]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201971_s_at	125	0.808	0.165523	-	0.563968	0.711486	0.0742704	1.08 [0.73 - 1.60]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201972_at	62	0.806452	0.176245	-	0.680119	0.676728	-0.179312	0.84 [0.36 - 1.94]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201971_s_at	125	0.328	0.28858	-	-0.341013	0.737702	-0.0520952	0.95 [0.70 - 1.29]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201971_s_at	54	0.148148	0.0458573	0.466133	-1.32258	0.473135	-0.353329	0.70 [0.27 - 1.84]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201972_at	125	0.8	0.00610563	0.110656	1.01911	0.171159	0.746629	2.11 [0.72 - 6.15]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201972_at	125	0.8	0.0900892	-	0.531702	0.403641	0.360481	1.43 [0.62 - 3.34]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201972_at	54	0.796296	0.343528	-	0.582982	0.84611	-0.102657	0.90 [0.32 - 2.54]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201971_s_at	62	0.290323	0.0399162	0.427107	-1.00907	0.330341	-0.372522	0.69 [0.33 - 1.46]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201972_at	198	0.287879	0.0401257	0.428536	0.671263	0.995382	0.00160385	1.00 [0.58 - 1.72]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201972_at	198	0.287879	0.0336211	0.382113	0.755501	0.590351	0.155999	1.17 [0.66 - 2.06]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201971_s_at	198	0.843434	1.731e-05	0.000733423	0.997652	0.0516857	0.261046	1.30 [1.00 - 1.69]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201971_s_at	198	0.878788	0.0527773	-	0.618104	0.233678	0.184945	1.20 [0.89 - 1.63]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201972_at	198	0.409091	0.0279701	0.337937	0.486855	0.0778941	0.405167	1.50 [0.96 - 2.35]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201971_s_at	198	0.858586	0.108872	-	0.503645	0.337372	0.154455	1.17 [0.85 - 1.60]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201971_s_at	51	0.45098	0.251041	-	1.20845	0.376675	1.6685	5.30 [0.13 - 214.37]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201971_s_at	62	0.83871	0.0754712	-	1.04562	0.0467671	1.99748	7.37 [1.03 - 52.80]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201972_at	51	0.803922	0.000149709	0.00499151	3.0011	0.0740725	2.88173	17.85 [0.76 - 421.54]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201972_at	62	0.774194	0.0102352	0.164309	1.37702	0.22658	1.16215	3.20 [0.49 - 21.03]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201972_at	177	0.728814	0.415792	-	0.237435	0.987147	-0.00992026	0.99 [0.30 - 3.31]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201971_s_at	145	0.2	0.0750378	-	0.913934	0.567905	0.169326	1.18 [0.66 - 2.12]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201971_s_at	177	0.632768	0.17622	-	-0.41741	0.851845	-0.0436763	0.96 [0.61 - 1.51]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201972_at	177	0.694915	0.105683	-	0.388027	0.337379	0.513754	1.67 [0.59 - 4.77]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201971_s_at	177	0.361582	0.191639	-	0.327883	0.984283	-0.00404789	1.00 [0.67 - 1.49]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201972_at	145	0.234483	0.155221	-	0.673483	0.393784	0.648223	1.91 [0.43 - 8.48]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201972_at	226	0.216814	0.135583	-	0.600555	0.311505	0.581406	1.79 [0.58 - 5.51]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201971_s_at	226	0.123894	0.0764194	-	1.01363	0.896654	0.0362173	1.04 [0.60 - 1.79]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201972_at	55	0.872727	0.0168338	0.236972	1.18453	0.39231	0.696757	2.01 [0.41 - 9.91]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201972_at	55	0.363636	0.0148087	0.215976	-1.19561	0.651736	-0.374188	0.69 [0.14 - 3.49]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201971_s_at	55	0.381818	0.140092	-	0.745215	0.501337	0.205798	1.23 [0.67 - 2.24]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201972_at	49	0.326531	0.0419092	0.440544	-1.13036	0.634911	-0.52717	0.59 [0.07 - 5.20]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201971_s_at	55	0.6	0.245102	-	-0.626082	0.888169	-0.0406841	0.96 [0.54 - 1.69]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201971_s_at	49	0.183673	0.048359	0.481685	-1.15042	0.393791	-0.265063	0.77 [0.42 - 1.41]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	825170	34	0.176471	0.064742	-	1.69283	0.726551	0.332703	1.39 [0.22 - 9.00]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	131291	34	0.882353	0.0124173	0.18978	1.38394	0.22264	0.566001	1.76 [0.71 - 4.37]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201972_at	63	0.793651	0.00282174	0.0599498	-1.89669	0.0320236	-0.644011	0.53 [0.29 - 0.95]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201971_s_at	63	0.47619	0.224074	-	-0.410683	0.922653	0.0380911	1.04 [0.48 - 2.24]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502304_3p_a_at	28	0.571429	0.210469	-	-0.709438	0.350209	-1.30533	0.27 [0.02 - 4.19]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6523820_3p_at	28	0.892857	0.263331	-	0.860973	0.404891	0.11884	1.13 [0.85 - 1.49]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201971_s_at	82	0.682927	0.0225795	0.291735	-0.983226	0.074032	-0.615387	0.54 [0.28 - 1.06]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201972_at	82	0.743902	0.0863504	-	-0.808473	0.559648	-0.254615	0.78 [0.33 - 1.82]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34889_at	84	0.845238	0.0371091	0.407543	0.702543	0.288057	0.332982	1.40 [0.75 - 2.58]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34890_at	84	0.678571	0.377129	-	-0.281137	0.954412	-0.0159956	0.98 [0.57 - 1.70]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201971_s_at	79	0.873418	0.178888	-	0.488421	0.415262	0.244604	1.28 [0.71 - 2.30]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201972_at	79	0.35443	0.0469014	0.472684	-0.523874	0.94856	-0.0379555	0.96 [0.30 - 3.05]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201972_at	104	0.586538	0.0598611	-	-0.664123	0.397138	-0.448014	0.64 [0.23 - 1.80]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201971_s_at	104	0.865385	0.238768	-	-0.697016	0.664081	-0.118532	0.89 [0.52 - 1.52]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P211965	117	0.282051	0.0248803	0.311996	0.844047	0.126389	0.453255	1.57 [0.88 - 2.81]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P396994	117	0.897436	0.00740648	0.128485	0.957403	0.350743	0.312693	1.37 [0.71 - 2.64]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201971_s_at	204	0.313726	0.00522185	0.0979277	0.980679	0.0384331	0.782625	2.19 [1.04 - 4.59]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201972_at	204	0.54902	0.00202389	0.0457378	1.1643	0.0151956	2.0126	7.48 [1.47 - 38.00]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201972_at	204	0.617647	0.000116303	0.00400002	1.02372	0.000881381	2.05728	7.82 [2.33 - 26.30]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201971_s_at	204	0.22549	0.0251946	0.314699	1.49552	0.226504	0.619833	1.86 [0.68 - 5.08]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201971_s_at	178	0.629214	0.0592547	-	-0.396027	0.200956	-0.298812	0.74 [0.47 - 1.17]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201972_at	178	0.533708	0.110091	-	-0.317272	0.946209	-0.0255682	0.97 [0.46 - 2.05]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201972_at	111	0.711712	0.0376367	0.411279	-0.664939	0.867614	-0.0667493	0.94 [0.43 - 2.05]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201971_s_at	111	0.864865	0.103318	-	-0.690138	0.683581	-0.0744081	0.93 [0.65 - 1.33]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201971_s_at	90	0.177778	0.0542054	-	-0.696081	0.994953	-0.00176663	1.00 [0.58 - 1.73]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201971_s_at	90	0.866667	0.0557932	-	0.810974	0.402101	0.26511	1.30 [0.70 - 2.42]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201972_at	90	0.466667	0.241514	-	0.391552	0.724169	0.116575	1.12 [0.59 - 2.15]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201972_at	90	0.822222	0.104208	-	0.664325	0.674692	0.158716	1.17 [0.56 - 2.46]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	4940	50	0.12	0.0886338	-	15.255	0.903531	-0.0620452	0.94 [0.34 - 2.56]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5097	50	0.82	0.149575	-	-1.36784	0.716901	0.162772	1.18 [0.49 - 2.84]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201972_at	138	0.144928	0.0128338	0.194462	1.10587	0.299206	0.250832	1.29 [0.80 - 2.06]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201971_s_at	138	0.862319	0.00595754	0.108561	0.804613	0.0805228	0.186312	1.20 [0.98 - 1.48]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201972_at	129	0.627907	0.16481	-	0.34631	0.983639	-0.0106138	0.99 [0.36 - 2.73]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201971_s_at	129	0.860465	0.185502	-	-0.608563	0.52179	-0.222297	0.80 [0.41 - 1.58]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31939	56	0.482143	0.192955	-	-0.440857	0.497566	-0.214806	0.81 [0.43 - 1.50]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19688	56	0.125	0.00271701	0.0581424	-1.2463	0.519761	-0.212675	0.81 [0.42 - 1.54]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31939	56	0.482143	0.252396	-	-0.406686	0.744443	-0.109833	0.90 [0.46 - 1.73]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19688	56	0.125	0.0139498	0.206753	-1.1021	0.94403	-0.0236283	0.98 [0.50 - 1.89]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201972_at	278	0.44964	0.0267789	0.328098	-0.415609	0.290885	-0.259636	0.77 [0.48 - 1.25]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201971_s_at	278	0.503597	0.0152433	0.220567	-0.470465	0.121395	-0.199279	0.82 [0.64 - 1.05]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201972_at	133	0.218045	0.00169746	0.0395801	-0.791739	0.0194993	-0.394229	0.67 [0.48 - 0.94]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201971_s_at	133	0.308271	0.0110643	0.174182	-0.602578	0.0903433	-0.181558	0.83 [0.68 - 1.03]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5470	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201971_s_at	185	0.275676	0.126881	-	0.275346	0.97071	0.00500711	1.01 [0.77 - 1.31]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201972_at	185	0.897297	0.0761615	-	-0.557054	0.892215	-0.0200977	0.98 [0.73 - 1.31]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201971_s_at	185	0.816216	0.0351584	0.393481	-0.590565	0.403274	-0.128436	0.88 [0.65 - 1.19]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201972_at	185	0.897297	0.104873	-	-0.441971	0.970948	-0.00488657	1.00 [0.77 - 1.29]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P396994	110	0.827273	0.000119687	0.00410212	1.33325	0.0791862	0.493469	1.64 [0.94 - 2.84]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P211965	110	0.190909	0.238472	-	0.357888	0.407608	0.214902	1.24 [0.75 - 2.06]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P396994	110	0.818182	0.00389596	0.0776739	0.800904	0.325345	0.201285	1.22 [0.82 - 1.83]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P211965	110	0.718182	0.0901408	-	0.540183	0.296261	0.394192	1.48 [0.71 - 3.11]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201972_at	80	0.65	0.18269	-	-0.654936	0.455703	-0.360508	0.70 [0.27 - 1.80]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201971_s_at	80	0.45	0.0218848	0.285446	1.1199	0.179331	0.413824	1.51 [0.83 - 2.77]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_3468	281	0.854093	0.0145088	0.212778	0.46467	0.682577	0.0648934	1.07 [0.78 - 1.46]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201972_at	38	0.763158	0.0923068	-	0.914284	0.396118	0.676667	1.97 [0.41 - 9.39]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201971_s_at	38	0.894737	0.0113273	0.177262	1.36023	0.654398	0.155117	1.17 [0.59 - 2.30]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201971_s_at	140	0.535714	0.00477134	0.0912163	-0.844	0.100892	-0.508833	0.60 [0.33 - 1.10]
GENE	ATP6V1A	ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201972_at	140	0.185714	0.00256668	0.0555198	-0.930249	0.276645	-0.35823	0.70 [0.37 - 1.33]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205473_at	30	0.433333	0.00130512	0.0318355	1.35206	0.137583	0.964946	2.62 [0.73 - 9.38]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1812073	165	0.460606	0.000200221	0.00643356	0.941756	0.0016701	0.292954	1.34 [1.12 - 1.61]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1812073	165	0.466667	6.87478e-05	0.00251533	1.72185	0.000475926	0.437389	1.55 [1.21 - 1.98]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205473_at	163	0.165644	0.114355	-	-0.3838	0.924476	-0.0730278	0.93 [0.21 - 4.21]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1554847_at	79	0.278481	0.125998	-	0.523722	0.714341	0.306511	1.36 [0.26 - 7.01]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205473_at	79	0.379747	0.114172	-	-0.457634	0.455447	-0.748151	0.47 [0.07 - 3.38]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205473_at	58	0.172414	0.188742	-	0.478242	0.727986	0.0517796	1.05 [0.79 - 1.41]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205473_at	34	0.117647	0.137779	-	-0.803694	0.926564	0.0275137	1.03 [0.57 - 1.85]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205473_at	158	0.170886	0.0286513	0.343476	-0.595782	0.71744	-0.28279	0.75 [0.16 - 3.49]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205473_at	53	0.603774	0.0329908	0.377376	0.719053	0.43148	0.214178	1.24 [0.73 - 2.11]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205473_at	53	0.603774	0.128364	-	0.551344	0.488856	0.202789	1.22 [0.69 - 2.18]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205473_at	180	0.277778	0.0500901	-	0.501332	0.342796	0.0890983	1.09 [0.91 - 1.31]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1554847_at	559	0.711986	0.0239995	0.30434	-0.568539	0.045642	-0.217226	0.80 [0.65 - 1.00]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205473_at	559	0.636852	0.135739	-	-0.335868	0.611493	-0.0610207	0.94 [0.74 - 1.19]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205473_at	77	0.103896	0.113712	-	-0.633615	0.736472	-0.0477229	0.95 [0.72 - 1.26]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1554847_at	70	0.471429	0.411683	-	0.21646	0.688556	0.268357	1.31 [0.35 - 4.86]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205473_at	70	0.371429	0.143317	-	0.398334	0.62419	-0.320018	0.73 [0.20 - 2.61]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32959_at	50	0.12	0.00850703	0.142854	-1.21602	0.131362	-1.84306	0.16 [0.01 - 1.74]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205473_at	74	0.891892	0.192048	-	-0.761217	0.515046	-0.106207	0.90 [0.65 - 1.24]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1554847_at	67	0.895522	0.10317	-	1.25192	0.573031	1.3155	3.73 [0.04 - 361.55]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205473_at	67	0.477612	0.0767104	-	1.33685	0.944939	-0.138315	0.87 [0.02 - 44.12]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205473_at	115	0.173913	0.0747692	-	15.3292	0.418872	0.292317	1.34 [0.66 - 2.72]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1554847_at	115	0.895652	0.00091202	0.0235882	1.65175	0.722961	0.353879	1.42 [0.20 - 10.08]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32959_at	158	0.28481	0.0556936	-	-0.562116	0.438025	-0.194353	0.82 [0.50 - 1.35]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32959_at	76	0.565789	0.0777043	-	-1.08567	0.650904	-0.199781	0.82 [0.34 - 1.95]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1554847_at	204	0.897059	0.00406689	0.080375	-0.655521	0.0891983	-0.113676	0.89 [0.78 - 1.02]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205473_at	204	0.72549	0.00218453	0.0486878	-0.488826	0.0126823	-0.137895	0.87 [0.78 - 0.97]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205473_at	87	0.678161	0.015043	0.218457	0.890612	0.159724	0.210653	1.23 [0.92 - 1.66]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1554847_at	87	0.482759	0.00197856	0.0448962	1.32634	0.259487	0.654116	1.92 [0.62 - 6.00]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1554847_at	87	0.482759	0.00197856	0.0448962	1.32634	0.259487	0.654116	1.92 [0.62 - 6.00]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205473_at	87	0.678161	0.015043	0.218457	0.890612	0.159724	0.210653	1.23 [0.92 - 1.66]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554847_at	77	0.103896	0.0169868	0.238518	-1.50601	0.583309	-0.652813	0.52 [0.05 - 5.36]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205473_at	77	0.181818	0.126188	-	15.3397	0.532905	0.164529	1.18 [0.70 - 1.98]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554847_at	77	0.103896	0.0758196	-	-1.11257	0.701278	-0.391697	0.68 [0.09 - 5.00]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205473_at	77	0.181818	0.0781728	-	15.3469	0.823209	0.0544332	1.06 [0.66 - 1.70]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205473_at	136	0.558824	0.0245032	0.308733	1.01634	0.451209	0.131847	1.14 [0.81 - 1.61]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205473_at	200	0.31	0.050656	-	0.711229	0.55011	0.0864953	1.09 [0.82 - 1.45]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5652	60	0.8	0.0816606	-	0.690379	0.44883	0.0905809	1.09 [0.87 - 1.38]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5652	60	0.716667	0.00675809	0.119722	1.00536	0.295758	0.15821	1.17 [0.87 - 1.58]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205473_at	286	0.160839	0.0029221	0.061667	-0.660339	0.142796	-0.117571	0.89 [0.76 - 1.04]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205473_at	159	0.691824	0.00739839	0.128377	0.82581	0.0270679	0.337218	1.40 [1.04 - 1.89]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205473_at	159	0.106918	0.153842	-	1.34734	0.259257	0.19406	1.21 [0.87 - 1.70]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205473_at	159	0.106918	0.0628516	-	1.67971	0.280324	0.156924	1.17 [0.88 - 1.56]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205473_at	54	0.462963	0.0179302	0.247937	2.10991	0.378962	0.237188	1.27 [0.75 - 2.15]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205473_at	117	0.273504	0.132931	-	-0.494689	0.893356	-0.0226364	0.98 [0.70 - 1.36]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205473_at	117	0.777778	0.212864	-	-0.661564	0.504889	-0.142053	0.87 [0.57 - 1.32]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205473_at	117	0.273504	0.132931	-	-0.494689	0.893356	-0.0226364	0.98 [0.70 - 1.36]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205473_at	117	0.179487	0.139138	-	1.04196	0.840472	-0.0427828	0.96 [0.63 - 1.45]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205473_at	236	0.275424	0.019058	0.258948	0.86943	0.183919	0.156915	1.17 [0.93 - 1.47]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205473_at	249	0.433735	0.0948866	-	0.365069	0.8005	0.023493	1.02 [0.85 - 1.23]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205473_at	62	0.16129	0.210863	-	-0.806362	0.808057	-0.0519308	0.95 [0.62 - 1.44]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205473_at	125	0.128	0.172927	-	1.29708	0.465057	0.159088	1.17 [0.77 - 1.80]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205473_at	125	0.864	0.341387	-	-0.414871	0.757049	-0.060271	0.94 [0.64 - 1.38]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205473_at	54	0.148148	0.090337	-	-1.33783	0.896993	0.0324141	1.03 [0.63 - 1.69]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205473_at	198	0.565657	0.0448058	0.459447	0.51003	0.32156	0.0700277	1.07 [0.93 - 1.23]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205473_at	198	0.565657	0.052095	-	0.515644	0.387152	0.0642748	1.07 [0.92 - 1.23]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205473_at	198	0.227273	0.00404735	0.0800677	0.865809	0.033601	0.126664	1.14 [1.01 - 1.28]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205473_at	51	0.470588	0.0264626	0.325452	16.1933	0.486377	1.69946	5.47 [0.05 - 655.07]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205473_at	62	0.806452	0.105017	-	-15.3193	0.378854	-1.39611	0.25 [0.01 - 5.55]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205473_at	177	0.694915	0.0823986	-	-0.579367	0.438152	-0.586523	0.56 [0.13 - 2.45]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1554847_at	177	0.480226	0.103927	-	-0.38301	0.343093	-0.466903	0.63 [0.24 - 1.65]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1554847_at	177	0.175141	0.0563988	-	-0.599704	0.40713	-0.471466	0.62 [0.20 - 1.90]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205473_at	177	0.875706	0.0716456	-	-0.812458	0.297766	-0.691731	0.50 [0.14 - 1.84]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205473_at	145	0.675862	0.0277341	0.336003	-0.94833	0.278083	-1.04886	0.35 [0.05 - 2.33]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1554847_at	145	0.37931	0.164755	-	0.513115	0.764363	-0.216592	0.81 [0.20 - 3.32]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1554847_at	226	0.106195	0.0791554	-	1.19518	0.959628	-0.00504262	0.99 [0.82 - 1.21]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205473_at	226	0.163717	0.0989143	-	0.762608	0.895697	-0.0226753	0.98 [0.70 - 1.37]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1554847_at	55	0.327273	0.15878	-	-0.624745	0.762442	-0.344713	0.71 [0.08 - 6.62]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205473_at	55	0.581818	0.21497	-	-0.596879	0.498753	-0.96576	0.38 [0.02 - 6.25]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205473_at	55	0.781818	0.0522368	-	-1.71903	0.231752	-1.96911	0.14 [0.01 - 3.52]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205473_at	49	0.755102	0.237675	-	-0.892438	0.472607	-1.2247	0.29 [0.01 - 8.31]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1554847_at	55	0.872727	0.0596632	-	1.0061	0.612881	0.551651	1.74 [0.20 - 14.71]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1554847_at	49	0.142857	0.106622	-	15.3224	0.765324	0.380899	1.46 [0.12 - 17.85]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1554847_at	63	0.619048	0.0648568	-	-0.700146	0.35529	-1.20579	0.30 [0.02 - 3.86]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205473_at	63	0.142857	3.3879e-05	0.00133993	-1.59848	0.34755	-4.57077	0.01 [0.00 - 143.50]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502308_3p_s_at	28	0.321429	0.031022	0.362282	-1.21575	0.234049	-0.611186	0.54 [0.20 - 1.49]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	205473_3p_at	28	0.678571	0.215727	-	-0.79302	0.668738	-1.62928	0.20 [0.00 - 341.73]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502308_3p_x_at	28	0.214286	0.236911	-	-0.71599	0.615537	-1.45915	0.23 [0.00 - 69.12]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502308_3p_at	28	0.214286	0.027653	0.335337	-1.23725	0.113583	-18.8266	0.00 [0.00 - 89.48]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.385681.1.S1_3p_at	28	0.107143	0.187708	-	15.2153	0.997423	-0.00224701	1.00 [0.26 - 3.90]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205473_at	82	0.890244	0.174234	-	0.609631	0.863329	-0.0709016	0.93 [0.42 - 2.09]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32959_at	84	0.416667	0.0973208	-	0.504102	0.982712	-0.0121615	0.99 [0.33 - 2.97]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205473_at	79	0.607595	0.0327468	0.37553	0.560989	0.363787	0.257391	1.29 [0.74 - 2.25]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M25809_at	86	0.209302	0.0144218	0.211846	-1.03328	0.199308	-0.627636	0.53 [0.20 - 1.39]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205473_at	104	0.778846	0.0175764	0.244428	-1.19249	0.257029	-0.517389	0.60 [0.24 - 1.46]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P142815	117	0.888889	0.0338105	0.383527	0.768658	0.127016	0.181864	1.20 [0.95 - 1.52]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205473_at	204	0.661765	0.0490734	0.486036	-0.63374	0.976279	-0.00520723	0.99 [0.71 - 1.40]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1554847_at	204	0.20098	0.000166944	0.00549047	-1.29017	0.0128804	-0.454228	0.63 [0.44 - 0.91]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1554847_at	204	0.220588	2.33545e-05	0.000960135	-1.11618	0.00207859	-0.435985	0.65 [0.49 - 0.85]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205473_at	204	0.151961	0.0431587	0.448787	1.80829	0.40431	0.208915	1.23 [0.75 - 2.01]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205473_at	178	0.275281	0.0239274	0.303708	-0.473026	0.788896	-0.0593183	0.94 [0.61 - 1.45]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300007336	41	0.243902	0.0745852	-	1.0562	0.777133	0.0488161	1.05 [0.75 - 1.47]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1554847_at	111	0.117117	0.0457539	0.465479	-0.718093	0.183453	-0.185722	0.83 [0.63 - 1.09]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205473_at	111	0.711712	0.121036	-	-0.484887	0.818601	0.0469861	1.05 [0.70 - 1.57]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205473_at	90	0.8	0.0936681	-	0.611318	0.660589	0.361535	1.44 [0.29 - 7.21]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205473_at	90	0.8	0.00936451	0.153656	0.982225	0.122444	1.22506	3.40 [0.72 - 16.11]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	4924	50	0.58	0.177416	-	-0.693891	0.97955	-0.00984395	0.99 [0.47 - 2.10]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1554847_at	138	0.514493	0.0327297	0.3754	-0.522155	0.111402	-1.66962	0.19 [0.02 - 1.47]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205473_at	138	0.297101	0.0227404	0.293181	-0.552623	0.725908	0.118633	1.13 [0.58 - 2.19]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205473_at	129	0.883721	0.0238102	0.302679	0.732603	0.0162796	0.357293	1.43 [1.07 - 1.91]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13242	56	0.464286	0.346019	-	0.331116	0.534417	0.20436	1.23 [0.64 - 2.34]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25218	56	0.160714	0.21784	-	-0.568541	0.926563	-0.0313983	0.97 [0.50 - 1.89]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3472	56	0.178571	0.00446881	0.0866151	-1.19582	0.431985	-0.770039	0.46 [0.07 - 3.16]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13242	56	0.107143	0.396263	-	0.510503	0.728472	0.112017	1.12 [0.59 - 2.11]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3472	56	0.125	0.00415499	0.0817558	-1.30065	0.341496	-0.916764	0.40 [0.06 - 2.64]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25218	56	0.160714	0.300318	-	-0.473188	0.860393	0.0629316	1.06 [0.53 - 2.15]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205473_at	278	0.848921	0.0259293	0.320959	-0.664111	0.596228	-0.0325577	0.97 [0.86 - 1.09]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1554847_at	278	0.690647	0.038823	0.419579	-0.433887	0.402185	-0.144199	0.87 [0.62 - 1.21]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205473_at	133	0.142857	0.0391125	0.421583	0.857314	0.103982	0.113573	1.12 [0.98 - 1.28]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2719	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205473_at	185	0.189189	0.0668752	-	-0.365569	0.904316	-0.00995969	0.99 [0.84 - 1.16]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205473_at	185	0.189189	0.1543	-	-0.313779	0.818455	0.0204276	1.02 [0.86 - 1.22]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P142815	110	0.109091	0.0747298	-	-0.599718	0.750285	-0.0220406	0.98 [0.85 - 1.12]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P145249	110	0.845455	0.200281	-	-0.417345	0.951515	0.0142632	1.01 [0.64 - 1.61]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P142815	110	0.2	0.0310513	0.36251	-0.755077	0.924098	-0.00837193	0.99 [0.83 - 1.18]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P145249	110	0.127273	0.244915	-	-0.457096	0.989568	-0.00431338	1.00 [0.52 - 1.90]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205473_at	80	0.125	0.10027	-	-0.82526	0.525613	-0.0873774	0.92 [0.70 - 1.20]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_5741	281	0.814947	0.0416751	0.438985	0.344726	0.603155	0.0534374	1.05 [0.86 - 1.29]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:714494	59	0.322034	0.0223517	0.289683	-1.0695	0.233328	-1.05047	0.35 [0.06 - 1.97]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1554847_at	38	0.394737	0.0141288	0.208692	-1.15198	0.0566661	-0.700489	0.50 [0.24 - 1.02]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205473_at	38	0.631579	0.0116993	0.181578	1.17385	0.0850199	1.077	2.94 [0.86 - 10.00]
GENE	ATP6V1B1	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205473_at	140	0.5	0.124957	-	-0.450512	0.372578	-0.77185	0.46 [0.08 - 2.52]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201089_at	30	0.2	0.0831423	-	-0.798651	0.908798	-0.0385544	0.96 [0.50 - 1.86]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1787705	165	0.624242	0.15052	-	0.348812	0.356112	0.191242	1.21 [0.81 - 1.82]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1787705	165	0.757576	0.277272	-	-0.523288	0.967695	-0.0121709	0.99 [0.55 - 1.78]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201089_at	163	0.668712	0.203166	-	-0.278999	0.732364	0.0507406	1.05 [0.79 - 1.41]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201089_at	79	0.101266	0.149324	-	0.836756	0.379762	0.20431	1.23 [0.78 - 1.94]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201089_at	58	0.344828	0.000985852	0.0251824	1.01255	0.00584514	0.735485	2.09 [1.24 - 3.52]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201089_at	34	0.470588	0.201829	-	-0.513537	0.980798	-0.00742938	0.99 [0.54 - 1.82]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201089_at	158	0.107595	2.63339e-05	0.00106935	-1.1667	0.000425788	-0.844794	0.43 [0.27 - 0.69]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201089_at	53	0.169811	0.187212	-	-0.553295	0.632069	-0.182074	0.83 [0.40 - 1.76]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201089_at	53	0.339623	0.250007	-	-0.42707	0.657501	-0.176124	0.84 [0.38 - 1.83]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201089_at	180	0.183333	0.234592	-	-0.302439	0.917382	0.0306464	1.03 [0.58 - 1.84]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201089_at	559	0.899821	0.0552564	-	0.56407	0.744327	0.113455	1.12 [0.57 - 2.22]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201089_at	77	0.415584	0.0036586	0.0738731	-0.744109	0.00161824	-1.09649	0.33 [0.17 - 0.66]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201089_at	70	0.771429	0.000718042	0.0192777	-1.23897	0.0584268	-0.416287	0.66 [0.43 - 1.01]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40568_at	50	0.14	0.412599	-	0.398916	0.719831	0.0993269	1.10 [0.64 - 1.90]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201089_at	74	0.77027	0.0265358	0.326066	0.692776	0.0995055	0.509744	1.66 [0.91 - 3.05]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201089_at	67	0.895522	0.00150439	0.035821	2.08623	0.364321	1.02583	2.79 [0.30 - 25.59]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201089_at	115	0.208696	0.148029	-	-0.790862	0.876116	-0.12573	0.88 [0.18 - 4.28]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40568_at	158	0.639241	0.116812	-	-0.5025	0.455134	-0.330611	0.72 [0.30 - 1.71]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40568_at	76	0.894737	0.105284	-	1.00588	0.737618	0.240596	1.27 [0.31 - 5.20]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201089_at	204	0.22549	0.0625909	-	-0.321286	0.684671	-0.0822832	0.92 [0.62 - 1.37]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201089_at	87	0.402299	0.00997039	0.161101	-0.957349	0.0630827	-0.599686	0.55 [0.29 - 1.03]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201089_at	87	0.402299	0.00997039	0.161101	-0.957349	0.0630827	-0.599686	0.55 [0.29 - 1.03]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201089_at	77	0.844156	0.237356	-	0.795257	0.572193	0.349607	1.42 [0.42 - 4.77]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201089_at	77	0.428571	0.144355	-	0.927973	0.52748	0.343468	1.41 [0.49 - 4.09]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201089_at	136	0.117647	0.0605298	-	-0.948405	0.172055	-0.599909	0.55 [0.23 - 1.30]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201089_at	200	0.105	0.00820452	0.138963	-0.951185	0.254637	-0.574775	0.56 [0.21 - 1.51]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1248	60	0.6	0.0173746	0.242414	0.899769	0.526888	0.195802	1.22 [0.66 - 2.23]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1248	60	0.4	0.236871	-	0.475813	0.682127	0.1424	1.15 [0.58 - 2.28]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201089_at	286	0.167832	0.0256605	0.318678	-0.498551	0.494896	-0.18799	0.83 [0.48 - 1.42]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201089_at	159	0.767296	0.00879063	0.146462	0.833063	0.128997	0.541456	1.72 [0.85 - 3.46]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201089_at	159	0.716981	0.085554	-	0.638416	0.542218	0.275814	1.32 [0.54 - 3.20]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201089_at	159	0.716981	0.135536	-	0.483562	0.874415	0.0641729	1.07 [0.48 - 2.36]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201089_at	54	0.425926	0.0719136	-	1.69947	0.441958	0.315395	1.37 [0.61 - 3.06]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201089_at	117	0.752137	0.08306	-	0.573678	0.970105	-0.00932936	0.99 [0.61 - 1.61]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201089_at	117	0.564103	0.188938	-	-0.525463	0.713698	-0.109771	0.90 [0.50 - 1.61]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201089_at	117	0.752137	0.08306	-	0.573678	0.970105	-0.00932936	0.99 [0.61 - 1.61]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201089_at	117	0.111111	0.049879	0.490897	-0.898838	0.182937	-0.428772	0.65 [0.35 - 1.22]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201089_at	236	0.15678	0.00275245	0.0587558	-0.900936	0.194014	-0.46781	0.63 [0.31 - 1.27]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201089_at	249	0.819277	0.0566277	-	0.472856	0.424986	0.220592	1.25 [0.73 - 2.14]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201089_at	62	0.887097	0.195392	-	-1.25587	0.939058	-0.020924	0.98 [0.57 - 1.67]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201089_at	125	0.68	0.0948124	-	-0.763879	0.314568	-0.372574	0.69 [0.33 - 1.42]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201089_at	125	0.104	0.182473	-	-0.583794	0.196167	-0.366427	0.69 [0.40 - 1.21]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201089_at	54	0.111111	0.233988	-	-0.914772	0.875561	-0.0519264	0.95 [0.50 - 1.82]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201089_at	198	0.792929	0.0300066	0.354315	-0.847019	0.280365	-0.25594	0.77 [0.49 - 1.23]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201089_at	198	0.580808	0.0310353	0.362386	-0.628537	0.299179	-0.261425	0.77 [0.47 - 1.26]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201089_at	198	0.116162	0.0836492	-	0.671013	0.81877	0.0441941	1.05 [0.72 - 1.53]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201089_at	51	0.333333	0.0195146	0.263332	-2.16639	0.0453782	-3.37072	0.03 [0.00 - 0.93]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201089_at	62	0.854839	0.112645	-	-15.3089	0.571789	-0.395461	0.67 [0.17 - 2.65]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201089_at	177	0.875706	0.223994	-	-0.622666	0.955441	-0.0162643	0.98 [0.56 - 1.74]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201089_at	177	0.875706	0.416797	-	-0.32176	0.89034	-0.0347857	0.97 [0.59 - 1.58]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201089_at	145	0.117241	0.156636	-	0.99193	0.457309	0.281788	1.33 [0.63 - 2.79]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201089_at	226	0.876106	0.121832	-	-0.89184	0.527593	0.162241	1.18 [0.71 - 1.95]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201089_at	55	0.818182	0.0456687	0.46494	0.94645	0.263383	0.45426	1.58 [0.71 - 3.49]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201089_at	55	0.890909	0.110689	-	-15.2089	0.985868	-0.00725541	0.99 [0.44 - 2.22]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201089_at	49	0.897959	0.277331	-	-15.1539	0.683109	-0.203477	0.82 [0.31 - 2.17]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	1323203	34	0.411765	0.071388	-	0.85217	0.253032	0.487845	1.63 [0.71 - 3.76]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201089_at	63	0.142857	0.0638296	-	-0.770376	0.585019	-0.0977357	0.91 [0.64 - 1.29]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502310_3p_at	28	0.535714	0.14363	-	-0.858318	0.511473	-0.828255	0.44 [0.04 - 5.18]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201089_at	82	0.390244	0.00555005	0.102719	-0.919401	0.104424	-0.596962	0.55 [0.27 - 1.13]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40568_at	84	0.107143	0.00677763	0.11999	-1.09564	0.585854	0.241599	1.27 [0.53 - 3.04]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201089_at	79	0.632911	0.292049	-	-0.287003	0.810169	-0.092453	0.91 [0.43 - 1.94]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	L35249_s_at	86	0.604651	0.0936068	-	-0.741131	0.382824	-0.394581	0.67 [0.28 - 1.63]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201089_at	104	0.740385	0.159892	-	0.497977	0.808474	0.0973876	1.10 [0.50 - 2.42]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P31844	117	0.145299	0.00988354	0.160043	-0.860075	0.458619	-0.164871	0.85 [0.55 - 1.31]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201089_at	204	0.269608	0.00216158	0.0482693	2.45538	0.0240226	1.13993	3.13 [1.16 - 8.41]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201089_at	204	0.171569	0.00236469	0.0519396	1.89546	0.0258713	0.827851	2.29 [1.10 - 4.74]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201089_at	178	0.533708	0.0341268	0.385881	-0.421532	0.420846	-0.276541	0.76 [0.39 - 1.49]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200000443	41	0.658537	0.114145	-	-0.781403	0.881605	-0.0492974	0.95 [0.50 - 1.82]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201089_at	111	0.153153	0.0307089	0.359839	-0.691058	0.645136	-0.135524	0.87 [0.49 - 1.55]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201089_at	90	0.855556	0.103499	-	0.638	0.419097	-0.209884	0.81 [0.49 - 1.35]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201089_at	90	0.855556	0.0594693	-	0.797832	0.287979	-0.307967	0.73 [0.42 - 1.30]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201089_at	138	0.862319	0.0198845	0.266852	0.688138	0.195122	0.192984	1.21 [0.91 - 1.62]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201089_at	129	0.736434	0.113738	-	-0.516725	0.594582	-0.192603	0.82 [0.41 - 1.68]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30857	56	0.714286	0.159699	-	-0.588257	0.697358	-0.102118	0.90 [0.54 - 1.51]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21344	56	0.875	0.0385276	0.417525	-1.83402	0.915945	-0.0305474	0.97 [0.55 - 1.71]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30857	56	0.714286	0.149761	-	-0.642663	0.697362	-0.107004	0.90 [0.52 - 1.54]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21344	56	0.875	0.0591752	-	-1.70521	0.884986	-0.0444699	0.96 [0.52 - 1.75]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201089_at	278	0.81295	0.0248432	0.311676	0.492265	0.308954	0.196637	1.22 [0.83 - 1.78]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201089_at	133	0.105263	0.00251899	0.0546804	-0.981225	0.370261	-0.116514	0.89 [0.69 - 1.15]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11621	81	0.876543	0.00208449	0.0468565	1.67168	0.0228158	0.864748	2.37 [1.13 - 5.00]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7115	81	0.407407	0.0258517	0.320301	1.26279	0.0794392	0.546497	1.73 [0.94 - 3.18]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201089_at	185	0.891892	0.15146	-	0.383107	0.527775	0.106255	1.11 [0.80 - 1.55]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201089_at	185	0.135135	0.0896148	-	-0.396379	0.478736	0.109806	1.12 [0.82 - 1.51]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P31844	110	0.581818	0.0707222	-	0.543625	0.991068	0.00269179	1.00 [0.63 - 1.61]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P31844	110	0.145455	0.149778	-	-0.420844	0.818156	-0.043864	0.96 [0.66 - 1.39]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201089_at	80	0.8375	0.00206997	0.0465892	1.45779	0.416743	0.301636	1.35 [0.65 - 2.80]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3536	281	0.103203	0.105283	-	0.407399	0.644737	0.0651735	1.07 [0.81 - 1.41]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201089_at	38	0.184211	0.11304	-	1.13374	0.252737	0.602916	1.83 [0.65 - 5.14]
GENE	ATP6V1B2	ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201089_at	140	0.657143	0.0205687	0.273295	0.659011	0.194861	0.371868	1.45 [0.83 - 2.54]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202872_at	30	0.7	0.143055	-	0.641479	0.181592	0.642644	1.90 [0.74 - 4.88]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202873_at	30	0.166667	0.136271	-	0.892721	0.370666	0.657485	1.93 [0.46 - 8.14]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202874_s_at	30	0.8	0.00084749	0.0221749	1.8559	0.0591693	0.905231	2.47 [0.97 - 6.33]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1659801	165	0.884848	0.000292867	0.0089482	1.0177	0.242196	0.245994	1.28 [0.85 - 1.93]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1659801	165	0.866667	0.0180046	0.248672	0.933437	0.853555	-0.0588796	0.94 [0.50 - 1.76]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202873_at	163	0.453988	0.00396278	0.0787333	-0.566883	0.00856794	-1.39654	0.25 [0.09 - 0.70]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202874_s_at	163	0.294479	0.0295857	0.350974	-0.449615	0.0858051	-0.290011	0.75 [0.54 - 1.04]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202872_at	163	0.484663	0.0540053	-	-0.379984	0.137241	-0.26819	0.76 [0.54 - 1.09]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226463_at	163	0.226994	0.00550676	0.102091	-0.594941	0.0411162	-0.346478	0.71 [0.51 - 0.99]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202872_at	79	0.898734	0.253324	-	-0.669535	0.80648	-0.0362157	0.96 [0.72 - 1.29]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226463_at	79	0.556962	0.130576	-	-0.453037	0.414136	-0.158055	0.85 [0.58 - 1.25]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202874_s_at	79	0.898734	0.253324	-	-0.669535	0.572805	-0.0829832	0.92 [0.69 - 1.23]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202873_at	79	0.721519	0.0323801	0.372742	-0.749913	0.0932066	-0.817001	0.44 [0.17 - 1.15]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202872_at	58	0.172414	0.141763	-	0.516595	0.682987	0.0694997	1.07 [0.77 - 1.50]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202873_at	58	0.896552	0.307752	-	0.45315	0.72578	0.0678725	1.07 [0.73 - 1.56]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202874_s_at	58	0.603448	0.00455285	0.0879012	0.811858	0.119406	0.350037	1.42 [0.91 - 2.20]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202874_s_at	34	0.882353	0.102083	-	-1.52044	0.636764	-0.216182	0.81 [0.33 - 1.98]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202872_at	34	0.176471	0.023186	0.29716	1.3338	0.191999	0.322292	1.38 [0.85 - 2.24]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202873_at	34	0.794118	0.0037818	0.0758534	-1.91827	0.472515	-0.176908	0.84 [0.52 - 1.36]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202874_s_at	158	0.177215	0.011426	0.178411	-0.689864	0.134574	-0.358286	0.70 [0.44 - 1.12]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202872_at	158	0.101266	0.00633102	0.113818	-0.875375	0.198773	-0.409243	0.66 [0.36 - 1.24]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202873_at	158	0.411392	0.300022	-	0.24928	0.965672	0.0222747	1.02 [0.37 - 2.82]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202873_at	53	0.792453	0.00264532	0.0568961	1.16204	0.0605826	0.936495	2.55 [0.96 - 6.78]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202872_at	53	0.377358	0.229777	-	-0.413	0.883571	-0.0725265	0.93 [0.35 - 2.46]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202874_s_at	53	0.150943	0.308579	-	0.610501	0.446773	-0.38261	0.68 [0.25 - 1.83]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202873_at	53	0.792453	0.00368884	0.0743606	1.06074	0.0832129	0.802906	2.23 [0.90 - 5.54]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202872_at	53	0.679245	0.199978	-	0.473897	0.889735	-0.0748035	0.93 [0.32 - 2.67]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202874_s_at	53	0.433962	0.142635	-	-0.49962	0.551368	-0.26327	0.77 [0.32 - 1.83]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202872_at	180	0.877778	0.0207056	0.274574	0.629732	0.961944	0.0153971	1.02 [0.54 - 1.91]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202873_at	180	0.105556	0.0614802	-	-0.554781	0.207458	-0.257851	0.77 [0.52 - 1.15]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202874_s_at	180	0.827778	0.158802	-	-0.433753	0.916186	-0.0291351	0.97 [0.56 - 1.67]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226463_at	180	0.894444	0.188111	-	0.405572	0.97267	-0.013207	0.99 [0.46 - 2.10]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202872_at	559	0.899821	0.00108562	0.027301	0.798976	0.0307037	0.662985	1.94 [1.06 - 3.54]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226463_at	559	0.509839	0.297704	-	0.208368	0.997497	0.000699863	1.00 [0.65 - 1.55]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202874_s_at	559	0.797853	0.0011703	0.0290699	0.704684	0.0543147	0.467425	1.60 [0.99 - 2.57]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202873_at	559	0.554562	0.00592676	0.108123	0.551327	0.281066	0.134371	1.14 [0.90 - 1.46]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202874_s_at	77	0.883117	0.0344555	0.388315	-1.048	0.0862944	-0.441759	0.64 [0.39 - 1.07]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202872_at	77	0.350649	0.0406446	0.43206	-0.53167	0.19483	-0.46039	0.63 [0.31 - 1.27]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202873_at	77	0.545455	0.0078129	0.133861	-0.709427	0.021631	-0.554787	0.57 [0.36 - 0.92]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226463_at	77	0.233766	0.000698018	0.0188214	-0.974023	0.000918789	-1.03052	0.36 [0.19 - 0.66]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202872_at	70	0.142857	0.0907004	-	-0.582989	0.318661	-0.261874	0.77 [0.46 - 1.29]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226463_at	70	0.171429	0.0528851	-	0.781312	0.721991	-0.0923116	0.91 [0.55 - 1.52]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202874_s_at	70	0.157143	0.0038131	0.0763538	-0.970227	0.456808	-0.181047	0.83 [0.52 - 1.34]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202873_at	70	0.885714	0.13926	-	0.578105	0.462552	0.885787	2.42 [0.23 - 25.76]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37948_at	50	0.4	0.00395773	0.0786534	-0.994765	0.138689	-0.745349	0.47 [0.18 - 1.27]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202872_at	74	0.364865	0.031898	0.369055	-0.620984	0.588458	-0.236682	0.79 [0.33 - 1.86]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202873_at	74	0.337838	0.0328954	0.376655	-0.630965	0.107397	-0.356071	0.70 [0.45 - 1.08]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202874_s_at	74	0.445946	0.00849795	0.142737	-0.759989	0.0525372	-0.92199	0.40 [0.16 - 1.01]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226463_at	74	0.77027	0.0878739	-	-0.624965	0.591126	-0.193617	0.82 [0.41 - 1.67]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202872_at	67	0.895522	0.0131161	0.197605	1.6253	0.159624	1.275	3.58 [0.61 - 21.16]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202874_s_at	67	0.895522	4.10065e-05	0.001589	2.63137	0.0725624	2.39157	10.93 [0.80 - 148.73]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226463_at	67	0.104478	0.167995	-	-1.07741	0.942943	-0.0911785	0.91 [0.08 - 11.09]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202873_at	67	0.850746	0.0011435	0.028513	2.15907	0.598702	0.494002	1.64 [0.26 - 10.32]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226463_at	115	0.86087	0.00854982	0.1434	1.36262	0.16375	0.995449	2.71 [0.67 - 10.98]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202872_at	115	0.878261	3.08688e-05	0.00123292	1.94206	0.0143165	1.43322	4.19 [1.33 - 13.20]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202874_s_at	115	0.869565	9.91277e-05	0.00347537	1.84013	0.00235145	1.65476	5.23 [1.80 - 15.20]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202873_at	115	0.895652	0.138352	-	0.927531	0.756142	0.309366	1.36 [0.19 - 9.60]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37948_at	158	0.835443	0.190124	-	0.452583	0.905711	0.0447563	1.05 [0.50 - 2.19]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37948_at	76	0.526316	0.0238172	0.302741	-1.35399	0.545963	-0.34008	0.71 [0.24 - 2.15]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202874_s_at	204	0.887255	0.0606879	-	0.412357	0.330976	0.149607	1.16 [0.86 - 1.57]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226463_at	204	0.122549	0.0169734	0.238383	-0.508393	0.354959	-0.178047	0.84 [0.57 - 1.22]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202873_at	204	0.205882	0.0757003	-	-0.307897	0.35016	-0.0648358	0.94 [0.82 - 1.07]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202872_at	204	0.79902	0.10368	-	0.280716	0.335878	0.146509	1.16 [0.86 - 1.56]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202873_at	87	0.724138	0.154019	-	0.5572	0.147212	0.556914	1.75 [0.82 - 3.71]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226463_at	87	0.62069	0.0542127	-	0.714101	0.600518	0.152861	1.17 [0.66 - 2.06]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226463_at	87	0.62069	0.0542127	-	0.714101	0.600518	0.152861	1.17 [0.66 - 2.06]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202872_at	87	0.356322	0.00949839	0.155314	1.30659	0.290049	0.271309	1.31 [0.79 - 2.17]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202874_s_at	87	0.390805	0.0361776	0.400877	0.931498	0.177886	0.343546	1.41 [0.86 - 2.32]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202873_at	87	0.724138	0.154019	-	0.5572	0.147212	0.556914	1.75 [0.82 - 3.71]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202874_s_at	87	0.390805	0.0361776	0.400877	0.931498	0.177886	0.343546	1.41 [0.86 - 2.32]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202872_at	87	0.356322	0.00949839	0.155314	1.30659	0.290049	0.271309	1.31 [0.79 - 2.17]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226463_at	77	0.675325	0.00910493	0.15042	-15.6967	0.082195	-0.763098	0.47 [0.20 - 1.10]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202873_at	77	0.168831	0.193201	-	-0.870769	0.874936	-0.163527	0.85 [0.11 - 6.51]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202874_s_at	77	0.233766	0.0344966	0.388618	-1.11881	0.218668	-0.496818	0.61 [0.28 - 1.34]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226463_at	77	0.662338	0.020068	0.268589	-15.7165	0.237353	-0.591184	0.55 [0.21 - 1.48]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202872_at	77	0.805195	0.119808	-	-15.3511	0.720982	-0.153725	0.86 [0.37 - 1.99]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202873_at	77	0.467532	0.0585875	-	-1.08377	0.563456	-0.599914	0.55 [0.07 - 4.20]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202872_at	77	0.805195	0.0717945	-	-15.3601	0.403287	-0.323244	0.72 [0.34 - 1.54]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202874_s_at	77	0.792208	0.107166	-	-15.3754	0.498217	-0.292294	0.75 [0.32 - 1.74]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202873_at	136	0.786765	0.121115	-	0.759304	0.988899	-0.00400015	1.00 [0.57 - 1.75]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202874_s_at	136	0.882353	0.138704	-	0.811448	0.497974	0.2857	1.33 [0.58 - 3.04]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202872_at	136	0.838235	0.323194	-	0.508409	0.496568	0.314339	1.37 [0.55 - 3.39]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202872_at	200	0.565	0.00703303	0.123466	0.787002	0.0366645	0.698035	2.01 [1.04 - 3.87]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202873_at	200	0.105	0.000581347	0.0161138	-1.23533	0.00109227	-0.972562	0.38 [0.21 - 0.68]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202874_s_at	200	0.26	0.0892692	-	0.649554	0.229263	0.38901	1.48 [0.78 - 2.78]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17164	60	0.216667	0.260358	-	-0.464855	0.984589	-0.00477206	1.00 [0.61 - 1.62]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17164	60	0.25	0.0481424	0.480357	-0.770195	0.602817	0.137487	1.15 [0.68 - 1.93]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202872_at	286	0.776224	0.00041467	0.0120726	0.715223	0.00173854	0.641434	1.90 [1.27 - 2.84]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202873_at	286	0.416084	0.134563	-	-0.289383	0.514367	-0.105289	0.90 [0.66 - 1.24]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202874_s_at	286	0.825175	0.000222819	0.0070607	0.786448	0.124611	0.282638	1.33 [0.92 - 1.90]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202872_at	159	0.490566	0.0753866	-	0.573257	0.0582339	0.791186	2.21 [0.97 - 5.00]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202873_at	159	0.591195	0.0943601	-	0.52421	0.708107	0.134909	1.14 [0.56 - 2.32]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202872_at	159	0.100629	0.0627554	-	15.1808	0.0887405	0.811226	2.25 [0.88 - 5.73]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202874_s_at	159	0.352201	0.0104199	0.16653	1.02208	0.082624	0.587505	1.80 [0.93 - 3.49]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202873_at	159	0.591195	0.212777	-	0.392057	0.827231	0.0770531	1.08 [0.54 - 2.16]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202873_at	159	0.591195	0.0870658	-	0.629184	0.868884	0.0695071	1.07 [0.47 - 2.45]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202872_at	159	0.893082	0.0761001	-	0.722632	0.190161	0.540798	1.72 [0.76 - 3.86]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202874_s_at	159	0.352201	0.00275394	0.0587816	1.24492	0.0115901	0.852906	2.35 [1.21 - 4.55]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202874_s_at	159	0.352201	0.00970639	0.157875	1.30039	0.0210772	0.913108	2.49 [1.15 - 5.41]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226463_at	159	0.327044	0.120333	-	-0.492245	0.604164	-0.214192	0.81 [0.36 - 1.81]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226463_at	159	0.72956	0.142037	-	0.4823	0.497709	0.266634	1.31 [0.60 - 2.82]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226463_at	159	0.320755	0.233374	-	-0.445893	0.876625	-0.0742954	0.93 [0.36 - 2.37]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202873_at	54	0.851852	0.2495	-	-15.2516	0.688664	-0.66934	0.51 [0.02 - 13.53]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202874_s_at	54	0.222222	0.0789093	-	15.4875	0.468486	0.292813	1.34 [0.61 - 2.96]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202872_at	54	0.314815	0.0930612	-	1.64692	0.652774	0.206643	1.23 [0.50 - 3.02]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202874_s_at	117	0.769231	0.209787	-	0.4353	0.771119	0.0522399	1.05 [0.74 - 1.50]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202874_s_at	117	0.606838	0.147046	-	-0.622405	0.675994	-0.0930521	0.91 [0.59 - 1.41]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202872_at	117	0.350427	0.23395	-	0.420251	0.581896	0.0998319	1.10 [0.77 - 1.58]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202874_s_at	117	0.606838	0.213295	-	-0.541369	0.855393	-0.040922	0.96 [0.62 - 1.49]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202872_at	117	0.769231	0.103837	-	-0.957446	0.985812	0.00393406	1.00 [0.65 - 1.55]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202874_s_at	117	0.769231	0.209787	-	0.4353	0.771119	0.0522399	1.05 [0.74 - 1.50]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202872_at	117	0.350427	0.23395	-	0.420251	0.581896	0.0998319	1.10 [0.77 - 1.58]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202872_at	117	0.700855	0.23474	-	0.475106	0.683365	0.0888898	1.09 [0.71 - 1.68]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202873_at	117	0.128205	0.0298319	0.352931	15.2569	0.782167	0.206216	1.23 [0.28 - 5.30]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202873_at	117	0.128205	0.0223094	0.2893	1.98008	0.658741	0.264097	1.30 [0.40 - 4.20]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202873_at	117	0.128205	0.0223094	0.2893	1.98008	0.658741	0.264097	1.30 [0.40 - 4.20]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202873_at	117	0.128205	0.0318828	0.368937	15.2693	0.567567	0.417654	1.52 [0.36 - 6.36]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202873_at	236	0.817797	0.135595	-	0.47029	0.678	0.191051	1.21 [0.49 - 2.98]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202874_s_at	236	0.724576	0.0744252	-	0.496351	0.463583	0.204645	1.23 [0.71 - 2.12]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202872_at	236	0.872881	0.0200841	0.268742	0.743061	0.110771	0.481205	1.62 [0.90 - 2.92]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226463_at	236	0.826271	0.0193208	0.261476	0.694583	0.807439	0.0815005	1.08 [0.56 - 2.09]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202874_s_at	249	0.763052	0.023109	0.296474	0.50879	0.513469	0.146585	1.16 [0.75 - 1.80]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202872_at	249	0.678715	0.135845	-	0.328794	0.355745	0.224287	1.25 [0.78 - 2.01]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202873_at	249	0.104418	0.0570425	-	-0.565406	0.63864	-0.167743	0.85 [0.42 - 1.70]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226463_at	249	0.831325	0.0638825	-	0.465815	0.686833	0.106854	1.11 [0.66 - 1.87]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202873_at	125	0.216	0.0394639	0.424006	-0.677462	0.247691	-0.444671	0.64 [0.30 - 1.36]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202873_at	54	0.888889	0.00905931	0.149848	1.47752	0.877188	-0.0408645	0.96 [0.57 - 1.61]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202874_s_at	125	0.792	0.226591	-	-0.648277	0.991401	0.00272057	1.00 [0.61 - 1.64]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202874_s_at	125	0.648	0.239587	-	0.339326	0.960828	-0.00953989	0.99 [0.68 - 1.45]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202872_at	62	0.870968	0.015829	0.226679	1.21118	0.487625	0.127072	1.14 [0.79 - 1.63]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202872_at	125	0.184	0.0671322	-	-0.75105	0.800073	0.0974405	1.10 [0.52 - 2.34]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202874_s_at	54	0.648148	0.00193242	0.0440354	1.72837	0.0421511	0.857977	2.36 [1.03 - 5.40]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202873_at	62	0.887097	0.00131785	0.0320937	1.49267	0.832633	-0.0449799	0.96 [0.63 - 1.45]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202872_at	125	0.432	0.027155	0.331226	0.672907	0.60874	0.145682	1.16 [0.66 - 2.02]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202872_at	54	0.833333	0.0732141	-	1.05702	0.578301	0.127693	1.14 [0.72 - 1.78]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202874_s_at	62	0.870968	0.000373906	0.0110459	1.93705	0.0123091	0.801348	2.23 [1.19 - 4.17]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202873_at	125	0.216	0.149429	-	-0.603146	0.627728	-0.240812	0.79 [0.30 - 2.08]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202874_s_at	198	0.631313	0.0473397	0.475408	0.500287	0.465869	0.128821	1.14 [0.80 - 1.61]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202874_s_at	198	0.858586	0.0443893	0.456773	0.627868	0.38883	0.154133	1.17 [0.82 - 1.66]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202872_at	198	0.515152	0.0565481	-	0.486831	0.194605	0.245693	1.28 [0.88 - 1.85]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202873_at	198	0.722222	0.0475819	0.476907	0.437636	0.682376	0.0648955	1.07 [0.78 - 1.46]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202872_at	198	0.388889	0.0276687	0.335466	0.654021	0.0990023	0.318257	1.37 [0.94 - 2.01]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202874_s_at	198	0.70202	0.00802389	0.136619	0.566142	0.0837101	0.25366	1.29 [0.97 - 1.72]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202873_at	198	0.166667	0.0269528	0.329547	-0.662784	0.636532	-0.0876827	0.92 [0.64 - 1.32]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202873_at	198	0.166667	0.00649973	0.116163	-0.819398	0.520184	-0.122772	0.88 [0.61 - 1.29]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202872_at	198	0.707071	0.0205206	0.272846	0.501468	0.105641	0.266033	1.30 [0.95 - 1.80]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202873_at	62	0.693548	0.0142764	0.210284	1.33535	0.595371	0.605348	1.83 [0.20 - 17.11]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202874_s_at	51	0.607843	0.0405324	0.4313	1.96529	0.515768	0.701242	2.02 [0.24 - 16.71]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202874_s_at	62	0.596774	0.143034	-	0.836786	0.67995	0.317757	1.37 [0.30 - 6.22]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202872_at	51	0.647059	0.193864	-	1.12745	0.902939	0.0777638	1.08 [0.31 - 3.77]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202872_at	62	0.193548	0.29927	-	1.03751	0.8563	-0.0760794	0.93 [0.41 - 2.11]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202873_at	51	0.764706	0.35916	-	0.814604	0.892321	-0.275343	0.76 [0.01 - 40.91]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202873_at	177	0.694915	0.0230231	0.295709	-0.776734	0.404354	-0.270166	0.76 [0.40 - 1.44]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202874_s_at	177	0.19209	0.0413697	0.436942	0.713586	0.391248	0.176092	1.19 [0.80 - 1.78]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226463_at	145	0.344828	0.0396307	0.425151	0.805018	0.072499	0.652172	1.92 [0.94 - 3.91]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202874_s_at	145	0.22069	0.00548287	0.101745	1.77854	0.148039	0.40353	1.50 [0.87 - 2.59]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202872_at	177	0.112994	0.160848	-	0.714009	0.723057	0.0991111	1.10 [0.64 - 1.91]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202873_at	177	0.694915	0.0275207	0.334248	-0.628999	0.576812	-0.156613	0.86 [0.49 - 1.48]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202872_at	177	0.338983	0.0603833	-	0.489265	0.412248	0.197396	1.22 [0.76 - 1.95]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202873_at	145	0.227586	0.0684555	-	0.932618	0.926774	-0.0347066	0.97 [0.46 - 2.02]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202872_at	145	0.282759	0.0128147	0.194248	1.14004	0.164922	0.451531	1.57 [0.83 - 2.97]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202874_s_at	177	0.107345	0.0445889	0.458056	1.34418	0.497313	0.161507	1.18 [0.74 - 1.87]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226463_at	177	0.107345	0.0293994	0.349488	1.2094	0.117966	0.401758	1.49 [0.90 - 2.47]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226463_at	177	0.107345	0.0507012	-	1.31245	0.253995	0.3377	1.40 [0.78 - 2.50]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226463_at	226	0.778761	0.000102425	0.003577	1.07567	0.00494448	0.944718	2.57 [1.33 - 4.97]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202874_s_at	226	0.504425	0.000940849	0.0242134	0.98409	0.0316358	0.566624	1.76 [1.05 - 2.95]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202873_at	226	0.30531	0.284635	-	-0.311088	0.873949	0.0212606	1.02 [0.79 - 1.33]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202872_at	226	0.513274	0.000333656	0.0100142	1.0784	0.0305086	0.570344	1.77 [1.06 - 2.97]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202873_at	55	0.381818	0.182453	-	-0.588235	0.580072	-0.31442	0.73 [0.24 - 2.22]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202874_s_at	55	0.818182	0.0162758	0.231286	1.1544	0.300739	0.406332	1.50 [0.70 - 3.24]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226463_at	55	0.890909	0.00112113	0.0280461	1.61148	0.0862696	0.807081	2.24 [0.89 - 5.64]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202874_s_at	49	0.22449	0.11411	-	-0.943796	0.691588	-0.167357	0.85 [0.37 - 1.93]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226463_at	49	0.408163	0.225653	-	-0.707128	0.62046	-0.318066	0.73 [0.21 - 2.56]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202873_at	55	0.890909	0.0354963	0.395945	1.18628	0.819263	0.148457	1.16 [0.32 - 4.15]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202872_at	55	0.345455	0.0392394	0.422459	1.21583	0.241022	0.576052	1.78 [0.68 - 4.66]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202873_at	49	0.387755	0.0615059	-	-1.05562	0.255454	-0.850129	0.43 [0.10 - 1.85]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202872_at	55	0.781818	0.0123976	0.189557	1.17781	0.0597006	1.03165	2.81 [0.96 - 8.21]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226463_at	55	0.654545	0.225528	-	0.538946	0.746926	0.153699	1.17 [0.46 - 2.97]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202872_at	49	0.673469	0.286411	-	0.606575	0.559032	0.371835	1.45 [0.42 - 5.05]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202874_s_at	55	0.6	0.0236658	0.301408	0.993753	0.391604	0.298583	1.35 [0.68 - 2.67]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	270561	34	0.294118	0.0988004	-	-0.719213	0.143412	-0.593183	0.55 [0.25 - 1.22]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202873_at	63	0.15873	0.00172472	0.0401033	-1.18481	0.637393	0.461179	1.59 [0.23 - 10.79]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202872_at	63	0.84127	0.000807984	0.0212999	1.25125	0.0436584	0.303618	1.35 [1.01 - 1.82]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226463_at	63	0.539683	0.0250357	0.313334	0.752334	0.0285613	0.363457	1.44 [1.04 - 1.99]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202874_s_at	63	0.809524	0.000225151	0.00712484	1.28077	0.0107784	0.382736	1.47 [1.09 - 1.97]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.86905.0.S2_3p_at	28	0.714286	0.0278363	0.336842	1.15111	0.12292	1.09527	2.99 [0.74 - 12.02]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502314_3p_a_at	28	0.571429	0.0767562	-	0.930871	0.27123	0.704094	2.02 [0.58 - 7.09]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.86905.0.S3_3p_at	28	0.785714	0.0416632	0.438905	-1.86914	0.441264	-2.94811	0.05 [0.00 - 95.16]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.290880.0.A1_3p_at	28	0.607143	0.155935	-	-0.859815	0.811713	-0.479065	0.62 [0.01 - 31.90]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202873_at	82	0.256098	0.0124699	0.190374	1.39368	0.178856	0.813049	2.25 [0.69 - 7.38]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202874_s_at	82	0.134146	0.153337	-	0.997556	0.732617	-0.108501	0.90 [0.48 - 1.67]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202872_at	82	0.146341	0.128834	-	1.05447	0.685837	0.136695	1.15 [0.59 - 2.22]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37948_at	84	0.190476	0.0606149	-	0.801559	0.595303	0.228477	1.26 [0.54 - 2.92]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202873_at	79	0.481013	0.128138	-	-0.396277	0.340311	-0.576336	0.56 [0.17 - 1.84]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202874_s_at	79	0.316456	0.0555491	-	-0.50136	0.873926	-0.0661444	0.94 [0.41 - 2.12]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202872_at	79	0.367089	0.176121	-	-0.350083	0.897862	-0.0516611	0.95 [0.43 - 2.09]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	J05682_at	86	0.813953	0.0899308	-	0.74934	0.713996	0.171368	1.19 [0.47 - 2.97]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202872_at	104	0.153846	0.311225	-	-0.420048	0.815505	-0.0963412	0.91 [0.40 - 2.04]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202873_at	104	0.134615	0.013806	0.20519	-0.957233	0.0833597	-1.21651	0.30 [0.07 - 1.17]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202874_s_at	104	0.326923	0.145785	-	0.572095	0.759404	0.106166	1.11 [0.56 - 2.19]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P286598	117	0.880342	0.000539517	0.0151207	1.13801	0.0150428	0.420617	1.52 [1.08 - 2.14]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P146058	117	0.880342	0.00426851	0.0835242	0.981623	0.0598795	0.450292	1.57 [0.98 - 2.51]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202872_at	204	0.666667	0.00464401	0.0892892	0.753486	0.0491346	0.748951	2.11 [1.00 - 4.46]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202874_s_at	204	0.313726	0.00504594	0.0953263	1.54838	0.00458276	1.42601	4.16 [1.55 - 11.16]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226463_at	204	0.191176	0.244961	-	-0.475654	0.999381	0.0005259	1.00 [0.26 - 3.78]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202874_s_at	204	0.416667	0.000149799	0.00499414	1.20794	0.000460658	1.27967	3.60 [1.76 - 7.36]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226463_at	204	0.191176	0.0500741	-	-0.587011	0.621087	-0.262215	0.77 [0.27 - 2.18]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202873_at	204	0.205882	0.0474041	0.475807	1.34737	0.133084	0.713619	2.04 [0.80 - 5.18]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202873_at	204	0.102941	0.024548	0.309122	1.94744	0.0391483	0.73079	2.08 [1.04 - 4.16]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202872_at	204	0.666667	0.00295369	0.0622046	1.04736	0.011916	1.26685	3.55 [1.32 - 9.53]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202873_at	178	0.202247	0.0174916	0.243583	-0.529159	0.541818	-0.331081	0.72 [0.25 - 2.08]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202874_s_at	178	0.898876	0.0859114	-	-0.626602	0.832386	0.057708	1.06 [0.62 - 1.81]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202872_at	178	0.191011	0.0203445	0.271194	0.72546	0.259665	0.296578	1.35 [0.80 - 2.25]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200010203	41	0.146341	0.142068	-	-0.731858	0.832566	-0.0456332	0.96 [0.63 - 1.46]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202874_s_at	111	0.711712	0.0898775	-	-0.545005	0.752324	0.0961305	1.10 [0.61 - 2.00]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202873_at	111	0.810811	0.224385	-	0.381458	0.695188	0.0658926	1.07 [0.77 - 1.49]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226463_at	111	0.405405	0.211941	-	0.34338	0.770062	0.113202	1.12 [0.52 - 2.39]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202872_at	111	0.891892	0.241948	-	0.471194	0.720387	0.140085	1.15 [0.53 - 2.48]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202873_at	90	0.333333	0.188313	-	-0.430291	0.854374	0.127132	1.14 [0.29 - 4.41]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202873_at	90	0.2	0.128544	-	0.898478	0.405052	0.65609	1.93 [0.41 - 9.03]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202874_s_at	90	0.477778	0.0129122	0.195338	0.84344	0.382429	0.20859	1.23 [0.77 - 1.97]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202874_s_at	90	0.766667	0.0175817	0.244481	0.882199	0.207532	0.342345	1.41 [0.83 - 2.40]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202872_at	90	0.766667	0.0537012	-	0.649266	0.301247	0.447699	1.56 [0.67 - 3.66]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202872_at	90	0.855556	0.0418523	0.440165	0.858229	0.312484	0.501072	1.65 [0.62 - 4.36]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2633	50	0.6	0.0130078	0.196402	1.1985	0.142837	0.856607	2.36 [0.75 - 7.41]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202874_s_at	138	0.318841	0.0646341	-	0.504306	0.262568	0.141607	1.15 [0.90 - 1.48]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202873_at	138	0.797101	0.00590692	0.107841	0.720768	0.229449	0.238095	1.27 [0.86 - 1.87]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226463_at	138	0.804348	0.0716316	-	0.491105	0.756564	0.0601148	1.06 [0.73 - 1.55]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202872_at	138	0.355072	0.0268481	0.328675	0.583254	0.456742	0.107685	1.11 [0.84 - 1.48]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202872_at	129	0.666667	0.165357	-	-0.387634	0.826233	0.0946896	1.10 [0.47 - 2.56]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202873_at	129	0.286822	0.00915085	0.150994	-0.645412	0.3451	-0.381745	0.68 [0.31 - 1.51]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202874_s_at	129	0.728682	0.122493	-	-0.459546	0.817757	-0.0813578	0.92 [0.46 - 1.84]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36352	56	0.357143	0.290575	-	0.413563	0.869246	0.0455897	1.05 [0.61 - 1.80]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15532	56	0.714286	0.200416	-	-0.510883	0.91764	-0.0274061	0.97 [0.58 - 1.64]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30198	56	0.642857	0.0184302	0.252852	0.830633	0.254261	0.329195	1.39 [0.79 - 2.45]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15532	56	0.357143	0.290575	-	0.413563	0.773395	0.0815488	1.08 [0.62 - 1.89]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36352	56	0.660714	0.170872	-	-0.494782	0.836409	-0.0535533	0.95 [0.57 - 1.58]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30198	56	0.642857	0.0996593	-	0.558905	0.505585	0.179765	1.20 [0.71 - 2.03]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202874_s_at	278	0.208633	0.261901	-	0.294843	0.869228	-0.0227795	0.98 [0.75 - 1.28]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226463_at	278	0.47482	0.164258	-	0.265432	0.818986	0.0374449	1.04 [0.75 - 1.43]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202873_at	278	0.107914	0.0214521	0.281486	-0.600964	0.305398	-0.193361	0.82 [0.57 - 1.19]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202872_at	278	0.107914	0.229134	-	0.436061	0.74568	0.0426271	1.04 [0.81 - 1.35]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202874_s_at	133	0.609023	0.178284	-	-0.341936	0.372262	-0.104217	0.90 [0.72 - 1.13]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202872_at	133	0.62406	0.0715348	-	-0.454744	0.337568	-0.101079	0.90 [0.74 - 1.11]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202873_at	133	0.43609	0.00240614	0.0526797	0.746264	0.362606	0.26571	1.30 [0.74 - 2.31]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9058	81	0.691358	0.135909	-	0.775751	0.544907	0.21846	1.24 [0.61 - 2.52]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14798	81	0.888889	0.0199511	0.267483	1.28786	0.504532	0.32167	1.38 [0.54 - 3.55]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202874_s_at	185	0.751351	0.0989056	-	-0.366029	0.265714	-0.137042	0.87 [0.68 - 1.11]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202872_at	185	0.686486	0.179551	-	-0.233718	0.938653	0.0126762	1.01 [0.73 - 1.40]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202873_at	185	0.162162	0.00772951	0.132765	-0.564326	0.209978	-0.435095	0.65 [0.33 - 1.28]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202872_at	185	0.697297	0.0132295	0.198862	-0.498471	0.32744	-0.178506	0.84 [0.59 - 1.20]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202874_s_at	185	0.4	0.238837	-	-0.196001	0.813818	-0.0258945	0.97 [0.79 - 1.21]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202873_at	185	0.162162	0.0367701	0.405127	-0.430483	0.361542	-0.281962	0.75 [0.41 - 1.38]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P286598	110	0.118182	0.0151004	0.219062	-0.81619	0.787721	-0.047876	0.95 [0.67 - 1.35]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P146058	110	0.7	0.0363401	0.402047	0.501403	0.328962	0.160611	1.17 [0.85 - 1.62]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P286598	110	0.109091	0.00029424	0.00898444	-1.28557	0.885555	-0.0311394	0.97 [0.63 - 1.48]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P146058	110	0.181818	0.0969489	-	0.715048	0.279693	0.218289	1.24 [0.84 - 1.85]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202872_at	80	0.2375	0.023195	0.29724	1.98478	0.0694962	0.650638	1.92 [0.95 - 3.87]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202873_at	80	0.85	0.0840367	-	0.83718	0.457385	0.259403	1.30 [0.65 - 2.57]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202874_s_at	80	0.8875	0.297874	-	0.539599	0.475268	0.213494	1.24 [0.69 - 2.22]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_3465	281	0.846975	0.00752181	0.130019	0.500139	0.648341	0.107637	1.11 [0.70 - 1.77]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202874_s_at	38	0.342105	0.00627276	0.113004	1.51857	0.0270916	0.877647	2.41 [1.10 - 5.24]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202873_at	38	0.394737	0.0065723	0.117167	1.41596	0.0153512	0.851829	2.34 [1.18 - 4.67]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226463_at	38	0.236842	0.00693389	0.122121	1.85955	0.0232345	0.885357	2.42 [1.13 - 5.21]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202872_at	38	0.289474	0.00248204	0.0540276	2.04451	0.0117283	1.0757	2.93 [1.27 - 6.77]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202873_at	140	0.157143	0.00444452	0.0862421	-0.927976	0.0500982	-1.42798	0.24 [0.06 - 1.00]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202874_s_at	140	0.707143	0.0588804	-	0.555068	0.304285	0.30655	1.36 [0.76 - 2.44]
GENE	ATP6V1C1	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202872_at	140	0.535714	0.219893	-	0.357375	0.969867	0.0138827	1.01 [0.49 - 2.08]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1660729	165	0.212121	0.0218253	0.284903	0.801406	0.691348	0.106956	1.11 [0.66 - 1.89]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1660729	165	0.89697	0.0188199	0.256646	1.02306	0.215591	0.398062	1.49 [0.79 - 2.80]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1552532_a_at	79	0.620253	0.0807476	-	-0.540297	0.488496	-0.621506	0.54 [0.09 - 3.12]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1553989_a_at	79	0.101266	0.0892397	-	1.16243	0.453928	0.66429	1.94 [0.34 - 11.06]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1552532_a_at	559	0.101968	0.0133618	0.200323	-0.700393	0.224171	-0.136571	0.87 [0.70 - 1.09]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1553989_a_at	559	0.100179	0.020973	0.277061	-0.656674	0.27823	-0.162753	0.85 [0.63 - 1.14]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1552532_a_at	70	0.614286	0.18158	-	0.363875	0.612314	0.379219	1.46 [0.34 - 6.33]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1553989_a_at	70	0.342857	0.21	-	-0.337027	0.804769	0.148155	1.16 [0.36 - 3.75]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1552532_a_at	67	0.567164	0.376189	-	-0.705611	0.763348	-1.24582	0.29 [0.00 - 957.35]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1553989_a_at	67	0.38806	0.00835328	0.140882	-1.85733	0.309164	-1.90055	0.15 [0.00 - 5.83]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1552532_a_at	115	0.895652	0.15871	-	0.892226	0.62357	0.194583	1.21 [0.56 - 2.64]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1553989_a_at	115	0.13913	0.119022	-	15.2566	0.384414	0.34384	1.41 [0.65 - 3.06]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1552532_a_at	204	0.79902	2.91818e-06	0.000145553	0.834285	0.00336418	0.153267	1.17 [1.05 - 1.29]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1553989_a_at	204	0.818627	3.99373e-06	0.000193903	0.856794	0.00952136	0.153027	1.17 [1.04 - 1.31]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1552532_a_at	87	0.321839	0.11359	-	0.714047	0.55819	-0.361907	0.70 [0.21 - 2.34]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1552532_a_at	87	0.321839	0.11359	-	0.714047	0.55819	-0.361907	0.70 [0.21 - 2.34]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1553989_a_at	87	0.114943	0.03837	0.416426	15.2293	0.884793	0.0700367	1.07 [0.42 - 2.77]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1553989_a_at	87	0.114943	0.03837	0.416426	15.2293	0.884793	0.0700367	1.07 [0.42 - 2.77]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552532_a_at	77	0.337662	0.121883	-	1.12987	0.966511	-0.0209505	0.98 [0.37 - 2.60]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553989_a_at	77	0.246753	0.127881	-	1.45397	0.518621	0.381121	1.46 [0.46 - 4.66]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552532_a_at	77	0.454545	0.0738743	-	1.3188	0.787176	0.136036	1.15 [0.43 - 3.08]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553989_a_at	77	0.246753	0.257159	-	1.13318	0.700399	0.270389	1.31 [0.33 - 5.20]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18288	60	0.466667	0.0605786	-	0.73205	0.321405	0.161496	1.18 [0.85 - 1.62]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18288	60	0.5	0.0298983	0.353457	0.835907	0.0924664	0.331413	1.39 [0.95 - 2.05]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1552532_a_at	177	0.661017	0.199873	-	0.306889	0.428671	0.164071	1.18 [0.78 - 1.77]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1552532_a_at	177	0.870057	0.0635739	-	0.617125	0.188149	0.296998	1.35 [0.86 - 2.09]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1553989_a_at	177	0.836158	0.0739896	-	0.504516	0.408427	0.186841	1.21 [0.77 - 1.88]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1553989_a_at	177	0.757062	0.0666374	-	0.523938	0.293055	0.268281	1.31 [0.79 - 2.16]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1552532_a_at	145	0.731034	0.269013	-	0.382004	0.907349	0.0360284	1.04 [0.57 - 1.90]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1553989_a_at	145	0.531034	0.194028	-	0.432993	0.976636	0.0098211	1.01 [0.52 - 1.95]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1552532_a_at	226	0.884956	0.0652841	-	-1.24809	0.838803	-0.0158378	0.98 [0.84 - 1.15]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1553989_a_at	226	0.579646	0.136412	-	-0.440866	0.235642	-0.154754	0.86 [0.66 - 1.11]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1552532_a_at	55	0.545455	0.119587	-	-0.74301	0.746355	0.167549	1.18 [0.43 - 3.26]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1553989_a_at	55	0.563636	0.0434274	0.450541	-1.00225	0.938392	0.0431888	1.04 [0.35 - 3.12]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1552532_a_at	55	0.890909	0.0244648	0.3084	1.16253	0.0907796	0.779952	2.18 [0.88 - 5.39]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1553989_a_at	55	0.872727	0.0108176	0.17127	1.19059	0.0941634	0.807256	2.24 [0.87 - 5.77]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1552532_a_at	49	0.22449	0.202166	-	-0.763598	0.308928	0.558982	1.75 [0.60 - 5.13]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1553989_a_at	49	0.530612	0.136268	-	-0.888398	0.604558	0.321763	1.38 [0.41 - 4.66]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1552532_a_at	63	0.539683	0.0766504	-	-0.622189	0.0984624	-4.52235	0.01 [0.00 - 2.32]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1553989_a_at	63	0.555556	0.000875052	0.0227809	-1.22113	0.0231621	2.72346	15.23 [1.45 - 159.85]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.372429.2.A1_3p_a_at	28	0.714286	0.0968984	-	-1.20903	0.741753	-1.74863	0.17 [0.00 - 5721.09]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.372429.1.S1_3p_a_at	28	0.321429	0.120787	-	-0.860162	0.635644	0.328565	1.39 [0.36 - 5.41]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P276932	117	0.854701	4.23408e-05	0.00163503	1.25232	0.0081503	0.443497	1.56 [1.12 - 2.16]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P250914	117	0.632479	0.000371286	0.0109793	0.98608	0.0131402	0.151014	1.16 [1.03 - 1.31]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1552532_a_at	204	0.191176	0.0379644	0.413585	-0.784227	0.58601	-0.072928	0.93 [0.72 - 1.21]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1553989_a_at	204	0.107843	0.0211126	0.278355	-1.01677	0.477832	-0.105572	0.90 [0.67 - 1.20]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1552532_a_at	204	0.117647	0.0755083	-	-0.613756	0.447308	-0.0761267	0.93 [0.76 - 1.13]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1553989_a_at	204	0.602941	0.114476	-	0.426656	0.940961	0.00832003	1.01 [0.81 - 1.26]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1552532_a_at	111	0.72973	0.0794529	-	0.487334	0.831893	0.0225311	1.02 [0.83 - 1.26]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1553989_a_at	111	0.882883	0.0194525	0.262738	0.794634	0.611178	-0.0828252	0.92 [0.67 - 1.27]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	949	50	0.58	0.238808	-	-0.615709	0.810457	0.172096	1.19 [0.29 - 4.85]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1552532_a_at	138	0.65942	0.00302182	0.0633596	-0.846984	0.958413	-0.0067103	0.99 [0.77 - 1.28]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1553989_a_at	138	0.289855	0.0371283	0.407679	-0.519134	0.934492	0.00930682	1.01 [0.81 - 1.26]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9662	56	0.142857	0.165552	-	-0.67582	0.61026	-0.0726263	0.93 [0.70 - 1.23]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12596	56	0.375	0.049139	0.486434	0.730824	0.899498	-0.0471259	0.95 [0.46 - 1.98]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9662	56	0.142857	0.135949	-	-0.721386	0.396505	-0.127	0.88 [0.66 - 1.18]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12596	56	0.375	0.0791288	-	0.680641	0.878326	-0.0556852	0.95 [0.46 - 1.93]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1552532_a_at	278	0.485611	0.00527359	0.0986884	-0.527635	0.0117218	-0.351722	0.70 [0.54 - 0.92]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1553989_a_at	278	0.485611	0.00793843	0.135505	-0.502423	0.0104979	-0.286566	0.75 [0.60 - 0.94]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12990	81	0.753086	0.00197169	0.0447685	1.58937	0.0197892	0.449269	1.57 [1.07 - 2.29]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5201	81	0.888889	0.106327	-	1.0207	0.926959	0.0301724	1.03 [0.54 - 1.96]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P250914	110	0.190909	0.0012656	0.0310309	-1.0246	0.285039	-0.107796	0.90 [0.74 - 1.09]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P276932	110	0.2	0.0864247	-	0.53567	0.652859	0.0821779	1.09 [0.76 - 1.55]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P250914	110	0.281818	0.00157652	0.0372364	-0.750437	0.211248	-0.0952943	0.91 [0.78 - 1.06]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P276932	110	0.209091	0.061872	-	0.857278	0.258471	0.260193	1.30 [0.83 - 2.04]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1552532_a_at	38	0.131579	0.281117	-	-0.682294	0.897609	-0.0311807	0.97 [0.60 - 1.56]
GENE	ATP6V1C2	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1553989_a_at	38	0.789474	0.0128619	0.194776	1.18883	0.0383488	0.541055	1.72 [1.03 - 2.87]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208899_x_at	30	0.633333	0.155512	-	0.585763	0.543199	0.241332	1.27 [0.58 - 2.77]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214923_at	30	0.166667	0.0199735	0.267695	-1.23707	0.868757	0.0968077	1.10 [0.35 - 3.47]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208898_at	30	0.333333	0.208435	-	0.561294	0.832263	-0.082578	0.92 [0.43 - 1.98]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1797310	165	0.884848	0.0233912	0.298981	-1.13285	0.696039	0.0571648	1.06 [0.79 - 1.41]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1797310	165	0.866667	0.0578909	-	-1.71104	0.689613	-0.0851672	0.92 [0.60 - 1.39]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214923_at	163	0.404908	0.253	-	0.232005	0.92704	0.0626077	1.06 [0.28 - 4.07]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208898_at	163	0.828221	0.0997325	-	-0.48403	0.496663	-0.0911753	0.91 [0.70 - 1.19]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208899_x_at	163	0.116564	0.0718406	-	-0.499556	0.251443	-0.187076	0.83 [0.60 - 1.14]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	235864_at	163	0.687117	0.0331611	0.37866	0.438748	0.728531	0.258853	1.30 [0.30 - 5.59]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208898_at	79	0.177215	0.0648295	-	-0.629906	0.386517	-0.149698	0.86 [0.61 - 1.21]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	235864_at	79	0.240506	0.00969509	0.157736	1.08013	0.233272	0.761801	2.14 [0.61 - 7.50]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214923_at	79	0.822785	0.0409611	0.434197	0.694921	0.65132	0.441883	1.56 [0.23 - 10.57]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208899_x_at	79	0.341772	0.0323872	0.372797	-0.627805	0.254228	-0.213736	0.81 [0.56 - 1.17]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208898_at	58	0.37931	0.0540534	-	0.543857	0.638551	0.102546	1.11 [0.72 - 1.70]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208899_x_at	58	0.258621	0.125018	-	0.48556	0.690666	0.120527	1.13 [0.62 - 2.04]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214923_at	58	0.844828	0.141844	-	0.559435	0.676618	0.127193	1.14 [0.62 - 2.06]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208898_at	34	0.382353	0.125555	-	0.622518	0.718494	-0.083529	0.92 [0.58 - 1.45]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208899_x_at	34	0.235294	0.0187015	0.255496	1.14544	0.59234	-0.173217	0.84 [0.45 - 1.59]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214923_at	34	0.617647	0.200571	-	-0.505646	0.660206	-0.241321	0.79 [0.27 - 2.30]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208899_x_at	158	0.126582	0.0276462	0.335281	-0.668019	0.111671	-0.539016	0.58 [0.30 - 1.13]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214923_at	158	0.607595	0.0461082	0.467715	-0.491142	0.575187	-0.454131	0.63 [0.13 - 3.11]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208898_at	158	0.5	0.0485462	0.482828	-0.457851	0.029252	-0.743802	0.48 [0.24 - 0.93]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208899_x_at	53	0.113208	0.153794	-	0.998778	0.87015	0.0940244	1.10 [0.36 - 3.39]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208898_at	53	0.188679	0.0363925	0.402423	1.41461	0.963744	-0.0259379	0.97 [0.32 - 2.98]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214923_at	53	0.188679	0.261122	-	-0.452671	0.883493	-0.0777871	0.93 [0.33 - 2.62]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208899_x_at	53	0.132075	0.180374	-	0.945276	0.867949	0.0993666	1.10 [0.34 - 3.56]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208898_at	53	0.698113	0.123105	-	-0.614975	0.751955	-0.171103	0.84 [0.29 - 2.44]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214923_at	53	0.754717	0.233692	-	0.47197	0.564525	0.325787	1.39 [0.46 - 4.20]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208899_x_at	180	0.683333	0.0598599	-	-0.450789	0.305535	-0.284617	0.75 [0.44 - 1.30]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214923_at	180	0.227778	0.0162696	0.231222	0.653479	0.288836	0.269158	1.31 [0.80 - 2.15]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208898_at	180	0.122222	0.132477	-	-0.436707	0.614232	-0.191941	0.83 [0.39 - 1.74]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	235864_at	180	0.688889	0.10445	-	-0.401167	0.320931	-0.0828388	0.92 [0.78 - 1.08]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208898_at	559	0.620751	0.0345482	0.388999	0.422442	0.473567	0.212737	1.24 [0.69 - 2.21]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	235864_at	559	0.838998	0.0318343	0.368565	-0.632014	0.0989524	-0.185838	0.83 [0.67 - 1.04]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214923_at	559	0.806798	0.0154827	0.223076	-0.755892	0.158604	-0.357038	0.70 [0.43 - 1.15]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208899_x_at	559	0.135957	0.0854529	-	0.566947	0.692639	0.125313	1.13 [0.61 - 2.11]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208898_at	77	0.103896	0.0599405	-	-0.701247	0.285553	-0.41246	0.66 [0.31 - 1.41]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208899_x_at	77	0.805195	0.0162414	0.230933	-0.888627	0.11603	-0.617198	0.54 [0.25 - 1.16]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214923_at	77	0.103896	0.137824	-	-0.594816	0.504896	-0.322346	0.72 [0.28 - 1.87]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	235864_at	77	0.220779	0.0316701	0.367301	-0.618567	0.203384	-0.249205	0.78 [0.53 - 1.14]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208898_at	70	0.828571	0.129044	-	-0.569625	0.671751	-0.136365	0.87 [0.46 - 1.64]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	235864_at	70	0.871429	0.112304	-	-0.672462	0.970501	0.0274896	1.03 [0.24 - 4.41]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214923_at	70	0.871429	0.0109324	0.172628	0.913391	0.482163	0.493803	1.64 [0.41 - 6.49]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208899_x_at	70	0.742857	0.215072	-	-0.386726	0.904217	-0.0339225	0.97 [0.56 - 1.68]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33854_at	50	0.88	0.0331305	0.378429	1.15724	0.732546	0.123635	1.13 [0.56 - 2.30]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208899_x_at	74	0.297297	0.194135	-	-0.408695	0.708348	0.166468	1.18 [0.49 - 2.83]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214923_at	74	0.621622	0.0578443	-	-0.602109	0.733652	-0.178574	0.84 [0.30 - 2.34]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208898_at	74	0.608108	0.131198	-	0.433067	0.29116	0.38609	1.47 [0.72 - 3.01]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	235864_at	74	0.743243	0.0496593	0.489576	0.594697	0.693302	0.0662222	1.07 [0.77 - 1.48]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208898_at	67	0.238806	0.0237642	0.302274	-1.40916	0.417065	-1.0205	0.36 [0.03 - 4.24]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214923_at	67	0.134328	0.0309327	0.361586	-1.41937	0.783026	0.548326	1.73 [0.03 - 85.72]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	235864_at	67	0.134328	0.0475129	0.47648	-1.31059	0.558949	-0.882755	0.41 [0.02 - 7.99]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208899_x_at	67	0.358209	0.00654699	0.116817	-1.89088	0.136942	-1.97157	0.14 [0.01 - 1.87]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	235864_at	115	0.278261	0.015333	0.221509	15.5743	0.202305	1.20144	3.32 [0.52 - 21.08]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208898_at	115	0.269565	0.259288	-	0.838257	0.757348	-0.294607	0.74 [0.11 - 4.83]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214923_at	115	0.173913	0.00635373	0.114135	-1.37742	0.0618638	-2.0349	0.13 [0.02 - 1.11]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208899_x_at	115	0.869565	0.00564404	0.104077	1.41841	0.579904	0.513085	1.67 [0.27 - 10.28]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33854_at	158	0.867089	0.00183159	0.0421385	1.02794	0.775635	0.111071	1.12 [0.52 - 2.40]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33854_at	76	0.118421	0.121467	-	15.2464	0.432209	0.479747	1.62 [0.49 - 5.35]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214923_at	204	0.647059	0.0130489	0.196859	-0.362567	0.638339	-0.07906	0.92 [0.66 - 1.28]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	235864_at	204	0.372549	0.0580268	-	-0.273287	0.610764	-0.0687642	0.93 [0.72 - 1.22]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208899_x_at	204	0.578431	0.0040203	0.0796417	-0.409135	0.0556785	-0.408472	0.66 [0.44 - 1.01]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208898_at	204	0.897059	0.0160924	0.229401	0.560203	0.549929	-0.141529	0.87 [0.55 - 1.38]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208899_x_at	87	0.689655	0.0194136	0.262365	0.861265	0.181694	0.693536	2.00 [0.72 - 5.54]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	235864_at	87	0.770115	0.0527922	-	0.758749	0.111503	0.937379	2.55 [0.80 - 8.10]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	235864_at	87	0.770115	0.0527922	-	0.758749	0.111503	0.937379	2.55 [0.80 - 8.10]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208898_at	87	0.678161	0.0171014	0.239673	0.874852	0.0948569	0.936142	2.55 [0.85 - 7.65]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214923_at	87	0.252874	0.0639198	-	1.07942	0.446089	0.660963	1.94 [0.35 - 10.60]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208899_x_at	87	0.689655	0.0194136	0.262365	0.861265	0.181694	0.693536	2.00 [0.72 - 5.54]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214923_at	87	0.252874	0.0639198	-	1.07942	0.446089	0.660963	1.94 [0.35 - 10.60]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208898_at	87	0.678161	0.0171014	0.239673	0.874852	0.0948569	0.936142	2.55 [0.85 - 7.65]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	235864_at	77	0.116883	0.000929791	0.023974	-1.68777	0.0118281	-3.21997	0.04 [0.00 - 0.49]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208899_x_at	77	0.272727	0.0919563	-	-1.0213	0.247907	-0.604889	0.55 [0.20 - 1.52]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214923_at	77	0.441558	0.0515918	-	-1.11217	0.262033	-1.73651	0.18 [0.01 - 3.66]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	235864_at	77	0.116883	2.3952e-05	0.000982158	-2.21249	0.00953685	-3.99334	0.02 [0.00 - 0.38]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208898_at	77	0.688312	0.0275453	0.334451	-15.6526	0.126996	-1.02521	0.36 [0.10 - 1.34]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208899_x_at	77	0.376623	0.0522553	-	-1.05751	0.209694	-0.567283	0.57 [0.23 - 1.38]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208898_at	77	0.766234	0.163946	-	-1.34537	0.380234	-0.506153	0.60 [0.19 - 1.87]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214923_at	77	0.441558	0.00210238	0.0471854	-2.52108	0.0403556	-3.63115	0.03 [0.00 - 0.85]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214923_at	136	0.198529	0.229356	-	-0.57109	0.689479	-0.155933	0.86 [0.40 - 1.84]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208898_at	136	0.441176	0.0245391	0.309044	1.18785	0.0590881	1.26178	3.53 [0.95 - 13.09]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208899_x_at	136	0.860294	0.0225805	0.291745	1.033	0.27806	0.75614	2.13 [0.54 - 8.35]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208899_x_at	200	0.845	0.00136895	0.0331248	1.05076	0.795775	-0.148343	0.86 [0.28 - 2.65]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214923_at	200	0.63	0.191491	-	-0.416559	0.854391	-0.0823212	0.92 [0.38 - 2.22]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208898_at	200	0.805	0.00506824	0.0956573	0.87942	0.509377	0.379619	1.46 [0.47 - 4.51]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18821	60	0.183333	0.159608	-	0.837245	0.422593	0.245301	1.28 [0.70 - 2.33]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18821	60	0.783333	0.0584902	-	0.785551	0.510694	0.299815	1.35 [0.55 - 3.30]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208899_x_at	286	0.846154	0.109912	-	0.387609	0.768356	0.0828129	1.09 [0.63 - 1.88]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214923_at	286	0.898601	0.0332468	0.379305	0.555288	0.814989	0.0796244	1.08 [0.56 - 2.11]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208898_at	286	0.818182	0.00105297	0.0266119	0.694308	0.0303337	0.59342	1.81 [1.06 - 3.10]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214923_at	159	0.893082	0.145083	-	0.5976	0.976413	-0.0209291	0.98 [0.24 - 3.92]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208899_x_at	159	0.402516	0.0609635	-	0.652414	0.329744	0.429232	1.54 [0.65 - 3.64]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208899_x_at	159	0.566038	0.0184585	0.253129	0.874418	0.136202	0.731107	2.08 [0.79 - 5.43]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208898_at	159	0.849057	0.000641207	0.0175139	1.12074	0.101978	0.731363	2.08 [0.86 - 4.99]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214923_at	159	0.459119	0.0596438	-	-0.594564	0.581432	-0.393889	0.67 [0.17 - 2.74]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214923_at	159	0.415094	0.155962	-	-0.52147	0.871077	-0.135302	0.87 [0.17 - 4.48]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208898_at	159	0.867925	0.00438456	0.0853194	1.0003	0.0475928	0.878096	2.41 [1.01 - 5.74]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208899_x_at	159	0.566038	0.0120671	0.1858	0.790251	0.125688	0.646092	1.91 [0.83 - 4.36]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208898_at	159	0.849057	2.47899e-05	0.00101294	1.47864	0.0124964	1.23386	3.43 [1.30 - 9.04]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235864_at	159	0.509434	0.241698	-	0.437932	0.780487	0.0566818	1.06 [0.71 - 1.58]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235864_at	159	0.509434	0.361849	-	0.288816	0.981848	0.00393044	1.00 [0.72 - 1.41]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235864_at	159	0.886792	0.141549	-	0.602414	0.764454	0.0523247	1.05 [0.75 - 1.48]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208898_at	54	0.518519	0.167192	-	1.06062	0.476875	0.471243	1.60 [0.44 - 5.87]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208899_x_at	54	0.592593	0.199399	-	0.883429	0.67687	0.247993	1.28 [0.40 - 4.11]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214923_at	54	0.12963	0.181155	-	-0.929414	0.96092	-0.0710598	0.93 [0.05 - 15.98]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208898_at	117	0.213675	0.301561	-	-0.365202	0.921757	0.0317877	1.03 [0.55 - 1.95]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208898_at	117	0.478632	0.100131	-	-0.665187	0.535554	-0.245965	0.78 [0.36 - 1.70]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208899_x_at	117	0.247863	0.147287	-	0.764883	0.710423	0.131509	1.14 [0.57 - 2.28]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208899_x_at	117	0.247863	0.11847	-	0.681077	0.809213	0.0701238	1.07 [0.61 - 1.90]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208899_x_at	117	0.247863	0.11847	-	0.681077	0.809213	0.0701238	1.07 [0.61 - 1.90]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208899_x_at	117	0.888889	0.0861936	-	-15.1741	0.28174	-0.37436	0.69 [0.35 - 1.36]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214923_at	117	0.897436	0.0660863	-	0.796518	0.767043	0.200117	1.22 [0.33 - 4.59]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214923_at	117	0.145299	0.0141027	0.20841	-0.987528	0.632147	-0.424475	0.65 [0.12 - 3.72]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208898_at	117	0.213675	0.301561	-	-0.365202	0.921757	0.0317877	1.03 [0.55 - 1.95]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214923_at	117	0.145299	0.0438368	0.453203	-0.865916	0.776129	-0.25552	0.77 [0.13 - 4.51]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208898_at	117	0.111111	0.166827	-	1.31191	0.505565	0.260807	1.30 [0.60 - 2.80]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214923_at	117	0.897436	0.0660863	-	0.796518	0.767043	0.200117	1.22 [0.33 - 4.59]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214923_at	236	0.70339	0.013652	0.203509	-0.87189	0.82859	0.125515	1.13 [0.36 - 3.53]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208898_at	236	0.813559	0.000461175	0.0132239	0.971562	0.0467422	0.830153	2.29 [1.01 - 5.20]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208899_x_at	236	0.720339	0.0782123	-	0.489123	0.433115	0.33406	1.40 [0.61 - 3.22]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	235864_at	236	0.114407	0.152907	-	0.825652	0.41675	0.152435	1.16 [0.81 - 1.68]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208898_at	249	0.851406	7.75947e-06	0.000354983	1.04423	0.000294808	1.23887	3.45 [1.76 - 6.75]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208899_x_at	249	0.763052	0.00674987	0.11961	0.605414	0.100472	0.570121	1.77 [0.90 - 3.49]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214923_at	249	0.694779	0.000172705	0.00565554	-1.04621	0.202976	-0.580035	0.56 [0.23 - 1.37]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	235864_at	249	0.240964	0.0976626	-	-0.385282	0.664663	-0.0591846	0.94 [0.72 - 1.23]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208898_at	62	0.854839	8.66025e-05	0.00308507	1.84473	0.813235	-0.0925855	0.91 [0.42 - 1.97]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208898_at	125	0.16	0.194547	-	0.919658	0.593593	0.205816	1.23 [0.58 - 2.62]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214923_at	54	0.296296	0.134182	-	-0.95937	0.614043	-0.0996969	0.91 [0.61 - 1.33]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208899_x_at	62	0.854839	0.0252711	0.315354	1.14734	0.693792	0.234556	1.26 [0.39 - 4.06]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208898_at	125	0.144	0.0448592	0.459789	1.34735	0.671641	0.126313	1.13 [0.63 - 2.03]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208898_at	54	0.87037	0.00117622	0.0291927	1.85074	0.731063	-0.162796	0.85 [0.34 - 2.15]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214923_at	62	0.854839	0.096486	-	-1.56211	0.565062	-0.0938224	0.91 [0.66 - 1.25]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208899_x_at	125	0.264	0.0692688	-	1.06395	0.840857	0.0675942	1.07 [0.55 - 2.07]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208899_x_at	125	0.88	0.0640095	-	-1.05786	0.757808	-0.0804335	0.92 [0.55 - 1.54]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208899_x_at	54	0.851852	0.0223203	0.289398	1.33819	0.816629	0.169428	1.18 [0.28 - 4.96]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214923_at	125	0.832	0.0461573	0.468024	-1.78563	0.359412	-0.805019	0.45 [0.08 - 2.50]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214923_at	125	0.872	0.0267906	0.328196	-1.92802	0.193124	-0.896291	0.41 [0.11 - 1.57]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208898_at	198	0.616162	0.0554333	-	-0.571072	0.940065	0.0221846	1.02 [0.57 - 1.82]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214923_at	198	0.717172	0.0802378	-	-0.448881	0.755136	-0.0750973	0.93 [0.58 - 1.49]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208899_x_at	198	0.50505	0.0108155	0.171245	-0.672581	0.355235	-0.233797	0.79 [0.48 - 1.30]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208899_x_at	198	0.449495	0.0444669	0.457272	-0.537193	0.620208	-0.130035	0.88 [0.53 - 1.47]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208898_at	198	0.777778	0.172382	-	0.325246	0.683151	0.0952455	1.10 [0.70 - 1.74]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214923_at	198	0.454545	0.071356	-	0.47106	0.668634	0.127613	1.14 [0.63 - 2.04]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214923_at	198	0.454545	0.0456463	0.464798	0.551636	0.720965	0.112994	1.12 [0.60 - 2.08]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208898_at	198	0.616162	0.0258961	0.320677	-0.636397	0.696792	-0.109232	0.90 [0.52 - 1.55]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208899_x_at	198	0.873737	0.10297	-	0.471852	0.822668	0.0476499	1.05 [0.69 - 1.59]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208898_at	51	0.764706	0.0358024	0.398168	1.70453	0.506864	0.501745	1.65 [0.38 - 7.27]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208898_at	62	0.870968	0.122372	-	0.992092	0.926016	0.0481707	1.05 [0.38 - 2.90]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208899_x_at	51	0.588235	0.00410619	0.0809919	16.8277	0.00206983	1.68981	5.42 [1.85 - 15.88]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208899_x_at	62	0.612903	0.0268745	0.328895	1.2729	0.0142857	0.922287	2.52 [1.20 - 5.26]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214923_at	51	0.862745	0.00180865	0.0417038	2.30554	0.194708	2.1652	8.72 [0.33 - 229.93]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214923_at	62	0.66129	0.126115	-	0.857445	0.927543	0.113456	1.12 [0.10 - 12.92]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214923_at	177	0.60452	0.125544	-	0.366143	0.674376	-0.219021	0.80 [0.29 - 2.23]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208899_x_at	177	0.429379	0.00359589	0.0728589	0.855979	0.0110724	0.86663	2.38 [1.22 - 4.64]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	235864_at	145	0.8	0.0109237	0.172525	0.903707	0.220679	1.16937	3.22 [0.50 - 20.92]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214923_at	145	0.17931	0.0174861	0.243528	-0.83912	0.216317	-1.00387	0.37 [0.07 - 1.80]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208898_at	177	0.384181	0.000536151	0.0150402	1.11108	0.00102005	1.25023	3.49 [1.66 - 7.36]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208899_x_at	177	0.542373	0.00168777	0.0393935	0.738712	0.0139669	0.723171	2.06 [1.16 - 3.67]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208898_at	177	0.457627	0.000343096	0.0102578	0.896285	0.00068242	1.1143	3.05 [1.60 - 5.80]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208899_x_at	145	0.896552	0.000824963	0.0216769	1.27665	0.028548	0.916839	2.50 [1.10 - 5.68]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208898_at	145	0.758621	0.00742822	0.128774	0.891192	0.0198714	1.10094	3.01 [1.19 - 7.60]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214923_at	177	0.60452	0.249267	-	0.319108	0.851655	-0.11091	0.90 [0.28 - 2.86]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	235864_at	177	0.774011	0.0293511	0.349102	0.550988	0.0760434	1.1968	3.31 [0.88 - 12.42]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	235864_at	177	0.779661	0.029115	0.347211	0.630061	0.133948	1.16241	3.20 [0.70 - 14.62]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	235864_at	226	0.247788	0.208053	-	-0.380133	0.902714	-0.0172404	0.98 [0.75 - 1.30]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214923_at	226	0.884956	0.211702	-	-0.728659	0.830569	-0.0797064	0.92 [0.44 - 1.92]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208899_x_at	226	0.318584	0.00506579	0.095621	1.04135	0.0230532	0.879172	2.41 [1.13 - 5.14]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208898_at	226	0.455752	0.00570961	0.10502	0.845862	0.0203624	0.914449	2.50 [1.15 - 5.40]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214923_at	55	0.854545	0.0541525	-	-15.2993	0.194572	-2.84662	0.06 [0.00 - 4.28]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208899_x_at	55	0.781818	0.0107834	0.170865	1.11035	0.095778	1.07563	2.93 [0.83 - 10.39]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	235864_at	55	0.581818	0.141273	-	-0.766891	0.951597	0.071861	1.07 [0.11 - 10.94]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214923_at	49	0.77551	0.0490219	0.485723	-15.4555	0.220711	-3.28419	0.04 [0.00 - 7.19]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	235864_at	49	0.877551	0.0871473	-	1.0897	0.426932	1.15614	3.18 [0.18 - 55.06]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208898_at	55	0.745455	0.0064538	0.115527	1.16616	0.0155233	1.53611	4.65 [1.34 - 16.12]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208899_x_at	55	0.890909	0.0212901	0.279994	1.39889	0.700434	0.242217	1.27 [0.37 - 4.38]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208899_x_at	49	0.816327	0.0579658	-	1.10726	0.814331	0.190341	1.21 [0.25 - 5.92]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208898_at	55	0.890909	0.00093917	0.0241771	1.87725	0.0731186	1.34378	3.83 [0.88 - 16.67]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	235864_at	55	0.872727	0.267381	-	0.610983	0.765189	0.339974	1.40 [0.15 - 13.08]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208898_at	49	0.632653	0.00525397	0.0984001	1.55637	0.0600034	1.54165	4.67 [0.94 - 23.30]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214923_at	55	0.781818	0.124196	-	-1.09284	0.39262	-1.6823	0.19 [0.00 - 8.80]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	298827	34	0.382353	0.0578484	-	0.902509	0.157069	0.745342	2.11 [0.75 - 5.92]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208899_x_at	63	0.84127	0.0813747	-	-1.01185	0.871172	0.0234316	1.02 [0.77 - 1.36]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208898_at	63	0.777778	0.0335644	0.381689	-0.991432	0.793499	-0.0425092	0.96 [0.70 - 1.32]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	235864_at	63	0.380952	0.0108092	0.171171	-0.846263	0.189826	-0.286424	0.75 [0.49 - 1.15]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214923_at	63	0.190476	0.0138407	0.205567	-0.940418	0.458583	-1.25223	0.29 [0.01 - 7.84]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.199726.0.A1_3p_at	28	0.5	0.028335	0.340912	-1.26011	0.481691	-0.810055	0.44 [0.05 - 4.25]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11999089_3p_at	28	0.428571	0.0356712	0.397216	1.30293	0.125265	0.335324	1.40 [0.91 - 2.15]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.306415.0.S1_3p_at	28	0.678571	0.0916654	-	-1.25377	0.24556	-4.13992	0.02 [0.00 - 17.25]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5138992_3p_s_at	28	0.571429	0.0745633	-	0.947026	0.244542	0.538622	1.71 [0.69 - 4.25]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214923_at	82	0.780488	0.144661	-	0.542501	0.510257	0.374947	1.45 [0.48 - 4.44]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208898_at	82	0.170732	0.0222523	0.288783	-0.930181	0.484452	-0.255294	0.77 [0.38 - 1.58]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208899_x_at	82	0.451219	0.0050547	0.0954563	-0.948024	0.174277	-0.551521	0.58 [0.26 - 1.28]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214923_at	79	0.78481	0.0894897	-	0.495019	0.709136	0.330637	1.39 [0.24 - 7.91]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208898_at	79	0.56962	0.137479	-	-0.397896	0.620728	-0.187013	0.83 [0.40 - 1.74]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208899_x_at	79	0.556962	0.323241	-	0.256963	0.880603	0.0639835	1.07 [0.46 - 2.46]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208899_x_at	104	0.375	0.0637851	-	-0.59273	0.193258	-0.776544	0.46 [0.14 - 1.48]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214923_at	104	0.134615	0.0420352	0.441382	-0.79378	0.722152	-0.414901	0.66 [0.07 - 6.50]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208898_at	104	0.576923	0.0045177	0.087364	-1.04263	0.0959587	-0.799664	0.45 [0.18 - 1.15]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P140115	117	0.495726	0.152332	-	0.413585	0.383439	0.278378	1.32 [0.71 - 2.47]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208898_at	204	0.534314	0.0142363	0.209852	0.671733	0.0558105	0.962624	2.62 [0.98 - 7.02]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214923_at	204	0.852941	1.10482e-07	7.04649e-06	1.73892	0.000823137	2.93121	18.75 [3.37 - 104.46]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	235864_at	204	0.833333	0.00992983	0.160607	0.962059	0.258411	0.598902	1.82 [0.64 - 5.14]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214923_at	204	0.833333	2.53723e-07	1.52843e-05	1.35486	0.00871505	1.63369	5.12 [1.51 - 17.36]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	235864_at	204	0.622549	0.194382	-	0.352544	0.743882	0.122453	1.13 [0.54 - 2.36]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208899_x_at	204	0.852941	9.46327e-05	0.0033361	1.37067	0.000269891	1.97113	7.18 [2.49 - 20.73]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208899_x_at	204	0.607843	0.00119892	0.0296622	0.864875	0.00108344	1.35166	3.86 [1.72 - 8.69]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208898_at	204	0.803922	0.000127272	0.00432949	1.32141	0.00164879	2.06533	7.89 [2.18 - 28.55]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214923_at	178	0.41573	0.216775	-	0.255046	0.612627	0.305059	1.36 [0.42 - 4.42]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208898_at	178	0.280899	0.00134227	0.0325873	0.795895	0.00906887	0.785484	2.19 [1.22 - 3.96]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208899_x_at	178	0.101124	0.00957621	0.156274	1.13321	0.0368407	0.760087	2.14 [1.05 - 4.37]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200016941	41	0.609756	0.0905207	-	0.695431	0.321008	0.329899	1.39 [0.72 - 2.67]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214923_at	111	0.108108	0.0276464	0.335282	-0.751985	0.653351	-0.207325	0.81 [0.33 - 2.01]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208899_x_at	111	0.252252	0.0194367	0.262587	0.79584	0.0546799	0.68751	1.99 [0.99 - 4.01]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	235864_at	111	0.162162	0.0954397	-	0.76125	0.477335	0.0965249	1.10 [0.84 - 1.44]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208898_at	111	0.459459	0.00620057	0.111992	0.74484	0.149498	0.494691	1.64 [0.84 - 3.21]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214923_at	90	0.144444	0.093377	-	0.97305	0.523827	0.445669	1.56 [0.40 - 6.15]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214923_at	90	0.144444	0.295984	-	0.628135	0.505827	0.521328	1.68 [0.36 - 7.82]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208898_at	90	0.788889	0.120635	-	0.548734	0.876037	-0.039281	0.96 [0.59 - 1.58]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208898_at	90	0.788889	0.0352602	0.394225	0.801644	0.717553	-0.105791	0.90 [0.51 - 1.60]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208899_x_at	90	0.422222	0.262497	-	0.381017	0.659374	-0.114988	0.89 [0.53 - 1.49]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208899_x_at	90	0.677778	0.227677	-	0.451188	0.726126	-0.104848	0.90 [0.50 - 1.62]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214923_at	138	0.217391	0.0146102	0.213862	-0.621487	0.857192	-0.257126	0.77 [0.05 - 12.72]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208899_x_at	138	0.869565	0.000491882	0.0139734	0.986745	0.00601836	0.511672	1.67 [1.16 - 2.40]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	235864_at	138	0.101449	0.0939038	-	-0.566723	0.601701	-0.151313	0.86 [0.49 - 1.52]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208898_at	138	0.188406	0.00391719	0.0780111	1.16671	0.0102374	0.479745	1.62 [1.12 - 2.33]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208899_x_at	129	0.139535	0.0707064	-	-0.537528	0.461042	-0.30273	0.74 [0.33 - 1.65]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214923_at	129	0.248062	0.210258	-	0.399439	0.994435	-0.00367213	1.00 [0.36 - 2.80]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208898_at	129	0.248062	0.237949	-	-0.314885	0.922476	0.0359449	1.04 [0.50 - 2.14]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11017	56	0.5	0.0995077	-	-0.561641	0.423586	-0.277005	0.76 [0.38 - 1.49]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32551	56	0.625	0.0503004	-	-0.785025	0.885365	-0.0530627	0.95 [0.46 - 1.95]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11017	56	0.5	0.23632	-	-0.423588	0.949168	-0.0233352	0.98 [0.48 - 2.00]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32551	56	0.625	0.0297618	0.352374	-0.823363	0.384006	-0.308522	0.73 [0.37 - 1.47]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	235864_at	278	0.111511	0.070102	-	-0.462311	0.52861	-0.249055	0.78 [0.36 - 1.69]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208899_x_at	278	0.719424	0.00750541	0.129801	0.526213	0.0605545	0.446015	1.56 [0.98 - 2.49]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208898_at	278	0.561151	0.0204523	0.272206	0.450315	0.110604	0.370486	1.45 [0.92 - 2.28]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214923_at	278	0.363309	0.142189	-	-0.27722	0.648626	-0.218484	0.80 [0.31 - 2.06]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208898_at	133	0.759399	0.0649695	-	-0.546953	0.212861	-0.239349	0.79 [0.54 - 1.15]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208899_x_at	133	0.112782	0.00721959	0.125983	-0.816546	0.0164932	-0.357179	0.70 [0.52 - 0.94]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214923_at	133	0.736842	0.0004944	0.0140345	0.829334	0.000496472	1.98424	7.27 [2.38 - 22.22]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11850	81	0.876543	0.234473	-	-1.18975	0.902423	-0.0608969	0.94 [0.36 - 2.49]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214923_at	185	0.205405	0.0579573	-	0.413832	0.322658	0.227381	1.26 [0.80 - 1.97]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208898_at	185	0.891892	0.0621305	-	-0.493594	0.68608	0.0412381	1.04 [0.85 - 1.27]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208899_x_at	185	0.886486	0.121525	-	-0.485234	0.642401	0.0567317	1.06 [0.83 - 1.34]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208898_at	185	0.891892	0.0534233	-	-0.587325	0.696409	0.0441664	1.05 [0.84 - 1.30]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214923_at	185	0.205405	0.0389532	0.420481	0.409818	0.374204	0.187041	1.21 [0.80 - 1.82]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208899_x_at	185	0.443243	0.162783	-	0.228593	0.375448	0.0980444	1.10 [0.89 - 1.37]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P140115	110	0.590909	0.0345879	0.389292	0.485609	0.104884	0.406669	1.50 [0.92 - 2.46]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P140115	110	0.609091	0.0117297	0.181929	0.738233	0.190904	0.379763	1.46 [0.83 - 2.58]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208899_x_at	80	0.25	0.132451	-	0.909953	0.382518	0.364223	1.44 [0.64 - 3.26]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214923_at	80	0.55	0.0679669	-	0.801098	0.429375	0.485905	1.63 [0.49 - 5.43]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208898_at	80	0.3125	0.157806	-	0.766698	0.715354	0.159547	1.17 [0.50 - 2.77]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214923_at	38	0.605263	0.0122994	0.188444	1.22482	0.0425997	1.75099	5.76 [1.06 - 31.30]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208899_x_at	38	0.894737	0.130562	-	0.934545	0.286267	0.629703	1.88 [0.59 - 5.97]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	235864_at	38	0.105263	0.10081	-	15.2655	0.304442	0.577574	1.78 [0.59 - 5.37]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208898_at	38	0.894737	0.130562	-	0.934545	0.312332	0.605266	1.83 [0.57 - 5.93]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214923_at	140	0.878571	0.0889577	-	-0.975862	0.0900069	-1.20645	0.30 [0.07 - 1.21]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208898_at	140	0.892857	0.0265736	0.326383	0.844931	0.143387	0.448299	1.57 [0.86 - 2.85]
GENE	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208899_x_at	140	0.642857	0.164635	-	0.40513	0.388769	0.251596	1.29 [0.73 - 2.28]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208678_at	30	0.5	0.201441	-	0.523469	0.762554	0.162073	1.18 [0.41 - 3.37]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1798485	165	0.460606	0.0228628	0.294277	0.560389	0.11488	0.330138	1.39 [0.92 - 2.10]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1798485	165	0.509091	0.00038756	0.0113917	1.35221	0.0777693	0.613019	1.85 [0.93 - 3.65]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208678_at	163	0.153374	0.181386	-	0.383171	0.990737	0.00230624	1.00 [0.68 - 1.48]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208678_at	79	0.531646	0.0577284	-	0.55107	0.947046	0.0191884	1.02 [0.58 - 1.80]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208678_at	58	0.810345	0.186468	-	-0.469021	0.371627	-0.305472	0.74 [0.38 - 1.44]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208678_at	34	0.882353	0.000153252	0.00509471	2.09917	0.0408896	1.09534	2.99 [1.05 - 8.54]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208678_at	158	0.21519	1.33864e-05	0.000581654	-1.03502	0.00252588	-1.2194	0.30 [0.13 - 0.65]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208678_at	53	0.716981	0.0375781	0.410865	-0.906219	0.113897	-1.09576	0.33 [0.09 - 1.30]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208678_at	53	0.641509	0.0771436	-	-0.716184	0.447231	-0.52025	0.59 [0.16 - 2.27]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208678_at	180	0.672222	0.0258251	0.320075	-0.53802	0.109083	-0.669869	0.51 [0.23 - 1.16]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208678_at	559	0.533095	0.00520596	0.0976937	0.554934	0.0339347	0.557837	1.75 [1.04 - 2.93]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208678_at	77	0.207792	8.95279e-06	0.000404176	-1.31028	4.0389e-05	-1.34599	0.26 [0.14 - 0.49]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208678_at	70	0.728571	0.0250403	0.313374	-0.698631	0.125472	-0.558471	0.57 [0.28 - 1.17]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37367_at	50	0.64	0.12176	-	-0.622931	0.501759	-0.176143	0.84 [0.50 - 1.40]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208678_at	74	0.891892	0.0423555	0.443504	0.77995	0.163997	0.454374	1.58 [0.83 - 2.99]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208678_at	67	0.61194	0.0699404	-	-1.70906	0.208334	-1.39063	0.25 [0.03 - 2.17]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208678_at	115	0.13913	0.0965775	-	-0.954851	0.655651	-0.445447	0.64 [0.09 - 4.54]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37367_at	158	0.303797	0.159308	-	-0.401851	0.3404	-0.454601	0.63 [0.25 - 1.62]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37367_at	76	0.223684	0.140989	-	1.40608	0.659076	0.3313	1.39 [0.32 - 6.07]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208678_at	204	0.122549	0.0403997	0.4304	0.44166	0.76522	0.0608318	1.06 [0.71 - 1.58]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208678_at	87	0.83908	0.00667349	0.118561	1.09295	0.0701945	0.825864	2.28 [0.93 - 5.58]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208678_at	87	0.83908	0.00667349	0.118561	1.09295	0.0701945	0.825864	2.28 [0.93 - 5.58]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208678_at	77	0.363636	0.339366	-	-0.595694	0.879593	-0.120375	0.89 [0.19 - 4.21]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208678_at	77	0.805195	0.238129	-	0.695007	0.900295	0.0880153	1.09 [0.28 - 4.33]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208678_at	136	0.897059	0.0404304	0.430609	1.024	0.605416	-0.201393	0.82 [0.38 - 1.76]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208678_at	200	0.585	0.171562	-	0.40144	0.96512	0.0248802	1.03 [0.34 - 3.13]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14469	60	0.783333	0.174085	-	-0.720391	0.540607	-0.378509	0.68 [0.20 - 2.30]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14469	60	0.75	0.00391667	0.0780028	1.0893	0.228809	0.926772	2.53 [0.56 - 11.43]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208678_at	286	0.548951	0.00205969	0.0463995	0.593133	0.100069	0.533988	1.71 [0.90 - 3.22]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208678_at	159	0.893082	0.00544408	0.101181	1.01117	0.0694684	0.739825	2.10 [0.94 - 4.66]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208678_at	159	0.572327	0.0339436	0.384519	0.791004	0.115462	0.760556	2.14 [0.83 - 5.52]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208678_at	159	0.893082	0.0947531	-	0.68231	0.502096	0.273415	1.31 [0.59 - 2.92]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208678_at	54	0.759259	0.120733	-	-15.4283	0.927486	-0.0517573	0.95 [0.31 - 2.89]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208678_at	117	0.410256	0.153527	-	0.479298	0.550533	0.235447	1.27 [0.58 - 2.74]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208678_at	117	0.880342	0.0145807	0.213547	1.07514	0.486138	0.32932	1.39 [0.55 - 3.51]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208678_at	117	0.410256	0.153527	-	0.479298	0.550533	0.235447	1.27 [0.58 - 2.74]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208678_at	117	0.102564	0.0171291	0.239952	-1.06749	0.493646	-0.338439	0.71 [0.27 - 1.88]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208678_at	236	0.733051	0.0503744	-	0.543147	0.204134	0.500521	1.65 [0.76 - 3.57]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208678_at	249	0.787149	0.00285207	0.0604702	0.67705	0.0325449	0.680097	1.97 [1.06 - 3.68]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208678_at	62	0.258065	0.200592	-	0.931838	0.741838	0.12987	1.14 [0.53 - 2.47]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208678_at	125	0.84	0.00743999	0.128931	1.03786	0.148625	0.731323	2.08 [0.77 - 5.61]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208678_at	125	0.84	0.0313227	0.364617	0.706974	0.164965	0.545686	1.73 [0.80 - 3.73]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208678_at	54	0.666667	0.424501	-	-0.530439	0.800921	0.121514	1.13 [0.44 - 2.90]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208678_at	198	0.459596	0.0926426	-	-0.428828	0.983881	0.00608979	1.01 [0.56 - 1.82]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208678_at	198	0.121212	0.126995	-	0.773452	0.62909	0.151382	1.16 [0.63 - 2.15]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208678_at	198	0.111111	0.10567	-	0.628161	0.289597	0.266275	1.31 [0.80 - 2.14]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208678_at	51	0.215686	0.00038283	0.0112722	-2.88215	0.00817668	-3.04494	0.05 [0.00 - 0.45]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208678_at	62	0.467742	0.0758995	-	-1.04119	0.324513	-0.873593	0.42 [0.07 - 2.37]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208678_at	177	0.107345	0.0444154	0.456941	-0.759855	0.246829	0.559072	1.75 [0.68 - 4.51]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208678_at	177	0.107345	0.0335947	0.381915	-0.715715	0.20622	0.531187	1.70 [0.75 - 3.88]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208678_at	145	0.296552	0.0393336	0.423109	0.895039	0.214087	0.755627	2.13 [0.65 - 7.01]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208678_at	226	0.530973	0.000182742	0.00594131	1.10387	0.00280617	1.50848	4.52 [1.68 - 12.16]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208678_at	55	0.527273	0.00453114	0.0875696	1.3029	0.0382952	1.81601	6.15 [1.10 - 34.26]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208678_at	55	0.418182	0.00213688	0.0478179	1.9484	0.00812634	2.76055	15.81 [2.05 - 122.10]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208678_at	49	0.489796	0.0292515	0.348305	1.35668	0.0994035	1.81621	6.15 [0.71 - 53.34]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	32649	34	0.823529	0.214107	-	-0.897575	0.853293	0.0943715	1.10 [0.40 - 2.99]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208678_at	63	0.238095	0.0830135	-	0.762464	0.225254	0.270743	1.31 [0.85 - 2.03]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13325247_3p_at	28	0.25	0.209024	-	0.941482	0.651971	0.0826245	1.09 [0.76 - 1.56]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208678_at	82	0.731707	0.127391	-	-0.633635	0.613877	-0.323333	0.72 [0.21 - 2.54]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37367_at	84	0.77381	0.294156	-	0.341265	0.977762	0.0162327	1.02 [0.32 - 3.18]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208678_at	79	0.860759	0.00977704	0.158741	0.847278	0.427133	0.475843	1.61 [0.50 - 5.21]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X76228_at	86	0.267442	0.0187144	0.255621	-0.933209	0.623109	0.341113	1.41 [0.36 - 5.48]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208678_at	104	0.644231	0.142638	-	-0.536503	0.583595	-0.388049	0.68 [0.17 - 2.72]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P143551	117	0.247863	0.280572	-	-0.333792	0.689921	-0.0909491	0.91 [0.58 - 1.43]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208678_at	204	0.161765	0.0396201	0.425079	1.82816	0.0295385	1.66661	5.29 [1.18 - 23.75]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208678_at	204	0.264706	0.00903298	0.149518	1.01499	0.0167954	1.37582	3.96 [1.28 - 12.23]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208678_at	178	0.893258	0.108662	-	0.458284	0.777997	0.140039	1.15 [0.43 - 3.05]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200006449	41	0.365854	0.31972	-	0.447611	0.766361	0.154839	1.17 [0.42 - 3.24]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208678_at	111	0.207207	0.111544	-	0.598651	0.445857	0.245693	1.28 [0.68 - 2.40]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208678_at	90	0.233333	0.05209	-	-0.667661	0.0700992	-0.686943	0.50 [0.24 - 1.06]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208678_at	90	0.233333	0.108965	-	-0.634841	0.123009	-0.666843	0.51 [0.22 - 1.20]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208678_at	138	0.898551	0.153451	-	-0.72074	0.611506	-0.119456	0.89 [0.56 - 1.41]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208678_at	129	0.131783	0.071304	-	0.81877	0.3758	0.32277	1.38 [0.68 - 2.82]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18474	56	0.517857	0.0085722	0.143686	-0.95186	0.0634748	-0.753809	0.47 [0.21 - 1.04]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25827	56	0.803571	0.0440574	0.454632	-1.15792	0.123562	-0.461136	0.63 [0.35 - 1.13]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18851	56	0.589286	0.0293176	0.348834	-0.802697	0.133067	-0.40633	0.67 [0.39 - 1.13]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25827	56	0.803571	0.0542781	-	-1.11705	0.309352	-0.31715	0.73 [0.40 - 1.34]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18474	56	0.482143	0.00351552	0.0715525	-0.988073	0.0318024	-0.819584	0.44 [0.21 - 0.93]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18851	56	0.821429	0.0599966	-	-1.09468	0.389433	-0.246654	0.78 [0.45 - 1.37]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208678_at	278	0.284173	0.0156037	0.224339	-0.478045	0.884087	-0.0273903	0.97 [0.67 - 1.41]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208678_at	133	0.360902	0.0593962	-	-0.453596	0.399638	-0.129145	0.88 [0.65 - 1.19]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2778	81	0.740741	0.13257	-	0.760799	0.474781	0.385033	1.47 [0.51 - 4.22]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3317	81	0.876543	0.00799292	0.136216	1.51691	0.241687	0.825218	2.28 [0.57 - 9.09]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2530	81	0.123457	0.189241	-	15.1852	0.625281	0.32032	1.38 [0.38 - 4.98]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	10023	81	0.518519	0.185049	-	-0.691422	0.99195	-0.00626461	0.99 [0.29 - 3.36]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208678_at	185	0.12973	0.0628948	-	0.487415	0.695844	-0.0538478	0.95 [0.72 - 1.24]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208678_at	185	0.12973	0.0816328	-	0.504235	0.531857	-0.0949737	0.91 [0.68 - 1.22]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P143551	110	0.654545	0.0193763	0.262008	0.542636	0.413839	0.128408	1.14 [0.84 - 1.55]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P143551	110	0.781818	0.0241732	0.30586	0.720441	0.370514	0.172432	1.19 [0.81 - 1.73]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208678_at	80	0.1125	0.093321	-	1.60238	0.27764	0.404511	1.50 [0.72 - 3.11]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208678_at	38	0.736842	0.000650538	0.01773	1.63019	0.0117284	1.88633	6.60 [1.52 - 28.60]
GENE	ATP6V1E1	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208678_at	140	0.892857	0.0543206	-	0.732393	0.982617	0.0104842	1.01 [0.39 - 2.60]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1810235	165	0.842424	0.115673	-	0.469706	0.805414	0.0567087	1.06 [0.67 - 1.66]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1810235	165	0.169697	0.133442	-	-0.606668	0.62343	-0.160876	0.85 [0.45 - 1.62]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1552286_at	79	0.164557	0.125617	-	0.710763	0.438	0.253744	1.29 [0.68 - 2.45]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1557372_at	79	0.189873	0.0385538	0.417708	0.944757	0.571582	0.29423	1.34 [0.48 - 3.72]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1552286_at	559	0.760286	0.00362501	0.0733304	-0.816335	0.0577588	-0.329931	0.72 [0.51 - 1.01]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1557372_at	559	0.726297	0.00547635	0.10165	-0.710567	0.336298	-0.240779	0.79 [0.48 - 1.28]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1552286_at	70	0.3	0.128533	-	-0.425289	0.396249	-0.294416	0.74 [0.38 - 1.47]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1557372_at	70	0.114286	0.0652011	-	-0.693505	0.225248	-0.919578	0.40 [0.09 - 1.76]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1552286_at	67	0.238806	0.0268156	0.328404	-1.3778	0.102307	-2.74037	0.06 [0.00 - 1.73]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1557372_at	67	0.567164	0.140523	-	1.00698	0.600146	0.637803	1.89 [0.17 - 20.54]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1552286_at	115	0.765217	0.0109235	0.172522	1.27218	0.094438	2.09078	8.09 [0.70 - 93.79]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1557372_at	115	0.556522	0.000949516	0.0244007	2.11282	0.00175258	2.90882	18.34 [2.97 - 113.38]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1552286_at	204	0.828431	0.00136785	0.0331025	0.610916	0.084317	0.219249	1.25 [0.97 - 1.60]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1557372_at	204	0.803922	0.150868	-	-0.250537	0.890219	-0.018488	0.98 [0.76 - 1.28]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1552286_at	87	0.551724	0.0242445	0.306482	-0.912698	0.228333	-0.407245	0.67 [0.34 - 1.29]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1552286_at	87	0.551724	0.0242445	0.306482	-0.912698	0.228333	-0.407245	0.67 [0.34 - 1.29]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1557372_at	87	0.103448	1.37746e-05	0.000596865	-1.72495	0.20292	-0.920856	0.40 [0.10 - 1.64]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1557372_at	87	0.103448	1.37746e-05	0.000596865	-1.72495	0.20292	-0.920856	0.40 [0.10 - 1.64]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552286_at	77	0.207792	2.86936e-06	0.000143323	-2.22386	0.013574	-1.36192	0.26 [0.09 - 0.76]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1557372_at	77	0.285714	0.0104901	0.167372	-1.32865	0.126951	-1.64774	0.19 [0.02 - 1.60]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552286_at	77	0.207792	0.000237417	0.00746071	-2.02516	0.031279	-1.35392	0.26 [0.08 - 0.89]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1557372_at	77	0.103896	0.0277235	0.335916	-1.40221	0.114731	-1.9974	0.14 [0.01 - 1.62]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	818	60	0.716667	0.120409	-	0.593092	0.8683	-0.0311532	0.97 [0.67 - 1.40]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	818	60	0.816667	0.0039102	0.0779	1.13772	0.319896	0.247295	1.28 [0.79 - 2.08]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1552286_at	145	0.751724	0.0207054	0.274572	-1.30153	0.982667	-0.0158576	0.98 [0.24 - 4.12]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1557372_at	145	0.124138	0.0368054	0.405379	-0.81813	0.556964	-0.476693	0.62 [0.13 - 3.05]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1552286_at	177	0.361582	0.0687438	-	0.468891	0.570158	0.299289	1.35 [0.48 - 3.79]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1552286_at	177	0.310734	0.00283102	0.0601092	1.09188	0.164931	0.832895	2.30 [0.71 - 7.45]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1557372_at	177	0.830508	0.0231285	0.296648	-1.01031	0.384174	-0.493588	0.61 [0.20 - 1.86]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1557372_at	177	0.830508	0.1198	-	-0.715637	0.801707	-0.161796	0.85 [0.24 - 3.01]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1552286_at	226	0.721239	0.0329163	0.376813	-0.802089	0.299558	-0.192547	0.82 [0.57 - 1.19]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1557372_at	226	0.10177	0.161263	-	-0.534548	0.564004	-0.207588	0.81 [0.40 - 1.64]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1552286_at	55	0.236364	0.0380474	0.414168	1.81434	0.201475	1.10511	3.02 [0.55 - 16.46]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1557372_at	55	0.272727	0.0240786	0.305033	-1.10308	0.0107777	-2.20526	0.11 [0.02 - 0.60]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1552286_at	49	0.244898	0.0350223	0.392485	15.5158	0.289197	1.14671	3.15 [0.38 - 26.24]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1557372_at	49	0.122449	0.0108047	0.171117	-1.45527	0.0299434	-1.79292	0.17 [0.03 - 0.84]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1552286_at	55	0.2	0.168738	-	0.986572	0.663357	0.344297	1.41 [0.30 - 6.65]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1557372_at	55	0.690909	0.0517123	-	-1.15544	0.0923815	-1.28149	0.28 [0.06 - 1.23]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1552286_at	63	0.650794	0.00461652	0.0888714	0.932768	0.579252	0.12591	1.13 [0.73 - 1.77]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1557372_at	63	0.253968	0.00661876	0.117808	-0.92533	0.33766	-2.36422	0.09 [0.00 - 11.81]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.405881.1.S1_3p_at	28	0.321429	0.0691516	-	-1.03791	0.521507	-1.80426	0.16 [0.00 - 40.95]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.336620.1.S1_3p_at	28	0.321429	0.297284	-	-0.578889	0.592476	-0.449618	0.64 [0.12 - 3.31]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P143047	117	0.820513	0.00476353	0.0910984	0.868736	0.502987	0.160883	1.17 [0.73 - 1.88]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1552286_at	204	0.897059	0.134285	-	0.719064	0.611523	0.301502	1.35 [0.42 - 4.33]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1557372_at	204	0.357843	0.123428	-	0.65346	0.712602	0.214093	1.24 [0.40 - 3.87]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1552286_at	204	0.534314	0.0229615	0.295159	-0.645682	0.452458	-0.320801	0.73 [0.31 - 1.68]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1557372_at	204	0.79902	0.285351	-	-0.406637	0.718322	-0.153435	0.86 [0.37 - 1.97]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1552286_at	111	0.333333	0.053813	-	-0.512851	0.475831	-0.127454	0.88 [0.62 - 1.25]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1557372_at	111	0.522523	0.00444395	0.0862335	-0.755542	0.142725	-0.630529	0.53 [0.23 - 1.24]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1552286_at	138	0.188406	0.158782	-	-0.400648	0.863513	-0.0237494	0.98 [0.74 - 1.28]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1557372_at	138	0.108696	0.163748	-	-0.439186	0.806334	-0.0871699	0.92 [0.46 - 1.84]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	191	56	0.892857	0.201098	-	-0.759361	0.591063	-0.117991	0.89 [0.58 - 1.37]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39977	56	0.75	0.139471	-	-0.628832	0.659714	-0.099091	0.91 [0.58 - 1.41]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	191	56	0.892857	0.1629	-	-0.829539	0.908567	-0.0244422	0.98 [0.64 - 1.48]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39977	56	0.267857	0.0636411	-	-0.668763	0.335633	-0.216715	0.81 [0.52 - 1.25]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1552286_at	278	0.125899	0.00444522	0.086253	1.13305	0.453726	0.116553	1.12 [0.83 - 1.52]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1557372_at	278	0.71223	0.120223	-	-0.357024	0.580354	-0.140941	0.87 [0.53 - 1.43]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	604	81	0.506173	0.0824865	-	-0.898406	0.330376	-0.261332	0.77 [0.45 - 1.30]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P143047	110	0.154545	0.0358328	0.398388	-0.643564	0.99616	-0.000807435	1.00 [0.72 - 1.39]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P143047	110	0.109091	0.0768708	-	-0.934051	0.844693	-0.0453582	0.96 [0.61 - 1.50]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1317	281	0.790036	0.123025	-	-0.273407	0.645264	-0.0450304	0.96 [0.79 - 1.16]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1552286_at	38	0.131579	0.0977727	-	1.55262	0.490185	0.283789	1.33 [0.59 - 2.97]
GENE	ATP6V1E2	ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1557372_at	38	0.5	0.0153938	0.222146	1.1385	0.0166283	1.12754	3.09 [1.23 - 7.77]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201527_at	30	0.566667	0.00634216	0.113973	1.07713	0.312701	0.664957	1.94 [0.53 - 7.07]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1678308	165	0.860606	0.0781956	-	-0.738002	0.967057	0.00884155	1.01 [0.66 - 1.53]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1678308	165	0.466667	0.0593209	-	0.705094	0.487909	0.238714	1.27 [0.65 - 2.49]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201527_at	163	0.815951	0.158527	-	-0.391501	0.777644	-0.0551598	0.95 [0.65 - 1.39]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201527_at	79	0.822785	0.162675	-	0.494252	0.957406	0.0135728	1.01 [0.62 - 1.67]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201527_at	58	0.103448	0.0511974	-	-0.865906	0.427522	0.293838	1.34 [0.65 - 2.77]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201527_at	34	0.823529	0.191049	-	-0.698339	0.336179	0.284195	1.33 [0.74 - 2.37]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201527_at	158	0.341772	0.0198225	0.266264	-0.544986	0.162897	-0.495925	0.61 [0.30 - 1.22]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201527_at	53	0.830189	0.0241366	0.30554	-1.28143	0.42938	-0.656151	0.52 [0.10 - 2.64]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201527_at	53	0.830189	0.00581981	0.106599	-2.28703	0.269908	-0.9528	0.39 [0.07 - 2.10]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201527_at	180	0.261111	0.0261145	0.322524	0.578617	0.0674026	0.615768	1.85 [0.96 - 3.58]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201527_at	559	0.128801	0.0108189	0.171285	1.02778	0.0222168	0.666728	1.95 [1.10 - 3.45]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201527_at	77	0.649351	0.0697534	-	0.470808	0.812733	-0.0805689	0.92 [0.47 - 1.80]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201527_at	70	0.742857	0.0039466	0.0784772	-0.98487	0.0376998	-1.23331	0.29 [0.09 - 0.93]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37395_at	50	0.24	0.131871	-	0.619976	0.504713	0.146964	1.16 [0.75 - 1.78]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201527_at	74	0.810811	9.81878e-05	0.00344632	1.23458	0.00500483	1.73339	5.66 [1.69 - 18.99]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201527_at	67	0.522388	0.0248329	0.311587	1.62741	0.578652	0.7839	2.19 [0.14 - 34.83]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201527_at	115	0.13913	0.103392	-	-0.925704	0.481529	-0.580893	0.56 [0.11 - 2.82]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37395_at	158	0.85443	0.0247537	0.310903	0.746546	0.535314	0.354154	1.42 [0.47 - 4.37]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37395_at	76	0.618421	0.00802593	0.136646	-2.24542	0.0995508	-1.2441	0.29 [0.07 - 1.27]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201527_at	204	0.563725	0.0631826	-	-0.266788	0.487358	-0.169522	0.84 [0.52 - 1.36]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201527_at	87	0.885057	0.0235399	0.300297	1.00238	0.735441	0.15419	1.17 [0.48 - 2.85]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201527_at	87	0.885057	0.0235399	0.300297	1.00238	0.735441	0.15419	1.17 [0.48 - 2.85]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201527_at	77	0.597403	0.0446278	0.458306	-1.84539	0.36254	-0.780387	0.46 [0.09 - 2.46]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201527_at	77	0.792208	0.261974	-	0.662287	0.855822	0.13965	1.15 [0.25 - 5.19]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201527_at	136	0.757353	0.090498	-	0.759045	0.966064	-0.0254461	0.97 [0.30 - 3.15]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201527_at	200	0.84	0.020463	0.272305	0.785377	0.484348	0.385082	1.47 [0.50 - 4.32]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6239	60	0.183333	0.0508515	-	1.33637	0.0923091	0.824256	2.28 [0.87 - 5.95]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6239	60	0.516667	0.0139601	0.206866	0.961411	0.0524365	1.18711	3.28 [0.99 - 10.88]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201527_at	286	0.101399	0.0899201	-	-0.468869	0.759494	-0.0857456	0.92 [0.53 - 1.59]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201527_at	159	0.672956	0.00137583	0.033263	0.975665	0.00304254	1.49186	4.45 [1.66 - 11.92]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201527_at	159	0.459119	0.013245	0.199033	1.02943	0.0322298	1.27321	3.57 [1.11 - 11.46]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201527_at	159	0.647799	0.12577	-	0.482318	0.22613	0.601633	1.83 [0.69 - 4.83]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201527_at	54	0.888889	1.77831e-08	1.27283e-06	4.06189	0.0634621	1.6403	5.16 [0.91 - 29.15]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201527_at	117	0.888889	0.149753	-	0.632209	0.705529	0.163377	1.18 [0.50 - 2.75]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201527_at	117	0.57265	0.180969	-	-0.535612	0.981598	0.0118028	1.01 [0.37 - 2.76]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201527_at	117	0.888889	0.149753	-	0.632209	0.705529	0.163377	1.18 [0.50 - 2.75]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201527_at	117	0.854701	0.11803	-	0.711918	0.431163	0.445153	1.56 [0.52 - 4.73]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201527_at	236	0.555085	0.0187373	0.255844	0.633534	0.182007	0.595076	1.81 [0.76 - 4.34]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201527_at	249	0.574297	0.0017718	0.0410031	0.655486	0.042421	0.718943	2.05 [1.02 - 4.11]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201527_at	62	0.467742	0.226659	-	0.632631	0.756593	0.156295	1.17 [0.44 - 3.14]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201527_at	125	0.288	0.131487	-	0.798797	0.513805	0.231565	1.26 [0.63 - 2.53]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201527_at	125	0.288	0.209309	-	0.489599	0.699815	0.108555	1.11 [0.64 - 1.94]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201527_at	54	0.888889	0.181195	-	0.871712	0.876165	0.0972073	1.10 [0.32 - 3.74]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201527_at	198	0.686869	0.056879	-	0.492945	0.674847	0.0978274	1.10 [0.70 - 1.74]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201527_at	198	0.686869	0.0185681	0.254198	0.633099	0.370821	0.214412	1.24 [0.77 - 1.98]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201527_at	198	0.686869	0.0948343	-	0.366913	0.516695	0.120898	1.13 [0.78 - 1.63]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201527_at	51	0.509804	0.188938	-	-1.3614	0.662922	-0.408539	0.66 [0.11 - 4.17]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201527_at	62	0.322581	0.148044	-	1.06942	0.882871	0.0869215	1.09 [0.34 - 3.47]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201527_at	177	0.367232	0.0716698	-	0.541202	0.631791	0.223739	1.25 [0.50 - 3.12]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201527_at	177	0.237288	0.0307386	0.360071	0.694901	0.226955	0.49255	1.64 [0.74 - 3.64]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201527_at	145	0.289655	0.0302747	0.356431	0.94784	0.214993	0.703844	2.02 [0.66 - 6.15]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201527_at	226	0.738938	0.0556664	-	-0.763005	0.914128	0.0379828	1.04 [0.52 - 2.07]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201527_at	55	0.545455	0.0515471	-	0.865264	0.496476	0.422504	1.53 [0.45 - 5.16]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201527_at	55	0.381818	0.000753502	0.0200801	2.60573	0.0255626	1.64021	5.16 [1.22 - 21.76]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201527_at	49	0.408163	0.0687136	-	1.3183	0.888907	0.105584	1.11 [0.25 - 4.89]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	855438	34	0.264706	0.0401975	0.429025	1.21211	0.0566738	1.20452	3.34 [0.97 - 11.51]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	126278	34	0.352941	0.243269	-	0.559352	0.215938	0.663921	1.94 [0.68 - 5.56]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201527_at	63	0.15873	0.0861721	-	-0.715307	0.989154	-0.00369062	1.00 [0.59 - 1.70]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4757819_3p_at	28	0.464286	0.0383672	0.416406	1.20793	0.871396	-0.0712425	0.93 [0.39 - 2.21]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4757819_3p_x_at	28	0.107143	0.0593188	-	-1.1806	0.90924	-0.0545014	0.95 [0.37 - 2.42]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201527_at	82	0.780488	0.000729903	0.0195469	1.18971	0.303066	0.674058	1.96 [0.54 - 7.08]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37395_at	84	0.702381	0.0175488	0.244153	0.692366	0.0988651	0.984562	2.68 [0.83 - 8.62]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201527_at	79	0.772152	0.00971609	0.157994	0.73618	0.532731	0.332309	1.39 [0.49 - 3.96]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D49400_at	86	0.860465	0.0959992	-	0.825764	0.855227	0.124486	1.13 [0.30 - 4.31]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201527_at	104	0.846154	0.00845026	0.142127	0.939208	0.0216136	1.45456	4.28 [1.24 - 14.82]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P93623	117	0.854701	0.0284319	0.341699	0.73625	0.674486	0.170327	1.19 [0.54 - 2.63]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201527_at	204	0.27451	0.000349815	0.0104306	15.5897	0.00332579	1.75585	5.79 [1.79 - 18.69]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201527_at	204	0.509804	5.94562e-06	0.00027868	1.3404	3.02216e-06	2.07875	7.99 [3.34 - 19.13]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201527_at	178	0.780899	0.00450935	0.0872363	0.602714	0.012903	0.939374	2.56 [1.22 - 5.36]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300001683	41	0.365854	0.187231	-	-0.546289	0.949092	-0.0316921	0.97 [0.37 - 2.56]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201527_at	111	0.576577	0.0113493	0.177519	-0.71982	0.362852	-0.305198	0.74 [0.38 - 1.42]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201527_at	90	0.155556	0.33365	-	0.506188	0.864373	0.0780284	1.08 [0.44 - 2.65]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201527_at	90	0.488889	0.233568	-	-0.445781	0.93436	-0.0426781	0.96 [0.35 - 2.65]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5019	50	0.86	0.147761	-	0.798797	0.89856	0.0713846	1.07 [0.36 - 3.22]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201527_at	138	0.550725	0.164896	-	0.3338	0.703596	0.10939	1.12 [0.63 - 1.96]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201527_at	129	0.891473	0.0644803	-	0.671062	0.717917	0.180687	1.20 [0.45 - 3.19]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23694	56	0.339286	0.195372	-	0.485205	0.973949	0.0133311	1.01 [0.46 - 2.26]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23694	56	0.107143	0.0556867	-	-0.861382	0.971795	-0.0155729	0.98 [0.42 - 2.33]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201527_at	278	0.248201	0.146868	-	0.341382	0.904618	-0.0351123	0.97 [0.54 - 1.71]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201527_at	133	0.714286	0.0543247	-	0.475943	0.226488	0.296448	1.35 [0.83 - 2.17]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1045	81	0.888889	0.0835734	-	0.97499	0.207368	0.53718	1.71 [0.74 - 3.94]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12739	81	0.308642	0.0183668	0.252232	2.05884	0.114332	0.798718	2.22 [0.82 - 5.99]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201527_at	185	0.167568	0.0124645	0.190313	-0.52322	0.183821	-0.18847	0.83 [0.63 - 1.09]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201527_at	185	0.167568	0.00323793	0.0669828	-0.642881	0.243773	-0.181086	0.83 [0.62 - 1.13]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P93623	110	0.618182	0.0232852	0.298042	0.671085	0.423123	0.208921	1.23 [0.74 - 2.05]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P93623	110	0.618182	0.0207723	0.275195	0.535175	0.115275	0.370544	1.45 [0.91 - 2.30]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201527_at	80	0.475	0.00225079	0.0498905	1.4546	0.0907984	0.734244	2.08 [0.89 - 4.88]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_5537	281	0.640569	0.00144464	0.0346379	0.449921	0.0495395	0.534999	1.71 [1.00 - 2.91]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201527_at	38	0.631579	0.000166536	0.00547873	2.12709	0.00191185	1.812	6.12 [1.95 - 19.23]
GENE	ATP6V1F	ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201527_at	140	0.878571	0.182467	-	0.543643	0.671086	0.209063	1.23 [0.47 - 3.23]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208737_at	30	0.8	0.0411246	0.435297	-1.22532	0.150647	-0.5684	0.57 [0.26 - 1.23]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1784523	165	0.551515	0.0254675	0.317033	-0.55713	0.761272	-0.0561475	0.95 [0.66 - 1.36]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1784523	165	0.357576	0.000485891	0.0138278	-1.20411	0.12743	-0.354296	0.70 [0.44 - 1.11]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208737_at	163	0.220859	0.00824963	0.139546	0.689706	0.243368	0.270184	1.31 [0.83 - 2.06]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	238765_at	163	0.147239	0.0333105	0.379784	0.668221	0.219254	0.472019	1.60 [0.75 - 3.40]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	238765_at	79	0.556962	0.00365615	0.0738335	0.83022	0.121178	0.64807	1.91 [0.84 - 4.34]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208737_at	79	0.848101	0.00425568	0.083325	0.967898	0.458551	0.299683	1.35 [0.61 - 2.98]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208737_at	58	0.844828	0.0353553	0.394918	-0.840205	0.388071	-0.251908	0.78 [0.44 - 1.38]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208737_at	34	0.764706	0.0930331	-	-0.82179	0.607423	0.182374	1.20 [0.60 - 2.41]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208737_at	158	0.537975	0.0277789	0.336371	-0.520927	0.291101	-0.313205	0.73 [0.41 - 1.31]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208737_at	53	0.698113	0.0545056	-	-0.796873	0.301404	-0.545088	0.58 [0.21 - 1.63]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208737_at	53	0.698113	0.064162	-	-0.824789	0.402607	-0.468068	0.63 [0.21 - 1.87]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208737_at	180	0.255556	0.374945	-	-0.209628	0.679913	-0.0979634	0.91 [0.57 - 1.44]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	238765_at	180	0.311111	0.103902	-	0.377426	0.771306	0.0818089	1.09 [0.63 - 1.88]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	238765_at	559	0.86941	0.0349115	0.391673	0.558027	0.998388	-0.000644035	1.00 [0.53 - 1.87]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208737_at	559	0.504472	0.0214495	0.281461	-0.463287	0.3945	-0.278756	0.76 [0.40 - 1.44]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208737_at	77	0.675325	0.00146816	0.0351048	0.877551	0.0365891	0.84064	2.32 [1.05 - 5.10]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	238765_at	77	0.844156	0.0148657	0.216581	0.814151	0.339951	0.449132	1.57 [0.62 - 3.94]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	238765_at	70	0.142857	0.0617392	-	-0.649416	0.222456	-0.862611	0.42 [0.11 - 1.69]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208737_at	70	0.128571	0.138052	-	-0.534309	0.706893	-0.14855	0.86 [0.40 - 1.87]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38814_at	50	0.32	0.0203431	0.271181	-0.809935	0.451995	-0.391016	0.68 [0.24 - 1.87]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208737_at	74	0.135135	0.103298	-	-0.661561	0.951922	0.038577	1.04 [0.30 - 3.64]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	238765_at	74	0.851351	0.00318352	0.0660762	0.987974	0.0485526	1.15857	3.19 [1.01 - 10.07]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	238765_at	67	0.149254	0.025635	0.318461	-1.38767	0.291624	-1.41243	0.24 [0.02 - 3.36]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208737_at	67	0.850746	0.00703825	0.123537	1.64305	0.179447	2.93228	18.77 [0.26 - 1357.54]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	238765_at	115	0.295652	0.180353	-	0.98428	0.904224	-0.09718	0.91 [0.19 - 4.42]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208737_at	115	0.86087	0.0111863	0.175614	1.31994	0.156863	1.12726	3.09 [0.65 - 14.70]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38814_at	158	0.113924	0.196154	-	-0.496489	0.524542	-0.26338	0.77 [0.34 - 1.73]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38814_at	76	0.144737	0.0358191	0.398288	-1.09875	0.504813	0.509216	1.66 [0.37 - 7.43]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	238765_at	204	0.328431	0.128302	-	-0.224996	0.814374	-0.0455853	0.96 [0.65 - 1.40]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208737_at	204	0.661765	0.059611	-	-0.274664	0.421094	-0.164571	0.85 [0.57 - 1.27]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208737_at	87	0.827586	0.0195179	0.263363	0.945013	0.671071	0.210488	1.23 [0.47 - 3.26]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	238765_at	87	0.505747	0.00912515	0.150673	1.01501	0.218581	0.461173	1.59 [0.76 - 3.31]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	238765_at	87	0.505747	0.00912515	0.150673	1.01501	0.218581	0.461173	1.59 [0.76 - 3.31]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208737_at	87	0.827586	0.0195179	0.263363	0.945013	0.671071	0.210488	1.23 [0.47 - 3.26]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208737_at	77	0.74026	0.0459956	0.467006	-15.5502	0.673289	-0.25844	0.77 [0.23 - 2.57]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	238765_at	77	0.181818	0.00142667	0.0342801	-1.60266	0.00716332	-1.49815	0.22 [0.08 - 0.67]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208737_at	77	0.74026	0.02134	0.280454	-15.5631	0.438881	-0.403309	0.67 [0.24 - 1.85]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	238765_at	77	0.181818	0.00299686	0.0629372	-1.67781	0.156442	-0.747859	0.47 [0.17 - 1.33]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208737_at	136	0.889706	0.278597	-	0.597099	0.585431	0.306184	1.36 [0.45 - 4.08]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208737_at	200	0.485	0.238267	-	0.350691	0.869034	0.0829739	1.09 [0.41 - 2.91]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14446	60	0.2	0.203176	-	-0.558187	0.854066	-0.0886045	0.92 [0.36 - 2.35]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14446	60	0.683333	0.02411	0.305308	0.833916	0.263552	0.641342	1.90 [0.62 - 5.85]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208737_at	286	0.84965	0.0819127	-	0.421031	0.335756	0.210034	1.23 [0.80 - 1.89]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208737_at	159	0.899371	0.00832334	0.140496	1.00205	0.982502	-0.0120273	0.99 [0.34 - 2.89]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208737_at	159	0.899371	0.0478987	0.47886	0.878991	0.704673	0.237728	1.27 [0.37 - 4.34]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208737_at	159	0.283019	0.142327	-	-0.475363	0.962876	0.0250838	1.03 [0.36 - 2.95]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238765_at	159	0.540881	0.164703	-	-0.450281	0.784417	0.163536	1.18 [0.36 - 3.80]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238765_at	159	0.786164	0.0327309	0.375409	0.706005	0.278751	0.664296	1.94 [0.58 - 6.46]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238765_at	159	0.899371	0.0450657	0.461108	0.889519	0.721861	0.250903	1.29 [0.32 - 5.12]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208737_at	54	0.240741	0.030095	0.355013	15.8572	0.136051	1.03984	2.83 [0.72 - 11.10]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208737_at	117	0.726496	0.0332802	0.379556	0.683881	0.754167	0.0840682	1.09 [0.64 - 1.84]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208737_at	117	0.726496	0.0163566	0.232114	0.888754	0.280647	0.345229	1.41 [0.75 - 2.64]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208737_at	117	0.726496	0.0332802	0.379556	0.683881	0.754167	0.0840682	1.09 [0.64 - 1.84]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208737_at	117	0.897436	0.0937594	-	-15.1658	0.841489	0.0672552	1.07 [0.55 - 2.07]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208737_at	236	0.84322	0.00350556	0.0713901	0.858139	0.223621	0.483834	1.62 [0.74 - 3.54]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	238765_at	236	0.309322	0.0471476	0.474216	0.657618	0.329216	0.463659	1.59 [0.63 - 4.04]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208737_at	249	0.851406	0.0474478	0.476077	0.517372	0.610967	0.161462	1.18 [0.63 - 2.19]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	238765_at	249	0.811245	0.0539424	-	0.470209	0.350946	0.344812	1.41 [0.68 - 2.91]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208737_at	62	0.693548	0.0807379	-	0.809414	0.349954	0.545707	1.73 [0.55 - 5.42]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208737_at	125	0.456	0.190271	-	0.526523	0.349252	0.346943	1.41 [0.68 - 2.93]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208737_at	125	0.888	0.102918	-	0.595133	0.27759	0.31031	1.36 [0.78 - 2.39]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208737_at	54	0.666667	0.0596061	-	1.05925	0.368295	0.653341	1.92 [0.46 - 7.98]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208737_at	198	0.141414	0.0126538	0.192444	1.36912	0.369308	0.193716	1.21 [0.80 - 1.85]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208737_at	198	0.141414	0.0103489	0.165678	1.65261	0.279796	0.248641	1.28 [0.82 - 2.01]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208737_at	198	0.141414	0.0335936	0.381907	0.774315	0.1059	0.297779	1.35 [0.94 - 1.93]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208737_at	51	0.568627	0.0776861	-	1.74518	0.380621	0.640858	1.90 [0.45 - 7.95]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208737_at	62	0.725806	0.00584662	0.106982	1.47777	0.190419	0.604563	1.83 [0.74 - 4.52]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208737_at	177	0.282486	0.190547	-	0.439127	0.804535	0.10109	1.11 [0.50 - 2.46]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	238765_at	177	0.107345	0.0936062	-	-0.564413	0.8044	0.101838	1.11 [0.49 - 2.48]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	238765_at	177	0.107345	0.100059	-	-0.620805	0.891104	0.065135	1.07 [0.42 - 2.71]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208737_at	177	0.60452	0.221863	-	-0.30438	0.746558	-0.113429	0.89 [0.45 - 1.78]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	238765_at	145	0.172414	0.252607	-	0.59742	0.733718	0.202325	1.22 [0.38 - 3.93]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208737_at	145	0.124138	0.159312	-	0.985274	0.939232	0.0385999	1.04 [0.39 - 2.80]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	238765_at	226	0.106195	0.0410566	0.43484	1.80792	0.315792	0.402523	1.50 [0.68 - 3.28]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208737_at	226	0.292035	0.000333662	0.0100143	1.67071	0.0381005	1.00424	2.73 [1.06 - 7.05]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208737_at	55	0.436364	0.0016018	0.0377293	1.74903	0.0529637	1.44086	4.22 [0.98 - 18.18]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208737_at	55	0.436364	0.00122351	0.0301687	2.0595	0.0622128	1.48101	4.40 [0.93 - 20.86]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	238765_at	55	0.327273	0.0550754	-	1.13723	0.31201	0.969116	2.64 [0.40 - 17.25]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208737_at	49	0.469388	0.0196204	0.264341	1.62532	0.283454	0.988861	2.69 [0.44 - 16.38]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	238765_at	49	0.346939	0.0141538	0.208962	2.13923	0.258781	1.29741	3.66 [0.39 - 34.79]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	238765_at	55	0.327273	0.0294045	0.349529	1.27842	0.163927	1.27465	3.58 [0.59 - 21.53]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	146646	34	0.382353	0.293378	-	0.48305	0.835226	0.111811	1.12 [0.39 - 3.21]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208737_at	63	0.809524	0.0571779	-	0.722325	0.816226	0.0690425	1.07 [0.60 - 1.92]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	238765_at	63	0.857143	0.121219	-	-0.911527	0.790731	-0.0482102	0.95 [0.67 - 1.36]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13097719_3p_at	28	0.857143	0.0685508	-	1.19105	0.841395	0.0244935	1.02 [0.81 - 1.30]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.136271.0.A1_3p_at	28	0.821429	0.00450816	0.0872181	1.59325	0.0949213	0.424616	1.53 [0.93 - 2.52]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208737_at	82	0.231707	0.00275887	0.0588668	-1.00885	0.0890762	-0.848443	0.43 [0.16 - 1.14]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38814_at	84	0.119048	0.137119	-	0.766027	0.44946	0.417354	1.52 [0.51 - 4.48]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208737_at	79	0.405063	0.101016	-	0.450546	0.223253	0.594741	1.81 [0.70 - 4.72]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208737_at	104	0.384615	0.0287541	0.344306	0.814766	0.153087	0.815028	2.26 [0.74 - 6.91]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P20882	117	0.74359	0.0648959	-	0.547913	0.728787	0.115676	1.12 [0.58 - 2.16]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	238765_at	204	0.882353	0.000266041	0.00823455	1.10645	0.0461517	0.704449	2.02 [1.01 - 4.04]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208737_at	204	0.833333	1.96389e-06	0.000101246	1.59366	1.19436e-05	2.76049	15.81 [4.59 - 54.39]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	238765_at	204	0.892157	0.00163635	0.0384003	1.22421	0.147987	0.704014	2.02 [0.78 - 5.25]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208737_at	204	0.77451	9.58028e-06	0.00042977	1.15785	3.16604e-05	2.12808	8.40 [3.08 - 22.88]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208737_at	178	0.623595	0.0198977	0.266978	-0.489667	0.299942	-0.437223	0.65 [0.28 - 1.48]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200010428	41	0.243902	0.179282	-	-0.580742	0.71038	-0.161827	0.85 [0.36 - 2.00]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208737_at	111	0.594595	0.0822718	-	-0.489871	0.697056	-0.114368	0.89 [0.50 - 1.59]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	238765_at	111	0.513514	0.00449104	0.0869559	-0.760439	0.36005	-0.329138	0.72 [0.36 - 1.46]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208737_at	90	0.222222	0.000168043	0.00552201	-1.18523	0.0280795	-0.624853	0.54 [0.31 - 0.94]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208737_at	90	0.166667	0.0150527	0.218559	-0.974777	0.300227	-0.345047	0.71 [0.37 - 1.36]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	238765_at	138	0.65942	0.126178	-	0.373942	0.572218	0.12201	1.13 [0.74 - 1.73]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208737_at	138	0.463768	0.00093565	0.0241009	0.826919	0.0298733	0.595013	1.81 [1.06 - 3.10]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208737_at	129	0.294574	0.0299282	0.353694	-0.564426	0.190162	-0.572799	0.56 [0.24 - 1.33]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29434	56	0.125	0.000212495	0.00677542	-1.49105	0.0692621	-0.624719	0.54 [0.27 - 1.05]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31729	56	0.160714	0.0179898	0.248526	-0.989357	0.442091	-0.24699	0.78 [0.42 - 1.47]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29434	56	0.589286	0.0772474	-	-0.652972	0.461559	-0.244014	0.78 [0.41 - 1.50]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31729	56	0.160714	1.33352e-05	0.000579646	-1.61771	0.062759	-0.627818	0.53 [0.28 - 1.03]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208737_at	278	0.568345	0.000430438	0.0124652	-0.698644	0.00424742	-0.587528	0.56 [0.37 - 0.83]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	238765_at	278	0.133094	0.00657479	0.117201	-0.680388	0.0418857	-0.366335	0.69 [0.49 - 0.99]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208737_at	133	0.315789	0.000757078	0.0201607	-0.78948	0.0901774	-0.28822	0.75 [0.54 - 1.05]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1091	81	0.246914	0.110993	-	-0.807659	0.452959	-0.407399	0.67 [0.23 - 1.93]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9863	81	0.679012	0.0839423	-	-1.61494	0.516594	-0.367917	0.69 [0.23 - 2.10]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208737_at	185	0.556757	0.0970055	-	-0.297154	0.423042	-0.0907407	0.91 [0.73 - 1.14]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208737_at	185	0.702703	0.0910169	-	-0.307425	0.522638	-0.0664081	0.94 [0.76 - 1.15]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P20882	110	0.363636	0.0525342	-	0.649992	0.0954046	0.443559	1.56 [0.93 - 2.62]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P20882	110	0.818182	0.0490558	0.48593	0.55569	0.22738	0.26071	1.30 [0.85 - 1.98]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208737_at	80	0.7375	0.235794	-	-0.647325	0.669145	-0.197038	0.82 [0.33 - 2.03]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208737_at	38	0.868421	0.0126847	0.192791	1.42273	0.434873	0.643775	1.90 [0.38 - 9.58]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	238765_at	38	0.236842	0.0118275	0.183055	1.73154	0.0646369	0.791233	2.21 [0.95 - 5.11]
GENE	ATP6V1G1	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208737_at	140	0.771429	0.00151395	0.0360094	0.906439	0.0140542	0.928266	2.53 [1.21 - 5.31]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214762_at	30	0.6	0.0788186	-	0.7287	0.695906	0.192439	1.21 [0.46 - 3.18]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1674778	165	0.290909	0.2221	-	-0.307275	0.896027	-0.0532719	0.95 [0.43 - 2.11]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1674778	165	0.89697	0.081911	-	0.768584	0.30283	0.422177	1.53 [0.68 - 3.40]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214762_at	163	0.472393	0.195974	-	-0.25536	0.75668	-0.212225	0.81 [0.21 - 3.10]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214762_at	79	0.303797	0.0286005	0.343065	0.7622	0.562407	0.351349	1.42 [0.43 - 4.67]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214762_at	58	0.189655	0.048864	0.484765	0.694082	0.185134	0.343919	1.41 [0.85 - 2.35]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214762_at	34	0.558824	0.00410501	0.0809734	-1.10993	0.0173587	-0.832777	0.43 [0.22 - 0.86]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214762_at	158	0.170886	0.14164	-	0.496429	0.540092	0.479945	1.62 [0.35 - 7.50]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214762_at	53	0.113208	0.0456484	0.464812	1.7936	0.408814	0.346159	1.41 [0.62 - 3.21]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214762_at	53	0.113208	0.117722	-	1.08734	0.614289	0.199037	1.22 [0.56 - 2.65]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214762_at	180	0.744444	0.0679808	-	-0.475718	0.240757	-0.294857	0.74 [0.45 - 1.22]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214762_at	559	0.719141	0.00558813	0.10327	0.553675	0.218485	0.177102	1.19 [0.90 - 1.58]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214762_at	77	0.701299	2.99463e-06	0.000149039	-1.45335	0.00018947	-0.523025	0.59 [0.45 - 0.78]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214762_at	70	0.814286	0.0512538	-	-0.701402	0.250928	-0.196439	0.82 [0.59 - 1.15]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33033_at	50	0.3	0.000272662	0.00841168	-1.26291	0.0216832	-0.610207	0.54 [0.32 - 0.91]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214762_at	74	0.243243	0.0116056	0.180495	-0.794577	0.143545	-0.231841	0.79 [0.58 - 1.08]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214762_at	67	0.895522	7.998e-05	0.00287572	2.27875	0.0241536	1.91056	6.76 [1.28 - 35.57]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214762_at	115	0.765217	0.0537383	-	0.999434	0.311536	0.749779	2.12 [0.50 - 9.04]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33033_at	158	0.335443	0.144232	-	-0.428089	0.661352	-0.0809494	0.92 [0.64 - 1.32]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33033_at	76	0.118421	0.152262	-	15.2129	0.652821	-0.200823	0.82 [0.34 - 1.96]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214762_at	204	0.485294	0.0114753	0.178985	-0.362858	0.349583	-0.0984225	0.91 [0.74 - 1.11]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214762_at	87	0.287356	0.131553	-	0.728832	0.281438	0.214307	1.24 [0.84 - 1.83]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214762_at	87	0.287356	0.131553	-	0.728832	0.281438	0.214307	1.24 [0.84 - 1.83]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214762_at	77	0.662338	0.0952689	-	0.898937	0.388168	0.472555	1.60 [0.55 - 4.69]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214762_at	77	0.155844	0.104088	-	-1.07395	0.569195	0.358933	1.43 [0.42 - 4.93]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214762_at	136	0.794118	0.00654381	0.116773	1.18244	0.196204	0.538152	1.71 [0.76 - 3.87]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214762_at	200	0.14	0.0313622	0.364923	1.43033	0.102321	0.548111	1.73 [0.90 - 3.34]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1451	60	0.283333	0.085131	-	-0.660751	0.153231	-0.574375	0.56 [0.26 - 1.24]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1451	60	0.883333	0.00207147	0.0466168	1.37947	0.00240204	1.50911	4.52 [1.71 - 11.98]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214762_at	286	0.475524	0.0102683	0.164708	-0.496534	0.475785	-0.150698	0.86 [0.57 - 1.30]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214762_at	159	0.553459	0.134214	-	-0.491881	0.843733	-0.0988706	0.91 [0.34 - 2.42]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214762_at	159	0.18239	0.145591	-	0.749024	0.998931	-0.000669544	1.00 [0.38 - 2.66]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214762_at	159	0.18239	0.0993319	-	1.1445	0.938414	-0.0455819	0.96 [0.30 - 3.04]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214762_at	54	0.388889	0.0368366	0.405602	-1.54876	0.506329	-0.811476	0.44 [0.04 - 4.86]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214762_at	117	0.239316	0.00173787	0.0403552	-0.965713	0.708722	-0.206288	0.81 [0.28 - 2.40]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214762_at	117	0.666667	0.0471703	0.474357	0.765056	0.763865	-0.222109	0.80 [0.19 - 3.41]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214762_at	117	0.239316	0.00173787	0.0403552	-0.965713	0.708722	-0.206288	0.81 [0.28 - 2.40]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214762_at	117	0.239316	0.00889963	0.14784	-0.961476	0.688681	0.236643	1.27 [0.40 - 4.03]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214762_at	236	0.127119	0.0799624	-	-0.582861	0.244183	-0.45369	0.64 [0.30 - 1.36]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214762_at	249	0.128514	0.00411085	0.0810649	-0.726865	0.0126888	-0.752145	0.47 [0.26 - 0.85]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214762_at	62	0.33871	0.29931	-	0.588228	0.653389	-0.0797402	0.92 [0.65 - 1.31]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214762_at	125	0.4	0.130267	-	-0.580228	0.401606	-0.323328	0.72 [0.34 - 1.54]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214762_at	125	0.872	0.281048	-	-0.635021	0.713099	-0.110346	0.90 [0.50 - 1.61]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214762_at	54	0.333333	0.277763	-	0.825113	0.662775	-0.0944605	0.91 [0.60 - 1.39]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214762_at	198	0.232323	0.0313882	0.365124	-0.59932	0.0796617	-0.302017	0.74 [0.53 - 1.04]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214762_at	198	0.30303	0.0153142	0.221312	-0.519722	0.0522099	-0.260093	0.77 [0.59 - 1.00]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214762_at	198	0.232323	0.0820519	-	-0.476781	0.220753	-0.20638	0.81 [0.58 - 1.13]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214762_at	51	0.823529	0.180927	-	1.15667	0.243103	2.02222	7.56 [0.25 - 225.38]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214762_at	62	0.467742	0.295837	-	-0.604148	0.766023	0.403536	1.50 [0.10 - 21.36]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214762_at	177	0.80226	0.0123672	0.189212	-0.960742	0.29501	-0.691938	0.50 [0.14 - 1.83]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214762_at	145	0.889655	0.299881	-	-0.737855	0.807423	0.232203	1.26 [0.19 - 8.16]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214762_at	177	0.80226	0.0493301	0.48759	-0.830166	0.639029	-0.355478	0.70 [0.16 - 3.10]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214762_at	226	0.132743	0.169859	-	0.704188	0.6046	0.0956261	1.10 [0.77 - 1.58]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214762_at	55	0.618182	0.000970547	0.0248538	-2.60243	0.0194456	-3.31758	0.04 [0.00 - 0.59]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214762_at	49	0.714286	0.0163684	0.232235	-15.6483	0.0313599	-3.64302	0.03 [0.00 - 0.72]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214762_at	55	0.618182	0.0424173	0.443912	-1.08335	0.0810754	-2.10328	0.12 [0.01 - 1.30]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214762_at	63	0.539683	0.0246339	0.309866	-0.782916	0.89078	-0.0352194	0.97 [0.58 - 1.60]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.249227.0.S1_3p_at	28	0.214286	0.027653	0.335337	-1.23725	0.697081	0.499733	1.65 [0.13 - 20.41]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214762_at	82	0.280488	0.0850117	-	0.755495	0.164402	0.924516	2.52 [0.68 - 9.28]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214762_at	79	0.177215	0.0450172	0.460798	0.790247	0.226465	0.946608	2.58 [0.56 - 11.95]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214762_at	104	0.105769	0.207615	-	-0.593017	0.905645	-0.102844	0.90 [0.16 - 4.94]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P500410	117	0.230769	0.00954384	0.155875	-0.760929	0.358088	-0.257028	0.77 [0.45 - 1.34]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214762_at	204	0.504902	0.0272741	0.332212	-0.855349	0.0828794	-0.933365	0.39 [0.14 - 1.13]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214762_at	204	0.176471	0.0413676	0.436928	-0.624032	0.118506	-0.652752	0.52 [0.23 - 1.18]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214762_at	178	0.696629	0.0919126	-	0.352571	0.865666	0.0897682	1.09 [0.39 - 3.10]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214762_at	111	0.783784	0.0311113	0.362977	-0.845984	0.626453	-0.118304	0.89 [0.55 - 1.43]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214762_at	90	0.211111	0.104387	-	0.761335	0.743893	0.247886	1.28 [0.29 - 5.67]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214762_at	90	0.233333	0.0416097	0.438548	1.17445	0.441531	0.667887	1.95 [0.36 - 10.68]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214762_at	138	0.297101	0.0251896	0.314655	-0.546586	0.039535	0.734438	2.08 [1.04 - 4.19]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214762_at	129	0.565891	0.0509134	-	0.480153	0.21432	0.464522	1.59 [0.76 - 3.31]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28216	56	0.160714	0.0422463	0.442782	1.05998	0.673238	0.157179	1.17 [0.56 - 2.43]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28216	56	0.160714	0.0820766	-	0.921003	0.96562	-0.0171955	0.98 [0.45 - 2.15]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214762_at	278	0.553957	0.000173601	0.00568116	0.706095	0.0125865	0.696541	2.01 [1.16 - 3.47]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214762_at	133	0.496241	0.0225558	0.291523	0.539824	0.0106303	4.14388	63.05 [2.62 - 1515.07]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13483	81	0.111111	0.000966503	0.0247668	-1.66877	0.117842	-0.181206	0.83 [0.66 - 1.05]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214762_at	185	0.513514	0.00547816	0.101676	0.493589	0.0795599	0.386086	1.47 [0.96 - 2.27]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214762_at	185	0.318919	0.00829377	0.140115	0.470217	0.17195	0.275342	1.32 [0.89 - 1.96]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P500410	110	0.154545	0.278912	-	-0.330238	0.45479	-0.237559	0.79 [0.42 - 1.47]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P500410	110	0.590909	0.0710478	-	-0.578259	0.0908264	-0.771318	0.46 [0.19 - 1.13]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214762_at	80	0.6875	0.200548	-	-0.6488	0.621043	-0.136165	0.87 [0.51 - 1.50]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214762_at	38	0.868421	0.0807219	-	-15.2712	0.801681	0.164481	1.18 [0.33 - 4.25]
GENE	ATP6V1G2	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214762_at	140	0.892857	0.0308201	0.360708	0.784087	0.346711	0.712472	2.04 [0.46 - 8.99]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1726273	165	0.29697	0.0910009	-	0.478238	0.311171	1.24025	3.46 [0.31 - 38.11]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1726273	165	0.151515	0.0996742	-	1.14003	0.740238	0.588688	1.80 [0.06 - 58.49]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	230565_at	163	0.159509	0.221689	-	-0.310332	0.805281	0.178711	1.20 [0.29 - 4.95]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	230565_at	79	0.886076	0.0186401	0.254899	0.895064	0.870397	0.140035	1.15 [0.21 - 6.19]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	230565_at	180	0.155556	0.00405872	0.0802465	-0.727563	0.0340273	-0.321398	0.73 [0.54 - 0.98]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	230565_at	559	0.722719	0.1917	-	-0.290583	0.872101	0.0283665	1.03 [0.73 - 1.45]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	230565_at	77	0.623377	7.34688e-05	0.00266767	1.0396	0.0050813	0.623206	1.86 [1.21 - 2.88]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	230565_at	70	0.885714	0.0368997	0.406052	-1.03767	0.303862	-0.938623	0.39 [0.07 - 2.34]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	230565_at	74	0.864865	0.0168568	0.237204	0.872159	0.922512	0.0270835	1.03 [0.60 - 1.77]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	230565_at	67	0.164179	0.192484	-	15.2833	0.626616	1.72002	5.58 [0.01 - 5708.20]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	230565_at	115	0.182609	0.000676807	0.0183355	-1.63822	0.219566	-0.427719	0.65 [0.33 - 1.29]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	230565_at	204	0.77451	0.00617702	0.111661	-0.456202	0.615181	-0.0449398	0.96 [0.80 - 1.14]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	230565_at	87	0.241379	0.219757	-	-0.51382	0.83347	-0.196319	0.82 [0.13 - 5.12]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	230565_at	87	0.241379	0.219757	-	-0.51382	0.83347	-0.196319	0.82 [0.13 - 5.12]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	230565_at	77	0.558442	0.0215391	0.282284	-1.594	0.160402	-2.00052	0.14 [0.01 - 2.21]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	230565_at	77	0.311688	0.043944	0.453898	-1.22332	0.15598	-2.3391	0.10 [0.00 - 2.44]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230565_at	159	0.345912	0.000161205	0.00532516	-1.14475	0.0776957	-0.379392	0.68 [0.45 - 1.04]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230565_at	159	0.345912	0.00249144	0.0541938	-0.925781	0.140646	-0.324812	0.72 [0.47 - 1.11]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230565_at	159	0.345912	0.000165729	0.00545554	-1.34015	0.0967664	-0.418587	0.66 [0.40 - 1.08]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	230565_at	236	0.330508	0.00421433	0.0826817	0.964469	0.0192441	0.641955	1.90 [1.11 - 3.25]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	230565_at	249	0.325301	0.0231233	0.296602	0.55196	0.18784	0.24916	1.28 [0.89 - 1.86]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	230565_at	177	0.898305	0.153955	-	-0.718667	0.348649	-0.463824	0.63 [0.24 - 1.66]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	230565_at	177	0.875706	0.113069	-	-0.910445	0.260219	-0.636842	0.53 [0.17 - 1.60]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	230565_at	145	0.882759	0.0683288	-	-1.65498	0.584477	-0.40025	0.67 [0.16 - 2.81]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	230565_at	226	0.234513	0.267946	-	0.405512	0.619875	0.0995915	1.10 [0.75 - 1.64]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	230565_at	55	0.672727	0.305481	-	0.464934	0.902907	-0.145016	0.87 [0.08 - 8.89]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	230565_at	55	0.672727	0.309116	-	0.51501	0.874002	0.203047	1.23 [0.10 - 15.07]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	230565_at	49	0.122449	0.173988	-	15.2508	0.842467	0.299035	1.35 [0.07 - 25.74]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	1590213	34	0.441176	0.0154309	0.222534	1.1299	0.205341	1.5058	4.51 [0.44 - 46.35]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	230565_at	63	0.587302	0.0046897	0.0899824	-1.04848	0.122026	-6.75995	0.00 [0.00 - 6.10]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.127743.0.A1_3p_at	28	0.75	0.00151446	0.0360194	-16.2847	0.00963754	-2.44245	0.09 [0.01 - 0.55]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	230565_at	204	0.308824	0.367711	-	0.386482	0.613621	0.143308	1.15 [0.66 - 2.01]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	230565_at	204	0.122549	0.0285899	0.342979	-0.7243	0.394913	-0.16846	0.84 [0.57 - 1.25]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	230565_at	111	0.324324	0.219713	-	0.357866	0.650994	0.0980951	1.10 [0.72 - 1.69]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	230565_at	138	0.108696	0.00510215	0.0961602	-0.843112	0.236528	-1.68981	0.18 [0.01 - 3.03]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33392	56	0.803571	0.0978034	-	0.708066	0.618014	0.252378	1.29 [0.48 - 3.47]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	33392	56	0.803571	0.0831209	-	0.733155	0.512396	0.311298	1.37 [0.54 - 3.46]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	230565_at	278	0.223022	0.293985	-	0.259445	0.770592	-0.107519	0.90 [0.44 - 1.85]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P23797	110	0.236364	0.0613812	-	0.548395	0.736943	0.0380738	1.04 [0.83 - 1.30]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P23797	110	0.4	0.299858	-	-0.311566	0.848964	0.0284206	1.03 [0.77 - 1.38]
GENE	ATP6V1G3	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	230565_at	38	0.105263	0.0360902	0.400247	-1.34061	0.034405	-0.694756	0.50 [0.26 - 0.95]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221504_s_at	30	0.833333	0.197587	-	0.645014	0.655287	0.202925	1.22 [0.50 - 2.99]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1763387	165	0.890909	0.0840662	-	-0.864126	0.877057	-0.0258565	0.97 [0.70 - 1.35]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1763387	165	0.648485	0.194041	-	-0.524613	0.793373	0.0687313	1.07 [0.64 - 1.79]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221504_s_at	163	0.644172	0.292396	-	0.215439	0.987022	0.00292915	1.00 [0.70 - 1.43]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221504_s_at	79	0.746835	0.0533203	-	0.599871	0.295979	0.380056	1.46 [0.72 - 2.98]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221504_s_at	58	0.637931	0.00522203	0.0979303	0.783162	0.139581	0.428236	1.53 [0.87 - 2.71]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221504_s_at	34	0.882353	4.49318e-06	0.000215915	2.62489	0.0115954	1.48441	4.41 [1.39 - 13.97]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221504_s_at	158	0.234177	0.000144246	0.0048317	-0.900228	0.0110761	-0.845754	0.43 [0.22 - 0.82]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221504_s_at	53	0.264151	0.00310051	0.0646857	-1.02128	0.0212035	-1.37409	0.25 [0.08 - 0.81]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221504_s_at	53	0.396226	0.0059084	0.107862	-0.982534	0.0351894	-1.31106	0.27 [0.08 - 0.91]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221504_s_at	180	0.322222	0.145025	-	-0.314122	0.61773	-0.207436	0.81 [0.36 - 1.84]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221504_s_at	559	0.813953	0.13356	-	0.382071	0.864135	0.0306639	1.03 [0.73 - 1.47]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221504_s_at	77	0.818182	0.0060042	0.109223	-1.12128	0.00255202	-1.22051	0.30 [0.13 - 0.65]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221504_s_at	70	0.614286	0.0232034	0.297315	-0.627923	0.154026	-0.430666	0.65 [0.36 - 1.18]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33742_f_at	50	0.12	0.0400093	0.427742	-0.934497	0.626928	-0.126656	0.88 [0.53 - 1.47]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33741_at	50	0.82	0.0965508	-	-0.975509	0.594691	-0.157389	0.85 [0.48 - 1.53]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221504_s_at	74	0.567568	0.0823364	-	0.497251	0.421267	0.276663	1.32 [0.67 - 2.59]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221504_s_at	67	0.731343	0.0415261	0.437989	-15.6525	0.629632	-0.625238	0.54 [0.04 - 6.79]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221504_s_at	115	0.895652	0.108966	-	1.00586	0.861426	-0.141102	0.87 [0.18 - 4.23]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33741_at	158	0.208861	0.178044	-	0.515699	0.500449	0.232628	1.26 [0.64 - 2.48]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33742_f_at	158	0.392405	0.0146879	0.214691	-0.689913	0.407686	-0.173702	0.84 [0.56 - 1.27]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33741_at	76	0.855263	0.0875941	-	-15.291	0.907793	0.0490608	1.05 [0.46 - 2.41]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33742_f_at	76	0.815789	0.135439	-	-1.42573	0.621292	-0.149808	0.86 [0.48 - 1.56]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221504_s_at	204	0.166667	0.0603805	-	0.364199	0.813451	0.0426384	1.04 [0.73 - 1.49]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221504_s_at	87	0.781609	0.275789	-	0.453277	0.806411	-0.110569	0.90 [0.37 - 2.17]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221504_s_at	87	0.781609	0.275789	-	0.453277	0.806411	-0.110569	0.90 [0.37 - 2.17]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221504_s_at	77	0.285714	0.185409	-	1.30242	0.829858	-0.126658	0.88 [0.28 - 2.80]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221504_s_at	77	0.766234	0.156941	-	-1.36504	0.393592	-0.48535	0.62 [0.20 - 1.88]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221504_s_at	136	0.411765	0.105021	-	-0.728973	0.0878639	-0.581367	0.56 [0.29 - 1.09]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221504_s_at	200	0.825	0.0106171	0.168888	0.81524	0.124947	0.59744	1.82 [0.85 - 3.90]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12923	60	0.75	0.0983896	-	0.673764	0.449557	0.219856	1.25 [0.70 - 2.20]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	12923	60	0.5	0.310593	-	-0.38824	0.877241	-0.0500347	0.95 [0.50 - 1.79]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221504_s_at	286	0.297203	0.0464638	0.469949	0.457792	0.339011	0.218649	1.24 [0.79 - 1.95]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221504_s_at	159	0.691824	0.00679372	0.12021	0.833962	0.219516	0.522623	1.69 [0.73 - 3.88]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221504_s_at	159	0.691824	0.00713196	0.124803	0.963287	0.140907	0.728757	2.07 [0.79 - 5.47]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221504_s_at	159	0.691824	0.0255843	0.318029	0.696198	0.215551	0.522559	1.69 [0.74 - 3.86]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221504_s_at	54	0.296296	0.204431	-	-0.830553	0.715017	0.187288	1.21 [0.44 - 3.30]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221504_s_at	117	0.25641	0.033116	0.37832	0.913959	0.314918	0.249057	1.28 [0.79 - 2.09]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221504_s_at	117	0.598291	0.238508	-	0.443603	0.82578	0.0666216	1.07 [0.59 - 1.93]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221504_s_at	117	0.25641	0.033116	0.37832	0.913959	0.314918	0.249057	1.28 [0.79 - 2.09]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221504_s_at	117	0.820513	0.14777	-	0.634489	0.724287	-0.111963	0.89 [0.48 - 1.67]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221504_s_at	236	0.707627	0.03803	0.414046	0.564302	0.429409	0.236464	1.27 [0.70 - 2.28]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221504_s_at	249	0.835341	0.0239476	0.303885	0.556125	0.390304	0.203098	1.23 [0.77 - 1.95]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221504_s_at	54	0.888889	0.0236564	0.301325	1.30772	0.220464	0.430375	1.54 [0.77 - 3.06]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221504_s_at	62	0.887097	0.0307994	0.360547	1.09107	0.511983	0.1805	1.20 [0.70 - 2.05]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221504_s_at	125	0.344	0.202041	-	0.55033	0.769084	0.101882	1.11 [0.56 - 2.19]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221504_s_at	125	0.624	0.195897	-	-0.417469	0.598232	0.139045	1.15 [0.69 - 1.93]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221504_s_at	198	0.292929	0.098734	-	-0.361248	0.901873	0.024042	1.02 [0.70 - 1.50]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221504_s_at	198	0.30303	0.0462192	0.468414	-0.517326	0.437472	-0.191691	0.83 [0.51 - 1.34]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221504_s_at	198	0.30303	0.0541531	-	-0.521714	0.474431	-0.181007	0.83 [0.51 - 1.37]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221504_s_at	51	0.843137	0.119412	-	1.32609	0.313322	0.624166	1.87 [0.55 - 6.28]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221504_s_at	62	0.225806	0.0447756	0.459253	15.475	0.990843	-0.00438205	1.00 [0.47 - 2.10]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221504_s_at	177	0.858757	0.168476	-	0.477908	0.480374	0.281397	1.32 [0.61 - 2.89]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221504_s_at	177	0.548023	0.0702913	-	0.424703	0.37492	0.306411	1.36 [0.69 - 2.67]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221504_s_at	145	0.862069	0.0628326	-	0.734182	0.328545	0.467238	1.60 [0.62 - 4.07]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221504_s_at	226	0.588496	0.00628121	0.113122	0.763775	0.153147	0.491666	1.64 [0.83 - 3.21]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221504_s_at	55	0.527273	0.0417845	0.439714	0.922963	0.280225	0.49589	1.64 [0.67 - 4.04]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221504_s_at	55	0.563636	0.000599624	0.0165439	1.75383	0.00299672	1.24732	3.48 [1.53 - 7.93]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221504_s_at	49	0.571429	0.0655329	-	1.07611	0.11799	0.871621	2.39 [0.80 - 7.13]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	214230	34	0.617647	0.0260781	0.322216	-1.09497	0.364348	-0.510211	0.60 [0.20 - 1.81]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221504_s_at	63	0.873016	4.12602e-06	0.000199758	1.79069	0.00151316	0.680868	1.98 [1.30 - 3.01]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6563195_3p_s_at	28	0.892857	0.000579779	0.0160768	2.53424	0.97021	0.00757965	1.01 [0.68 - 1.50]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221504_s_at	82	0.841463	0.0315568	0.366428	0.810381	0.575525	0.298894	1.35 [0.47 - 3.84]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33741_at	84	0.845238	0.0489442	0.485252	0.714349	0.484259	0.258855	1.30 [0.63 - 2.68]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221504_s_at	79	0.151899	0.0598999	-	-0.627192	0.351615	-0.407644	0.67 [0.28 - 1.57]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221504_s_at	104	0.25	0.282644	-	-0.379142	0.416512	-0.408558	0.66 [0.25 - 1.78]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P157478	117	0.529915	0.0431424	0.44868	0.577943	0.29888	0.320177	1.38 [0.75 - 2.52]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P363679	117	0.564103	0.00743343	0.128844	0.764609	0.240619	0.215047	1.24 [0.87 - 1.78]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221504_s_at	204	0.642157	0.000801166	0.0211481	1.19846	0.00414111	1.66319	5.28 [1.69 - 16.45]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221504_s_at	204	0.897059	0.00377384	0.0757259	0.944151	0.211648	0.605193	1.83 [0.71 - 4.73]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221504_s_at	178	0.775281	0.149904	-	-0.360288	0.485744	-0.258889	0.77 [0.37 - 1.60]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200002840	41	0.512195	0.00400275	0.0793648	-1.29168	0.19768	-0.389524	0.68 [0.37 - 1.23]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221504_s_at	111	0.261261	0.0496966	0.4898	0.647782	0.383808	0.265116	1.30 [0.72 - 2.37]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221504_s_at	90	0.466667	0.0462287	0.468473	0.683298	0.741744	0.136304	1.15 [0.51 - 2.58]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221504_s_at	90	0.555556	0.0413109	0.436548	0.76369	0.708496	0.175926	1.19 [0.47 - 3.00]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221504_s_at	138	0.695652	0.0113228	0.177209	0.624819	0.0275538	0.397822	1.49 [1.04 - 2.12]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221504_s_at	129	0.286822	0.0396439	0.425242	0.612184	0.202326	0.490035	1.63 [0.77 - 3.47]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43058	56	0.410714	0.0392711	0.422678	0.76185	0.43042	0.198317	1.22 [0.74 - 2.00]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9155	56	0.321429	0.122663	-	0.575158	0.501394	0.193732	1.21 [0.69 - 2.14]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43058	56	0.410714	0.0172925	0.241593	0.990958	0.193285	0.350361	1.42 [0.84 - 2.41]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9155	56	0.321429	0.116015	-	0.623199	0.515231	0.202994	1.23 [0.66 - 2.26]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221504_s_at	278	0.888489	0.129865	-	0.426578	0.332138	0.198315	1.22 [0.82 - 1.82]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221504_s_at	133	0.278196	0.0233278	0.298419	-0.562159	0.0735443	-0.224851	0.80 [0.62 - 1.02]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	3315	81	0.888889	0.0374759	0.410143	1.26926	0.898233	-0.0798775	0.92 [0.27 - 3.14]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221504_s_at	185	0.854054	0.342561	-	-0.209213	0.699833	-0.0416231	0.96 [0.78 - 1.19]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221504_s_at	185	0.135135	0.270202	-	-0.274829	0.580837	-0.0655642	0.94 [0.74 - 1.18]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P363679	110	0.181818	0.198925	-	0.526766	0.806547	-0.0390966	0.96 [0.70 - 1.31]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P157478	110	0.6	0.0521932	-	0.571953	0.550079	0.180949	1.20 [0.66 - 2.17]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P363679	110	0.509091	0.165888	-	0.317896	0.37874	-0.110454	0.90 [0.70 - 1.15]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P157478	110	0.509091	0.0941502	-	0.383706	0.726014	0.0848281	1.09 [0.68 - 1.75]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221504_s_at	80	0.8125	0.130584	-	0.718818	0.930476	-0.0330277	0.97 [0.46 - 2.03]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221504_s_at	38	0.421053	0.00495785	0.0940145	1.55687	0.0142425	1.47491	4.37 [1.34 - 14.22]
GENE	ATP6V1H	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221504_s_at	140	0.885714	0.294496	-	0.455944	0.96692	0.015529	1.02 [0.49 - 2.12]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210192_at	30	0.366667	0.354278	-	0.392376	0.916371	0.0843503	1.09 [0.23 - 5.25]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213106_at	30	0.866667	0.0590676	-	-1.31037	0.194287	-0.551875	0.58 [0.25 - 1.33]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1778358	165	0.357576	0.0883238	-	-0.412943	0.452092	-0.403371	0.67 [0.23 - 1.91]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1778358	165	0.848485	0.0109444	0.17277	0.966354	0.574428	0.37408	1.45 [0.39 - 5.36]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213106_at	163	0.355828	0.00767278	0.132017	0.574596	0.0674972	0.264251	1.30 [0.98 - 1.73]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210192_at	163	0.760736	0.00993239	0.160638	0.549131	0.00460136	0.937873	2.55 [1.34 - 4.89]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213106_at	79	0.329114	0.00918302	0.151396	0.904391	0.0386299	0.407639	1.50 [1.02 - 2.21]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210192_at	79	0.392405	0.0153478	0.221664	0.760142	0.0345601	0.690152	1.99 [1.05 - 3.78]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1569773_at	79	0.405063	0.178316	-	0.419284	0.406501	0.568203	1.77 [0.46 - 6.75]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210192_at	58	0.62069	0.134427	-	-0.427494	0.560344	-0.0942446	0.91 [0.66 - 1.25]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213106_at	58	0.689655	0.0308369	0.360839	0.645684	0.532389	0.143673	1.15 [0.74 - 1.81]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213106_at	34	0.352941	0.0123227	0.188709	1.13342	0.870126	0.0482137	1.05 [0.59 - 1.87]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210192_at	34	0.705882	0.184019	-	0.544801	0.72012	-0.126545	0.88 [0.44 - 1.76]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210192_at	158	0.481013	0.0255952	0.318122	-0.516156	0.0839438	-0.573916	0.56 [0.29 - 1.08]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213106_at	158	0.639241	0.0182337	0.250927	-0.598948	0.03713	-0.3136	0.73 [0.54 - 0.98]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213106_at	53	0.113208	0.0957721	-	-0.799312	0.387242	-0.227629	0.80 [0.48 - 1.33]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210192_at	53	0.113208	0.10213	-	1.13206	0.958682	-0.0128958	0.99 [0.61 - 1.61]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213106_at	53	0.528302	0.0232614	0.29783	-0.805571	0.187449	-0.316085	0.73 [0.46 - 1.17]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210192_at	53	0.132075	0.0311024	0.362907	1.89886	0.531693	0.170104	1.19 [0.70 - 2.02]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210192_at	180	0.561111	0.0396372	0.425196	-0.442799	0.239123	-0.18249	0.83 [0.61 - 1.13]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213106_at	180	0.111111	0.0174665	0.243332	-0.701529	0.283556	-0.213337	0.81 [0.55 - 1.19]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213106_at	559	0.105546	0.0137167	0.204216	-0.700509	0.0887836	-0.323945	0.72 [0.50 - 1.05]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1569773_at	559	0.697674	0.00927443	0.152536	-0.58917	0.256098	-0.12669	0.88 [0.71 - 1.10]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210192_at	559	0.527728	0.145452	-	0.29052	0.656064	0.0492685	1.05 [0.85 - 1.30]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213106_at	77	0.649351	2.37988e-05	0.000976518	-1.23371	0.021616	-0.384521	0.68 [0.49 - 0.95]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210192_at	77	0.519481	0.00266372	0.0572167	-0.796299	0.0517668	-0.338909	0.71 [0.51 - 1.00]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210192_at	70	0.871429	0.0402977	0.429707	0.739136	0.585426	0.32123	1.38 [0.43 - 4.37]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1569773_at	70	0.114286	0.133068	-	0.762101	0.954968	-0.0774973	0.93 [0.06 - 13.63]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213106_at	70	0.714286	0.0320296	0.370064	-0.642423	0.877159	-0.0178394	0.98 [0.78 - 1.23]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34973_at	50	0.16	0.0111205	0.174842	-1.09843	0.51172	-0.372082	0.69 [0.23 - 2.09]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33267_at	50	0.2	0.0011265	0.0281582	-1.2376	0.00992428	-0.410382	0.66 [0.49 - 0.91]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210192_at	74	0.216216	0.01459	0.213646	-0.780158	0.265422	-0.228168	0.80 [0.53 - 1.19]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213106_at	74	0.162162	0.0175414	0.244079	-0.812356	0.398476	-0.153854	0.86 [0.60 - 1.23]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213106_at	67	0.656716	0.141976	-	0.960803	0.782608	0.101651	1.11 [0.54 - 2.28]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210192_at	67	0.432836	0.0483316	0.481517	1.83648	0.835711	0.133162	1.14 [0.32 - 4.02]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1569773_at	67	0.283582	0.291829	-	1.0683	0.685752	1.94077	6.96 [0.00 - 84270.94]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210192_at	115	0.469565	0.00168309	0.0393034	2.5308	0.00567465	1.05979	2.89 [1.36 - 6.12]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1569773_at	115	0.878261	0.0416544	0.438846	1.14506	0.601934	0.303019	1.35 [0.43 - 4.23]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213106_at	115	0.356522	0.0626588	-	-0.968687	0.654335	-0.198522	0.82 [0.34 - 1.96]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33267_at	158	0.873418	0.000884568	0.0229893	1.03203	0.596705	0.0980703	1.10 [0.77 - 1.59]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34973_at	158	0.696203	0.0491701	0.486622	0.557058	0.187217	0.203443	1.23 [0.91 - 1.66]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33267_at	76	0.618421	0.0342611	0.386877	-1.47267	0.417396	-0.235728	0.79 [0.45 - 1.40]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34973_at	76	0.144737	0.0514136	-	-1.09759	0.150769	-0.405559	0.67 [0.38 - 1.16]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1569773_at	204	0.857843	0.100739	-	0.33266	0.943975	0.00467715	1.00 [0.88 - 1.14]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213106_at	204	0.122549	0.0767542	-	-0.38763	0.661408	0.0470752	1.05 [0.85 - 1.29]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210192_at	204	0.127451	0.220415	-	0.257924	0.746505	0.0194407	1.02 [0.91 - 1.15]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1569773_at	87	0.678161	0.0101014	0.162691	0.939733	0.421374	0.852496	2.35 [0.29 - 18.74]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210192_at	87	0.505747	0.0553355	-	0.727091	0.408242	0.39514	1.48 [0.58 - 3.79]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213106_at	87	0.264368	0.0936241	-	-0.639428	0.458007	-0.133394	0.88 [0.62 - 1.24]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1569773_at	87	0.678161	0.0101014	0.162691	0.939733	0.421374	0.852496	2.35 [0.29 - 18.74]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210192_at	87	0.505747	0.0553355	-	0.727091	0.408242	0.39514	1.48 [0.58 - 3.79]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213106_at	87	0.264368	0.0936241	-	-0.639428	0.458007	-0.133394	0.88 [0.62 - 1.24]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1569773_at	77	0.220779	0.146737	-	-0.905725	0.324282	-2.03624	0.13 [0.00 - 7.48]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213106_at	77	0.896104	0.0247052	0.310483	1.42814	0.947095	-0.0222912	0.98 [0.51 - 1.89]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210192_at	77	0.74026	0.229969	-	-1.19447	0.695523	-0.612766	0.54 [0.03 - 11.66]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213106_at	77	0.857143	0.0310611	0.362586	1.22037	0.61474	0.144463	1.16 [0.66 - 2.03]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1569773_at	77	0.896104	0.194225	-	-15.1967	0.904267	-0.194111	0.82 [0.03 - 19.48]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210192_at	77	0.74026	0.116278	-	-1.49354	0.552307	-0.81027	0.44 [0.03 - 6.44]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210192_at	136	0.779412	0.0692405	-	0.834746	0.727181	0.0876696	1.09 [0.67 - 1.79]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213106_at	136	0.117647	0.0021446	0.047959	-1.39468	0.33449	-0.275468	0.76 [0.43 - 1.33]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210192_at	200	0.59	0.323971	-	-0.300424	0.569841	-0.109744	0.90 [0.61 - 1.31]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213106_at	200	0.465	0.00577906	0.106016	-0.81791	0.0483379	-0.56196	0.57 [0.33 - 1.00]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4823	60	0.766667	0.189165	-	0.540617	0.335162	0.115793	1.12 [0.89 - 1.42]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4823	60	0.833333	0.00221777	0.049292	1.2432	0.00897616	0.344422	1.41 [1.09 - 1.83]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	6664	155	0.367742	0.0112537	0.176402	-0.685839	0.0847167	-0.387276	0.68 [0.44 - 1.05]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210192_at	286	0.335664	0.141505	-	-0.291566	0.782066	-0.0359035	0.96 [0.75 - 1.24]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213106_at	286	0.167832	0.0279215	0.337539	-0.506002	0.237301	-0.166245	0.85 [0.64 - 1.12]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210192_at	159	0.320755	0.121574	-	0.578409	0.438403	0.190107	1.21 [0.75 - 1.96]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213106_at	159	0.119497	0.00194405	0.0442528	-1.08003	0.0233106	-0.476955	0.62 [0.41 - 0.94]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210192_at	159	0.320755	0.13436	-	0.673644	0.42073	0.235546	1.27 [0.71 - 2.25]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213106_at	159	0.150943	0.000261888	0.00812308	-1.16776	0.00153868	-0.625475	0.54 [0.36 - 0.79]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210192_at	159	0.125786	0.10587	-	1.11479	0.287744	0.267802	1.31 [0.80 - 2.14]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213106_at	159	0.119497	1.50069e-05	0.00064485	-1.53817	0.00138932	-0.711506	0.49 [0.32 - 0.76]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	HC-AF035315_at	54	0.888889	0.186483	-	1.0816	0.77258	0.118922	1.13 [0.50 - 2.52]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210192_at	54	0.759259	0.123724	-	-15.4234	0.612861	-0.974163	0.38 [0.01 - 16.43]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213106_at	54	0.87037	0.0397694	0.426102	1.53416	0.840341	0.0845068	1.09 [0.48 - 2.48]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213106_at	117	0.358974	0.0547396	-	0.690408	0.357695	0.148851	1.16 [0.85 - 1.59]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213106_at	117	0.350427	0.130646	-	0.692837	0.581667	0.110885	1.12 [0.75 - 1.66]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210192_at	117	0.863248	0.308946	-	0.423169	0.788602	0.191127	1.21 [0.30 - 4.90]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210192_at	117	0.153846	0.162573	-	-0.601584	0.430215	-0.776817	0.46 [0.07 - 3.17]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210192_at	117	0.863248	0.308946	-	0.423169	0.788602	0.191127	1.21 [0.30 - 4.90]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210192_at	117	0.239316	0.176311	-	-0.544411	0.697941	-0.365839	0.69 [0.11 - 4.40]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213106_at	117	0.376068	0.385807	-	0.350083	0.931316	0.0169467	1.02 [0.69 - 1.50]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213106_at	117	0.358974	0.0547396	-	0.690408	0.357695	0.148851	1.16 [0.85 - 1.59]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213106_at	236	0.122881	0.0878282	-	-0.589178	0.926816	-0.023958	0.98 [0.59 - 1.63]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210192_at	236	0.110169	0.200666	-	-0.463156	0.964105	0.0120962	1.01 [0.60 - 1.71]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210192_at	249	0.851406	0.115492	-	0.41271	0.989819	0.00271526	1.00 [0.66 - 1.52]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213106_at	249	0.807229	0.0642311	-	0.443582	0.854178	-0.0389404	0.96 [0.63 - 1.46]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210192_at	54	0.888889	0.00032577	0.00980975	1.98467	0.876915	0.0623729	1.06 [0.48 - 2.34]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213106_at	125	0.136	0.00108689	0.0273278	-1.24564	0.0341396	-0.722278	0.49 [0.25 - 0.95]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213106_at	125	0.136	0.0326305	0.374647	-0.719408	0.278647	-0.256121	0.77 [0.49 - 1.23]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213106_at	54	0.740741	0.354514	-	-0.705642	0.944417	-0.0154574	0.98 [0.64 - 1.52]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210192_at	62	0.887097	0.000426761	0.0123739	1.71989	0.809309	0.0791735	1.08 [0.57 - 2.06]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210192_at	125	0.656	0.155418	-	0.535385	0.911582	0.0488184	1.05 [0.44 - 2.49]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213106_at	62	0.870968	0.161203	-	0.780514	0.741392	0.059337	1.06 [0.75 - 1.51]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210192_at	125	0.88	0.232981	-	-0.558938	0.743909	-0.117085	0.89 [0.44 - 1.80]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210192_at	198	0.757576	0.0543872	-	-0.502138	0.358714	-0.0704687	0.93 [0.80 - 1.08]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210192_at	198	0.717172	0.123068	-	-0.464929	0.490443	-0.0642622	0.94 [0.78 - 1.13]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213106_at	198	0.20202	0.142683	-	-0.358295	0.533619	-0.0723725	0.93 [0.74 - 1.17]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210192_at	198	0.737374	0.0444718	0.457303	-0.688178	0.30586	-0.0997191	0.91 [0.75 - 1.10]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213106_at	198	0.454545	0.0167292	0.235911	-0.605565	0.846682	-0.0269351	0.97 [0.74 - 1.28]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213106_at	198	0.454545	0.0415373	0.438064	-0.543837	0.924125	0.0141272	1.01 [0.76 - 1.36]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213106_at	51	0.431373	0.0781315	-	-1.74225	0.314663	-0.565174	0.57 [0.19 - 1.71]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213106_at	62	0.451613	0.0239577	0.303974	-1.39266	0.104231	-0.573335	0.56 [0.28 - 1.13]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210192_at	51	0.372549	0.209491	-	-1.09366	0.483447	-1.26946	0.28 [0.01 - 9.79]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210192_at	62	0.112903	0.092151	-	-1.07866	0.319348	-1.15722	0.31 [0.03 - 3.07]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213106_at	177	0.344633	0.106244	-	-0.43647	0.574822	-0.098765	0.91 [0.64 - 1.28]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1569773_at	145	0.510345	0.00693598	0.12215	-0.974017	0.0664689	-2.29829	0.10 [0.01 - 1.17]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210192_at	177	0.853107	0.221923	-	-0.566238	0.649816	-0.117782	0.89 [0.53 - 1.48]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213106_at	177	0.819209	0.0556104	-	-0.703483	0.223234	-0.182856	0.83 [0.62 - 1.12]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213106_at	145	0.282759	0.269299	-	-0.381826	0.907076	-0.0248469	0.98 [0.64 - 1.48]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1569773_at	177	0.60452	0.0110645	0.174184	-0.791558	0.0464014	-2.00776	0.13 [0.02 - 0.97]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210192_at	177	0.853107	0.0443415	0.456465	-0.901943	0.170195	-0.32501	0.72 [0.45 - 1.15]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1569773_at	177	0.819209	0.0268107	0.328364	-0.856572	0.308026	-0.823608	0.44 [0.09 - 2.14]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210192_at	145	0.372414	0.0546417	-	0.728072	0.950472	0.0186722	1.02 [0.57 - 1.84]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1569773_at	226	0.309735	0.16194	-	0.490069	0.679545	0.047752	1.05 [0.84 - 1.32]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213106_at	226	0.623894	0.0176103	0.244766	0.6654	0.543917	0.116779	1.12 [0.77 - 1.64]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210192_at	226	0.429204	0.0314369	0.365501	0.642256	0.217183	0.216963	1.24 [0.88 - 1.75]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1569773_at	49	0.204082	0.0757796	-	-0.998635	0.185472	-3.69063	0.02 [0.00 - 5.89]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213106_at	55	0.327273	0.310092	-	0.518894	0.745802	0.086838	1.09 [0.65 - 1.84]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213106_at	55	0.527273	0.0632578	-	-0.901144	0.172964	-0.370009	0.69 [0.41 - 1.18]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210192_at	55	0.636364	0.259093	-	0.502774	0.816401	0.089052	1.09 [0.52 - 2.32]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213106_at	49	0.163265	0.114788	-	15.3102	0.481298	0.252943	1.29 [0.64 - 2.60]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210192_at	55	0.672727	0.0789015	-	-1.02231	0.158363	-0.648106	0.52 [0.21 - 1.29]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1569773_at	55	0.218182	0.051302	-	-0.887933	0.251097	-2.37301	0.09 [0.00 - 5.36]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210192_at	49	0.306122	0.438968	-	-0.44972	0.840801	-0.102779	0.90 [0.33 - 2.46]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1569773_at	55	0.490909	0.00806082	0.1371	-1.40051	0.0275114	-4.99076	0.01 [0.00 - 0.58]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	322514	34	0.823529	0.0137681	0.204777	1.20065	0.641064	0.217582	1.24 [0.50 - 3.10]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213106_at	63	0.603175	0.0246752	0.310224	-0.822084	0.0730787	-0.219771	0.80 [0.63 - 1.02]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1569773_at	63	0.190476	0.000438959	0.0126764	-1.25157	0.497041	-3.39749	0.03 [0.00 - 606.37]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210192_at	63	0.539683	0.000129725	0.00440263	-1.3819	0.980137	-0.0272724	0.97 [0.11 - 8.33]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.382840.1.S1_3p_at	28	0.5	0.0672245	-	-1.06577	0.197275	-1.70724	0.18 [0.01 - 2.43]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4704323_3p_at	28	0.75	0.132812	-	-1.11021	0.298592	-6.57576	0.00 [0.00 - 338.14]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.382840.1.S1_3p_x_at	28	0.607143	0.18989	-	-0.772984	0.744822	0.404758	1.50 [0.13 - 17.15]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.180737.0.S1_3p_at	28	0.214286	0.117386	-	-0.851659	0.611136	-0.0866628	0.92 [0.66 - 1.28]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210192_at	82	0.158537	0.0217397	0.284122	1.98221	0.211782	0.792912	2.21 [0.64 - 7.67]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213106_at	82	0.231707	0.002949	0.0621249	-1.02569	0.351127	-0.180117	0.84 [0.57 - 1.22]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33267_at	84	0.797619	0.0606494	-	-0.75366	0.14616	-0.28594	0.75 [0.51 - 1.10]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210192_at	79	0.21519	0.00928951	0.152724	-0.755488	0.331945	-0.429726	0.65 [0.27 - 1.55]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213106_at	79	0.367089	0.00369131	0.0744004	-0.759078	0.110031	-0.339467	0.71 [0.47 - 1.08]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210192_at	104	0.105769	0.248762	-	-0.557267	0.410824	-0.487768	0.61 [0.19 - 1.96]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213106_at	104	0.375	0.000103544	0.00361138	-1.21512	0.0079184	-0.494114	0.61 [0.42 - 0.88]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P30075	117	0.119658	0.0132156	0.198708	-0.886355	0.0318803	-0.310788	0.73 [0.55 - 0.97]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210192_at	204	0.117647	0.000387802	0.0113978	-1.32625	0.0168552	-0.572824	0.56 [0.35 - 0.90]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210192_at	204	0.117647	0.00301299	0.0632102	-0.939228	0.106598	-0.306496	0.74 [0.51 - 1.07]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1569773_at	204	0.132353	3.36962e-05	0.00133346	-1.48518	0.000935754	-0.559024	0.57 [0.41 - 0.80]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1569773_at	204	0.431373	0.000569978	0.0158452	-0.929468	0.0187074	-0.299311	0.74 [0.58 - 0.95]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213106_at	204	0.181373	6.60853e-06	0.000306804	-1.5146	8.10167e-06	-1.18664	0.31 [0.18 - 0.51]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213106_at	204	0.102941	1.31806e-05	0.00057357	-1.33129	3.00514e-06	-0.951002	0.39 [0.26 - 0.58]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213106_at	178	0.331461	0.0105336	0.167892	-0.50962	0.0571809	-0.266016	0.77 [0.58 - 1.01]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210192_at	178	0.168539	0.0708812	-	-0.461072	0.852873	-0.0527609	0.95 [0.54 - 1.66]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1569773_at	111	0.162162	0.131902	-	-0.486179	0.362214	-0.119739	0.89 [0.69 - 1.15]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213106_at	111	0.702703	0.0323905	0.372822	-0.663565	0.0990997	-0.239983	0.79 [0.59 - 1.05]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210192_at	111	0.810811	0.0434433	0.450645	0.599535	0.513718	0.0877358	1.09 [0.84 - 1.42]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213106_at	90	0.788889	0.233716	-	0.435478	0.983037	-0.00671948	0.99 [0.53 - 1.85]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213106_at	90	0.788889	0.211341	-	0.513842	0.732591	0.119455	1.13 [0.57 - 2.24]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210192_at	90	0.422222	0.0459821	0.46692	0.689497	0.240711	0.95507	2.60 [0.53 - 12.82]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210192_at	90	0.366667	0.0286111	0.343151	0.968742	0.137056	1.38428	3.99 [0.64 - 24.76]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4356	50	0.12	0.282412	-	-0.663204	0.757513	-0.132292	0.88 [0.38 - 2.03]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210192_at	138	0.15942	0.00425392	0.0832976	-0.783727	0.581334	-0.141595	0.87 [0.52 - 1.44]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1569773_at	138	0.369565	0.165198	-	-0.334872	0.18172	-4.25325	0.01 [0.00 - 7.31]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213106_at	138	0.101449	0.113618	-	-0.560144	0.160901	-0.101304	0.90 [0.78 - 1.04]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210192_at	129	0.604651	0.0135988	0.202927	-0.683248	0.234133	-0.224153	0.80 [0.55 - 1.16]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213106_at	129	0.379845	0.0188179	0.256626	-0.57294	0.216753	-0.282286	0.75 [0.48 - 1.18]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3996	56	0.107143	0.00133092	0.0323581	-1.38565	0.0136498	-0.719131	0.49 [0.28 - 0.86]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3996	56	0.107143	0.000210285	0.00671409	-1.58945	0.00226549	-1.0356	0.36 [0.18 - 0.69]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213106_at	278	0.888489	0.126866	-	0.435974	0.508285	0.0647623	1.07 [0.88 - 1.29]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210192_at	278	0.111511	0.00692116	0.121948	1.17522	0.402471	0.213615	1.24 [0.75 - 2.04]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1569773_at	278	0.827338	0.0471386	0.47416	-0.515018	0.437425	-0.584752	0.56 [0.13 - 2.44]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210192_at	133	0.849624	0.00193781	0.0441361	0.864528	0.0114865	4.1429	62.99 [2.54 - 1564.84]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213106_at	133	0.781955	0.00638143	0.11452	-0.983607	0.0781539	-0.202408	0.82 [0.65 - 1.02]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15298	81	0.469136	0.137794	-	-0.806791	0.653227	0.17402	1.19 [0.56 - 2.54]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213106_at	185	0.227027	0.0507128	-	0.402618	0.521966	0.102959	1.11 [0.81 - 1.52]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210192_at	185	0.605405	0.0229953	0.295461	-0.383876	0.411585	-0.242564	0.78 [0.44 - 1.40]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213106_at	185	0.227027	0.0182179	0.250772	0.556864	0.235197	0.202697	1.22 [0.88 - 1.71]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210192_at	185	0.605405	0.0536623	-	-0.353882	0.76644	-0.0962038	0.91 [0.48 - 1.71]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P30075	110	0.236364	0.0903421	-	-0.547331	0.264704	-0.185805	0.83 [0.60 - 1.15]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P30075	110	0.445455	0.186389	-	-0.301652	0.463336	-0.0972321	0.91 [0.70 - 1.18]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210192_at	80	0.1125	0.00121472	0.0299878	-1.56117	0.961415	0.0106735	1.01 [0.66 - 1.56]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213106_at	80	0.2625	0.0360573	0.40001	1.24687	0.193087	0.285928	1.33 [0.87 - 2.05]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1569773_at	38	0.394737	0.0692502	-	-0.853552	0.712868	-0.0814287	0.92 [0.60 - 1.42]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213106_at	38	0.578947	0.00186414	0.0427533	-1.98865	0.00608249	-0.941398	0.39 [0.20 - 0.76]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210192_at	38	0.763158	0.0722495	-	0.890607	0.698322	0.115684	1.12 [0.63 - 2.02]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213106_at	140	0.828571	0.0176266	0.244928	-1.32009	0.0337861	-0.704654	0.49 [0.26 - 0.95]
GENE	ATP8A1	ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210192_at	140	0.4	0.0129424	0.195675	-0.71944	0.15997	-1.23961	0.29 [0.05 - 1.63]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205052_at	30	0.8	0.0129208	0.195433	-1.69024	0.0494018	-0.908512	0.40 [0.16 - 1.00]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1740349	165	0.133333	0.00397194	0.0788781	-0.852934	0.0796159	-0.337799	0.71 [0.49 - 1.04]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1740349	165	0.29697	2.03395e-05	0.000847994	-1.41603	0.00339092	-0.767769	0.46 [0.28 - 0.78]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205052_at	163	0.153374	0.228854	-	-0.304611	0.821354	0.0404414	1.04 [0.73 - 1.48]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205052_at	79	0.683544	0.0241971	0.306069	0.66065	0.217784	0.28013	1.32 [0.85 - 2.07]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205052_at	58	0.706897	0.0891396	-	-0.516151	0.810337	-0.0753174	0.93 [0.50 - 1.72]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205052_at	34	0.882353	0.0540369	-	-1.74165	0.695851	0.107262	1.11 [0.65 - 1.91]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205052_at	158	0.170886	0.0179881	0.24851	-0.645962	0.569475	-0.182899	0.83 [0.44 - 1.56]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205052_at	53	0.849057	0.000156973	0.00520274	1.4627	0.0327937	1.19429	3.30 [1.10 - 9.88]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205052_at	53	0.849057	1.59567e-05	0.000681545	1.68217	0.0168404	1.49481	4.46 [1.31 - 15.19]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205052_at	180	0.866667	0.0443946	0.456806	0.546999	0.612174	-0.15643	0.86 [0.47 - 1.57]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205052_at	559	0.332737	0.00700734	0.123118	-0.53488	0.0210443	-0.582143	0.56 [0.34 - 0.92]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205052_at	77	0.428571	0.0956811	-	-0.419534	0.896514	0.0635811	1.07 [0.41 - 2.78]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205052_at	70	0.585714	0.0134016	0.200761	0.661383	0.0853424	0.5207	1.68 [0.93 - 3.05]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37616_at	50	0.88	0.23335	-	0.580114	0.624253	0.229498	1.26 [0.50 - 3.15]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205052_at	74	0.121622	0.0038468	0.0768916	-1.10279	0.866646	-0.078709	0.92 [0.37 - 2.32]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205052_at	67	0.686567	0.00937908	0.153837	1.65328	0.136941	2.15715	8.65 [0.50 - 148.40]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205052_at	115	0.652174	0.0869344	-	-1.22972	0.37173	-0.627387	0.53 [0.13 - 2.12]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37616_at	158	0.879747	0.0844464	-	-0.988399	0.55812	-0.220654	0.80 [0.38 - 1.68]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37616_at	76	0.368421	0.17065	-	0.858413	0.696915	0.32958	1.39 [0.26 - 7.30]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205052_at	204	0.539216	0.21802	-	-0.172174	0.58821	-0.0949745	0.91 [0.64 - 1.28]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205052_at	87	0.149425	0.0126439	0.192333	-1.04389	0.455927	-0.291889	0.75 [0.35 - 1.61]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205052_at	87	0.149425	0.0126439	0.192333	-1.04389	0.455927	-0.291889	0.75 [0.35 - 1.61]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205052_at	77	0.103896	0.000350106	0.0104381	-1.9881	0.0014236	-1.93295	0.14 [0.04 - 0.47]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205052_at	77	0.103896	1.56368e-05	0.000669215	-2.09583	0.000580407	-1.81	0.16 [0.06 - 0.46]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205052_at	136	0.867647	0.234176	-	0.6151	0.769617	-0.183236	0.83 [0.24 - 2.84]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205052_at	200	0.44	0.00682238	0.120602	-0.805985	0.135793	-0.588293	0.56 [0.26 - 1.20]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21168	60	0.7	0.418957	-	-0.35179	0.913445	0.0306171	1.03 [0.59 - 1.79]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21168	60	0.216667	0.000673972	0.0182704	-1.25254	0.0153881	-0.707265	0.49 [0.28 - 0.87]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	4665	155	0.83871	0.000368921	0.0109191	1.01275	0.000796624	0.343568	1.41 [1.15 - 1.72]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205052_at	286	0.206294	0.143977	-	-0.328595	0.293343	-0.29356	0.75 [0.43 - 1.29]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205052_at	159	0.899371	0.279386	-	-0.76602	0.704645	-0.154646	0.86 [0.39 - 1.91]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205052_at	159	0.72956	0.21638	-	0.478557	0.77068	-0.14355	0.87 [0.33 - 2.27]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205052_at	159	0.874214	0.0487947	0.484343	0.76141	0.876831	0.0676715	1.07 [0.45 - 2.52]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205052_at	54	0.296296	0.0724357	-	15.508	0.724661	0.207517	1.23 [0.39 - 3.90]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205052_at	117	0.897436	0.0180517	0.249137	1.01384	0.203058	0.365137	1.44 [0.82 - 2.53]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205052_at	117	0.897436	0.0160388	0.228849	1.12941	0.0631203	0.651184	1.92 [0.97 - 3.81]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205052_at	117	0.897436	0.0180517	0.249137	1.01384	0.203058	0.365137	1.44 [0.82 - 2.53]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205052_at	117	0.854701	0.0707123	-	0.81475	0.325286	0.345895	1.41 [0.71 - 2.82]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205052_at	236	0.830508	0.10371	-	0.510842	0.828012	0.10036	1.11 [0.45 - 2.73]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205052_at	249	0.86747	0.315869	-	0.289601	0.799581	0.0920465	1.10 [0.54 - 2.23]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205052_at	62	0.241935	0.00106227	0.0268086	-1.44464	0.0307305	-1.02847	0.36 [0.14 - 0.91]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205052_at	125	0.84	0.110637	-	-1.11432	0.656536	-0.123942	0.88 [0.51 - 1.53]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205052_at	125	0.896	0.0770928	-	-1.20416	0.579536	-0.119391	0.89 [0.58 - 1.35]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205052_at	54	0.111111	1.95055e-05	0.000816655	-2.2458	0.00827958	-1.51743	0.22 [0.07 - 0.68]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205052_at	198	0.409091	0.0699719	-	-0.462142	0.404935	-0.175678	0.84 [0.55 - 1.27]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205052_at	198	0.383838	0.0523963	-	-0.514407	0.346117	-0.20413	0.82 [0.53 - 1.25]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205052_at	198	0.510101	0.207175	-	-0.266644	0.93971	-0.0132755	0.99 [0.70 - 1.39]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205052_at	51	0.666667	0.106626	-	-15.6933	0.387622	-0.956623	0.38 [0.04 - 3.37]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205052_at	62	0.387097	0.339858	-	-0.544562	0.758327	-0.174837	0.84 [0.28 - 2.56]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205052_at	177	0.508475	0.113236	-	-0.435963	0.763485	-0.123449	0.88 [0.40 - 1.98]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205052_at	177	0.864407	0.0833877	-	0.525416	0.491588	0.250615	1.28 [0.63 - 2.62]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205052_at	145	0.786207	0.00601433	0.109366	-2.26903	0.480495	-0.341651	0.71 [0.28 - 1.84]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205052_at	226	0.650442	0.0179002	0.247641	-0.84884	0.475445	-0.317581	0.73 [0.30 - 1.74]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205052_at	55	0.563636	0.0015353	0.0364292	1.42874	0.00465246	1.23431	3.44 [1.46 - 8.08]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205052_at	55	0.345455	0.00306327	0.0640592	2.41359	0.00890999	1.30037	3.67 [1.39 - 9.73]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205052_at	49	0.653061	0.00368229	0.0742552	1.61542	0.0109147	1.35038	3.86 [1.36 - 10.92]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	786213	34	0.5	0.30963	-	-0.447998	0.852221	-0.0778831	0.93 [0.41 - 2.10]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205052_at	63	0.349206	0.114292	-	0.584731	0.47627	0.112686	1.12 [0.82 - 1.53]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502326_3p_at	28	0.571429	0.0283875	0.341338	1.2452	0.267933	0.30733	1.36 [0.79 - 2.34]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205052_at	82	0.865854	0.050297	-	-1.75341	0.852186	-0.0762987	0.93 [0.42 - 2.07]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37616_at	84	0.869048	0.156976	-	-0.667131	0.347096	-0.313061	0.73 [0.38 - 1.40]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205052_at	79	0.455696	0.00411887	0.0811907	0.785099	0.178327	0.382076	1.47 [0.84 - 2.56]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X79888_at	86	0.151163	0.0378377	0.412695	-0.950437	0.427231	-0.371229	0.69 [0.28 - 1.72]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205052_at	104	0.403846	0.202917	-	-0.410275	0.750177	-0.17514	0.84 [0.29 - 2.47]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P20852	117	0.145299	0.00484705	0.0923555	-0.908381	0.135376	-0.432613	0.65 [0.37 - 1.14]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205052_at	204	0.318627	0.178874	-	-0.491156	0.870984	-0.101525	0.90 [0.27 - 3.08]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205052_at	204	0.333333	0.154105	-	-0.390279	0.983211	0.00999874	1.01 [0.40 - 2.56]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205052_at	178	0.11236	0.05792	-	-0.54271	0.381547	-0.282957	0.75 [0.40 - 1.42]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200006860	41	0.756098	0.197231	-	0.580889	0.722981	0.178478	1.20 [0.45 - 3.21]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205052_at	111	0.351351	0.0395764	0.424779	-0.537401	0.0562289	-0.811049	0.44 [0.19 - 1.02]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205052_at	90	0.144444	0.0106879	0.16973	-0.986169	0.900148	0.0761768	1.08 [0.33 - 3.55]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205052_at	90	0.166667	0.00691937	0.121924	-1.07879	0.960076	-0.0349748	0.97 [0.25 - 3.80]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1002	50	0.2	0.125816	-	-0.793875	0.998568	0.000837027	1.00 [0.40 - 2.50]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205052_at	138	0.594203	0.0409643	0.434219	0.491636	0.328987	0.174335	1.19 [0.84 - 1.69]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205052_at	129	0.674419	0.0510958	-	0.493745	0.417032	0.377151	1.46 [0.59 - 3.63]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38165	56	0.357143	0.0717415	-	0.739875	0.447228	0.210459	1.23 [0.72 - 2.12]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38165	56	0.857143	0.108001	-	-0.938893	0.816209	0.0601099	1.06 [0.64 - 1.76]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205052_at	278	0.23741	0.0381424	0.414834	-0.421749	0.775535	-0.0466608	0.95 [0.69 - 1.32]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205052_at	133	0.240602	0.0365461	0.403525	-0.551466	0.179771	-0.187962	0.83 [0.63 - 1.09]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	8862	81	0.716049	0.115459	-	-1.13628	0.925923	-0.0509972	0.95 [0.32 - 2.78]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205052_at	185	0.854054	0.120723	-	-0.358648	0.675162	-0.0492702	0.95 [0.76 - 1.20]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205052_at	185	0.291892	0.0587964	-	0.383483	0.920502	-0.0127966	0.99 [0.77 - 1.27]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P20852	110	0.172727	0.14281	-	0.472031	0.895718	0.0233542	1.02 [0.72 - 1.45]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P20852	110	0.454545	0.107729	-	-0.475015	0.752145	-0.0760084	0.93 [0.58 - 1.49]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205052_at	80	0.7875	0.0687097	-	-1.66927	0.696919	-0.167128	0.85 [0.36 - 1.96]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3087	281	0.202847	0.0837421	-	-0.289053	0.144482	-0.323962	0.72 [0.47 - 1.12]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205052_at	38	0.263158	0.0488828	0.484879	1.19904	0.993102	0.00346983	1.00 [0.46 - 2.20]
GENE	AUH	AU RNA binding protein/enoyl-CoA hydratase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205052_at	140	0.114286	0.0024773	0.0539437	-1.00338	0.0329578	-0.553924	0.57 [0.35 - 0.96]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211812_s_at	30	0.766667	0.294796	-	-0.526163	0.770202	-0.0896011	0.91 [0.50 - 1.67]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211379_x_at	30	0.2	0.0567035	-	-0.902937	0.620074	-0.145389	0.86 [0.49 - 1.54]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1787595	165	0.248485	0.000426945	0.0123785	-0.86369	0.0257029	-0.436899	0.65 [0.44 - 0.95]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1787595	165	0.272727	9.08423e-05	0.00321798	-1.29983	0.0566145	-0.555629	0.57 [0.32 - 1.02]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211379_x_at	163	0.595092	0.0824115	-	0.343334	0.962991	-0.0069826	0.99 [0.74 - 1.33]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211812_s_at	163	0.453988	0.268305	-	-0.217409	0.801334	-0.0557788	0.95 [0.61 - 1.46]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	223374_s_at	163	0.582822	0.100772	-	-0.3337	0.929969	-0.0110547	0.99 [0.77 - 1.27]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	223374_s_at	79	0.708861	0.0475857	0.47693	0.594804	0.301442	0.140291	1.15 [0.88 - 1.50]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211812_s_at	79	0.708861	0.0956924	-	0.503358	0.448683	0.143984	1.15 [0.80 - 1.68]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211379_x_at	79	0.734177	0.0618999	-	0.5681	0.308335	0.145485	1.16 [0.87 - 1.53]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211379_x_at	58	0.534483	0.0250821	0.313733	0.618942	0.493558	0.109096	1.12 [0.82 - 1.52]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211812_s_at	58	0.155172	0.0128893	0.195082	-0.895687	0.268988	-0.185732	0.83 [0.60 - 1.15]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211379_x_at	34	0.235294	0.0758463	-	-0.768235	0.292309	-0.183237	0.83 [0.59 - 1.17]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211812_s_at	34	0.411765	0.324376	-	-0.37891	0.562666	-0.173907	0.84 [0.47 - 1.51]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211812_s_at	158	0.196203	0.143889	-	0.491257	0.454797	0.228216	1.26 [0.69 - 2.29]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211379_x_at	158	0.278481	0.100258	-	0.481995	0.618164	0.116801	1.12 [0.71 - 1.78]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211812_s_at	53	0.716981	0.0778154	-	0.62725	0.982106	-0.00360066	1.00 [0.73 - 1.36]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211379_x_at	53	0.113208	0.0822142	-	1.59492	0.251849	0.216853	1.24 [0.86 - 1.80]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211812_s_at	53	0.716981	0.00587386	0.10737	1.01365	0.641337	0.0848715	1.09 [0.76 - 1.56]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211379_x_at	53	0.811321	0.106616	-	-0.836649	0.41541	0.133363	1.14 [0.83 - 1.58]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211812_s_at	180	0.316667	0.0271946	0.331554	-0.485858	0.779707	-0.0333827	0.97 [0.77 - 1.22]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211379_x_at	180	0.688889	0.23206	-	-0.274178	0.451532	0.108223	1.11 [0.84 - 1.48]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	223374_s_at	180	0.311111	0.171063	-	0.323789	0.79243	0.040424	1.04 [0.77 - 1.41]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	223374_s_at	559	0.198569	0.118916	-	0.475876	0.682827	0.0284646	1.03 [0.90 - 1.18]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211812_s_at	559	0.101968	0.0816576	-	-0.531943	0.44141	-0.0691171	0.93 [0.78 - 1.11]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211379_x_at	559	0.445438	0.196822	-	0.265875	0.748881	0.0177901	1.02 [0.91 - 1.14]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211379_x_at	77	0.61039	0.00585951	0.107166	0.729973	0.214816	0.281188	1.32 [0.85 - 2.07]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211812_s_at	77	0.818182	0.00184675	0.0424251	0.961589	0.517766	0.13917	1.15 [0.75 - 1.75]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	223374_s_at	77	0.857143	0.0777467	-	0.614011	0.950203	0.0145296	1.01 [0.64 - 1.60]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	223374_s_at	70	0.4	0.0206282	0.273851	0.631079	0.396152	0.160252	1.17 [0.81 - 1.70]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211812_s_at	70	0.242857	0.0685355	-	0.585654	0.675771	0.0957682	1.10 [0.70 - 1.72]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211379_x_at	70	0.457143	0.0253987	0.316445	0.595871	0.425292	0.136232	1.15 [0.82 - 1.60]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39293_at	50	0.66	0.0509245	-	-0.738646	0.401619	-0.60182	0.55 [0.13 - 2.24]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211812_s_at	74	0.513514	0.174776	-	0.391072	0.658391	-0.100585	0.90 [0.58 - 1.41]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211379_x_at	74	0.824324	0.189157	-	-0.566112	0.916548	0.0368076	1.04 [0.52 - 2.07]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	223374_s_at	74	0.108108	0.0077337	0.13282	1.75688	0.051463	0.697111	2.01 [1.00 - 4.05]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211812_s_at	67	0.865672	0.195322	-	-15.3135	0.873073	-0.0979653	0.91 [0.27 - 3.02]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	223374_s_at	67	0.134328	0.227268	-	15.2465	0.666616	0.305241	1.36 [0.34 - 5.44]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211379_x_at	67	0.895522	0.194156	-	-15.3324	0.957042	-0.0332707	0.97 [0.29 - 3.25]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211812_s_at	115	0.808696	3.57083e-05	0.0014044	1.92573	0.00332863	1.76349	5.83 [1.80 - 18.93]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211379_x_at	115	0.556522	0.000857586	0.0223973	2.12355	0.00635978	1.51378	4.54 [1.53 - 13.48]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	223374_s_at	115	0.773913	2.26288e-05	0.000933301	2.01494	0.00543776	2.38526	10.86 [2.02 - 58.38]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39293_at	158	0.101266	0.00367668	0.0741647	-0.998424	0.213149	-0.230198	0.79 [0.55 - 1.14]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39293_at	76	0.828947	0.0502749	-	-15.3751	0.888294	0.0521579	1.05 [0.51 - 2.18]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211812_s_at	204	0.794118	0.273735	-	0.189071	0.815866	0.0254576	1.03 [0.83 - 1.27]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	223374_s_at	204	0.372549	0.18536	-	0.190613	0.833928	0.0310742	1.03 [0.77 - 1.38]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211379_x_at	204	0.661765	0.159706	-	0.206398	0.629502	0.0557504	1.06 [0.84 - 1.33]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211379_x_at	87	0.436782	0.0265556	0.326232	0.934553	0.108668	0.393923	1.48 [0.92 - 2.40]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	223374_s_at	87	0.517241	0.000414159	0.0120598	1.42716	0.0324944	0.583598	1.79 [1.05 - 3.06]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	223374_s_at	87	0.517241	0.000414159	0.0120598	1.42716	0.0324944	0.583598	1.79 [1.05 - 3.06]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211812_s_at	87	0.885057	0.0106928	0.169789	1.12717	0.192051	0.334123	1.40 [0.85 - 2.31]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211379_x_at	87	0.436782	0.0265556	0.326232	0.934553	0.108668	0.393923	1.48 [0.92 - 2.40]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211812_s_at	87	0.885057	0.0106928	0.169789	1.12717	0.192051	0.334123	1.40 [0.85 - 2.31]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	223374_s_at	77	0.103896	9.81347e-05	0.00344468	-1.92991	0.0384277	-0.639647	0.53 [0.29 - 0.97]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211379_x_at	77	0.103896	0.000371437	0.0109831	-1.97432	0.278407	-0.389775	0.68 [0.33 - 1.37]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211812_s_at	77	0.142857	0.00361475	0.0731643	-1.51386	0.493791	-0.392498	0.68 [0.22 - 2.08]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	223374_s_at	77	0.103896	0.027279	0.332253	-1.41185	0.100271	-0.598609	0.55 [0.27 - 1.12]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211379_x_at	77	0.116883	2.56174e-06	0.000129186	-2.17733	0.171945	-0.422418	0.66 [0.36 - 1.20]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211812_s_at	77	0.12987	0.073119	-	-1.17095	0.853822	-0.115935	0.89 [0.26 - 3.06]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211379_x_at	136	0.705882	0.221645	-	-0.674096	0.648889	-0.13586	0.87 [0.49 - 1.57]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211812_s_at	136	0.110294	0.0911371	-	-0.925075	0.391985	-0.215857	0.81 [0.49 - 1.32]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211812_s_at	200	0.19	0.00878184	0.146351	-0.823143	0.665048	-0.15012	0.86 [0.44 - 1.70]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211379_x_at	200	0.83	0.0364334	0.402717	0.689687	0.314412	0.334787	1.40 [0.73 - 2.68]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21944	60	0.216667	0.157294	-	-0.581481	0.949538	0.0247934	1.03 [0.48 - 2.21]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21944	60	0.25	2.47567e-05	0.00101172	-1.52635	0.0385885	-1.22581	0.29 [0.09 - 0.94]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211812_s_at	286	0.863636	0.0795641	-	0.441425	0.111428	0.284018	1.33 [0.94 - 1.88]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211379_x_at	286	0.79021	7.81318e-06	0.000357212	0.884002	0.013605	0.525527	1.69 [1.11 - 2.57]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211812_s_at	159	0.591195	0.00283985	0.0602606	0.930862	0.0581682	0.622822	1.86 [0.98 - 3.55]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211812_s_at	159	0.603774	0.00374947	0.0753353	1.06135	0.0328972	0.853458	2.35 [1.07 - 5.14]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211379_x_at	159	0.886792	0.0013068	0.0318695	1.16145	0.110736	0.616741	1.85 [0.87 - 3.95]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211379_x_at	159	0.880503	0.0188104	0.256554	0.902164	0.230414	0.465317	1.59 [0.74 - 3.41]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211812_s_at	159	0.779874	0.000664176	0.0180449	1.05525	0.00632586	0.936733	2.55 [1.30 - 5.00]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211379_x_at	159	0.886792	0.00217242	0.0484671	1.25706	0.230625	0.546331	1.73 [0.71 - 4.22]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223374_s_at	159	0.849057	0.000348337	0.0103927	1.17437	0.104902	0.62526	1.87 [0.88 - 3.98]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223374_s_at	159	0.855346	1.9974e-05	0.000834278	1.34681	0.0821429	0.650828	1.92 [0.92 - 3.99]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	223374_s_at	159	0.849057	0.00013759	0.00463582	1.38733	0.0966371	0.749561	2.12 [0.87 - 5.12]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211379_x_at	54	0.333333	0.0250717	0.313643	15.7375	0.218044	0.608979	1.84 [0.70 - 4.85]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211812_s_at	54	0.611111	0.10927	-	1.1117	0.526791	0.354376	1.43 [0.48 - 4.27]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211379_x_at	117	0.854701	0.145765	-	-0.852713	0.394782	-0.17285	0.84 [0.56 - 1.25]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211379_x_at	117	0.666667	0.0287813	0.344525	-1.12892	0.371345	-0.229572	0.79 [0.48 - 1.31]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211812_s_at	117	0.102564	0.148892	-	1.36291	0.749313	-0.0977666	0.91 [0.50 - 1.65]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211812_s_at	117	0.102564	0.140891	-	1.02496	0.467229	-0.18643	0.83 [0.50 - 1.37]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211812_s_at	117	0.102564	0.140891	-	1.02496	0.467229	-0.18643	0.83 [0.50 - 1.37]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211812_s_at	117	0.863248	0.0375034	0.410338	-15.247	0.17547	-0.516389	0.60 [0.28 - 1.26]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211379_x_at	117	0.854701	0.145765	-	-0.852713	0.394782	-0.17285	0.84 [0.56 - 1.25]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211379_x_at	117	0.65812	0.14722	-	-0.655427	0.489427	-0.170731	0.84 [0.52 - 1.37]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211379_x_at	236	0.65678	0.047333	0.475366	0.534122	0.567356	0.159747	1.17 [0.68 - 2.03]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211812_s_at	236	0.690678	0.105449	-	0.446906	0.577031	0.160719	1.17 [0.67 - 2.07]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	223374_s_at	236	0.834746	0.115913	-	0.508537	0.992571	0.00277066	1.00 [0.56 - 1.80]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211379_x_at	249	0.13253	0.108017	-	-0.428972	0.994185	-0.00162797	1.00 [0.64 - 1.55]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211812_s_at	249	0.690763	0.0516448	-	0.428374	0.761382	-0.0640418	0.94 [0.62 - 1.42]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	223374_s_at	249	0.566265	0.0690284	-	0.383558	0.741844	0.0760199	1.08 [0.69 - 1.70]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211379_x_at	62	0.887097	0.0634163	-	1.1527	0.994903	-0.00192108	1.00 [0.55 - 1.80]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211379_x_at	125	0.768	0.000132891	0.00449671	1.34963	0.00379661	0.679796	1.97 [1.25 - 3.13]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211812_s_at	62	0.33871	0.323187	-	0.557728	0.676361	0.168666	1.18 [0.54 - 2.61]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211379_x_at	125	0.768	0.00390492	0.0778163	0.832268	0.0258927	0.429692	1.54 [1.05 - 2.24]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211379_x_at	54	0.611111	0.294645	-	-0.660695	0.773876	-0.108538	0.90 [0.43 - 1.88]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211812_s_at	125	0.888	0.0102456	0.164433	1.07575	0.0952459	0.420669	1.52 [0.93 - 2.50]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211812_s_at	125	0.88	0.0502892	-	0.683179	0.283286	0.218606	1.24 [0.83 - 1.86]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211812_s_at	54	0.814815	0.347434	-	-0.94935	0.920613	0.0502524	1.05 [0.39 - 2.83]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211379_x_at	198	0.707071	0.0580407	-	0.509994	0.33257	0.163676	1.18 [0.85 - 1.64]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211812_s_at	198	0.181818	0.0156212	0.22452	1.07654	0.0402266	0.314722	1.37 [1.01 - 1.85]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211812_s_at	198	0.181818	0.0351881	0.393698	0.952588	0.0709855	0.286385	1.33 [0.98 - 1.82]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211379_x_at	198	0.166667	0.164432	-	0.430726	0.659215	0.0561766	1.06 [0.82 - 1.36]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211379_x_at	198	0.707071	0.0627912	-	0.480887	0.354299	0.147941	1.16 [0.85 - 1.59]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211812_s_at	198	0.131313	0.00750351	0.129776	1.17493	0.0791362	0.207403	1.23 [0.98 - 1.55]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211379_x_at	51	0.705882	0.127896	-	1.29714	0.770134	-0.671213	0.51 [0.01 - 46.11]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211379_x_at	62	0.177419	0.0946077	-	15.339	0.473563	-1.20746	0.30 [0.01 - 8.12]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211812_s_at	51	0.117647	0.0168993	0.237634	-1.89644	0.319722	-4.085	0.02 [0.00 - 52.54]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211812_s_at	62	0.193548	0.0232059	0.297337	-1.25022	0.162816	-3.74506	0.02 [0.00 - 4.55]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	223374_s_at	145	0.331034	0.00307429	0.0642447	1.44282	0.00542492	0.651976	1.92 [1.21 - 3.04]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211379_x_at	177	0.412429	0.0617991	-	0.547774	0.174924	0.226201	1.25 [0.90 - 1.74]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211812_s_at	177	0.101695	0.0323384	0.372425	1.2001	0.434094	0.196282	1.22 [0.74 - 1.99]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211379_x_at	177	0.858757	0.0112007	0.175782	0.710657	0.128437	0.219928	1.25 [0.94 - 1.65]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211812_s_at	145	0.406897	0.0242971	0.306941	0.842709	0.105505	0.555173	1.74 [0.89 - 3.41]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211379_x_at	145	0.4	0.00701569	0.123232	1.08269	0.0104952	0.505014	1.66 [1.13 - 2.44]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211812_s_at	177	0.101695	0.0160203	0.228658	2.06927	0.4662	0.211239	1.24 [0.70 - 2.18]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	223374_s_at	177	0.79096	0.014488	0.212556	0.617733	0.0645635	0.316522	1.37 [0.98 - 1.92]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	223374_s_at	177	0.333333	0.0303039	0.356661	0.71627	0.092721	0.33126	1.39 [0.95 - 2.05]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211812_s_at	226	0.464602	0.0650861	-	0.545416	0.279149	0.115785	1.12 [0.91 - 1.38]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211379_x_at	226	0.89823	0.00124304	0.0305695	1.09486	0.0125092	0.396143	1.49 [1.09 - 2.03]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	223374_s_at	226	0.858407	0.0341572	0.386107	0.709373	0.0236412	0.440402	1.55 [1.06 - 2.27]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211812_s_at	55	0.872727	0.00945127	0.154731	1.37599	0.026585	0.713628	2.04 [1.09 - 3.84]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211379_x_at	55	0.872727	0.000786183	0.0208137	1.52143	0.00239276	0.697675	2.01 [1.28 - 3.15]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	223374_s_at	55	0.654545	0.000876953	0.0228225	1.5504	0.000896445	0.756489	2.13 [1.36 - 3.33]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211812_s_at	49	0.897959	0.00374224	0.0752192	1.61424	0.0460099	1.16259	3.20 [1.02 - 10.02]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	223374_s_at	49	0.877551	0.000118307	0.00406054	1.96048	0.00327384	0.920175	2.51 [1.36 - 4.63]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211379_x_at	55	0.436364	0.000763274	0.0203001	2.11441	0.0043577	0.663064	1.94 [1.23 - 3.06]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211379_x_at	49	0.897959	0.00374224	0.0752192	1.61424	0.0261932	0.695604	2.00 [1.09 - 3.70]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	223374_s_at	55	0.854545	8.8957e-05	0.00315898	1.68577	0.000526982	0.822746	2.28 [1.43 - 3.63]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211812_s_at	55	0.872727	0.000786183	0.0208137	1.52143	0.00343966	0.925807	2.52 [1.36 - 4.69]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	42737	34	0.823529	0.0742383	-	0.898563	0.454025	0.430713	1.54 [0.50 - 4.75]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211379_x_at	63	0.587302	0.000209752	0.00669928	-1.40366	0.00475797	-0.734209	0.48 [0.29 - 0.80]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	223374_s_at	63	0.650794	0.0124767	0.19045	-0.975374	0.0581303	-0.356339	0.70 [0.48 - 1.01]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211812_s_at	63	0.126984	0.00302842	0.0634711	-1.16676	0.541627	-0.478734	0.62 [0.13 - 2.88]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g8099351_3p_x_at	28	0.142857	0.185388	-	1.29036	0.623705	-0.260429	0.77 [0.27 - 2.18]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11136456_3p_a_at	28	0.75	0.132812	-	-1.11021	0.257152	-3.67152	0.03 [0.00 - 14.57]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g8099351_3p_a_at	28	0.214286	0.0395782	0.424791	-1.12935	0.326798	-0.759105	0.47 [0.10 - 2.13]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211379_x_at	82	0.670732	0.158267	-	0.486722	0.759014	0.0937123	1.10 [0.60 - 2.00]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211812_s_at	82	0.512195	0.0319637	0.369559	0.730611	0.714868	0.133853	1.14 [0.56 - 2.34]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211379_x_at	79	0.253165	0.0332956	0.379672	0.684535	0.0773805	0.3954	1.48 [0.96 - 2.30]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211812_s_at	79	0.253165	0.000999259	0.0254694	1.10442	0.0134409	0.519234	1.68 [1.11 - 2.54]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211812_s_at	104	0.894231	0.00984204	0.159536	1.04769	0.244825	0.335735	1.40 [0.79 - 2.46]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211379_x_at	104	0.875	0.0107869	0.170907	0.985322	0.167906	0.378721	1.46 [0.85 - 2.50]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P88870	117	0.760684	3.03953e-05	0.00121598	1.1539	0.00038274	0.410289	1.51 [1.20 - 1.89]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P41166	117	0.871795	0.00394076	0.0783847	0.986201	0.0493932	0.333147	1.40 [1.00 - 1.95]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211812_s_at	204	0.735294	0.00851056	0.142899	0.930397	0.0465484	0.721621	2.06 [1.01 - 4.19]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	223374_s_at	204	0.480392	0.0394593	0.423974	0.800073	0.472001	0.269408	1.31 [0.63 - 2.73]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211812_s_at	204	0.720588	0.000207211	0.00662862	0.974852	0.043489	0.55175	1.74 [1.02 - 2.97]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	223374_s_at	204	0.632353	0.0222751	0.28899	0.613252	0.719691	0.102022	1.11 [0.63 - 1.93]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211379_x_at	204	0.446078	0.0172981	0.241648	0.988495	0.231072	0.406717	1.50 [0.77 - 2.92]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211379_x_at	204	0.544118	0.0597763	-	0.510105	0.755207	0.0784079	1.08 [0.66 - 1.77]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211379_x_at	178	0.870786	0.286399	-	0.298083	0.967827	-0.00670275	0.99 [0.72 - 1.38]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211812_s_at	178	0.123596	0.115024	-	0.573567	0.813769	0.0431074	1.04 [0.73 - 1.49]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300022462	41	0.268293	0.104557	-	-0.700599	0.441842	-0.161449	0.85 [0.56 - 1.28]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211812_s_at	111	0.225225	0.324374	-	0.32995	0.6994	0.0441912	1.05 [0.84 - 1.31]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211379_x_at	111	0.342342	0.0993613	-	-0.438209	0.519095	-0.0835262	0.92 [0.71 - 1.19]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	223374_s_at	111	0.873874	0.177678	-	0.514992	0.692008	-0.0626751	0.94 [0.69 - 1.28]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211379_x_at	90	0.888889	0.0441796	0.455421	0.820364	0.339789	0.588159	1.80 [0.54 - 6.02]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211379_x_at	90	0.888889	0.026548	0.326168	0.979	0.228443	0.806552	2.24 [0.60 - 8.32]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211812_s_at	90	0.844444	0.177208	-	0.531682	0.412949	0.437513	1.55 [0.54 - 4.41]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211812_s_at	90	0.844444	0.102069	-	0.696744	0.191507	0.749803	2.12 [0.69 - 6.52]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211812_s_at	138	0.514493	0.00227088	0.0502536	0.740178	0.0136509	0.296049	1.34 [1.06 - 1.70]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211379_x_at	138	0.891304	0.000616281	0.0169338	1.04435	0.0379408	0.207497	1.23 [1.01 - 1.50]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	223374_s_at	138	0.688406	0.00184774	0.0424437	0.745946	0.0199913	0.252734	1.29 [1.04 - 1.59]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211812_s_at	129	0.108527	0.21847	-	-0.46343	0.515605	-0.135454	0.87 [0.58 - 1.31]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211379_x_at	129	0.124031	0.00593685	0.108267	-0.831166	0.332285	-0.229432	0.79 [0.50 - 1.26]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15304	56	0.892857	0.112239	-	0.707233	0.678676	0.0973044	1.10 [0.70 - 1.75]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16932	56	0.803571	0.0641577	-	0.755037	0.529999	0.15486	1.17 [0.72 - 1.89]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15304	56	0.767857	0.414359	-	-0.371817	0.961951	-0.0121628	0.99 [0.60 - 1.63]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16932	56	0.803571	0.00365921	0.0738829	1.11364	0.21628	0.279549	1.32 [0.85 - 2.06]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211379_x_at	278	0.133094	0.125722	-	0.463209	0.285093	0.102482	1.11 [0.92 - 1.34]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211812_s_at	278	0.374101	0.0328431	0.376259	0.433593	0.4683	0.0799198	1.08 [0.87 - 1.34]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	223374_s_at	278	0.23741	0.0821687	-	0.406425	0.184554	0.138788	1.15 [0.94 - 1.41]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211379_x_at	133	0.315789	0.104014	-	-0.391831	0.28077	-0.108286	0.90 [0.74 - 1.09]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211812_s_at	133	0.135338	0.0703969	-	-0.533787	0.936929	-0.00750221	0.99 [0.82 - 1.20]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4689	81	0.765432	0.241217	-	0.6269	0.783812	0.101021	1.11 [0.54 - 2.28]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14851	81	0.839506	0.0681943	-	0.97345	0.543159	0.214722	1.24 [0.62 - 2.48]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211812_s_at	185	0.664865	0.0280298	0.338425	-0.426012	0.391824	-0.120502	0.89 [0.67 - 1.17]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211379_x_at	185	0.2	0.0863579	-	0.396477	0.713135	0.0480318	1.05 [0.81 - 1.36]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211812_s_at	185	0.702703	0.0482519	0.481029	-0.355644	0.898251	-0.0153664	0.98 [0.78 - 1.25]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211379_x_at	185	0.340541	0.0626635	-	0.325626	0.200188	0.144992	1.16 [0.93 - 1.44]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P41166	110	0.681818	0.28358	-	-0.362511	0.736355	-0.0695508	0.93 [0.62 - 1.40]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P88870	110	0.636364	0.0366318	0.404138	-0.509582	0.757702	-0.0367189	0.96 [0.76 - 1.22]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P41166	110	0.236364	0.210723	-	-0.316362	0.591477	-0.0808369	0.92 [0.69 - 1.24]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P88870	110	0.627273	0.0697634	-	-0.575231	0.862017	-0.0274942	0.97 [0.71 - 1.33]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211812_s_at	80	0.2875	0.0930746	-	0.871398	0.347928	0.214431	1.24 [0.79 - 1.94]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211379_x_at	80	0.8875	0.00329987	0.0680105	1.33221	0.532272	0.145282	1.16 [0.73 - 1.82]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_5123	281	0.501779	0.115295	-	-0.22286	0.496172	-0.0738607	0.93 [0.75 - 1.15]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211812_s_at	38	0.736842	0.000330144	0.00992324	1.67476	0.139258	0.303728	1.35 [0.91 - 2.03]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211379_x_at	38	0.552632	0.00490476	0.0932208	1.35357	0.0664329	0.407999	1.50 [0.97 - 2.32]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	223374_s_at	38	0.868421	0.0127954	0.194032	1.38205	0.068328	0.466705	1.59 [0.97 - 2.63]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211379_x_at	140	0.214286	0.00396515	0.0787708	1.55638	0.0112612	0.803074	2.23 [1.20 - 4.15]
GENE	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211812_s_at	140	0.842857	0.00457089	0.0881764	0.923925	0.0588894	0.574499	1.78 [0.98 - 3.22]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210205_at	30	0.8	0.141488	-	-0.8821	0.167112	-1.00495	0.37 [0.09 - 1.52]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1690682	165	0.50303	0.259567	-	-0.271846	0.931531	-0.0143425	0.99 [0.71 - 1.37]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1690682	165	0.151515	0.151996	-	-0.603248	0.369529	-0.222123	0.80 [0.49 - 1.30]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210205_at	163	0.417178	0.0645486	-	-0.362501	0.349263	-0.398829	0.67 [0.29 - 1.55]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210205_at	79	0.886076	0.245304	-	-0.681049	0.746436	-0.149201	0.86 [0.35 - 2.13]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210205_at	58	0.327586	0.279587	-	-0.313217	0.728904	-0.0679277	0.93 [0.64 - 1.37]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210205_at	34	0.823529	0.0135362	0.202241	-1.66787	0.964641	-0.0166079	0.98 [0.47 - 2.05]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210205_at	158	0.310127	0.189898	-	0.351742	0.900867	0.0570308	1.06 [0.43 - 2.60]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210205_at	53	0.150943	0.0282378	0.340121	1.92368	0.289675	0.622808	1.86 [0.59 - 5.90]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210205_at	53	0.150943	0.165529	-	0.817753	0.296503	0.568643	1.77 [0.61 - 5.14]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210205_at	180	0.233333	0.0150927	0.218982	0.67568	0.319916	0.253569	1.29 [0.78 - 2.12]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210205_at	559	0.726297	0.00846767	0.14235	-0.791222	0.047353	-0.28804	0.75 [0.56 - 1.00]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210205_at	77	0.831169	0.237432	-	0.364568	0.631199	0.0801679	1.08 [0.78 - 1.50]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210205_at	70	0.642857	0.105858	-	0.440368	0.3418	0.480517	1.62 [0.60 - 4.35]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210205_at	74	0.837838	0.0023848	0.052299	1.0269	0.0663058	0.393264	1.48 [0.97 - 2.25]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210205_at	67	0.507463	0.017008	0.238732	-2.12289	0.556858	-0.766249	0.46 [0.04 - 5.99]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210205_at	115	0.730435	0.248071	-	-0.853769	0.856043	0.157945	1.17 [0.21 - 6.45]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210205_at	204	0.107843	0.00486733	0.09266	-0.64239	0.141691	-0.277393	0.76 [0.52 - 1.10]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210205_at	87	0.655172	0.203462	-	0.483188	0.77629	0.133549	1.14 [0.45 - 2.87]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210205_at	87	0.655172	0.203462	-	0.483188	0.77629	0.133549	1.14 [0.45 - 2.87]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210205_at	77	0.233766	0.137894	-	-0.82267	0.860581	-0.0985249	0.91 [0.30 - 2.72]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210205_at	77	0.233766	0.182833	-	-0.835504	0.654324	-0.283125	0.75 [0.22 - 2.60]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210205_at	136	0.536765	0.102618	-	-0.778789	0.758174	0.154168	1.17 [0.44 - 3.11]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210205_at	200	0.88	0.00605117	0.109887	0.986828	0.562994	0.19458	1.21 [0.63 - 2.35]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9172	60	0.65	0.0814157	-	0.674093	0.115291	0.367076	1.44 [0.91 - 2.28]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9172	60	0.833333	0.000536422	0.0150466	1.39574	0.0416057	0.639816	1.90 [1.02 - 3.51]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	7556	155	0.896774	8.88097e-05	0.00315436	1.26143	0.00711017	0.592014	1.81 [1.17 - 2.78]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210205_at	286	0.898601	0.0166261	0.234864	0.639441	0.83529	-0.0403074	0.96 [0.66 - 1.40]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210205_at	159	0.433962	0.0156377	0.224693	-0.761867	0.207736	-0.269203	0.76 [0.50 - 1.16]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210205_at	159	0.113208	0.0207925	0.275384	-0.887281	0.0458037	-0.403428	0.67 [0.45 - 0.99]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210205_at	159	0.427673	0.0516302	-	-0.718401	0.142287	-0.352957	0.70 [0.44 - 1.13]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210205_at	54	0.833333	0.214574	-	-15.3215	0.884668	-0.13639	0.87 [0.14 - 5.51]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210205_at	117	0.145299	0.00111476	0.0279126	-1.14258	0.672289	-0.173691	0.84 [0.38 - 1.88]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210205_at	117	0.589744	0.0894434	-	0.655066	0.277348	0.470305	1.60 [0.69 - 3.74]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210205_at	117	0.145299	0.00111476	0.0279126	-1.14258	0.672289	-0.173691	0.84 [0.38 - 1.88]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210205_at	117	0.589744	0.0762002	-	0.660332	0.537578	0.271712	1.31 [0.55 - 3.11]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210205_at	236	0.75	0.0077286	0.132753	0.723589	0.405474	0.225385	1.25 [0.74 - 2.13]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210205_at	249	0.759036	0.0338448	0.383783	0.479858	0.512073	0.131321	1.14 [0.77 - 1.69]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210205_at	125	0.168	0.0984327	-	1.53034	0.378184	0.419094	1.52 [0.60 - 3.86]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210205_at	125	0.344	0.100037	-	-0.497257	0.622712	-0.184695	0.83 [0.40 - 1.74]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210205_at	54	0.407407	0.0481256	0.480255	1.81996	0.76471	0.0817068	1.09 [0.64 - 1.85]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210205_at	62	0.822581	0.0868577	-	0.852211	0.959291	0.0114058	1.01 [0.65 - 1.57]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210205_at	198	0.121212	0.00621368	0.112176	-0.731054	0.265614	-0.209203	0.81 [0.56 - 1.17]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210205_at	198	0.10101	0.0256743	0.318795	-0.789538	0.985632	-0.00420067	1.00 [0.63 - 1.57]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210205_at	198	0.10101	0.00952576	0.155652	-0.917677	0.887604	-0.0346983	0.97 [0.60 - 1.56]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210205_at	51	0.333333	0.106626	-	15.6933	0.308255	1.19083	3.29 [0.33 - 32.51]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210205_at	62	0.629032	0.106629	-	-1.18053	0.967075	0.0327557	1.03 [0.22 - 4.89]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210205_at	145	0.627586	0.0219186	0.285754	0.749805	0.0503816	1.04348	2.84 [1.00 - 8.07]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210205_at	177	0.666667	0.0733737	-	0.487835	0.7187	0.163735	1.18 [0.48 - 2.87]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210205_at	177	0.858757	0.206337	-	-0.49811	0.994511	-0.00272881	1.00 [0.46 - 2.17]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210205_at	226	0.146018	0.0552939	-	0.970767	0.132205	0.356192	1.43 [0.90 - 2.27]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210205_at	55	0.472727	0.135319	-	0.687869	0.904857	-0.0984171	0.91 [0.18 - 4.55]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210205_at	55	0.763636	0.197396	-	-0.902552	0.822673	-0.203209	0.82 [0.14 - 4.83]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210205_at	49	0.795918	0.0891491	-	-15.3486	0.606625	-0.627026	0.53 [0.05 - 5.81]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210205_at	63	0.444444	0.076193	-	0.635684	0.651702	0.0894582	1.09 [0.74 - 1.61]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6683013_3p_at	28	0.321429	0.00359	0.0727633	-1.4731	0.453615	0.462631	1.59 [0.47 - 5.33]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210205_at	82	0.609756	0.0621376	-	0.628485	0.902783	0.072964	1.08 [0.33 - 3.47]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210205_at	79	0.139241	0.0256614	0.318685	-0.751503	0.12846	-0.822097	0.44 [0.15 - 1.27]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210205_at	104	0.596154	0.0287672	0.344412	0.712657	0.244849	0.746425	2.11 [0.60 - 7.42]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P111171	117	0.760684	0.0378704	0.412925	0.626791	0.565501	0.18618	1.20 [0.64 - 2.27]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P422071	117	0.854701	0.0345173	0.388771	0.711413	0.649951	0.141991	1.15 [0.62 - 2.13]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210205_at	204	0.887255	0.0945455	-	0.746239	0.638799	0.332309	1.39 [0.35 - 5.58]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210205_at	204	0.176471	0.0412554	0.436176	-0.62408	0.183451	-0.689643	0.50 [0.18 - 1.39]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210205_at	178	0.88764	0.110674	-	0.456121	0.739574	0.145445	1.16 [0.49 - 2.73]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200003033	41	0.390244	0.0556285	-	0.89077	0.213343	0.554068	1.74 [0.73 - 4.17]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210205_at	111	0.18018	0.206513	-	-0.409452	0.667136	-0.127829	0.88 [0.49 - 1.58]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210205_at	90	0.855556	0.0865934	-	0.730945	0.750564	0.187467	1.21 [0.38 - 3.83]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210205_at	90	0.5	0.0624649	-	0.612507	0.673029	0.215837	1.24 [0.46 - 3.38]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210205_at	138	0.297101	0.0626766	-	0.551122	0.772689	-0.0536446	0.95 [0.66 - 1.36]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210205_at	129	0.542636	0.0277798	0.336378	0.542754	0.414986	0.120153	1.13 [0.84 - 1.51]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32334	56	0.517857	0.0674442	-	-0.680428	0.211702	-0.309947	0.73 [0.45 - 1.19]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32334	56	0.821429	0.093397	-	-0.871991	0.28271	-0.25351	0.78 [0.49 - 1.23]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210205_at	278	0.830935	0.297216	-	-0.298338	0.602289	-0.106047	0.90 [0.60 - 1.34]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210205_at	133	0.706767	0.0922972	-	0.414726	0.193013	0.200508	1.22 [0.90 - 1.65]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9472	81	0.111111	0.000329676	0.0099111	-1.95018	0.0823091	-1.31911	0.27 [0.06 - 1.18]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210205_at	185	0.794595	0.00584749	0.106994	-0.574893	0.0195051	-0.448381	0.64 [0.44 - 0.93]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210205_at	185	0.794595	0.0200047	0.267991	-0.529646	0.0559047	-0.400169	0.67 [0.44 - 1.01]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P111171	110	0.890909	0.018723	0.255705	0.898213	0.26363	-0.245002	0.78 [0.51 - 1.20]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P422071	110	0.881818	0.0131445	0.197921	0.7937	0.795542	-0.042932	0.96 [0.69 - 1.33]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P111171	110	0.890909	0.028164	0.33952	0.728352	0.741983	-0.0542908	0.95 [0.69 - 1.31]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P422071	110	0.118182	0.0153413	0.221596	-1.00217	0.261196	-0.246608	0.78 [0.51 - 1.20]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210205_at	80	0.8625	0.110938	-	-1.4976	0.999645	-9.31997e-05	1.00 [0.66 - 1.51]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210205_at	38	0.552632	0.0299319	0.353723	-1.15657	0.282947	-0.500912	0.61 [0.24 - 1.51]
GENE	B3GALT4	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210205_at	140	0.578571	0.0026795	0.0574912	-0.991737	0.00363478	-1.61293	0.20 [0.07 - 0.59]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206947_at	30	0.8	0.300038	-	0.485403	0.587329	0.344373	1.41 [0.41 - 4.89]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1800713	165	0.163636	0.0257238	0.319216	-0.618671	0.0605767	-2.03579	0.13 [0.02 - 1.09]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1800713	165	0.618182	0.0644197	-	-0.771964	0.183067	-2.18565	0.11 [0.00 - 2.81]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206947_at	163	0.190184	0.0964143	-	0.449447	0.555427	-0.290904	0.75 [0.28 - 1.97]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206947_at	79	0.594937	0.0186825	0.255312	0.678082	0.195512	0.980641	2.67 [0.60 - 11.77]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206947_at	58	0.482759	0.136951	-	-0.409456	0.780259	-0.0475748	0.95 [0.68 - 1.33]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206947_at	34	0.823529	0.0596374	-	-1.00858	0.688215	-0.111711	0.89 [0.52 - 1.54]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206947_at	158	0.613924	0.0245765	0.309369	0.518132	0.265597	0.995795	2.71 [0.47 - 15.63]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206947_at	53	0.490566	0.0285173	0.342391	-0.752877	0.151913	-0.286061	0.75 [0.51 - 1.11]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206947_at	53	0.490566	0.00350107	0.0713169	-1.08584	0.0424392	-0.430944	0.65 [0.43 - 0.99]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206947_at	180	0.111111	0.000170613	0.00559569	-1.11968	0.0392397	-0.301824	0.74 [0.56 - 0.99]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206947_at	559	0.899821	0.0502447	-	-0.870778	0.394992	-0.0967905	0.91 [0.73 - 1.13]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206947_at	77	0.818182	0.00690903	0.121783	-0.995141	0.771579	-0.0643695	0.94 [0.61 - 1.45]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206947_at	70	0.142857	0.159132	-	-0.489831	0.90482	0.114276	1.12 [0.17 - 7.30]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34128_at	50	0.18	0.0154645	0.222886	-1.05599	0.129112	-1.86298	0.16 [0.01 - 1.72]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206947_at	74	0.202703	0.00312432	0.0650854	-0.923677	0.0157314	-0.486238	0.61 [0.41 - 0.91]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206947_at	67	0.238806	0.0958572	-	15.444	0.734437	0.985594	2.68 [0.01 - 796.46]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206947_at	115	0.8	0.0202263	0.270082	1.18386	0.240418	0.709296	2.03 [0.62 - 6.64]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34128_at	158	0.202532	0.121907	-	-0.483946	0.428893	-0.236821	0.79 [0.44 - 1.42]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34128_at	76	0.302632	0.144792	-	1.05785	0.787567	0.128297	1.14 [0.45 - 2.89]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206947_at	204	0.156863	0.102168	-	-0.318432	0.806571	-0.0173825	0.98 [0.86 - 1.13]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206947_at	87	0.505747	0.113008	-	0.604388	0.879416	-0.123903	0.88 [0.18 - 4.38]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206947_at	87	0.505747	0.113008	-	0.604388	0.879416	-0.123903	0.88 [0.18 - 4.38]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206947_at	77	0.792208	0.0151747	0.219846	1.41503	0.378615	0.957943	2.61 [0.31 - 21.99]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206947_at	77	0.792208	0.078039	-	0.967264	0.505835	0.640175	1.90 [0.29 - 12.50]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206947_at	136	0.279412	0.285152	-	-0.493132	0.970822	0.00894399	1.01 [0.62 - 1.63]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206947_at	200	0.6	0.0941196	-	0.490004	0.992309	-0.00275802	1.00 [0.57 - 1.75]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8786	60	0.15	0.184785	-	0.937331	0.752988	0.0422503	1.04 [0.80 - 1.36]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8786	60	0.116667	0.0758078	-	1.62636	0.400381	0.139688	1.15 [0.83 - 1.59]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	13001	155	0.167742	0.000753593	0.0200822	-0.95459	0.0191752	-0.44446	0.64 [0.44 - 0.93]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206947_at	286	0.335664	0.0254349	0.316754	-0.438925	0.118574	-0.282686	0.75 [0.53 - 1.07]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206947_at	159	0.169811	0.0079186	0.135246	2.21101	0.0345298	0.820352	2.27 [1.06 - 4.86]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206947_at	159	0.125786	0.0319079	0.36913	15.2363	0.103916	0.7414	2.10 [0.86 - 5.13]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206947_at	159	0.622642	0.0300965	0.355025	0.674304	0.219398	0.45796	1.58 [0.76 - 3.28]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206947_at	54	0.796296	0.0865863	-	-15.4708	0.431567	-1.67554	0.19 [0.00 - 12.18]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206947_at	117	0.837607	0.146741	-	0.543221	0.571072	0.534944	1.71 [0.27 - 10.87]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206947_at	117	0.393162	0.0838509	-	0.738199	0.44764	0.831715	2.30 [0.27 - 19.66]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206947_at	117	0.837607	0.146741	-	0.543221	0.571072	0.534944	1.71 [0.27 - 10.87]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206947_at	117	0.598291	0.151085	-	-0.623134	0.955846	-0.0674171	0.93 [0.09 - 10.17]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206947_at	236	0.847458	0.204259	-	0.423037	0.697832	-0.101091	0.90 [0.54 - 1.51]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206947_at	249	0.899598	0.092562	-	-0.754703	0.91427	-0.0221362	0.98 [0.65 - 1.46]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206947_at	62	0.193548	0.064902	-	-1.06635	0.730929	-0.0806157	0.92 [0.58 - 1.46]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206947_at	125	0.888	0.209553	-	-1.20552	0.783684	-0.242671	0.78 [0.14 - 4.44]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206947_at	125	0.896	0.0625611	-	-1.68098	0.377499	-0.618639	0.54 [0.14 - 2.13]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206947_at	54	0.518519	0.052259	-	1.40393	0.742441	-0.0941417	0.91 [0.52 - 1.60]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206947_at	198	0.141414	0.102789	-	-0.521284	0.522083	-0.0666878	0.94 [0.76 - 1.15]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206947_at	198	0.141414	0.131263	-	-0.503521	0.614357	-0.0546153	0.95 [0.77 - 1.17]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206947_at	198	0.191919	0.0370352	0.407017	-0.507776	0.250266	-0.0982442	0.91 [0.77 - 1.07]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206947_at	51	0.372549	0.0717054	-	15.838	0.534393	-0.806763	0.45 [0.04 - 5.69]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206947_at	62	0.306452	0.0411099	0.435198	1.85874	0.834093	-0.123256	0.88 [0.28 - 2.80]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206947_at	177	0.220339	0.0624674	-	0.701255	0.879318	-0.0562405	0.95 [0.46 - 1.95]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206947_at	177	0.186441	0.0869358	-	0.577502	0.448653	-0.255731	0.77 [0.40 - 1.50]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206947_at	145	0.896552	0.0709887	-	-1.64236	0.24216	-0.606311	0.55 [0.20 - 1.51]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206947_at	226	0.176991	0.1425	-	-0.469242	0.907949	0.0173391	1.02 [0.76 - 1.37]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206947_at	55	0.745455	0.0284569	0.341901	0.967935	0.530501	0.288089	1.33 [0.54 - 3.28]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206947_at	55	0.436364	0.281971	-	-0.473327	0.710505	-0.205401	0.81 [0.28 - 2.41]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206947_at	49	0.734694	0.17988	-	0.771908	0.687992	0.239462	1.27 [0.39 - 4.09]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206947_at	63	0.206349	0.000179405	0.00584655	-1.28554	0.124543	-17.839	0.00 [0.00 - 137.64]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5174396_3p_at	28	0.142857	0.0685508	-	-1.19105	0.208624	-6.35909	0.00 [0.00 - 34.94]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206947_at	82	0.426829	0.0132674	0.199281	0.899654	0.119684	0.855829	2.35 [0.80 - 6.92]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34128_at	84	0.428571	0.00757635	0.130742	-0.759604	0.330029	-0.389877	0.68 [0.31 - 1.48]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206947_at	79	0.101266	0.0742768	-	-0.680526	0.167826	-0.841433	0.43 [0.13 - 1.43]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206947_at	104	0.307692	0.0173181	0.241849	1.08689	0.394274	0.628399	1.87 [0.44 - 7.96]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206947_at	204	0.122549	0.0681165	-	1.03703	0.211631	0.135187	1.14 [0.93 - 1.42]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206947_at	204	0.122549	0.0297801	0.352519	15.2365	0.0689785	0.243988	1.28 [0.98 - 1.66]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206947_at	178	0.803371	0.151278	-	0.351016	0.173014	0.554872	1.74 [0.78 - 3.87]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206947_at	111	0.351351	0.00360051	0.0729337	-0.756793	0.0688387	-0.340114	0.71 [0.49 - 1.03]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206947_at	90	0.111111	0.136412	-	-0.614152	0.917962	-0.075703	0.93 [0.22 - 3.92]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206947_at	90	0.855556	0.215752	-	-0.878992	0.643356	0.368006	1.44 [0.30 - 6.86]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206947_at	138	0.173913	0.0666833	-	-0.520945	0.362303	0.300477	1.35 [0.71 - 2.58]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206947_at	129	0.542636	0.125559	-	0.376261	0.6324	0.160111	1.17 [0.61 - 2.26]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41952	56	0.75	0.384331	-	-0.365257	0.843265	0.105409	1.11 [0.39 - 3.16]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2873	56	0.660714	0.123534	-	0.527296	0.337637	0.494556	1.64 [0.60 - 4.51]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41952	56	0.160714	0.166992	-	0.733859	0.527089	0.345522	1.41 [0.48 - 4.12]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2873	56	0.660714	0.138715	-	0.538319	0.363295	0.4999	1.65 [0.56 - 4.84]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206947_at	278	0.18705	0.0774825	-	-0.397415	0.943812	0.0323355	1.03 [0.42 - 2.54]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206947_at	133	0.849624	0.00193781	0.0441361	0.864528	0.00870066	4.04147	56.91 [2.78 - 1165.28]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14354	81	0.308642	0.0397598	0.426037	-1.02216	0.629658	-0.401759	0.67 [0.13 - 3.43]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17372	81	0.839506	0.0346946	0.390079	1.18721	0.400575	-0.85203	0.43 [0.06 - 3.11]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206947_at	185	0.102703	0.0411744	0.435632	0.555289	0.822465	0.061476	1.06 [0.62 - 1.82]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206947_at	185	0.102703	0.0708292	-	0.545074	0.571735	0.169014	1.18 [0.66 - 2.13]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P102917	110	0.663636	0.00247289	0.0538657	-0.798958	0.00439293	-0.450864	0.64 [0.47 - 0.87]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P102919	110	0.436364	0.125362	-	0.462637	0.319379	0.198138	1.22 [0.83 - 1.80]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P102917	110	0.663636	0.0953737	-	-0.58946	0.329809	-0.175532	0.84 [0.59 - 1.19]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P102919	110	0.436364	0.014336	0.210925	0.574464	0.0538767	0.285535	1.33 [1.00 - 1.78]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206947_at	80	0.3375	0.116276	-	0.847443	0.696031	0.0990794	1.10 [0.67 - 1.82]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206947_at	38	0.236842	0.00776004	0.133167	-1.30019	0.0405234	-0.67832	0.51 [0.27 - 0.97]
GENE	B3GALT5	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206947_at	140	0.8	0.0551694	-	0.603335	0.457233	0.832692	2.30 [0.26 - 20.66]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1739749	165	0.151515	0.077238	-	0.691952	0.140827	0.319486	1.38 [0.90 - 2.11]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1739749	165	0.769697	0.0200337	0.268265	0.826305	0.0268758	0.723646	2.06 [1.09 - 3.91]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226427_s_at	163	0.895706	0.17899	-	-0.489295	0.876834	-0.0922743	0.91 [0.28 - 2.93]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	225733_at	163	0.705521	0.000230727	0.00727787	0.747596	0.0342077	0.532391	1.70 [1.04 - 2.79]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226427_s_at	79	0.253165	0.0766207	-	-0.549275	0.665529	-0.330621	0.72 [0.16 - 3.22]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1553959_a_at	79	0.670886	0.0762742	-	0.52011	0.217659	0.289513	1.34 [0.84 - 2.12]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	225733_at	79	0.632911	0.0779723	-	0.514174	0.367426	0.239349	1.27 [0.75 - 2.14]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	225733_at	180	0.111111	0.00346689	0.0707585	-0.815627	0.287194	-0.315244	0.73 [0.41 - 1.30]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226427_s_at	180	0.561111	0.025042	0.313388	-0.491697	0.083061	-0.261405	0.77 [0.57 - 1.03]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226427_s_at	559	0.19678	0.0320849	0.370487	-0.499665	0.403894	-0.101812	0.90 [0.71 - 1.15]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1553959_a_at	559	0.105546	0.21572	-	-0.345364	0.971345	0.0082562	1.01 [0.64 - 1.58]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	225733_at	559	0.651163	0.0318503	0.368688	-0.479299	0.143057	-0.357453	0.70 [0.43 - 1.13]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	225733_at	77	0.181818	0.13752	-	-0.464575	0.856938	0.0842107	1.09 [0.44 - 2.72]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226427_s_at	77	0.181818	0.130053	-	0.540567	0.67246	0.0954548	1.10 [0.71 - 1.71]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226427_s_at	70	0.514286	0.357996	-	-0.244645	0.863262	0.120722	1.13 [0.29 - 4.46]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1553959_a_at	70	0.2	0.0224656	0.29071	-0.722822	0.278489	-0.367351	0.69 [0.36 - 1.35]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	225733_at	70	0.157143	0.0114562	0.178762	-0.860504	0.167677	-0.520291	0.59 [0.28 - 1.24]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	225733_at	74	0.864865	0.023335	0.298483	0.872674	0.500419	0.332026	1.39 [0.53 - 3.66]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226427_s_at	74	0.635135	0.000907851	0.0234974	0.938232	0.00188837	0.79587	2.22 [1.34 - 3.66]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	225733_at	67	0.432836	0.0507673	-	-1.44649	0.0433072	-2.34499	0.10 [0.01 - 0.93]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226427_s_at	67	0.626866	0.0175757	0.244422	1.54348	0.205128	3.45476	31.65 [0.15 - 6626.40]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1553959_a_at	67	0.447761	0.055482	-	-1.42422	0.95952	0.0520642	1.05 [0.14 - 7.87]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226427_s_at	115	0.130435	0.0571166	-	-1.08283	0.0310394	-0.586017	0.56 [0.33 - 0.95]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1553959_a_at	115	0.182609	0.255082	-	1.1175	0.993982	-0.00676536	0.99 [0.17 - 5.76]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	225733_at	115	0.33913	0.0366134	0.404007	-1.07488	0.327387	-0.600216	0.55 [0.17 - 1.82]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	225733_at	204	0.769608	0.0309655	0.361842	-0.355463	0.0997014	-0.303716	0.74 [0.51 - 1.06]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226427_s_at	204	0.107843	0.00691875	0.121915	-0.617907	0.0269179	-0.190986	0.83 [0.70 - 0.98]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1553959_a_at	204	0.72549	0.169202	-	0.213446	0.707994	0.0773882	1.08 [0.72 - 1.62]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226427_s_at	87	0.885057	0.0895899	-	-1.56757	0.678297	-0.272188	0.76 [0.21 - 2.76]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226427_s_at	87	0.885057	0.0895899	-	-1.56757	0.678297	-0.272188	0.76 [0.21 - 2.76]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1553959_a_at	87	0.609195	0.00794792	0.135629	0.978148	0.154439	0.596968	1.82 [0.80 - 4.13]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1553959_a_at	87	0.609195	0.00794792	0.135629	0.978148	0.154439	0.596968	1.82 [0.80 - 4.13]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	225733_at	87	0.402299	0.0365514	0.403563	-0.777804	0.380425	-0.439053	0.64 [0.24 - 1.72]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	225733_at	87	0.402299	0.0365514	0.403563	-0.777804	0.380425	-0.439053	0.64 [0.24 - 1.72]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226427_s_at	77	0.454545	0.0778831	-	1.10514	0.261186	1.4837	4.41 [0.33 - 58.67]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553959_a_at	77	0.298701	0.0452341	0.462181	-1.06388	0.274574	-0.578004	0.56 [0.20 - 1.58]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	225733_at	77	0.181818	0.0204757	0.272425	-1.2468	0.264702	-0.853904	0.43 [0.09 - 1.91]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226427_s_at	77	0.454545	0.0729165	-	1.32142	0.519903	0.969336	2.64 [0.14 - 50.49]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553959_a_at	77	0.298701	0.171434	-	-0.840237	0.352522	-0.562304	0.57 [0.17 - 1.86]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	225733_at	77	0.181818	0.00263719	0.0567541	-1.69985	0.269826	-0.954047	0.39 [0.07 - 2.10]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225733_at	159	0.125786	0.147972	-	-0.652014	0.807159	-0.149201	0.86 [0.26 - 2.85]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226427_s_at	159	0.893082	0.00727112	0.126675	1.01849	0.144061	0.369084	1.45 [0.88 - 2.37]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226427_s_at	159	0.132075	0.0953217	-	-0.648172	0.898864	0.0349435	1.04 [0.60 - 1.78]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226427_s_at	159	0.327044	0.283619	-	0.461235	0.663497	0.138145	1.15 [0.62 - 2.14]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225733_at	159	0.314465	0.0332784	0.379543	-0.66475	0.477216	-0.357747	0.70 [0.26 - 1.88]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225733_at	159	0.125786	0.124097	-	-0.599908	0.934563	-0.0427699	0.96 [0.35 - 2.66]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	225733_at	236	0.872881	0.00033448	0.0100355	1.08842	0.0362794	1.36635	3.92 [1.09 - 14.09]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226427_s_at	236	0.838983	0.0567127	-	0.598688	0.40392	0.306794	1.36 [0.66 - 2.79]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	225733_at	249	0.883534	0.00253302	0.0549277	0.835225	0.253206	0.545465	1.73 [0.68 - 4.40]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226427_s_at	249	0.827309	0.00203107	0.0458707	0.735646	0.239118	0.34032	1.41 [0.80 - 2.48]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226427_s_at	145	0.737931	0.0611375	-	-0.877575	0.542955	-0.400723	0.67 [0.18 - 2.44]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1553959_a_at	145	0.8	0.023494	0.299891	-1.50354	0.246205	-0.552843	0.58 [0.23 - 1.46]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	225733_at	145	0.537931	0.0103926	0.166203	0.863614	0.618324	0.371131	1.45 [0.34 - 6.24]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	225733_at	177	0.519774	0.0809076	-	0.473182	0.813181	0.138533	1.15 [0.36 - 3.62]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226427_s_at	177	0.723164	0.171921	-	-0.385187	0.304059	-0.496615	0.61 [0.24 - 1.57]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1553959_a_at	177	0.186441	0.129552	-	-0.418487	0.219527	-0.414904	0.66 [0.34 - 1.28]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226427_s_at	177	0.661017	0.0830612	-	-0.531642	0.19388	-0.742001	0.48 [0.16 - 1.46]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1553959_a_at	177	0.288136	0.0573333	-	-0.525331	0.104856	-0.627025	0.53 [0.25 - 1.14]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	225733_at	177	0.169492	0.0461556	0.468013	-0.561204	0.802001	-0.127983	0.88 [0.32 - 2.39]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226427_s_at	226	0.247788	0.00678906	0.120146	-0.787149	0.181243	-0.24706	0.78 [0.54 - 1.12]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1553959_a_at	226	0.862832	0.10204	-	-0.939121	0.458426	-0.226185	0.80 [0.44 - 1.45]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	225733_at	226	0.641593	0.0591422	-	0.529888	0.345168	0.346796	1.41 [0.69 - 2.91]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	225733_at	55	0.309091	0.364615	-	0.504994	0.842677	-0.153968	0.86 [0.19 - 3.92]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226427_s_at	55	0.672727	0.0664664	-	0.8719	0.693908	0.580992	1.79 [0.10 - 32.28]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1553959_a_at	55	0.4	0.0454752	0.463714	1.09357	0.35061	0.558798	1.75 [0.54 - 5.65]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	225733_at	49	0.102041	0.107413	-	-1.21818	0.622598	-0.468064	0.63 [0.10 - 4.04]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226427_s_at	49	0.877551	0.0572213	-	1.22397	0.80053	0.44867	1.57 [0.05 - 50.87]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1553959_a_at	49	0.428571	0.119877	-	0.998111	0.563134	0.451873	1.57 [0.34 - 7.27]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226427_s_at	55	0.127273	0.0523261	-	-0.972219	0.854092	-0.274599	0.76 [0.04 - 14.18]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1553959_a_at	55	0.4	0.0468115	0.472123	0.989933	0.561305	0.300688	1.35 [0.49 - 3.73]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	225733_at	55	0.418182	0.302608	-	0.479122	0.801077	-0.180223	0.84 [0.21 - 3.39]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226427_s_at	63	0.15873	3.26114e-07	1.92969e-05	-1.88216	0.0139016	-32.4505	0.00 [0.00 - 0.00]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1553959_a_at	63	0.571429	0.0801778	-	0.585855	0.311073	0.165681	1.18 [0.86 - 1.63]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	225733_at	63	0.555556	0.281632	-	0.364741	0.50931	0.151604	1.16 [0.74 - 1.83]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.284284.1.A1_3p_at	28	0.107143	0.143034	-	-1.12063	0.743635	0.647936	1.91 [0.04 - 92.86]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.284284.1.S1_3p_s_at	28	0.107143	0.0443481	0.456507	-1.58841	0.411982	-0.156343	0.86 [0.59 - 1.24]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.284284.0.A1_3p_at	28	0.678571	0.0279426	0.337712	-1.56099	0.408214	-7.50983	0.00 [0.00 - 29369.01]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P35021	117	0.102564	0.105909	-	1.1099	0.584643	0.179965	1.20 [0.63 - 2.28]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	225733_at	204	0.617647	0.0111522	0.175214	0.914399	0.292431	0.611231	1.84 [0.59 - 5.75]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226427_s_at	204	0.593137	0.1927	-	0.472638	0.775093	0.0689242	1.07 [0.67 - 1.72]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1553959_a_at	204	0.20098	0.0459094	0.466462	1.35553	0.254073	0.595235	1.81 [0.65 - 5.04]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	225733_at	204	0.102941	0.0206997	0.274519	-0.822452	0.442899	0.336096	1.40 [0.59 - 3.30]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226427_s_at	204	0.112745	0.0479382	0.479103	-0.680338	0.765973	-0.0552513	0.95 [0.66 - 1.36]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1553959_a_at	204	0.759804	0.0160639	0.229108	0.667224	0.034902	0.811363	2.25 [1.06 - 4.78]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300005640	41	0.682927	0.00641849	0.115036	1.10361	0.415071	0.247903	1.28 [0.71 - 2.33]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226427_s_at	111	0.108108	0.163583	-	0.70793	0.641054	0.0736383	1.08 [0.79 - 1.47]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1553959_a_at	111	0.342342	0.00793641	0.135478	0.800567	0.01759	0.634699	1.89 [1.12 - 3.19]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	225733_at	111	0.783784	0.0129942	0.196251	0.712852	0.531074	0.206262	1.23 [0.64 - 2.34]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226427_s_at	138	0.115942	0.0029059	0.0613908	-0.870441	0.797231	1.12119	3.07 [0.00 - 15900.73]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1553959_a_at	138	0.869565	0.13455	-	-0.631012	0.448886	-0.136682	0.87 [0.61 - 1.24]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	225733_at	138	0.891304	0.28392	-	-0.458473	0.828418	-0.0379218	0.96 [0.68 - 1.36]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1283	56	0.125	0.161499	-	0.98232	0.550572	0.16781	1.18 [0.68 - 2.05]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1283	56	0.125	0.258679	-	0.805517	0.566491	0.17484	1.19 [0.66 - 2.17]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	225733_at	278	0.363309	0.00946599	0.154913	0.553461	0.0617478	0.343912	1.41 [0.98 - 2.02]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226427_s_at	278	0.881295	0.0511182	-	-0.574393	0.238595	-0.458854	0.63 [0.29 - 1.36]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1553959_a_at	278	0.83813	0.271022	-	0.24711	0.92495	0.0152734	1.02 [0.74 - 1.40]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P35021	110	0.581818	0.363621	-	0.207478	0.843029	0.0365566	1.04 [0.72 - 1.49]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P35021	110	0.154545	0.250274	-	0.545118	0.760537	0.0673587	1.07 [0.69 - 1.65]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226427_s_at	38	0.473684	0.0857982	-	-0.835887	0.830424	0.0728891	1.08 [0.55 - 2.10]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1553959_a_at	38	0.552632	0.0411164	0.435242	0.972259	0.154529	0.801681	2.23 [0.74 - 6.72]
GENE	B3GALT6	UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	225733_at	38	0.789474	0.0182515	0.251102	1.17799	0.265177	0.78002	2.18 [0.55 - 8.60]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219521_at	30	0.133333	0.0609148	-	-1.00302	0.169558	-0.708916	0.49 [0.18 - 1.35]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1761093	165	0.545455	0.000954086	0.0244993	-0.82577	0.00412938	-0.723893	0.48 [0.30 - 0.80]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1761093	165	0.484848	0.000111369	0.00385047	-1.5111	0.0140967	-1.0231	0.36 [0.16 - 0.81]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219521_at	163	0.773006	0.167707	-	0.309026	0.75492	0.186366	1.20 [0.37 - 3.88]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219521_at	79	0.405063	0.0932978	-	-0.489019	0.818108	0.158476	1.17 [0.30 - 4.52]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219521_at	58	0.724138	0.109405	-	-0.511483	0.799084	-0.0402638	0.96 [0.70 - 1.31]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219521_at	34	0.882353	0.264971	-	0.600541	0.939464	0.0148656	1.01 [0.69 - 1.49]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219521_at	158	0.670886	0.108115	-	0.384993	0.702945	0.252803	1.29 [0.35 - 4.72]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219521_at	53	0.264151	0.038281	0.415804	1.06611	0.682856	0.0949516	1.10 [0.70 - 1.73]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219521_at	53	0.264151	0.00763545	0.131524	1.33065	0.311136	0.217304	1.24 [0.82 - 1.89]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219521_at	180	0.855556	0.00864844	0.144658	0.695143	0.703518	0.0256761	1.03 [0.90 - 1.17]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219521_at	559	0.49195	0.0371445	0.407795	-0.415974	0.272905	-0.139391	0.87 [0.68 - 1.12]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219521_at	77	0.714286	0.000107938	0.00374591	-1.20492	0.0468875	-0.17672	0.84 [0.70 - 1.00]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219521_at	70	0.571429	0.204721	-	0.334068	0.962754	0.00883083	1.01 [0.70 - 1.46]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219521_at	74	0.121622	0.043641	0.451932	-0.819087	0.262007	-0.203394	0.82 [0.57 - 1.16]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219521_at	67	0.522388	0.01857	0.254216	2.09832	0.380761	1.57725	4.84 [0.14 - 164.72]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219521_at	115	0.252174	0.103657	-	1.53413	0.392393	0.602877	1.83 [0.46 - 7.28]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219521_at	204	0.602941	0.0481205	0.480223	0.286321	0.266015	0.0714976	1.07 [0.95 - 1.22]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219521_at	87	0.183908	0.0611701	-	1.28516	0.827362	0.113258	1.12 [0.40 - 3.10]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219521_at	87	0.183908	0.0611701	-	1.28516	0.827362	0.113258	1.12 [0.40 - 3.10]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219521_at	77	0.857143	0.176952	-	-15.2693	0.378195	-1.0278	0.36 [0.04 - 3.52]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219521_at	77	0.857143	0.121796	-	-15.2721	0.710738	-0.328621	0.72 [0.13 - 4.09]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219521_at	136	0.316176	0.0247173	0.310588	1.52698	0.0971851	0.456552	1.58 [0.92 - 2.71]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219521_at	200	0.11	0.061754	-	1.68278	0.792786	-0.0488131	0.95 [0.66 - 1.37]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17523	60	0.616667	0.00546823	0.101532	1.02432	0.207649	0.162038	1.18 [0.91 - 1.51]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17523	60	0.733333	0.00541525	0.100761	1.03051	0.19781	0.173204	1.19 [0.91 - 1.55]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5729	155	0.103226	0.00945937	0.154831	-0.859059	0.154886	-0.264422	0.77 [0.53 - 1.11]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219521_at	286	0.297203	0.0203973	0.27169	-0.463272	0.274323	-0.164101	0.85 [0.63 - 1.14]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219521_at	159	0.433962	0.0573549	-	0.644868	0.674901	-0.0911165	0.91 [0.60 - 1.40]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219521_at	159	0.761006	0.0503254	-	-0.905343	0.544709	-0.137229	0.87 [0.56 - 1.36]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219521_at	159	0.433962	0.0233109	0.298269	0.948752	0.52942	-0.170501	0.84 [0.50 - 1.43]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219521_at	54	0.481481	0.0321479	0.37097	-1.56243	0.16275	-2.49049	0.08 [0.00 - 2.74]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219521_at	117	0.478632	0.0743062	-	-0.573339	0.776026	-0.116727	0.89 [0.40 - 1.99]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219521_at	117	0.478632	0.173623	-	-0.514175	0.912312	-0.050291	0.95 [0.39 - 2.33]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219521_at	117	0.401709	0.0831068	-	0.7899	0.50055	-0.390234	0.68 [0.22 - 2.11]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219521_at	117	0.478632	0.0743062	-	-0.573339	0.776026	-0.116727	0.89 [0.40 - 1.99]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219521_at	236	0.148305	0.199472	-	0.548488	0.631302	-0.146076	0.86 [0.48 - 1.57]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219521_at	249	0.75502	0.0469277	0.472848	0.453897	0.693138	0.0810268	1.08 [0.73 - 1.62]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219521_at	125	0.896	0.196795	-	0.628261	0.788847	0.15923	1.17 [0.37 - 3.76]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219521_at	125	0.104	0.156303	-	-0.618051	0.877499	-0.0727793	0.93 [0.37 - 2.35]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219521_at	62	0.870968	0.150988	-	-1.3783	0.54815	-0.125876	0.88 [0.58 - 1.33]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219521_at	54	0.851852	0.294569	-	-1.05544	0.647272	-0.115832	0.89 [0.54 - 1.46]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219521_at	198	0.89899	0.260766	-	0.451587	0.189457	0.169291	1.18 [0.92 - 1.53]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219521_at	198	0.449495	0.199238	-	0.331861	0.274311	0.137543	1.15 [0.90 - 1.47]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219521_at	198	0.777778	0.096604	-	0.401921	0.0688547	0.189802	1.21 [0.99 - 1.48]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219521_at	51	0.803922	0.265377	-	-15.3583	0.907738	0.27712	1.32 [0.01 - 143.14]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219521_at	62	0.612903	0.30093	-	0.589363	0.924829	-0.139818	0.87 [0.05 - 15.87]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219521_at	177	0.898305	0.0600097	-	-1.05865	0.297491	-0.759108	0.47 [0.11 - 1.95]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219521_at	145	0.813793	0.312182	-	0.404553	0.963543	0.0475664	1.05 [0.14 - 8.06]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219521_at	177	0.276836	0.111823	-	-0.449791	0.272714	-0.921276	0.40 [0.08 - 2.06]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219521_at	226	0.486726	0.307514	-	0.291753	0.74484	0.0420775	1.04 [0.81 - 1.34]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219521_at	55	0.509091	0.0527064	-	-0.980972	0.570432	-0.993024	0.37 [0.01 - 11.44]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219521_at	49	0.857143	0.159672	-	0.91016	0.779432	0.520574	1.68 [0.04 - 64.32]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219521_at	55	0.709091	0.311692	-	-0.558545	0.704145	-0.602264	0.55 [0.02 - 12.26]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219521_at	63	0.460317	0.0094628	0.154874	-0.872058	0.692998	0.146662	1.16 [0.56 - 2.40]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12408651_3p_at	28	0.642857	0.116773	-	-1.00635	0.880291	0.123602	1.13 [0.23 - 5.65]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P1833	117	0.888889	0.12566	-	-0.884024	0.999108	-7.60408e-05	1.00 [0.88 - 1.14]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219521_at	204	0.210784	0.0139305	0.206544	-0.8914	0.13533	-0.187353	0.83 [0.65 - 1.06]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219521_at	204	0.22549	2.24357e-05	0.000926143	-1.11102	0.00398388	-0.283887	0.75 [0.62 - 0.91]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219521_at	111	0.405405	0.313188	-	-0.268045	0.810316	-0.0396416	0.96 [0.70 - 1.33]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219521_at	90	0.822222	0.0934037	-	0.633534	0.413639	0.505777	1.66 [0.49 - 5.58]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219521_at	90	0.822222	0.0517504	-	0.790769	0.339878	0.670973	1.96 [0.49 - 7.76]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3091	50	0.76	0.080452	-	0.868015	0.99586	-0.00142106	1.00 [0.58 - 1.71]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219521_at	138	0.413043	0.00126865	0.0310932	-0.772432	0.987796	0.00341231	1.00 [0.65 - 1.55]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219521_at	129	0.658915	0.00942021	0.154346	0.63623	0.295952	0.158362	1.17 [0.87 - 1.58]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6197	56	0.892857	0.126139	-	0.734645	0.889986	0.0202365	1.02 [0.77 - 1.36]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6197	56	0.892857	0.028257	0.340277	1.0529	0.985829	0.0028664	1.00 [0.73 - 1.38]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219521_at	278	0.618705	0.000439506	0.01269	-0.789741	0.00882421	-0.63759	0.53 [0.33 - 0.85]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219521_at	133	0.488722	0.00210538	0.0472405	0.736937	0.873071	-0.0347325	0.97 [0.63 - 1.48]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16921	81	0.716049	0.156282	-	-0.938382	0.961722	0.0112791	1.01 [0.64 - 1.60]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219521_at	185	0.32973	0.301378	-	0.19735	0.891507	0.0275025	1.03 [0.69 - 1.53]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219521_at	185	0.32973	0.34641	-	0.163786	0.992787	-0.00165862	1.00 [0.70 - 1.43]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P1833	110	0.5	0.00271604	0.0581257	-0.6954	0.103131	-0.157748	0.85 [0.71 - 1.03]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P1833	110	0.563636	0.00193769	0.044134	-0.981232	0.0697879	-0.244154	0.78 [0.60 - 1.02]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219521_at	80	0.8125	0.166626	-	0.723104	0.392813	0.190415	1.21 [0.78 - 1.87]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219521_at	38	0.894737	0.00477793	0.0913156	1.48562	0.0411298	0.632549	1.88 [1.03 - 3.45]
GENE	B3GAT1	beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219521_at	140	0.578571	0.0246834	0.310295	-0.693019	0.197423	-0.396825	0.67 [0.37 - 1.23]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1774208	165	0.563636	0.0126876	0.192825	0.600365	0.172787	1.37011	3.94 [0.55 - 28.22]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1774208	165	0.466667	0.0766797	-	0.663469	0.583219	0.803925	2.23 [0.13 - 39.48]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	239144_at	163	0.208589	0.0890913	-	0.44755	0.859516	0.137888	1.15 [0.25 - 5.29]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	239144_at	79	0.164557	0.0430023	0.447762	-0.710457	0.470173	-0.649448	0.52 [0.09 - 3.04]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	239144_at	180	0.177778	0.0211392	0.278601	0.726173	0.798611	0.0394909	1.04 [0.77 - 1.41]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	239144_at	559	0.202147	0.033685	0.382591	0.694484	0.680416	0.0647416	1.07 [0.78 - 1.45]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	239144_at	77	0.883117	0.0164165	0.232726	0.864478	0.463183	-0.0884318	0.92 [0.72 - 1.16]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	239144_at	70	0.328571	0.0897024	-	0.505755	0.205649	0.132871	1.14 [0.93 - 1.40]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	239144_at	74	0.108108	0.127319	-	-0.616034	0.408988	-0.123218	0.88 [0.66 - 1.18]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	239144_at	67	0.791045	0.0794765	-	-15.511	0.450724	-1.27127	0.28 [0.01 - 7.63]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	239144_at	115	0.504348	0.0225878	0.291811	1.3739	0.257346	0.788531	2.20 [0.56 - 8.61]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	239144_at	204	0.161765	0.00887723	0.147557	0.489563	0.0238416	0.239589	1.27 [1.03 - 1.56]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	239144_at	87	0.275862	0.0297439	0.352232	-0.808763	0.688716	-0.283652	0.75 [0.19 - 3.02]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	239144_at	87	0.275862	0.0297439	0.352232	-0.808763	0.688716	-0.283652	0.75 [0.19 - 3.02]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	239144_at	77	0.376623	0.0651478	-	1.32081	0.371701	0.84772	2.33 [0.36 - 15.00]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	239144_at	77	0.376623	0.202404	-	0.969834	0.479377	0.77941	2.18 [0.25 - 18.90]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239144_at	159	0.572327	0.0657903	-	-0.624822	0.691076	-0.0985695	0.91 [0.56 - 1.47]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239144_at	159	0.408805	0.107192	-	0.548858	0.689612	0.105404	1.11 [0.66 - 1.86]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239144_at	159	0.100629	0.0382265	0.415423	-0.918227	0.239371	-0.315915	0.73 [0.43 - 1.23]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	239144_at	236	0.457627	0.12963	-	-0.406335	0.597624	0.138468	1.15 [0.69 - 1.92]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	239144_at	249	0.710843	0.116719	-	0.347901	0.795141	-0.0518131	0.95 [0.64 - 1.40]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	239144_at	177	0.723164	0.00327072	0.0675274	-0.930347	0.0941172	-1.06694	0.34 [0.10 - 1.20]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	239144_at	177	0.412429	0.00535184	0.0998349	-0.749424	0.036888	-1.57922	0.21 [0.05 - 0.91]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	239144_at	145	0.475862	0.0235082	0.300016	-0.757061	0.0555772	-1.78208	0.17 [0.03 - 1.04]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	239144_at	226	0.862832	0.0187073	0.255553	-1.54145	0.191495	-0.195992	0.82 [0.61 - 1.10]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	239144_at	55	0.836364	0.03026	0.356315	-15.3836	0.151109	-1.82185	0.16 [0.01 - 1.95]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	239144_at	49	0.163265	0.0102824	0.164877	-1.4025	0.151843	-2.33805	0.10 [0.00 - 2.36]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	239144_at	55	0.127273	0.0144284	0.211916	-1.19738	0.0720962	-2.30876	0.10 [0.01 - 1.23]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	30459	34	0.294118	0.0163662	0.232212	1.42157	0.118444	1.01552	2.76 [0.77 - 9.88]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	239144_at	63	0.777778	0.101444	-	-0.774076	0.329288	-0.31286	0.73 [0.39 - 1.37]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.12825.0.A1_3p_at	28	0.535714	0.0110734	0.174289	-1.57222	0.736611	0.146196	1.16 [0.49 - 2.71]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P167805	117	0.401709	0.046191	0.468236	-0.564522	0.376181	-0.166406	0.85 [0.59 - 1.22]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	239144_at	204	0.519608	0.000237963	0.00747562	-1.62114	0.000971245	-1.19954	0.30 [0.15 - 0.61]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	239144_at	204	0.681373	7.25747e-05	0.00263891	-1.66521	0.000604301	-0.961438	0.38 [0.22 - 0.66]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	239144_at	111	0.855856	0.309889	-	0.351664	0.846303	0.0326702	1.03 [0.74 - 1.44]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3199	50	0.84	0.148193	-	0.818783	0.757704	0.0868407	1.09 [0.63 - 1.89]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	239144_at	138	0.478261	0.0038941	0.0776443	-0.699718	0.369671	-0.403679	0.67 [0.28 - 1.61]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20350	56	0.357143	0.253982	-	-0.395133	0.721882	-0.120354	0.89 [0.46 - 1.72]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	20350	56	0.196429	0.111473	-	-0.62319	0.520826	-0.238157	0.79 [0.38 - 1.63]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	239144_at	278	0.442446	0.0519741	-	-0.372103	0.371089	-0.231325	0.79 [0.48 - 1.32]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P167805	110	0.845455	0.0213447	0.280498	0.783346	0.553922	0.139119	1.15 [0.73 - 1.82]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P167805	110	0.845455	0.0233122	0.298281	0.673182	0.504185	0.123343	1.13 [0.79 - 1.62]
GENE	B3GAT2	beta-1,3-glucuronyltransferase 2 (glucuronosyltransferase S)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	239144_at	38	0.447368	0.0479373	0.479097	-0.898424	0.259619	-0.591329	0.55 [0.20 - 1.55]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203452_at	30	0.866667	0.00171961	0.0400054	1.74129	0.0684889	1.10747	3.03 [0.92 - 9.96]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	35179_at	30	0.866667	0.00171961	0.0400054	1.74129	0.0678129	1.48208	4.40 [0.90 - 21.60]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1721432	165	0.145455	0.0835895	-	0.725098	0.367523	0.215107	1.24 [0.78 - 1.98]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1721432	165	0.581818	0.0238204	0.302768	0.794415	0.146629	0.505533	1.66 [0.84 - 3.28]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203452_at	163	0.496933	0.258619	-	0.222907	0.978085	-0.010889	0.99 [0.45 - 2.15]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	35179_at	163	0.306748	0.0318434	0.368635	0.484296	0.470346	0.313032	1.37 [0.58 - 3.20]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	35179_at	79	0.810127	0.102986	-	0.553847	0.262127	0.598004	1.82 [0.64 - 5.17]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203452_at	79	0.759494	0.0608991	-	0.589437	0.402706	0.333863	1.40 [0.64 - 3.05]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	35179_at	58	0.103448	0.0294627	0.349993	0.994612	0.745152	0.0554303	1.06 [0.76 - 1.48]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203452_at	58	0.103448	0.166089	-	0.644059	0.778549	0.0398323	1.04 [0.79 - 1.37]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	35179_at	34	0.117647	2.46711e-06	0.000124807	-2.58956	0.0286036	-0.60932	0.54 [0.32 - 0.94]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203452_at	34	0.794118	0.0294866	0.350184	-1.08393	0.151842	-0.560151	0.57 [0.27 - 1.23]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203452_at	158	0.85443	0.207865	-	-0.466856	0.961762	-0.0261468	0.97 [0.33 - 2.84]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	35179_at	158	0.746835	0.0747686	-	0.437979	0.560344	0.379778	1.46 [0.41 - 5.25]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	35179_at	53	0.735849	0.0598757	-	0.715579	0.889759	0.0666299	1.07 [0.42 - 2.74]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203452_at	53	0.245283	0.000956682	0.0245553	-1.1912	0.0192153	-0.577257	0.56 [0.35 - 0.91]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	35179_at	53	0.735849	0.0663218	-	0.66288	0.68791	0.18552	1.20 [0.49 - 2.98]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203452_at	53	0.245283	0.000133543	0.00451605	-1.39714	0.00534413	-0.744212	0.48 [0.28 - 0.80]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203452_at	180	0.166667	0.0272077	0.331663	-0.551748	0.45835	-0.102376	0.90 [0.69 - 1.18]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	35179_at	180	0.116667	0.00665462	0.118302	-0.775192	0.116415	-0.554336	0.57 [0.29 - 1.15]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	35179_at	559	0.579606	0.00749377	0.129647	-0.572044	0.289773	-0.256857	0.77 [0.48 - 1.24]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203452_at	559	0.277281	0.00249145	0.0541941	-0.637893	0.0527635	-0.417942	0.66 [0.43 - 1.01]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	35179_at	77	0.896104	0.348997	-	-0.398592	0.855382	-0.0553378	0.95 [0.52 - 1.72]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203452_at	77	0.714286	0.00749204	0.129624	0.713411	0.504485	0.117702	1.12 [0.80 - 1.59]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203452_at	70	0.171429	0.0248859	0.312044	-0.745437	0.0983659	-0.815194	0.44 [0.17 - 1.16]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	35179_at	70	0.228571	0.0046402	0.0892315	-0.833781	0.126537	-0.927915	0.40 [0.12 - 1.30]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35179_at	50	0.56	0.0146202	0.213969	-0.888101	0.14679	-0.684275	0.50 [0.20 - 1.27]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203452_at	74	0.756757	0.161497	-	-0.514121	0.608879	-0.120095	0.89 [0.56 - 1.40]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	35179_at	74	0.675676	0.0240986	0.305208	0.655876	0.547626	0.343563	1.41 [0.46 - 4.32]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	35179_at	67	0.164179	0.171611	-	15.3052	0.417266	1.02318	2.78 [0.23 - 32.96]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203452_at	67	0.58209	0.212068	-	0.821402	0.516483	0.768718	2.16 [0.21 - 22.00]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203452_at	115	0.843478	0.376923	-	-0.888288	0.937946	-0.0363048	0.96 [0.39 - 2.41]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	35179_at	115	0.773913	0.00585924	0.107162	1.3647	0.138687	1.81832	6.16 [0.56 - 68.39]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35179_at	158	0.835443	0.138604	-	-0.698798	0.421991	-0.309446	0.73 [0.34 - 1.56]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35179_at	76	0.184211	0.273352	-	-0.630163	0.742408	-0.235159	0.79 [0.19 - 3.21]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	35179_at	204	0.480392	0.200761	-	-0.176976	0.75003	-0.0757629	0.93 [0.58 - 1.48]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203452_at	204	0.147059	0.0038689	0.0772436	-0.574294	0.22243	-0.205326	0.81 [0.59 - 1.13]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	35179_at	87	0.758621	0.0700698	-	0.703381	0.233599	0.59982	1.82 [0.68 - 4.89]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203452_at	87	0.896552	0.053324	-	0.92558	0.439496	0.376287	1.46 [0.56 - 3.78]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203452_at	87	0.896552	0.053324	-	0.92558	0.439496	0.376287	1.46 [0.56 - 3.78]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	35179_at	87	0.758621	0.0700698	-	0.703381	0.233599	0.59982	1.82 [0.68 - 4.89]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203452_at	77	0.61039	0.068298	-	0.997789	0.943635	-0.0405576	0.96 [0.31 - 2.96]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	35179_at	77	0.103896	0.0174968	0.243635	-1.50706	0.411955	-0.620242	0.54 [0.12 - 2.37]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203452_at	77	0.103896	0.0219782	0.286297	-1.45437	0.414323	-0.55357	0.57 [0.15 - 2.17]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	35179_at	77	0.103896	0.0892125	-	-1.07194	0.689463	-0.260227	0.77 [0.22 - 2.76]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203452_at	136	0.889706	2.46114e-05	0.00100639	1.76518	0.203199	0.391514	1.48 [0.81 - 2.70]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	35179_at	136	0.897059	0.0396033	0.424964	1.11059	0.637379	-0.251682	0.78 [0.27 - 2.21]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203452_at	200	0.15	0.000113602	0.00391826	-1.17564	0.184891	-0.285737	0.75 [0.49 - 1.15]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	35179_at	200	0.62	0.121994	-	0.452716	0.275367	0.644229	1.90 [0.60 - 6.06]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14398	60	0.183333	0.312382	-	0.542281	0.92614	0.035479	1.04 [0.49 - 2.19]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14398	60	0.666667	0.106161	-	-0.728268	0.87355	0.0594181	1.06 [0.51 - 2.21]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	9130	155	0.470968	0.00223597	0.0496222	-0.894443	0.060227	-0.435031	0.65 [0.41 - 1.02]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203452_at	286	0.171329	0.103014	-	-0.381628	0.649902	-0.0562454	0.95 [0.74 - 1.21]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	35179_at	286	0.234266	0.0212654	0.279766	-0.481632	0.451323	-0.237815	0.79 [0.42 - 1.46]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	35179_at	159	0.849057	0.150187	-	0.538423	0.978275	0.0144226	1.01 [0.36 - 2.86]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203452_at	159	0.459119	0.0247517	0.310886	-0.851429	0.740079	-0.0674472	0.93 [0.63 - 1.39]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203452_at	159	0.408805	0.0999083	-	-0.515665	0.988796	0.00247784	1.00 [0.71 - 1.42]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	35179_at	159	0.572327	0.0654472	-	0.578544	0.361649	0.490137	1.63 [0.57 - 4.68]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203452_at	159	0.459119	0.0244927	0.308642	-0.719192	0.575294	-0.0962344	0.91 [0.65 - 1.27]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	35179_at	159	0.849057	0.0436963	0.452291	0.8155	0.580495	0.351556	1.42 [0.41 - 4.94]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	35179_at	54	0.87037	0.170596	-	-15.3578	0.283857	-1.01068	0.36 [0.06 - 2.31]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203452_at	54	0.166667	0.20656	-	-1.00257	0.347738	-0.747928	0.47 [0.10 - 2.26]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	35179_at	117	0.777778	0.05081	-	0.652179	0.336608	0.359495	1.43 [0.69 - 2.98]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203452_at	117	0.777778	0.0275686	0.334643	0.722347	0.208929	0.488091	1.63 [0.76 - 3.49]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	35179_at	117	0.777778	0.0917562	-	0.680429	0.351615	0.414091	1.51 [0.63 - 3.62]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203452_at	117	0.136752	0.22156	-	0.873556	0.432553	0.372238	1.45 [0.57 - 3.68]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	35179_at	117	0.777778	0.0581832	-	0.732825	0.369248	0.390409	1.48 [0.63 - 3.46]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203452_at	117	0.777778	0.0275686	0.334643	0.722347	0.208929	0.488091	1.63 [0.76 - 3.49]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203452_at	117	0.777778	0.0513329	-	0.753391	0.329587	0.453712	1.57 [0.63 - 3.92]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	35179_at	117	0.777778	0.05081	-	0.652179	0.336608	0.359495	1.43 [0.69 - 2.98]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203452_at	236	0.898305	0.00648769	0.115997	0.889676	0.481428	0.128949	1.14 [0.79 - 1.63]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	35179_at	236	0.898305	0.00829092	0.140079	0.897728	0.3459	0.469499	1.60 [0.60 - 4.25]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	35179_at	249	0.875502	2.27603e-05	0.000938171	1.03996	0.129786	0.607057	1.84 [0.84 - 4.02]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203452_at	249	0.891566	0.000254699	0.00792952	0.955327	0.414482	0.117685	1.12 [0.85 - 1.49]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	35179_at	62	0.870968	0.207315	-	0.708	0.813121	-0.0494991	0.95 [0.63 - 1.43]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203452_at	125	0.424	0.142236	-	0.485114	0.748565	0.114422	1.12 [0.56 - 2.26]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	35179_at	125	0.28	0.113774	-	0.834948	0.242437	0.593113	1.81 [0.67 - 4.89]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	35179_at	125	0.28	0.0805481	-	0.708367	0.847528	0.077439	1.08 [0.49 - 2.38]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	35179_at	54	0.87037	0.226539	-	0.791095	0.83872	-0.0518058	0.95 [0.58 - 1.56]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203452_at	125	0.44	0.0262004	0.323248	0.993287	0.171938	0.629679	1.88 [0.76 - 4.63]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203452_at	54	0.12963	0.113552	-	-1.25448	0.750038	-0.105789	0.90 [0.47 - 1.72]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203452_at	62	0.870968	0.207315	-	0.708	0.863165	-0.0461999	0.95 [0.56 - 1.61]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203452_at	198	0.833333	0.16234	-	0.451427	0.932544	-0.00999848	0.99 [0.79 - 1.25]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	35179_at	198	0.459596	0.119599	-	-0.415632	0.915632	0.0268134	1.03 [0.63 - 1.69]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	35179_at	198	0.606061	0.0601312	-	0.394285	0.320948	0.189343	1.21 [0.83 - 1.76]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203452_at	198	0.853535	0.260186	-	0.373672	0.78814	0.0306669	1.03 [0.82 - 1.29]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	35179_at	198	0.858586	0.0931142	-	-0.844051	0.786959	0.0635738	1.07 [0.67 - 1.69]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203452_at	198	0.863636	0.0841214	-	0.473218	0.988255	0.00142307	1.00 [0.83 - 1.21]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203452_at	62	0.83871	0.447885	-	-0.773705	0.892336	-0.116604	0.89 [0.16 - 4.82]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203452_at	51	0.764706	0.0458583	0.46614	1.63843	0.939005	-0.102714	0.90 [0.06 - 12.53]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	35179_at	51	0.784314	0.235924	-	-15.4008	0.783184	-0.454824	0.63 [0.02 - 16.20]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	35179_at	62	0.887097	0.0818992	-	1.10548	0.503184	0.639549	1.90 [0.29 - 12.33]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203452_at	145	0.144828	0.0940556	-	1.15421	0.811276	0.204227	1.23 [0.23 - 6.56]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	35179_at	177	0.225989	0.0645503	-	0.665377	0.538751	0.36734	1.44 [0.45 - 4.66]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203452_at	177	0.152542	0.052017	-	0.978127	0.585205	0.372124	1.45 [0.38 - 5.52]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	35179_at	177	0.225989	0.0581065	-	0.574931	0.603936	0.267719	1.31 [0.48 - 3.59]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	35179_at	145	0.103448	0.176992	-	-0.59619	0.856825	-0.136197	0.87 [0.20 - 3.83]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203452_at	177	0.316384	0.0642553	-	0.499577	0.607845	0.305589	1.36 [0.42 - 4.36]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203452_at	226	0.672566	0.0275026	0.334099	0.616433	0.282421	0.157029	1.17 [0.88 - 1.56]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	35179_at	226	0.823009	0.160104	-	-0.650856	0.85232	0.0653642	1.07 [0.54 - 2.12]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	35179_at	55	0.127273	0.0852158	-	-0.864321	0.657023	-0.405213	0.67 [0.11 - 3.99]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	35179_at	55	0.709091	0.0744701	-	-1.22305	0.794687	-0.266722	0.77 [0.10 - 5.71]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	35179_at	49	0.714286	0.113244	-	-1.50807	0.463781	-0.851737	0.43 [0.04 - 4.17]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203452_at	55	0.581818	0.0704363	-	-0.986596	0.502208	-0.565619	0.57 [0.11 - 2.96]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203452_at	55	0.581818	0.0991311	-	-0.828417	0.423257	-0.572098	0.56 [0.14 - 2.29]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203452_at	49	0.571429	0.0311041	0.362921	-1.52331	0.150092	-1.16059	0.31 [0.06 - 1.52]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	35179_at	63	0.587302	0.190891	-	0.439753	0.714729	0.104529	1.11 [0.63 - 1.94]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203452_at	63	0.603175	0.0392833	0.422762	0.685385	0.243035	0.318886	1.38 [0.81 - 2.35]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12408653_3p_s_at	28	0.392857	0.192676	-	0.773316	0.949703	-0.0196394	0.98 [0.53 - 1.81]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	35179_at	82	0.402439	0.083515	-	0.636669	0.142304	0.622116	1.86 [0.81 - 4.28]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	35179_at	84	0.464286	0.0489252	0.485137	-0.569111	0.917968	0.0245561	1.02 [0.64 - 1.64]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203452_at	79	0.78481	0.00100022	0.0254899	-1.25458	0.298457	-0.16413	0.85 [0.62 - 1.16]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	35179_at	79	0.772152	0.141382	-	-0.488883	0.407246	-0.290543	0.75 [0.38 - 1.49]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203452_at	104	0.663462	0.0485781	0.483023	-0.771946	0.269952	-0.138267	0.87 [0.68 - 1.11]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	35179_at	104	0.855769	0.156455	-	0.557474	0.659669	0.249641	1.28 [0.42 - 3.90]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P36140	117	0.521368	0.00224241	0.0497387	-0.904453	0.00546724	-0.921927	0.40 [0.21 - 0.76]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203452_at	204	0.578431	0.0577796	-	0.68683	0.524968	0.467942	1.60 [0.38 - 6.76]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203452_at	204	0.769608	0.0420354	0.441383	0.587869	0.0849655	0.947521	2.58 [0.88 - 7.58]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	35179_at	204	0.171569	0.0978655	-	1.14818	0.483702	0.525863	1.69 [0.39 - 7.37]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	35179_at	204	0.117647	0.0535622	-	1.29809	0.41305	0.460093	1.58 [0.53 - 4.77]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	35179_at	178	0.101124	0.0334778	0.38104	-0.604831	0.751501	-0.0890968	0.91 [0.53 - 1.59]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200003650	41	0.219512	0.254966	-	0.691846	0.734227	0.119933	1.13 [0.56 - 2.25]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	35179_at	111	0.27027	0.0947038	-	0.539837	0.397313	0.318773	1.38 [0.66 - 2.88]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203452_at	111	0.873874	0.0327582	0.375616	0.701735	0.938963	-0.0191548	0.98 [0.60 - 1.60]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203452_at	90	0.788889	0.0293585	0.349161	0.829718	0.273961	0.682718	1.98 [0.58 - 6.73]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	35179_at	90	0.722222	0.236481	-	-0.490943	0.979721	0.0162289	1.02 [0.29 - 3.55]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	35179_at	90	0.577778	0.130308	-	0.556673	0.681618	0.295956	1.34 [0.33 - 5.53]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203452_at	90	0.166667	0.0540986	-	-0.697698	0.890751	0.077804	1.08 [0.36 - 3.28]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5542	50	0.14	0.0620551	-	15.3027	0.846763	0.0943725	1.10 [0.42 - 2.86]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203452_at	138	0.884058	0.0236616	0.301371	-1.14557	0.540631	-0.0888491	0.91 [0.69 - 1.22]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	35179_at	138	0.898551	0.0646882	-	-0.95656	0.287443	-0.201544	0.82 [0.56 - 1.19]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203452_at	129	0.48062	0.0560462	-	0.47775	0.1344	0.199176	1.22 [0.94 - 1.58]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	35179_at	129	0.75969	0.0113681	0.177737	0.652325	0.171983	0.452212	1.57 [0.82 - 3.01]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34178	56	0.5	0.0501798	-	-0.692665	0.858776	-0.0690412	0.93 [0.44 - 2.00]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16273	56	0.785714	0.134791	-	-0.715909	0.901374	-0.0640965	0.94 [0.34 - 2.58]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34178	56	0.517857	0.0314954	0.365953	-0.823601	0.478795	-0.283972	0.75 [0.34 - 1.65]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16273	56	0.767857	0.0383017	0.415948	-1.19457	0.524583	-0.342988	0.71 [0.25 - 2.04]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	35179_at	278	0.643885	0.0102346	0.164301	0.484009	0.238399	0.251165	1.29 [0.85 - 1.95]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203452_at	278	0.107914	0.0457106	0.465205	-0.531777	0.74319	0.069261	1.07 [0.71 - 1.62]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203452_at	133	0.691729	0.0630164	-	0.44805	0.0695934	0.380942	1.46 [0.97 - 2.21]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	35179_at	133	0.87218	0.0028143	0.0598219	0.856791	0.00620069	0.58939	1.80 [1.18 - 2.75]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7216	81	0.790123	0.0524509	-	0.98412	0.783664	0.152334	1.16 [0.39 - 3.46]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	35179_at	185	0.286486	0.0021378	0.0478348	-0.567462	0.0123273	-0.591705	0.55 [0.35 - 0.88]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203452_at	185	0.875676	0.00765789	0.131821	-0.668269	0.0257608	-0.490978	0.61 [0.40 - 0.94]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	35179_at	185	0.113514	0.00309667	0.0646212	-0.731434	0.0152585	-0.631161	0.53 [0.32 - 0.89]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203452_at	185	0.875676	0.0120194	0.185255	-0.706722	0.0809603	-0.416614	0.66 [0.41 - 1.05]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P36140	110	0.554545	0.00400104	0.0793378	0.652613	0.0832015	0.409311	1.51 [0.95 - 2.39]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P36140	110	0.163636	0.0530186	-	-0.658387	0.539645	-0.189316	0.83 [0.45 - 1.52]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203452_at	80	0.3125	0.115292	-	0.852639	0.235094	0.226178	1.25 [0.86 - 1.82]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	35179_at	80	0.1125	0.0275636	0.334601	-1.21164	0.476559	-0.264744	0.77 [0.37 - 1.59]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:345326	59	0.220339	0.149855	-	1.03666	0.745818	0.319771	1.38 [0.20 - 9.52]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203452_at	38	0.578947	0.000832739	0.0218491	1.54672	0.131561	0.879824	2.41 [0.77 - 7.56]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	35179_at	38	0.578947	0.000212839	0.00678497	1.75801	0.0159567	2.09797	8.15 [1.48 - 44.89]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203452_at	140	0.871429	0.011663	0.181159	0.91863	0.0869533	0.882895	2.42 [0.88 - 6.65]
GENE	B3GAT3	beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	35179_at	140	0.878571	0.0256128	0.318271	0.851549	0.230132	0.883336	2.42 [0.57 - 10.24]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219326_s_at	30	0.133333	0.0504926	-	-1.08317	0.649854	-0.259138	0.77 [0.25 - 2.36]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1711102	165	0.775758	0.107798	-	0.432897	0.298938	0.385655	1.47 [0.71 - 3.04]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1711102	165	0.206061	0.130789	-	-0.571318	0.913013	0.0601804	1.06 [0.36 - 3.13]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219326_s_at	163	0.736196	0.369758	-	-0.205946	0.588193	-0.0951824	0.91 [0.64 - 1.28]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	222870_s_at	163	0.668712	0.118059	-	-0.33773	0.790316	0.0323124	1.03 [0.81 - 1.31]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	224154_at	163	0.760736	0.0590028	-	-0.475754	0.63132	0.370532	1.45 [0.32 - 6.58]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219326_s_at	79	0.898734	0.0711978	-	-1.22717	0.526415	-0.145421	0.86 [0.55 - 1.36]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	224154_at	79	0.822785	0.0292209	0.34806	0.740397	0.899513	0.11105	1.12 [0.20 - 6.26]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222870_s_at	79	0.139241	0.0886348	-	0.86593	0.287875	0.279078	1.32 [0.79 - 2.21]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219326_s_at	58	0.155172	0.139662	-	-0.545795	0.408129	-0.144106	0.87 [0.62 - 1.22]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219326_s_at	34	0.676471	0.0733505	-	0.72158	0.321391	0.215431	1.24 [0.81 - 1.90]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219326_s_at	158	0.734177	0.147446	-	-0.408364	0.606395	-0.149198	0.86 [0.49 - 1.52]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219326_s_at	53	0.471698	0.0601315	-	0.717137	0.521809	0.375415	1.46 [0.46 - 4.59]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219326_s_at	53	0.471698	0.0241756	0.305881	0.815711	0.299829	0.565339	1.76 [0.60 - 5.12]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219326_s_at	180	0.105556	0.102847	-	-0.50087	0.755199	-0.043176	0.96 [0.73 - 1.26]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	224154_at	180	0.272222	0.0896044	-	0.43429	0.821662	0.0199732	1.02 [0.86 - 1.21]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	222870_s_at	180	0.138889	0.0301792	0.355678	-0.596562	0.102419	-0.389975	0.68 [0.42 - 1.08]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219326_s_at	559	0.73703	0.0668394	-	-0.442007	0.748196	0.0586562	1.06 [0.74 - 1.52]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	224154_at	559	0.49195	0.0413134	0.436565	-0.414083	0.433443	-0.0832806	0.92 [0.75 - 1.13]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222870_s_at	559	0.887299	0.0869163	-	-0.706169	0.441011	-0.146174	0.86 [0.60 - 1.25]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219326_s_at	77	0.415584	0.0874325	-	-0.446885	0.236581	-0.248832	0.78 [0.52 - 1.18]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	224154_at	77	0.61039	0.158158	-	-0.37614	0.971745	-0.00476553	1.00 [0.76 - 1.30]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	222870_s_at	77	0.675325	0.187799	-	-0.371884	0.839687	-0.0460057	0.96 [0.61 - 1.49]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219326_s_at	70	0.314286	0.267963	-	-0.309458	0.920555	-0.042983	0.96 [0.41 - 2.23]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	224154_at	70	0.142857	0.107114	-	-0.555412	0.174774	-1.93539	0.14 [0.01 - 2.36]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222870_s_at	70	0.128571	0.0473668	0.475576	-0.710036	0.329329	-0.222858	0.80 [0.51 - 1.25]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219326_s_at	74	0.162162	0.00111733	0.0279665	-1.07866	0.0303159	-0.549526	0.58 [0.35 - 0.95]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	222870_s_at	74	0.581081	0.159223	-	-0.428939	0.992692	-0.00276443	1.00 [0.55 - 1.80]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	224154_at	74	0.756757	0.234958	-	-0.436186	0.840046	0.0369872	1.04 [0.72 - 1.49]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219326_s_at	67	0.731343	0.081118	-	-15.4859	0.412268	-0.553008	0.58 [0.15 - 2.16]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	224154_at	67	0.283582	0.0512694	-	15.5897	0.576567	-0.972835	0.38 [0.01 - 11.49]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222870_s_at	67	0.686567	0.0460746	0.467503	-15.6081	0.422643	-0.578674	0.56 [0.14 - 2.31]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219326_s_at	115	0.286957	0.0603874	-	1.72336	0.21285	0.818971	2.27 [0.63 - 8.23]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	224154_at	115	0.356522	0.0204957	0.272612	2.03536	0.265149	0.735583	2.09 [0.57 - 7.61]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222870_s_at	115	0.791304	0.138773	-	0.804511	0.996414	0.00417575	1.00 [0.16 - 6.20]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	224154_at	204	0.107843	0.182496	-	-0.300609	0.815703	-0.0153583	0.98 [0.87 - 1.12]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222870_s_at	204	0.127451	0.0113665	0.177719	0.524658	0.0335509	0.419323	1.52 [1.03 - 2.24]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219326_s_at	204	0.455882	0.19398	-	0.180242	0.527507	0.0545349	1.06 [0.89 - 1.25]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219326_s_at	87	0.103448	0.035706	0.397469	-1.00601	0.818789	0.0662495	1.07 [0.61 - 1.88]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	224154_at	87	0.126437	0.129485	-	-0.686113	0.645668	-0.564396	0.57 [0.05 - 6.31]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	224154_at	87	0.126437	0.129485	-	-0.686113	0.645668	-0.564396	0.57 [0.05 - 6.31]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222870_s_at	87	0.149425	0.118666	-	1.09227	0.389979	0.371091	1.45 [0.62 - 3.38]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222870_s_at	87	0.149425	0.118666	-	1.09227	0.389979	0.371091	1.45 [0.62 - 3.38]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219326_s_at	87	0.103448	0.035706	0.397469	-1.00601	0.818789	0.0662495	1.07 [0.61 - 1.88]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	224154_at	77	0.675325	0.00731078	0.127206	-15.7329	0.0253057	-4.44651	0.01 [0.00 - 0.58]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219326_s_at	77	0.25974	0.188793	-	-0.826894	0.692988	-0.206199	0.81 [0.29 - 2.26]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222870_s_at	77	0.155844	0.161665	-	15.2877	0.894986	-0.0969807	0.91 [0.22 - 3.83]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222870_s_at	77	0.428571	0.0270484	0.330342	-1.24812	0.480144	-0.469661	0.63 [0.17 - 2.30]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	224154_at	77	0.38961	0.00317583	0.0659477	-1.99084	0.0109113	-6.00581	0.00 [0.00 - 0.25]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219326_s_at	77	0.25974	0.0496481	0.489509	-1.04696	0.335476	-0.46525	0.63 [0.24 - 1.62]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219326_s_at	136	0.205882	0.031172	0.363449	-0.956572	0.0855707	-0.459746	0.63 [0.37 - 1.07]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219326_s_at	200	0.76	0.0414359	0.437386	-0.931717	0.238048	-0.47738	0.62 [0.28 - 1.37]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2980	60	0.2	0.11586	-	0.929151	0.948224	-0.015176	0.98 [0.62 - 1.56]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2980	60	0.316667	8.84369e-05	0.00314268	-1.40061	0.14869	-0.502021	0.61 [0.31 - 1.20]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219326_s_at	286	0.713287	0.0274825	0.333933	-0.521442	0.0315764	-0.264733	0.77 [0.60 - 0.98]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219326_s_at	159	0.295597	0.00696547	0.12255	1.21562	0.0326	0.840036	2.32 [1.07 - 5.01]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219326_s_at	159	0.295597	0.0209048	0.276429	0.983408	0.0597074	0.733342	2.08 [0.97 - 4.47]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219326_s_at	159	0.566038	0.0148596	0.216516	0.902912	0.0337105	0.9826	2.67 [1.08 - 6.62]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222870_s_at	159	0.886792	0.00111279	0.0278714	1.17484	0.114576	0.653317	1.92 [0.85 - 4.33]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222870_s_at	159	0.899371	8.83783e-07	4.85532e-05	1.63068	0.0138712	1.0223	2.78 [1.23 - 6.28]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222870_s_at	159	0.899371	5.37569e-05	0.00202214	1.53638	0.0521188	0.942469	2.57 [0.99 - 6.64]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224154_at	159	0.603774	0.0628548	-	-0.647659	0.592525	-0.0985396	0.91 [0.63 - 1.30]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224154_at	159	0.603774	0.0888267	-	-0.593856	0.446851	-0.140789	0.87 [0.60 - 1.25]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	224154_at	159	0.603774	0.116245	-	-0.641822	0.615973	-0.108353	0.90 [0.59 - 1.37]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219326_s_at	54	0.185185	0.0150073	0.218079	-1.64106	0.776451	-0.188237	0.83 [0.23 - 3.04]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219326_s_at	117	0.871795	0.206957	-	-0.758038	0.455034	-0.157863	0.85 [0.56 - 1.29]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219326_s_at	117	0.102564	0.00222992	0.0495125	-1.27371	0.0808033	-0.513064	0.60 [0.34 - 1.06]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219326_s_at	117	0.871795	0.206957	-	-0.758038	0.455034	-0.157863	0.85 [0.56 - 1.29]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219326_s_at	117	0.444444	0.120076	-	0.604286	0.658487	-0.112504	0.89 [0.54 - 1.47]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219326_s_at	236	0.355932	0.019759	0.265661	-0.621213	0.0607374	-0.50302	0.60 [0.36 - 1.02]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	224154_at	236	0.898305	1.90944e-05	0.000801151	1.28519	0.911171	0.0192623	1.02 [0.73 - 1.43]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	222870_s_at	236	0.101695	0.178689	-	-0.509223	0.470082	-0.288647	0.75 [0.34 - 1.64]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219326_s_at	249	0.11245	0.0131843	0.198361	-0.689924	0.0680012	-0.413943	0.66 [0.42 - 1.03]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	224154_at	249	0.899598	0.0428966	0.447069	0.600002	0.777492	-0.037874	0.96 [0.74 - 1.25]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	222870_s_at	249	0.831325	0.189214	-	-0.436422	0.751901	-0.0988645	0.91 [0.49 - 1.67]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219326_s_at	125	0.136	0.0234892	0.299849	-0.956085	0.155307	-0.565117	0.57 [0.26 - 1.24]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219326_s_at	125	0.144	0.0146952	0.214768	-0.817697	0.293238	-0.306784	0.74 [0.42 - 1.30]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219326_s_at	54	0.833333	0.0672052	-	-15.4398	0.353299	-0.25145	0.78 [0.46 - 1.32]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219326_s_at	62	0.854839	0.118947	-	-1.47544	0.415877	-0.178595	0.84 [0.54 - 1.29]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219326_s_at	198	0.80303	0.0865431	-	0.419148	0.117144	0.278289	1.32 [0.93 - 1.87]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219326_s_at	198	0.19697	0.0576151	-	0.795749	0.211783	0.258897	1.30 [0.86 - 1.95]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219326_s_at	198	0.19697	0.0597155	-	0.856555	0.124474	0.339265	1.40 [0.91 - 2.16]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219326_s_at	51	0.333333	0.0928124	-	15.7477	0.389699	1.33524	3.80 [0.18 - 79.66]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219326_s_at	62	0.290323	0.254308	-	0.857854	0.915496	0.114536	1.12 [0.14 - 9.30]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222870_s_at	177	0.655367	0.00302624	0.0634342	0.781733	0.0902581	0.68101	1.98 [0.90 - 4.34]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	224154_at	177	0.276836	0.0779329	-	0.495693	0.796973	-0.226912	0.80 [0.14 - 4.49]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	224154_at	177	0.276836	0.0761062	-	0.59193	0.867633	0.164988	1.18 [0.17 - 8.21]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219326_s_at	177	0.728814	0.0644408	-	0.532616	0.214456	0.425383	1.53 [0.78 - 3.00]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222870_s_at	177	0.655367	0.00641033	0.114923	0.631477	0.105428	0.565361	1.76 [0.89 - 3.49]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	224154_at	145	0.289655	0.106276	-	0.669856	0.574724	0.623641	1.87 [0.21 - 16.48]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219326_s_at	177	0.740113	0.0558505	-	0.48913	0.517548	0.185716	1.20 [0.69 - 2.11]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222870_s_at	145	0.268966	0.000963036	0.0246922	2.0421	0.0470061	0.986132	2.68 [1.01 - 7.09]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219326_s_at	145	0.731034	0.0468716	0.472498	0.679573	0.229868	0.49937	1.65 [0.73 - 3.72]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	224154_at	226	0.853982	0.0114706	0.178931	0.819296	0.304494	0.104062	1.11 [0.91 - 1.35]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222870_s_at	226	0.809735	0.00188272	0.0431032	0.899804	0.00530157	1.35708	3.88 [1.50 - 10.09]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219326_s_at	226	0.845133	0.00352055	0.0716344	0.891451	0.0812568	0.504118	1.66 [0.94 - 2.92]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222870_s_at	55	0.854545	0.000212816	0.00678433	1.61935	0.0340629	0.943626	2.57 [1.07 - 6.15]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219326_s_at	55	0.872727	0.295855	-	0.577964	0.508226	0.304181	1.36 [0.55 - 3.34]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222870_s_at	55	0.854545	4.57287e-05	0.00175111	1.98933	0.00538763	1.45979	4.31 [1.54 - 12.04]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	224154_at	55	0.781818	0.00890533	0.147912	-15.5419	0.00822429	-4.17656	0.02 [0.00 - 0.34]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222870_s_at	49	0.857143	8.12528e-06	0.00037014	2.27439	0.0387944	1.09573	2.99 [1.06 - 8.46]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	224154_at	49	0.755102	0.0326438	0.374748	-15.5288	0.0259946	-3.96916	0.02 [0.00 - 0.62]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219326_s_at	55	0.872727	0.0972174	-	1.01989	0.626622	0.243419	1.28 [0.48 - 3.40]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219326_s_at	49	0.22449	0.149466	-	-0.85956	0.805827	-0.127656	0.88 [0.32 - 2.44]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	224154_at	55	0.781818	0.0261991	0.323237	-1.95748	0.140072	-2.21822	0.11 [0.01 - 2.07]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	143402	34	0.205882	0.0201388	0.269257	1.62294	0.235799	0.587773	1.80 [0.68 - 4.76]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222870_s_at	63	0.698413	0.0141792	0.209237	-1.05657	0.459503	-0.156073	0.86 [0.57 - 1.29]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219326_s_at	63	0.285714	0.02757	0.334654	-0.756869	0.650905	-0.17928	0.84 [0.38 - 1.82]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	224154_at	63	0.460317	0.0589341	-	-0.635736	0.309095	1.58702	4.89 [0.23 - 104.09]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.48730.1.S2_3p_at	28	0.892857	0.0584863	-	1.51013	0.734785	0.783767	2.19 [0.02 - 204.05]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9664886_3p_s_at	28	0.642857	0.00259868	0.0560809	1.60918	0.0454709	0.50299	1.65 [1.01 - 2.71]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9845237_3p_s_at	28	0.642857	0.116773	-	-1.00635	0.712839	0.691477	2.00 [0.05 - 79.35]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219326_s_at	82	0.719512	0.226417	-	-0.485498	0.867316	-0.11413	0.89 [0.23 - 3.40]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219326_s_at	79	0.683544	0.0500305	-	0.526781	0.110242	0.764334	2.15 [0.84 - 5.49]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219326_s_at	104	0.701923	0.00807965	0.137344	0.86402	0.333911	0.59228	1.81 [0.54 - 6.01]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P500956	117	0.717949	0.0143537	0.211115	0.708488	0.0238861	0.474747	1.61 [1.06 - 2.43]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219326_s_at	204	0.666667	0.000627492	0.0171952	0.901355	0.0168343	0.92013	2.51 [1.18 - 5.34]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222870_s_at	204	0.598039	0.00946377	0.154886	0.948747	0.0168627	1.79496	6.02 [1.38 - 26.24]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	224154_at	204	0.769608	0.0780686	-	-1.02682	0.286937	-0.247757	0.78 [0.49 - 1.23]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222870_s_at	204	0.598039	0.00673458	0.1194	0.726446	0.0488416	1.1093	3.03 [1.01 - 9.14]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	224154_at	204	0.490196	0.0534896	-	-0.532746	0.229564	-0.21141	0.81 [0.57 - 1.14]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219326_s_at	204	0.632353	0.0145806	0.213546	0.874046	0.109608	0.822987	2.28 [0.83 - 6.24]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219326_s_at	178	0.505618	0.11538	-	0.311282	0.6747	0.114251	1.12 [0.66 - 1.91]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200008122	41	0.536585	0.0433198	0.44984	-0.889969	0.0684227	-0.801069	0.45 [0.19 - 1.06]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219326_s_at	111	0.423423	0.195125	-	0.349004	0.995181	0.00121204	1.00 [0.68 - 1.48]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222870_s_at	111	0.288288	0.00499419	0.0945564	0.94492	0.217653	0.348971	1.42 [0.81 - 2.47]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	224154_at	111	0.828829	0.153669	-	0.460679	0.863895	-0.022813	0.98 [0.75 - 1.27]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219326_s_at	90	0.866667	0.00562051	0.103737	1.10319	0.374028	0.330076	1.39 [0.67 - 2.88]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219326_s_at	90	0.888889	0.049189	0.486737	0.806503	0.740382	0.110569	1.12 [0.58 - 2.15]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3473	50	0.42	0.0679389	-	1.00671	0.117054	0.743439	2.10 [0.83 - 5.33]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	4057	50	0.16	0.0428971	0.447073	15.3522	0.534793	0.224927	1.25 [0.62 - 2.55]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	224154_at	138	0.202899	0.0309532	0.361746	-0.565928	0.14976	-5.51119	0.00 [0.00 - 7.30]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222870_s_at	138	0.608696	0.0441284	0.45509	0.482123	0.938667	0.0111103	1.01 [0.76 - 1.34]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219326_s_at	138	0.507246	0.0563646	-	0.459934	0.552443	0.0519015	1.05 [0.89 - 1.25]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219326_s_at	129	0.100775	0.189491	-	-0.474396	0.793453	-0.096934	0.91 [0.44 - 1.88]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18411	56	0.125	1.96492e-05	0.000822067	-2.14044	0.614767	-0.142113	0.87 [0.50 - 1.51]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8110	56	0.178571	0.0547969	-	1.02974	0.817305	0.0565036	1.06 [0.66 - 1.71]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18411	56	0.107143	0.00169645	0.0395606	-1.95412	0.683944	-0.113991	0.89 [0.52 - 1.54]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8110	56	0.178571	0.0132388	0.198965	1.69631	0.677237	0.0997514	1.10 [0.69 - 1.77]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222870_s_at	278	0.255396	0.21522	-	0.274942	0.551492	0.102	1.11 [0.79 - 1.55]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	224154_at	278	0.830935	0.0733594	-	-0.522463	0.256169	-0.671787	0.51 [0.16 - 1.63]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219326_s_at	278	0.730216	0.117121	-	0.314681	0.880643	-0.024043	0.98 [0.71 - 1.34]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219326_s_at	133	0.255639	0.289872	-	-0.267544	0.763836	-0.0302745	0.97 [0.80 - 1.18]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219326_s_at	185	0.145946	0.0107256	0.170179	0.592051	0.334439	0.148689	1.16 [0.86 - 1.57]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219326_s_at	185	0.167568	0.0162466	0.230987	0.588733	0.85774	0.030527	1.03 [0.74 - 1.44]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P500956	110	0.763636	0.00871672	0.145525	0.667781	0.388251	0.155938	1.17 [0.82 - 1.67]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P500956	110	0.854545	0.00196992	0.0447354	1.04481	0.140039	0.308059	1.36 [0.90 - 2.05]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219326_s_at	80	0.7625	0.00213067	0.0477041	1.30103	0.00754398	1.02367	2.78 [1.31 - 5.90]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222870_s_at	38	0.789474	0.341212	-	0.551343	0.754643	0.156115	1.17 [0.44 - 3.11]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219326_s_at	38	0.789474	0.0332252	0.379142	1.17037	0.697762	0.136238	1.15 [0.58 - 2.28]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	224154_at	38	0.342105	0.0814643	-	-0.904683	0.737685	0.124266	1.13 [0.55 - 2.34]
GENE	B3GNT2	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219326_s_at	140	0.892857	0.00661813	0.117799	0.935349	0.993081	-0.00302559	1.00 [0.50 - 1.98]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204856_at	30	0.266667	0.0128276	0.194393	-1.08104	0.130972	-1.14008	0.32 [0.07 - 1.40]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1800082	165	0.109091	0.130716	-	0.762266	0.783869	0.0433481	1.04 [0.77 - 1.42]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1800082	165	0.321212	0.0649937	-	-0.643263	0.715145	-0.0834559	0.92 [0.59 - 1.44]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204856_at	163	0.349693	0.145727	-	-0.29336	0.539216	-0.395888	0.67 [0.19 - 2.38]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204856_at	79	0.21519	0.0189527	0.257931	-0.756538	0.0403276	-1.36771	0.25 [0.07 - 0.94]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204856_at	58	0.12069	0.119193	-	-0.632707	0.844855	-0.0312437	0.97 [0.71 - 1.33]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204856_at	34	0.382353	0.0188804	0.257232	1.03343	0.101924	0.423141	1.53 [0.92 - 2.54]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204856_at	158	0.310127	0.0420548	0.441512	0.556894	0.144952	1.19616	3.31 [0.66 - 16.52]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204856_at	53	0.45283	0.0196537	0.264659	-0.848927	0.218196	-0.367415	0.69 [0.39 - 1.24]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204856_at	53	0.45283	0.033629	0.382172	-0.731078	0.265477	-0.318457	0.73 [0.42 - 1.27]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204856_at	180	0.211111	0.193058	-	-0.303777	0.965867	-0.0062104	0.99 [0.75 - 1.32]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204856_at	559	0.760286	0.0020607	0.0464181	-0.842294	0.147054	-0.212637	0.81 [0.61 - 1.08]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204856_at	77	0.727273	0.239162	-	-0.345633	0.740673	-0.0682524	0.93 [0.62 - 1.40]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204856_at	70	0.114286	0.0575365	-	-0.715342	0.530463	-0.517366	0.60 [0.12 - 3.00]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36832_at	50	0.12	0.0235239	0.300156	-1.02425	0.227513	-1.23721	0.29 [0.04 - 2.16]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204856_at	74	0.851351	0.130205	-	-0.705786	0.750276	0.0696267	1.07 [0.70 - 1.65]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204856_at	67	0.537313	0.0410972	0.435113	1.50613	0.286991	1.80867	6.10 [0.22 - 170.39]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204856_at	115	0.86087	0.0987964	-	0.937707	0.364987	0.449549	1.57 [0.59 - 4.15]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36832_at	158	0.5	0.0291155	0.347215	-0.629957	0.500896	-0.14446	0.87 [0.57 - 1.32]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36832_at	76	0.894737	0.082597	-	1.08257	0.710793	0.171732	1.19 [0.48 - 2.94]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204856_at	204	0.808824	0.063061	-	-0.330303	0.917813	0.00803895	1.01 [0.87 - 1.17]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204856_at	87	0.609195	0.279237	-	0.40634	0.906106	-0.0808368	0.92 [0.24 - 3.53]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204856_at	87	0.609195	0.279237	-	0.40634	0.906106	-0.0808368	0.92 [0.24 - 3.53]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204856_at	77	0.727273	0.0131239	0.197693	1.29203	0.420413	0.66379	1.94 [0.39 - 9.76]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204856_at	77	0.896104	0.014355	0.211129	1.54641	0.630318	0.467654	1.60 [0.24 - 10.72]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204856_at	136	0.235294	0.0211882	0.279054	-0.996177	0.378714	-0.247262	0.78 [0.45 - 1.35]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204856_at	200	0.65	0.0190556	0.258925	0.679151	0.300734	0.246318	1.28 [0.80 - 2.04]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11148	60	0.75	0.024473	0.30847	0.882204	0.343036	0.377225	1.46 [0.67 - 3.18]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11148	60	0.766667	0.000534576	0.0150025	1.27861	0.051169	0.490054	1.63 [1.00 - 2.67]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	19327	155	0.212903	1.43015e-05	0.000617439	-1.15803	0.000813801	-0.301051	0.74 [0.62 - 0.88]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204856_at	286	0.143357	0.280938	-	0.327979	0.909846	0.014572	1.01 [0.79 - 1.31]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204856_at	159	0.899371	0.0259441	0.321084	0.898216	0.649208	0.105202	1.11 [0.71 - 1.75]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204856_at	159	0.144654	0.0641387	-	1.25844	0.252261	0.26517	1.30 [0.83 - 2.05]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204856_at	159	0.899371	0.0113871	0.177959	1.10548	0.10839	0.458256	1.58 [0.90 - 2.77]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204856_at	54	0.388889	0.0450055	0.460723	1.85445	0.120248	1.31573	3.73 [0.71 - 19.60]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204856_at	117	0.880342	0.0987831	-	-1.13888	0.24858	-0.402484	0.67 [0.34 - 1.32]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204856_at	117	0.692308	0.0766268	-	-0.927921	0.397683	-0.383662	0.68 [0.28 - 1.66]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204856_at	117	0.880342	0.0987831	-	-1.13888	0.24858	-0.402484	0.67 [0.34 - 1.32]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204856_at	117	0.692308	0.0168011	0.23664	-1.35532	0.120755	-0.765041	0.47 [0.18 - 1.22]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204856_at	236	0.737288	0.0561931	-	0.530106	0.229422	0.233771	1.26 [0.86 - 1.85]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204856_at	249	0.236948	0.0449434	0.460326	0.575571	0.240568	0.181192	1.20 [0.89 - 1.62]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204856_at	62	0.193548	0.222684	-	1.18681	0.670656	-0.119701	0.89 [0.51 - 1.54]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204856_at	125	0.512	0.0732538	-	0.715434	0.580292	0.329453	1.39 [0.43 - 4.47]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204856_at	125	0.504	0.173027	-	0.40763	0.932129	0.0390297	1.04 [0.42 - 2.55]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204856_at	54	0.888889	0.168393	-	-15.2688	0.702171	-0.130467	0.88 [0.45 - 1.71]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204856_at	198	0.722222	0.0622023	-	0.514702	0.733579	0.0404023	1.04 [0.83 - 1.31]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204856_at	198	0.323232	0.104504	-	-0.353308	0.463002	-0.0675344	0.93 [0.78 - 1.12]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204856_at	198	0.722222	0.0396194	0.425074	0.5351	0.543901	0.0695822	1.07 [0.86 - 1.34]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204856_at	51	0.470588	0.127208	-	-1.54699	0.532385	-0.642122	0.53 [0.07 - 3.95]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204856_at	62	0.870968	0.177259	-	-15.2273	0.769618	-0.202969	0.82 [0.21 - 3.18]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204856_at	145	0.896552	0.101667	-	0.78313	0.770677	0.126926	1.14 [0.48 - 2.67]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204856_at	177	0.751412	0.0313297	0.364671	-0.847009	0.377462	-0.292857	0.75 [0.39 - 1.43]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204856_at	177	0.621469	0.0933224	-	-0.432556	0.758412	-0.0894171	0.91 [0.52 - 1.62]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204856_at	226	0.234513	0.0283183	0.340775	0.869153	0.0900728	0.494097	1.64 [0.93 - 2.90]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204856_at	55	0.163636	0.0471254	0.474078	-0.936651	0.468	-0.420053	0.66 [0.21 - 2.04]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204856_at	55	0.872727	0.130348	-	0.865456	0.997824	-0.00172705	1.00 [0.29 - 3.45]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204856_at	49	0.734694	0.166673	-	0.791396	0.705294	0.284513	1.33 [0.30 - 5.81]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204856_at	63	0.285714	0.184756	-	0.555573	0.744253	-0.185072	0.83 [0.27 - 2.53]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7657171_3p_at	28	0.678571	0.190772	-	-0.835497	0.410058	-1.00431	0.37 [0.03 - 4.00]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g7657171_3p_x_at	28	0.642857	0.0144954	0.212635	-1.70821	0.127386	-3.6235	0.03 [0.00 - 2.82]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204856_at	82	0.768293	0.0782112	-	-0.905719	0.544994	-0.195405	0.82 [0.44 - 1.55]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204856_at	79	0.607595	0.0642598	-	0.494807	0.497701	0.166613	1.18 [0.73 - 1.91]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204856_at	104	0.317308	0.000343649	0.0102721	1.87262	0.00571587	0.807326	2.24 [1.26 - 3.97]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P78980	117	0.897436	0.175077	-	0.547548	0.769691	0.0298005	1.03 [0.84 - 1.26]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204856_at	204	0.740196	2.5536e-05	0.00104025	1.43159	0.000590677	0.84867	2.34 [1.44 - 3.79]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204856_at	204	0.730392	2.87915e-05	0.00115836	1.08938	3.15574e-05	0.783601	2.19 [1.51 - 3.17]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204856_at	178	0.331461	0.0293702	0.349254	0.483847	0.251119	0.226711	1.25 [0.85 - 1.85]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200005657	41	0.756098	0.00427176	0.0835747	1.19434	0.0619058	0.225478	1.25 [0.99 - 1.59]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204856_at	111	0.864865	0.0879129	-	0.569581	0.308586	0.215406	1.24 [0.82 - 1.88]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204856_at	90	0.766667	0.00600617	0.10925	0.896758	0.239032	0.585124	1.80 [0.68 - 4.75]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204856_at	90	0.766667	0.0117168	0.181781	0.93379	0.38415	0.499236	1.65 [0.54 - 5.07]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204856_at	138	0.789855	0.0061795	0.111696	0.714552	0.174473	0.120357	1.13 [0.95 - 1.34]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204856_at	129	0.837209	0.0189507	0.257912	0.667617	0.862685	0.0298084	1.03 [0.73 - 1.44]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3367	56	0.892857	0.381111	-	0.470746	0.904943	0.0146346	1.01 [0.80 - 1.29]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16193	56	0.160714	0.209982	-	-0.528798	0.523661	-0.0766414	0.93 [0.73 - 1.17]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3367	56	0.535714	0.232491	-	-0.409343	0.499309	-0.0829818	0.92 [0.72 - 1.17]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16193	56	0.892857	0.381111	-	0.470746	0.836589	0.024414	1.02 [0.81 - 1.29]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204856_at	278	0.615108	0.121858	-	-0.3105	0.560264	-0.0704017	0.93 [0.74 - 1.18]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204856_at	133	0.879699	0.134943	-	-0.629005	0.770461	-0.0293009	0.97 [0.80 - 1.18]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204856_at	185	0.8	0.016807	0.2367	-0.501008	0.121242	-0.263263	0.77 [0.55 - 1.07]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204856_at	185	0.8	0.0498453	0.490695	-0.445207	0.219526	-0.228748	0.80 [0.55 - 1.15]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P78980	110	0.136364	0.0398341	0.426545	1.37318	0.592924	0.0475254	1.05 [0.88 - 1.25]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P78980	110	0.118182	0.135728	-	0.579609	0.928391	-0.00579487	0.99 [0.88 - 1.13]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204856_at	80	0.7	0.0773705	-	0.771143	0.079917	0.440158	1.55 [0.95 - 2.54]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204856_at	38	0.763158	0.0949007	-	-1.03557	0.999802	0.000135096	1.00 [0.34 - 2.91]
GENE	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204856_at	140	0.107143	0.000206151	0.00659909	-1.24908	0.0132274	-2.39892	0.09 [0.01 - 0.61]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221240_s_at	30	0.366667	0.169778	-	-0.568248	0.804822	0.191938	1.21 [0.26 - 5.55]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1771260	165	0.715151	1.52944e-05	0.000655985	1.02811	0.000682886	1.24982	3.49 [1.70 - 7.18]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1771260	165	0.787879	0.00305871	0.0639823	1.04251	0.00950423	1.34451	3.84 [1.39 - 10.60]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221240_s_at	163	0.699386	0.255163	-	0.238879	0.946427	-0.0593731	0.94 [0.17 - 5.33]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221240_s_at	79	0.177215	0.022831	0.293992	1.13199	0.496355	0.6737	1.96 [0.28 - 13.67]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221240_s_at	58	0.275862	0.0695162	-	-0.548549	0.569484	-0.0944114	0.91 [0.66 - 1.26]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221240_s_at	34	0.529412	0.140734	-	-0.584666	0.768864	-0.0932909	0.91 [0.49 - 1.70]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221240_s_at	158	0.202532	0.0118733	0.183582	-0.639958	0.235787	-1.00042	0.37 [0.07 - 1.92]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221240_s_at	53	0.867925	0.00328539	0.0677706	1.22154	0.0707721	0.693956	2.00 [0.94 - 4.25]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221240_s_at	53	0.867925	0.0069684	0.12259	1.11368	0.260894	0.399335	1.49 [0.74 - 2.99]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221240_s_at	180	0.883333	0.000436434	0.0126139	0.923412	0.97934	0.00479717	1.00 [0.70 - 1.44]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221240_s_at	559	0.724508	0.00673519	0.119408	-0.666293	0.239077	-0.223976	0.80 [0.55 - 1.16]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221240_s_at	77	0.883117	0.0519509	-	0.737965	0.633479	0.130915	1.14 [0.67 - 1.95]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221240_s_at	70	0.814286	0.144887	-	0.468246	0.691324	0.375352	1.46 [0.23 - 9.28]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221240_s_at	74	0.554054	0.00197739	0.0448746	0.87592	0.0819425	0.77234	2.16 [0.91 - 5.17]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221240_s_at	67	0.80597	0.00243601	0.0532113	1.80523	0.0216364	3.4307	30.90 [1.65 - 577.36]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221240_s_at	115	0.356522	0.0207125	0.274638	2.03277	0.451639	0.487026	1.63 [0.46 - 5.78]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221240_s_at	204	0.181373	0.0666389	-	0.329653	0.07122	0.198329	1.22 [0.98 - 1.51]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221240_s_at	87	0.103448	0.00487649	0.0927973	-1.23656	0.591393	-0.486797	0.61 [0.10 - 3.63]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221240_s_at	87	0.103448	0.00487649	0.0927973	-1.23656	0.591393	-0.486797	0.61 [0.10 - 3.63]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221240_s_at	77	0.714286	0.0183291	0.251862	1.40492	0.66324	0.572074	1.77 [0.13 - 23.27]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221240_s_at	77	0.714286	0.00287236	0.0608176	1.54383	0.194621	1.45895	4.30 [0.47 - 39.00]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221240_s_at	136	0.602941	0.344468	-	0.429861	0.999592	-0.000210677	1.00 [0.45 - 2.24]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221240_s_at	200	0.735	0.0157644	0.22601	0.708427	0.311947	0.323475	1.38 [0.74 - 2.59]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8210	60	0.8	0.000959982	0.0246264	1.32393	0.0570729	0.238748	1.27 [0.99 - 1.62]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8210	60	0.733333	0.00564238	0.104053	1.05456	0.0368912	0.257632	1.29 [1.02 - 1.65]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	2742	155	0.412903	0.00151831	0.0360952	0.999252	0.00545027	0.766982	2.15 [1.25 - 3.70]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221240_s_at	286	0.20979	0.0573868	-	-0.414506	0.71319	-0.0677894	0.93 [0.65 - 1.34]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221240_s_at	159	0.188679	0.101529	-	0.838467	0.583858	0.231205	1.26 [0.55 - 2.88]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221240_s_at	159	0.377358	0.0293697	0.349251	0.803427	0.142444	0.659023	1.93 [0.80 - 4.66]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221240_s_at	159	0.377358	0.0592742	-	0.839917	0.331954	0.501031	1.65 [0.60 - 4.54]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221240_s_at	54	0.240741	0.0765624	-	15.4983	0.59545	0.519033	1.68 [0.25 - 11.42]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221240_s_at	117	0.632479	0.0354941	0.395929	0.666221	0.394919	0.41492	1.51 [0.58 - 3.94]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221240_s_at	117	0.854701	0.034177	0.386254	0.909679	0.390414	0.547056	1.73 [0.50 - 6.02]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221240_s_at	117	0.632479	0.0354941	0.395929	0.666221	0.394919	0.41492	1.51 [0.58 - 3.94]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221240_s_at	117	0.632479	0.0325281	0.373869	0.789141	0.522214	0.383166	1.47 [0.45 - 4.74]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221240_s_at	236	0.881356	0.183181	-	-0.771267	0.761812	0.130147	1.14 [0.49 - 2.64]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221240_s_at	249	0.168675	0.0909333	-	0.560287	0.43667	0.250954	1.29 [0.68 - 2.42]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221240_s_at	125	0.632	0.100274	-	0.622434	0.553666	0.330572	1.39 [0.47 - 4.16]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221240_s_at	125	0.184	0.27617	-	-0.406822	0.867975	-0.0731611	0.93 [0.39 - 2.20]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221240_s_at	54	0.333333	0.0155131	0.223394	15.6995	0.886731	-0.0361679	0.96 [0.59 - 1.59]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221240_s_at	62	0.354839	0.00832533	0.140522	2.23332	0.937709	-0.0162566	0.98 [0.65 - 1.48]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221240_s_at	198	0.792929	0.15446	-	-0.411283	0.926433	-0.0115269	0.99 [0.77 - 1.26]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221240_s_at	198	0.722222	0.133966	-	-0.478869	0.472404	-0.108188	0.90 [0.67 - 1.21]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221240_s_at	198	0.30303	0.141939	-	-0.402925	0.478696	-0.113522	0.89 [0.65 - 1.22]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221240_s_at	51	0.588235	0.305668	-	-1.09059	0.744516	-0.460307	0.63 [0.04 - 10.06]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221240_s_at	62	0.112903	0.00594327	0.108358	-1.53519	0.442049	-0.698567	0.50 [0.08 - 2.95]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221240_s_at	177	0.152542	0.149983	-	-0.482778	0.440626	-0.586916	0.56 [0.13 - 2.47]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221240_s_at	177	0.728814	0.0755422	-	-0.52332	0.223113	-0.816734	0.44 [0.12 - 1.64]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221240_s_at	145	0.255172	0.0979484	-	0.777995	0.844553	0.1759	1.19 [0.21 - 6.92]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221240_s_at	226	0.893805	0.137805	-	-1.0266	0.526699	0.156537	1.17 [0.72 - 1.90]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221240_s_at	55	0.254545	0.0138771	0.205964	-1.06185	0.123354	-2.23458	0.11 [0.01 - 1.84]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221240_s_at	55	0.345455	0.0321398	0.370908	-1.01006	0.108225	-2.65577	0.07 [0.00 - 1.79]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221240_s_at	49	0.244898	0.012494	0.190646	-1.3903	0.278779	-1.8618	0.16 [0.01 - 4.52]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	1535839	34	0.147059	0.0381932	0.41519	-1.06167	0.15216	-1.35938	0.26 [0.04 - 1.65]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	2271314	34	0.794118	0.0396115	0.42502	0.973808	0.231561	1.43452	4.20 [0.40 - 44.02]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221240_s_at	63	0.492063	0.0544404	-	-0.655782	0.634491	0.443512	1.56 [0.25 - 9.70]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13540526_3p_s_at	28	0.678571	0.0144877	0.212552	-1.78359	0.20701	-6.13599	0.00 [0.00 - 29.82]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221240_s_at	82	0.853659	0.000388813	0.0114234	1.31488	0.470703	0.430183	1.54 [0.48 - 4.95]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221240_s_at	79	0.772152	0.0078267	0.134042	0.759847	0.899266	0.0617616	1.06 [0.41 - 2.77]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221240_s_at	104	0.182692	0.267962	-	0.576408	0.675556	0.293749	1.34 [0.34 - 5.31]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P76071	117	0.478632	0.122572	-	0.44944	0.946609	-0.00973675	0.99 [0.74 - 1.32]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221240_s_at	204	0.882353	0.00180551	0.0416442	1.21809	0.174626	0.687929	1.99 [0.74 - 5.37]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221240_s_at	204	0.872549	0.000576686	0.0160038	1.05181	0.0297628	0.842125	2.32 [1.09 - 4.96]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221240_s_at	178	0.426966	0.000593196	0.0163929	-0.672718	0.318741	-0.262684	0.77 [0.46 - 1.29]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221240_s_at	111	0.666667	0.259806	-	0.30288	0.700611	-0.0994741	0.91 [0.55 - 1.50]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221240_s_at	90	0.233333	0.215182	-	0.602527	0.439168	0.639197	1.89 [0.38 - 9.57]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221240_s_at	90	0.233333	0.0805636	-	0.763083	0.499268	0.482045	1.62 [0.40 - 6.56]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221240_s_at	138	0.101449	0.37936	-	-0.314046	0.827988	0.0796045	1.08 [0.53 - 2.22]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221240_s_at	129	0.108527	0.124581	-	0.702221	0.126096	0.582114	1.79 [0.85 - 3.77]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8062	56	0.767857	0.381973	-	-0.351931	0.611515	0.127513	1.14 [0.69 - 1.86]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8062	56	0.5	0.174294	-	0.487293	0.210051	0.327264	1.39 [0.83 - 2.31]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221240_s_at	278	0.769784	0.0699223	-	-0.431958	0.745941	-0.122729	0.88 [0.42 - 1.86]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221240_s_at	133	0.684211	0.00260657	0.056219	0.737793	0.927933	-0.0455943	0.96 [0.36 - 2.57]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221240_s_at	185	0.281081	0.18006	-	0.241294	0.634092	0.119784	1.13 [0.69 - 1.85]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221240_s_at	185	0.854054	0.361982	-	-0.24962	0.97224	0.0096517	1.01 [0.59 - 1.74]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P76071	110	0.181818	0.263324	-	-0.384593	0.81695	0.0664036	1.07 [0.61 - 1.88]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P945355	110	0.372727	0.140973	-	0.465675	0.435005	0.13148	1.14 [0.82 - 1.59]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P76071	110	0.863636	0.0405998	0.431756	0.631484	0.481568	0.154376	1.17 [0.76 - 1.79]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P945355	110	0.527273	0.182234	-	-0.308026	0.846994	-0.0235622	0.98 [0.77 - 1.24]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221240_s_at	80	0.375	0.0321157	0.370723	-0.9346	0.698133	-0.124027	0.88 [0.47 - 1.65]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221240_s_at	38	0.131579	0.0025332	0.054931	-1.55834	0.269259	-0.701534	0.50 [0.14 - 1.72]
GENE	B3GNT4	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221240_s_at	140	0.757143	0.0398744	0.426821	-0.820127	0.344795	-0.601952	0.55 [0.16 - 1.91]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1702609	165	0.884848	0.140597	-	0.499607	0.695564	0.0576644	1.06 [0.79 - 1.41]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1702609	165	0.884848	0.0725751	-	0.793422	0.774235	0.0625679	1.06 [0.69 - 1.63]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	225612_s_at	163	0.760736	0.0602708	-	0.41315	0.155756	0.16069	1.17 [0.94 - 1.47]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	225612_s_at	79	0.886076	0.000780814	0.0206935	1.21453	0.00145174	0.632795	1.88 [1.28 - 2.78]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1554835_a_at	79	0.708861	0.000272012	0.00839433	1.04715	0.00242806	0.654322	1.92 [1.26 - 2.94]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1556134_a_at	79	0.873418	0.4671	-	-0.343752	0.887983	-0.0794138	0.92 [0.31 - 2.79]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	225612_s_at	180	0.888889	0.024848	0.311717	0.644634	0.126996	0.232634	1.26 [0.94 - 1.70]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	225612_s_at	559	0.146691	0.00149882	0.0357111	-0.751647	0.164173	-0.174274	0.84 [0.66 - 1.07]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1554835_a_at	559	0.205725	0.0921453	-	0.512877	0.454341	0.0968651	1.10 [0.85 - 1.42]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1556134_a_at	559	0.37746	0.0072254	0.126061	-0.531897	0.494024	-0.0719453	0.93 [0.76 - 1.14]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	225612_s_at	77	0.493506	0.00107752	0.0271305	0.843324	0.0155797	0.418597	1.52 [1.08 - 2.13]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	225612_s_at	70	0.8	0.0497519	0.490133	0.620716	0.0590047	0.293074	1.34 [0.99 - 1.82]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1554835_a_at	70	0.514286	0.0321895	0.371288	0.572623	0.326157	0.87842	2.41 [0.42 - 13.90]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1556134_a_at	70	0.842857	0.196693	-	0.44977	0.912112	-0.0964234	0.91 [0.16 - 5.03]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	225612_s_at	74	0.554054	0.00318948	0.0661757	0.874533	0.00595385	0.601555	1.82 [1.19 - 2.80]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1556134_a_at	67	0.850746	0.0306539	0.359408	1.46771	0.0938526	6.62469	753.47 [0.32 - 1749162.40]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	225612_s_at	67	0.134328	0.251282	-	15.2203	0.928969	0.0507176	1.05 [0.34 - 3.21]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1554835_a_at	67	0.537313	0.0936254	-	-1.26436	0.524455	-0.80425	0.45 [0.04 - 5.32]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	225612_s_at	115	0.113043	0.0221351	0.287722	-1.27924	0.426372	0.26349	1.30 [0.68 - 2.49]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1554835_a_at	115	0.643478	0.0176639	0.245299	1.24308	0.0619031	0.786315	2.20 [0.96 - 5.01]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1556134_a_at	115	0.591304	0.0145992	0.213745	1.34212	0.211841	1.11809	3.06 [0.53 - 17.70]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1556134_a_at	204	0.588235	0.103489	-	0.229416	0.194763	0.0899939	1.09 [0.96 - 1.25]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	225612_s_at	204	0.607843	1.13835e-05	0.000502394	0.634996	0.000177872	0.263766	1.30 [1.13 - 1.49]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1554835_a_at	204	0.77451	0.00262794	0.0565927	0.501633	0.0111904	0.153937	1.17 [1.04 - 1.31]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	225612_s_at	87	0.344828	0.0889352	-	-0.64403	0.411715	-0.164396	0.85 [0.57 - 1.26]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	225612_s_at	87	0.344828	0.0889352	-	-0.64403	0.411715	-0.164396	0.85 [0.57 - 1.26]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1554835_a_at	87	0.183908	0.00207272	0.0466398	-1.1923	0.229184	-1.21373	0.30 [0.04 - 2.15]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1554835_a_at	87	0.183908	0.00207272	0.0466398	-1.1923	0.229184	-1.21373	0.30 [0.04 - 2.15]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1556134_a_at	87	0.551724	0.0500576	-	0.733622	0.66663	0.359251	1.43 [0.28 - 7.34]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1556134_a_at	87	0.551724	0.0500576	-	0.733622	0.66663	0.359251	1.43 [0.28 - 7.34]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	225612_s_at	77	0.220779	0.120784	-	-0.858897	0.416177	-0.383895	0.68 [0.27 - 1.72]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554835_a_at	77	0.116883	0.000128478	0.00436548	-1.90057	0.0577484	-2.73705	0.06 [0.00 - 1.09]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1556134_a_at	77	0.636364	0.0428462	0.446738	1.09872	0.228325	1.72996	5.64 [0.34 - 94.12]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	225612_s_at	77	0.181818	0.0639984	-	-1.13412	0.304652	-0.564192	0.57 [0.19 - 1.67]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554835_a_at	77	0.116883	1.25471e-06	6.70664e-05	-2.44644	0.00437372	-4.11779	0.02 [0.00 - 0.28]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1556134_a_at	77	0.116883	0.24015	-	15.208	0.590319	0.893686	2.44 [0.09 - 63.26]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1773	60	0.666667	0.0353475	0.394861	0.782845	0.233698	0.246006	1.28 [0.85 - 1.92]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1773	60	0.283333	0.127098	-	-0.60535	0.364673	-0.274786	0.76 [0.42 - 1.38]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12013	155	0.780645	0.00127516	0.0312261	0.896726	0.0233396	0.384175	1.47 [1.05 - 2.05]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225612_s_at	159	0.867925	0.118139	-	0.608491	0.96614	0.0111312	1.01 [0.60 - 1.69]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225612_s_at	159	0.27044	0.0423292	0.44333	-0.644562	0.677683	-0.115413	0.89 [0.52 - 1.54]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225612_s_at	159	0.232704	0.133458	-	-0.578855	0.870145	-0.0516495	0.95 [0.51 - 1.76]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	225612_s_at	236	0.372881	0.0184933	0.253469	-0.625371	0.791295	-0.0550101	0.95 [0.63 - 1.42]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	225612_s_at	249	0.522088	0.0686044	-	-0.393079	0.845634	-0.0340612	0.97 [0.69 - 1.36]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	225612_s_at	177	0.581921	0.085885	-	0.402359	0.323151	0.264606	1.30 [0.77 - 2.20]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1554835_a_at	177	0.768362	0.148742	-	-0.453098	0.634545	0.100736	1.11 [0.73 - 1.68]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	225612_s_at	177	0.898305	0.0850714	-	0.621074	0.448798	0.233472	1.26 [0.69 - 2.31]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1554835_a_at	177	0.768362	0.223184	-	-0.441414	0.692545	0.0965742	1.10 [0.68 - 1.78]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1556134_a_at	177	0.706215	0.134692	-	-0.431175	0.397604	-0.645552	0.52 [0.12 - 2.34]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1556134_a_at	177	0.694915	0.0600251	-	-0.647781	0.493274	-0.599665	0.55 [0.10 - 3.05]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	225612_s_at	145	0.310345	0.118371	-	0.61878	0.684592	0.157277	1.17 [0.55 - 2.50]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1554835_a_at	145	0.42069	0.128015	-	-0.505488	0.963303	0.0137605	1.01 [0.56 - 1.82]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1556134_a_at	145	0.744828	0.00307404	0.0642406	-1.86913	0.0729491	-2.0197	0.13 [0.01 - 1.21]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	225612_s_at	226	0.800885	0.124988	-	0.479643	0.682195	0.147089	1.16 [0.57 - 2.34]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1554835_a_at	226	0.389381	0.0314302	0.365449	-0.602391	0.922141	0.0132611	1.01 [0.78 - 1.32]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1556134_a_at	226	0.110619	0.0182433	0.251021	2.02618	0.425566	0.197152	1.22 [0.75 - 1.98]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	225612_s_at	55	0.890909	0.0361411	0.400615	1.18085	0.467004	0.353979	1.42 [0.55 - 3.70]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1554835_a_at	55	0.509091	0.0445259	0.457651	-0.983445	0.72361	-0.152082	0.86 [0.37 - 2.00]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1556134_a_at	55	0.545455	0.150969	-	0.687524	0.471282	1.06205	2.89 [0.16 - 52.02]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	225612_s_at	49	0.530612	0.025405	0.3165	1.38165	0.160207	0.976793	2.66 [0.68 - 10.38]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1554835_a_at	49	0.510204	0.112343	-	-0.942434	0.432669	-0.449645	0.64 [0.21 - 1.96]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1556134_a_at	49	0.55102	0.0293759	0.3493	1.34937	0.358892	1.68954	5.42 [0.15 - 200.12]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	225612_s_at	55	0.527273	0.0701812	-	0.826287	0.282982	0.481567	1.62 [0.67 - 3.90]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1554835_a_at	55	0.854545	0.0682516	-	0.916156	0.520919	0.239143	1.27 [0.61 - 2.64]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1556134_a_at	55	0.563636	0.1032	-	0.728537	0.456592	1.04461	2.84 [0.18 - 44.47]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	225612_s_at	63	0.52381	0.131662	-	-0.516481	0.515934	-0.172953	0.84 [0.50 - 1.42]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1554835_a_at	63	0.190476	2.30766e-06	0.000117393	-1.64132	0.0155706	-27.074	0.00 [0.00 - 0.01]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1556134_a_at	63	0.238095	0.000642111	0.0175348	-1.15333	0.0412063	-22.8421	0.00 [0.00 - 0.40]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.136414.2.S1_3p_s_at	28	0.25	0.0395524	0.424614	-1.17533	0.169919	-1.2293	0.29 [0.05 - 1.69]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.259656.1.S1_3p_s_at	28	0.321429	0.10723	-	-0.899809	0.148084	0.679098	1.97 [0.79 - 4.95]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.101799.0.A1_3p_s_at	28	0.821429	0.0439685	0.454057	1.26512	0.654511	0.185607	1.20 [0.53 - 2.71]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P18372	117	0.350427	0.00945607	0.15479	0.86551	0.00712563	0.450242	1.57 [1.13 - 2.18]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	225612_s_at	204	0.181373	0.00633601	0.113887	15.361	0.00703108	1.02276	2.78 [1.32 - 5.85]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1554835_a_at	204	0.666667	0.00802385	0.136619	0.938139	0.0167925	0.802044	2.23 [1.16 - 4.30]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1556134_a_at	204	0.436274	5.20715e-05	0.00196569	2.07661	0.00134051	0.894225	2.45 [1.42 - 4.22]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	225612_s_at	204	0.617647	0.0480702	0.479914	0.532771	0.247031	0.334007	1.40 [0.79 - 2.46]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1554835_a_at	204	0.843137	0.00606933	0.110144	0.829459	0.0727095	0.451555	1.57 [0.96 - 2.57]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1556134_a_at	204	0.47549	0.00122832	0.0302676	0.930849	0.00769797	0.531395	1.70 [1.15 - 2.51]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300014940	41	0.878049	0.0198361	0.266393	1.22461	0.0750703	0.46073	1.59 [0.95 - 2.63]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	225612_s_at	111	0.774775	0.0326158	0.374536	-0.760425	0.658495	-0.0768693	0.93 [0.66 - 1.30]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1554835_a_at	111	0.648649	0.10359	-	-0.469304	0.847209	-0.0277457	0.97 [0.73 - 1.29]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1556134_a_at	111	0.873874	0.0228814	0.294443	0.783419	0.807364	0.042431	1.04 [0.74 - 1.47]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	2061	50	0.5	0.034504	0.388674	1.0778	0.307589	0.729279	2.07 [0.51 - 8.42]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	225612_s_at	138	0.543478	0.220159	-	0.294191	0.51602	0.0505671	1.05 [0.90 - 1.23]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1554835_a_at	138	0.818841	0.0277526	0.336155	0.608112	0.448178	0.0581225	1.06 [0.91 - 1.23]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1556134_a_at	138	0.434783	0.11256	-	-0.381126	0.576544	-0.1254	0.88 [0.57 - 1.37]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17376	56	0.892857	0.159908	-	-0.831871	0.437824	-0.092702	0.91 [0.72 - 1.15]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42417	56	0.767857	0.0998642	-	-0.749958	0.531052	-0.0750571	0.93 [0.73 - 1.17]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10072	56	0.642857	0.122614	-	-0.560616	0.385566	-0.099765	0.91 [0.72 - 1.13]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17376	56	0.553571	0.178588	-	-0.483696	0.745046	-0.0414712	0.96 [0.75 - 1.23]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42575	56	0.732143	0.104259	-	-0.650781	0.32502	-0.111957	0.89 [0.72 - 1.12]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	10072	56	0.642857	0.173124	-	-0.514319	0.664697	-0.0530262	0.95 [0.75 - 1.21]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42417	56	0.767857	0.0793207	-	-0.773332	0.272172	-0.12373	0.88 [0.71 - 1.10]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42575	56	0.732143	0.106492	-	-0.66755	0.602846	-0.0628997	0.94 [0.74 - 1.19]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1556134_a_at	278	0.273381	0.00098145	0.025088	-0.650682	0.258274	-0.815727	0.44 [0.11 - 1.82]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	225612_s_at	278	0.158273	0.000830032	0.0217892	1.07158	0.192937	0.120647	1.13 [0.94 - 1.35]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1554835_a_at	278	0.431655	0.133796	-	-0.284653	0.247292	-0.27327	0.76 [0.48 - 1.21]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P18372	110	0.518182	0.0455736	0.464338	-0.462367	0.255959	-0.12474	0.88 [0.71 - 1.09]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P18372	110	0.145455	0.39453	-	-0.32902	0.970699	0.00499126	1.01 [0.77 - 1.31]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	225612_s_at	38	0.263158	0.0236706	0.301451	1.56046	0.265583	0.313947	1.37 [0.79 - 2.38]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1554835_a_at	38	0.710526	0.00422402	0.0828326	1.26627	0.477748	0.144907	1.16 [0.77 - 1.72]
GENE	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1556134_a_at	38	0.631579	0.0359818	0.399465	0.96329	0.578071	0.298482	1.35 [0.47 - 3.86]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1806613	165	0.690909	0.0764214	-	0.435415	0.394061	0.540208	1.72 [0.50 - 5.94]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1806613	165	0.29697	0.05285	-	0.912103	0.493701	0.644267	1.90 [0.30 - 12.05]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1552833_at	79	0.708861	0.0756898	-	-0.624778	0.479208	-0.656592	0.52 [0.08 - 3.20]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1552834_at	79	0.898734	0.0157737	0.226106	0.968723	0.687565	0.391724	1.48 [0.22 - 9.98]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1552833_at	559	0.756708	0.0709063	-	-0.456733	0.180917	-0.244486	0.78 [0.55 - 1.12]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1552834_at	559	0.162791	0.0551222	-	-0.446741	0.190079	-0.152401	0.86 [0.68 - 1.08]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1552833_at	70	0.3	0.062891	-	-0.514133	0.529728	-0.484084	0.62 [0.14 - 2.79]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1552834_at	70	0.585714	0.160767	-	0.373318	0.427397	0.515834	1.68 [0.47 - 5.99]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1552833_at	67	0.119403	0.243505	-	15.2328	0.314054	1.8554	6.39 [0.17 - 236.89]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1552834_at	67	0.477612	0.17273	-	-0.934488	0.586773	-1.26167	0.28 [0.00 - 26.79]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1552833_at	115	0.852174	0.00167934	0.0392312	1.54268	0.0363637	1.36015	3.90 [1.09 - 13.93]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1552834_at	115	0.278261	0.00838948	0.141347	-1.3277	0.0758811	-0.422068	0.66 [0.41 - 1.04]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1552833_at	204	0.328431	0.0604215	-	0.280173	0.554476	0.0535235	1.05 [0.88 - 1.26]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1552834_at	204	0.803922	0.0681361	-	0.327233	0.235426	0.0846649	1.09 [0.95 - 1.25]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1552833_at	87	0.229885	0.0240741	0.304994	1.50899	0.88716	0.117789	1.13 [0.22 - 5.72]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1552833_at	87	0.229885	0.0240741	0.304994	1.50899	0.88716	0.117789	1.13 [0.22 - 5.72]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1552834_at	87	0.862069	0.145143	-	-1.02819	0.686836	-0.359916	0.70 [0.12 - 4.01]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1552834_at	87	0.862069	0.145143	-	-1.02819	0.686836	-0.359916	0.70 [0.12 - 4.01]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552833_at	77	0.844156	0.101698	-	-15.3023	0.532922	-0.897005	0.41 [0.02 - 6.84]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552834_at	77	0.220779	0.0365164	0.403312	15.4796	0.461478	0.975309	2.65 [0.20 - 35.56]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552833_at	77	0.194805	0.0802832	-	-1.07671	0.21455	-2.02815	0.13 [0.01 - 3.24]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552834_at	77	0.220779	0.0689036	-	15.4707	0.701773	0.575755	1.78 [0.09 - 33.88]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5478	155	0.696774	0.00141831	0.0341133	0.862428	0.241451	0.276086	1.32 [0.83 - 2.09]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1552833_at	177	0.587571	0.00893365	0.148268	-0.66608	0.244998	-0.295948	0.74 [0.45 - 1.23]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1552833_at	177	0.112994	0.0201795	0.269641	-0.800972	0.423701	-0.224301	0.80 [0.46 - 1.38]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1552834_at	177	0.689266	0.129268	-	-0.402976	0.845051	-0.0358553	0.96 [0.67 - 1.38]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1552834_at	177	0.107345	0.13958	-	-0.560617	0.871679	-0.0341972	0.97 [0.64 - 1.46]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1552833_at	145	0.462069	0.0214685	0.281636	-0.76944	0.472722	-0.243217	0.78 [0.40 - 1.52]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1552834_at	145	0.268966	0.00575591	0.105685	-0.899572	0.730211	-0.092222	0.91 [0.54 - 1.54]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1552833_at	226	0.300885	0.0842022	-	-0.494326	0.345397	-0.077782	0.93 [0.79 - 1.09]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1552834_at	226	0.10177	0.0037876	0.0759462	-1.03117	0.0535599	-0.151188	0.86 [0.74 - 1.00]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1552833_at	55	0.163636	0.13029	-	-0.764254	0.467234	-0.272062	0.76 [0.37 - 1.59]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1552834_at	55	0.127273	0.208068	-	-0.69075	0.91282	-0.0370599	0.96 [0.50 - 1.87]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1552833_at	55	0.4	0.00730512	0.12713	-1.30259	0.0234987	-1.3057	0.27 [0.09 - 0.84]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1552834_at	55	0.618182	0.0276215	0.335078	-1.26313	0.0988998	-0.754503	0.47 [0.19 - 1.15]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1552833_at	49	0.591837	0.0626592	-	-1.3403	0.277286	-0.584779	0.56 [0.19 - 1.60]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1552834_at	49	0.653061	0.138025	-	-1.09383	0.354603	-0.498578	0.61 [0.21 - 1.75]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1552833_at	63	0.15873	9.08683e-05	0.00321879	-1.43563	0.00147595	-50.7175	0.00 [0.00 - 0.00]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1552834_at	63	0.460317	0.0375758	0.410849	-0.697271	0.347889	-0.808515	0.45 [0.08 - 2.41]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	1552834_3p_at	28	0.5	0.0320713	0.370384	-1.24337	0.071312	-2.47053	0.08 [0.01 - 1.24]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.352622.1.S2_3p_x_at	28	0.785714	0.0809242	-	1.02053	0.225526	0.429764	1.54 [0.77 - 3.08]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.352622.1.S1_3p_at	28	0.714286	0.11058	-	-1.16857	0.168352	-15.7848	0.00 [0.00 - 792.07]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.352622.1.S2_3p_at	28	0.892857	0.000306106	0.0092966	2.41818	0.284683	0.711758	2.04 [0.55 - 7.51]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P366895	117	0.179487	0.138446	-	-0.502936	0.800044	-0.0406292	0.96 [0.70 - 1.31]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1552833_at	204	0.887255	0.0127701	0.193749	0.847749	0.2902	0.174775	1.19 [0.86 - 1.65]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1552834_at	204	0.862745	0.00995577	0.160923	0.821312	0.524561	0.0797982	1.08 [0.85 - 1.38]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1552833_at	204	0.887255	0.00231299	0.0510122	1.19109	0.0695069	0.358067	1.43 [0.97 - 2.11]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1552834_at	204	0.862745	0.00313881	0.0653283	1.11957	0.287872	0.168492	1.18 [0.87 - 1.61]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1552833_at	111	0.81982	0.0271867	0.331489	0.667609	0.0893926	0.251685	1.29 [0.96 - 1.72]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1552834_at	111	0.864865	0.00134656	0.0326739	1.01148	0.0859282	0.187536	1.21 [0.97 - 1.49]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1552833_at	138	0.231884	0.00087634	0.0228091	-0.824515	0.881053	0.025288	1.03 [0.74 - 1.43]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1552834_at	138	0.282609	0.0102708	0.164738	-0.623085	0.778747	-0.0332531	0.97 [0.77 - 1.22]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28027	56	0.553571	0.0735846	-	-0.633243	0.369518	-0.463789	0.63 [0.23 - 1.73]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19768	56	0.107143	0.193439	-	-0.627277	0.345658	-0.650978	0.52 [0.13 - 2.02]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28027	56	0.553571	0.127075	-	-0.576037	0.267445	-0.620121	0.54 [0.18 - 1.61]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19768	56	0.214286	0.234352	-	-0.488309	0.487556	-0.535105	0.59 [0.13 - 2.65]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1552833_at	278	0.715827	0.00879599	0.14653	-0.587833	0.112306	-0.733887	0.48 [0.19 - 1.19]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1552834_at	278	0.42446	0.0313383	0.364738	-0.40488	0.949858	-0.0333881	0.97 [0.34 - 2.74]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P366895	110	0.627273	0.251468	-	0.340597	0.649344	0.159233	1.17 [0.59 - 2.33]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P127978	110	0.472727	0.0461759	0.468141	-0.457181	0.642901	-0.104847	0.90 [0.58 - 1.40]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P366895	110	0.354545	0.292459	-	0.258669	0.827456	0.0577585	1.06 [0.63 - 1.78]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P127978	110	0.472727	0.162076	-	-0.419912	0.678349	0.12699	1.14 [0.62 - 2.07]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1552833_at	38	0.368421	0.0819003	-	0.954894	0.362548	0.734212	2.08 [0.43 - 10.12]
GENE	B3GNT6	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1552834_at	38	0.447368	0.0509683	-	-0.936772	0.86456	-0.0628212	0.94 [0.46 - 1.93]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1721523	165	0.49697	0.0590764	-	-0.460117	0.606565	-0.649838	0.52 [0.04 - 6.19]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1721523	165	0.872727	0.224089	-	0.5458	0.954197	0.109071	1.12 [0.03 - 46.11]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	232337_at	163	0.736196	0.0796814	-	0.371868	0.312668	0.983522	2.67 [0.40 - 18.04]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1555963_x_at	79	0.303797	0.013097	0.197394	-0.74254	0.589676	-0.116884	0.89 [0.58 - 1.36]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1552965_a_at	79	0.202532	0.0429146	0.447187	0.85963	0.482196	0.677096	1.97 [0.30 - 13.01]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	232337_at	79	0.772152	0.0294429	0.349835	0.685853	0.828842	0.206103	1.23 [0.19 - 7.96]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1555962_at	79	0.78481	0.0508482	-	0.617414	0.883996	-0.0361751	0.96 [0.59 - 1.57]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	232337_at	180	0.794444	0.0209879	0.2772	-0.664474	0.422168	-0.266258	0.77 [0.40 - 1.47]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1555963_x_at	559	0.13059	0.120411	-	0.537655	0.749623	0.0310598	1.03 [0.85 - 1.25]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1552965_a_at	559	0.323792	0.00893729	0.148314	-0.531951	0.0218119	-0.274593	0.76 [0.60 - 0.96]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	232337_at	559	0.824687	0.012015	0.185205	-0.89648	0.0354769	-0.449946	0.64 [0.42 - 0.97]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1555962_at	559	0.152057	0.10848	-	0.530211	0.941852	0.00696844	1.01 [0.84 - 1.21]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	232337_at	77	0.155844	0.183229	-	-0.447552	0.713669	0.141029	1.15 [0.54 - 2.45]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1555963_x_at	70	0.671429	0.0623854	-	0.514816	0.790277	0.0634404	1.07 [0.67 - 1.70]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1552965_a_at	70	0.385714	0.366461	-	-0.244984	0.450507	0.687644	1.99 [0.33 - 11.87]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	232337_at	70	0.2	0.236539	-	-0.376508	0.492261	-0.762187	0.47 [0.05 - 4.11]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1555962_at	70	0.614286	0.0123723	0.189271	0.668964	0.962672	-0.0129187	0.99 [0.57 - 1.70]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	232337_at	74	0.810811	0.000247978	0.00774779	1.15503	0.0474395	0.99382	2.70 [1.01 - 7.22]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	232337_at	67	0.820895	0.00596796	0.108709	1.65512	0.0968847	4.10942	60.91 [0.48 - 7793.67]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1555962_at	67	0.850746	0.00149509	0.0356374	1.88625	0.200219	1.87172	6.50 [0.37 - 113.94]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1555963_x_at	67	0.149254	0.117274	-	-1.06064	0.824848	0.329215	1.39 [0.08 - 25.66]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1552965_a_at	67	0.328358	0.14434	-	-0.956345	0.94289	-0.241867	0.79 [0.00 - 587.32]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1555963_x_at	115	0.53913	0.172464	-	-0.786299	0.964923	-0.0359497	0.96 [0.19 - 4.79]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1552965_a_at	115	0.843478	0.0945956	-	-15.2924	0.885871	-0.108062	0.90 [0.21 - 3.93]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	232337_at	115	0.321739	0.135482	-	1.08409	0.172997	1.11113	3.04 [0.61 - 15.02]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1555962_at	115	0.895652	0.117986	-	0.983001	0.0956032	0.701673	2.02 [0.88 - 4.60]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	232337_at	204	0.808824	0.00644835	0.115451	-0.489804	0.0695716	-0.239212	0.79 [0.61 - 1.02]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1555962_at	204	0.764706	0.000238796	0.00749833	0.609845	0.00580137	0.241131	1.27 [1.07 - 1.51]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1555963_x_at	204	0.637255	3.46096e-05	0.00136572	0.609438	0.00883658	0.220349	1.25 [1.06 - 1.47]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1552965_a_at	204	0.52451	0.141914	-	-0.205355	0.438919	-0.0527353	0.95 [0.83 - 1.08]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1555963_x_at	87	0.528736	0.105041	-	-0.632438	0.951819	0.0238133	1.02 [0.47 - 2.22]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1555963_x_at	87	0.528736	0.105041	-	-0.632438	0.951819	0.0238133	1.02 [0.47 - 2.22]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1552965_a_at	87	0.827586	0.0330844	0.378082	-1.88262	0.274485	-1.15681	0.31 [0.04 - 2.50]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1552965_a_at	87	0.827586	0.0330844	0.378082	-1.88262	0.274485	-1.15681	0.31 [0.04 - 2.50]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	232337_at	87	0.137931	0.0173849	0.242517	15.3069	0.315587	0.720841	2.06 [0.50 - 8.40]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	232337_at	87	0.137931	0.0173849	0.242517	15.3069	0.315587	0.720841	2.06 [0.50 - 8.40]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1555962_at	87	0.632184	0.0594928	-	-0.846925	0.713544	-0.210442	0.81 [0.26 - 2.49]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1555962_at	87	0.632184	0.0594928	-	-0.846925	0.713544	-0.210442	0.81 [0.26 - 2.49]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555963_x_at	77	0.857143	0.029397	0.349469	1.23889	0.368928	0.392859	1.48 [0.63 - 3.49]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552965_a_at	77	0.220779	0.0863759	-	-0.944281	0.642691	-0.848737	0.43 [0.01 - 15.44]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	232337_at	77	0.753247	0.112134	-	-1.50763	0.356895	-1.10327	0.33 [0.03 - 3.47]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555962_at	77	0.896104	0.00100332	0.0255561	1.78263	0.0133482	1.08612	2.96 [1.25 - 7.00]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555963_x_at	77	0.168831	0.0297333	0.352148	-1.30879	0.845969	0.111003	1.12 [0.36 - 3.42]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1552965_a_at	77	0.220779	0.0125129	0.190859	-1.45353	0.137735	-3.03381	0.05 [0.00 - 2.64]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	232337_at	77	0.753247	0.0527769	-	-15.5242	0.108507	-2.11004	0.12 [0.01 - 1.59]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555962_at	77	0.194805	0.0939842	-	15.405	0.156048	0.767885	2.16 [0.75 - 6.23]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	882	60	0.216667	0.132849	-	0.790533	0.955131	-0.00809048	0.99 [0.75 - 1.31]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	882	60	0.783333	0.0971469	-	-0.974709	0.249204	-0.279899	0.76 [0.47 - 1.22]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232337_at	159	0.855346	0.000445548	0.0128393	1.15139	0.0272701	1.2768	3.59 [1.15 - 11.14]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232337_at	159	0.855346	0.00211744	0.0474617	1.04418	0.062907	1.06178	2.89 [0.94 - 8.85]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232337_at	159	0.855346	0.000192037	0.0062039	1.3566	0.00723638	1.90109	6.69 [1.67 - 26.80]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	232337_at	236	0.868644	0.167713	-	-0.70372	0.980643	0.0111367	1.01 [0.41 - 2.49]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	232337_at	249	0.100402	0.0346216	0.389541	-0.607435	0.546473	-0.215674	0.81 [0.40 - 1.62]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1555963_x_at	177	0.175141	0.0324178	0.37303	-0.604137	0.861175	-0.0276209	0.97 [0.71 - 1.33]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1552965_a_at	177	0.485876	0.0160286	0.228743	-0.56949	0.170509	-1.11465	0.33 [0.07 - 1.62]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1555963_x_at	177	0.112994	0.139221	-	-0.560369	0.851649	0.0337617	1.03 [0.73 - 1.47]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	232337_at	177	0.214689	0.0315977	0.366743	-0.543835	0.2538	-0.667161	0.51 [0.16 - 1.61]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1552965_a_at	177	0.485876	0.0782985	-	-0.477937	0.364766	-0.838912	0.43 [0.07 - 2.65]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1555962_at	177	0.542373	0.0212916	0.280008	0.541675	0.777799	0.0632654	1.07 [0.69 - 1.65]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	232337_at	177	0.225989	0.068652	-	-0.519676	0.535694	-0.407078	0.67 [0.18 - 2.41]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1555962_at	177	0.542373	0.00912218	0.150636	0.713047	0.554852	0.152558	1.16 [0.70 - 1.93]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1555963_x_at	145	0.855172	0.070571	-	0.684157	0.744017	0.0720081	1.07 [0.70 - 1.66]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1552965_a_at	145	0.289655	0.374696	-	-0.306518	0.494169	-0.770585	0.46 [0.05 - 4.21]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	232337_at	145	0.213793	0.0841768	-	-0.601846	0.158417	-1.18547	0.31 [0.06 - 1.59]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1555962_at	145	0.4	0.0415029	0.437834	0.766862	0.494255	0.215512	1.24 [0.67 - 2.30]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1555963_x_at	226	0.473451	0.0143021	0.210561	0.739336	0.782452	0.0381626	1.04 [0.79 - 1.36]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1552965_a_at	226	0.376106	0.109213	-	0.511652	0.318808	0.114348	1.12 [0.90 - 1.40]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	232337_at	226	0.89823	0.0381598	0.414956	-1.8294	0.951831	-0.0168472	0.98 [0.57 - 1.70]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1555962_at	226	0.10177	0.210349	-	-0.540833	0.649944	0.0526942	1.05 [0.84 - 1.32]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1555963_x_at	55	0.654545	0.00336323	0.0690568	-2.36617	0.0686477	-0.518521	0.60 [0.34 - 1.04]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1552965_a_at	55	0.418182	0.00353081	0.0718015	-1.40073	0.0147116	-3.05666	0.05 [0.00 - 0.55]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	232337_at	55	0.618182	0.243266	-	0.563003	0.811385	-0.353689	0.70 [0.04 - 12.82]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1555962_at	55	0.672727	0.00563312	0.103919	-2.26871	0.0874447	-0.545592	0.58 [0.31 - 1.08]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1555963_x_at	49	0.673469	0.0293641	0.349206	-1.95342	0.578677	-0.168588	0.84 [0.47 - 1.53]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1552965_a_at	49	0.204082	8.3796e-05	0.00299661	-1.9808	0.133225	-2.16995	0.11 [0.01 - 1.94]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	232337_at	49	0.122449	0.0193141	0.261411	-1.33915	0.390641	-1.67721	0.19 [0.00 - 8.60]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1555962_at	49	0.653061	0.0175565	0.24423	-2.08749	0.528514	-0.216965	0.80 [0.41 - 1.58]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1555963_x_at	55	0.654545	0.109497	-	-0.868333	0.822568	-0.0487716	0.95 [0.62 - 1.46]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1552965_a_at	55	0.181818	0.00264775	0.0569384	-1.32536	0.0565006	-2.3053	0.10 [0.01 - 1.07]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	232337_at	55	0.218182	0.0680558	-	-0.831926	0.303352	-1.5448	0.21 [0.01 - 4.04]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1555962_at	55	0.672727	0.159046	-	-0.768977	0.926639	-0.0217579	0.98 [0.62 - 1.55]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1555963_x_at	63	0.714286	0.000184722	0.0059974	1.23068	0.0529347	0.339473	1.40 [1.00 - 1.98]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1552965_a_at	63	0.126984	7.42604e-05	0.00269309	-1.51747	0.0261029	-32.4772	0.00 [0.00 - 0.02]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	232337_at	63	0.206349	3.14802e-07	1.86748e-05	-1.70987	0.313643	-6.11126	0.00 [0.00 - 322.59]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1555962_at	63	0.634921	0.00407466	0.0804971	0.942664	0.121274	0.2446	1.28 [0.94 - 1.74]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.299329.2.A1_3p_x_at	28	0.25	0.10564	-	-0.929474	0.955735	0.0510892	1.05 [0.17 - 6.39]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.299329.0.A1_3p_at	28	0.535714	0.108747	-	-0.944635	0.704719	-1.16415	0.31 [0.00 - 128.62]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.299329.1.S1_3p_a_at	28	0.714286	0.0104544	0.166944	-2.25124	0.0767542	-21.1403	0.00 [0.00 - 9.69]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.299329.0.A1_3p_x_at	28	0.75	0.0171766	0.240429	-2.10666	0.103493	-9.57682	0.00 [0.00 - 7.04]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.299329.2.A1_3p_at	28	0.75	0.000261301	0.00810732	1.82186	0.0125713	1.47317	4.36 [1.37 - 13.88]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.299329.1.S1_3p_at	28	0.714286	0.0499211	0.49115	-1.42805	0.703561	-0.569395	0.57 [0.03 - 10.63]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P39755	117	0.102564	0.0002601	0.00807504	-1.23689	0.21425	-0.265382	0.77 [0.50 - 1.17]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	232337_at	204	0.367647	0.023896	0.303433	-0.607198	0.356585	-0.377257	0.69 [0.31 - 1.53]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1555963_x_at	204	0.676471	0.0798082	-	-0.781058	0.443716	-0.304316	0.74 [0.34 - 1.61]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1552965_a_at	204	0.25	0.0435754	0.451505	1.16233	0.198073	0.297374	1.35 [0.86 - 2.12]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	232337_at	204	0.465686	0.0444127	0.456923	-0.744634	0.369788	-0.498028	0.61 [0.20 - 1.80]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1555962_at	204	0.5	0.17617	-	-0.50124	0.391763	-0.336897	0.71 [0.33 - 1.54]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1555963_x_at	204	0.872549	0.0770525	-	0.589321	0.865837	0.0530245	1.05 [0.57 - 1.95]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1552965_a_at	204	0.764706	6.73701e-05	0.00247062	1.05019	0.00576807	0.510075	1.67 [1.16 - 2.39]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1555962_at	204	0.838235	0.0077207	0.132649	0.789474	0.964929	0.0137577	1.01 [0.55 - 1.87]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1555963_x_at	111	0.855856	0.0100895	0.162547	0.798479	0.281439	0.210045	1.23 [0.84 - 1.81]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1552965_a_at	111	0.207207	0.0546004	-	-0.551253	0.149129	-0.181066	0.83 [0.65 - 1.07]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	232337_at	111	0.792793	0.0864316	-	-0.614759	0.936961	-0.030204	0.97 [0.46 - 2.05]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1555962_at	111	0.882883	0.0899206	-	0.582886	0.945511	0.0105066	1.01 [0.75 - 1.37]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1555963_x_at	138	0.891304	0.285552	-	0.370259	0.723766	0.029901	1.03 [0.87 - 1.22]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1552965_a_at	138	0.268116	0.0153517	0.221705	-0.595405	0.62578	-3.63543	0.03 [0.00 - 58431.22]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	232337_at	138	0.869565	0.110466	-	-0.68782	0.210931	-4.36509	0.01 [0.00 - 11.87]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1555962_at	138	0.789855	0.106386	-	0.435505	0.622205	0.0427027	1.04 [0.88 - 1.24]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	14079	56	0.482143	0.0371635	0.40793	-0.73016	0.219017	-0.537138	0.58 [0.25 - 1.38]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	14079	56	0.482143	0.0115727	0.180115	-0.966985	0.0616214	-0.94464	0.39 [0.14 - 1.05]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1555962_at	278	0.514389	0.00509476	0.0960506	-0.542643	0.128881	-0.226406	0.80 [0.60 - 1.07]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1555963_x_at	278	0.564748	0.00250584	0.0544484	-0.595409	0.163219	-0.173028	0.84 [0.66 - 1.07]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1552965_a_at	278	0.640288	0.0912619	-	-0.339058	0.700665	-0.201915	0.82 [0.29 - 2.29]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	232337_at	278	0.402878	0.0107553	0.170532	-0.476938	0.682678	-0.18498	0.83 [0.34 - 2.02]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P39755	110	0.654545	0.198943	-	-0.326542	0.628145	-0.153616	0.86 [0.46 - 1.60]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P39755	110	0.463636	0.0416073	0.438531	-0.612768	0.217136	-0.601092	0.55 [0.21 - 1.42]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1555963_x_at	38	0.131579	0.172758	-	1.02325	0.862215	0.0598532	1.06 [0.54 - 2.09]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1552965_a_at	38	0.763158	0.0861417	-	0.860714	0.462648	0.469258	1.60 [0.46 - 5.59]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	232337_at	38	0.421053	0.182979	-	-0.646352	0.951534	0.0206602	1.02 [0.52 - 1.99]
GENE	B3GNT7	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1555962_at	38	0.447368	0.0316143	0.366871	1.06487	0.462614	0.203144	1.23 [0.71 - 2.11]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1741389	165	0.266667	0.00318812	0.0661529	-0.727281	0.43145	-0.182527	0.83 [0.53 - 1.31]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1741389	165	0.266667	0.00485078	0.0924115	-0.966333	0.853473	-0.0616036	0.94 [0.49 - 1.81]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	237338_at	163	0.122699	0.168516	-	-0.382328	0.345448	-0.336289	0.71 [0.36 - 1.44]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	237338_at	79	0.746835	0.0684594	-	0.579691	0.346368	0.417865	1.52 [0.64 - 3.62]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	237338_at	180	0.344444	0.105948	-	-0.342922	0.774389	-0.0353137	0.97 [0.76 - 1.23]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	237338_at	559	0.781753	0.157048	-	0.308167	0.89684	0.0176028	1.02 [0.78 - 1.33]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	237338_at	77	0.272727	0.10737	-	0.489635	0.583038	0.101099	1.11 [0.77 - 1.59]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	237338_at	70	0.785714	0.214927	-	0.379108	0.526617	0.562006	1.75 [0.31 - 9.99]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	237338_at	74	0.621622	0.08836	-	0.496073	0.460632	0.164041	1.18 [0.76 - 1.82]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	237338_at	67	0.208955	0.114235	-	15.405	0.933848	-0.0696622	0.93 [0.18 - 4.83]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	237338_at	115	0.104348	0.12129	-	-0.966898	0.349351	-0.533754	0.59 [0.19 - 1.79]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	237338_at	204	0.642157	0.000248019	0.00774891	-0.541794	0.0228082	-0.182266	0.83 [0.71 - 0.97]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	237338_at	87	0.655172	0.0862372	-	0.637967	0.685745	0.179986	1.20 [0.50 - 2.86]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	237338_at	87	0.655172	0.0862372	-	0.637967	0.685745	0.179986	1.20 [0.50 - 2.86]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	237338_at	77	0.25974	0.0125897	0.191724	-1.29708	0.170705	-1.04046	0.35 [0.08 - 1.57]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	237338_at	77	0.25974	0.000545206	0.0152565	-2.0261	0.122929	-1.41917	0.24 [0.04 - 1.47]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	237338_at	159	0.761006	0.272051	-	-0.453217	0.812794	0.0627536	1.06 [0.63 - 1.79]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	237338_at	159	0.176101	0.0169716	0.238365	1.56722	0.0536783	0.564278	1.76 [0.99 - 3.12]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	237338_at	159	0.176101	0.0307608	0.360245	1.89995	0.153948	0.483842	1.62 [0.83 - 3.16]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	237338_at	236	0.724576	8.23968e-06	0.000374866	1.1418	0.00173879	0.87206	2.39 [1.39 - 4.13]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	237338_at	249	0.626506	0.00237763	0.0521709	0.63499	0.0158407	0.550821	1.73 [1.11 - 2.71]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	237338_at	145	0.331034	0.0076633	0.131892	-0.862034	0.0944786	-0.777027	0.46 [0.18 - 1.14]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	237338_at	177	0.344633	0.00174141	0.0404229	-0.725967	0.0318771	-0.723425	0.49 [0.25 - 0.94]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	237338_at	177	0.344633	0.000953989	0.0244972	-0.872716	0.016598	-0.93016	0.39 [0.18 - 0.84]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	237338_at	226	0.606195	0.00221841	0.0493037	-1.03539	0.0230747	-0.342106	0.71 [0.53 - 0.95]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	237338_at	55	0.890909	0.25284	-	-1.15136	0.727619	0.228087	1.26 [0.35 - 4.53]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	237338_at	49	0.897959	0.194087	-	-15.2126	0.720895	0.298206	1.35 [0.26 - 6.92]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	237338_at	55	0.181818	0.074959	-	-0.84633	0.993528	0.00520047	1.01 [0.29 - 3.53]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	237338_at	63	0.238095	0.00274081	0.0585546	-1.01245	0.519095	0.695217	2.00 [0.24 - 16.59]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.179391.0.A1_3p_at	28	0.25	0.210466	-	-0.668359	0.432223	-16.8709	0.00 [0.00 - 90758502757.51]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.179391.0.A1_3p_x_at	28	0.857143	0.128303	-	1.25454	0.305485	-19.507	0.00 [0.00 - 53949554.93]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P101380	117	0.324786	0.000221375	0.00702092	-1.01559	0.000316155	-0.456031	0.63 [0.49 - 0.81]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	237338_at	204	0.70098	0.00238662	0.0523315	-1.91749	0.0513178	-0.46816	0.63 [0.39 - 1.00]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	237338_at	204	0.553922	0.0296222	0.351264	-0.618513	0.0718213	-0.333123	0.72 [0.50 - 1.03]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	237338_at	111	0.342342	0.267906	-	0.317943	0.708543	0.0623223	1.06 [0.77 - 1.48]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	237338_at	138	0.478261	0.381746	-	0.213365	0.534276	-0.0791703	0.92 [0.72 - 1.19]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17529	56	0.267857	0.00373684	0.0751326	-1.04164	0.451167	-0.169506	0.84 [0.54 - 1.31]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17529	56	0.232143	0.0157735	0.226104	-0.958162	0.759651	-0.0704063	0.93 [0.59 - 1.46]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	237338_at	278	0.140288	0.0759946	-	-0.46957	0.891006	0.0501251	1.05 [0.51 - 2.15]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P101380	110	0.736364	0.234342	-	0.397015	0.941222	0.0166839	1.02 [0.65 - 1.58]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P101380	110	0.7	0.0225196	0.291197	0.540319	0.173148	0.242416	1.27 [0.90 - 1.81]
GENE	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	237338_at	38	0.789474	0.00890919	0.14796	-15.5404	0.346055	-0.322871	0.72 [0.37 - 1.42]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206435_at	30	0.3	0.266505	-	-0.487504	0.93595	0.0486441	1.05 [0.32 - 3.44]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1805725	165	0.333333	0.000393595	0.011544	1.02565	0.0063617	0.771645	2.16 [1.24 - 3.77]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1805725	165	0.709091	4.85172e-06	0.000231571	1.50781	9.05339e-05	1.24196	3.46 [1.86 - 6.45]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206435_at	163	0.386503	0.0713892	-	0.3721	0.755663	0.188372	1.21 [0.37 - 3.95]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206435_at	79	0.797468	0.0767968	-	-0.758308	0.58081	-0.492987	0.61 [0.11 - 3.51]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1555385_at	79	0.35443	0.0809798	-	-0.515492	0.610508	-0.467631	0.63 [0.10 - 3.79]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206435_at	58	0.172414	0.100209	-	-0.573974	0.413295	-0.152174	0.86 [0.60 - 1.24]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206435_at	34	0.117647	0.40273	-	0.517078	0.842566	-0.0738649	0.93 [0.45 - 1.93]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206435_at	158	0.670886	0.403385	-	0.201782	0.942484	-0.0588678	0.94 [0.19 - 4.67]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206435_at	53	0.509434	0.0711608	-	0.662143	0.370518	0.193741	1.21 [0.79 - 1.85]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206435_at	53	0.509434	0.118686	-	0.534268	0.404583	0.162266	1.18 [0.80 - 1.72]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206435_at	180	0.872222	0.0053326	0.0995534	0.777004	0.279275	0.281	1.32 [0.80 - 2.20]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206435_at	559	0.363148	0.0369013	0.406063	0.472328	0.559423	0.0762701	1.08 [0.84 - 1.39]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1555385_at	559	0.157424	0.0963343	-	-0.422613	0.745295	0.041049	1.04 [0.81 - 1.33]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206435_at	77	0.818182	0.189618	-	-0.476626	0.988598	0.00251592	1.00 [0.71 - 1.42]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206435_at	70	0.642857	0.000687133	0.0185724	-0.982305	0.955808	0.0110612	1.01 [0.68 - 1.50]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1555385_at	70	0.314286	0.0413104	0.436545	-0.571187	0.375418	0.139465	1.15 [0.84 - 1.56]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38212_at	50	0.12	0.00039356	0.0115431	-1.59022	0.0113009	-2.13637	0.12 [0.02 - 0.62]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206435_at	74	0.351351	0.064578	-	-0.539138	0.920966	-0.0319771	0.97 [0.51 - 1.82]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1555385_at	67	0.238806	0.110598	-	15.4143	0.67429	1.03378	2.81 [0.02 - 348.98]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206435_at	67	0.134328	0.290251	-	-0.841372	0.887832	-0.217087	0.80 [0.04 - 16.44]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1555385_at	115	0.452174	0.0121328	0.18655	1.70426	0.79255	0.168396	1.18 [0.34 - 4.15]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206435_at	115	0.8	0.0184838	0.253375	1.20475	0.336	0.873712	2.40 [0.40 - 14.21]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38212_at	158	0.797468	0.0135743	0.202658	-1.12477	0.154941	-0.375661	0.69 [0.41 - 1.15]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38212_at	76	0.828947	0.114814	-	0.907937	0.405327	0.387487	1.47 [0.59 - 3.67]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206435_at	204	0.887255	0.002226	0.0494414	0.688311	0.367415	-0.082103	0.92 [0.77 - 1.10]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1555385_at	204	0.318627	0.0524058	-	0.294669	0.497629	0.0583737	1.06 [0.90 - 1.25]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1555385_at	87	0.563218	0.0333058	0.379749	0.79652	0.132276	1.19467	3.30 [0.70 - 15.65]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206435_at	87	0.597701	0.0148581	0.2165	0.902354	0.239557	0.646429	1.91 [0.65 - 5.61]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1555385_at	87	0.563218	0.0333058	0.379749	0.79652	0.132276	1.19467	3.30 [0.70 - 15.65]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206435_at	87	0.597701	0.0148581	0.2165	0.902354	0.239557	0.646429	1.91 [0.65 - 5.61]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206435_at	77	0.792208	0.113219	-	0.982497	0.92249	0.0971619	1.10 [0.16 - 7.80]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206435_at	77	0.896104	0.0557795	-	1.19219	0.501767	0.572578	1.77 [0.33 - 9.42]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555385_at	77	0.701299	0.000183191	0.00595402	1.95409	0.0154158	3.08661	21.90 [1.80 - 266.12]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1555385_at	77	0.701299	9.19699e-05	0.00325318	2.46076	0.0208471	3.3378	28.16 [1.66 - 477.69]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206435_at	136	0.852941	0.0198736	0.266749	1.0857	0.716219	0.0968084	1.10 [0.65 - 1.86]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206435_at	200	0.215	0.0240425	0.304717	1.12136	0.0441769	0.673453	1.96 [1.02 - 3.78]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206435_at	286	0.51049	0.00946337	0.154881	0.504543	0.0161934	0.444906	1.56 [1.09 - 2.24]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206435_at	159	0.106918	0.00936611	0.153676	-0.988863	0.455779	-0.244293	0.78 [0.41 - 1.49]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206435_at	159	0.106918	0.0117602	0.182281	-0.96151	0.482881	-0.229895	0.79 [0.42 - 1.51]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206435_at	159	0.106918	0.000230852	0.00728129	-1.41336	0.0626199	-0.648634	0.52 [0.26 - 1.03]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206435_at	54	0.203704	0.183306	-	15.3378	0.709282	0.238802	1.27 [0.36 - 4.46]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206435_at	117	0.529915	0.0346812	0.38998	0.671942	0.551629	0.182014	1.20 [0.66 - 2.18]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206435_at	117	0.367521	0.0493173	0.487513	0.890691	0.171253	0.462218	1.59 [0.82 - 3.08]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206435_at	117	0.529915	0.0346812	0.38998	0.671942	0.551629	0.182014	1.20 [0.66 - 2.18]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206435_at	117	0.42735	0.0464124	0.469626	0.811607	0.312215	0.331161	1.39 [0.73 - 2.65]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206435_at	236	0.614407	0.126254	-	0.411196	0.910254	0.0349058	1.04 [0.56 - 1.90]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206435_at	249	0.839357	0.273159	-	-0.351379	0.867079	-0.0405516	0.96 [0.60 - 1.54]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206435_at	62	0.209677	0.0427888	0.446361	15.3839	0.840346	-0.0465292	0.95 [0.61 - 1.50]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206435_at	125	0.56	0.180115	-	0.523634	0.720499	0.171853	1.19 [0.46 - 3.04]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206435_at	125	0.88	0.221479	-	-0.552818	0.849074	-0.0715979	0.93 [0.45 - 1.95]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206435_at	54	0.296296	0.0612203	-	15.5158	0.903881	-0.0338836	0.97 [0.56 - 1.68]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206435_at	198	0.863636	0.000585955	0.0162225	1.05329	0.0300221	0.314692	1.37 [1.03 - 1.82]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206435_at	198	0.873737	0.0324614	0.373362	0.597794	0.158405	0.14744	1.16 [0.94 - 1.42]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206435_at	198	0.863636	0.000436924	0.0126261	1.03394	0.0255256	0.305636	1.36 [1.04 - 1.78]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206435_at	51	0.392157	0.0644534	-	15.8759	0.301022	2.23751	9.37 [0.13 - 650.55]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206435_at	62	0.709677	0.0258402	0.320203	1.2148	0.194975	1.74369	5.72 [0.41 - 79.90]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1555385_at	177	0.836158	0.0525777	-	-0.969628	0.272352	-0.625764	0.53 [0.17 - 1.63]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206435_at	177	0.344633	0.0226036	0.291952	-0.536767	0.171185	-1.16949	0.31 [0.06 - 1.66]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1555385_at	177	0.423729	0.0526315	-	-0.450377	0.11457	-0.784338	0.46 [0.17 - 1.21]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206435_at	145	0.868966	0.0919132	-	0.664898	0.797975	0.309813	1.36 [0.13 - 14.62]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1555385_at	145	0.324138	0.107625	-	-0.538568	0.848218	0.131788	1.14 [0.30 - 4.40]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206435_at	177	0.344633	0.0602722	-	-0.512299	0.379764	-0.857557	0.42 [0.06 - 2.88]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206435_at	226	0.10177	0.0203622	0.27136	-0.833057	0.104895	-0.196475	0.82 [0.65 - 1.04]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1555385_at	226	0.765487	0.0687371	-	0.562708	0.942339	-0.0104272	0.99 [0.75 - 1.31]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206435_at	55	0.254545	0.00485221	0.0924331	15.6085	0.0898343	2.7689	15.94 [0.65 - 390.84]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206435_at	49	0.22449	0.04386	0.453353	15.4787	0.527662	1.38206	3.98 [0.05 - 290.34]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1555385_at	55	0.727273	0.00277129	0.0590811	-15.6803	0.0295648	-2.7451	0.06 [0.01 - 0.76]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1555385_at	49	0.714286	0.0195013	0.263205	-15.6202	0.138858	-2.20883	0.11 [0.01 - 2.05]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206435_at	55	0.254545	0.0395712	0.424743	1.41641	0.217032	1.9527	7.05 [0.32 - 156.50]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1555385_at	55	0.727273	0.0296036	0.351116	-1.48473	0.150156	-1.52315	0.22 [0.03 - 1.74]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206435_at	63	0.412698	0.0108136	0.171223	-0.849519	0.609215	0.626457	1.87 [0.17 - 20.66]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1555385_at	63	0.174603	0.00222208	0.0493702	-1.10547	0.022864	-21.8855	0.00 [0.00 - 0.05]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4809289_3p_at	28	0.857143	0.000444716	0.0128187	1.94106	0.0183389	0.985141	2.68 [1.18 - 6.07]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.159481.2.S1_3p_s_at	28	0.535714	0.177968	-	-0.757613	0.573375	-0.584248	0.56 [0.07 - 4.26]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206435_at	82	0.634146	0.0421044	0.44184	0.678302	0.240164	0.926376	2.53 [0.54 - 11.85]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206435_at	79	0.468354	0.0325017	0.373669	0.566264	0.237089	0.946711	2.58 [0.54 - 12.38]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206435_at	104	0.509615	0.010285	0.164909	0.881406	0.368111	0.879364	2.41 [0.35 - 16.35]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P359291	117	0.307692	0.00146921	0.0351255	-0.889716	0.0899693	-0.668519	0.51 [0.24 - 1.11]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P87461	117	0.418803	0.0943036	-	-0.475132	0.63943	-0.125981	0.88 [0.52 - 1.49]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206435_at	204	0.490196	0.00474948	0.0908864	1.11052	0.109562	0.573084	1.77 [0.88 - 3.58]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206435_at	204	0.789216	0.000270918	0.0083651	0.978016	0.0629456	0.496273	1.64 [0.97 - 2.77]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1555385_at	204	0.112745	0.0135342	0.202219	-1.02376	0.0283543	-0.558987	0.57 [0.35 - 0.94]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1555385_at	204	0.534314	0.00103508	0.0262326	-0.944487	4.99036e-05	-0.770479	0.46 [0.32 - 0.67]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206435_at	178	0.853933	1.54847e-05	0.000663341	1.04405	0.04145	1.32317	3.76 [1.05 - 13.40]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1555385_at	111	0.891892	0.0818707	-	-0.87484	0.232669	-0.226334	0.80 [0.55 - 1.16]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206435_at	111	0.234234	4.21028e-06	0.000203477	-1.24235	0.00168951	-0.476397	0.62 [0.46 - 0.84]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206435_at	90	0.355556	0.0431158	0.448506	0.755886	0.571267	0.327279	1.39 [0.45 - 4.31]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206435_at	90	0.355556	0.0434621	0.450768	0.897133	0.387673	0.579235	1.78 [0.48 - 6.64]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1555385_at	138	0.833333	0.0259179	0.320862	-0.878493	0.129578	-1.93531	0.14 [0.01 - 1.76]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206435_at	138	0.826087	0.152588	-	0.415036	0.344413	0.165705	1.18 [0.84 - 1.66]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206435_at	129	0.565891	0.0375401	0.410597	0.508245	0.172609	0.363675	1.44 [0.85 - 2.43]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31078	56	0.321429	0.187582	-	0.555694	0.472038	0.178733	1.20 [0.73 - 1.95]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38094	56	0.696429	0.0365266	0.403385	0.73158	0.11165	0.37117	1.45 [0.92 - 2.29]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31078	56	0.321429	0.0524591	-	0.920165	0.145672	0.368338	1.45 [0.88 - 2.37]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38094	56	0.696429	0.0484223	0.482072	0.685384	0.296712	0.24128	1.27 [0.81 - 2.00]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206435_at	278	0.456835	0.0047964	0.0915938	-0.53397	0.0896507	-0.804175	0.45 [0.18 - 1.13]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1555385_at	278	0.802158	0.000770943	0.0204723	-0.945907	0.0498444	-0.8	0.45 [0.20 - 1.00]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206435_at	133	0.721804	0.000322275	0.00971892	0.877446	0.00809187	5.13503	169.87 [3.80 - 7597.60]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18285	81	0.246914	0.0281001	0.338999	-1.13415	0.310086	-0.584486	0.56 [0.18 - 1.72]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206435_at	185	0.113514	0.0251959	0.314709	0.620063	0.756811	0.0657296	1.07 [0.70 - 1.62]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206435_at	185	0.118919	0.0134772	0.201592	0.599839	0.677423	0.0790881	1.08 [0.75 - 1.57]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P359291	110	0.209091	0.090481	-	0.653131	0.567317	0.103133	1.11 [0.78 - 1.58]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P87461	110	0.554545	0.187284	-	-0.308918	0.560403	-0.201047	0.82 [0.42 - 1.61]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P359291	110	0.209091	0.14872	-	0.4191	0.711421	-0.0532237	0.95 [0.72 - 1.26]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P87461	110	0.418182	0.23407	-	-0.356251	0.959084	0.0228704	1.02 [0.43 - 2.45]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206435_at	80	0.475	0.0123276	0.188764	1.30031	0.0682169	0.60341	1.83 [0.96 - 3.50]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_0931	281	0.896797	0.175812	-	0.287832	0.498718	0.0972095	1.10 [0.83 - 1.46]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206435_at	38	0.473684	0.00232348	0.0512008	1.56294	0.0244886	1.53668	4.65 [1.22 - 17.74]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1555385_at	38	0.184211	0.127736	-	1.43893	0.537744	0.302323	1.35 [0.52 - 3.54]
GENE	B4GALNT1	beta-1,4-N-acetyl-galactosaminyl transferase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206435_at	140	0.835714	0.0114995	0.179265	0.800965	0.0518242	0.275488	1.32 [1.00 - 1.74]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	216627_s_at	30	0.8	0.193487	-	0.60988	0.39079	0.507261	1.66 [0.52 - 5.29]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201882_x_at	30	0.733333	0.0810327	-	0.765441	0.891883	0.120578	1.13 [0.20 - 6.42]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201883_s_at	30	0.166667	0.0874062	-	-0.844546	0.447555	-0.37603	0.69 [0.26 - 1.81]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211631_x_at	30	0.3	0.0807151	-	-0.746312	0.926736	0.0770643	1.08 [0.21 - 5.58]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1766221	165	0.157576	0.235188	-	-0.358978	0.875776	0.0290736	1.03 [0.72 - 1.48]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1766221	165	0.557576	0.126456	-	-0.574921	0.754033	-0.0860996	0.92 [0.54 - 1.57]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201883_s_at	163	0.441718	0.025885	0.320583	-0.437805	0.433682	-0.151339	0.86 [0.59 - 1.26]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211631_x_at	163	0.337423	0.156891	-	-0.288264	0.7917	0.0768679	1.08 [0.61 - 1.91]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	216627_s_at	163	0.147239	0.0676486	-	-0.471696	0.392205	-0.171689	0.84 [0.57 - 1.25]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201882_x_at	163	0.141104	0.111575	-	0.484392	0.659963	0.279042	1.32 [0.38 - 4.58]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	238987_at	163	0.269939	0.0390883	0.421416	-0.441293	0.895702	-0.0336685	0.97 [0.58 - 1.60]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	229403_at	163	0.141104	0.0254355	0.31676	-0.577568	0.34267	-0.658914	0.52 [0.13 - 2.02]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201882_x_at	79	0.544304	0.0987157	-	0.481881	0.686117	0.38223	1.47 [0.23 - 9.36]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	229403_at	79	0.139241	0.0225418	0.291396	-0.835495	0.410981	-0.504935	0.60 [0.18 - 2.01]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	238987_at	79	0.822785	0.00565422	0.104223	0.930584	0.0257822	0.603328	1.83 [1.08 - 3.11]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	216627_s_at	79	0.303797	0.118041	-	0.534799	0.672256	0.144696	1.16 [0.59 - 2.26]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211631_x_at	79	0.594937	0.306592	-	-0.30522	0.99987	-8.25525e-05	1.00 [0.37 - 2.69]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201883_s_at	79	0.632911	0.161665	-	0.40961	0.448478	0.225132	1.25 [0.70 - 2.24]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211631_x_at	58	0.862069	0.00856151	0.14355	1.09105	0.892098	-0.0422768	0.96 [0.52 - 1.77]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216627_s_at	58	0.672414	0.0395004	0.424257	0.616137	0.438971	0.12502	1.13 [0.83 - 1.56]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201882_x_at	58	0.189655	0.050263	-	0.75528	0.30977	0.182033	1.20 [0.84 - 1.70]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201883_s_at	58	0.706897	0.0627108	-	-0.575862	0.69798	-0.0799837	0.92 [0.62 - 1.38]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201883_s_at	34	0.882353	0.00189077	0.0432545	-15.7583	0.199694	-0.373168	0.69 [0.39 - 1.22]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211631_x_at	34	0.147059	0.0181133	0.249744	-1.17511	0.144022	-0.377838	0.69 [0.41 - 1.14]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	216627_s_at	34	0.852941	0.00959743	0.156535	-2.18898	0.0660318	-0.327125	0.72 [0.51 - 1.02]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201882_x_at	34	0.735294	0.139484	-	0.620291	0.919876	-0.0272938	0.97 [0.57 - 1.66]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211631_x_at	158	0.126582	0.11609	-	0.613997	0.380445	0.416694	1.52 [0.60 - 3.85]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	216627_s_at	158	0.620253	0.225574	-	0.280942	0.575293	0.18157	1.20 [0.64 - 2.26]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201882_x_at	158	0.721519	0.00724298	0.126297	0.631507	0.0551266	1.03724	2.82 [0.98 - 8.14]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201883_s_at	158	0.158228	0.112488	-	0.582807	0.978532	0.00836025	1.01 [0.55 - 1.85]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	216627_s_at	53	0.113208	0.129974	-	1.05539	0.44076	0.163816	1.18 [0.78 - 1.79]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201883_s_at	53	0.792453	0.00228922	0.0505843	1.17016	0.120735	0.712864	2.04 [0.83 - 5.02]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201882_x_at	53	0.188679	0.0231358	0.296713	1.28674	0.212594	0.25399	1.29 [0.86 - 1.92]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211631_x_at	53	0.169811	0.262378	-	-0.482388	0.971608	-0.0120729	0.99 [0.51 - 1.92]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201883_s_at	53	0.792453	0.0118851	0.183716	0.953357	0.195752	0.552942	1.74 [0.75 - 4.02]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	216627_s_at	53	0.113208	0.198342	-	0.911022	0.625199	0.108597	1.11 [0.72 - 1.72]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201882_x_at	53	0.207547	0.00856915	0.143647	1.71585	0.235325	0.258465	1.29 [0.85 - 1.98]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211631_x_at	53	0.660377	0.167836	-	-0.531975	0.925957	-0.0290668	0.97 [0.53 - 1.79]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211631_x_at	180	0.844444	0.145844	-	0.38039	0.883338	0.0329424	1.03 [0.67 - 1.60]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	216627_s_at	180	0.877778	0.059519	-	-0.689603	0.816269	-0.018591	0.98 [0.84 - 1.15]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201882_x_at	180	0.116667	0.0523981	-	0.71069	0.66988	0.044753	1.05 [0.85 - 1.28]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201883_s_at	180	0.7	0.280115	-	0.23867	0.694982	0.0884205	1.09 [0.70 - 1.70]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	238987_at	180	0.3	0.0906578	-	-0.369209	0.662249	-0.0635949	0.94 [0.71 - 1.25]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	229403_at	180	0.5	0.147472	-	-0.303281	0.585926	-0.0656349	0.94 [0.74 - 1.19]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201882_x_at	559	0.67263	0.0827956	-	-0.403871	0.286326	-0.138688	0.87 [0.67 - 1.12]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	229403_at	559	0.679785	0.109512	-	-0.354789	0.460298	-0.0906788	0.91 [0.72 - 1.16]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	238987_at	559	0.450805	0.00146511	0.0350443	-0.636252	0.0148004	-0.326604	0.72 [0.55 - 0.94]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	216627_s_at	559	0.336315	0.00463923	0.0892167	-0.560099	0.0949434	-0.172253	0.84 [0.69 - 1.03]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211631_x_at	559	0.16458	0.00846131	0.142268	-0.580368	0.0607804	-0.288538	0.75 [0.55 - 1.01]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201883_s_at	559	0.268336	0.041371	0.436951	-0.422162	0.149584	-0.389058	0.68 [0.40 - 1.15]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201883_s_at	77	0.116883	0.225364	-	-0.432847	0.938087	0.0263175	1.03 [0.53 - 1.99]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211631_x_at	77	0.883117	0.00465656	0.0894798	1.01199	0.595797	0.122793	1.13 [0.72 - 1.78]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	216627_s_at	77	0.844156	0.0105454	0.168032	-1.00905	0.481257	-0.0894464	0.91 [0.71 - 1.17]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201882_x_at	77	0.220779	0.114562	-	0.505875	0.822478	-0.0399016	0.96 [0.68 - 1.36]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	238987_at	77	0.155844	0.016431	0.232875	1.01213	0.308091	0.166061	1.18 [0.86 - 1.62]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	229403_at	77	0.545455	0.0664225	-	-0.47297	0.171424	-0.255275	0.77 [0.54 - 1.12]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	229403_at	70	0.2	0.213308	-	0.45467	0.356634	0.910945	2.49 [0.36 - 17.25]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	238987_at	70	0.8	0.00662084	0.117837	-1.00389	0.0351091	-1.45239	0.23 [0.06 - 0.90]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	216627_s_at	70	0.285714	0.0856189	-	0.535429	0.314415	0.637832	1.89 [0.55 - 6.56]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211631_x_at	70	0.728571	0.174615	-	0.393429	0.646868	0.371392	1.45 [0.30 - 7.10]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201883_s_at	70	0.585714	0.0438987	0.453604	-0.548028	0.374575	-0.325933	0.72 [0.35 - 1.48]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201882_x_at	70	0.285714	0.00305918	0.0639903	-0.835072	0.169626	-1.08105	0.34 [0.07 - 1.59]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32772_s_at	50	0.84	0.177306	-	-0.615342	0.320907	-0.89209	0.41 [0.07 - 2.39]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40960_at	50	0.86	0.000411152	0.0119847	1.51362	0.00551943	0.805391	2.24 [1.27 - 3.95]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	216627_s_at	74	0.581081	0.109192	-	0.462977	0.839827	-0.029711	0.97 [0.73 - 1.29]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201882_x_at	74	0.743243	0.096345	-	-0.585614	0.293088	-0.223748	0.80 [0.53 - 1.21]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201883_s_at	74	0.527027	0.0212649	0.279762	0.67919	0.468859	0.260136	1.30 [0.64 - 2.62]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211631_x_at	74	0.243243	0.114859	-	0.564416	0.812632	-0.0996283	0.91 [0.40 - 2.06]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	229403_at	74	0.337838	0.0733334	-	0.589116	0.360503	0.181966	1.20 [0.81 - 1.77]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	238987_at	74	0.635135	0.0927711	-	-0.540222	0.632523	-0.0883438	0.92 [0.64 - 1.31]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201882_x_at	67	0.791045	0.00075053	0.0200132	1.96613	0.0205612	4.62443	101.94 [2.04 - 5105.73]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	229403_at	67	0.731343	0.0791368	-	-15.5021	0.766208	-0.953545	0.39 [0.00 - 206.86]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	216627_s_at	67	0.507463	0.0512251	-	1.44201	0.518598	0.345675	1.41 [0.49 - 4.04]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	238987_at	67	0.104478	0.000631715	0.0172935	-2.11099	0.0427119	-0.860276	0.42 [0.18 - 0.97]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211631_x_at	67	0.507463	0.0555624	-	1.41964	0.15095	1.02995	2.80 [0.69 - 11.42]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201883_s_at	67	0.343284	0.102483	-	1.57461	0.793678	0.193525	1.21 [0.28 - 5.17]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	216627_s_at	115	0.843478	0.0204408	0.272098	1.21292	0.38999	0.365545	1.44 [0.63 - 3.32]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211631_x_at	115	0.773913	0.0517221	-	1.00331	0.328572	0.769577	2.16 [0.46 - 10.11]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	229403_at	115	0.426087	0.0992056	-	-0.893089	0.627453	-0.20457	0.81 [0.36 - 1.86]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	238987_at	115	0.426087	0.0928713	-	-0.909204	0.617568	-0.223681	0.80 [0.33 - 1.92]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201883_s_at	115	0.843478	0.129023	-	0.866688	0.815195	0.20125	1.22 [0.23 - 6.61]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201882_x_at	115	0.321739	0.129847	-	1.09854	0.582638	0.349283	1.42 [0.41 - 4.93]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32772_s_at	158	0.810127	0.238909	-	-0.477717	0.812307	0.0466679	1.05 [0.71 - 1.54]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40960_at	158	0.120253	0.0576221	-	1.28489	0.730447	0.0882832	1.09 [0.66 - 1.80]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32772_s_at	76	0.868421	0.0799112	-	0.984886	0.537758	0.287165	1.33 [0.53 - 3.32]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40960_at	76	0.118421	0.0361563	0.400724	-1.16169	0.886971	-0.0977185	0.91 [0.24 - 3.49]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	229403_at	204	0.651961	0.131342	-	-0.219649	0.759427	-0.0200967	0.98 [0.86 - 1.11]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	216627_s_at	204	0.142157	0.0533247	-	0.383942	0.587768	0.0374689	1.04 [0.91 - 1.19]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	238987_at	204	0.235294	0.0166715	0.235326	-0.399664	0.08813	-0.179934	0.84 [0.68 - 1.03]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211631_x_at	204	0.813725	0.22907	-	-0.215205	0.90331	-0.0129529	0.99 [0.80 - 1.22]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201883_s_at	204	0.818627	0.0469147	0.472766	-0.368588	0.521239	-0.0991789	0.91 [0.67 - 1.23]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201882_x_at	204	0.460784	0.0344382	0.388187	0.305097	0.138149	0.129582	1.14 [0.96 - 1.35]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201883_s_at	87	0.873563	0.0830577	-	-1.59295	0.949352	-0.0205612	0.98 [0.52 - 1.85]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	216627_s_at	87	0.632184	0.0833436	-	0.643748	0.887188	-0.0731137	0.93 [0.34 - 2.55]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201882_x_at	87	0.114943	0.165308	-	1.3165	0.895946	-0.114025	0.89 [0.16 - 4.93]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211631_x_at	87	0.114943	0.102714	-	1.51418	0.513748	0.45881	1.58 [0.40 - 6.27]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	216627_s_at	87	0.632184	0.0833436	-	0.643748	0.887188	-0.0731137	0.93 [0.34 - 2.55]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201883_s_at	87	0.873563	0.0830577	-	-1.59295	0.949352	-0.0205612	0.98 [0.52 - 1.85]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211631_x_at	87	0.114943	0.102714	-	1.51418	0.513748	0.45881	1.58 [0.40 - 6.27]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201882_x_at	87	0.114943	0.165308	-	1.3165	0.895946	-0.114025	0.89 [0.16 - 4.93]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	229403_at	87	0.850575	0.0430667	0.448184	-1.80699	0.244989	-1.35648	0.26 [0.03 - 2.54]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	229403_at	87	0.850575	0.0430667	0.448184	-1.80699	0.244989	-1.35648	0.26 [0.03 - 2.54]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	238987_at	87	0.413793	0.0604642	-	-0.69875	0.19839	-0.31464	0.73 [0.45 - 1.18]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	238987_at	87	0.413793	0.0604642	-	-0.69875	0.19839	-0.31464	0.73 [0.45 - 1.18]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	229403_at	77	0.116883	0.000344587	0.0102962	-1.99282	0.0392257	-4.92228	0.01 [0.00 - 0.78]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	216627_s_at	77	0.376623	0.0750638	-	1.27998	0.781858	0.102144	1.11 [0.54 - 2.28]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	238987_at	77	0.662338	0.326959	-	-0.756951	0.968128	0.0167753	1.02 [0.45 - 2.32]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201883_s_at	77	0.766234	0.00131449	0.0320255	1.8196	0.0263308	1.24814	3.48 [1.16 - 10.48]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211631_x_at	77	0.883117	0.112821	-	1.00915	0.32238	0.680525	1.97 [0.51 - 7.60]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201882_x_at	77	0.142857	0.0175981	0.244644	-1.41288	0.196669	-2.14238	0.12 [0.00 - 3.03]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201883_s_at	77	0.766234	0.0194633	0.262841	1.22512	0.215562	0.651229	1.92 [0.68 - 5.38]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	216627_s_at	77	0.597403	0.201516	-	-0.971409	0.521701	-0.360905	0.70 [0.23 - 2.10]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201882_x_at	77	0.493506	0.0291005	0.347094	-1.33547	0.379749	-1.26338	0.28 [0.02 - 4.74]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	229403_at	77	0.116883	0.00560914	0.103573	-1.52515	0.0793543	-3.46988	0.03 [0.00 - 1.50]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	238987_at	77	0.38961	0.221597	-	0.784418	0.331092	0.342761	1.41 [0.71 - 2.81]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211631_x_at	77	0.61039	0.215036	-	-0.945146	0.919135	-0.0946592	0.91 [0.15 - 5.66]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201882_x_at	136	0.897059	0.0160421	0.228882	1.18613	0.370447	0.252858	1.29 [0.74 - 2.24]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201883_s_at	136	0.852941	0.238241	-	-1.14713	0.366213	-0.252421	0.78 [0.45 - 1.34]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211631_x_at	136	0.25	0.0599991	-	-0.82629	0.651264	-0.183903	0.83 [0.37 - 1.85]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	216627_s_at	136	0.477941	0.152135	-	0.66333	0.969475	0.00875886	1.01 [0.64 - 1.58]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	216627_s_at	200	0.895	0.160824	-	0.568349	0.689072	0.107311	1.11 [0.66 - 1.88]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201882_x_at	200	0.55	0.0177172	0.245828	0.703797	0.111355	0.343123	1.41 [0.92 - 2.15]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201883_s_at	200	0.63	0.115661	-	-0.510169	0.309614	-0.331771	0.72 [0.38 - 1.36]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211631_x_at	200	0.205	0.0745724	-	-0.579022	0.582793	0.240012	1.27 [0.54 - 2.99]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20136	60	0.166667	0.291221	-	0.634759	0.859635	-0.0599917	0.94 [0.48 - 1.83]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20136	60	0.8	0.153722	-	0.591706	0.518682	0.252961	1.29 [0.60 - 2.78]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3791	155	0.690323	6.67436e-06	0.000309581	1.19588	0.000295493	0.335857	1.40 [1.17 - 1.68]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	216627_s_at	286	0.72028	0.0790386	-	-0.405056	0.671317	-0.0488543	0.95 [0.76 - 1.19]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201882_x_at	286	0.877622	0.0128871	0.195057	-1.00185	0.0838171	-0.226275	0.80 [0.62 - 1.03]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201883_s_at	286	0.835664	0.120681	-	0.376826	0.649433	0.116511	1.12 [0.68 - 1.86]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211631_x_at	286	0.15035	0.17375	-	0.41373	0.798737	0.0629934	1.07 [0.66 - 1.73]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216627_s_at	159	0.138365	0.0496991	0.489816	-0.727008	0.185993	-0.234913	0.79 [0.56 - 1.12]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201882_x_at	159	0.157233	0.111258	-	0.923193	0.227525	0.267675	1.31 [0.85 - 2.02]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201883_s_at	159	0.792453	0.0510083	-	0.661858	0.637793	0.158433	1.17 [0.61 - 2.27]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216627_s_at	159	0.125786	0.108143	-	-0.721416	0.409537	-0.177368	0.84 [0.55 - 1.28]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201882_x_at	159	0.157233	0.130591	-	1.05802	0.344881	0.243955	1.28 [0.77 - 2.12]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211631_x_at	159	0.893082	0.1039	-	0.664946	0.84443	-0.0858876	0.92 [0.39 - 2.16]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201883_s_at	159	0.72327	0.196267	-	0.425495	0.540226	0.20512	1.23 [0.64 - 2.37]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	216627_s_at	159	0.842767	0.0989861	-	-0.954181	0.535292	-0.115965	0.89 [0.62 - 1.28]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201882_x_at	159	0.100629	0.0749311	-	1.62057	0.217172	0.271761	1.31 [0.85 - 2.02]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201883_s_at	159	0.792453	0.0674431	-	0.719134	0.561952	0.230416	1.26 [0.58 - 2.74]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211631_x_at	159	0.100629	0.0112347	0.17618	-0.965931	0.395602	-0.368149	0.69 [0.30 - 1.62]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211631_x_at	159	0.899371	0.165788	-	0.669208	0.724524	-0.180654	0.83 [0.31 - 2.28]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229403_at	159	0.899371	0.0155399	0.223673	0.924294	0.223249	0.224324	1.25 [0.87 - 1.80]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229403_at	159	0.213836	0.0250605	0.313547	-0.73947	0.575204	-0.104118	0.90 [0.63 - 1.30]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229403_at	159	0.899371	0.00464625	0.0893233	1.16303	0.390075	0.185818	1.20 [0.79 - 1.84]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238987_at	159	0.874214	0.106392	-	-1.1134	0.570029	-0.13362	0.87 [0.55 - 1.39]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238987_at	159	0.874214	0.00877625	0.14628	-15.2574	0.406912	-0.191855	0.83 [0.52 - 1.30]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	238987_at	159	0.754717	0.0267049	0.32748	-1.48419	0.299278	-0.276696	0.76 [0.45 - 1.28]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211631_x_at	54	0.425926	0.108193	-	-1.09621	0.431838	-0.578735	0.56 [0.13 - 2.37]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201882_x_at	54	0.740741	0.108702	-	1.04029	0.594603	0.706282	2.03 [0.15 - 27.32]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	216627_s_at	54	0.314815	0.0687305	-	1.75212	0.941315	0.0284223	1.03 [0.48 - 2.19]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201883_s_at	54	0.203704	0.00572484	0.105239	-1.73313	0.579228	-0.233015	0.79 [0.35 - 1.81]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201883_s_at	117	0.888889	0.0732313	-	0.732357	0.735482	0.0774362	1.08 [0.69 - 1.69]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201883_s_at	117	0.282051	0.00358626	0.0727027	-1.09855	0.389981	-0.259254	0.77 [0.43 - 1.39]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211631_x_at	117	0.863248	0.227861	-	-0.629547	0.909123	-0.0385431	0.96 [0.50 - 1.87]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216627_s_at	117	0.82906	0.172257	-	-0.708405	0.361641	-0.314076	0.73 [0.37 - 1.43]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216627_s_at	117	0.811966	0.099285	-	-1.14613	0.562853	-0.229081	0.80 [0.37 - 1.73]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201882_x_at	117	0.837607	0.0773737	-	0.660352	0.918681	-0.0835753	0.92 [0.18 - 4.58]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211631_x_at	117	0.863248	0.106816	-	-1.50058	0.339537	-0.486178	0.61 [0.23 - 1.67]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201882_x_at	117	0.863248	0.0359798	0.39945	0.887521	0.641072	0.40797	1.50 [0.27 - 8.36]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211631_x_at	117	0.863248	0.227861	-	-0.629547	0.909123	-0.0385431	0.96 [0.50 - 1.87]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216627_s_at	117	0.82906	0.172257	-	-0.708405	0.361641	-0.314076	0.73 [0.37 - 1.43]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	216627_s_at	117	0.794872	0.00714043	0.124917	-15.398	0.0396011	-2.01291	0.13 [0.02 - 0.91]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201882_x_at	117	0.837607	0.0773737	-	0.660352	0.918681	-0.0835753	0.92 [0.18 - 4.58]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201882_x_at	117	0.863248	0.0935492	-	0.763863	0.954875	0.0560068	1.06 [0.15 - 7.36]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201883_s_at	117	0.888889	0.0211224	0.278445	1.02033	0.46976	0.191464	1.21 [0.72 - 2.04]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201883_s_at	117	0.888889	0.0732313	-	0.732357	0.735482	0.0774362	1.08 [0.69 - 1.69]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211631_x_at	117	0.162393	0.250495	-	0.688851	0.64315	0.176553	1.19 [0.57 - 2.52]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201883_s_at	236	0.894068	0.0692476	-	0.65105	0.551655	0.182809	1.20 [0.66 - 2.19]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211631_x_at	236	0.864407	0.266747	-	0.401711	0.570718	0.272286	1.31 [0.51 - 3.37]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	216627_s_at	236	0.20339	0.091777	-	0.670373	0.513101	0.107476	1.11 [0.81 - 1.54]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201882_x_at	236	0.165254	0.0348325	0.391092	1.0472	0.813308	0.0514876	1.05 [0.69 - 1.61]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	229403_at	236	0.309322	0.104149	-	0.524621	0.282764	0.223822	1.25 [0.83 - 1.88]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	238987_at	236	0.101695	0.00376813	0.0756344	-0.944583	0.0169818	-0.422563	0.66 [0.46 - 0.93]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211631_x_at	249	0.228916	0.192847	-	-0.305309	0.53655	-0.248051	0.78 [0.36 - 1.71]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	216627_s_at	249	0.305221	0.166299	-	0.334174	0.72894	0.044884	1.05 [0.81 - 1.35]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201882_x_at	249	0.899598	0.0306275	0.359201	-1.05643	0.775164	-0.0491527	0.95 [0.68 - 1.33]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201883_s_at	249	0.883534	0.0151658	0.219752	0.679019	0.209702	0.303034	1.35 [0.84 - 2.17]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	238987_at	249	0.100402	0.0872098	-	-0.525407	0.0641019	-0.30935	0.73 [0.53 - 1.02]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	229403_at	249	0.184739	0.0512146	-	0.643481	0.75821	0.0510746	1.05 [0.76 - 1.46]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201882_x_at	54	0.240741	0.0715132	-	15.412	0.626234	0.477131	1.61 [0.24 - 10.99]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211631_x_at	62	0.758065	0.159201	-	0.679223	0.902776	-0.0336939	0.97 [0.56 - 1.66]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201883_s_at	125	0.872	0.0789261	-	0.851399	0.994538	0.0021468	1.00 [0.54 - 1.85]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201883_s_at	125	0.872	0.00425139	0.0832583	1.03776	0.428121	0.194261	1.21 [0.75 - 1.96]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201883_s_at	54	0.222222	0.018125	0.249859	-1.33984	0.569842	-0.108673	0.90 [0.62 - 1.30]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216627_s_at	62	0.870968	0.225637	-	0.685674	0.950152	-0.014047	0.99 [0.63 - 1.53]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211631_x_at	125	0.344	0.0861902	-	-0.65298	0.876683	-0.105105	0.90 [0.24 - 3.40]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211631_x_at	125	0.464	0.0762113	-	-0.525811	0.814907	-0.123429	0.88 [0.31 - 2.48]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211631_x_at	54	0.740741	0.221479	-	0.708675	0.817598	-0.0769487	0.93 [0.48 - 1.78]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201882_x_at	62	0.241935	0.0288138	0.344788	15.3996	0.541622	0.500481	1.65 [0.33 - 8.23]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216627_s_at	125	0.368	0.190565	-	-0.491308	0.975566	-0.0219094	0.98 [0.24 - 3.98]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201882_x_at	125	0.88	0.0795063	-	-1.62918	0.583376	0.232197	1.26 [0.55 - 2.89]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216627_s_at	125	0.776	0.186396	-	0.41538	0.687517	0.212795	1.24 [0.44 - 3.49]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	216627_s_at	54	0.888889	0.190008	-	0.866636	0.820848	-0.0627226	0.94 [0.55 - 1.62]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201883_s_at	62	0.112903	0.012308	0.188541	-1.36987	0.483647	-0.111896	0.89 [0.65 - 1.22]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201882_x_at	125	0.848	0.0297717	0.352453	-1.06479	0.754958	-0.102532	0.90 [0.47 - 1.72]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201882_x_at	198	0.550505	0.0166399	0.235004	-0.517676	0.0558271	-0.192871	0.82 [0.68 - 1.00]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211631_x_at	198	0.782828	0.190874	-	0.367358	0.482711	0.14328	1.15 [0.77 - 1.72]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211631_x_at	198	0.89899	0.119129	-	-0.896626	0.651513	0.0959857	1.10 [0.73 - 1.67]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216627_s_at	198	0.388889	0.0716992	-	0.499598	0.666821	0.0562685	1.06 [0.82 - 1.37]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216627_s_at	198	0.388889	0.136461	-	0.429823	0.917694	0.0139955	1.01 [0.78 - 1.32]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201882_x_at	198	0.106061	0.0312987	0.364431	-0.732994	0.471463	-0.0869018	0.92 [0.72 - 1.16]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201883_s_at	198	0.10101	0.0433268	0.449885	0.905716	0.937008	-0.0145764	0.99 [0.69 - 1.41]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201882_x_at	198	0.106061	0.0218089	0.284754	-0.784681	0.31871	-0.12838	0.88 [0.68 - 1.13]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211631_x_at	198	0.767677	0.0127557	0.193588	0.556788	0.278042	0.182875	1.20 [0.86 - 1.67]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201883_s_at	198	0.207071	0.171447	-	0.488657	0.80609	-0.0557566	0.95 [0.61 - 1.48]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201883_s_at	198	0.873737	0.153448	-	-0.725114	0.532588	-0.152263	0.86 [0.53 - 1.39]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	216627_s_at	198	0.388889	0.0107468	0.170431	0.578488	0.227207	0.131794	1.14 [0.92 - 1.41]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201883_s_at	51	0.882353	0.0430256	0.447915	1.65504	0.233264	1.45538	4.29 [0.39 - 46.92]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201883_s_at	62	0.709677	0.167123	-	-1.34045	0.970014	-0.0314146	0.97 [0.19 - 4.99]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211631_x_at	51	0.588235	0.338397	-	0.848958	0.875898	0.264289	1.30 [0.05 - 35.92]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211631_x_at	62	0.693548	0.0929684	-	0.938152	0.585864	0.593325	1.81 [0.21 - 15.30]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	216627_s_at	51	0.117647	0.0310139	0.362219	-1.74498	0.141929	-4.24465	0.01 [0.00 - 4.14]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201882_x_at	51	0.784314	0.235924	-	-15.4008	0.930731	-0.143475	0.87 [0.03 - 22.01]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	216627_s_at	62	0.516129	0.0551041	-	-1.20795	0.132053	-2.67001	0.07 [0.00 - 2.24]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201882_x_at	62	0.83871	0.115753	-	-15.3033	0.987428	0.0166038	1.02 [0.13 - 8.02]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211631_x_at	177	0.322034	0.190968	-	-0.312909	0.567566	-0.220972	0.80 [0.38 - 1.71]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	216627_s_at	145	0.758621	0.0208249	0.275686	0.787261	0.184847	0.349843	1.42 [0.85 - 2.38]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201883_s_at	177	0.423729	0.0147159	0.214989	0.713302	0.0448602	0.601191	1.82 [1.01 - 3.28]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211631_x_at	145	0.896552	0.097405	-	0.72625	0.13986	0.746655	2.11 [0.78 - 5.69]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201882_x_at	177	0.107345	0.141453	-	-0.598207	0.382421	-0.527499	0.59 [0.18 - 1.93]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201883_s_at	177	0.508475	0.00580826	0.106434	0.660986	0.0703735	0.473004	1.60 [0.96 - 2.68]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201882_x_at	177	0.107345	0.0251827	0.314597	-0.763555	0.184484	-0.701414	0.50 [0.18 - 1.40]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	229403_at	177	0.79661	0.0573309	-	-0.802465	0.256332	-0.859013	0.42 [0.10 - 1.87]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201883_s_at	145	0.365517	0.00219785	0.0489302	1.28427	0.0119063	0.899613	2.46 [1.22 - 4.96]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	216627_s_at	177	0.655367	0.0397987	0.426303	0.562573	0.745622	0.0754864	1.08 [0.68 - 1.70]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	229403_at	177	0.79661	0.0497533	0.490142	-0.686784	0.346393	-0.61981	0.54 [0.15 - 1.95]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	238987_at	177	0.112994	0.0693491	-	0.902808	0.217953	0.316202	1.37 [0.83 - 2.27]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	238987_at	177	0.864407	0.0292009	0.3479	0.687695	0.063188	0.510529	1.67 [0.97 - 2.86]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201882_x_at	145	0.668966	0.122264	-	-0.588203	0.54866	-0.47333	0.62 [0.13 - 2.93]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	238987_at	145	0.331034	0.0230941	0.296342	0.98015	0.835577	0.0885263	1.09 [0.47 - 2.52]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211631_x_at	177	0.728814	0.291323	-	0.310204	0.989573	0.00572503	1.01 [0.43 - 2.37]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	216627_s_at	177	0.644068	0.0731829	-	0.430128	0.803459	0.0505879	1.05 [0.71 - 1.57]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	229403_at	145	0.793103	0.0312573	0.36411	-1.22264	0.427149	-0.724854	0.48 [0.08 - 2.90]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211631_x_at	226	0.163717	0.0154094	0.22231	1.58016	0.186791	0.267032	1.31 [0.88 - 1.94]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201883_s_at	226	0.340708	0.0235803	0.300653	0.781118	0.108431	0.387418	1.47 [0.92 - 2.36]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201882_x_at	226	0.876106	0.29136	-	0.389224	0.718831	0.0499295	1.05 [0.80 - 1.38]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	229403_at	226	0.80531	0.164218	-	-0.597762	0.713895	-0.0505269	0.95 [0.73 - 1.25]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	238987_at	226	0.50885	0.0086195	0.144289	0.766789	0.589288	0.116552	1.12 [0.74 - 1.72]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	216627_s_at	226	0.823009	0.021741	0.284133	0.728638	0.087147	0.295547	1.34 [0.96 - 1.89]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211631_x_at	55	0.709091	0.00997293	0.161131	-2.14942	0.0113325	-2.41655	0.09 [0.01 - 0.58]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201883_s_at	55	0.309091	0.0480981	0.480085	-0.863437	0.137433	-0.604333	0.55 [0.25 - 1.21]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211631_x_at	49	0.673469	0.02752	0.334242	-1.97284	0.0584703	-1.9547	0.14 [0.02 - 1.07]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201882_x_at	55	0.672727	0.00932942	0.15322	-1.72023	0.0956991	-1.73091	0.18 [0.02 - 1.36]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	229403_at	55	0.381818	0.00482336	0.0919995	-1.21962	0.035341	-3.406	0.03 [0.00 - 0.79]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201883_s_at	55	0.890909	0.185291	-	0.749467	0.760108	0.134796	1.14 [0.48 - 2.72]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	238987_at	55	0.690909	0.170827	-	-0.749302	0.718672	-0.205686	0.81 [0.27 - 2.49]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201883_s_at	49	0.489796	0.0796709	-	-1.05225	0.310011	-0.519154	0.60 [0.22 - 1.62]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201882_x_at	55	0.381818	0.0261458	0.322788	-1.06388	0.136919	-1.80593	0.16 [0.02 - 1.78]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	216627_s_at	55	0.163636	0.0495032	0.488636	-0.933156	0.139592	-0.634699	0.53 [0.23 - 1.23]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201882_x_at	49	0.612245	0.0144519	0.212169	-2.1315	0.105727	-2.06385	0.13 [0.01 - 1.55]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211631_x_at	55	0.690909	0.0498374	0.490647	-1.1635	0.168064	-1.01606	0.36 [0.09 - 1.54]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	229403_at	55	0.381818	0.0148948	0.216889	-1.13473	0.152998	-2.40476	0.09 [0.00 - 2.44]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	216627_s_at	55	0.618182	0.00581771	0.106569	-1.78372	0.0204093	-1.25281	0.29 [0.10 - 0.82]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	238987_at	55	0.581818	0.129574	-	-0.758577	0.302286	-0.715328	0.49 [0.13 - 1.90]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	229403_at	49	0.857143	0.217773	-	0.801084	0.648678	-0.967371	0.38 [0.01 - 24.39]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	216627_s_at	49	0.306122	0.0668796	-	-1.02509	0.109255	-0.929353	0.39 [0.13 - 1.23]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	238987_at	49	0.673469	0.0684431	-	-1.69415	0.231579	-1.08301	0.34 [0.06 - 2.00]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	487172	34	0.294118	0.0259225	0.320901	1.3022	0.112395	0.793534	2.21 [0.83 - 5.89]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201883_s_at	63	0.507937	0.00353342	0.071844	1.00074	0.0577549	0.457609	1.58 [0.99 - 2.54]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201882_x_at	63	0.126984	2.15166e-05	0.000891985	-1.65991	0.238093	-2.89556	0.06 [0.00 - 6.79]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	229403_at	63	0.238095	0.0475547	0.476738	-0.693471	0.915249	-0.255123	0.77 [0.01 - 85.08]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	238987_at	63	0.253968	0.00362517	0.0733329	-0.993735	0.282302	-1.38455	0.25 [0.02 - 3.13]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	216627_s_at	63	0.269841	0.0163281	0.231822	-0.809632	0.132375	-7.40954	0.00 [0.00 - 9.41]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211631_x_at	63	0.174603	0.000578565	0.0160482	-1.23537	0.455614	-0.616658	0.54 [0.11 - 2.73]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.198248.3.S1_3p_s_at	28	0.285714	0.0473916	0.475729	-1.11911	0.812405	0.351946	1.42 [0.08 - 26.01]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g474986_3p_a_at	28	0.821429	0.0229761	0.29529	1.37487	0.758774	0.100221	1.11 [0.58 - 2.10]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.198248.0.S1_3p_s_at	28	0.107143	0.12219	-	-1.16158	0.227616	-2.21277	0.11 [0.00 - 3.98]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g474986_3p_x_at	28	0.785714	0.027653	0.335337	1.23725	0.614485	0.126317	1.13 [0.69 - 1.85]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.198248.2.A1_3p_at	28	0.75	0.132812	-	-1.11021	0.785494	-0.358213	0.70 [0.05 - 9.22]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.176725.0.S1_3p_at	28	0.5	0.288703	-	-0.604635	0.715536	-0.455252	0.63 [0.05 - 7.34]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201882_x_at	82	0.231707	0.0409013	0.433794	1.04011	0.460917	0.346166	1.41 [0.56 - 3.55]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201883_s_at	82	0.134146	0.0141428	0.208843	-0.96318	0.277164	-0.555634	0.57 [0.21 - 1.56]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211631_x_at	82	0.487805	0.0759811	-	0.61492	0.749628	0.207629	1.23 [0.34 - 4.41]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	216627_s_at	82	0.329268	0.177386	-	0.534876	0.53122	0.255638	1.29 [0.58 - 2.87]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40960_at	84	0.428571	0.193178	-	-0.377598	0.935293	-0.0356774	0.96 [0.41 - 2.28]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201882_x_at	79	0.607595	0.247969	-	0.302024	0.666055	0.199225	1.22 [0.49 - 3.02]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201883_s_at	79	0.544304	0.069475	-	0.475603	0.381934	0.378436	1.46 [0.63 - 3.41]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211631_x_at	79	0.151899	0.022354	0.289703	-0.75504	0.85543	0.106369	1.11 [0.35 - 3.49]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	216627_s_at	79	0.721519	0.00357109	0.0724565	0.812311	0.0749883	0.467659	1.60 [0.95 - 2.67]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D29805_at	86	0.802326	0.0843283	-	0.732313	0.394587	0.657721	1.93 [0.42 - 8.78]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211631_x_at	104	0.221154	0.1442	-	0.686529	0.83197	0.138533	1.15 [0.32 - 4.13]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	216627_s_at	104	0.557692	0.00685845	0.121094	0.878688	0.0253345	0.926335	2.53 [1.12 - 5.69]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201882_x_at	104	0.807692	0.0891706	-	-0.808903	0.689875	-0.221222	0.80 [0.27 - 2.38]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201883_s_at	104	0.865385	0.120937	-	0.636934	0.365593	0.543231	1.72 [0.53 - 5.58]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P135271	117	0.205128	0.0530097	-	-0.603539	0.391193	-0.161078	0.85 [0.59 - 1.23]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P103803	117	0.333333	0.12094	-	0.511408	0.658954	0.107742	1.11 [0.69 - 1.80]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201882_x_at	204	0.735294	2.61352e-05	0.00106211	1.09526	0.00234776	0.595077	1.81 [1.24 - 2.66]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	229403_at	204	0.455882	0.000625889	0.0171579	-1.31896	0.0740663	-0.487934	0.61 [0.36 - 1.05]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	216627_s_at	204	0.676471	0.000384325	0.01131	1.23448	0.0661747	0.647618	1.91 [0.96 - 3.81]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	238987_at	204	0.357843	0.00993942	0.160724	-0.919335	0.150554	-0.588156	0.56 [0.25 - 1.24]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	229403_at	204	0.431373	0.00366421	0.0739637	-0.786109	0.20356	-0.252413	0.78 [0.53 - 1.15]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	216627_s_at	204	0.794118	0.000117194	0.00402696	1.0533	0.0328975	0.539595	1.72 [1.04 - 2.82]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	238987_at	204	0.504902	0.000403193	0.0117853	-1.03084	0.00808735	-0.80662	0.45 [0.25 - 0.81]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211631_x_at	204	0.495098	0.000239839	0.00752672	1.52778	0.00958181	1.41637	4.12 [1.41 - 12.04]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211631_x_at	204	0.573529	0.000920916	0.0237815	0.896183	0.0399412	0.705225	2.02 [1.03 - 3.97]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201883_s_at	204	0.240196	0.00103325	0.0261938	15.5044	0.00411551	1.49535	4.46 [1.61 - 12.39]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201883_s_at	204	0.485294	3.71712e-07	2.17883e-05	1.5608	6.35727e-06	1.80327	6.07 [2.77 - 13.28]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201882_x_at	204	0.852941	0.00156132	0.0369393	1.16138	0.0202974	0.590279	1.80 [1.10 - 2.97]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201883_s_at	178	0.707865	0.000676825	0.018336	0.682082	0.0181976	0.813987	2.26 [1.15 - 4.44]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211631_x_at	178	0.842697	0.0326582	0.374858	0.536869	0.865735	0.0750411	1.08 [0.45 - 2.57]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	216627_s_at	178	0.820225	0.0128068	0.19416	0.57378	0.128713	0.371224	1.45 [0.90 - 2.34]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201882_x_at	178	0.168539	0.0873781	-	0.539336	0.125191	0.530334	1.70 [0.86 - 3.35]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	216627_s_at	111	0.234234	0.0967514	-	0.54948	0.264987	0.150453	1.16 [0.89 - 1.51]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211631_x_at	111	0.18018	0.166467	-	0.550842	0.844508	0.0537359	1.06 [0.62 - 1.81]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	229403_at	111	0.486486	0.0151735	0.219833	0.639501	0.162402	0.189997	1.21 [0.93 - 1.58]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	238987_at	111	0.36036	0.269594	-	0.31655	0.895519	0.0250017	1.03 [0.71 - 1.49]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201883_s_at	111	0.747748	0.000192842	0.00622654	0.985218	0.0369183	0.543772	1.72 [1.03 - 2.87]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201882_x_at	111	0.315315	0.190115	-	0.389926	0.919095	-0.0159286	0.98 [0.72 - 1.34]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201883_s_at	90	0.466667	0.232516	-	-0.387672	0.3346	-0.305381	0.74 [0.40 - 1.37]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201883_s_at	90	0.466667	0.280814	-	-0.40048	0.275255	-0.395182	0.67 [0.33 - 1.37]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211631_x_at	90	0.477778	0.260997	-	0.368208	0.801142	0.159335	1.17 [0.34 - 4.05]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211631_x_at	90	0.422222	0.0711298	-	0.734448	0.425272	0.553152	1.74 [0.45 - 6.77]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	216627_s_at	90	0.877778	0.0239068	0.303527	0.873913	0.403614	0.315928	1.37 [0.65 - 2.88]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	216627_s_at	90	0.877778	0.0148166	0.21606	1.01663	0.248474	0.473127	1.61 [0.72 - 3.58]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201882_x_at	90	0.744444	0.139731	-	-0.647695	0.750694	0.183052	1.20 [0.39 - 3.71]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201882_x_at	90	0.388889	0.215611	-	0.494888	0.436442	0.496902	1.64 [0.47 - 5.75]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	2501	50	0.76	0.00816615	0.138467	-15.5712	0.573303	-0.188661	0.83 [0.43 - 1.60]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	34	50	0.7	0.0133498	0.200191	-2.12376	0.647965	-0.20563	0.81 [0.34 - 1.97]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	216627_s_at	138	0.898551	0.00139513	0.0336499	1.01283	0.00379997	0.434404	1.54 [1.15 - 2.07]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211631_x_at	138	0.891304	0.00379298	0.0760322	0.926094	0.000188749	0.644065	1.90 [1.36 - 2.67]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	229403_at	138	0.884058	0.0126492	0.192394	-1.36535	0.0293349	-4.39769	0.01 [0.00 - 0.64]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	238987_at	138	0.311594	0.00176409	0.0408561	-0.749205	0.652442	-0.0810847	0.92 [0.65 - 1.31]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201883_s_at	138	0.123188	0.211873	-	-0.408421	0.431333	-0.160647	0.85 [0.57 - 1.27]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201882_x_at	138	0.84058	0.0362534	0.401423	0.606791	0.0420685	0.861606	2.37 [1.03 - 5.43]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211631_x_at	129	0.790698	0.0550171	-	0.528732	0.574275	0.174521	1.19 [0.65 - 2.19]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	216627_s_at	129	0.891473	0.0109629	0.172987	0.867925	0.881979	-0.0215578	0.98 [0.74 - 1.30]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201882_x_at	129	0.341085	0.0396323	0.425163	-0.520731	0.337816	-0.196532	0.82 [0.55 - 1.23]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201883_s_at	129	0.139535	0.26443	-	-0.383644	0.651135	-0.131174	0.88 [0.50 - 1.55]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201883_s_at	278	0.802158	0.0143738	0.211331	0.537118	0.224232	0.197296	1.22 [0.89 - 1.67]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201882_x_at	278	0.744604	0.00860308	0.14408	-0.587608	0.281648	-0.327378	0.72 [0.40 - 1.31]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	229403_at	278	0.586331	0.110648	-	-0.309145	0.314759	-0.584453	0.56 [0.18 - 1.74]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	216627_s_at	278	0.68705	0.000133138	0.00450404	-0.852405	0.0472588	-0.330584	0.72 [0.52 - 1.00]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	238987_at	278	0.100719	0.0219023	0.285605	-0.614611	0.0413699	-0.214502	0.81 [0.66 - 0.99]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211631_x_at	278	0.597122	0.00438241	0.0852863	-0.566098	0.054937	-0.496499	0.61 [0.37 - 1.01]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211631_x_at	133	0.488722	0.00347503	0.0708915	0.696451	0.941743	-0.0130859	0.99 [0.69 - 1.40]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	216627_s_at	133	0.293233	0.0499034	0.491044	0.547433	0.760399	0.0367875	1.04 [0.82 - 1.31]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201882_x_at	133	0.105263	0.0450702	0.461136	0.805372	0.234766	0.52347	1.69 [0.71 - 4.00]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201883_s_at	133	0.218045	0.374958	-	-0.255999	0.722352	-0.0433087	0.96 [0.75 - 1.22]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211631_x_at	185	0.837838	0.210025	-	-0.333876	0.74794	-0.0821831	0.92 [0.56 - 1.52]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201882_x_at	185	0.172973	0.0259878	0.321453	-0.447978	0.275641	-0.304557	0.74 [0.43 - 1.28]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201883_s_at	185	0.2	0.0352407	0.394082	0.544014	0.713232	-0.0432735	0.96 [0.76 - 1.21]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216627_s_at	185	0.735135	0.139595	-	-0.284135	0.97516	0.00779975	1.01 [0.62 - 1.65]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201882_x_at	185	0.627027	0.0380919	0.41448	-0.385051	0.261604	-0.344898	0.71 [0.39 - 1.29]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211631_x_at	185	0.837838	0.174335	-	-0.328162	0.827385	-0.0498484	0.95 [0.61 - 1.49]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	216627_s_at	185	0.735135	0.0723403	-	-0.387223	0.772548	-0.0790844	0.92 [0.54 - 1.58]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201883_s_at	185	0.567568	0.154221	-	-0.239061	0.386682	-0.0940066	0.91 [0.74 - 1.13]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P103803	110	0.309091	0.0163014	0.231548	-0.570144	0.967397	0.00613453	1.01 [0.75 - 1.35]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P103803	110	0.254545	0.0553047	-	-0.606876	0.872507	-0.0276239	0.97 [0.69 - 1.36]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	216627_s_at	80	0.85	0.102549	-	0.827012	0.966331	0.00792772	1.01 [0.70 - 1.46]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201882_x_at	80	0.5875	0.0187106	0.255585	-1.16695	0.168757	-0.278028	0.76 [0.51 - 1.13]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201883_s_at	80	0.575	0.285656	-	-0.492321	0.73349	-0.108686	0.90 [0.48 - 1.68]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211631_x_at	80	0.775	0.120577	-	0.691861	0.766064	-0.121578	0.89 [0.40 - 1.97]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_2721	281	0.103203	0.0989829	-	0.398616	0.660362	0.04495	1.05 [0.86 - 1.28]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211631_x_at	38	0.157895	0.0299819	0.354119	15.3756	0.123848	0.985053	2.68 [0.76 - 9.39]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	229403_at	38	0.394737	0.0057832	0.106075	-1.23107	0.0389413	-0.305373	0.74 [0.55 - 0.98]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	238987_at	38	0.894737	0.0767711	-	-15.2801	0.359885	-0.364692	0.69 [0.32 - 1.52]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201883_s_at	38	0.710526	0.0145994	0.213746	1.25543	0.072822	0.816702	2.26 [0.93 - 5.52]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201882_x_at	38	0.105263	0.0940162	-	-1.03591	0.631461	-0.350333	0.70 [0.17 - 2.95]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	216627_s_at	38	0.631579	0.000378209	0.0111551	1.63109	0.00805256	0.734343	2.08 [1.21 - 3.59]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201883_s_at	140	0.857143	0.00139686	0.0336846	1.06292	0.0211882	0.758237	2.13 [1.12 - 4.07]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211631_x_at	140	0.742857	0.0725928	-	0.554772	0.749584	0.186856	1.21 [0.38 - 3.80]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	216627_s_at	140	0.357143	0.00415172	0.0817046	1.0176	0.175626	0.769693	2.16 [0.71 - 6.58]
GENE	B4GALT1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201882_x_at	140	0.478571	0.183965	-	-0.38524	0.610308	-0.408778	0.66 [0.14 - 3.20]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209413_at	30	0.766667	0.0743773	-	0.803822	0.827349	-0.165514	0.85 [0.19 - 3.75]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1806508	165	0.775758	0.0176235	0.244897	0.61364	0.11558	0.452008	1.57 [0.89 - 2.76]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1806508	165	0.775758	0.00898962	0.148973	0.922633	0.0639113	0.747659	2.11 [0.96 - 4.66]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209413_at	163	0.834356	0.00198596	0.045034	0.731323	0.541311	0.414137	1.51 [0.40 - 5.71]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209413_at	79	0.151899	0.00528264	0.0988211	-0.953027	0.671219	-0.416552	0.66 [0.10 - 4.51]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209413_at	58	0.241379	0.0137561	0.204646	-0.799717	0.132913	-0.436588	0.65 [0.37 - 1.14]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209413_at	34	0.882353	0.0120889	0.186049	-2.19769	0.174217	-0.550879	0.58 [0.26 - 1.28]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209413_at	158	0.886076	0.000744493	0.0198769	0.968491	0.0223714	1.34076	3.82 [1.21 - 12.08]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209413_at	53	0.867925	0.0176802	0.245461	0.996336	0.241548	0.639449	1.90 [0.65 - 5.53]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209413_at	53	0.867925	0.0143366	0.210932	1.02657	0.20801	0.757583	2.13 [0.66 - 6.94]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209413_at	180	0.194444	0.0889816	-	-0.438767	0.5256	-0.212019	0.81 [0.42 - 1.56]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209413_at	559	0.880143	0.0174618	0.243286	-1.54328	0.570734	-0.0944066	0.91 [0.66 - 1.26]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209413_at	77	0.12987	0.0137723	0.204823	-0.887451	0.788013	0.127964	1.14 [0.45 - 2.89]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209413_at	70	0.885714	0.0439945	0.454225	0.752832	0.977998	0.0170209	1.02 [0.30 - 3.41]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34177_at	50	0.52	0.00509142	0.0960011	1.01299	0.0300002	0.502237	1.65 [1.05 - 2.60]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209413_at	74	0.108108	0.0274534	0.333694	1.46429	0.538292	0.389715	1.48 [0.43 - 5.11]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209413_at	67	0.104478	0.0157436	0.225794	-1.55301	0.169771	-1.86151	0.16 [0.01 - 2.22]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209413_at	115	0.2	0.0911568	-	-0.911541	0.531629	-0.585314	0.56 [0.09 - 3.49]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34177_at	158	0.639241	0.0205111	0.272757	0.645201	0.179005	0.416686	1.52 [0.83 - 2.79]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34177_at	76	0.315789	0.0329171	0.376819	-1.07459	0.271376	-0.648726	0.52 [0.16 - 1.66]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209413_at	204	0.107843	0.0489031	0.485002	-0.448012	0.603196	-0.111962	0.89 [0.59 - 1.36]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209413_at	87	0.551724	0.00675722	0.11971	1.02446	0.098277	1.01418	2.76 [0.83 - 9.18]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209413_at	87	0.551724	0.00675722	0.11971	1.02446	0.098277	1.01418	2.76 [0.83 - 9.18]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209413_at	77	0.532468	0.0559262	-	-1.18941	0.703851	-0.307308	0.74 [0.15 - 3.59]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209413_at	77	0.337662	0.0516983	-	-1.18799	0.678581	-0.382768	0.68 [0.11 - 4.17]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209413_at	136	0.816176	0.0386413	0.418316	0.997318	0.429497	0.417894	1.52 [0.54 - 4.28]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209413_at	200	0.75	0.0536495	-	0.589694	0.31361	0.603098	1.83 [0.57 - 5.91]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4069	60	0.416667	0.195414	-	-0.487519	0.577949	-0.262943	0.77 [0.30 - 1.94]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4069	60	0.516667	0.126232	-	-0.596376	0.930817	-0.0250825	0.98 [0.55 - 1.72]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	14469	155	0.612903	0.00246152	0.0536642	-0.991097	0.0143918	-0.321386	0.73 [0.56 - 0.94]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209413_at	286	0.608392	0.178921	-	0.260576	0.707373	0.134657	1.14 [0.57 - 2.31]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209413_at	159	0.622642	0.192146	-	0.41053	0.375062	0.560141	1.75 [0.51 - 6.04]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209413_at	159	0.289308	0.0504647	-	1.01008	0.42363	0.593906	1.81 [0.42 - 7.76]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209413_at	159	0.289308	0.0341537	0.386081	0.906817	0.859078	0.112738	1.12 [0.32 - 3.89]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209413_at	54	0.759259	0.197463	-	0.916155	0.986591	0.0169466	1.02 [0.14 - 7.34]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209413_at	117	0.803419	0.0632127	-	0.635805	0.801296	0.0983142	1.10 [0.51 - 2.37]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209413_at	117	0.452991	0.114687	-	-0.594211	0.902112	-0.0586218	0.94 [0.37 - 2.40]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209413_at	117	0.803419	0.0632127	-	0.635805	0.801296	0.0983142	1.10 [0.51 - 2.37]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209413_at	117	0.264957	0.155631	-	0.752949	0.998754	0.000794211	1.00 [0.37 - 2.71]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209413_at	236	0.70339	0.127671	-	-0.493436	0.432387	-0.481933	0.62 [0.19 - 2.06]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209413_at	249	0.37751	0.156889	-	-0.301269	0.795232	-0.124858	0.88 [0.34 - 2.27]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209413_at	62	0.564516	0.298485	-	0.510329	0.819667	-0.0445534	0.96 [0.65 - 1.40]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209413_at	125	0.168	0.0233943	0.299009	15.2899	0.913758	0.053018	1.05 [0.40 - 2.75]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209413_at	125	0.88	0.0472773	0.475021	-1.13593	0.336493	-0.399484	0.67 [0.30 - 1.51]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209413_at	54	0.555556	0.297588	-	0.641428	0.889879	-0.0328626	0.97 [0.61 - 1.54]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209413_at	198	0.893939	0.107996	-	-0.919409	0.666093	-0.135936	0.87 [0.47 - 1.62]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209413_at	198	0.893939	0.14174	-	-0.847645	0.601035	-0.1731	0.84 [0.44 - 1.61]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209413_at	198	0.262626	0.211539	-	-0.287274	0.541822	-0.158958	0.85 [0.51 - 1.42]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209413_at	51	0.156863	0.312017	-	15.3005	0.766124	0.421441	1.52 [0.09 - 24.49]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209413_at	62	0.887097	0.200126	-	-15.2107	0.877955	-0.142958	0.87 [0.14 - 5.37]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209413_at	145	0.241379	0.0296764	0.351696	1.09824	0.628078	0.286029	1.33 [0.42 - 4.23]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209413_at	177	0.468927	0.134319	-	-0.407613	0.67127	0.208582	1.23 [0.47 - 3.23]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209413_at	177	0.242938	0.057943	-	0.591841	0.320224	0.421126	1.52 [0.66 - 3.50]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209413_at	226	0.637168	0.160906	-	-0.449868	0.747011	-0.10752	0.90 [0.47 - 1.73]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209413_at	55	0.563636	0.0147615	0.215474	-1.27599	0.182813	-1.05319	0.35 [0.07 - 1.64]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209413_at	55	0.2	0.0690401	-	-0.938362	0.411901	-0.724841	0.48 [0.09 - 2.74]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209413_at	49	0.183673	0.175054	-	-0.810969	0.426706	-0.769162	0.46 [0.07 - 3.09]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209413_at	63	0.888889	0.0714488	-	0.791602	0.979218	-0.0126957	0.99 [0.38 - 2.57]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12803236_3p_at	28	0.428571	0.0496505	0.489523	1.15572	0.347089	0.23417	1.26 [0.78 - 2.06]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209413_at	82	0.256098	0.0278702	0.337119	-0.745939	0.0647889	-0.880534	0.41 [0.16 - 1.06]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	34177_at	84	0.22619	0.00810424	0.137664	1.11228	0.0127875	0.717406	2.05 [1.16 - 3.60]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209413_at	79	0.35443	0.0601584	-	-0.48628	0.655382	-0.158113	0.85 [0.43 - 1.71]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209413_at	104	0.567308	0.273414	-	0.356161	0.668437	0.190765	1.21 [0.51 - 2.90]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P242440	117	0.65812	0.00158408	0.037384	0.878277	0.149148	0.344372	1.41 [0.88 - 2.25]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P353709	117	0.136752	0.0108644	0.171824	-0.886498	0.104432	-0.816897	0.44 [0.16 - 1.18]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P149206	117	0.299145	0.000984301	0.0251491	1.33629	0.0759914	0.515522	1.67 [0.95 - 2.96]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209413_at	204	0.45098	0.0843864	-	-0.632713	0.474227	-0.533292	0.59 [0.14 - 2.53]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209413_at	204	0.843137	0.104943	-	0.525117	0.754341	-0.176083	0.84 [0.28 - 2.53]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209413_at	178	0.134831	0.112457	-	0.525283	0.972906	0.0121169	1.01 [0.50 - 2.04]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200015011	41	0.536585	0.0182412	0.251	0.981166	0.513329	0.245949	1.28 [0.61 - 2.67]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209413_at	111	0.423423	0.00391606	0.0779931	0.802625	0.0165688	0.898133	2.46 [1.18 - 5.12]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209413_at	90	0.211111	0.0367083	0.404685	-0.715191	0.191539	-0.584758	0.56 [0.23 - 1.34]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209413_at	90	0.855556	0.0494604	0.488377	-1.76301	0.190049	-0.668469	0.51 [0.19 - 1.39]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209413_at	138	0.347826	0.0103207	0.165339	0.705347	0.875422	0.0364329	1.04 [0.66 - 1.64]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209413_at	129	0.899225	0.234499	-	-0.547325	0.916823	-0.0577337	0.94 [0.32 - 2.79]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31493	56	0.892857	0.0507514	-	0.936506	0.148209	0.435051	1.55 [0.86 - 2.79]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36876	56	0.285714	0.115353	-	0.625602	0.45407	0.248774	1.28 [0.67 - 2.46]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31493	56	0.892857	0.0470777	0.473781	0.944683	0.44653	0.23891	1.27 [0.69 - 2.35]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36876	56	0.285714	0.0746109	-	0.749	0.238932	0.410889	1.51 [0.76 - 2.99]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209413_at	278	0.874101	0.0297357	0.352167	0.550849	0.847342	0.0505077	1.05 [0.63 - 1.76]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209413_at	133	0.699248	0.020608	0.273663	-0.622967	0.257486	-0.183478	0.83 [0.61 - 1.14]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14651	81	0.679012	0.0106409	0.169171	1.26917	0.211415	0.986447	2.68 [0.57 - 12.60]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5968	81	0.814815	0.0216736	0.283517	1.22047	0.314768	1.12116	3.07 [0.34 - 27.31]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209413_at	185	0.8	0.00906933	0.149974	-0.531427	0.0611869	-0.370303	0.69 [0.47 - 1.02]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209413_at	185	0.8	0.0129946	0.196255	-0.561561	0.150691	-0.30866	0.73 [0.48 - 1.12]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P242440	110	0.163636	0.0398761	0.426833	0.790912	0.268291	0.216783	1.24 [0.85 - 1.82]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P149206	110	0.218182	0.0800687	-	0.56142	0.264736	0.193948	1.21 [0.86 - 1.71]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P242440	110	0.8	0.0768062	-	-0.716237	0.306891	-0.247635	0.78 [0.49 - 1.26]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P353709	110	0.881818	0.0653106	-	-0.770253	0.190619	-0.448819	0.64 [0.33 - 1.25]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P149206	110	0.318182	0.0878546	-	-0.53257	0.876701	0.0379588	1.04 [0.64 - 1.68]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P353709	110	0.390909	0.00132668	0.0322723	-0.923469	0.0188231	-1.08215	0.34 [0.14 - 0.84]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209413_at	80	0.3375	0.145073	-	-0.628614	0.856248	0.107138	1.11 [0.35 - 3.55]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209413_at	38	0.526316	0.00441679	0.0858159	1.40398	0.053878	1.19863	3.32 [0.98 - 11.22]
GENE	B4GALT2	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209413_at	140	0.585714	0.165363	-	0.40402	0.530532	0.278618	1.32 [0.55 - 3.16]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210243_s_at	30	0.5	0.0340986	0.385671	-0.85713	0.520279	-0.2858	0.75 [0.31 - 1.80]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1692267	165	0.757576	0.00735341	0.127776	0.676534	0.00408283	0.430828	1.54 [1.15 - 2.06]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1692267	165	0.890909	0.00116451	0.0289499	1.24563	0.00194764	0.648382	1.91 [1.27 - 2.88]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210243_s_at	163	0.834356	0.000165662	0.00545361	-1.36842	0.0449356	-0.594274	0.55 [0.31 - 0.99]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210243_s_at	79	0.658228	0.0129152	0.195371	-0.812245	0.179372	-0.347768	0.71 [0.43 - 1.17]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210243_s_at	58	0.396552	0.00781349	0.133869	-0.773424	0.00207626	-1.14957	0.32 [0.15 - 0.66]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210243_s_at	34	0.235294	0.0952062	-	-0.724469	0.295456	-0.5942	0.55 [0.18 - 1.68]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210243_s_at	158	0.107595	0.0678603	-	0.821241	0.127602	0.425834	1.53 [0.89 - 2.65]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210243_s_at	53	0.339623	0.000885111	0.0230012	1.39629	0.00466975	1.49275	4.45 [1.58 - 12.52]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210243_s_at	53	0.603774	0.00211876	0.0474859	1.08767	0.00797631	1.52158	4.58 [1.49 - 14.09]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210243_s_at	180	0.416667	0.0056814	0.104614	0.607649	0.0203987	0.725737	2.07 [1.12 - 3.82]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210243_s_at	559	0.613596	0.000220951	0.00700923	0.724768	0.000518787	0.72385	2.06 [1.37 - 3.10]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210243_s_at	77	0.818182	0.00244649	0.0533975	0.956725	0.440496	0.300598	1.35 [0.63 - 2.90]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210243_s_at	70	0.871429	0.0912796	-	-0.71977	0.236041	-0.564059	0.57 [0.22 - 1.45]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39445_at	50	0.82	0.249052	-	-0.608986	0.791488	0.208969	1.23 [0.26 - 5.80]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210243_s_at	74	0.743243	0.0730983	-	-0.65648	0.515981	-0.37721	0.69 [0.22 - 2.14]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210243_s_at	67	0.641791	0.047161	0.474299	1.2774	0.136674	2.19858	9.01 [0.50 - 163.04]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210243_s_at	115	0.817391	0.0602265	-	1.00622	0.58789	0.411264	1.51 [0.34 - 6.68]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39445_at	158	0.740506	0.0517833	-	-0.73431	0.676423	-0.210396	0.81 [0.30 - 2.18]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39445_at	76	0.197368	0.0341653	0.386167	15.4357	0.290966	0.974999	2.65 [0.43 - 16.19]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210243_s_at	204	0.803922	0.00243173	0.0531352	0.545758	0.00504695	0.496002	1.64 [1.16 - 2.32]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210243_s_at	87	0.609195	0.0580199	-	-0.806241	0.252145	-0.445687	0.64 [0.30 - 1.37]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210243_s_at	87	0.609195	0.0580199	-	-0.806241	0.252145	-0.445687	0.64 [0.30 - 1.37]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210243_s_at	77	0.571429	0.108281	-	-1.01358	0.672187	-0.201438	0.82 [0.32 - 2.08]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210243_s_at	77	0.545455	0.0921821	-	-1.24868	0.804807	-0.1327	0.88 [0.31 - 2.51]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210243_s_at	136	0.110294	0.00629518	0.113317	-1.33842	0.114749	-0.996503	0.37 [0.11 - 1.27]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210243_s_at	200	0.3	0.113624	-	-0.473444	0.388923	-0.347749	0.71 [0.32 - 1.56]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20926	60	0.35	0.155246	-	0.612762	0.907954	0.0326476	1.03 [0.59 - 1.80]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20926	60	0.616667	0.038288	0.415853	0.767494	0.304233	0.305779	1.36 [0.76 - 2.43]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	13319	155	0.193548	0.000142104	0.00476879	-1.04902	0.0086588	-0.244413	0.78 [0.65 - 0.94]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210243_s_at	286	0.821678	0.131752	-	-0.428561	0.786709	0.0697468	1.07 [0.65 - 1.78]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210243_s_at	159	0.358491	0.00687445	0.121312	1.07313	0.0405751	0.977462	2.66 [1.04 - 6.77]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210243_s_at	159	0.358491	0.0348994	0.391584	0.995563	0.140054	0.851695	2.34 [0.76 - 7.26]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210243_s_at	159	0.358491	0.264406	-	0.392747	0.997571	-0.00157576	1.00 [0.36 - 2.75]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210243_s_at	54	0.333333	0.14988	-	-0.980259	0.742386	-0.181383	0.83 [0.28 - 2.46]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210243_s_at	117	0.213675	0.164723	-	-0.465542	0.907692	0.0344594	1.04 [0.58 - 1.85]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210243_s_at	117	0.213675	0.238383	-	-0.473136	0.811941	0.0843409	1.09 [0.54 - 2.18]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210243_s_at	117	0.213675	0.164723	-	-0.465542	0.907692	0.0344594	1.04 [0.58 - 1.85]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210243_s_at	117	0.897436	0.076381	-	0.853667	0.689502	0.147761	1.16 [0.56 - 2.39]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210243_s_at	236	0.597458	0.0883897	-	0.455482	0.10881	0.783292	2.19 [0.84 - 5.70]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210243_s_at	249	0.839357	0.461811	-	-0.236813	0.684096	0.152014	1.16 [0.56 - 2.42]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210243_s_at	62	0.145161	0.0958016	-	-0.930163	0.698414	-0.0897103	0.91 [0.58 - 1.44]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210243_s_at	125	0.6	0.0914431	-	0.637014	0.58921	0.209829	1.23 [0.58 - 2.64]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210243_s_at	125	0.24	0.228576	-	-0.403462	0.888002	-0.0423252	0.96 [0.53 - 1.73]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210243_s_at	54	0.111111	0.0445221	0.457627	-1.29775	0.534591	-0.17408	0.84 [0.49 - 1.46]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210243_s_at	198	0.368687	0.329142	-	0.269753	0.951661	0.01398	1.01 [0.65 - 1.59]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210243_s_at	198	0.368687	0.168467	-	0.405305	0.876612	0.0364975	1.04 [0.65 - 1.64]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210243_s_at	198	0.116162	0.11527	-	-0.469153	0.73789	-0.0635816	0.94 [0.65 - 1.36]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210243_s_at	51	0.117647	0.0206202	0.273777	-1.85388	0.381814	-1.50496	0.22 [0.01 - 6.47]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210243_s_at	62	0.112903	0.000355847	0.0105853	-1.92734	0.430254	-0.83742	0.43 [0.05 - 3.47]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210243_s_at	145	0.510345	0.00851176	0.142914	0.903296	0.187736	0.834316	2.30 [0.67 - 7.97]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210243_s_at	177	0.734463	0.111939	-	0.455968	0.970271	0.0196725	1.02 [0.36 - 2.87]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210243_s_at	177	0.734463	0.00509225	0.0960134	0.670451	0.208909	0.567994	1.76 [0.73 - 4.28]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210243_s_at	226	0.893805	0.118889	-	-1.07377	0.553951	-0.249527	0.78 [0.34 - 1.78]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210243_s_at	49	0.122449	0.0407083	0.432491	-1.29674	0.176247	-1.1764	0.31 [0.06 - 1.70]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210243_s_at	55	0.545455	0.207578	-	0.560338	0.799198	-0.213564	0.81 [0.16 - 4.19]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210243_s_at	55	0.109091	0.295969	-	-0.642985	0.47521	-0.65222	0.52 [0.09 - 3.12]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	767188	34	0.647059	0.0430334	0.447967	0.864428	0.0608023	1.54059	4.67 [0.93 - 23.36]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210243_s_at	63	0.555556	0.276568	-	0.367826	0.729082	0.0802374	1.08 [0.69 - 1.71]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g3132897_3p_s_at	28	0.107143	0.0593188	-	-1.1806	0.974345	-0.0120943	0.99 [0.47 - 2.06]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210243_s_at	82	0.548781	0.0115819	0.180222	-0.920092	0.583146	-0.333386	0.72 [0.22 - 2.36]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	39445_at	84	0.833333	0.335905	-	-0.394007	0.814414	-0.153558	0.86 [0.24 - 3.09]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210243_s_at	79	0.873418	0.00121969	0.0300901	1.13113	0.754895	0.159817	1.17 [0.43 - 3.20]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210243_s_at	104	0.221154	0.372492	-	0.428122	0.853341	0.122977	1.13 [0.31 - 4.17]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P103919	117	0.521368	0.0346465	0.389724	0.603981	0.160237	0.41588	1.52 [0.85 - 2.71]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210243_s_at	204	0.686275	0.0736643	-	-0.85048	0.200725	-0.863479	0.42 [0.11 - 1.58]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210243_s_at	204	0.382353	0.0343509	0.387542	0.646004	0.91144	0.0518535	1.05 [0.42 - 2.63]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210243_s_at	178	0.893258	0.0773003	-	0.505442	0.505068	-0.268425	0.76 [0.35 - 1.68]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300020692	41	0.146341	0.000244268	0.00764716	-1.64994	0.0247294	-0.882857	0.41 [0.19 - 0.89]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300016887	41	0.536585	0.262522	-	0.464596	0.834088	-0.11569	0.89 [0.30 - 2.63]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210243_s_at	111	0.297297	0.0111983	0.175754	0.82636	0.236861	0.482033	1.62 [0.73 - 3.60]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210243_s_at	90	0.877778	0.0100897	0.162549	0.986381	0.289455	0.517208	1.68 [0.64 - 4.37]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210243_s_at	90	0.888889	0.00752045	0.130001	1.16412	0.118685	0.871235	2.39 [0.80 - 7.14]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210243_s_at	138	0.681159	0.000585032	0.0162007	0.819788	0.0837992	0.454001	1.57 [0.94 - 2.63]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210243_s_at	129	0.635659	0.172968	-	0.339329	0.603856	0.261218	1.30 [0.48 - 3.48]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21511	56	0.625	0.0200245	0.268178	-0.952315	0.104036	-0.698396	0.50 [0.21 - 1.15]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3675	56	0.214286	0.0735244	-	-0.691866	0.391414	-0.381456	0.68 [0.29 - 1.63]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44809	56	0.464286	0.0612199	-	-0.631932	0.231873	-0.470416	0.62 [0.29 - 1.35]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21511	56	0.178571	0.00531989	0.0993674	-1.08159	0.187755	-0.549805	0.58 [0.25 - 1.31]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44809	56	0.464286	0.0552821	-	-0.696856	0.194867	-0.525765	0.59 [0.27 - 1.31]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3675	56	0.857143	0.0696971	-	0.767088	0.536212	-0.275169	0.76 [0.32 - 1.82]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210243_s_at	278	0.723022	0.189331	-	-0.292405	0.528604	-0.149541	0.86 [0.54 - 1.37]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210243_s_at	133	0.593985	0.12407	-	0.361677	0.635499	0.0915825	1.10 [0.75 - 1.60]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2542	81	0.308642	0.0116895	0.181466	-1.23307	0.145926	-0.796389	0.45 [0.15 - 1.32]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210243_s_at	185	0.854054	0.0401477	0.428686	-0.488284	0.726924	-0.066806	0.94 [0.64 - 1.36]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210243_s_at	185	0.854054	0.0676331	-	-0.480065	0.712725	-0.0785446	0.92 [0.61 - 1.40]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P103919	110	0.263636	0.135391	-	0.41743	0.93234	-0.0196207	0.98 [0.62 - 1.54]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P103919	110	0.890909	0.139256	-	-0.854857	0.163848	-0.436157	0.65 [0.35 - 1.19]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210243_s_at	80	0.675	0.00157139	0.0371362	1.32973	0.0710833	0.988256	2.69 [0.92 - 7.86]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210243_s_at	38	0.342105	1.65147e-05	0.000702993	3.40649	0.000349163	1.50099	4.49 [1.97 - 10.21]
GENE	B4GALT3	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210243_s_at	140	0.892857	0.119106	-	-1.07434	0.42704	-0.20297	0.82 [0.49 - 1.35]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221485_at	30	0.7	0.0533008	-	0.838977	0.451306	0.291941	1.34 [0.63 - 2.86]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1653749	165	0.569697	0.0983754	-	0.396394	0.390271	0.133347	1.14 [0.84 - 1.55]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1653749	165	0.587879	0.0341524	0.386071	0.739093	0.145857	0.340869	1.41 [0.89 - 2.23]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221485_at	163	0.533742	0.163558	-	-0.277509	0.560758	-0.0691728	0.93 [0.74 - 1.18]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221485_at	79	0.822785	0.277514	-	0.387992	0.6526	0.0798552	1.08 [0.77 - 1.53]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221485_at	58	0.137931	0.157474	-	0.57252	0.771974	0.0571551	1.06 [0.72 - 1.56]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221485_at	34	0.441176	0.0697385	-	0.738289	0.177275	0.386997	1.47 [0.84 - 2.58]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221485_at	158	0.449367	0.0369015	0.406065	-0.480788	0.142798	-0.316349	0.73 [0.48 - 1.11]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221485_at	53	0.603774	0.200492	-	-0.492025	0.511756	-0.246201	0.78 [0.37 - 1.63]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221485_at	53	0.245283	0.110953	-	-0.593304	0.56197	-0.2017	0.82 [0.41 - 1.62]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221485_at	180	0.733333	0.148148	-	-0.3794	0.805695	-0.0463979	0.95 [0.66 - 1.38]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221485_at	559	0.899821	0.0109023	0.172273	0.665767	0.074215	0.397172	1.49 [0.96 - 2.30]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221485_at	77	0.584416	1.7786e-05	0.000751563	1.11153	0.0001044	1.23878	3.45 [1.85 - 6.45]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221485_at	70	0.371429	0.01196	0.184576	-0.683796	0.162412	-0.414952	0.66 [0.37 - 1.18]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39888_at	50	0.88	0.000729372	0.0195348	1.45749	0.076371	1.37011	3.94 [0.86 - 17.91]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39889_at	50	0.72	0.0612106	-	-0.749421	0.290837	-1.00176	0.37 [0.06 - 2.36]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221485_at	74	0.175676	0.258637	-	-0.402007	0.862729	-0.0708801	0.93 [0.42 - 2.08]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221485_at	67	0.656716	0.00090932	0.0235294	2.20645	0.0697115	1.35168	3.86 [0.90 - 16.65]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221485_at	115	0.469565	0.00976007	0.158533	1.74296	0.120443	1.07008	2.92 [0.76 - 11.25]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39888_at	158	0.879747	0.180981	-	-0.778028	0.841856	0.0404424	1.04 [0.70 - 1.55]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39889_at	158	0.746835	0.0761718	-	0.512419	0.654045	0.123149	1.13 [0.66 - 1.94]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39888_at	76	0.5	0.127586	-	-0.81368	0.501054	-0.20859	0.81 [0.44 - 1.49]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39889_at	76	0.5	0.396127	-	0.444075	0.893748	-0.065279	0.94 [0.36 - 2.44]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221485_at	204	0.833333	0.0511915	-	0.368645	0.0561701	0.250665	1.28 [0.99 - 1.66]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221485_at	87	0.701149	0.214817	-	-0.566291	0.973986	0.00995216	1.01 [0.56 - 1.84]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221485_at	87	0.701149	0.214817	-	-0.566291	0.973986	0.00995216	1.01 [0.56 - 1.84]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221485_at	77	0.792208	0.0888174	-	1.05017	0.649263	-0.213346	0.81 [0.32 - 2.03]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221485_at	77	0.792208	0.294383	-	0.620414	0.702829	-0.166652	0.85 [0.36 - 1.99]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221485_at	136	0.455882	0.00182645	0.0420412	-1.5213	0.067304	-0.741813	0.48 [0.22 - 1.05]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221485_at	200	0.875	0.00713264	0.124812	0.901772	0.0124612	0.997011	2.71 [1.24 - 5.92]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5837	60	0.683333	0.0503219	-	0.728059	0.246785	0.255921	1.29 [0.84 - 1.99]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5837	60	0.316667	0.223226	-	0.555384	0.86027	0.043996	1.04 [0.64 - 1.71]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12494	155	0.154839	0.11564	-	0.798447	0.445011	0.123532	1.13 [0.82 - 1.55]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221485_at	286	0.486014	0.00439008	0.0854045	0.559178	0.136529	0.308552	1.36 [0.91 - 2.04]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221485_at	159	0.440252	0.120772	-	0.613309	0.579156	0.229999	1.26 [0.56 - 2.84]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221485_at	159	0.893082	0.0382722	0.415742	0.797875	0.492745	0.241428	1.27 [0.64 - 2.54]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221485_at	159	0.440252	0.152598	-	0.470038	0.737343	0.120679	1.13 [0.56 - 2.28]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221484_at	54	0.87037	0.0636573	-	1.4131	0.447385	0.363245	1.44 [0.56 - 3.67]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221485_at	54	0.814815	0.183306	-	-15.3378	0.9972	0.00155148	1.00 [0.42 - 2.38]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221485_at	117	0.179487	0.0930193	-	-0.606732	0.680531	-0.0771748	0.93 [0.64 - 1.34]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221485_at	117	0.179487	0.00300285	0.0630386	-1.11372	0.0721116	-0.406078	0.67 [0.43 - 1.04]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221485_at	117	0.179487	0.0930193	-	-0.606732	0.680531	-0.0771748	0.93 [0.64 - 1.34]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221485_at	117	0.179487	0.0232201	0.297463	-0.934655	0.198067	-0.294758	0.74 [0.48 - 1.17]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221485_at	236	0.851695	0.0100463	0.162023	0.796887	0.0207931	0.735286	2.09 [1.12 - 3.89]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221485_at	249	0.168675	0.0443477	0.456505	0.663457	0.136038	0.391094	1.48 [0.88 - 2.47]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221485_at	62	0.532258	0.040498	0.431067	-1.03328	0.299884	-0.207758	0.81 [0.55 - 1.20]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221485_at	125	0.592	0.00612289	0.110899	1.02935	0.461392	0.240969	1.27 [0.67 - 2.42]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221485_at	125	0.288	0.00201811	0.0456308	1.19492	0.203611	0.309705	1.36 [0.85 - 2.20]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221485_at	54	0.5	0.0549694	-	-1.18146	0.175574	-0.333772	0.72 [0.44 - 1.16]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221485_at	198	0.737374	0.0116792	0.181346	0.661908	0.156803	0.281413	1.33 [0.90 - 1.96]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221485_at	198	0.782828	0.00377657	0.0757697	0.812945	0.117346	0.318002	1.37 [0.92 - 2.05]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221485_at	198	0.611111	0.00612107	0.110874	0.568459	0.0722447	0.287641	1.33 [0.97 - 1.82]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221485_at	51	0.666667	0.188076	-	1.1393	0.702576	0.257184	1.29 [0.35 - 4.84]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221485_at	62	0.145161	0.129698	-	15.2892	0.87979	-0.0600189	0.94 [0.43 - 2.05]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221485_at	177	0.627119	0.0386368	0.418285	-0.630661	0.634195	-0.149974	0.86 [0.46 - 1.60]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221485_at	177	0.101695	0.141745	-	0.73961	0.872128	0.0443521	1.05 [0.61 - 1.79]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221485_at	145	0.165517	0.0543158	-	1.30607	0.37352	0.350575	1.42 [0.66 - 3.07]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221485_at	226	0.10177	0.0116062	0.180503	15.1939	0.623599	0.177082	1.19 [0.59 - 2.42]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221485_at	55	0.109091	0.122161	-	-0.840465	0.853324	-0.104452	0.90 [0.30 - 2.73]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221485_at	55	0.781818	0.0175919	0.244583	1.12337	0.425729	0.464999	1.59 [0.51 - 5.00]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221485_at	49	0.122449	0.0315124	0.366085	-1.23792	0.351602	-0.67806	0.51 [0.12 - 2.11]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	29392	34	0.794118	0.00490145	0.0931712	1.27327	0.0197267	0.907276	2.48 [1.16 - 5.31]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221485_at	63	0.111111	0.0960332	-	1.53532	0.703648	0.126835	1.14 [0.59 - 2.18]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.107526.0.A3_3p_at	28	0.357143	0.162196	-	-0.739032	0.680359	-0.244784	0.78 [0.24 - 2.51]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221485_at	82	0.829268	0.0578641	-	0.756586	0.739287	0.153624	1.17 [0.47 - 2.88]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221485_at	79	0.468354	0.193323	-	-0.335281	0.496988	-0.203046	0.82 [0.45 - 1.47]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221485_at	104	0.182692	0.119941	-	-0.587102	0.667582	-0.157266	0.85 [0.42 - 1.75]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P239731	117	0.692308	0.0219619	0.286148	0.651997	0.0340774	0.387212	1.47 [1.03 - 2.11]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P365469	117	0.752137	3.43797e-05	0.00135761	1.14316	0.000186289	0.865185	2.38 [1.51 - 3.74]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221485_at	204	0.872549	0.000269854	0.00833665	1.31603	0.0100116	1.32851	3.78 [1.37 - 10.38]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221485_at	204	0.862745	0.000200012	0.00642771	1.07861	0.00495517	1.14571	3.14 [1.41 - 6.99]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221485_at	178	0.893258	0.155429	-	0.419845	0.610315	0.119994	1.13 [0.71 - 1.79]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221485_at	111	0.594595	0.00277632	0.0591679	0.779471	0.0816606	0.504046	1.66 [0.94 - 2.92]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221485_at	90	0.822222	0.0375655	0.410777	0.749619	0.87181	-0.0474247	0.95 [0.54 - 1.70]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221485_at	90	0.822222	0.0103359	0.165521	0.989917	0.895852	0.0437389	1.04 [0.54 - 2.01]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221485_at	138	0.833333	0.00349169	0.0711638	0.804627	0.0813058	0.231798	1.26 [0.97 - 1.64]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221485_at	129	0.162791	0.0708023	-	0.713052	0.243284	0.359267	1.43 [0.78 - 2.62]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26226	56	0.375	0.314803	-	-0.348692	0.854591	-0.0607659	0.94 [0.49 - 1.80]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38744	56	0.214286	0.311321	-	0.507988	0.596719	0.125965	1.13 [0.71 - 1.81]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	14042	56	0.785714	0.120197	-	0.602063	0.389468	0.596325	1.82 [0.47 - 7.06]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26226	56	0.375	0.127149	-	-0.54622	0.739432	-0.119927	0.89 [0.44 - 1.80]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	14042	56	0.785714	0.0265907	0.326525	0.866351	0.171678	1.00886	2.74 [0.65 - 11.65]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	38744	56	0.821429	0.223852	-	-0.585601	0.742525	0.073343	1.08 [0.69 - 1.67]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221485_at	278	0.730216	1.65168e-05	0.000703074	0.847801	2.50148e-05	0.735791	2.09 [1.48 - 2.94]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221485_at	133	0.894737	0.0631129	-	0.607361	0.214259	0.176938	1.19 [0.90 - 1.58]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	10174	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221485_at	185	0.875676	0.0055749	0.103078	0.654543	0.155347	0.149894	1.16 [0.94 - 1.43]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221485_at	185	0.875676	0.000621508	0.0170558	0.813349	0.141755	0.171838	1.19 [0.94 - 1.49]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P239731	110	0.8	0.00854779	0.143374	0.690954	0.0994747	0.242835	1.27 [0.95 - 1.70]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P365469	110	0.836364	3.83114e-05	0.00149548	1.1237	0.00196156	0.520468	1.68 [1.21 - 2.34]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P239731	110	0.636364	0.00222695	0.0494586	0.884708	0.00581457	0.502744	1.65 [1.16 - 2.36]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P365469	110	0.836364	0.000165185	0.00543988	1.13576	0.00140189	0.66073	1.94 [1.29 - 2.90]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221485_at	80	0.55	0.244151	-	-0.532044	0.702455	-0.111413	0.89 [0.51 - 1.58]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221485_at	38	0.631579	0.0110539	0.174059	1.18246	0.0289942	1.00881	2.74 [1.11 - 6.78]
GENE	B4GALT5	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221485_at	140	0.864286	2.82504e-07	1.68889e-05	1.49304	6.52046e-07	1.14565	3.14 [2.00 - 4.94]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	53076_at	30	0.766667	0.00608679	0.11039	-1.59175	0.030578	-2.06229	0.13 [0.02 - 0.82]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	222191_s_at	30	0.466667	0.0936829	-	-0.676451	0.385865	-0.616958	0.54 [0.13 - 2.18]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1663541	165	0.50303	0.131049	-	-0.366693	0.736163	0.0605355	1.06 [0.75 - 1.51]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1663541	165	0.878788	0.169148	-	0.61316	0.69456	0.117885	1.13 [0.62 - 2.03]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	222191_s_at	163	0.730061	0.0260592	0.322057	0.474166	0.256114	0.490924	1.63 [0.70 - 3.81]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	53076_at	163	0.773006	0.00397969	0.0790007	0.627858	0.134564	0.577407	1.78 [0.84 - 3.80]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	53076_at	79	0.759494	0.00130111	0.0317541	0.98502	0.0407257	0.896496	2.45 [1.04 - 5.78]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222191_s_at	79	0.772152	0.0372091	0.408253	0.692175	0.512422	0.36585	1.44 [0.48 - 4.31]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	53076_at	58	0.137931	0.135271	-	0.603718	0.427171	0.285885	1.33 [0.66 - 2.70]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	222191_s_at	58	0.517241	0.0824943	-	0.479758	0.495959	0.150812	1.16 [0.75 - 1.79]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	222191_s_at	34	0.647059	0.0717724	-	-0.785831	0.114833	-0.519949	0.59 [0.31 - 1.13]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	53076_at	34	0.117647	0.0527041	-	1.75301	0.194397	0.666009	1.95 [0.71 - 5.32]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	53076_at	158	0.367089	0.0825732	-	0.437762	0.247737	0.773305	2.17 [0.58 - 8.04]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	222191_s_at	158	0.753165	0.00110356	0.0276781	0.779413	0.0384245	1.5585	4.75 [1.09 - 20.78]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	222191_s_at	53	0.320755	0.0045278	0.0875184	1.31785	0.317361	0.495496	1.64 [0.62 - 4.34]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	53076_at	53	0.226415	0.0295577	0.350751	1.12444	0.418457	0.647479	1.91 [0.40 - 9.17]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	222191_s_at	53	0.320755	0.00217546	0.0485226	1.29818	0.221479	0.540592	1.72 [0.72 - 4.08]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	53076_at	53	0.226415	0.0875617	-	0.75405	0.516394	0.476129	1.61 [0.38 - 6.78]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	53076_at	180	0.8	0.0158617	0.227019	0.578295	0.573997	0.190076	1.21 [0.62 - 2.35]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	222191_s_at	180	0.316667	0.118895	-	-0.334614	0.753536	-0.0922935	0.91 [0.51 - 1.62]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	53076_at	559	0.227191	0.00133933	0.032528	-0.641365	0.00036488	-0.918807	0.40 [0.24 - 0.66]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222191_s_at	559	0.322004	5.13404e-08	3.44225e-06	-1.06714	0.00189187	-0.434031	0.65 [0.49 - 0.85]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	222191_s_at	77	0.246753	0.13997	-	-0.419577	0.811923	-0.0748305	0.93 [0.50 - 1.72]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	53076_at	77	0.337662	0.0293268	0.348908	0.626388	0.251977	0.478475	1.61 [0.71 - 3.66]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	53076_at	70	0.757143	0.0826941	-	-0.559798	0.766408	-0.157094	0.85 [0.30 - 2.41]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222191_s_at	70	0.171429	0.0572431	-	-0.634922	0.700661	-0.279759	0.76 [0.18 - 3.15]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	222191_s_at	74	0.864865	0.000123338	0.00421179	1.3236	0.210383	0.520918	1.68 [0.75 - 3.80]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	53076_at	74	0.351351	0.000121953	0.00417023	1.41448	0.00100589	1.64295	5.17 [1.94 - 13.76]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	53076_at	67	0.358209	0.263582	-	-0.735492	0.951129	-0.104614	0.90 [0.03 - 25.56]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222191_s_at	67	0.373134	0.100489	-	1.57868	0.558566	1.17015	3.22 [0.06 - 162.53]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	53076_at	115	0.356522	0.247397	-	-0.613356	0.726011	0.330323	1.39 [0.22 - 8.83]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222191_s_at	115	0.26087	0.0238314	0.302866	-1.14798	0.54608	-0.413268	0.66 [0.17 - 2.53]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222191_s_at	204	0.137255	0.0392567	0.422579	-0.420634	0.815102	0.0434065	1.04 [0.73 - 1.50]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	53076_at	204	0.691176	0.320899	-	0.155986	0.806453	-0.0589022	0.94 [0.59 - 1.51]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	53076_at	87	0.678161	0.0555945	-	0.718585	0.378382	0.594517	1.81 [0.48 - 6.80]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222191_s_at	87	0.609195	0.0119674	0.184661	0.92685	0.139483	0.927805	2.53 [0.74 - 8.66]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222191_s_at	87	0.609195	0.0119674	0.184661	0.92685	0.139483	0.927805	2.53 [0.74 - 8.66]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	53076_at	87	0.678161	0.0555945	-	0.718585	0.378382	0.594517	1.81 [0.48 - 6.80]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222191_s_at	77	0.376623	0.0666974	-	-1.00389	0.324304	-0.842808	0.43 [0.08 - 2.30]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	53076_at	77	0.636364	0.0118563	0.183386	-15.8212	0.075778	-1.86832	0.15 [0.02 - 1.21]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	53076_at	77	0.636364	0.0943474	-	-1.21136	0.432794	-0.681111	0.51 [0.09 - 2.78]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222191_s_at	77	0.376623	0.00437259	0.0851349	-1.93818	0.0448922	-1.93068	0.15 [0.02 - 0.96]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	222191_s_at	136	0.882353	0.40878	-	-0.825691	0.983097	-0.0106028	0.99 [0.37 - 2.64]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	53076_at	136	0.897059	0.00702301	0.123331	1.32333	0.150106	1.10714	3.03 [0.67 - 13.67]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	222191_s_at	200	0.165	0.0593891	-	-0.624612	0.446592	-0.367983	0.69 [0.27 - 1.79]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	53076_at	200	0.66	0.00411501	0.0811302	0.826516	0.473209	0.366922	1.44 [0.53 - 3.93]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19654	60	0.85	0.125702	-	0.699953	0.335122	0.373803	1.45 [0.68 - 3.11]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19654	60	0.416667	0.00596443	0.108659	1.1983	0.110348	0.698801	2.01 [0.85 - 4.74]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	6656	155	0.8	0.0143088	0.210632	0.704597	0.0171352	0.499989	1.65 [1.09 - 2.49]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	222191_s_at	286	0.807692	0.0423772	0.443647	-0.573911	0.321851	-0.209094	0.81 [0.54 - 1.23]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	53076_at	286	0.727273	0.037172	0.40799	0.417899	0.693256	0.144561	1.16 [0.56 - 2.37]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	53076_at	159	0.566038	0.100957	-	0.609023	0.75917	0.185925	1.20 [0.37 - 3.95]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222191_s_at	159	0.257862	0.209562	-	-0.420706	0.768715	-0.135598	0.87 [0.35 - 2.16]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222191_s_at	159	0.867925	0.0290335	0.346557	0.806005	0.630682	0.232879	1.26 [0.49 - 3.26]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	53076_at	159	0.100629	0.0590673	-	-0.76734	0.223227	-0.639163	0.53 [0.19 - 1.48]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222191_s_at	159	0.201258	0.377013	-	0.471395	0.786403	0.150517	1.16 [0.39 - 3.45]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	53076_at	159	0.748428	0.0788117	-	0.575422	0.708744	0.191505	1.21 [0.44 - 3.31]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	53076_at	54	0.5	0.0305617	0.358686	-1.96809	0.386406	-0.95114	0.39 [0.04 - 3.32]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	222191_s_at	54	0.203704	0.130101	-	15.4119	0.480658	0.530484	1.70 [0.39 - 7.42]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222191_s_at	117	0.769231	0.149525	-	0.492969	0.947865	0.020733	1.02 [0.55 - 1.90]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222191_s_at	117	0.811966	0.0112211	0.176021	1.01147	0.404143	0.317505	1.37 [0.65 - 2.90]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	53076_at	117	0.495726	0.196171	-	0.50435	0.710912	0.154451	1.17 [0.52 - 2.64]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	53076_at	117	0.888889	0.0912137	-	-1.15998	0.918216	-0.0366265	0.96 [0.48 - 1.94]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	53076_at	117	0.735043	0.0510131	-	0.76047	0.514449	0.278162	1.32 [0.57 - 3.05]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	53076_at	117	0.888889	0.0912137	-	-1.15998	0.918216	-0.0366265	0.96 [0.48 - 1.94]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222191_s_at	117	0.769231	0.149525	-	0.492969	0.947865	0.020733	1.02 [0.55 - 1.90]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222191_s_at	117	0.700855	0.0401939	0.429001	0.759518	0.416598	0.30364	1.35 [0.65 - 2.82]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	222191_s_at	236	0.504237	0.011571	0.180095	0.693701	0.53422	0.294498	1.34 [0.53 - 3.40]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	53076_at	236	0.584746	0.00982653	0.159346	0.686807	0.0556892	0.931691	2.54 [0.98 - 6.59]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	53076_at	249	0.566265	0.0205414	0.27304	0.487541	0.168345	0.534999	1.71 [0.80 - 3.66]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	222191_s_at	249	0.710843	0.008618	0.14427	0.567933	0.399051	0.321717	1.38 [0.65 - 2.91]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222191_s_at	125	0.832	0.00549876	0.101975	1.05635	0.0199707	1.22307	3.40 [1.21 - 9.52]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	53076_at	62	0.790323	0.0696722	-	-1.30244	0.532617	-0.11371	0.89 [0.62 - 1.28]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222191_s_at	125	0.16	0.0969228	-	0.957878	0.317924	0.394419	1.48 [0.68 - 3.22]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222191_s_at	54	0.851852	0.206744	-	0.828346	0.948856	-0.0278902	0.97 [0.41 - 2.28]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	53076_at	125	0.208	0.0387427	0.419021	1.40441	0.212912	0.911466	2.49 [0.59 - 10.44]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	53076_at	125	0.88	0.171317	-	0.55942	0.304076	0.564173	1.76 [0.60 - 5.16]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	53076_at	54	0.462963	0.206708	-	-0.76013	0.712195	-0.0801979	0.92 [0.60 - 1.41]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222191_s_at	62	0.322581	0.172882	-	-0.644525	0.57971	-0.202568	0.82 [0.40 - 1.67]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	53076_at	198	0.388889	0.204718	-	-0.325687	0.745425	0.112043	1.12 [0.57 - 2.20]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	53076_at	198	0.388889	0.205199	-	-0.337974	0.852796	0.0679787	1.07 [0.52 - 2.19]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222191_s_at	198	0.737374	0.0214667	0.28162	0.517282	0.344745	0.21648	1.24 [0.79 - 1.95]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222191_s_at	198	0.707071	0.0791693	-	0.468209	0.596733	0.144945	1.16 [0.68 - 1.98]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	53076_at	198	0.388889	0.05942	-	-0.396628	0.633354	0.136241	1.15 [0.65 - 2.01]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222191_s_at	198	0.893939	0.0359699	0.399379	0.754563	0.553437	0.168487	1.18 [0.68 - 2.07]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	222191_s_at	51	0.215686	0.0270083	0.330008	-1.77724	0.44895	-1.0626	0.35 [0.02 - 5.41]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	222191_s_at	62	0.516129	0.16503	-	0.828016	0.755941	0.309978	1.36 [0.19 - 9.63]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	53076_at	51	0.686275	0.120463	-	-15.6485	0.451158	-0.657351	0.52 [0.09 - 2.87]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	53076_at	62	0.677419	0.158201	-	-1.04543	0.771785	-0.182765	0.83 [0.24 - 2.86]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222191_s_at	177	0.259887	0.00453338	0.0876039	-0.695204	0.015569	-1.30811	0.27 [0.09 - 0.78]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222191_s_at	145	0.22069	0.000433989	0.0125533	-1.1667	0.0811691	-1.38083	0.25 [0.05 - 1.19]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	53076_at	177	0.423729	0.00696346	0.122523	-0.726352	0.0144676	-1.66786	0.19 [0.05 - 0.72]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222191_s_at	177	0.254237	0.000660356	0.0179568	-0.920265	0.00968865	-1.61524	0.20 [0.06 - 0.68]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	53076_at	177	0.446328	0.0191592	0.259923	-0.548979	0.0341686	-1.25817	0.28 [0.09 - 0.91]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	53076_at	145	0.834483	0.0280091	0.338256	-1.46567	0.0820027	-1.59865	0.20 [0.03 - 1.23]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222191_s_at	226	0.442478	0.0597844	-	-0.530456	0.811295	-0.0499652	0.95 [0.63 - 1.43]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	53076_at	226	0.380531	0.000223281	0.00707341	-1.02435	0.000196598	-1.33712	0.26 [0.13 - 0.53]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222191_s_at	55	0.690909	0.094549	-	0.759087	0.488108	0.510446	1.67 [0.39 - 7.05]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	53076_at	55	0.890909	0.0850131	-	-15.2236	0.310467	-0.621352	0.54 [0.16 - 1.78]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	53076_at	55	0.327273	0.108842	-	0.943323	0.726918	0.258849	1.30 [0.30 - 5.54]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	53076_at	49	0.346939	0.142806	-	1.0825	0.970272	-0.0298953	0.97 [0.20 - 4.68]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222191_s_at	55	0.109091	0.10858	-	-0.873767	0.614746	-0.335115	0.72 [0.19 - 2.64]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222191_s_at	49	0.428571	0.191015	-	0.847029	0.911155	0.0954788	1.10 [0.21 - 5.89]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	305967	34	0.264706	0.00679174	0.120183	-1.18473	0.272863	-1.64887	0.19 [0.01 - 3.66]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	53076_at	63	0.507937	0.0818981	-	0.587037	0.447621	0.235594	1.27 [0.69 - 2.32]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222191_s_at	63	0.746032	0.282545	-	0.389552	0.948618	-0.0239919	0.98 [0.47 - 2.03]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	222191_s_at	82	0.609756	0.151681	-	-0.526034	0.403465	-0.437294	0.65 [0.23 - 1.80]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	53076_at	82	0.878049	0.0437603	0.452707	-1.79793	0.242561	-1.01734	0.36 [0.07 - 1.99]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	222191_s_at	79	0.835443	0.0781236	-	-0.701617	0.241657	-0.65825	0.52 [0.17 - 1.56]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	53076_at	79	0.898734	0.0912054	-	-0.853181	0.615912	-0.313438	0.73 [0.21 - 2.49]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	53076_at	104	0.105769	0.000223116	0.00706888	-1.39838	0.00712163	-2.11528	0.12 [0.03 - 0.56]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	222191_s_at	104	0.192308	0.0108175	0.171269	-0.843408	0.0832533	-0.942758	0.39 [0.13 - 1.13]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P41872	117	0.111111	0.0538592	-	-0.730817	0.46948	-0.172213	0.84 [0.53 - 1.34]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	53076_at	204	0.52451	0.0235929	0.300765	0.622011	0.560375	0.281658	1.33 [0.51 - 3.42]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222191_s_at	204	0.196078	0.00273353	0.0584286	1.6035	0.01523	0.955869	2.60 [1.20 - 5.63]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222191_s_at	204	0.22549	0.0275533	0.334517	1.47628	0.20918	0.690605	1.99 [0.68 - 5.86]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	53076_at	204	0.534314	0.121517	-	0.569487	0.818816	-0.154938	0.86 [0.23 - 3.22]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	222191_s_at	178	0.101124	0.00130815	0.0318969	-0.885347	0.568728	-0.27858	0.76 [0.29 - 1.97]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	53076_at	178	0.898876	0.100407	-	0.52913	0.705415	0.208072	1.23 [0.42 - 3.62]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200005122	41	0.121951	0.155453	-	1.34869	0.269317	0.373514	1.45 [0.75 - 2.82]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222191_s_at	111	0.891892	0.0492588	0.487159	0.679815	0.654128	-0.157255	0.85 [0.43 - 1.70]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	53076_at	111	0.738739	0.0250378	0.313352	0.634833	0.118494	0.628541	1.87 [0.85 - 4.13]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	222191_s_at	90	0.222222	0.354147	-	0.451947	0.801594	0.160253	1.17 [0.34 - 4.10]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	222191_s_at	90	0.177778	0.283595	-	0.509401	0.614884	0.28051	1.32 [0.44 - 3.95]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	53076_at	90	0.188889	0.0958443	-	0.854761	0.481721	0.443261	1.56 [0.45 - 5.36]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	53076_at	90	0.211111	0.192021	-	0.689471	0.730073	0.246345	1.28 [0.32 - 5.18]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222191_s_at	138	0.898551	0.108052	-	0.543536	0.322614	0.169056	1.18 [0.85 - 1.66]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	53076_at	138	0.898551	0.0870164	-	0.588932	0.406147	0.172782	1.19 [0.79 - 1.79]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	53076_at	129	0.248062	0.314309	-	0.318525	0.86675	-0.0789851	0.92 [0.37 - 2.32]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	222191_s_at	129	0.310078	0.0497726	0.490258	0.581108	0.237464	0.476704	1.61 [0.73 - 3.55]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32579	56	0.160714	0.147449	-	-0.620119	0.371366	0.330865	1.39 [0.67 - 2.88]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32579	56	0.857143	0.188738	-	0.593724	0.488807	0.269735	1.31 [0.61 - 2.81]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	53076_at	278	0.856115	0.0193569	0.261822	0.542634	0.271892	0.312822	1.37 [0.78 - 2.39]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222191_s_at	278	0.877698	0.00890611	0.147921	0.64336	0.216835	0.314789	1.37 [0.83 - 2.26]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	53076_at	133	0.135338	0.102909	-	0.683966	0.476812	0.114793	1.12 [0.82 - 1.54]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	222191_s_at	133	0.210526	0.00760955	0.131182	0.883237	0.562686	0.151658	1.16 [0.70 - 1.94]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	222191_s_at	185	0.594595	0.165021	-	0.246664	0.644268	-0.0875854	0.92 [0.63 - 1.33]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	53076_at	185	0.891892	0.0363199	0.401901	-0.545376	0.0869701	-0.385062	0.68 [0.44 - 1.06]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	53076_at	185	0.891892	0.0459178	0.466515	-0.586885	0.186235	-0.321594	0.72 [0.45 - 1.17]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	222191_s_at	185	0.535135	0.153558	-	-0.243431	0.200893	-0.228461	0.80 [0.56 - 1.13]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P41872	110	0.536364	0.0771841	-	0.401081	0.348495	0.219226	1.25 [0.79 - 1.97]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P41872	110	0.163636	0.0127411	0.193425	-0.819816	0.488547	-0.212134	0.81 [0.44 - 1.47]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	53076_at	80	0.3	0.0324589	0.373343	1.4637	0.358567	0.445745	1.56 [0.60 - 4.04]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	222191_s_at	80	0.2375	0.109578	-	1.13111	0.852081	0.0567488	1.06 [0.58 - 1.92]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222191_s_at	38	0.894737	0.024821	0.311484	1.39489	0.0293817	0.980368	2.67 [1.10 - 6.44]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	53076_at	38	0.473684	0.000458008	0.0131461	1.85838	0.0127108	1.47725	4.38 [1.37 - 14.00]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	222191_s_at	140	0.871429	0.0345471	0.388991	0.766946	0.361349	0.512563	1.67 [0.56 - 5.02]
GENE	B4GALT7	xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	53076_at	140	0.378571	0.0871506	-	0.539371	0.350586	0.536642	1.71 [0.55 - 5.28]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206913_at	30	0.566667	0.146253	-	0.587921	0.703437	0.373979	1.45 [0.21 - 9.97]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1771308	165	0.345455	0.168625	-	0.358987	0.00535435	0.636036	1.89 [1.21 - 2.96]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1771308	165	0.10303	0.110217	-	-0.708604	0.0123033	0.681164	1.98 [1.16 - 3.37]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206913_at	163	0.834356	0.103112	-	-0.466057	0.692559	-0.241393	0.79 [0.24 - 2.60]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206913_at	79	0.455696	0.000884209	0.0229814	-0.968967	0.0382578	-1.84871	0.16 [0.03 - 0.90]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206913_at	58	0.103448	0.0654851	-	0.854585	0.138354	0.281102	1.32 [0.91 - 1.92]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206913_at	34	0.264706	0.265143	-	-0.469943	0.981688	-0.0127938	0.99 [0.33 - 2.94]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206913_at	158	0.601266	0.0904829	-	0.391105	0.446462	0.73646	2.09 [0.31 - 13.91]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206913_at	53	0.396226	0.0382527	0.415606	0.765449	0.277877	0.394429	1.48 [0.73 - 3.02]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206913_at	53	0.830189	0.0468658	0.472462	0.804044	0.217993	0.480489	1.62 [0.75 - 3.47]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206913_at	180	0.894444	0.0217487	0.284203	0.705141	0.467331	0.151878	1.16 [0.77 - 1.75]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206913_at	559	0.894454	0.00992867	0.160593	-1.39572	0.295648	-0.130768	0.88 [0.69 - 1.12]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206913_at	77	0.467532	0.0332014	0.378963	-0.548673	0.229162	-0.442899	0.64 [0.31 - 1.32]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206913_at	70	0.2	0.0703751	-	-0.573611	0.534107	-0.695931	0.50 [0.06 - 4.47]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36384_at	50	0.46	0.0248183	0.311461	-0.772352	0.13526	-1.10244	0.33 [0.08 - 1.41]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206913_at	74	0.351351	0.109199	-	0.495708	0.772213	-0.116311	0.89 [0.41 - 1.96]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206913_at	67	0.38806	0.00340381	0.0697244	16.227	0.0173815	4.73187	113.51 [2.30 - 5603.20]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206913_at	115	0.182609	0.0706949	-	-0.98061	0.551969	-0.467779	0.63 [0.13 - 2.93]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36384_at	158	0.683544	0.0662035	-	-0.620794	0.804906	0.0534162	1.05 [0.69 - 1.61]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36384_at	76	0.118421	0.158783	-	15.2053	0.770098	-0.118627	0.89 [0.40 - 1.97]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206913_at	204	0.490196	0.0627764	-	0.259353	0.415075	0.0676064	1.07 [0.91 - 1.26]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206913_at	87	0.298851	0.00571745	0.105133	1.53763	0.100619	1.64393	5.18 [0.73 - 36.83]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206913_at	87	0.298851	0.00571745	0.105133	1.53763	0.100619	1.64393	5.18 [0.73 - 36.83]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206913_at	77	0.12987	0.00361533	0.0731738	-1.6771	0.18624	-2.08499	0.12 [0.01 - 2.74]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206913_at	77	0.12987	0.00256114	0.0554224	-1.55827	0.384704	-1.15716	0.31 [0.02 - 4.27]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206913_at	136	0.132353	0.251151	-	1.11859	0.766832	0.114389	1.12 [0.53 - 2.39]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206913_at	200	0.875	0.0956291	-	0.6101	0.371729	0.214048	1.24 [0.77 - 1.98]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7200	60	0.116667	0.0142677	0.21019	-1.08511	0.296311	-0.45652	0.63 [0.27 - 1.49]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7200	60	0.266667	1.96517e-05	0.000822159	-1.5111	0.00927955	-1.23339	0.29 [0.12 - 0.74]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16434	155	0.612903	0.106665	-	-0.483656	0.544513	-0.21476	0.81 [0.40 - 1.62]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206913_at	286	0.437063	0.009356	0.15355	-0.499328	0.00809446	-0.636561	0.53 [0.33 - 0.85]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206913_at	159	0.132075	0.0261306	0.32266	-0.820241	0.825736	-0.0773294	0.93 [0.46 - 1.84]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206913_at	159	0.823899	0.0600457	-	0.65432	0.254247	0.284345	1.33 [0.82 - 2.17]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206913_at	159	0.496855	0.142949	-	-0.553663	0.548656	0.193211	1.21 [0.65 - 2.28]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206913_at	54	0.759259	0.108339	-	-15.4245	0.201177	-2.92212	0.05 [0.00 - 4.75]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206913_at	117	0.880342	0.132081	-	-1.41507	0.588964	-0.526683	0.59 [0.09 - 3.99]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206913_at	117	0.82906	0.0381341	0.414776	-1.17806	0.1042	-1.37371	0.25 [0.05 - 1.33]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206913_at	117	0.82906	0.0698137	-	-1.24895	0.181575	-1.35303	0.26 [0.04 - 1.88]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206913_at	117	0.82906	0.0381341	0.414776	-1.17806	0.1042	-1.37371	0.25 [0.05 - 1.33]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206913_at	236	0.135593	0.0310753	0.362697	-0.692944	0.384094	0.316006	1.37 [0.67 - 2.79]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206913_at	249	0.136546	0.177077	-	-0.380446	0.769326	0.0848832	1.09 [0.62 - 1.92]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206913_at	125	0.856	0.0224681	0.290733	-1.14598	0.10988	-1.1921	0.30 [0.07 - 1.31]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206913_at	125	0.896	0.0281783	0.339636	-15.2946	0.328833	-0.947492	0.39 [0.06 - 2.60]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206913_at	54	0.12963	0.191805	-	15.2162	0.757824	-0.0849948	0.92 [0.54 - 1.58]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206913_at	62	0.112903	0.113299	-	15.2112	0.757951	-0.0697293	0.93 [0.60 - 1.45]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206913_at	198	0.843434	0.299256	-	-0.414402	0.681799	-0.0971685	0.91 [0.57 - 1.44]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206913_at	198	0.10101	0.0165204	0.233787	-0.706346	0.188548	-0.27174	0.76 [0.51 - 1.14]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206913_at	198	0.686869	0.294925	-	0.288598	0.659285	-0.11011	0.90 [0.55 - 1.46]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206913_at	62	0.709677	0.0799758	-	0.973307	0.874915	0.20417	1.23 [0.10 - 15.58]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206913_at	51	0.803922	0.252861	-	-15.3758	0.493382	-1.38321	0.25 [0.00 - 13.13]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206913_at	177	0.468927	0.0209659	0.276996	-0.629631	0.314668	-0.637489	0.53 [0.15 - 1.83]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206913_at	177	0.305085	0.0122499	0.187882	-0.588794	0.599446	-0.273352	0.76 [0.27 - 2.11]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206913_at	145	0.324138	0.0202056	0.269887	-0.758564	0.218481	-1.05455	0.35 [0.06 - 1.87]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206913_at	226	0.314159	0.0102584	0.164588	-0.712108	0.805598	-0.0279932	0.97 [0.78 - 1.22]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206913_at	55	0.181818	0.0162821	0.231351	-1.08301	0.0910503	-2.10598	0.12 [0.01 - 1.40]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206913_at	55	0.763636	0.0205275	0.27291	-2.01399	0.255303	-1.39541	0.25 [0.02 - 2.74]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206913_at	49	0.163265	0.03985	0.426654	-1.2148	0.30595	-1.65542	0.19 [0.01 - 4.54]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206913_at	63	0.333333	0.00227911	0.0504019	-0.999358	0.288964	-3.05485	0.05 [0.00 - 13.35]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502350_3p_at	28	0.642857	0.116773	-	-1.00635	0.71562	-1.59643	0.20 [0.00 - 1088.13]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206913_at	79	0.101266	0.102889	-	0.82326	0.920544	0.0235545	1.02 [0.64 - 1.63]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206913_at	104	0.240385	0.000640541	0.0174984	-1.08792	0.0503814	-0.676296	0.51 [0.26 - 1.00]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206913_at	204	0.897059	0.00814493	0.138192	1.08969	0.310366	0.218188	1.24 [0.82 - 1.90]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206913_at	204	0.151961	0.172074	-	0.630967	0.95109	0.00927967	1.01 [0.75 - 1.36]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206913_at	178	0.544944	0.000780728	0.0206916	0.661299	0.0511681	0.506031	1.66 [1.00 - 2.76]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206913_at	111	0.882883	0.0446237	0.458279	0.715008	0.663422	0.0698844	1.07 [0.78 - 1.47]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206913_at	90	0.788889	0.0812072	-	-1.01971	0.675209	-0.25873	0.77 [0.23 - 2.59]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206913_at	90	0.788889	0.0213845	0.280863	-1.2937	0.731392	-0.184198	0.83 [0.29 - 2.38]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	3464	50	0.8	0.0037298	0.0750194	1.32848	0.0368862	1.17879	3.25 [1.07 - 9.83]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206913_at	138	0.413043	0.032585	0.374302	-0.509576	0.438948	0.185596	1.20 [0.75 - 1.93]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206913_at	129	0.627907	0.1257	-	0.385839	0.728983	0.0981363	1.10 [0.63 - 1.92]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44594	56	0.732143	0.0283879	0.341342	0.78624	0.378623	0.235683	1.27 [0.75 - 2.14]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44594	56	0.732143	0.0582222	-	0.675018	0.557128	0.152902	1.17 [0.70 - 1.94]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206913_at	278	0.161871	0.0519785	-	0.588241	0.975313	-0.0131065	0.99 [0.43 - 2.26]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206913_at	133	0.601504	0.00296092	0.0623275	0.695667	0.0115547	2.15401	8.62 [1.62 - 45.87]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206913_at	185	0.135135	0.183289	-	-0.312756	0.258035	-0.285318	0.75 [0.46 - 1.23]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206913_at	185	0.135135	0.350427	-	-0.242951	0.582692	-0.148162	0.86 [0.51 - 1.46]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P71810	110	0.254545	0.0524703	-	0.552173	0.259272	0.214795	1.24 [0.85 - 1.80]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P71810	110	0.890909	0.0142539	0.210042	0.960249	0.453889	0.203287	1.23 [0.72 - 2.09]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206913_at	80	0.1875	0.040634	0.431988	1.43175	0.862115	0.0589826	1.06 [0.55 - 2.06]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206913_at	38	0.5	0.0153459	0.221645	1.19869	0.0554202	0.333742	1.40 [0.99 - 1.96]
GENE	BAAT	bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206913_at	140	0.442857	0.00134851	0.0327131	-0.916833	0.00358075	-3.0724	0.05 [0.01 - 0.37]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205363_at	30	0.2	0.0593534	-	-0.905506	0.777889	0.278362	1.32 [0.19 - 9.14]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1734929	165	0.10303	0.206181	-	-0.452056	0.875967	0.0260987	1.03 [0.74 - 1.42]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1734929	165	0.412121	0.0304968	0.358177	-0.760432	0.856869	0.0425997	1.04 [0.66 - 1.66]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205363_at	163	0.490798	0.00657712	0.117234	-0.541797	0.445762	-0.497545	0.61 [0.17 - 2.18]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205363_at	79	0.189873	0.100127	-	0.759875	0.367567	0.728718	2.07 [0.42 - 10.11]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205363_at	58	0.672414	0.00430976	0.0841638	0.816174	0.205645	0.148144	1.16 [0.92 - 1.46]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205363_at	34	0.117647	0.0046534	0.0894318	-1.50619	0.26648	-0.230327	0.79 [0.53 - 1.19]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205363_at	158	0.126582	0.0640908	-	-0.559447	0.519067	0.168958	1.18 [0.71 - 1.98]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205363_at	53	0.886792	0.000365219	0.0108248	1.60671	0.0713492	0.254849	1.29 [0.98 - 1.70]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205363_at	53	0.886792	0.0025755	0.0556746	1.34057	0.475042	0.104126	1.11 [0.83 - 1.48]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205363_at	180	0.344444	0.0354263	0.395436	0.489579	0.132226	0.134797	1.14 [0.96 - 1.36]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205363_at	559	0.16458	0.141851	-	-0.373146	0.451726	-0.0591369	0.94 [0.81 - 1.10]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205363_at	77	0.103896	0.000141348	0.00474655	-1.45773	0.186083	-0.226522	0.80 [0.57 - 1.12]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205363_at	70	0.371429	0.000376065	0.0111007	1.02461	0.00348717	0.312496	1.37 [1.11 - 1.69]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38339_at	50	0.18	0.000214505	0.00683111	-1.51994	0.672075	-0.113891	0.89 [0.53 - 1.51]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205363_at	74	0.851351	0.151053	-	-0.619326	0.582642	0.10114	1.11 [0.77 - 1.59]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205363_at	67	0.104478	0.0163177	0.231716	-1.57908	0.168432	-2.52201	0.08 [0.00 - 2.91]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205363_at	115	0.826087	0.0447434	0.459047	1.06947	0.519251	0.165019	1.18 [0.71 - 1.95]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38339_at	158	0.841772	0.0223433	0.289607	0.772688	0.71144	0.0446167	1.05 [0.83 - 1.32]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38339_at	76	0.394737	0.0488703	0.484803	-1.03565	0.170857	-0.292868	0.75 [0.49 - 1.13]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205363_at	204	0.651961	0.00014597	0.00488223	0.564215	0.0952268	0.0836531	1.09 [0.99 - 1.20]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205363_at	87	0.873563	0.211553	-	0.608433	0.62272	0.0895369	1.09 [0.77 - 1.56]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205363_at	87	0.873563	0.211553	-	0.608433	0.62272	0.0895369	1.09 [0.77 - 1.56]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205363_at	77	0.74026	0.10118	-	-1.54886	0.669702	-0.162906	0.85 [0.40 - 1.80]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205363_at	77	0.493506	0.140058	-	-0.979666	0.983748	0.00815748	1.01 [0.46 - 2.21]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205363_at	136	0.867647	0.066749	-	-15.2602	0.474325	-0.146837	0.86 [0.58 - 1.29]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205363_at	200	0.88	0.129387	-	0.583863	0.767543	0.038575	1.04 [0.80 - 1.34]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5898	60	0.883333	0.0481224	0.480235	0.974803	0.430624	0.110276	1.12 [0.85 - 1.47]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5898	60	0.8	0.0184069	0.252624	0.977439	0.622746	0.0772408	1.08 [0.79 - 1.47]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15149	155	0.187097	0.00012208	0.00417407	-1.05825	0.0311392	-0.207816	0.81 [0.67 - 0.98]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205363_at	286	0.874126	0.174633	-	-0.468007	0.575524	-0.0382082	0.96 [0.84 - 1.10]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205363_at	159	0.144654	0.332568	-	0.505405	0.773883	-0.0341772	0.97 [0.77 - 1.22]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205363_at	159	0.522013	0.0891187	-	-0.5561	0.332543	-0.114069	0.89 [0.71 - 1.12]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205363_at	159	0.880503	0.227204	-	0.585395	0.87387	0.022433	1.02 [0.78 - 1.35]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205363_at	54	0.314815	0.0608043	-	-1.28705	0.702218	-0.294957	0.74 [0.16 - 3.38]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205363_at	117	0.777778	0.192433	-	-0.537276	0.4236	-0.109324	0.90 [0.69 - 1.17]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205363_at	117	0.145299	0.0050379	0.0952068	-1.13639	0.262418	-0.235701	0.79 [0.52 - 1.19]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205363_at	117	0.777778	0.192433	-	-0.537276	0.4236	-0.109324	0.90 [0.69 - 1.17]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205363_at	117	0.675214	0.0454433	0.463511	-0.9516	0.17065	-0.297261	0.74 [0.49 - 1.14]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205363_at	236	0.394068	0.0674536	-	-0.488434	0.576446	-0.0592989	0.94 [0.77 - 1.16]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205363_at	249	0.883534	0.00701214	0.123183	0.728885	0.961163	-0.00412228	1.00 [0.84 - 1.18]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205363_at	62	0.112903	0.00563781	0.103987	-1.55243	0.121137	-0.569857	0.57 [0.28 - 1.16]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205363_at	125	0.152	0.0892657	-	1.56773	0.718611	0.0663546	1.07 [0.74 - 1.53]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205363_at	125	0.152	0.137048	-	0.865028	0.174105	0.183033	1.20 [0.92 - 1.56]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205363_at	54	0.407407	0.0317136	0.367637	-1.32053	0.252883	-0.490585	0.61 [0.26 - 1.42]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205363_at	198	0.732323	0.192053	-	-0.436334	0.980945	-0.00168531	1.00 [0.87 - 1.15]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205363_at	198	0.267677	0.114921	-	0.405385	0.564484	0.0318114	1.03 [0.93 - 1.15]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205363_at	198	0.151515	0.20701	-	0.537022	0.777909	0.0191242	1.02 [0.89 - 1.16]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205363_at	51	0.431373	0.0421399	0.442076	16.0272	0.675716	1.25973	3.52 [0.01 - 1289.66]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205363_at	62	0.887097	0.194398	-	-15.2147	0.88219	-0.292282	0.75 [0.02 - 35.64]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205363_at	145	0.744828	0.0577326	-	-0.887051	0.880856	0.0785441	1.08 [0.39 - 3.02]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205363_at	177	0.841808	0.05425	-	-0.96366	0.101405	-1.14441	0.32 [0.08 - 1.25]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205363_at	177	0.310734	0.0142319	0.209805	-0.577235	0.0536774	-1.17019	0.31 [0.09 - 1.02]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205363_at	226	0.146018	0.173133	-	0.697042	0.534021	0.0797383	1.08 [0.84 - 1.39]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205363_at	55	0.836364	0.0181466	0.250071	1.10078	0.449394	0.648491	1.91 [0.36 - 10.27]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205363_at	55	0.436364	0.049036	0.485809	-0.986544	0.279311	-1.82345	0.16 [0.01 - 4.39]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205363_at	49	0.44898	0.0322264	0.37157	-1.3295	0.39897	-1.79861	0.17 [0.00 - 10.81]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205363_at	63	0.111111	0.00895442	0.14853	-1.13406	0.260282	-6.11079	0.00 [0.00 - 92.64]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502368_3p_at	28	0.821429	0.0795344	-	1.13743	0.826394	0.070081	1.07 [0.57 - 2.01]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205363_at	82	0.170732	0.158722	-	0.731487	0.465674	0.232362	1.26 [0.68 - 2.36]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205363_at	79	0.151899	0.178647	-	-0.465337	0.506729	-0.136663	0.87 [0.58 - 1.31]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205363_at	104	0.692308	0.100385	-	0.533344	0.507414	0.258712	1.30 [0.60 - 2.78]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P127495	117	0.632479	0.00562342	0.103779	0.774635	0.156824	0.088833	1.09 [0.97 - 1.24]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205363_at	204	0.343137	0.081318	-	0.7763	0.403021	0.150234	1.16 [0.82 - 1.65]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205363_at	204	0.343137	0.129414	-	0.466886	0.685738	0.0535079	1.05 [0.81 - 1.37]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205363_at	178	0.106742	0.137868	-	0.516284	0.381986	0.128164	1.14 [0.85 - 1.52]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300002199	41	0.512195	0.000230926	0.00728331	1.55692	0.189925	0.225919	1.25 [0.89 - 1.76]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205363_at	111	0.324324	0.0103725	0.165961	-0.665958	0.277414	-0.145189	0.86 [0.67 - 1.12]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205363_at	90	0.111111	0.392693	-	0.50886	0.385472	0.33065	1.39 [0.66 - 2.94]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205363_at	90	0.422222	0.208599	-	0.499747	0.889867	0.0704282	1.07 [0.40 - 2.91]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205363_at	138	0.797101	0.106638	-	0.448196	0.373783	0.0959796	1.10 [0.89 - 1.36]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205363_at	129	0.457364	0.024664	0.310127	-0.551981	0.160031	-0.153106	0.86 [0.69 - 1.06]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6323	56	0.107143	0.200213	-	-0.619478	0.358119	-0.139938	0.87 [0.65 - 1.17]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6323	56	0.196429	0.208121	-	-0.508652	0.441784	-0.107343	0.90 [0.68 - 1.18]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205363_at	278	0.201439	0.140371	-	0.36433	0.664673	0.0234364	1.02 [0.92 - 1.14]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205363_at	133	0.819549	0.0723093	-	0.492932	0.195937	0.0848983	1.09 [0.96 - 1.24]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205363_at	185	0.237838	0.0756675	-	-0.328414	0.381263	-0.0591657	0.94 [0.83 - 1.08]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205363_at	185	0.221622	0.0457821	0.465658	-0.398696	0.164447	-0.105519	0.90 [0.78 - 1.04]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P127495	110	0.190909	0.00248067	0.0540034	-0.954738	0.23778	-0.0964054	0.91 [0.77 - 1.07]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P127495	110	0.190909	0.00512879	0.0965545	-0.729911	0.365922	-0.0625457	0.94 [0.82 - 1.08]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205363_at	80	0.875	0.24026	-	0.646165	0.77143	0.0428517	1.04 [0.78 - 1.39]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_0051	281	0.793594	0.17321	-	-0.247119	0.403681	-0.0783964	0.92 [0.77 - 1.11]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205363_at	38	0.105263	0.0974381	-	15.2696	0.849136	-0.0397129	0.96 [0.64 - 1.45]
GENE	BBOX1	butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205363_at	140	0.478571	0.00243104	0.0531229	-0.886701	0.0690765	-0.807882	0.45 [0.19 - 1.07]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214452_at	30	0.533333	0.0159046	0.227462	0.966091	0.226881	0.37545	1.46 [0.79 - 2.68]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214390_s_at	30	0.133333	0.031047	0.362477	1.92406	0.224975	0.511648	1.67 [0.73 - 3.81]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1766169	165	0.739394	0.00050674	0.0143332	0.864127	0.00427423	0.295601	1.34 [1.10 - 1.65]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1766169	165	0.806061	3.74218e-06	0.000182718	1.50796	4.0693e-05	0.545653	1.73 [1.33 - 2.24]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214390_s_at	163	0.368098	7.95927e-06	0.00036327	1.00006	4.303e-05	0.943694	2.57 [1.63 - 4.04]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214452_at	163	0.165644	0.000185388	0.00601625	1.29179	0.00431902	0.338387	1.40 [1.11 - 1.77]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226517_at	163	0.312883	2.62578e-05	0.00106658	1.01548	1.38923e-05	0.363642	1.44 [1.22 - 1.69]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	225285_at	163	0.650307	2.16793e-05	0.000898044	0.835989	9.65199e-06	0.386979	1.47 [1.24 - 1.75]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226517_at	79	0.78481	0.00647134	0.11577	0.873269	0.101758	0.157251	1.17 [0.97 - 1.41]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	225285_at	79	0.898734	0.00662405	0.117881	1.08187	0.114239	0.157708	1.17 [0.96 - 1.42]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214452_at	79	0.898734	0.00287844	0.0609217	1.17545	0.0398742	0.346766	1.41 [1.02 - 1.97]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214390_s_at	79	0.797468	0.000368332	0.0109041	1.10223	0.00230032	0.729634	2.07 [1.30 - 3.32]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214390_s_at	58	0.103448	0.0806383	-	0.806058	0.20211	0.202609	1.22 [0.90 - 1.67]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214452_at	58	0.603448	0.0276149	0.335024	0.636312	0.323917	0.219863	1.25 [0.80 - 1.93]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214390_s_at	34	0.882353	0.0455226	0.464014	-1.41321	0.258681	-0.36825	0.69 [0.37 - 1.31]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214452_at	34	0.117647	0.073674	-	-0.971851	0.256074	-0.212799	0.81 [0.56 - 1.17]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214452_at	158	0.537975	0.0848517	-	-0.407447	0.198024	-0.183311	0.83 [0.63 - 1.10]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214390_s_at	158	0.835443	0.0924896	-	-0.594913	0.489671	-0.158239	0.85 [0.54 - 1.34]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214452_at	53	0.226415	0.0168006	0.236636	1.20718	0.32949	0.232638	1.26 [0.79 - 2.01]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214390_s_at	53	0.301887	0.0193191	0.261459	1.096	0.172997	0.242623	1.27 [0.90 - 1.81]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214452_at	53	0.226415	0.0173178	0.241846	1.35015	0.282725	0.281259	1.32 [0.79 - 2.21]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214390_s_at	53	0.301887	0.00905328	0.149772	1.12346	0.145739	0.237972	1.27 [0.92 - 1.75]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214452_at	180	0.105556	0.0475972	0.477001	0.884664	0.131621	0.230305	1.26 [0.93 - 1.70]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214390_s_at	180	0.4	0.00526037	0.0984942	0.637403	0.0957545	0.122907	1.13 [0.98 - 1.31]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226517_at	180	0.316667	0.115248	-	0.377029	0.868885	0.0199086	1.02 [0.81 - 1.29]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	225285_at	180	0.722222	0.114741	-	-0.384664	0.899277	0.0152535	1.02 [0.80 - 1.29]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226517_at	559	0.899821	0.139839	-	-0.571862	0.763907	-0.0279939	0.97 [0.81 - 1.17]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	225285_at	559	0.896243	0.259629	-	-0.412968	0.579946	-0.0564535	0.95 [0.77 - 1.15]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214452_at	559	0.452594	0.00560235	0.103475	-0.551438	0.107116	-0.222645	0.80 [0.61 - 1.05]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214390_s_at	559	0.386404	0.247017	-	0.255968	0.964656	0.00558959	1.01 [0.79 - 1.29]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214390_s_at	77	0.402597	0.125792	-	0.403742	0.449905	0.074159	1.08 [0.89 - 1.31]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214452_at	77	0.207792	0.0644735	-	0.614977	0.142406	0.217419	1.24 [0.93 - 1.66]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226517_at	77	0.558442	0.0358993	0.398869	0.539121	0.0771431	0.203823	1.23 [0.98 - 1.54]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	225285_at	77	0.220779	0.0559788	-	0.613867	0.174137	0.160266	1.17 [0.93 - 1.48]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226517_at	70	0.885714	0.164431	-	-0.708166	0.957758	-0.00503281	0.99 [0.83 - 1.20]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	225285_at	70	0.871429	0.316106	-	-0.467373	0.856235	-0.018278	0.98 [0.81 - 1.20]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214452_at	70	0.657143	0.206286	-	-0.37046	0.713396	-0.0476606	0.95 [0.74 - 1.23]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214390_s_at	70	0.685714	0.309596	-	-0.301511	0.91717	-0.0483309	0.95 [0.38 - 2.37]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38201_at	50	0.68	0.00962683	0.156897	0.889454	0.153553	0.198441	1.22 [0.93 - 1.60]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214452_at	74	0.405405	0.000802986	0.0211886	1.06222	0.0172454	0.390583	1.48 [1.07 - 2.04]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214390_s_at	74	0.689189	0.0158133	0.226517	0.712998	0.0481629	0.211824	1.24 [1.00 - 1.52]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	225285_at	74	0.418919	8.4385e-06	0.000383063	1.41597	0.000361045	0.471283	1.60 [1.24 - 2.08]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226517_at	74	0.283784	5.74249e-06	0.000270001	1.85824	0.000262119	0.490334	1.63 [1.25 - 2.12]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	225285_at	67	0.328358	0.18928	-	-0.85793	0.807334	0.0905453	1.09 [0.53 - 2.27]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214452_at	67	0.791045	0.148225	-	0.993617	0.51412	0.177058	1.19 [0.70 - 2.03]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226517_at	67	0.283582	0.154277	-	1.40039	0.580828	0.186321	1.20 [0.62 - 2.33]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214390_s_at	67	0.820895	0.116201	-	1.06787	0.498167	0.274665	1.32 [0.59 - 2.91]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214452_at	115	0.278261	0.015333	0.221509	15.5743	0.124764	0.854175	2.35 [0.79 - 6.99]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214390_s_at	115	0.278261	0.015333	0.221509	15.5743	0.184889	1.00105	2.72 [0.62 - 11.95]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226517_at	115	0.895652	0.197606	-	0.812539	0.710995	0.169455	1.18 [0.48 - 2.90]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	225285_at	115	0.226087	0.155915	-	1.36459	0.968941	0.0235026	1.02 [0.31 - 3.34]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38201_at	158	0.297468	0.193338	-	0.458363	0.640064	-0.132416	0.88 [0.50 - 1.53]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38201_at	76	0.605263	0.0212956	0.280045	1.19498	0.655204	0.213689	1.24 [0.48 - 3.16]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	225285_at	204	0.789216	0.00699875	0.123002	0.468252	0.00944561	0.260351	1.30 [1.07 - 1.58]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214452_at	204	0.720588	0.0012145	0.0299832	0.505352	0.0482361	0.198892	1.22 [1.00 - 1.49]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226517_at	204	0.220588	0.020942	0.276774	0.385794	0.0581152	0.191985	1.21 [0.99 - 1.48]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214390_s_at	204	0.857843	0.00773039	0.132777	0.535866	0.0833529	0.109229	1.12 [0.99 - 1.26]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214390_s_at	87	0.471264	0.168476	-	-0.520397	0.83134	-0.146803	0.86 [0.22 - 3.33]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226517_at	87	0.126437	0.104733	-	-0.732733	0.308035	-0.180351	0.83 [0.59 - 1.18]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226517_at	87	0.126437	0.104733	-	-0.732733	0.308035	-0.180351	0.83 [0.59 - 1.18]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	225285_at	87	0.126437	0.0476116	0.47709	-0.889359	0.342409	-0.170535	0.84 [0.59 - 1.20]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	225285_at	87	0.126437	0.0476116	0.47709	-0.889359	0.342409	-0.170535	0.84 [0.59 - 1.20]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214452_at	87	0.747126	0.0562881	-	-0.993101	0.351619	-0.376386	0.69 [0.31 - 1.52]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214390_s_at	87	0.471264	0.168476	-	-0.520397	0.83134	-0.146803	0.86 [0.22 - 3.33]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214452_at	87	0.747126	0.0562881	-	-0.993101	0.351619	-0.376386	0.69 [0.31 - 1.52]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226517_at	77	0.194805	0.0891718	-	-0.936374	0.948281	-0.0179392	0.98 [0.57 - 1.69]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	225285_at	77	0.155844	0.140378	-	-0.860223	0.759196	0.103577	1.11 [0.57 - 2.15]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214390_s_at	77	0.831169	0.13104	-	-15.3326	0.782436	-0.396177	0.67 [0.04 - 11.20]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226517_at	77	0.155844	0.0348477	0.391204	-1.27507	0.863927	-0.0541161	0.95 [0.51 - 1.76]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214452_at	77	0.896104	0.027819	0.3367	1.35521	0.261507	0.807352	2.24 [0.55 - 9.18]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	225285_at	77	0.896104	0.152063	-	1.08308	0.738829	0.129884	1.14 [0.53 - 2.44]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214390_s_at	77	0.142857	0.123683	-	15.2694	0.598291	0.681632	1.98 [0.16 - 24.96]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214452_at	77	0.896104	0.00468379	0.0898928	1.7449	0.164208	1.07659	2.93 [0.64 - 13.38]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214390_s_at	136	0.654412	0.00597954	0.108873	1.19004	0.473513	0.214098	1.24 [0.69 - 2.22]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214452_at	136	0.161765	0.368435	-	0.659111	0.997319	0.001047	1.00 [0.54 - 1.84]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214452_at	200	0.89	0.000941233	0.0242217	1.09348	0.0928075	0.463458	1.59 [0.93 - 2.73]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214390_s_at	200	0.385	0.0355227	0.396137	-0.611475	0.797141	-0.0568488	0.94 [0.61 - 1.46]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19800	60	0.116667	0.086299	-	-0.848799	0.880435	-0.0556338	0.95 [0.46 - 1.95]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3824	60	0.566667	0.102723	-	-0.651001	0.457209	-0.15906	0.85 [0.56 - 1.30]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19800	60	0.116667	0.17978	-	-0.655974	0.756601	-0.128015	0.88 [0.39 - 1.98]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3824	60	0.633333	0.0338555	0.383863	0.794236	0.264266	0.275792	1.32 [0.81 - 2.14]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	17294	155	0.225806	0.000772061	0.0204974	-0.924593	0.0177746	-0.408072	0.66 [0.47 - 0.93]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214452_at	286	0.188811	0.163025	-	0.376528	0.639027	0.0637168	1.07 [0.82 - 1.39]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214390_s_at	286	0.13986	0.0414123	0.437227	-0.514161	0.820032	0.0445259	1.05 [0.71 - 1.53]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214452_at	159	0.339623	0.0120222	0.185287	1.00301	0.0474444	0.529421	1.70 [1.01 - 2.87]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214452_at	159	0.339623	0.0311259	0.36309	1.01621	0.0959954	0.519836	1.68 [0.91 - 3.10]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214390_s_at	159	0.761006	0.00513307	0.0966178	0.87704	0.168009	0.296964	1.35 [0.88 - 2.05]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214390_s_at	159	0.786164	0.00508701	0.0959357	0.88784	0.043872	0.410318	1.51 [1.01 - 2.25]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214452_at	159	0.220126	0.028391	0.341366	1.09976	0.0860007	0.453032	1.57 [0.94 - 2.64]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214390_s_at	159	0.761006	0.0101541	0.163329	0.937203	0.253324	0.289857	1.34 [0.81 - 2.20]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225285_at	159	0.27044	0.21751	-	0.483028	0.752786	0.0832215	1.09 [0.65 - 1.82]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225285_at	159	0.654088	0.0449291	0.460235	0.624787	0.222454	0.305569	1.36 [0.83 - 2.22]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	225285_at	159	0.886792	0.0878842	-	0.764041	0.526169	0.192131	1.21 [0.67 - 2.20]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226517_at	159	0.477987	0.00724147	0.126277	0.897181	0.25547	0.283883	1.33 [0.81 - 2.17]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226517_at	159	0.477987	0.00191816	0.0437684	1.05049	0.0370278	0.507711	1.66 [1.03 - 2.68]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226517_at	159	0.490566	0.024806	0.311355	0.873421	0.142639	0.42343	1.53 [0.87 - 2.69]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214452_at	54	0.888889	0.186954	-	-15.3366	0.85591	-0.242262	0.78 [0.06 - 10.73]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	HC-U21551_at	54	0.814815	0.212654	-	-15.3228	0.549562	-1.03097	0.36 [0.01 - 10.44]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214390_s_at	54	0.648148	0.1425	-	-1.43183	0.564683	-0.497934	0.61 [0.11 - 3.31]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214390_s_at	117	0.444444	0.0382185	0.415366	-0.653086	0.395058	-0.537071	0.58 [0.17 - 2.02]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214390_s_at	117	0.461538	0.00885352	0.147258	-1.06133	0.0205094	-2.22774	0.11 [0.02 - 0.71]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214452_at	117	0.239316	0.00679877	0.120279	-0.992172	0.22379	-1.00653	0.37 [0.07 - 1.85]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214452_at	117	0.222222	0.171119	-	-0.484828	0.652643	-0.258071	0.77 [0.25 - 2.38]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214452_at	117	0.222222	0.171119	-	-0.484828	0.652643	-0.258071	0.77 [0.25 - 2.38]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214452_at	117	0.846154	0.0186729	0.255218	-15.3118	0.0558551	-1.9152	0.15 [0.02 - 1.05]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214390_s_at	117	0.444444	0.0382185	0.415366	-0.653086	0.395058	-0.537071	0.58 [0.17 - 2.02]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214390_s_at	117	0.444444	0.014045	0.207786	-0.936816	0.081572	-1.49067	0.23 [0.04 - 1.21]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214390_s_at	236	0.483051	0.0492762	0.487265	0.544913	0.631021	0.19918	1.22 [0.54 - 2.75]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214452_at	236	0.512712	0.045127	0.461499	-0.555597	0.264674	-0.219827	0.80 [0.55 - 1.18]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	225285_at	236	0.79661	0.0182206	0.250798	0.678245	0.804466	-0.0649019	0.94 [0.56 - 1.57]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226517_at	236	0.110169	0.171145	-	-0.519827	0.322242	-0.246931	0.78 [0.48 - 1.27]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214390_s_at	249	0.2249	0.0938691	-	-0.392488	0.585727	-0.185323	0.83 [0.43 - 1.62]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214452_at	249	0.518072	0.0359001	0.398875	-0.450825	0.26956	-0.176877	0.84 [0.61 - 1.15]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226517_at	249	0.84739	0.0914478	-	0.442507	0.789645	0.0514086	1.05 [0.72 - 1.54]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	225285_at	249	0.767068	0.00647243	0.115785	0.616628	0.31181	0.205989	1.23 [0.82 - 1.83]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214390_s_at	62	0.548387	0.16899	-	0.689639	0.700066	-0.0632017	0.94 [0.68 - 1.29]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214390_s_at	125	0.104	0.0174144	0.242812	-1.01098	0.143969	-0.777035	0.46 [0.16 - 1.30]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214452_at	62	0.145161	0.106715	-	15.2436	0.90266	0.0654755	1.07 [0.37 - 3.05]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214390_s_at	125	0.744	0.0243618	0.307504	-1.02703	0.180594	-0.527254	0.59 [0.27 - 1.28]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214390_s_at	54	0.5	0.166207	-	0.906152	0.772238	-0.0576009	0.94 [0.64 - 1.39]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214452_at	125	0.832	0.103559	-	-1.13443	0.568731	-0.27209	0.76 [0.30 - 1.94]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214452_at	125	0.28	0.219027	-	-0.399923	0.338379	-0.397635	0.67 [0.30 - 1.52]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214452_at	54	0.87037	0.0516646	-	1.13894	0.790189	0.172778	1.19 [0.33 - 4.24]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214390_s_at	198	0.818182	0.0528598	-	-0.87908	0.474904	-0.0712558	0.93 [0.77 - 1.13]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214452_at	198	0.671717	0.157605	-	-0.416147	0.975156	0.00305755	1.00 [0.83 - 1.22]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214452_at	198	0.181818	0.0972801	-	0.701976	0.608944	0.0548487	1.06 [0.86 - 1.30]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214390_s_at	198	0.136364	0.0408192	0.43324	0.709849	0.35927	0.0680619	1.07 [0.93 - 1.24]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214390_s_at	198	0.818182	0.141308	-	-0.58289	0.823624	-0.0207872	0.98 [0.82 - 1.18]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214452_at	198	0.888889	0.0320813	0.37046	0.636201	0.897448	0.0104857	1.01 [0.86 - 1.19]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214390_s_at	51	0.235294	0.373361	-	-0.792002	0.799726	-0.503412	0.60 [0.01 - 29.54]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214390_s_at	62	0.467742	0.128319	-	0.975965	0.433292	0.926889	2.53 [0.25 - 25.67]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214452_at	51	0.333333	0.100082	-	15.7169	0.326526	3.36852	29.04 [0.03 - 24288.75]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214452_at	62	0.887097	0.0285033	0.342278	1.36323	0.0973751	3.54229	34.55 [0.52 - 2276.78]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226517_at	145	0.627586	7.80392e-05	0.00281395	1.28191	8.8703e-05	0.65367	1.92 [1.39 - 2.67]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214390_s_at	177	0.514124	0.0321616	0.371074	0.585912	0.143629	0.615787	1.85 [0.81 - 4.23]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214452_at	177	0.305085	0.0282569	0.340276	0.600811	0.18265	0.186666	1.21 [0.92 - 1.59]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	225285_at	145	0.358621	9.43475e-05	0.00332724	2.00592	0.000240957	0.711255	2.04 [1.39 - 2.98]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214452_at	145	0.282759	0.0020111	0.0455009	1.50307	0.0122608	0.476182	1.61 [1.11 - 2.34]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214390_s_at	177	0.418079	0.062435	-	0.458162	0.423607	0.29056	1.34 [0.66 - 2.72]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214390_s_at	145	0.517241	0.00186738	0.0428143	1.07831	0.0068024	1.40691	4.08 [1.47 - 11.31]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226517_at	177	0.429379	0.00557492	0.103079	0.702785	0.0150644	0.278655	1.32 [1.06 - 1.65]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226517_at	177	0.457627	0.00256495	0.0554894	0.884135	0.00340223	0.390012	1.48 [1.14 - 1.92]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214452_at	177	0.242938	0.024899	0.312157	0.836072	0.0784972	0.278474	1.32 [0.97 - 1.80]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	225285_at	177	0.892655	0.00747252	0.129364	0.786135	0.0324427	0.289188	1.34 [1.02 - 1.74]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	225285_at	177	0.892655	0.000647002	0.0176482	1.05284	0.00919902	0.406752	1.50 [1.11 - 2.04]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214452_at	226	0.477876	0.00992431	0.16054	0.765011	0.0482564	0.333061	1.40 [1.00 - 1.94]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214390_s_at	226	0.893805	0.000143747	0.00481706	1.16348	0.0246978	0.222432	1.25 [1.03 - 1.52]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226517_at	226	0.787611	0.000379667	0.0111921	0.987096	0.00190905	0.467388	1.60 [1.19 - 2.14]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	225285_at	226	0.172566	0.00118954	0.0294683	15.3102	0.00110021	0.472733	1.60 [1.21 - 2.13]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226517_at	55	0.763636	0.00382957	0.0766167	1.34568	0.0144885	0.421632	1.52 [1.09 - 2.14]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214452_at	55	0.363636	0.0539163	-	1.15536	0.565937	0.152327	1.16 [0.69 - 1.96]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214390_s_at	55	0.309091	0.113998	-	-0.697129	0.914183	-0.0733173	0.93 [0.24 - 3.53]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	225285_at	55	0.709091	0.0278338	0.336821	0.969542	0.12859	0.298098	1.35 [0.92 - 1.98]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226517_at	49	0.714286	0.00211743	0.0474616	1.63874	0.0385773	0.40138	1.49 [1.02 - 2.19]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214452_at	49	0.897959	0.102383	-	1.05365	0.633132	0.143536	1.15 [0.64 - 2.08]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	225285_at	49	0.632653	0.0307687	0.360306	1.20435	0.164839	0.302611	1.35 [0.88 - 2.07]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214390_s_at	55	0.309091	0.0761261	-	-0.877133	0.285422	-0.963229	0.38 [0.07 - 2.23]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214390_s_at	49	0.244898	0.0226303	0.292192	-1.23953	0.30592	-1.12692	0.32 [0.04 - 2.80]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226517_at	55	0.509091	0.00221842	0.0493039	1.45657	0.0219648	0.370871	1.45 [1.06 - 1.99]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	225285_at	55	0.4	0.0232742	0.297944	1.19764	0.12661	0.280726	1.32 [0.92 - 1.90]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214452_at	55	0.836364	0.00911038	0.150488	1.16941	0.193821	0.282737	1.33 [0.87 - 2.03]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214390_s_at	63	0.111111	0.000719159	0.0193031	-1.36634	0.243723	-12.4032	0.00 [0.00 - 4679.77]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226517_at	63	0.507937	8.93646e-05	0.00317175	1.37347	0.00128281	0.298951	1.35 [1.12 - 1.62]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	225285_at	63	0.793651	0.000103308	0.00360413	1.36012	0.00239349	0.304815	1.36 [1.11 - 1.65]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214452_at	63	0.111111	0.013349	0.200182	-1.06821	0.633768	0.636722	1.89 [0.14 - 25.95]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.157205.0.S1_3p_a_at	28	0.892857	0.000444846	0.0128219	2.24681	0.00985159	2.64407	14.07 [1.89 - 104.79]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.7567.0.S1_3p_at	28	0.892857	0.0389708	0.420603	1.57294	0.24192	0.231227	1.26 [0.86 - 1.86]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.157205.1.S1_3p_at	28	0.678571	0.033703	0.382725	1.22597	0.130039	0.424759	1.53 [0.88 - 2.65]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.317432.0.S1_3p_at	28	0.857143	0.0514315	-	1.27646	0.422245	0.12109	1.13 [0.84 - 1.52]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214390_s_at	82	0.890244	0.22621	-	-0.85771	0.755548	-0.154084	0.86 [0.32 - 2.26]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214452_at	82	0.439024	0.0995392	-	-0.556133	0.234959	-0.421449	0.66 [0.33 - 1.32]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214390_s_at	79	0.164557	0.083004	-	-0.581244	0.258772	-0.386868	0.68 [0.35 - 1.33]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214452_at	79	0.78481	0.124337	-	-0.527557	0.212434	-0.279464	0.76 [0.49 - 1.17]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U21551_at	86	0.116279	0.0744615	-	-0.878771	0.917559	-0.0408269	0.96 [0.44 - 2.08]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214452_at	104	0.826923	0.0339813	0.3848	-1.08891	0.157536	-0.453846	0.64 [0.34 - 1.19]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214390_s_at	104	0.865385	0.0656067	-	-1.08647	0.304601	-0.489218	0.61 [0.24 - 1.56]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P935986	117	0.17094	0.135295	-	-0.524945	0.902341	-0.0108736	0.99 [0.83 - 1.18]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P87528	117	0.871795	0.133304	-	0.547433	0.77208	0.0239506	1.02 [0.87 - 1.20]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P52921	117	0.290598	0.129321	-	0.532105	0.667238	0.0413933	1.04 [0.86 - 1.26]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226517_at	204	0.671569	0.120864	-	0.565191	0.705309	0.0794772	1.08 [0.72 - 1.63]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214452_at	204	0.254902	0.0251911	0.314669	1.27555	0.248545	0.235164	1.27 [0.85 - 1.89]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	225285_at	204	0.838235	0.130032	-	-1.0591	0.756738	0.0702864	1.07 [0.69 - 1.67]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226517_at	204	0.671569	0.0248516	0.311748	0.606318	0.13682	0.236525	1.27 [0.93 - 1.73]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214452_at	204	0.289216	0.00189454	0.0433252	1.18956	0.0104115	0.394468	1.48 [1.10 - 2.01]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	225285_at	204	0.666667	0.0176538	0.245199	0.637593	0.109159	0.278905	1.32 [0.94 - 1.86]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214390_s_at	204	0.54902	0.000567886	0.0157956	1.32657	0.0284536	0.411976	1.51 [1.04 - 2.18]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214390_s_at	204	0.563725	0.000138846	0.00467286	1.04153	0.00146452	0.456363	1.58 [1.19 - 2.09]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214390_s_at	178	0.893258	0.000594734	0.016429	0.914883	0.0205826	0.637162	1.89 [1.10 - 3.24]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214452_at	178	0.898876	0.0185455	0.253978	0.666779	0.198281	0.22263	1.25 [0.89 - 1.75]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214452_at	111	0.675676	0.0211955	0.279121	0.601809	0.124869	0.288574	1.33 [0.92 - 1.93]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214390_s_at	111	0.684685	0.0201316	0.26919	0.610554	0.082785	0.220388	1.25 [0.97 - 1.60]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226517_at	111	0.369369	0.122258	-	0.442817	0.651586	0.0674739	1.07 [0.80 - 1.43]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	225285_at	111	0.567568	0.0591187	-	0.491944	0.527778	0.0852197	1.09 [0.84 - 1.42]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214390_s_at	90	0.111111	0.0703376	-	-0.741893	0.962767	-0.0249867	0.98 [0.34 - 2.78]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214390_s_at	90	0.244444	0.122715	-	0.809373	0.475589	0.402174	1.50 [0.50 - 4.51]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214452_at	90	0.844444	0.116863	-	-0.912821	0.467081	-0.235179	0.79 [0.42 - 1.49]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214452_at	90	0.111111	0.0378825	0.41301	-0.919502	0.652324	-0.161387	0.85 [0.42 - 1.72]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214452_at	138	0.289855	0.0454913	0.463816	0.568953	0.0595412	0.140894	1.15 [0.99 - 1.33]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214390_s_at	138	0.442029	0.0487988	0.484368	0.490818	0.108671	0.147414	1.16 [0.97 - 1.39]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226517_at	138	0.144928	0.0377272	0.411917	0.865751	0.162945	0.107532	1.11 [0.96 - 1.30]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	225285_at	138	0.173913	0.0585177	-	0.700502	0.119687	0.124419	1.13 [0.97 - 1.32]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214452_at	129	0.162791	0.093116	-	0.658457	0.712725	-0.0833784	0.92 [0.59 - 1.43]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214390_s_at	129	0.55814	0.0469171	0.472781	-0.510025	0.375297	-0.0879927	0.92 [0.75 - 1.11]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	45077	56	0.892857	0.0793208	-	-1.60742	0.964291	0.00624952	1.01 [0.77 - 1.32]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5117	56	0.160714	0.118109	-	-0.59667	0.656065	-0.0838461	0.92 [0.64 - 1.33]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15249	56	0.375	0.116628	-	0.60032	0.74952	0.0502518	1.05 [0.77 - 1.43]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5117	56	0.857143	0.308796	-	-0.609863	0.813991	-0.0467098	0.95 [0.65 - 1.41]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	45077	56	0.892857	0.0358501	0.398512	-1.85583	0.8929	-0.0172736	0.98 [0.76 - 1.26]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	15249	56	0.375	0.284447	-	0.384536	0.972128	0.00518802	1.01 [0.75 - 1.34]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214390_s_at	278	0.233813	0.0238513	0.30304	-0.459776	0.386385	-0.0587774	0.94 [0.83 - 1.08]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226517_at	278	0.266187	0.112093	-	-0.315726	0.503011	-0.0393692	0.96 [0.86 - 1.08]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214452_at	278	0.302158	0.0384583	0.417042	-0.404355	0.381105	-0.0455178	0.96 [0.86 - 1.06]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	225285_at	278	0.161871	0.171299	-	-0.320557	0.585501	-0.0334907	0.97 [0.86 - 1.09]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214390_s_at	133	0.323308	0.114496	-	-0.374914	0.74632	-0.0152884	0.98 [0.90 - 1.08]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214452_at	133	0.330827	0.0255277	0.317547	-0.522743	0.341535	-0.0435976	0.96 [0.88 - 1.05]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11431	81	0.54321	0.124517	-	-0.876131	0.992606	-0.00234653	1.00 [0.61 - 1.64]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4087	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214452_at	185	0.113514	0.000334768	0.0100429	-0.869497	0.0808154	-0.152662	0.86 [0.72 - 1.02]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214390_s_at	185	0.562162	0.00641566	0.114997	-0.497376	0.138384	-0.184381	0.83 [0.65 - 1.06]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214452_at	185	0.113514	0.00276348	0.0589464	-0.721162	0.266832	-0.0846937	0.92 [0.79 - 1.07]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214390_s_at	185	0.572973	0.011431	0.178469	-0.427486	0.204361	-0.142891	0.87 [0.70 - 1.08]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P87528	110	0.718182	0.0185454	0.253977	-0.630619	0.240949	-0.0662939	0.94 [0.84 - 1.05]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P52921	110	0.754545	0.0168669	0.237306	-0.681476	0.25667	-0.0839163	0.92 [0.80 - 1.06]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P87528	110	0.709091	0.0158092	0.226474	-0.87577	0.154761	-0.112197	0.89 [0.77 - 1.04]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P935986	110	0.554545	0.0268693	0.328851	-0.522736	0.162439	-0.0966114	0.91 [0.79 - 1.04]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P52921	110	0.790909	0.0304093	0.35749	-0.86866	0.210127	-0.128994	0.88 [0.72 - 1.08]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P935986	110	0.8	0.0671506	-	-0.742629	0.201178	-0.121883	0.89 [0.73 - 1.07]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214452_at	80	0.15	0.228573	-	-0.610481	0.7107	-0.0580652	0.94 [0.69 - 1.28]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214390_s_at	80	0.625	0.142551	-	-0.735733	0.84993	-0.0202626	0.98 [0.79 - 1.21]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_0742	281	0.66548	0.0903984	-	0.24731	0.779982	0.0207265	1.02 [0.88 - 1.18]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214452_at	38	0.631579	0.00481219	0.0918316	1.33164	0.0152663	0.793454	2.21 [1.16 - 4.20]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214390_s_at	38	0.842105	0.00363411	0.0734775	1.42909	0.00780355	1.41318	4.11 [1.45 - 11.64]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226517_at	38	0.894737	0.109134	-	0.990596	0.335639	0.251988	1.29 [0.77 - 2.15]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	225285_at	38	0.263158	0.0773724	-	1.08612	0.131987	0.395944	1.49 [0.89 - 2.49]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214390_s_at	140	0.657143	0.0017211	0.0400339	0.87912	0.0856555	0.623432	1.87 [0.92 - 3.80]
GENE	BCAT1	branched chain amino-acid transaminase 1, cytosolic	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214452_at	140	0.728571	0.00200407	0.0453705	0.878593	0.0133012	0.471762	1.60 [1.10 - 2.33]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215654_at	30	0.133333	0.195805	-	-0.70981	0.712178	0.253362	1.29 [0.34 - 4.95]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203576_at	30	0.366667	0.105974	-	-0.642758	0.569691	-0.18232	0.83 [0.44 - 1.56]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1695110	165	0.212121	0.15908	-	-0.392527	0.592501	0.0675613	1.07 [0.84 - 1.37]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1695110	165	0.2	0.0170928	0.239587	-0.861962	0.770585	0.0553893	1.06 [0.73 - 1.53]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203576_at	163	0.889571	0.00644652	0.115426	0.732091	0.331516	0.381959	1.47 [0.68 - 3.17]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215654_at	163	0.889571	0.0926266	-	-0.611695	0.627198	-0.29287	0.75 [0.23 - 2.43]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215654_at	79	0.113924	0.00134068	0.0325552	-1.18798	0.190688	-0.949186	0.39 [0.09 - 1.60]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203576_at	79	0.316456	0.0281835	0.339678	0.74191	0.185849	0.348282	1.42 [0.85 - 2.37]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203576_at	58	0.5	0.143662	-	-0.401148	0.977307	0.00674422	1.01 [0.63 - 1.60]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215654_at	58	0.672414	0.0182957	0.251535	-0.731732	0.190394	-0.217615	0.80 [0.58 - 1.11]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203576_at	34	0.117647	0.162741	-	0.989369	0.434536	0.20183	1.22 [0.74 - 2.03]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215654_at	34	0.882353	0.083468	-	-1.21335	0.449752	-0.167856	0.85 [0.55 - 1.31]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215654_at	158	0.101266	0.0268591	0.328767	-0.714963	0.593586	-0.579129	0.56 [0.07 - 4.70]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203576_at	158	0.835443	0.000681541	0.0184442	0.875185	0.0676377	0.859705	2.36 [0.94 - 5.94]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215654_at	53	0.566038	0.0767234	-	-0.642131	0.370387	-0.209271	0.81 [0.51 - 1.28]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203576_at	53	0.735849	0.108745	-	0.614804	0.562196	0.251058	1.29 [0.55 - 3.00]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215654_at	53	0.528302	0.274543	-	-0.406433	0.95463	-0.0144091	0.99 [0.60 - 1.62]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203576_at	53	0.113208	0.164739	-	0.974831	0.726455	0.140197	1.15 [0.52 - 2.52]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215654_at	180	0.205556	0.104518	-	-0.410019	0.611759	-0.0598425	0.94 [0.75 - 1.19]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203576_at	180	0.433333	0.0136545	0.203537	-0.511625	0.375311	-0.318498	0.73 [0.36 - 1.47]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215654_at	559	0.157424	0.0111055	0.174666	-0.60518	0.4325	0.167612	1.18 [0.78 - 1.80]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203576_at	559	0.747764	0.0408604	0.433518	0.503946	0.371568	0.145516	1.16 [0.84 - 1.59]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203576_at	77	0.61039	0.0543611	-	0.495387	0.254429	0.310715	1.36 [0.80 - 2.33]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215654_at	77	0.350649	0.0394941	0.424213	0.575817	0.0646173	0.419238	1.52 [0.97 - 2.37]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203576_at	70	0.7	0.0138249	0.205396	0.679418	0.0597541	0.93342	2.54 [0.96 - 6.72]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215654_at	70	0.314286	0.022541	0.291389	0.664097	0.18459	0.890028	2.44 [0.65 - 9.07]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41111_at	50	0.88	0.025006	0.313079	1.07501	0.0548934	0.867718	2.38 [0.98 - 5.78]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215654_at	74	0.459459	0.0155332	0.223603	0.717924	0.29497	0.244963	1.28 [0.81 - 2.02]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203576_at	74	0.216216	0.0101383	0.163138	1.01867	0.129746	0.662978	1.94 [0.82 - 4.58]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215654_at	67	0.522388	0.00851635	0.142973	2.2738	0.428044	1.56793	4.80 [0.10 - 231.71]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203576_at	67	0.895522	0.0873671	-	1.33213	0.395864	0.749886	2.12 [0.37 - 11.95]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203576_at	115	0.417391	0.08373	-	-0.93125	0.219043	-0.6923	0.50 [0.17 - 1.51]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215654_at	115	0.643478	0.0200595	0.268509	-2.04065	0.396057	-0.446459	0.64 [0.23 - 1.79]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41111_at	158	0.392405	0.0245959	0.309537	-0.637308	0.0606733	-0.350664	0.70 [0.49 - 1.02]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41111_at	76	0.263158	0.0110048	0.173482	15.5962	0.0852144	0.798132	2.22 [0.90 - 5.51]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215654_at	204	0.593137	0.00921659	0.151815	-0.369609	0.131384	-0.11833	0.89 [0.76 - 1.04]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203576_at	204	0.235294	3.04592e-05	0.00121826	-0.705264	0.00556564	-0.463332	0.63 [0.45 - 0.87]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215654_at	87	0.597701	0.0111281	0.174931	0.94865	0.035425	1.70417	5.50 [1.12 - 26.90]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203576_at	87	0.816092	0.00619367	0.111895	1.06322	0.782756	0.110332	1.12 [0.51 - 2.45]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203576_at	87	0.816092	0.00619367	0.111895	1.06322	0.782756	0.110332	1.12 [0.51 - 2.45]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215654_at	87	0.597701	0.0111281	0.174931	0.94865	0.035425	1.70417	5.50 [1.12 - 26.90]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215654_at	77	0.428571	0.115136	-	1.17774	0.875369	0.276082	1.32 [0.04 - 41.52]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203576_at	77	0.506494	0.00774867	0.133017	-2.28088	0.0396537	-1.6528	0.19 [0.04 - 0.92]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215654_at	77	0.38961	0.0610351	-	1.33889	0.534468	0.964187	2.62 [0.13 - 54.95]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203576_at	77	0.103896	0.00483544	0.0921811	-1.53877	0.0528874	-1.2662	0.28 [0.08 - 1.02]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203576_at	136	0.801471	0.000391763	0.0114978	1.46225	0.283382	0.551768	1.74 [0.63 - 4.76]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215654_at	136	0.632353	0.115266	-	-0.856922	0.568077	-0.149233	0.86 [0.52 - 1.44]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215654_at	200	0.335	0.128989	-	-0.458803	0.432228	-0.179013	0.84 [0.53 - 1.31]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203576_at	200	0.785	0.00584088	0.1069	0.832157	0.631193	0.162975	1.18 [0.61 - 2.29]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19442	60	0.233333	0.159369	-	-0.567109	0.599188	-0.169299	0.84 [0.45 - 1.59]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19442	60	0.883333	0.344895	-	-0.678541	0.873281	-0.0599979	0.94 [0.45 - 1.97]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	16857	155	0.187097	0.00178231	0.0412033	-0.893816	0.156445	-0.162934	0.85 [0.68 - 1.06]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215654_at	286	0.199301	0.176476	-	-0.304998	0.530756	-0.0858022	0.92 [0.70 - 1.20]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203576_at	286	0.472028	0.0101493	0.163271	-0.49622	0.059141	-0.376624	0.69 [0.46 - 1.01]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215654_at	159	0.899371	0.0693163	-	0.738788	0.38799	0.222148	1.25 [0.75 - 2.07]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215654_at	159	0.100629	0.195391	-	1.23756	0.9319	0.0253239	1.03 [0.57 - 1.83]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203576_at	159	0.295597	0.0516095	-	0.789676	0.712829	0.139761	1.15 [0.55 - 2.42]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203576_at	159	0.238994	0.057933	-	0.878367	0.696061	0.146512	1.16 [0.56 - 2.41]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215654_at	159	0.742138	0.214036	-	0.416581	0.458426	0.189547	1.21 [0.73 - 1.99]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203576_at	159	0.295597	0.092295	-	0.805965	0.788472	0.11978	1.13 [0.47 - 2.70]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203576_at	54	0.555556	4.52399e-05	0.00173443	17.0399	0.0288424	1.11176	3.04 [1.12 - 8.24]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215654_at	54	0.203704	0.158043	-	15.3647	0.878982	-0.159075	0.85 [0.11 - 6.61]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203576_at	117	0.213675	0.314078	-	0.417243	0.550018	0.159214	1.17 [0.70 - 1.98]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203576_at	117	0.188034	0.0776354	-	1.22248	0.162292	0.443983	1.56 [0.84 - 2.91]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215654_at	117	0.102564	0.00755509	0.130461	-1.17172	0.683207	0.270268	1.31 [0.36 - 4.80]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215654_at	117	0.102564	0.0291148	0.347209	-0.884908	0.685378	0.227092	1.25 [0.42 - 3.76]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215654_at	117	0.102564	0.0291148	0.347209	-0.884908	0.685378	0.227092	1.25 [0.42 - 3.76]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215654_at	117	0.367521	0.117065	-	0.714382	0.505907	0.441907	1.56 [0.42 - 5.72]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203576_at	117	0.213675	0.314078	-	0.417243	0.550018	0.159214	1.17 [0.70 - 1.98]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203576_at	117	0.34188	0.0480704	0.479915	0.940045	0.0624385	0.580702	1.79 [0.97 - 3.29]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203576_at	236	0.864407	0.00146158	0.0349743	0.953396	0.359861	0.298776	1.35 [0.71 - 2.56]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215654_at	236	0.707627	0.0199968	0.267916	0.628331	0.373852	0.253756	1.29 [0.74 - 2.25]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203576_at	249	0.86747	0.0451761	0.461811	0.547071	0.17545	0.34852	1.42 [0.86 - 2.35]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215654_at	249	0.706827	0.0955195	-	0.366972	0.555704	0.129356	1.14 [0.74 - 1.75]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203576_at	62	0.112903	0.0180722	0.249339	-1.28465	0.943998	0.0200644	1.02 [0.58 - 1.79]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203576_at	125	0.4	0.329849	-	0.407471	0.567409	0.262923	1.30 [0.53 - 3.20]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215654_at	62	0.580645	0.334236	-	0.475062	0.800744	-0.071979	0.93 [0.53 - 1.63]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203576_at	125	0.52	0.325532	-	-0.289372	0.934936	-0.0291881	0.97 [0.48 - 1.96]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203576_at	54	0.296296	0.256816	-	1.13533	0.60855	0.185415	1.20 [0.59 - 2.45]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215654_at	125	0.432	0.120381	-	0.674578	0.591423	0.318224	1.37 [0.43 - 4.39]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215654_at	125	0.84	0.165127	-	-0.570917	0.727321	-0.161086	0.85 [0.34 - 2.11]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215654_at	54	0.203704	0.174665	-	-0.91629	0.700481	-0.135525	0.87 [0.44 - 1.74]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203576_at	198	0.454545	0.0406455	0.432066	0.577898	0.770712	0.0646577	1.07 [0.69 - 1.65]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215654_at	198	0.843434	0.0210838	0.278089	-1.13268	0.275714	-0.112617	0.89 [0.73 - 1.09]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215654_at	198	0.843434	0.0476257	0.477177	-0.98754	0.20477	-0.136963	0.87 [0.71 - 1.08]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203576_at	198	0.454545	0.0655909	-	0.404299	0.545384	0.107627	1.11 [0.79 - 1.58]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203576_at	198	0.545455	0.0150629	0.218667	0.620209	0.544767	0.128229	1.14 [0.75 - 1.72]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215654_at	198	0.621212	0.112578	-	0.334233	0.774223	0.0247178	1.03 [0.87 - 1.21]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203576_at	51	0.529412	0.20844	-	-1.31075	0.966192	0.0590211	1.06 [0.07 - 16.25]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203576_at	62	0.725806	0.0256979	0.318996	1.21962	0.262867	0.853504	2.35 [0.53 - 10.46]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215654_at	51	0.529412	0.215186	-	-1.29364	0.974485	0.0515275	1.05 [0.04 - 24.76]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215654_at	62	0.758065	0.455785	-	-0.570289	0.946357	0.0715584	1.07 [0.13 - 8.64]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215654_at	177	0.468927	0.0339749	0.384752	-0.577287	0.223141	-0.694132	0.50 [0.16 - 1.53]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203576_at	145	0.882759	0.016805	0.23668	-15.2415	0.374489	-0.440441	0.64 [0.24 - 1.70]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203576_at	177	0.819209	0.148734	-	-0.61534	0.760937	-0.130014	0.88 [0.38 - 2.03]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215654_at	177	0.813559	0.0212745	0.279851	-0.839257	0.164973	-0.686885	0.50 [0.19 - 1.33]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215654_at	145	0.103448	0.0468613	0.472434	-0.871051	0.263841	-0.790677	0.45 [0.11 - 1.82]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203576_at	177	0.853107	0.339611	-	-0.356143	0.85686	0.0664359	1.07 [0.52 - 2.20]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203576_at	226	0.309735	0.0133117	0.19977	-0.69044	0.18226	-0.283415	0.75 [0.50 - 1.14]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215654_at	226	0.349558	0.00917661	0.151316	-0.723998	0.214266	-0.201558	0.82 [0.59 - 1.12]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215654_at	55	0.509091	0.107301	-	0.740378	0.825281	0.255883	1.29 [0.13 - 12.53]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215654_at	55	0.363636	0.208542	-	0.668093	0.951007	0.0779098	1.08 [0.09 - 12.98]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215654_at	49	0.55102	0.159086	-	0.838158	0.878705	-0.233467	0.79 [0.04 - 15.88]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203576_at	55	0.890909	0.0361411	0.400615	1.18085	0.897527	-0.0712482	0.93 [0.31 - 2.75]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203576_at	55	0.890909	0.0226554	0.292418	1.21269	0.539709	0.313097	1.37 [0.50 - 3.72]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203576_at	49	0.571429	0.230142	-	0.689696	0.723847	0.230664	1.26 [0.35 - 4.53]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	756490	34	0.852941	0.171794	-	-0.988703	0.551408	-0.26107	0.77 [0.33 - 1.82]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215654_at	63	0.269841	0.00198274	0.044974	-1.04582	0.331411	-0.89135	0.41 [0.07 - 2.48]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203576_at	63	0.222222	0.317315	-	0.445668	0.864606	0.0548397	1.06 [0.56 - 1.98]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502374_3p_at	28	0.214286	0.0372481	0.40853	-1.11235	0.0783258	-0.533409	0.59 [0.32 - 1.06]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.306660.0.S1_3p_at	28	0.75	0.0284686	0.341996	1.19898	0.294394	0.6739	1.96 [0.56 - 6.91]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203576_at	82	0.756098	0.36723	-	0.329561	0.753938	0.127285	1.14 [0.51 - 2.52]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215654_at	82	0.780488	0.157975	-	0.512612	0.518487	0.389781	1.48 [0.45 - 4.82]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203576_at	79	0.860759	0.0772693	-	-0.808217	0.898699	-0.0294844	0.97 [0.62 - 1.53]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215654_at	79	0.544304	0.118736	-	-0.412867	0.770487	-0.165	0.85 [0.28 - 2.57]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U62739_at	86	0.162791	0.00166074	0.0388722	-1.30627	0.0198349	-1.83669	0.16 [0.03 - 0.75]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215654_at	104	0.153846	0.00281912	0.0599048	-1.00976	0.0291982	-1.49382	0.22 [0.06 - 0.86]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203576_at	104	0.451923	0.0709178	-	-0.586594	0.432662	-0.301713	0.74 [0.35 - 1.57]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P101551	117	0.529915	0.0266084	0.326673	0.640851	0.236564	0.397436	1.49 [0.77 - 2.87]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P90163	117	0.102564	0.0422745	0.442968	-0.77206	0.665735	-0.129985	0.88 [0.49 - 1.58]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203576_at	204	0.862745	0.0190584	0.258952	-15.2848	0.332171	-0.547858	0.58 [0.19 - 1.75]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203576_at	204	0.313726	0.126409	-	-0.424146	0.965457	0.0182649	1.02 [0.45 - 2.33]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215654_at	204	0.848039	0.0145492	0.21321	-15.2996	0.828298	0.0457275	1.05 [0.69 - 1.58]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215654_at	204	0.323529	0.0340364	0.38521	0.702014	0.183904	0.21634	1.24 [0.90 - 1.71]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203576_at	178	0.146067	0.000178758	0.00582817	-0.932158	0.00421293	-0.693416	0.50 [0.31 - 0.80]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215654_at	178	0.359551	0.0229772	0.295299	-0.45294	0.284372	-0.502982	0.60 [0.24 - 1.52]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215654_at	111	0.855856	0.0675915	-	-0.832645	0.276035	-0.218953	0.80 [0.54 - 1.19]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203576_at	111	0.207207	0.173066	-	-0.417075	0.718043	-0.120593	0.89 [0.46 - 1.71]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203576_at	90	0.844444	7.77004e-05	0.00280314	1.33612	0.00477961	1.27818	3.59 [1.48 - 8.72]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203576_at	90	0.844444	0.000193144	0.00623505	1.40112	0.0121799	1.29189	3.64 [1.33 - 9.99]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215654_at	90	0.144444	0.00653924	0.11671	2.25856	0.330998	0.582972	1.79 [0.55 - 5.80]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215654_at	90	0.144444	0.00900881	0.149214	15.3613	0.177672	0.862945	2.37 [0.68 - 8.31]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3630	50	0.76	0.0460547	0.467378	-1.80296	0.945802	-0.0240948	0.98 [0.49 - 1.96]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203576_at	138	0.615942	0.0400138	0.427773	0.496458	0.361573	0.185091	1.20 [0.81 - 1.79]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215654_at	138	0.891304	0.0181145	0.249755	-1.31187	0.130824	-3.12008	0.04 [0.00 - 2.53]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215654_at	129	0.372093	0.14785	-	0.375589	0.587325	0.120425	1.13 [0.73 - 1.74]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203576_at	129	0.837209	0.220481	-	0.38026	0.99988	-4.48464e-05	1.00 [0.56 - 1.79]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26768	56	0.75	0.00542639	0.100923	0.95976	0.185382	0.648619	1.91 [0.73 - 5.00]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31687	56	0.107143	0.000178454	0.00581952	-1.67668	0.05706	-0.835765	0.43 [0.18 - 1.03]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11768	56	0.125	0.0556662	-	-0.860088	0.659704	-0.172555	0.84 [0.39 - 1.81]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26768	56	0.75	0.0219828	0.286338	0.821024	0.716657	0.173688	1.19 [0.47 - 3.04]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11768	56	0.125	0.00494842	0.0938736	-1.27503	0.0695027	-0.775305	0.46 [0.20 - 1.06]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31687	56	0.107143	0.0052692	0.0986238	-1.25014	0.623152	-0.198045	0.82 [0.37 - 1.81]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215654_at	278	0.794964	0.134181	-	0.319722	0.777985	0.109264	1.12 [0.52 - 2.38]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203576_at	278	0.136691	0.0543079	-	0.585404	0.672615	0.0692856	1.07 [0.78 - 1.48]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203576_at	133	0.180451	0.0201585	0.269444	0.848536	0.286392	0.188393	1.21 [0.85 - 1.71]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215654_at	133	0.87218	0.00045812	0.0131489	1.0232	0.0119235	2.91043	18.36 [1.90 - 177.53]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5511	81	0.888889	0.000919948	0.0237605	1.77445	0.00717536	1.58999	4.90 [1.54 - 15.63]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13437	81	0.444444	0.0094747	0.155021	1.48486	0.0143442	2.12024	8.33 [1.53 - 45.49]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14426	81	0.851852	2.79693e-05	0.00112868	1.93062	0.00444985	2.23025	9.30 [2.00 - 43.25]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215654_at	185	0.340541	0.00963133	0.156953	-0.429854	0.125139	-0.315964	0.73 [0.49 - 1.09]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203576_at	185	0.389189	0.00476141	0.0910665	-0.480537	0.0846524	-0.378646	0.68 [0.45 - 1.05]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215654_at	185	0.340541	0.00365479	0.0738116	-0.517997	0.207463	-0.286468	0.75 [0.48 - 1.17]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203576_at	185	0.308108	0.000306291	0.00930144	-0.686348	0.0259917	-0.532905	0.59 [0.37 - 0.94]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P90163	110	0.827273	0.101396	-	0.477699	0.827277	0.0597501	1.06 [0.62 - 1.82]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P101551	110	0.436364	0.0041694	0.0819809	0.936624	0.130807	0.355588	1.43 [0.90 - 2.26]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P90163	110	0.836364	0.254021	-	0.426252	0.946503	0.0227975	1.02 [0.53 - 1.99]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P101551	110	0.454545	0.0449151	0.460146	0.465265	0.314883	0.18398	1.20 [0.84 - 1.72]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215654_at	80	0.7625	0.110869	-	-0.967825	0.926564	0.0163662	1.02 [0.72 - 1.44]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203576_at	80	0.3125	0.0753838	-	-0.785442	0.430848	-0.245057	0.78 [0.43 - 1.44]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_3366	281	0.24911	0.141055	-	-0.236844	0.829107	-0.0225848	0.98 [0.80 - 1.20]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215654_at	38	0.105263	0.00760494	0.131121	-1.45389	0.280161	-0.584743	0.56 [0.19 - 1.61]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203576_at	38	0.157895	0.0122209	0.187553	15.5645	0.0580101	0.806429	2.24 [0.97 - 5.16]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203576_at	140	0.3	0.0148337	0.216241	-0.695398	0.0975914	-0.757572	0.47 [0.19 - 1.15]
GENE	BCAT2	branched chain amino-acid transaminase 2, mitochondrial	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215654_at	140	0.342857	0.137165	-	0.491548	0.379547	0.707573	2.03 [0.42 - 9.83]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202331_at	30	0.733333	0.00269032	0.0576792	1.36434	0.0665361	1.71535	5.56 [0.89 - 34.74]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1731442	165	0.854545	0.0101511	0.163293	0.719093	0.51822	0.10419	1.11 [0.81 - 1.52]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1731442	165	0.890909	0.0342493	0.386789	0.876558	0.546431	0.15175	1.16 [0.71 - 1.91]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202331_at	163	0.251534	0.0918831	-	0.404842	0.344528	0.241251	1.27 [0.77 - 2.10]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202331_at	79	0.43038	0.0173196	0.241864	0.721178	0.101844	0.420859	1.52 [0.92 - 2.52]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202331_at	58	0.896552	0.125601	-	0.672391	0.791855	0.0886767	1.09 [0.57 - 2.11]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202331_at	34	0.617647	0.0795798	-	-0.752976	0.93776	-0.0331372	0.97 [0.42 - 2.22]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202331_at	158	0.455696	0.195633	-	-0.298988	0.692136	-0.225538	0.80 [0.26 - 2.44]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202331_at	53	0.679245	0.00290549	0.0613838	1.00943	0.128708	0.995505	2.71 [0.75 - 9.78]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202331_at	53	0.54717	0.0083662	0.141048	0.95695	0.092869	1.16873	3.22 [0.82 - 12.58]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202331_at	180	0.738889	0.00134233	0.0325885	0.697396	0.736856	-0.155617	0.86 [0.35 - 2.12]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202331_at	559	0.479428	0.0457456	0.465427	0.409643	0.109833	0.410339	1.51 [0.91 - 2.49]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202331_at	77	0.194805	0.0121298	0.186515	-0.775291	0.590999	-0.177841	0.84 [0.44 - 1.60]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202331_at	70	0.642857	0.119064	-	0.420714	0.781724	0.11808	1.13 [0.49 - 2.59]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37704_at	50	0.16	0.0125946	0.191779	-0.980484	0.897928	-0.0511855	0.95 [0.43 - 2.08]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202331_at	74	0.797297	0.00764401	0.131637	-1.19588	0.2492	-0.408178	0.66 [0.33 - 1.33]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202331_at	67	0.597015	0.00942134	0.154361	1.87594	0.695467	0.588686	1.80 [0.09 - 34.34]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202331_at	115	0.704348	0.222931	-	0.652852	0.450169	0.613853	1.85 [0.38 - 9.09]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37704_at	158	0.14557	0.00639565	0.114718	-0.881711	0.28696	-0.484886	0.62 [0.25 - 1.50]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37704_at	76	0.828947	0.0660291	-	-15.3285	0.511355	0.59578	1.81 [0.31 - 10.74]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202331_at	204	0.205882	0.0615377	-	-0.325745	0.295071	-0.201245	0.82 [0.56 - 1.19]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202331_at	87	0.137931	0.021638	0.283191	-0.968434	0.741054	-0.176159	0.84 [0.29 - 2.38]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202331_at	87	0.137931	0.021638	0.283191	-0.968434	0.741054	-0.176159	0.84 [0.29 - 2.38]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202331_at	77	0.155844	0.022561	0.291569	-1.36493	0.535665	-0.551239	0.58 [0.10 - 3.30]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202331_at	77	0.155844	0.00846869	0.142363	-1.38856	0.451748	-0.592553	0.55 [0.12 - 2.59]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202331_at	136	0.625	0.253389	-	-0.558565	0.517876	-0.307007	0.74 [0.29 - 1.87]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202331_at	200	0.895	0.000543782	0.0152225	1.18473	0.0507391	0.977846	2.66 [1.00 - 7.09]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1664	60	0.583333	0.353156	-	0.349128	0.814123	0.129348	1.14 [0.39 - 3.35]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1664	60	0.75	0.0809627	-	-0.91146	0.7804	-0.127986	0.88 [0.36 - 2.16]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	22286	155	0.341935	0.0172846	0.241513	-0.64967	0.286861	-0.193217	0.82 [0.58 - 1.18]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202331_at	286	0.157343	0.0571346	-	-0.460325	0.270791	-0.398952	0.67 [0.33 - 1.36]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202331_at	159	0.874214	0.0191971	0.260288	0.86129	0.537381	0.339465	1.40 [0.48 - 4.13]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202331_at	159	0.666667	0.0160873	0.229348	0.867752	0.954487	0.0375609	1.04 [0.29 - 3.77]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202331_at	159	0.503145	0.107801	-	0.51371	0.854692	0.101954	1.11 [0.37 - 3.30]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202331_at	54	0.425926	0.0231307	0.296668	2.05516	0.367693	0.903611	2.47 [0.35 - 17.63]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202331_at	117	0.632479	0.104812	-	0.509953	0.790805	0.0886692	1.09 [0.57 - 2.10]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202331_at	117	0.632479	0.0642045	-	0.685518	0.339059	0.391138	1.48 [0.66 - 3.30]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202331_at	117	0.632479	0.104812	-	0.509953	0.790805	0.0886692	1.09 [0.57 - 2.10]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202331_at	117	0.632479	0.356182	-	0.362164	0.876597	-0.0652421	0.94 [0.41 - 2.13]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202331_at	236	0.898305	0.00287608	0.0608813	0.972881	0.424346	0.469	1.60 [0.51 - 5.05]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202331_at	249	0.899598	0.000292595	0.008941	0.968856	0.204362	0.586106	1.80 [0.73 - 4.44]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202331_at	62	0.870968	0.0983003	-	0.930753	0.947767	-0.0224746	0.98 [0.50 - 1.92]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202331_at	125	0.128	0.0305655	0.358716	-0.97142	0.356853	-0.613507	0.54 [0.15 - 2.00]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202331_at	125	0.128	0.0198941	0.266943	-0.850532	0.081668	-0.886748	0.41 [0.15 - 1.12]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202331_at	54	0.185185	0.148523	-	-0.866113	0.827154	-0.0910263	0.91 [0.40 - 2.07]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202331_at	198	0.131313	0.0719327	-	-0.573958	0.447408	-0.199359	0.82 [0.49 - 1.37]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202331_at	198	0.131313	0.0381464	0.414862	-0.665799	0.340201	-0.263501	0.77 [0.45 - 1.32]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202331_at	198	0.727273	0.191096	-	0.298412	0.853576	0.0396964	1.04 [0.68 - 1.59]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202331_at	51	0.862745	0.368342	-	-15.2407	0.885339	-0.192753	0.82 [0.06 - 11.33]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202331_at	62	0.822581	0.330445	-	0.638788	0.807225	0.215105	1.24 [0.22 - 6.98]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202331_at	177	0.785311	0.0597708	-	-0.746405	0.755896	-0.174434	0.84 [0.28 - 2.52]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202331_at	177	0.785311	0.0833843	-	-0.560731	0.576531	-0.27228	0.76 [0.29 - 1.98]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202331_at	145	0.827586	0.292982	-	-0.550165	0.991235	0.00745995	1.01 [0.27 - 3.81]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202331_at	226	0.486726	0.0530536	-	-0.556476	0.434569	-0.292145	0.75 [0.36 - 1.55]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202331_at	55	0.472727	0.038086	0.414438	0.977135	0.549209	0.494831	1.64 [0.32 - 8.28]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202331_at	55	0.472727	0.0673986	-	0.926653	0.426045	0.704069	2.02 [0.36 - 11.45]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202331_at	49	0.489796	0.00886108	0.147353	1.79335	0.235643	1.31926	3.74 [0.42 - 33.10]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202331_at	63	0.301587	0.000185695	0.00602495	1.96826	0.0385624	0.399082	1.49 [1.02 - 2.18]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11386134_3p_at	28	0.357143	0.119824	-	-0.813505	0.944784	-0.0270708	0.97 [0.45 - 2.09]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202331_at	82	0.109756	0.0315339	0.366251	-0.939077	0.247736	-0.946671	0.39 [0.08 - 1.93]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37704_at	84	0.357143	0.0488167	0.484477	-0.58107	0.255789	-0.39887	0.67 [0.34 - 1.34]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202331_at	79	0.481013	0.0298331	0.35294	0.567289	0.152372	0.78306	2.19 [0.75 - 6.39]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202331_at	104	0.855769	0.0266958	0.327404	-1.47692	0.127312	-1.01971	0.36 [0.10 - 1.34]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P67188	117	0.119658	2.62177e-05	0.00106512	-1.35808	0.00421997	-1.12835	0.32 [0.15 - 0.70]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202331_at	204	0.485294	0.110806	-	-0.588052	0.455703	-0.454263	0.63 [0.19 - 2.09]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202331_at	204	0.622549	0.117143	-	-0.463438	0.988994	0.00617693	1.01 [0.42 - 2.42]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202331_at	178	0.275281	0.000263092	0.00815544	-0.733421	0.00723447	-1.07966	0.34 [0.15 - 0.75]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300020189	41	0.878049	0.0252513	0.315185	-15.3376	0.18489	-0.326769	0.72 [0.44 - 1.17]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300013681	41	0.121951	0.125049	-	-0.824536	0.712477	-0.148749	0.86 [0.39 - 1.90]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202331_at	111	0.135135	0.0324435	0.373226	1.06177	0.187582	0.612137	1.84 [0.74 - 4.58]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202331_at	90	0.3	0.203078	-	0.501908	0.677922	-0.182084	0.83 [0.35 - 1.97]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202331_at	90	0.3	0.23171	-	0.542214	0.620919	-0.254987	0.77 [0.28 - 2.13]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3350	50	0.36	0.0741452	-	1.08666	0.648426	0.172368	1.19 [0.57 - 2.49]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202331_at	138	0.789855	0.0257143	0.319135	0.585121	0.0939191	0.307452	1.36 [0.95 - 1.95]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202331_at	129	0.860465	0.00932017	0.153105	0.775726	0.215646	0.54885	1.73 [0.73 - 4.13]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35054	56	0.339286	0.163955	-	-0.493024	0.768394	-0.111512	0.89 [0.43 - 1.88]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24419	56	0.678571	0.0961937	-	-0.645308	0.397938	-0.32335	0.72 [0.34 - 1.53]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35054	56	0.660714	0.150828	-	-0.593027	0.69619	-0.152627	0.86 [0.40 - 1.85]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24419	56	0.678571	0.0151886	0.219992	-1.07863	0.196616	-0.529464	0.59 [0.26 - 1.32]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202331_at	278	0.298561	0.210521	-	-0.249308	0.603423	0.120424	1.13 [0.72 - 1.78]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202331_at	133	0.503759	0.0343315	0.387399	0.501457	0.626915	0.0749323	1.08 [0.80 - 1.46]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2602	81	0.82716	0.073872	-	0.944809	0.536669	0.253005	1.29 [0.58 - 2.87]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202331_at	185	0.578378	0.0263155	0.324217	0.396013	0.167148	0.3699	1.45 [0.86 - 2.45]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202331_at	185	0.583784	0.0102057	0.163952	0.423645	0.0398951	0.50522	1.66 [1.02 - 2.68]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P67188	110	0.609091	0.0519841	-	0.448071	0.722146	0.08031	1.08 [0.70 - 1.69]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P67188	110	0.6	0.0745211	-	0.530776	0.88887	0.0393502	1.04 [0.60 - 1.81]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202331_at	80	0.1375	0.219257	-	1.18964	0.916185	-0.0441421	0.96 [0.42 - 2.18]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1079	281	0.199288	0.0476811	0.477519	-0.332871	0.879336	-0.016783	0.98 [0.79 - 1.22]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202331_at	38	0.894737	0.000129625	0.00439963	2.09942	0.0575168	0.891435	2.44 [0.97 - 6.12]
GENE	BCKDHA	branched chain keto acid dehydrogenase E1, alpha polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202331_at	140	0.135714	8.4902e-08	5.51032e-06	-1.52412	0.0209547	-1.01959	0.36 [0.15 - 0.86]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210653_s_at	30	0.766667	0.0629384	-	-0.977313	0.233393	-0.342577	0.71 [0.40 - 1.25]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213321_at	30	0.166667	0.0529004	-	-0.959066	0.654311	-0.328333	0.72 [0.17 - 3.03]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1655433	165	0.333333	0.0442172	0.455663	-0.488912	0.527788	-0.104793	0.90 [0.65 - 1.25]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1655433	165	0.333333	7.04865e-05	0.00257159	-1.34983	0.101582	-0.381842	0.68 [0.43 - 1.08]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213321_at	163	0.736196	0.0495035	0.488637	0.421346	0.29364	0.510659	1.67 [0.64 - 4.32]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210653_s_at	163	0.785276	0.00423039	0.0829318	0.623629	0.374807	0.146369	1.16 [0.84 - 1.60]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210653_s_at	79	0.78481	0.170722	-	0.455064	0.742235	0.0614063	1.06 [0.74 - 1.53]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213321_at	79	0.658228	0.0264116	0.325025	0.645052	0.27043	0.393957	1.48 [0.74 - 2.99]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210653_s_at	58	0.482759	0.0870601	-	-0.471518	0.696702	-0.0781224	0.92 [0.62 - 1.37]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213321_at	58	0.551724	0.000719849	0.0193188	0.975826	0.000448558	0.631525	1.88 [1.32 - 2.68]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213321_at	34	0.441176	0.0639741	-	-0.709442	0.084038	-0.453318	0.64 [0.38 - 1.06]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210653_s_at	34	0.470588	0.00838814	0.14133	0.999308	0.205179	0.411414	1.51 [0.80 - 2.85]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210653_s_at	158	0.341772	0.0597108	-	0.494462	0.462347	0.225332	1.25 [0.69 - 2.28]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213321_at	158	0.164557	0.0587483	-	0.734552	0.809486	0.14609	1.16 [0.35 - 3.80]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213321_at	53	0.113208	0.0654546	-	-0.881521	0.41356	-0.243168	0.78 [0.44 - 1.40]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210653_s_at	53	0.320755	0.000101038	0.00353429	2.05452	0.0705338	0.89001	2.44 [0.93 - 6.39]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213321_at	53	0.113208	0.064246	-	-0.876026	0.34534	-0.271328	0.76 [0.43 - 1.34]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210653_s_at	53	0.320755	0.000279788	0.00860158	1.60871	0.0721472	0.806416	2.24 [0.93 - 5.39]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213321_at	180	0.238889	0.0836835	-	0.444898	0.926479	0.00775859	1.01 [0.85 - 1.19]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210653_s_at	180	0.15	0.0126991	0.192954	-0.686266	0.060316	-0.229898	0.79 [0.63 - 1.01]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213321_at	559	0.586762	0.0241492	0.30565	0.449926	0.045049	0.291703	1.34 [1.01 - 1.78]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210653_s_at	559	0.744186	0.0139574	0.206836	0.528978	0.465969	0.0770069	1.08 [0.88 - 1.33]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213321_at	77	0.74026	0.0124505	0.190155	0.692876	0.0757805	0.226349	1.25 [0.98 - 1.61]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210653_s_at	77	0.818182	0.00490637	0.093245	0.858811	0.802909	0.0753107	1.08 [0.60 - 1.95]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213321_at	70	0.871429	0.00450039	0.0870991	1.03351	0.0110691	0.555336	1.74 [1.14 - 2.67]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210653_s_at	70	0.457143	0.000420523	0.0122186	0.953295	0.0205818	0.456562	1.58 [1.07 - 2.32]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41684_at	50	0.54	0.00947134	0.154979	-0.907748	0.307896	-0.611032	0.54 [0.17 - 1.76]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41682_s_at	50	0.26	0.049302	0.48742	-0.735851	0.332675	-0.770139	0.46 [0.10 - 2.20]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41683_i_at	50	0.32	0.0234539	0.299536	-0.805744	0.104249	-0.809587	0.45 [0.17 - 1.18]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213321_at	74	0.851351	0.235463	-	-0.553977	0.92631	0.0130593	1.01 [0.77 - 1.34]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210653_s_at	74	0.135135	0.0960526	-	-0.639135	0.42186	-0.298658	0.74 [0.36 - 1.54]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213321_at	67	0.701493	0.0627277	-	1.17991	0.937895	-0.107974	0.90 [0.06 - 13.57]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210653_s_at	67	0.119403	0.0610989	-	-1.25022	0.362672	-0.667885	0.51 [0.12 - 2.16]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213321_at	115	0.669565	0.150411	-	0.75285	0.769397	0.195581	1.22 [0.33 - 4.50]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210653_s_at	115	0.869565	0.0625439	-	1.04868	0.686219	0.222757	1.25 [0.42 - 3.68]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41682_s_at	158	0.892405	0.14762	-	0.554155	0.806345	-0.0537383	0.95 [0.62 - 1.46]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41683_i_at	158	0.588608	0.0413287	0.436667	-0.617212	0.391543	-0.153289	0.86 [0.60 - 1.22]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41684_at	158	0.696203	0.012839	0.19452	-0.863455	0.250568	-0.181626	0.83 [0.61 - 1.14]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41682_s_at	76	0.105263	0.198703	-	15.1754	0.499499	0.297381	1.35 [0.57 - 3.19]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41683_i_at	76	0.197368	0.0403646	0.430162	15.4047	0.221568	0.490518	1.63 [0.74 - 3.59]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41684_at	76	0.276316	0.0533958	-	1.76363	0.302454	0.377651	1.46 [0.71 - 2.99]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213321_at	204	0.764706	0.0986102	-	-0.270134	0.639632	-0.0446407	0.96 [0.79 - 1.15]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210653_s_at	204	0.338235	0.0253242	0.315808	0.332677	0.200458	0.191166	1.21 [0.90 - 1.62]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213321_at	87	0.310345	9.03001e-06	0.000407336	-1.55332	0.00117836	-1.50535	0.22 [0.09 - 0.55]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210653_s_at	87	0.195402	0.00143126	0.0343717	-1.2306	0.00913984	-0.574947	0.56 [0.37 - 0.87]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213321_at	87	0.310345	9.03001e-06	0.000407336	-1.55332	0.00117836	-1.50535	0.22 [0.09 - 0.55]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210653_s_at	87	0.195402	0.00143126	0.0343717	-1.2306	0.00913984	-0.574947	0.56 [0.37 - 0.87]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210653_s_at	77	0.350649	0.0150592	0.218628	-1.52624	0.0746263	-0.762771	0.47 [0.20 - 1.08]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213321_at	77	0.103896	3.56975e-05	0.00140402	-2.01974	0.0105408	-2.67101	0.07 [0.01 - 0.54]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210653_s_at	77	0.558442	0.00392304	0.0781037	-2.39205	0.0321532	-0.810093	0.44 [0.21 - 0.93]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213321_at	77	0.103896	0.000422474	0.0122672	-1.96324	0.0119611	-3.23685	0.04 [0.00 - 0.49]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210653_s_at	136	0.5	0.000389793	0.0114481	-1.93103	0.036385	-0.659726	0.52 [0.28 - 0.96]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213321_at	136	0.125	0.0341688	0.386193	-1.05705	0.790838	0.0636196	1.07 [0.67 - 1.71]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213321_at	200	0.52	0.183776	-	0.393715	0.683291	0.0616849	1.06 [0.79 - 1.43]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210653_s_at	200	0.195	0.0821095	-	-0.552791	0.309843	-0.309734	0.73 [0.40 - 1.33]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1028	60	0.4	0.144528	-	0.605238	0.674722	0.114436	1.12 [0.66 - 1.91]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1028	60	0.3	0.0153787	0.221988	-0.903295	0.99092	-0.00311061	1.00 [0.58 - 1.70]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	7994	155	0.619355	0.0204853	0.272515	0.635163	0.0637301	0.465499	1.59 [0.97 - 2.61]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213321_at	286	0.881119	0.0777477	-	-0.637529	0.462504	-0.07475	0.93 [0.76 - 1.13]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210653_s_at	286	0.104895	0.00197265	0.0447862	-0.769656	0.00516998	-0.387554	0.68 [0.52 - 0.89]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210653_s_at	159	0.113208	0.00207539	0.0466891	-1.20565	0.26271	-0.361101	0.70 [0.37 - 1.31]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213321_at	159	0.36478	0.101931	-	-0.512376	0.641873	-0.0864703	0.92 [0.64 - 1.32]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210653_s_at	159	0.119497	0.00476518	0.0911233	-0.990264	0.447443	-0.225988	0.80 [0.45 - 1.43]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213321_at	159	0.36478	0.0233832	0.29891	-0.823399	0.210526	-0.273772	0.76 [0.50 - 1.17]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210653_s_at	159	0.157233	0.0211129	0.278358	-0.795528	0.365638	-0.263476	0.77 [0.43 - 1.36]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213321_at	159	0.36478	0.0483385	0.481559	-0.614882	0.177233	-0.250848	0.78 [0.54 - 1.12]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213321_at	54	0.12963	8.27763e-05	0.00296438	-2.50574	0.0336737	-2.71933	0.07 [0.01 - 0.81]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210653_s_at	54	0.481481	0.0460878	0.467587	-1.47125	0.942844	0.0364458	1.04 [0.38 - 2.81]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213321_at	117	0.25641	0.159852	-	0.550211	0.811395	0.0695193	1.07 [0.61 - 1.90]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213321_at	117	0.512821	0.0355134	0.39607	-0.853923	0.539748	-0.21771	0.80 [0.40 - 1.61]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210653_s_at	117	0.837607	0.05546	-	0.695932	0.486692	0.181179	1.20 [0.72 - 2.00]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210653_s_at	117	0.880342	0.0398598	0.426721	0.915429	0.422143	0.250498	1.28 [0.70 - 2.37]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210653_s_at	117	0.555556	0.0543251	-	-0.830209	0.114439	-0.706287	0.49 [0.21 - 1.19]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213321_at	117	0.25641	0.159852	-	0.550211	0.811395	0.0695193	1.07 [0.61 - 1.90]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210653_s_at	117	0.837607	0.05546	-	0.695932	0.486692	0.181179	1.20 [0.72 - 2.00]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213321_at	117	0.512821	0.00158925	0.0374847	-1.44526	0.0621935	-0.74118	0.48 [0.22 - 1.04]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213321_at	236	0.144068	0.341144	-	0.408639	0.666007	0.0670008	1.07 [0.79 - 1.45]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210653_s_at	236	0.186441	0.0226927	0.292753	-0.66634	0.0173175	-0.544534	0.58 [0.37 - 0.91]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210653_s_at	249	0.104418	0.00818852	0.138756	-0.73259	0.0609613	-0.405494	0.67 [0.44 - 1.02]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213321_at	249	0.654619	0.0681589	-	-0.437591	0.498629	-0.0804786	0.92 [0.73 - 1.16]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213321_at	125	0.808	0.0625149	-	0.584547	0.966294	-0.0255967	0.97 [0.30 - 3.20]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210653_s_at	62	0.322581	0.035554	0.396365	-1.00496	0.169897	-0.524139	0.59 [0.28 - 1.25]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210653_s_at	125	0.864	0.031351	0.364836	-1.92666	0.712434	-0.099569	0.91 [0.53 - 1.54]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210653_s_at	125	0.872	0.0287818	0.34453	-1.05531	0.631014	-0.0993591	0.91 [0.60 - 1.36]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213321_at	54	0.111111	0.0175878	0.244542	-1.54192	0.451866	-0.278338	0.76 [0.37 - 1.56]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210653_s_at	54	0.851852	0.0386294	0.418233	-15.6307	0.0908589	-0.829904	0.44 [0.17 - 1.14]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213321_at	125	0.624	0.373599	-	-0.362531	0.828864	-0.172684	0.84 [0.18 - 4.03]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213321_at	62	0.677419	0.172122	-	-0.738264	0.525923	-0.192151	0.83 [0.46 - 1.49]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210653_s_at	198	0.318182	0.0143301	0.210861	-0.625883	0.262849	-0.216982	0.80 [0.55 - 1.18]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213321_at	198	0.777778	0.00416853	0.0819674	-0.863516	0.116883	-0.107613	0.90 [0.78 - 1.03]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213321_at	198	0.722222	0.125098	-	-0.494967	0.999593	-4.57495e-05	1.00 [0.84 - 1.19]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210653_s_at	198	0.318182	0.0149999	0.218001	-0.645557	0.365871	-0.183714	0.83 [0.56 - 1.24]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213321_at	198	0.722222	0.0967259	-	-0.51302	0.842613	-0.0169072	0.98 [0.83 - 1.16]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210653_s_at	198	0.691919	0.00207762	0.04673	-0.791537	0.0190836	-0.376973	0.69 [0.50 - 0.94]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213321_at	62	0.677419	0.155868	-	-1.05077	0.390933	-1.18945	0.30 [0.02 - 4.61]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210653_s_at	51	0.313726	0.135105	-	-1.27694	0.948992	-0.0365184	0.96 [0.31 - 2.95]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213321_at	51	0.372549	0.257755	-	-0.992679	0.736857	0.728397	2.07 [0.03 - 145.06]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210653_s_at	62	0.516129	0.0865889	-	-1.08853	0.401997	-0.356121	0.70 [0.30 - 1.61]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213321_at	145	0.510345	0.0103007	0.165098	-0.897891	0.0880814	-0.907833	0.40 [0.14 - 1.14]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210653_s_at	177	0.118644	0.0258821	0.320559	1.09216	0.945912	0.0155936	1.02 [0.65 - 1.59]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213321_at	177	0.519774	0.0437654	0.45274	-0.567375	0.243	-0.488164	0.61 [0.27 - 1.39]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210653_s_at	145	0.524138	0.0164342	0.232908	-0.844189	0.258205	-0.34995	0.70 [0.38 - 1.29]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210653_s_at	177	0.548023	0.0768416	-	-0.505853	0.591387	-0.141785	0.87 [0.52 - 1.46]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213321_at	177	0.485876	0.0207784	0.275253	-0.552724	0.206715	-0.457595	0.63 [0.31 - 1.29]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213321_at	226	0.353982	0.00731795	0.127302	-0.74207	0.338324	-0.252419	0.78 [0.46 - 1.30]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210653_s_at	226	0.615044	0.0133005	0.199647	-0.800084	0.148158	-0.26428	0.77 [0.54 - 1.10]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213321_at	49	0.734694	0.00379531	0.0760694	1.58377	0.0563795	1.38359	3.99 [0.96 - 16.52]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210653_s_at	55	0.745455	0.158429	-	0.729328	0.348923	0.333489	1.40 [0.69 - 2.80]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210653_s_at	49	0.816327	0.0738427	-	1.0067	0.469076	0.295397	1.34 [0.60 - 2.99]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213321_at	55	0.727273	0.0099783	0.161197	1.11094	0.307471	0.630275	1.88 [0.56 - 6.30]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213321_at	55	0.6	0.00133196	0.0323792	1.62987	0.00907364	1.61082	5.01 [1.49 - 16.79]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210653_s_at	55	0.8	0.0298261	0.352885	0.984504	0.448249	0.251741	1.29 [0.67 - 2.47]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	785338	34	0.882353	2.87424e-06	0.000143546	2.54373	0.185636	1.6626	5.27 [0.45 - 61.84]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210653_s_at	63	0.555556	0.0983517	-	-0.5822	0.380029	-0.158642	0.85 [0.60 - 1.22]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213321_at	63	0.238095	0.0110392	0.173887	-0.874875	0.91726	-0.0298606	0.97 [0.55 - 1.70]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g179361_3p_a_at	28	0.785714	0.0162207	0.230721	-2.16437	0.582552	-0.514343	0.60 [0.10 - 3.74]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.1265.2.A1_3p_at	28	0.714286	0.293712	-	-0.68016	0.729357	0.243859	1.28 [0.32 - 5.08]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213321_at	82	0.548781	0.0344561	0.38832	-0.742071	0.128075	-0.325309	0.72 [0.48 - 1.10]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210653_s_at	82	0.109756	0.138555	-	-0.653432	0.456032	-0.234666	0.79 [0.43 - 1.47]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213321_at	79	0.582278	0.0820248	-	0.459621	0.583558	0.0623716	1.06 [0.85 - 1.33]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210653_s_at	79	0.886076	0.140078	-	0.562249	0.652152	0.105577	1.11 [0.70 - 1.76]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210653_s_at	104	0.625	0.108353	-	-0.57302	0.792134	-0.0857561	0.92 [0.49 - 1.74]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P93464	117	0.786325	0.0114016	0.178128	0.753637	0.0152455	0.524166	1.69 [1.11 - 2.58]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P239664	117	0.82906	0.0035463	0.0720537	0.894243	0.123043	0.289572	1.34 [0.92 - 1.93]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P914513	117	0.854701	0.0143732	0.211325	0.795119	0.256192	0.225011	1.25 [0.85 - 1.85]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213321_at	204	0.230392	0.00033788	0.0101233	-1.23703	0.0671914	-0.843847	0.43 [0.17 - 1.06]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213321_at	204	0.264706	5.34515e-07	3.05061e-05	-1.28635	0.0111735	-0.885509	0.41 [0.21 - 0.82]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210653_s_at	204	0.877451	0.182586	-	0.599987	0.803892	0.131961	1.14 [0.40 - 3.23]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210653_s_at	204	0.22549	0.204112	-	-0.376419	0.622473	-0.200555	0.82 [0.37 - 1.82]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210653_s_at	178	0.853933	0.00934357	0.153396	0.646289	0.91046	0.0209929	1.02 [0.71 - 1.47]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213321_at	111	0.261261	0.0501463	-	-0.544118	0.506527	-0.113339	0.89 [0.64 - 1.25]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210653_s_at	111	0.873874	0.0113056	0.177009	0.898979	0.238752	-0.203965	0.82 [0.58 - 1.14]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213321_at	90	0.577778	0.313782	-	-0.343154	0.581008	-0.65338	0.52 [0.05 - 5.30]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213321_at	90	0.211111	0.371185	-	-0.370005	0.935482	-0.107202	0.90 [0.07 - 12.04]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210653_s_at	90	0.644444	0.0104785	0.167232	0.813442	0.0972463	1.42921	4.18 [0.77 - 22.61]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210653_s_at	90	0.644444	0.00172562	0.0401205	1.12761	0.031105	2.14299	8.52 [1.21 - 59.82]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3349	50	0.5	0.0618462	-	-0.955319	0.675963	-0.138409	0.87 [0.46 - 1.67]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213321_at	138	0.137681	0.157102	-	-0.447558	0.816231	-0.058005	0.94 [0.58 - 1.54]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210653_s_at	138	0.652174	0.043697	0.452296	0.489989	0.275817	0.135388	1.14 [0.90 - 1.46]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210653_s_at	129	0.209302	0.11635	-	0.534141	0.723861	0.120376	1.13 [0.58 - 2.20]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213321_at	129	0.651163	0.00918708	0.151447	0.639825	0.191966	0.372234	1.45 [0.83 - 2.54]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23686	56	0.803571	0.0463166	0.469026	0.747216	0.474776	0.170059	1.19 [0.74 - 1.89]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16099	56	0.142857	0.0447924	0.459361	-0.895686	0.741866	0.123907	1.13 [0.54 - 2.37]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34794	56	0.732143	0.164503	-	0.500152	0.485655	0.183676	1.20 [0.72 - 2.01]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23686	56	0.803571	0.03081	0.360629	0.810212	0.274282	0.255505	1.29 [0.82 - 2.04]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34794	56	0.767857	0.0669261	-	0.700202	0.591457	0.149201	1.16 [0.67 - 2.00]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16099	56	0.857143	0.0139674	0.206945	0.970318	0.344475	0.341932	1.41 [0.69 - 2.86]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210653_s_at	278	0.179856	0.175561	-	-0.313121	0.743091	-0.0490935	0.95 [0.71 - 1.28]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213321_at	278	0.654676	0.173315	-	0.265072	0.862301	-0.0396745	0.96 [0.61 - 1.50]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210653_s_at	133	0.781955	0.0408049	0.433144	-0.657848	0.236151	-0.246561	0.78 [0.52 - 1.18]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213321_at	133	0.774436	0.0552379	-	0.494774	0.152095	0.395614	1.49 [0.86 - 2.55]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	2560	81	0.765432	0.0518193	-	1.01695	0.130772	0.850445	2.34 [0.78 - 7.05]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12632	81	0.135802	0.0396586	0.425343	-1.14645	0.721418	-0.2178	0.80 [0.24 - 2.66]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210653_s_at	185	0.854054	0.178534	-	0.329858	0.636677	0.130373	1.14 [0.66 - 1.96]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213321_at	185	0.891892	0.177445	-	-0.376455	0.681022	-0.157318	0.85 [0.40 - 1.81]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210653_s_at	185	0.848649	0.0547604	-	0.42362	0.24847	0.289488	1.34 [0.82 - 2.18]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213321_at	185	0.275676	0.118435	-	0.328736	0.60372	0.212434	1.24 [0.55 - 2.76]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P914513	110	0.163636	0.0214387	0.281362	-0.660133	0.0637272	-0.28457	0.75 [0.56 - 1.02]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P239664	110	0.590909	0.0943171	-	0.495741	0.760367	-0.0564479	0.95 [0.66 - 1.36]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P93464	110	0.390909	0.0843908	-	-0.396481	0.335315	-0.147428	0.86 [0.64 - 1.16]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P914513	110	0.163636	0.0364493	0.402831	-0.726919	0.628723	-0.0958091	0.91 [0.62 - 1.34]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P93464	110	0.6	0.110439	-	0.4744	0.476072	0.150885	1.16 [0.77 - 1.76]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P239664	110	0.118182	0.00322652	0.0667929	-0.877666	0.0718114	-0.255998	0.77 [0.59 - 1.02]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210653_s_at	80	0.7	0.0951729	-	0.717008	0.47196	0.233138	1.26 [0.67 - 2.38]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213321_at	80	0.8375	0.000625834	0.0171566	1.53562	0.082985	0.372595	1.45 [0.95 - 2.21]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213321_at	38	0.236842	0.00138748	0.0334966	2.64386	0.00207463	1.78431	5.96 [1.91 - 18.54]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210653_s_at	38	0.578947	0.00464689	0.0893331	1.43618	0.0253221	0.894837	2.45 [1.12 - 5.36]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210653_s_at	140	0.364286	2.28918e-05	0.000943038	-1.18927	0.000406509	-1.40202	0.25 [0.11 - 0.54]
GENE	BCKDHB	branched chain keto acid dehydrogenase E1, beta polypeptide	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213321_at	140	0.171429	6.53785e-05	0.00240579	-1.18492	0.000563009	-3.16086	0.04 [0.01 - 0.26]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211715_s_at	30	0.433333	0.000978979	0.0250349	-1.36983	0.0143632	-1.07244	0.34 [0.14 - 0.81]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1677637	165	0.436364	0.160546	-	-0.337486	0.456861	-0.214899	0.81 [0.46 - 1.42]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1677637	165	0.763636	0.217614	-	-0.591446	0.819518	-0.0937256	0.91 [0.41 - 2.04]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211715_s_at	163	0.705521	0.0144051	0.211667	0.505525	0.308986	0.226825	1.25 [0.81 - 1.94]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211715_s_at	79	0.468354	0.0264223	0.325114	0.664966	0.173938	0.314553	1.37 [0.87 - 2.16]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1570336_at	79	0.683544	0.209931	-	0.374802	0.900598	0.100517	1.11 [0.23 - 5.35]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211715_s_at	58	0.103448	0.0662457	-	-0.816299	0.881908	-0.0355578	0.97 [0.60 - 1.54]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211715_s_at	34	0.352941	0.0363692	0.402255	-0.832493	0.0826561	-0.485155	0.62 [0.36 - 1.06]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211715_s_at	158	0.139241	0.00663062	0.117971	1.30197	0.0276603	0.759168	2.14 [1.09 - 4.20]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211715_s_at	53	0.132075	0.228932	-	-0.538349	0.49933	0.250984	1.29 [0.62 - 2.66]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211715_s_at	53	0.283019	0.22926	-	0.516151	0.784961	0.0986765	1.10 [0.54 - 2.24]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211715_s_at	180	0.583333	0.0885445	-	0.356654	0.841094	-0.0414887	0.96 [0.64 - 1.44]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1570336_at	559	0.738819	0.0416549	0.43885	-0.536028	0.0786773	-0.275974	0.76 [0.56 - 1.03]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211715_s_at	559	0.381038	0.0015529	0.0367744	0.715925	0.0105296	0.433117	1.54 [1.11 - 2.15]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211715_s_at	77	0.857143	0.0792623	-	-0.738489	0.740099	-0.0604901	0.94 [0.66 - 1.35]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1570336_at	70	0.428571	2.8295e-05	0.00114045	-1.08775	0.0163723	-2.66605	0.07 [0.01 - 0.61]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211715_s_at	70	0.771429	0.0419344	0.440712	0.599056	0.215571	0.489754	1.63 [0.75 - 3.54]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37211_at	50	0.8	6.24513e-06	0.000291423	1.73338	0.00553314	1.05195	2.86 [1.36 - 6.02]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211715_s_at	74	0.540541	0.0051024	0.0961638	0.806779	0.031707	0.642471	1.90 [1.06 - 3.42]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211715_s_at	67	0.731343	0.174215	-	0.896131	0.210301	1.22354	3.40 [0.50 - 23.05]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1570336_at	67	0.38806	0.10764	-	1.54909	0.647505	0.934987	2.55 [0.05 - 140.19]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1570336_at	115	0.773913	0.151025	-	-1.37866	0.782406	-0.214984	0.81 [0.18 - 3.71]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211715_s_at	115	0.895652	0.0168745	0.237383	1.32011	0.107607	1.02929	2.80 [0.80 - 9.81]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37211_at	158	0.139241	0.0222139	0.288436	-0.76881	0.230184	-0.300652	0.74 [0.45 - 1.21]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37211_at	76	0.710526	0.222932	-	0.625256	0.639027	0.209116	1.23 [0.51 - 2.95]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211715_s_at	204	0.29902	0.0385687	0.417811	0.315323	0.580426	0.0626682	1.06 [0.85 - 1.33]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1570336_at	204	0.720588	0.0463464	0.469213	0.310849	0.646747	0.0324869	1.03 [0.90 - 1.19]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1570336_at	87	0.505747	0.0117373	0.182016	0.983871	0.260482	0.685034	1.98 [0.60 - 6.54]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211715_s_at	87	0.862069	0.222119	-	-0.86875	0.832067	-0.0568308	0.94 [0.56 - 1.60]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1570336_at	87	0.505747	0.0117373	0.182016	0.983871	0.260482	0.685034	1.98 [0.60 - 6.54]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211715_s_at	87	0.862069	0.222119	-	-0.86875	0.832067	-0.0568308	0.94 [0.56 - 1.60]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1570336_at	77	0.12987	0.0240562	0.304837	-1.27131	0.317501	-1.05717	0.35 [0.04 - 2.76]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211715_s_at	77	0.220779	0.0132451	0.199035	-1.28978	0.0627172	-0.832127	0.44 [0.18 - 1.05]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1570336_at	77	0.116883	0.0430609	0.448147	-1.30508	0.324553	-1.19534	0.30 [0.03 - 3.26]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211715_s_at	77	0.194805	0.00639626	0.114727	-1.56433	0.0737729	-0.911812	0.40 [0.15 - 1.09]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211715_s_at	136	0.830882	0.107183	-	0.779212	0.353762	0.546015	1.73 [0.54 - 5.47]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211715_s_at	200	0.62	0.164372	-	-0.451774	0.964349	0.0126704	1.01 [0.58 - 1.77]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3191	60	0.55	0.00285026	0.0604392	1.12447	0.0880283	0.39795	1.49 [0.94 - 2.35]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	3191	60	0.533333	0.00741863	0.128646	1.01951	0.0828309	0.358756	1.43 [0.95 - 2.15]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211715_s_at	286	0.185315	0.0671703	-	-0.41518	0.861774	-0.0307651	0.97 [0.69 - 1.37]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211715_s_at	159	0.861635	0.000538901	0.0151059	1.13609	0.448776	-0.252902	0.78 [0.40 - 1.49]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211715_s_at	159	0.867925	0.00225972	0.050052	1.16096	0.256747	-0.412698	0.66 [0.32 - 1.35]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211715_s_at	159	0.849057	0.00292712	0.0617525	0.987378	0.747179	-0.112443	0.89 [0.45 - 1.77]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211715_s_at	54	0.240741	0.117308	-	15.4147	0.644518	0.216572	1.24 [0.49 - 3.12]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211715_s_at	117	0.820513	0.137119	-	0.538527	0.717478	-0.0813958	0.92 [0.59 - 1.43]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211715_s_at	117	0.863248	0.432765	-	0.385866	0.8375	-0.0550993	0.95 [0.56 - 1.60]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211715_s_at	117	0.820513	0.137119	-	0.538527	0.717478	-0.0813958	0.92 [0.59 - 1.43]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211715_s_at	117	0.239316	0.151725	-	-0.583196	0.665689	-0.122187	0.88 [0.51 - 1.54]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211715_s_at	236	0.898305	0.0554075	-	0.684308	0.486849	0.244822	1.28 [0.64 - 2.55]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211715_s_at	249	0.899598	0.0275824	0.334756	0.651675	0.845672	0.0529008	1.05 [0.62 - 1.80]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211715_s_at	62	0.387097	0.12746	-	-0.718117	0.738493	-0.106377	0.90 [0.48 - 1.68]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211715_s_at	125	0.44	0.0571318	-	0.778297	0.234086	0.536238	1.71 [0.71 - 4.14]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211715_s_at	125	0.512	0.137744	-	0.428194	0.996208	-0.00162983	1.00 [0.51 - 1.96]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211715_s_at	54	0.351852	0.121121	-	-0.880001	0.452872	-0.297754	0.74 [0.34 - 1.62]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211715_s_at	198	0.79798	0.048877	0.484844	0.55956	0.107182	0.298847	1.35 [0.94 - 1.94]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211715_s_at	198	0.79798	0.03807	0.414326	0.609026	0.122857	0.302541	1.35 [0.92 - 1.99]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211715_s_at	198	0.787879	0.00151568	0.0360433	0.7125	0.0741082	0.269394	1.31 [0.97 - 1.76]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211715_s_at	51	0.156863	0.0051584	0.0969922	-2.12913	0.376966	-0.757174	0.47 [0.09 - 2.52]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211715_s_at	62	0.145161	0.00069378	0.0187246	-1.76078	0.0833384	-0.965295	0.38 [0.13 - 1.14]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1570336_at	177	0.169492	0.00222137	0.0493574	-0.904558	0.0462345	-1.44314	0.24 [0.06 - 0.98]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211715_s_at	177	0.248588	0.0489053	0.485016	-0.483258	0.149834	-0.32653	0.72 [0.46 - 1.13]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1570336_at	177	0.169492	0.00110784	0.0277677	-0.851111	0.119312	-0.984346	0.37 [0.11 - 1.29]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211715_s_at	145	0.275862	0.006027	0.109545	-0.892757	0.0197921	-0.714271	0.49 [0.27 - 0.89]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1570336_at	145	0.172414	0.00866893	0.144918	-0.94383	0.221102	-1.12034	0.33 [0.05 - 1.96]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211715_s_at	177	0.248588	0.0439271	0.453789	-0.560133	0.0417943	-0.507145	0.60 [0.37 - 0.98]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1570336_at	226	0.884956	0.0169855	0.238505	-2.03964	0.173962	-0.231432	0.79 [0.57 - 1.11]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211715_s_at	226	0.429204	9.1942e-05	0.00325231	-1.12974	0.00037047	-0.593605	0.55 [0.40 - 0.77]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211715_s_at	55	0.236364	0.039521	0.424398	1.80339	0.315406	0.441282	1.55 [0.66 - 3.68]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211715_s_at	49	0.22449	0.131605	-	1.4472	0.632037	0.250206	1.28 [0.46 - 3.58]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1570336_at	55	0.127273	0.0670881	-	15.2762	0.419337	0.956701	2.60 [0.26 - 26.54]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1570336_at	49	0.489796	0.0532524	-	-1.2139	0.626226	-0.711694	0.49 [0.03 - 8.61]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211715_s_at	55	0.781818	0.362258	-	-0.56355	0.963762	-0.0167496	0.98 [0.48 - 2.03]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1570336_at	55	0.472727	0.0849456	-	-0.787531	0.909781	0.120362	1.13 [0.14 - 9.05]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1570336_at	63	0.730159	0.000844849	0.0221166	-1.77848	0.0299692	-26.732	0.00 [0.00 - 0.07]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211715_s_at	63	0.47619	0.021914	0.285712	-0.775953	0.203117	-0.255288	0.77 [0.52 - 1.15]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13543366_3p_s_at	28	0.107143	0.165854	-	-1.08819	0.855812	-0.0431899	0.96 [0.60 - 1.53]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.434245.1.S1_3p_at	28	0.214286	0.027653	0.335337	-1.23725	0.219523	0.922276	2.52 [0.58 - 10.96]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211715_s_at	82	0.585366	0.0696439	-	0.606938	0.423847	0.341011	1.41 [0.61 - 3.24]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37211_at	84	0.880952	0.234237	-	-0.613744	0.692338	-0.0782669	0.92 [0.63 - 1.36]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211715_s_at	79	0.481013	0.00866615	0.144883	0.70963	0.151461	0.396447	1.49 [0.86 - 2.56]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M93107_at	86	0.267442	0.0176954	0.245612	1.58623	0.424992	0.302767	1.35 [0.64 - 2.85]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211715_s_at	104	0.317308	0.0695009	-	0.713861	0.860177	-0.0742183	0.93 [0.41 - 2.12]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P29754	117	0.74359	0.0402693	0.429514	-0.773997	0.764169	-0.0664696	0.94 [0.61 - 1.44]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211715_s_at	204	0.568627	0.109846	-	0.581151	0.776713	0.134392	1.14 [0.45 - 2.90]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211715_s_at	204	0.470588	0.0691039	-	0.507001	0.416977	0.274822	1.32 [0.68 - 2.56]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1570336_at	204	0.465686	0.0546303	-	-0.713251	0.259595	-0.337538	0.71 [0.40 - 1.28]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1570336_at	204	0.102941	0.0611041	-	-0.672377	0.552394	-0.126305	0.88 [0.58 - 1.34]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211715_s_at	178	0.780899	0.151288	-	-0.360294	0.868945	-0.0374432	0.96 [0.62 - 1.50]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200006336	41	0.268293	0.0431878	0.448977	1.18953	0.147996	0.376066	1.46 [0.88 - 2.42]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211715_s_at	111	0.684685	0.0712115	-	-0.549571	0.361641	-0.145466	0.86 [0.63 - 1.18]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1570336_at	111	0.81982	0.00292545	0.061724	0.872172	0.224735	0.259219	1.30 [0.85 - 1.97]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211715_s_at	90	0.166667	0.18792	-	-0.49806	0.463751	-0.195476	0.82 [0.49 - 1.39]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211715_s_at	90	0.844444	0.305424	-	-0.615659	0.891675	-0.0401646	0.96 [0.54 - 1.71]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	668	50	0.14	0.257819	-	1.1098	0.650021	0.182511	1.20 [0.55 - 2.64]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	815	50	0.12	0.0533365	-	-1.05798	0.0223555	-1.58184	0.21 [0.05 - 0.80]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1570336_at	138	0.108696	0.0753728	-	-0.578961	0.451671	0.25423	1.29 [0.67 - 2.50]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211715_s_at	138	0.492754	0.0800295	-	0.424195	0.537099	0.0515397	1.05 [0.89 - 1.24]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211715_s_at	129	0.348837	0.160405	-	0.386746	0.768196	0.0447547	1.05 [0.78 - 1.41]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1570336_at	278	0.482014	0.0100333	0.161865	0.487729	0.988357	0.00379013	1.00 [0.60 - 1.67]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211715_s_at	278	0.179856	0.169985	-	-0.297188	0.684137	-0.0450751	0.96 [0.77 - 1.19]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211715_s_at	133	0.691729	0.0536836	-	0.469807	0.409638	0.0657071	1.07 [0.91 - 1.25]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12041	81	0.135802	0.104792	-	-0.931047	0.848849	-0.0757576	0.93 [0.43 - 2.02]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13059	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211715_s_at	185	0.108108	0.0877418	-	-0.45773	0.561666	-0.0826382	0.92 [0.70 - 1.22]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211715_s_at	185	0.362162	0.085105	-	0.300114	0.521741	-0.0840643	0.92 [0.71 - 1.19]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P29754	110	0.818182	0.15167	-	0.388906	0.422378	0.102857	1.11 [0.86 - 1.42]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P29754	110	0.218182	0.0990778	-	0.768725	0.564735	0.0915473	1.10 [0.80 - 1.50]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211715_s_at	80	0.425	0.0477371	0.477865	0.931982	0.0966036	0.542116	1.72 [0.91 - 3.26]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_5736	281	0.608541	0.0342437	0.386748	0.301099	0.758332	-0.0372794	0.96 [0.76 - 1.22]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211715_s_at	38	0.263158	0.00167399	0.039128	2.56419	0.000249286	1.53706	4.65 [2.04 - 10.59]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1570336_at	38	0.631579	0.00622572	0.112345	1.25218	0.158573	1.23548	3.44 [0.62 - 19.16]
GENE	BDH1	3-hydroxybutyrate dehydrogenase, type 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211715_s_at	140	0.114286	4.39849e-06	0.000211761	-1.47651	0.0962355	-0.490849	0.61 [0.34 - 1.09]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206119_at	30	0.166667	0.00429422	0.0839229	-1.46591	0.309838	-0.262576	0.77 [0.46 - 1.28]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1656638	165	0.89697	0.031418	0.365355	0.699175	0.909527	-0.00654047	0.99 [0.89 - 1.11]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1656638	165	0.212121	0.00488572	0.0929356	-0.990516	0.0637532	-0.153481	0.86 [0.73 - 1.01]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206119_at	163	0.858896	0.1029	-	-0.515768	0.587473	-0.355344	0.70 [0.19 - 2.53]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	231591_at	163	0.638037	0.285948	-	0.214707	0.699317	0.370615	1.45 [0.22 - 9.50]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206119_at	79	0.506329	0.254924	-	-0.336093	0.949361	0.0481297	1.05 [0.24 - 4.63]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	231591_at	79	0.848101	0.0157673	0.226039	0.810465	0.128232	1.38758	4.01 [0.67 - 23.94]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206119_at	58	0.87931	0.0144055	0.211672	1.03466	0.474015	0.129848	1.14 [0.80 - 1.62]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206119_at	34	0.117647	0.00653758	0.116687	-1.44613	0.508028	-0.225328	0.80 [0.41 - 1.56]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206119_at	158	0.841772	0.194704	-	0.396591	0.76568	0.249472	1.28 [0.25 - 6.62]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206119_at	53	0.264151	0.210361	-	0.566944	0.869305	0.0488696	1.05 [0.59 - 1.88]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206119_at	53	0.603774	0.125178	-	0.524117	0.413475	0.237828	1.27 [0.72 - 2.24]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206119_at	180	0.444444	0.113517	-	0.338646	0.315603	0.135868	1.15 [0.88 - 1.49]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	231591_at	180	0.116667	0.30098	-	0.361791	0.820639	-0.0199932	0.98 [0.82 - 1.17]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206119_at	559	0.710197	0.179833	-	-0.302976	0.849731	0.0230503	1.02 [0.81 - 1.30]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	231591_at	559	0.391771	0.194813	-	-0.265924	0.751871	-0.0396778	0.96 [0.75 - 1.23]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206119_at	77	0.714286	0.0163774	0.232327	-0.72621	0.113616	-0.261043	0.77 [0.56 - 1.06]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	231591_at	77	0.896104	0.061944	-	0.709859	0.190724	0.244159	1.28 [0.89 - 1.84]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	231591_at	70	0.842857	0.15488	-	-0.541384	0.762246	0.32576	1.39 [0.17 - 11.43]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206119_at	70	0.542857	0.0651778	-	-0.489686	0.310823	-0.608557	0.54 [0.17 - 1.77]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37594_at	50	0.12	0.0822602	-	-0.849129	0.38431	-0.920241	0.40 [0.05 - 3.17]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206119_at	74	0.837838	0.0452491	0.462277	-0.91906	0.220869	-0.268565	0.76 [0.50 - 1.18]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	231591_at	74	0.864865	0.00392789	0.0781807	0.998174	0.28126	0.196646	1.22 [0.85 - 1.74]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206119_at	67	0.328358	0.202589	-	1.26828	0.868787	0.117521	1.12 [0.28 - 4.54]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	231591_at	67	0.447761	0.0826661	-	1.30625	0.414222	2.15468	8.63 [0.05 - 1520.91]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	231591_at	115	0.46087	0.154555	-	0.816175	0.569139	0.257481	1.29 [0.53 - 3.14]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206119_at	115	0.895652	0.000641252	0.0175149	1.7002	0.402789	0.671519	1.96 [0.41 - 9.44]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37594_at	158	0.56962	0.268218	-	-0.321409	0.945817	-0.016095	0.98 [0.62 - 1.57]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37594_at	76	0.855263	0.140002	-	0.84226	0.487035	0.349201	1.42 [0.53 - 3.80]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	231591_at	204	0.877451	0.0501895	-	-0.427141	0.344544	-0.0645164	0.94 [0.82 - 1.07]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206119_at	204	0.897059	0.125152	-	-0.376137	0.788496	-0.0207496	0.98 [0.84 - 1.14]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206119_at	87	0.229885	0.0908207	-	0.993496	0.765958	0.259792	1.30 [0.23 - 7.17]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	231591_at	87	0.114943	0.0380917	0.414479	15.2319	0.560399	0.737146	2.09 [0.17 - 24.99]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	231591_at	87	0.114943	0.0380917	0.414479	15.2319	0.560399	0.737146	2.09 [0.17 - 24.99]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206119_at	87	0.229885	0.0908207	-	0.993496	0.765958	0.259792	1.30 [0.23 - 7.17]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206119_at	77	0.454545	0.0759189	-	-1.16002	0.477518	-0.803905	0.45 [0.05 - 4.11]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	231591_at	77	0.38961	0.0673966	-	-1.00139	0.285357	-2.2292	0.11 [0.00 - 6.43]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206119_at	77	0.688312	0.173581	-	-1.00411	0.865458	0.170748	1.19 [0.16 - 8.55]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	231591_at	77	0.38961	0.0287415	0.344204	-1.39467	0.185457	-3.22938	0.04 [0.00 - 4.72]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206119_at	136	0.308824	0.173743	-	0.748405	0.857563	0.0528749	1.05 [0.59 - 1.88]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206119_at	200	0.305	0.00529143	0.0989502	-0.805201	0.230612	-0.246335	0.78 [0.52 - 1.17]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5333	60	0.166667	2.80644e-06	0.000140443	-1.84331	0.0489902	-1.57235	0.21 [0.04 - 0.99]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5333	60	0.133333	3.73091e-06	0.000182216	-1.92825	0.0371188	-1.05774	0.35 [0.13 - 0.94]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15615	155	0.129032	6.42089e-06	0.000298873	-1.27642	0.000245738	-0.233804	0.79 [0.70 - 0.90]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206119_at	286	0.125874	0.0620676	-	-0.478832	0.280941	-0.150551	0.86 [0.65 - 1.13]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206119_at	159	0.484277	0.319242	-	0.320262	0.793657	0.066939	1.07 [0.65 - 1.77]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206119_at	159	0.245283	0.164503	-	0.605598	0.73713	0.0855614	1.09 [0.66 - 1.80]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206119_at	159	0.559748	0.380218	-	-0.334452	0.702205	0.115732	1.12 [0.62 - 2.03]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231591_at	159	0.113208	0.158198	-	0.983694	0.484725	0.133714	1.14 [0.79 - 1.66]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231591_at	159	0.874214	0.29704	-	0.430396	0.658814	0.0833083	1.09 [0.75 - 1.57]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231591_at	159	0.893082	0.207353	-	0.610466	0.580447	0.123996	1.13 [0.73 - 1.76]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206119_at	54	0.759259	0.0889316	-	-15.4632	0.391346	-0.751741	0.47 [0.08 - 2.63]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206119_at	117	0.136752	0.0143577	0.211158	2.09042	0.828526	0.129242	1.14 [0.35 - 3.66]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206119_at	117	0.162393	0.178094	-	0.95577	0.869188	0.116184	1.12 [0.28 - 4.48]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206119_at	117	0.136752	0.0143577	0.211158	2.09042	0.828526	0.129242	1.14 [0.35 - 3.66]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206119_at	117	0.136752	0.0716448	-	1.64346	0.927574	-0.0653473	0.94 [0.23 - 3.83]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206119_at	236	0.105932	0.321384	-	0.510704	0.941512	0.0198787	1.02 [0.60 - 1.73]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	231591_at	236	0.601695	0.0188713	0.257143	-0.712348	0.142909	-0.239623	0.79 [0.57 - 1.08]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206119_at	249	0.738956	0.170727	-	-0.359511	0.48463	-0.144963	0.87 [0.58 - 1.30]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	231591_at	249	0.333333	0.00249652	0.0542837	-0.633189	0.0743169	-0.240158	0.79 [0.60 - 1.02]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206119_at	62	0.790323	0.0821348	-	-1.25414	0.567496	-0.108172	0.90 [0.62 - 1.30]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206119_at	125	0.496	0.270783	-	0.43971	0.7985	0.116887	1.12 [0.46 - 2.76]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206119_at	125	0.144	0.183742	-	-0.515636	0.580132	-0.197917	0.82 [0.41 - 1.65]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206119_at	54	0.111111	0.107177	-	-1.2224	0.652115	-0.103113	0.90 [0.58 - 1.41]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206119_at	198	0.383838	0.139851	-	0.426227	0.974088	-0.00417353	1.00 [0.77 - 1.28]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206119_at	198	0.121212	0.00630726	0.113486	-0.747577	0.211258	-0.132874	0.88 [0.71 - 1.08]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206119_at	198	0.121212	0.162709	-	-0.464516	0.870767	-0.0199771	0.98 [0.77 - 1.25]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206119_at	51	0.745098	0.188414	-	-15.4843	0.881846	-0.21547	0.81 [0.05 - 13.82]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206119_at	62	0.177419	0.158346	-	-0.839427	0.533821	-0.565466	0.57 [0.10 - 3.37]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206119_at	177	0.59887	0.0606433	-	-0.541201	0.360354	-0.392734	0.68 [0.29 - 1.57]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	231591_at	177	0.468927	0.105289	-	-0.380203	0.710793	-0.308404	0.73 [0.14 - 3.75]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206119_at	177	0.59887	0.0118268	0.183047	-0.64045	0.177746	-0.508207	0.60 [0.29 - 1.26]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	231591_at	145	0.193103	0.0118106	0.18286	2.12893	0.247852	1.35429	3.87 [0.39 - 38.53]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206119_at	145	0.641379	0.035328	0.39472	-0.822345	0.220095	-0.659418	0.52 [0.18 - 1.48]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	231591_at	177	0.745763	0.0942477	-	-0.578846	0.580401	-0.528793	0.59 [0.09 - 3.84]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	231591_at	226	0.309735	0.0137294	0.204355	0.879643	0.20663	0.145226	1.16 [0.92 - 1.45]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206119_at	226	0.570796	0.00026447	0.00819241	-1.21572	0.000565172	-0.534531	0.59 [0.43 - 0.79]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206119_at	55	0.618182	0.00783825	0.134194	-1.52408	0.0662669	-1.67351	0.19 [0.03 - 1.12]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	231591_at	49	0.204082	0.143733	-	-0.834223	0.581363	-1.3941	0.25 [0.00 - 35.21]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206119_at	55	0.6	0.00350794	0.0714289	-1.86929	0.0997361	-1.57038	0.21 [0.03 - 1.35]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	231591_at	55	0.4	0.194142	-	-0.624813	0.629129	-0.979925	0.38 [0.01 - 20.02]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206119_at	49	0.102041	0.00226769	0.0501959	-1.71605	0.0264861	-2.90875	0.05 [0.00 - 0.71]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	231591_at	55	0.4	0.126128	-	-0.675689	0.62394	-0.93062	0.39 [0.01 - 16.28]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	294688	34	0.882353	2.87424e-06	0.000143546	2.54373	0.173429	1.93351	6.91 [0.43 - 111.88]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	231591_at	63	0.15873	0.00158967	0.0374929	-1.1877	0.164283	-8.35949	0.00 [0.00 - 30.60]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206119_at	63	0.111111	0.0029868	0.0627666	-1.22278	0.162478	1.89272	6.64 [0.47 - 94.50]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502406_3p_at	28	0.321429	0.00259046	0.0559369	-1.67017	0.31442	-1.42946	0.24 [0.01 - 3.88]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.80756.1.A1_3p_at	28	0.428571	0.477196	-	0.400616	0.942162	-0.115355	0.89 [0.04 - 20.10]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206119_at	82	0.695122	0.0998408	-	0.558026	0.768174	0.189958	1.21 [0.34 - 4.28]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206119_at	79	0.405063	0.108757	-	0.434138	0.968709	-0.0118875	0.99 [0.55 - 1.79]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206119_at	104	0.423077	0.0222777	0.289013	-0.729052	0.0787274	-1.12062	0.33 [0.09 - 1.14]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	231591_at	204	0.264706	0.0490512	0.485901	1.01721	0.267481	0.215519	1.24 [0.85 - 1.82]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	231591_at	204	0.553922	0.00537195	0.100129	0.754676	0.064248	0.271324	1.31 [0.98 - 1.75]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206119_at	204	0.176471	0.00277121	0.0590797	-1.08147	0.0880774	-0.348484	0.71 [0.47 - 1.05]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206119_at	204	0.205882	0.0272154	0.331726	-0.647718	0.381029	-0.122191	0.88 [0.67 - 1.16]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206119_at	178	0.741573	0.356566	-	-0.215326	0.793739	-0.0973111	0.91 [0.44 - 1.88]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	231591_at	111	0.378378	0.0461723	0.468119	0.579236	0.615872	0.0728734	1.08 [0.81 - 1.43]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206119_at	111	0.108108	0.152584	-	-0.5715	0.60003	-0.0969373	0.91 [0.63 - 1.30]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206119_at	90	0.588889	0.0739312	-	-0.628992	0.975034	0.0172951	1.02 [0.34 - 3.01]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206119_at	90	0.811111	0.0226971	0.292792	-1.97997	0.775486	-0.180225	0.84 [0.24 - 2.88]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1159	50	0.36	0.017877	0.247412	1.60429	0.0315278	0.931968	2.54 [1.09 - 5.94]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	231591_at	138	0.195652	0.00528018	0.0987851	-0.717433	0.0652925	-6.79039	0.00 [0.00 - 1.54]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206119_at	138	0.804348	0.0422588	0.442864	-0.713204	0.774575	-0.149935	0.86 [0.31 - 2.40]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206119_at	129	0.899225	0.00198703	0.0450539	1.0411	0.457422	-0.174657	0.84 [0.53 - 1.33]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5053	56	0.642857	0.353419	-	0.324693	0.754235	0.0636393	1.07 [0.72 - 1.59]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41102	56	0.178571	0.150971	-	0.848843	0.507843	0.161888	1.18 [0.73 - 1.90]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5053	56	0.892857	0.217755	-	0.596048	0.805675	0.054219	1.06 [0.69 - 1.63]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41102	56	0.107143	0.0648175	-	1.67468	0.530507	0.140634	1.15 [0.74 - 1.79]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	231591_at	278	0.158273	0.283025	-	-0.254758	0.529796	-0.392979	0.68 [0.20 - 2.30]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206119_at	278	0.226619	0.217112	-	0.281801	0.647399	-0.0893114	0.91 [0.62 - 1.34]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206119_at	133	0.300752	0.0127527	0.193555	0.72471	0.106492	0.925134	2.52 [0.82 - 7.76]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5650	81	0.703704	0.213303	-	0.633782	0.91295	-0.0113369	0.99 [0.81 - 1.21]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12142	81	0.567901	0.212289	-	-0.661993	0.470867	-0.126754	0.88 [0.62 - 1.24]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206119_at	185	0.118919	0.0388643	0.419865	0.508195	0.431402	0.125508	1.13 [0.83 - 1.55]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206119_at	185	0.118919	0.092931	-	0.450134	0.355514	0.161718	1.18 [0.83 - 1.66]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P257511	110	0.763636	0.00608332	0.110341	0.671823	0.00736443	0.199977	1.22 [1.06 - 1.41]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P81581	110	0.890909	0.185354	-	0.426882	0.104946	0.202022	1.22 [0.96 - 1.56]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P257511	110	0.172727	0.123616	-	-0.528056	0.812545	0.028385	1.03 [0.81 - 1.30]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P81581	110	0.172727	0.121772	-	-0.582901	0.730506	-0.0765236	0.93 [0.60 - 1.43]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206119_at	80	0.75	0.0576661	-	0.843293	0.0802635	0.377262	1.46 [0.96 - 2.23]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1340	281	0.120996	0.0386481	0.418364	-0.421129	0.515497	-0.0861599	0.92 [0.71 - 1.19]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:209502	59	0.169492	0.199312	-	-0.678284	0.898159	-0.0948251	0.91 [0.21 - 3.89]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206119_at	38	0.736842	0.0451514	0.461654	0.92073	0.288751	0.60138	1.82 [0.60 - 5.54]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	231591_at	38	0.657895	0.128828	-	0.699602	0.447662	0.378258	1.46 [0.55 - 3.88]
GENE	BHMT	betaine--homocysteine S-methyltransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206119_at	140	0.557143	0.024902	0.312183	-0.675878	0.484477	-0.332644	0.72 [0.28 - 1.82]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219902_at	30	0.833333	0.139648	-	0.741604	0.917377	0.0553921	1.06 [0.37 - 3.01]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1813043	165	0.181818	0.00641005	0.114919	-0.723837	0.239234	-0.335859	0.71 [0.41 - 1.25]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1813043	165	0.872727	0.262929	-	0.501918	0.998086	-0.000695848	1.00 [0.57 - 1.76]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219902_at	163	0.128834	0.0826681	-	-0.46891	0.456855	-0.569655	0.57 [0.13 - 2.54]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219902_at	79	0.189873	0.238315	-	-0.417121	0.986849	-0.0150584	0.99 [0.16 - 5.90]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219902_at	58	0.896552	0.0444984	0.457474	0.873077	0.913151	-0.0165067	0.98 [0.73 - 1.32]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219902_at	34	0.411765	0.066266	-	0.737556	0.0946717	0.399482	1.49 [0.93 - 2.38]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219902_at	158	0.310127	0.41808	-	-0.195455	0.963995	-0.0389019	0.96 [0.18 - 5.21]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219902_at	53	0.169811	0.176528	-	-0.580896	0.531169	-0.124842	0.88 [0.60 - 1.30]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219902_at	53	0.188679	0.267225	-	-0.447028	0.962828	-0.00872275	0.99 [0.69 - 1.43]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219902_at	180	0.883333	0.054285	-	0.590113	0.667475	-0.0445824	0.96 [0.78 - 1.17]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219902_at	559	0.150268	0.18966	-	0.510051	0.852105	-0.0225432	0.98 [0.77 - 1.24]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219902_at	77	0.87013	0.0865508	-	-0.77934	0.232738	-0.158997	0.85 [0.66 - 1.11]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219902_at	70	0.4	0.0749852	-	-0.474559	0.836248	-0.0867941	0.92 [0.40 - 2.09]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219902_at	74	0.864865	0.00176721	0.0409157	1.07037	0.0346351	0.395546	1.49 [1.03 - 2.14]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219902_at	67	0.701493	0.0593317	-	-15.5536	0.914971	0.0511707	1.05 [0.41 - 2.69]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219902_at	115	0.113043	0.0167301	0.23592	-1.32277	0.588963	-0.516718	0.60 [0.09 - 3.89]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219902_at	204	0.259804	0.23297	-	-0.194292	0.969574	0.00322659	1.00 [0.85 - 1.18]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219902_at	87	0.666667	0.0865528	-	-0.773666	0.470819	-0.198939	0.82 [0.48 - 1.41]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219902_at	87	0.666667	0.0865528	-	-0.773666	0.470819	-0.198939	0.82 [0.48 - 1.41]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219902_at	77	0.506494	0.0441204	0.455039	1.45939	0.238432	0.667685	1.95 [0.64 - 5.92]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219902_at	77	0.506494	0.123419	-	0.896404	0.676847	0.215618	1.24 [0.45 - 3.42]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219902_at	136	0.860294	0.0429841	0.447643	-15.3225	0.658774	-0.12031	0.89 [0.52 - 1.51]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219902_at	200	0.765	0.204045	-	-0.490074	0.854842	-0.0336018	0.97 [0.67 - 1.39]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20312	60	0.816667	0.17233	-	-0.813026	0.469602	-0.203322	0.82 [0.47 - 1.42]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20312	60	0.55	0.188236	-	-0.513691	0.249393	-0.355547	0.70 [0.38 - 1.28]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	8379	155	0.845161	0.0219733	0.286252	-1.50789	0.0161826	-0.622605	0.54 [0.32 - 0.89]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219902_at	286	0.244755	0.041326	0.436649	-0.425006	0.154064	-0.192146	0.83 [0.63 - 1.07]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219902_at	159	0.440252	3.65695e-06	0.000178913	-1.54089	0.000237841	-0.795478	0.45 [0.30 - 0.69]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219902_at	159	0.301887	5.24901e-07	2.99979e-05	-1.48702	0.000570245	-0.737611	0.48 [0.31 - 0.73]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219902_at	159	0.440252	1.00353e-05	0.00044822	-1.78617	0.000893779	-0.837455	0.43 [0.26 - 0.71]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219902_at	54	0.37037	0.00471753	0.0904036	-1.97893	0.0894783	-1.53655	0.22 [0.04 - 1.27]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219902_at	117	0.17094	0.153232	-	0.736558	0.664437	-0.131467	0.88 [0.48 - 1.59]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219902_at	117	0.188034	0.106441	-	1.12838	0.876774	-0.0546765	0.95 [0.47 - 1.89]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219902_at	117	0.17094	0.153232	-	0.736558	0.664437	-0.131467	0.88 [0.48 - 1.59]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219902_at	117	0.179487	0.0295554	0.350732	1.91172	0.816104	-0.0803329	0.92 [0.47 - 1.82]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219902_at	236	0.233051	0.0264478	0.325328	-0.629227	0.180842	-0.26582	0.77 [0.52 - 1.13]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219902_at	249	0.638554	0.110571	-	-0.366045	0.632268	-0.079931	0.92 [0.67 - 1.28]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219902_at	125	0.248	0.0327863	0.375829	-0.801077	0.581646	-0.244385	0.78 [0.33 - 1.87]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219902_at	125	0.104	0.174213	-	0.71239	0.647041	-0.151551	0.86 [0.45 - 1.64]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219902_at	54	0.203704	0.192615	-	-0.883401	0.81866	-0.0587581	0.94 [0.57 - 1.56]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219902_at	62	0.758065	0.070201	-	-1.1396	0.580915	-0.117976	0.89 [0.58 - 1.35]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219902_at	198	0.116162	0.112413	-	-0.458943	0.485422	-0.0691316	0.93 [0.77 - 1.13]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219902_at	198	0.479798	0.211391	-	-0.318347	0.412218	-0.0970369	0.91 [0.72 - 1.14]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219902_at	198	0.479798	0.194968	-	-0.348482	0.356998	-0.112707	0.89 [0.70 - 1.14]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219902_at	51	0.882353	0.0132073	0.198616	1.95667	0.653011	1.53495	4.64 [0.01 - 3739.49]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219902_at	62	0.790323	0.105349	-	0.958294	0.633684	1.11028	3.04 [0.03 - 292.01]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219902_at	177	0.525424	0.00427218	0.0835812	0.779807	0.0849761	0.651611	1.92 [0.91 - 4.03]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219902_at	177	0.451977	0.00569167	0.104762	0.673548	0.172016	0.500977	1.65 [0.80 - 3.39]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219902_at	145	0.648276	0.211145	-	0.419584	0.385638	0.69727	2.01 [0.42 - 9.70]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219902_at	226	0.849558	0.117528	-	0.513226	0.873724	0.0183176	1.02 [0.81 - 1.28]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219902_at	55	0.654545	0.00545528	0.101343	1.19545	0.00233275	1.20858	3.35 [1.54 - 7.29]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219902_at	55	0.654545	0.0063019	0.113411	1.27014	0.00645204	0.865101	2.38 [1.27 - 4.43]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219902_at	49	0.714286	0.0495866	0.489138	1.08438	0.325433	1.02644	2.79 [0.36 - 21.59]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	1555682	34	0.676471	0.119642	-	0.681518	0.802729	0.298851	1.35 [0.13 - 14.06]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219902_at	63	0.222222	0.153107	-	-0.529981	0.350073	0.770235	2.16 [0.43 - 10.87]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13162289_3p_at	28	0.178571	0.0538124	-	-1.13257	0.20347	-1.21428	0.30 [0.05 - 1.93]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219902_at	82	0.182927	0.0204209	0.271911	1.53124	0.869161	0.0543202	1.06 [0.55 - 2.02]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219902_at	79	0.43038	0.152736	-	-0.37597	0.640972	-0.0966707	0.91 [0.60 - 1.36]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219902_at	104	0.105769	0.0506303	-	-0.855161	0.544632	0.256036	1.29 [0.56 - 2.96]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P92983	117	0.777778	0.0256596	0.31867	0.680822	0.379968	0.0505156	1.05 [0.94 - 1.18]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P231829	117	0.769231	0.0507124	-	0.597933	0.209872	0.0884477	1.09 [0.95 - 1.25]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219902_at	204	0.102941	1.03376e-05	0.000460429	-1.5889	0.174454	-0.249037	0.78 [0.54 - 1.12]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219902_at	204	0.102941	0.00223384	0.0495835	-1.02722	0.310943	-0.136789	0.87 [0.67 - 1.14]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219902_at	178	0.101124	0.0871721	-	-0.487944	0.735018	0.0525924	1.05 [0.78 - 1.43]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219902_at	111	0.828829	0.277648	-	0.350715	0.586393	0.0499834	1.05 [0.88 - 1.26]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219902_at	90	0.255556	0.019616	0.264299	1.32553	0.525631	0.324458	1.38 [0.51 - 3.77]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219902_at	90	0.877778	0.0392145	0.422288	0.841551	0.191396	0.550752	1.73 [0.76 - 3.96]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219902_at	138	0.384058	0.0224232	0.290328	-0.54705	0.807736	0.0194458	1.02 [0.87 - 1.19]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219902_at	129	0.899225	0.203702	-	0.476055	0.660699	0.049625	1.05 [0.84 - 1.31]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16002	56	0.857143	0.00223547	0.0496131	1.21654	0.00415733	0.434288	1.54 [1.15 - 2.08]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	997	56	0.821429	0.027201	0.331607	0.842186	0.0105422	0.522917	1.69 [1.13 - 2.52]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16002	56	0.857143	0.00218581	0.048711	1.30611	0.0239773	0.370848	1.45 [1.05 - 2.00]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	997	56	0.821429	0.0261018	0.322417	0.896763	0.0645106	0.416014	1.52 [0.98 - 2.36]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219902_at	278	0.352518	0.164913	-	0.282079	0.926419	0.00861838	1.01 [0.84 - 1.21]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219902_at	133	0.879699	0.0236649	0.3014	-1.25148	0.477454	-0.182886	0.83 [0.50 - 1.38]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219902_at	185	0.718919	0.00649293	0.116069	0.488912	0.0760764	0.427179	1.53 [0.96 - 2.46]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219902_at	185	0.718919	0.00894207	0.148375	0.506431	0.0378966	0.518609	1.68 [1.03 - 2.74]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P231829	110	0.118182	0.280223	-	0.635936	0.901195	0.0106181	1.01 [0.85 - 1.20]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P92983	110	0.590909	0.275983	-	0.32534	0.847031	0.0159763	1.02 [0.86 - 1.20]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P231829	110	0.109091	0.0734873	-	0.742696	0.182056	0.0853416	1.09 [0.96 - 1.23]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P92983	110	0.581818	0.109623	-	0.369369	0.15986	0.0875837	1.09 [0.97 - 1.23]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219902_at	80	0.6	0.0255792	0.317986	0.966472	0.192705	0.213202	1.24 [0.90 - 1.71]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219902_at	38	0.605263	0.102447	-	-0.807327	0.759311	0.149525	1.16 [0.45 - 3.02]
GENE	BHMT2	betaine--homocysteine S-methyltransferase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219902_at	140	0.285714	6.89985e-06	0.000319073	-1.22672	0.000642898	-0.794633	0.45 [0.29 - 0.71]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BLVRA	biliverdin reductase A	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203772_at	30	0.666667	0.100457	-	0.686855	0.655217	0.340715	1.41 [0.32 - 6.27]
GENE	BLVRA	biliverdin reductase A	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203773_x_at	30	0.4	0.192114	-	0.541007	0.740476	0.148205	1.16 [0.48 - 2.79]
GENE	BLVRA	biliverdin reductase A	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203771_s_at	30	0.8	0.253237	-	-0.625554	0.856661	-0.0668142	0.94 [0.45 - 1.93]
GENE	BLVRA	biliverdin reductase A	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211729_x_at	30	0.3	0.0767281	-	0.812321	0.519378	0.307678	1.36 [0.53 - 3.47]
GENE	BLVRA	biliverdin reductase A	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1691436	165	0.145455	0.0491898	0.486742	-0.583433	0.997883	-0.000463783	1.00 [0.71 - 1.41]
GENE	BLVRA	biliverdin reductase A	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1691436	165	0.890909	0.057337	-	0.837628	0.718659	0.094174	1.10 [0.66 - 1.83]
GENE	BLVRA	biliverdin reductase A	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203773_x_at	163	0.184049	0.245109	-	-0.279248	0.611166	-0.0618773	0.94 [0.74 - 1.19]
GENE	BLVRA	biliverdin reductase A	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211729_x_at	163	0.895706	0.150509	-	-0.55581	0.561725	-0.0734964	0.93 [0.72 - 1.19]
GENE	BLVRA	biliverdin reductase A	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203772_at	163	0.828221	0.0700702	-	-0.549398	0.192345	-0.803995	0.45 [0.13 - 1.50]
GENE	BLVRA	biliverdin reductase A	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203771_s_at	163	0.343558	0.203402	-	0.268505	0.562261	-0.0884615	0.92 [0.68 - 1.23]
GENE	BLVRA	biliverdin reductase A	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	229109_s_at	163	0.153374	0.00486465	0.0926197	-0.709664	0.173502	-0.839832	0.43 [0.13 - 1.45]
GENE	BLVRA	biliverdin reductase A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203771_s_at	79	0.594937	0.183514	-	0.390009	0.845513	0.0330606	1.03 [0.74 - 1.44]
GENE	BLVRA	biliverdin reductase A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	229109_s_at	79	0.367089	0.167013	-	-0.405527	0.620935	-0.270822	0.76 [0.26 - 2.23]
GENE	BLVRA	biliverdin reductase A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211729_x_at	79	0.139241	0.345336	-	0.444954	0.982569	0.0026823	1.00 [0.79 - 1.28]
GENE	BLVRA	biliverdin reductase A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203773_x_at	79	0.189873	0.389479	-	-0.296491	0.807038	-0.0291552	0.97 [0.77 - 1.23]
GENE	BLVRA	biliverdin reductase A	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203772_at	79	0.835443	0.0207421	0.274915	0.782028	0.299293	0.817157	2.26 [0.48 - 10.59]
GENE	BLVRA	biliverdin reductase A	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203771_s_at	58	0.775862	0.142088	-	-0.485631	0.596945	-0.0821166	0.92 [0.68 - 1.25]
GENE	BLVRA	biliverdin reductase A	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203772_at	58	0.103448	0.0280474	0.338568	1.0961	0.210091	0.177168	1.19 [0.90 - 1.57]
GENE	BLVRA	biliverdin reductase A	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203773_x_at	58	0.327586	0.00164258	0.038521	-0.945104	0.0333912	-0.327946	0.72 [0.53 - 0.97]
GENE	BLVRA	biliverdin reductase A	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211729_x_at	58	0.465517	0.00035713	0.0106182	-1.0245	0.00798472	-0.527293	0.59 [0.40 - 0.87]
GENE	BLVRA	biliverdin reductase A	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203772_at	34	0.117647	2.46711e-06	0.000124807	-2.58956	0.993053	0.00192631	1.00 [0.65 - 1.55]
GENE	BLVRA	biliverdin reductase A	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203773_x_at	34	0.352941	0.0127919	0.193994	-0.934509	0.02789	-0.728655	0.48 [0.25 - 0.92]
GENE	BLVRA	biliverdin reductase A	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203771_s_at	34	0.882353	0.0188304	0.256748	-1.62333	0.197791	-0.310799	0.73 [0.46 - 1.18]
GENE	BLVRA	biliverdin reductase A	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211729_x_at	34	0.264706	0.0104647	0.167067	-1.02181	0.0170493	-0.968333	0.38 [0.17 - 0.84]
GENE	BLVRA	biliverdin reductase A	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203771_s_at	158	0.101266	0.101377	-	-0.551474	0.757676	0.0912541	1.10 [0.61 - 1.96]
GENE	BLVRA	biliverdin reductase A	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203773_x_at	158	0.132911	0.0940853	-	0.700202	0.517148	0.139381	1.15 [0.75 - 1.75]
GENE	BLVRA	biliverdin reductase A	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211729_x_at	158	0.132911	0.0962451	-	0.695746	0.624258	0.104857	1.11 [0.73 - 1.69]
GENE	BLVRA	biliverdin reductase A	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203772_at	158	0.208861	0.121386	-	0.501751	0.601554	0.549884	1.73 [0.22 - 13.65]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211729_x_at	53	0.169811	0.0289283	0.34571	-0.928799	0.683588	0.218625	1.24 [0.43 - 3.56]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203771_s_at	53	0.245283	0.164555	-	-0.520804	0.882282	-0.045121	0.96 [0.53 - 1.74]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203773_x_at	53	0.264151	0.0200851	0.268751	-0.838729	0.712752	-0.166423	0.85 [0.35 - 2.05]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211729_x_at	53	0.169811	0.105177	-	-0.680587	0.752294	0.154524	1.17 [0.45 - 3.05]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203772_at	53	0.207547	0.115094	-	0.824963	0.944279	-0.0139333	0.99 [0.67 - 1.46]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203773_x_at	53	0.264151	0.0191528	0.259861	-0.894087	0.746878	-0.158413	0.85 [0.33 - 2.23]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203771_s_at	53	0.773585	0.127319	-	0.584584	0.873483	0.0539397	1.06 [0.54 - 2.05]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203772_at	53	0.169811	0.0795382	-	1.01719	0.733137	0.0636018	1.07 [0.74 - 1.54]
GENE	BLVRA	biliverdin reductase A	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203771_s_at	180	0.722222	0.0856939	-	0.380588	0.546591	0.0775095	1.08 [0.84 - 1.39]
GENE	BLVRA	biliverdin reductase A	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203773_x_at	180	0.872222	1.89884e-05	0.00079715	1.14684	0.010557	0.855428	2.35 [1.22 - 4.53]
GENE	BLVRA	biliverdin reductase A	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211729_x_at	180	0.844444	0.00228522	0.0505122	0.772361	0.00882678	1.03889	2.83 [1.30 - 6.15]
GENE	BLVRA	biliverdin reductase A	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203772_at	180	0.85	0.0501241	-	0.500261	0.220971	0.109944	1.12 [0.94 - 1.33]
GENE	BLVRA	biliverdin reductase A	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	229109_s_at	180	0.694444	0.091468	-	0.371963	0.988791	0.00131198	1.00 [0.83 - 1.20]
GENE	BLVRA	biliverdin reductase A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203771_s_at	559	0.851521	0.00172406	0.0400908	0.795673	0.0179563	0.246272	1.28 [1.04 - 1.57]
GENE	BLVRA	biliverdin reductase A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	229109_s_at	559	0.155635	0.0748282	-	0.686074	0.883718	-0.0181206	0.98 [0.77 - 1.25]
GENE	BLVRA	biliverdin reductase A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211729_x_at	559	0.899821	0.00648619	0.115976	0.798991	0.44796	0.157938	1.17 [0.78 - 1.76]
GENE	BLVRA	biliverdin reductase A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203773_x_at	559	0.887299	0.00455942	0.0880015	0.740131	0.652592	0.0546846	1.06 [0.83 - 1.34]
GENE	BLVRA	biliverdin reductase A	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203772_at	559	0.243292	0.0235911	0.300749	-0.482177	0.0672587	-0.247518	0.78 [0.60 - 1.02]
GENE	BLVRA	biliverdin reductase A	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203773_x_at	77	0.844156	0.124667	-	-0.608672	0.291787	-0.43923	0.64 [0.28 - 1.46]
GENE	BLVRA	biliverdin reductase A	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203771_s_at	77	0.194805	0.0170266	0.23892	-0.716237	0.543269	-0.137592	0.87 [0.56 - 1.36]
GENE	BLVRA	biliverdin reductase A	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203772_at	77	0.792208	0.186908	-	0.391951	0.975983	0.00473369	1.00 [0.74 - 1.37]
GENE	BLVRA	biliverdin reductase A	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211729_x_at	77	0.701299	0.0216811	0.283586	0.628814	0.846719	-0.100651	0.90 [0.33 - 2.51]
GENE	BLVRA	biliverdin reductase A	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	229109_s_at	77	0.779221	0.0622846	-	0.555349	0.676683	0.0663614	1.07 [0.78 - 1.46]
GENE	BLVRA	biliverdin reductase A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	229109_s_at	70	0.128571	0.0377385	0.411997	-0.755521	0.709445	-0.191045	0.83 [0.30 - 2.26]
GENE	BLVRA	biliverdin reductase A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211729_x_at	70	0.114286	0.273031	-	-0.443793	0.845913	-0.0657227	0.94 [0.48 - 1.82]
GENE	BLVRA	biliverdin reductase A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203773_x_at	70	0.457143	0.241083	-	0.312009	0.761678	-0.103956	0.90 [0.46 - 1.76]
GENE	BLVRA	biliverdin reductase A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203772_at	70	0.757143	0.1007	-	0.483064	0.71893	0.344907	1.41 [0.22 - 9.24]
GENE	BLVRA	biliverdin reductase A	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203771_s_at	70	0.142857	0.0332843	0.379587	-0.730424	0.949648	-0.0213523	0.98 [0.50 - 1.90]
GENE	BLVRA	biliverdin reductase A	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32618_at	50	0.46	0.00633819	0.113918	1.00934	0.0701474	0.857827	2.36 [0.93 - 5.97]
GENE	BLVRA	biliverdin reductase A	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203773_x_at	74	0.297297	0.282428	-	-0.327978	0.940252	0.0343707	1.03 [0.42 - 2.54]
GENE	BLVRA	biliverdin reductase A	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203771_s_at	74	0.743243	0.00598921	0.10901	0.859226	0.829523	-0.0514484	0.95 [0.59 - 1.52]
GENE	BLVRA	biliverdin reductase A	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211729_x_at	74	0.891892	0.00452972	0.0875479	1.06979	0.0208233	1.44204	4.23 [1.24 - 14.37]
GENE	BLVRA	biliverdin reductase A	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203772_at	74	0.702703	0.125658	-	-0.528914	0.626448	-0.0906113	0.91 [0.63 - 1.32]
GENE	BLVRA	biliverdin reductase A	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	229109_s_at	74	0.405405	0.286213	-	0.315524	0.658859	0.0791937	1.08 [0.76 - 1.54]
GENE	BLVRA	biliverdin reductase A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203771_s_at	67	0.626866	0.00340273	0.0697067	2.00976	0.00190514	3.95956	52.43 [4.31 - 638.60]
GENE	BLVRA	biliverdin reductase A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	229109_s_at	67	0.850746	0.0674357	-	1.21885	0.0443871	2.56927	13.06 [1.07 - 159.83]
GENE	BLVRA	biliverdin reductase A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211729_x_at	67	0.731343	0.000842787	0.0220711	2.05937	0.000710704	5.30867	202.08 [9.35 - 4368.37]
GENE	BLVRA	biliverdin reductase A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203773_x_at	67	0.61194	0.00170199	0.0396671	2.573	0.00239081	4.61615	101.10 [5.14 - 1989.16]
GENE	BLVRA	biliverdin reductase A	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203772_at	67	0.850746	0.0483114	0.481393	1.35512	0.590544	1.64759	5.19 [0.01 - 2099.48]
GENE	BLVRA	biliverdin reductase A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211729_x_at	115	0.626087	0.0648972	-	-1.31452	0.299841	-0.585089	0.56 [0.18 - 1.68]
GENE	BLVRA	biliverdin reductase A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203773_x_at	115	0.495652	0.0250662	0.313596	-1.35566	0.32353	-0.561663	0.57 [0.19 - 1.74]
GENE	BLVRA	biliverdin reductase A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	229109_s_at	115	0.104348	0.000742869	0.0198403	-1.69063	0.575416	-0.290183	0.75 [0.27 - 2.07]
GENE	BLVRA	biliverdin reductase A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203772_at	115	0.895652	0.0107015	0.169892	1.39109	0.922913	0.115284	1.12 [0.11 - 11.59]
GENE	BLVRA	biliverdin reductase A	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203771_s_at	115	0.191304	0.0846166	-	-0.938187	0.63248	-0.256304	0.77 [0.27 - 2.21]
GENE	BLVRA	biliverdin reductase A	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32618_at	158	0.835443	0.0152393	0.220525	-1.34759	0.0827866	-0.635295	0.53 [0.26 - 1.09]
GENE	BLVRA	biliverdin reductase A	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32618_at	76	0.144737	0.112621	-	15.2538	0.603538	0.305022	1.36 [0.43 - 4.29]
GENE	BLVRA	biliverdin reductase A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	229109_s_at	204	0.789216	0.0264733	0.325542	-0.374791	0.350856	-0.124124	0.88 [0.68 - 1.15]
GENE	BLVRA	biliverdin reductase A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211729_x_at	204	0.480392	0.00032207	0.00971357	-0.506055	0.00310575	-0.408593	0.66 [0.51 - 0.87]
GENE	BLVRA	biliverdin reductase A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203773_x_at	204	0.102941	0.000678756	0.0183803	-0.791024	0.00494847	-0.344565	0.71 [0.56 - 0.90]
GENE	BLVRA	biliverdin reductase A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203772_at	204	0.509804	0.0821722	-	0.24347	0.475853	0.0505569	1.05 [0.92 - 1.21]
GENE	BLVRA	biliverdin reductase A	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203771_s_at	204	0.588235	0.00087822	0.0228503	-0.474723	0.00996431	-0.304153	0.74 [0.59 - 0.93]
GENE	BLVRA	biliverdin reductase A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203772_at	87	0.103448	0.0149238	0.217197	-1.15575	0.356798	-0.871506	0.42 [0.07 - 2.67]
GENE	BLVRA	biliverdin reductase A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211729_x_at	87	0.735632	0.0379008	0.413139	0.775085	0.201355	0.351445	1.42 [0.83 - 2.44]
GENE	BLVRA	biliverdin reductase A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203771_s_at	87	0.804598	0.056891	-	0.755095	0.208116	0.26221	1.30 [0.86 - 1.96]
GENE	BLVRA	biliverdin reductase A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203773_x_at	87	0.747126	0.0943238	-	0.637835	0.283165	0.292598	1.34 [0.79 - 2.29]
GENE	BLVRA	biliverdin reductase A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211729_x_at	87	0.735632	0.0379008	0.413139	0.775085	0.201355	0.351445	1.42 [0.83 - 2.44]
GENE	BLVRA	biliverdin reductase A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203772_at	87	0.103448	0.0149238	0.217197	-1.15575	0.356798	-0.871506	0.42 [0.07 - 2.67]
GENE	BLVRA	biliverdin reductase A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203773_x_at	87	0.747126	0.0943238	-	0.637835	0.283165	0.292598	1.34 [0.79 - 2.29]
GENE	BLVRA	biliverdin reductase A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203771_s_at	87	0.804598	0.056891	-	0.755095	0.208116	0.26221	1.30 [0.86 - 1.96]
GENE	BLVRA	biliverdin reductase A	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	229109_s_at	87	0.827586	0.00463152	0.0890995	1.09569	0.143299	0.500646	1.65 [0.84 - 3.23]
GENE	BLVRA	biliverdin reductase A	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	229109_s_at	87	0.827586	0.00463152	0.0890995	1.09569	0.143299	0.500646	1.65 [0.84 - 3.23]
GENE	BLVRA	biliverdin reductase A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211729_x_at	77	0.896104	0.136576	-	0.944575	0.467028	0.274839	1.32 [0.63 - 2.76]
GENE	BLVRA	biliverdin reductase A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	229109_s_at	77	0.87013	0.00465679	0.0894833	1.64019	0.360101	0.575543	1.78 [0.52 - 6.10]
GENE	BLVRA	biliverdin reductase A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203772_at	77	0.103896	0.244119	-	-0.892658	0.479079	-1.20702	0.30 [0.01 - 8.46]
GENE	BLVRA	biliverdin reductase A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203773_x_at	77	0.896104	0.136576	-	0.944575	0.465761	0.276601	1.32 [0.63 - 2.77]
GENE	BLVRA	biliverdin reductase A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203771_s_at	77	0.87013	0.0742661	-	1.16575	0.441018	0.248895	1.28 [0.68 - 2.42]
GENE	BLVRA	biliverdin reductase A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203772_at	77	0.25974	0.225087	-	-0.678735	0.663091	-0.625764	0.53 [0.03 - 8.93]
GENE	BLVRA	biliverdin reductase A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211729_x_at	77	0.896104	0.039712	0.425709	1.32133	0.313059	0.453402	1.57 [0.65 - 3.80]
GENE	BLVRA	biliverdin reductase A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203771_s_at	77	0.116883	0.162567	-	15.2252	0.879976	0.0428452	1.04 [0.60 - 1.82]
GENE	BLVRA	biliverdin reductase A	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	229109_s_at	77	0.87013	0.0343097	0.387237	1.19985	0.611169	0.278073	1.32 [0.45 - 3.86]
GENE	BLVRA	biliverdin reductase A	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203773_x_at	77	0.831169	0.0370393	0.407046	1.26136	0.361545	0.408157	1.50 [0.63 - 3.61]
GENE	BLVRA	biliverdin reductase A	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203773_x_at	136	0.367647	0.00880403	0.146632	-1.16303	0.218356	-0.535454	0.59 [0.25 - 1.37]
GENE	BLVRA	biliverdin reductase A	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211729_x_at	136	0.455882	0.0317267	0.367737	-1.00889	0.347548	-0.45235	0.64 [0.25 - 1.63]
GENE	BLVRA	biliverdin reductase A	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203772_at	136	0.110294	0.0864572	-	15.2329	0.732484	0.0668835	1.07 [0.73 - 1.57]
GENE	BLVRA	biliverdin reductase A	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203771_s_at	136	0.272059	0.0143896	0.2115	-1.04698	0.436487	-0.184154	0.83 [0.52 - 1.32]
GENE	BLVRA	biliverdin reductase A	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203771_s_at	200	0.865	0.00904077	0.149615	0.911971	0.350059	0.217929	1.24 [0.79 - 1.96]
GENE	BLVRA	biliverdin reductase A	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203773_x_at	200	0.885	0.000116722	0.0040127	1.31466	0.00495454	0.796147	2.22 [1.27 - 3.86]
GENE	BLVRA	biliverdin reductase A	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211729_x_at	200	0.74	1.23249e-05	0.000539816	1.23995	0.00925183	0.861154	2.37 [1.24 - 4.53]
GENE	BLVRA	biliverdin reductase A	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203772_at	200	0.3	0.0120053	0.185094	0.990988	0.0628761	0.271533	1.31 [0.99 - 1.75]
GENE	BLVRA	biliverdin reductase A	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15165	60	0.266667	0.00252206	0.0547346	1.9169	0.0777161	0.698027	2.01 [0.93 - 4.36]
GENE	BLVRA	biliverdin reductase A	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15165	60	0.25	0.000510007	0.014412	2.6874	0.00401932	1.26372	3.54 [1.50 - 8.37]
GENE	BLVRA	biliverdin reductase A	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	4455	155	0.167742	3.88423e-07	2.26952e-05	-1.35898	5.15142e-06	-0.472348	0.62 [0.51 - 0.76]
GENE	BLVRA	biliverdin reductase A	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203771_s_at	286	0.832168	0.00309477	0.0645893	0.655919	0.567037	-0.0692295	0.93 [0.74 - 1.18]
GENE	BLVRA	biliverdin reductase A	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203772_at	286	0.587413	0.00204623	0.0461511	0.58901	0.0309641	0.203809	1.23 [1.02 - 1.48]
GENE	BLVRA	biliverdin reductase A	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203773_x_at	286	0.608392	0.0941189	-	0.323223	0.276775	0.193187	1.21 [0.86 - 1.72]
GENE	BLVRA	biliverdin reductase A	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211729_x_at	286	0.468531	0.090213	-	0.332329	0.420807	0.160053	1.17 [0.79 - 1.73]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203771_s_at	159	0.591195	0.0621921	-	0.582727	0.391173	0.217683	1.24 [0.76 - 2.04]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211729_x_at	159	0.842767	0.0262517	0.32368	0.768289	0.397573	0.273264	1.31 [0.70 - 2.48]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203772_at	159	0.163522	0.0349474	0.391936	1.41042	0.992485	-0.00168856	1.00 [0.70 - 1.42]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203772_at	159	0.163522	0.00935496	0.153537	2.17645	0.593356	-0.0990174	0.91 [0.63 - 1.30]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203772_at	159	0.786164	0.0382006	0.415242	-1.40151	0.429324	-0.178913	0.84 [0.54 - 1.30]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203773_x_at	159	0.660377	0.000605026	0.0166705	1.04394	0.360904	0.269656	1.31 [0.73 - 2.34]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203773_x_at	159	0.691824	0.00182546	0.0420225	1.10761	0.258082	0.391232	1.48 [0.75 - 2.91]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203771_s_at	159	0.672956	0.0507614	-	0.711492	0.227541	0.377603	1.46 [0.79 - 2.69]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211729_x_at	159	0.471698	0.00374829	0.0753163	0.986474	0.382068	0.280014	1.32 [0.71 - 2.48]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211729_x_at	159	0.515723	0.00647958	0.115884	1.07853	0.272519	0.414179	1.51 [0.72 - 3.17]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203771_s_at	159	0.559748	0.181734	-	0.420137	0.544117	0.151385	1.16 [0.71 - 1.90]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203773_x_at	159	0.710692	0.0094055	0.154164	0.804384	0.285156	0.316692	1.37 [0.77 - 2.45]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229109_s_at	159	0.767296	0.0268547	0.32873	0.718968	0.194431	0.217144	1.24 [0.90 - 1.72]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229109_s_at	159	0.666667	0.0153925	0.222133	0.750407	0.143683	0.243208	1.28 [0.92 - 1.77]
GENE	BLVRA	biliverdin reductase A	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229109_s_at	159	0.767296	0.0220618	0.287056	0.851176	0.105264	0.319994	1.38 [0.94 - 2.03]
GENE	BLVRA	biliverdin reductase A	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203772_at	54	0.12963	0.0230197	0.295678	-1.43905	0.249793	-2.36742	0.09 [0.00 - 5.28]
GENE	BLVRA	biliverdin reductase A	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203773_x_at	54	0.12963	0.118773	-	15.4106	0.242758	0.681684	1.98 [0.63 - 6.21]
GENE	BLVRA	biliverdin reductase A	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203771_s_at	54	0.296296	0.0390402	0.421084	15.6398	0.308859	0.38333	1.47 [0.70 - 3.07]
GENE	BLVRA	biliverdin reductase A	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211729_x_at	54	0.462963	0.161428	-	1.0748	0.206727	0.731543	2.08 [0.67 - 6.47]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203772_at	117	0.735043	0.0468616	0.472435	-0.919378	0.213691	-1.27208	0.28 [0.04 - 2.08]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203771_s_at	117	0.709402	0.106014	-	-0.636678	0.447414	-0.153341	0.86 [0.58 - 1.27]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203771_s_at	117	0.222222	0.26777	-	0.590464	0.907233	-0.0275115	0.97 [0.61 - 1.55]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203771_s_at	117	0.709402	0.106014	-	-0.636678	0.447414	-0.153341	0.86 [0.58 - 1.27]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203773_x_at	117	0.606838	0.144082	-	-0.500783	0.629072	-0.104065	0.90 [0.59 - 1.37]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203773_x_at	117	0.606838	0.0943208	-	-0.714618	0.694334	-0.103212	0.90 [0.54 - 1.51]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203771_s_at	117	0.820513	0.0613255	-	-1.69207	0.387661	-0.220493	0.80 [0.49 - 1.32]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211729_x_at	117	0.42735	0.0818184	-	-0.652996	0.822988	-0.0551605	0.95 [0.58 - 1.53]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211729_x_at	117	0.74359	0.169681	-	-0.565873	0.650362	-0.0916459	0.91 [0.61 - 1.36]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203773_x_at	117	0.102564	0.0559022	-	15.2127	0.980009	-0.00691161	0.99 [0.58 - 1.71]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203773_x_at	117	0.606838	0.144082	-	-0.500783	0.629072	-0.104065	0.90 [0.59 - 1.37]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211729_x_at	117	0.74359	0.169681	-	-0.565873	0.650362	-0.0916459	0.91 [0.61 - 1.36]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203772_at	117	0.769231	0.266088	-	-0.59139	0.848628	-0.205801	0.81 [0.10 - 6.74]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211729_x_at	117	0.128205	0.103517	-	1.51209	0.94697	0.0171145	1.02 [0.61 - 1.68]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203772_at	117	0.136752	0.0570089	-	-0.813109	0.727264	-0.403003	0.67 [0.07 - 6.44]
GENE	BLVRA	biliverdin reductase A	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203772_at	117	0.735043	0.0468616	0.472435	-0.919378	0.213691	-1.27208	0.28 [0.04 - 2.08]
GENE	BLVRA	biliverdin reductase A	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211729_x_at	236	0.665254	0.00746455	0.129258	0.708967	0.279511	0.327941	1.39 [0.77 - 2.52]
GENE	BLVRA	biliverdin reductase A	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203772_at	236	0.466102	0.0109784	0.173171	-0.69193	0.211694	-0.247829	0.78 [0.53 - 1.15]
GENE	BLVRA	biliverdin reductase A	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203771_s_at	236	0.800847	0.0442679	0.45599	0.589649	0.565512	0.11723	1.12 [0.75 - 1.68]
GENE	BLVRA	biliverdin reductase A	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203773_x_at	236	0.635593	0.0138022	0.205148	0.65267	0.262119	0.296686	1.35 [0.80 - 2.26]
GENE	BLVRA	biliverdin reductase A	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	229109_s_at	236	0.487288	0.0457815	0.465654	0.552759	0.476095	0.113337	1.12 [0.82 - 1.53]
GENE	BLVRA	biliverdin reductase A	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203771_s_at	249	0.807229	0.0484913	0.482493	0.474693	0.347788	0.152061	1.16 [0.85 - 1.60]
GENE	BLVRA	biliverdin reductase A	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203773_x_at	249	0.64257	0.00282498	0.0600055	0.624658	0.12838	0.318948	1.38 [0.91 - 2.08]
GENE	BLVRA	biliverdin reductase A	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211729_x_at	249	0.674699	0.00187077	0.0428782	0.653575	0.14439	0.351247	1.42 [0.89 - 2.28]
GENE	BLVRA	biliverdin reductase A	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203772_at	249	0.253012	0.102127	-	-0.371021	0.676131	-0.0589546	0.94 [0.71 - 1.24]
GENE	BLVRA	biliverdin reductase A	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	229109_s_at	249	0.184739	0.108326	-	0.512143	0.438514	0.0962606	1.10 [0.86 - 1.40]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203772_at	125	0.16	0.0172809	0.241476	-0.743088	0.22399	-0.884881	0.41 [0.10 - 1.72]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203773_x_at	125	0.6	0.0211842	0.279017	0.653761	0.481129	0.207774	1.23 [0.69 - 2.19]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211729_x_at	125	0.592	0.00643575	0.115276	0.774254	0.516557	0.188908	1.21 [0.68 - 2.14]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203773_x_at	54	0.240741	0.074609	-	15.3854	0.731848	0.136147	1.15 [0.53 - 2.50]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211729_x_at	54	0.703704	0.0271422	0.33112	-2.00004	0.607081	0.208302	1.23 [0.56 - 2.72]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203772_at	62	0.129032	0.100621	-	15.2274	0.694681	-0.0873744	0.92 [0.59 - 1.42]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203773_x_at	62	0.741935	0.116904	-	-0.964041	0.607185	-0.150235	0.86 [0.49 - 1.53]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203771_s_at	62	0.419355	0.149833	-	0.798253	0.466186	0.215691	1.24 [0.69 - 2.22]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203772_at	54	0.425926	0.120443	-	1.14576	0.70462	-0.102711	0.90 [0.53 - 1.53]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203771_s_at	125	0.832	0.0218439	0.285073	0.898362	0.411278	0.223914	1.25 [0.73 - 2.13]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211729_x_at	62	0.741935	0.0229894	0.295408	-1.57078	0.721649	-0.104104	0.90 [0.51 - 1.60]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203773_x_at	125	0.544	0.0572923	-	0.721049	0.539895	0.232946	1.26 [0.60 - 2.66]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203771_s_at	125	0.696	0.0681603	-	0.523285	0.526321	0.134159	1.14 [0.76 - 1.73]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203771_s_at	54	0.462963	0.0345593	0.389081	1.4998	0.213183	0.506561	1.66 [0.75 - 3.68]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211729_x_at	125	0.736	0.107885	-	0.612739	0.654188	0.169308	1.18 [0.56 - 2.48]
GENE	BLVRA	biliverdin reductase A	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203772_at	125	0.136	0.0852588	-	-0.736877	0.155582	-1.34602	0.26 [0.04 - 1.67]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203772_at	198	0.671717	0.016704	0.235655	-0.762957	0.13435	-0.130359	0.88 [0.74 - 1.04]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203773_x_at	198	0.277778	0.310416	-	0.252726	0.993096	-0.001109	1.00 [0.78 - 1.28]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203771_s_at	198	0.888889	0.157233	-	-0.716956	0.288517	-0.159688	0.85 [0.63 - 1.14]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211729_x_at	198	0.479798	0.108653	-	-0.337853	0.634245	-0.0719773	0.93 [0.69 - 1.25]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203772_at	198	0.752525	0.0294307	0.349738	-0.593546	0.0456801	-0.137501	0.87 [0.76 - 1.00]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203772_at	198	0.727273	0.01913	0.259642	-0.789272	0.129272	-0.124741	0.88 [0.75 - 1.04]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203771_s_at	198	0.388889	0.0602588	-	-0.498252	0.229121	-0.186053	0.83 [0.61 - 1.12]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203773_x_at	198	0.540404	0.33068	-	-0.250246	0.780304	-0.0431639	0.96 [0.71 - 1.30]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203773_x_at	198	0.540404	0.31208	-	-0.274109	0.664258	-0.0700523	0.93 [0.68 - 1.28]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211729_x_at	198	0.479798	0.0721134	-	-0.457737	0.393703	-0.156906	0.85 [0.60 - 1.23]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211729_x_at	198	0.474747	0.0344913	0.388579	-0.564916	0.293755	-0.199766	0.82 [0.56 - 1.19]
GENE	BLVRA	biliverdin reductase A	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203771_s_at	198	0.888889	0.158788	-	-0.548246	0.669273	-0.0522865	0.95 [0.75 - 1.21]
GENE	BLVRA	biliverdin reductase A	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211729_x_at	62	0.33871	0.0387837	0.419306	1.8739	0.478726	0.223993	1.25 [0.67 - 2.33]
GENE	BLVRA	biliverdin reductase A	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203772_at	51	0.156863	0.312017	-	15.3005	0.857116	0.41663	1.52 [0.02 - 141.47]
GENE	BLVRA	biliverdin reductase A	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203771_s_at	51	0.862745	0.00139413	0.03363	2.34759	0.0175604	6.63964	764.82 [3.19 - 183440.05]
GENE	BLVRA	biliverdin reductase A	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203772_at	62	0.693548	0.0488767	0.484842	-1.8042	0.28231	-1.60313	0.20 [0.01 - 3.74]
GENE	BLVRA	biliverdin reductase A	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203773_x_at	51	0.568627	0.086477	-	1.70359	0.711479	0.186307	1.20 [0.45 - 3.23]
GENE	BLVRA	biliverdin reductase A	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203773_x_at	62	0.387097	0.0637004	-	1.33752	0.443247	0.244147	1.28 [0.68 - 2.38]
GENE	BLVRA	biliverdin reductase A	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203771_s_at	62	0.112903	0.181423	-	-0.864647	0.660818	0.934614	2.55 [0.04 - 165.58]
GENE	BLVRA	biliverdin reductase A	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211729_x_at	51	0.509804	0.158814	-	1.44626	0.684829	0.201975	1.22 [0.46 - 3.25]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211729_x_at	145	0.137931	0.0859394	-	1.17935	0.986795	0.00538251	1.01 [0.53 - 1.90]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203772_at	177	0.112994	0.0132189	0.198744	-0.848823	0.0679874	-1.52321	0.22 [0.04 - 1.12]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203773_x_at	177	0.169492	0.0454591	0.463611	0.735762	0.794999	0.0598766	1.06 [0.68 - 1.67]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203771_s_at	177	0.271186	0.0878119	-	0.570162	0.444098	0.183014	1.20 [0.75 - 1.92]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203772_at	177	0.728814	0.0130189	0.196525	-0.766888	0.0438876	-1.45978	0.23 [0.06 - 0.96]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203773_x_at	145	0.537931	0.350152	-	0.312235	0.942634	-0.0237415	0.98 [0.51 - 1.86]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203772_at	145	0.841379	0.00413393	0.0814265	-15.3356	0.145918	-1.4573	0.23 [0.03 - 1.66]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203771_s_at	177	0.220339	0.176913	-	0.411841	0.802607	0.0522438	1.05 [0.70 - 1.59]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211729_x_at	177	0.152542	0.0319223	0.369241	1.06571	0.442046	0.204525	1.23 [0.73 - 2.07]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	229109_s_at	177	0.779661	0.242864	-	-0.38222	0.465289	-0.389003	0.68 [0.24 - 1.93]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	229109_s_at	177	0.779661	0.139154	-	-0.593483	0.468588	-0.443524	0.64 [0.19 - 2.13]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203771_s_at	145	0.572414	0.218466	-	-0.433467	0.707385	-0.113489	0.89 [0.49 - 1.61]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203773_x_at	177	0.169492	0.041019	0.434587	0.928325	0.447741	0.202777	1.22 [0.73 - 2.07]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211729_x_at	177	0.146893	0.0579659	-	0.739152	0.778067	0.0647532	1.07 [0.68 - 1.67]
GENE	BLVRA	biliverdin reductase A	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	229109_s_at	145	0.158621	0.0736252	-	1.03961	0.557504	0.435641	1.55 [0.36 - 6.63]
GENE	BLVRA	biliverdin reductase A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203773_x_at	226	0.247788	0.334221	-	-0.303771	0.947179	0.0118271	1.01 [0.71 - 1.44]
GENE	BLVRA	biliverdin reductase A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203772_at	226	0.336283	0.0408891	0.433712	0.70991	0.409859	0.105319	1.11 [0.86 - 1.43]
GENE	BLVRA	biliverdin reductase A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203771_s_at	226	0.464602	0.206172	-	-0.357421	0.894238	-0.0115442	0.99 [0.83 - 1.17]
GENE	BLVRA	biliverdin reductase A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	229109_s_at	226	0.376106	0.0746769	-	0.554639	0.1236	0.189158	1.21 [0.95 - 1.54]
GENE	BLVRA	biliverdin reductase A	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211729_x_at	226	0.858407	0.18383	-	0.467392	0.779866	0.0604467	1.06 [0.70 - 1.62]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203773_x_at	55	0.472727	0.0771113	-	0.898913	0.413232	0.377989	1.46 [0.59 - 3.61]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203773_x_at	49	0.469388	0.137531	-	0.954546	0.409932	0.451869	1.57 [0.54 - 4.60]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203771_s_at	55	0.436364	0.00576704	0.105844	1.42717	0.0749975	0.641433	1.90 [0.94 - 3.85]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203772_at	55	0.272727	0.0960884	-	-0.806957	0.266753	-1.86831	0.15 [0.01 - 4.17]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	229109_s_at	55	0.218182	0.032981	0.377302	1.89382	0.585653	0.520982	1.68 [0.26 - 10.96]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203772_at	49	0.755102	0.111431	-	0.90974	0.614914	0.915835	2.50 [0.07 - 88.59]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203771_s_at	55	0.636364	0.0219644	0.286171	1.06435	0.297105	0.408403	1.50 [0.70 - 3.24]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211729_x_at	55	0.454545	0.0274346	0.333538	1.08959	0.0986922	0.709388	2.03 [0.88 - 4.72]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203771_s_at	49	0.734694	0.018017	0.248795	1.31271	0.410157	0.396146	1.49 [0.58 - 3.81]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211729_x_at	55	0.472727	0.0771113	-	0.898913	0.331837	0.44736	1.56 [0.63 - 3.86]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203773_x_at	55	0.381818	0.0441236	0.455059	1.0762	0.0880819	0.743365	2.10 [0.90 - 4.94]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	229109_s_at	55	0.581818	0.219985	-	-0.631274	0.761847	-0.33846	0.71 [0.08 - 6.36]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211729_x_at	49	0.489796	0.0892424	-	1.08187	0.381904	0.462761	1.59 [0.56 - 4.48]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	229109_s_at	49	0.571429	0.0598447	-	-1.35372	0.935342	0.0961251	1.10 [0.11 - 11.23]
GENE	BLVRA	biliverdin reductase A	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203772_at	55	0.672727	0.0522362	-	0.843991	0.505845	0.977787	2.66 [0.15 - 47.38]
GENE	BLVRA	biliverdin reductase A	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	627542	34	0.235294	0.0953078	-	-0.776887	0.500249	-0.257183	0.77 [0.37 - 1.63]
GENE	BLVRA	biliverdin reductase A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203772_at	63	0.15873	0.00632414	0.113722	-1.08574	0.587313	1.18091	3.26 [0.05 - 231.73]
GENE	BLVRA	biliverdin reductase A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203771_s_at	63	0.333333	0.0701579	-	-0.629263	0.331815	0.275602	1.32 [0.76 - 2.30]
GENE	BLVRA	biliverdin reductase A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	229109_s_at	63	0.126984	5.11395e-05	0.00193437	-1.60127	0.0152694	-22.4855	0.00 [0.00 - 0.01]
GENE	BLVRA	biliverdin reductase A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211729_x_at	63	0.825397	0.0570373	-	0.699187	0.742408	0.118542	1.13 [0.56 - 2.28]
GENE	BLVRA	biliverdin reductase A	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203773_x_at	63	0.888889	0.0550362	-	0.791321	0.880214	-0.0516206	0.95 [0.49 - 1.86]
GENE	BLVRA	biliverdin reductase A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.81029.1.A1_3p_a_at	28	0.464286	0.0475256	0.476559	-1.10043	0.125086	-9.69308	0.00 [0.00 - 14.79]
GENE	BLVRA	biliverdin reductase A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	203771_3p_s_at	28	0.178571	0.0974044	-	-0.969688	0.28487	-1.04242	0.35 [0.05 - 2.38]
GENE	BLVRA	biliverdin reductase A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.81029.0.A1_3p_s_at	28	0.285714	0.102156	-	-0.85706	0.391225	-18.8601	0.00 [0.00 - 34143019669.30]
GENE	BLVRA	biliverdin reductase A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502416_3p_s_at	28	0.75	0.137552	-	-1.4206	0.460834	-0.27823	0.76 [0.36 - 1.59]
GENE	BLVRA	biliverdin reductase A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.81029.0.A1_3p_x_at	28	0.392857	0.0514643	-	-1.01961	0.360139	1.43156	4.19 [0.20 - 89.81]
GENE	BLVRA	biliverdin reductase A	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.81029.0.A1_3p_at	28	0.785714	0.146783	-	-1.07729	0.962984	-0.101043	0.90 [0.01 - 64.48]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203773_x_at	82	0.817073	0.0268724	0.328878	-1.47505	0.0647177	-0.764123	0.47 [0.21 - 1.05]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211729_x_at	82	0.890244	0.0915893	-	-1.55128	0.168641	-0.612271	0.54 [0.23 - 1.30]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203771_s_at	82	0.121951	0.0810653	-	-0.768203	0.216329	-0.366491	0.69 [0.39 - 1.24]
GENE	BLVRA	biliverdin reductase A	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32618_at	84	0.119048	0.021374	0.280768	1.51628	0.283971	0.282442	1.33 [0.79 - 2.22]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211729_x_at	79	0.113924	0.038823	0.419579	-0.773987	0.144337	-0.471961	0.62 [0.33 - 1.18]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203773_x_at	79	0.113924	0.0442402	0.455812	-0.723658	0.126093	-0.476329	0.62 [0.34 - 1.14]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203771_s_at	79	0.113924	0.038823	0.419579	-0.773987	0.21765	-0.31489	0.73 [0.44 - 1.20]
GENE	BLVRA	biliverdin reductase A	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U34877_at	86	0.767442	0.0219248	0.285811	-1.99492	0.175197	-0.523382	0.59 [0.28 - 1.26]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203771_s_at	104	0.798077	0.116905	-	-0.734991	0.817032	-0.0558698	0.95 [0.59 - 1.52]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203773_x_at	104	0.846154	0.137523	-	-0.869329	0.794902	-0.0864082	0.92 [0.48 - 1.76]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211729_x_at	104	0.875	0.130477	-	-1.0537	0.721175	-0.121687	0.89 [0.45 - 1.73]
GENE	BLVRA	biliverdin reductase A	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P71148	117	0.512821	0.071255	-	-0.52384	0.182221	-0.254883	0.78 [0.53 - 1.13]
GENE	BLVRA	biliverdin reductase A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211729_x_at	204	0.401961	0.0245857	0.309449	0.986374	0.449267	0.428221	1.53 [0.51 - 4.65]
GENE	BLVRA	biliverdin reductase A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	229109_s_at	204	0.132353	0.0472321	0.47474	-0.836837	0.183016	-0.70574	0.49 [0.17 - 1.40]
GENE	BLVRA	biliverdin reductase A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	229109_s_at	204	0.372549	0.0113841	0.177925	0.806703	0.691935	-0.168167	0.85 [0.37 - 1.94]
GENE	BLVRA	biliverdin reductase A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211729_x_at	204	0.45098	0.00533668	0.0996131	0.823608	0.20685	0.527535	1.69 [0.75 - 3.84]
GENE	BLVRA	biliverdin reductase A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203773_x_at	204	0.490196	0.00349699	0.0712503	1.19083	0.146903	0.714724	2.04 [0.78 - 5.37]
GENE	BLVRA	biliverdin reductase A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203773_x_at	204	0.509804	0.00158348	0.0373723	0.884173	0.0485871	0.707708	2.03 [1.00 - 4.10]
GENE	BLVRA	biliverdin reductase A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203772_at	204	0.632353	0.0325117	0.373745	-0.941695	0.816769	-0.0436407	0.96 [0.66 - 1.38]
GENE	BLVRA	biliverdin reductase A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203772_at	204	0.372549	0.00194941	0.044353	-0.824326	0.0117592	-0.321108	0.73 [0.56 - 0.93]
GENE	BLVRA	biliverdin reductase A	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203771_s_at	204	0.818627	0.0946437	-	-1.1582	0.554609	-0.223856	0.80 [0.38 - 1.68]
GENE	BLVRA	biliverdin reductase A	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203771_s_at	204	0.142157	0.102953	-	0.824101	0.644252	0.130277	1.14 [0.66 - 1.98]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211729_x_at	178	0.814607	0.0376891	0.411649	-0.607838	0.218457	-0.30579	0.74 [0.45 - 1.20]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203771_s_at	178	0.657303	0.0146764	0.214568	-0.535295	0.170888	-0.270865	0.76 [0.52 - 1.12]
GENE	BLVRA	biliverdin reductase A	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203773_x_at	178	0.61236	0.0446676	0.458561	-0.424529	0.27134	-0.281584	0.75 [0.46 - 1.25]
GENE	BLVRA	biliverdin reductase A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211729_x_at	111	0.657658	0.119793	-	0.413472	0.792954	0.107705	1.11 [0.50 - 2.49]
GENE	BLVRA	biliverdin reductase A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203773_x_at	111	0.891892	0.130233	-	0.541922	0.832053	0.0850572	1.09 [0.50 - 2.39]
GENE	BLVRA	biliverdin reductase A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	229109_s_at	111	0.333333	0.107379	-	-0.427661	0.607198	-0.0843688	0.92 [0.67 - 1.27]
GENE	BLVRA	biliverdin reductase A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203772_at	111	0.459459	0.00197193	0.0447728	0.844415	0.0680876	0.274796	1.32 [0.98 - 1.77]
GENE	BLVRA	biliverdin reductase A	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203771_s_at	111	0.891892	0.0645872	-	0.65983	0.446847	0.104006	1.11 [0.85 - 1.45]
GENE	BLVRA	biliverdin reductase A	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203773_x_at	90	0.888889	0.00079366	0.0209807	1.26727	0.175502	0.536595	1.71 [0.79 - 3.72]
GENE	BLVRA	biliverdin reductase A	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203773_x_at	90	0.888889	0.00571833	0.105145	1.2084	0.315639	0.450884	1.57 [0.65 - 3.79]
GENE	BLVRA	biliverdin reductase A	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211729_x_at	90	0.533333	0.00141252	0.0339978	1.04818	0.126417	0.61862	1.86 [0.84 - 4.10]
GENE	BLVRA	biliverdin reductase A	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203772_at	90	0.122222	0.081094	-	1.19849	0.133473	1.06732	2.91 [0.72 - 11.72]
GENE	BLVRA	biliverdin reductase A	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211729_x_at	90	0.533333	0.00237644	0.0521497	1.15766	0.161111	0.64743	1.91 [0.77 - 4.73]
GENE	BLVRA	biliverdin reductase A	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203771_s_at	90	0.8	0.00686512	0.121185	0.916603	0.660039	0.182576	1.20 [0.53 - 2.71]
GENE	BLVRA	biliverdin reductase A	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203771_s_at	90	0.8	0.00100603	0.0256141	1.19532	0.386544	0.411517	1.51 [0.59 - 3.83]
GENE	BLVRA	biliverdin reductase A	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203772_at	90	0.122222	0.0893113	-	1.5671	0.106204	1.22636	3.41 [0.77 - 15.09]
GENE	BLVRA	biliverdin reductase A	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2078	50	0.7	0.386308	-	-0.492211	0.988789	-0.0083683	0.99 [0.31 - 3.19]
GENE	BLVRA	biliverdin reductase A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211729_x_at	138	0.847826	0.049768	0.49023	0.566998	0.896448	0.0222306	1.02 [0.73 - 1.43]
GENE	BLVRA	biliverdin reductase A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203773_x_at	138	0.688406	0.164279	-	-0.379464	0.902206	0.0203993	1.02 [0.74 - 1.41]
GENE	BLVRA	biliverdin reductase A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	229109_s_at	138	0.731884	0.00941889	0.15433	0.635267	0.0181529	0.552549	1.74 [1.10 - 2.75]
GENE	BLVRA	biliverdin reductase A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203772_at	138	0.123188	0.0786266	-	-0.552327	0.663183	-0.519475	0.59 [0.06 - 6.16]
GENE	BLVRA	biliverdin reductase A	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203771_s_at	138	0.898551	0.0130143	0.196475	0.800994	0.497731	0.068107	1.07 [0.88 - 1.30]
GENE	BLVRA	biliverdin reductase A	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203771_s_at	129	0.852713	0.0541056	-	-0.80331	0.70225	-0.109517	0.90 [0.51 - 1.57]
GENE	BLVRA	biliverdin reductase A	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203773_x_at	129	0.775194	0.109515	-	0.466728	0.70511	0.159405	1.17 [0.51 - 2.68]
GENE	BLVRA	biliverdin reductase A	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211729_x_at	129	0.581395	0.0912049	-	0.417207	0.911443	-0.0532301	0.95 [0.37 - 2.42]
GENE	BLVRA	biliverdin reductase A	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203772_at	129	0.325581	0.185163	-	-0.3393	0.763156	0.054305	1.06 [0.74 - 1.50]
GENE	BLVRA	biliverdin reductase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36964	56	0.178571	0.237023	-	-0.462641	0.660876	0.198048	1.22 [0.50 - 2.95]
GENE	BLVRA	biliverdin reductase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2631	56	0.178571	0.0916693	-	-0.692564	0.842908	0.0802847	1.08 [0.49 - 2.40]
GENE	BLVRA	biliverdin reductase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7515	56	0.303571	0.0668104	-	0.703574	0.55781	0.206985	1.23 [0.62 - 2.46]
GENE	BLVRA	biliverdin reductase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36964	56	0.785714	0.113736	-	0.682303	0.469031	0.346251	1.41 [0.55 - 3.61]
GENE	BLVRA	biliverdin reductase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3949	56	0.339286	0.162647	-	-0.473454	0.837241	0.0823039	1.09 [0.50 - 2.38]
GENE	BLVRA	biliverdin reductase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	7515	56	0.303571	0.0556153	-	0.781164	0.381304	0.33188	1.39 [0.66 - 2.93]
GENE	BLVRA	biliverdin reductase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2631	56	0.303571	0.201346	-	-0.446499	0.912739	0.0416455	1.04 [0.49 - 2.20]
GENE	BLVRA	biliverdin reductase A	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3949	56	0.892857	0.147463	-	0.771064	0.647073	0.196823	1.22 [0.52 - 2.83]
GENE	BLVRA	biliverdin reductase A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203772_at	278	0.348921	0.00439157	0.0854276	-0.535518	0.0487703	-1.15234	0.32 [0.10 - 0.99]
GENE	BLVRA	biliverdin reductase A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203771_s_at	278	0.640288	0.0600422	-	-0.387695	0.417141	-0.107441	0.90 [0.69 - 1.16]
GENE	BLVRA	biliverdin reductase A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	229109_s_at	278	0.809353	0.0464759	0.470025	-0.532953	0.354218	-0.2508	0.78 [0.46 - 1.32]
GENE	BLVRA	biliverdin reductase A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211729_x_at	278	0.643885	0.0742301	-	-0.372803	0.329382	-0.144578	0.87 [0.65 - 1.16]
GENE	BLVRA	biliverdin reductase A	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203773_x_at	278	0.561151	0.0706478	-	-0.352311	0.345736	-0.138855	0.87 [0.65 - 1.16]
GENE	BLVRA	biliverdin reductase A	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203771_s_at	133	0.849624	0.0605782	-	-0.781404	0.503236	-0.181888	0.83 [0.49 - 1.42]
GENE	BLVRA	biliverdin reductase A	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203772_at	133	0.669173	0.00040694	0.0118792	0.826084	0.0092454	0.839771	2.32 [1.23 - 4.36]
GENE	BLVRA	biliverdin reductase A	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203773_x_at	133	0.105263	0.000660274	0.0179549	-1.06414	0.000377909	-0.54487	0.58 [0.43 - 0.78]
GENE	BLVRA	biliverdin reductase A	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211729_x_at	133	0.120301	1.40476e-05	0.000607535	-1.29061	0.00116021	-0.557904	0.57 [0.41 - 0.80]
GENE	BLVRA	biliverdin reductase A	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18073	81	0.888889	0.0806909	-	1.08603	0.850397	-0.0763249	0.93 [0.42 - 2.05]
GENE	BLVRA	biliverdin reductase A	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6046	81	0.839506	0.142678	-	0.8451	0.886779	0.0610763	1.06 [0.46 - 2.46]
GENE	BLVRA	biliverdin reductase A	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203773_x_at	185	0.508108	0.113647	-	0.279359	0.538613	0.11466	1.12 [0.78 - 1.62]
GENE	BLVRA	biliverdin reductase A	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203771_s_at	185	0.481081	0.0992016	-	0.268832	0.89212	0.0255746	1.03 [0.71 - 1.48]
GENE	BLVRA	biliverdin reductase A	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203772_at	185	0.405405	0.0249934	0.31297	-0.394277	0.378115	-0.301099	0.74 [0.38 - 1.45]
GENE	BLVRA	biliverdin reductase A	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211729_x_at	185	0.475676	0.0450015	0.460698	0.325903	0.57789	0.0975292	1.10 [0.78 - 1.55]
GENE	BLVRA	biliverdin reductase A	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203771_s_at	185	0.708108	0.154955	-	0.275563	0.792829	-0.0562611	0.95 [0.62 - 1.44]
GENE	BLVRA	biliverdin reductase A	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203773_x_at	185	0.508108	0.10493	-	0.263069	0.468182	0.124335	1.13 [0.81 - 1.58]
GENE	BLVRA	biliverdin reductase A	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211729_x_at	185	0.475676	0.0560959	-	0.338228	0.553103	0.11337	1.12 [0.77 - 1.63]
GENE	BLVRA	biliverdin reductase A	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203772_at	185	0.405405	0.0927388	-	-0.274889	0.376105	-0.272909	0.76 [0.42 - 1.39]
GENE	BLVRA	biliverdin reductase A	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P71148	110	0.772727	0.0587708	-	0.620259	0.510069	0.163117	1.18 [0.72 - 1.91]
GENE	BLVRA	biliverdin reductase A	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P71148	110	0.763636	0.111294	-	0.417802	0.992278	0.00203662	1.00 [0.66 - 1.51]
GENE	BLVRA	biliverdin reductase A	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203771_s_at	80	0.5625	0.121558	-	-0.731862	0.8281	0.054173	1.06 [0.65 - 1.72]
GENE	BLVRA	biliverdin reductase A	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203772_at	80	0.325	0.00199818	0.0452611	2.08412	0.129877	0.23861	1.27 [0.93 - 1.73]
GENE	BLVRA	biliverdin reductase A	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203773_x_at	80	0.2875	0.00647976	0.115887	-1.20324	0.114694	-0.616982	0.54 [0.25 - 1.16]
GENE	BLVRA	biliverdin reductase A	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211729_x_at	80	0.25	0.186716	-	-0.655136	0.343259	-0.442466	0.64 [0.26 - 1.60]
GENE	BLVRA	biliverdin reductase A	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_2117	281	0.47331	0.0565331	-	-0.266657	0.357835	-0.0878423	0.92 [0.76 - 1.10]
GENE	BLVRA	biliverdin reductase A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203773_x_at	38	0.815789	0.0226088	0.291999	1.1216	0.38019	0.496033	1.64 [0.54 - 4.97]
GENE	BLVRA	biliverdin reductase A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	229109_s_at	38	0.184211	0.137256	-	1.07323	0.403195	0.384898	1.47 [0.60 - 3.62]
GENE	BLVRA	biliverdin reductase A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203772_at	38	0.842105	0.0020567	0.0463444	1.5848	0.11067	1.60335	4.97 [0.69 - 35.64]
GENE	BLVRA	biliverdin reductase A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203771_s_at	38	0.894737	0.000129625	0.00439963	2.09942	0.0588138	0.969768	2.64 [0.96 - 7.21]
GENE	BLVRA	biliverdin reductase A	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211729_x_at	38	0.842105	0.0519927	-	1.00655	0.239619	0.649402	1.91 [0.65 - 5.65]
GENE	BLVRA	biliverdin reductase A	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211729_x_at	140	0.435714	0.00596086	0.108608	-0.786746	0.219246	-0.40078	0.67 [0.35 - 1.27]
GENE	BLVRA	biliverdin reductase A	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203771_s_at	140	0.214286	0.0659873	-	-0.59235	0.530378	-0.18418	0.83 [0.47 - 1.48]
GENE	BLVRA	biliverdin reductase A	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203772_at	140	0.85	0.0811244	-	-0.882814	0.992719	-0.0119184	0.99 [0.08 - 12.78]
GENE	BLVRA	biliverdin reductase A	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203773_x_at	140	0.428571	0.0438477	0.453274	-0.577825	0.301866	-0.331954	0.72 [0.38 - 1.35]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202201_at	30	0.166667	0.136318	-	0.893007	0.498813	0.234507	1.26 [0.64 - 2.49]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1797793	165	0.89697	8.60062e-05	0.00306631	1.15726	0.06801	0.298296	1.35 [0.98 - 1.86]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1797793	165	0.89697	0.00435946	0.0849322	1.1609	0.385034	0.20005	1.22 [0.78 - 1.92]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202201_at	163	0.226994	3.1156e-05	0.00124318	-0.877938	0.00126378	-0.366282	0.69 [0.55 - 0.87]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202201_at	79	0.189873	0.00999482	0.161398	-0.84356	0.0339858	-0.237319	0.79 [0.63 - 0.98]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202201_at	58	0.344828	0.000893514	0.0231848	-1.00126	0.0033849	-0.339092	0.71 [0.57 - 0.89]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202201_at	34	0.676471	0.0284284	0.34167	-0.936049	0.0760484	-0.351042	0.70 [0.48 - 1.04]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202201_at	158	0.202532	0.00563267	0.103913	-0.701526	0.0606222	-0.742117	0.48 [0.22 - 1.03]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202201_at	53	0.188679	0.0983975	-	0.856332	0.841729	0.0612127	1.06 [0.58 - 1.94]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202201_at	53	0.886792	0.0747866	-	-1.63092	0.885731	0.0480441	1.05 [0.54 - 2.02]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202201_at	180	0.705556	0.0148659	0.216582	0.524964	0.242417	0.204575	1.23 [0.87 - 1.73]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202201_at	559	0.157424	0.0078664	0.134563	0.902701	0.0454479	0.35648	1.43 [1.01 - 2.03]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202201_at	77	0.818182	0.000422071	0.0122572	1.07145	0.817775	0.0561382	1.06 [0.66 - 1.71]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202201_at	70	0.157143	0.0682078	-	0.723142	0.686795	0.0999989	1.11 [0.68 - 1.80]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37002_at	50	0.74	0.00748535	0.129535	0.995978	0.219829	0.371211	1.45 [0.80 - 2.62]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202201_at	74	0.72973	0.00300111	0.0630091	0.912881	0.231756	0.333247	1.40 [0.81 - 2.41]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202201_at	67	0.537313	0.00013874	0.00466974	16.8155	0.0127965	3.03783	20.86 [1.91 - 228.07]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202201_at	115	0.878261	0.029026	0.346496	1.21165	0.45041	0.32056	1.38 [0.60 - 3.17]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37002_at	158	0.886076	0.00212626	0.0476235	1.05402	0.290238	0.303628	1.35 [0.77 - 2.38]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37002_at	76	0.697368	0.231177	-	0.6117	0.770507	0.150197	1.16 [0.42 - 3.19]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202201_at	204	0.132353	0.0406586	0.432154	-0.428156	0.832393	-0.0240649	0.98 [0.78 - 1.22]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202201_at	87	0.666667	0.0244807	0.308537	0.82756	0.422482	0.218067	1.24 [0.73 - 2.12]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202201_at	87	0.666667	0.0244807	0.308537	0.82756	0.422482	0.218067	1.24 [0.73 - 2.12]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202201_at	77	0.467532	0.0212373	0.279508	-1.6347	0.104903	-0.716829	0.49 [0.21 - 1.16]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202201_at	77	0.103896	0.102828	-	-1.02907	0.754715	-0.117104	0.89 [0.43 - 1.85]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202201_at	136	0.845588	0.0467721	0.471877	0.937842	0.447823	0.310439	1.36 [0.61 - 3.04]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202201_at	200	0.87	0.0193522	0.261777	0.814211	0.157609	0.388486	1.47 [0.86 - 2.53]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13396	60	0.416667	0.173245	-	0.542493	0.525375	0.159462	1.17 [0.72 - 1.92]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13396	60	0.566667	0.0916196	-	0.631472	0.251761	0.350368	1.42 [0.78 - 2.58]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12573	155	0.167742	0.0572691	-	-0.60061	0.999543	0.000110028	1.00 [0.69 - 1.46]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202201_at	286	0.185315	0.0768525	-	-0.407415	0.876804	0.025445	1.03 [0.74 - 1.42]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202201_at	159	0.754717	0.000140886	0.00473296	1.15163	0.0351549	0.461844	1.59 [1.03 - 2.44]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202201_at	159	0.899371	0.00108841	0.0273597	1.32257	0.0399956	0.516571	1.68 [1.02 - 2.74]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202201_at	159	0.899371	0.00439514	0.0854825	1.07577	0.0605248	0.416047	1.52 [0.98 - 2.34]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202201_at	54	0.759259	0.0263213	0.324266	1.44747	0.581326	0.297051	1.35 [0.47 - 3.87]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202201_at	117	0.641026	0.131957	-	0.478789	0.389498	0.161782	1.18 [0.81 - 1.70]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202201_at	117	0.641026	0.0878277	-	0.637769	0.347365	0.209406	1.23 [0.80 - 1.91]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202201_at	117	0.641026	0.131957	-	0.478789	0.389498	0.161782	1.18 [0.81 - 1.70]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202201_at	117	0.495726	0.138888	-	0.589333	0.446154	0.178055	1.19 [0.76 - 1.89]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202201_at	236	0.228814	0.316004	-	-0.302962	0.886095	-0.0348261	0.97 [0.60 - 1.56]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202201_at	249	0.855422	0.0934028	-	0.450441	0.630399	0.0916946	1.10 [0.75 - 1.59]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202201_at	62	0.112903	0.164793	-	15.1649	0.619281	0.171962	1.19 [0.60 - 2.34]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202201_at	125	0.176	0.126012	-	-0.657339	0.678142	0.124863	1.13 [0.63 - 2.04]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202201_at	125	0.672	0.155029	-	0.411803	0.683991	0.0919411	1.10 [0.70 - 1.71]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202201_at	54	0.888889	0.192399	-	0.989532	0.325589	0.465462	1.59 [0.63 - 4.03]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202201_at	198	0.888889	0.0929716	-	0.574619	0.737185	0.048629	1.05 [0.79 - 1.39]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202201_at	198	0.888889	0.103704	-	0.561098	0.794662	0.0387499	1.04 [0.78 - 1.39]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202201_at	198	0.888889	0.0296925	0.351823	0.627867	0.156817	0.1696	1.18 [0.94 - 1.50]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202201_at	51	0.137255	0.0569767	-	-1.57489	0.551708	-0.552377	0.58 [0.09 - 3.55]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202201_at	62	0.145161	0.0240281	0.304591	-1.29348	0.359091	-0.559491	0.57 [0.17 - 1.89]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202201_at	177	0.129944	0.0635045	-	0.937172	0.837986	-0.0565531	0.95 [0.55 - 1.63]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202201_at	177	0.355932	0.0422333	0.442695	-0.47584	0.916838	0.0249871	1.03 [0.64 - 1.64]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202201_at	145	0.737931	0.0938207	-	-0.787401	0.936254	0.0265025	1.03 [0.54 - 1.97]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202201_at	226	0.628319	0.0941562	-	-0.533808	0.783824	-0.0667125	0.94 [0.58 - 1.51]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202201_at	55	0.872727	0.00476885	0.0911786	1.37739	0.0690745	1.01447	2.76 [0.92 - 8.23]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202201_at	55	0.872727	0.00834039	0.140716	1.39313	0.203857	0.7249	2.06 [0.67 - 6.32]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202201_at	49	0.897959	0.016879	0.237429	1.4785	0.254648	0.803749	2.23 [0.56 - 8.91]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202201_at	63	0.460317	0.0726983	-	0.631531	0.691648	0.0875005	1.09 [0.71 - 1.68]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502418_3p_at	28	0.892857	0.187708	-	-15.2153	0.577361	-0.186253	0.83 [0.43 - 1.60]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202201_at	82	0.207317	0.253996	-	-0.442308	0.811778	-0.0734377	0.93 [0.51 - 1.70]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37002_at	84	0.25	0.100438	-	-0.516523	0.592868	-0.136157	0.87 [0.53 - 1.44]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202201_at	79	0.898734	1.49318e-06	7.87122e-05	1.76632	0.00363063	0.76613	2.15 [1.28 - 3.61]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202201_at	104	0.798077	0.084289	-	0.609698	0.438496	0.20606	1.23 [0.73 - 2.07]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P153351	117	0.25641	0.0450689	0.461128	-0.593992	0.161417	-0.328149	0.72 [0.46 - 1.14]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202201_at	204	0.720588	0.0261912	0.32317	0.611385	0.164612	0.4413	1.55 [0.83 - 2.90]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202201_at	204	0.75	0.00843011	0.141868	0.937193	0.256387	0.49433	1.64 [0.70 - 3.85]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202201_at	178	0.382022	0.01112	0.174836	-0.499912	0.915688	0.0207421	1.02 [0.70 - 1.50]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200006276	41	0.219512	0.156375	-	0.853724	0.346296	0.400647	1.49 [0.65 - 3.44]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202201_at	111	0.351351	0.126	-	-0.407306	0.226267	-0.211438	0.81 [0.57 - 1.14]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202201_at	90	0.111111	0.14381	-	-0.640313	0.551279	-0.149456	0.86 [0.53 - 1.41]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202201_at	90	0.111111	0.0305442	0.358549	-0.956138	0.202992	-0.376451	0.69 [0.38 - 1.23]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202201_at	138	0.181159	0.00935672	0.153559	1.06532	0.193352	0.143846	1.15 [0.93 - 1.43]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202201_at	129	0.372093	0.0627758	-	0.510562	0.456294	0.140949	1.15 [0.79 - 1.67]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44765	56	0.107143	0.00800846	0.136418	-1.17757	0.430129	-0.170532	0.84 [0.55 - 1.29]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9365	56	0.642857	0.110543	-	-0.565715	0.383586	-0.19108	0.83 [0.54 - 1.27]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44765	56	0.107143	0.0512331	-	-0.947169	0.74674	-0.0698872	0.93 [0.61 - 1.43]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9365	56	0.517857	0.12845	-	-0.543106	0.699648	-0.0844992	0.92 [0.60 - 1.41]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202201_at	278	0.874101	0.0212271	0.279413	0.565528	0.313212	0.152927	1.17 [0.87 - 1.57]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202201_at	133	0.443609	0.144589	-	0.348559	0.923877	0.010228	1.01 [0.82 - 1.25]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	6318	81	0.851852	0.266434	-	0.71204	0.647749	0.176852	1.19 [0.56 - 2.55]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202201_at	185	0.556757	0.10416	-	0.262953	0.513308	0.076997	1.08 [0.86 - 1.36]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202201_at	185	0.227027	0.227485	-	-0.238994	0.781578	0.0362353	1.04 [0.80 - 1.34]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P153351	110	0.790909	0.0661789	-	0.477303	0.306008	0.160906	1.17 [0.86 - 1.60]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P153351	110	0.272727	0.0750932	-	0.632282	0.222985	0.22378	1.25 [0.87 - 1.79]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202201_at	80	0.15	0.0703584	-	-0.912611	0.364615	-0.306912	0.74 [0.38 - 1.43]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_1825	281	0.604982	0.00956892	0.156184	-0.378478	0.0526731	-0.208774	0.81 [0.66 - 1.00]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202201_at	38	0.157895	0.128094	-	1.1236	0.452122	0.296277	1.34 [0.62 - 2.91]
GENE	BLVRB	biliverdin reductase B (flavin reductase (NADPH))	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202201_at	140	0.2	0.000152309	0.00506728	-1.0913	0.0252153	-0.544589	0.58 [0.36 - 0.93]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203502_at	30	0.7	0.340132	-	0.420498	0.962054	-0.0111297	0.99 [0.63 - 1.56]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1734562	165	0.30303	0.263547	-	0.301184	0.529686	0.085038	1.09 [0.84 - 1.42]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1734562	165	0.175758	0.146127	-	0.856528	0.571406	0.112027	1.12 [0.76 - 1.65]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203502_at	163	0.472393	0.00132504	0.0322392	-0.629333	0.0148346	-0.217434	0.80 [0.68 - 0.96]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203502_at	79	0.455696	0.00349156	0.0711616	-0.840037	0.0168406	-0.256193	0.77 [0.63 - 0.95]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203502_at	58	0.396552	0.000988299	0.0252348	-0.955315	0.0195424	-0.469992	0.63 [0.42 - 0.93]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203502_at	34	0.264706	0.197374	-	0.637607	0.705788	-0.0708222	0.93 [0.64 - 1.35]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203502_at	158	0.873418	0.0220299	0.286766	0.690267	0.900748	0.0408891	1.04 [0.55 - 1.98]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203502_at	53	0.773585	0.130402	-	0.566297	0.652036	0.239349	1.27 [0.45 - 3.60]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203502_at	53	0.886792	0.196633	-	0.624361	0.969368	-0.0210671	0.98 [0.33 - 2.87]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203502_at	180	0.7	0.156778	-	0.305078	0.893183	0.0378594	1.04 [0.60 - 1.80]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203502_at	559	0.352415	0.313188	-	0.219758	0.555179	0.180836	1.20 [0.66 - 2.18]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203502_at	77	0.337662	0.000109025	0.0037791	1.20177	0.0209333	0.769435	2.16 [1.12 - 4.15]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203502_at	70	0.671429	0.0155523	0.223802	0.666803	0.258566	0.233953	1.26 [0.84 - 1.90]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33759_at	50	0.78	0.171941	-	0.534876	0.749845	0.145087	1.16 [0.47 - 2.82]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203502_at	74	0.202703	0.0440075	0.454309	0.806292	0.276691	0.632023	1.88 [0.60 - 5.88]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203502_at	67	0.119403	0.0286016	0.343074	-1.46512	0.395095	-0.742154	0.48 [0.09 - 2.63]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203502_at	115	0.773913	0.0353524	0.394897	-15.446	0.586175	-0.391417	0.68 [0.17 - 2.77]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33759_at	158	0.291139	0.0222102	0.288402	-0.642684	0.45727	-0.227134	0.80 [0.44 - 1.45]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33759_at	76	0.868421	0.042172	0.442289	1.13686	0.722207	0.244343	1.28 [0.33 - 4.91]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203502_at	204	0.892157	0.255577	-	0.260541	0.847845	0.0417389	1.04 [0.68 - 1.60]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203502_at	87	0.390805	0.154596	-	-0.532865	0.89293	0.0570569	1.06 [0.46 - 2.43]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203502_at	87	0.390805	0.154596	-	-0.532865	0.89293	0.0570569	1.06 [0.46 - 2.43]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203502_at	77	0.363636	0.012572	0.191525	-1.56478	0.0748741	-1.03116	0.36 [0.11 - 1.11]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203502_at	77	0.714286	0.013798	0.205103	-15.6342	0.0973997	-0.838809	0.43 [0.16 - 1.17]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203502_at	136	0.639706	0.188538	-	-0.721105	0.981479	-0.0182732	0.98 [0.21 - 4.59]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203502_at	200	0.12	0.000644713	0.0175952	-1.12836	0.0692731	-0.870892	0.42 [0.16 - 1.07]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	22304	60	0.666667	0.105792	-	0.63146	0.73441	0.123736	1.13 [0.55 - 2.31]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	22304	60	0.65	0.01688	0.237439	0.938666	0.26799	0.590594	1.81 [0.63 - 5.13]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5700	155	0.56129	0.091147	-	-0.481728	0.198505	-0.221811	0.80 [0.57 - 1.12]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203502_at	286	0.846154	0.000103874	0.00362151	0.831956	0.00620429	0.934618	2.55 [1.30 - 4.97]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203502_at	159	0.125786	0.187339	-	-0.542063	0.596571	-0.282206	0.75 [0.27 - 2.14]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203502_at	159	0.125786	0.0979896	-	-0.743011	0.406401	-0.525974	0.59 [0.17 - 2.05]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203502_at	159	0.125786	0.0697871	-	-0.703648	0.29015	-0.569176	0.57 [0.20 - 1.62]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203502_at	54	0.111111	0.175363	-	15.346	0.614706	0.267027	1.31 [0.46 - 3.69]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203502_at	117	0.273504	0.0829132	-	0.709223	0.512842	0.139858	1.15 [0.76 - 1.75]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203502_at	117	0.282051	0.0592118	-	0.980004	0.771231	0.0749843	1.08 [0.65 - 1.79]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203502_at	117	0.273504	0.0829132	-	0.709223	0.512842	0.139858	1.15 [0.76 - 1.75]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203502_at	117	0.290598	0.10976	-	0.83717	0.938176	0.0205691	1.02 [0.61 - 1.72]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203502_at	236	0.114407	0.044478	0.457343	1.3442	0.635007	0.214835	1.24 [0.51 - 3.01]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203502_at	249	0.626506	0.240812	-	0.253128	0.886477	-0.0544015	0.95 [0.45 - 2.00]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203502_at	62	0.112903	0.000111603	0.00385759	-1.74188	0.258878	-0.269809	0.76 [0.48 - 1.22]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203502_at	125	0.12	0.000483147	0.013761	-1.38062	0.606657	-0.250362	0.78 [0.30 - 2.02]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203502_at	125	0.312	0.0184688	0.253229	-0.717666	0.987028	0.00577112	1.01 [0.50 - 2.02]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203502_at	54	0.111111	0.00750108	0.129744	-1.56628	0.288327	-0.308232	0.73 [0.42 - 1.30]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203502_at	198	0.186869	0.177777	-	-0.410662	0.765505	0.0782547	1.08 [0.65 - 1.81]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203502_at	198	0.186869	0.149058	-	-0.456353	0.627713	0.137142	1.15 [0.66 - 2.00]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203502_at	198	0.565657	0.189572	-	-0.283199	0.94123	-0.0159652	0.98 [0.64 - 1.50]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203502_at	51	0.72549	0.160146	-	-15.5436	0.314079	-1.53366	0.22 [0.01 - 4.27]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203502_at	62	0.322581	0.372518	-	-0.517214	0.702149	0.235928	1.27 [0.38 - 4.24]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203502_at	177	0.101695	0.10834	-	0.930842	0.371657	0.240558	1.27 [0.75 - 2.16]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203502_at	177	0.502825	0.0241384	0.305556	0.533934	0.231428	0.27941	1.32 [0.84 - 2.09]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203502_at	145	0.786207	0.367691	-	0.334986	0.737532	0.113881	1.12 [0.58 - 2.18]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203502_at	226	0.685841	0.0375158	0.410425	0.58711	0.0736227	0.596882	1.82 [0.94 - 3.49]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203502_at	55	0.345455	0.00820228	0.138934	1.74376	0.15863	0.688439	1.99 [0.76 - 5.18]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203502_at	55	0.345455	0.22576	-	0.671474	0.7537	0.186002	1.20 [0.38 - 3.85]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203502_at	49	0.102041	0.0196277	0.264411	-1.77903	0.719588	0.240148	1.27 [0.34 - 4.72]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203502_at	63	0.587302	0.0742595	-	0.596037	0.283473	0.234327	1.26 [0.82 - 1.94]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502444_3p_at	28	0.571429	0.0268916	0.329038	1.23896	0.0953329	0.238759	1.27 [0.96 - 1.68]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203502_at	82	0.756098	0.0550092	-	-0.899648	0.177904	-0.511753	0.60 [0.28 - 1.26]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33759_at	84	0.440476	0.0889715	-	-0.492037	0.746489	-0.0986123	0.91 [0.50 - 1.65]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203502_at	79	0.835443	0.0612068	-	0.6011	0.147525	0.373367	1.45 [0.88 - 2.41]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X04327_at	86	0.895349	0.206638	-	0.777715	0.850583	-0.0796899	0.92 [0.40 - 2.12]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203502_at	104	0.5	0.0399562	0.42738	-0.677126	0.199725	-0.519614	0.59 [0.27 - 1.32]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P70843	117	0.57265	0.194572	-	0.369045	0.6951	0.0807803	1.08 [0.72 - 1.62]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203502_at	204	0.897059	0.0639106	-	0.826354	0.253404	0.501623	1.65 [0.70 - 3.91]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203502_at	204	0.735294	0.0701912	-	0.511539	0.237884	0.380391	1.46 [0.78 - 2.75]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203502_at	178	0.123596	0.0387777	0.419264	-0.595891	0.795377	0.069481	1.07 [0.63 - 1.81]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200014812	41	0.658537	0.152979	-	0.595116	0.430796	0.320254	1.38 [0.62 - 3.06]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203502_at	111	0.135135	0.0157922	0.226299	-0.792952	0.315991	-0.299253	0.74 [0.41 - 1.33]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203502_at	90	0.377778	0.071538	-	-0.578726	0.361259	-0.27889	0.76 [0.42 - 1.38]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203502_at	90	0.377778	0.0957475	-	-0.61086	0.454366	-0.261216	0.77 [0.39 - 1.53]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203502_at	138	0.326087	0.00458627	0.088411	0.807347	0.00258781	0.41087	1.51 [1.15 - 1.97]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203502_at	129	0.891473	0.0713736	-	0.612232	0.558989	0.222569	1.25 [0.59 - 2.64]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41770	56	0.428571	0.37407	-	-0.300741	0.976103	-0.00660009	0.99 [0.65 - 1.53]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	41770	56	0.196429	0.107237	-	0.847356	0.371001	0.205226	1.23 [0.78 - 1.92]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203502_at	278	0.471223	0.0518372	-	0.36539	0.398908	0.111383	1.12 [0.86 - 1.45]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203502_at	133	0.849624	0.0051833	0.0973597	-1.13695	0.0669771	-0.283201	0.75 [0.56 - 1.02]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4791	81	0.209877	0.00226294	0.0501101	-1.46127	0.400367	-0.442929	0.64 [0.23 - 1.80]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16878	81	0.296296	0.00153069	0.0363386	-1.54879	0.780475	-0.13352	0.88 [0.34 - 2.24]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203502_at	185	0.405405	0.130583	-	-0.268592	0.740244	-0.08964	0.91 [0.54 - 1.55]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203502_at	185	0.897297	0.217471	-	0.3275	0.921019	0.0245188	1.02 [0.63 - 1.66]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P70843	110	0.872727	0.0257259	0.319233	0.697338	0.898589	0.0268944	1.03 [0.68 - 1.55]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P70843	110	0.354545	0.057801	-	0.648622	0.473754	0.184637	1.20 [0.73 - 1.99]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203502_at	80	0.85	0.118587	-	0.7414	0.893772	-0.0415745	0.96 [0.52 - 1.77]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_2995	281	0.44484	0.0723542	-	-0.251362	0.876199	-0.0184471	0.98 [0.78 - 1.24]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203502_at	38	0.368421	0.0228513	0.294174	1.19386	0.0758135	0.831015	2.30 [0.92 - 5.75]
GENE	BPGM	2,3-bisphosphoglycerate mutase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203502_at	140	0.271429	0.0170418	0.239073	0.906627	0.980662	0.0103058	1.01 [0.44 - 2.32]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219391_at	30	0.133333	0.0329747	0.377254	-1.27534	0.757337	-0.312599	0.73 [0.10 - 5.31]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1712718	165	0.672727	0.0305565	0.358645	-0.5886	0.39655	-0.140908	0.87 [0.63 - 1.20]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1712718	165	0.606061	0.00621843	0.112242	-1.17367	0.0994294	-0.376186	0.69 [0.44 - 1.07]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219391_at	163	0.588957	0.100142	-	-0.33493	0.660076	-0.248346	0.78 [0.26 - 2.36]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	232103_at	163	0.153374	0.0262485	0.323654	0.696167	0.11621	0.493167	1.64 [0.89 - 3.03]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1554575_a_at	79	0.873418	0.0475859	0.476931	0.753204	0.0947999	1.0862	2.96 [0.83 - 10.60]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219391_at	79	0.113924	0.0110241	0.173709	-0.967598	0.712404	-0.342149	0.71 [0.12 - 4.38]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	232103_at	79	0.848101	0.000519066	0.0146303	1.18926	0.0968924	0.46335	1.59 [0.92 - 2.75]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219391_at	58	0.655172	0.000166907	0.0054894	1.14722	0.0265078	0.359672	1.43 [1.04 - 1.97]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219391_at	34	0.588235	0.0418238	0.439976	-0.815893	0.193932	-0.267999	0.76 [0.51 - 1.15]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219391_at	158	0.341772	0.0669233	-	0.468544	0.312489	0.801828	2.23 [0.47 - 10.57]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219391_at	53	0.226415	0.109519	-	0.835685	0.445629	0.150801	1.16 [0.79 - 1.71]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219391_at	53	0.283019	0.227123	-	0.484314	0.774697	0.0536783	1.06 [0.73 - 1.52]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219391_at	180	0.833333	0.000298224	0.00908946	0.858704	0.0959109	0.157632	1.17 [0.97 - 1.41]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	232103_at	180	0.883333	0.131362	-	-0.584785	0.517987	-0.11909	0.89 [0.62 - 1.27]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1554575_a_at	559	0.493739	0.0371709	0.407982	0.428679	0.285171	0.115211	1.12 [0.91 - 1.39]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219391_at	559	0.896243	0.0352059	0.393828	-0.861241	0.83967	-0.0315175	0.97 [0.71 - 1.31]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	232103_at	559	0.695886	0.0228335	0.294015	0.45449	0.19014	0.34592	1.41 [0.84 - 2.37]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219391_at	77	0.194805	0.0679907	-	-0.557237	0.335621	-0.157262	0.85 [0.62 - 1.18]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	232103_at	77	0.74026	0.110059	-	0.456971	0.750598	0.125256	1.13 [0.52 - 2.45]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1554575_a_at	70	0.6	0.117577	-	-0.435094	0.323721	-0.785962	0.46 [0.10 - 2.17]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219391_at	70	0.857143	0.000362686	0.0107602	1.26026	0.183276	1.55657	4.74 [0.48 - 46.95]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	232103_at	70	0.842857	0.0406303	0.431963	-0.805477	0.131462	-0.437117	0.65 [0.37 - 1.14]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219391_at	74	0.851351	0.00645282	0.115513	0.921813	0.777737	0.0505104	1.05 [0.74 - 1.49]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	232103_at	74	0.513514	0.0206502	0.274057	-0.67965	0.310326	-0.602077	0.55 [0.17 - 1.75]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219391_at	67	0.343284	0.200008	-	1.28801	0.709086	1.42588	4.16 [0.00 - 7456.07]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	232103_at	67	0.492537	0.0593191	-	1.40169	0.500892	0.933389	2.54 [0.17 - 38.53]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1554575_a_at	67	0.104478	0.050806	-	-1.49903	0.412159	-1.6307	0.20 [0.00 - 9.65]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219391_at	115	0.547826	0.126474	-	0.826225	0.829887	0.10369	1.11 [0.43 - 2.86]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	232103_at	115	0.130435	0.0784371	-	-1.00115	0.65416	-0.331966	0.72 [0.17 - 3.07]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1554575_a_at	115	0.313043	0.123104	-	-0.804409	0.996201	-0.00292128	1.00 [0.30 - 3.32]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1554575_a_at	204	0.627451	0.0515603	-	0.281426	0.466938	0.0897736	1.09 [0.86 - 1.39]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219391_at	204	0.857843	0.130367	-	-0.306049	0.558839	-0.0419765	0.96 [0.83 - 1.10]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	232103_at	204	0.220588	0.161282	-	0.2345	0.709457	0.0629358	1.06 [0.76 - 1.48]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1554575_a_at	87	0.609195	0.0210128	0.27743	0.861999	0.401459	0.28791	1.33 [0.68 - 2.61]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1554575_a_at	87	0.609195	0.0210128	0.27743	0.861999	0.401459	0.28791	1.33 [0.68 - 2.61]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219391_at	87	0.37931	0.0937734	-	0.716767	0.56829	0.550575	1.73 [0.26 - 11.49]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219391_at	87	0.37931	0.0937734	-	0.716767	0.56829	0.550575	1.73 [0.26 - 11.49]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	232103_at	87	0.206897	0.0372757	0.408725	-0.850455	0.491822	-0.263578	0.77 [0.36 - 1.63]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	232103_at	87	0.206897	0.0372757	0.408725	-0.850455	0.491822	-0.263578	0.77 [0.36 - 1.63]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554575_a_at	77	0.480519	0.00111168	0.0278483	16.271	0.00800002	1.7102	5.53 [1.56 - 19.57]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	232103_at	77	0.428571	0.112461	-	1.00281	0.673036	0.212881	1.24 [0.46 - 3.33]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219391_at	77	0.103896	0.0192725	0.261012	-1.47873	0.556492	-1.33933	0.26 [0.00 - 22.75]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	232103_at	77	0.545455	0.0190836	0.259195	1.65724	0.195823	0.720864	2.06 [0.69 - 6.13]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554575_a_at	77	0.480519	0.0105583	0.168187	1.74106	0.0348772	1.14977	3.16 [1.09 - 9.19]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219391_at	77	0.727273	0.0758042	-	0.95302	0.822724	0.418549	1.52 [0.04 - 59.15]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219391_at	136	0.102941	0.000214186	0.00682227	-1.57275	0.0553264	-0.423269	0.65 [0.42 - 1.01]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219391_at	200	0.895	0.0858269	-	0.696705	0.793855	-0.044352	0.96 [0.69 - 1.33]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10332	60	0.533333	0.00663799	0.118073	1.05759	0.230894	0.43886	1.55 [0.76 - 3.18]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	10332	60	0.816667	0.000305281	0.00927495	1.37578	0.00182929	1.69541	5.45 [1.88 - 15.83]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1926	155	0.851613	0.136636	-	0.551135	0.713874	0.0697989	1.07 [0.74 - 1.56]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219391_at	286	0.388112	0.033013	0.377543	-0.411045	0.0694724	-0.180597	0.83 [0.69 - 1.01]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219391_at	159	0.100629	0.0893901	-	1.55794	0.265874	0.27026	1.31 [0.81 - 2.11]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219391_at	159	0.704403	0.0164709	0.233282	0.745062	0.0638562	0.492141	1.64 [0.97 - 2.75]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219391_at	159	0.100629	0.197025	-	1.23331	0.389384	0.242915	1.27 [0.73 - 2.22]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232103_at	159	0.36478	0.00220105	0.0489884	1.26944	0.0519226	0.757609	2.13 [0.99 - 4.58]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232103_at	159	0.383648	0.00251615	0.0546303	1.18732	0.0108412	1.01065	2.75 [1.26 - 5.98]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232103_at	159	0.383648	0.000884276	0.0229829	1.78274	0.0135525	1.07915	2.94 [1.25 - 6.93]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219391_at	54	0.166667	0.0881237	-	15.4766	0.708884	-0.429624	0.65 [0.07 - 6.21]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219391_at	117	0.897436	0.0455499	0.464188	-1.78168	0.292941	-1.0323	0.36 [0.05 - 2.44]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219391_at	117	0.794872	0.119688	-	0.628824	0.757452	-0.340776	0.71 [0.08 - 6.18]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219391_at	117	0.897436	0.0455499	0.464188	-1.78168	0.292941	-1.0323	0.36 [0.05 - 2.44]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219391_at	117	0.897436	0.12119	-	-1.44919	0.593796	-0.579316	0.56 [0.07 - 4.71]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219391_at	236	0.15678	0.090387	-	-0.531269	0.610117	-0.084916	0.92 [0.66 - 1.27]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	232103_at	236	0.885593	0.0716162	-	0.647814	0.520284	0.239635	1.27 [0.61 - 2.64]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219391_at	249	0.746988	0.0586277	-	-0.516579	0.947632	-0.0087047	0.99 [0.76 - 1.29]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	232103_at	249	0.883534	0.00865401	0.144728	0.750482	0.203502	0.356974	1.43 [0.82 - 2.48]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219391_at	125	0.544	0.224373	-	0.473165	0.639923	0.365925	1.44 [0.31 - 6.68]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219391_at	125	0.12	0.243586	-	-0.513383	0.944524	-0.0426514	0.96 [0.29 - 3.19]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219391_at	54	0.240741	0.239058	-	1.16536	0.721264	-0.2505	0.78 [0.20 - 3.08]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219391_at	62	0.774194	0.0927628	-	-1.06958	0.506472	-0.39132	0.68 [0.21 - 2.15]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219391_at	198	0.464646	0.044237	0.455791	-0.423258	0.358764	-0.0663183	0.94 [0.81 - 1.08]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219391_at	198	0.121212	0.276071	-	0.504154	0.798878	-0.0225469	0.98 [0.82 - 1.16]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219391_at	198	0.570707	0.160166	-	-0.389578	0.503235	-0.061354	0.94 [0.79 - 1.13]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219391_at	51	0.862745	0.0830895	-	1.45188	0.834033	0.814411	2.26 [0.00 - 4594.33]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219391_at	62	0.322581	0.106152	-	-0.903391	0.935882	0.193793	1.21 [0.01 - 136.36]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	232103_at	177	0.485876	0.080578	-	0.411475	0.819634	0.0510859	1.05 [0.68 - 1.63]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	232103_at	177	0.446328	0.22171	-	0.3352	0.70251	-0.0998994	0.90 [0.54 - 1.51]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	232103_at	145	0.2	0.075549	-	0.913131	0.885743	0.0458518	1.05 [0.56 - 1.96]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219391_at	177	0.694915	0.0161534	0.230029	-0.853944	0.0391761	-1.96408	0.14 [0.02 - 0.91]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1554575_a_at	177	0.19774	0.206173	-	0.427505	0.975928	0.00845809	1.01 [0.58 - 1.75]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1554575_a_at	177	0.514124	0.308927	-	-0.277512	0.650485	-0.147493	0.86 [0.46 - 1.63]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219391_at	177	0.870057	0.00808513	0.137416	-1.6915	0.0852265	-1.38653	0.25 [0.05 - 1.21]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1554575_a_at	145	0.117241	0.149282	-	1.00672	0.53291	-0.260701	0.77 [0.34 - 1.75]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219391_at	145	0.696552	0.0046685	0.089661	-1.39044	0.109591	-1.85206	0.16 [0.02 - 1.52]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	232103_at	226	0.106195	0.0209981	0.277294	-0.7952	0.168296	-0.387947	0.68 [0.39 - 1.18]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1554575_a_at	226	0.225664	0.0665021	-	-0.542501	0.347632	-0.135222	0.87 [0.66 - 1.16]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219391_at	226	0.216814	0.0187121	0.2556	1.16155	0.251748	0.199727	1.22 [0.87 - 1.72]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1554575_a_at	49	0.755102	0.0566689	-	1.07064	0.512916	0.608212	1.84 [0.30 - 11.36]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1554575_a_at	55	0.636364	0.016953	0.238177	1.03171	0.232127	0.864335	2.37 [0.57 - 9.80]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219391_at	55	0.309091	0.00474255	0.0907817	-1.20103	0.059562	-2.75196	0.06 [0.00 - 1.12]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	232103_at	55	0.872727	0.006131	0.111013	1.44384	0.612284	0.252748	1.29 [0.48 - 3.42]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219391_at	49	0.265306	0.0151109	0.219174	-1.3252	0.10509	-2.91307	0.05 [0.00 - 1.84]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	232103_at	49	0.877551	0.000507666	0.0143555	1.96571	0.07672	1.14169	3.13 [0.88 - 11.09]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219391_at	55	0.527273	0.074705	-	-0.905485	0.416754	-1.26957	0.28 [0.01 - 6.02]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1554575_a_at	55	0.490909	0.242958	-	0.552762	0.489793	0.536003	1.71 [0.37 - 7.82]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	232103_at	55	0.872727	0.0171744	0.240407	1.17224	0.378293	0.409729	1.51 [0.61 - 3.75]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	144784	34	0.264706	0.0987028	-	-0.762063	0.424489	-0.461072	0.63 [0.20 - 1.96]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	232103_at	63	0.253968	0.0836593	-	-0.612659	0.908613	0.03064	1.03 [0.61 - 1.74]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1554575_a_at	63	0.238095	0.067913	-	0.857882	0.785761	0.0846129	1.09 [0.59 - 2.00]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219391_at	63	0.238095	0.000490659	0.0139437	-1.17356	0.0750048	-14.9001	0.00 [0.00 - 4.49]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.271752.2.S1_3p_s_at	28	0.392857	0.0202939	0.270718	-1.27232	0.813172	-0.365453	0.69 [0.03 - 14.37]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5174398_3p_at	28	0.321429	0.0691516	-	-1.03791	0.509134	-1.55199	0.21 [0.00 - 21.23]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.271752.1.S1_3p_at	28	0.714286	0.0285111	0.342341	1.21802	0.518508	0.197235	1.22 [0.67 - 2.22]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219391_at	82	0.817073	0.0052882	0.0989027	1.03065	0.897225	0.0430675	1.04 [0.54 - 2.01]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219391_at	79	0.113924	0.0419151	0.440583	1.01524	0.195692	0.562379	1.75 [0.75 - 4.11]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219391_at	104	0.673077	0.0311833	0.363536	0.694512	0.0686831	1.11853	3.06 [0.92 - 10.20]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P122636	117	0.119658	0.00350371	0.0713599	15.261	0.0383746	0.398583	1.49 [1.02 - 2.17]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P104046	117	0.307692	0.0152567	0.220708	0.868353	0.441279	0.153361	1.17 [0.79 - 1.72]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219391_at	204	0.156863	0.0146116	0.213877	15.2925	0.0352727	0.52419	1.69 [1.04 - 2.75]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1554575_a_at	204	0.416667	0.0117334	0.181971	1.095	0.129098	0.583536	1.79 [0.84 - 3.81]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1554575_a_at	204	0.490196	0.00246808	0.0537804	0.860915	0.0208255	0.662685	1.94 [1.11 - 3.40]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	232103_at	204	0.25	0.0464027	0.469566	1.14839	0.965069	-0.0229674	0.98 [0.35 - 2.73]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219391_at	204	0.318627	0.0811503	-	0.563515	0.172729	0.219135	1.24 [0.91 - 1.71]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	232103_at	204	0.686275	0.147876	-	-0.456741	0.637637	-0.189215	0.83 [0.38 - 1.82]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219391_at	178	0.297753	0.00378931	0.0759735	-0.583316	0.213983	-0.282213	0.75 [0.48 - 1.18]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300020828	41	0.560976	0.328868	-	-0.425369	0.727844	-0.113571	0.89 [0.47 - 1.69]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	232103_at	111	0.216216	0.0650139	-	-0.527204	0.622332	-0.171954	0.84 [0.42 - 1.67]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1554575_a_at	111	0.414414	0.379491	-	0.237034	0.796298	0.0370536	1.04 [0.78 - 1.37]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219391_at	111	0.81982	0.25331	-	0.367673	0.934491	-0.016094	0.98 [0.67 - 1.44]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219391_at	90	0.388889	0.0164726	0.233299	-0.877371	0.601016	-0.62907	0.53 [0.05 - 5.63]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219391_at	90	0.4	0.012951	0.195771	-0.796624	0.752228	-0.331373	0.72 [0.09 - 5.62]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219391_at	138	0.753623	0.00296473	0.0623921	-1.01995	0.00513301	-6.55543	0.00 [0.00 - 0.14]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	232103_at	138	0.137681	0.011169	0.175411	1.23046	0.131131	0.212424	1.24 [0.94 - 1.63]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1554575_a_at	138	0.282609	0.000895168	0.0232209	1.08506	0.0280987	0.38428	1.47 [1.04 - 2.07]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219391_at	129	0.821705	0.249659	-	0.355595	0.830197	-0.0393945	0.96 [0.67 - 1.38]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26064	56	0.857143	0.0210385	0.277669	-1.31031	0.251203	-0.278038	0.76 [0.47 - 1.22]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1271	56	0.821429	0.190285	-	-0.583745	0.960336	-0.0136456	0.99 [0.58 - 1.69]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26064	56	0.857143	0.0538501	-	-1.11643	0.645117	-0.115986	0.89 [0.54 - 1.46]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1271	56	0.410714	0.0344922	0.388586	0.878596	0.41666	0.240168	1.27 [0.71 - 2.27]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219391_at	278	0.104317	0.205253	-	0.489123	0.557104	0.393919	1.48 [0.40 - 5.52]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	232103_at	278	0.133094	0.00529278	0.0989699	1.04081	0.132056	0.259154	1.30 [0.92 - 1.82]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1554575_a_at	278	0.503597	0.187512	-	0.247731	0.820075	-0.0475586	0.95 [0.63 - 1.44]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219391_at	133	0.684211	0.00181228	0.0417726	0.746597	0.0573341	1.12355	3.08 [0.97 - 9.80]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14118	81	0.308642	0.0463684	0.469351	-1.01477	0.573517	-0.343009	0.71 [0.21 - 2.34]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219391_at	185	0.464865	0.00779719	0.133655	0.438552	0.976016	0.00872495	1.01 [0.57 - 1.78]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219391_at	185	0.464865	0.00489715	0.0931069	0.50632	0.749311	0.101565	1.11 [0.59 - 2.06]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P122636	110	0.518182	0.0712229	-	-0.538982	0.376316	-0.122557	0.88 [0.67 - 1.16]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P104046	110	0.109091	0.190429	-	0.552951	0.38448	0.175719	1.19 [0.80 - 1.77]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P122636	110	0.527273	0.186251	-	-0.30931	0.555475	-0.0624247	0.94 [0.76 - 1.16]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P104046	110	0.145455	0.172089	-	0.796825	0.497247	0.178627	1.20 [0.71 - 2.00]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219391_at	80	0.1375	0.0291735	0.34768	-1.02561	0.319731	-0.148471	0.86 [0.64 - 1.15]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:308273	59	0.898305	0.034347	0.387513	1.17005	0.127852	0.926989	2.53 [0.77 - 8.33]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1554575_a_at	38	0.736842	0.0881761	-	0.802921	0.355961	0.57262	1.77 [0.53 - 5.98]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219391_at	38	0.131579	0.0497911	0.490369	15.3186	0.5114	0.215271	1.24 [0.65 - 2.36]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	232103_at	38	0.131579	0.0241187	0.305383	15.4824	0.216003	0.575309	1.78 [0.71 - 4.42]
GENE	BPNT1	3'(2'), 5'-bisphosphate nucleotidase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219391_at	140	0.221429	0.0135492	0.202383	1.21481	0.423218	0.963595	2.62 [0.25 - 27.71]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	BTD	biotinidase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204167_at	30	0.166667	0.00966579	0.157376	-1.34162	0.042806	-1.10825	0.33 [0.11 - 0.96]
GENE	BTD	biotinidase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214116_at	30	0.366667	0.0203635	0.271373	-0.93746	0.0633478	-1.89953	0.15 [0.02 - 1.11]
GENE	BTD	biotinidase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214117_s_at	30	0.633333	0.0676546	-	-0.809089	0.133097	-0.995133	0.37 [0.10 - 1.35]
GENE	BTD	biotinidase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1699728	165	0.89697	0.043893	0.453567	-1.1315	0.292717	-0.226575	0.80 [0.52 - 1.22]
GENE	BTD	biotinidase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1699728	165	0.878788	0.0911942	-	-1.55521	0.408599	-0.269219	0.76 [0.40 - 1.45]
GENE	BTD	biotinidase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214116_at	163	0.711656	0.0109292	0.17259	0.521419	0.164988	0.704422	2.02 [0.75 - 5.47]
GENE	BTD	biotinidase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214117_s_at	163	0.705521	0.262578	-	0.234149	0.464409	0.307473	1.36 [0.60 - 3.10]
GENE	BTD	biotinidase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204167_at	163	0.153374	0.0546053	-	-0.473428	0.515822	-0.264384	0.77 [0.35 - 1.70]
GENE	BTD	biotinidase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214117_s_at	79	0.544304	0.00851326	0.142933	0.764608	0.0825098	0.775885	2.17 [0.90 - 5.22]
GENE	BTD	biotinidase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214116_at	79	0.759494	0.160671	-	0.450414	0.334224	0.515764	1.67 [0.59 - 4.77]
GENE	BTD	biotinidase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204167_at	79	0.78481	0.110135	-	0.527588	0.310902	0.367525	1.44 [0.71 - 2.94]
GENE	BTD	biotinidase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204167_at	58	0.758621	0.101882	-	0.508392	0.91188	0.0210058	1.02 [0.70 - 1.48]
GENE	BTD	biotinidase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214116_at	58	0.655172	0.243591	-	0.338023	0.84269	-0.0343272	0.97 [0.69 - 1.36]
GENE	BTD	biotinidase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214117_s_at	58	0.689655	0.0227481	0.293249	0.670184	0.99963	8.13478e-05	1.00 [0.71 - 1.41]
GENE	BTD	biotinidase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214117_s_at	34	0.264706	0.0180429	0.24905	-1.0084	0.0750784	-0.366928	0.69 [0.46 - 1.04]
GENE	BTD	biotinidase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204167_at	34	0.5	0.196078	-	-0.527435	0.53779	-0.115864	0.89 [0.62 - 1.29]
GENE	BTD	biotinidase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214116_at	34	0.823529	0.258047	-	0.525254	0.823321	-0.0476571	0.95 [0.63 - 1.45]
GENE	BTD	biotinidase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214117_s_at	158	0.886076	0.133196	-	-0.62821	0.59806	-0.349703	0.70 [0.19 - 2.59]
GENE	BTD	biotinidase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204167_at	158	0.601266	0.191322	-	-0.316752	0.808201	-0.188727	0.83 [0.18 - 3.80]
GENE	BTD	biotinidase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214116_at	158	0.886076	0.137246	-	0.465345	0.326482	0.537796	1.71 [0.58 - 5.01]
GENE	BTD	biotinidase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214116_at	53	0.735849	0.0175725	0.24439	0.881794	0.232145	0.608675	1.84 [0.68 - 4.99]
GENE	BTD	biotinidase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204167_at	53	0.188679	0.142684	-	-0.587154	0.193172	-0.301187	0.74 [0.47 - 1.16]
GENE	BTD	biotinidase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214117_s_at	53	0.792453	0.118016	-	-0.81992	0.581452	-0.172451	0.84 [0.46 - 1.55]
GENE	BTD	biotinidase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214116_at	53	0.207547	0.0187949	0.256403	-0.88864	0.632193	0.239732	1.27 [0.48 - 3.39]
GENE	BTD	biotinidase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204167_at	53	0.188679	0.0450239	0.460841	-0.810714	0.0903583	-0.390966	0.68 [0.43 - 1.06]
GENE	BTD	biotinidase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214117_s_at	53	0.792453	0.0549868	-	-0.984741	0.373729	-0.2521	0.78 [0.45 - 1.35]
GENE	BTD	biotinidase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204167_at	180	0.155556	0.156073	-	-0.372449	0.608861	-0.048132	0.95 [0.79 - 1.15]
GENE	BTD	biotinidase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214116_at	180	0.2	0.0130587	0.196968	-0.56928	0.00367784	-0.47852	0.62 [0.45 - 0.86]
GENE	BTD	biotinidase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214117_s_at	180	0.511111	0.00619135	0.111862	-0.579048	0.0429271	-0.243037	0.78 [0.62 - 0.99]
GENE	BTD	biotinidase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214117_s_at	559	0.286225	0.0112037	0.175817	-0.512539	0.082314	-0.301764	0.74 [0.53 - 1.04]
GENE	BTD	biotinidase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214116_at	559	0.654741	0.0532574	-	-0.43291	0.694413	-0.0983407	0.91 [0.55 - 1.48]
GENE	BTD	biotinidase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204167_at	559	0.456172	2.22867e-05	0.000920619	-0.888769	0.240534	-0.130849	0.88 [0.71 - 1.09]
GENE	BTD	biotinidase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214117_s_at	77	0.116883	0.0697858	-	-0.688792	0.483451	-0.21517	0.81 [0.44 - 1.47]
GENE	BTD	biotinidase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204167_at	77	0.103896	0.00698369	0.122798	-1.00428	0.254241	-0.172791	0.84 [0.63 - 1.13]
GENE	BTD	biotinidase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214116_at	77	0.636364	0.0614804	-	0.486017	0.565373	0.177004	1.19 [0.65 - 2.18]
GENE	BTD	biotinidase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214117_s_at	70	0.557143	0.286659	-	0.282614	0.716865	0.196137	1.22 [0.42 - 3.51]
GENE	BTD	biotinidase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214116_at	70	0.585714	0.14687	-	-0.390519	0.816573	-0.110436	0.90 [0.35 - 2.28]
GENE	BTD	biotinidase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204167_at	70	0.3	0.230492	-	0.353678	0.748762	0.151379	1.16 [0.46 - 2.94]
GENE	BTD	biotinidase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37274_at	50	0.52	0.0197852	0.26591	-0.827135	0.101421	-1.54494	0.21 [0.03 - 1.35]
GENE	BTD	biotinidase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204167_at	74	0.797297	0.0277369	0.336026	0.722702	0.562194	0.158844	1.17 [0.69 - 2.01]
GENE	BTD	biotinidase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214116_at	74	0.297297	0.0513455	-	-0.59509	0.335539	-0.50067	0.61 [0.22 - 1.68]
GENE	BTD	biotinidase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214117_s_at	74	0.324324	0.0138604	0.205782	-0.716996	0.0315407	-1.0472	0.35 [0.14 - 0.91]
GENE	BTD	biotinidase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214117_s_at	67	0.522388	0.0224873	0.290906	-2.05198	0.179852	-1.35238	0.26 [0.04 - 1.87]
GENE	BTD	biotinidase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214116_at	67	0.298507	0.0329099	0.376765	15.6839	0.507079	0.668509	1.95 [0.27 - 14.06]
GENE	BTD	biotinidase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204167_at	67	0.328358	0.0221694	0.288033	-1.4814	0.221969	-1.40125	0.25 [0.03 - 2.33]
GENE	BTD	biotinidase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214117_s_at	115	0.73913	0.089092	-	-1.58798	0.657239	-0.357221	0.70 [0.14 - 3.39]
GENE	BTD	biotinidase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214116_at	115	0.286957	0.000897016	0.0232613	-1.65634	0.0698689	-1.08704	0.34 [0.10 - 1.09]
GENE	BTD	biotinidase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204167_at	115	0.269565	0.00433941	0.0846225	-1.41876	0.0285073	-0.913475	0.40 [0.18 - 0.91]
GENE	BTD	biotinidase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37274_at	158	0.360759	1.61263e-07	1.00255e-05	-1.45022	2.85847e-05	-1.95256	0.14 [0.06 - 0.35]
GENE	BTD	biotinidase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37274_at	76	0.868421	0.00668642	0.118739	1.38204	0.0766917	1.33801	3.81 [0.87 - 16.77]
GENE	BTD	biotinidase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214117_s_at	204	0.666667	0.0251652	0.314447	-0.331303	0.187691	-0.181429	0.83 [0.64 - 1.09]
GENE	BTD	biotinidase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214116_at	204	0.323529	0.0788915	-	-0.26435	0.560138	-0.0848283	0.92 [0.69 - 1.22]
GENE	BTD	biotinidase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204167_at	204	0.259804	3.93076e-05	0.00153014	-0.668404	0.0163912	-0.421906	0.66 [0.46 - 0.93]
GENE	BTD	biotinidase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204167_at	87	0.45977	0.0038296	0.0766174	-1.11391	0.055853	-0.548385	0.58 [0.33 - 1.01]
GENE	BTD	biotinidase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214117_s_at	87	0.218391	0.00283852	0.0602379	-1.12632	0.3881	-0.304827	0.74 [0.37 - 1.47]
GENE	BTD	biotinidase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214116_at	87	0.298851	0.110046	-	-0.609768	0.286353	-0.461786	0.63 [0.27 - 1.47]
GENE	BTD	biotinidase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214117_s_at	87	0.218391	0.00283852	0.0602379	-1.12632	0.3881	-0.304827	0.74 [0.37 - 1.47]
GENE	BTD	biotinidase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204167_at	87	0.45977	0.0038296	0.0766174	-1.11391	0.055853	-0.548385	0.58 [0.33 - 1.01]
GENE	BTD	biotinidase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214116_at	87	0.298851	0.110046	-	-0.609768	0.286353	-0.461786	0.63 [0.27 - 1.47]
GENE	BTD	biotinidase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214117_s_at	77	0.61039	0.180325	-	-0.855888	0.922133	-0.0426968	0.96 [0.41 - 2.26]
GENE	BTD	biotinidase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204167_at	77	0.103896	0.227261	-	-0.92271	0.628696	-0.254133	0.78 [0.28 - 2.17]
GENE	BTD	biotinidase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214116_at	77	0.701299	0.199416	-	-0.950454	0.872517	0.0908053	1.10 [0.36 - 3.32]
GENE	BTD	biotinidase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204167_at	77	0.116883	0.0894603	-	-1.0682	0.561545	-0.268868	0.76 [0.31 - 1.89]
GENE	BTD	biotinidase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214117_s_at	77	0.142857	0.108155	-	-1.05961	0.75262	-0.157439	0.85 [0.32 - 2.27]
GENE	BTD	biotinidase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214116_at	77	0.636364	0.0666325	-	-1.71558	0.600718	-0.336294	0.71 [0.20 - 2.52]
GENE	BTD	biotinidase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214116_at	136	0.705882	0.00361813	0.073219	1.23852	0.471406	0.353636	1.42 [0.54 - 3.73]
GENE	BTD	biotinidase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214117_s_at	136	0.397059	0.140132	-	0.745821	0.620679	0.229428	1.26 [0.51 - 3.12]
GENE	BTD	biotinidase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204167_at	136	0.257353	0.0534108	-	-0.848516	0.0803085	-0.483435	0.62 [0.36 - 1.06]
GENE	BTD	biotinidase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204167_at	200	0.52	0.000242021	0.00758611	-1.19648	0.00199123	-0.548018	0.58 [0.41 - 0.82]
GENE	BTD	biotinidase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214116_at	200	0.89	0.0562159	-	0.781689	0.749233	0.130674	1.14 [0.51 - 2.54]
GENE	BTD	biotinidase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214117_s_at	200	0.105	2.34414e-05	0.000963344	-1.37562	0.00100567	-1.11329	0.33 [0.17 - 0.64]
GENE	BTD	biotinidase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20731	60	0.883333	0.395689	-	-0.612544	0.634587	-0.128255	0.88 [0.52 - 1.49]
GENE	BTD	biotinidase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20731	60	0.766667	0.191579	-	-0.692899	0.390492	-0.298572	0.74 [0.38 - 1.47]
GENE	BTD	biotinidase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	10769	155	0.135484	0.0175453	0.244118	-0.792356	0.793226	0.0792103	1.08 [0.60 - 1.96]
GENE	BTD	biotinidase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204167_at	286	0.374126	0.000137318	0.00462777	-0.72252	0.0247892	-0.372699	0.69 [0.50 - 0.95]
GENE	BTD	biotinidase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214116_at	286	0.594406	0.0330253	0.377636	-0.43468	0.675874	0.0763551	1.08 [0.75 - 1.54]
GENE	BTD	biotinidase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214117_s_at	286	0.520979	0.0620513	-	-0.364358	0.250514	-0.186125	0.83 [0.60 - 1.14]
GENE	BTD	biotinidase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204167_at	159	0.584906	0.0144949	0.21263	-0.865988	0.321705	-0.298025	0.74 [0.41 - 1.34]
GENE	BTD	biotinidase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214116_at	159	0.899371	0.261955	-	0.491944	0.674898	0.131867	1.14 [0.62 - 2.11]
GENE	BTD	biotinidase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204167_at	159	0.584906	0.0315993	0.366756	-0.902019	0.739434	-0.121593	0.89 [0.43 - 1.81]
GENE	BTD	biotinidase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214117_s_at	159	0.308176	0.171673	-	0.512298	0.506421	0.237577	1.27 [0.63 - 2.56]
GENE	BTD	biotinidase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214116_at	159	0.176101	0.0150935	0.21899	-0.816221	0.4668	-0.197199	0.82 [0.48 - 1.40]
GENE	BTD	biotinidase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214116_at	159	0.176101	0.0459984	0.467023	-0.781083	0.763954	-0.0983539	0.91 [0.48 - 1.72]
GENE	BTD	biotinidase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204167_at	159	0.522013	0.0243639	0.307523	-0.742988	0.805873	-0.0771758	0.93 [0.50 - 1.71]
GENE	BTD	biotinidase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214117_s_at	159	0.220126	0.110064	-	0.746776	0.270074	0.40232	1.50 [0.73 - 3.06]
GENE	BTD	biotinidase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214117_s_at	159	0.232704	0.0824633	-	1.01502	0.424482	0.341594	1.41 [0.61 - 3.25]
GENE	BTD	biotinidase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214117_s_at	54	0.481481	0.0400689	0.428149	1.50755	0.247442	0.540429	1.72 [0.69 - 4.29]
GENE	BTD	biotinidase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204167_at	54	0.148148	0.133023	-	-1.16175	0.921721	-0.0539369	0.95 [0.32 - 2.78]
GENE	BTD	biotinidase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214116_at	54	0.462963	0.0505991	-	1.45726	0.258999	0.68552	1.98 [0.60 - 6.53]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214117_s_at	117	0.820513	0.00658453	0.117336	0.937845	0.0398908	0.744902	2.11 [1.03 - 4.29]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214117_s_at	117	0.17094	0.0236313	0.301104	1.9709	0.0415574	0.866618	2.38 [1.03 - 5.47]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204167_at	117	0.726496	0.00761999	0.13132	0.852305	0.0811102	0.474864	1.61 [0.94 - 2.74]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214117_s_at	117	0.205128	0.0499911	0.491569	1.34108	0.843325	0.0903965	1.09 [0.45 - 2.68]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204167_at	117	0.726496	0.00453629	0.0876482	1.04181	0.0459843	0.621035	1.86 [1.01 - 3.42]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214117_s_at	117	0.820513	0.00658453	0.117336	0.937845	0.0398908	0.744902	2.11 [1.03 - 4.29]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204167_at	117	0.726496	0.00761999	0.13132	0.852305	0.0811102	0.474864	1.61 [0.94 - 2.74]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204167_at	117	0.119658	0.0949548	-	-0.75907	0.860897	0.0615155	1.06 [0.53 - 2.12]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214116_at	117	0.410256	0.0307246	0.359962	0.912056	0.313643	0.382762	1.47 [0.70 - 3.09]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214116_at	117	0.470085	0.0150916	0.21897	0.802739	0.170016	0.433092	1.54 [0.83 - 2.86]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214116_at	117	0.470085	0.0150916	0.21897	0.802739	0.170016	0.433092	1.54 [0.83 - 2.86]
GENE	BTD	biotinidase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214116_at	117	0.555556	0.233877	-	0.466155	0.865629	0.0687023	1.07 [0.48 - 2.37]
GENE	BTD	biotinidase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214116_at	236	0.139831	0.188698	-	0.6076	0.98523	0.00660034	1.01 [0.50 - 2.02]
GENE	BTD	biotinidase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214117_s_at	236	0.148305	0.152021	-	0.65974	0.974264	-0.0100821	0.99 [0.54 - 1.83]
GENE	BTD	biotinidase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204167_at	236	0.449153	0.00982186	0.159289	-0.697675	0.114985	-0.364349	0.69 [0.44 - 1.09]
GENE	BTD	biotinidase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214117_s_at	249	0.108434	0.14588	-	0.604947	0.525444	0.163561	1.18 [0.71 - 1.95]
GENE	BTD	biotinidase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204167_at	249	0.188755	0.00323799	0.0669839	-0.691727	0.218047	-0.239633	0.79 [0.54 - 1.15]
GENE	BTD	biotinidase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214116_at	249	0.566265	0.0315809	0.366613	0.452075	0.209598	0.374722	1.45 [0.81 - 2.61]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214116_at	125	0.808	0.0892123	-	0.534377	0.754628	0.147209	1.16 [0.46 - 2.92]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214116_at	54	0.814815	0.245503	-	-1.16021	0.574276	-0.199827	0.82 [0.41 - 1.64]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214117_s_at	125	0.136	0.0131456	0.197933	-1.0411	0.105044	-0.944473	0.39 [0.12 - 1.22]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214117_s_at	125	0.728	0.0375216	0.410466	-0.719641	0.110065	-0.702325	0.50 [0.21 - 1.17]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204167_at	62	0.193548	0.0456019	0.464517	-0.979371	0.546153	-0.116296	0.89 [0.61 - 1.30]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204167_at	125	0.408	0.0266287	0.326844	-0.838779	0.0507661	-0.859817	0.42 [0.18 - 1.00]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214117_s_at	54	0.111111	0.153622	-	-0.921175	0.518664	-0.23069	0.79 [0.39 - 1.60]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214116_at	62	0.354839	0.226673	-	-0.578159	0.67038	-0.123876	0.88 [0.50 - 1.56]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204167_at	125	0.408	0.0599572	-	-0.538472	0.127755	-0.514781	0.60 [0.31 - 1.16]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204167_at	54	0.185185	0.0876081	-	-1.01806	0.493563	-0.160573	0.85 [0.54 - 1.35]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214117_s_at	62	0.129032	0.0484603	0.482304	-0.999765	0.615152	-0.146123	0.86 [0.49 - 1.53]
GENE	BTD	biotinidase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214116_at	125	0.832	0.00228217	0.0504573	1.14473	0.228863	0.720024	2.05 [0.64 - 6.64]
GENE	BTD	biotinidase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214117_s_at	198	0.338384	0.0233944	0.29901	-0.574658	0.354373	-0.13288	0.88 [0.66 - 1.16]
GENE	BTD	biotinidase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214117_s_at	198	0.338384	0.00408968	0.0807328	-0.753597	0.226786	-0.171271	0.84 [0.64 - 1.11]
GENE	BTD	biotinidase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204167_at	198	0.141414	0.0174006	0.242674	-0.712885	0.107442	-0.243544	0.78 [0.58 - 1.05]
GENE	BTD	biotinidase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214116_at	198	0.186869	0.0231896	0.297192	0.71749	0.380045	0.165445	1.18 [0.82 - 1.71]
GENE	BTD	biotinidase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204167_at	198	0.878788	0.0188843	0.257269	-2.01308	0.126294	-0.233202	0.79 [0.59 - 1.07]
GENE	BTD	biotinidase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214117_s_at	198	0.338384	0.0814626	-	-0.374744	0.856707	-0.0225815	0.98 [0.77 - 1.25]
GENE	BTD	biotinidase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214116_at	198	0.828283	0.0306181	0.359128	-0.97106	0.894074	-0.0303164	0.97 [0.62 - 1.52]
GENE	BTD	biotinidase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214116_at	198	0.828283	0.0576798	-	-0.863395	0.765037	-0.073287	0.93 [0.57 - 1.50]
GENE	BTD	biotinidase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204167_at	198	0.141414	0.000513545	0.0144974	-0.85768	0.0448676	-0.248983	0.78 [0.61 - 0.99]
GENE	BTD	biotinidase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214116_at	62	0.225806	0.0530817	-	-1.08063	0.375241	-0.901363	0.41 [0.06 - 2.98]
GENE	BTD	biotinidase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214117_s_at	51	0.235294	0.0425029	0.444478	-1.6588	0.262167	-2.37072	0.09 [0.00 - 5.89]
GENE	BTD	biotinidase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214117_s_at	62	0.274194	0.0393379	0.423138	-1.13145	0.551515	-0.783533	0.46 [0.03 - 6.02]
GENE	BTD	biotinidase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204167_at	51	0.196078	0.0147338	0.215179	-1.92129	0.598191	-0.706746	0.49 [0.04 - 6.83]
GENE	BTD	biotinidase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204167_at	62	0.612903	0.0241937	0.306039	-2.0028	0.0710813	-1.71258	0.18 [0.03 - 1.16]
GENE	BTD	biotinidase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214116_at	51	0.372549	0.0388876	0.420027	-1.97459	0.43442	-1.24173	0.29 [0.01 - 6.50]
GENE	BTD	biotinidase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204167_at	177	0.683616	0.0232529	0.297755	-0.748774	0.472843	-0.31148	0.73 [0.31 - 1.71]
GENE	BTD	biotinidase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214116_at	177	0.446328	0.00356966	0.0724333	-0.679055	0.219567	-0.564577	0.57 [0.23 - 1.40]
GENE	BTD	biotinidase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214117_s_at	145	0.227586	0.224838	-	0.537004	0.902591	0.0634927	1.07 [0.39 - 2.95]
GENE	BTD	biotinidase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204167_at	177	0.683616	0.0430988	0.448395	-0.553768	0.663662	-0.164173	0.85 [0.40 - 1.78]
GENE	BTD	biotinidase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214116_at	145	0.317241	0.37664	-	0.338815	0.828407	0.144142	1.16 [0.31 - 4.25]
GENE	BTD	biotinidase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204167_at	145	0.889655	0.0333295	0.379927	0.875739	0.349738	0.505602	1.66 [0.57 - 4.78]
GENE	BTD	biotinidase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214117_s_at	177	0.881356	0.0201362	0.269233	-1.52388	0.242018	-0.508497	0.60 [0.26 - 1.41]
GENE	BTD	biotinidase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214116_at	177	0.446328	0.00341708	0.0699424	-0.78874	0.0768186	-0.931017	0.39 [0.14 - 1.11]
GENE	BTD	biotinidase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214117_s_at	177	0.881356	0.021173	0.278913	-1.12657	0.368735	-0.336188	0.71 [0.34 - 1.49]
GENE	BTD	biotinidase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214116_at	226	0.752212	0.0278937	0.337312	0.639235	0.943375	-0.0190446	0.98 [0.58 - 1.66]
GENE	BTD	biotinidase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204167_at	226	0.637168	0.10503	-	0.456336	0.241446	0.274682	1.32 [0.83 - 2.08]
GENE	BTD	biotinidase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214117_s_at	226	0.309735	0.0941131	-	-0.479422	0.364418	-0.213657	0.81 [0.51 - 1.28]
GENE	BTD	biotinidase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204167_at	55	0.818182	0.000257941	0.00801691	1.5896	0.00547965	1.42617	4.16 [1.52 - 11.39]
GENE	BTD	biotinidase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214116_at	55	0.890909	0.0212901	0.279994	1.28759	0.0840817	1.47852	4.39 [0.82 - 23.48]
GENE	BTD	biotinidase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214116_at	49	0.55102	0.0046506	0.0893893	1.70686	0.0163013	2.25163	9.50 [1.51 - 59.67]
GENE	BTD	biotinidase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204167_at	55	0.781818	0.00847764	0.142477	1.29094	0.0476761	1.03418	2.81 [1.01 - 7.83]
GENE	BTD	biotinidase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204167_at	49	0.816327	0.00102727	0.0260666	1.76368	0.225501	0.969479	2.64 [0.55 - 12.64]
GENE	BTD	biotinidase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214117_s_at	55	0.818182	0.000591339	0.0163492	1.5294	0.00552226	1.27062	3.56 [1.45 - 8.74]
GENE	BTD	biotinidase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214117_s_at	55	0.672727	0.00307315	0.0642256	1.43073	0.0167385	1.07159	2.92 [1.21 - 7.03]
GENE	BTD	biotinidase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214116_at	55	0.509091	0.00242447	0.053006	1.44534	0.00976154	2.04343	7.72 [1.64 - 36.35]
GENE	BTD	biotinidase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214117_s_at	49	0.653061	0.0134157	0.200917	1.37891	0.12819	0.953623	2.60 [0.76 - 8.87]
GENE	BTD	biotinidase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204167_at	63	0.571429	0.357105	-	-0.316847	0.73016	0.0683452	1.07 [0.73 - 1.58]
GENE	BTD	biotinidase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214117_s_at	63	0.809524	0.0138095	0.205228	0.943389	0.176594	0.745191	2.11 [0.71 - 6.21]
GENE	BTD	biotinidase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214116_at	63	0.619048	0.0732128	-	0.598934	0.638759	0.232967	1.26 [0.48 - 3.34]
GENE	BTD	biotinidase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557372_3p_at	28	0.607143	0.085593	-	-1.08969	0.764207	-0.917844	0.40 [0.00 - 160.70]
GENE	BTD	biotinidase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.78885.1.S1_3p_a_at	28	0.607143	0.0558946	-	-1.20532	0.354877	-1.15171	0.32 [0.03 - 3.63]
GENE	BTD	biotinidase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214116_at	82	0.548781	0.0333153	0.37982	-0.763387	0.12353	-1.01132	0.36 [0.10 - 1.32]
GENE	BTD	biotinidase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214117_s_at	82	0.268293	0.11732	-	-0.550841	0.438416	-0.32817	0.72 [0.31 - 1.65]
GENE	BTD	biotinidase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204167_at	82	0.853659	0.124166	-	-0.900511	0.837303	-0.128702	0.88 [0.26 - 3.00]
GENE	BTD	biotinidase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37274_at	84	0.142857	0.103784	-	-0.603107	0.441865	-0.37979	0.68 [0.26 - 1.80]
GENE	BTD	biotinidase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214116_at	79	0.594937	0.170979	-	-0.362897	0.975343	-0.016919	0.98 [0.34 - 2.87]
GENE	BTD	biotinidase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214117_s_at	79	0.56962	0.0490779	0.486063	0.518406	0.176075	0.531628	1.70 [0.79 - 3.68]
GENE	BTD	biotinidase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204167_at	79	0.113924	0.137867	-	0.686891	0.791703	0.0904456	1.09 [0.56 - 2.14]
GENE	BTD	biotinidase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U03274_at	86	0.674419	0.117664	-	-0.767894	0.631051	-0.188842	0.83 [0.38 - 1.79]
GENE	BTD	biotinidase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204167_at	104	0.259615	0.014873	0.216658	-0.793101	0.170816	-0.766096	0.46 [0.16 - 1.39]
GENE	BTD	biotinidase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214116_at	104	0.115385	0.183664	-	0.933555	0.144255	1.18455	3.27 [0.67 - 16.03]
GENE	BTD	biotinidase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214117_s_at	104	0.538462	0.196925	-	0.416783	0.534428	0.248144	1.28 [0.59 - 2.80]
GENE	BTD	biotinidase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P155351	117	0.42735	0.122435	-	-0.439672	0.955792	-0.00863754	0.99 [0.73 - 1.35]
GENE	BTD	biotinidase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214117_s_at	204	0.843137	0.126607	-	-1.06709	0.852229	-0.111333	0.89 [0.28 - 2.89]
GENE	BTD	biotinidase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214117_s_at	204	0.612745	0.0441068	0.454951	0.541829	0.449094	0.321743	1.38 [0.60 - 3.17]
GENE	BTD	biotinidase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214116_at	204	0.166667	0.283777	-	0.641416	0.73687	0.192162	1.21 [0.40 - 3.72]
GENE	BTD	biotinidase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214116_at	204	0.833333	0.0887191	-	-0.779933	0.945442	-0.029413	0.97 [0.42 - 2.25]
GENE	BTD	biotinidase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204167_at	204	0.25	0.00874231	0.14585	2.1986	0.321403	0.47411	1.61 [0.63 - 4.10]
GENE	BTD	biotinidase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204167_at	204	0.132353	0.0693188	-	1.03284	0.579271	0.200291	1.22 [0.60 - 2.48]
GENE	BTD	biotinidase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214116_at	178	0.865169	0.147892	-	-0.477405	0.691882	-0.160927	0.85 [0.38 - 1.89]
GENE	BTD	biotinidase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214117_s_at	178	0.814607	0.058945	-	-0.522361	0.347955	-0.283246	0.75 [0.42 - 1.36]
GENE	BTD	biotinidase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204167_at	178	0.275281	0.0671545	-	-0.382139	0.594708	-0.213342	0.81 [0.37 - 1.77]
GENE	BTD	biotinidase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200006572	41	0.853659	0.0312852	0.364327	1.05814	0.646271	0.209372	1.23 [0.50 - 3.01]
GENE	BTD	biotinidase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214117_s_at	111	0.333333	0.155509	-	0.414903	0.557274	0.116895	1.12 [0.76 - 1.66]
GENE	BTD	biotinidase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214116_at	111	0.27027	0.107358	-	0.532311	0.936807	0.0214776	1.02 [0.60 - 1.74]
GENE	BTD	biotinidase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204167_at	111	0.36036	0.0412783	0.436329	0.592579	0.237731	0.212453	1.24 [0.87 - 1.76]
GENE	BTD	biotinidase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214116_at	90	0.866667	0.0765465	-	-1.21156	0.410045	-0.587147	0.56 [0.14 - 2.25]
GENE	BTD	biotinidase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214116_at	90	0.666667	0.0807161	-	-0.781067	0.688144	-0.327812	0.72 [0.15 - 3.57]
GENE	BTD	biotinidase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214117_s_at	90	0.655556	0.0227589	0.293347	0.727107	0.89126	-0.0829316	0.92 [0.28 - 3.02]
GENE	BTD	biotinidase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214117_s_at	90	0.888889	0.107538	-	-1.49527	0.540312	-0.432973	0.65 [0.16 - 2.59]
GENE	BTD	biotinidase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204167_at	90	0.566667	0.0531661	-	0.62139	0.740024	0.23265	1.26 [0.32 - 4.99]
GENE	BTD	biotinidase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204167_at	90	0.566667	0.0957245	-	0.612971	0.948336	-0.0514132	0.95 [0.20 - 4.50]
GENE	BTD	biotinidase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3354	50	0.66	0.122457	-	-0.946275	0.738979	-0.0897196	0.91 [0.54 - 1.55]
GENE	BTD	biotinidase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214117_s_at	138	0.601449	0.0442017	0.455563	0.482285	0.921698	0.0209564	1.02 [0.67 - 1.55]
GENE	BTD	biotinidase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214116_at	138	0.702899	0.249787	-	-0.320565	0.866904	-0.027637	0.97 [0.70 - 1.34]
GENE	BTD	biotinidase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204167_at	138	0.507246	0.109798	-	0.387995	0.651662	0.0705054	1.07 [0.79 - 1.46]
GENE	BTD	biotinidase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204167_at	129	0.449612	0.207725	-	-0.309836	0.871261	-0.0231937	0.98 [0.74 - 1.29]
GENE	BTD	biotinidase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214116_at	129	0.224806	0.0399172	0.427114	0.722329	0.297557	0.272012	1.31 [0.79 - 2.19]
GENE	BTD	biotinidase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214117_s_at	129	0.217054	0.0674779	-	0.619217	0.316422	0.245057	1.28 [0.79 - 2.06]
GENE	BTD	biotinidase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18897	56	0.803571	0.0761627	-	0.691011	0.777642	0.0902049	1.09 [0.59 - 2.05]
GENE	BTD	biotinidase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37136	56	0.392857	0.200394	-	0.457088	0.668969	0.175081	1.19 [0.53 - 2.66]
GENE	BTD	biotinidase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18897	56	0.803571	0.0653634	-	0.708311	0.587159	0.162107	1.18 [0.66 - 2.11]
GENE	BTD	biotinidase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37136	56	0.142857	0.146029	-	-0.70653	0.932427	-0.0376425	0.96 [0.40 - 2.30]
GENE	BTD	biotinidase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204167_at	278	0.532374	0.0441334	0.455122	-0.384246	0.253648	-0.242336	0.78 [0.52 - 1.19]
GENE	BTD	biotinidase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214117_s_at	278	0.741007	0.0191241	0.259585	-0.526686	0.097863	-0.282438	0.75 [0.54 - 1.05]
GENE	BTD	biotinidase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214116_at	278	0.57554	0.086117	-	-0.329258	0.190542	-0.276225	0.76 [0.50 - 1.15]
GENE	BTD	biotinidase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214117_s_at	133	0.300752	0.00209661	0.0470795	0.859825	0.873083	-0.0485652	0.95 [0.52 - 1.73]
GENE	BTD	biotinidase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204167_at	133	0.62406	0.00152254	0.0361785	0.732889	0.583622	0.248715	1.28 [0.53 - 3.12]
GENE	BTD	biotinidase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214116_at	133	0.578947	0.00526714	0.0985936	0.659951	0.0235593	0.582784	1.79 [1.08 - 2.97]
GENE	BTD	biotinidase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4160	81	0.209877	0.00788726	0.134836	-1.31664	0.216505	-0.67979	0.51 [0.17 - 1.49]
GENE	BTD	biotinidase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11028	81	0.111111	3.66949e-07	2.15292e-05	-2.27273	0.00269925	-1.66158	0.19 [0.06 - 0.56]
GENE	BTD	biotinidase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214116_at	185	0.405405	0.026284	0.323952	-0.394155	0.190131	-0.481323	0.62 [0.30 - 1.27]
GENE	BTD	biotinidase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204167_at	185	0.681081	0.0765705	-	-0.346435	0.707124	-0.100908	0.90 [0.53 - 1.53]
GENE	BTD	biotinidase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214117_s_at	185	0.881081	0.0427286	0.445965	-0.535227	0.994898	-0.00200672	1.00 [0.54 - 1.85]
GENE	BTD	biotinidase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214116_at	185	0.113514	0.0425471	0.444769	-0.495247	0.0969864	-0.564107	0.57 [0.29 - 1.11]
GENE	BTD	biotinidase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214117_s_at	185	0.113514	0.0843038	-	0.501816	0.908107	-0.0394353	0.96 [0.49 - 1.88]
GENE	BTD	biotinidase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204167_at	185	0.681081	0.0954685	-	-0.296097	0.710303	-0.0914513	0.91 [0.56 - 1.48]
GENE	BTD	biotinidase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P155351	110	0.572727	0.0333938	0.38041	-0.504613	0.234831	-0.136886	0.87 [0.70 - 1.09]
GENE	BTD	biotinidase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P155351	110	0.590909	0.064629	-	-0.58875	0.130668	-0.215496	0.81 [0.61 - 1.07]
GENE	BTD	biotinidase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204167_at	80	0.25	0.110968	-	-0.70711	0.213743	-0.207733	0.81 [0.59 - 1.13]
GENE	BTD	biotinidase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214116_at	80	0.2375	0.302726	-	0.635244	0.812217	-0.0661298	0.94 [0.54 - 1.62]
GENE	BTD	biotinidase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214117_s_at	80	0.6	0.136398	-	0.647742	0.73762	-0.0943039	0.91 [0.52 - 1.58]
GENE	BTD	biotinidase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_2170	281	0.576512	0.000393963	0.0115532	-0.510681	0.0399408	-0.242931	0.78 [0.62 - 0.99]
GENE	BTD	biotinidase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214116_at	38	0.631579	0.164538	-	0.648056	0.194162	0.745426	2.11 [0.68 - 6.49]
GENE	BTD	biotinidase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204167_at	38	0.657895	0.0275747	0.334693	1.068	0.431807	0.302448	1.35 [0.64 - 2.88]
GENE	BTD	biotinidase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214117_s_at	38	0.842105	0.0348273	0.391054	1.2139	0.16004	0.591828	1.81 [0.79 - 4.13]
GENE	BTD	biotinidase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214116_at	140	0.135714	9.0557e-05	0.00320906	-1.2168	0.0149883	-1.22329	0.29 [0.11 - 0.79]
GENE	BTD	biotinidase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214117_s_at	140	0.214286	6.52758e-10	5.59623e-08	-1.66463	1.3923e-05	-1.60865	0.20 [0.10 - 0.41]
GENE	BTD	biotinidase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204167_at	140	0.107143	1.51015e-10	1.38964e-08	-1.8409	3.34129e-06	-1.9142	0.15 [0.07 - 0.33]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219439_at	30	0.4	0.268875	-	0.455693	0.871444	-0.0532189	0.95 [0.50 - 1.81]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1662578	165	0.606061	0.0136052	0.202996	0.587833	0.249934	0.180857	1.20 [0.88 - 1.63]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1662578	165	0.866667	0.0729622	-	-1.63529	0.737545	0.0768663	1.08 [0.69 - 1.69]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219439_at	163	0.392638	0.0878041	-	0.349849	0.945339	0.0147111	1.01 [0.67 - 1.55]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219439_at	79	0.886076	0.135295	-	0.608073	0.606177	0.163433	1.18 [0.63 - 2.19]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219439_at	58	0.137931	0.369273	-	0.344929	0.360364	0.182102	1.20 [0.81 - 1.77]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219439_at	34	0.205882	0.0547956	-	1.17456	0.409735	0.318011	1.37 [0.65 - 2.93]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219439_at	158	0.449367	0.00183694	0.0422397	0.749883	0.131622	0.489851	1.63 [0.86 - 3.09]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219439_at	53	0.358491	0.00552668	0.10238	1.27675	0.218172	0.644214	1.90 [0.68 - 5.31]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219439_at	53	0.358491	0.00185927	0.0426614	1.32098	0.0729655	0.909569	2.48 [0.92 - 6.71]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219439_at	180	0.233333	0.248492	-	0.308658	0.690407	0.0917839	1.10 [0.70 - 1.72]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219439_at	559	0.159213	0.160845	-	-0.363476	0.459866	0.209196	1.23 [0.71 - 2.15]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219439_at	77	0.74026	0.000388327	0.0114111	0.997685	0.00429371	0.722588	2.06 [1.25 - 3.38]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219439_at	70	0.771429	0.0119844	0.184854	0.743084	0.0340786	0.54839	1.73 [1.04 - 2.87]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219439_at	74	0.27027	0.0769297	-	0.619719	0.218112	0.609703	1.84 [0.70 - 4.86]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219439_at	67	0.850746	0.00685792	0.121087	1.64167	0.0909851	1.31434	3.72 [0.81 - 17.09]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219439_at	115	0.808696	0.0670197	-	0.977958	0.384276	0.392674	1.48 [0.61 - 3.59]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219439_at	204	0.348039	0.0396803	0.425492	0.304991	0.10168	0.186005	1.20 [0.96 - 1.50]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219439_at	87	0.149425	0.024515	0.308836	-0.955228	0.257802	-0.253839	0.78 [0.50 - 1.20]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219439_at	87	0.149425	0.024515	0.308836	-0.955228	0.257802	-0.253839	0.78 [0.50 - 1.20]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219439_at	77	0.233766	0.175619	-	-0.849494	0.982926	0.0100526	1.01 [0.40 - 2.54]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219439_at	77	0.233766	0.0312396	0.363973	-1.1374	0.497752	-0.276444	0.76 [0.34 - 1.69]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219439_at	136	0.801471	0.25731	-	0.54676	0.935243	-0.0332478	0.97 [0.43 - 2.16]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219439_at	200	0.735	5.46508e-05	0.002052	1.1349	0.000900408	0.878783	2.41 [1.43 - 4.05]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1054	60	0.566667	0.287299	-	-0.415785	0.81517	-0.0584216	0.94 [0.58 - 1.54]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1054	60	0.45	0.185488	-	-0.497787	0.796366	0.0782413	1.08 [0.60 - 1.96]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	11250	155	0.645161	0.000575576	0.0159776	0.928075	0.0271529	0.256096	1.29 [1.03 - 1.62]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219439_at	286	0.573427	0.254663	-	0.221383	0.96077	0.00910475	1.01 [0.70 - 1.45]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219439_at	159	0.163522	0.0921343	-	-0.607167	0.803891	-0.0805567	0.92 [0.49 - 1.74]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219439_at	159	0.220126	0.0223009	0.289223	-0.741012	0.656248	-0.147452	0.86 [0.45 - 1.65]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219439_at	159	0.125786	0.0417991	0.439811	-0.858369	0.982481	0.00824925	1.01 [0.48 - 2.11]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219439_at	54	0.796296	0.368414	-	-0.92371	0.67303	-0.201228	0.82 [0.32 - 2.08]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219439_at	117	0.803419	0.185837	-	-0.622164	0.885357	-0.0229332	0.98 [0.72 - 1.33]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219439_at	117	0.153846	0.247647	-	0.825932	0.90386	0.0241946	1.02 [0.69 - 1.52]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219439_at	117	0.803419	0.185837	-	-0.622164	0.885357	-0.0229332	0.98 [0.72 - 1.33]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219439_at	117	0.803419	0.172782	-	-0.809063	0.702805	-0.0766794	0.93 [0.62 - 1.37]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219439_at	236	0.665254	0.0754151	-	0.479868	0.270216	0.294573	1.34 [0.80 - 2.27]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219439_at	249	0.895582	0.273892	-	0.352254	0.869371	-0.0373255	0.96 [0.62 - 1.50]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219439_at	125	0.288	0.153338	-	-0.539905	0.358299	-0.41327	0.66 [0.27 - 1.60]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219439_at	125	0.104	0.173807	-	0.712714	0.718704	-0.105195	0.90 [0.51 - 1.60]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219439_at	54	0.759259	0.0441664	0.455336	-1.87612	0.402923	-0.358765	0.70 [0.30 - 1.62]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219439_at	62	0.790323	0.0129319	0.195558	-2.17566	0.339924	-0.343006	0.71 [0.35 - 1.44]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219439_at	198	0.747475	0.000520067	0.0146544	-1.03319	0.0163688	-0.322158	0.72 [0.56 - 0.94]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219439_at	198	0.732323	0.0134532	0.201329	-0.864222	0.20555	-0.202705	0.82 [0.60 - 1.12]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219439_at	198	0.732323	0.0396243	0.425107	-0.732592	0.505931	-0.109199	0.90 [0.65 - 1.24]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219439_at	51	0.470588	0.0225215	0.291214	16.2527	0.398557	0.992339	2.70 [0.27 - 27.01]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219439_at	62	0.467742	0.0165656	0.234248	1.66538	0.174598	1.04122	2.83 [0.63 - 12.74]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219439_at	177	0.655367	0.0638177	-	0.497657	0.517173	0.192316	1.21 [0.68 - 2.17]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219439_at	177	0.898305	0.00323496	0.0669334	0.901505	0.105216	0.419164	1.52 [0.92 - 2.53]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219439_at	145	0.648276	0.0368289	0.405547	0.682344	0.512986	0.258233	1.29 [0.60 - 2.81]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219439_at	226	0.836283	0.107951	-	-0.815681	0.494737	-0.217893	0.80 [0.43 - 1.50]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219439_at	55	0.236364	0.255467	-	0.698102	0.680637	0.176035	1.19 [0.52 - 2.76]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219439_at	55	0.345455	0.0212475	0.279601	1.53325	0.33793	0.428255	1.53 [0.64 - 3.68]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219439_at	49	0.428571	0.0279227	0.337549	1.96745	0.141188	0.862626	2.37 [0.75 - 7.48]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	138419	34	0.588235	0.239079	-	0.513677	0.754941	0.381694	1.46 [0.13 - 16.09]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219439_at	63	0.15873	0.00646124	0.11563	-1.02938	0.349866	-0.21726	0.80 [0.51 - 1.27]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9910143_3p_at	28	0.142857	0.0697633	-	-1.17687	0.941808	0.0282408	1.03 [0.48 - 2.20]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219439_at	82	0.207317	0.0204615	0.272292	-0.820458	0.171448	-0.462514	0.63 [0.32 - 1.22]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219439_at	79	0.531646	0.0272232	0.331791	0.579231	0.243596	0.269191	1.31 [0.83 - 2.06]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219439_at	104	0.826923	0.0116292	0.180768	0.909597	0.0632702	0.565445	1.76 [0.97 - 3.20]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P252145	117	0.162393	0.0534525	-	0.969746	0.616513	0.0790298	1.08 [0.79 - 1.47]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219439_at	204	0.142157	0.0672279	-	1.66325	0.64753	0.164928	1.18 [0.58 - 2.39]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219439_at	204	0.431373	0.0488938	0.484946	0.569534	0.238052	0.311065	1.36 [0.81 - 2.29]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219439_at	178	0.870786	0.0267336	0.32772	0.582666	0.190103	0.262937	1.30 [0.88 - 1.93]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200004797	41	0.878049	0.0280536	0.338619	-15.3199	0.132102	-0.554403	0.57 [0.28 - 1.18]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219439_at	111	0.324324	0.0235592	0.300467	0.702272	0.349668	0.229753	1.26 [0.78 - 2.04]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219439_at	90	0.377778	0.0688835	-	0.770564	0.214852	0.579616	1.79 [0.71 - 4.46]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219439_at	90	0.144444	0.271263	-	0.574163	0.574958	0.270282	1.31 [0.51 - 3.37]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219439_at	138	0.847826	0.000603744	0.0166405	0.954593	0.00536523	0.346664	1.41 [1.11 - 1.81]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219439_at	129	0.534884	0.128054	-	0.374889	0.195005	0.44221	1.56 [0.80 - 3.04]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2027	56	0.875	0.00642916	0.115184	1.22383	0.157988	0.402405	1.50 [0.86 - 2.61]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	2027	56	0.875	0.0424368	0.444041	0.906976	0.650695	0.12254	1.13 [0.67 - 1.92]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219439_at	278	0.104317	0.230549	-	0.394752	0.571238	0.0935543	1.10 [0.79 - 1.52]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219439_at	133	0.75188	0.138659	-	-0.452865	0.321279	-0.17205	0.84 [0.60 - 1.18]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219439_at	185	0.113514	0.0764217	-	0.467761	0.453766	0.130905	1.14 [0.81 - 1.61]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219439_at	185	0.12973	0.112602	-	0.425726	0.659357	0.084721	1.09 [0.75 - 1.59]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P252145	110	0.863636	0.0257349	0.31931	0.668124	0.772656	-0.0551768	0.95 [0.65 - 1.38]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P252145	110	0.863636	0.0247323	0.310718	0.757886	0.831463	0.0507483	1.05 [0.66 - 1.68]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219439_at	80	0.675	0.0634387	-	0.788687	0.173573	0.603667	1.83 [0.77 - 4.36]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219439_at	38	0.657895	0.000161206	0.00532519	1.74433	0.0526753	0.919993	2.51 [0.99 - 6.36]
GENE	C1GALT1	core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219439_at	140	0.685714	0.379704	-	0.261954	0.651721	0.185016	1.20 [0.54 - 2.69]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CA1	carbonic anhydrase I	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205950_s_at	30	0.633333	0.131261	-	0.620771	0.451233	0.489314	1.63 [0.46 - 5.83]
GENE	CA1	carbonic anhydrase I	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205949_at	30	0.466667	0.158735	-	0.589294	0.433369	0.381231	1.46 [0.56 - 3.80]
GENE	CA1	carbonic anhydrase I	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1652431	165	0.169697	0.099423	-	-0.463212	0.253865	-0.439596	0.64 [0.30 - 1.37]
GENE	CA1	carbonic anhydrase I	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1652431	165	0.757576	0.143998	-	-0.762646	0.373056	-0.661333	0.52 [0.12 - 2.21]
GENE	CA1	carbonic anhydrase I	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205950_s_at	163	0.625767	0.00623676	0.112499	-0.581576	0.101793	-0.0957175	0.91 [0.81 - 1.02]
GENE	CA1	carbonic anhydrase I	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205949_at	163	0.417178	0.0425684	0.44491	-0.399858	0.149604	-0.508271	0.60 [0.30 - 1.20]
GENE	CA1	carbonic anhydrase I	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205950_s_at	79	0.113924	3.51101e-06	0.000172377	-1.7114	0.00154823	-0.237291	0.79 [0.68 - 0.91]
GENE	CA1	carbonic anhydrase I	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205949_at	79	0.253165	0.00137547	0.0332557	-0.9925	0.0644283	-0.77423	0.46 [0.20 - 1.05]
GENE	CA1	carbonic anhydrase I	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205949_at	58	0.103448	0.253284	-	-0.501166	0.884313	-0.0374734	0.96 [0.58 - 1.60]
GENE	CA1	carbonic anhydrase I	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205950_s_at	58	0.465517	0.000110103	0.00381193	-1.14433	0.000264891	-0.347008	0.71 [0.59 - 0.85]
GENE	CA1	carbonic anhydrase I	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205950_s_at	34	0.147059	0.0149477	0.21745	-1.26293	0.0808748	-0.222782	0.80 [0.62 - 1.03]
GENE	CA1	carbonic anhydrase I	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205949_at	34	0.705882	0.0177806	0.246457	-1.06845	0.0715816	-0.924227	0.40 [0.15 - 1.08]
GENE	CA1	carbonic anhydrase I	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205950_s_at	158	0.886076	0.146574	-	-0.660541	0.836608	-0.147119	0.86 [0.21 - 3.49]
GENE	CA1	carbonic anhydrase I	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205949_at	158	0.227848	0.161084	-	0.424778	0.687267	-0.305023	0.74 [0.17 - 3.25]
GENE	CA1	carbonic anhydrase I	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205950_s_at	53	0.698113	0.0233155	0.29831	0.832528	0.518763	0.185339	1.20 [0.69 - 2.11]
GENE	CA1	carbonic anhydrase I	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205949_at	53	0.603774	0.147727	-	-0.572063	0.809826	-0.0770945	0.93 [0.49 - 1.73]
GENE	CA1	carbonic anhydrase I	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205950_s_at	53	0.754717	0.0497344	0.490028	0.709778	0.69267	0.102956	1.11 [0.67 - 1.85]
GENE	CA1	carbonic anhydrase I	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205949_at	53	0.150943	0.0373507	0.409257	-0.841322	0.175406	-0.388754	0.68 [0.39 - 1.19]
GENE	CA1	carbonic anhydrase I	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205950_s_at	180	0.166667	0.106625	-	0.513474	0.179729	0.144965	1.16 [0.94 - 1.43]
GENE	CA1	carbonic anhydrase I	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205949_at	180	0.888889	0.0298991	0.353463	0.60677	0.755005	0.0727086	1.08 [0.68 - 1.70]
GENE	CA1	carbonic anhydrase I	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205950_s_at	559	0.518784	0.280232	-	-0.217893	0.839048	-0.0396349	0.96 [0.66 - 1.41]
GENE	CA1	carbonic anhydrase I	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205949_at	559	0.70483	0.0186754	0.255243	-0.53279	0.148227	-0.283927	0.75 [0.51 - 1.11]
GENE	CA1	carbonic anhydrase I	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205949_at	77	0.376623	0.0804106	-	0.473238	0.239687	0.365329	1.44 [0.78 - 2.65]
GENE	CA1	carbonic anhydrase I	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205950_s_at	77	0.337662	0.0125345	0.191102	0.693288	0.061545	0.366907	1.44 [0.98 - 2.12]
GENE	CA1	carbonic anhydrase I	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205950_s_at	70	0.628571	0.00557692	0.103108	-0.771484	0.14011	-1.77072	0.17 [0.02 - 1.79]
GENE	CA1	carbonic anhydrase I	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205949_at	70	0.114286	0.0285658	0.342784	1.09521	0.641503	0.627856	1.87 [0.13 - 26.33]
GENE	CA1	carbonic anhydrase I	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39241_at	50	0.76	0.0663382	-	-0.773557	0.176676	-1.38859	0.25 [0.03 - 1.87]
GENE	CA1	carbonic anhydrase I	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205950_s_at	74	0.22973	0.0373261	0.409083	-0.656204	0.0738684	-0.419628	0.66 [0.41 - 1.04]
GENE	CA1	carbonic anhydrase I	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205949_at	74	0.77027	0.0292668	0.348428	-0.867946	0.806556	-0.0895076	0.91 [0.45 - 1.87]
GENE	CA1	carbonic anhydrase I	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205950_s_at	67	0.268657	0.0621545	-	15.5373	0.0207555	1.21051	3.36 [1.20 - 9.36]
GENE	CA1	carbonic anhydrase I	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205949_at	67	0.58209	0.165544	-	0.94757	0.867805	0.430279	1.54 [0.01 - 243.96]
GENE	CA1	carbonic anhydrase I	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205950_s_at	115	0.243478	0.0270553	0.330399	15.4874	0.310555	0.821781	2.27 [0.46 - 11.14]
GENE	CA1	carbonic anhydrase I	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205949_at	115	0.8	0.0518817	-	-15.3863	0.212531	-0.784889	0.46 [0.13 - 1.57]
GENE	CA1	carbonic anhydrase I	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39241_at	158	0.221519	0.0272121	0.331699	1.00111	0.140918	0.265056	1.30 [0.92 - 1.86]
GENE	CA1	carbonic anhydrase I	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39241_at	76	0.644737	0.0534894	-	0.982222	0.188808	0.80948	2.25 [0.67 - 7.51]
GENE	CA1	carbonic anhydrase I	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205949_at	204	0.436274	0.0614616	-	-0.265464	0.351564	-0.0713776	0.93 [0.80 - 1.08]
GENE	CA1	carbonic anhydrase I	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205950_s_at	204	0.632353	0.176463	-	-0.19766	0.753593	0.0257962	1.03 [0.87 - 1.21]
GENE	CA1	carbonic anhydrase I	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205950_s_at	87	0.655172	0.0212161	0.279311	0.846992	0.373511	0.794162	2.21 [0.38 - 12.72]
GENE	CA1	carbonic anhydrase I	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205950_s_at	87	0.655172	0.0212161	0.279311	0.846992	0.373511	0.794162	2.21 [0.38 - 12.72]
GENE	CA1	carbonic anhydrase I	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205949_at	87	0.655172	0.03002	0.354421	0.802412	0.207287	1.33527	3.80 [0.48 - 30.28]
GENE	CA1	carbonic anhydrase I	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205949_at	87	0.655172	0.03002	0.354421	0.802412	0.207287	1.33527	3.80 [0.48 - 30.28]
GENE	CA1	carbonic anhydrase I	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205949_at	77	0.155844	0.124708	-	-1.02253	0.209112	-2.49315	0.08 [0.00 - 4.04]
GENE	CA1	carbonic anhydrase I	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205949_at	77	0.155844	0.337639	-	-0.623631	0.953872	-0.0883844	0.92 [0.05 - 18.29]
GENE	CA1	carbonic anhydrase I	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205950_s_at	77	0.545455	0.0834092	-	-1.28048	0.815134	-0.363229	0.70 [0.03 - 14.61]
GENE	CA1	carbonic anhydrase I	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205950_s_at	77	0.350649	0.11817	-	1.13896	0.520819	0.820957	2.27 [0.19 - 27.85]
GENE	CA1	carbonic anhydrase I	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205950_s_at	136	0.757353	0.0426197	0.445248	0.903776	0.883573	-0.0396438	0.96 [0.57 - 1.63]
GENE	CA1	carbonic anhydrase I	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205949_at	136	0.125	0.0330907	0.37813	15.446	0.596401	0.102051	1.11 [0.76 - 1.62]
GENE	CA1	carbonic anhydrase I	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205950_s_at	200	0.84	0.0044001	0.0855589	0.904355	0.0453225	0.514288	1.67 [1.01 - 2.77]
GENE	CA1	carbonic anhydrase I	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205949_at	200	0.345	0.0358543	0.398543	0.7648	0.0847377	0.481264	1.62 [0.94 - 2.80]
GENE	CA1	carbonic anhydrase I	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	328	60	0.6	0.282937	-	0.40378	0.875129	-0.15182	0.86 [0.13 - 5.71]
GENE	CA1	carbonic anhydrase I	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	328	60	0.733333	0.0112018	0.175795	-1.43055	0.433271	-0.451891	0.64 [0.21 - 1.97]
GENE	CA1	carbonic anhydrase I	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	20269	155	0.458065	0.000365802	0.0108397	1.09071	0.140771	0.124743	1.13 [0.96 - 1.34]
GENE	CA1	carbonic anhydrase I	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205949_at	286	0.667832	0.0292292	0.348126	-0.476167	0.246157	-0.225759	0.80 [0.54 - 1.17]
GENE	CA1	carbonic anhydrase I	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205950_s_at	286	0.41958	0.0555688	-	-0.368479	0.32498	-0.133479	0.88 [0.67 - 1.14]
GENE	CA1	carbonic anhydrase I	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205949_at	159	0.125786	0.121942	-	1.07038	0.282751	0.483862	1.62 [0.67 - 3.92]
GENE	CA1	carbonic anhydrase I	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205949_at	159	0.710692	0.187036	-	0.427415	0.58694	0.236333	1.27 [0.54 - 2.97]
GENE	CA1	carbonic anhydrase I	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205950_s_at	159	0.761006	0.383679	-	0.299496	0.981824	-0.00612052	0.99 [0.59 - 1.68]
GENE	CA1	carbonic anhydrase I	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205950_s_at	159	0.811321	0.184241	-	0.465719	0.400887	0.24241	1.27 [0.72 - 2.24]
GENE	CA1	carbonic anhydrase I	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205950_s_at	159	0.855346	0.203288	-	-0.901783	0.922596	0.0310224	1.03 [0.55 - 1.93]
GENE	CA1	carbonic anhydrase I	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205949_at	159	0.710692	0.215172	-	0.470131	0.65343	0.232502	1.26 [0.46 - 3.48]
GENE	CA1	carbonic anhydrase I	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205949_at	54	0.12963	0.00252689	0.0548197	-1.86761	0.21642	-2.61698	0.07 [0.00 - 4.63]
GENE	CA1	carbonic anhydrase I	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205950_s_at	54	0.833333	0.116021	-	-15.4119	0.327112	-0.805464	0.45 [0.09 - 2.24]
GENE	CA1	carbonic anhydrase I	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205949_at	117	0.794872	0.0162926	0.231458	-1.57574	0.0790934	-2.16498	0.11 [0.01 - 1.29]
GENE	CA1	carbonic anhydrase I	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205949_at	117	0.641026	0.00638383	0.114554	-1.52161	0.0364703	-3.53015	0.03 [0.00 - 0.80]
GENE	CA1	carbonic anhydrase I	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205950_s_at	117	0.358974	0.164086	-	0.598011	0.739563	0.178358	1.20 [0.42 - 3.42]
GENE	CA1	carbonic anhydrase I	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205950_s_at	117	0.273504	0.0435514	0.451349	1.17146	0.518881	0.349754	1.42 [0.49 - 4.11]
GENE	CA1	carbonic anhydrase I	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205950_s_at	117	0.666667	0.204149	-	-0.460445	0.784759	0.126011	1.13 [0.46 - 2.80]
GENE	CA1	carbonic anhydrase I	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205950_s_at	117	0.666667	0.204149	-	-0.460445	0.784759	0.126011	1.13 [0.46 - 2.80]
GENE	CA1	carbonic anhydrase I	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205949_at	117	0.794872	0.0162926	0.231458	-1.57574	0.0790934	-2.16498	0.11 [0.01 - 1.29]
GENE	CA1	carbonic anhydrase I	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205949_at	117	0.837607	0.019972	0.267681	-15.2864	0.036356	-3.41552	0.03 [0.00 - 0.80]
GENE	CA1	carbonic anhydrase I	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205949_at	236	0.317797	0.0709931	-	-0.489131	0.744169	-0.124599	0.88 [0.42 - 1.87]
GENE	CA1	carbonic anhydrase I	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205950_s_at	236	0.652542	0.104867	-	0.437373	0.832493	-0.0620687	0.94 [0.53 - 1.67]
GENE	CA1	carbonic anhydrase I	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205949_at	249	0.289157	0.0651572	-	-0.40608	0.457009	-0.213251	0.81 [0.46 - 1.42]
GENE	CA1	carbonic anhydrase I	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205950_s_at	249	0.273092	0.139609	-	-0.332269	0.652213	-0.101965	0.90 [0.58 - 1.41]
GENE	CA1	carbonic anhydrase I	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205949_at	62	0.854839	0.0398953	0.426964	-15.36	0.623904	-0.114149	0.89 [0.57 - 1.41]
GENE	CA1	carbonic anhydrase I	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205950_s_at	54	0.888889	0.195319	-	-15.2121	0.675518	-0.0837806	0.92 [0.62 - 1.36]
GENE	CA1	carbonic anhydrase I	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205949_at	125	0.816	0.0798058	-	-1.2102	0.333632	-1.08253	0.34 [0.04 - 3.04]
GENE	CA1	carbonic anhydrase I	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205949_at	125	0.344	0.0159133	0.227553	-0.705066	0.120103	-1.34625	0.26 [0.05 - 1.42]
GENE	CA1	carbonic anhydrase I	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205949_at	54	0.833333	0.0782621	-	-15.3869	0.651781	-0.127718	0.88 [0.51 - 1.53]
GENE	CA1	carbonic anhydrase I	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205950_s_at	125	0.336	0.0930991	-	-0.627507	0.510226	-0.430156	0.65 [0.18 - 2.34]
GENE	CA1	carbonic anhydrase I	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205950_s_at	125	0.688	0.0670629	-	-0.701138	0.420102	-0.409821	0.66 [0.25 - 1.80]
GENE	CA1	carbonic anhydrase I	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205950_s_at	62	0.112903	0.188307	-	15.1778	0.583856	-0.090264	0.91 [0.66 - 1.26]
GENE	CA1	carbonic anhydrase I	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205949_at	198	0.186869	0.0364379	0.402749	-0.624103	0.423353	-0.0806909	0.92 [0.76 - 1.12]
GENE	CA1	carbonic anhydrase I	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205949_at	198	0.212121	0.0112717	0.176613	-0.592419	0.195647	-0.103068	0.90 [0.77 - 1.05]
GENE	CA1	carbonic anhydrase I	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205950_s_at	198	0.186869	0.0504405	-	0.887704	0.388363	0.144647	1.16 [0.83 - 1.61]
GENE	CA1	carbonic anhydrase I	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205949_at	198	0.186869	0.0506155	-	-0.562557	0.700692	-0.0372225	0.96 [0.80 - 1.16]
GENE	CA1	carbonic anhydrase I	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205950_s_at	198	0.787879	0.0368622	0.405785	0.487411	0.578747	0.0731597	1.08 [0.83 - 1.39]
GENE	CA1	carbonic anhydrase I	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205950_s_at	198	0.186869	0.0346083	0.389443	0.880017	0.242729	0.187307	1.21 [0.88 - 1.65]
GENE	CA1	carbonic anhydrase I	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205949_at	51	0.843137	0.0915072	-	1.42009	0.249367	3.60765	36.88 [0.08 - 17090.06]
GENE	CA1	carbonic anhydrase I	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205950_s_at	62	0.83871	0.36045	-	-0.922559	0.497015	-0.124473	0.88 [0.62 - 1.26]
GENE	CA1	carbonic anhydrase I	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205949_at	62	0.177419	0.148445	-	-0.858733	0.61221	0.838196	2.31 [0.09 - 59.09]
GENE	CA1	carbonic anhydrase I	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205950_s_at	51	0.27451	0.164482	-	15.5337	0.50502	-0.295784	0.74 [0.31 - 1.78]
GENE	CA1	carbonic anhydrase I	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205949_at	177	0.60452	0.064178	-	-0.491521	0.403962	-0.59576	0.55 [0.14 - 2.23]
GENE	CA1	carbonic anhydrase I	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205949_at	145	0.144828	0.0563496	-	1.29688	0.849546	0.176031	1.19 [0.19 - 7.35]
GENE	CA1	carbonic anhydrase I	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205950_s_at	177	0.40113	0.0451431	0.461601	-0.535029	0.401988	0.127387	1.14 [0.84 - 1.53]
GENE	CA1	carbonic anhydrase I	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205949_at	177	0.305085	0.279924	-	0.334536	0.89383	-0.106519	0.90 [0.19 - 4.30]
GENE	CA1	carbonic anhydrase I	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205950_s_at	177	0.40113	0.0372457	0.408513	-0.483989	0.45157	0.101097	1.11 [0.85 - 1.44]
GENE	CA1	carbonic anhydrase I	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205950_s_at	145	0.503448	0.0293576	0.349154	-0.753254	0.419023	-0.18341	0.83 [0.53 - 1.30]
GENE	CA1	carbonic anhydrase I	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205949_at	226	0.783186	0.0707425	-	-0.82948	0.933281	-0.0187991	0.98 [0.63 - 1.52]
GENE	CA1	carbonic anhydrase I	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205950_s_at	226	0.150442	0.0534092	-	1.09516	0.885513	0.0122656	1.01 [0.86 - 1.20]
GENE	CA1	carbonic anhydrase I	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205949_at	49	0.306122	0.0774724	-	-0.983976	0.398389	-1.83906	0.16 [0.00 - 11.35]
GENE	CA1	carbonic anhydrase I	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205950_s_at	55	0.490909	0.0743213	-	-0.816	0.469004	-0.135005	0.87 [0.61 - 1.26]
GENE	CA1	carbonic anhydrase I	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205950_s_at	55	0.581818	0.000270337	0.00834956	-2.75466	0.0139376	-1.23052	0.29 [0.11 - 0.78]
GENE	CA1	carbonic anhydrase I	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205950_s_at	49	0.489796	0.00315269	0.0655609	-1.97809	0.297192	-0.328266	0.72 [0.39 - 1.33]
GENE	CA1	carbonic anhydrase I	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205949_at	55	0.327273	0.0185974	0.254483	-1.04706	0.215589	-2.28361	0.10 [0.00 - 3.78]
GENE	CA1	carbonic anhydrase I	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205949_at	55	0.818182	0.073531	-	-1.64581	0.211761	-2.18377	0.11 [0.00 - 3.47]
GENE	CA1	carbonic anhydrase I	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	275738	34	0.676471	0.0362066	0.401087	0.90871	0.321674	0.409892	1.51 [0.67 - 3.39]
GENE	CA1	carbonic anhydrase I	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205949_at	63	0.126984	0.00182765	0.0420638	-1.23192	0.12554	-15.3101	0.00 [0.00 - 72.10]
GENE	CA1	carbonic anhydrase I	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205950_s_at	63	0.52381	0.00924115	0.152121	-0.901363	0.187113	-1.05789	0.35 [0.07 - 1.67]
GENE	CA1	carbonic anhydrase I	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g179792_3p_at	28	0.642857	0.0502235	-	-1.27383	0.364678	-2.05438	0.13 [0.00 - 10.89]
GENE	CA1	carbonic anhydrase I	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502516_3p_a_at	28	0.321429	0.0987843	-	-0.914952	0.416196	-1.63396	0.20 [0.00 - 10.02]
GENE	CA1	carbonic anhydrase I	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205949_at	82	0.109756	0.264589	-	0.793476	0.835176	0.111628	1.12 [0.39 - 3.20]
GENE	CA1	carbonic anhydrase I	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205949_at	79	0.316456	0.0715068	-	-0.484943	0.34913	-0.561992	0.57 [0.18 - 1.85]
GENE	CA1	carbonic anhydrase I	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205949_at	104	0.259615	0.141993	-	0.643229	0.467585	0.447009	1.56 [0.47 - 5.22]
GENE	CA1	carbonic anhydrase I	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205950_s_at	204	0.852941	0.019645	0.264575	-15.273	0.089263	-0.607059	0.54 [0.27 - 1.10]
GENE	CA1	carbonic anhydrase I	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205950_s_at	204	0.882353	0.013118	0.197627	-2.09771	0.161626	-0.348436	0.71 [0.43 - 1.15]
GENE	CA1	carbonic anhydrase I	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205949_at	204	0.857843	0.200779	-	-0.906629	0.917334	0.0346839	1.04 [0.54 - 1.99]
GENE	CA1	carbonic anhydrase I	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205949_at	204	0.205882	0.0943588	-	0.665587	0.165785	0.399482	1.49 [0.85 - 2.62]
GENE	CA1	carbonic anhydrase I	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205949_at	178	0.202247	0.228921	-	-0.280799	0.698488	-0.1615	0.85 [0.38 - 1.93]
GENE	CA1	carbonic anhydrase I	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205949_at	111	0.585586	0.0660544	-	0.47974	0.868621	0.0438701	1.04 [0.62 - 1.76]
GENE	CA1	carbonic anhydrase I	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205950_s_at	111	0.495495	0.096443	-	0.440828	0.739434	0.0750417	1.08 [0.69 - 1.68]
GENE	CA1	carbonic anhydrase I	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205949_at	90	0.877778	0.0104727	0.167163	1.00068	0.346406	0.671136	1.96 [0.48 - 7.91]
GENE	CA1	carbonic anhydrase I	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205949_at	90	0.877778	0.00167837	0.0392124	1.24107	0.202057	1.03569	2.82 [0.57 - 13.83]
GENE	CA1	carbonic anhydrase I	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205950_s_at	90	0.788889	0.0986109	-	-0.969773	0.863947	-0.134082	0.87 [0.19 - 4.05]
GENE	CA1	carbonic anhydrase I	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205950_s_at	90	0.8	0.0265073	0.325828	-1.25258	0.68755	-0.271533	0.76 [0.20 - 2.86]
GENE	CA1	carbonic anhydrase I	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2616	50	0.3	0.255687	-	-0.549172	0.853565	0.138856	1.15 [0.26 - 5.02]
GENE	CA1	carbonic anhydrase I	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205950_s_at	138	0.144928	0.113593	-	-0.472337	0.103574	0.27766	1.32 [0.94 - 1.84]
GENE	CA1	carbonic anhydrase I	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205949_at	138	0.891304	0.067962	-	-0.909774	0.265709	-4.1537	0.02 [0.00 - 23.59]
GENE	CA1	carbonic anhydrase I	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205950_s_at	129	0.821705	0.108536	-	0.478746	0.536023	0.12863	1.14 [0.76 - 1.71]
GENE	CA1	carbonic anhydrase I	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205949_at	129	0.147287	0.0914344	-	-0.558035	0.926865	-0.0340481	0.97 [0.47 - 2.00]
GENE	CA1	carbonic anhydrase I	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	14761	56	0.732143	0.0136567	0.20356	0.942128	0.844707	0.0709707	1.07 [0.53 - 2.18]
GENE	CA1	carbonic anhydrase I	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	14761	56	0.839286	0.00956139	0.156091	1.07779	0.579667	0.201772	1.22 [0.60 - 2.50]
GENE	CA1	carbonic anhydrase I	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205950_s_at	278	0.863309	0.0380789	0.414389	-0.593163	0.0809905	-0.710625	0.49 [0.22 - 1.09]
GENE	CA1	carbonic anhydrase I	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205949_at	278	0.111511	0.342666	-	0.300798	0.659685	0.295525	1.34 [0.36 - 5.01]
GENE	CA1	carbonic anhydrase I	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205949_at	133	0.781955	0.000166848	0.00548768	0.964016	0.0705294	3.03191	20.74 [0.78 - 554.36]
GENE	CA1	carbonic anhydrase I	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205950_s_at	133	0.669173	0.000461311	0.0132272	0.837028	0.115783	0.614757	1.85 [0.86 - 3.98]
GENE	CA1	carbonic anhydrase I	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	7878	81	0.888889	0.285942	-	-1.06062	0.708794	-0.223621	0.80 [0.25 - 2.59]
GENE	CA1	carbonic anhydrase I	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5924	81	0.82716	0.11002	-	-15.2527	0.465553	-0.499447	0.61 [0.16 - 2.32]
GENE	CA1	carbonic anhydrase I	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205949_at	185	0.578378	0.0475252	0.476556	0.349207	0.198961	0.345437	1.41 [0.83 - 2.39]
GENE	CA1	carbonic anhydrase I	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205950_s_at	185	0.151351	0.0122631	0.188032	0.566864	0.135288	0.337961	1.40 [0.90 - 2.18]
GENE	CA1	carbonic anhydrase I	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205949_at	185	0.562162	0.0825017	-	0.282125	0.229124	0.298343	1.35 [0.83 - 2.19]
GENE	CA1	carbonic anhydrase I	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205950_s_at	185	0.151351	0.0728609	-	0.432482	0.198659	0.319046	1.38 [0.85 - 2.24]
GENE	CA1	carbonic anhydrase I	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P168916	110	0.2	0.228062	-	0.450129	0.813756	0.0508905	1.05 [0.69 - 1.61]
GENE	CA1	carbonic anhydrase I	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P168916	110	0.763636	0.117274	-	0.403659	0.306491	0.1782	1.20 [0.85 - 1.68]
GENE	CA1	carbonic anhydrase I	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205950_s_at	80	0.6125	0.0130406	0.196767	1.0657	0.0504688	0.484726	1.62 [1.00 - 2.64]
GENE	CA1	carbonic anhydrase I	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205949_at	80	0.575	0.0664533	-	-0.866931	0.57878	-0.16197	0.85 [0.48 - 1.51]
GENE	CA1	carbonic anhydrase I	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_2398	281	0.217082	0.0997517	-	0.283775	0.394414	-0.115117	0.89 [0.68 - 1.16]
GENE	CA1	carbonic anhydrase I	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205949_at	38	0.552632	0.188245	-	-0.627356	0.477482	-0.203779	0.82 [0.46 - 1.43]
GENE	CA1	carbonic anhydrase I	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205950_s_at	38	0.631579	0.294243	-	-0.510382	0.900642	-0.087179	0.92 [0.23 - 3.60]
GENE	CA1	carbonic anhydrase I	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205949_at	140	0.135714	0.00199593	0.0452193	-1.06649	0.0373239	-3.01553	0.05 [0.00 - 0.84]
GENE	CA1	carbonic anhydrase I	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205950_s_at	140	0.421429	0.14949	-	0.465022	0.61058	0.338108	1.40 [0.38 - 5.15]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CA12	carbonic anhydrase XII	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214164_x_at	30	0.3	0.0169403	0.238049	1.15827	0.52201	0.105588	1.11 [0.80 - 1.54]
GENE	CA12	carbonic anhydrase XII	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204508_s_at	30	0.266667	0.0200899	0.268796	1.22207	0.667903	0.0800398	1.08 [0.75 - 1.56]
GENE	CA12	carbonic anhydrase XII	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204509_at	30	0.166667	0.0106625	0.169429	-1.35261	0.960571	0.0331089	1.03 [0.28 - 3.84]
GENE	CA12	carbonic anhydrase XII	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	210735_s_at	30	0.166667	0.00398174	0.079033	2.41695	0.360266	0.171413	1.19 [0.82 - 1.71]
GENE	CA12	carbonic anhydrase XII	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	203963_at	30	0.333333	0.041932	0.440696	0.939634	0.652413	0.0780597	1.08 [0.77 - 1.52]
GENE	CA12	carbonic anhydrase XII	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1720998	165	0.509091	0.00197224	0.0447787	-0.75836	0.0772464	-0.139466	0.87 [0.75 - 1.02]
GENE	CA12	carbonic anhydrase XII	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1720998	165	0.50303	0.00028144	0.00864549	-1.4302	0.00729486	-0.306349	0.74 [0.59 - 0.92]
GENE	CA12	carbonic anhydrase XII	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204509_at	163	0.472393	0.0556245	-	0.381958	0.236048	0.568315	1.77 [0.69 - 4.52]
GENE	CA12	carbonic anhydrase XII	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	210735_s_at	163	0.300613	0.0400796	0.428222	0.474673	0.122675	0.947483	2.58 [0.77 - 8.59]
GENE	CA12	carbonic anhydrase XII	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	203963_at	163	0.693252	0.0272369	0.331905	-0.504456	0.268921	-0.602699	0.55 [0.19 - 1.59]
GENE	CA12	carbonic anhydrase XII	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214164_x_at	163	0.423313	0.0445124	0.457565	-0.395319	0.378249	-0.553467	0.57 [0.17 - 1.97]
GENE	CA12	carbonic anhydrase XII	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204508_s_at	163	0.122699	0.232566	-	0.395433	0.713312	-0.246517	0.78 [0.21 - 2.91]
GENE	CA12	carbonic anhydrase XII	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	203963_at	79	0.202532	0.0525588	-	0.829364	0.645702	0.340813	1.41 [0.33 - 6.01]
GENE	CA12	carbonic anhydrase XII	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214164_x_at	79	0.873418	0.0919489	-	-0.969231	0.771757	-0.314541	0.73 [0.09 - 6.12]
GENE	CA12	carbonic anhydrase XII	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	210735_s_at	79	0.417722	0.102657	-	0.506842	0.638226	0.406338	1.50 [0.28 - 8.17]
GENE	CA12	carbonic anhydrase XII	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204509_at	79	0.379747	0.00478991	0.0914961	-0.80668	0.0984514	-1.13016	0.32 [0.08 - 1.23]
GENE	CA12	carbonic anhydrase XII	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204508_s_at	79	0.126582	0.0970194	-	-0.639938	0.96347	-0.037731	0.96 [0.19 - 4.84]
GENE	CA12	carbonic anhydrase XII	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203963_at	58	0.896552	0.0442534	0.455897	0.895135	0.854093	0.0345666	1.04 [0.72 - 1.50]
GENE	CA12	carbonic anhydrase XII	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214164_x_at	58	0.275862	0.0617797	-	-0.555044	0.813156	-0.0453692	0.96 [0.66 - 1.39]
GENE	CA12	carbonic anhydrase XII	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204508_s_at	58	0.87931	0.217222	-	-0.533096	0.870762	0.0229539	1.02 [0.78 - 1.35]
GENE	CA12	carbonic anhydrase XII	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204509_at	58	0.362069	0.00344851	0.0704577	0.889446	0.0516305	0.441356	1.55 [1.00 - 2.43]
GENE	CA12	carbonic anhydrase XII	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210735_s_at	58	0.706897	0.192668	-	0.388322	0.926499	0.0227493	1.02 [0.63 - 1.66]
GENE	CA12	carbonic anhydrase XII	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	210735_s_at	34	0.705882	0.0939833	-	-0.722481	0.953523	0.0193613	1.02 [0.53 - 1.96]
GENE	CA12	carbonic anhydrase XII	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	203963_at	34	0.352941	0.103191	-	-0.643155	0.354724	-0.257711	0.77 [0.45 - 1.33]
GENE	CA12	carbonic anhydrase XII	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214164_x_at	34	0.676471	0.224183	-	-0.508858	0.906164	-0.0397288	0.96 [0.50 - 1.86]
GENE	CA12	carbonic anhydrase XII	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204508_s_at	34	0.558824	0.1302	-	-0.581801	0.628756	-0.195567	0.82 [0.37 - 1.82]
GENE	CA12	carbonic anhydrase XII	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204509_at	34	0.705882	0.187414	-	-0.576883	0.572505	-0.339508	0.71 [0.22 - 2.32]
GENE	CA12	carbonic anhydrase XII	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214164_x_at	158	0.164557	0.0255349	0.317608	-0.621222	0.0587657	-0.634805	0.53 [0.27 - 1.02]
GENE	CA12	carbonic anhydrase XII	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204508_s_at	158	0.860759	0.0147765	0.215633	-1.07485	0.127416	-0.707432	0.49 [0.20 - 1.22]
GENE	CA12	carbonic anhydrase XII	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204509_at	158	0.85443	0.0211197	0.278421	0.661826	0.320603	0.866782	2.38 [0.43 - 13.16]
GENE	CA12	carbonic anhydrase XII	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	210735_s_at	158	0.841772	0.0424317	0.444007	-0.785315	0.0950979	-0.705913	0.49 [0.22 - 1.13]
GENE	CA12	carbonic anhydrase XII	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	203963_at	158	0.727848	0.0174887	0.243554	-0.710151	0.186926	-0.37919	0.68 [0.39 - 1.20]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204508_s_at	53	0.54717	0.0854879	-	0.590704	0.224542	0.184494	1.20 [0.89 - 1.62]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	210735_s_at	53	0.641509	0.060571	-	0.681145	0.678666	0.15944	1.17 [0.55 - 2.49]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	203963_at	53	0.415094	0.0542705	-	0.753901	0.321568	0.210844	1.23 [0.81 - 1.87]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204509_at	53	0.716981	0.0316085	0.366826	0.748321	0.445664	0.273769	1.31 [0.65 - 2.66]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	210735_s_at	53	0.132075	0.0692917	-	-0.802055	0.902655	0.0452548	1.05 [0.51 - 2.16]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214164_x_at	53	0.358491	0.0898788	-	0.692406	0.284585	0.245273	1.28 [0.82 - 2.00]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204508_s_at	53	0.54717	0.0417123	0.439233	0.741039	0.175208	0.214452	1.24 [0.91 - 1.69]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	203963_at	53	0.679245	0.109809	-	0.562815	0.343929	0.19446	1.21 [0.81 - 1.82]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204509_at	53	0.716981	0.0120172	0.18523	0.916259	0.0468028	0.773573	2.17 [1.01 - 4.65]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214164_x_at	53	0.792453	0.119124	-	0.604431	0.343055	0.209785	1.23 [0.80 - 1.90]
GENE	CA12	carbonic anhydrase XII	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214164_x_at	180	0.388889	0.00107037	0.0269797	0.745032	0.0248848	0.355758	1.43 [1.05 - 1.95]
GENE	CA12	carbonic anhydrase XII	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204508_s_at	180	0.838889	0.0125856	0.191678	0.636941	0.0409387	0.271135	1.31 [1.01 - 1.70]
GENE	CA12	carbonic anhydrase XII	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204509_at	180	0.466667	0.0189508	0.257912	0.496957	0.134548	0.253072	1.29 [0.92 - 1.79]
GENE	CA12	carbonic anhydrase XII	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	210735_s_at	180	0.472222	0.223713	-	-0.253789	0.706	-0.0979218	0.91 [0.55 - 1.51]
GENE	CA12	carbonic anhydrase XII	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	203963_at	180	0.85	0.0103284	0.165431	0.66768	0.202132	0.195004	1.22 [0.90 - 1.64]
GENE	CA12	carbonic anhydrase XII	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	203963_at	559	0.227191	0.213427	-	-0.302557	0.75434	-0.056567	0.95 [0.66 - 1.35]
GENE	CA12	carbonic anhydrase XII	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214164_x_at	559	0.21288	0.0607055	-	-0.446176	0.730928	-0.0866278	0.92 [0.56 - 1.50]
GENE	CA12	carbonic anhydrase XII	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	210735_s_at	559	0.898032	0.164027	-	-0.508239	0.512302	-0.11553	0.89 [0.63 - 1.26]
GENE	CA12	carbonic anhydrase XII	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204509_at	559	0.318426	0.163758	-	-0.287568	0.854392	-0.0308378	0.97 [0.70 - 1.35]
GENE	CA12	carbonic anhydrase XII	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204508_s_at	559	0.867621	0.125066	-	-0.55854	0.62874	-0.0822746	0.92 [0.66 - 1.29]
GENE	CA12	carbonic anhydrase XII	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	210735_s_at	77	0.454545	0.0197558	0.265631	0.617896	0.483365	0.116882	1.12 [0.81 - 1.56]
GENE	CA12	carbonic anhydrase XII	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	203963_at	77	0.207792	0.000185261	0.00601264	1.52021	0.144014	0.171492	1.19 [0.94 - 1.49]
GENE	CA12	carbonic anhydrase XII	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214164_x_at	77	0.246753	0.000100669	0.00352292	1.43522	0.194329	0.176281	1.19 [0.91 - 1.56]
GENE	CA12	carbonic anhydrase XII	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204508_s_at	77	0.25974	0.000111418	0.00385194	1.36159	0.0124029	0.207061	1.23 [1.05 - 1.45]
GENE	CA12	carbonic anhydrase XII	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204509_at	77	0.857143	0.0849131	-	-0.727801	0.833516	-0.0627848	0.94 [0.52 - 1.69]
GENE	CA12	carbonic anhydrase XII	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	203963_at	70	0.2	0.410122	-	-0.259715	0.706021	-0.0387012	0.96 [0.79 - 1.18]
GENE	CA12	carbonic anhydrase XII	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214164_x_at	70	0.228571	0.289505	-	-0.317103	0.551147	-0.0696374	0.93 [0.74 - 1.17]
GENE	CA12	carbonic anhydrase XII	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	210735_s_at	70	0.357143	0.111014	-	-0.426338	0.849875	-0.041546	0.96 [0.62 - 1.48]
GENE	CA12	carbonic anhydrase XII	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204509_at	70	0.114286	0.0061062	0.110664	-1.02989	0.489755	-0.430774	0.65 [0.19 - 2.21]
GENE	CA12	carbonic anhydrase XII	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204508_s_at	70	0.657143	0.135796	-	-0.431674	0.745024	-0.0516609	0.95 [0.70 - 1.30]
GENE	CA12	carbonic anhydrase XII	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	36454_at	50	0.82	0.00128634	0.0314538	1.3363	0.00266655	0.347872	1.42 [1.13 - 1.78]
GENE	CA12	carbonic anhydrase XII	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204508_s_at	74	0.202703	0.00401638	0.0795798	1.21338	0.179672	0.120778	1.13 [0.95 - 1.35]
GENE	CA12	carbonic anhydrase XII	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204509_at	74	0.756757	0.0920742	-	0.531846	0.837663	0.0713326	1.07 [0.54 - 2.12]
GENE	CA12	carbonic anhydrase XII	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	210735_s_at	74	0.891892	0.0378008	0.412435	0.840014	0.216991	0.197323	1.22 [0.89 - 1.67]
GENE	CA12	carbonic anhydrase XII	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	203963_at	74	0.418919	0.0594964	-	0.565949	0.178783	0.166292	1.18 [0.93 - 1.50]
GENE	CA12	carbonic anhydrase XII	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214164_x_at	74	0.22973	0.0300718	0.35483	0.88177	0.148465	0.211065	1.23 [0.93 - 1.64]
GENE	CA12	carbonic anhydrase XII	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	203963_at	67	0.104478	0.00119146	0.029508	-2.09364	0.390553	-0.504228	0.60 [0.19 - 1.91]
GENE	CA12	carbonic anhydrase XII	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214164_x_at	67	0.134328	0.0140342	0.207668	-1.6304	0.656989	-0.30232	0.74 [0.19 - 2.81]
GENE	CA12	carbonic anhydrase XII	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	210735_s_at	67	0.164179	0.198652	-	15.2824	0.646648	0.308841	1.36 [0.36 - 5.10]
GENE	CA12	carbonic anhydrase XII	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204509_at	67	0.731343	0.0454052	0.463269	1.26302	0.0840266	4.60933	100.42 [0.54 - 18734.83]
GENE	CA12	carbonic anhydrase XII	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204508_s_at	67	0.134328	1.13676e-05	0.000501757	-2.38529	0.32194	-1.03274	0.36 [0.05 - 2.75]
GENE	CA12	carbonic anhydrase XII	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	203963_at	115	0.443478	0.00679478	0.120224	-1.59007	0.348032	-0.179131	0.84 [0.58 - 1.22]
GENE	CA12	carbonic anhydrase XII	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214164_x_at	115	0.426087	0.0041847	0.0822198	-1.66612	0.375761	-0.154955	0.86 [0.61 - 1.21]
GENE	CA12	carbonic anhydrase XII	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	210735_s_at	115	0.304348	0.0913581	-	-0.876456	0.555251	-0.131456	0.88 [0.57 - 1.36]
GENE	CA12	carbonic anhydrase XII	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204509_at	115	0.895652	0.00868509	0.145124	1.42531	0.537087	-0.642252	0.53 [0.07 - 4.04]
GENE	CA12	carbonic anhydrase XII	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204508_s_at	115	0.504348	0.0281422	0.339342	-1.32913	0.501343	-0.10692	0.90 [0.66 - 1.23]
GENE	CA12	carbonic anhydrase XII	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	36454_at	158	0.107595	0.00703939	0.123553	-0.960116	0.12355	-0.161505	0.85 [0.69 - 1.05]
GENE	CA12	carbonic anhydrase XII	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	36454_at	76	0.473684	0.105649	-	0.913147	0.440389	0.146328	1.16 [0.80 - 1.68]
GENE	CA12	carbonic anhydrase XII	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	210735_s_at	204	0.5	1.62115e-06	8.48932e-05	-0.677236	0.000516849	-0.16368	0.85 [0.77 - 0.93]
GENE	CA12	carbonic anhydrase XII	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204509_at	204	0.460784	5.76378e-06	0.000270912	-0.646384	6.9004e-05	-0.311476	0.73 [0.63 - 0.85]
GENE	CA12	carbonic anhydrase XII	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204508_s_at	204	0.446078	3.99812e-06	0.000194097	-0.653276	0.00940119	-0.0887401	0.92 [0.86 - 0.98]
GENE	CA12	carbonic anhydrase XII	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	203963_at	204	0.495098	2.97542e-06	0.000148164	-0.662631	0.00186462	-0.129338	0.88 [0.81 - 0.95]
GENE	CA12	carbonic anhydrase XII	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214164_x_at	204	0.465686	1.76528e-06	9.18042e-05	-0.676806	0.000497792	-0.17188	0.84 [0.76 - 0.93]
GENE	CA12	carbonic anhydrase XII	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204508_s_at	87	0.758621	0.212975	-	-0.661128	0.662751	-0.113601	0.89 [0.54 - 1.49]
GENE	CA12	carbonic anhydrase XII	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	210735_s_at	87	0.482759	0.0696468	-	-0.689724	0.448863	-0.17774	0.84 [0.53 - 1.33]
GENE	CA12	carbonic anhydrase XII	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	203963_at	87	0.448276	0.136165	-	-0.56247	0.494511	-0.180337	0.83 [0.50 - 1.40]
GENE	CA12	carbonic anhydrase XII	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214164_x_at	87	0.195402	0.186284	-	-0.571181	0.592332	-0.162213	0.85 [0.47 - 1.54]
GENE	CA12	carbonic anhydrase XII	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204509_at	87	0.804598	0.248236	-	-0.69234	0.804336	-0.0905322	0.91 [0.45 - 1.87]
GENE	CA12	carbonic anhydrase XII	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	210735_s_at	87	0.482759	0.0696468	-	-0.689724	0.448863	-0.17774	0.84 [0.53 - 1.33]
GENE	CA12	carbonic anhydrase XII	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204508_s_at	87	0.758621	0.212975	-	-0.661128	0.662751	-0.113601	0.89 [0.54 - 1.49]
GENE	CA12	carbonic anhydrase XII	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204509_at	87	0.804598	0.248236	-	-0.69234	0.804336	-0.0905322	0.91 [0.45 - 1.87]
GENE	CA12	carbonic anhydrase XII	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	203963_at	87	0.448276	0.136165	-	-0.56247	0.494511	-0.180337	0.83 [0.50 - 1.40]
GENE	CA12	carbonic anhydrase XII	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214164_x_at	87	0.195402	0.186284	-	-0.571181	0.592332	-0.162213	0.85 [0.47 - 1.54]
GENE	CA12	carbonic anhydrase XII	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	210735_s_at	77	0.441558	0.144226	-	-0.810775	0.493614	-0.151087	0.86 [0.56 - 1.33]
GENE	CA12	carbonic anhydrase XII	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204508_s_at	77	0.116883	0.246634	-	-0.888016	0.231237	-0.30936	0.73 [0.44 - 1.22]
GENE	CA12	carbonic anhydrase XII	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204509_at	77	0.558442	0.194807	-	0.723338	0.777677	-0.184996	0.83 [0.23 - 3.00]
GENE	CA12	carbonic anhydrase XII	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	203963_at	77	0.272727	0.282499	-	-0.681174	0.136924	-0.302343	0.74 [0.50 - 1.10]
GENE	CA12	carbonic anhydrase XII	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214164_x_at	77	0.883117	0.231451	-	-15.2146	0.109137	-0.410938	0.66 [0.40 - 1.10]
GENE	CA12	carbonic anhydrase XII	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204508_s_at	77	0.727273	0.334961	-	0.54304	0.440036	-0.194958	0.82 [0.50 - 1.35]
GENE	CA12	carbonic anhydrase XII	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	210735_s_at	77	0.376623	0.112669	-	-0.984181	0.331115	-0.233308	0.79 [0.49 - 1.27]
GENE	CA12	carbonic anhydrase XII	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	203963_at	77	0.688312	0.22078	-	0.668847	0.347132	-0.196867	0.82 [0.54 - 1.24]
GENE	CA12	carbonic anhydrase XII	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214164_x_at	77	0.662338	0.117057	-	0.846721	0.289214	-0.277971	0.76 [0.45 - 1.27]
GENE	CA12	carbonic anhydrase XII	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204509_at	77	0.272727	0.0608967	-	-1.12627	0.459223	-0.608803	0.54 [0.11 - 2.73]
GENE	CA12	carbonic anhydrase XII	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204509_at	136	0.308824	0.093038	-	1.01254	0.955614	-0.0226242	0.98 [0.44 - 2.17]
GENE	CA12	carbonic anhydrase XII	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	210735_s_at	136	0.220588	0.0149528	0.217503	-1.06693	0.119744	-0.432427	0.65 [0.38 - 1.12]
GENE	CA12	carbonic anhydrase XII	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	203963_at	136	0.580882	0.122808	-	-0.749078	0.948401	-0.0243064	0.98 [0.47 - 2.04]
GENE	CA12	carbonic anhydrase XII	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214164_x_at	136	0.117647	0.159835	-	-0.770101	0.999008	-0.000506157	1.00 [0.45 - 2.22]
GENE	CA12	carbonic anhydrase XII	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204508_s_at	136	0.625	0.250631	-	-0.586098	0.407554	-0.203436	0.82 [0.50 - 1.32]
GENE	CA12	carbonic anhydrase XII	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204508_s_at	200	0.26	0.0232809	0.298003	-0.670563	0.157609	-0.132801	0.88 [0.73 - 1.05]
GENE	CA12	carbonic anhydrase XII	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204509_at	200	0.125	0.179786	-	0.78119	0.551718	0.195319	1.22 [0.64 - 2.31]
GENE	CA12	carbonic anhydrase XII	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	210735_s_at	200	0.3	0.0204133	0.271839	-0.675056	0.0684418	-0.279795	0.76 [0.56 - 1.02]
GENE	CA12	carbonic anhydrase XII	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	203963_at	200	0.88	0.0670428	-	0.698898	0.414463	-0.108316	0.90 [0.69 - 1.16]
GENE	CA12	carbonic anhydrase XII	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214164_x_at	200	0.89	0.0326749	0.374984	0.8613	0.606516	-0.0765524	0.93 [0.69 - 1.24]
GENE	CA12	carbonic anhydrase XII	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9382	60	0.116667	0.123593	-	-0.749123	0.33843	-0.103024	0.90 [0.73 - 1.11]
GENE	CA12	carbonic anhydrase XII	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4224	60	0.166667	0.00182185	0.0419541	-1.26595	0.313503	-0.142708	0.87 [0.66 - 1.14]
GENE	CA12	carbonic anhydrase XII	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14906	60	0.266667	0.00134071	0.0325559	-1.24883	0.19042	-0.154348	0.86 [0.68 - 1.08]
GENE	CA12	carbonic anhydrase XII	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13963	60	0.116667	0.00390966	0.0778914	-1.28252	0.290065	-0.11354	0.89 [0.72 - 1.10]
GENE	CA12	carbonic anhydrase XII	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13963	60	0.2	0.00270834	0.0579921	-1.13968	0.0465504	-0.320422	0.73 [0.53 - 1.00]
GENE	CA12	carbonic anhydrase XII	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9382	60	0.766667	0.0655623	-	-1.06895	0.207422	-0.225527	0.80 [0.56 - 1.13]
GENE	CA12	carbonic anhydrase XII	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4224	60	0.133333	0.00126806	0.0310812	-1.36361	0.702539	-0.0728175	0.93 [0.64 - 1.35]
GENE	CA12	carbonic anhydrase XII	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	14906	60	0.316667	0.103732	-	-0.613306	0.579511	-0.16964	0.84 [0.46 - 1.54]
GENE	CA12	carbonic anhydrase XII	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3212	155	0.780645	8.20288e-05	0.00294072	1.06497	0.0150281	0.164868	1.18 [1.03 - 1.35]
GENE	CA12	carbonic anhydrase XII	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204508_s_at	286	0.101399	0.00466845	0.0896603	-0.7528	0.0680181	-0.111043	0.89 [0.79 - 1.01]
GENE	CA12	carbonic anhydrase XII	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204509_at	286	0.699301	0.113227	-	-0.351211	0.301062	-0.192849	0.82 [0.57 - 1.19]
GENE	CA12	carbonic anhydrase XII	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	210735_s_at	286	0.101399	0.00802928	0.136689	-0.706812	0.113333	-0.172834	0.84 [0.68 - 1.04]
GENE	CA12	carbonic anhydrase XII	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	203963_at	286	0.248252	0.177431	-	-0.29397	0.480334	-0.0592527	0.94 [0.80 - 1.11]
GENE	CA12	carbonic anhydrase XII	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214164_x_at	286	0.388112	0.085949	-	-0.334926	0.489493	-0.0573806	0.94 [0.80 - 1.11]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204509_at	159	0.72956	0.0186856	0.255341	0.735968	0.0375744	0.868786	2.38 [1.05 - 5.41]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204508_s_at	159	0.119497	0.010199	0.163871	-0.939829	0.261054	-0.121417	0.89 [0.72 - 1.09]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210735_s_at	159	0.169811	0.103928	-	-0.585518	0.604029	-0.078589	0.92 [0.69 - 1.24]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214164_x_at	159	0.125786	0.0253592	0.316108	-0.936368	0.141993	-0.246125	0.78 [0.56 - 1.09]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204508_s_at	159	0.119497	0.0183476	0.252043	-0.983689	0.430519	-0.101162	0.90 [0.70 - 1.16]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203963_at	159	0.201258	0.0576658	-	-0.643947	0.293481	-0.139667	0.87 [0.67 - 1.13]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204509_at	159	0.201258	0.0774975	-	0.900007	0.464036	0.298081	1.35 [0.61 - 2.99]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204509_at	159	0.201258	0.0170243	0.238897	2.05048	0.110521	0.785106	2.19 [0.84 - 5.75]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214164_x_at	159	0.125786	0.0232809	0.298003	-0.83516	0.167144	-0.200424	0.82 [0.62 - 1.09]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210735_s_at	159	0.100629	0.166524	-	-0.604606	0.390641	-0.128847	0.88 [0.66 - 1.18]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203963_at	159	0.100629	0.0469672	0.473094	-0.806342	0.151131	-0.187067	0.83 [0.64 - 1.07]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204508_s_at	159	0.125786	0.0257141	0.319133	-0.82158	0.669059	-0.04882	0.95 [0.76 - 1.19]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	210735_s_at	159	0.194969	0.173165	-	-0.558804	0.601	-0.0928065	0.91 [0.64 - 1.29]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	203963_at	159	0.138365	0.0591822	-	-0.797914	0.22008	-0.186263	0.83 [0.62 - 1.12]
GENE	CA12	carbonic anhydrase XII	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214164_x_at	159	0.125786	0.0172105	0.24077	-0.876002	0.0987833	-0.236205	0.79 [0.60 - 1.05]
GENE	CA12	carbonic anhydrase XII	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	210735_s_at	54	0.759259	0.0290223	0.346467	1.36326	0.218609	0.380054	1.46 [0.80 - 2.68]
GENE	CA12	carbonic anhydrase XII	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204508_s_at	54	0.833333	0.0164579	0.233149	1.54005	0.173596	0.404767	1.50 [0.84 - 2.69]
GENE	CA12	carbonic anhydrase XII	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214164_x_at	54	0.685185	0.0547244	-	1.22022	0.266049	0.488996	1.63 [0.69 - 3.86]
GENE	CA12	carbonic anhydrase XII	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204509_at	54	0.87037	0.068806	-	1.24755	0.16326	0.556974	1.75 [0.80 - 3.82]
GENE	CA12	carbonic anhydrase XII	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215867_x_at	54	0.685185	0.0279717	0.33795	1.43132	0.197089	0.523328	1.69 [0.76 - 3.74]
GENE	CA12	carbonic anhydrase XII	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	203963_at	54	0.703704	0.131196	-	0.974685	0.405629	0.303481	1.35 [0.66 - 2.77]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210735_s_at	117	0.521368	0.087435	-	0.542674	0.423747	0.0684488	1.07 [0.91 - 1.27]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210735_s_at	117	0.863248	0.141684	-	-1.38363	0.983142	0.00227776	1.00 [0.81 - 1.24]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203963_at	117	0.487179	0.0813926	-	0.558053	0.472851	0.0541415	1.06 [0.91 - 1.22]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214164_x_at	117	0.538462	0.106186	-	0.510748	0.41772	0.0621283	1.06 [0.92 - 1.24]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214164_x_at	117	0.547009	0.0398878	0.426913	0.776139	0.0851392	0.173785	1.19 [0.98 - 1.45]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203963_at	117	0.316239	0.188121	-	0.604618	0.617448	0.0464873	1.05 [0.87 - 1.26]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204508_s_at	117	0.487179	0.0231892	0.297189	0.890284	0.101167	0.159407	1.17 [0.97 - 1.42]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204508_s_at	117	0.487179	0.0939253	-	0.536802	0.379401	0.0689188	1.07 [0.92 - 1.25]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214164_x_at	117	0.102564	0.176749	-	1.28749	0.474111	0.0684225	1.07 [0.89 - 1.29]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214164_x_at	117	0.538462	0.106186	-	0.510748	0.41772	0.0621283	1.06 [0.92 - 1.24]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204508_s_at	117	0.487179	0.0939253	-	0.536802	0.379401	0.0689188	1.07 [0.92 - 1.25]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204508_s_at	117	0.316239	0.188121	-	0.604618	0.628532	0.0468367	1.05 [0.87 - 1.27]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204509_at	117	0.564103	0.0453555	0.462953	0.627124	0.437056	0.173871	1.19 [0.77 - 1.84]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204509_at	117	0.564103	0.01059	0.168565	0.970311	0.22168	0.295166	1.34 [0.84 - 2.16]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210735_s_at	117	0.521368	0.0284763	0.342059	0.839739	0.204995	0.129032	1.14 [0.93 - 1.39]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	210735_s_at	117	0.521368	0.087435	-	0.542674	0.423747	0.0684488	1.07 [0.91 - 1.27]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203963_at	117	0.487179	0.0813926	-	0.558053	0.472851	0.0541415	1.06 [0.91 - 1.22]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204509_at	117	0.564103	0.050955	-	0.761473	0.528334	0.176342	1.19 [0.69 - 2.06]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	203963_at	117	0.487179	0.0204952	0.272607	0.907649	0.0921758	0.166294	1.18 [0.97 - 1.43]
GENE	CA12	carbonic anhydrase XII	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204509_at	117	0.564103	0.0453555	0.462953	0.627124	0.437056	0.173871	1.19 [0.77 - 1.84]
GENE	CA12	carbonic anhydrase XII	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204509_at	236	0.15678	0.000267627	0.00827704	-1.03917	0.0943199	-0.593318	0.55 [0.28 - 1.11]
GENE	CA12	carbonic anhydrase XII	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	210735_s_at	236	0.762712	0.141286	-	-0.530262	0.388315	-0.145707	0.86 [0.62 - 1.20]
GENE	CA12	carbonic anhydrase XII	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	203963_at	236	0.733051	0.139172	-	-0.512178	0.47747	-0.0964232	0.91 [0.70 - 1.18]
GENE	CA12	carbonic anhydrase XII	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214164_x_at	236	0.538136	0.142778	-	-0.404606	0.560179	-0.0829566	0.92 [0.70 - 1.22]
GENE	CA12	carbonic anhydrase XII	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204508_s_at	236	0.881356	0.0452095	0.462024	-1.34023	0.434545	-0.0747856	0.93 [0.77 - 1.12]
GENE	CA12	carbonic anhydrase XII	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	203963_at	249	0.196787	0.0781608	-	-0.439277	0.520004	-0.0700466	0.93 [0.75 - 1.15]
GENE	CA12	carbonic anhydrase XII	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214164_x_at	249	0.538153	0.0394694	0.424044	-0.446643	0.584591	-0.0620502	0.94 [0.75 - 1.17]
GENE	CA12	carbonic anhydrase XII	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204508_s_at	249	0.497992	0.0533211	-	-0.412387	0.488449	-0.0549129	0.95 [0.81 - 1.11]
GENE	CA12	carbonic anhydrase XII	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204509_at	249	0.325301	0.00132237	0.0321851	-0.675851	0.014912	-0.653846	0.52 [0.31 - 0.88]
GENE	CA12	carbonic anhydrase XII	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	210735_s_at	249	0.293173	0.0435103	0.451082	-0.443319	0.440727	-0.104152	0.90 [0.69 - 1.17]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203963_at	62	0.629032	0.0802923	-	-0.962389	0.895822	-0.0275686	0.97 [0.64 - 1.47]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210735_s_at	125	0.808	0.0718301	-	-1.0689	0.775387	-0.0377665	0.96 [0.74 - 1.25]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203963_at	125	0.6	0.063861	-	-0.769592	0.937033	0.00913358	1.01 [0.80 - 1.27]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214164_x_at	62	0.33871	0.147137	-	-0.712849	0.881771	-0.0310653	0.97 [0.64 - 1.46]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210735_s_at	125	0.816	0.020084	0.26874	-0.993055	0.564243	-0.0576138	0.94 [0.78 - 1.15]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204509_at	54	0.796296	0.135825	-	-1.44502	0.661485	-0.0884378	0.92 [0.62 - 1.36]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210735_s_at	54	0.87037	0.0910144	-	1.0964	0.735361	0.0993719	1.10 [0.62 - 1.97]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204508_s_at	62	0.274194	0.116252	-	-0.791013	0.949503	-0.0107978	0.99 [0.71 - 1.38]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203963_at	125	0.688	0.0269367	0.329413	-0.742832	0.798005	-0.022087	0.98 [0.83 - 1.16]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214164_x_at	125	0.8	0.0919303	-	-0.99148	0.925896	0.0116807	1.01 [0.79 - 1.29]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	203963_at	54	0.481481	0.294787	-	0.632394	0.98029	0.00637561	1.01 [0.61 - 1.67]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204509_at	62	0.822581	0.0525343	-	-1.77367	0.626232	-0.080777	0.92 [0.67 - 1.28]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204508_s_at	125	0.576	0.0664698	-	-0.75286	0.825887	-0.0280869	0.97 [0.76 - 1.25]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214164_x_at	125	0.8	0.0250933	0.313829	-0.948952	0.881278	-0.0139664	0.99 [0.82 - 1.18]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204508_s_at	125	0.68	0.0413409	0.436749	-0.693695	0.628812	-0.0464759	0.95 [0.79 - 1.15]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214164_x_at	54	0.814815	0.226345	-	0.739192	0.964835	-0.0113227	0.99 [0.60 - 1.64]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204508_s_at	54	0.481481	0.252146	-	-0.666582	0.883494	0.0313678	1.03 [0.68 - 1.57]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	210735_s_at	62	0.758065	0.287838	-	-0.6623	0.818697	0.0533881	1.05 [0.67 - 1.67]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204509_at	125	0.104	2.5277e-08	1.77123e-06	-1.99067	0.129965	-0.523709	0.59 [0.30 - 1.17]
GENE	CA12	carbonic anhydrase XII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204509_at	125	0.104	1.48686e-08	1.07561e-06	-1.73781	0.137568	-0.398513	0.67 [0.40 - 1.14]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203963_at	198	0.479798	0.272735	-	-0.292792	0.741854	-0.0213634	0.98 [0.86 - 1.11]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214164_x_at	198	0.156566	0.182903	-	-0.425976	0.695873	-0.02713	0.97 [0.85 - 1.12]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204509_at	198	0.646465	0.171462	-	-0.313721	0.472372	0.0884953	1.09 [0.86 - 1.39]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214164_x_at	198	0.328283	0.179602	-	-0.368997	0.547548	-0.0431091	0.96 [0.83 - 1.10]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204508_s_at	198	0.454545	0.21547	-	-0.313638	0.937727	-0.00438881	1.00 [0.89 - 1.11]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210735_s_at	198	0.606061	0.0558065	-	0.401812	0.177415	0.0817252	1.09 [0.96 - 1.22]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204508_s_at	198	0.454545	0.0705593	-	-0.480784	0.672891	-0.0241995	0.98 [0.87 - 1.09]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203963_at	198	0.828283	0.0280441	0.338542	0.534033	0.160452	0.0780465	1.08 [0.97 - 1.21]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204509_at	198	0.848485	0.0802541	-	0.542233	0.704696	0.0562077	1.06 [0.79 - 1.41]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214164_x_at	198	0.70202	0.0773008	-	0.388681	0.233512	0.0726568	1.08 [0.95 - 1.21]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204509_at	198	0.580808	0.0637771	-	-0.524885	0.946938	0.0101773	1.01 [0.75 - 1.36]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210735_s_at	198	0.282828	0.384175	-	-0.239449	0.829266	-0.0150591	0.99 [0.86 - 1.13]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	210735_s_at	198	0.419192	0.226503	-	-0.323089	0.611655	-0.0363558	0.96 [0.84 - 1.11]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	203963_at	198	0.868687	0.253377	-	-0.487314	0.902535	-0.00770987	0.99 [0.88 - 1.12]
GENE	CA12	carbonic anhydrase XII	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204508_s_at	198	0.106061	0.0579493	-	0.848511	0.145879	0.072334	1.08 [0.98 - 1.19]
GENE	CA12	carbonic anhydrase XII	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	210735_s_at	51	0.588235	0.0684499	-	1.78905	0.426513	0.972406	2.64 [0.24 - 29.06]
GENE	CA12	carbonic anhydrase XII	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	203963_at	51	0.627451	0.0658622	-	-15.8724	0.788039	-0.0961737	0.91 [0.45 - 1.83]
GENE	CA12	carbonic anhydrase XII	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	210735_s_at	62	0.112903	0.0553886	-	-1.20886	0.618248	0.422758	1.53 [0.29 - 8.05]
GENE	CA12	carbonic anhydrase XII	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	203963_at	62	0.290323	0.102436	-	1.54713	0.929473	-0.0205354	0.98 [0.62 - 1.54]
GENE	CA12	carbonic anhydrase XII	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214164_x_at	51	0.294118	0.14326	-	15.5847	0.748656	0.102876	1.11 [0.59 - 2.08]
GENE	CA12	carbonic anhydrase XII	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204508_s_at	51	0.686275	0.108715	-	-15.6896	0.37247	-0.810202	0.44 [0.07 - 2.64]
GENE	CA12	carbonic anhydrase XII	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214164_x_at	62	0.806452	0.236848	-	-1.16881	0.997291	0.000687691	1.00 [0.67 - 1.49]
GENE	CA12	carbonic anhydrase XII	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204508_s_at	62	0.774194	0.0445134	0.457571	-15.477	0.216787	-0.661462	0.52 [0.18 - 1.47]
GENE	CA12	carbonic anhydrase XII	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204509_at	51	0.235294	0.0421916	0.442419	-1.66093	0.675933	0.826731	2.29 [0.05 - 110.29]
GENE	CA12	carbonic anhydrase XII	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204509_at	62	0.209677	0.0737409	-	-1.00515	0.851851	0.244667	1.28 [0.10 - 16.65]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	210735_s_at	145	0.393103	0.0091129	0.150519	-0.856922	0.198724	-0.277081	0.76 [0.50 - 1.16]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204508_s_at	177	0.361582	0.138714	-	-0.403277	0.694519	-0.0651641	0.94 [0.68 - 1.30]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204509_at	177	0.186441	0.031595	0.366722	-0.580605	0.0664581	-1.17133	0.31 [0.09 - 1.08]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	203963_at	177	0.384181	0.0782068	-	-0.475966	0.520045	-0.0930517	0.91 [0.69 - 1.21]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204508_s_at	177	0.548023	0.320205	-	-0.236432	0.677358	-0.0598718	0.94 [0.71 - 1.25]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204509_at	145	0.503448	0.0175903	0.244566	-0.835824	0.164337	-1.28518	0.28 [0.05 - 1.69]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214164_x_at	177	0.423729	0.152749	-	-0.384063	0.558265	-0.105004	0.90 [0.63 - 1.28]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204508_s_at	145	0.303448	0.0150372	0.218395	-0.800261	0.240012	-0.248215	0.78 [0.52 - 1.18]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	203963_at	177	0.333333	0.187729	-	-0.318059	0.590318	-0.0677389	0.93 [0.73 - 1.20]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	210735_s_at	177	0.282486	0.0342132	0.386522	-0.579669	0.649948	-0.0790968	0.92 [0.66 - 1.30]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214164_x_at	177	0.548023	0.304469	-	-0.244127	0.722064	-0.055852	0.95 [0.70 - 1.29]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	210735_s_at	177	0.282486	0.118401	-	-0.381718	0.653058	-0.0678681	0.93 [0.70 - 1.26]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	203963_at	145	0.365517	0.0125122	0.190851	-0.814077	0.193477	-0.226221	0.80 [0.57 - 1.12]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204509_at	177	0.451977	0.018912	0.257537	-0.635343	0.0702014	-1.33012	0.26 [0.06 - 1.12]
GENE	CA12	carbonic anhydrase XII	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214164_x_at	145	0.296552	0.0066979	0.118897	-0.879784	0.157446	-0.300155	0.74 [0.49 - 1.12]
GENE	CA12	carbonic anhydrase XII	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204509_at	226	0.836283	0.0983171	-	-0.83862	0.714744	-0.0843814	0.92 [0.58 - 1.45]
GENE	CA12	carbonic anhydrase XII	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204508_s_at	226	0.292035	0.0112901	0.176828	-0.715797	0.727661	-0.0388695	0.96 [0.77 - 1.20]
GENE	CA12	carbonic anhydrase XII	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	203963_at	226	0.274336	0.00301093	0.0631753	-0.83219	0.0884264	-0.218999	0.80 [0.62 - 1.03]
GENE	CA12	carbonic anhydrase XII	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214164_x_at	226	0.283186	0.00185864	0.0426496	-0.863288	0.146731	-0.22563	0.80 [0.59 - 1.08]
GENE	CA12	carbonic anhydrase XII	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	210735_s_at	226	0.292035	0.00201408	0.045556	-0.854158	0.143303	-0.223246	0.80 [0.59 - 1.08]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204508_s_at	55	0.545455	0.110139	-	0.71529	0.523726	0.153885	1.17 [0.73 - 1.87]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204509_at	55	0.127273	0.00516488	0.0970879	-1.47262	0.039783	-2.8665	0.06 [0.00 - 0.87]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204509_at	49	0.897959	0.0661113	-	1.16613	0.825598	-0.366614	0.69 [0.03 - 18.07]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204508_s_at	55	0.218182	0.309394	-	-0.494536	0.850754	-0.0492866	0.95 [0.57 - 1.59]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	203963_at	55	0.581818	0.0452176	0.462076	0.886771	0.554083	0.122976	1.13 [0.75 - 1.70]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214164_x_at	55	0.472727	0.0527243	-	0.915455	0.584179	0.135539	1.15 [0.70 - 1.86]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204508_s_at	49	0.346939	0.165994	-	1.02968	0.574616	0.187618	1.21 [0.63 - 2.32]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	203963_at	55	0.836364	0.33223	-	0.549403	0.887094	-0.0308937	0.97 [0.63 - 1.49]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	210735_s_at	55	0.636364	0.124899	-	0.674769	0.721337	0.0828341	1.09 [0.69 - 1.71]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214164_x_at	55	0.745455	0.269218	-	0.574935	0.998717	-0.00041936	1.00 [0.60 - 1.67]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	203963_at	49	0.857143	0.154003	-	0.926445	0.507342	0.207225	1.23 [0.67 - 2.27]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214164_x_at	49	0.857143	0.119984	-	1.00798	0.43258	0.289301	1.34 [0.65 - 2.75]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	210735_s_at	55	0.418182	0.203973	-	-0.605792	0.450235	-0.198979	0.82 [0.49 - 1.37]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204509_at	55	0.109091	0.0095152	0.155521	-1.36217	0.312715	-1.29742	0.27 [0.02 - 3.39]
GENE	CA12	carbonic anhydrase XII	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	210735_s_at	49	0.816327	0.30624	-	-1.02398	0.928332	-0.0297829	0.97 [0.51 - 1.86]
GENE	CA12	carbonic anhydrase XII	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	594633	34	0.647059	0.099664	-	-0.823745	0.680684	0.136972	1.15 [0.60 - 2.20]
GENE	CA12	carbonic anhydrase XII	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204508_s_at	63	0.68254	3.69307e-11	3.62208e-09	2.21378	8.47061e-06	0.32706	1.39 [1.20 - 1.60]
GENE	CA12	carbonic anhydrase XII	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	203963_at	63	0.777778	5.66847e-08	3.77662e-06	1.83077	3.09799e-06	0.250951	1.29 [1.16 - 1.43]
GENE	CA12	carbonic anhydrase XII	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214164_x_at	63	0.746032	5.49701e-09	4.21058e-07	1.96128	8.35148e-06	0.254698	1.29 [1.15 - 1.44]
GENE	CA12	carbonic anhydrase XII	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	210735_s_at	63	0.746032	7.57613e-07	4.21169e-05	1.66151	0.000651081	0.327187	1.39 [1.15 - 1.67]
GENE	CA12	carbonic anhydrase XII	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204509_at	63	0.603175	0.0363489	0.40211	-0.78944	0.335106	0.426542	1.53 [0.64 - 3.65]
GENE	CA12	carbonic anhydrase XII	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12654376_3p_s_at	28	0.214286	0.00726517	0.126595	-1.5845	0.23997	-9.9483	0.00 [0.00 - 769.26]
GENE	CA12	carbonic anhydrase XII	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.5344.1.A1_3p_s_at	28	0.107143	0.0642932	-	15.4298	0.434654	-0.394524	0.67 [0.25 - 1.81]
GENE	CA12	carbonic anhydrase XII	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	214164_3p_x_at	28	0.571429	0.0351638	0.393521	1.15412	0.214989	0.161142	1.17 [0.91 - 1.52]
GENE	CA12	carbonic anhydrase XII	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g8923149_3p_at	28	0.75	0.171776	-	-1.00737	0.757831	-0.130567	0.88 [0.38 - 2.01]
GENE	CA12	carbonic anhydrase XII	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12653028_3p_a_at	28	0.107143	0.173573	-	-1.05681	0.963878	0.0684636	1.07 [0.06 - 20.73]
GENE	CA12	carbonic anhydrase XII	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9951924_3p_at	28	0.392857	0.0397266	0.425809	1.27997	0.143888	0.18993	1.21 [0.94 - 1.56]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204509_at	82	0.195122	0.303663	-	0.491589	0.704843	0.238439	1.27 [0.37 - 4.36]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	210735_s_at	82	0.5	0.0185921	0.254432	0.805165	0.0618285	0.517367	1.68 [0.97 - 2.89]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	203963_at	82	0.609756	0.0357881	0.398064	0.696534	0.18801	0.237509	1.27 [0.89 - 1.81]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214164_x_at	82	0.585366	0.0183553	0.252119	0.783503	0.199255	0.200543	1.22 [0.90 - 1.66]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204508_s_at	82	0.597561	0.0135992	0.202931	0.817122	0.100577	0.187006	1.21 [0.96 - 1.51]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204509_at	79	0.164557	0.041582	0.438363	-0.681294	0.476314	-0.525281	0.59 [0.14 - 2.51]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	210735_s_at	79	0.873418	0.0318903	0.368996	0.769298	0.0721538	0.292498	1.34 [0.97 - 1.84]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	203963_at	79	0.493671	0.00303228	0.0635363	0.782056	0.0955636	0.183341	1.20 [0.97 - 1.49]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214164_x_at	79	0.556962	0.0176862	0.24552	0.621988	0.0826353	0.172472	1.19 [0.98 - 1.44]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204508_s_at	79	0.455696	0.00145128	0.0347698	0.852119	0.0640191	0.148552	1.16 [0.99 - 1.36]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214164_x_at	104	0.480769	0.0558863	-	0.632701	0.526872	0.0802746	1.08 [0.85 - 1.39]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204508_s_at	104	0.519231	0.0794926	-	0.56917	0.440803	0.0791399	1.08 [0.89 - 1.32]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204509_at	104	0.663462	0.177424	-	-0.478576	0.601696	-0.389829	0.68 [0.16 - 2.93]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	210735_s_at	104	0.355769	0.00628659	0.113197	1.15091	0.453608	0.205923	1.23 [0.72 - 2.11]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	203963_at	104	0.173077	0.0312493	0.364049	1.44002	0.667395	0.066394	1.07 [0.79 - 1.45]
GENE	CA12	carbonic anhydrase XII	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P330518	117	0.487179	0.125338	-	-0.437979	0.510147	-0.0694729	0.93 [0.76 - 1.15]
GENE	CA12	carbonic anhydrase XII	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P163336	117	0.700855	0.0401796	0.428904	-0.713242	0.14338	-0.116514	0.89 [0.76 - 1.04]
GENE	CA12	carbonic anhydrase XII	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P372234	117	0.102564	0.022484	0.290876	-0.860121	0.274606	-0.116028	0.89 [0.72 - 1.10]
GENE	CA12	carbonic anhydrase XII	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	203963_at	204	0.892157	0.0610851	-	0.672975	0.137827	0.15336	1.17 [0.95 - 1.43]
GENE	CA12	carbonic anhydrase XII	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214164_x_at	204	0.436274	0.0281964	0.339784	0.633412	0.0446495	0.220527	1.25 [1.01 - 1.55]
GENE	CA12	carbonic anhydrase XII	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	210735_s_at	204	0.406863	0.00766198	0.131875	1.15332	0.236032	0.229116	1.26 [0.86 - 1.84]
GENE	CA12	carbonic anhydrase XII	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	210735_s_at	204	0.215686	0.00227171	0.0502684	1.45614	0.10886	0.234646	1.26 [0.95 - 1.68]
GENE	CA12	carbonic anhydrase XII	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204509_at	204	0.303922	0.00263869	0.0567804	-1.05212	0.0310756	-0.46109	0.63 [0.41 - 0.96]
GENE	CA12	carbonic anhydrase XII	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204509_at	204	0.529412	0.000157272	0.00521141	-1.11751	0.008609	-0.414185	0.66 [0.49 - 0.90]
GENE	CA12	carbonic anhydrase XII	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204508_s_at	204	0.519608	0.134346	-	0.55116	0.341541	0.120798	1.13 [0.88 - 1.45]
GENE	CA12	carbonic anhydrase XII	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204508_s_at	204	0.838235	0.0556329	-	0.600948	0.0923296	0.159208	1.17 [0.97 - 1.41]
GENE	CA12	carbonic anhydrase XII	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	203963_at	204	0.897059	0.139568	-	0.709617	0.635791	0.0676026	1.07 [0.81 - 1.42]
GENE	CA12	carbonic anhydrase XII	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214164_x_at	204	0.843137	0.136992	-	0.631813	0.39647	0.128653	1.14 [0.84 - 1.53]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204509_at	178	0.882023	0.0423745	0.44363	0.579465	0.519483	-0.265096	0.77 [0.34 - 1.72]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	210735_s_at	178	0.11236	0.0584111	-	-0.525838	0.883823	-0.0200657	0.98 [0.75 - 1.28]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	203963_at	178	0.320225	0.231207	-	0.258969	0.677964	0.0349429	1.04 [0.88 - 1.22]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214164_x_at	178	0.404494	0.215272	-	0.252358	0.645047	0.0348009	1.04 [0.89 - 1.20]
GENE	CA12	carbonic anhydrase XII	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204508_s_at	178	0.432584	0.149081	-	0.290757	0.789732	0.0155268	1.02 [0.91 - 1.14]
GENE	CA12	carbonic anhydrase XII	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200001041	41	0.219512	0.0215214	0.282122	1.55079	0.173632	0.184599	1.20 [0.92 - 1.57]
GENE	CA12	carbonic anhydrase XII	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	210735_s_at	111	0.414414	0.106411	-	0.442387	0.897943	-0.0165555	0.98 [0.76 - 1.27]
GENE	CA12	carbonic anhydrase XII	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204509_at	111	0.108108	0.19023	-	0.666243	0.49962	0.192109	1.21 [0.69 - 2.12]
GENE	CA12	carbonic anhydrase XII	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204508_s_at	111	0.756757	0.117219	-	-0.53934	0.4796	-0.0561437	0.95 [0.81 - 1.10]
GENE	CA12	carbonic anhydrase XII	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	203963_at	111	0.108108	0.156351	-	-0.537282	0.669663	-0.0447738	0.96 [0.78 - 1.17]
GENE	CA12	carbonic anhydrase XII	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214164_x_at	111	0.738739	0.225626	-	-0.391752	0.706145	-0.0447295	0.96 [0.76 - 1.21]
GENE	CA12	carbonic anhydrase XII	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204509_at	90	0.311111	0.107783	-	-0.528215	0.618866	-0.291729	0.75 [0.24 - 2.36]
GENE	CA12	carbonic anhydrase XII	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204509_at	90	0.566667	0.183665	-	-0.514641	0.846632	-0.128637	0.88 [0.24 - 3.24]
GENE	CA12	carbonic anhydrase XII	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	210735_s_at	90	0.444444	0.0121686	0.186958	-0.804878	0.133181	-0.247315	0.78 [0.57 - 1.08]
GENE	CA12	carbonic anhydrase XII	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	210735_s_at	90	0.422222	0.0175179	0.243846	-0.87055	0.176277	-0.256259	0.77 [0.53 - 1.12]
GENE	CA12	carbonic anhydrase XII	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	203963_at	90	0.4	0.0289949	0.346246	-0.697649	0.195969	-0.165832	0.85 [0.66 - 1.09]
GENE	CA12	carbonic anhydrase XII	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	203963_at	90	0.166667	0.0340194	0.385083	-0.855863	0.129835	-0.226576	0.80 [0.59 - 1.07]
GENE	CA12	carbonic anhydrase XII	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214164_x_at	90	0.4	0.0177535	0.246188	-0.754001	0.185249	-0.149425	0.86 [0.69 - 1.07]
GENE	CA12	carbonic anhydrase XII	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214164_x_at	90	0.4	0.0567634	-	-0.694616	0.160655	-0.181654	0.83 [0.65 - 1.07]
GENE	CA12	carbonic anhydrase XII	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204508_s_at	90	0.366667	0.00251231	0.0545625	-0.949765	0.189862	-0.232395	0.79 [0.56 - 1.12]
GENE	CA12	carbonic anhydrase XII	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204508_s_at	90	0.366667	0.0139998	0.207296	-0.885857	0.170413	-0.285973	0.75 [0.50 - 1.13]
GENE	CA12	carbonic anhydrase XII	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	210735_s_at	138	0.782609	0.051451	-	0.520146	0.31646	0.0534501	1.05 [0.95 - 1.17]
GENE	CA12	carbonic anhydrase XII	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204509_at	138	0.855072	0.06253	-	-0.781222	0.465954	-0.73038	0.48 [0.07 - 3.43]
GENE	CA12	carbonic anhydrase XII	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204508_s_at	138	0.768116	0.0719564	-	0.474612	0.3942	0.044857	1.05 [0.94 - 1.16]
GENE	CA12	carbonic anhydrase XII	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	203963_at	138	0.688406	0.146192	-	0.361901	0.509216	0.0300612	1.03 [0.94 - 1.13]
GENE	CA12	carbonic anhydrase XII	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214164_x_at	138	0.695652	0.0994907	-	0.40976	0.33346	0.0498668	1.05 [0.95 - 1.16]
GENE	CA12	carbonic anhydrase XII	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214164_x_at	129	0.813953	0.0268235	0.32847	0.631201	0.509626	0.099791	1.10 [0.82 - 1.49]
GENE	CA12	carbonic anhydrase XII	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204508_s_at	129	0.821705	0.0850396	-	0.504052	0.896096	0.0131485	1.01 [0.83 - 1.23]
GENE	CA12	carbonic anhydrase XII	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204509_at	129	0.100775	0.287967	-	-0.404138	0.783789	0.0951476	1.10 [0.56 - 2.17]
GENE	CA12	carbonic anhydrase XII	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	210735_s_at	129	0.744186	0.0424887	0.444384	0.531972	0.581629	0.0857632	1.09 [0.80 - 1.48]
GENE	CA12	carbonic anhydrase XII	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	203963_at	129	0.767442	0.0162579	0.231102	0.637593	0.661297	0.0630091	1.07 [0.80 - 1.41]
GENE	CA12	carbonic anhydrase XII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31733	56	0.821429	0.173896	-	0.545502	0.649386	0.0435124	1.04 [0.87 - 1.26]
GENE	CA12	carbonic anhydrase XII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37925	56	0.767857	0.0398072	0.426361	0.757728	0.33183	0.0934235	1.10 [0.91 - 1.33]
GENE	CA12	carbonic anhydrase XII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31221	56	0.660714	0.0848716	-	0.583586	0.556391	0.0573809	1.06 [0.87 - 1.28]
GENE	CA12	carbonic anhydrase XII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31733	56	0.821429	0.0510929	-	0.787699	0.331691	0.0960392	1.10 [0.91 - 1.34]
GENE	CA12	carbonic anhydrase XII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11997	56	0.803571	0.131843	-	0.580783	0.692996	0.0363347	1.04 [0.87 - 1.24]
GENE	CA12	carbonic anhydrase XII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31221	56	0.660714	0.016967	0.238319	0.837305	0.232781	0.121645	1.13 [0.92 - 1.38]
GENE	CA12	carbonic anhydrase XII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37925	56	0.767857	0.141272	-	0.53203	0.640471	0.0434419	1.04 [0.87 - 1.25]
GENE	CA12	carbonic anhydrase XII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11997	56	0.696429	0.0395581	0.424653	0.729099	0.355307	0.0880375	1.09 [0.91 - 1.32]
GENE	CA12	carbonic anhydrase XII	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204508_s_at	278	0.723022	0.0052098	0.0977502	-0.640689	0.357536	-0.0740005	0.93 [0.79 - 1.09]
GENE	CA12	carbonic anhydrase XII	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	203963_at	278	0.751799	0.00991176	0.160387	-0.623839	0.123769	-0.0921033	0.91 [0.81 - 1.03]
GENE	CA12	carbonic anhydrase XII	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214164_x_at	278	0.697842	0.017743	0.246084	-0.515846	0.262199	-0.0810422	0.92 [0.80 - 1.06]
GENE	CA12	carbonic anhydrase XII	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	210735_s_at	278	0.791367	0.0204048	0.27176	-0.585604	0.153773	-0.107972	0.90 [0.77 - 1.04]
GENE	CA12	carbonic anhydrase XII	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204509_at	278	0.100719	0.0155196	0.223462	-0.668496	0.452359	-0.360927	0.70 [0.27 - 1.79]
GENE	CA12	carbonic anhydrase XII	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	203963_at	133	0.293233	0.000439944	0.0127008	-0.832636	0.00869143	-0.183545	0.83 [0.73 - 0.95]
GENE	CA12	carbonic anhydrase XII	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214164_x_at	133	0.796992	4.76446e-05	0.00181629	-1.68754	0.00133169	-0.226328	0.80 [0.69 - 0.92]
GENE	CA12	carbonic anhydrase XII	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204508_s_at	133	0.796992	0.000118649	0.00407084	-1.50319	0.00260834	-0.309743	0.73 [0.60 - 0.90]
GENE	CA12	carbonic anhydrase XII	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204509_at	133	0.345865	0.0149093	0.217042	0.644009	0.501046	0.490848	1.63 [0.39 - 6.83]
GENE	CA12	carbonic anhydrase XII	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	210735_s_at	133	0.586466	0.000258128	0.00802195	-0.92483	0.00172369	-0.330771	0.72 [0.58 - 0.88]
GENE	CA12	carbonic anhydrase XII	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204509_at	185	0.102703	0.331888	-	0.277522	0.866692	-0.0364036	0.96 [0.63 - 1.47]
GENE	CA12	carbonic anhydrase XII	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203963_at	185	0.221622	0.16798	-	-0.263529	0.676255	-0.0497788	0.95 [0.75 - 1.20]
GENE	CA12	carbonic anhydrase XII	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214164_x_at	185	0.891892	0.0493812	0.487899	-0.536335	0.505539	-0.0635218	0.94 [0.78 - 1.13]
GENE	CA12	carbonic anhydrase XII	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204508_s_at	185	0.891892	0.0044008	0.0855697	-0.888735	0.077162	-0.359734	0.70 [0.47 - 1.04]
GENE	CA12	carbonic anhydrase XII	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210735_s_at	185	0.864865	0.0790471	-	-0.4368	0.779182	0.0426418	1.04 [0.77 - 1.41]
GENE	CA12	carbonic anhydrase XII	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	203963_at	185	0.194595	0.0689157	-	-0.376166	0.366673	-0.118653	0.89 [0.69 - 1.15]
GENE	CA12	carbonic anhydrase XII	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214164_x_at	185	0.891892	0.0242647	0.306658	-0.732971	0.268532	-0.116832	0.89 [0.72 - 1.09]
GENE	CA12	carbonic anhydrase XII	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204509_at	185	0.713513	0.318665	-	0.181199	0.792064	-0.0515588	0.95 [0.65 - 1.39]
GENE	CA12	carbonic anhydrase XII	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	210735_s_at	185	0.859459	0.0983273	-	-0.452454	0.979404	0.00437672	1.00 [0.72 - 1.40]
GENE	CA12	carbonic anhydrase XII	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204508_s_at	185	0.891892	0.005716	0.105112	-0.735042	0.116511	-0.289368	0.75 [0.52 - 1.07]
GENE	CA12	carbonic anhydrase XII	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P163336	110	0.272727	0.120666	-	0.550873	0.780586	0.0496172	1.05 [0.74 - 1.49]
GENE	CA12	carbonic anhydrase XII	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P372234	110	0.127273	0.140154	-	-0.48091	0.449616	-0.0476877	0.95 [0.84 - 1.08]
GENE	CA12	carbonic anhydrase XII	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P163338	110	0.563636	0.0400326	0.427901	0.611134	0.374872	0.128761	1.14 [0.86 - 1.51]
GENE	CA12	carbonic anhydrase XII	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P330518	110	0.109091	0.0574161	-	-0.640929	0.422209	-0.0486946	0.95 [0.85 - 1.07]
GENE	CA12	carbonic anhydrase XII	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P372234	110	0.109091	0.151773	-	-0.581939	0.83904	-0.0167154	0.98 [0.84 - 1.16]
GENE	CA12	carbonic anhydrase XII	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P163336	110	0.145455	0.052785	-	-0.595035	0.625203	-0.0670086	0.94 [0.71 - 1.22]
GENE	CA12	carbonic anhydrase XII	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P330518	110	0.745455	0.161877	-	-0.546682	0.348025	-0.0705919	0.93 [0.80 - 1.08]
GENE	CA12	carbonic anhydrase XII	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P163338	110	0.554545	0.185182	-	0.310633	0.705604	0.0406616	1.04 [0.84 - 1.29]
GENE	CA12	carbonic anhydrase XII	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214164_x_at	80	0.625	0.182139	-	-0.672196	0.568762	-0.119549	0.89 [0.59 - 1.34]
GENE	CA12	carbonic anhydrase XII	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204508_s_at	80	0.5375	0.299872	-	0.455256	0.815273	0.0302067	1.03 [0.80 - 1.33]
GENE	CA12	carbonic anhydrase XII	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204509_at	80	0.85	0.0730909	-	-1.65297	0.574549	-0.166917	0.85 [0.47 - 1.52]
GENE	CA12	carbonic anhydrase XII	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	210735_s_at	80	0.8875	0.454922	-	-0.554593	0.841817	-0.0504498	0.95 [0.58 - 1.56]
GENE	CA12	carbonic anhydrase XII	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	203963_at	80	0.5125	0.229793	-	-0.531969	0.947808	-0.0129272	0.99 [0.67 - 1.45]
GENE	CA12	carbonic anhydrase XII	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_4919	281	0.103203	0.178625	-	0.329951	0.853989	-0.0117826	0.99 [0.87 - 1.12]
GENE	CA12	carbonic anhydrase XII	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204509_at	38	0.710526	0.32772	-	0.452745	0.956168	-0.0256417	0.97 [0.39 - 2.43]
GENE	CA12	carbonic anhydrase XII	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204508_s_at	38	0.5	0.000860711	0.022466	1.63349	0.0341302	0.230456	1.26 [1.02 - 1.56]
GENE	CA12	carbonic anhydrase XII	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	203963_at	38	0.342105	0.0122032	0.187352	1.47742	0.165103	0.202621	1.22 [0.92 - 1.63]
GENE	CA12	carbonic anhydrase XII	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214164_x_at	38	0.394737	0.0137198	0.20425	1.31832	0.106283	0.269416	1.31 [0.94 - 1.82]
GENE	CA12	carbonic anhydrase XII	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	210735_s_at	38	0.447368	0.0015836	0.0373747	1.63519	0.0393565	0.451896	1.57 [1.02 - 2.42]
GENE	CA12	carbonic anhydrase XII	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204509_at	140	0.135714	0.00214314	0.0479323	-1.05431	0.327975	-0.68645	0.50 [0.13 - 1.99]
GENE	CA12	carbonic anhydrase XII	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	210735_s_at	140	0.107143	0.0502138	-	-0.74354	0.938067	-0.0174228	0.98 [0.63 - 1.53]
GENE	CA12	carbonic anhydrase XII	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	203963_at	140	0.842857	0.0329818	0.377307	0.72315	0.516389	-0.101262	0.90 [0.67 - 1.23]
GENE	CA12	carbonic anhydrase XII	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214164_x_at	140	0.207143	0.0708477	-	-0.569109	0.501854	-0.0922025	0.91 [0.70 - 1.19]
GENE	CA12	carbonic anhydrase XII	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204508_s_at	140	0.892857	0.00326625	0.0674533	1.01219	0.767779	0.0582815	1.06 [0.72 - 1.56]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CA13	carbonic anhydrase XIII	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1802414	165	0.460606	0.00769696	0.132336	-0.647687	0.107755	-0.84386	0.43 [0.15 - 1.20]
GENE	CA13	carbonic anhydrase XIII	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1802414	165	0.272727	0.000197072	0.00634536	-1.23985	0.0306841	-2.0492	0.13 [0.02 - 0.83]
GENE	CA13	carbonic anhydrase XIII	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	231270_at	163	0.717791	0.00191696	0.0437459	0.630167	0.00253323	1.44571	4.24 [1.66 - 10.85]
GENE	CA13	carbonic anhydrase XIII	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	235899_at	163	0.760736	0.151977	-	-0.355443	0.668286	-0.25396	0.78 [0.24 - 2.48]
GENE	CA13	carbonic anhydrase XIII	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	231270_at	79	0.797468	0.104569	-	0.537427	0.548785	0.164121	1.18 [0.69 - 2.02]
GENE	CA13	carbonic anhydrase XIII	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	235899_at	79	0.164557	0.0222235	0.288523	1.27709	0.719685	-0.185904	0.83 [0.30 - 2.29]
GENE	CA13	carbonic anhydrase XIII	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	231270_at	180	0.744444	0.0110894	0.174476	0.581684	0.0563419	0.340391	1.41 [0.99 - 1.99]
GENE	CA13	carbonic anhydrase XIII	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	235899_at	180	0.644444	0.0980911	-	0.3478	0.412834	0.127476	1.14 [0.84 - 1.54]
GENE	CA13	carbonic anhydrase XIII	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	231270_at	559	0.881932	0.00402992	0.0797933	0.705598	0.683864	0.0818941	1.09 [0.73 - 1.61]
GENE	CA13	carbonic anhydrase XIII	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	235899_at	559	0.370304	0.0536955	-	0.437555	0.280836	0.128285	1.14 [0.90 - 1.44]
GENE	CA13	carbonic anhydrase XIII	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	231270_at	77	0.727273	0.111003	-	0.446991	0.127461	0.313481	1.37 [0.91 - 2.05]
GENE	CA13	carbonic anhydrase XIII	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	235899_at	77	0.792208	0.0454192	0.463358	0.593862	0.554139	0.169492	1.18 [0.68 - 2.08]
GENE	CA13	carbonic anhydrase XIII	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	231270_at	70	0.6	0.0261107	0.322491	-0.611773	0.544054	-0.108455	0.90 [0.63 - 1.27]
GENE	CA13	carbonic anhydrase XIII	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	235899_at	70	0.528571	0.188842	-	-0.346931	0.519493	-0.851702	0.43 [0.03 - 5.70]
GENE	CA13	carbonic anhydrase XIII	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	235899_at	74	0.837838	0.00868687	0.145146	-1.28752	0.0409763	-0.538587	0.58 [0.35 - 0.98]
GENE	CA13	carbonic anhydrase XIII	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	231270_at	74	0.337838	0.00166463	0.0389474	1.04561	0.119485	0.380341	1.46 [0.91 - 2.36]
GENE	CA13	carbonic anhydrase XIII	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	235899_at	67	0.895522	0.202569	-	0.984286	0.837762	0.409439	1.51 [0.03 - 75.85]
GENE	CA13	carbonic anhydrase XIII	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	231270_at	67	0.61194	0.00246971	0.0538093	2.13848	0.11962	0.742705	2.10 [0.82 - 5.35]
GENE	CA13	carbonic anhydrase XIII	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	231270_at	115	0.730435	0.269678	-	-0.817799	0.616969	-0.251408	0.78 [0.29 - 2.08]
GENE	CA13	carbonic anhydrase XIII	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	235899_at	115	0.243478	0.0270553	0.330399	15.4874	0.0887844	1.68389	5.39 [0.77 - 37.46]
GENE	CA13	carbonic anhydrase XIII	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	235899_at	204	0.77451	0.0021144	0.047406	0.513704	0.157044	0.122066	1.13 [0.95 - 1.34]
GENE	CA13	carbonic anhydrase XIII	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	231270_at	204	0.882353	0.000351064	0.0104627	0.78421	0.063387	0.195027	1.22 [0.99 - 1.49]
GENE	CA13	carbonic anhydrase XIII	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	231270_at	87	0.896552	0.0720384	-	-15.1768	0.251026	-0.221732	0.80 [0.55 - 1.17]
GENE	CA13	carbonic anhydrase XIII	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	231270_at	87	0.896552	0.0720384	-	-15.1768	0.251026	-0.221732	0.80 [0.55 - 1.17]
GENE	CA13	carbonic anhydrase XIII	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	235899_at	87	0.367816	0.340291	-	-0.362978	0.993979	0.00638617	1.01 [0.19 - 5.29]
GENE	CA13	carbonic anhydrase XIII	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	235899_at	87	0.367816	0.340291	-	-0.362978	0.993979	0.00638617	1.01 [0.19 - 5.29]
GENE	CA13	carbonic anhydrase XIII	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	231270_at	77	0.844156	0.0883774	-	0.984266	0.563032	0.190013	1.21 [0.64 - 2.30]
GENE	CA13	carbonic anhydrase XIII	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	235899_at	77	0.467532	0.0507982	-	1.21165	0.780459	0.411376	1.51 [0.08 - 27.23]
GENE	CA13	carbonic anhydrase XIII	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	231270_at	77	0.844156	0.165066	-	0.925006	0.692186	0.147856	1.16 [0.56 - 2.41]
GENE	CA13	carbonic anhydrase XIII	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	235899_at	77	0.467532	0.22998	-	0.806614	0.908997	0.196953	1.22 [0.04 - 35.67]
GENE	CA13	carbonic anhydrase XIII	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235899_at	159	0.201258	0.159398	-	0.833712	0.544683	0.203365	1.23 [0.63 - 2.37]
GENE	CA13	carbonic anhydrase XIII	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231270_at	159	0.490566	0.119922	-	-0.497051	0.734107	-0.0692684	0.93 [0.63 - 1.39]
GENE	CA13	carbonic anhydrase XIII	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231270_at	159	0.490566	0.00635556	0.11416	-0.891753	0.297424	-0.209993	0.81 [0.55 - 1.20]
GENE	CA13	carbonic anhydrase XIII	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231270_at	159	0.522013	0.00758234	0.130822	-1.10239	0.163621	-0.321823	0.72 [0.46 - 1.14]
GENE	CA13	carbonic anhydrase XIII	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235899_at	159	0.176101	0.0833576	-	0.997663	0.361092	0.266792	1.31 [0.74 - 2.31]
GENE	CA13	carbonic anhydrase XIII	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	235899_at	159	0.201258	0.0844287	-	0.880898	0.431147	0.226908	1.25 [0.71 - 2.21]
GENE	CA13	carbonic anhydrase XIII	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	235899_at	236	0.101695	0.189549	-	0.761268	0.844766	0.0637689	1.07 [0.56 - 2.02]
GENE	CA13	carbonic anhydrase XIII	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	231270_at	236	0.402542	0.0110126	0.173574	-0.676091	0.506847	-0.116981	0.89 [0.63 - 1.26]
GENE	CA13	carbonic anhydrase XIII	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	231270_at	249	0.212851	0.000228707	0.00722249	-0.800277	0.287086	-0.153471	0.86 [0.65 - 1.14]
GENE	CA13	carbonic anhydrase XIII	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	235899_at	249	0.100402	0.0351394	0.393342	1.03182	0.49363	0.177986	1.19 [0.72 - 1.99]
GENE	CA13	carbonic anhydrase XIII	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	231270_at	145	0.841379	0.13343	-	-1.04434	0.991142	0.00255356	1.00 [0.64 - 1.57]
GENE	CA13	carbonic anhydrase XIII	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	235899_at	145	0.117241	0.0490038	0.485614	1.76129	0.638471	-0.192978	0.82 [0.37 - 1.84]
GENE	CA13	carbonic anhydrase XIII	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	235899_at	177	0.118644	0.00410196	0.0809256	2.34516	0.762455	0.0984609	1.10 [0.58 - 2.09]
GENE	CA13	carbonic anhydrase XIII	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	231270_at	177	0.694915	0.0347138	0.39022	0.501738	0.212409	0.203318	1.23 [0.89 - 1.69]
GENE	CA13	carbonic anhydrase XIII	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	231270_at	177	0.508475	0.107345	-	0.43686	0.454051	0.140159	1.15 [0.80 - 1.66]
GENE	CA13	carbonic anhydrase XIII	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	235899_at	177	0.107345	0.00412621	0.0813056	1.81313	0.567003	0.158678	1.17 [0.68 - 2.02]
GENE	CA13	carbonic anhydrase XIII	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	231270_at	226	0.60177	0.296873	-	-0.315204	0.940336	0.0130237	1.01 [0.72 - 1.42]
GENE	CA13	carbonic anhydrase XIII	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	235899_at	226	0.172566	0.0437095	0.452377	1.00826	0.616123	0.108044	1.11 [0.73 - 1.70]
GENE	CA13	carbonic anhydrase XIII	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	235899_at	55	0.163636	0.000300824	0.00915787	-1.76141	0.594735	-0.624284	0.54 [0.05 - 5.34]
GENE	CA13	carbonic anhydrase XIII	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	231270_at	55	0.890909	0.045325	0.462759	1.13509	0.30763	0.346784	1.41 [0.73 - 2.75]
GENE	CA13	carbonic anhydrase XIII	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	235899_at	49	0.163265	2.26102e-05	0.000932612	-2.08624	0.040069	-2.90258	0.05 [0.00 - 0.88]
GENE	CA13	carbonic anhydrase XIII	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	231270_at	49	0.897959	0.13303	-	0.965699	0.84276	0.0905146	1.09 [0.45 - 2.68]
GENE	CA13	carbonic anhydrase XIII	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	231270_at	55	0.890909	0.0887102	-	0.922657	0.838569	-0.0745814	0.93 [0.45 - 1.90]
GENE	CA13	carbonic anhydrase XIII	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	235899_at	55	0.163636	0.000699182	0.018848	-1.47028	0.416449	-0.899396	0.41 [0.05 - 3.56]
GENE	CA13	carbonic anhydrase XIII	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	231270_at	63	0.206349	0.0513059	-	-0.732319	0.988836	-0.00180554	1.00 [0.78 - 1.29]
GENE	CA13	carbonic anhydrase XIII	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	235899_at	63	0.714286	0.0126674	0.192598	-1.1429	0.627476	-3.04922	0.05 [0.00 - 10575.16]
GENE	CA13	carbonic anhydrase XIII	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.122127.0.A1_3p_at	28	0.392857	0.0149689	0.217674	-1.34702	0.189553	-3.19228	0.04 [0.00 - 4.84]
GENE	CA13	carbonic anhydrase XIII	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.99624.0.A1_3p_at	28	0.857143	0.128137	-	-1.46287	0.309449	-1.19662	0.30 [0.03 - 3.04]
GENE	CA13	carbonic anhydrase XIII	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P381714	117	0.854701	0.057686	-	0.662561	0.861617	-0.0252269	0.98 [0.73 - 1.29]
GENE	CA13	carbonic anhydrase XIII	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	235899_at	204	0.102941	0.179818	-	-0.646999	0.361186	-0.276526	0.76 [0.42 - 1.37]
GENE	CA13	carbonic anhydrase XIII	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	231270_at	204	0.112745	0.215026	-	-0.599245	0.819124	-0.0605007	0.94 [0.56 - 1.58]
GENE	CA13	carbonic anhydrase XIII	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	235899_at	204	0.323529	0.0447638	0.459178	-0.546361	0.193517	-0.29458	0.74 [0.48 - 1.16]
GENE	CA13	carbonic anhydrase XIII	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	231270_at	204	0.372549	0.0427201	0.445909	-0.545623	0.470978	-0.143242	0.87 [0.59 - 1.28]
GENE	CA13	carbonic anhydrase XIII	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	231270_at	111	0.612613	0.150725	-	-0.397574	0.580641	-0.101956	0.90 [0.63 - 1.30]
GENE	CA13	carbonic anhydrase XIII	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	235899_at	111	0.108108	0.0154364	0.222592	-0.862374	0.10058	-0.298794	0.74 [0.52 - 1.06]
GENE	CA13	carbonic anhydrase XIII	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	231270_at	138	0.217391	0.0689049	-	0.612727	0.622793	0.0419452	1.04 [0.88 - 1.23]
GENE	CA13	carbonic anhydrase XIII	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	235899_at	138	0.130435	0.102662	-	-0.49927	0.992744	0.00357831	1.00 [0.46 - 2.17]
GENE	CA13	carbonic anhydrase XIII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43590	56	0.642857	0.159397	-	-0.539025	0.366753	-0.196332	0.82 [0.54 - 1.26]
GENE	CA13	carbonic anhydrase XIII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3241	56	0.75	0.0702625	-	-0.816907	0.499862	-0.36396	0.69 [0.24 - 2.00]
GENE	CA13	carbonic anhydrase XIII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35498	56	0.482143	0.044332	0.456404	-0.725806	0.348814	-0.24334	0.78 [0.47 - 1.30]
GENE	CA13	carbonic anhydrase XIII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3241	56	0.75	0.0339544	0.384599	-1.09252	0.37396	-0.522543	0.59 [0.19 - 1.88]
GENE	CA13	carbonic anhydrase XIII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43590	56	0.125	0.0403208	0.429864	-0.973611	0.125606	-0.353486	0.70 [0.45 - 1.10]
GENE	CA13	carbonic anhydrase XIII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35498	56	0.482143	0.0169334	0.23798	-0.817858	0.109557	-0.40074	0.67 [0.41 - 1.09]
GENE	CA13	carbonic anhydrase XIII	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	235899_at	278	0.604317	0.0273731	0.333031	-0.442418	0.381835	-0.367637	0.69 [0.30 - 1.58]
GENE	CA13	carbonic anhydrase XIII	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	231270_at	278	0.705036	0.0177339	0.245994	-0.529143	0.623037	-0.0547573	0.95 [0.76 - 1.18]
GENE	CA13	carbonic anhydrase XIII	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P136619	110	0.563636	0.110155	-	-0.372984	0.345558	-0.123808	0.88 [0.68 - 1.14]
GENE	CA13	carbonic anhydrase XIII	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P381714	110	0.318182	5.44648e-05	0.00204579	-0.923955	0.0921366	-0.297942	0.74 [0.52 - 1.05]
GENE	CA13	carbonic anhydrase XIII	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P136619	110	0.7	0.13536	-	-0.501117	0.748751	-0.0556777	0.95 [0.67 - 1.33]
GENE	CA13	carbonic anhydrase XIII	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P381714	110	0.254545	1.44661e-05	0.000623848	-1.33171	0.19619	-0.294518	0.74 [0.48 - 1.16]
GENE	CA13	carbonic anhydrase XIII	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	231270_at	38	0.394737	0.0840969	-	0.904106	0.548261	0.203438	1.23 [0.63 - 2.38]
GENE	CA13	carbonic anhydrase XIII	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	235899_at	38	0.894737	0.372427	-	-0.889995	0.793293	0.119027	1.13 [0.46 - 2.74]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CA14	carbonic anhydrase XIV	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219464_at	30	0.266667	0.0857896	-	-0.771157	0.723694	0.173667	1.19 [0.45 - 3.12]
GENE	CA14	carbonic anhydrase XIV	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1742358	165	0.224242	0.0141659	0.209092	-0.640229	0.131961	-1.26511	0.28 [0.05 - 1.46]
GENE	CA14	carbonic anhydrase XIV	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1742358	165	0.187879	0.0440629	0.454667	-0.75471	0.393725	-0.975968	0.38 [0.04 - 3.55]
GENE	CA14	carbonic anhydrase XIV	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219464_at	163	0.736196	0.0157519	0.22588	-0.596294	0.0990262	-0.908864	0.40 [0.14 - 1.19]
GENE	CA14	carbonic anhydrase XIV	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219464_at	79	0.544304	0.0520121	-	-0.578401	0.380326	-0.617726	0.54 [0.14 - 2.14]
GENE	CA14	carbonic anhydrase XIV	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219464_at	58	0.37931	0.053155	-	-0.557582	0.553749	-0.101832	0.90 [0.64 - 1.27]
GENE	CA14	carbonic anhydrase XIV	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219464_at	34	0.823529	0.0505215	-	-1.14256	0.105055	-0.374626	0.69 [0.44 - 1.08]
GENE	CA14	carbonic anhydrase XIV	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219464_at	158	0.879747	0.261803	-	0.382375	0.861581	-0.156359	0.86 [0.15 - 4.96]
GENE	CA14	carbonic anhydrase XIV	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219464_at	53	0.679245	0.0237677	0.302305	0.821432	0.371582	0.256557	1.29 [0.74 - 2.27]
GENE	CA14	carbonic anhydrase XIV	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219464_at	53	0.679245	0.0573998	-	0.655567	0.834186	0.0538656	1.06 [0.64 - 1.75]
GENE	CA14	carbonic anhydrase XIV	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219464_at	180	0.861111	0.0189901	0.258292	0.598259	0.962766	0.00751747	1.01 [0.73 - 1.38]
GENE	CA14	carbonic anhydrase XIV	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219464_at	559	0.461538	0.0052215	0.0979225	0.609262	0.0335762	0.241683	1.27 [1.02 - 1.59]
GENE	CA14	carbonic anhydrase XIV	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219464_at	77	0.883117	0.00193181	0.044024	1.10723	0.274602	0.259062	1.30 [0.81 - 2.06]
GENE	CA14	carbonic anhydrase XIV	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219464_at	70	0.528571	0.0718402	-	0.469947	0.842873	-0.0514358	0.95 [0.57 - 1.58]
GENE	CA14	carbonic anhydrase XIV	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219464_at	74	0.391892	0.0254778	0.317121	0.689944	0.595186	0.139637	1.15 [0.69 - 1.92]
GENE	CA14	carbonic anhydrase XIV	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219464_at	67	0.298507	0.0389847	0.420699	15.6503	0.747355	0.196663	1.22 [0.37 - 4.03]
GENE	CA14	carbonic anhydrase XIV	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219464_at	115	0.4	0.00994351	0.160773	-1.40697	0.551934	-0.190092	0.83 [0.44 - 1.55]
GENE	CA14	carbonic anhydrase XIV	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219464_at	204	0.112745	0.00096423	0.0247179	-0.729815	0.225824	-0.0826331	0.92 [0.81 - 1.05]
GENE	CA14	carbonic anhydrase XIV	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219464_at	87	0.793103	0.137659	-	0.592773	0.913165	0.0234982	1.02 [0.67 - 1.56]
GENE	CA14	carbonic anhydrase XIV	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219464_at	87	0.793103	0.137659	-	0.592773	0.913165	0.0234982	1.02 [0.67 - 1.56]
GENE	CA14	carbonic anhydrase XIV	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219464_at	77	0.233766	0.0203273	0.271033	-1.36539	0.472799	-0.729907	0.48 [0.07 - 3.54]
GENE	CA14	carbonic anhydrase XIV	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219464_at	77	0.116883	0.112796	-	-1.00468	0.650428	-0.368323	0.69 [0.14 - 3.40]
GENE	CA14	carbonic anhydrase XIV	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219464_at	136	0.154412	0.232743	-	0.882141	0.460297	0.226395	1.25 [0.69 - 2.29]
GENE	CA14	carbonic anhydrase XIV	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219464_at	200	0.405	0.217465	-	0.39299	0.711775	0.0931537	1.10 [0.67 - 1.80]
GENE	CA14	carbonic anhydrase XIV	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9018	60	0.233333	0.183155	-	-0.559608	0.604129	-0.0870741	0.92 [0.66 - 1.27]
GENE	CA14	carbonic anhydrase XIV	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9018	60	0.35	0.199372	-	-0.488783	0.415641	-0.162713	0.85 [0.57 - 1.26]
GENE	CA14	carbonic anhydrase XIV	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	12183	155	0.858065	8.86145e-06	0.000400435	1.23074	0.00112658	0.305136	1.36 [1.13 - 1.63]
GENE	CA14	carbonic anhydrase XIV	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219464_at	286	0.321678	3.37222e-06	0.000166138	-0.876176	0.00853095	-0.385401	0.68 [0.51 - 0.91]
GENE	CA14	carbonic anhydrase XIV	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219464_at	159	0.893082	2.0342e-06	0.000104568	1.50507	0.67591	0.135167	1.14 [0.61 - 2.16]
GENE	CA14	carbonic anhydrase XIV	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219464_at	159	0.893082	0.00464231	0.0892634	1.02827	0.652618	-0.129042	0.88 [0.50 - 1.54]
GENE	CA14	carbonic anhydrase XIV	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219464_at	159	0.893082	0.000349521	0.0104231	1.38244	0.572463	-0.188663	0.83 [0.43 - 1.59]
GENE	CA14	carbonic anhydrase XIV	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219464_at	54	0.611111	0.0445884	0.458053	-1.8844	0.379802	-0.822783	0.44 [0.07 - 2.75]
GENE	CA14	carbonic anhydrase XIV	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219464_at	117	0.641026	0.168307	-	-0.484203	0.701852	-0.165135	0.85 [0.36 - 1.97]
GENE	CA14	carbonic anhydrase XIV	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219464_at	117	0.188034	0.100257	-	-0.692857	0.573871	-0.325518	0.72 [0.23 - 2.25]
GENE	CA14	carbonic anhydrase XIV	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219464_at	117	0.641026	0.168307	-	-0.484203	0.701852	-0.165135	0.85 [0.36 - 1.97]
GENE	CA14	carbonic anhydrase XIV	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219464_at	117	0.888889	0.281885	-	0.573242	0.77012	-0.152643	0.86 [0.31 - 2.39]
GENE	CA14	carbonic anhydrase XIV	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219464_at	236	0.338983	0.0169676	0.238325	-0.634662	0.384782	-0.315293	0.73 [0.36 - 1.49]
GENE	CA14	carbonic anhydrase XIV	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219464_at	249	0.413655	0.0332312	0.379188	-0.446711	0.517196	-0.182175	0.83 [0.48 - 1.45]
GENE	CA14	carbonic anhydrase XIV	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219464_at	125	0.112	0.173972	-	-0.724714	0.837879	0.079417	1.08 [0.51 - 2.32]
GENE	CA14	carbonic anhydrase XIV	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219464_at	125	0.112	0.0284874	0.342149	-0.885245	0.674932	-0.127504	0.88 [0.49 - 1.60]
GENE	CA14	carbonic anhydrase XIV	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219464_at	54	0.685185	0.220066	-	-0.822742	0.635006	-0.129838	0.88 [0.51 - 1.50]
GENE	CA14	carbonic anhydrase XIV	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219464_at	62	0.709677	0.135891	-	-0.848366	0.627418	-0.108912	0.90 [0.58 - 1.39]
GENE	CA14	carbonic anhydrase XIV	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219464_at	198	0.873737	0.134803	-	-0.550203	0.905544	-0.0100175	0.99 [0.84 - 1.17]
GENE	CA14	carbonic anhydrase XIV	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219464_at	198	0.888889	0.178432	-	-0.684222	0.599106	0.0545886	1.06 [0.86 - 1.29]
GENE	CA14	carbonic anhydrase XIV	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219464_at	198	0.853535	0.071596	-	-0.904324	0.874006	0.0170389	1.02 [0.82 - 1.26]
GENE	CA14	carbonic anhydrase XIV	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219464_at	51	0.509804	0.141418	-	1.50014	0.868144	0.31982	1.38 [0.03 - 60.08]
GENE	CA14	carbonic anhydrase XIV	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219464_at	62	0.532258	0.154636	-	0.8469	0.848141	0.22869	1.26 [0.12 - 13.06]
GENE	CA14	carbonic anhydrase XIV	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219464_at	177	0.423729	0.24717	-	-0.31133	0.680298	-0.173389	0.84 [0.37 - 1.92]
GENE	CA14	carbonic anhydrase XIV	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219464_at	177	0.423729	0.0853118	-	-0.40057	0.584586	-0.198632	0.82 [0.40 - 1.67]
GENE	CA14	carbonic anhydrase XIV	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219464_at	145	0.213793	0.134706	-	-0.53602	0.814574	-0.120632	0.89 [0.32 - 2.43]
GENE	CA14	carbonic anhydrase XIV	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219464_at	226	0.831858	0.0561018	-	0.609482	0.97567	0.00403421	1.00 [0.77 - 1.30]
GENE	CA14	carbonic anhydrase XIV	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219464_at	55	0.309091	0.00311855	0.0649886	-1.25083	0.132772	-1.33904	0.26 [0.05 - 1.50]
GENE	CA14	carbonic anhydrase XIV	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219464_at	55	0.309091	0.00202229	0.0457082	-1.40911	0.0170804	-2.30036	0.10 [0.02 - 0.66]
GENE	CA14	carbonic anhydrase XIV	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219464_at	49	0.265306	0.00642489	0.115125	-1.46623	0.167006	-1.56044	0.21 [0.02 - 1.92]
GENE	CA14	carbonic anhydrase XIV	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219464_at	63	0.571429	0.00171141	0.0398479	1.0951	0.0124431	0.37023	1.45 [1.08 - 1.94]
GENE	CA14	carbonic anhydrase XIV	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6912283_3p_at	28	0.75	0.0171766	0.240429	-2.10666	0.0595309	-4.00535	0.02 [0.00 - 1.17]
GENE	CA14	carbonic anhydrase XIV	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219464_at	82	0.780488	0.0259115	0.320807	0.799077	0.383321	0.43797	1.55 [0.58 - 4.15]
GENE	CA14	carbonic anhydrase XIV	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219464_at	79	0.164557	0.211174	-	0.432502	0.93682	0.0420542	1.04 [0.37 - 2.95]
GENE	CA14	carbonic anhydrase XIV	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219464_at	104	0.192308	0.084662	-	0.997962	0.328225	0.776178	2.17 [0.46 - 10.30]
GENE	CA14	carbonic anhydrase XIV	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P63379	117	0.444444	0.030557	0.358649	-0.612745	0.317935	-0.187611	0.83 [0.57 - 1.20]
GENE	CA14	carbonic anhydrase XIV	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219464_at	204	0.426471	0.210293	-	0.480847	0.573109	0.107594	1.11 [0.77 - 1.62]
GENE	CA14	carbonic anhydrase XIV	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219464_at	204	0.897059	0.0406367	0.432007	0.732141	0.142226	0.211976	1.24 [0.93 - 1.64]
GENE	CA14	carbonic anhydrase XIV	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219464_at	178	0.275281	0.000230146	0.00726195	-0.750123	0.0544448	-0.74512	0.47 [0.22 - 1.01]
GENE	CA14	carbonic anhydrase XIV	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219464_at	111	0.720721	0.00584162	0.10691	-0.968598	0.0189176	-0.511906	0.60 [0.39 - 0.92]
GENE	CA14	carbonic anhydrase XIV	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219464_at	90	0.4	0.0842742	-	0.703178	0.530597	0.441626	1.56 [0.39 - 6.18]
GENE	CA14	carbonic anhydrase XIV	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219464_at	90	0.855556	0.202354	-	-0.749697	0.647683	0.283432	1.33 [0.39 - 4.48]
GENE	CA14	carbonic anhydrase XIV	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219464_at	138	0.311594	0.107095	-	-0.395409	0.361594	-1.39422	0.25 [0.01 - 4.96]
GENE	CA14	carbonic anhydrase XIV	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219464_at	129	0.255814	0.135034	-	0.474102	0.854275	0.0583625	1.06 [0.57 - 1.98]
GENE	CA14	carbonic anhydrase XIV	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4347	56	0.803571	0.00570345	0.104932	1.02765	0.275562	0.26395	1.30 [0.81 - 2.09]
GENE	CA14	carbonic anhydrase XIV	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	4347	56	0.803571	0.0227955	0.293675	0.935411	0.429804	0.200742	1.22 [0.74 - 2.01]
GENE	CA14	carbonic anhydrase XIV	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219464_at	278	0.881295	0.00995954	0.160968	0.643313	0.0321045	0.382811	1.47 [1.03 - 2.08]
GENE	CA14	carbonic anhydrase XIV	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219464_at	133	0.135338	0.00332146	0.0683675	-0.834444	0.837064	0.0431046	1.04 [0.69 - 1.57]
GENE	CA14	carbonic anhydrase XIV	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16370	81	0.185185	0.0318361	0.368579	15.4468	0.594753	0.192449	1.21 [0.60 - 2.46]
GENE	CA14	carbonic anhydrase XIV	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219464_at	185	0.594595	0.0325804	0.374267	0.381744	0.140531	0.283382	1.33 [0.91 - 1.94]
GENE	CA14	carbonic anhydrase XIV	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219464_at	185	0.594595	0.0829858	-	0.28788	0.228788	0.2104	1.23 [0.88 - 1.74]
GENE	CA14	carbonic anhydrase XIV	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P63379	110	0.781818	0.0577855	-	-0.554112	0.435672	-0.0916965	0.91 [0.72 - 1.15]
GENE	CA14	carbonic anhydrase XIV	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P63379	110	0.772727	0.0499966	0.491603	-0.751648	0.20155	-0.197572	0.82 [0.61 - 1.11]
GENE	CA14	carbonic anhydrase XIV	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219464_at	80	0.325	0.154433	-	0.725737	0.268224	0.194616	1.21 [0.86 - 1.71]
GENE	CA14	carbonic anhydrase XIV	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219464_at	38	0.789474	0.00151691	0.0360677	1.52431	0.0642196	0.280628	1.32 [0.98 - 1.78]
GENE	CA14	carbonic anhydrase XIV	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219464_at	140	0.142857	0.0537634	-	-0.73927	0.324787	-0.651354	0.52 [0.14 - 1.91]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CA2	carbonic anhydrase II	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209301_at	30	0.733333	0.167914	-	0.589048	0.957604	0.00745881	1.01 [0.77 - 1.33]
GENE	CA2	carbonic anhydrase II	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1662795	165	0.30303	0.0684525	-	-0.443933	0.784921	-0.0246558	0.98 [0.82 - 1.16]
GENE	CA2	carbonic anhydrase II	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1662795	165	0.830303	0.0528027	-	0.744282	0.786052	0.0351466	1.04 [0.80 - 1.33]
GENE	CA2	carbonic anhydrase II	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209301_at	163	0.233129	0.0140768	0.20813	-0.529014	0.0543756	-0.139111	0.87 [0.76 - 1.00]
GENE	CA2	carbonic anhydrase II	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209301_at	79	0.658228	0.0179262	0.247899	-0.797611	0.353202	-0.0947094	0.91 [0.74 - 1.11]
GENE	CA2	carbonic anhydrase II	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209301_at	58	0.465517	8.39282e-05	0.00300079	-1.20164	0.00490304	-0.265982	0.77 [0.64 - 0.92]
GENE	CA2	carbonic anhydrase II	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209301_at	34	0.264706	0.386669	-	-0.354355	0.738169	-0.0519695	0.95 [0.70 - 1.29]
GENE	CA2	carbonic anhydrase II	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209301_at	158	0.322785	0.0126483	0.192383	-0.585413	0.119086	-0.432692	0.65 [0.38 - 1.12]
GENE	CA2	carbonic anhydrase II	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209301_at	53	0.415094	0.326132	-	-0.357889	0.599178	-0.12945	0.88 [0.54 - 1.42]
GENE	CA2	carbonic anhydrase II	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209301_at	53	0.603774	0.378613	-	0.303949	0.936646	0.019069	1.02 [0.64 - 1.63]
GENE	CA2	carbonic anhydrase II	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209301_at	180	0.494444	0.227551	-	-0.252463	0.893253	-0.0138118	0.99 [0.81 - 1.21]
GENE	CA2	carbonic anhydrase II	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209301_at	559	0.470483	0.0039351	0.078295	0.590417	0.0039873	0.266913	1.31 [1.09 - 1.57]
GENE	CA2	carbonic anhydrase II	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209301_at	77	0.87013	0.0514319	-	0.678969	0.228862	0.18369	1.20 [0.89 - 1.62]
GENE	CA2	carbonic anhydrase II	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209301_at	70	0.242857	0.0270444	0.330308	0.731408	0.123087	0.151511	1.16 [0.96 - 1.41]
GENE	CA2	carbonic anhydrase II	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40095_at	50	0.72	0.00149633	0.0356619	1.14089	0.0507393	0.301845	1.35 [1.00 - 1.83]
GENE	CA2	carbonic anhydrase II	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209301_at	74	0.337838	0.000546739	0.015293	1.18593	0.00631425	0.52771	1.70 [1.16 - 2.48]
GENE	CA2	carbonic anhydrase II	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209301_at	67	0.641791	0.0403684	0.430188	1.37695	0.315853	0.416312	1.52 [0.67 - 3.42]
GENE	CA2	carbonic anhydrase II	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209301_at	115	0.530435	0.172936	-	0.745888	0.841093	0.0527834	1.05 [0.63 - 1.77]
GENE	CA2	carbonic anhydrase II	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40095_at	158	0.867089	0.0224543	0.290608	-1.50392	0.397809	-0.12127	0.89 [0.67 - 1.17]
GENE	CA2	carbonic anhydrase II	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40095_at	76	0.197368	0.107204	-	1.52431	0.874236	0.0275705	1.03 [0.73 - 1.45]
GENE	CA2	carbonic anhydrase II	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209301_at	204	0.446078	0.0690603	-	-0.26063	0.400203	-0.0483172	0.95 [0.85 - 1.07]
GENE	CA2	carbonic anhydrase II	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209301_at	87	0.643678	0.120066	-	-0.667206	0.774035	-0.0238842	0.98 [0.83 - 1.15]
GENE	CA2	carbonic anhydrase II	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209301_at	87	0.643678	0.120066	-	-0.667206	0.774035	-0.0238842	0.98 [0.83 - 1.15]
GENE	CA2	carbonic anhydrase II	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209301_at	77	0.363636	0.12315	-	-0.834434	0.943653	0.00918067	1.01 [0.78 - 1.30]
GENE	CA2	carbonic anhydrase II	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209301_at	77	0.311688	0.156666	-	-0.869596	0.927465	0.0135144	1.01 [0.76 - 1.36]
GENE	CA2	carbonic anhydrase II	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209301_at	136	0.235294	0.00877606	0.146278	-1.17962	0.864511	-0.0272257	0.97 [0.71 - 1.33]
GENE	CA2	carbonic anhydrase II	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209301_at	200	0.83	0.0753561	-	0.609634	0.465738	0.086824	1.09 [0.86 - 1.38]
GENE	CA2	carbonic anhydrase II	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21192	60	0.816667	0.151566	-	0.592911	0.515413	0.0946328	1.10 [0.83 - 1.46]
GENE	CA2	carbonic anhydrase II	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21192	60	0.116667	6.17591e-06	0.000288483	-2.0082	0.771261	-0.045751	0.96 [0.70 - 1.30]
GENE	CA2	carbonic anhydrase II	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	4063	155	0.83871	0.00043812	0.0126557	1.04149	0.022186	0.287904	1.33 [1.04 - 1.71]
GENE	CA2	carbonic anhydrase II	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209301_at	286	0.555944	0.0454582	0.463606	-0.397541	0.473527	-0.0611702	0.94 [0.80 - 1.11]
GENE	CA2	carbonic anhydrase II	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209301_at	159	0.157233	0.0374731	0.410123	1.39422	0.457581	0.0940777	1.10 [0.86 - 1.41]
GENE	CA2	carbonic anhydrase II	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209301_at	159	0.201258	0.0235551	0.300431	1.27217	0.563042	0.0734787	1.08 [0.84 - 1.38]
GENE	CA2	carbonic anhydrase II	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209301_at	159	0.748428	0.0632861	-	0.697234	0.634475	0.0715334	1.07 [0.80 - 1.44]
GENE	CA2	carbonic anhydrase II	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209301_at	54	0.888889	0.0051053	0.0962068	1.74805	0.0236186	0.281704	1.33 [1.04 - 1.69]
GENE	CA2	carbonic anhydrase II	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209301_at	117	0.34188	0.0708838	-	-0.566389	0.356119	-0.0841867	0.92 [0.77 - 1.10]
GENE	CA2	carbonic anhydrase II	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209301_at	117	0.478632	0.180815	-	-0.529637	0.837817	-0.0211702	0.98 [0.80 - 1.20]
GENE	CA2	carbonic anhydrase II	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209301_at	117	0.34188	0.0708838	-	-0.566389	0.356119	-0.0841867	0.92 [0.77 - 1.10]
GENE	CA2	carbonic anhydrase II	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209301_at	117	0.34188	0.0832438	-	-0.643691	0.885158	-0.0143137	0.99 [0.81 - 1.20]
GENE	CA2	carbonic anhydrase II	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209301_at	236	0.504237	0.112112	-	0.434485	0.727565	0.0399023	1.04 [0.83 - 1.30]
GENE	CA2	carbonic anhydrase II	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209301_at	249	0.839357	0.032244	0.371705	-0.774299	0.348167	-0.0875641	0.92 [0.76 - 1.10]
GENE	CA2	carbonic anhydrase II	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209301_at	62	0.112903	0.0104988	0.167475	-1.38452	0.0871549	-0.284297	0.75 [0.54 - 1.04]
GENE	CA2	carbonic anhydrase II	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209301_at	125	0.888	0.037406	0.409649	0.930152	0.286748	0.133045	1.14 [0.89 - 1.46]
GENE	CA2	carbonic anhydrase II	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209301_at	125	0.272	0.093163	-	0.610713	0.42018	0.0784682	1.08 [0.89 - 1.31]
GENE	CA2	carbonic anhydrase II	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209301_at	54	0.111111	0.00149598	0.0356551	-1.81377	0.0144372	-0.532601	0.59 [0.38 - 0.90]
GENE	CA2	carbonic anhydrase II	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209301_at	198	0.353535	0.00947548	0.155031	0.802028	0.457178	0.0522579	1.05 [0.92 - 1.21]
GENE	CA2	carbonic anhydrase II	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209301_at	198	0.313131	0.00127888	0.0313019	0.827587	0.494944	0.0381154	1.04 [0.93 - 1.16]
GENE	CA2	carbonic anhydrase II	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209301_at	198	0.353535	0.0226066	0.291979	0.654094	0.832935	0.0145516	1.01 [0.89 - 1.16]
GENE	CA2	carbonic anhydrase II	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209301_at	51	0.490196	0.0234339	0.299359	16.2311	0.425183	-0.363057	0.70 [0.28 - 1.70]
GENE	CA2	carbonic anhydrase II	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209301_at	62	0.129032	0.133513	-	15.281	0.498664	-0.120583	0.89 [0.63 - 1.26]
GENE	CA2	carbonic anhydrase II	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209301_at	145	0.386207	0.103636	-	-0.538438	0.74665	-0.0377087	0.96 [0.77 - 1.21]
GENE	CA2	carbonic anhydrase II	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209301_at	177	0.723164	0.275786	-	0.318193	0.7678	0.0282762	1.03 [0.85 - 1.24]
GENE	CA2	carbonic anhydrase II	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209301_at	177	0.723164	0.0944761	-	0.415652	0.47377	0.0597158	1.06 [0.90 - 1.25]
GENE	CA2	carbonic anhydrase II	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209301_at	226	0.150442	0.219328	-	-0.431545	0.781313	-0.023933	0.98 [0.82 - 1.16]
GENE	CA2	carbonic anhydrase II	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209301_at	49	0.55102	0.0146653	0.214449	1.49259	0.283795	0.201412	1.22 [0.85 - 1.77]
GENE	CA2	carbonic anhydrase II	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209301_at	55	0.527273	0.0115906	0.180322	1.17061	0.163791	0.186827	1.21 [0.93 - 1.57]
GENE	CA2	carbonic anhydrase II	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209301_at	55	0.745455	0.0737137	-	-1.25265	0.446813	-0.100458	0.90 [0.70 - 1.17]
GENE	CA2	carbonic anhydrase II	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	51865	34	0.764706	0.0858043	-	-1.06247	0.557763	-0.0818695	0.92 [0.70 - 1.21]
GENE	CA2	carbonic anhydrase II	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209301_at	63	0.52381	0.0142875	0.210404	0.833265	0.379053	0.076952	1.08 [0.91 - 1.28]
GENE	CA2	carbonic anhydrase II	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g179794_3p_at	28	0.857143	0.0861324	-	-15.3314	0.312938	-0.548691	0.58 [0.20 - 1.68]
GENE	CA2	carbonic anhydrase II	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209301_at	82	0.560976	0.113849	-	0.532079	0.546141	-0.145627	0.86 [0.54 - 1.39]
GENE	CA2	carbonic anhydrase II	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209301_at	79	0.632911	0.0890457	-	-0.472201	0.623242	-0.089772	0.91 [0.64 - 1.31]
GENE	CA2	carbonic anhydrase II	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209301_at	104	0.480769	0.182407	-	-0.441858	0.802521	0.0689084	1.07 [0.62 - 1.84]
GENE	CA2	carbonic anhydrase II	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P8913	117	0.606838	0.00199323	0.0451691	-1.01535	0.0611881	-0.180116	0.84 [0.69 - 1.01]
GENE	CA2	carbonic anhydrase II	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209301_at	204	0.666667	0.154518	-	-0.639833	0.609193	0.0933783	1.10 [0.77 - 1.57]
GENE	CA2	carbonic anhydrase II	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209301_at	204	0.696078	0.0181363	0.24997	-0.838224	0.894045	-0.0188996	0.98 [0.74 - 1.30]
GENE	CA2	carbonic anhydrase II	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209301_at	178	0.707865	0.00176227	0.0408213	0.641741	0.0109907	0.365015	1.44 [1.09 - 1.91]
GENE	CA2	carbonic anhydrase II	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200014027	41	0.804878	0.0206312	0.27388	-2.01777	0.0712719	-0.272548	0.76 [0.57 - 1.02]
GENE	CA2	carbonic anhydrase II	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209301_at	111	0.891892	0.141113	-	-0.847677	0.899233	-0.0129	0.99 [0.81 - 1.21]
GENE	CA2	carbonic anhydrase II	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209301_at	90	0.422222	0.0503158	-	-0.629688	0.384242	-0.152355	0.86 [0.61 - 1.21]
GENE	CA2	carbonic anhydrase II	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209301_at	90	0.411111	0.0486363	0.483378	-0.723023	0.390016	-0.174521	0.84 [0.56 - 1.25]
GENE	CA2	carbonic anhydrase II	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2615	50	0.8	0.0531789	-	0.947114	0.387407	1.83532	6.27 [0.10 - 402.29]
GENE	CA2	carbonic anhydrase II	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209301_at	138	0.246377	0.0350488	0.392679	0.682473	0.277568	0.0620014	1.06 [0.95 - 1.19]
GENE	CA2	carbonic anhydrase II	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209301_at	129	0.209302	0.0361783	0.400882	0.735967	0.758833	0.0367202	1.04 [0.82 - 1.31]
GENE	CA2	carbonic anhydrase II	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28807	56	0.857143	0.0541184	-	-1.3151	0.34012	-0.118092	0.89 [0.70 - 1.13]
GENE	CA2	carbonic anhydrase II	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8437	56	0.857143	0.0541184	-	-1.3151	0.343618	-0.0990947	0.91 [0.74 - 1.11]
GENE	CA2	carbonic anhydrase II	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28807	56	0.857143	0.017899	0.24763	-1.56769	0.288703	-0.122655	0.88 [0.71 - 1.11]
GENE	CA2	carbonic anhydrase II	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8437	56	0.857143	0.017899	0.24763	-1.56769	0.233835	-0.117406	0.89 [0.73 - 1.08]
GENE	CA2	carbonic anhydrase II	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209301_at	278	0.877698	0.052892	-	0.495002	0.216579	0.0899631	1.09 [0.95 - 1.26]
GENE	CA2	carbonic anhydrase II	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209301_at	133	0.616541	0.0653165	-	-0.474647	0.401688	-0.0682527	0.93 [0.80 - 1.10]
GENE	CA2	carbonic anhydrase II	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11322	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	CA2	carbonic anhydrase II	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209301_at	185	0.724324	0.16027	-	0.246582	0.58073	-0.0495562	0.95 [0.80 - 1.13]
GENE	CA2	carbonic anhydrase II	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209301_at	185	0.897297	0.0797575	-	0.453928	0.815433	-0.0229683	0.98 [0.81 - 1.19]
GENE	CA2	carbonic anhydrase II	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P8913	110	0.809091	0.0243652	0.307534	0.596154	0.487285	0.127777	1.14 [0.79 - 1.63]
GENE	CA2	carbonic anhydrase II	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P8913	110	0.827273	0.051943	-	0.690342	0.811885	0.0499309	1.05 [0.70 - 1.59]
GENE	CA2	carbonic anhydrase II	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209301_at	80	0.6	0.0269854	0.329818	0.965752	0.23671	0.171713	1.19 [0.89 - 1.58]
GENE	CA2	carbonic anhydrase II	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_1679	281	0.13879	0.0163738	0.23229	0.516507	0.149505	0.18818	1.21 [0.93 - 1.56]
GENE	CA2	carbonic anhydrase II	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209301_at	38	0.236842	0.0463517	0.469246	1.39533	0.457868	0.152156	1.16 [0.78 - 1.74]
GENE	CA2	carbonic anhydrase II	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209301_at	140	0.685714	2.3257e-05	0.000956536	1.19988	0.00043683	0.533601	1.71 [1.27 - 2.30]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204865_at	30	0.533333	0.371191	-	0.369577	0.720553	0.332557	1.39 [0.23 - 8.63]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1740996	165	0.781818	0.156975	-	-0.462728	0.289274	-0.94063	0.39 [0.07 - 2.22]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1740996	165	0.848485	0.039825	0.426483	-1.82487	0.248212	-1.573	0.21 [0.01 - 3.00]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204865_at	163	0.766871	0.11569	-	-0.383538	0.331963	-0.284504	0.75 [0.42 - 1.34]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204865_at	79	0.481013	0.382559	-	-0.25423	0.644939	-0.0823278	0.92 [0.65 - 1.31]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204865_at	58	0.293103	0.0739251	-	0.54433	0.470399	0.106118	1.11 [0.83 - 1.48]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204865_at	34	0.176471	0.171408	-	0.74378	0.823235	0.0376819	1.04 [0.75 - 1.45]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204865_at	158	0.101266	0.0470873	0.473841	-0.66737	0.284488	-0.416072	0.66 [0.31 - 1.41]
GENE	CA3	carbonic anhydrase III, muscle specific	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204865_at	53	0.773585	9.18337e-05	0.00324894	1.45787	0.0676624	0.306215	1.36 [0.98 - 1.89]
GENE	CA3	carbonic anhydrase III, muscle specific	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204865_at	53	0.773585	0.0030285	0.0634724	1.06697	0.152667	0.206494	1.23 [0.93 - 1.63]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204865_at	180	0.144444	0.06386	-	-0.521845	0.583509	-0.0385156	0.96 [0.84 - 1.10]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204865_at	559	0.125224	0.0457879	0.465695	0.764241	0.229989	0.147165	1.16 [0.91 - 1.47]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204865_at	77	0.649351	0.00666438	0.118436	0.717597	0.0156091	0.168317	1.18 [1.03 - 1.36]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204865_at	70	0.742857	0.00111351	0.0278866	0.958487	0.00345767	0.210164	1.23 [1.07 - 1.42]
GENE	CA3	carbonic anhydrase III, muscle specific	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37624_at	50	0.48	0.073009	-	-0.621606	0.818828	-0.0393989	0.96 [0.69 - 1.35]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204865_at	74	0.324324	0.00862547	0.144365	0.86724	0.00616863	0.382332	1.47 [1.11 - 1.93]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204865_at	67	0.820895	0.0822969	-	1.11561	0.588938	0.0894069	1.09 [0.79 - 1.51]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204865_at	115	0.226087	0.195233	-	-0.711972	0.821864	0.0865091	1.09 [0.51 - 2.32]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37624_at	158	0.392405	0.000136418	0.00460118	-1.07048	0.00240539	-0.423147	0.65 [0.50 - 0.86]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37624_at	76	0.815789	0.191957	-	-1.26537	0.541706	-0.176216	0.84 [0.48 - 1.48]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204865_at	204	0.764706	0.00835122	0.140855	0.442251	0.177627	0.0809905	1.08 [0.96 - 1.22]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204865_at	87	0.298851	0.0698698	-	-0.681232	0.588152	-0.326649	0.72 [0.22 - 2.35]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204865_at	87	0.298851	0.0698698	-	-0.681232	0.588152	-0.326649	0.72 [0.22 - 2.35]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204865_at	77	0.142857	0.125072	-	-1.01648	0.27418	-1.48008	0.23 [0.02 - 3.23]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204865_at	77	0.87013	0.139755	-	-15.2499	0.482935	-0.718526	0.49 [0.07 - 3.63]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204865_at	136	0.132353	0.00640019	0.114782	-1.21947	0.0714524	-0.357629	0.70 [0.47 - 1.03]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204865_at	200	0.775	0.0865757	-	-0.733769	0.494515	-0.0989914	0.91 [0.68 - 1.20]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21037	60	0.2	0.000794888	0.0210081	-1.28269	0.110663	-0.676319	0.51 [0.22 - 1.17]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21037	60	0.133333	0.00931111	0.152992	-1.17894	0.34117	-0.253187	0.78 [0.46 - 1.31]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	14147	155	0.43871	0.012595	0.191784	-0.692611	0.0775464	-0.420121	0.66 [0.41 - 1.05]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204865_at	286	0.660839	0.089118	-	-0.364974	0.299027	-0.0988817	0.91 [0.75 - 1.09]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204865_at	159	0.490566	0.00680579	0.120375	-0.88573	0.0716699	-0.245057	0.78 [0.60 - 1.02]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204865_at	159	0.490566	0.000567243	0.0157804	-1.157	0.0235891	-0.303284	0.74 [0.57 - 0.96]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204865_at	159	0.490566	0.00458576	0.0884032	-1.12016	0.0263962	-0.339703	0.71 [0.53 - 0.96]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204865_at	54	0.12963	0.0279597	0.337852	-1.4738	0.435363	-1.22013	0.30 [0.01 - 6.33]
GENE	CA3	carbonic anhydrase III, muscle specific	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204865_at	117	0.888889	0.109386	-	-1.10507	0.290846	-0.664682	0.51 [0.15 - 1.77]
GENE	CA3	carbonic anhydrase III, muscle specific	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204865_at	117	0.863248	0.0737621	-	-1.63195	0.397051	-0.664238	0.51 [0.11 - 2.39]
GENE	CA3	carbonic anhydrase III, muscle specific	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204865_at	117	0.888889	0.109386	-	-1.10507	0.290846	-0.664682	0.51 [0.15 - 1.77]
GENE	CA3	carbonic anhydrase III, muscle specific	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204865_at	117	0.205128	0.104093	-	1.13168	0.650092	-0.309541	0.73 [0.19 - 2.80]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204865_at	236	0.800847	0.0825335	-	-0.68955	0.264099	-0.149087	0.86 [0.66 - 1.12]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204865_at	249	0.253012	0.0224867	0.2909	-0.50306	0.0243445	-0.23442	0.79 [0.65 - 0.97]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204865_at	62	0.870968	0.383044	-	-0.649654	0.740079	-0.209162	0.81 [0.24 - 2.79]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204865_at	125	0.888	0.0722781	-	0.809062	0.608681	0.256759	1.29 [0.48 - 3.45]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204865_at	125	0.88	0.0987854	-	0.606082	0.85844	-0.0839347	0.92 [0.37 - 2.31]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204865_at	54	0.222222	0.371753	-	0.906834	0.861686	-0.133602	0.87 [0.19 - 3.93]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204865_at	198	0.388889	0.00360385	0.0729878	-0.766724	0.0416093	-0.154232	0.86 [0.74 - 0.99]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204865_at	198	0.459596	0.0313629	0.364929	-0.451891	0.314041	-0.0645509	0.94 [0.83 - 1.06]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204865_at	198	0.388889	0.00664729	0.118201	-0.690209	0.0642275	-0.13564	0.87 [0.76 - 1.01]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204865_at	51	0.843137	0.0976364	-	1.40393	0.95188	0.120358	1.13 [0.02 - 56.23]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204865_at	62	0.129032	0.133513	-	15.281	0.999862	0.000240014	1.00 [0.07 - 15.14]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204865_at	177	0.316384	0.0018819	0.0430877	1.13064	0.694394	0.0899631	1.09 [0.70 - 1.71]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204865_at	177	0.299435	0.00124412	0.0305917	1.01447	0.737673	0.069391	1.07 [0.71 - 1.61]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204865_at	145	0.331034	0.0452968	0.46258	0.821581	0.421278	0.193116	1.21 [0.76 - 1.94]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204865_at	226	0.756637	0.153187	-	0.440268	0.445621	0.0838457	1.09 [0.88 - 1.35]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204865_at	55	0.654545	0.0324266	0.373097	0.926465	0.786932	0.24799	1.28 [0.21 - 7.74]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204865_at	55	0.490909	0.001435	0.0344461	1.79067	0.0738077	1.39177	4.02 [0.87 - 18.50]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204865_at	49	0.469388	0.00155155	0.036748	2.55864	0.426853	0.749267	2.12 [0.33 - 13.43]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	838856	34	0.176471	0.241153	-	-0.595626	0.940971	0.0227556	1.02 [0.56 - 1.87]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204865_at	63	0.492063	0.18516	-	-0.449642	0.68185	-0.656635	0.52 [0.02 - 11.98]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6996001_3p_at	28	0.607143	0.149922	-	-0.845873	0.469872	0.378864	1.46 [0.52 - 4.08]
GENE	CA3	carbonic anhydrase III, muscle specific	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204865_at	82	0.804878	0.382697	-	0.334195	0.522781	0.22482	1.25 [0.63 - 2.50]
GENE	CA3	carbonic anhydrase III, muscle specific	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204865_at	79	0.202532	0.110998	-	0.572205	0.470547	0.189923	1.21 [0.72 - 2.03]
GENE	CA3	carbonic anhydrase III, muscle specific	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204865_at	104	0.240385	0.0140499	0.207839	-0.82283	0.0415675	-0.814976	0.44 [0.20 - 0.97]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204865_at	204	0.245098	5.33525e-07	3.04538e-05	-1.28398	0.0020279	-0.371237	0.69 [0.54 - 0.87]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204865_at	204	0.127451	9.54834e-05	0.00336253	-1.3976	0.00452848	-0.445054	0.64 [0.47 - 0.87]
GENE	CA3	carbonic anhydrase III, muscle specific	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204865_at	178	0.898876	0.280524	-	0.330582	0.654145	0.0924531	1.10 [0.73 - 1.64]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204865_at	111	0.108108	0.14184	-	-0.586084	0.709417	-0.0497873	0.95 [0.73 - 1.24]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204865_at	90	0.166667	0.0304966	0.358176	-0.77924	0.675061	-0.210434	0.81 [0.30 - 2.17]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204865_at	90	0.155556	0.00404996	0.0801087	-1.10058	0.283058	-0.86311	0.42 [0.09 - 2.04]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	4620	50	0.18	0.0597016	-	-0.967502	0.679633	-0.16946	0.84 [0.38 - 1.89]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204865_at	138	0.5	0.0215073	0.281993	-0.558408	0.413797	-0.2259	0.80 [0.46 - 1.37]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204865_at	129	0.147287	0.000506302	0.0143226	-0.971584	0.0752585	-0.227339	0.80 [0.62 - 1.02]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42628	56	0.107143	0.0221993	0.288303	-1.00566	0.729456	-0.0503994	0.95 [0.71 - 1.27]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42628	56	0.107143	0.00229889	0.0507586	-1.33225	0.187549	-0.21722	0.80 [0.58 - 1.11]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204865_at	278	0.852518	0.167138	-	0.327313	0.629628	0.083319	1.09 [0.77 - 1.52]
GENE	CA3	carbonic anhydrase III, muscle specific	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204865_at	133	0.684211	0.00110578	0.0277246	0.765741	0.174989	0.301045	1.35 [0.87 - 2.09]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9514	81	0.111111	0.0281849	0.33969	-1.21463	0.33203	-0.375049	0.69 [0.32 - 1.47]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18145	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204865_at	185	0.172973	0.000173327	0.00567331	-0.808662	0.0541914	-0.922274	0.40 [0.16 - 1.02]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204865_at	185	0.178378	0.00316321	0.0657367	-0.687862	0.157465	-0.700011	0.50 [0.19 - 1.31]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P20316	110	0.709091	0.126977	-	-0.397586	0.4199	-0.0672326	0.93 [0.79 - 1.10]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P20316	110	0.445455	0.0726134	-	-0.531946	0.501022	-0.0767207	0.93 [0.74 - 1.16]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204865_at	80	0.75	0.115092	-	-0.955275	0.542653	-0.0844853	0.92 [0.70 - 1.21]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_2161	281	0.729537	0.000665078	0.0180657	0.508503	0.190523	0.160957	1.17 [0.92 - 1.49]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204865_at	38	0.684211	0.00598713	0.108981	1.34445	0.175976	0.319025	1.38 [0.87 - 2.18]
GENE	CA3	carbonic anhydrase III, muscle specific	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204865_at	140	0.214286	0.000398878	0.0116769	-1.01642	0.625414	0.0496109	1.05 [0.86 - 1.28]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CA4	carbonic anhydrase IV	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206208_at	30	0.166667	0.0668802	-	-0.950621	0.751947	-0.252368	0.78 [0.16 - 3.72]
GENE	CA4	carbonic anhydrase IV	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206209_s_at	30	0.2	0.215614	-	-0.62566	0.829433	-0.165994	0.85 [0.19 - 3.84]
GENE	CA4	carbonic anhydrase IV	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1695157	165	0.29697	0.0229104	0.294702	-0.555176	0.703613	0.0455668	1.05 [0.83 - 1.32]
GENE	CA4	carbonic anhydrase IV	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1695157	165	0.29697	0.102691	-	-0.579691	0.872871	-0.0293508	0.97 [0.68 - 1.39]
GENE	CA4	carbonic anhydrase IV	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206209_s_at	163	0.159509	0.0149188	0.217143	-0.599724	0.199922	-0.541842	0.58 [0.25 - 1.33]
GENE	CA4	carbonic anhydrase IV	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206208_at	163	0.883436	0.223446	-	-0.403403	0.812888	-0.111978	0.89 [0.35 - 2.26]
GENE	CA4	carbonic anhydrase IV	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206209_s_at	79	0.468354	0.00919468	0.151542	0.784702	0.406333	0.201683	1.22 [0.76 - 1.97]
GENE	CA4	carbonic anhydrase IV	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206208_at	79	0.202532	0.21835	-	-0.42334	0.853073	-0.080611	0.92 [0.39 - 2.17]
GENE	CA4	carbonic anhydrase IV	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206208_at	58	0.672414	0.00214296	0.0479291	0.907053	0.0315067	0.2543	1.29 [1.02 - 1.63]
GENE	CA4	carbonic anhydrase IV	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206209_s_at	58	0.37931	0.153346	-	0.406143	0.454023	0.1346	1.14 [0.80 - 1.63]
GENE	CA4	carbonic anhydrase IV	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206208_at	34	0.852941	0.227245	-	-0.727518	0.58424	-0.108536	0.90 [0.61 - 1.32]
GENE	CA4	carbonic anhydrase IV	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206209_s_at	34	0.558824	0.0122999	0.18845	-0.997164	0.099733	-0.64886	0.52 [0.24 - 1.13]
GENE	CA4	carbonic anhydrase IV	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206208_at	158	0.822785	0.0351961	0.393756	0.574974	0.146621	0.975683	2.65 [0.71 - 9.91]
GENE	CA4	carbonic anhydrase IV	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206209_s_at	158	0.683544	0.152671	-	-0.368044	0.679656	-0.294674	0.74 [0.18 - 3.02]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206209_s_at	53	0.867925	0.0578464	-	0.85152	0.918266	0.0426532	1.04 [0.46 - 2.36]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206208_at	53	0.169811	0.0472939	0.475124	1.13909	0.464194	0.13354	1.14 [0.80 - 1.63]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206209_s_at	53	0.132075	0.252606	-	-0.512144	0.714649	-0.140789	0.87 [0.41 - 1.85]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206208_at	53	0.433962	0.113255	-	0.594391	0.498006	0.134503	1.14 [0.78 - 1.69]
GENE	CA4	carbonic anhydrase IV	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206208_at	180	0.877778	0.0213058	0.280139	0.664489	0.3918	0.111679	1.12 [0.87 - 1.44]
GENE	CA4	carbonic anhydrase IV	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206209_s_at	180	0.327778	0.0655158	-	0.440031	0.111364	0.325631	1.38 [0.93 - 2.07]
GENE	CA4	carbonic anhydrase IV	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206209_s_at	559	0.586762	0.0827792	-	0.34541	0.502621	0.0814546	1.08 [0.85 - 1.38]
GENE	CA4	carbonic anhydrase IV	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206208_at	559	0.173524	0.000392813	0.0115242	-0.822394	0.0249646	-0.326432	0.72 [0.54 - 0.96]
GENE	CA4	carbonic anhydrase IV	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206208_at	77	0.428571	0.0194904	0.2631	-0.589119	0.0951147	-0.197303	0.82 [0.65 - 1.03]
GENE	CA4	carbonic anhydrase IV	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206209_s_at	77	0.324675	0.0739797	-	-0.493313	0.331927	-0.202588	0.82 [0.54 - 1.23]
GENE	CA4	carbonic anhydrase IV	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206209_s_at	70	0.328571	0.074902	-	0.512849	0.805839	0.0735887	1.08 [0.60 - 1.94]
GENE	CA4	carbonic anhydrase IV	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206208_at	70	0.642857	0.102347	-	0.443308	0.673883	0.206715	1.23 [0.47 - 3.22]
GENE	CA4	carbonic anhydrase IV	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40739_at	50	0.3	2.99785e-08	2.07883e-06	-2.15129	0.11272	-0.87519	0.42 [0.14 - 1.23]
GENE	CA4	carbonic anhydrase IV	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206208_at	74	0.837838	0.00474857	0.0908726	0.949257	0.617418	-0.0854538	0.92 [0.66 - 1.28]
GENE	CA4	carbonic anhydrase IV	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206209_s_at	74	0.716216	0.217724	-	0.37862	0.848073	0.0637959	1.07 [0.55 - 2.05]
GENE	CA4	carbonic anhydrase IV	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206209_s_at	67	0.492537	0.0324777	0.373486	-1.56417	0.20472	-1.74582	0.17 [0.01 - 2.59]
GENE	CA4	carbonic anhydrase IV	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206208_at	67	0.208955	0.0523207	-	-1.22581	0.295472	-2.35041	0.10 [0.00 - 7.79]
GENE	CA4	carbonic anhydrase IV	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206209_s_at	115	0.73913	0.138428	-	0.779627	0.849157	0.19933	1.22 [0.16 - 9.52]
GENE	CA4	carbonic anhydrase IV	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206208_at	115	0.417391	0.0157493	0.225853	-1.32911	0.19763	-0.642746	0.53 [0.20 - 1.40]
GENE	CA4	carbonic anhydrase IV	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40739_at	158	0.506329	0.305076	-	-0.293715	0.747642	0.103282	1.11 [0.59 - 2.08]
GENE	CA4	carbonic anhydrase IV	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40739_at	76	0.105263	0.0064626	0.115649	-1.46919	0.127307	-1.29297	0.27 [0.05 - 1.45]
GENE	CA4	carbonic anhydrase IV	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206208_at	204	0.362745	0.118578	-	0.229758	0.808993	-0.0163596	0.98 [0.86 - 1.12]
GENE	CA4	carbonic anhydrase IV	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206209_s_at	204	0.112745	0.00046101	0.0132198	-0.774077	0.0555263	-0.13793	0.87 [0.76 - 1.00]
GENE	CA4	carbonic anhydrase IV	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206209_s_at	87	0.195402	0.126404	-	-0.63047	0.508755	-0.455454	0.63 [0.16 - 2.45]
GENE	CA4	carbonic anhydrase IV	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206209_s_at	87	0.195402	0.126404	-	-0.63047	0.508755	-0.455454	0.63 [0.16 - 2.45]
GENE	CA4	carbonic anhydrase IV	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206208_at	87	0.517241	0.167592	-	-0.530363	0.475458	-0.497313	0.61 [0.16 - 2.38]
GENE	CA4	carbonic anhydrase IV	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206208_at	87	0.517241	0.167592	-	-0.530363	0.475458	-0.497313	0.61 [0.16 - 2.38]
GENE	CA4	carbonic anhydrase IV	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206208_at	77	0.571429	0.028866	0.345209	1.23573	0.193608	1.42612	4.16 [0.48 - 35.74]
GENE	CA4	carbonic anhydrase IV	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206209_s_at	77	0.61039	0.00742835	0.128776	-15.9136	0.145799	-2.18652	0.11 [0.01 - 2.14]
GENE	CA4	carbonic anhydrase IV	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206208_at	77	0.506494	0.156734	-	0.942746	0.762546	0.420455	1.52 [0.10 - 23.29]
GENE	CA4	carbonic anhydrase IV	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206209_s_at	77	0.701299	0.0113986	0.178093	-15.6636	0.292929	-1.21317	0.30 [0.03 - 2.85]
GENE	CA4	carbonic anhydrase IV	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206209_s_at	136	0.169118	0.0111631	0.175342	-1.11827	0.123402	-0.325217	0.72 [0.48 - 1.09]
GENE	CA4	carbonic anhydrase IV	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206208_at	136	0.492647	0.0207793	0.275261	-1.0906	0.0796055	-0.375847	0.69 [0.45 - 1.05]
GENE	CA4	carbonic anhydrase IV	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206208_at	200	0.12	0.0272717	0.332193	1.92235	0.276407	0.164896	1.18 [0.88 - 1.59]
GENE	CA4	carbonic anhydrase IV	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206209_s_at	200	0.54	0.201617	-	0.376337	0.26027	0.385108	1.47 [0.75 - 2.87]
GENE	CA4	carbonic anhydrase IV	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7692	60	0.433333	0.0796585	-	-0.652955	0.761787	-0.202177	0.82 [0.22 - 3.02]
GENE	CA4	carbonic anhydrase IV	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20991	60	0.5	0.0850079	-	0.654436	0.847887	0.0986158	1.10 [0.40 - 3.02]
GENE	CA4	carbonic anhydrase IV	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	20991	60	0.433333	0.188237	-	-0.498235	0.95798	-0.00912941	0.99 [0.71 - 1.39]
GENE	CA4	carbonic anhydrase IV	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7692	60	0.116667	0.000262531	0.00814036	-1.58733	0.660019	-0.258649	0.77 [0.24 - 2.44]
GENE	CA4	carbonic anhydrase IV	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15136	155	0.741935	0.00428873	0.0838379	-1.25982	0.0226291	-0.378283	0.69 [0.49 - 0.95]
GENE	CA4	carbonic anhydrase IV	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206208_at	286	0.405594	0.000797309	0.0210621	-0.639359	0.00448971	-0.356192	0.70 [0.55 - 0.90]
GENE	CA4	carbonic anhydrase IV	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206209_s_at	286	0.63986	0.000897628	0.0232746	-0.733683	0.0175166	-0.53025	0.59 [0.38 - 0.91]
GENE	CA4	carbonic anhydrase IV	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206208_at	159	0.352201	0.169936	-	-0.433261	0.394095	-0.16195	0.85 [0.59 - 1.23]
GENE	CA4	carbonic anhydrase IV	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206209_s_at	159	0.125786	0.0589904	-	-0.731494	0.309405	-0.494473	0.61 [0.24 - 1.58]
GENE	CA4	carbonic anhydrase IV	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206208_at	159	0.213836	0.423174	-	-0.331322	0.666973	-0.0954253	0.91 [0.59 - 1.40]
GENE	CA4	carbonic anhydrase IV	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206209_s_at	159	0.63522	0.15231	-	-0.501922	0.26799	-0.525891	0.59 [0.23 - 1.50]
GENE	CA4	carbonic anhydrase IV	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206209_s_at	159	0.169811	0.0553347	-	-0.777452	0.271734	-0.641443	0.53 [0.17 - 1.65]
GENE	CA4	carbonic anhydrase IV	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206208_at	159	0.169811	0.199039	-	0.664719	0.592406	0.0949888	1.10 [0.78 - 1.56]
GENE	CA4	carbonic anhydrase IV	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206208_at	54	0.740741	0.0509693	-	-15.8183	0.423116	-1.29273	0.27 [0.01 - 6.49]
GENE	CA4	carbonic anhydrase IV	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206209_s_at	54	0.759259	0.0632917	-	-15.8145	0.305193	-1.60147	0.20 [0.01 - 4.30]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206208_at	117	0.205128	0.0377407	0.412012	1.0501	0.939186	0.0449266	1.05 [0.33 - 3.32]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206208_at	117	0.205128	0.0469773	0.473156	1.35336	0.949857	0.0437524	1.04 [0.27 - 4.09]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206208_at	117	0.205128	0.0377407	0.412012	1.0501	0.939186	0.0449266	1.05 [0.33 - 3.32]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206208_at	117	0.179487	0.0988384	-	1.14804	0.851362	0.133229	1.14 [0.28 - 4.60]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206209_s_at	117	0.179487	0.117161	-	1.09458	0.849855	0.122147	1.13 [0.32 - 4.00]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206209_s_at	117	0.111111	0.327087	-	0.587178	0.710095	0.198931	1.22 [0.43 - 3.48]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206209_s_at	117	0.111111	0.327087	-	0.587178	0.710095	0.198931	1.22 [0.43 - 3.48]
GENE	CA4	carbonic anhydrase IV	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206209_s_at	117	0.581197	0.173826	-	-0.565857	0.722622	-0.26486	0.77 [0.18 - 3.31]
GENE	CA4	carbonic anhydrase IV	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206209_s_at	236	0.29661	0.00534783	0.0997763	-0.739484	0.0105984	-1.16923	0.31 [0.13 - 0.76]
GENE	CA4	carbonic anhydrase IV	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206208_at	236	0.898305	0.0219119	0.285692	-1.97493	0.0470577	-0.461002	0.63 [0.40 - 0.99]
GENE	CA4	carbonic anhydrase IV	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206208_at	249	0.180723	0.00209125	0.0469808	-0.723258	0.041618	-0.348899	0.71 [0.50 - 0.99]
GENE	CA4	carbonic anhydrase IV	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206209_s_at	249	0.365462	0.00608536	0.11037	-0.576496	0.00988137	-0.918384	0.40 [0.20 - 0.80]
GENE	CA4	carbonic anhydrase IV	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206209_s_at	125	0.128	0.147254	-	1.00779	0.835187	-0.0432138	0.96 [0.64 - 1.44]
GENE	CA4	carbonic anhydrase IV	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206209_s_at	54	0.87037	0.107067	-	-15.3697	0.543162	-0.234772	0.79 [0.37 - 1.69]
GENE	CA4	carbonic anhydrase IV	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206208_at	62	0.564516	0.207384	-	-0.633998	0.531961	-0.199994	0.82 [0.44 - 1.53]
GENE	CA4	carbonic anhydrase IV	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206208_at	125	0.184	0.0185164	0.253693	-0.922222	0.644676	-0.302552	0.74 [0.20 - 2.67]
GENE	CA4	carbonic anhydrase IV	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206209_s_at	62	0.241935	0.0615662	-	-0.954861	0.468794	-0.230471	0.79 [0.43 - 1.48]
GENE	CA4	carbonic anhydrase IV	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206208_at	125	0.184	0.141072	-	-0.487033	0.485291	-0.35763	0.70 [0.26 - 1.91]
GENE	CA4	carbonic anhydrase IV	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206208_at	54	0.111111	0.152298	-	-1.10157	0.49368	-0.269953	0.76 [0.35 - 1.65]
GENE	CA4	carbonic anhydrase IV	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206209_s_at	125	0.128	0.17582	-	1.28981	0.709218	0.0922439	1.10 [0.68 - 1.78]
GENE	CA4	carbonic anhydrase IV	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206208_at	198	0.494949	0.269905	-	0.282627	0.738319	0.0334265	1.03 [0.85 - 1.26]
GENE	CA4	carbonic anhydrase IV	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206209_s_at	198	0.848485	0.255646	-	0.312992	0.525321	0.0670211	1.07 [0.87 - 1.31]
GENE	CA4	carbonic anhydrase IV	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206208_at	198	0.136364	0.215641	-	-0.429057	0.949629	-0.00676528	0.99 [0.81 - 1.23]
GENE	CA4	carbonic anhydrase IV	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206209_s_at	198	0.121212	0.400915	-	-0.303609	0.628767	0.0609318	1.06 [0.83 - 1.36]
GENE	CA4	carbonic anhydrase IV	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206209_s_at	198	0.121212	0.170943	-	-0.49404	0.9778	-0.00365797	1.00 [0.77 - 1.29]
GENE	CA4	carbonic anhydrase IV	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206208_at	198	0.651515	0.116348	-	-0.36427	0.653736	-0.0370769	0.96 [0.82 - 1.13]
GENE	CA4	carbonic anhydrase IV	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206209_s_at	62	0.693548	0.0967943	-	-1.56903	0.465829	-0.172487	0.84 [0.53 - 1.34]
GENE	CA4	carbonic anhydrase IV	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206208_at	51	0.431373	0.0708511	-	-1.77796	0.371344	-1.20382	0.30 [0.02 - 4.20]
GENE	CA4	carbonic anhydrase IV	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206208_at	62	0.467742	0.0201221	0.2691	-1.4272	0.61252	-0.218868	0.80 [0.34 - 1.87]
GENE	CA4	carbonic anhydrase IV	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206209_s_at	51	0.490196	0.182983	-	1.37785	0.508082	-0.369023	0.69 [0.23 - 2.06]
GENE	CA4	carbonic anhydrase IV	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206208_at	177	0.220339	0.126991	-	-0.415	0.57092	-0.165705	0.85 [0.48 - 1.50]
GENE	CA4	carbonic anhydrase IV	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206209_s_at	177	0.305085	0.0156083	0.224386	-0.648848	0.585113	-0.0905718	0.91 [0.66 - 1.26]
GENE	CA4	carbonic anhydrase IV	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206208_at	145	0.675862	0.032937	0.37697	-0.921598	0.0532038	-0.91944	0.40 [0.16 - 1.01]
GENE	CA4	carbonic anhydrase IV	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206208_at	177	0.214689	0.142793	-	-0.453837	0.443547	-0.262824	0.77 [0.39 - 1.51]
GENE	CA4	carbonic anhydrase IV	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206209_s_at	177	0.310734	0.00995845	0.160955	-0.603442	0.740782	-0.0460663	0.95 [0.73 - 1.25]
GENE	CA4	carbonic anhydrase IV	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206209_s_at	145	0.448276	0.000985709	0.0251793	-1.13654	0.0500558	-0.529158	0.59 [0.35 - 1.00]
GENE	CA4	carbonic anhydrase IV	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206208_at	226	0.402655	0.0230212	0.295692	-0.636227	0.315276	-0.0890789	0.91 [0.77 - 1.09]
GENE	CA4	carbonic anhydrase IV	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206209_s_at	226	0.278761	0.00320547	0.0664424	-0.819522	0.14098	-0.109704	0.90 [0.77 - 1.04]
GENE	CA4	carbonic anhydrase IV	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206208_at	49	0.367347	0.0625401	-	-1.0514	0.675352	-0.117853	0.89 [0.51 - 1.54]
GENE	CA4	carbonic anhydrase IV	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206209_s_at	55	0.4	0.296022	-	-0.463625	0.988344	0.00210844	1.00 [0.76 - 1.33]
GENE	CA4	carbonic anhydrase IV	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206209_s_at	55	0.4	0.00842392	0.141789	-1.28098	0.0569524	-0.363373	0.70 [0.48 - 1.01]
GENE	CA4	carbonic anhydrase IV	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206209_s_at	49	0.387755	0.0379621	0.41357	-1.1718	0.49082	-0.140172	0.87 [0.58 - 1.30]
GENE	CA4	carbonic anhydrase IV	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206208_at	55	0.872727	0.0431161	0.448508	-15.4084	0.0973211	-0.439391	0.64 [0.38 - 1.08]
GENE	CA4	carbonic anhydrase IV	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206208_at	55	0.818182	0.383699	-	0.446625	0.819301	0.0465891	1.05 [0.70 - 1.56]
GENE	CA4	carbonic anhydrase IV	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	1389018	34	0.411765	0.159783	-	-0.607909	0.896801	0.0326977	1.03 [0.63 - 1.69]
GENE	CA4	carbonic anhydrase IV	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206208_at	63	0.238095	0.0014491	0.0347265	-1.09565	0.851201	-0.0916468	0.91 [0.35 - 2.38]
GENE	CA4	carbonic anhydrase IV	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206209_s_at	63	0.507937	0.0195962	0.264111	-0.799614	0.276914	-0.373095	0.69 [0.35 - 1.35]
GENE	CA4	carbonic anhydrase IV	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9951925_3p_s_at	28	0.428571	0.00197898	0.0449042	-1.90269	0.352613	-1.91572	0.15 [0.00 - 8.36]
GENE	CA4	carbonic anhydrase IV	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	206208_3p_at	28	0.285714	0.04538	0.463109	-1.11789	0.331476	0.531538	1.70 [0.58 - 4.97]
GENE	CA4	carbonic anhydrase IV	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9951925_3p_at	28	0.321429	0.000929116	0.0239594	-1.76816	0.318611	-0.588233	0.56 [0.17 - 1.76]
GENE	CA4	carbonic anhydrase IV	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206209_s_at	82	0.719512	0.0301814	0.355695	0.737211	0.655606	0.18306	1.20 [0.54 - 2.68]
GENE	CA4	carbonic anhydrase IV	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206208_at	82	0.365854	0.00199825	0.0452623	1.2483	0.0517739	0.747212	2.11 [0.99 - 4.48]
GENE	CA4	carbonic anhydrase IV	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40739_at	84	0.5	0.0128966	0.195163	-0.730508	0.0142805	-0.82787	0.44 [0.23 - 0.85]
GENE	CA4	carbonic anhydrase IV	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206209_s_at	79	0.126582	0.145557	-	0.621748	0.333153	0.44151	1.56 [0.64 - 3.80]
GENE	CA4	carbonic anhydrase IV	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206208_at	79	0.860759	0.111615	-	-0.686248	0.423351	0.415905	1.52 [0.55 - 4.20]
GENE	CA4	carbonic anhydrase IV	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206208_at	104	0.365385	0.00382081	0.076477	-0.908667	0.0625866	-1.3385	0.26 [0.06 - 1.07]
GENE	CA4	carbonic anhydrase IV	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206209_s_at	104	0.307692	0.0239432	0.303847	0.97414	0.815566	0.140622	1.15 [0.35 - 3.75]
GENE	CA4	carbonic anhydrase IV	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P4096	117	0.358974	0.00263566	0.0567274	-0.836645	0.109182	-0.125251	0.88 [0.76 - 1.03]
GENE	CA4	carbonic anhydrase IV	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206209_s_at	204	0.107843	0.0432231	0.449208	15.2082	0.738697	-0.0538473	0.95 [0.69 - 1.30]
GENE	CA4	carbonic anhydrase IV	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206209_s_at	204	0.705882	0.00130186	0.0317693	-1.29948	0.0481046	-0.242044	0.79 [0.62 - 1.00]
GENE	CA4	carbonic anhydrase IV	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206208_at	204	0.269608	0.00056037	0.0156174	-1.19259	0.0162743	-0.403909	0.67 [0.48 - 0.93]
GENE	CA4	carbonic anhydrase IV	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206208_at	204	0.294118	2.62176e-06	0.000131956	-1.21123	4.02851e-05	-0.518522	0.60 [0.46 - 0.76]
GENE	CA4	carbonic anhydrase IV	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206209_s_at	178	0.898876	0.00217743	0.0485584	0.818528	0.10793	0.671373	1.96 [0.86 - 4.44]
GENE	CA4	carbonic anhydrase IV	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206208_at	178	0.488764	0.00507578	0.0957693	0.554692	0.0459879	0.66747	1.95 [1.01 - 3.75]
GENE	CA4	carbonic anhydrase IV	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206208_at	111	0.306306	0.122438	-	-0.424755	0.359497	-0.224996	0.80 [0.49 - 1.29]
GENE	CA4	carbonic anhydrase IV	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206209_s_at	111	0.603604	0.0329229	0.376863	-0.599509	0.362448	-0.165481	0.85 [0.59 - 1.21]
GENE	CA4	carbonic anhydrase IV	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206209_s_at	90	0.111111	0.105935	-	-0.706424	0.72131	0.133924	1.14 [0.55 - 2.39]
GENE	CA4	carbonic anhydrase IV	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206209_s_at	90	0.111111	0.102866	-	-0.782913	0.824891	0.0959978	1.10 [0.47 - 2.58]
GENE	CA4	carbonic anhydrase IV	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206208_at	90	0.255556	0.160277	-	0.582633	0.732582	0.173847	1.19 [0.44 - 3.23]
GENE	CA4	carbonic anhydrase IV	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206208_at	90	0.322222	0.115805	-	0.707183	0.584486	0.302707	1.35 [0.46 - 4.01]
GENE	CA4	carbonic anhydrase IV	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206209_s_at	138	0.246377	0.0511748	-	-0.499649	0.57094	-0.0852461	0.92 [0.68 - 1.23]
GENE	CA4	carbonic anhydrase IV	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206208_at	138	0.326087	0.0524819	-	-0.467916	0.763758	-0.0717269	0.93 [0.58 - 1.49]
GENE	CA4	carbonic anhydrase IV	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206208_at	129	0.875969	0.142355	-	-0.672365	0.398342	-0.172108	0.84 [0.56 - 1.26]
GENE	CA4	carbonic anhydrase IV	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206209_s_at	129	0.883721	0.00805868	0.137072	0.86315	0.147412	0.559434	1.75 [0.82 - 3.73]
GENE	CA4	carbonic anhydrase IV	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24550	56	0.785714	0.186823	-	-0.63427	0.591457	-0.0903706	0.91 [0.66 - 1.27]
GENE	CA4	carbonic anhydrase IV	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24550	56	0.821429	0.227929	-	-0.5769	0.911813	-0.0185683	0.98 [0.71 - 1.36]
GENE	CA4	carbonic anhydrase IV	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206209_s_at	278	0.154676	0.00431469	0.08424	-0.656426	0.0258646	0.289656	1.34 [1.04 - 1.72]
GENE	CA4	carbonic anhydrase IV	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206208_at	278	0.78777	0.0694439	-	0.380445	0.103921	0.35418	1.43 [0.93 - 2.18]
GENE	CA4	carbonic anhydrase IV	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206208_at	133	0.593985	0.00480562	0.0917326	0.661715	0.203047	0.562077	1.75 [0.74 - 4.17]
GENE	CA4	carbonic anhydrase IV	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206209_s_at	133	0.639098	0.00675609	0.119695	0.645416	0.701228	-0.149824	0.86 [0.40 - 1.85]
GENE	CA4	carbonic anhydrase IV	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4050	81	0.481481	0.00357789	0.0725669	1.71514	0.020775	0.437092	1.55 [1.07 - 2.24]
GENE	CA4	carbonic anhydrase IV	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206209_s_at	185	0.194595	0.0337045	0.382736	0.443337	0.0732299	0.478722	1.61 [0.96 - 2.73]
GENE	CA4	carbonic anhydrase IV	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206208_at	185	0.335135	0.0238056	0.302638	-0.385411	0.269675	-0.312855	0.73 [0.42 - 1.27]
GENE	CA4	carbonic anhydrase IV	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206209_s_at	185	0.194595	0.0692726	-	0.411114	0.22995	0.357223	1.43 [0.80 - 2.56]
GENE	CA4	carbonic anhydrase IV	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206208_at	185	0.335135	0.0309824	0.361973	-0.395091	0.437037	-0.238322	0.79 [0.43 - 1.44]
GENE	CA4	carbonic anhydrase IV	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P4096	110	0.618182	0.118593	-	0.359006	0.871747	0.0148443	1.01 [0.85 - 1.22]
GENE	CA4	carbonic anhydrase IV	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P4096	110	0.8	0.247997	-	-0.500491	0.476794	-0.0894954	0.91 [0.71 - 1.17]
GENE	CA4	carbonic anhydrase IV	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206208_at	80	0.675	0.0884978	-	0.731488	0.343714	0.14009	1.15 [0.86 - 1.54]
GENE	CA4	carbonic anhydrase IV	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206209_s_at	80	0.8625	0.429067	-	0.405369	0.761837	0.104538	1.11 [0.56 - 2.18]
GENE	CA4	carbonic anhydrase IV	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_5379	281	0.345196	0.00347289	0.0708566	0.439556	0.276275	0.102905	1.11 [0.92 - 1.33]
GENE	CA4	carbonic anhydrase IV	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:687974	59	0.644068	0.182191	-	0.641877	0.440396	0.418877	1.52 [0.52 - 4.41]
GENE	CA4	carbonic anhydrase IV	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206208_at	38	0.105263	0.00618046	0.111709	-1.48601	0.053448	-0.683938	0.50 [0.25 - 1.01]
GENE	CA4	carbonic anhydrase IV	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206209_s_at	38	0.552632	0.0266295	0.32685	-1.09178	0.848056	-0.0458427	0.96 [0.60 - 1.53]
GENE	CA4	carbonic anhydrase IV	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206209_s_at	140	0.45	0.00113646	0.0283662	-0.960598	0.0143508	-0.372565	0.69 [0.51 - 0.93]
GENE	CA4	carbonic anhydrase IV	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206208_at	140	0.4	0.000201565	0.00647113	-1.07134	0.0158967	-0.491315	0.61 [0.41 - 0.91]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207421_at	30	0.166667	0.0391711	0.421988	-1.08962	0.436807	0.625862	1.87 [0.39 - 9.06]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1731292	165	0.806061	0.0224477	0.290548	0.599069	0.945346	0.0489336	1.05 [0.26 - 4.25]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1731292	165	0.854545	0.0188313	0.256756	0.894736	0.645638	0.455163	1.58 [0.23 - 10.97]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207421_at	163	0.895706	0.0546794	-	-0.737393	0.328261	-0.610797	0.54 [0.16 - 1.85]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207421_at	79	0.392405	0.164622	-	-0.403804	0.399073	-0.681315	0.51 [0.10 - 2.47]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207421_at	58	0.137931	0.209872	-	0.511565	0.560308	0.0963556	1.10 [0.80 - 1.52]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207421_at	34	0.117647	0.000594401	0.0164212	-1.90769	0.132294	-0.559775	0.57 [0.28 - 1.18]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207421_at	158	0.886076	0.000489447	0.0139142	1.00723	0.146788	1.38665	4.00 [0.61 - 26.04]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207421_at	53	0.566038	0.00974884	0.158396	-1.04483	0.0547795	-0.35502	0.70 [0.49 - 1.01]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207421_at	53	0.566038	0.0263773	0.324737	-0.799619	0.131857	-0.263487	0.77 [0.55 - 1.08]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207421_at	180	0.316667	0.0783728	-	-0.385925	0.387466	-0.0876558	0.92 [0.75 - 1.12]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207421_at	559	0.830054	0.283936	-	-0.299799	0.995132	0.000660673	1.00 [0.81 - 1.24]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207421_at	77	0.87013	0.035484	0.395856	0.776229	0.791365	0.0577007	1.06 [0.69 - 1.62]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207421_at	70	0.185714	0.0257953	0.319822	-0.704287	0.148082	-1.10763	0.33 [0.07 - 1.48]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32296_at	50	0.14	0.00040094	0.0117287	-1.55292	0.152365	-0.983769	0.37 [0.10 - 1.44]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207421_at	74	0.216216	0.00702855	0.123406	1.21925	0.0560318	0.477939	1.61 [0.99 - 2.63]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207421_at	67	0.701493	0.0274733	0.333858	1.37834	0.594617	0.958103	2.61 [0.08 - 88.85]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207421_at	115	0.730435	0.0392558	0.422573	1.0555	0.254957	0.903275	2.47 [0.52 - 11.69]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32296_at	158	0.531646	0.0870159	-	-0.492946	0.580029	-0.136922	0.87 [0.54 - 1.42]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32296_at	76	0.881579	0.150412	-	0.904466	0.660144	0.304575	1.36 [0.35 - 5.27]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207421_at	204	0.617647	0.016245	0.23097	-0.354569	0.0656942	-0.139677	0.87 [0.75 - 1.01]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207421_at	87	0.735632	0.118368	-	-0.820504	0.924842	0.0767323	1.08 [0.22 - 5.32]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207421_at	87	0.735632	0.118368	-	-0.820504	0.924842	0.0767323	1.08 [0.22 - 5.32]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207421_at	77	0.298701	0.0296285	0.351315	-1.30992	0.0688892	-2.8062	0.06 [0.00 - 1.24]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207421_at	77	0.168831	0.174566	-	-0.795005	0.528021	-0.910846	0.40 [0.02 - 6.81]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207421_at	136	0.639706	0.0354267	0.395438	0.967035	0.66975	-0.0928786	0.91 [0.59 - 1.40]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207421_at	200	0.825	0.167563	-	-0.642644	0.681569	-0.0767202	0.93 [0.64 - 1.34]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18648	60	0.816667	0.177048	-	-0.803581	0.654799	-0.23983	0.79 [0.27 - 2.25]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	18648	60	0.166667	0.00135504	0.0328448	-1.2803	0.00892352	-1.79747	0.17 [0.04 - 0.64]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1100	155	0.83871	0.00147877	0.0353148	0.944199	0.0241023	0.539155	1.71 [1.07 - 2.74]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207421_at	286	0.111888	0.309107	-	-0.281677	0.771103	0.0364119	1.04 [0.81 - 1.33]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207421_at	159	0.106918	0.0715316	-	1.63638	0.958654	0.011987	1.01 [0.64 - 1.59]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207421_at	159	0.861635	0.00852268	0.143054	0.902261	0.491865	0.164556	1.18 [0.74 - 1.88]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207421_at	159	0.861635	0.0279904	0.338103	0.884688	0.745065	0.0900173	1.09 [0.64 - 1.88]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207421_at	54	0.12963	0.0439136	0.453701	-1.36712	0.44766	-1.19955	0.30 [0.01 - 6.66]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207421_at	117	0.179487	0.203517	-	0.599996	0.611335	-0.39545	0.67 [0.15 - 3.10]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207421_at	117	0.495726	0.247442	-	-0.457368	0.682974	-0.398002	0.67 [0.10 - 4.54]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207421_at	117	0.179487	0.203517	-	0.599996	0.611335	-0.39545	0.67 [0.15 - 3.10]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207421_at	117	0.752137	0.193749	-	0.520825	0.903611	0.10574	1.11 [0.20 - 6.15]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207421_at	236	0.864407	0.138181	-	-0.752599	0.66559	-0.0910287	0.91 [0.60 - 1.38]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207421_at	249	0.140562	0.11926	-	-0.415273	0.664498	-0.0686815	0.93 [0.68 - 1.27]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207421_at	62	0.306452	0.0092893	0.152721	15.56	0.877162	-0.044466	0.96 [0.54 - 1.68]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207421_at	125	0.872	0.291227	-	-0.758423	0.925508	0.0961318	1.10 [0.15 - 8.26]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207421_at	125	0.528	0.197786	-	-0.374965	0.566792	-0.449753	0.64 [0.14 - 2.97]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207421_at	54	0.388889	0.0430862	0.448312	1.84916	0.904506	-0.0421187	0.96 [0.48 - 1.91]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207421_at	198	0.883838	0.0150557	0.218591	0.799653	0.511551	0.0682362	1.07 [0.87 - 1.31]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207421_at	198	0.262626	0.0771968	-	0.453238	0.502339	0.0529756	1.05 [0.90 - 1.23]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207421_at	198	0.883838	0.0750611	-	0.589761	0.946908	0.0063826	1.01 [0.83 - 1.21]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207421_at	51	0.705882	0.130834	-	-15.6193	0.637027	-0.989831	0.37 [0.01 - 22.68]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207421_at	62	0.225806	0.360664	-	-0.553306	0.907335	0.146473	1.16 [0.10 - 13.64]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207421_at	177	0.112994	0.0386489	0.418369	-0.645208	0.265782	-0.818866	0.44 [0.10 - 1.87]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207421_at	145	0.62069	0.0715834	-	-0.680979	0.59428	-0.563141	0.57 [0.07 - 4.52]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207421_at	177	0.813559	0.101749	-	-0.694906	0.305573	-0.863004	0.42 [0.08 - 2.20]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207421_at	226	0.362832	0.0301662	0.355576	0.703863	0.270378	0.132118	1.14 [0.90 - 1.44]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207421_at	55	0.509091	0.161705	-	0.717175	0.450742	1.39224	4.02 [0.11 - 149.97]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207421_at	49	0.591837	0.12044	-	-0.996442	0.731801	-0.682941	0.51 [0.01 - 25.09]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207421_at	55	0.6	0.207732	-	-0.606409	0.854414	0.305918	1.36 [0.05 - 35.65]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207421_at	63	0.126984	0.000332305	0.00997922	-1.39262	0.106077	-16.6087	0.00 [0.00 - 34.28]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502520_3p_at	28	0.892857	0.126995	-	-15.2751	0.263361	-5.59611	0.00 [0.00 - 67.38]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207421_at	82	0.170732	0.0740287	-	-0.684657	0.0594807	-0.833301	0.43 [0.18 - 1.03]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207421_at	79	0.481013	0.0344445	0.388234	0.552915	0.259924	0.790304	2.20 [0.56 - 8.72]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207421_at	104	0.692308	0.15285	-	-0.537883	0.775002	-0.311941	0.73 [0.09 - 6.22]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P540057	117	0.57265	0.00589146	0.107621	-0.867382	0.0195131	-0.376265	0.69 [0.50 - 0.94]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P95683	117	0.367521	0.0214106	0.281104	0.747288	0.281868	0.160524	1.17 [0.88 - 1.57]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207421_at	204	0.455882	0.00623602	0.112489	1.12233	0.061669	0.352617	1.42 [0.98 - 2.06]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207421_at	204	0.455882	0.000404267	0.0118122	1.05126	0.00242148	0.417191	1.52 [1.16 - 1.99]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207421_at	178	0.151685	0.134601	-	-0.371688	0.532248	-0.314499	0.73 [0.27 - 1.96]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207421_at	111	0.810811	0.00815452	0.138316	0.781646	0.939142	-0.0114432	0.99 [0.74 - 1.33]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207421_at	90	0.155556	0.251365	-	0.59837	0.959543	0.0380948	1.04 [0.24 - 4.53]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207421_at	90	0.644444	0.222415	-	-0.524248	0.912157	0.0952913	1.10 [0.20 - 5.98]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207421_at	138	0.362319	0.0375851	0.410914	-0.498131	0.416305	-4.16827	0.02 [0.00 - 358.73]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207421_at	129	0.79845	0.0451833	0.461857	0.573741	0.804138	-0.0487066	0.95 [0.65 - 1.40]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12835	56	0.660714	0.0482203	0.480835	0.67335	0.337909	0.157452	1.17 [0.85 - 1.62]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12835	56	0.678571	0.131813	-	0.553703	0.403052	0.148876	1.16 [0.82 - 1.65]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207421_at	278	0.68705	0.00578352	0.10608	0.521087	0.91525	0.0483777	1.05 [0.43 - 2.56]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207421_at	133	0.729323	0.00385478	0.0770187	0.726712	0.153959	1.63697	5.14 [0.54 - 48.79]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207421_at	185	0.583784	0.09305	-	-0.301485	0.812602	0.0799538	1.08 [0.56 - 2.10]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207421_at	185	0.583784	0.0520281	-	-0.32108	0.894827	-0.0391372	0.96 [0.54 - 1.72]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P95683	110	0.263636	0.314523	-	0.278713	0.680126	0.0930007	1.10 [0.71 - 1.71]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P540057	110	0.554545	0.121719	-	0.449234	0.686241	0.0710992	1.07 [0.76 - 1.52]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P95683	110	0.854545	0.275283	-	0.385618	0.544549	0.180141	1.20 [0.67 - 2.14]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P540057	110	0.245455	0.150797	-	0.391007	0.641096	0.0629069	1.06 [0.82 - 1.39]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207421_at	80	0.8875	0.0257677	0.319589	1.10357	0.609517	0.0970813	1.10 [0.76 - 1.60]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207421_at	38	0.789474	0.00835546	0.14091	1.22581	0.0180375	1.6135	5.02 [1.32 - 19.12]
GENE	CA5A	carbonic anhydrase VA, mitochondrial	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207421_at	140	0.2	0.0231305	0.296666	-0.724266	0.324017	-0.798302	0.45 [0.09 - 2.20]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	214082_at	30	0.133333	0.000214731	0.00683737	-2.27065	0.403536	-0.880874	0.41 [0.05 - 3.27]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207129_at	30	0.633333	0.234566	-	0.492198	0.719599	0.228813	1.26 [0.36 - 4.38]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1672807	165	0.430303	0.0155817	0.224109	-0.579568	0.148857	-0.470888	0.62 [0.33 - 1.18]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1672807	165	0.218182	0.00357252	0.0724798	-1.0078	0.0873015	-0.802951	0.45 [0.18 - 1.12]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207129_at	163	0.184049	0.0153344	0.221523	-0.559108	0.273289	-0.721402	0.49 [0.13 - 1.77]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	214082_at	163	0.809816	0.13852	-	-0.392188	0.924571	-0.0412319	0.96 [0.41 - 2.25]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207129_at	79	0.43038	0.00955559	0.15602	0.806128	0.214361	0.576832	1.78 [0.72 - 4.43]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	214082_at	79	0.544304	0.182171	-	0.38709	0.562258	0.168361	1.18 [0.67 - 2.09]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207129_at	58	0.155172	0.131063	-	0.575257	0.524612	0.120151	1.13 [0.78 - 1.63]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214082_at	58	0.603448	0.0268116	0.328371	0.617894	0.466429	0.11712	1.12 [0.82 - 1.54]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207129_at	34	0.882353	0.0589149	-	-1.71412	0.302116	-0.259247	0.77 [0.47 - 1.26]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	214082_at	34	0.852941	0.176984	-	0.758637	0.588355	0.144397	1.16 [0.68 - 1.95]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207129_at	158	0.841772	0.0393176	0.422999	0.579316	0.993975	0.00782625	1.01 [0.13 - 7.68]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	214082_at	158	0.113924	0.0637846	-	0.836978	0.526376	0.603853	1.83 [0.28 - 11.85]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	214082_at	53	0.867925	0.0581494	-	0.839723	0.581721	0.134311	1.14 [0.71 - 1.84]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207129_at	53	0.264151	0.0416614	0.438893	-0.761216	0.459928	-0.218054	0.80 [0.45 - 1.43]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	214082_at	53	0.867925	0.00832416	0.140507	1.16644	0.196751	0.335782	1.40 [0.84 - 2.33]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207129_at	53	0.264151	0.0572039	-	-0.689714	0.567772	-0.155027	0.86 [0.50 - 1.46]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	214082_at	180	0.194444	0.000794312	0.0209952	1.17463	0.16508	0.123177	1.13 [0.95 - 1.35]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207129_at	180	0.116667	0.0160671	0.22914	1.06157	0.773541	0.0403865	1.04 [0.79 - 1.37]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	214082_at	559	0.511628	0.0372635	0.408639	-0.418291	0.254774	-0.152531	0.86 [0.66 - 1.12]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207129_at	559	0.177102	0.0869855	-	0.623778	0.325624	0.14439	1.16 [0.87 - 1.54]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207129_at	77	0.792208	0.0572721	-	0.56135	0.908158	-0.0321516	0.97 [0.56 - 1.67]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	214082_at	77	0.857143	0.0961611	-	0.548995	0.560234	0.0989734	1.10 [0.79 - 1.54]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207129_at	70	0.871429	0.0772136	-	0.642076	0.861316	-0.152897	0.86 [0.15 - 4.77]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	214082_at	70	0.485714	0.134247	-	0.400157	0.40832	0.555167	1.74 [0.47 - 6.50]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35636_at	50	0.12	0.0822602	-	-0.849129	0.224115	-1.01231	0.36 [0.07 - 1.86]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	39922_at	50	0.76	0.210077	-	-0.511922	0.273567	-0.994604	0.37 [0.06 - 2.19]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	214082_at	74	0.783784	0.0353156	0.394629	0.67574	0.113883	0.354801	1.43 [0.92 - 2.21]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207129_at	74	0.175676	0.198178	-	-0.456432	0.598061	-0.202533	0.82 [0.38 - 1.73]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	214082_at	67	0.238806	0.0844736	-	15.4867	0.50399	1.11631	3.05 [0.12 - 80.69]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207129_at	67	0.835821	0.00387104	0.0772776	1.81744	0.0838712	2.44161	11.49 [0.72 - 183.09]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	214082_at	115	0.869565	0.00445492	0.086402	1.45979	0.200013	0.793287	2.21 [0.66 - 7.44]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207129_at	115	0.434783	0.00346321	0.0706982	2.40934	0.0177627	1.96954	7.17 [1.41 - 36.52]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35636_at	158	0.588608	0.214495	-	0.354932	0.523967	0.121942	1.13 [0.78 - 1.64]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	39922_at	158	0.21519	0.0948716	-	0.713053	0.493633	0.141776	1.15 [0.77 - 1.73]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35636_at	76	0.421053	0.110467	-	-0.824019	0.355775	-0.421653	0.66 [0.27 - 1.61]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	39922_at	76	0.513158	0.0159905	0.22835	1.43188	0.149791	0.870991	2.39 [0.73 - 7.82]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	214082_at	204	0.882353	0.109125	-	-0.342283	0.118334	-0.126002	0.88 [0.75 - 1.03]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207129_at	204	0.887255	0.00195918	0.0445353	0.694571	0.568954	0.0480661	1.05 [0.89 - 1.24]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207129_at	87	0.126437	0.0789112	-	1.61077	0.168678	0.81494	2.26 [0.71 - 7.21]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	214082_at	87	0.747126	0.0474731	0.476234	0.764785	0.177329	0.500438	1.65 [0.80 - 3.41]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	214082_at	87	0.747126	0.0474731	0.476234	0.764785	0.177329	0.500438	1.65 [0.80 - 3.41]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207129_at	87	0.126437	0.0789112	-	1.61077	0.168678	0.81494	2.26 [0.71 - 7.21]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207129_at	77	0.883117	0.0216613	0.283404	1.45882	0.329276	0.966665	2.63 [0.38 - 18.33]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	214082_at	77	0.168831	0.0140947	0.208323	-1.30981	0.254505	-0.947618	0.39 [0.08 - 1.98]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207129_at	77	0.883117	0.0910124	-	1.06474	0.549846	0.540005	1.72 [0.29 - 10.07]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	214082_at	77	0.142857	0.0111688	0.175408	-1.49951	0.297018	-0.98498	0.37 [0.06 - 2.38]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	214082_at	136	0.139706	0.0550201	-	-0.909008	0.726317	-0.103015	0.90 [0.51 - 1.61]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207129_at	136	0.125	0.0941437	-	-0.841635	0.646648	-0.132509	0.88 [0.50 - 1.54]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	214082_at	200	0.73	0.117936	-	-0.575162	0.812922	-0.045359	0.96 [0.66 - 1.39]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207129_at	200	0.325	0.169855	-	-0.413034	0.75249	-0.0749288	0.93 [0.58 - 1.48]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17884	60	0.65	0.032068	0.370358	-0.956668	0.32125	-0.187466	0.83 [0.57 - 1.20]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17884	60	0.133333	0.0880221	-	1.56748	0.997464	0.00114011	1.00 [0.50 - 2.02]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	6668	155	0.232258	0.0137931	0.205049	1.21158	0.646619	0.104873	1.11 [0.71 - 1.74]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	214082_at	286	0.129371	0.222007	-	-0.330969	0.923452	-0.0122459	0.99 [0.77 - 1.27]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207129_at	286	0.444056	0.0227098	0.292906	-0.439022	0.255069	-0.187343	0.83 [0.60 - 1.14]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207129_at	159	0.339623	0.00300087	0.0630051	1.62677	0.0101878	0.837477	2.31 [1.22 - 4.38]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214082_at	159	0.320755	0.0844545	-	-0.545722	0.314816	-0.207773	0.81 [0.54 - 1.22]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207129_at	159	0.792453	0.00134739	0.0326906	1.00543	0.00345262	0.810138	2.25 [1.31 - 3.87]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214082_at	159	0.534591	0.0799856	-	-0.689165	0.334996	-0.232059	0.79 [0.49 - 1.27]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207129_at	159	0.339623	0.0341862	0.386322	0.815268	0.143413	0.407392	1.50 [0.87 - 2.59]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	214082_at	159	0.125786	0.0883976	-	-0.661672	0.678163	-0.0880448	0.92 [0.60 - 1.39]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207129_at	54	0.203704	0.0769699	-	15.5518	0.849293	-0.128303	0.88 [0.23 - 3.30]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	214082_at	54	0.111111	0.178946	-	15.3444	0.531725	0.435132	1.55 [0.40 - 6.04]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207129_at	117	0.606838	0.0776893	-	-0.616498	0.509356	-0.385872	0.68 [0.22 - 2.14]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207129_at	117	0.504274	0.102636	-	-0.634238	0.642232	-0.323611	0.72 [0.18 - 2.83]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207129_at	117	0.606838	0.0776893	-	-0.616498	0.509356	-0.385872	0.68 [0.22 - 2.14]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207129_at	117	0.111111	0.166879	-	1.31344	0.718431	0.252165	1.29 [0.33 - 5.07]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214082_at	117	0.162393	0.0724853	-	-0.765625	0.575162	0.240039	1.27 [0.55 - 2.94]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214082_at	117	0.247863	0.0852084	-	-0.575595	0.749912	0.121198	1.13 [0.54 - 2.38]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214082_at	117	0.247863	0.0852084	-	-0.575595	0.749912	0.121198	1.13 [0.54 - 2.38]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	214082_at	117	0.529915	0.0933256	-	0.667361	0.131307	0.699899	2.01 [0.81 - 5.00]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207129_at	236	0.101695	0.159116	-	0.814008	0.6765	0.126378	1.13 [0.63 - 2.05]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	214082_at	236	0.889831	0.0410809	0.435004	0.729702	0.470203	0.139446	1.15 [0.79 - 1.68]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207129_at	249	0.746988	0.0394892	0.424179	-0.574866	0.558866	-0.143359	0.87 [0.54 - 1.40]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	214082_at	249	0.104418	0.0442415	0.45582	0.987135	0.796244	0.0384424	1.04 [0.78 - 1.39]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214082_at	54	0.87037	0.0813583	-	-15.4186	0.732336	-0.0745931	0.93 [0.61 - 1.42]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207129_at	62	0.33871	0.0377821	0.412304	1.86273	0.759291	-0.0613219	0.94 [0.64 - 1.39]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207129_at	125	0.888	0.118522	-	-1.46434	0.692027	-0.349945	0.70 [0.12 - 3.98]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214082_at	62	0.290323	0.118831	-	0.95571	0.706178	-0.0679213	0.93 [0.66 - 1.33]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207129_at	125	0.176	0.0956271	-	-0.573113	0.194017	-0.879376	0.42 [0.11 - 1.56]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207129_at	54	0.296296	0.0428389	0.44669	15.4952	0.781974	-0.0674833	0.93 [0.58 - 1.51]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214082_at	125	0.768	0.00163845	0.0384411	1.14492	0.0209308	2.35452	10.53 [1.43 - 77.71]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	214082_at	125	0.888	0.00795034	0.13566	0.9528	0.151501	1.13874	3.12 [0.66 - 14.80]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207129_at	198	0.247475	0.0187181	0.255658	-0.624387	0.155018	-0.169135	0.84 [0.67 - 1.07]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214082_at	198	0.292929	0.0371581	0.407891	0.532706	0.52458	0.0618131	1.06 [0.88 - 1.29]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207129_at	198	0.242424	0.0195564	0.263731	-0.648448	0.176945	-0.171091	0.84 [0.66 - 1.08]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214082_at	198	0.313131	0.0196947	0.265049	0.733384	0.283678	0.130112	1.14 [0.90 - 1.44]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	214082_at	198	0.313131	0.0318204	0.368458	0.707436	0.369706	0.114185	1.12 [0.87 - 1.44]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207129_at	198	0.10101	0.0828953	-	-0.533185	0.466866	-0.0711028	0.93 [0.77 - 1.13]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207129_at	51	0.45098	0.242644	-	1.22789	0.852219	0.289147	1.34 [0.06 - 27.98]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207129_at	62	0.887097	0.187452	-	-15.2175	0.864893	-0.174547	0.84 [0.11 - 6.27]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	214082_at	51	0.705882	0.00732283	0.127367	2.3921	0.22029	2.13371	8.45 [0.28 - 256.09]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	214082_at	62	0.629032	0.00911399	0.150533	1.47013	0.416747	0.898715	2.46 [0.28 - 21.49]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207129_at	177	0.141243	0.0532645	-	1.09322	0.76051	0.219278	1.25 [0.30 - 5.10]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	214082_at	177	0.80791	0.110586	-	-0.563007	0.907113	-0.0819383	0.92 [0.23 - 3.65]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	214082_at	145	0.331034	0.1128	-	-0.533714	0.646462	-0.483002	0.62 [0.08 - 4.86]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207129_at	177	0.129944	0.150729	-	0.603264	0.672343	-0.272647	0.76 [0.22 - 2.69]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	214082_at	177	0.847458	0.14477	-	-0.676285	0.598921	0.414155	1.51 [0.32 - 7.08]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207129_at	145	0.151724	0.239209	-	0.696151	0.645557	0.42529	1.53 [0.25 - 9.37]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	214082_at	226	0.566372	0.202426	-	0.359619	0.622433	0.0685034	1.07 [0.82 - 1.41]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207129_at	226	0.526549	0.0020058	0.0454025	0.88669	0.14216	0.301999	1.35 [0.90 - 2.02]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	214082_at	55	0.654545	0.0804136	-	-1.05742	0.285677	-2.51597	0.08 [0.00 - 8.19]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	214082_at	49	0.244898	0.103721	-	-0.921553	0.481361	-2.01178	0.13 [0.00 - 36.17]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207129_at	55	0.509091	0.000895673	0.0232319	-1.83988	0.00523127	-5.04661	0.01 [0.00 - 0.22]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207129_at	55	0.418182	0.0268233	0.328468	-0.975305	0.0626726	-3.03762	0.05 [0.00 - 1.17]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207129_at	49	0.367347	0.010148	0.163255	-1.45052	0.116113	-3.20833	0.04 [0.00 - 2.21]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	214082_at	55	0.309091	0.0519896	-	-0.849211	0.158943	-3.07302	0.05 [0.00 - 3.33]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207129_at	63	0.539683	0.0182604	0.251189	-0.839861	0.214582	-1.19754	0.30 [0.05 - 2.00]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	214082_at	63	0.507937	0.23252	-	-0.40609	0.584808	-0.128286	0.88 [0.56 - 1.39]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6005722_3p_at	28	0.178571	0.00623835	0.112522	-1.59373	0.838515	-0.235114	0.79 [0.08 - 7.58]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.13503.0.A1_3p_at	28	0.821429	0.154618	-	-1.37705	0.241193	-2.1566	0.12 [0.00 - 4.26]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	214082_at	82	0.792683	0.01484	0.216308	0.860287	0.122104	0.447566	1.56 [0.89 - 2.76]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207129_at	82	0.573171	0.113426	-	0.530457	0.407633	0.38285	1.47 [0.59 - 3.63]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	214082_at	79	0.835443	0.121156	-	0.486417	0.212855	0.356148	1.43 [0.82 - 2.50]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207129_at	79	0.759494	0.0510007	-	0.556856	0.647966	0.186607	1.21 [0.54 - 2.68]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	214082_at	104	0.865385	0.132649	-	-0.904593	0.24237	-0.463913	0.63 [0.29 - 1.37]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207129_at	104	0.163462	0.219986	-	-0.48316	0.737852	-0.163197	0.85 [0.33 - 2.21]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P307346	117	0.230769	0.159607	-	0.537369	0.728632	0.0739474	1.08 [0.71 - 1.64]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P941268	117	0.136752	0.00480971	0.0917942	-0.968054	0.0193131	-0.572586	0.56 [0.35 - 0.91]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	214082_at	204	0.245098	0.0358934	0.398826	-0.763463	0.61318	-0.173612	0.84 [0.43 - 1.65]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	214082_at	204	0.132353	0.0151847	0.219951	-0.77604	0.557954	-0.148186	0.86 [0.53 - 1.42]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207129_at	204	0.632353	0.0189447	0.257854	0.840186	0.035675	0.562413	1.75 [1.04 - 2.97]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207129_at	204	0.215686	0.00463189	0.0891052	1.36351	0.0348505	0.422113	1.53 [1.03 - 2.26]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207129_at	178	0.898876	0.143269	-	-0.606729	0.884573	-0.0457146	0.96 [0.52 - 1.77]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	214082_at	178	0.123596	0.030453	0.357833	0.779641	0.252192	0.188147	1.21 [0.87 - 1.67]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	214082_at	111	0.171171	0.026865	0.328816	-0.694408	0.713058	-0.0676392	0.93 [0.65 - 1.34]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207129_at	111	0.702703	0.0278099	0.336625	-0.702048	0.138025	-0.348369	0.71 [0.45 - 1.12]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207129_at	90	0.2	0.157699	-	0.666393	0.479872	0.467498	1.60 [0.44 - 5.84]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207129_at	90	0.2	0.0455406	0.464128	1.35926	0.415481	0.612142	1.84 [0.42 - 8.05]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	214082_at	90	0.444444	0.100757	-	0.55355	0.599633	0.350869	1.42 [0.38 - 5.26]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	214082_at	90	0.166667	0.197588	-	-0.552625	0.722158	0.271426	1.31 [0.29 - 5.86]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	214082_at	138	0.144928	0.00105419	0.0266379	-0.931008	0.200261	-0.789481	0.45 [0.14 - 1.52]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207129_at	138	0.746377	0.000382525	0.0112644	0.86994	0.0367388	0.614742	1.85 [1.04 - 3.29]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	214082_at	129	0.837209	0.151598	-	0.431959	0.494491	0.132096	1.14 [0.78 - 1.67]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207129_at	129	0.883721	0.21536	-	-0.527435	0.990636	-0.00368024	1.00 [0.54 - 1.84]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37082	56	0.107143	0.157278	-	0.991867	0.569499	0.22577	1.25 [0.58 - 2.73]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37082	56	0.357143	0.134222	-	0.603958	0.566897	0.223717	1.25 [0.58 - 2.69]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207129_at	278	0.352518	0.00815558	0.13833	-0.499521	0.0317581	-0.694943	0.50 [0.26 - 0.94]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	214082_at	278	0.618705	0.000134516	0.0045449	-0.831035	0.0968591	-0.488219	0.61 [0.34 - 1.09]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207129_at	133	0.398496	0.00197675	0.0448626	0.780811	0.438219	0.773561	2.17 [0.31 - 15.32]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	214082_at	133	0.225564	0.0986606	-	0.533454	0.56422	-0.169292	0.84 [0.47 - 1.50]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16094	81	0.740741	0.00139677	0.0336829	1.57859	0.226352	0.401178	1.49 [0.78 - 2.86]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214082_at	185	0.118919	0.00727914	0.126782	0.760808	0.45494	0.165099	1.18 [0.76 - 1.82]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207129_at	185	0.762162	0.0376716	0.411525	0.437461	0.27974	0.271769	1.31 [0.80 - 2.15]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	214082_at	185	0.118919	0.00604202	0.109758	0.681731	0.547314	0.121022	1.13 [0.76 - 1.67]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207129_at	185	0.762162	0.0172675	0.241342	0.464594	0.122801	0.357103	1.43 [0.91 - 2.25]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P96451	110	0.136364	0.0158064	0.226446	1.06568	0.359597	-0.123819	0.88 [0.68 - 1.15]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P307346	110	0.545455	0.23898	-	-0.359206	0.954176	0.0169956	1.02 [0.57 - 1.82]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P941268	110	0.781818	0.0428216	0.446577	-0.604752	0.270636	-0.168621	0.84 [0.63 - 1.14]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P96451	110	0.827273	0.0402311	0.429254	-0.881682	0.509052	-0.113703	0.89 [0.64 - 1.25]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P941268	110	0.463636	0.0272686	0.332167	-0.656068	0.181679	-0.286647	0.75 [0.49 - 1.14]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P307346	110	0.545455	0.184532	-	-0.309515	0.949883	-0.0137928	0.99 [0.64 - 1.52]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	214082_at	80	0.5625	0.245249	-	-0.518919	0.597135	-0.0907867	0.91 [0.65 - 1.28]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207129_at	80	0.25	0.0752533	-	1.64067	0.890219	-0.0330761	0.97 [0.60 - 1.55]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	214082_at	38	0.789474	0.0648625	-	1.01619	0.999219	-0.000357633	1.00 [0.49 - 2.05]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207129_at	38	0.710526	0.00180765	0.0416849	1.6366	0.629125	0.149759	1.16 [0.63 - 2.13]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207129_at	140	0.514286	0.364795	-	-0.261658	0.88108	-0.0820075	0.92 [0.31 - 2.70]
GENE	CA5B	carbonic anhydrase VB, mitochondrial	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	214082_at	140	0.285714	0.0891691	-	-0.507891	0.75068	0.166468	1.18 [0.42 - 3.30]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CA7	carbonic anhydrase VII	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	207504_at	30	0.633333	0.13711	-	0.621696	0.647248	0.337597	1.40 [0.33 - 5.95]
GENE	CA7	carbonic anhydrase VII	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1784626	165	0.89697	0.120361	-	-0.888484	0.384526	-0.977101	0.38 [0.04 - 3.40]
GENE	CA7	carbonic anhydrase VII	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1784626	165	0.606061	0.196482	-	-0.50291	0.384854	-1.42033	0.24 [0.01 - 5.95]
GENE	CA7	carbonic anhydrase VII	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	207504_at	163	0.515337	0.031724	0.367717	-0.42511	0.0874262	-1.23969	0.29 [0.07 - 1.20]
GENE	CA7	carbonic anhydrase VII	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	207504_at	79	0.227848	0.21207	-	-0.406766	0.784139	-0.249903	0.78 [0.13 - 4.66]
GENE	CA7	carbonic anhydrase VII	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207504_at	58	0.155172	0.301878	-	-0.380068	0.802132	-0.0550276	0.95 [0.62 - 1.46]
GENE	CA7	carbonic anhydrase VII	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	207504_at	34	0.294118	0.00199204	0.0451471	-1.28774	0.0659975	-0.892054	0.41 [0.16 - 1.06]
GENE	CA7	carbonic anhydrase VII	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	207504_at	158	0.892405	0.0154721	0.222965	0.74836	0.0352986	2.37567	10.76 [1.18 - 98.28]
GENE	CA7	carbonic anhydrase VII	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	207504_at	53	0.792453	0.0208873	0.276266	0.899251	0.651739	-0.123669	0.88 [0.52 - 1.51]
GENE	CA7	carbonic anhydrase VII	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	207504_at	53	0.792453	0.0186665	0.255156	0.863933	0.699428	-0.0993602	0.91 [0.55 - 1.50]
GENE	CA7	carbonic anhydrase VII	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	207504_at	180	0.861111	0.0370399	0.407051	0.570496	0.240908	0.327637	1.39 [0.80 - 2.40]
GENE	CA7	carbonic anhydrase VII	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	207504_at	559	0.355993	0.128685	-	-0.305418	0.438929	-0.123104	0.88 [0.65 - 1.21]
GENE	CA7	carbonic anhydrase VII	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	207504_at	77	0.233766	0.184542	-	-0.398433	0.590227	-0.156095	0.86 [0.48 - 1.51]
GENE	CA7	carbonic anhydrase VII	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	207504_at	70	0.857143	0.00803115	0.136714	0.94807	0.290268	1.05093	2.86 [0.41 - 20.06]
GENE	CA7	carbonic anhydrase VII	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	34572_at	50	0.3	0.00330377	0.068075	-1.07632	0.168592	-0.901913	0.41 [0.11 - 1.47]
GENE	CA7	carbonic anhydrase VII	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	207504_at	74	0.27027	0.215287	-	0.423234	0.735894	-0.14014	0.87 [0.39 - 1.96]
GENE	CA7	carbonic anhydrase VII	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	207504_at	67	0.104478	0.0351027	0.393074	-1.61718	0.941195	-0.141701	0.87 [0.02 - 37.46]
GENE	CA7	carbonic anhydrase VII	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	207504_at	115	0.4	0.0429907	0.447686	-1.07412	0.837193	0.141191	1.15 [0.30 - 4.43]
GENE	CA7	carbonic anhydrase VII	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	34572_at	158	0.886076	0.0610478	-	0.655285	0.525362	0.14598	1.16 [0.74 - 1.82]
GENE	CA7	carbonic anhydrase VII	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	34572_at	76	0.473684	0.0134363	0.201143	-1.34877	0.223929	-0.525481	0.59 [0.25 - 1.38]
GENE	CA7	carbonic anhydrase VII	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	207504_at	204	0.465686	0.0389308	0.420326	-0.291706	0.156048	-0.118758	0.89 [0.75 - 1.05]
GENE	CA7	carbonic anhydrase VII	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	207504_at	87	0.62069	0.0470316	0.473494	0.737603	0.296724	0.802067	2.23 [0.49 - 10.06]
GENE	CA7	carbonic anhydrase VII	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	207504_at	87	0.62069	0.0470316	0.473494	0.737603	0.296724	0.802067	2.23 [0.49 - 10.06]
GENE	CA7	carbonic anhydrase VII	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	207504_at	77	0.766234	0.0156475	0.224795	1.26498	0.133708	2.06963	7.92 [0.53 - 118.46]
GENE	CA7	carbonic anhydrase VII	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	207504_at	77	0.766234	0.0205632	0.273244	1.36188	0.253832	1.81377	6.13 [0.27 - 138.27]
GENE	CA7	carbonic anhydrase VII	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	207504_at	136	0.808824	0.0338201	0.383599	0.966272	0.382392	0.276374	1.32 [0.71 - 2.45]
GENE	CA7	carbonic anhydrase VII	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	207504_at	200	0.11	0.00121874	0.0300705	-1.16496	0.150986	-0.385808	0.68 [0.40 - 1.15]
GENE	CA7	carbonic anhydrase VII	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6843	60	0.633333	0.348879	-	-0.378638	0.99075	0.00252306	1.00 [0.65 - 1.54]
GENE	CA7	carbonic anhydrase VII	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6843	60	0.15	0.0286136	0.343171	1.92451	0.309041	0.223073	1.25 [0.81 - 1.92]
GENE	CA7	carbonic anhydrase VII	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1264	155	0.193548	0.000130722	0.00443227	-1.04816	0.00157245	-0.466697	0.63 [0.47 - 0.84]
GENE	CA7	carbonic anhydrase VII	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	207504_at	286	0.227273	0.0783493	-	-0.381185	0.221533	-0.234185	0.79 [0.54 - 1.15]
GENE	CA7	carbonic anhydrase VII	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207504_at	159	0.899371	0.296902	-	0.458071	0.379813	0.564663	1.76 [0.50 - 6.20]
GENE	CA7	carbonic anhydrase VII	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207504_at	159	0.201258	0.158183	-	-0.494981	0.584211	-0.325898	0.72 [0.22 - 2.32]
GENE	CA7	carbonic anhydrase VII	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	207504_at	159	0.672956	0.231999	-	-0.513141	0.946049	0.0491984	1.05 [0.25 - 4.37]
GENE	CA7	carbonic anhydrase VII	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	207504_at	54	0.796296	0.184045	-	-15.3212	0.487186	-1.08709	0.34 [0.02 - 7.24]
GENE	CA7	carbonic anhydrase VII	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207504_at	117	0.452991	0.1898	-	0.423644	0.879054	-0.0695944	0.93 [0.38 - 2.29]
GENE	CA7	carbonic anhydrase VII	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207504_at	117	0.452991	0.0572934	-	0.791812	0.891532	0.0751673	1.08 [0.37 - 3.18]
GENE	CA7	carbonic anhydrase VII	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207504_at	117	0.452991	0.1898	-	0.423644	0.879054	-0.0695944	0.93 [0.38 - 2.29]
GENE	CA7	carbonic anhydrase VII	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	207504_at	117	0.452991	0.0786228	-	0.696755	0.814008	0.120967	1.13 [0.41 - 3.09]
GENE	CA7	carbonic anhydrase VII	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	207504_at	236	0.131356	0.0964682	-	-0.554164	0.951732	0.0323181	1.03 [0.36 - 2.94]
GENE	CA7	carbonic anhydrase VII	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	207504_at	249	0.337349	0.0174605	0.243273	-0.501543	0.41904	-0.326241	0.72 [0.33 - 1.59]
GENE	CA7	carbonic anhydrase VII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207504_at	62	0.241935	0.0243467	0.307372	15.4108	0.684842	-0.111981	0.89 [0.52 - 1.54]
GENE	CA7	carbonic anhydrase VII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207504_at	125	0.784	0.266268	-	0.45087	0.854074	0.093351	1.10 [0.41 - 2.97]
GENE	CA7	carbonic anhydrase VII	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207504_at	125	0.352	0.265467	-	-0.348378	0.636139	-0.18757	0.83 [0.38 - 1.80]
GENE	CA7	carbonic anhydrase VII	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	207504_at	54	0.222222	0.0713655	-	15.3947	0.809189	-0.0803204	0.92 [0.48 - 1.77]
GENE	CA7	carbonic anhydrase VII	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207504_at	198	0.20202	0.161804	-	-0.431384	0.686714	-0.0611708	0.94 [0.70 - 1.27]
GENE	CA7	carbonic anhydrase VII	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207504_at	198	0.888889	0.0563685	-	-0.791472	0.775994	-0.0327312	0.97 [0.77 - 1.21]
GENE	CA7	carbonic anhydrase VII	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	207504_at	198	0.570707	0.0740912	-	0.452358	0.92795	0.013313	1.01 [0.76 - 1.35]
GENE	CA7	carbonic anhydrase VII	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	207504_at	51	0.215686	0.241695	-	15.3918	0.775584	-0.443847	0.64 [0.03 - 13.57]
GENE	CA7	carbonic anhydrase VII	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	207504_at	62	0.322581	0.094549	-	-0.933014	0.288252	-0.988896	0.37 [0.06 - 2.31]
GENE	CA7	carbonic anhydrase VII	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	207504_at	145	0.151724	0.00111375	0.0278915	-1.17409	0.102204	-2.01934	0.13 [0.01 - 1.50]
GENE	CA7	carbonic anhydrase VII	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	207504_at	177	0.20904	0.0130349	0.196704	-0.733809	0.0688946	-1.76842	0.17 [0.03 - 1.15]
GENE	CA7	carbonic anhydrase VII	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	207504_at	177	0.20904	0.00907606	0.150058	-0.682098	0.018442	-2.0027	0.13 [0.03 - 0.71]
GENE	CA7	carbonic anhydrase VII	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	207504_at	226	0.269911	0.00721895	0.125974	-0.753582	0.319892	-0.151143	0.86 [0.64 - 1.16]
GENE	CA7	carbonic anhydrase VII	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	207504_at	55	0.163636	0.00109398	0.027477	-1.43909	0.14083	-1.6695	0.19 [0.02 - 1.74]
GENE	CA7	carbonic anhydrase VII	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	207504_at	55	0.218182	0.000157272	0.00521141	-1.73468	0.00179386	-4.73384	0.01 [0.00 - 0.17]
GENE	CA7	carbonic anhydrase VII	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	207504_at	49	0.163265	0.000289603	0.00886192	-1.91814	0.0514065	-3.10654	0.04 [0.00 - 1.02]
GENE	CA7	carbonic anhydrase VII	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	207504_at	63	0.126984	0.00182765	0.0420638	-1.23192	0.795453	-1.03217	0.36 [0.00 - 872.78]
GENE	CA7	carbonic anhydrase VII	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4885100_3p_at	28	0.857143	0.00138498	0.0334466	1.78573	0.302323	2.02929	7.61 [0.16 - 359.74]
GENE	CA7	carbonic anhydrase VII	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	207504_at	82	0.829268	0.372783	-	0.374865	0.662448	0.341061	1.41 [0.30 - 6.50]
GENE	CA7	carbonic anhydrase VII	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	207504_at	79	0.481013	0.174383	-	-0.353138	0.83348	-0.167989	0.85 [0.18 - 4.05]
GENE	CA7	carbonic anhydrase VII	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	M76424_at	86	0.116279	0.0161547	0.230042	-1.16506	0.118081	-1.50485	0.22 [0.03 - 1.47]
GENE	CA7	carbonic anhydrase VII	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	207504_at	104	0.605769	0.142511	-	-0.521995	0.726724	-0.335914	0.71 [0.11 - 4.70]
GENE	CA7	carbonic anhydrase VII	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	207504_at	204	0.720588	0.000305132	0.00927103	-15.5957	0.108765	-0.36402	0.69 [0.45 - 1.08]
GENE	CA7	carbonic anhydrase VII	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	207504_at	204	0.720588	0.00140328	0.033813	-1.29224	0.170047	-0.230496	0.79 [0.57 - 1.10]
GENE	CA7	carbonic anhydrase VII	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	207504_at	178	0.247191	0.307415	-	-0.230669	0.865075	0.0837871	1.09 [0.41 - 2.86]
GENE	CA7	carbonic anhydrase VII	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	207504_at	111	0.198198	0.0354147	0.395351	-0.622372	0.267611	-0.223956	0.80 [0.54 - 1.19]
GENE	CA7	carbonic anhydrase VII	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	207504_at	90	0.811111	0.18195	-	-0.693251	0.937937	0.0501961	1.05 [0.30 - 3.72]
GENE	CA7	carbonic anhydrase VII	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	207504_at	90	0.322222	0.259621	-	-0.423254	0.742059	0.237011	1.27 [0.31 - 5.20]
GENE	CA7	carbonic anhydrase VII	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	207504_at	138	0.224638	0.0594022	-	-0.488924	0.462464	-1.69162	0.18 [0.00 - 16.79]
GENE	CA7	carbonic anhydrase VII	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	207504_at	129	0.596899	0.0545158	-	0.48127	0.0855671	0.627174	1.87 [0.92 - 3.83]
GENE	CA7	carbonic anhydrase VII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35148	56	0.25	0.0666689	-	-0.673132	0.531541	-0.345898	0.71 [0.24 - 2.09]
GENE	CA7	carbonic anhydrase VII	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35148	56	0.214286	0.0172848	0.241515	-0.894313	0.356411	-0.476613	0.62 [0.23 - 1.71]
GENE	CA7	carbonic anhydrase VII	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	207504_at	278	0.535971	0.00424674	0.083186	-0.561817	0.00370271	-1.24084	0.29 [0.13 - 0.67]
GENE	CA7	carbonic anhydrase VII	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	207504_at	133	0.466165	0.00162726	0.0382241	0.757688	0.00478437	2.07168	7.94 [1.88 - 33.48]
GENE	CA7	carbonic anhydrase VII	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9552	81	0.246914	0.0529165	-	1.46734	0.212465	1.15716	3.18 [0.52 - 19.61]
GENE	CA7	carbonic anhydrase VII	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207504_at	185	0.12973	0.073597	-	0.431195	0.627533	0.103937	1.11 [0.73 - 1.69]
GENE	CA7	carbonic anhydrase VII	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	207504_at	185	0.12973	0.0763936	-	0.480471	0.665552	0.10203	1.11 [0.70 - 1.76]
GENE	CA7	carbonic anhydrase VII	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P106656	110	0.263636	0.00372131	0.074883	-0.712529	0.148594	-0.42674	0.65 [0.37 - 1.16]
GENE	CA7	carbonic anhydrase VII	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P106656	110	0.236364	0.00212926	0.0476783	-0.934042	0.0240041	-0.952054	0.39 [0.17 - 0.88]
GENE	CA7	carbonic anhydrase VII	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	207504_at	80	0.4875	0.124702	-	0.702042	0.73229	0.128449	1.14 [0.54 - 2.37]
GENE	CA7	carbonic anhydrase VII	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_4919	281	0.690391	0.34279	-	0.142926	0.889288	0.0130146	1.01 [0.84 - 1.22]
GENE	CA7	carbonic anhydrase VII	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	207504_at	38	0.105263	0.0231436	0.296783	-1.39665	0.375401	-0.207443	0.81 [0.51 - 1.29]
GENE	CA7	carbonic anhydrase VII	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	207504_at	140	0.842857	0.0217521	0.284235	-1.5103	0.207407	-1.10307	0.33 [0.06 - 1.84]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CA9	carbonic anhydrase IX	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205199_at	30	0.133333	0.25454	-	0.824659	0.715336	-0.0991806	0.91 [0.53 - 1.54]
GENE	CA9	carbonic anhydrase IX	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1725139	165	0.430303	0.216463	-	0.306262	0.661569	0.0368164	1.04 [0.88 - 1.22]
GENE	CA9	carbonic anhydrase IX	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1725139	165	0.70303	0.0962922	-	-0.789359	0.801739	-0.0314782	0.97 [0.76 - 1.24]
GENE	CA9	carbonic anhydrase IX	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205199_at	163	0.122699	0.0424478	0.444114	-0.534767	0.364656	-0.499559	0.61 [0.21 - 1.79]
GENE	CA9	carbonic anhydrase IX	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205199_at	79	0.898734	0.139302	-	0.638907	0.507726	0.647811	1.91 [0.28 - 13.00]
GENE	CA9	carbonic anhydrase IX	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205199_at	58	0.344828	0.0333807	0.380311	0.620576	0.275689	0.213814	1.24 [0.84 - 1.82]
GENE	CA9	carbonic anhydrase IX	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205199_at	34	0.852941	0.0765439	-	-1.22637	0.563658	-0.17327	0.84 [0.47 - 1.51]
GENE	CA9	carbonic anhydrase IX	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205199_at	158	0.689873	2.90745e-05	0.00116856	0.951152	0.156244	0.42685	1.53 [0.85 - 2.76]
GENE	CA9	carbonic anhydrase IX	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205199_at	53	0.716981	0.000244923	0.00766494	1.32779	0.15843	0.496132	1.64 [0.82 - 3.27]
GENE	CA9	carbonic anhydrase IX	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205199_at	53	0.716981	0.0121843	0.187137	0.875216	0.35899	0.276396	1.32 [0.73 - 2.38]
GENE	CA9	carbonic anhydrase IX	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205199_at	180	0.505556	0.134732	-	0.31328	0.937896	0.0180546	1.02 [0.65 - 1.60]
GENE	CA9	carbonic anhydrase IX	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205199_at	559	0.579606	0.238512	-	-0.239064	0.854358	-0.0358907	0.96 [0.66 - 1.42]
GENE	CA9	carbonic anhydrase IX	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205199_at	77	0.779221	0.0437269	0.45249	0.58737	0.200594	0.232781	1.26 [0.88 - 1.80]
GENE	CA9	carbonic anhydrase IX	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205199_at	70	0.8	0.0740704	-	0.546986	0.394428	0.242015	1.27 [0.73 - 2.22]
GENE	CA9	carbonic anhydrase IX	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40309_at	50	0.78	0.00733366	0.127512	1.0715	0.00577194	0.472374	1.60 [1.15 - 2.24]
GENE	CA9	carbonic anhydrase IX	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205199_at	74	0.648649	0.0124333	0.189961	0.731319	0.39463	0.185424	1.20 [0.79 - 1.84]
GENE	CA9	carbonic anhydrase IX	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205199_at	67	0.850746	0.125331	-	-15.456	0.241173	-2.06769	0.13 [0.00 - 4.02]
GENE	CA9	carbonic anhydrase IX	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205199_at	115	0.556522	0.0321407	0.370915	1.19797	0.657155	0.3567	1.43 [0.30 - 6.90]
GENE	CA9	carbonic anhydrase IX	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40309_at	158	0.860759	0.0305793	0.358824	0.728674	0.196702	0.205629	1.23 [0.90 - 1.68]
GENE	CA9	carbonic anhydrase IX	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40309_at	76	0.710526	0.121334	-	-1.12508	0.336202	-0.328806	0.72 [0.37 - 1.41]
GENE	CA9	carbonic anhydrase IX	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205199_at	204	0.715686	0.0078243	0.134011	0.415197	0.280069	0.080075	1.08 [0.94 - 1.25]
GENE	CA9	carbonic anhydrase IX	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205199_at	87	0.367816	0.447823	-	0.306149	0.792804	0.0880601	1.09 [0.57 - 2.11]
GENE	CA9	carbonic anhydrase IX	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205199_at	87	0.367816	0.447823	-	0.306149	0.792804	0.0880601	1.09 [0.57 - 2.11]
GENE	CA9	carbonic anhydrase IX	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205199_at	77	0.896104	0.0138265	0.205414	1.54666	0.119811	1.35134	3.86 [0.70 - 21.20]
GENE	CA9	carbonic anhydrase IX	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205199_at	77	0.883117	0.00485384	0.0924576	1.54211	0.162254	1.08462	2.96 [0.65 - 13.54]
GENE	CA9	carbonic anhydrase IX	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205199_at	136	0.551471	0.016859	0.237227	1.09417	0.601557	0.169649	1.18 [0.63 - 2.24]
GENE	CA9	carbonic anhydrase IX	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205199_at	200	0.875	7.14403e-05	0.00260237	1.2306	0.0152591	0.393605	1.48 [1.08 - 2.04]
GENE	CA9	carbonic anhydrase IX	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7984	60	0.883333	0.00456471	0.0880822	1.24992	0.027121	0.228927	1.26 [1.03 - 1.54]
GENE	CA9	carbonic anhydrase IX	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7984	60	0.883333	3.11998e-05	0.00124474	1.73042	0.00783856	0.253214	1.29 [1.07 - 1.55]
GENE	CA9	carbonic anhydrase IX	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	18341	155	0.296774	1.95053e-08	1.3884e-06	-1.47881	1.70137e-05	-0.510262	0.60 [0.48 - 0.76]
GENE	CA9	carbonic anhydrase IX	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205199_at	286	0.870629	0.0446475	0.458432	0.51406	0.480185	0.0994048	1.10 [0.84 - 1.46]
GENE	CA9	carbonic anhydrase IX	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205199_at	159	0.591195	0.00861885	0.144281	0.817833	0.305026	0.27118	1.31 [0.78 - 2.20]
GENE	CA9	carbonic anhydrase IX	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205199_at	159	0.591195	0.00289052	0.0611281	0.928999	0.0920009	0.431998	1.54 [0.93 - 2.55]
GENE	CA9	carbonic anhydrase IX	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205199_at	159	0.591195	0.00168021	0.0392479	1.16176	0.102717	0.486571	1.63 [0.91 - 2.92]
GENE	CA9	carbonic anhydrase IX	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205199_at	54	0.814815	0.140022	-	-15.3778	0.655978	-0.306495	0.74 [0.19 - 2.83]
GENE	CA9	carbonic anhydrase IX	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205199_at	117	0.102564	0.137972	-	-0.611941	0.528853	-0.237907	0.79 [0.38 - 1.65]
GENE	CA9	carbonic anhydrase IX	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205199_at	117	0.307692	0.000870739	0.0226863	-1.24175	0.295753	-0.554452	0.57 [0.20 - 1.62]
GENE	CA9	carbonic anhydrase IX	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205199_at	117	0.102564	0.137972	-	-0.611941	0.528853	-0.237907	0.79 [0.38 - 1.65]
GENE	CA9	carbonic anhydrase IX	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205199_at	117	0.307692	0.0600331	-	-0.700765	0.860431	-0.0748798	0.93 [0.40 - 2.14]
GENE	CA9	carbonic anhydrase IX	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205199_at	236	0.898305	3.77827e-09	2.95473e-07	1.59267	0.000152258	0.828588	2.29 [1.49 - 3.52]
GENE	CA9	carbonic anhydrase IX	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205199_at	249	0.899598	3.89948e-05	0.00151927	1.08732	0.0119692	0.522831	1.69 [1.12 - 2.54]
GENE	CA9	carbonic anhydrase IX	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205199_at	62	0.758065	0.119346	-	-0.975998	0.65243	-0.0872175	0.92 [0.63 - 1.34]
GENE	CA9	carbonic anhydrase IX	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205199_at	125	0.896	0.121949	-	0.749165	0.260933	0.305056	1.36 [0.80 - 2.31]
GENE	CA9	carbonic anhydrase IX	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205199_at	125	0.376	0.116812	-	-0.457772	0.416598	0.18728	1.21 [0.77 - 1.89]
GENE	CA9	carbonic anhydrase IX	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205199_at	54	0.555556	0.308089	-	-0.626248	0.675997	-0.0981739	0.91 [0.57 - 1.44]
GENE	CA9	carbonic anhydrase IX	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205199_at	198	0.636364	0.155844	-	0.381681	0.779417	0.0380409	1.04 [0.80 - 1.36]
GENE	CA9	carbonic anhydrase IX	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205199_at	198	0.111111	0.0404309	0.430612	-0.589424	0.280848	-0.12421	0.88 [0.70 - 1.11]
GENE	CA9	carbonic anhydrase IX	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205199_at	198	0.808081	0.238617	-	0.357245	0.980372	-0.00327219	1.00 [0.77 - 1.29]
GENE	CA9	carbonic anhydrase IX	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205199_at	51	0.392157	0.307584	-	-0.901181	0.67886	-0.25347	0.78 [0.23 - 2.58]
GENE	CA9	carbonic anhydrase IX	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205199_at	62	0.306452	0.0548031	-	1.76751	0.649747	0.15572	1.17 [0.60 - 2.29]
GENE	CA9	carbonic anhydrase IX	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205199_at	177	0.666667	0.0387569	0.41912	0.492213	0.335026	0.143324	1.15 [0.86 - 1.54]
GENE	CA9	carbonic anhydrase IX	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205199_at	145	0.772414	0.136398	-	0.532506	0.650957	0.0953548	1.10 [0.73 - 1.66]
GENE	CA9	carbonic anhydrase IX	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205199_at	177	0.740113	0.0111813	0.175555	0.70164	0.0734213	0.295663	1.34 [0.97 - 1.86]
GENE	CA9	carbonic anhydrase IX	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205199_at	226	0.150442	0.230268	-	-0.424417	0.955229	-0.00613345	0.99 [0.80 - 1.23]
GENE	CA9	carbonic anhydrase IX	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205199_at	55	0.854545	0.0011371	0.0283796	1.55665	0.00693205	0.580356	1.79 [1.17 - 2.72]
GENE	CA9	carbonic anhydrase IX	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205199_at	49	0.836735	9.79034e-05	0.00343752	2.0382	0.00574462	0.793555	2.21 [1.26 - 3.88]
GENE	CA9	carbonic anhydrase IX	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205199_at	55	0.854545	0.0186541	0.255035	1.16434	0.144918	0.338138	1.40 [0.89 - 2.21]
GENE	CA9	carbonic anhydrase IX	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205199_at	63	0.650794	0.000712255	0.0191461	-1.41678	0.236877	-0.756799	0.47 [0.13 - 1.64]
GENE	CA9	carbonic anhydrase IX	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9955947_3p_at	28	0.642857	0.0298833	0.353338	1.13015	0.302013	0.208304	1.23 [0.83 - 1.83]
GENE	CA9	carbonic anhydrase IX	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205199_at	82	0.414634	0.0386646	0.418478	0.781704	0.893536	-0.042202	0.96 [0.52 - 1.78]
GENE	CA9	carbonic anhydrase IX	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205199_at	79	0.898734	0.040729	0.432631	-1.15071	0.0964186	-0.537149	0.58 [0.31 - 1.10]
GENE	CA9	carbonic anhydrase IX	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X66839_at	86	0.674419	0.0177295	0.24595	0.964723	0.130235	0.334865	1.40 [0.91 - 2.16]
GENE	CA9	carbonic anhydrase IX	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205199_at	104	0.125	0.082136	-	1.19258	0.25371	0.417876	1.52 [0.74 - 3.11]
GENE	CA9	carbonic anhydrase IX	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P157793	117	0.82906	0.0396723	0.425437	0.671509	0.564691	0.0415342	1.04 [0.90 - 1.20]
GENE	CA9	carbonic anhydrase IX	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205199_at	204	0.833333	7.92428e-05	0.00285228	1.3657	0.000887772	0.545682	1.73 [1.25 - 2.38]
GENE	CA9	carbonic anhydrase IX	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205199_at	204	0.79902	8.5416e-09	6.38154e-07	1.45404	5.50074e-06	0.557892	1.75 [1.37 - 2.22]
GENE	CA9	carbonic anhydrase IX	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205199_at	178	0.679775	0.0031015	0.0647024	0.602744	0.0589179	0.468966	1.60 [0.98 - 2.60]
GENE	CA9	carbonic anhydrase IX	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205199_at	111	0.54955	0.0007841	0.0207671	0.878394	0.0047763	0.454521	1.58 [1.15 - 2.16]
GENE	CA9	carbonic anhydrase IX	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205199_at	90	0.855556	0.0115669	0.180047	-2.135	0.093281	-0.343977	0.71 [0.47 - 1.06]
GENE	CA9	carbonic anhydrase IX	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205199_at	90	0.855556	0.0450949	0.461294	-1.79199	0.276313	-0.248783	0.78 [0.50 - 1.22]
GENE	CA9	carbonic anhydrase IX	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205199_at	138	0.608696	0.000720615	0.0193362	0.799183	0.00212016	0.20571	1.23 [1.08 - 1.40]
GENE	CA9	carbonic anhydrase IX	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205199_at	129	0.356589	0.0417534	0.439507	0.541094	0.347492	0.135766	1.15 [0.86 - 1.52]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6259	56	0.642857	0.00411115	0.0810697	1.04065	0.0324492	0.249798	1.28 [1.02 - 1.61]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	917	56	0.589286	0.00129065	0.0315414	1.10428	0.0252362	0.278229	1.32 [1.04 - 1.69]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16261	56	0.785714	0.00326754	0.0674747	1.07626	0.0331295	0.263494	1.30 [1.02 - 1.66]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3623	56	0.732143	0.00304842	0.0638087	1.11446	0.034513	0.246193	1.28 [1.02 - 1.61]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44480	56	0.767857	0.0059251	0.1081	1.04576	0.0385192	0.259633	1.30 [1.01 - 1.66]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8895	56	0.589286	0.00129065	0.0315414	1.10428	0.0191415	0.287845	1.33 [1.05 - 1.70]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	917	56	0.589286	0.00154376	0.0365953	1.14844	0.035276	0.273663	1.31 [1.02 - 1.70]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16261	56	0.660714	0.0035923	0.0728007	1.05345	0.0452771	0.258816	1.30 [1.01 - 1.67]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6259	56	0.660714	0.00258445	0.0558316	1.03392	0.0292512	0.244779	1.28 [1.03 - 1.59]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	8895	56	0.589286	0.00154376	0.0365953	1.14844	0.0274431	0.28363	1.33 [1.03 - 1.71]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3623	56	0.732143	0.000507451	0.0143503	1.22325	0.0294532	0.24158	1.27 [1.02 - 1.58]
GENE	CA9	carbonic anhydrase IX	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	44480	56	0.785714	0.00326754	0.0674747	1.07626	0.0288102	0.262191	1.30 [1.03 - 1.64]
GENE	CA9	carbonic anhydrase IX	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205199_at	278	0.154676	0.21468	-	-0.296377	0.749515	-0.0352851	0.97 [0.78 - 1.20]
GENE	CA9	carbonic anhydrase IX	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205199_at	133	0.105263	0.00857114	0.143673	1.681	0.713263	-0.045558	0.96 [0.75 - 1.22]
GENE	CA9	carbonic anhydrase IX	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	5158	81	0.160494	0.174885	-	-0.774645	0.775318	0.0521729	1.05 [0.74 - 1.51]
GENE	CA9	carbonic anhydrase IX	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205199_at	185	0.286486	0.104237	-	-0.309485	0.817998	-0.0394672	0.96 [0.69 - 1.35]
GENE	CA9	carbonic anhydrase IX	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205199_at	185	0.113514	0.0396893	0.425553	-0.494589	0.578914	-0.0887999	0.92 [0.67 - 1.25]
GENE	CA9	carbonic anhydrase IX	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P157793	110	0.218182	0.0491349	0.486409	-0.499294	0.254878	-0.0776781	0.93 [0.81 - 1.06]
GENE	CA9	carbonic anhydrase IX	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P157793	110	0.127273	0.0292293	0.348127	-0.801143	0.32515	-0.0868899	0.92 [0.77 - 1.09]
GENE	CA9	carbonic anhydrase IX	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205199_at	80	0.375	0.320692	-	-0.431332	0.991768	0.00237082	1.00 [0.64 - 1.57]
GENE	CA9	carbonic anhydrase IX	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_3906	281	0.850534	0.0313779	0.365045	-0.458634	0.0994442	-0.267004	0.77 [0.56 - 1.05]
GENE	CA9	carbonic anhydrase IX	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205199_at	38	0.473684	0.00993914	0.16072	1.35309	0.285191	0.529037	1.70 [0.64 - 4.48]
GENE	CA9	carbonic anhydrase IX	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205199_at	140	0.892857	0.0668155	-	0.698583	0.658391	0.0970238	1.10 [0.72 - 1.69]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202715_at	30	0.833333	0.00174438	0.0404796	1.65238	0.00360228	1.53664	4.65 [1.65 - 13.08]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1810992	165	0.418182	0.0181842	0.250441	0.605392	0.056403	0.462454	1.59 [0.99 - 2.55]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1810992	165	0.854545	0.00132954	0.0323301	1.15988	0.00167946	1.1393	3.12 [1.54 - 6.36]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202715_at	163	0.846626	0.0537222	-	0.478156	0.972553	-0.00650858	0.99 [0.69 - 1.44]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1564084_at	79	0.658228	0.220183	-	-0.392609	0.700953	-0.290631	0.75 [0.17 - 3.30]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202715_at	79	0.506329	0.0937531	-	0.490134	0.276186	0.224347	1.25 [0.84 - 1.87]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202715_at	58	0.258621	0.140029	-	-0.455465	0.779338	-0.0445179	0.96 [0.70 - 1.31]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202715_at	34	0.823529	0.09988	-	-0.840662	0.567223	-0.104219	0.90 [0.63 - 1.29]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202715_at	158	0.14557	0.0368284	0.405543	0.807528	0.889594	0.0348028	1.04 [0.63 - 1.69]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202715_at	53	0.622642	0.133891	-	0.545312	0.68768	0.20454	1.23 [0.45 - 3.33]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202715_at	53	0.679245	0.0363939	0.402433	0.719008	0.438298	0.377465	1.46 [0.56 - 3.79]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202715_at	180	0.711111	0.00339062	0.0695077	0.639238	0.00870707	0.850231	2.34 [1.24 - 4.42]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1564084_at	559	0.252236	0.143851	-	-0.31786	0.377303	-0.107415	0.90 [0.71 - 1.14]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202715_at	559	0.831843	4.79932e-05	0.00182811	0.890982	0.0126763	0.648106	1.91 [1.15 - 3.18]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202715_at	77	0.688312	0.0157555	0.225917	0.640249	0.161403	0.387906	1.47 [0.86 - 2.54]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1564084_at	70	0.242857	0.351612	-	-0.272187	0.823776	-0.284018	0.75 [0.06 - 9.17]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202715_at	70	0.871429	0.129397	-	0.578732	0.921548	0.0375573	1.04 [0.49 - 2.19]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	749_at	50	0.62	0.000885225	0.0230037	1.14229	0.00241116	1.46459	4.33 [1.68 - 11.14]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32031_at	50	0.86	0.0745016	-	0.807774	0.899443	0.10136	1.11 [0.23 - 5.33]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202715_at	74	0.108108	0.018419	0.252742	-0.893531	0.38172	-0.390142	0.68 [0.28 - 1.62]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1564084_at	67	0.552239	0.123831	-	1.06717	0.10302	3.88658	48.74 [0.46 - 5212.98]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202715_at	67	0.283582	0.0062958	0.113326	-1.92732	0.373768	-1.34908	0.26 [0.01 - 5.07]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202715_at	115	0.478261	0.130807	-	0.868867	0.578219	0.381494	1.46 [0.38 - 5.62]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1564084_at	115	0.521739	0.0688756	-	1.02998	0.53087	0.579174	1.78 [0.29 - 10.92]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32031_at	158	0.360759	0.145892	-	0.518466	0.963381	0.0292332	1.03 [0.30 - 3.59]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	749_at	158	0.259494	0.0342113	0.386508	0.840248	0.156402	0.753218	2.12 [0.75 - 6.02]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32031_at	76	0.789474	0.107374	-	0.86257	0.629609	0.634608	1.89 [0.14 - 24.87]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	749_at	76	0.210526	0.122628	-	1.46436	0.794869	-0.270736	0.76 [0.10 - 5.87]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1564084_at	204	0.132353	0.00658927	0.117401	-0.573723	0.0259937	-0.195664	0.82 [0.69 - 0.98]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202715_at	204	0.303922	0.0787415	-	0.267368	0.442911	0.13635	1.15 [0.81 - 1.62]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202715_at	87	0.241379	0.00836825	0.141074	-0.992057	0.339516	-0.438079	0.65 [0.26 - 1.59]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1564084_at	87	0.45977	0.00125727	0.0308608	-1.26656	0.0273249	-3.00126	0.05 [0.00 - 0.71]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1564084_at	87	0.45977	0.00125727	0.0308608	-1.26656	0.0273249	-3.00126	0.05 [0.00 - 0.71]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202715_at	87	0.241379	0.00836825	0.141074	-0.992057	0.339516	-0.438079	0.65 [0.26 - 1.59]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1564084_at	77	0.324675	0.0523849	-	-1.18248	0.635166	-0.93297	0.39 [0.01 - 18.56]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202715_at	77	0.87013	5.87188e-05	0.0021871	2.12857	0.0109257	2.27574	9.74 [1.69 - 56.17]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1564084_at	77	0.87013	0.0159877	0.228322	1.34977	0.719912	0.612125	1.84 [0.06 - 52.35]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202715_at	77	0.87013	0.00183814	0.0422624	1.60342	0.0369909	1.56774	4.80 [1.10 - 20.92]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202715_at	136	0.639706	0.159172	-	-0.719897	0.264988	-0.396749	0.67 [0.33 - 1.35]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202715_at	200	0.615	0.0826492	-	-0.551256	0.502812	-0.331285	0.72 [0.27 - 1.89]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16756	60	0.316667	0.247848	-	-0.467286	0.670475	-0.191676	0.83 [0.34 - 2.00]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16756	60	0.3	0.143538	-	0.66626	0.78364	0.13958	1.15 [0.42 - 3.11]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5930	155	0.664516	2.42315e-05	0.000992439	1.13646	0.00504178	0.459152	1.58 [1.15 - 2.18]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202715_at	286	0.797203	0.019792	0.265974	-0.676147	0.821569	-0.0326565	0.97 [0.73 - 1.29]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202715_at	159	0.72956	0.00166775	0.0390076	0.963225	0.0348209	0.935524	2.55 [1.07 - 6.08]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202715_at	159	0.742138	0.000113561	0.00391701	1.16088	0.00456903	1.2019	3.33 [1.45 - 7.63]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202715_at	159	0.842767	0.0007678	0.0204018	1.23647	0.00441173	1.36391	3.91 [1.53 - 10.00]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202715_at	54	0.388889	0.0201074	0.268961	15.7858	0.0827498	1.89083	6.62 [0.78 - 56.09]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202715_at	117	0.803419	0.216824	-	-0.743382	0.794932	-0.0989936	0.91 [0.43 - 1.91]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202715_at	117	0.888889	0.18948	-	0.538971	0.657847	0.137095	1.15 [0.63 - 2.10]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202715_at	117	0.888889	0.18948	-	0.538971	0.657847	0.137095	1.15 [0.63 - 2.10]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202715_at	117	0.615385	0.115255	-	-0.674956	0.436906	-0.283312	0.75 [0.37 - 1.54]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202715_at	236	0.898305	0.0710206	-	0.649794	0.37941	0.444856	1.56 [0.58 - 4.21]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202715_at	249	0.835341	0.0987957	-	0.433826	0.400215	0.344605	1.41 [0.63 - 3.15]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202715_at	125	0.72	0.0367398	0.404911	0.779943	0.376679	0.452821	1.57 [0.58 - 4.29]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202715_at	125	0.376	0.196453	-	0.437265	0.950108	0.02554	1.03 [0.46 - 2.28]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202715_at	54	0.185185	0.0353605	0.394957	-1.27947	0.692451	-0.107971	0.90 [0.53 - 1.53]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202715_at	62	0.16129	0.042278	0.442991	-1.05071	0.626869	-0.110815	0.90 [0.57 - 1.40]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202715_at	198	0.661616	0.209347	-	0.271241	0.654332	0.0771953	1.08 [0.77 - 1.51]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202715_at	198	0.171717	0.0354939	0.395928	0.946226	0.384019	0.184896	1.20 [0.79 - 1.82]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202715_at	198	0.151515	0.061303	-	0.936904	0.528346	0.13962	1.15 [0.74 - 1.77]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202715_at	51	0.490196	0.171796	-	-1.40906	0.722127	-0.220903	0.80 [0.24 - 2.71]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202715_at	62	0.387097	0.23114	-	0.77944	0.990941	0.00474971	1.00 [0.44 - 2.28]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202715_at	177	0.59322	0.0470494	0.473605	-0.573377	0.684226	-0.167962	0.85 [0.38 - 1.90]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1564084_at	177	0.101695	0.000226271	0.00715564	-1.0891	0.0444622	-2.10123	0.12 [0.02 - 0.95]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1564084_at	177	0.491525	0.00306169	0.0640325	-0.817303	0.124824	-1.84082	0.16 [0.02 - 1.67]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202715_at	177	0.570621	0.105546	-	-0.39095	0.873358	-0.0570809	0.94 [0.47 - 1.91]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202715_at	145	0.441379	0.186382	-	-0.439502	0.730521	-0.175692	0.84 [0.31 - 2.28]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1564084_at	145	0.448276	0.0601033	-	-0.627084	0.259055	-1.6417	0.19 [0.01 - 3.35]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1564084_at	226	0.845133	0.263002	-	-0.521683	0.77775	-0.0386865	0.96 [0.74 - 1.26]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202715_at	226	0.575221	0.0133833	0.200559	-0.767169	0.12337	-0.493313	0.61 [0.33 - 1.14]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1564084_at	55	0.654545	0.00496687	0.094149	-1.83187	0.0487843	-3.57031	0.03 [0.00 - 0.98]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202715_at	55	0.836364	0.121307	-	0.787827	0.761209	-0.117939	0.89 [0.42 - 1.90]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202715_at	55	0.781818	0.272529	-	0.55445	0.87127	0.0769091	1.08 [0.43 - 2.74]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202715_at	49	0.857143	0.216473	-	0.811228	0.794321	-0.13259	0.88 [0.32 - 2.37]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1564084_at	55	0.654545	0.00276517	0.0589755	-2.43126	0.0178196	-4.81907	0.01 [0.00 - 0.43]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1564084_at	49	0.612245	0.0161998	0.230505	-2.1041	0.130382	-3.49445	0.03 [0.00 - 2.81]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	726205	34	0.117647	0.159181	-	1.34377	0.749238	0.187761	1.21 [0.38 - 3.82]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1564084_at	63	0.190476	0.00826602	0.139758	-0.959401	0.590106	-2.70897	0.07 [0.00 - 1271.12]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202715_at	63	0.603175	0.000121643	0.00416092	1.28876	0.00797059	0.541191	1.72 [1.15 - 2.56]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.377010.1.S1_3p_at	28	0.571429	0.0136592	0.203588	-1.54803	0.151876	-5.39314	0.00 [0.00 - 7.27]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4757895_3p_at	28	0.392857	0.117846	-	-0.823506	0.570846	0.52849	1.70 [0.27 - 10.55]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202715_at	82	0.585366	0.0136068	0.203014	0.825563	0.0978095	0.822836	2.28 [0.86 - 6.03]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32031_at	84	0.666667	0.0669636	-	0.539697	0.255104	0.73947	2.09 [0.59 - 7.49]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	749_at	84	0.107143	0.00681997	0.120569	2.25435	0.0115131	1.53667	4.65 [1.41 - 15.31]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202715_at	79	0.670886	0.206932	-	0.342839	0.818834	0.0776853	1.08 [0.56 - 2.10]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D78586_at	86	0.872093	0.0159357	0.227784	1.08913	0.131324	0.897786	2.45 [0.76 - 7.88]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202715_at	104	0.875	0.000290213	0.00887807	1.27286	0.00829317	0.949356	2.58 [1.28 - 5.23]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P40049	117	0.282051	0.0176312	0.244974	-0.685527	0.0583425	-0.730009	0.48 [0.23 - 1.03]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202715_at	204	0.789216	0.0237933	0.30253	0.651098	0.121843	0.724153	2.06 [0.82 - 5.16]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1564084_at	204	0.196078	0.139495	-	0.872009	0.315066	0.297053	1.35 [0.75 - 2.40]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1564084_at	204	0.102941	0.180869	-	0.775731	0.379159	0.184544	1.20 [0.80 - 1.81]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202715_at	204	0.367647	0.0559088	-	-0.687546	0.383791	-0.555128	0.57 [0.16 - 2.00]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202715_at	178	0.404494	0.108601	-	0.334312	0.492206	0.177955	1.19 [0.72 - 1.99]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1564084_at	111	0.585586	0.132668	-	0.39225	0.787565	0.0499654	1.05 [0.73 - 1.51]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202715_at	111	0.27027	0.0085952	0.143979	0.921069	0.257862	0.337027	1.40 [0.78 - 2.51]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202715_at	90	0.833333	0.0855494	-	0.64564	0.732917	0.139807	1.15 [0.52 - 2.57]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202715_at	90	0.866667	0.264776	-	0.542186	0.944079	0.0327557	1.03 [0.41 - 2.58]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	542	50	0.88	0.0849349	-	0.963172	0.615609	0.470399	1.60 [0.26 - 10.04]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1564084_at	138	0.173913	0.0990642	-	-0.46844	0.605674	-1.54427	0.21 [0.00 - 75.08]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202715_at	138	0.898551	0.0374664	0.410076	0.701725	0.306211	0.162682	1.18 [0.86 - 1.61]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202715_at	129	0.875969	0.170072	-	-0.62855	0.885571	-0.0642107	0.94 [0.39 - 2.25]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22865	56	0.642857	0.13094	-	0.530678	0.544843	0.304792	1.36 [0.51 - 3.64]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6450	56	0.803571	0.116544	-	0.630512	0.370486	0.347704	1.42 [0.66 - 3.03]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	22865	56	0.642857	0.186705	-	0.473499	0.940015	0.0351028	1.04 [0.42 - 2.58]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6450	56	0.196429	0.217716	-	0.59271	0.826054	0.0840904	1.09 [0.51 - 2.30]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202715_at	278	0.625899	0.000560266	0.0156149	0.650664	0.0585554	0.393165	1.48 [0.99 - 2.23]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1564084_at	278	0.802158	0.0491796	0.48668	-0.539694	0.0469262	-1.174	0.31 [0.10 - 0.98]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202715_at	133	0.721804	0.020346	0.271208	0.581124	0.0244959	0.340223	1.41 [1.04 - 1.89]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14393	81	0.777778	0.0010659	0.0268854	1.58273	0.0147538	1.02542	2.79 [1.22 - 6.36]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18287	81	0.82716	0.000638182	0.0174437	1.65315	0.0211601	0.949477	2.58 [1.15 - 5.79]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202715_at	185	0.859459	0.305373	-	-0.24064	0.653125	-0.0633682	0.94 [0.71 - 1.24]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202715_at	185	0.897297	0.185317	-	-0.400389	0.535519	-0.0954051	0.91 [0.67 - 1.23]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P40049	110	0.209091	0.0326755	0.374989	0.686682	0.506706	0.150792	1.16 [0.75 - 1.81]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P40049	110	0.827273	0.35469	-	-0.404277	0.907802	-0.0351346	0.97 [0.53 - 1.75]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202715_at	80	0.55	0.0950712	-	-0.791023	0.552963	-0.213111	0.81 [0.40 - 1.63]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_4087	281	0.857651	0.00478361	0.0914013	0.51052	0.245682	0.109011	1.12 [0.93 - 1.34]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1564084_at	38	0.552632	0.00509975	0.0961246	1.3371	0.0168867	1.99559	7.36 [1.43 - 37.82]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202715_at	38	0.526316	0.00201925	0.045652	1.53839	0.00391863	1.59851	4.95 [1.67 - 14.65]
GENE	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202715_at	140	0.835714	0.000309069	0.00937425	1.16455	0.115837	0.69729	2.01 [0.84 - 4.79]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	46323_at	30	0.866667	0.000128885	0.00437761	2.32743	0.130284	0.746314	2.11 [0.80 - 5.55]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221732_at	30	0.866667	0.0304335	0.35768	1.2021	0.0818178	0.985181	2.68 [0.88 - 8.12]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1664012	165	0.49697	0.0958702	-	0.403672	0.392815	0.122464	1.13 [0.85 - 1.50]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1664012	165	0.70303	0.00545053	0.101274	0.94672	0.0514931	0.467794	1.60 [1.00 - 2.56]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221732_at	163	0.552147	0.126778	-	-0.308217	0.712254	-0.0885984	0.92 [0.57 - 1.47]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	46323_at	163	0.748466	0.0854692	-	-0.425703	0.795489	-0.053317	0.95 [0.63 - 1.42]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	46323_at	79	0.139241	0.019912	0.267113	-0.846434	0.799252	-0.0847496	0.92 [0.48 - 1.77]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221732_at	79	0.151899	0.000488111	0.0138818	-1.21479	0.260455	-0.408256	0.66 [0.33 - 1.35]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1554327_a_at	79	0.101266	0.00552622	0.102374	-1.16483	0.0483612	-1.18607	0.31 [0.09 - 0.99]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	46323_at	58	0.465517	0.149696	-	0.398037	0.988335	0.00623721	1.01 [0.44 - 2.32]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221732_at	58	0.741379	0.268819	-	-0.349345	0.584505	-0.0762158	0.93 [0.71 - 1.22]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221732_at	34	0.882353	0.416409	-	-0.494069	0.972367	0.00619647	1.01 [0.71 - 1.43]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	46323_at	34	0.529412	0.150367	-	-0.570959	0.777859	-0.0914045	0.91 [0.48 - 1.72]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	46323_at	158	0.525316	0.123081	-	-0.362011	0.430827	-0.318883	0.73 [0.33 - 1.61]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221732_at	158	0.594937	0.0167123	0.23574	-0.598721	0.268889	-0.475976	0.62 [0.27 - 1.44]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221732_at	53	0.603774	0.237744	-	0.42941	0.898631	0.0478025	1.05 [0.50 - 2.19]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	46323_at	53	0.54717	0.161086	-	0.508559	0.607937	0.508029	1.66 [0.24 - 11.58]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221732_at	53	0.603774	0.0629212	-	0.631044	0.628853	0.176001	1.19 [0.58 - 2.43]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	46323_at	53	0.54717	0.119329	-	0.532057	0.915126	0.104716	1.11 [0.16 - 7.62]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	46323_at	180	0.538889	0.0040822	0.0806154	0.593532	0.207961	0.526103	1.69 [0.75 - 3.84]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221732_at	180	0.127778	0.0578717	-	0.690151	0.347111	0.150183	1.16 [0.85 - 1.59]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	46323_at	559	0.101968	0.112209	-	-0.441522	0.91834	0.0343465	1.03 [0.54 - 2.00]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221732_at	559	0.119857	0.145514	-	0.563685	0.962254	-0.00684771	0.99 [0.75 - 1.32]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1554327_a_at	559	0.123435	0.0939651	-	-0.404734	0.386457	-0.0917168	0.91 [0.74 - 1.12]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221732_at	77	0.675325	0.00325075	0.067196	0.789361	0.014266	0.461587	1.59 [1.10 - 2.30]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	46323_at	77	0.727273	0.00120956	0.0298816	0.90054	0.0132779	1.09996	3.00 [1.26 - 7.18]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	46323_at	70	0.357143	0.000780138	0.0206784	-0.921846	0.0540875	-0.864021	0.42 [0.17 - 1.02]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221732_at	70	0.314286	0.0205156	0.272798	-0.63662	0.173711	-0.66198	0.52 [0.20 - 1.34]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1554327_a_at	70	0.6	0.244711	-	0.309294	0.975524	-0.0287361	0.97 [0.15 - 6.09]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221732_at	74	0.418919	0.0097543	0.158462	0.787968	0.293627	0.206405	1.23 [0.84 - 1.81]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	46323_at	74	0.797297	0.0346057	0.389423	0.691232	0.351921	0.384049	1.47 [0.65 - 3.30]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	46323_at	67	0.134328	0.0363062	0.401803	-1.41013	0.616003	-0.634447	0.53 [0.04 - 6.33]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221732_at	67	0.701493	0.0913222	-	1.0841	0.682579	0.56744	1.76 [0.12 - 26.76]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1554327_a_at	67	0.791045	0.206612	-	0.869285	0.837909	0.257222	1.29 [0.11 - 15.21]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	46323_at	115	0.321739	0.0338938	0.384148	-1.08931	0.737633	-0.209512	0.81 [0.24 - 2.76]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1554327_a_at	115	0.173913	0.0747692	-	15.3292	0.329596	0.415927	1.52 [0.66 - 3.50]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221732_at	115	0.330435	0.152655	-	-0.742719	0.726081	-0.210112	0.81 [0.25 - 2.63]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221732_at	204	0.289216	7.10516e-05	0.00258983	-0.614845	0.0543778	-0.257718	0.77 [0.59 - 1.00]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1554327_a_at	204	0.147059	0.0304899	0.358123	-0.432916	0.188233	-0.0838943	0.92 [0.81 - 1.04]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	46323_at	204	0.259804	3.72876e-05	0.00145975	-0.659826	0.110366	-0.233304	0.79 [0.59 - 1.05]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	46323_at	87	0.37931	0.0476146	0.477108	0.84437	0.21454	0.411022	1.51 [0.79 - 2.89]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221732_at	87	0.390805	0.0212907	0.28	1.01842	0.228807	0.412506	1.51 [0.77 - 2.96]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	46323_at	87	0.37931	0.0476146	0.477108	0.84437	0.21454	0.411022	1.51 [0.79 - 2.89]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1554327_a_at	87	0.586207	0.00477996	0.0913461	1.05364	0.109742	0.531981	1.70 [0.89 - 3.27]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1554327_a_at	87	0.586207	0.00477996	0.0913461	1.05364	0.109742	0.531981	1.70 [0.89 - 3.27]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221732_at	87	0.390805	0.0212907	0.28	1.01842	0.228807	0.412506	1.51 [0.77 - 2.96]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221732_at	77	0.766234	0.179338	-	-1.30343	0.353629	-0.481054	0.62 [0.22 - 1.71]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554327_a_at	77	0.142857	0.00300552	0.0630838	-1.53849	0.18085	-0.753863	0.47 [0.16 - 1.42]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	46323_at	77	0.428571	0.0751426	-	-1.16172	0.240334	-0.678678	0.51 [0.16 - 1.57]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1554327_a_at	77	0.142857	0.0111709	0.175433	-1.49605	0.158301	-0.918609	0.40 [0.11 - 1.43]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221732_at	77	0.207792	0.109502	-	-0.99212	0.23184	-0.729241	0.48 [0.15 - 1.59]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	46323_at	77	0.428571	0.133663	-	-0.831037	0.375016	-0.43363	0.65 [0.25 - 1.69]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221732_at	136	0.338235	0.00375809	0.0754735	2.37581	0.0461537	0.771657	2.16 [1.01 - 4.62]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	46323_at	136	0.125	0.0613195	-	15.2712	0.119217	0.66657	1.95 [0.84 - 4.50]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221732_at	200	0.895	0.00337972	0.0693283	1.00823	0.0256955	0.601484	1.82 [1.08 - 3.10]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	46323_at	200	0.89	0.00117692	0.0292073	1.07355	0.0247212	0.74746	2.11 [1.10 - 4.05]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13031	60	0.15	0.0139532	0.206791	-1.04154	0.533433	-0.230256	0.79 [0.38 - 1.64]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13031	60	0.716667	0.0638489	-	0.705746	0.950069	0.0288807	1.03 [0.42 - 2.54]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221732_at	286	0.388112	0.0555152	-	0.398329	0.345704	0.141406	1.15 [0.86 - 1.55]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	46323_at	286	0.828671	0.153326	-	0.33527	0.469949	0.138758	1.15 [0.79 - 1.67]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	46323_at	159	0.855346	0.090325	-	0.71963	0.313549	0.376597	1.46 [0.70 - 3.03]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221732_at	159	0.867925	0.119399	-	0.606551	0.457149	0.158398	1.17 [0.77 - 1.78]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221732_at	159	0.641509	0.0131286	0.197745	0.767274	0.175763	0.286835	1.33 [0.88 - 2.02]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	46323_at	159	0.213836	0.100535	-	-0.559466	0.553485	0.197469	1.22 [0.63 - 2.34]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221732_at	159	0.45283	0.0400947	0.428325	0.829544	0.221064	0.308919	1.36 [0.83 - 2.23]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	46323_at	159	0.754717	0.0950912	-	0.546479	0.393077	0.27533	1.32 [0.70 - 2.48]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	46323_at	54	0.814815	0.00345384	0.0705449	1.82197	0.0175604	1.06268	2.89 [1.20 - 6.96]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221732_at	54	0.888889	0.00442606	0.0859585	2.01758	0.014233	1.16031	3.19 [1.26 - 8.07]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221732_at	117	0.34188	0.00715299	0.125087	-0.838012	0.248493	-0.254192	0.78 [0.50 - 1.19]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221732_at	117	0.863248	0.0666542	-	0.837675	0.598967	-0.141279	0.87 [0.51 - 1.47]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	46323_at	117	0.350427	0.0523899	-	-0.718274	0.554635	-0.149246	0.86 [0.53 - 1.41]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	46323_at	117	0.358974	0.0201298	0.269173	-0.728917	0.211586	-0.26927	0.76 [0.50 - 1.17]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	46323_at	117	0.128205	0.0653062	-	-0.8394	0.553434	-0.157973	0.85 [0.51 - 1.44]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	46323_at	117	0.358974	0.0201298	0.269173	-0.728917	0.211586	-0.26927	0.76 [0.50 - 1.17]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221732_at	117	0.34188	0.00715299	0.125087	-0.838012	0.248493	-0.254192	0.78 [0.50 - 1.19]
GENE	CANT1	calcium activated nucleotidase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221732_at	117	0.34188	0.0363633	0.402213	-0.772508	0.618591	-0.128178	0.88 [0.53 - 1.46]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221732_at	236	0.673729	0.000815362	0.0214639	0.877266	0.084893	0.40413	1.50 [0.95 - 2.37]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	46323_at	236	0.783898	0.00112587	0.0281451	0.896108	0.0447054	0.633257	1.88 [1.02 - 3.50]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	46323_at	249	0.783133	1.37515e-06	7.29701e-05	1.03713	0.0175088	0.585153	1.80 [1.11 - 2.91]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221732_at	249	0.682731	3.57418e-06	0.000175209	0.951666	0.0110644	0.454962	1.58 [1.11 - 2.24]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221732_at	125	0.328	0.0853421	-	0.901908	0.250957	0.342814	1.41 [0.78 - 2.53]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	46323_at	62	0.887097	0.000127105	0.00432451	2.17978	0.481141	0.181598	1.20 [0.72 - 1.99]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221732_at	125	0.616	0.199027	-	-0.387757	0.967045	-0.00972071	0.99 [0.62 - 1.57]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221732_at	54	0.87037	0.0134139	0.200896	1.55574	0.196407	0.489717	1.63 [0.78 - 3.43]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	46323_at	125	0.472	0.0442294	0.455742	0.856582	0.219587	0.410442	1.51 [0.78 - 2.90]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	46323_at	125	0.84	0.261081	-	-0.460834	0.881436	-0.0388599	0.96 [0.58 - 1.60]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	46323_at	54	0.888889	0.0213885	0.2809	1.77078	0.337071	0.32515	1.38 [0.71 - 2.69]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221732_at	62	0.887097	0.000127105	0.00432451	2.17978	0.357696	0.259894	1.30 [0.75 - 2.26]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	46323_at	198	0.166667	0.0427297	0.445972	-0.628283	0.675759	0.0767485	1.08 [0.75 - 1.55]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	46323_at	198	0.166667	0.0301043	0.355087	-0.701375	0.676335	0.0805072	1.08 [0.74 - 1.58]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221732_at	198	0.868687	0.0265763	0.326405	0.591659	0.257518	0.145317	1.16 [0.90 - 1.49]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221732_at	198	0.752525	0.0907916	-	0.456731	0.586539	0.083296	1.09 [0.81 - 1.47]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	46323_at	198	0.883838	0.0296692	0.351638	0.610384	0.290083	0.162069	1.18 [0.87 - 1.59]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221732_at	198	0.752525	0.042345	0.443435	0.56751	0.607439	0.0825126	1.09 [0.79 - 1.49]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221732_at	51	0.235294	1.04227e-05	0.00046386	-18.9371	0.00917333	-3.20638	0.04 [0.00 - 0.45]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221732_at	62	0.209677	0.0438555	0.453324	-1.12257	0.383343	-0.55831	0.57 [0.16 - 2.01]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	46323_at	51	0.313726	0.000462652	0.0132601	-17.5736	0.0144133	-2.63133	0.07 [0.01 - 0.59]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	46323_at	62	0.274194	0.207856	-	-0.723036	0.613052	-0.298723	0.74 [0.23 - 2.36]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1554327_a_at	177	0.638418	0.0731158	-	-0.46787	0.562723	-0.116396	0.89 [0.60 - 1.32]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221732_at	145	0.103448	0.044426	0.457009	-0.877718	0.337539	-0.389225	0.68 [0.31 - 1.50]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	46323_at	177	0.881356	0.167161	-	-0.70514	0.920176	-0.0269836	0.97 [0.57 - 1.65]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1554327_a_at	145	0.793103	0.0369112	0.406134	-1.18784	0.309837	-0.286399	0.75 [0.43 - 1.31]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	46323_at	177	0.327684	0.273133	-	0.287299	0.931869	-0.0200084	0.98 [0.62 - 1.55]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221732_at	177	0.892655	0.117259	-	-0.902003	0.830801	-0.0659864	0.94 [0.51 - 1.71]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	46323_at	145	0.2	0.0672267	-	-0.671315	0.365013	-0.303307	0.74 [0.38 - 1.42]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1554327_a_at	177	0.638418	0.0190221	0.258602	-0.750369	0.625309	-0.113622	0.89 [0.57 - 1.41]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221732_at	177	0.214689	0.226591	-	0.38108	0.843104	-0.0531637	0.95 [0.56 - 1.61]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221732_at	226	0.146018	0.0784573	-	-0.579763	0.196767	-0.255599	0.77 [0.53 - 1.14]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1554327_a_at	226	0.10177	0.143941	-	-0.55759	0.534237	-0.0722768	0.93 [0.74 - 1.17]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	46323_at	226	0.889381	0.265832	-	-0.65243	0.492326	-0.201883	0.82 [0.46 - 1.45]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221732_at	49	0.122449	0.117955	-	15.3092	0.726404	0.1856	1.20 [0.43 - 3.40]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1554327_a_at	49	0.102041	0.00251953	0.05469	-1.65895	0.144479	-0.579395	0.56 [0.26 - 1.22]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	46323_at	55	0.127273	0.151143	-	-0.783894	0.54228	-0.22459	0.80 [0.39 - 1.65]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1554327_a_at	55	0.418182	0.00380192	0.0761752	-1.4232	0.0168399	-0.805488	0.45 [0.23 - 0.87]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	46323_at	55	0.763636	0.028876	0.345289	-1.93021	0.280639	-0.427812	0.65 [0.30 - 1.42]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221732_at	55	0.781818	0.15696	-	-1.01176	0.678392	-0.168938	0.84 [0.38 - 1.88]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	46323_at	49	0.612245	0.344342	-	0.540476	0.871991	0.0765463	1.08 [0.43 - 2.74]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1554327_a_at	55	0.163636	0.0401295	0.428563	-0.965809	0.0996149	-0.518041	0.60 [0.32 - 1.10]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221732_at	55	0.272727	0.0308204	0.36071	-1.02032	0.384874	-0.383208	0.68 [0.29 - 1.62]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1554327_a_at	63	0.238095	1.12372e-05	0.00049655	-1.4409	0.447232	0.921501	2.51 [0.23 - 27.06]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	46323_at	63	0.349206	0.130301	-	-0.51985	0.640129	0.0995061	1.10 [0.73 - 1.68]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221732_at	63	0.126984	0.0556673	-	1.72246	0.496783	0.143186	1.15 [0.76 - 1.74]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.8859.0.S1_3p_s_at	28	0.607143	0.017944	0.248074	1.30832	0.100986	0.478369	1.61 [0.91 - 2.86]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.8859.2.S1_3p_s_at	28	0.25	0.0183719	0.252282	-1.41629	0.09382	-15.2739	0.00 [0.00 - 13.37]
GENE	CANT1	calcium activated nucleotidase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221732_at	82	0.634146	0.0257572	0.319499	-0.87376	0.150225	-0.643649	0.53 [0.22 - 1.26]
GENE	CANT1	calcium activated nucleotidase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	46323_at	82	0.231707	0.0614357	-	-0.700038	0.402377	-0.555118	0.57 [0.16 - 2.10]
GENE	CANT1	calcium activated nucleotidase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221732_at	79	0.822785	0.19058	-	0.427879	0.699576	0.118501	1.13 [0.62 - 2.06]
GENE	CANT1	calcium activated nucleotidase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	46323_at	79	0.341772	0.0748101	-	-0.468983	0.653751	-0.302611	0.74 [0.20 - 2.77]
GENE	CANT1	calcium activated nucleotidase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	46323_at	104	0.721154	0.0910276	-	-0.694851	0.897256	-0.0878179	0.92 [0.24 - 3.47]
GENE	CANT1	calcium activated nucleotidase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221732_at	104	0.384615	0.116791	-	0.538003	0.821282	0.117994	1.13 [0.40 - 3.13]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P116669	117	0.17094	0.171866	-	0.634555	0.321714	0.223615	1.25 [0.80 - 1.95]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P26759	117	0.871795	0.00619697	0.111941	0.950756	0.0211975	0.49074	1.63 [1.08 - 2.48]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	46323_at	204	0.254902	0.0142669	0.210181	1.61319	0.0363111	1.08614	2.96 [1.07 - 8.19]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	46323_at	204	0.558824	0.000364175	0.0107982	0.977864	0.00217314	1.18275	3.26 [1.53 - 6.95]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221732_at	204	0.54902	0.0344596	0.388345	0.781664	0.077356	0.819247	2.27 [0.91 - 5.63]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221732_at	204	0.578431	0.00110708	0.0277519	0.882481	0.00698387	0.934436	2.55 [1.29 - 5.02]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1554327_a_at	204	0.455882	0.147604	-	-0.527797	0.839495	-0.0567241	0.94 [0.55 - 1.64]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1554327_a_at	204	0.872549	0.0770551	-	0.589239	0.420681	0.185386	1.20 [0.77 - 1.89]
GENE	CANT1	calcium activated nucleotidase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221732_at	178	0.814607	0.0812529	-	0.417904	0.360748	0.296942	1.35 [0.71 - 2.54]
GENE	CANT1	calcium activated nucleotidase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	46323_at	178	0.88764	0.0116986	0.18157	0.721472	0.132436	0.744476	2.11 [0.80 - 5.55]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1554327_a_at	111	0.891892	0.00376563	0.0755944	0.988097	0.79175	0.036878	1.04 [0.79 - 1.36]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221732_at	111	0.675676	0.00774379	0.132953	0.704514	0.0334274	0.405537	1.50 [1.03 - 2.18]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	46323_at	111	0.792793	0.00723989	0.126255	0.791945	0.0350566	0.731463	2.08 [1.05 - 4.10]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221732_at	90	0.655556	0.0091095	0.150477	0.937242	0.148531	0.567025	1.76 [0.82 - 3.80]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221732_at	90	0.655556	0.0191826	0.260149	0.745647	0.100216	0.566764	1.76 [0.90 - 3.46]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	46323_at	90	0.355556	0.0935051	-	0.630928	0.230272	0.342948	1.41 [0.80 - 2.47]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	46323_at	90	0.511111	0.0721686	-	0.676632	0.425843	0.258586	1.30 [0.69 - 2.45]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	46323_at	138	0.688406	0.0278837	0.33723	0.538553	0.160949	0.235031	1.26 [0.91 - 1.76]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1554327_a_at	138	0.695652	7.72202e-05	0.00278782	0.931098	0.0173928	0.363679	1.44 [1.07 - 1.94]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221732_at	138	0.710145	0.0205611	0.273224	0.570816	0.0824542	0.262418	1.30 [0.97 - 1.75]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	46323_at	129	0.852713	0.000315763	0.00954925	1.0707	0.149621	0.677949	1.97 [0.78 - 4.95]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221732_at	129	0.875969	0.00142726	0.0342919	1.0405	0.682809	0.0693213	1.07 [0.77 - 1.49]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5752	56	0.392857	0.19049	-	0.487744	0.916957	0.0428853	1.04 [0.47 - 2.34]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40647	56	0.178571	0.125549	-	0.89613	0.852002	0.0785345	1.08 [0.47 - 2.47]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	5752	56	0.892857	0.0468625	0.472441	0.952677	0.688382	0.173585	1.19 [0.51 - 2.78]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40647	56	0.446429	0.0442175	0.455666	-0.710873	0.487515	-0.309273	0.73 [0.31 - 1.76]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1554327_a_at	278	0.266187	0.000133834	0.00452469	-0.757065	0.0104867	-0.531762	0.59 [0.39 - 0.88]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	46323_at	278	0.420863	0.0249778	0.312836	-0.423454	0.163181	-0.284121	0.75 [0.50 - 1.12]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221732_at	278	0.158273	0.0128218	0.194328	-0.579345	0.101581	-0.370538	0.69 [0.44 - 1.08]
GENE	CANT1	calcium activated nucleotidase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	46323_at	133	0.834586	0.0266344	0.326891	-0.855753	0.201539	-0.220049	0.80 [0.57 - 1.12]
GENE	CANT1	calcium activated nucleotidase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221732_at	133	0.330827	0.0186499	0.254995	-0.555247	0.1844	-0.252306	0.78 [0.54 - 1.13]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17177	81	0.37037	0.0209642	0.27698	-1.15474	0.4514	-0.370231	0.69 [0.26 - 1.81]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	46323_at	185	0.751351	0.0214542	0.281505	-0.435434	0.451376	-0.093286	0.91 [0.71 - 1.16]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221732_at	185	0.740541	0.0167324	0.235944	-0.441383	0.162041	-0.192619	0.82 [0.63 - 1.08]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	46323_at	185	0.751351	0.0368547	0.405731	-0.433524	0.404209	-0.114772	0.89 [0.68 - 1.17]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221732_at	185	0.686486	0.0309618	0.361813	-0.416022	0.225949	-0.184174	0.83 [0.62 - 1.12]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P26759	110	0.536364	0.301321	-	0.313765	0.788141	-0.0633153	0.94 [0.59 - 1.49]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P116669	110	0.245455	0.0390636	0.421245	0.588284	0.348066	0.198116	1.22 [0.81 - 1.84]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P26759	110	0.318182	0.0642582	-	0.470522	0.451788	0.147385	1.16 [0.79 - 1.70]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P116669	110	0.881818	0.116473	-	-1.0806	0.804268	-0.0691185	0.93 [0.54 - 1.61]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	46323_at	80	0.1125	0.245324	-	-0.64033	0.987768	0.00721378	1.01 [0.40 - 2.53]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221732_at	80	0.875	0.0219297	0.285855	1.13504	0.674643	0.0799724	1.08 [0.75 - 1.57]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221732_at	38	0.157895	0.0105712	0.168341	15.6114	0.0227373	0.923842	2.52 [1.14 - 5.58]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	46323_at	38	0.736842	0.0303361	0.356914	1.03672	0.0420183	1.03976	2.83 [1.04 - 7.71]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1554327_a_at	38	0.657895	0.0417435	0.43944	1.00698	0.166929	0.660097	1.93 [0.76 - 4.93]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221732_at	140	0.721429	1.4587e-05	0.000628548	1.19688	8.93038e-05	1.86199	6.44 [2.54 - 16.34]
GENE	CANT1	calcium activated nucleotidase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	46323_at	140	0.778571	8.35682e-06	0.000379697	1.23658	0.000252546	1.45636	4.29 [1.97 - 9.36]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CAT	catalase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201432_at	30	0.4	0.0882469	-	-0.697297	0.748015	-0.0812498	0.92 [0.56 - 1.51]
GENE	CAT	catalase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	211922_s_at	30	0.866667	0.00678861	0.12014	1.52871	0.766042	0.0773363	1.08 [0.65 - 1.80]
GENE	CAT	catalase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	215573_at	30	0.2	0.000891471	0.0231402	-1.8585	0.832299	-0.298154	0.74 [0.05 - 11.72]
GENE	CAT	catalase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1805905	165	0.169697	0.000572829	0.0159126	-0.94639	0.0199582	-0.341055	0.71 [0.53 - 0.95]
GENE	CAT	catalase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1805905	165	0.169697	4.79222e-05	0.00182571	-1.39113	0.000434111	-0.727181	0.48 [0.32 - 0.72]
GENE	CAT	catalase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	211922_s_at	163	0.104294	0.234324	-	-0.351238	0.678809	-0.0309783	0.97 [0.84 - 1.12]
GENE	CAT	catalase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	215573_at	163	0.104294	0.208287	-	-0.370634	0.69915	-0.165896	0.85 [0.37 - 1.96]
GENE	CAT	catalase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201432_at	163	0.509202	0.0897861	-	-0.336089	0.25638	-0.161385	0.85 [0.64 - 1.12]
GENE	CAT	catalase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	232624_at	163	0.693252	0.0263461	0.324474	-0.498879	0.683113	-0.222773	0.80 [0.27 - 2.33]
GENE	CAT	catalase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	232624_at	79	0.101266	0.018948	0.257886	-0.935159	0.59721	-0.496299	0.61 [0.10 - 3.84]
GENE	CAT	catalase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	215573_at	79	0.101266	0.00641378	0.114971	-1.07615	0.0635725	-0.723626	0.48 [0.23 - 1.04]
GENE	CAT	catalase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	211922_s_at	79	0.278481	0.0978448	-	0.584278	0.650594	-0.0845172	0.92 [0.64 - 1.32]
GENE	CAT	catalase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201432_at	79	0.898734	0.187682	-	0.570832	0.730516	-0.111441	0.89 [0.47 - 1.69]
GENE	CAT	catalase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201432_at	58	0.810345	0.149989	-	-0.505606	0.887391	-0.0359963	0.96 [0.59 - 1.59]
GENE	CAT	catalase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211922_s_at	58	0.517241	0.103616	-	0.454372	0.812796	0.0382979	1.04 [0.76 - 1.43]
GENE	CAT	catalase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215573_at	58	0.793103	0.000360202	0.0106967	1.3697	0.0434797	0.307741	1.36 [1.01 - 1.83]
GENE	CAT	catalase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	215573_at	34	0.588235	0.096365	-	-0.670982	0.80787	-0.0557412	0.95 [0.60 - 1.48]
GENE	CAT	catalase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201432_at	34	0.176471	0.102966	-	0.995491	0.604776	0.178551	1.20 [0.61 - 2.35]
GENE	CAT	catalase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	211922_s_at	34	0.117647	0.130493	-	-0.853282	0.554114	-0.192403	0.82 [0.44 - 1.56]
GENE	CAT	catalase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	215573_at	158	0.848101	0.000645446	0.0176122	0.912759	0.0362186	1.60474	4.98 [1.11 - 22.34]
GENE	CAT	catalase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201432_at	158	0.5	0.0855809	-	-0.401891	0.57083	-0.172134	0.84 [0.46 - 1.53]
GENE	CAT	catalase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	211922_s_at	158	0.139241	0.0446257	0.458292	-0.634162	0.414877	-0.252913	0.78 [0.42 - 1.43]
GENE	CAT	catalase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	211922_s_at	53	0.867925	0.0490969	0.486179	0.87696	0.154331	1.12282	3.07 [0.66 - 14.41]
GENE	CAT	catalase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201432_at	53	0.132075	0.0390061	0.420848	1.39465	0.386619	0.515449	1.67 [0.52 - 5.38]
GENE	CAT	catalase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	215573_at	53	0.754717	0.000935933	0.0241071	1.21959	0.0364932	0.425247	1.53 [1.03 - 2.28]
GENE	CAT	catalase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	211922_s_at	53	0.169811	0.0542344	-	1.10867	0.16457	0.999471	2.72 [0.66 - 11.12]
GENE	CAT	catalase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201432_at	53	0.132075	0.03505	0.392687	1.86534	0.45732	0.493984	1.64 [0.45 - 6.03]
GENE	CAT	catalase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	215573_at	53	0.754717	0.00305731	0.0639587	1.08021	0.203252	0.230268	1.26 [0.88 - 1.79]
GENE	CAT	catalase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201432_at	180	0.711111	0.0274148	0.333375	-0.543706	0.332117	-0.246378	0.78 [0.48 - 1.29]
GENE	CAT	catalase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	211922_s_at	180	0.611111	0.0282578	0.340284	-0.479136	0.333896	-0.185478	0.83 [0.57 - 1.21]
GENE	CAT	catalase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	215573_at	180	0.516667	0.154768	-	0.298697	0.692937	0.0349059	1.04 [0.87 - 1.23]
GENE	CAT	catalase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	232624_at	180	0.366667	0.0163817	0.23237	0.547881	0.0477668	0.280041	1.32 [1.00 - 1.75]
GENE	CAT	catalase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	232624_at	559	0.520572	0.195242	-	-0.264072	0.481294	-0.115373	0.89 [0.65 - 1.23]
GENE	CAT	catalase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	215573_at	559	0.559928	0.156996	-	0.282748	0.709341	0.0406521	1.04 [0.84 - 1.29]
GENE	CAT	catalase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	211922_s_at	559	0.466905	0.188779	-	0.264215	0.932654	0.0120702	1.01 [0.77 - 1.34]
GENE	CAT	catalase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201432_at	559	0.289803	0.0300903	0.354976	0.526725	0.388399	0.194776	1.22 [0.78 - 1.89]
GENE	CAT	catalase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	215573_at	77	0.337662	0.116252	-	-0.425288	0.653683	-0.063141	0.94 [0.71 - 1.24]
GENE	CAT	catalase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201432_at	77	0.116883	0.0092427	0.152141	-0.935629	0.590111	-0.20584	0.81 [0.38 - 1.72]
GENE	CAT	catalase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	211922_s_at	77	0.12987	0.0211174	0.278399	-0.795333	0.601955	-0.20143	0.82 [0.38 - 1.74]
GENE	CAT	catalase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	232624_at	77	0.506494	0.00429791	0.0839801	-0.740573	0.115968	-0.43829	0.65 [0.37 - 1.11]
GENE	CAT	catalase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	232624_at	70	0.128571	0.126163	-	-0.556162	0.776162	-0.193973	0.82 [0.22 - 3.14]
GENE	CAT	catalase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	215573_at	70	0.271429	0.00872871	0.145677	-0.766966	0.246425	-1.72489	0.18 [0.01 - 3.29]
GENE	CAT	catalase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	211922_s_at	70	0.228571	0.0238823	0.303312	-0.678949	0.874676	0.0450529	1.05 [0.60 - 1.83]
GENE	CAT	catalase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201432_at	70	0.728571	0.288924	-	0.310128	0.910118	0.0280828	1.03 [0.63 - 1.67]
GENE	CAT	catalase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37009_at	50	0.16	0.0371623	0.407921	-0.879367	0.184382	-0.578031	0.56 [0.24 - 1.32]
GENE	CAT	catalase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201432_at	74	0.486486	0.0787448	-	-0.506828	0.330026	-0.376975	0.69 [0.32 - 1.46]
GENE	CAT	catalase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	211922_s_at	74	0.202703	0.000908401	0.0235094	-1.01272	0.0427509	-0.656757	0.52 [0.27 - 0.98]
GENE	CAT	catalase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	215573_at	74	0.351351	0.212329	-	-0.36382	0.326771	-0.162133	0.85 [0.61 - 1.18]
GENE	CAT	catalase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	232624_at	74	0.256757	0.0376151	0.411127	0.755692	0.261284	0.282483	1.33 [0.81 - 2.17]
GENE	CAT	catalase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	215573_at	67	0.253731	0.0940186	-	-1.08429	0.923447	-0.129608	0.88 [0.06 - 12.35]
GENE	CAT	catalase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	232624_at	67	0.686567	0.00223806	0.0496599	2.07627	0.00385827	7.59987	1997.94 [11.53 - 346266.50]
GENE	CAT	catalase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	211922_s_at	67	0.895522	0.136607	-	1.15538	0.733007	0.262421	1.30 [0.29 - 5.87]
GENE	CAT	catalase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201432_at	67	0.686567	0.0898428	-	1.0861	0.453501	0.692919	2.00 [0.33 - 12.24]
GENE	CAT	catalase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	215573_at	115	0.895652	0.166248	-	0.877282	0.690708	0.344796	1.41 [0.26 - 7.72]
GENE	CAT	catalase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	211922_s_at	115	0.486957	0.31047	-	0.558672	0.678083	0.277664	1.32 [0.36 - 4.90]
GENE	CAT	catalase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	232624_at	115	0.313043	0.00825305	0.13959	15.6674	0.0757818	1.03535	2.82 [0.90 - 8.83]
GENE	CAT	catalase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201432_at	115	0.113043	0.201516	-	-0.812727	0.707762	-0.284793	0.75 [0.17 - 3.33]
GENE	CAT	catalase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37009_at	158	0.455696	0.00347454	0.0708835	-0.849141	0.129658	-0.510468	0.60 [0.31 - 1.16]
GENE	CAT	catalase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37009_at	76	0.671053	0.0558566	-	0.953743	0.311346	0.556693	1.74 [0.59 - 5.13]
GENE	CAT	catalase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	215573_at	204	0.789216	0.00181744	0.0418705	-0.563457	0.151435	-0.0988256	0.91 [0.79 - 1.04]
GENE	CAT	catalase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	232624_at	204	0.240196	0.00469374	0.0900436	-0.470742	0.0600282	-0.218725	0.80 [0.64 - 1.01]
GENE	CAT	catalase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	211922_s_at	204	0.887255	0.0656725	-	-0.405409	0.890134	-0.016659	0.98 [0.78 - 1.25]
GENE	CAT	catalase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201432_at	204	0.122549	0.137022	-	-0.318703	0.673392	-0.0744786	0.93 [0.66 - 1.31]
GENE	CAT	catalase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	215573_at	87	0.103448	0.0679901	-	-0.818421	0.664419	0.296549	1.35 [0.35 - 5.14]
GENE	CAT	catalase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	211922_s_at	87	0.137931	0.0112404	0.176246	-1.0607	0.270625	-0.392585	0.68 [0.34 - 1.36]
GENE	CAT	catalase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	215573_at	87	0.103448	0.0679901	-	-0.818421	0.664419	0.296549	1.35 [0.35 - 5.14]
GENE	CAT	catalase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201432_at	87	0.103448	0.0609218	-	-0.897804	0.118606	-0.627041	0.53 [0.24 - 1.17]
GENE	CAT	catalase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	211922_s_at	87	0.137931	0.0112404	0.176246	-1.0607	0.270625	-0.392585	0.68 [0.34 - 1.36]
GENE	CAT	catalase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	232624_at	87	0.678161	0.136536	-	0.56963	0.473294	0.386589	1.47 [0.51 - 4.23]
GENE	CAT	catalase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	232624_at	87	0.678161	0.136536	-	0.56963	0.473294	0.386589	1.47 [0.51 - 4.23]
GENE	CAT	catalase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201432_at	87	0.103448	0.0609218	-	-0.897804	0.118606	-0.627041	0.53 [0.24 - 1.17]
GENE	CAT	catalase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	232624_at	77	0.103896	0.0212771	0.279874	-1.45866	0.591857	-0.771367	0.46 [0.03 - 7.76]
GENE	CAT	catalase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201432_at	77	0.298701	0.0145814	0.213555	-1.44934	0.292973	-0.547129	0.58 [0.21 - 1.60]
GENE	CAT	catalase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	211922_s_at	77	0.441558	0.0372715	0.408696	-1.18257	0.350189	-0.327103	0.72 [0.36 - 1.43]
GENE	CAT	catalase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201432_at	77	0.337662	0.0150741	0.218786	-1.29551	0.183418	-0.601378	0.55 [0.23 - 1.33]
GENE	CAT	catalase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	215573_at	77	0.896104	0.035965	0.399343	1.34469	0.980388	-0.0375587	0.96 [0.05 - 19.24]
GENE	CAT	catalase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	232624_at	77	0.675325	0.0142008	0.209469	1.30459	0.826787	0.268789	1.31 [0.12 - 14.53]
GENE	CAT	catalase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	211922_s_at	77	0.87013	0.20607	-	-15.238	0.64442	-0.186222	0.83 [0.38 - 1.83]
GENE	CAT	catalase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	215573_at	77	0.896104	0.0032221	0.0667195	1.59774	0.565919	0.733307	2.08 [0.17 - 25.46]
GENE	CAT	catalase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	211922_s_at	136	0.257353	0.00121793	0.0300538	-1.39409	0.00132009	-0.756233	0.47 [0.30 - 0.74]
GENE	CAT	catalase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	215573_at	136	0.529412	0.0561209	-	0.873423	0.389764	0.190082	1.21 [0.78 - 1.87]
GENE	CAT	catalase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201432_at	136	0.757353	0.237343	-	-0.73201	0.440844	-0.400551	0.67 [0.24 - 1.86]
GENE	CAT	catalase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201432_at	200	0.115	0.00343459	0.0702296	-1.00429	0.969265	0.0170708	1.02 [0.43 - 2.42]
GENE	CAT	catalase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	211922_s_at	200	0.105	7.67669e-05	0.00277334	-1.28451	0.133595	-0.483832	0.62 [0.33 - 1.16]
GENE	CAT	catalase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	215573_at	200	0.78	0.0225497	0.291467	0.692814	0.0534099	0.360448	1.43 [0.99 - 2.07]
GENE	CAT	catalase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15156	60	0.2	0.00499171	0.0945194	2.31415	0.0279418	0.641697	1.90 [1.07 - 3.37]
GENE	CAT	catalase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15156	60	0.766667	0.0525406	-	0.756012	0.489526	0.279168	1.32 [0.60 - 2.92]
GENE	CAT	catalase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	2965	155	0.858065	0.000179797	0.00585771	1.0868	0.0306735	0.155456	1.17 [1.01 - 1.35]
GENE	CAT	catalase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201432_at	286	0.755245	0.00449166	0.0869654	-0.752953	0.243519	-0.262992	0.77 [0.49 - 1.20]
GENE	CAT	catalase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	211922_s_at	286	0.660839	0.000798378	0.0210859	-0.76028	0.0490581	-0.359853	0.70 [0.49 - 1.00]
GENE	CAT	catalase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	215573_at	286	0.36014	0.151362	-	-0.28026	0.738358	-0.0342951	0.97 [0.79 - 1.18]
GENE	CAT	catalase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201432_at	159	0.647799	0.0241929	0.306031	-0.864443	0.582193	-0.240655	0.79 [0.33 - 1.85]
GENE	CAT	catalase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211922_s_at	159	0.113208	0.134697	-	1.03842	0.72562	0.103406	1.11 [0.62 - 1.98]
GENE	CAT	catalase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201432_at	159	0.685535	0.0092811	0.152619	-1.45524	0.246896	-0.598447	0.55 [0.20 - 1.51]
GENE	CAT	catalase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215573_at	159	0.100629	0.225034	-	-0.531947	0.91783	-0.0167179	0.98 [0.72 - 1.35]
GENE	CAT	catalase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211922_s_at	159	0.339623	0.186048	-	-0.41963	0.967763	0.0115522	1.01 [0.58 - 1.77]
GENE	CAT	catalase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	211922_s_at	159	0.339623	0.110508	-	-0.585269	0.846155	-0.0636073	0.94 [0.49 - 1.78]
GENE	CAT	catalase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201432_at	159	0.685535	0.0153406	0.221588	-1.02819	0.572428	-0.246934	0.78 [0.33 - 1.84]
GENE	CAT	catalase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215573_at	159	0.100629	0.0134571	0.201372	-0.94324	0.0299567	-0.303762	0.74 [0.56 - 0.97]
GENE	CAT	catalase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	215573_at	159	0.100629	0.0410273	0.434643	-0.90749	0.272905	-0.189388	0.83 [0.59 - 1.16]
GENE	CAT	catalase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232624_at	159	0.754717	0.053933	-	0.629021	0.308316	0.350424	1.42 [0.72 - 2.79]
GENE	CAT	catalase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232624_at	159	0.830189	0.0334675	0.380963	0.737574	0.220915	0.418825	1.52 [0.78 - 2.97]
GENE	CAT	catalase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	232624_at	159	0.754717	0.0137182	0.204233	0.899287	0.0552764	0.733188	2.08 [0.98 - 4.41]
GENE	CAT	catalase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	211922_s_at	54	0.574074	0.149063	-	-1.11552	0.888981	-0.0552721	0.95 [0.44 - 2.06]
GENE	CAT	catalase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	215573_at	54	0.777778	0.263762	-	-1.12727	0.574836	-0.669597	0.51 [0.05 - 5.31]
GENE	CAT	catalase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201432_at	54	0.314815	0.168332	-	1.35592	0.817209	0.12279	1.13 [0.40 - 3.20]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215573_at	117	0.837607	0.257001	-	0.428063	0.389946	0.615889	1.85 [0.45 - 7.54]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215573_at	117	0.837607	0.177141	-	0.583069	0.716962	0.31916	1.38 [0.25 - 7.73]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201432_at	117	0.512821	0.0483359	0.481543	0.6367	0.602888	0.103242	1.11 [0.75 - 1.64]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215573_at	117	0.837607	0.110548	-	0.689976	0.416921	0.712232	2.04 [0.37 - 11.38]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201432_at	117	0.512821	0.023546	0.30035	0.887896	0.528226	0.151534	1.16 [0.73 - 1.86]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	215573_at	117	0.837607	0.257001	-	0.428063	0.389946	0.615889	1.85 [0.45 - 7.54]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201432_at	117	0.512821	0.0483359	0.481543	0.6367	0.602888	0.103242	1.11 [0.75 - 1.64]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201432_at	117	0.512821	0.0368706	0.405844	0.836247	0.824499	0.0556599	1.06 [0.65 - 1.73]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211922_s_at	117	0.213675	0.228078	-	0.640397	0.783035	0.052726	1.05 [0.72 - 1.53]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211922_s_at	117	0.803419	0.135654	-	0.526678	0.828132	0.034379	1.03 [0.76 - 1.41]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211922_s_at	117	0.803419	0.135654	-	0.526678	0.828132	0.034379	1.03 [0.76 - 1.41]
GENE	CAT	catalase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	211922_s_at	117	0.897436	0.0923021	-	-15.1661	0.499525	-0.139669	0.87 [0.58 - 1.30]
GENE	CAT	catalase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	211922_s_at	236	0.228814	0.000264755	0.00820006	-0.97781	0.00435126	-0.910523	0.40 [0.22 - 0.75]
GENE	CAT	catalase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	215573_at	236	0.419492	0.0919212	-	0.48134	0.771305	0.0494499	1.05 [0.75 - 1.47]
GENE	CAT	catalase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201432_at	236	0.207627	0.000211652	0.00675204	-1.00071	0.015669	-0.893549	0.41 [0.20 - 0.84]
GENE	CAT	catalase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	232624_at	236	0.144068	0.00181681	0.0418585	-0.938246	0.788864	-0.094528	0.91 [0.46 - 1.82]
GENE	CAT	catalase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	215573_at	249	0.554217	0.164684	-	0.292916	0.920964	0.0132522	1.01 [0.78 - 1.32]
GENE	CAT	catalase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201432_at	249	0.192771	0.00850842	0.142871	-0.628976	0.647681	-0.138515	0.87 [0.48 - 1.58]
GENE	CAT	catalase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	211922_s_at	249	0.2249	0.00096691	0.0247756	-0.740454	0.043137	-0.548994	0.58 [0.34 - 0.98]
GENE	CAT	catalase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	232624_at	249	0.124498	0.00334298	0.0687229	-0.77652	0.146105	-0.412087	0.66 [0.38 - 1.15]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211922_s_at	125	0.888	0.0720979	-	-1.03597	0.925467	-0.0166548	0.98 [0.69 - 1.39]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211922_s_at	54	0.12963	5.42278e-05	0.00203788	-2.45728	0.0222949	-1.39593	0.25 [0.07 - 0.82]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215573_at	125	0.888	0.0395016	0.424265	0.919018	0.473771	0.355236	1.43 [0.54 - 3.77]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215573_at	125	0.176	0.148207	-	0.742095	0.929831	0.0345402	1.04 [0.48 - 2.23]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201432_at	62	0.129032	0.00264698	0.0569251	-1.54266	0.056916	-0.799309	0.45 [0.20 - 1.02]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201432_at	125	0.32	0.118204	-	-0.605263	0.5275	-0.195954	0.82 [0.45 - 1.51]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215573_at	54	0.259259	0.108911	-	15.3582	0.986437	-0.0178858	0.98 [0.12 - 7.72]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211922_s_at	62	0.112903	5.38015e-05	0.00202363	-2.00834	0.0736576	-0.859303	0.42 [0.17 - 1.09]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201432_at	125	0.32	0.201415	-	-0.394535	0.733412	-0.0789047	0.92 [0.59 - 1.46]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201432_at	54	0.12963	0.00168912	0.0394196	-1.86836	0.0218483	-1.24902	0.29 [0.10 - 0.83]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	215573_at	62	0.258065	0.0426572	0.445495	15.3672	0.950115	0.0543294	1.06 [0.19 - 5.79]
GENE	CAT	catalase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	211922_s_at	125	0.848	0.253665	-	-0.691054	0.817186	-0.0544991	0.95 [0.60 - 1.50]
GENE	CAT	catalase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215573_at	198	0.434343	0.123169	-	0.404402	0.414817	0.0714073	1.07 [0.90 - 1.28]
GENE	CAT	catalase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215573_at	198	0.459596	0.0465418	0.470437	0.549372	0.188117	0.124685	1.13 [0.94 - 1.36]
GENE	CAT	catalase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201432_at	198	0.333333	0.155168	-	-0.367889	0.866674	0.0384606	1.04 [0.66 - 1.63]
GENE	CAT	catalase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211922_s_at	198	0.888889	0.0756809	-	0.512113	0.287226	0.18603	1.20 [0.86 - 1.70]
GENE	CAT	catalase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201432_at	198	0.353535	0.080736	-	-0.466366	0.723705	0.0843082	1.09 [0.68 - 1.74]
GENE	CAT	catalase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	215573_at	198	0.691919	0.065298	-	0.399754	0.350619	0.0681939	1.07 [0.93 - 1.24]
GENE	CAT	catalase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211922_s_at	198	0.116162	0.228195	-	-0.417048	0.904297	0.0245297	1.02 [0.69 - 1.53]
GENE	CAT	catalase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	211922_s_at	198	0.535354	0.324747	-	-0.266779	0.897303	0.0275478	1.03 [0.68 - 1.56]
GENE	CAT	catalase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201432_at	198	0.89899	0.0363307	0.401979	0.630232	0.45833	0.145627	1.16 [0.79 - 1.70]
GENE	CAT	catalase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	211922_s_at	62	0.370968	0.0085599	0.143529	-1.47605	0.00849899	-3.4102	0.03 [0.00 - 0.42]
GENE	CAT	catalase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	215573_at	51	0.764706	0.28221	-	0.947576	0.575058	3.33707	28.14 [0.00 - 3281956.84]
GENE	CAT	catalase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	215573_at	62	0.16129	0.0168897	0.237537	-1.30812	0.741395	-1.18059	0.31 [0.00 - 340.79]
GENE	CAT	catalase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201432_at	51	0.823529	0.277317	-	-15.3433	0.780552	-0.24334	0.78 [0.14 - 4.34]
GENE	CAT	catalase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201432_at	62	0.16129	0.00467764	0.0897996	-1.58121	0.0458829	-1.16126	0.31 [0.10 - 0.98]
GENE	CAT	catalase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	211922_s_at	51	0.333333	0.0167726	0.236352	-2.20378	0.0959322	-3.83779	0.02 [0.00 - 1.97]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201432_at	177	0.124294	0.0551581	-	-0.580757	0.170422	-0.34795	0.71 [0.43 - 1.16]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	211922_s_at	145	0.868966	0.357247	-	-0.548814	0.872595	-0.0526173	0.95 [0.50 - 1.80]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201432_at	145	0.227586	0.358085	-	0.409511	0.777295	-0.103558	0.90 [0.44 - 1.85]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	215573_at	177	0.887006	0.0527031	-	0.666511	0.203867	2.04009	7.69 [0.33 - 178.94]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	232624_at	177	0.841808	0.103369	-	-0.637444	0.191801	-0.662286	0.52 [0.19 - 1.39]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	232624_at	177	0.841808	0.137328	-	-0.684458	0.222796	-0.717701	0.49 [0.15 - 1.55]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	211922_s_at	177	0.853107	0.0290125	0.346388	-1.22086	0.132217	-0.392897	0.68 [0.40 - 1.13]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	215573_at	177	0.214689	0.134005	-	0.487156	0.337009	1.36456	3.91 [0.24 - 63.45]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	232624_at	145	0.896552	0.0768364	-	-1.6141	0.343718	-0.682616	0.51 [0.12 - 2.08]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	215573_at	145	0.524138	0.14167	-	-0.498488	0.715714	-0.776728	0.46 [0.01 - 30.07]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201432_at	177	0.813559	0.0123047	0.188505	-1.22584	0.05492	-0.551179	0.58 [0.33 - 1.01]
GENE	CAT	catalase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	211922_s_at	177	0.158192	0.0224845	0.29088	-0.624942	0.246329	-0.265938	0.77 [0.49 - 1.20]
GENE	CAT	catalase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	211922_s_at	226	0.451327	0.0460695	0.467472	-0.561287	0.301117	-0.252372	0.78 [0.48 - 1.25]
GENE	CAT	catalase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201432_at	226	0.628319	0.319942	-	-0.296201	0.520248	-0.206395	0.81 [0.43 - 1.53]
GENE	CAT	catalase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	232624_at	226	0.876106	0.0498869	0.490945	0.710905	0.305278	0.159348	1.17 [0.86 - 1.59]
GENE	CAT	catalase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	215573_at	226	0.287611	0.110558	-	-0.470025	0.42818	-0.0841839	0.92 [0.75 - 1.13]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	211922_s_at	49	0.897959	0.00103435	0.0262172	1.82135	0.160914	0.78862	2.20 [0.73 - 6.63]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201432_at	55	0.4	0.0145075	0.212764	1.41448	0.0615663	0.817172	2.26 [0.96 - 5.33]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	232624_at	55	0.236364	0.0168027	0.236657	-1.04622	0.0927096	-2.10802	0.12 [0.01 - 1.42]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201432_at	49	0.714286	0.0508455	-	1.08402	0.126086	0.715748	2.05 [0.82 - 5.12]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	215573_at	55	0.818182	0.257599	-	-0.820876	0.904877	-0.232045	0.79 [0.02 - 35.65]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	211922_s_at	55	0.854545	0.000263991	0.00817958	1.57849	0.115218	0.657155	1.93 [0.85 - 4.37]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	215573_at	55	0.836364	0.173371	-	-1.31823	0.820277	0.473521	1.61 [0.03 - 95.46]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	232624_at	55	0.2	0.00856252	0.143563	-1.2434	0.120242	-2.17461	0.11 [0.01 - 1.77]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	215573_at	49	0.244898	0.265562	-	-0.641594	0.899993	-0.31097	0.73 [0.01 - 93.60]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	232624_at	49	0.795918	0.0439558	0.453974	-15.4809	0.207381	-1.89516	0.15 [0.01 - 2.86]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201432_at	55	0.690909	0.0903982	-	0.747998	0.220226	0.466364	1.59 [0.76 - 3.36]
GENE	CAT	catalase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	211922_s_at	55	0.854545	0.00143794	0.0345046	1.60394	0.0328484	1.03091	2.80 [1.09 - 7.23]
GENE	CAT	catalase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	111572	34	0.176471	0.270757	-	0.799453	0.221266	0.375377	1.46 [0.80 - 2.66]
GENE	CAT	catalase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201432_at	63	0.285714	0.000111289	0.00384802	-1.30059	0.00629154	-0.572545	0.56 [0.37 - 0.85]
GENE	CAT	catalase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	232624_at	63	0.206349	0.00526585	0.0985747	-0.987893	0.156494	-18.6479	0.00 [0.00 - 1269.88]
GENE	CAT	catalase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	215573_at	63	0.793651	0.0384656	0.417093	-1.05422	0.0426647	-2.25179	0.11 [0.01 - 0.93]
GENE	CAT	catalase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	211922_s_at	63	0.444444	0.00584291	0.106929	-0.92791	0.0912389	-0.311006	0.73 [0.51 - 1.05]
GENE	CAT	catalase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.221018.0.S1_3p_at	28	0.178571	0.0289048	0.345522	-1.32686	0.087387	-12.5596	0.00 [0.00 - 6.31]
GENE	CAT	catalase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13562131_3p_s_at	28	0.285714	0.0712131	-	-1.01944	0.516015	-0.702091	0.50 [0.06 - 4.12]
GENE	CAT	catalase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.221018.0.S1_3p_x_at	28	0.142857	0.0685508	-	-1.19105	0.149509	-9.81478	0.00 [0.00 - 34.21]
GENE	CAT	catalase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557013_3p_at	28	0.821429	0.127884	-	1.01767	0.291532	0.262635	1.30 [0.80 - 2.12]
GENE	CAT	catalase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.287482.0.S1_3p_at	28	0.214286	0.0760583	-	-1.06351	0.353355	0.328139	1.39 [0.69 - 2.78]
GENE	CAT	catalase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	211922_s_at	82	0.207317	0.000767577	0.0203968	-1.14422	0.155625	-0.480697	0.62 [0.32 - 1.20]
GENE	CAT	catalase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	215573_at	82	0.146341	0.115586	-	1.09236	0.430174	0.228214	1.26 [0.71 - 2.21]
GENE	CAT	catalase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201432_at	82	0.195122	5.81818e-06	0.000273239	-1.48279	0.0788912	-0.699348	0.50 [0.23 - 1.08]
GENE	CAT	catalase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37009_at	84	0.52381	0.00762731	0.131417	-0.811408	0.00353655	-0.826014	0.44 [0.25 - 0.76]
GENE	CAT	catalase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	211922_s_at	79	0.21519	0.145442	-	-0.445135	0.749522	-0.0892615	0.91 [0.53 - 1.58]
GENE	CAT	catalase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	215573_at	79	0.810127	0.0264389	0.325253	-0.82339	0.308547	-0.364335	0.69 [0.34 - 1.40]
GENE	CAT	catalase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201432_at	79	0.316456	0.129408	-	-0.417114	0.61757	-0.161702	0.85 [0.45 - 1.60]
GENE	CAT	catalase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	X04085_rna1_at	86	0.488372	0.0387674	0.419193	-0.870998	0.5178	-0.320277	0.73 [0.28 - 1.92]
GENE	CAT	catalase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201432_at	104	0.442308	0.00243028	0.0531095	-0.998562	0.0189726	-0.808873	0.45 [0.23 - 0.88]
GENE	CAT	catalase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	211922_s_at	104	0.432692	0.000289969	0.00887161	-1.20039	0.0226307	-0.758152	0.47 [0.24 - 0.90]
GENE	CAT	catalase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	215573_at	104	0.461538	0.00810877	0.137723	-0.85654	0.13964	-0.415054	0.66 [0.38 - 1.15]
GENE	CAT	catalase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P105138	117	0.324786	8.5024e-05	0.00303537	-1.07741	0.0283155	-0.410218	0.66 [0.46 - 0.96]
GENE	CAT	catalase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	215573_at	204	0.671569	0.00072569	0.0194514	-2.08069	0.00500474	-0.563667	0.57 [0.38 - 0.84]
GENE	CAT	catalase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	232624_at	204	0.127451	0.0244753	0.308491	15.2531	0.610741	0.150771	1.16 [0.65 - 2.08]
GENE	CAT	catalase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	215573_at	204	0.558824	0.00144537	0.0346523	-0.954204	0.0178072	-0.396858	0.67 [0.48 - 0.93]
GENE	CAT	catalase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	232624_at	204	0.127451	0.167146	-	0.703489	0.762657	0.0692779	1.07 [0.68 - 1.68]
GENE	CAT	catalase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	211922_s_at	204	0.568627	0.0259554	0.32118	-0.928702	0.260371	-0.417553	0.66 [0.32 - 1.36]
GENE	CAT	catalase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	211922_s_at	204	0.882353	0.10015	-	-0.941792	0.690323	-0.112527	0.89 [0.51 - 1.55]
GENE	CAT	catalase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201432_at	204	0.29902	0.0715452	-	-0.652983	0.265781	-0.482882	0.62 [0.26 - 1.44]
GENE	CAT	catalase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201432_at	204	0.460784	0.0675319	-	-0.495765	0.278042	-0.361404	0.70 [0.36 - 1.34]
GENE	CAT	catalase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	211922_s_at	178	0.488764	0.00860875	0.144152	-0.521115	0.215019	-0.284463	0.75 [0.48 - 1.18]
GENE	CAT	catalase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	215573_at	178	0.865169	0.18618	-	0.368748	0.622823	0.131817	1.14 [0.67 - 1.93]
GENE	CAT	catalase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201432_at	178	0.578652	0.0283595	0.34111	-0.454725	0.374308	-0.219831	0.80 [0.49 - 1.30]
GENE	CAT	catalase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	211922_s_at	111	0.252252	0.20731	-	0.418709	0.634963	-0.0840055	0.92 [0.65 - 1.30]
GENE	CAT	catalase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	232624_at	111	0.495495	0.154213	-	0.375386	0.5218	0.162634	1.18 [0.72 - 1.94]
GENE	CAT	catalase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201432_at	111	0.513514	0.0126911	0.192864	-0.658569	0.165251	-0.331158	0.72 [0.45 - 1.15]
GENE	CAT	catalase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	215573_at	111	0.117117	0.000104477	0.00364	-1.30848	0.976314	-0.00409988	1.00 [0.76 - 1.31]
GENE	CAT	catalase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	211922_s_at	90	0.222222	0.132625	-	0.707258	0.93949	-0.0192786	0.98 [0.60 - 1.61]
GENE	CAT	catalase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	211922_s_at	90	0.222222	0.210741	-	0.662249	0.996804	-0.00116945	1.00 [0.56 - 1.77]
GENE	CAT	catalase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	215573_at	90	0.388889	0.0899618	-	-0.543922	0.644642	-0.656415	0.52 [0.03 - 8.44]
GENE	CAT	catalase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	215573_at	90	0.888889	0.0395866	0.424849	0.913408	0.477633	1.06828	2.91 [0.15 - 55.53]
GENE	CAT	catalase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201432_at	90	0.3	0.06822	-	0.746214	0.923952	0.0194995	1.02 [0.68 - 1.52]
GENE	CAT	catalase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201432_at	90	0.888889	0.293959	-	-0.751725	0.825131	-0.0527037	0.95 [0.59 - 1.51]
GENE	CAT	catalase	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2274	50	0.7	0.0517785	-	-1.35171	0.443491	-0.353007	0.70 [0.28 - 1.73]
GENE	CAT	catalase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4075	50	0.56	0.191114	-	0.638159	0.365412	0.378026	1.46 [0.64 - 3.31]
GENE	CAT	catalase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	215573_at	138	0.833333	0.0120537	0.185647	-1.03164	0.0229539	-3.43721	0.03 [0.00 - 0.62]
GENE	CAT	catalase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	211922_s_at	138	0.355072	0.0234026	0.299082	0.616579	0.488758	0.0737888	1.08 [0.87 - 1.33]
GENE	CAT	catalase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	232624_at	138	0.326087	0.00456179	0.0880376	-0.673896	0.108502	-14.0238	0.00 [0.00 - 22.25]
GENE	CAT	catalase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201432_at	138	0.268116	0.0065212	0.116461	0.87003	0.38724	0.119673	1.13 [0.86 - 1.48]
GENE	CAT	catalase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201432_at	129	0.100775	0.0884678	-	-0.639148	0.155685	-0.508456	0.60 [0.30 - 1.21]
GENE	CAT	catalase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	211922_s_at	129	0.837209	0.080489	-	-0.686265	0.37356	-0.259819	0.77 [0.44 - 1.37]
GENE	CAT	catalase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	215573_at	129	0.310078	0.106582	-	-0.406113	0.434051	-0.121333	0.89 [0.65 - 1.20]
GENE	CAT	catalase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	213	56	0.482143	0.000995863	0.0253968	-1.18822	0.0451993	-0.628199	0.53 [0.29 - 0.99]
GENE	CAT	catalase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29098	56	0.571429	0.0117905	0.18263	-0.887296	0.0576223	-0.582045	0.56 [0.31 - 1.02]
GENE	CAT	catalase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	213	56	0.464286	0.00360849	0.0730629	-0.98205	0.0869066	-0.52897	0.59 [0.32 - 1.08]
GENE	CAT	catalase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29098	56	0.571429	0.00300811	0.0631277	-1.10932	0.0358856	-0.662316	0.52 [0.28 - 0.96]
GENE	CAT	catalase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201432_at	278	0.438849	0.0237324	0.301995	-0.424482	0.156476	-0.264239	0.77 [0.53 - 1.11]
GENE	CAT	catalase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	215573_at	278	0.579137	0.0144055	0.211671	0.475257	0.417463	0.235477	1.27 [0.72 - 2.24]
GENE	CAT	catalase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	232624_at	278	0.654676	0.13965	-	-0.298815	0.944937	-0.0272698	0.97 [0.45 - 2.11]
GENE	CAT	catalase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	211922_s_at	278	0.539568	0.00492105	0.0934646	-0.541563	0.170403	-0.243488	0.78 [0.55 - 1.11]
GENE	CAT	catalase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	215573_at	133	0.714286	0.000200228	0.00643376	0.879382	0.0480904	0.400657	1.49 [1.00 - 2.22]
GENE	CAT	catalase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201432_at	133	0.180451	6.77169e-07	3.79675e-05	-1.28441	2.63568e-05	-0.379635	0.68 [0.57 - 0.82]
GENE	CAT	catalase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	211922_s_at	133	0.285714	0.000523253	0.014731	-0.816806	0.00385362	-0.318328	0.73 [0.59 - 0.90]
GENE	CAT	catalase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	10506	81	0.876543	0.123956	-	-15.2691	0.507297	-0.236928	0.79 [0.39 - 1.59]
GENE	CAT	catalase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201432_at	185	0.886486	0.0131393	0.197863	0.612332	0.548999	0.0653741	1.07 [0.86 - 1.32]
GENE	CAT	catalase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215573_at	185	0.8	0.122531	-	0.301079	0.292535	0.534727	1.71 [0.63 - 4.62]
GENE	CAT	catalase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211922_s_at	185	0.254054	0.0639552	-	-0.335954	0.938945	-0.00955607	0.99 [0.78 - 1.26]
GENE	CAT	catalase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	215573_at	185	0.8	0.0576912	-	0.390618	0.309494	0.556633	1.74 [0.60 - 5.10]
GENE	CAT	catalase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201432_at	185	0.891892	0.0118729	0.183577	0.600589	0.366591	0.0902608	1.09 [0.90 - 1.33]
GENE	CAT	catalase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	211922_s_at	185	0.216216	0.126573	-	-0.31452	0.806596	-0.0331397	0.97 [0.74 - 1.26]
GENE	CAT	catalase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P105138	110	0.336364	0.0124604	0.190267	-0.729585	0.107242	-0.421854	0.66 [0.39 - 1.10]
GENE	CAT	catalase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P105138	110	0.272727	0.00679959	0.12029	-0.668316	0.013853	-0.492182	0.61 [0.41 - 0.90]
GENE	CAT	catalase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201432_at	80	0.8875	0.235469	-	0.652494	0.908876	0.0417581	1.04 [0.51 - 2.13]
GENE	CAT	catalase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	211922_s_at	80	0.8875	0.0559466	-	1.04062	0.230096	0.482115	1.62 [0.74 - 3.56]
GENE	CAT	catalase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	215573_at	80	0.45	0.0640522	-	0.918781	0.545346	0.0999561	1.11 [0.80 - 1.53]
GENE	CAT	catalase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_3495	281	0.683274	0.0992716	-	-0.2551	0.320003	-0.13182	0.88 [0.68 - 1.14]
GENE	CAT	catalase	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:309301	59	0.694915	0.156079	-	0.725181	0.830463	0.13314	1.14 [0.34 - 3.86]
GENE	CAT	catalase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	211922_s_at	38	0.842105	0.0329761	0.377265	1.23527	0.554158	0.223281	1.25 [0.60 - 2.62]
GENE	CAT	catalase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	232624_at	38	0.605263	0.0101377	0.163131	1.18786	0.0624037	0.526723	1.69 [0.97 - 2.95]
GENE	CAT	catalase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201432_at	38	0.236842	0.307717	-	-0.483953	0.979355	-0.012299	0.99 [0.39 - 2.51]
GENE	CAT	catalase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	215573_at	38	0.447368	0.0542645	-	-0.923801	0.362449	-0.242002	0.79 [0.47 - 1.32]
GENE	CAT	catalase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	211922_s_at	140	0.221429	3.50211e-05	0.00138023	-1.1519	3.80551e-05	-0.685496	0.50 [0.36 - 0.70]
GENE	CAT	catalase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	215573_at	140	0.235714	0.0123905	0.189477	-0.750229	0.191035	-1.73309	0.18 [0.01 - 2.37]
GENE	CAT	catalase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201432_at	140	0.478571	7.02594e-05	0.00256425	-1.21724	4.51477e-05	-0.682472	0.51 [0.36 - 0.70]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CBR1	carbonyl reductase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209213_at	30	0.733333	0.124912	-	-0.755718	0.533001	-0.244838	0.78 [0.36 - 1.69]
GENE	CBR1	carbonyl reductase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1809003	165	0.139394	0.102099	-	0.68649	0.523161	0.117714	1.12 [0.78 - 1.61]
GENE	CBR1	carbonyl reductase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1809003	165	0.4	0.0463287	0.469101	0.793046	0.274962	0.292465	1.34 [0.79 - 2.26]
GENE	CBR1	carbonyl reductase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209213_at	163	0.877301	0.0292631	0.348398	0.586316	0.216176	0.215316	1.24 [0.88 - 1.74]
GENE	CBR1	carbonyl reductase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209213_at	79	0.797468	0.000190576	0.00616274	1.1896	0.0357785	0.476812	1.61 [1.03 - 2.51]
GENE	CBR1	carbonyl reductase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209213_at	58	0.103448	0.0581815	-	0.870846	0.240091	0.199446	1.22 [0.88 - 1.70]
GENE	CBR1	carbonyl reductase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209213_at	34	0.647059	0.107149	-	-0.670135	0.369904	-0.17202	0.84 [0.58 - 1.23]
GENE	CBR1	carbonyl reductase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209213_at	158	0.5	0.0227637	0.29339	-0.528445	0.459716	-0.22953	0.79 [0.43 - 1.46]
GENE	CBR1	carbonyl reductase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209213_at	53	0.339623	0.0869133	-	0.725799	0.630569	-0.126947	0.88 [0.53 - 1.48]
GENE	CBR1	carbonyl reductase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209213_at	53	0.339623	0.0633465	-	0.737126	0.608078	-0.132378	0.88 [0.53 - 1.45]
GENE	CBR1	carbonyl reductase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209213_at	180	0.805556	0.0495739	0.489062	0.47633	0.566109	0.072261	1.07 [0.84 - 1.38]
GENE	CBR1	carbonyl reductase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209213_at	559	0.876565	0.00454895	0.0878416	0.740773	0.351743	0.0793119	1.08 [0.92 - 1.28]
GENE	CBR1	carbonyl reductase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209213_at	77	0.883117	0.00518201	0.0973406	1.00134	0.0762805	0.178633	1.20 [0.98 - 1.46]
GENE	CBR1	carbonyl reductase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209213_at	70	0.6	0.0766411	-	0.471773	0.17847	0.28477	1.33 [0.88 - 2.01]
GENE	CBR1	carbonyl reductase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38172_at	50	0.26	0.241887	-	0.498247	0.861862	0.130394	1.14 [0.26 - 4.95]
GENE	CBR1	carbonyl reductase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38773_at	50	0.58	0.00887066	0.147474	0.92426	0.139293	0.515281	1.67 [0.85 - 3.31]
GENE	CBR1	carbonyl reductase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209213_at	74	0.635135	0.000298056	0.00908503	1.01705	0.0105866	0.410025	1.51 [1.10 - 2.06]
GENE	CBR1	carbonyl reductase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209213_at	67	0.701493	0.0809152	-	1.13421	0.239011	1.11031	3.04 [0.48 - 19.27]
GENE	CBR1	carbonyl reductase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209213_at	115	0.878261	0.0367422	0.404928	1.17098	0.652442	-0.188901	0.83 [0.36 - 1.88]
GENE	CBR1	carbonyl reductase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38172_at	158	0.468354	0.0508004	-	0.566595	0.251268	0.215477	1.24 [0.86 - 1.79]
GENE	CBR1	carbonyl reductase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38773_at	158	0.544304	0.230675	-	-0.347918	0.914238	0.0244202	1.02 [0.66 - 1.60]
GENE	CBR1	carbonyl reductase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38172_at	76	0.473684	0.334337	-	-0.504092	0.940394	0.0267464	1.03 [0.51 - 2.07]
GENE	CBR1	carbonyl reductase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38773_at	76	0.671053	0.0948058	-	-1.19781	0.143998	-0.501804	0.61 [0.31 - 1.19]
GENE	CBR1	carbonyl reductase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209213_at	204	0.838235	0.00257465	0.0556596	0.578206	0.523475	0.05677	1.06 [0.89 - 1.26]
GENE	CBR1	carbonyl reductase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209213_at	87	0.218391	0.0770262	-	-0.70736	0.963099	-0.00846144	0.99 [0.69 - 1.42]
GENE	CBR1	carbonyl reductase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209213_at	87	0.218391	0.0770262	-	-0.70736	0.963099	-0.00846144	0.99 [0.69 - 1.42]
GENE	CBR1	carbonyl reductase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209213_at	77	0.545455	0.0556955	-	-1.19057	0.286878	-0.293463	0.75 [0.43 - 1.28]
GENE	CBR1	carbonyl reductase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209213_at	77	0.545455	0.0144086	0.211705	-2.14579	0.0986747	-0.522886	0.59 [0.32 - 1.10]
GENE	CBR1	carbonyl reductase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209213_at	136	0.654412	0.00520952	0.0977461	1.23709	0.218245	0.282381	1.33 [0.85 - 2.08]
GENE	CBR1	carbonyl reductase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209213_at	200	0.195	0.0601244	-	0.947956	0.209551	0.24169	1.27 [0.87 - 1.86]
GENE	CBR1	carbonyl reductase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5004	60	0.85	0.0701144	-	0.774178	0.595565	0.0553217	1.06 [0.86 - 1.30]
GENE	CBR1	carbonyl reductase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5004	60	0.866667	0.081422	-	0.788411	0.799328	0.0412563	1.04 [0.76 - 1.43]
GENE	CBR1	carbonyl reductase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	13374	155	0.193548	0.000782839	0.0207389	-0.929722	0.00346713	-0.528958	0.59 [0.41 - 0.84]
GENE	CBR1	carbonyl reductase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209213_at	286	0.814685	0.0926214	-	0.388959	0.689336	0.0477269	1.05 [0.83 - 1.33]
GENE	CBR1	carbonyl reductase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209213_at	159	0.308176	0.0119404	0.184351	-0.905124	0.168627	-0.271087	0.76 [0.52 - 1.12]
GENE	CBR1	carbonyl reductase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209213_at	159	0.308176	0.00158894	0.0374787	-0.963052	0.0314488	-0.346513	0.71 [0.52 - 0.97]
GENE	CBR1	carbonyl reductase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209213_at	159	0.308176	0.00784056	0.134224	-0.818925	0.168391	-0.231608	0.79 [0.57 - 1.10]
GENE	CBR1	carbonyl reductase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209213_at	54	0.814815	0.0307358	0.360049	1.4546	0.0716779	0.727276	2.07 [0.94 - 4.57]
GENE	CBR1	carbonyl reductase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209213_at	117	0.837607	0.00340399	0.0697275	0.977993	0.0684185	0.373302	1.45 [0.97 - 2.17]
GENE	CBR1	carbonyl reductase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209213_at	117	0.897436	0.031224	0.363852	0.958154	0.287881	0.25116	1.29 [0.81 - 2.04]
GENE	CBR1	carbonyl reductase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209213_at	117	0.837607	0.00340399	0.0697275	0.977993	0.0684185	0.373302	1.45 [0.97 - 2.17]
GENE	CBR1	carbonyl reductase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209213_at	117	0.82906	0.00585601	0.107116	1.08789	0.109635	0.391052	1.48 [0.92 - 2.39]
GENE	CBR1	carbonyl reductase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209213_at	236	0.25	0.146582	-	-0.420269	0.952759	-0.00901237	0.99 [0.74 - 1.34]
GENE	CBR1	carbonyl reductase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209213_at	249	0.562249	0.0555475	-	-0.420714	0.542917	-0.072429	0.93 [0.74 - 1.17]
GENE	CBR1	carbonyl reductase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209213_at	62	0.112903	0.0296351	0.351367	-1.19422	0.783509	-0.0658838	0.94 [0.59 - 1.50]
GENE	CBR1	carbonyl reductase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209213_at	125	0.104	0.0115683	0.180064	-1.07661	0.0942505	-0.49562	0.61 [0.34 - 1.09]
GENE	CBR1	carbonyl reductase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209213_at	125	0.664	0.00733827	0.127574	-0.954724	0.164981	-0.302242	0.74 [0.48 - 1.13]
GENE	CBR1	carbonyl reductase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209213_at	54	0.407407	0.147713	-	1.08131	0.585747	0.159583	1.17 [0.66 - 2.08]
GENE	CBR1	carbonyl reductase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209213_at	198	0.767677	0.0300589	0.354728	-0.847161	0.334254	-0.10762	0.90 [0.72 - 1.12]
GENE	CBR1	carbonyl reductase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209213_at	198	0.767677	0.073882	-	-0.707861	0.392735	-0.103373	0.90 [0.71 - 1.14]
GENE	CBR1	carbonyl reductase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209213_at	198	0.787879	0.0323451	0.372476	-0.676588	0.490203	-0.0654611	0.94 [0.78 - 1.13]
GENE	CBR1	carbonyl reductase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209213_at	51	0.196078	0.202077	-	-1.10847	0.95216	0.084866	1.09 [0.07 - 17.42]
GENE	CBR1	carbonyl reductase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209213_at	62	0.66129	0.0254374	0.316777	1.2367	0.554077	0.518091	1.68 [0.30 - 9.34]
GENE	CBR1	carbonyl reductase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209213_at	177	0.898305	0.122637	-	-0.775412	0.392304	-0.208994	0.81 [0.50 - 1.31]
GENE	CBR1	carbonyl reductase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209213_at	145	0.6	0.0609862	-	-0.685944	0.709498	-0.121968	0.89 [0.47 - 1.68]
GENE	CBR1	carbonyl reductase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209213_at	177	0.898305	0.191914	-	-0.757608	0.950254	0.0180806	1.02 [0.58 - 1.80]
GENE	CBR1	carbonyl reductase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209213_at	226	0.50885	0.0751964	-	-0.514623	0.667833	-0.0628336	0.94 [0.70 - 1.25]
GENE	CBR1	carbonyl reductase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209213_at	55	0.363636	0.0609164	-	-0.922007	0.951276	-0.0264798	0.97 [0.42 - 2.28]
GENE	CBR1	carbonyl reductase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209213_at	49	0.857143	0.14206	-	0.955395	0.55659	-0.341568	0.71 [0.23 - 2.22]
GENE	CBR1	carbonyl reductase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209213_at	55	0.418182	0.180921	-	-0.59301	0.905377	-0.0491999	0.95 [0.42 - 2.14]
GENE	CBR1	carbonyl reductase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209213_at	63	0.460317	0.000445683	0.0128426	1.2795	0.0249364	0.539529	1.72 [1.07 - 2.75]
GENE	CBR1	carbonyl reductase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12803380_3p_at	28	0.464286	0.0396054	0.424978	1.17233	0.404506	0.363686	1.44 [0.61 - 3.38]
GENE	CBR1	carbonyl reductase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209213_at	82	0.317073	0.307352	-	-0.358856	0.675236	-0.0999624	0.90 [0.57 - 1.44]
GENE	CBR1	carbonyl reductase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209213_at	79	0.759494	0.00267906	0.0574835	0.876444	0.0141729	0.363805	1.44 [1.08 - 1.92]
GENE	CBR1	carbonyl reductase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209213_at	104	0.221154	0.192335	-	-0.479832	0.452651	-0.171375	0.84 [0.54 - 1.32]
GENE	CBR1	carbonyl reductase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P29046	117	0.735043	0.0487016	0.483776	0.584793	0.34685	0.182102	1.20 [0.82 - 1.75]
GENE	CBR1	carbonyl reductase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209213_at	204	0.176471	0.0291864	0.347783	1.91373	0.0597213	0.591683	1.81 [0.98 - 3.35]
GENE	CBR1	carbonyl reductase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209213_at	204	0.176471	0.0666472	-	0.836743	0.546116	0.165269	1.18 [0.69 - 2.02]
GENE	CBR1	carbonyl reductase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209213_at	178	0.707865	0.0802876	-	-0.392577	0.371599	-0.11247	0.89 [0.70 - 1.14]
GENE	CBR1	carbonyl reductase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200010291	41	0.585366	0.00949671	0.155293	1.05288	0.110323	0.291811	1.34 [0.94 - 1.92]
GENE	CBR1	carbonyl reductase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209213_at	111	0.477477	0.02222	0.288491	-0.604868	0.135144	-0.138078	0.87 [0.73 - 1.04]
GENE	CBR1	carbonyl reductase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209213_at	90	0.2	0.0271577	0.331248	1.24725	0.529461	0.085013	1.09 [0.84 - 1.42]
GENE	CBR1	carbonyl reductase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209213_at	90	0.222222	0.0209863	0.277185	1.53673	0.517481	0.0992946	1.10 [0.82 - 1.49]
GENE	CBR1	carbonyl reductase 1	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	2064	50	0.54	0.329664	-	-0.492906	0.849771	-0.489013	0.61 [0.00 - 96.67]
GENE	CBR1	carbonyl reductase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209213_at	138	0.268116	0.0107207	0.170121	0.817357	0.582821	-0.0374415	0.96 [0.84 - 1.10]
GENE	CBR1	carbonyl reductase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209213_at	129	0.124031	0.0645892	-	0.8381	0.580103	0.0577495	1.06 [0.86 - 1.30]
GENE	CBR1	carbonyl reductase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1145	56	0.785714	0.0268545	0.328728	-1.13202	0.271024	-0.125329	0.88 [0.71 - 1.10]
GENE	CBR1	carbonyl reductase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6718	56	0.875	0.0365569	0.403602	-1.85405	0.58463	-0.0639082	0.94 [0.75 - 1.18]
GENE	CBR1	carbonyl reductase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1145	56	0.767857	0.0476592	0.477384	-0.946649	0.505508	-0.077067	0.93 [0.74 - 1.16]
GENE	CBR1	carbonyl reductase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13584	56	0.785714	0.0268545	0.328728	-1.13202	0.306518	-0.117306	0.89 [0.71 - 1.11]
GENE	CBR1	carbonyl reductase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6718	56	0.875	0.0237897	0.302499	-1.98608	0.304229	-0.119773	0.89 [0.71 - 1.11]
GENE	CBR1	carbonyl reductase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	13584	56	0.785714	0.0678829	-	-0.946219	0.552117	-0.0692112	0.93 [0.74 - 1.17]
GENE	CBR1	carbonyl reductase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209213_at	278	0.467626	0.0800486	-	-0.328024	0.789237	-0.0385683	0.96 [0.73 - 1.28]
GENE	CBR1	carbonyl reductase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209213_at	133	0.293233	0.0193217	0.261485	0.688542	0.702719	0.0606701	1.06 [0.78 - 1.45]
GENE	CBR1	carbonyl reductase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	13264	81	0.679012	0.116363	-	0.832904	0.455657	0.228449	1.26 [0.69 - 2.29]
GENE	CBR1	carbonyl reductase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209213_at	185	0.264865	0.000635889	0.0173905	-0.643927	0.0193387	-0.40532	0.67 [0.47 - 0.94]
GENE	CBR1	carbonyl reductase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209213_at	185	0.459459	0.00499432	0.0945583	-0.459685	0.0790984	-0.277999	0.76 [0.56 - 1.03]
GENE	CBR1	carbonyl reductase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P29046	110	0.7	0.0144278	0.211911	0.733765	0.397859	0.2055	1.23 [0.76 - 1.98]
GENE	CBR1	carbonyl reductase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P29046	110	0.654545	0.0816262	-	0.423368	0.750565	0.0639136	1.07 [0.72 - 1.58]
GENE	CBR1	carbonyl reductase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209213_at	80	0.1875	0.0996817	-	1.5335	0.667667	0.117963	1.13 [0.66 - 1.93]
GENE	CBR1	carbonyl reductase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_3937	281	0.654804	0.104091	-	-0.248595	0.40292	0.13781	1.15 [0.83 - 1.59]
GENE	CBR1	carbonyl reductase 1	None	E-DKFZ-1	Renal cell carcinoma		Overall Survival	RZPD	Sueltmann	A-RZPD-20	rzpd.de:huber1:Reporter:IMAGE:25461	59	0.457627	0.00173229	0.0402484	-1.62551	0.0123568	-1.4783	0.23 [0.07 - 0.73]
GENE	CBR1	carbonyl reductase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209213_at	38	0.315789	0.01148	0.179039	1.50024	0.0245547	0.954307	2.60 [1.13 - 5.97]
GENE	CBR1	carbonyl reductase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209213_at	140	0.892857	0.0276845	0.335596	0.840218	0.180087	0.365169	1.44 [0.84 - 2.46]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CBS	cystathionine-beta-synthase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212816_s_at	30	0.333333	0.0146709	0.21451	-1.04038	0.75882	-0.105975	0.90 [0.46 - 1.77]
GENE	CBS	cystathionine-beta-synthase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1804735	165	0.89697	0.0995871	-	0.580969	0.396313	0.07893	1.08 [0.90 - 1.30]
GENE	CBS	cystathionine-beta-synthase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1804735	165	0.89697	0.000375097	0.0110761	1.34902	0.0989073	0.221685	1.25 [0.96 - 1.62]
GENE	CBS	cystathionine-beta-synthase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212816_s_at	163	0.294479	0.0214047	0.28105	0.538517	0.182083	0.90863	2.48 [0.65 - 9.42]
GENE	CBS	cystathionine-beta-synthase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	240517_at	163	0.883436	0.0883592	-	0.488019	0.535546	0.559657	1.75 [0.30 - 10.28]
GENE	CBS	cystathionine-beta-synthase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	240517_at	79	0.620253	0.0120982	0.186156	-0.79965	0.0495161	-1.54445	0.21 [0.05 - 1.00]
GENE	CBS	cystathionine-beta-synthase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1553972_a_at	79	0.544304	0.0278656	0.337082	-0.658274	0.405002	-0.505127	0.60 [0.18 - 1.98]
GENE	CBS	cystathionine-beta-synthase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212816_s_at	79	0.443038	0.00102725	0.0260664	-0.943271	0.00987185	-2.09087	0.12 [0.03 - 0.60]
GENE	CBS	cystathionine-beta-synthase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212816_s_at	58	0.551724	0.119604	-	0.436013	0.382201	0.145745	1.16 [0.83 - 1.60]
GENE	CBS	cystathionine-beta-synthase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212816_s_at	34	0.882353	0.0671742	-	-1.67164	0.611619	-0.0921619	0.91 [0.64 - 1.30]
GENE	CBS	cystathionine-beta-synthase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212816_s_at	158	0.848101	0.00650819	0.116281	-1.18917	0.040382	-0.955697	0.38 [0.15 - 0.96]
GENE	CBS	cystathionine-beta-synthase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212816_s_at	53	0.226415	0.0566672	-	0.894738	0.914454	0.022954	1.02 [0.67 - 1.56]
GENE	CBS	cystathionine-beta-synthase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212816_s_at	53	0.830189	0.0354158	0.395359	-1.42292	0.920355	0.0232437	1.02 [0.65 - 1.61]
GENE	CBS	cystathionine-beta-synthase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212816_s_at	180	0.8	0.079554	-	0.455364	0.871253	-0.0211978	0.98 [0.76 - 1.27]
GENE	CBS	cystathionine-beta-synthase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	240517_at	180	0.772222	0.0463195	0.469044	0.476015	0.247692	0.194542	1.21 [0.87 - 1.69]
GENE	CBS	cystathionine-beta-synthase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	240517_at	559	0.440072	0.0297174	0.352022	0.463126	0.355377	0.130416	1.14 [0.86 - 1.50]
GENE	CBS	cystathionine-beta-synthase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1553972_a_at	559	0.851521	0.0879093	-	0.416934	0.629094	0.0613234	1.06 [0.83 - 1.36]
GENE	CBS	cystathionine-beta-synthase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212816_s_at	559	0.833631	0.170103	-	0.325502	0.510549	0.0783394	1.08 [0.86 - 1.37]
GENE	CBS	cystathionine-beta-synthase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212816_s_at	77	0.116883	0.0242568	0.30659	-0.853071	0.037707	-0.440884	0.64 [0.42 - 0.98]
GENE	CBS	cystathionine-beta-synthase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	240517_at	77	0.194805	0.0099926	0.161371	-0.770008	0.118831	-0.454192	0.63 [0.36 - 1.12]
GENE	CBS	cystathionine-beta-synthase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	240517_at	70	0.885714	0.012247	0.187849	0.930733	0.13577	0.972881	2.65 [0.74 - 9.50]
GENE	CBS	cystathionine-beta-synthase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1553972_a_at	70	0.885714	0.117812	-	0.593309	0.55771	0.125675	1.13 [0.74 - 1.73]
GENE	CBS	cystathionine-beta-synthase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212816_s_at	70	0.871429	0.131004	-	0.548144	0.616042	0.104154	1.11 [0.74 - 1.67]
GENE	CBS	cystathionine-beta-synthase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	38474_at	50	0.56	0.00707015	0.123969	-0.988151	0.145949	-0.450176	0.64 [0.35 - 1.17]
GENE	CBS	cystathionine-beta-synthase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212816_s_at	74	0.648649	4.31119e-07	2.49988e-05	-1.8186	0.000503302	-1.00566	0.37 [0.21 - 0.64]
GENE	CBS	cystathionine-beta-synthase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	240517_at	74	0.162162	0.0389363	0.420364	-0.725863	0.135114	-0.423855	0.65 [0.38 - 1.14]
GENE	CBS	cystathionine-beta-synthase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1553972_a_at	67	0.835821	0.0163432	0.231976	1.65537	0.67047	0.337791	1.40 [0.30 - 6.64]
GENE	CBS	cystathionine-beta-synthase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	240517_at	67	0.686567	0.276911	-	-1.10196	0.719041	-0.527955	0.59 [0.03 - 10.47]
GENE	CBS	cystathionine-beta-synthase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212816_s_at	67	0.850746	0.0107602	0.170589	1.73438	0.414718	0.572868	1.77 [0.45 - 7.03]
GENE	CBS	cystathionine-beta-synthase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1553972_a_at	115	0.104348	0.117887	-	-0.983335	0.96285	-0.0140444	0.99 [0.55 - 1.78]
GENE	CBS	cystathionine-beta-synthase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212816_s_at	115	0.113043	0.165964	-	-0.877942	0.817188	-0.0649814	0.94 [0.54 - 1.63]
GENE	CBS	cystathionine-beta-synthase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	240517_at	115	0.330435	0.161229	-	-0.734131	0.87895	-0.0669507	0.94 [0.40 - 2.21]
GENE	CBS	cystathionine-beta-synthase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	38474_at	158	0.379747	0.00626053	0.112832	0.971877	0.38222	0.170352	1.19 [0.81 - 1.74]
GENE	CBS	cystathionine-beta-synthase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	38474_at	76	0.789474	0.0383648	0.416389	-15.4121	0.514343	-0.193598	0.82 [0.46 - 1.47]
GENE	CBS	cystathionine-beta-synthase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212816_s_at	204	0.823529	0.00208723	0.0469068	0.567048	0.0709507	0.113431	1.12 [0.99 - 1.27]
GENE	CBS	cystathionine-beta-synthase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	240517_at	204	0.892157	0.000657998	0.0179024	0.781235	0.24567	0.107517	1.11 [0.93 - 1.34]
GENE	CBS	cystathionine-beta-synthase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1553972_a_at	204	0.789216	0.00214269	0.0479241	0.529585	0.105292	0.115569	1.12 [0.98 - 1.29]
GENE	CBS	cystathionine-beta-synthase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	240517_at	87	0.862069	0.0258316	0.32013	-15.2654	0.599632	-0.314013	0.73 [0.23 - 2.36]
GENE	CBS	cystathionine-beta-synthase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	240517_at	87	0.862069	0.0258316	0.32013	-15.2654	0.599632	-0.314013	0.73 [0.23 - 2.36]
GENE	CBS	cystathionine-beta-synthase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1553972_a_at	87	0.896552	0.293167	-	-1.02536	0.675938	-0.0813286	0.92 [0.63 - 1.35]
GENE	CBS	cystathionine-beta-synthase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1553972_a_at	87	0.896552	0.293167	-	-1.02536	0.675938	-0.0813286	0.92 [0.63 - 1.35]
GENE	CBS	cystathionine-beta-synthase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212816_s_at	87	0.37931	0.180325	-	-0.50153	0.664485	-0.0761037	0.93 [0.66 - 1.31]
GENE	CBS	cystathionine-beta-synthase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212816_s_at	87	0.37931	0.180325	-	-0.50153	0.664485	-0.0761037	0.93 [0.66 - 1.31]
GENE	CBS	cystathionine-beta-synthase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212816_s_at	77	0.493506	0.150166	-	-0.957244	0.430083	-0.261418	0.77 [0.40 - 1.47]
GENE	CBS	cystathionine-beta-synthase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	240517_at	77	0.662338	0.0463602	0.469299	1.21339	0.0562037	2.53707	12.64 [0.94 - 170.94]
GENE	CBS	cystathionine-beta-synthase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553972_a_at	77	0.311688	0.0346658	0.389866	-1.11961	0.32356	-0.355855	0.70 [0.35 - 1.42]
GENE	CBS	cystathionine-beta-synthase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212816_s_at	77	0.168831	0.124371	-	-0.896446	0.412891	-0.235416	0.79 [0.45 - 1.39]
GENE	CBS	cystathionine-beta-synthase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1553972_a_at	77	0.103896	0.0157578	0.225942	-1.5205	0.262972	-0.486933	0.61 [0.26 - 1.44]
GENE	CBS	cystathionine-beta-synthase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	240517_at	77	0.662338	0.0750057	-	0.95681	0.101897	1.96154	7.11 [0.68 - 74.59]
GENE	CBS	cystathionine-beta-synthase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212816_s_at	136	0.433824	0.128945	-	0.736149	0.310276	0.297602	1.35 [0.76 - 2.39]
GENE	CBS	cystathionine-beta-synthase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212816_s_at	200	0.63	0.120133	-	-0.515365	0.584862	-0.109805	0.90 [0.60 - 1.33]
GENE	CBS	cystathionine-beta-synthase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16899	60	0.65	0.106711	-	-0.692732	0.442427	-0.174313	0.84 [0.54 - 1.31]
GENE	CBS	cystathionine-beta-synthase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16899	60	0.116667	0.0324328	0.373144	-0.955465	0.962066	-0.0137776	0.99 [0.56 - 1.74]
GENE	CBS	cystathionine-beta-synthase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5567	155	0.890323	0.00177127	0.0409929	1.02105	0.503144	0.109346	1.12 [0.81 - 1.54]
GENE	CBS	cystathionine-beta-synthase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212816_s_at	286	0.15035	0.258514	-	0.344054	0.634954	0.0573081	1.06 [0.84 - 1.34]
GENE	CBS	cystathionine-beta-synthase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212816_s_at	159	0.402516	0.00909703	0.150321	0.952141	0.0438339	0.456539	1.58 [1.01 - 2.46]
GENE	CBS	cystathionine-beta-synthase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212816_s_at	159	0.761006	0.0211961	0.279127	0.85678	0.09059	0.448416	1.57 [0.93 - 2.63]
GENE	CBS	cystathionine-beta-synthase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212816_s_at	159	0.716981	0.000674343	0.0182789	1.0323	0.0155241	0.551953	1.74 [1.11 - 2.72]
GENE	CBS	cystathionine-beta-synthase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	240517_at	159	0.333333	0.0978316	-	0.617285	0.492063	0.207009	1.23 [0.68 - 2.22]
GENE	CBS	cystathionine-beta-synthase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	240517_at	159	0.106918	0.0172484	0.241151	15.2145	0.184441	0.394027	1.48 [0.83 - 2.65]
GENE	CBS	cystathionine-beta-synthase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	240517_at	159	0.333333	0.046076	0.467512	0.945305	0.338203	0.334067	1.40 [0.70 - 2.77]
GENE	CBS	cystathionine-beta-synthase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212816_s_at	54	0.388889	0.024411	0.307932	15.7436	0.0910838	0.431657	1.54 [0.93 - 2.54]
GENE	CBS	cystathionine-beta-synthase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212816_s_at	117	0.598291	0.0515825	-	-0.651388	0.449785	-0.0907407	0.91 [0.72 - 1.16]
GENE	CBS	cystathionine-beta-synthase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212816_s_at	117	0.598291	0.00237033	0.0520404	-1.38913	0.122528	-0.257103	0.77 [0.56 - 1.07]
GENE	CBS	cystathionine-beta-synthase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212816_s_at	117	0.598291	0.0515825	-	-0.651388	0.449785	-0.0907407	0.91 [0.72 - 1.16]
GENE	CBS	cystathionine-beta-synthase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212816_s_at	117	0.598291	0.0642749	-	-0.797247	0.807491	-0.0367415	0.96 [0.72 - 1.30]
GENE	CBS	cystathionine-beta-synthase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212816_s_at	236	0.805085	0.00120074	0.0296997	0.903995	0.901525	0.024717	1.03 [0.69 - 1.52]
GENE	CBS	cystathionine-beta-synthase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	240517_at	236	0.711864	0.00619106	0.111858	0.733131	0.498677	0.252131	1.29 [0.62 - 2.67]
GENE	CBS	cystathionine-beta-synthase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212816_s_at	249	0.831325	0.00449565	0.0870266	0.698073	0.771676	-0.0466014	0.95 [0.70 - 1.31]
GENE	CBS	cystathionine-beta-synthase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	240517_at	249	0.698795	0.139998	-	0.332261	0.944419	-0.0200185	0.98 [0.56 - 1.72]
GENE	CBS	cystathionine-beta-synthase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212816_s_at	62	0.112903	0.0200878	0.268776	-1.27807	0.510871	-0.130064	0.88 [0.60 - 1.29]
GENE	CBS	cystathionine-beta-synthase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212816_s_at	125	0.8	0.06192	-	0.740601	0.909758	0.0253533	1.03 [0.66 - 1.59]
GENE	CBS	cystathionine-beta-synthase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212816_s_at	125	0.12	0.176725	-	0.640892	0.669617	-0.0775375	0.93 [0.65 - 1.32]
GENE	CBS	cystathionine-beta-synthase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212816_s_at	54	0.648148	0.254511	-	-0.759162	0.736466	-0.0787498	0.92 [0.58 - 1.46]
GENE	CBS	cystathionine-beta-synthase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212816_s_at	198	0.161616	0.0279426	0.337712	0.986672	0.0638694	0.175422	1.19 [0.99 - 1.43]
GENE	CBS	cystathionine-beta-synthase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212816_s_at	198	0.161616	0.0097576	0.158503	1.41362	0.028539	0.219488	1.25 [1.02 - 1.52]
GENE	CBS	cystathionine-beta-synthase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212816_s_at	198	0.161616	0.0175332	0.243998	0.813896	0.101612	0.125226	1.13 [0.98 - 1.32]
GENE	CBS	cystathionine-beta-synthase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212816_s_at	51	0.627451	0.0859845	-	-15.7713	0.354658	-2.99257	0.05 [0.00 - 28.34]
GENE	CBS	cystathionine-beta-synthase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212816_s_at	62	0.225806	0.0185508	0.254029	-1.27289	0.162577	-2.89366	0.06 [0.00 - 3.21]
GENE	CBS	cystathionine-beta-synthase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1553972_a_at	177	0.841808	0.276679	-	0.322755	0.633277	0.132673	1.14 [0.66 - 1.97]
GENE	CBS	cystathionine-beta-synthase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1553972_a_at	177	0.847458	0.191322	-	0.438568	0.692997	0.126237	1.13 [0.61 - 2.12]
GENE	CBS	cystathionine-beta-synthase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212816_s_at	177	0.107345	0.0418135	0.439907	-0.634024	0.520713	0.158499	1.17 [0.72 - 1.90]
GENE	CBS	cystathionine-beta-synthase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1553972_a_at	145	0.2	0.138759	-	-0.545255	0.857785	0.0893664	1.09 [0.41 - 2.91]
GENE	CBS	cystathionine-beta-synthase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212816_s_at	145	0.662069	0.189125	-	0.43721	0.663339	0.177183	1.19 [0.54 - 2.65]
GENE	CBS	cystathionine-beta-synthase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212816_s_at	177	0.728814	0.0774687	-	0.492436	0.502361	0.186119	1.20 [0.70 - 2.07]
GENE	CBS	cystathionine-beta-synthase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	240517_at	177	0.813559	0.00128296	0.031385	-1.50929	0.0938008	-0.809844	0.44 [0.17 - 1.15]
GENE	CBS	cystathionine-beta-synthase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	240517_at	177	0.813559	0.00537539	0.100179	-1.50752	0.260861	-0.630428	0.53 [0.18 - 1.60]
GENE	CBS	cystathionine-beta-synthase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	240517_at	145	0.896552	0.0298594	0.353149	-15.2026	0.273481	-0.746055	0.47 [0.12 - 1.80]
GENE	CBS	cystathionine-beta-synthase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1553972_a_at	226	0.265487	0.0140251	0.20757	1.0246	0.338766	0.199214	1.22 [0.81 - 1.84]
GENE	CBS	cystathionine-beta-synthase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212816_s_at	226	0.243363	0.0207654	0.275132	1.04258	0.306504	0.173022	1.19 [0.85 - 1.66]
GENE	CBS	cystathionine-beta-synthase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	240517_at	226	0.176991	0.0572809	-	0.95541	0.802024	0.0421805	1.04 [0.75 - 1.45]
GENE	CBS	cystathionine-beta-synthase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212816_s_at	49	0.510204	0.151461	-	0.856337	0.961214	0.0261626	1.03 [0.36 - 2.95]
GENE	CBS	cystathionine-beta-synthase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	240517_at	49	0.44898	0.0981368	-	-0.975394	0.550955	-0.974838	0.38 [0.02 - 9.29]
GENE	CBS	cystathionine-beta-synthase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1553972_a_at	55	0.690909	0.00112295	0.0280841	1.52255	0.0127192	0.734879	2.09 [1.17 - 3.72]
GENE	CBS	cystathionine-beta-synthase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	240517_at	55	0.472727	0.0240079	0.304414	-1.05426	0.113624	-2.14391	0.12 [0.01 - 1.67]
GENE	CBS	cystathionine-beta-synthase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1553972_a_at	49	0.653061	0.0321364	0.370882	1.19278	0.194589	0.533516	1.70 [0.76 - 3.82]
GENE	CBS	cystathionine-beta-synthase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1553972_a_at	55	0.290909	0.0786897	-	1.05315	0.137116	0.494258	1.64 [0.85 - 3.15]
GENE	CBS	cystathionine-beta-synthase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212816_s_at	55	0.581818	0.0115005	0.179277	1.21264	0.0476148	0.575152	1.78 [1.01 - 3.14]
GENE	CBS	cystathionine-beta-synthase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212816_s_at	55	0.872727	0.143137	-	0.799527	0.337048	0.35355	1.42 [0.69 - 2.93]
GENE	CBS	cystathionine-beta-synthase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	240517_at	55	0.781818	0.244636	-	-0.858243	0.633477	-0.567663	0.57 [0.05 - 5.85]
GENE	CBS	cystathionine-beta-synthase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1553972_a_at	63	0.539683	0.000751409	0.020033	1.12959	0.0100491	0.410384	1.51 [1.10 - 2.06]
GENE	CBS	cystathionine-beta-synthase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212816_s_at	63	0.349206	0.000787242	0.0208373	1.41082	0.00367689	0.450173	1.57 [1.16 - 2.13]
GENE	CBS	cystathionine-beta-synthase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	240517_at	63	0.190476	0.00853861	0.143257	-0.953746	0.476658	0.453523	1.57 [0.45 - 5.49]
GENE	CBS	cystathionine-beta-synthase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.171003.0.A1_3p_at	28	0.214286	0.027653	0.335337	-1.23725	0.0816095	-23.9336	0.00 [0.00 - 20.17]
GENE	CBS	cystathionine-beta-synthase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.84152.2.S1_3p_s_at	28	0.821429	0.171166	-	0.808098	0.409233	0.553887	1.74 [0.47 - 6.48]
GENE	CBS	cystathionine-beta-synthase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212816_s_at	82	0.426829	0.0373089	0.408961	0.748989	0.0863889	0.303707	1.35 [0.96 - 1.92]
GENE	CBS	cystathionine-beta-synthase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	38474_at	84	0.404762	0.144452	-	-0.422411	0.942637	0.014401	1.01 [0.69 - 1.50]
GENE	CBS	cystathionine-beta-synthase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212816_s_at	79	0.392405	0.200997	-	0.346649	0.589906	0.0772331	1.08 [0.82 - 1.43]
GENE	CBS	cystathionine-beta-synthase	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	L00972_at	86	0.895349	0.00685625	0.121064	1.30255	0.713471	-0.137436	0.87 [0.42 - 1.82]
GENE	CBS	cystathionine-beta-synthase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212816_s_at	104	0.894231	0.0226832	0.292667	0.919338	0.0841948	0.294715	1.34 [0.96 - 1.88]
GENE	CBS	cystathionine-beta-synthase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P48856	117	0.111111	0.00470277	0.0901802	-0.96929	0.98229	-0.00773005	0.99 [0.50 - 1.96]
GENE	CBS	cystathionine-beta-synthase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P166306	117	0.82906	0.15937	-	0.477587	0.667517	0.135052	1.14 [0.62 - 2.12]
GENE	CBS	cystathionine-beta-synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212816_s_at	204	0.254902	0.0150897	0.21895	-0.868825	0.932387	-0.0290749	0.97 [0.50 - 1.90]
GENE	CBS	cystathionine-beta-synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	240517_at	204	0.460784	0.138318	-	0.566852	0.974545	-0.0122601	0.99 [0.47 - 2.10]
GENE	CBS	cystathionine-beta-synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212816_s_at	204	0.843137	0.11275	-	0.513853	0.735822	0.0840071	1.09 [0.67 - 1.77]
GENE	CBS	cystathionine-beta-synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	240517_at	204	0.455882	0.124572	-	0.42963	0.547306	0.16249	1.18 [0.69 - 2.00]
GENE	CBS	cystathionine-beta-synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1553972_a_at	204	0.843137	0.0144607	0.212263	0.940098	0.395449	0.294269	1.34 [0.68 - 2.65]
GENE	CBS	cystathionine-beta-synthase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1553972_a_at	204	0.843137	0.0927687	-	0.54414	0.936027	0.0215374	1.02 [0.60 - 1.73]
GENE	CBS	cystathionine-beta-synthase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212816_s_at	178	0.101124	0.0528204	-	-0.552289	0.367173	-0.105845	0.90 [0.71 - 1.13]
GENE	CBS	cystathionine-beta-synthase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300000561	41	0.219512	0.0229709	0.295244	-0.976339	0.742814	-0.0760346	0.93 [0.59 - 1.46]
GENE	CBS	cystathionine-beta-synthase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1553972_a_at	111	0.576577	0.0607713	-	-0.507995	0.495972	-0.137743	0.87 [0.59 - 1.30]
GENE	CBS	cystathionine-beta-synthase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212816_s_at	111	0.630631	0.0451546	0.461674	-0.571479	0.219726	-0.195653	0.82 [0.60 - 1.12]
GENE	CBS	cystathionine-beta-synthase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	240517_at	111	0.891892	0.0661042	-	0.627851	0.67209	0.0839853	1.09 [0.74 - 1.60]
GENE	CBS	cystathionine-beta-synthase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212816_s_at	90	0.844444	0.00012043	0.00412448	1.29927	0.00256536	0.571711	1.77 [1.22 - 2.57]
GENE	CBS	cystathionine-beta-synthase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212816_s_at	90	0.855556	1.99359e-06	0.000102651	1.68083	0.000560845	0.707415	2.03 [1.36 - 3.03]
GENE	CBS	cystathionine-beta-synthase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4038	50	0.22	0.0517916	-	-0.951696	0.86387	0.121469	1.13 [0.28 - 4.53]
GENE	CBS	cystathionine-beta-synthase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1553972_a_at	138	0.768116	0.0227583	0.293341	0.590989	0.163487	0.118629	1.13 [0.95 - 1.33]
GENE	CBS	cystathionine-beta-synthase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212816_s_at	138	0.73913	0.0305011	0.358211	0.548065	0.0798078	0.1454	1.16 [0.98 - 1.36]
GENE	CBS	cystathionine-beta-synthase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	240517_at	138	0.144928	0.00291345	0.0615195	-0.832983	0.370863	-0.60723	0.54 [0.14 - 2.06]
GENE	CBS	cystathionine-beta-synthase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212816_s_at	129	0.713178	0.105747	-	0.431307	0.961118	0.0117308	1.01 [0.63 - 1.62]
GENE	CBS	cystathionine-beta-synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34809	56	0.410714	0.0254531	0.316911	-0.790884	0.261279	-0.352879	0.70 [0.38 - 1.30]
GENE	CBS	cystathionine-beta-synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43421	56	0.125	0.00801168	0.13646	-1.27136	0.679872	-0.0865041	0.92 [0.61 - 1.38]
GENE	CBS	cystathionine-beta-synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16111	56	0.410714	0.0254531	0.316911	-0.790884	0.35868	-0.280739	0.76 [0.41 - 1.38]
GENE	CBS	cystathionine-beta-synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36123	56	0.107143	0.00134201	0.0325822	-1.66339	0.767647	-0.0690622	0.93 [0.59 - 1.48]
GENE	CBS	cystathionine-beta-synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43421	56	0.107143	0.00541612	0.100773	-1.4679	0.569772	-0.124647	0.88 [0.57 - 1.36]
GENE	CBS	cystathionine-beta-synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34809	56	0.428571	0.0458878	0.466326	-0.672855	0.413143	-0.242808	0.78 [0.44 - 1.40]
GENE	CBS	cystathionine-beta-synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	36123	56	0.107143	0.000495353	0.0140576	-1.81619	0.385244	-0.21048	0.81 [0.50 - 1.30]
GENE	CBS	cystathionine-beta-synthase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16111	56	0.410714	0.0610064	-	-0.633359	0.583144	-0.159367	0.85 [0.48 - 1.51]
GENE	CBS	cystathionine-beta-synthase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1553972_a_at	278	0.31295	0.00803227	0.136728	0.612328	0.081861	0.144571	1.16 [0.98 - 1.36]
GENE	CBS	cystathionine-beta-synthase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212816_s_at	278	0.276978	0.0238574	0.303093	0.53247	0.100478	0.12606	1.13 [0.98 - 1.32]
GENE	CBS	cystathionine-beta-synthase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	240517_at	278	0.363309	0.0195687	0.263848	0.489023	0.124265	0.348188	1.42 [0.91 - 2.21]
GENE	CBS	cystathionine-beta-synthase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212816_s_at	133	0.654135	0.0703627	-	0.425607	0.809597	0.0169378	1.02 [0.89 - 1.17]
GENE	CBS	cystathionine-beta-synthase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16602	81	0.135802	0.00626026	0.112829	-1.39482	0.445378	0.506087	1.66 [0.45 - 6.09]
GENE	CBS	cystathionine-beta-synthase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212816_s_at	185	0.518919	0.234147	-	-0.209859	0.466393	-0.0799067	0.92 [0.74 - 1.14]
GENE	CBS	cystathionine-beta-synthase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212816_s_at	185	0.632432	0.228502	-	-0.201177	0.714242	-0.0360299	0.96 [0.80 - 1.17]
GENE	CBS	cystathionine-beta-synthase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P48856	110	0.718182	0.061623	-	0.458936	0.344972	0.0967386	1.10 [0.90 - 1.35]
GENE	CBS	cystathionine-beta-synthase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P166306	110	0.718182	0.165809	-	0.422705	0.630659	0.0662867	1.07 [0.82 - 1.40]
GENE	CBS	cystathionine-beta-synthase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P48856	110	0.736364	0.147635	-	0.453485	0.669904	0.0553292	1.06 [0.82 - 1.36]
GENE	CBS	cystathionine-beta-synthase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P166306	110	0.818182	0.0595138	-	0.51609	0.450764	0.0806452	1.08 [0.88 - 1.34]
GENE	CBS	cystathionine-beta-synthase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212816_s_at	80	0.2625	0.112558	-	0.95898	0.909856	0.0246622	1.02 [0.67 - 1.57]
GENE	CBS	cystathionine-beta-synthase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_5670	281	0.825623	0.0913741	-	-0.323761	0.480384	-0.0491249	0.95 [0.83 - 1.09]
GENE	CBS	cystathionine-beta-synthase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212816_s_at	38	0.710526	0.000409826	0.0119515	1.56399	0.00146839	0.971476	2.64 [1.45 - 4.81]
GENE	CBS	cystathionine-beta-synthase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	240517_at	38	0.421053	0.103585	-	-0.773817	0.558174	-0.182918	0.83 [0.45 - 1.54]
GENE	CBS	cystathionine-beta-synthase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1553972_a_at	38	0.710526	0.000962601	0.0246828	1.46045	0.00192603	0.885617	2.42 [1.39 - 4.24]
GENE	CBS	cystathionine-beta-synthase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212816_s_at	140	0.842857	0.012863	0.194788	0.843133	0.122595	0.502565	1.65 [0.87 - 3.13]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CD38	CD38 molecule	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205692_s_at	30	0.733333	0.0886933	-	-0.835368	0.555672	-0.27391	0.76 [0.31 - 1.89]
GENE	CD38	CD38 molecule	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1754039	165	0.460606	0.0177244	0.2459	0.581302	0.297448	0.18669	1.21 [0.85 - 1.71]
GENE	CD38	CD38 molecule	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1754039	165	0.121212	0.0190845	0.259203	15.2654	0.0587378	0.383025	1.47 [0.99 - 2.18]
GENE	CD38	CD38 molecule	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205692_s_at	163	0.141104	0.228181	-	0.369143	0.726654	0.0455804	1.05 [0.81 - 1.35]
GENE	CD38	CD38 molecule	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205692_s_at	79	0.35443	0.0221549	0.287901	0.733204	0.0450789	0.254954	1.29 [1.01 - 1.66]
GENE	CD38	CD38 molecule	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205692_s_at	58	0.172414	0.136966	-	0.601795	0.247943	0.21061	1.23 [0.86 - 1.76]
GENE	CD38	CD38 molecule	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205692_s_at	34	0.823529	0.0937097	-	0.772801	0.865148	0.0568134	1.06 [0.55 - 2.04]
GENE	CD38	CD38 molecule	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205692_s_at	158	0.310127	0.000142551	0.00478193	-0.871259	0.000768225	-0.526039	0.59 [0.43 - 0.80]
GENE	CD38	CD38 molecule	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205692_s_at	53	0.773585	0.0601526	-	-0.97301	0.211823	-0.34305	0.71 [0.41 - 1.22]
GENE	CD38	CD38 molecule	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205692_s_at	53	0.603774	0.113121	-	-0.574306	0.552695	-0.16092	0.85 [0.50 - 1.45]
GENE	CD38	CD38 molecule	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205692_s_at	180	0.494444	0.328651	-	-0.204979	0.730087	-0.0739238	0.93 [0.61 - 1.41]
GENE	CD38	CD38 molecule	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205692_s_at	559	0.152057	0.0159427	0.227857	-0.543696	0.413138	-0.157309	0.85 [0.59 - 1.25]
GENE	CD38	CD38 molecule	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205692_s_at	77	0.61039	0.0612679	-	-0.504454	0.284406	-0.15928	0.85 [0.64 - 1.14]
GENE	CD38	CD38 molecule	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205692_s_at	70	0.871429	0.0976383	-	0.606347	0.251936	0.329047	1.39 [0.79 - 2.44]
GENE	CD38	CD38 molecule	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40323_at	50	0.42	0.0317337	0.367792	-0.745084	0.115076	-0.994241	0.37 [0.11 - 1.27]
GENE	CD38	CD38 molecule	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205692_s_at	74	0.891892	0.0372793	0.408751	-1.18287	0.421901	-0.136497	0.87 [0.63 - 1.22]
GENE	CD38	CD38 molecule	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205692_s_at	67	0.447761	0.0922586	-	1.3177	0.717012	0.433519	1.54 [0.15 - 16.08]
GENE	CD38	CD38 molecule	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205692_s_at	115	0.834783	0.0841638	-	-15.3107	0.211008	-0.595877	0.55 [0.22 - 1.40]
GENE	CD38	CD38 molecule	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40323_at	158	0.898734	0.00176795	0.0409297	1.10903	0.291232	0.154733	1.17 [0.88 - 1.56]
GENE	CD38	CD38 molecule	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40323_at	76	0.263158	0.177998	-	-0.69785	0.550046	-0.139084	0.87 [0.55 - 1.37]
GENE	CD38	CD38 molecule	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205692_s_at	204	0.348039	0.19503	-	0.189148	0.456306	0.0456431	1.05 [0.93 - 1.18]
GENE	CD38	CD38 molecule	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205692_s_at	87	0.252874	0.0322473	0.37173	-0.827664	0.576709	-0.105476	0.90 [0.62 - 1.30]
GENE	CD38	CD38 molecule	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205692_s_at	87	0.252874	0.0322473	0.37173	-0.827664	0.576709	-0.105476	0.90 [0.62 - 1.30]
GENE	CD38	CD38 molecule	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205692_s_at	77	0.155844	0.187561	-	-0.880782	0.332901	0.521585	1.68 [0.59 - 4.84]
GENE	CD38	CD38 molecule	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205692_s_at	77	0.636364	0.0391698	0.421979	1.11726	0.222783	0.556852	1.75 [0.71 - 4.27]
GENE	CD38	CD38 molecule	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205692_s_at	136	0.816176	0.0320067	0.369888	-15.3441	0.135717	-0.367737	0.69 [0.43 - 1.12]
GENE	CD38	CD38 molecule	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205692_s_at	200	0.15	0.0118293	0.183075	-0.888511	0.100508	-0.265736	0.77 [0.56 - 1.05]
GENE	CD38	CD38 molecule	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1782	60	0.583333	0.0895683	-	0.634345	0.908073	0.0391791	1.04 [0.53 - 2.02]
GENE	CD38	CD38 molecule	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1224	60	0.883333	0.0769578	-	0.798419	0.157606	0.232317	1.26 [0.91 - 1.74]
GENE	CD38	CD38 molecule	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1224	60	0.6	0.0435335	0.451233	0.745079	0.227714	0.152125	1.16 [0.91 - 1.49]
GENE	CD38	CD38 molecule	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	1782	60	0.366667	0.0302864	0.356523	0.960808	0.516344	0.190554	1.21 [0.68 - 2.15]
GENE	CD38	CD38 molecule	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	5188	155	0.329032	5.69684e-07	3.23591e-05	-1.36965	7.9832e-05	-0.271404	0.76 [0.67 - 0.87]
GENE	CD38	CD38 molecule	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205692_s_at	286	0.615385	0.0034948	0.0712145	-0.625231	0.00522566	-0.306825	0.74 [0.59 - 0.91]
GENE	CD38	CD38 molecule	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205692_s_at	159	0.899371	0.0614138	-	0.760781	0.829433	-0.0379138	0.96 [0.68 - 1.36]
GENE	CD38	CD38 molecule	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205692_s_at	159	0.899371	0.0107553	0.170532	0.972412	0.238683	0.205705	1.23 [0.87 - 1.73]
GENE	CD38	CD38 molecule	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205692_s_at	159	0.899371	0.00496366	0.0941012	1.15521	0.209582	0.257073	1.29 [0.87 - 1.93]
GENE	CD38	CD38 molecule	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205692_s_at	54	0.12963	0.245247	-	15.2509	0.731109	-0.205511	0.81 [0.25 - 2.63]
GENE	CD38	CD38 molecule	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205692_s_at	117	0.65812	0.0131598	0.19809	-0.946627	0.236351	-0.226016	0.80 [0.55 - 1.16]
GENE	CD38	CD38 molecule	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205692_s_at	117	0.65812	0.111455	-	-0.728984	0.940773	0.0148076	1.01 [0.69 - 1.50]
GENE	CD38	CD38 molecule	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205692_s_at	117	0.65812	0.0131598	0.19809	-0.946627	0.236351	-0.226016	0.80 [0.55 - 1.16]
GENE	CD38	CD38 molecule	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205692_s_at	117	0.65812	0.00245663	0.0535775	-1.65597	0.122133	-0.41466	0.66 [0.39 - 1.12]
GENE	CD38	CD38 molecule	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205692_s_at	236	0.724576	0.23292	-	0.341975	0.984433	-0.00284823	1.00 [0.75 - 1.33]
GENE	CD38	CD38 molecule	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205692_s_at	249	0.730924	0.0231969	0.297257	0.500187	0.825299	0.0250922	1.03 [0.82 - 1.28]
GENE	CD38	CD38 molecule	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205692_s_at	62	0.370968	0.12992	-	0.932484	0.872098	-0.0279815	0.97 [0.69 - 1.37]
GENE	CD38	CD38 molecule	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205692_s_at	125	0.848	0.0398607	0.426727	-1.82914	0.194928	-0.556422	0.57 [0.25 - 1.33]
GENE	CD38	CD38 molecule	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205692_s_at	125	0.76	0.21405	-	0.378415	0.866206	-0.0441753	0.96 [0.57 - 1.60]
GENE	CD38	CD38 molecule	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205692_s_at	54	0.833333	0.183555	-	0.878559	0.822998	-0.0475303	0.95 [0.63 - 1.45]
GENE	CD38	CD38 molecule	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205692_s_at	198	0.883838	0.0806277	-	-0.9959	0.760552	-0.0301665	0.97 [0.80 - 1.18]
GENE	CD38	CD38 molecule	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205692_s_at	198	0.626263	0.164906	-	-0.311498	0.621191	-0.0385523	0.96 [0.83 - 1.12]
GENE	CD38	CD38 molecule	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205692_s_at	198	0.59596	0.0514928	-	-0.532117	0.556601	-0.0557616	0.95 [0.79 - 1.14]
GENE	CD38	CD38 molecule	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205692_s_at	51	0.431373	0.0701562	-	-1.78305	0.478848	-1.28435	0.28 [0.01 - 9.68]
GENE	CD38	CD38 molecule	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205692_s_at	62	0.387097	0.00473042	0.0905985	-1.68402	0.279087	-1.34114	0.26 [0.02 - 2.97]
GENE	CD38	CD38 molecule	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205692_s_at	177	0.864407	0.0197124	0.265217	-1.52816	0.155178	-0.472631	0.62 [0.32 - 1.20]
GENE	CD38	CD38 molecule	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205692_s_at	177	0.864407	0.00978886	0.158886	-1.4053	0.299469	-0.290444	0.75 [0.43 - 1.29]
GENE	CD38	CD38 molecule	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205692_s_at	145	0.482759	0.0160871	0.229346	-0.830611	0.328263	-0.40297	0.67 [0.30 - 1.50]
GENE	CD38	CD38 molecule	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205692_s_at	226	0.323009	0.00201124	0.0455034	-0.848779	0.0295404	-0.214024	0.81 [0.67 - 0.98]
GENE	CD38	CD38 molecule	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205692_s_at	55	0.890909	7.24883e-07	4.04333e-05	2.15756	0.00353595	1.01577	2.76 [1.40 - 5.46]
GENE	CD38	CD38 molecule	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205692_s_at	55	0.545455	0.403652	-	0.401571	0.872886	0.0682362	1.07 [0.46 - 2.47]
GENE	CD38	CD38 molecule	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205692_s_at	49	0.857143	0.164418	-	0.899155	0.774169	0.189741	1.21 [0.33 - 4.42]
GENE	CD38	CD38 molecule	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	731731	34	0.852941	0.00783173	0.134108	1.33125	0.0477357	1.50511	4.50 [1.02 - 19.99]
GENE	CD38	CD38 molecule	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205692_s_at	63	0.126984	0.00206536	0.0465042	-1.21285	0.529468	0.115026	1.12 [0.78 - 1.61]
GENE	CD38	CD38 molecule	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502664_3p_a_at	28	0.892857	0.0734858	-	1.1251	0.4302	0.612906	1.85 [0.40 - 8.46]
GENE	CD38	CD38 molecule	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205692_s_at	82	0.256098	0.0144758	0.212425	-0.854564	0.16577	-0.55294	0.58 [0.26 - 1.26]
GENE	CD38	CD38 molecule	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205692_s_at	79	0.189873	0.116924	-	-0.488473	0.621571	-0.146196	0.86 [0.48 - 1.54]
GENE	CD38	CD38 molecule	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205692_s_at	104	0.509615	0.135736	-	0.493624	0.86312	0.0667058	1.07 [0.50 - 2.28]
GENE	CD38	CD38 molecule	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P167328	117	0.17094	0.0422969	0.443117	1.01569	0.863986	-0.0164041	0.98 [0.82 - 1.19]
GENE	CD38	CD38 molecule	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205692_s_at	204	0.867647	0.0477224	0.477774	0.838583	0.58602	0.11043	1.12 [0.75 - 1.66]
GENE	CD38	CD38 molecule	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205692_s_at	204	0.867647	0.001568	0.0370699	0.973307	0.403587	0.129104	1.14 [0.84 - 1.54]
GENE	CD38	CD38 molecule	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205692_s_at	178	0.674157	0.0907784	-	-0.370276	0.74496	-0.0583684	0.94 [0.66 - 1.34]
GENE	CD38	CD38 molecule	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205692_s_at	111	0.747748	0.296119	-	0.300277	0.789958	0.0305651	1.03 [0.82 - 1.29]
GENE	CD38	CD38 molecule	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205692_s_at	90	0.844444	0.207053	-	-0.655597	0.447607	-0.232273	0.79 [0.44 - 1.44]
GENE	CD38	CD38 molecule	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205692_s_at	90	0.533333	0.0512495	-	-0.764448	0.207965	-0.446012	0.64 [0.32 - 1.28]
GENE	CD38	CD38 molecule	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5439	50	0.6	0.0277321	0.335987	-1.3061	0.353765	-0.366303	0.69 [0.32 - 1.50]
GENE	CD38	CD38 molecule	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205692_s_at	138	0.644928	0.0155347	0.223619	-0.66647	0.148876	-0.100992	0.90 [0.79 - 1.04]
GENE	CD38	CD38 molecule	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205692_s_at	129	0.139535	0.015179	0.219891	-0.721797	0.0362069	-0.415791	0.66 [0.45 - 0.97]
GENE	CD38	CD38 molecule	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32715	56	0.75	0.0532713	-	-0.9972	0.0744292	-0.25312	0.78 [0.59 - 1.03]
GENE	CD38	CD38 molecule	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37747	56	0.767857	0.0386246	0.4182	-0.96678	0.0554272	-0.265635	0.77 [0.58 - 1.01]
GENE	CD38	CD38 molecule	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32715	56	0.75	0.0381287	0.414738	-0.968988	0.0822359	-0.235377	0.79 [0.61 - 1.03]
GENE	CD38	CD38 molecule	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37747	56	0.428571	0.0530905	-	-0.67979	0.0548065	-0.278092	0.76 [0.57 - 1.01]
GENE	CD38	CD38 molecule	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205692_s_at	278	0.866906	0.027262	0.332112	-0.689043	0.0966828	-0.1486	0.86 [0.72 - 1.03]
GENE	CD38	CD38 molecule	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205692_s_at	133	0.12782	0.0105444	0.16802	-0.750167	0.0831414	-0.296282	0.74 [0.53 - 1.04]
GENE	CD38	CD38 molecule	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	8931	81	0.654321	0.0244043	0.307873	1.11106	0.558511	-0.296759	0.74 [0.28 - 2.01]
GENE	CD38	CD38 molecule	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14423	81	0.160494	2.56538e-05	0.00104455	-1.91164	0.62685	-0.182235	0.83 [0.40 - 1.74]
GENE	CD38	CD38 molecule	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205692_s_at	185	0.724324	0.0269126	0.329212	-0.416874	0.211529	-0.226067	0.80 [0.56 - 1.14]
GENE	CD38	CD38 molecule	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205692_s_at	185	0.708108	0.00533152	0.0995376	-0.58804	0.10442	-0.328353	0.72 [0.48 - 1.07]
GENE	CD38	CD38 molecule	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P167328	110	0.654545	0.228168	-	-0.298545	0.852213	-0.0135514	0.99 [0.86 - 1.14]
GENE	CD38	CD38 molecule	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P167328	110	0.872727	0.180496	-	0.516396	0.950237	0.00575316	1.01 [0.84 - 1.20]
GENE	CD38	CD38 molecule	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205692_s_at	80	0.7	0.230603	-	-0.655772	0.799388	0.0390241	1.04 [0.77 - 1.40]
GENE	CD38	CD38 molecule	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_2941	281	0.836299	0.00122919	0.0302852	-0.700217	0.00464448	-0.144462	0.87 [0.78 - 0.96]
GENE	CD38	CD38 molecule	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205692_s_at	38	0.631579	0.0359643	0.399339	-1.25476	0.117557	-0.267273	0.77 [0.55 - 1.07]
GENE	CD38	CD38 molecule	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205692_s_at	140	0.157143	0.0239837	0.304202	-0.76455	0.278761	-0.292261	0.75 [0.44 - 1.27]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CDA	cytidine deaminase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205627_at	30	0.433333	0.00265109	0.0569966	1.27828	0.188975	0.212729	1.24 [0.90 - 1.70]
GENE	CDA	cytidine deaminase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1714592	165	0.89697	5.86204e-05	0.00218385	1.21673	1.10379e-07	0.75934	2.14 [1.61 - 2.83]
GENE	CDA	cytidine deaminase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1714592	165	0.89697	7.3201e-05	0.00265906	1.49495	4.6914e-06	0.779819	2.18 [1.56 - 3.05]
GENE	CDA	cytidine deaminase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205627_at	163	0.552147	0.0116006	0.180438	-0.506949	0.06399	-0.184238	0.83 [0.68 - 1.01]
GENE	CDA	cytidine deaminase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205627_at	79	0.278481	0.0707148	-	0.636586	0.58542	0.0521217	1.05 [0.87 - 1.27]
GENE	CDA	cytidine deaminase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205627_at	58	0.724138	0.0606503	-	-0.606732	0.50152	0.0825635	1.09 [0.85 - 1.38]
GENE	CDA	cytidine deaminase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205627_at	34	0.117647	0.00255305	0.0552803	-1.62818	0.50408	-0.135926	0.87 [0.59 - 1.30]
GENE	CDA	cytidine deaminase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205627_at	158	0.196203	0.139662	-	0.47878	0.617869	-0.357802	0.70 [0.17 - 2.85]
GENE	CDA	cytidine deaminase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205627_at	53	0.207547	0.0166582	0.235191	-0.911053	0.810371	0.0467742	1.05 [0.72 - 1.54]
GENE	CDA	cytidine deaminase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205627_at	53	0.867925	0.0362495	0.401395	0.939092	0.544834	0.119708	1.13 [0.77 - 1.66]
GENE	CDA	cytidine deaminase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205627_at	180	0.194444	0.00320117	0.0663706	0.919099	0.140423	0.15792	1.17 [0.95 - 1.44]
GENE	CDA	cytidine deaminase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205627_at	559	0.359571	0.00015154	0.00504488	1.01945	0.683895	0.0460017	1.05 [0.84 - 1.31]
GENE	CDA	cytidine deaminase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205627_at	77	0.103896	0.0903781	-	0.776448	0.745407	0.0511605	1.05 [0.77 - 1.43]
GENE	CDA	cytidine deaminase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205627_at	70	0.114286	0.140873	-	-0.569976	0.966843	0.0182256	1.02 [0.43 - 2.41]
GENE	CDA	cytidine deaminase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	1117_at	50	0.74	0.12749	-	-0.617443	0.219081	-1.16548	0.31 [0.05 - 2.00]
GENE	CDA	cytidine deaminase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205627_at	74	0.891892	0.00879606	0.146531	-2.18873	0.071124	-0.418546	0.66 [0.42 - 1.04]
GENE	CDA	cytidine deaminase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205627_at	67	0.402985	0.0128574	0.194725	15.8888	0.361297	0.729894	2.07 [0.43 - 9.94]
GENE	CDA	cytidine deaminase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205627_at	115	0.13913	0.119022	-	15.2566	0.410715	0.200189	1.22 [0.76 - 1.97]
GENE	CDA	cytidine deaminase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	1117_at	158	0.196203	0.27392	-	0.424756	0.84402	-0.0478593	0.95 [0.59 - 1.54]
GENE	CDA	cytidine deaminase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	1117_at	76	0.776316	0.204129	-	0.686615	0.565707	0.257381	1.29 [0.54 - 3.11]
GENE	CDA	cytidine deaminase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205627_at	204	0.563725	0.0347286	0.390329	0.306125	0.275468	0.0693721	1.07 [0.95 - 1.21]
GENE	CDA	cytidine deaminase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205627_at	87	0.310345	0.0144202	0.211829	-0.90633	0.0364641	-1.24673	0.29 [0.09 - 0.92]
GENE	CDA	cytidine deaminase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205627_at	87	0.310345	0.0144202	0.211829	-0.90633	0.0364641	-1.24673	0.29 [0.09 - 0.92]
GENE	CDA	cytidine deaminase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205627_at	77	0.324675	0.00340071	0.0696735	-1.78499	0.0630473	-1.87676	0.15 [0.02 - 1.11]
GENE	CDA	cytidine deaminase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205627_at	77	0.246753	0.046739	0.47167	-1.05788	0.0759307	-1.49913	0.22 [0.04 - 1.17]
GENE	CDA	cytidine deaminase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205627_at	136	0.617647	0.0180873	0.249488	1.04512	0.204858	0.28406	1.33 [0.86 - 2.06]
GENE	CDA	cytidine deaminase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205627_at	200	0.175	0.0818416	-	-0.575997	0.284742	-0.188206	0.83 [0.59 - 1.17]
GENE	CDA	cytidine deaminase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6529	60	0.883333	0.245994	-	-0.830942	0.694812	-0.151246	0.86 [0.40 - 1.83]
GENE	CDA	cytidine deaminase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6529	60	0.75	0.278271	-	-0.528337	0.93431	0.0233006	1.02 [0.59 - 1.78]
GENE	CDA	cytidine deaminase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	9153	155	0.103226	5.61373e-06	0.000264484	-1.41411	0.325849	-0.218216	0.80 [0.52 - 1.24]
GENE	CDA	cytidine deaminase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205627_at	286	0.562937	0.00015244	0.0050711	-0.780285	0.00723558	-0.339789	0.71 [0.56 - 0.91]
GENE	CDA	cytidine deaminase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205627_at	159	0.314465	0.249443	-	-0.369783	0.777931	0.053149	1.05 [0.73 - 1.53]
GENE	CDA	cytidine deaminase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205627_at	159	0.490566	0.168266	-	0.521523	0.645438	0.102037	1.11 [0.72 - 1.71]
GENE	CDA	cytidine deaminase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205627_at	159	0.459119	0.0428381	0.446685	0.671392	0.334319	0.181417	1.20 [0.83 - 1.73]
GENE	CDA	cytidine deaminase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205627_at	54	0.203704	0.0487307	0.483954	-1.25946	0.282016	-1.62976	0.20 [0.01 - 3.82]
GENE	CDA	cytidine deaminase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205627_at	117	0.74359	0.0753713	-	0.596593	0.351385	0.62742	1.87 [0.50 - 7.01]
GENE	CDA	cytidine deaminase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205627_at	117	0.74359	0.207325	-	0.504901	0.904504	0.100093	1.11 [0.22 - 5.67]
GENE	CDA	cytidine deaminase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205627_at	117	0.74359	0.0753713	-	0.596593	0.351385	0.62742	1.87 [0.50 - 7.01]
GENE	CDA	cytidine deaminase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205627_at	117	0.435897	0.0352567	0.394199	-0.845546	0.499982	-0.621268	0.54 [0.09 - 3.27]
GENE	CDA	cytidine deaminase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205627_at	236	0.54661	2.90044e-05	0.00116603	-1.27877	0.00526749	-0.435823	0.65 [0.48 - 0.88]
GENE	CDA	cytidine deaminase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205627_at	249	0.598394	7.37707e-05	0.00267737	-0.954877	0.005645	-0.334804	0.72 [0.56 - 0.91]
GENE	CDA	cytidine deaminase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205627_at	62	0.774194	0.151037	-	0.697992	0.859546	-0.0443642	0.96 [0.59 - 1.56]
GENE	CDA	cytidine deaminase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205627_at	125	0.104	0.227259	-	1.16357	0.989458	0.00980611	1.01 [0.24 - 4.33]
GENE	CDA	cytidine deaminase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205627_at	125	0.8	0.108536	-	-0.686627	0.819254	-0.129544	0.88 [0.29 - 2.67]
GENE	CDA	cytidine deaminase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205627_at	54	0.759259	0.22294	-	0.714086	0.939956	-0.0230498	0.98 [0.54 - 1.78]
GENE	CDA	cytidine deaminase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205627_at	198	0.318182	0.024317	0.307114	-0.575702	0.110974	-0.185355	0.83 [0.66 - 1.04]
GENE	CDA	cytidine deaminase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205627_at	198	0.318182	0.0342771	0.386996	-0.56512	0.120463	-0.190138	0.83 [0.65 - 1.05]
GENE	CDA	cytidine deaminase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205627_at	198	0.621212	0.0132356	0.19893	-0.563642	0.0645256	-0.17161	0.84 [0.70 - 1.01]
GENE	CDA	cytidine deaminase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205627_at	51	0.431373	0.0419753	0.440983	16.0285	0.575941	0.60543	1.83 [0.22 - 15.29]
GENE	CDA	cytidine deaminase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205627_at	62	0.483871	0.206429	-	-0.757185	0.816594	0.152144	1.16 [0.32 - 4.21]
GENE	CDA	cytidine deaminase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205627_at	177	0.259887	0.0730069	-	0.644081	0.22968	0.215543	1.24 [0.87 - 1.76]
GENE	CDA	cytidine deaminase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205627_at	177	0.259887	0.130721	-	0.446348	0.323454	0.155497	1.17 [0.86 - 1.59]
GENE	CDA	cytidine deaminase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205627_at	145	0.77931	0.272266	-	-0.52356	0.769835	-0.0690286	0.93 [0.59 - 1.48]
GENE	CDA	cytidine deaminase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205627_at	226	0.831858	0.128999	-	0.515184	0.725488	0.0251496	1.03 [0.89 - 1.18]
GENE	CDA	cytidine deaminase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205627_at	55	0.836364	0.0909011	-	0.851709	0.567597	0.152212	1.16 [0.69 - 1.96]
GENE	CDA	cytidine deaminase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205627_at	55	0.836364	0.0299836	0.354132	1.21774	0.14939	0.410542	1.51 [0.86 - 2.63]
GENE	CDA	cytidine deaminase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205627_at	49	0.877551	0.00759279	0.13096	1.99701	0.412639	0.418995	1.52 [0.56 - 4.14]
GENE	CDA	cytidine deaminase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205627_at	63	0.349206	0.000706722	0.01902	-1.10264	0.00946929	-29.7617	0.00 [0.00 - 0.00]
GENE	CDA	cytidine deaminase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11386156_3p_at	28	0.535714	0.0339842	0.384822	1.12977	0.144085	0.236917	1.27 [0.92 - 1.74]
GENE	CDA	cytidine deaminase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205627_at	82	0.134146	0.152204	-	-0.568105	0.604816	-0.0730763	0.93 [0.70 - 1.23]
GENE	CDA	cytidine deaminase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	1117_at	84	0.428571	0.14446	-	-0.417868	0.934964	-0.01934	0.98 [0.62 - 1.56]
GENE	CDA	cytidine deaminase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205627_at	79	0.772152	0.110918	-	0.466992	0.381963	0.117491	1.12 [0.86 - 1.46]
GENE	CDA	cytidine deaminase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205627_at	104	0.192308	0.00496642	0.0941424	2.30325	0.0492723	0.317971	1.37 [1.00 - 1.89]
GENE	CDA	cytidine deaminase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P34597	117	0.128205	0.0481278	0.480268	-0.722782	0.894966	-0.0167422	0.98 [0.77 - 1.26]
GENE	CDA	cytidine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205627_at	204	0.882353	9.35666e-06	0.000420669	1.29027	5.01659e-05	0.341709	1.41 [1.19 - 1.66]
GENE	CDA	cytidine deaminase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205627_at	204	0.882353	0.000126018	0.00429202	1.41437	0.00534332	0.313152	1.37 [1.10 - 1.70]
GENE	CDA	cytidine deaminase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205627_at	178	0.702247	0.00364374	0.0736331	0.581001	0.0140525	0.223909	1.25 [1.05 - 1.50]
GENE	CDA	cytidine deaminase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205627_at	111	0.765766	0.000504504	0.0142791	0.957028	0.00547791	0.216738	1.24 [1.07 - 1.45]
GENE	CDA	cytidine deaminase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205627_at	90	0.388889	0.0759559	-	-0.569037	0.629636	0.109703	1.12 [0.71 - 1.74]
GENE	CDA	cytidine deaminase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205627_at	90	0.388889	0.0918769	-	-0.617349	0.432916	0.194813	1.22 [0.75 - 1.98]
GENE	CDA	cytidine deaminase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205627_at	138	0.115942	0.00174417	0.0404756	-0.916171	0.140247	0.117794	1.13 [0.96 - 1.32]
GENE	CDA	cytidine deaminase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205627_at	129	0.844961	0.00632048	0.11367	0.872415	0.115743	0.178509	1.20 [0.96 - 1.49]
GENE	CDA	cytidine deaminase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34803	56	0.589286	0.0144514	0.212164	0.832574	0.46281	0.188488	1.21 [0.73 - 2.00]
GENE	CDA	cytidine deaminase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	34803	56	0.589286	0.00518659	0.0974081	0.996883	0.282537	0.30634	1.36 [0.78 - 2.38]
GENE	CDA	cytidine deaminase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205627_at	278	0.794964	0.346655	-	0.206801	0.400515	0.189744	1.21 [0.78 - 1.88]
GENE	CDA	cytidine deaminase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205627_at	133	0.819549	0.00957556	0.156266	0.715968	0.691616	-0.111364	0.89 [0.52 - 1.55]
GENE	CDA	cytidine deaminase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1701	81	0.148148	0.00334521	0.0687598	-1.53706	0.977134	-0.00788902	0.99 [0.58 - 1.70]
GENE	CDA	cytidine deaminase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15152	81	0.382716	0.045694	0.465101	-1.04944	0.641086	-0.137682	0.87 [0.49 - 1.55]
GENE	CDA	cytidine deaminase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205627_at	185	0.864865	0.226417	-	-0.302967	0.595827	-0.0944851	0.91 [0.64 - 1.29]
GENE	CDA	cytidine deaminase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205627_at	185	0.497297	0.158585	-	0.249055	0.79184	0.0505083	1.05 [0.72 - 1.53]
GENE	CDA	cytidine deaminase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P34597	110	0.136364	0.176869	-	0.497875	0.607329	0.11057	1.12 [0.73 - 1.70]
GENE	CDA	cytidine deaminase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P34597	110	0.581818	0.264182	-	0.331963	0.268594	0.273913	1.32 [0.81 - 2.14]
GENE	CDA	cytidine deaminase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205627_at	80	0.575	0.0104122	0.166437	1.11436	0.131251	0.20654	1.23 [0.94 - 1.61]
GENE	CDA	cytidine deaminase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_0130	281	0.11032	0.00604966	0.109866	0.687837	0.248117	0.0931366	1.10 [0.94 - 1.29]
GENE	CDA	cytidine deaminase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205627_at	38	0.263158	0.0296633	0.351592	-0.981846	0.220715	-0.559767	0.57 [0.23 - 1.40]
GENE	CDA	cytidine deaminase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205627_at	140	0.621429	0.108963	-	-0.504636	0.678034	-0.14371	0.87 [0.44 - 1.71]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	201253_s_at	30	0.466667	0.0887684	-	-0.678663	0.499623	-0.342668	0.71 [0.26 - 1.92]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1770425	165	0.878788	0.185627	-	0.450731	0.303594	0.321285	1.38 [0.75 - 2.54]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1770425	165	0.878788	0.00160646	0.03782	1.17603	0.0165189	0.840089	2.32 [1.17 - 4.60]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	201253_s_at	163	0.613497	0.0651978	-	0.368021	0.601304	0.100257	1.11 [0.76 - 1.61]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	201253_s_at	79	0.417722	0.235902	-	-0.349376	0.976535	-0.0087667	0.99 [0.55 - 1.78]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201253_s_at	58	0.706897	0.0387909	0.419356	-0.62687	0.329439	-0.298285	0.74 [0.41 - 1.35]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	201253_s_at	34	0.176471	0.0691883	-	-0.842241	0.597937	0.230507	1.26 [0.53 - 2.97]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	201253_s_at	158	0.841772	0.0207596	0.275078	0.647988	0.175515	0.475029	1.61 [0.81 - 3.20]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	201253_s_at	53	0.433962	0.060378	-	0.677799	0.401009	0.50554	1.66 [0.51 - 5.39]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	201253_s_at	53	0.433962	0.151536	-	0.549805	0.284891	0.729267	2.07 [0.54 - 7.89]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	201253_s_at	180	0.622222	0.00784257	0.13425	0.550932	0.160841	0.34289	1.41 [0.87 - 2.28]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	201253_s_at	559	0.579606	0.0919003	-	0.33645	0.387018	0.289135	1.34 [0.69 - 2.57]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	201253_s_at	77	0.415584	0.0298282	0.352901	-0.570546	0.714808	-0.167421	0.85 [0.34 - 2.08]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	201253_s_at	70	0.4	0.00785782	0.13445	-0.714255	0.0290511	-1.0283	0.36 [0.14 - 0.90]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	33397_at	50	0.82	0.0522726	-	-1.11973	0.59201	-0.197433	0.82 [0.40 - 1.69]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	201253_s_at	74	0.216216	0.0831766	-	-0.593136	0.649854	-0.23118	0.79 [0.29 - 2.15]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	201253_s_at	67	0.746269	0.0187706	0.256168	1.44911	0.102466	2.93305	18.78 [0.56 - 634.85]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	201253_s_at	115	0.895652	0.0100844	0.162485	1.41769	0.422944	0.751275	2.12 [0.34 - 13.31]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	33397_at	158	0.183544	0.0773307	-	0.756018	0.867548	-0.0932239	0.91 [0.30 - 2.72]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	33397_at	76	0.355263	0.16306	-	0.872772	0.805681	0.192779	1.21 [0.26 - 5.63]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	201253_s_at	204	0.632353	0.107993	-	-0.230364	0.748167	-0.0614991	0.94 [0.65 - 1.37]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	201253_s_at	87	0.448276	0.0844766	-	-0.648565	0.711337	-0.198912	0.82 [0.29 - 2.35]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	201253_s_at	87	0.448276	0.0844766	-	-0.648565	0.711337	-0.198912	0.82 [0.29 - 2.35]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	201253_s_at	77	0.402597	0.144531	-	-0.910645	0.967669	0.0355324	1.04 [0.19 - 5.78]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	201253_s_at	77	0.402597	0.0887993	-	-0.936354	0.859828	-0.134026	0.87 [0.20 - 3.87]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	201253_s_at	136	0.897059	0.000808851	0.0213192	1.49629	0.0429272	1.10296	3.01 [1.04 - 8.77]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	201253_s_at	200	0.77	0.0433818	0.450244	0.626172	0.769866	-0.166182	0.85 [0.28 - 2.58]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8200	60	0.166667	0.00045651	0.0131093	-1.44953	0.151392	-0.925378	0.40 [0.11 - 1.40]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	8200	60	0.233333	0.174244	-	0.721073	0.347858	0.789932	2.20 [0.42 - 11.46]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	18560	155	0.780645	1.72255e-05	0.000730198	1.15072	0.0198834	0.28208	1.33 [1.05 - 1.68]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	201253_s_at	286	0.608392	8.13279e-05	0.00291851	0.7487	0.0265523	0.532059	1.70 [1.06 - 2.72]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201253_s_at	159	0.18239	0.019093	0.259285	-0.789363	0.189983	-0.604931	0.55 [0.22 - 1.35]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201253_s_at	159	0.18239	0.00738306	0.128172	-1.00828	0.115669	-0.872725	0.42 [0.14 - 1.24]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	201253_s_at	159	0.18239	0.00126554	0.0310297	-1.02723	0.0860936	-0.805228	0.45 [0.18 - 1.12]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	201253_s_at	54	0.388889	0.0210886	0.278133	15.7786	0.11516	1.60474	4.98 [0.68 - 36.64]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201253_s_at	117	0.82906	0.0357404	0.397718	0.759858	0.409324	0.339848	1.40 [0.63 - 3.15]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201253_s_at	117	0.897436	0.0379426	0.413433	0.927371	0.30771	0.491437	1.63 [0.64 - 4.20]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201253_s_at	117	0.82906	0.0357404	0.397718	0.759858	0.409324	0.339848	1.40 [0.63 - 3.15]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	201253_s_at	117	0.119658	0.00442035	0.0858707	-1.19616	0.678698	0.216635	1.24 [0.45 - 3.46]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	201253_s_at	236	0.847458	0.0527857	-	0.605792	0.897604	0.0538016	1.06 [0.47 - 2.39]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	201253_s_at	249	0.827309	0.00165316	0.0387257	0.734831	0.227869	0.392514	1.48 [0.78 - 2.80]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201253_s_at	62	0.887097	0.0273405	0.332761	1.11852	0.936771	-0.0268225	0.97 [0.50 - 1.89]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201253_s_at	125	0.56	0.279174	-	-0.423944	0.887744	0.0809285	1.08 [0.35 - 3.34]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201253_s_at	125	0.616	0.105626	-	-0.494368	0.546132	-0.267161	0.77 [0.32 - 1.82]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	201253_s_at	54	0.888889	0.0217529	0.284242	1.3246	0.818331	-0.0950522	0.91 [0.40 - 2.05]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201253_s_at	198	0.868687	0.0553426	-	0.608866	0.690059	0.10384	1.11 [0.67 - 1.85]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201253_s_at	198	0.868687	0.112285	-	0.528463	0.950643	0.0167769	1.02 [0.60 - 1.73]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	201253_s_at	198	0.843434	0.0667279	-	0.47257	0.641007	0.0993334	1.10 [0.73 - 1.68]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	201253_s_at	51	0.627451	0.0717054	-	-15.838	0.664922	-0.493107	0.61 [0.07 - 5.69]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	201253_s_at	62	0.5	0.20802	-	0.753174	0.923859	-0.075748	0.93 [0.20 - 4.38]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	201253_s_at	177	0.762712	0.0167928	0.236556	0.661151	0.301021	0.483863	1.62 [0.65 - 4.06]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	201253_s_at	177	0.751412	0.00639068	0.114649	0.652668	0.104427	0.65139	1.92 [0.87 - 4.21]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	201253_s_at	145	0.358621	0.0241044	0.305258	0.919931	0.0709876	0.99328	2.70 [0.92 - 7.94]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	201253_s_at	226	0.106195	0.0292214	0.348064	1.90311	0.330702	0.348876	1.42 [0.70 - 2.86]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	201253_s_at	55	0.872727	0.000175934	0.00574772	1.66862	0.131881	1.12597	3.08 [0.71 - 13.34]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	201253_s_at	55	0.890909	0.00141979	0.0341428	1.65946	0.0241533	1.67032	5.31 [1.24 - 22.70]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	201253_s_at	49	0.897959	0.00339757	0.069622	1.62205	0.0927598	1.63252	5.12 [0.76 - 34.33]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	306047	34	0.852941	0.00126405	0.0309993	1.55622	0.0533967	2.77205	15.99 [0.96 - 266.32]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	201253_s_at	63	0.126984	0.0550067	-	1.30724	0.746436	0.0702461	1.07 [0.70 - 1.64]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5453905_3p_a_at	28	0.571429	0.00802817	0.136675	1.53486	0.534556	0.067306	1.07 [0.86 - 1.32]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	201253_s_at	82	0.182927	0.00343305	0.0702044	-1.03003	0.150692	-0.747194	0.47 [0.17 - 1.31]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	33397_at	84	0.154762	0.163718	-	-0.493031	0.720267	-0.224655	0.80 [0.23 - 2.73]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	201253_s_at	79	0.493671	0.0564938	-	-0.494132	0.542561	-0.368581	0.69 [0.21 - 2.27]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	201253_s_at	104	0.798077	0.0512684	-	-0.995015	0.319271	-0.62363	0.54 [0.16 - 1.83]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P501339	117	0.34188	0.0547586	-	-0.548746	0.347747	-0.188866	0.83 [0.56 - 1.23]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	201253_s_at	204	0.838235	0.0921199	-	0.684406	0.243943	0.939753	2.56 [0.53 - 12.44]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	201253_s_at	204	0.593137	0.0411651	0.435569	0.549704	0.159235	0.849563	2.34 [0.72 - 7.63]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	201253_s_at	178	0.101124	0.0398202	0.42645	-0.602156	0.240854	-0.583159	0.56 [0.21 - 1.48]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200015370	41	0.609756	0.094271	-	-0.777909	0.481601	-0.357362	0.70 [0.26 - 1.89]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	201253_s_at	111	0.477477	0.0347577	0.390543	-0.551528	0.793404	-0.0930199	0.91 [0.45 - 1.83]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	201253_s_at	90	0.844444	0.109948	-	0.626806	0.944527	0.0274542	1.03 [0.47 - 2.23]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	201253_s_at	90	0.111111	0.307779	-	-0.543644	0.604207	-0.223315	0.80 [0.34 - 1.86]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4690	50	0.12	0.0886338	-	15.255	0.815352	-0.101809	0.90 [0.38 - 2.12]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	201253_s_at	138	0.202899	0.0163953	0.23251	-0.649039	0.168116	-0.381248	0.68 [0.40 - 1.17]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	201253_s_at	129	0.124031	0.091129	-	0.847676	0.805071	0.0778067	1.08 [0.58 - 2.01]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25785	56	0.125	0.070964	-	-0.81567	0.660515	0.179625	1.20 [0.54 - 2.67]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25785	56	0.125	0.0214629	0.281585	-1.04178	0.883117	0.0641396	1.07 [0.45 - 2.51]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	201253_s_at	278	0.723022	0.0225235	0.291232	-0.497792	0.534554	-0.168779	0.84 [0.50 - 1.44]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	201253_s_at	133	0.172932	0.0907472	-	-0.505454	0.620563	-0.112674	0.89 [0.57 - 1.40]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	18270	81	0.271605	0.195734	-	0.948763	0.504638	0.412279	1.51 [0.45 - 5.07]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201253_s_at	185	0.854054	0.0844764	-	-0.472493	0.731165	0.0405584	1.04 [0.83 - 1.31]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	201253_s_at	185	0.367568	0.0241625	0.305766	0.38408	0.181283	0.146769	1.16 [0.93 - 1.44]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P501339	110	0.554545	0.197634	-	0.390286	0.981951	-0.00645438	0.99 [0.57 - 1.74]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P501339	110	0.209091	0.05232	-	0.599706	0.504521	0.149602	1.16 [0.75 - 1.80]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	201253_s_at	80	0.8375	0.16863	-	0.699867	0.424521	0.399231	1.49 [0.56 - 3.97]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_1229	281	0.345196	0.0360311	0.399821	-0.306162	0.32019	-0.105723	0.90 [0.73 - 1.11]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	201253_s_at	38	0.184211	0.0130168	0.196502	2.1878	0.395204	0.705764	2.03 [0.40 - 10.31]
GENE	CDIPT	CDP-diacylglycerol--inositol 3-phosphatidyltransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	201253_s_at	140	0.864286	0.00290849	0.0614349	0.939702	0.106152	0.699289	2.01 [0.86 - 4.70]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204154_at	30	0.866667	0.0820549	-	0.936597	0.376696	0.643785	1.90 [0.46 - 7.93]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1753931	165	0.569697	0.00566931	0.104441	0.661525	0.894434	-0.0369336	0.96 [0.56 - 1.66]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1753931	165	0.575758	0.0854464	-	0.604624	0.69348	0.152977	1.17 [0.54 - 2.49]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204154_at	163	0.110429	0.330689	-	-0.286673	0.694036	-0.205909	0.81 [0.29 - 2.27]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204154_at	79	0.126582	0.0348416	0.391159	-0.80578	0.190242	0.318331	1.37 [0.85 - 2.21]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204154_at	58	0.896552	0.0168217	0.236849	1.06706	0.235748	0.287149	1.33 [0.83 - 2.14]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204154_at	34	0.323529	0.00434288	0.0846761	-1.21343	0.206782	-0.832351	0.44 [0.12 - 1.58]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204154_at	158	0.791139	0.00395493	0.078609	0.710398	0.0874619	0.859208	2.36 [0.88 - 6.33]
GENE	CDO1	cysteine dioxygenase, type I	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204154_at	53	0.490566	0.0773264	-	0.659775	0.51232	0.205133	1.23 [0.66 - 2.27]
GENE	CDO1	cysteine dioxygenase, type I	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204154_at	53	0.226415	0.102582	-	0.773579	0.764863	0.090289	1.09 [0.61 - 1.98]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204154_at	180	0.522222	0.0156597	0.224921	0.506586	0.0206644	0.483023	1.62 [1.08 - 2.44]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204154_at	559	0.533095	0.0277002	0.335725	0.444801	0.27548	0.164751	1.18 [0.88 - 1.59]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204154_at	77	0.116883	0.00673437	0.119397	-1.0093	0.857368	0.0399145	1.04 [0.67 - 1.61]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204154_at	70	0.442857	0.000610065	0.0167885	0.963889	0.00815616	0.415698	1.52 [1.11 - 2.06]
GENE	CDO1	cysteine dioxygenase, type I	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	35649_at	50	0.2	0.00069267	0.0186992	-1.25468	0.498426	-0.28651	0.75 [0.33 - 1.72]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204154_at	74	0.108108	0.0742548	-	-0.721336	0.978	0.00714367	1.01 [0.61 - 1.67]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204154_at	67	0.522388	0.0250313	0.313296	-1.66357	0.930231	0.0472424	1.05 [0.36 - 3.02]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204154_at	115	0.704348	0.0516902	-	-1.77656	0.263943	-0.624498	0.54 [0.18 - 1.60]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	35649_at	158	0.107595	0.0303316	0.356879	-0.75845	0.275624	-0.174794	0.84 [0.61 - 1.15]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	35649_at	76	0.657895	0.195332	-	-0.814762	0.673415	-0.139697	0.87 [0.45 - 1.67]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204154_at	204	0.269608	0.00350367	0.0713592	-0.464471	0.0818679	-0.170183	0.84 [0.70 - 1.02]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204154_at	87	0.264368	0.00803193	0.136724	-0.982483	0.0447388	-0.335272	0.72 [0.52 - 0.99]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204154_at	87	0.264368	0.00803193	0.136724	-0.982483	0.0447388	-0.335272	0.72 [0.52 - 0.99]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204154_at	77	0.194805	0.0934339	-	-1.03611	0.58083	-0.185423	0.83 [0.43 - 1.60]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204154_at	77	0.688312	0.154233	-	-1.04773	0.822908	-0.0593435	0.94 [0.56 - 1.58]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204154_at	136	0.683824	0.0167617	0.236241	-1.61393	0.160814	-0.424693	0.65 [0.36 - 1.18]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204154_at	200	0.12	0.00648427	0.115949	-0.981952	0.147922	-0.309048	0.73 [0.48 - 1.12]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15408	60	0.333333	0.11522	-	0.709497	0.381183	0.0954668	1.10 [0.89 - 1.36]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15408	60	0.466667	0.206021	-	-0.480383	0.928408	0.0158253	1.02 [0.72 - 1.43]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	9484	155	0.529032	0.0526106	-	0.543355	0.760917	0.0592437	1.06 [0.72 - 1.55]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204154_at	286	0.800699	0.00525087	0.0983546	-0.831478	0.0704789	-0.266458	0.77 [0.57 - 1.02]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204154_at	159	0.471698	0.00266041	0.0571591	-0.977001	0.00245009	-1.00028	0.37 [0.19 - 0.70]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204154_at	159	0.27044	5.98605e-05	0.00222481	-1.20043	0.000544009	-1.10664	0.33 [0.18 - 0.62]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204154_at	159	0.471698	0.000538278	0.015091	-1.39013	0.00233232	-1.17216	0.31 [0.15 - 0.66]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204154_at	54	0.277778	0.0380946	0.414499	-1.36194	0.940569	-0.0270762	0.97 [0.48 - 1.98]
GENE	CDO1	cysteine dioxygenase, type I	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204154_at	117	0.247863	0.106198	-	0.704058	0.930698	0.0146676	1.01 [0.73 - 1.41]
GENE	CDO1	cysteine dioxygenase, type I	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204154_at	117	0.111111	0.164349	-	1.32032	0.792442	-0.0586155	0.94 [0.61 - 1.46]
GENE	CDO1	cysteine dioxygenase, type I	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204154_at	117	0.247863	0.106198	-	0.704058	0.930698	0.0146676	1.01 [0.73 - 1.41]
GENE	CDO1	cysteine dioxygenase, type I	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204154_at	117	0.247863	0.0507915	-	1.13264	0.749768	0.0610288	1.06 [0.73 - 1.55]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204154_at	236	0.508475	0.000340548	0.0101922	-1.01917	0.00412425	-0.892306	0.41 [0.22 - 0.75]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204154_at	249	0.550201	0.000421588	0.0122452	-0.786891	0.0150231	-0.56431	0.57 [0.36 - 0.90]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204154_at	62	0.806452	0.00806027	0.137093	-2.3411	0.0843851	-0.41584	0.66 [0.41 - 1.06]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204154_at	125	0.216	0.241578	-	-0.474014	0.713453	-0.138066	0.87 [0.42 - 1.82]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204154_at	125	0.336	0.205338	-	0.40533	0.77146	0.0744469	1.08 [0.65 - 1.78]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204154_at	54	0.148148	0.00243356	0.0531678	-1.79755	0.122596	-0.45154	0.64 [0.36 - 1.13]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204154_at	198	0.10101	0.0214046	0.281049	1.98178	0.963579	-0.00561625	0.99 [0.78 - 1.27]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204154_at	198	0.161616	0.0478446	0.478527	0.687303	0.879486	0.0146547	1.01 [0.84 - 1.23]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204154_at	198	0.10101	0.00914095	0.15087	2.17877	0.735687	0.0395356	1.04 [0.83 - 1.31]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204154_at	51	0.882353	0.0380387	0.414107	1.68786	0.248037	1.56483	4.78 [0.34 - 68.03]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204154_at	62	0.241935	0.036804	0.405369	15.5093	0.230856	1.21405	3.37 [0.46 - 24.53]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204154_at	177	0.887006	0.0326522	0.374812	0.7165	0.261698	0.34072	1.41 [0.78 - 2.55]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204154_at	177	0.118644	0.019517	0.263354	1.28726	0.475988	0.200249	1.22 [0.70 - 2.12]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204154_at	145	0.848276	0.00216843	0.0483943	1.06443	0.00623515	0.823616	2.28 [1.26 - 4.11]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204154_at	226	0.752212	0.00283155	0.0601183	0.833555	0.0573382	0.342092	1.41 [0.99 - 2.00]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204154_at	55	0.854545	0.11747	-	0.793091	0.346116	0.44448	1.56 [0.62 - 3.93]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204154_at	55	0.854545	0.0298741	0.353265	1.08282	0.0141477	1.07947	2.94 [1.24 - 6.97]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204154_at	49	0.857143	0.0397252	0.425799	1.19642	0.223584	0.621962	1.86 [0.68 - 5.07]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204154_at	63	0.285714	0.000158379	0.00524346	-1.24033	0.00612748	-0.339133	0.71 [0.56 - 0.91]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502754_3p_at	28	0.642857	0.106351	-	-1.03201	0.121976	-3.71376	0.02 [0.00 - 2.70]
GENE	CDO1	cysteine dioxygenase, type I	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204154_at	82	0.268293	0.19104	-	0.580533	0.995988	-0.00344527	1.00 [0.26 - 3.82]
GENE	CDO1	cysteine dioxygenase, type I	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204154_at	79	0.848101	0.215617	-	-0.450999	0.399092	-0.430869	0.65 [0.24 - 1.77]
GENE	CDO1	cysteine dioxygenase, type I	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	Z31357_at	86	0.139535	0.000347131	0.0103617	-1.59298	0.106735	-0.793698	0.45 [0.17 - 1.19]
GENE	CDO1	cysteine dioxygenase, type I	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204154_at	104	0.221154	0.0329552	0.377107	-0.734725	0.174296	-0.975744	0.38 [0.09 - 1.54]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P30294	117	0.615385	0.0274197	0.333415	-0.700174	0.988258	0.00166507	1.00 [0.80 - 1.25]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204154_at	204	0.480392	1.57635e-05	0.000674102	-1.23398	9.9902e-05	-0.593784	0.55 [0.41 - 0.74]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204154_at	204	0.421569	0.000731803	0.0195899	-1.26167	0.0111658	-0.53178	0.59 [0.39 - 0.89]
GENE	CDO1	cysteine dioxygenase, type I	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204154_at	178	0.224719	0.11869	-	-0.349117	0.734472	-0.135513	0.87 [0.40 - 1.91]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204154_at	111	0.522523	0.0132777	0.199395	-0.660549	0.0475177	-0.35611	0.70 [0.49 - 1.00]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204154_at	90	0.455556	0.00607832	0.110271	-0.893907	0.253211	-0.733147	0.48 [0.14 - 1.69]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204154_at	90	0.433333	0.0305463	0.358565	-0.795317	0.174116	-1.044	0.35 [0.08 - 1.59]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	1228	50	0.48	0.101288	-	0.844538	0.589226	0.390939	1.48 [0.36 - 6.11]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204154_at	138	0.101449	0.0147607	0.215465	-0.788456	0.149972	-0.18852	0.83 [0.64 - 1.07]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204154_at	129	0.899225	0.0771958	-	0.660254	0.192217	0.504253	1.66 [0.78 - 3.53]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32586	56	0.767857	0.0613644	-	0.678493	0.190635	0.179327	1.20 [0.91 - 1.57]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24320	56	0.714286	0.0678703	-	0.647682	0.189684	0.209244	1.23 [0.90 - 1.69]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32586	56	0.107143	0.189608	-	-0.640721	0.899396	0.0170986	1.02 [0.78 - 1.33]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24320	56	0.75	0.293053	-	0.413617	0.924484	0.0145874	1.01 [0.75 - 1.37]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204154_at	278	0.841727	0.240936	-	0.272136	0.644382	0.0364542	1.04 [0.89 - 1.21]
GENE	CDO1	cysteine dioxygenase, type I	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204154_at	133	0.496241	0.10249	-	0.387445	0.423673	-0.240098	0.79 [0.44 - 1.42]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	16558	81	0.481481	0.0485923	0.48311	-1.05277	0.260136	-0.272789	0.76 [0.47 - 1.22]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204154_at	185	0.151351	0.0102903	0.164973	0.584099	0.162752	0.251374	1.29 [0.90 - 1.83]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204154_at	185	0.156757	0.0219292	0.28585	0.560847	0.103994	0.313928	1.37 [0.94 - 2.00]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P30294	110	0.127273	0.0541958	-	-0.608528	0.456523	-0.0455271	0.96 [0.85 - 1.08]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P30294	110	0.527273	0.0269107	0.329196	-0.674164	0.186209	-0.100947	0.90 [0.78 - 1.05]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204154_at	80	0.7	0.172486	-	0.593861	0.677081	0.112305	1.12 [0.66 - 1.90]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_2356	281	0.156584	0.105363	-	-0.303306	0.241661	-0.0852763	0.92 [0.80 - 1.06]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204154_at	38	0.552632	0.160831	-	-0.692568	0.423039	-0.402751	0.67 [0.25 - 1.79]
GENE	CDO1	cysteine dioxygenase, type I	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204154_at	140	0.35	1.24285e-07	7.8645e-06	-1.46712	0.00018828	-0.399084	0.67 [0.54 - 0.83]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205709_s_at	30	0.3	0.0620959	-	-0.82058	0.144708	-0.628716	0.53 [0.23 - 1.24]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	222063_s_at	30	0.3	0.209024	-	-0.538001	0.400102	-0.878652	0.42 [0.05 - 3.22]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1801476	165	0.115152	0.113769	-	0.794973	0.166304	0.197934	1.22 [0.92 - 1.61]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1801476	165	0.690909	0.0300551	0.354698	-1.01248	0.926466	0.0168738	1.02 [0.71 - 1.46]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	222063_s_at	163	0.576687	0.0729774	-	-0.364114	0.7411	-0.193903	0.82 [0.26 - 2.60]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205709_s_at	163	0.214724	0.00485836	0.0925253	-0.612702	0.0535885	-1.24231	0.29 [0.08 - 1.02]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205709_s_at	79	0.848101	0.0439972	0.454242	0.710767	0.371507	0.706019	2.03 [0.43 - 9.53]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222063_s_at	79	0.341772	0.0461135	0.467749	-0.578952	0.258073	-0.989992	0.37 [0.07 - 2.07]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205709_s_at	58	0.293103	0.288972	-	-0.309745	0.718158	-0.0576877	0.94 [0.69 - 1.29]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	222063_s_at	58	0.155172	0.0195075	0.263264	-0.853532	0.381663	-0.123408	0.88 [0.67 - 1.17]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	222063_s_at	34	0.852941	0.0839847	-	0.885831	0.564646	0.155984	1.17 [0.69 - 1.99]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205709_s_at	34	0.558824	0.00238922	0.0523778	-1.18453	0.102682	-0.417109	0.66 [0.40 - 1.09]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205709_s_at	158	0.329114	0.0374514	0.40997	0.557155	0.591926	0.230312	1.26 [0.54 - 2.92]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	222063_s_at	158	0.120253	0.0214915	0.281848	1.12244	0.136729	0.929504	2.53 [0.74 - 8.62]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	222063_s_at	53	0.641509	0.0301513	0.355458	0.777023	0.756919	0.0650238	1.07 [0.71 - 1.61]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205709_s_at	53	0.226415	0.425963	-	0.337081	0.906343	0.0264125	1.03 [0.66 - 1.59]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	222063_s_at	53	0.641509	0.0586831	-	0.644381	0.896576	-0.0254394	0.97 [0.66 - 1.43]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205709_s_at	53	0.226415	0.174188	-	0.655613	0.433358	0.1839	1.20 [0.76 - 1.90]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205709_s_at	180	0.855556	0.000104524	0.00364147	0.975253	0.00379611	0.284862	1.33 [1.10 - 1.61]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	222063_s_at	180	0.883333	0.0625355	-	0.537793	0.801987	0.01843	1.02 [0.88 - 1.18]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222063_s_at	559	0.288014	0.191757	-	0.31985	0.80897	0.0281859	1.03 [0.82 - 1.29]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205709_s_at	559	0.221825	0.162684	-	0.378668	0.674092	0.0365522	1.04 [0.87 - 1.23]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	222063_s_at	77	0.831169	0.00244292	0.0533341	-1.23761	0.128996	-0.207892	0.81 [0.62 - 1.06]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205709_s_at	77	0.337662	0.0306506	0.359383	0.591716	0.115504	0.142216	1.15 [0.97 - 1.38]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205709_s_at	70	0.385714	0.0988762	-	0.44991	0.871956	0.0244299	1.02 [0.76 - 1.38]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222063_s_at	70	0.385714	0.0471971	0.474523	0.563561	0.689513	0.464355	1.59 [0.16 - 15.52]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40217_s_at	50	0.5	0.131222	-	-0.522598	0.740666	-0.0932675	0.91 [0.52 - 1.58]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40218_at	50	0.68	0.0142366	0.209855	-0.977756	0.63653	-0.204865	0.81 [0.35 - 1.91]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205709_s_at	74	0.391892	0.00546583	0.101497	0.879996	0.0223379	0.216017	1.24 [1.03 - 1.49]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	222063_s_at	74	0.891892	0.00251775	0.0546585	1.12342	0.230073	0.204758	1.23 [0.88 - 1.71]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222063_s_at	67	0.850746	0.197809	-	-15.2795	0.702619	-1.44672	0.24 [0.00 - 395.60]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205709_s_at	67	0.895522	0.0176313	0.244975	1.53427	0.0691583	1.14144	3.13 [0.91 - 10.72]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222063_s_at	115	0.165217	0.00371399	0.0747655	-1.44719	0.126253	-1.13314	0.32 [0.08 - 1.38]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205709_s_at	115	0.669565	0.12916	-	0.789339	0.719125	0.19942	1.22 [0.41 - 3.62]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40217_s_at	158	0.734177	0.177554	-	-0.460802	0.643545	-0.0885209	0.92 [0.63 - 1.33]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40218_at	158	0.341772	0.122368	-	-0.460103	0.997149	0.000942299	1.00 [0.60 - 1.68]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40217_s_at	76	0.434211	0.0621118	-	1.14184	0.514037	0.344928	1.41 [0.50 - 3.98]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40218_at	76	0.223684	0.370645	-	0.668631	0.675745	0.273747	1.31 [0.36 - 4.74]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222063_s_at	204	0.848039	0.0582466	-	-0.363829	0.971766	0.00267839	1.00 [0.86 - 1.16]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205709_s_at	204	0.720588	0.0717402	-	-0.282735	0.762891	-0.0351557	0.97 [0.77 - 1.21]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205709_s_at	87	0.666667	0.010065	0.16225	0.948777	0.0563736	0.606054	1.83 [0.98 - 3.42]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222063_s_at	87	0.574713	0.0350117	0.392407	-0.893302	0.223703	-1.39381	0.25 [0.03 - 2.34]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222063_s_at	87	0.574713	0.0350117	0.392407	-0.893302	0.223703	-1.39381	0.25 [0.03 - 2.34]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205709_s_at	87	0.666667	0.010065	0.16225	0.948777	0.0563736	0.606054	1.83 [0.98 - 3.42]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205709_s_at	77	0.844156	0.153979	-	-15.2981	0.537924	-0.363832	0.70 [0.22 - 2.21]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222063_s_at	77	0.220779	0.0423815	0.443676	15.4528	0.619873	0.802888	2.23 [0.09 - 53.27]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205709_s_at	77	0.844156	0.100262	-	-15.3048	0.515666	-0.334237	0.72 [0.26 - 1.96]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222063_s_at	77	0.220779	0.0774758	-	15.4444	0.915499	-0.213635	0.81 [0.02 - 41.79]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205709_s_at	136	0.735294	0.0231439	0.296785	0.983727	0.0226991	0.846048	2.33 [1.13 - 4.83]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	222063_s_at	136	0.352941	0.172974	-	0.745884	0.643074	0.115806	1.12 [0.69 - 1.83]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205709_s_at	200	0.74	0.0696833	-	0.568185	0.440431	0.252284	1.29 [0.68 - 2.44]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	222063_s_at	200	0.875	0.00114826	0.028612	1.04755	0.0202954	0.57296	1.77 [1.09 - 2.88]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	491	60	0.283333	0.0916633	-	0.814432	0.410472	0.273795	1.31 [0.69 - 2.52]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	491	60	0.533333	0.197847	-	0.490132	0.740042	0.110231	1.12 [0.58 - 2.14]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	6979	155	0.212903	0.00211913	0.0474928	-0.856348	0.00676926	-0.397933	0.67 [0.50 - 0.90]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205709_s_at	286	0.269231	0.0275367	0.33438	-0.447486	0.232799	-0.16218	0.85 [0.65 - 1.11]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	222063_s_at	286	0.807692	0.0208031	0.275482	-0.671646	0.627482	-0.0521769	0.95 [0.77 - 1.17]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205709_s_at	159	0.125786	0.231676	-	-0.493555	0.922345	-0.0255095	0.97 [0.58 - 1.63]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222063_s_at	159	0.308176	0.0116479	0.180984	1.06705	0.0392234	0.507628	1.66 [1.03 - 2.69]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205709_s_at	159	0.125786	0.0228935	0.294552	-0.954746	0.437212	-0.223647	0.80 [0.45 - 1.41]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222063_s_at	159	0.805031	0.00581458	0.106524	0.886522	0.0285357	0.550282	1.73 [1.06 - 2.84]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205709_s_at	159	0.125786	0.0686797	-	-0.707321	0.624232	-0.124046	0.88 [0.54 - 1.45]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	222063_s_at	159	0.654088	0.00518866	0.0974387	1.01117	0.00888069	0.870235	2.39 [1.24 - 4.58]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	222063_s_at	54	0.166667	0.0910492	-	-1.08906	0.170365	-2.22463	0.11 [0.00 - 2.60]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205709_s_at	54	0.888889	0.016161	0.230106	1.60208	0.297673	0.617815	1.85 [0.58 - 5.93]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222063_s_at	117	0.82906	0.0514249	-	-1.11349	0.461839	-0.661165	0.52 [0.09 - 3.00]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222063_s_at	117	0.803419	0.0749997	-	0.720917	0.942089	0.0735787	1.08 [0.15 - 7.84]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205709_s_at	117	0.25641	0.225753	-	0.475004	0.642374	0.0974412	1.10 [0.73 - 1.66]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205709_s_at	117	0.777778	0.109085	-	-0.94413	0.881777	0.0368648	1.04 [0.64 - 1.69]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205709_s_at	117	0.25641	0.225753	-	0.475004	0.642374	0.0974412	1.10 [0.73 - 1.66]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205709_s_at	117	0.623932	0.201698	-	-0.557805	0.895923	0.0337591	1.03 [0.62 - 1.72]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222063_s_at	117	0.82906	0.077029	-	-1.22112	0.619343	-0.514426	0.60 [0.08 - 4.55]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	222063_s_at	117	0.82906	0.0514249	-	-1.11349	0.461839	-0.661165	0.52 [0.09 - 3.00]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	222063_s_at	236	0.898305	0.140316	-	0.557317	0.950769	0.00989183	1.01 [0.74 - 1.38]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205709_s_at	236	0.877119	0.00218727	0.0487376	0.966704	0.866938	0.047726	1.05 [0.60 - 1.83]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205709_s_at	249	0.875502	4.43891e-05	0.00170534	1.0414	0.584043	0.12214	1.13 [0.73 - 1.75]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	222063_s_at	249	0.839357	0.0480727	0.47993	0.49784	0.254687	0.149995	1.16 [0.90 - 1.50]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205709_s_at	54	0.148148	0.26823	-	-0.748229	0.510223	-0.162168	0.85 [0.52 - 1.38]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222063_s_at	125	0.784	0.0724083	-	-1.23957	0.752842	-0.428558	0.65 [0.05 - 9.38]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222063_s_at	125	0.872	0.09397	-	-1.14779	0.828622	0.221727	1.25 [0.17 - 9.29]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222063_s_at	54	0.277778	0.0363029	0.401779	15.552	0.949439	-0.0257958	0.97 [0.44 - 2.16]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205709_s_at	62	0.629032	0.312277	-	-0.518128	0.518041	-0.129364	0.88 [0.59 - 1.30]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205709_s_at	125	0.696	0.00212531	0.0476061	1.12985	0.0695415	0.481781	1.62 [0.96 - 2.72]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	222063_s_at	62	0.193548	0.0392349	0.422428	15.3575	0.79314	-0.0881547	0.92 [0.47 - 1.77]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205709_s_at	125	0.696	0.0690406	-	0.535533	0.54672	0.122266	1.13 [0.76 - 1.68]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205709_s_at	198	0.459596	0.191176	-	0.279586	0.523905	0.0707266	1.07 [0.86 - 1.33]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205709_s_at	198	0.151515	0.234535	-	0.506288	0.45282	0.105005	1.11 [0.84 - 1.46]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222063_s_at	198	0.691919	0.277381	-	0.240536	0.705689	0.030208	1.03 [0.88 - 1.21]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205709_s_at	198	0.126263	0.110337	-	0.914979	0.461745	0.110989	1.12 [0.83 - 1.50]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222063_s_at	198	0.323232	0.111636	-	-0.409342	0.754203	-0.02918	0.97 [0.81 - 1.17]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	222063_s_at	198	0.373737	0.0914529	-	-0.44916	0.419333	-0.0776363	0.93 [0.77 - 1.12]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	222063_s_at	51	0.529412	0.105117	-	1.63015	0.911803	0.259083	1.30 [0.01 - 126.93]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	222063_s_at	62	0.758065	0.0387986	0.419409	-15.4959	0.304891	-1.93725	0.14 [0.00 - 5.83]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205709_s_at	51	0.431373	0.0478066	0.478293	15.9813	0.891328	0.0985747	1.10 [0.27 - 4.54]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205709_s_at	62	0.758065	0.122435	-	-1.47652	0.58621	-0.255789	0.77 [0.31 - 1.94]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205709_s_at	177	0.757062	0.0161353	0.229842	-1.0002	0.0359955	-0.345234	0.71 [0.51 - 0.98]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222063_s_at	177	0.887006	0.00127858	0.0312957	-2.52385	0.0284271	-2.41785	0.09 [0.01 - 0.77]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222063_s_at	145	0.393103	0.141749	-	-0.485518	0.606761	-0.827613	0.44 [0.02 - 10.22]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205709_s_at	177	0.785311	0.0628188	-	-0.624467	0.112838	-0.249323	0.78 [0.57 - 1.06]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222063_s_at	177	0.887006	0.00781412	0.133877	-2.21176	0.0370396	-2.64648	0.07 [0.01 - 0.85]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205709_s_at	145	0.455172	0.00359977	0.0729217	-1.01306	0.0299331	-0.525532	0.59 [0.37 - 0.95]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222063_s_at	226	0.889381	0.212177	-	-0.728424	0.951721	0.00870261	1.01 [0.76 - 1.34]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205709_s_at	226	0.336283	0.00077845	0.0206406	-0.928732	0.0425713	-0.421579	0.66 [0.44 - 0.99]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222063_s_at	55	0.327273	0.017777	0.246422	-1.14999	0.1088	-2.36636	0.09 [0.01 - 1.69]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222063_s_at	49	0.265306	0.00136274	0.0329999	-1.70923	0.0686548	-3.65814	0.03 [0.00 - 1.32]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205709_s_at	55	0.454545	0.0146587	0.21438	1.30979	0.0634248	0.856565	2.36 [0.95 - 5.82]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205709_s_at	55	0.181818	0.233912	-	0.860926	0.495486	0.245732	1.28 [0.63 - 2.59]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205709_s_at	49	0.44898	0.0236139	0.30095	1.58418	0.112583	0.974381	2.65 [0.80 - 8.83]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222063_s_at	55	0.345455	9.03231e-05	0.00320175	-1.65988	0.0111963	-3.53235	0.03 [0.00 - 0.45]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	135630	34	0.558824	0.213782	-	0.540764	0.818996	0.0696847	1.07 [0.59 - 1.95]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	133825	34	0.852941	0.00114387	0.0285207	1.60383	0.157188	0.684776	1.98 [0.77 - 5.12]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205709_s_at	63	0.507937	0.0140919	0.208293	-0.83849	0.271617	-0.232243	0.79 [0.52 - 1.20]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222063_s_at	63	0.111111	4.27797e-05	0.00165013	-1.66792	0.72245	-1.6616	0.19 [0.00 - 1821.65]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502756_3p_a_at	28	0.892857	0.0492425	0.48706	1.44317	0.833928	0.0453909	1.05 [0.68 - 1.60]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.152981.2.A1_3p_a_at	28	0.642857	0.116773	-	-1.00635	0.614957	0.50802	1.66 [0.23 - 12.03]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205709_s_at	82	0.621951	0.000978771	0.0250305	-1.31617	0.191562	-0.202521	0.82 [0.60 - 1.11]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	222063_s_at	82	0.121951	2.36762e-05	0.000972001	-1.52407	0.00295214	-0.805223	0.45 [0.26 - 0.76]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	40218_at	84	0.714286	0.085321	-	-0.606803	0.402117	-0.209484	0.81 [0.50 - 1.32]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205709_s_at	79	0.240506	0.132809	-	-0.447526	0.672654	-0.106535	0.90 [0.55 - 1.47]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	222063_s_at	79	0.708861	0.0589185	-	0.530375	0.548	0.204446	1.23 [0.63 - 2.39]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205709_s_at	104	0.75	0.0787036	-	0.58724	0.867568	0.042365	1.04 [0.63 - 1.72]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	222063_s_at	104	0.875	0.144216	-	0.645292	0.602822	0.219977	1.25 [0.54 - 2.85]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P7250	117	0.846154	0.0444856	0.457392	-1.13659	0.214617	-0.215426	0.81 [0.57 - 1.13]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P938614	117	0.649573	0.0348468	0.391198	-0.689897	0.0389102	-0.546372	0.58 [0.34 - 0.97]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222063_s_at	204	0.102941	0.0526864	-	15.1897	0.338127	0.238982	1.27 [0.78 - 2.07]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222063_s_at	204	0.107843	0.17374	-	-0.491954	0.453753	-0.123803	0.88 [0.64 - 1.22]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205709_s_at	204	0.583333	0.0553269	-	-0.772381	0.393652	-0.311717	0.73 [0.36 - 1.50]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205709_s_at	204	0.583333	0.000233518	0.00735423	-1.17627	0.0559049	-0.50406	0.60 [0.36 - 1.01]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	222063_s_at	178	0.106742	0.018055	0.249169	-0.673194	0.245376	-0.271347	0.76 [0.48 - 1.21]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205709_s_at	178	0.106742	0.110643	-	-0.455715	0.447193	-0.101024	0.90 [0.70 - 1.17]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222063_s_at	111	0.801802	0.420941	-	-0.269944	0.89381	-0.0213117	0.98 [0.72 - 1.34]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205709_s_at	111	0.117117	0.156341	-	-0.509721	0.800307	-0.0598799	0.94 [0.59 - 1.50]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	222063_s_at	90	0.811111	0.0457931	0.465727	-1.13969	0.65544	-0.323782	0.72 [0.17 - 3.00]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	222063_s_at	90	0.577778	0.0233341	0.298475	-0.949777	0.604982	-0.438573	0.64 [0.12 - 3.40]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205709_s_at	90	0.822222	4.75353e-05	0.00181258	1.31098	0.0686714	0.986437	2.68 [0.93 - 7.76]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205709_s_at	90	0.822222	0.000545624	0.0152665	1.27303	0.127102	0.93218	2.54 [0.77 - 8.41]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222063_s_at	138	0.101449	0.0524623	-	-0.630225	0.133959	-4.53746	0.01 [0.00 - 4.04]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205709_s_at	138	0.210145	0.142554	-	0.497005	0.409145	0.083532	1.09 [0.89 - 1.33]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205709_s_at	129	0.596899	0.0201872	0.269714	0.571267	0.25208	0.207746	1.23 [0.86 - 1.76]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	222063_s_at	129	0.511628	0.101416	-	-0.404707	0.913749	-0.0162642	0.98 [0.73 - 1.32]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3030	56	0.392857	0.130587	-	-0.511144	0.687515	-0.100814	0.90 [0.55 - 1.48]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17700	56	0.125	0.0340456	0.385278	-1.02064	0.903115	0.0414199	1.04 [0.53 - 2.03]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3030	56	0.875	0.158839	-	0.69653	0.36811	0.24117	1.27 [0.75 - 2.15]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	17700	56	0.178571	0.0191409	0.259747	-0.908718	0.285367	-0.34438	0.71 [0.38 - 1.33]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205709_s_at	278	0.233813	0.000415727	0.012099	-0.695377	0.0160728	-0.269408	0.76 [0.61 - 0.95]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222063_s_at	278	0.291367	0.0285652	0.342779	-0.436006	0.392911	-0.452881	0.64 [0.22 - 1.80]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205709_s_at	133	0.62406	0.00695246	0.122374	-0.699621	0.144106	-0.125425	0.88 [0.75 - 1.04]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	222063_s_at	133	0.819549	0.0146155	0.213918	0.672161	0.0250279	1.00242	2.72 [1.13 - 6.55]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	12099	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	222063_s_at	185	0.102703	0.0245531	0.309166	-0.600484	0.303963	-0.484019	0.62 [0.24 - 1.55]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205709_s_at	185	0.416216	0.0150743	0.218788	-0.431442	0.662	-0.0986543	0.91 [0.58 - 1.41]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	222063_s_at	185	0.102703	0.0412519	0.436152	-0.527811	0.256056	-0.479693	0.62 [0.27 - 1.42]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205709_s_at	185	0.416216	0.0318091	0.368372	-0.352667	0.875046	-0.0327351	0.97 [0.64 - 1.46]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P7250	110	0.363636	0.135349	-	-0.353616	0.320391	-0.120659	0.89 [0.70 - 1.12]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P7250	110	0.545455	0.229619	-	-0.368479	0.780297	-0.0416363	0.96 [0.72 - 1.29]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205709_s_at	80	0.5375	0.138546	-	-0.70556	0.647178	-0.0709579	0.93 [0.69 - 1.26]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	222063_s_at	80	0.1375	0.0584691	-	-0.951182	0.337879	-0.144014	0.87 [0.64 - 1.16]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_1334	281	0.875445	0.118038	-	0.317662	0.583881	0.0467879	1.05 [0.89 - 1.24]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222063_s_at	38	0.131579	0.0404192	0.430532	15.3477	0.138925	0.83128	2.30 [0.76 - 6.91]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205709_s_at	38	0.368421	0.274863	-	0.566152	0.792698	-0.0632043	0.94 [0.59 - 1.50]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	222063_s_at	140	0.214286	0.0192255	0.260561	1.05831	0.806706	0.36865	1.45 [0.08 - 27.71]
GENE	CDS1	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205709_s_at	140	0.65	0.0421177	0.441929	0.583851	0.286551	0.905919	2.47 [0.47 - 13.09]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212864_at	30	0.633333	0.0129786	0.196078	-1.16609	0.275338	-0.598801	0.55 [0.19 - 1.61]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	212862_at	30	0.766667	9.04249e-05	0.00320493	1.96227	0.350302	0.603739	1.83 [0.52 - 6.49]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1725917	165	0.872727	0.0304746	0.358003	0.67891	0.172722	0.343348	1.41 [0.86 - 2.31]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1725917	165	0.612121	0.0609983	-	0.652353	0.168983	0.536829	1.71 [0.80 - 3.68]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212862_at	163	0.490798	0.136559	-	0.293396	0.740348	0.0875071	1.09 [0.65 - 1.83]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	212864_at	163	0.509202	0.00205227	0.0462627	0.607424	0.0526045	0.393712	1.48 [1.00 - 2.21]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	234450_at	163	0.460123	0.00384083	0.0767964	-0.567443	0.157798	-1.1904	0.30 [0.06 - 1.59]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	233630_at	163	0.846626	0.129584	-	0.391536	0.496464	0.318133	1.37 [0.55 - 3.44]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	234450_at	79	0.746835	0.0160989	0.229468	-0.90556	0.265624	-0.853338	0.43 [0.09 - 1.91]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	233630_at	79	0.101266	0.403306	-	0.435953	0.849319	0.0608072	1.06 [0.57 - 1.99]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212864_at	79	0.772152	0.227115	-	0.401391	0.720864	0.103217	1.11 [0.63 - 1.95]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	212862_at	79	0.379747	0.309329	-	0.31319	0.80266	-0.0799767	0.92 [0.49 - 1.73]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212862_at	58	0.431034	0.0104796	0.167246	-0.734832	0.162367	-0.339787	0.71 [0.44 - 1.15]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212864_at	58	0.827586	0.0156146	0.224452	0.859194	0.0476941	0.827975	2.29 [1.01 - 5.19]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212862_at	34	0.470588	0.0434209	0.450499	0.778132	0.639717	0.253043	1.29 [0.45 - 3.72]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	212864_at	34	0.176471	0.000941588	0.0242294	2.65089	0.0244298	1.15339	3.17 [1.16 - 8.65]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212864_at	158	0.848101	0.171803	-	-0.50669	0.824842	-0.0772003	0.93 [0.47 - 1.83]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	212862_at	158	0.101266	0.00470257	0.0901773	-0.907782	0.0697742	-0.626274	0.53 [0.27 - 1.05]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212864_at	53	0.622642	0.120257	-	0.531678	0.620149	0.237976	1.27 [0.50 - 3.25]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212862_at	53	0.415094	0.13931	-	-0.539245	0.54519	-0.396677	0.67 [0.19 - 2.43]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	212864_at	53	0.622642	0.0787459	-	0.633845	0.517447	0.323885	1.38 [0.52 - 3.69]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	212862_at	53	0.433962	0.194623	-	-0.443363	0.734426	-0.208082	0.81 [0.24 - 2.70]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212864_at	180	0.827778	0.00704591	0.123641	0.663032	0.36468	0.320385	1.38 [0.69 - 2.75]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	212862_at	180	0.216667	0.0409855	0.434361	-0.466242	0.889203	-0.0376018	0.96 [0.57 - 1.63]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	234450_at	180	0.85	0.103205	-	0.435921	0.643305	-0.112315	0.89 [0.56 - 1.44]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	233630_at	180	0.144444	0.00106019	0.0267648	-0.8333	0.106927	-0.397965	0.67 [0.41 - 1.09]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	234450_at	559	0.779964	0.0157486	0.225845	-0.664434	0.0823674	-0.257223	0.77 [0.58 - 1.03]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	233630_at	559	0.762075	0.0004187	0.0121732	-1.04281	0.518874	-0.123788	0.88 [0.61 - 1.29]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212864_at	559	0.259392	0.22667	-	-0.256839	0.624726	-0.125783	0.88 [0.53 - 1.46]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	212862_at	559	0.531306	0.337441	-	0.192478	0.971524	-0.0106446	0.99 [0.55 - 1.78]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212862_at	77	0.87013	3.37566e-05	0.0013356	1.41763	0.187351	0.609156	1.84 [0.74 - 4.55]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	212864_at	77	0.87013	0.0428732	0.446915	-0.853455	0.346248	-0.397455	0.67 [0.29 - 1.54]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	234450_at	77	0.285714	0.0449236	0.4602	0.591067	0.225638	0.47334	1.61 [0.75 - 3.45]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	233630_at	77	0.428571	0.000613295	0.016864	-0.903741	0.078522	-0.349303	0.71 [0.48 - 1.04]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	234450_at	70	0.371429	0.11887	-	-0.422021	0.577662	-0.568925	0.57 [0.08 - 4.19]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	233630_at	70	0.385714	0.0181042	0.249654	0.657735	0.0830718	0.556705	1.74 [0.93 - 3.27]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212864_at	70	0.785714	0.129984	-	0.463822	0.873704	-0.0521984	0.95 [0.50 - 1.81]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	212862_at	70	0.885714	0.192445	-	0.523399	0.411369	0.306676	1.36 [0.65 - 2.82]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41343_at	50	0.82	0.14786	-	0.648511	0.700449	-0.170605	0.84 [0.35 - 2.01]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212864_at	74	0.364865	0.0137947	0.205067	-0.716609	0.215547	-0.704292	0.49 [0.16 - 1.51]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	212862_at	74	0.135135	0.00905007	0.149732	-0.954858	0.0857937	-1.09649	0.33 [0.10 - 1.17]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	233630_at	74	0.189189	0.0520214	-	-0.63263	0.118417	-0.446986	0.64 [0.36 - 1.12]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	234450_at	74	0.756757	0.0571846	-	0.587145	0.102872	0.845306	2.33 [0.84 - 6.43]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	234450_at	67	0.164179	0.289088	-	15.2499	0.624661	1.07195	2.92 [0.04 - 214.06]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212864_at	67	0.537313	0.157241	-	-1.08529	0.963253	0.0512091	1.05 [0.12 - 9.30]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	233630_at	67	0.283582	0.113887	-	-1.03454	0.678226	-0.493243	0.61 [0.06 - 6.28]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	212862_at	67	0.671642	0.180368	-	-1.32946	0.980148	-0.0325074	0.97 [0.07 - 12.53]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212864_at	115	0.382609	0.0411487	0.435459	-1.08584	0.894176	-0.086946	0.92 [0.25 - 3.30]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	212862_at	115	0.191304	0.0196602	0.264721	-1.18893	0.842065	-0.149942	0.86 [0.20 - 3.76]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	234450_at	115	0.834783	0.0321079	0.370664	1.13579	0.73056	0.258435	1.29 [0.30 - 5.64]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	233630_at	115	0.643478	0.0790737	-	-1.25502	0.680725	-0.205896	0.81 [0.31 - 2.17]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41343_at	158	0.765823	0.236058	-	-0.417489	0.825778	-0.0816359	0.92 [0.45 - 1.91]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41343_at	76	0.144737	0.0890831	-	15.2965	0.741212	-0.252123	0.78 [0.17 - 3.47]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	234450_at	204	0.887255	0.279283	-	0.245034	0.623003	0.0390117	1.04 [0.89 - 1.21]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212864_at	204	0.181373	0.000295759	0.00902452	-0.675943	0.173456	-0.296955	0.74 [0.48 - 1.14]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	233630_at	204	0.862745	0.0676662	-	-0.369174	0.380116	-0.0865397	0.92 [0.76 - 1.11]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	212862_at	204	0.52451	0.118367	-	-0.222526	0.9028	0.0238573	1.02 [0.70 - 1.50]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	234450_at	87	0.229885	0.0497517	0.490132	1.13786	0.244334	1.11326	3.04 [0.47 - 19.84]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	234450_at	87	0.229885	0.0497517	0.490132	1.13786	0.244334	1.11326	3.04 [0.47 - 19.84]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	233630_at	87	0.896552	0.0893263	-	0.822792	0.127118	0.687923	1.99 [0.82 - 4.82]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	233630_at	87	0.896552	0.0893263	-	0.822792	0.127118	0.687923	1.99 [0.82 - 4.82]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212864_at	87	0.103448	0.201994	-	1.22232	0.969709	0.0179036	1.02 [0.40 - 2.57]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	212862_at	87	0.172414	0.0468334	0.47226	-0.81144	0.846165	0.0791569	1.08 [0.49 - 2.41]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212864_at	87	0.103448	0.201994	-	1.22232	0.969709	0.0179036	1.02 [0.40 - 2.57]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	212862_at	87	0.172414	0.0468334	0.47226	-0.81144	0.846165	0.0791569	1.08 [0.49 - 2.41]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212862_at	77	0.584416	0.00117865	0.0292429	2.61341	0.0163403	1.34382	3.83 [1.28 - 11.48]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	234450_at	77	0.12987	0.0433812	0.45024	-1.30439	0.991713	0.0150782	1.02 [0.06 - 17.47]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212864_at	77	0.831169	0.13525	-	0.870853	0.184414	0.782951	2.19 [0.69 - 6.95]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	233630_at	77	0.792208	0.000516374	0.0145655	1.94105	0.0118717	1.50226	4.49 [1.39 - 14.48]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	212862_at	77	0.584416	0.00487007	0.092701	1.65911	0.0267169	1.08025	2.95 [1.13 - 7.66]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	212864_at	77	0.831169	0.0302857	0.356518	1.30676	0.0919047	1.17901	3.25 [0.83 - 12.81]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	234450_at	77	0.12987	0.147757	-	-0.922364	0.926244	-0.117161	0.89 [0.07 - 10.63]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	233630_at	77	0.792208	0.0110864	0.174442	1.32106	0.0328674	1.11929	3.06 [1.10 - 8.56]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212862_at	136	0.610294	0.149176	-	-0.793	0.170202	-0.602225	0.55 [0.23 - 1.29]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	212864_at	136	0.772059	0.0656905	-	-1.6846	0.276553	-0.616464	0.54 [0.18 - 1.64]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212864_at	200	0.21	0.170335	-	0.591909	0.80804	0.105081	1.11 [0.48 - 2.59]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	212862_at	200	0.15	0.0123501	0.189019	-0.85248	0.0935214	-0.81138	0.44 [0.17 - 1.15]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9133	60	0.333333	0.000950384	0.0244194	-1.20493	0.121705	-0.681582	0.51 [0.21 - 1.20]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9344	60	0.75	0.0708206	-	-0.943215	0.230963	-0.311469	0.73 [0.44 - 1.22]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9344	60	0.116667	0.0137909	0.205026	-1.09091	0.210466	-0.400938	0.67 [0.36 - 1.25]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9133	60	0.233333	0.000325539	0.00980377	-1.34915	0.00760868	-1.24812	0.29 [0.11 - 0.72]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	15654	155	0.193548	0.000159887	0.0052871	-1.04095	0.00137707	-0.359213	0.70 [0.56 - 0.87]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212864_at	286	0.370629	0.00832555	0.140525	-0.50809	0.212446	-0.302797	0.74 [0.46 - 1.19]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	212862_at	286	0.108392	0.0160349	0.228808	-0.643988	0.418684	-0.284893	0.75 [0.38 - 1.50]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212864_at	159	0.446541	0.000467245	0.0133727	-1.12325	0.122877	-0.713952	0.49 [0.20 - 1.21]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212864_at	159	0.503145	0.000319942	0.0096582	-1.50559	0.008419	-1.42014	0.24 [0.08 - 0.70]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212862_at	159	0.201258	0.151615	-	0.673423	0.350653	0.554748	1.74 [0.54 - 5.58]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212862_at	159	0.201258	0.0546519	-	0.974294	0.168298	0.797308	2.22 [0.71 - 6.90]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212864_at	159	0.421384	6.04933e-05	0.00224566	-1.27038	0.000718803	-1.54387	0.21 [0.09 - 0.52]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	212862_at	159	0.201258	0.051114	-	1.33027	0.203384	0.874458	2.40 [0.62 - 9.23]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	233630_at	159	0.106918	0.0583779	-	1.70369	0.419409	0.281536	1.33 [0.67 - 2.62]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	233630_at	159	0.106918	0.0731608	-	1.62875	0.235085	0.422275	1.53 [0.76 - 3.06]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	233630_at	159	0.106918	0.043759	0.452698	15.2112	0.513486	0.267055	1.31 [0.59 - 2.91]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234450_at	159	0.176101	0.191535	-	0.675542	0.963578	0.0251511	1.03 [0.35 - 3.02]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234450_at	159	0.584906	0.103879	-	-0.553962	0.612988	-0.249228	0.78 [0.30 - 2.05]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	234450_at	159	0.786164	0.189293	-	0.521263	0.574552	0.383822	1.47 [0.38 - 5.61]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212862_at	54	0.12963	0.149757	-	15.369	0.296087	0.663842	1.94 [0.56 - 6.75]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	212864_at	54	0.888889	0.234081	-	0.938088	0.769886	-0.228094	0.80 [0.17 - 3.67]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212862_at	117	0.735043	0.00175825	0.0407446	-1.67822	0.099128	-0.43044	0.65 [0.39 - 1.08]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212862_at	117	0.777778	0.0497891	0.490357	-1.33839	0.197875	-0.416746	0.66 [0.35 - 1.24]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212864_at	117	0.811966	0.225742	-	0.52385	0.486372	0.232795	1.26 [0.66 - 2.43]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212864_at	117	0.418803	0.0618337	-	-0.586232	0.648906	-0.122464	0.88 [0.52 - 1.50]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212864_at	117	0.418803	0.0618337	-	-0.586232	0.648906	-0.122464	0.88 [0.52 - 1.50]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212864_at	117	0.136752	0.263008	-	-0.515405	0.814977	-0.0773941	0.93 [0.48 - 1.77]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212862_at	117	0.735043	0.00175825	0.0407446	-1.67822	0.099128	-0.43044	0.65 [0.39 - 1.08]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	212862_at	117	0.735043	0.00978847	0.158881	-1.68961	0.227837	-0.37117	0.69 [0.38 - 1.26]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212862_at	236	0.271186	0.0201227	0.269105	0.86277	0.748282	0.175649	1.19 [0.41 - 3.48]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	212864_at	236	0.898305	0.0270047	0.329978	-1.92195	0.348933	-0.394996	0.67 [0.29 - 1.54]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	233630_at	236	0.766949	0.0339786	0.384779	-0.833479	0.337804	-0.308478	0.73 [0.39 - 1.38]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	234450_at	236	0.588983	0.0206171	0.273748	0.619269	0.669254	0.230963	1.26 [0.44 - 3.64]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212862_at	249	0.277108	0.058326	-	0.49536	0.906478	-0.0516192	0.95 [0.40 - 2.25]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	212864_at	249	0.835341	0.160234	-	0.361981	0.977349	-0.0091938	0.99 [0.53 - 1.87]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	234450_at	249	0.630522	0.00382612	0.0765617	0.60523	0.361218	0.399103	1.49 [0.63 - 3.51]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	233630_at	249	0.638554	0.0693881	-	0.384025	0.767017	0.0832377	1.09 [0.63 - 1.88]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212862_at	62	0.306452	0.102482	-	-0.807914	0.28637	-0.239761	0.79 [0.51 - 1.22]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212862_at	125	0.872	0.204402	-	0.577848	0.700633	0.16277	1.18 [0.51 - 2.70]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212864_at	62	0.435484	0.0219019	0.285601	-1.13402	0.141319	-0.411183	0.66 [0.38 - 1.15]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212862_at	125	0.616	0.186653	-	-0.416852	0.950674	-0.02089	0.98 [0.51 - 1.90]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212862_at	54	0.314815	0.126903	-	-0.934406	0.440254	-0.214718	0.81 [0.47 - 1.39]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212864_at	125	0.424	0.0940421	-	-0.627332	0.610077	0.236241	1.27 [0.51 - 3.14]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212864_at	125	0.608	0.0998079	-	-0.496887	0.959678	-0.0182465	0.98 [0.48 - 1.99]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	212864_at	54	0.37037	0.0683687	-	-1.12424	0.237195	-0.405134	0.67 [0.34 - 1.31]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212862_at	198	0.116162	0.0331096	0.378272	-0.763781	0.796342	-0.0863783	0.92 [0.48 - 1.77]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212864_at	198	0.343434	0.0764358	-	0.509154	0.652571	0.107518	1.11 [0.70 - 1.78]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212864_at	198	0.343434	0.033306	0.37975	0.662132	0.6849	0.10141	1.11 [0.68 - 1.81]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212862_at	198	0.686869	0.14279	-	0.325898	0.628802	0.124254	1.13 [0.68 - 1.87]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212862_at	198	0.131313	0.0356204	0.396847	-0.668239	0.852704	-0.0591328	0.94 [0.50 - 1.76]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	212864_at	198	0.257576	0.0106471	0.169245	0.692132	0.805265	0.0473425	1.05 [0.72 - 1.53]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212862_at	51	0.117647	0.0303592	0.357096	-1.75509	0.156832	-2.67927	0.07 [0.00 - 2.80]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212862_at	62	0.177419	0.187809	-	-0.786527	0.400475	-0.845343	0.43 [0.06 - 3.08]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	212864_at	51	0.686275	0.116345	-	-15.6624	0.485518	-0.447632	0.64 [0.18 - 2.25]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	212864_at	62	0.741935	0.0249156	0.3123	-15.575	0.504727	-0.282685	0.75 [0.33 - 1.73]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212864_at	145	0.365517	0.0056611	0.104322	-0.899248	0.139783	-0.592947	0.55 [0.25 - 1.21]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212862_at	177	0.847458	0.209616	-	0.383231	0.628243	0.129438	1.14 [0.67 - 1.92]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	212862_at	145	0.227586	0.196938	-	-0.464385	0.525226	-0.260781	0.77 [0.34 - 1.72]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	234450_at	177	0.887006	0.0197895	0.265951	-1.29318	0.273669	-0.852882	0.43 [0.09 - 1.96]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	234450_at	177	0.847458	0.00791737	0.13523	-1.71084	0.245449	-1.05218	0.35 [0.06 - 2.06]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212864_at	177	0.299435	0.000444929	0.012824	-0.924734	0.0311609	-0.693431	0.50 [0.27 - 0.94]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	233630_at	177	0.627119	0.083381	-	0.405101	0.492056	0.342789	1.41 [0.53 - 3.75]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	233630_at	177	0.779661	0.285479	-	-0.372719	0.974116	0.019909	1.02 [0.31 - 3.40]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	212862_at	177	0.288136	0.0786411	-	-0.48701	0.426438	-0.257944	0.77 [0.41 - 1.46]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	212864_at	177	0.299435	0.00943951	0.154585	-0.61458	0.355085	-0.250637	0.78 [0.46 - 1.32]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	233630_at	145	0.213793	0.235807	-	0.563541	0.777937	-0.23851	0.79 [0.15 - 4.13]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	234450_at	145	0.503448	0.0153363	0.221543	-0.851795	0.036077	-2.42363	0.09 [0.01 - 0.85]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212864_at	226	0.681416	0.0615906	-	-0.650159	0.33934	-0.27357	0.76 [0.43 - 1.33]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	212862_at	226	0.110619	0.138886	-	1.02263	0.798653	0.0947361	1.10 [0.53 - 2.28]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	234450_at	226	0.637168	0.00722627	0.126073	-0.953634	0.839849	-0.0342553	0.97 [0.69 - 1.35]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	233630_at	226	0.659292	0.0360167	0.399717	-0.689773	0.431952	-0.142739	0.87 [0.61 - 1.24]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	234450_at	49	0.408163	0.0146882	0.214694	-1.38753	0.149577	-2.9747	0.05 [0.00 - 2.92]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212864_at	49	0.571429	0.0546423	-	1.12007	0.678273	0.270281	1.31 [0.37 - 4.70]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	233630_at	49	0.163265	0.0529561	-	-1.1374	0.383409	-1.89953	0.15 [0.00 - 10.72]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212862_at	55	0.327273	0.318545	-	0.590434	0.76582	0.184383	1.20 [0.36 - 4.05]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	212862_at	49	0.183673	0.221541	-	-0.732564	0.435431	-0.577051	0.56 [0.13 - 2.39]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	234450_at	55	0.436364	0.0138107	0.205242	-1.09977	0.311023	-1.49513	0.22 [0.01 - 4.05]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	233630_at	55	0.181818	0.0307913	0.360483	-1.01933	0.432853	-1.38727	0.25 [0.01 - 8.00]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212864_at	55	0.545455	0.00187783	0.043011	1.40666	0.118653	0.796145	2.22 [0.82 - 6.03]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	234450_at	55	0.109091	0.0948625	-	15.2316	0.865462	-0.270125	0.76 [0.03 - 17.37]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	212864_at	55	0.545455	0.0262117	0.323344	1.10285	0.192571	0.742667	2.10 [0.69 - 6.42]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	212862_at	55	0.727273	0.037801	0.412437	0.920179	0.322105	0.575867	1.78 [0.57 - 5.56]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	233630_at	55	0.563636	0.0968182	-	-0.858772	0.31622	-1.83526	0.16 [0.00 - 5.78]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212862_at	63	0.634921	0.0140671	0.208025	0.817208	0.194172	0.264458	1.30 [0.87 - 1.94]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	234450_at	63	0.190476	2.30766e-06	0.000117393	-1.64132	0.0038808	-43.7872	0.00 [0.00 - 0.00]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	233630_at	63	0.698413	0.00679189	0.120185	0.904946	0.440792	0.309801	1.36 [0.62 - 3.00]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	212864_at	63	0.15873	0.090302	-	0.983975	0.397135	0.229074	1.26 [0.74 - 2.14]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	233630_3p_at	28	0.25	0.18121	-	-0.828742	0.284674	-2.8102	0.06 [0.00 - 10.36]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.283834.0.S1_3p_at	28	0.25	0.0468457	0.472336	-1.13531	0.26413	-8.55914	0.00 [0.00 - 641.51]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.24812.0.S1_3p_at	28	0.642857	0.126882	-	-0.966534	0.27359	-8.4958	0.00 [0.00 - 823.55]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.306912.0.S1_3p_x_at	28	0.892857	0.0391283	0.421692	1.29458	0.0915733	0.538101	1.71 [0.92 - 3.20]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.24812.0.S2_3p_at	28	0.571429	0.0790329	-	0.995569	0.152839	0.244864	1.28 [0.91 - 1.79]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212862_at	82	0.768293	0.000127588	0.00433892	1.24244	0.00184388	1.64282	5.17 [1.84 - 14.54]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	212864_at	82	0.865854	4.15402e-05	0.00160743	1.42771	0.101308	0.736969	2.09 [0.87 - 5.05]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212862_at	79	0.164557	0.317742	-	-0.347235	0.560154	-0.29847	0.74 [0.27 - 2.03]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	212864_at	79	0.772152	0.0489306	0.485169	-0.649233	0.82546	-0.0732472	0.93 [0.48 - 1.78]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212864_at	104	0.826923	0.166562	-	-0.719694	0.945316	-0.0291064	0.97 [0.42 - 2.23]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	212862_at	104	0.798077	0.152653	-	0.504284	0.826716	0.128613	1.14 [0.36 - 3.60]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P271363	117	0.700855	0.0722108	-	-0.627423	0.547678	0.148664	1.16 [0.71 - 1.88]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P154698	117	0.74359	0.13563	-	0.460094	0.738652	0.0872426	1.09 [0.65 - 1.82]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	234450_at	204	0.872549	0.00152619	0.0362502	1.19286	0.0676709	0.517222	1.68 [0.96 - 2.92]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212864_at	204	0.343137	0.0193271	0.261536	1.09284	0.138482	0.903625	2.47 [0.75 - 8.16]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	233630_at	204	0.196078	0.00117326	0.0291313	-1.14753	0.0640382	-0.637634	0.53 [0.27 - 1.04]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	234450_at	204	0.892157	0.00855697	0.143492	0.862918	0.121588	0.300272	1.35 [0.92 - 1.97]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212864_at	204	0.343137	0.00966854	0.15741	0.850203	0.276909	0.508299	1.66 [0.66 - 4.16]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	233630_at	204	0.284314	0.000564032	0.0157043	-0.910666	0.0273548	-0.575781	0.56 [0.34 - 0.94]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	212862_at	204	0.79902	0.124708	-	0.604304	0.307463	0.774172	2.17 [0.49 - 9.59]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	212862_at	204	0.441176	0.0460544	0.467376	0.568791	0.163045	0.777715	2.18 [0.73 - 6.49]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212862_at	178	0.662921	0.0216501	0.283302	-0.50179	0.317222	-0.330016	0.72 [0.38 - 1.37]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	212864_at	178	0.106742	0.00339597	0.0695956	-0.804704	0.550335	-0.19815	0.82 [0.43 - 1.57]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200003446	41	0.609756	0.0443095	0.456259	0.819538	0.494124	0.290961	1.34 [0.58 - 3.08]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212864_at	111	0.441441	0.0521553	-	-0.510289	0.347005	-0.304374	0.74 [0.39 - 1.39]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	212862_at	111	0.864865	0.159611	-	0.48416	0.963211	0.0193274	1.02 [0.45 - 2.32]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	234450_at	111	0.108108	0.077565	-	-0.660814	0.163914	-0.278564	0.76 [0.51 - 1.12]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	233630_at	111	0.126126	0.186793	-	-0.473765	0.716424	-0.0580481	0.94 [0.69 - 1.29]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212862_at	90	0.111111	0.00950222	0.155361	-1.04588	0.0496895	-0.825955	0.44 [0.19 - 1.00]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212862_at	90	0.111111	0.00707682	0.124059	-1.17604	0.0247472	-1.03982	0.35 [0.14 - 0.88]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	212864_at	90	0.111111	0.0102609	0.164619	-1.03829	0.35843	-0.406896	0.67 [0.28 - 1.59]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	212864_at	90	0.177778	0.00386666	0.077208	-1.11319	0.131324	-0.786428	0.46 [0.16 - 1.27]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212864_at	138	0.884058	0.0554621	-	0.60249	0.460025	0.146985	1.16 [0.78 - 1.71]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	212862_at	138	0.355072	0.00411771	0.0811724	0.801785	0.159401	0.206823	1.23 [0.92 - 1.64]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	234450_at	138	0.101449	0.101631	-	-0.534284	0.809467	0.495787	1.64 [0.03 - 92.39]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	233630_at	138	0.152174	0.0217771	0.284463	-0.647117	0.4125	0.414451	1.51 [0.56 - 4.08]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212864_at	129	0.124031	0.000173243	0.00567091	-1.0936	0.0783394	-0.760241	0.47 [0.20 - 1.09]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	212862_at	129	0.713178	0.0305983	0.358973	-0.631943	0.325659	-0.451848	0.64 [0.26 - 1.57]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42446	56	0.803571	0.0722338	-	0.734916	0.657396	0.171087	1.19 [0.56 - 2.53]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6970	56	0.803571	0.056535	-	0.773108	0.146656	0.576905	1.78 [0.82 - 3.88]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	42446	56	0.714286	0.23743	-	0.42402	0.971313	0.0125963	1.01 [0.51 - 2.01]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	6970	56	0.803571	0.159806	-	0.567003	0.348582	0.353135	1.42 [0.68 - 2.98]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212862_at	278	0.769784	0.0253082	0.315672	-0.528701	0.304552	-0.176071	0.84 [0.60 - 1.17]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	234450_at	278	0.438849	0.0086491	0.144666	-0.496725	0.142688	-0.714981	0.49 [0.19 - 1.27]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	212864_at	278	0.881295	0.201818	-	-0.375435	0.873705	-0.0302889	0.97 [0.67 - 1.41]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	233630_at	278	0.208633	0.0523895	-	-0.396784	0.336641	-0.195467	0.82 [0.55 - 1.23]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212862_at	133	0.586466	0.0639852	-	-0.454565	0.364103	-0.10195	0.90 [0.72 - 1.13]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	212864_at	133	0.240602	0.034263	0.386891	-0.534413	0.0660292	-0.245809	0.78 [0.60 - 1.02]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15629	81	0.888889	0.00313813	0.065317	1.58977	0.355717	0.647275	1.91 [0.48 - 7.55]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	17999	81	0.246914	0.280194	-	0.800714	0.519901	0.582704	1.79 [0.30 - 10.56]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212862_at	185	0.194595	0.0706051	-	0.436707	0.774284	0.0670516	1.07 [0.68 - 1.69]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212864_at	185	0.821622	0.0967995	-	0.330671	0.527003	0.116168	1.12 [0.78 - 1.61]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212862_at	185	0.194595	0.168212	-	0.291707	0.723516	0.0753184	1.08 [0.71 - 1.64]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	212864_at	185	0.102703	0.12003	-	0.506639	0.563122	0.115443	1.12 [0.76 - 1.66]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P271363	110	0.890909	0.0675871	-	0.734449	0.705858	0.0920746	1.10 [0.68 - 1.77]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P154698	110	0.854545	0.00637084	0.114373	0.928399	0.274679	0.288227	1.33 [0.80 - 2.24]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P271363	110	0.145455	0.0621259	-	-0.553664	0.509536	-0.124899	0.88 [0.61 - 1.28]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P154698	110	0.854545	0.00606637	0.110102	0.804831	0.530926	0.136365	1.15 [0.75 - 1.76]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212864_at	80	0.175	0.094292	-	-0.771174	0.13799	-0.795846	0.45 [0.16 - 1.29]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	212862_at	80	0.875	0.0411143	0.435228	-15.3259	0.17077	-0.723869	0.48 [0.17 - 1.37]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_4251	281	0.896797	0.146679	-	0.32814	0.799426	-0.0260623	0.97 [0.80 - 1.19]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212864_at	38	0.605263	0.0203945	0.271663	1.17402	0.162576	0.613365	1.85 [0.78 - 4.37]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	212862_at	38	0.394737	0.00792282	0.135301	1.49345	0.047739	0.777746	2.18 [1.01 - 4.70]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	234450_at	38	0.157895	0.119916	-	-0.893047	0.740746	0.212955	1.24 [0.35 - 4.37]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	233630_at	38	0.263158	0.0739571	-	-0.867373	0.59901	-0.186845	0.83 [0.41 - 1.66]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212862_at	140	0.107143	0.0192776	0.261061	-0.844959	0.850283	-0.0963217	0.91 [0.33 - 2.47]
GENE	CDS2	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	212864_at	140	0.314286	0.0585168	-	-0.54478	0.344546	-0.462285	0.63 [0.24 - 1.64]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219375_at	30	0.8	0.0168898	0.237539	1.15229	0.241547	0.923479	2.52 [0.54 - 11.81]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1771332	165	0.321212	0.145348	-	-0.365927	0.561737	0.158263	1.17 [0.69 - 2.00]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1771332	165	0.309091	0.312006	-	-0.367708	0.928856	0.0368157	1.04 [0.46 - 2.33]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219375_at	163	0.110429	0.354105	-	0.295435	0.933693	0.0194653	1.02 [0.64 - 1.61]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1561884_at	79	0.227848	0.0307805	0.360399	-0.683433	0.659321	-0.272519	0.76 [0.23 - 2.56]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219375_at	79	0.886076	0.00390718	0.0778521	1.13472	0.394961	0.23583	1.27 [0.74 - 2.18]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1558957_s_at	79	0.253165	0.0226135	0.292041	0.904734	0.393056	0.603334	1.83 [0.46 - 7.30]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219375_at	58	0.189655	0.00152097	0.0361476	1.27468	0.0147666	0.756866	2.13 [1.16 - 3.92]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219375_at	34	0.794118	0.0974004	-	0.777657	0.399558	0.3208	1.38 [0.65 - 2.91]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219375_at	158	0.85443	0.0794868	-	-0.683467	0.972924	0.00951736	1.01 [0.58 - 1.75]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219375_at	53	0.226415	0.0522278	-	1.0032	0.21202	0.583219	1.79 [0.72 - 4.48]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219375_at	53	0.886792	0.192565	-	0.623084	0.642373	0.21044	1.23 [0.51 - 3.00]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219375_at	180	0.883333	0.00294077	0.0619848	0.849769	0.584059	0.139404	1.15 [0.70 - 1.89]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1561884_at	559	0.880143	0.0234282	0.299309	-0.814655	0.207289	-0.279793	0.76 [0.49 - 1.17]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219375_at	559	0.200358	0.00418221	0.0821809	-0.603359	0.109862	-0.394006	0.67 [0.42 - 1.09]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1558957_s_at	559	0.783542	0.0449663	0.460473	-0.570992	0.586786	-0.0512465	0.95 [0.79 - 1.14]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219375_at	77	0.675325	0.00271174	0.058051	0.793445	0.661229	0.149746	1.16 [0.59 - 2.27]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1561884_at	70	0.285714	0.278751	-	-0.303922	0.633193	-0.24675	0.78 [0.28 - 2.15]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219375_at	70	0.428571	0.199009	-	-0.338462	0.789831	-0.112432	0.89 [0.39 - 2.04]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1558957_s_at	70	0.871429	0.310445	-	-0.408496	0.800173	-0.488478	0.61 [0.01 - 26.95]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219375_at	74	0.283784	0.0485454	0.482824	0.715885	0.586062	0.227693	1.26 [0.55 - 2.85]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1558957_s_at	67	0.746269	0.00998832	0.161319	1.59644	0.307021	3.0839	21.84 [0.06 - 8112.49]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1561884_at	67	0.179104	0.150368	-	15.3345	0.615306	0.695703	2.01 [0.13 - 30.24]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219375_at	67	0.895522	4.62107e-06	0.000221513	2.69323	0.51252	0.829568	2.29 [0.19 - 27.45]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1558957_s_at	115	0.713043	0.0543529	-	0.98685	0.635516	0.270663	1.31 [0.43 - 4.01]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1561884_at	115	0.304348	0.10327	-	-0.847381	0.0864779	-1.10601	0.33 [0.09 - 1.17]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219375_at	115	0.669565	0.127365	-	-1.10816	0.418154	-0.561976	0.57 [0.15 - 2.22]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219375_at	204	0.421569	0.0596572	-	0.26342	0.171418	0.230321	1.26 [0.91 - 1.75]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1558957_s_at	204	0.553922	0.00967956	0.157546	-0.365289	0.0996447	-0.126561	0.88 [0.76 - 1.02]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1561884_at	204	0.240196	0.034738	0.390398	-0.351156	0.18249	-0.177687	0.84 [0.64 - 1.09]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1561884_at	87	0.356322	0.205414	-	-0.475776	0.70808	0.101731	1.11 [0.65 - 1.89]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1561884_at	87	0.356322	0.205414	-	-0.475776	0.70808	0.101731	1.11 [0.65 - 1.89]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219375_at	87	0.321839	0.176395	-	0.613474	0.427761	0.326258	1.39 [0.62 - 3.10]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1558957_s_at	87	0.114943	0.155488	-	1.3437	0.901767	-0.120773	0.89 [0.13 - 6.03]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1558957_s_at	87	0.114943	0.155488	-	1.3437	0.901767	-0.120773	0.89 [0.13 - 6.03]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219375_at	87	0.321839	0.176395	-	0.613474	0.427761	0.326258	1.39 [0.62 - 3.10]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219375_at	77	0.25974	0.000721882	0.0193649	-1.99471	0.010916	-2.3541	0.09 [0.02 - 0.58]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1561884_at	77	0.480519	0.00503604	0.0951792	-1.8735	0.0902374	-0.927271	0.40 [0.14 - 1.16]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219375_at	77	0.25974	3.31563e-06	0.000163587	-2.43988	0.00191332	-2.53576	0.08 [0.02 - 0.39]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1558957_s_at	77	0.220779	0.014554	0.213261	-1.27655	0.250457	-2.25171	0.11 [0.00 - 4.90]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1558957_s_at	77	0.181818	0.00286964	0.0607712	-1.68867	0.227121	-2.73169	0.07 [0.00 - 5.48]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1561884_at	77	0.142857	0.010679	0.169624	-1.51159	0.151587	-0.901803	0.41 [0.12 - 1.39]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219375_at	136	0.816176	0.272182	-	0.571039	0.894498	0.0814392	1.08 [0.33 - 3.61]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219375_at	200	0.51	0.0118362	0.183154	0.761678	0.0402494	0.67248	1.96 [1.03 - 3.72]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16138	60	0.183333	0.00450117	0.0871111	-1.17116	0.475509	-0.255095	0.77 [0.38 - 1.56]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16138	60	0.3	0.0229566	0.295116	-0.852007	0.91659	0.0519131	1.05 [0.40 - 2.78]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	4628	155	0.858065	0.000499483	0.0141577	1.01449	0.000462528	0.482908	1.62 [1.24 - 2.12]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219375_at	286	0.881119	0.0452175	0.462075	0.525808	0.867764	0.0459967	1.05 [0.61 - 1.80]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219375_at	159	0.188679	0.122971	-	-0.539783	0.518418	-0.270066	0.76 [0.34 - 1.73]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219375_at	159	0.27044	0.000215039	0.0068459	-1.1139	0.0522143	-0.805857	0.45 [0.20 - 1.01]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219375_at	159	0.188679	0.0217075	0.283827	-0.869548	0.20614	-0.617177	0.54 [0.21 - 1.40]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219375_at	54	0.314815	0.161076	-	-0.955267	0.875537	0.108753	1.11 [0.29 - 4.35]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219375_at	117	0.82906	0.0212409	0.27954	-1.52263	0.582899	-0.190939	0.83 [0.42 - 1.63]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219375_at	117	0.709402	0.244025	-	-0.571154	0.741929	-0.142915	0.87 [0.37 - 2.03]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219375_at	117	0.82906	0.0212409	0.27954	-1.52263	0.582899	-0.190939	0.83 [0.42 - 1.63]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219375_at	117	0.82906	0.103079	-	-1.13549	0.981718	-0.0094514	0.99 [0.44 - 2.22]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219375_at	236	0.898305	0.0904801	-	0.608591	0.664785	-0.17637	0.84 [0.38 - 1.86]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219375_at	249	0.899598	0.0386352	0.418274	0.592829	0.972619	0.0106822	1.01 [0.55 - 1.86]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219375_at	125	0.656	0.0921423	-	-0.736283	0.95995	0.0174015	1.02 [0.52 - 2.01]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219375_at	125	0.656	0.023267	0.297879	-0.732055	0.441875	-0.202658	0.82 [0.49 - 1.37]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219375_at	54	0.111111	0.018645	0.254947	-1.49184	0.244067	-0.662132	0.52 [0.17 - 1.57]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219375_at	62	0.112903	0.0564299	-	-1.05443	0.160766	-0.67666	0.51 [0.20 - 1.31]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219375_at	198	0.570707	0.00887795	0.147566	-0.577248	0.435755	-0.214156	0.81 [0.47 - 1.38]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219375_at	198	0.560606	0.000980941	0.025077	-0.927027	0.0509939	-0.63558	0.53 [0.28 - 1.00]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219375_at	198	0.530303	0.00188009	0.0430536	-0.876271	0.128119	-0.510645	0.60 [0.31 - 1.16]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219375_at	51	0.529412	0.013597	0.202907	16.4181	0.230346	1.29065	3.64 [0.44 - 29.95]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219375_at	62	0.83871	0.066122	-	1.0737	0.4178	0.586671	1.80 [0.43 - 7.43]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1558957_s_at	177	0.40113	0.0573621	-	-0.51298	0.431544	-1.08398	0.34 [0.02 - 5.04]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1561884_at	177	0.745763	0.0190811	0.259171	-0.725664	0.550963	-0.35967	0.70 [0.21 - 2.28]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1561884_at	177	0.124294	0.0186465	0.254961	2.01583	0.715468	0.246849	1.28 [0.34 - 4.83]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219375_at	177	0.779661	0.109162	-	0.436664	0.522928	0.178891	1.20 [0.69 - 2.07]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1558957_s_at	177	0.655367	0.019089	0.259247	-0.668169	0.254312	-1.37835	0.25 [0.02 - 2.70]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1561884_at	145	0.793103	0.0597278	-	-0.963309	0.697071	-0.338445	0.71 [0.13 - 3.92]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219375_at	145	0.103448	0.282157	-	-0.477494	0.868546	-0.0669022	0.94 [0.42 - 2.07]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1558957_s_at	145	0.413793	0.0182055	0.25065	-0.778774	0.171242	-2.40505	0.09 [0.00 - 2.83]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219375_at	177	0.440678	0.233781	-	0.329564	0.596206	0.17093	1.19 [0.63 - 2.23]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1561884_at	226	0.734513	0.133829	-	-0.531252	0.890852	-0.0259486	0.97 [0.67 - 1.41]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219375_at	226	0.331858	0.176769	-	0.427366	0.883286	0.0376007	1.04 [0.63 - 1.72]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1558957_s_at	226	0.858407	0.0960139	-	0.607292	0.729084	0.0414698	1.04 [0.82 - 1.32]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1561884_at	55	0.472727	0.190258	-	-0.589852	0.975327	-0.0359415	0.96 [0.10 - 9.41]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219375_at	55	0.109091	0.00145528	0.0348492	-1.67972	0.0112231	-1.65696	0.19 [0.05 - 0.69]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219375_at	55	0.4	0.0638267	-	-0.812981	0.301716	-0.574098	0.56 [0.19 - 1.67]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1558957_s_at	55	0.290909	0.0994291	-	-0.737959	0.55534	-1.47306	0.23 [0.00 - 30.64]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219375_at	49	0.285714	0.174883	-	-0.778346	0.61451	-0.343345	0.71 [0.19 - 2.70]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1558957_s_at	55	0.218182	0.0260565	0.322034	-1.06212	0.531796	-1.79783	0.17 [0.00 - 46.42]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1561884_at	55	0.254545	0.0497723	0.490256	-0.903211	0.739329	-0.439113	0.64 [0.05 - 8.56]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1558957_s_at	49	0.122449	0.259037	-	-0.737471	0.883874	-0.404513	0.67 [0.00 - 151.98]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1561884_at	49	0.102041	0.14682	-	15.2768	0.71773	0.573041	1.77 [0.08 - 39.65]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1561884_at	63	0.333333	0.000154341	0.00512638	-1.26636	0.0089814	-0.885361	0.41 [0.21 - 0.80]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219375_at	63	0.412698	0.0156335	0.224649	-0.81045	0.110755	-0.402868	0.67 [0.41 - 1.10]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1558957_s_at	63	0.571429	0.0267508	0.327864	-0.796117	0.188943	-1.98335	0.14 [0.01 - 2.65]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.125779.1.A1_3p_at	28	0.892857	0.0642932	-	-15.4298	0.174904	-2.40749	0.09 [0.00 - 2.92]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.376275.1.A1_3p_s_at	28	0.642857	0.106351	-	-1.03201	0.177023	-1.03984	0.35 [0.08 - 1.60]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g5174414_3p_at	28	0.142857	0.0187744	0.256204	-1.55014	0.453585	0.543117	1.72 [0.42 - 7.12]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219375_at	82	0.585366	0.0105923	0.168592	-0.950551	0.156132	-0.780484	0.46 [0.16 - 1.35]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219375_at	79	0.797468	0.0872371	-	0.525984	0.921849	0.0487573	1.05 [0.40 - 2.78]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219375_at	104	0.538462	0.0723346	-	-0.621139	0.100656	-0.919136	0.40 [0.13 - 1.20]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P233944	117	0.897436	1.61221e-06	8.4463e-05	1.56888	0.00121885	0.819327	2.27 [1.38 - 3.73]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1558957_s_at	204	0.676471	0.00451721	0.0873566	-1.56434	0.154584	-0.579567	0.56 [0.25 - 1.24]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1561884_at	204	0.529412	0.00132906	0.0323206	-1.35951	0.0560048	-0.82079	0.44 [0.19 - 1.02]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1558957_s_at	204	0.338235	5.6102e-05	0.00210033	-1.05536	0.020905	-0.679168	0.51 [0.28 - 0.90]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1561884_at	204	0.529412	0.00192839	0.0439599	-0.895189	0.0177208	-0.752666	0.47 [0.25 - 0.88]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219375_at	204	0.166667	0.00880164	0.146602	15.3349	0.0115102	2.15428	8.62 [1.62 - 45.85]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219375_at	204	0.808824	0.000763147	0.0202972	0.940153	0.00028439	2.32296	10.21 [2.91 - 35.79]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219375_at	178	0.235955	0.160767	-	0.341066	0.950384	0.0243383	1.02 [0.48 - 2.21]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200012531	41	0.390244	0.125316	-	-0.632799	0.305169	-0.247829	0.78 [0.49 - 1.25]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1558957_s_at	111	0.891892	0.0270765	0.330575	-1.45928	0.689854	-0.0418559	0.96 [0.78 - 1.18]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1561884_at	111	0.882883	0.0361422	0.400622	-1.17736	0.21873	-0.2645	0.77 [0.50 - 1.17]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219375_at	111	0.405405	0.088356	-	0.466547	0.80389	0.0887231	1.09 [0.54 - 2.20]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219375_at	90	0.566667	0.0590797	-	-0.76609	0.570321	-0.345324	0.71 [0.21 - 2.33]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219375_at	90	0.888889	0.292967	-	0.463963	0.803832	0.132002	1.14 [0.40 - 3.23]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	222	50	0.72	0.0757471	-	-1.25221	0.518673	-0.186835	0.83 [0.47 - 1.46]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1561884_at	138	0.26087	0.0648167	-	-0.4635	0.434	-0.230807	0.79 [0.45 - 1.42]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1558957_s_at	138	0.775362	0.00316303	0.0657338	-1.06369	0.0113463	-2.82164	0.06 [0.01 - 0.53]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219375_at	138	0.594203	0.0099122	0.160392	0.612266	0.0450747	0.39224	1.48 [1.01 - 2.17]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219375_at	129	0.844961	0.283203	-	0.32963	0.989728	0.00556827	1.01 [0.43 - 2.35]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21138	56	0.142857	0.0101546	0.163335	-1.13348	0.338234	-0.464361	0.63 [0.24 - 1.63]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40822	56	0.857143	0.0618873	-	0.850563	0.452116	0.273575	1.31 [0.64 - 2.68]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21138	56	0.142857	0.000355633	0.0105798	-1.58948	0.191336	-0.694373	0.50 [0.18 - 1.42]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40822	56	0.107143	0.069972	-	-1.09039	0.715412	0.123285	1.13 [0.58 - 2.19]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219375_at	278	0.100719	0.0298258	0.352882	-0.620651	0.371732	-0.201928	0.82 [0.52 - 1.27]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1558957_s_at	278	0.100719	9.26459e-05	0.00327426	-0.959215	0.0856239	-1.11409	0.33 [0.09 - 1.17]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1561884_at	278	0.744604	0.117907	-	-0.371979	0.480082	-0.123563	0.88 [0.63 - 1.25]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219375_at	133	0.18797	0.0536566	-	-0.538555	0.0582223	-0.319305	0.73 [0.52 - 1.01]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219375_at	185	0.627027	0.172065	-	-0.247458	0.483867	-0.0918023	0.91 [0.71 - 1.18]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219375_at	185	0.632432	0.0403638	0.430156	-0.343495	0.32108	-0.118697	0.89 [0.70 - 1.12]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P233944	110	0.854545	0.0511455	-	-0.757878	0.875226	-0.0264936	0.97 [0.70 - 1.36]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P233944	110	0.309091	0.259994	-	0.3713	0.882072	0.0330448	1.03 [0.67 - 1.60]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219375_at	80	0.325	0.026991	0.329864	-0.978372	0.159736	-0.592828	0.55 [0.24 - 1.26]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1558957_s_at	38	0.868421	0.0795212	-	1.0135	0.342427	0.457201	1.58 [0.61 - 4.06]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1561884_at	38	0.710526	0.0525252	-	-1.16125	0.595146	-0.248673	0.78 [0.31 - 1.95]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219375_at	38	0.526316	0.0123392	0.188895	1.19211	0.123827	0.423129	1.53 [0.89 - 2.62]
GENE	CEPT1	choline/ethanolamine phosphotransferase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219375_at	140	0.121429	0.00139947	0.0337368	-1.15519	0.165012	-0.487517	0.61 [0.31 - 1.22]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CERK	ceramide kinase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	218421_at	30	0.5	0.111543	-	0.635346	0.767952	0.127313	1.14 [0.49 - 2.65]
GENE	CERK	ceramide kinase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1767475	165	0.69697	0.29711	-	-0.299376	0.925708	-0.0170032	0.98 [0.69 - 1.41]
GENE	CERK	ceramide kinase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1767475	165	0.278788	0.0315437	0.366327	1.09532	0.157909	0.355916	1.43 [0.87 - 2.34]
GENE	CERK	ceramide kinase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	218421_at	163	0.214724	0.00952972	0.155701	0.678025	0.0719122	0.365277	1.44 [0.97 - 2.14]
GENE	CERK	ceramide kinase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	218421_at	79	0.113924	0.196575	-	0.754179	0.893575	-0.0382766	0.96 [0.55 - 1.69]
GENE	CERK	ceramide kinase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218421_at	58	0.551724	0.00366722	0.0740122	-0.805808	0.384261	-0.252968	0.78 [0.44 - 1.37]
GENE	CERK	ceramide kinase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218421_at	34	0.558824	0.0196344	0.264474	-0.913687	0.16031	-0.807648	0.45 [0.14 - 1.38]
GENE	CERK	ceramide kinase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	218421_at	158	0.189873	0.242016	-	0.366365	0.82219	0.0534728	1.05 [0.66 - 1.68]
GENE	CERK	ceramide kinase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	218421_at	53	0.622642	0.106129	-	-0.659075	0.767144	-0.116164	0.89 [0.41 - 1.92]
GENE	CERK	ceramide kinase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	218421_at	53	0.867925	0.20062	-	-0.756414	0.979705	0.00949038	1.01 [0.49 - 2.10]
GENE	CERK	ceramide kinase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	218421_at	180	0.111111	0.346255	-	0.32951	0.989653	-0.00407392	1.00 [0.54 - 1.84]
GENE	CERK	ceramide kinase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	218421_at	559	0.252236	0.147918	-	0.353597	0.62461	0.110567	1.12 [0.72 - 1.74]
GENE	CERK	ceramide kinase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	218421_at	77	0.324675	0.118208	-	-0.418376	0.28478	-0.480656	0.62 [0.26 - 1.49]
GENE	CERK	ceramide kinase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	218421_at	70	0.642857	0.0222782	0.289018	-0.662058	0.206006	-0.381651	0.68 [0.38 - 1.23]
GENE	CERK	ceramide kinase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	218421_at	74	0.864865	0.000958019	0.0245841	1.13126	0.0587072	1.15547	3.18 [0.96 - 10.52]
GENE	CERK	ceramide kinase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	218421_at	67	0.134328	0.048096	0.480073	-1.3052	0.427003	-0.832671	0.43 [0.06 - 3.39]
GENE	CERK	ceramide kinase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	218421_at	115	0.252174	0.0852805	-	-0.902432	0.190063	-1.02484	0.36 [0.08 - 1.66]
GENE	CERK	ceramide kinase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	218421_at	204	0.769608	0.144962	-	-0.24276	0.616694	-0.0902729	0.91 [0.64 - 1.30]
GENE	CERK	ceramide kinase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	218421_at	87	0.850575	0.0105395	0.167962	1.02638	0.128811	0.462688	1.59 [0.87 - 2.89]
GENE	CERK	ceramide kinase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	218421_at	87	0.850575	0.0105395	0.167962	1.02638	0.128811	0.462688	1.59 [0.87 - 2.89]
GENE	CERK	ceramide kinase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	218421_at	77	0.142857	0.0116325	0.180807	-1.49511	0.391079	-0.445163	0.64 [0.23 - 1.77]
GENE	CERK	ceramide kinase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	218421_at	77	0.896104	0.0614932	-	1.16679	0.74919	-0.149628	0.86 [0.34 - 2.15]
GENE	CERK	ceramide kinase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	218421_at	136	0.544118	0.0651233	-	0.846555	0.945232	0.0345937	1.04 [0.39 - 2.78]
GENE	CERK	ceramide kinase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	218421_at	200	0.75	0.000659701	0.0179417	0.9759	0.0373727	0.91964	2.51 [1.06 - 5.96]
GENE	CERK	ceramide kinase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5297	60	0.416667	0.0177992	0.246641	0.997832	0.230951	0.22947	1.26 [0.86 - 1.83]
GENE	CERK	ceramide kinase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5297	60	0.3	0.0208555	0.27597	1.17924	0.283885	0.320854	1.38 [0.77 - 2.48]
GENE	CERK	ceramide kinase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	218421_at	286	0.832168	0.00919719	0.151573	0.587746	0.152886	0.361953	1.44 [0.87 - 2.36]
GENE	CERK	ceramide kinase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218421_at	159	0.125786	0.260209	-	0.663702	0.647108	0.238555	1.27 [0.46 - 3.53]
GENE	CERK	ceramide kinase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218421_at	159	0.226415	0.19709	-	-0.441765	0.909695	0.0592013	1.06 [0.38 - 2.95]
GENE	CERK	ceramide kinase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218421_at	159	0.125786	0.288421	-	0.759646	0.847668	0.116547	1.12 [0.34 - 3.69]
GENE	CERK	ceramide kinase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	218421_at	54	0.203704	0.0223849	0.289982	-1.48024	0.115941	-0.868757	0.42 [0.14 - 1.24]
GENE	CERK	ceramide kinase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218421_at	117	0.846154	0.0557549	-	-1.09489	0.30153	-0.268139	0.76 [0.46 - 1.27]
GENE	CERK	ceramide kinase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218421_at	117	0.811966	0.0875168	-	-1.18798	0.201967	-0.407796	0.67 [0.36 - 1.24]
GENE	CERK	ceramide kinase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218421_at	117	0.846154	0.0557549	-	-1.09489	0.30153	-0.268139	0.76 [0.46 - 1.27]
GENE	CERK	ceramide kinase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218421_at	117	0.888889	0.102902	-	-1.51348	0.774933	-0.087334	0.92 [0.50 - 1.67]
GENE	CERK	ceramide kinase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	218421_at	236	0.101695	0.00234655	0.0516147	-0.99072	0.940217	0.0347493	1.04 [0.42 - 2.57]
GENE	CERK	ceramide kinase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	218421_at	249	0.100402	0.0175199	0.243866	-0.700177	0.790366	0.0969896	1.10 [0.54 - 2.25]
GENE	CERK	ceramide kinase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218421_at	125	0.104	0.284564	-	-0.572377	0.900578	-0.055497	0.95 [0.40 - 2.26]
GENE	CERK	ceramide kinase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218421_at	125	0.536	0.253627	-	-0.331928	0.666004	-0.144611	0.87 [0.45 - 1.67]
GENE	CERK	ceramide kinase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218421_at	54	0.648148	0.181117	-	-0.888057	0.641402	0.144782	1.16 [0.63 - 2.13]
GENE	CERK	ceramide kinase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218421_at	62	0.677419	0.103216	-	-0.919411	0.580577	0.141341	1.15 [0.70 - 1.90]
GENE	CERK	ceramide kinase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218421_at	198	0.191919	0.0261286	0.322643	-0.534976	0.411734	-0.158477	0.85 [0.58 - 1.25]
GENE	CERK	ceramide kinase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218421_at	198	0.60101	0.00266623	0.0572604	-0.866258	0.0186568	-0.542051	0.58 [0.37 - 0.91]
GENE	CERK	ceramide kinase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218421_at	198	0.222222	0.00246231	0.0536781	-0.815703	0.0532185	-0.458513	0.63 [0.40 - 1.01]
GENE	CERK	ceramide kinase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	218421_at	51	0.627451	0.0745871	-	-15.8237	0.939439	-0.0436277	0.96 [0.31 - 2.95]
GENE	CERK	ceramide kinase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	218421_at	62	0.225806	0.0521781	-	15.4502	0.405053	0.325173	1.38 [0.64 - 2.98]
GENE	CERK	ceramide kinase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	218421_at	177	0.259887	0.128488	-	-0.43041	0.624848	-0.119146	0.89 [0.55 - 1.43]
GENE	CERK	ceramide kinase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	218421_at	177	0.327684	0.113442	-	-0.378591	0.429741	-0.166128	0.85 [0.56 - 1.28]
GENE	CERK	ceramide kinase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	218421_at	145	0.275862	0.159222	-	-0.476977	0.495743	-0.204489	0.82 [0.45 - 1.47]
GENE	CERK	ceramide kinase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	218421_at	226	0.867257	0.153666	-	-0.72717	0.885121	0.0350285	1.04 [0.64 - 1.67]
GENE	CERK	ceramide kinase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	218421_at	55	0.890909	0.0768993	-	-15.2375	0.719356	-0.156758	0.85 [0.36 - 2.01]
GENE	CERK	ceramide kinase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	218421_at	55	0.763636	0.365483	-	-0.527286	0.977412	0.0132317	1.01 [0.41 - 2.53]
GENE	CERK	ceramide kinase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	218421_at	49	0.428571	0.147396	-	-0.832177	0.466313	-0.400439	0.67 [0.23 - 1.97]
GENE	CERK	ceramide kinase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	195933	34	0.882353	0.523466	-	-0.471102	0.940164	-0.0637332	0.94 [0.18 - 4.96]
GENE	CERK	ceramide kinase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	218421_at	63	0.15873	0.104517	-	0.945526	0.559874	0.116134	1.12 [0.76 - 1.66]
GENE	CERK	ceramide kinase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12232440_3p_at	28	0.107143	0.0875821	-	-1.06993	0.925307	0.0201516	1.02 [0.67 - 1.55]
GENE	CERK	ceramide kinase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	218421_at	82	0.146341	0.120058	-	0.910573	0.530075	0.284303	1.33 [0.55 - 3.23]
GENE	CERK	ceramide kinase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	218421_at	79	0.56962	0.061229	-	-0.505289	0.461578	-0.290533	0.75 [0.35 - 1.62]
GENE	CERK	ceramide kinase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	218421_at	104	0.115385	0.028997	0.346263	-0.891897	0.274924	-0.582782	0.56 [0.20 - 1.59]
GENE	CERK	ceramide kinase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P211659	117	0.153846	0.0517536	-	-0.657603	0.973132	-0.00807677	0.99 [0.62 - 1.59]
GENE	CERK	ceramide kinase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P62237	117	0.188034	0.0537817	-	-0.63169	0.235504	-0.290708	0.75 [0.46 - 1.21]
GENE	CERK	ceramide kinase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	218421_at	204	0.54902	0.00211129	0.047349	-1.30905	0.0231851	-1.31229	0.27 [0.09 - 0.84]
GENE	CERK	ceramide kinase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	218421_at	204	0.54902	0.00383464	0.0766977	-0.83769	0.0178817	-1.02854	0.36 [0.15 - 0.84]
GENE	CERK	ceramide kinase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	218421_at	178	0.224719	0.0772217	-	-0.39388	0.354742	-0.286218	0.75 [0.41 - 1.38]
GENE	CERK	ceramide kinase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200004267	41	0.121951	0.0544939	-	-1.02254	0.197014	-0.534326	0.59 [0.26 - 1.32]
GENE	CERK	ceramide kinase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	218421_at	111	0.810811	0.000633835	0.0173428	0.960989	0.648123	0.189108	1.21 [0.54 - 2.72]
GENE	CERK	ceramide kinase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	218421_at	90	0.677778	0.0614392	-	-0.83463	0.140695	-0.752403	0.47 [0.17 - 1.28]
GENE	CERK	ceramide kinase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	218421_at	90	0.488889	0.00857192	0.143683	-0.86189	0.129181	-0.670143	0.51 [0.22 - 1.22]
GENE	CERK	ceramide kinase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	218421_at	138	0.275362	0.0146657	0.214454	-0.609534	0.158154	-0.178123	0.84 [0.65 - 1.07]
GENE	CERK	ceramide kinase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	218421_at	129	0.751938	0.148699	-	-0.444811	0.316214	-0.452262	0.64 [0.26 - 1.54]
GENE	CERK	ceramide kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39786	56	0.571429	0.0812563	-	-0.60969	0.978141	-0.00757337	0.99 [0.58 - 1.71]
GENE	CERK	ceramide kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11021	56	0.107143	0.298978	-	-0.503953	0.695377	0.152124	1.16 [0.54 - 2.49]
GENE	CERK	ceramide kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39786	56	0.785714	0.0887979	-	0.65063	0.770755	0.0806647	1.08 [0.63 - 1.86]
GENE	CERK	ceramide kinase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11021	56	0.732143	0.456319	-	0.296768	0.616816	0.189944	1.21 [0.57 - 2.54]
GENE	CERK	ceramide kinase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	218421_at	278	0.543165	0.00395344	0.0785855	-0.559535	0.164418	-0.178071	0.84 [0.65 - 1.08]
GENE	CERK	ceramide kinase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	218421_at	133	0.180451	0.0219965	0.286463	-0.673326	0.352931	-0.0959179	0.91 [0.74 - 1.11]
GENE	CERK	ceramide kinase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218421_at	185	0.524324	0.0561209	-	0.309429	0.355926	0.130406	1.14 [0.86 - 1.50]
GENE	CERK	ceramide kinase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218421_at	185	0.524324	0.00109142	0.027423	0.577369	0.01725	0.361853	1.44 [1.07 - 1.93]
GENE	CERK	ceramide kinase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P62237	110	0.290909	0.209553	-	-0.381316	0.48605	-0.156153	0.86 [0.55 - 1.33]
GENE	CERK	ceramide kinase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P211659	110	0.127273	0.179981	-	-0.534396	0.861268	-0.0319884	0.97 [0.68 - 1.39]
GENE	CERK	ceramide kinase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P62237	110	0.881818	0.0423959	0.443771	0.64625	0.682696	0.0698645	1.07 [0.77 - 1.50]
GENE	CERK	ceramide kinase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P211659	110	0.672727	0.160313	-	-0.35489	0.59331	-0.0764309	0.93 [0.70 - 1.23]
GENE	CERK	ceramide kinase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	218421_at	80	0.675	0.0154298	0.222522	1.02294	0.120966	0.537737	1.71 [0.87 - 3.38]
GENE	CERK	ceramide kinase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	218421_at	38	0.868421	0.306865	-	-1.00214	0.804701	0.158047	1.17 [0.33 - 4.10]
GENE	CERK	ceramide kinase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	218421_at	140	0.121429	0.0243944	0.307788	-0.782079	0.741989	-0.126652	0.88 [0.41 - 1.87]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CES2	carboxylesterase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209668_x_at	30	0.166667	0.16946	-	0.828088	0.591011	0.350226	1.42 [0.40 - 5.09]
GENE	CES2	carboxylesterase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	213509_x_at	30	0.666667	0.137565	-	-0.635991	0.460657	-0.495709	0.61 [0.16 - 2.27]
GENE	CES2	carboxylesterase 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	209667_at	30	0.233333	0.0572229	-	-0.867436	0.326839	-0.525439	0.59 [0.21 - 1.69]
GENE	CES2	carboxylesterase 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1696675	165	0.393939	0.070427	-	-0.435111	0.902738	-0.029138	0.97 [0.61 - 1.55]
GENE	CES2	carboxylesterase 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1696675	165	0.393939	0.00524587	0.0982811	-0.968176	0.363719	-0.311115	0.73 [0.37 - 1.43]
GENE	CES2	carboxylesterase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	213509_x_at	163	0.116564	0.0436307	0.451865	0.72696	0.270418	0.413607	1.51 [0.72 - 3.16]
GENE	CES2	carboxylesterase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209667_at	163	0.711656	0.210904	-	0.266019	0.472282	0.180867	1.20 [0.73 - 1.96]
GENE	CES2	carboxylesterase 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	209668_x_at	163	0.153374	0.172608	-	0.402426	0.67608	0.157853	1.17 [0.56 - 2.46]
GENE	CES2	carboxylesterase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209668_x_at	79	0.101266	0.0506386	-	1.31918	0.232724	0.530643	1.70 [0.71 - 4.06]
GENE	CES2	carboxylesterase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	209667_at	79	0.253165	0.0428148	0.446532	0.770828	0.180071	0.439205	1.55 [0.82 - 2.95]
GENE	CES2	carboxylesterase 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	213509_x_at	79	0.455696	0.0858339	-	0.506009	0.242836	0.506564	1.66 [0.71 - 3.88]
GENE	CES2	carboxylesterase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209667_at	58	0.87931	0.072202	-	0.75481	0.933075	0.0313293	1.03 [0.50 - 2.14]
GENE	CES2	carboxylesterase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209668_x_at	58	0.793103	0.0274572	0.333725	0.76455	0.212795	0.475923	1.61 [0.76 - 3.40]
GENE	CES2	carboxylesterase 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213509_x_at	58	0.396552	0.0235681	0.300546	0.649911	0.216878	0.438782	1.55 [0.77 - 3.11]
GENE	CES2	carboxylesterase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209667_at	34	0.794118	0.28042	-	-0.531798	0.498642	-0.385813	0.68 [0.22 - 2.08]
GENE	CES2	carboxylesterase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	209668_x_at	34	0.176471	0.278525	-	0.582386	0.629395	-0.224524	0.80 [0.32 - 1.99]
GENE	CES2	carboxylesterase 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	213509_x_at	34	0.794118	0.0862375	-	-0.926635	0.231063	-0.332941	0.72 [0.42 - 1.24]
GENE	CES2	carboxylesterase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209668_x_at	158	0.196203	0.0259801	0.321388	0.741385	0.283808	0.576001	1.78 [0.62 - 5.10]
GENE	CES2	carboxylesterase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	213509_x_at	158	0.398734	0.0101944	0.163816	0.634994	0.163485	0.678572	1.97 [0.76 - 5.12]
GENE	CES2	carboxylesterase 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	209667_at	158	0.651899	0.0335765	0.381779	0.492896	0.285401	0.448386	1.57 [0.69 - 3.56]
GENE	CES2	carboxylesterase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209668_x_at	53	0.113208	0.0941998	-	-0.798697	0.593916	-0.496812	0.61 [0.10 - 3.78]
GENE	CES2	carboxylesterase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209667_at	53	0.754717	0.0139816	0.207098	0.929098	0.461479	0.678144	1.97 [0.32 - 11.98]
GENE	CES2	carboxylesterase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	213509_x_at	53	0.754717	0.0623662	-	0.678378	0.617343	0.37491	1.45 [0.33 - 6.33]
GENE	CES2	carboxylesterase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	209668_x_at	53	0.226415	0.129195	-	0.794381	0.850951	-0.188834	0.83 [0.12 - 5.93]
GENE	CES2	carboxylesterase 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	209667_at	53	0.754717	0.100761	-	0.610848	0.889746	-0.114098	0.89 [0.18 - 4.48]
GENE	CES2	carboxylesterase 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	213509_x_at	53	0.754717	0.00629255	0.11328	1.01381	0.125586	1.20576	3.34 [0.71 - 15.62]
GENE	CES2	carboxylesterase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209668_x_at	180	0.811111	0.0166769	0.23538	0.562619	0.949856	0.0326924	1.03 [0.37 - 2.86]
GENE	CES2	carboxylesterase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	213509_x_at	180	0.25	0.310885	-	-0.241836	0.718914	-0.163999	0.85 [0.35 - 2.07]
GENE	CES2	carboxylesterase 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	209667_at	180	0.572222	0.0598048	-	0.393201	0.16774	0.530877	1.70 [0.80 - 3.62]
GENE	CES2	carboxylesterase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209668_x_at	559	0.101968	0.383041	-	0.305066	0.71718	0.0897522	1.09 [0.67 - 1.78]
GENE	CES2	carboxylesterase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	209667_at	559	0.679785	0.037232	0.408415	-0.52617	0.0468599	-0.379127	0.68 [0.47 - 0.99]
GENE	CES2	carboxylesterase 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	213509_x_at	559	0.708408	0.166796	-	-0.344732	0.471792	0.113674	1.12 [0.82 - 1.53]
GENE	CES2	carboxylesterase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209667_at	77	0.168831	0.000384825	0.0113226	-1.09377	0.710669	-0.194906	0.82 [0.29 - 2.30]
GENE	CES2	carboxylesterase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	209668_x_at	77	0.545455	0.00839071	0.141363	-0.696229	0.0927329	-0.515597	0.60 [0.33 - 1.09]
GENE	CES2	carboxylesterase 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	213509_x_at	77	0.285714	0.0287105	0.343954	-0.611789	0.0934017	-0.749944	0.47 [0.20 - 1.13]
GENE	CES2	carboxylesterase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209668_x_at	70	0.585714	0.1538	-	-0.393138	0.909051	0.0663032	1.07 [0.34 - 3.33]
GENE	CES2	carboxylesterase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	209667_at	70	0.857143	0.0145636	0.213365	-1.04397	0.600863	-0.181249	0.83 [0.42 - 1.65]
GENE	CES2	carboxylesterase 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	213509_x_at	70	0.414286	0.23563	-	-0.321223	0.762719	-0.199961	0.82 [0.22 - 3.00]
GENE	CES2	carboxylesterase 2	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	40882_at	50	0.76	0.161808	-	-0.566372	0.395149	-0.584415	0.56 [0.14 - 2.14]
GENE	CES2	carboxylesterase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209668_x_at	74	0.608108	0.013696	0.20399	0.706035	0.10923	1.04776	2.85 [0.79 - 10.28]
GENE	CES2	carboxylesterase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	213509_x_at	74	0.283784	0.0755099	-	0.626819	0.256597	0.967778	2.63 [0.49 - 14.01]
GENE	CES2	carboxylesterase 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	209667_at	74	0.810811	0.0311165	0.363017	0.717576	0.158036	0.895816	2.45 [0.71 - 8.50]
GENE	CES2	carboxylesterase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209668_x_at	67	0.895522	0.0232789	0.297986	1.47477	0.1253	1.99985	7.39 [0.57 - 95.29]
GENE	CES2	carboxylesterase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	209667_at	67	0.895522	0.0198786	0.266796	1.50515	0.155218	1.70263	5.49 [0.52 - 57.43]
GENE	CES2	carboxylesterase 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	213509_x_at	67	0.865672	0.000113301	0.00390913	2.1584	0.0528678	2.17133	8.77 [0.97 - 79.01]
GENE	CES2	carboxylesterase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209668_x_at	115	0.634783	0.253893	-	0.602571	0.988838	0.0218835	1.02 [0.05 - 21.93]
GENE	CES2	carboxylesterase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	209667_at	115	0.53913	0.0118066	0.182815	-1.70955	0.153237	-1.25277	0.29 [0.05 - 1.59]
GENE	CES2	carboxylesterase 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	213509_x_at	115	0.773913	0.208293	-	0.692307	0.939452	-0.0679855	0.93 [0.16 - 5.40]
GENE	CES2	carboxylesterase 2	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	40882_at	158	0.525316	0.0427953	0.446403	0.58105	0.206859	0.259444	1.30 [0.87 - 1.94]
GENE	CES2	carboxylesterase 2	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	40882_at	76	0.802632	0.184943	-	-1.28287	0.588918	-0.236874	0.79 [0.33 - 1.86]
GENE	CES2	carboxylesterase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209667_at	204	0.171569	0.00461534	0.0888535	-0.533544	0.106964	-0.32019	0.73 [0.49 - 1.07]
GENE	CES2	carboxylesterase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	213509_x_at	204	0.294118	0.0332707	0.379485	-0.324044	0.055084	-0.446883	0.64 [0.41 - 1.01]
GENE	CES2	carboxylesterase 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	209668_x_at	204	0.112745	0.000813961	0.0214328	-0.74843	0.131084	-0.376134	0.69 [0.42 - 1.12]
GENE	CES2	carboxylesterase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	213509_x_at	87	0.137931	0.231756	-	0.851718	0.646239	0.299049	1.35 [0.38 - 4.84]
GENE	CES2	carboxylesterase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209667_at	87	0.655172	0.102351	-	-0.737979	0.985597	0.00819256	1.01 [0.41 - 2.45]
GENE	CES2	carboxylesterase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209668_x_at	87	0.781609	0.140161	-	-0.873927	0.965065	-0.0259424	0.97 [0.31 - 3.11]
GENE	CES2	carboxylesterase 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	209667_at	87	0.655172	0.102351	-	-0.737979	0.985597	0.00819256	1.01 [0.41 - 2.45]
GENE	CES2	carboxylesterase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	213509_x_at	87	0.137931	0.231756	-	0.851718	0.646239	0.299049	1.35 [0.38 - 4.84]
GENE	CES2	carboxylesterase 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	209668_x_at	87	0.781609	0.140161	-	-0.873927	0.965065	-0.0259424	0.97 [0.31 - 3.11]
GENE	CES2	carboxylesterase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209667_at	77	0.207792	0.0567168	-	15.402	0.964728	0.0227152	1.02 [0.37 - 2.80]
GENE	CES2	carboxylesterase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	213509_x_at	77	0.376623	0.0695973	-	1.70061	0.680682	0.298762	1.35 [0.32 - 5.59]
GENE	CES2	carboxylesterase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209668_x_at	77	0.428571	0.150164	-	1.08399	0.75762	-0.242923	0.78 [0.17 - 3.67]
GENE	CES2	carboxylesterase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	213509_x_at	77	0.376623	0.0221594	0.287942	2.02013	0.548151	0.378258	1.46 [0.42 - 5.02]
GENE	CES2	carboxylesterase 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	209667_at	77	0.207792	0.0993218	-	15.3919	0.985565	-0.0106895	0.99 [0.31 - 3.15]
GENE	CES2	carboxylesterase 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	209668_x_at	77	0.428571	0.0420027	0.441165	1.43678	0.946355	0.0452598	1.05 [0.28 - 3.91]
GENE	CES2	carboxylesterase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	213509_x_at	136	0.669118	0.0277337	0.336	0.970021	0.497418	-0.451155	0.64 [0.17 - 2.34]
GENE	CES2	carboxylesterase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209667_at	136	0.786765	0.036088	0.400232	0.975866	0.832025	-0.132007	0.88 [0.26 - 2.97]
GENE	CES2	carboxylesterase 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	209668_x_at	136	0.154412	0.0108128	0.171213	-1.12987	0.23616	-0.860915	0.42 [0.10 - 1.76]
GENE	CES2	carboxylesterase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209668_x_at	200	0.135	0.0195277	0.263457	-0.868462	0.466353	-0.494633	0.61 [0.16 - 2.31]
GENE	CES2	carboxylesterase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	213509_x_at	200	0.89	0.00108311	0.0272483	1.11634	0.0584418	1.11713	3.06 [0.96 - 9.72]
GENE	CES2	carboxylesterase 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	209667_at	200	0.615	0.000180359	0.00587366	1.08303	0.025139	1.28006	3.60 [1.17 - 11.03]
GENE	CES2	carboxylesterase 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15797	60	0.866667	0.0694354	-	0.810995	0.254026	0.298773	1.35 [0.81 - 2.25]
GENE	CES2	carboxylesterase 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15797	60	0.383333	0.207523	-	0.507734	0.405004	0.301835	1.35 [0.66 - 2.75]
GENE	CES2	carboxylesterase 2	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	14891	155	0.735484	7.3641e-06	0.000338519	1.17759	0.00228477	0.541033	1.72 [1.21 - 2.43]
GENE	CES2	carboxylesterase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209668_x_at	286	0.216783	0.0389731	0.420619	-0.446141	0.712391	-0.13965	0.87 [0.41 - 1.83]
GENE	CES2	carboxylesterase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	213509_x_at	286	0.863636	0.185896	-	-0.417753	0.578749	0.226217	1.25 [0.56 - 2.79]
GENE	CES2	carboxylesterase 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	209667_at	286	0.36014	0.0119972	0.185001	0.546224	0.0592836	0.570541	1.77 [0.98 - 3.20]
GENE	CES2	carboxylesterase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213509_x_at	159	0.18239	0.15745	-	-0.511057	0.931629	0.0581472	1.06 [0.28 - 4.00]
GENE	CES2	carboxylesterase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209668_x_at	159	0.899371	1.40814e-06	7.45791e-05	1.55584	0.00249438	1.88405	6.58 [1.94 - 22.31]
GENE	CES2	carboxylesterase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209668_x_at	159	0.899371	3.93386e-06	0.000191247	1.66559	0.00338992	2.11753	8.31 [2.02 - 34.26]
GENE	CES2	carboxylesterase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209667_at	159	0.81761	0.234409	-	0.430934	0.546237	0.345688	1.41 [0.46 - 4.34]
GENE	CES2	carboxylesterase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213509_x_at	159	0.54717	0.0130597	0.196979	0.790234	0.146081	0.961824	2.62 [0.72 - 9.57]
GENE	CES2	carboxylesterase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	213509_x_at	159	0.54717	0.153215	-	0.532314	0.557787	0.459437	1.58 [0.34 - 7.36]
GENE	CES2	carboxylesterase 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209667_at	159	0.811321	0.0289842	0.34616	0.736804	0.13095	0.879555	2.41 [0.77 - 7.55]
GENE	CES2	carboxylesterase 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209668_x_at	159	0.899371	6.11413e-05	0.002267	1.36426	0.0417043	1.31369	3.72 [1.05 - 13.17]
GENE	CES2	carboxylesterase 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	209667_at	159	0.81761	0.0624491	-	0.731534	0.344625	0.640205	1.90 [0.50 - 7.16]
GENE	CES2	carboxylesterase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209667_at	54	0.851852	0.0293652	0.349215	1.46941	0.450597	0.564872	1.76 [0.41 - 7.63]
GENE	CES2	carboxylesterase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	209668_x_at	54	0.87037	0.00147528	0.0352458	2.00137	0.0455548	1.58491	4.88 [1.03 - 23.07]
GENE	CES2	carboxylesterase 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	213509_x_at	54	0.851852	0.0142988	0.210525	1.63284	0.0896446	1.1887	3.28 [0.83 - 12.95]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209667_at	117	0.820513	0.203867	-	0.461513	0.703721	0.130033	1.14 [0.58 - 2.23]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209667_at	117	0.410256	0.177602	-	0.566389	0.972449	-0.0143958	0.99 [0.44 - 2.23]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209668_x_at	117	0.299145	0.135599	-	-0.562788	0.575279	-0.276271	0.76 [0.29 - 1.99]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209668_x_at	117	0.230769	0.223252	-	-0.418152	0.85224	-0.0765315	0.93 [0.41 - 2.07]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209668_x_at	117	0.230769	0.223252	-	-0.418152	0.85224	-0.0765315	0.93 [0.41 - 2.07]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209668_x_at	117	0.153846	0.0404852	0.43098	-0.844926	0.25936	-0.60087	0.55 [0.19 - 1.56]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213509_x_at	117	0.606838	0.216073	-	0.389084	0.625973	0.179958	1.20 [0.58 - 2.47]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213509_x_at	117	0.547009	0.155478	-	0.536057	0.503268	0.289484	1.34 [0.57 - 3.12]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209667_at	117	0.820513	0.203867	-	0.461513	0.703721	0.130033	1.14 [0.58 - 2.23]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213509_x_at	117	0.401709	0.215492	-	0.521544	0.977826	0.0129037	1.01 [0.41 - 2.52]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	209667_at	117	0.376068	0.0616228	-	0.836608	0.48958	0.266485	1.31 [0.61 - 2.78]
GENE	CES2	carboxylesterase 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	213509_x_at	117	0.606838	0.216073	-	0.389084	0.625973	0.179958	1.20 [0.58 - 2.47]
GENE	CES2	carboxylesterase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	213509_x_at	236	0.733051	0.148286	-	0.413434	0.566812	0.393023	1.48 [0.39 - 5.69]
GENE	CES2	carboxylesterase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209667_at	236	0.79661	0.124455	-	0.473338	0.371942	0.528127	1.70 [0.53 - 5.41]
GENE	CES2	carboxylesterase 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	209668_x_at	236	0.211864	0.0632706	-	-0.545549	0.991835	-0.00670288	0.99 [0.28 - 3.59]
GENE	CES2	carboxylesterase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209667_at	249	0.815261	0.0160876	0.229351	0.597547	0.0907979	0.780261	2.18 [0.88 - 5.39]
GENE	CES2	carboxylesterase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	209668_x_at	249	0.706827	0.0665934	-	0.406657	0.367218	0.451176	1.57 [0.59 - 4.19]
GENE	CES2	carboxylesterase 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	213509_x_at	249	0.751004	0.0676505	-	0.420783	0.438894	0.428185	1.53 [0.52 - 4.54]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209667_at	62	0.225806	0.0491218	0.48633	-0.948708	0.580975	-0.102908	0.90 [0.63 - 1.30]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209667_at	125	0.808	0.00477215	0.0912284	1.05133	0.0535828	1.0512	2.86 [0.98 - 8.32]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213509_x_at	54	0.314815	0.196383	-	-0.751469	0.635131	-0.128629	0.88 [0.52 - 1.50]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209668_x_at	62	0.112903	0.0539817	-	-1.06219	0.405868	-0.201615	0.82 [0.51 - 1.31]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209667_at	125	0.28	0.0543488	-	0.727629	0.10064	0.684641	1.98 [0.88 - 4.49]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209667_at	54	0.111111	0.00574067	0.105466	-1.58304	0.530318	-0.141278	0.87 [0.56 - 1.35]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213509_x_at	62	0.774194	0.0644804	-	-1.32588	0.621228	-0.110989	0.89 [0.58 - 1.39]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209668_x_at	125	0.44	0.0316912	0.367464	0.961371	0.129567	0.626416	1.87 [0.83 - 4.21]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209668_x_at	125	0.16	0.0400941	0.428321	1.37648	0.281821	0.350006	1.42 [0.75 - 2.68]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	209668_x_at	54	0.12963	0.00546779	0.101525	-1.59334	0.400956	-0.246076	0.78 [0.44 - 1.39]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213509_x_at	125	0.616	0.0173926	0.242594	0.899012	0.068217	1.15475	3.17 [0.92 - 10.98]
GENE	CES2	carboxylesterase 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	213509_x_at	125	0.144	0.0403881	0.430321	1.37199	0.266918	0.543846	1.72 [0.66 - 4.50]
GENE	CES2	carboxylesterase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209667_at	198	0.792929	0.058088	-	0.544843	0.20383	0.356046	1.43 [0.82 - 2.47]
GENE	CES2	carboxylesterase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213509_x_at	198	0.616162	0.00618241	0.111737	0.57079	0.126494	0.422863	1.53 [0.89 - 2.63]
GENE	CES2	carboxylesterase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209668_x_at	198	0.873737	0.00646675	0.115706	0.83311	0.0359616	0.6755	1.97 [1.05 - 3.69]
GENE	CES2	carboxylesterase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209668_x_at	198	0.873737	0.0112532	0.176396	0.805969	0.124525	0.518331	1.68 [0.87 - 3.25]
GENE	CES2	carboxylesterase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209667_at	198	0.787879	0.000872161	0.0227175	0.745622	0.00313798	0.664886	1.94 [1.25 - 3.02]
GENE	CES2	carboxylesterase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213509_x_at	198	0.712121	0.000468342	0.0133995	0.872599	0.134132	0.508381	1.66 [0.85 - 3.23]
GENE	CES2	carboxylesterase 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	213509_x_at	198	0.712121	0.00399071	0.0791748	0.756488	0.289345	0.377536	1.46 [0.73 - 2.93]
GENE	CES2	carboxylesterase 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209667_at	198	0.792929	0.00876941	0.146193	0.701585	0.064581	0.493989	1.64 [0.97 - 2.77]
GENE	CES2	carboxylesterase 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	209668_x_at	198	0.444444	0.00533479	0.0995855	0.616695	0.0320507	0.565579	1.76 [1.05 - 2.95]
GENE	CES2	carboxylesterase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209667_at	51	0.196078	0.016714	0.235757	-1.89242	0.592107	-0.208151	0.81 [0.38 - 1.74]
GENE	CES2	carboxylesterase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209667_at	62	0.209677	0.0387313	0.418942	-1.14884	0.401547	-0.207628	0.81 [0.50 - 1.32]
GENE	CES2	carboxylesterase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	209668_x_at	51	0.156863	0.0051584	0.0969922	-2.12913	0.818358	-0.116331	0.89 [0.33 - 2.40]
GENE	CES2	carboxylesterase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	209668_x_at	62	0.209677	0.0544255	-	-1.07541	0.251538	-0.410976	0.66 [0.33 - 1.34]
GENE	CES2	carboxylesterase 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	213509_x_at	51	0.156863	0.00338516	0.0694178	-2.20835	0.772085	-0.128026	0.88 [0.37 - 2.09]
GENE	CES2	carboxylesterase 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	213509_x_at	62	0.225806	0.0334866	0.381106	-1.17837	0.268772	-0.332954	0.72 [0.40 - 1.29]
GENE	CES2	carboxylesterase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209667_at	145	0.489655	0.356698	-	0.311011	0.941082	0.013884	1.01 [0.70 - 1.47]
GENE	CES2	carboxylesterase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	213509_x_at	177	0.254237	0.0535189	-	-0.545089	0.253544	-0.237599	0.79 [0.52 - 1.19]
GENE	CES2	carboxylesterase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	213509_x_at	177	0.276836	0.0208136	0.27558	-0.556444	0.285071	-0.192448	0.82 [0.58 - 1.17]
GENE	CES2	carboxylesterase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209668_x_at	177	0.271186	0.0488579	0.484728	-0.548977	0.233721	-0.205896	0.81 [0.58 - 1.14]
GENE	CES2	carboxylesterase 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	209667_at	177	0.112994	0.0412014	0.435813	-0.685879	0.192553	-0.191901	0.83 [0.62 - 1.10]
GENE	CES2	carboxylesterase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209668_x_at	177	0.293785	0.017603	0.244693	-0.566976	0.232398	-0.178788	0.84 [0.62 - 1.12]
GENE	CES2	carboxylesterase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	213509_x_at	145	0.186207	0.121503	-	-0.570553	0.964595	-0.0114002	0.99 [0.60 - 1.64]
GENE	CES2	carboxylesterase 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	209667_at	177	0.225989	0.0128384	0.194513	-0.621759	0.204425	-0.162404	0.85 [0.66 - 1.09]
GENE	CES2	carboxylesterase 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	209668_x_at	145	0.896552	0.220842	-	0.543438	0.931951	0.0183458	1.02 [0.67 - 1.55]
GENE	CES2	carboxylesterase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	213509_x_at	226	0.185841	0.0976981	-	-0.528195	0.462616	-0.114443	0.89 [0.66 - 1.21]
GENE	CES2	carboxylesterase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209668_x_at	226	0.207965	0.0434297	0.450556	-0.615913	0.416335	-0.118876	0.89 [0.67 - 1.18]
GENE	CES2	carboxylesterase 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	209667_at	226	0.261062	0.168577	-	-0.41691	0.487946	-0.088181	0.92 [0.71 - 1.17]
GENE	CES2	carboxylesterase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	213509_x_at	55	0.890909	0.0403815	0.430276	1.09411	0.867986	0.0456237	1.05 [0.61 - 1.79]
GENE	CES2	carboxylesterase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	213509_x_at	55	0.890909	0.0324261	0.373093	1.20243	0.388534	0.241413	1.27 [0.74 - 2.20]
GENE	CES2	carboxylesterase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209668_x_at	55	0.127273	0.042505	0.444492	-1.01299	0.89911	-0.0315541	0.97 [0.59 - 1.58]
GENE	CES2	carboxylesterase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	213509_x_at	49	0.204082	0.156552	-	1.37144	0.506494	0.237811	1.27 [0.63 - 2.56]
GENE	CES2	carboxylesterase 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	209667_at	55	0.327273	0.0290428	0.346631	-0.945991	0.400815	-0.208584	0.81 [0.50 - 1.32]
GENE	CES2	carboxylesterase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209668_x_at	55	0.818182	0.162947	-	0.696604	0.511761	0.169436	1.18 [0.71 - 1.97]
GENE	CES2	carboxylesterase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209668_x_at	49	0.102041	0.400692	-	-0.649911	0.902959	0.0403809	1.04 [0.54 - 1.99]
GENE	CES2	carboxylesterase 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	209667_at	55	0.290909	0.192167	-	-0.622877	0.881295	-0.0383346	0.96 [0.58 - 1.59]
GENE	CES2	carboxylesterase 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	209667_at	49	0.265306	0.149254	-	-0.825466	0.760725	-0.101603	0.90 [0.47 - 1.74]
GENE	CES2	carboxylesterase 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	510702	34	0.176471	0.00697269	0.122648	-1.27823	0.315493	-0.663523	0.52 [0.14 - 1.88]
GENE	CES2	carboxylesterase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	213509_x_at	63	0.444444	0.266209	-	-0.374712	0.609285	-0.213239	0.81 [0.36 - 1.83]
GENE	CES2	carboxylesterase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209668_x_at	63	0.190476	0.319775	-	-0.399397	0.898604	-0.048686	0.95 [0.45 - 2.01]
GENE	CES2	carboxylesterase 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	209667_at	63	0.873016	0.249155	-	-0.68424	0.869397	0.0486024	1.05 [0.59 - 1.87]
GENE	CES2	carboxylesterase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g2641989_3p_a_at	28	0.535714	0.0011853	0.0293806	-2.11635	0.0723534	-8.10147	0.00 [0.00 - 2.09]
GENE	CES2	carboxylesterase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.282975.0.A2_3p_a_at	28	0.285714	0.117822	-	-0.908511	0.734953	-0.373417	0.69 [0.08 - 5.98]
GENE	CES2	carboxylesterase 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	209667_3p_at	28	0.107143	0.0593188	-	-1.1806	0.617207	-0.0807137	0.92 [0.67 - 1.27]
GENE	CES2	carboxylesterase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	213509_x_at	82	0.634146	0.0184322	0.252872	-0.917063	0.156978	-0.812156	0.44 [0.14 - 1.37]
GENE	CES2	carboxylesterase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209667_at	82	0.890244	0.0184347	0.252896	-15.2402	0.598892	-0.233531	0.79 [0.33 - 1.89]
GENE	CES2	carboxylesterase 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	209668_x_at	82	0.280488	0.152634	-	-0.507705	0.857585	-0.113052	0.89 [0.26 - 3.07]
GENE	CES2	carboxylesterase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	213509_x_at	79	0.101266	0.0042537	0.0832942	-1.07302	0.315114	-0.571122	0.56 [0.19 - 1.72]
GENE	CES2	carboxylesterase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209667_at	79	0.151899	0.0724632	-	-0.602076	0.622232	-0.16414	0.85 [0.44 - 1.63]
GENE	CES2	carboxylesterase 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	209668_x_at	79	0.64557	0.257157	-	-0.314014	0.947126	-0.0495137	0.95 [0.22 - 4.11]
GENE	CES2	carboxylesterase 2	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	Y09616_at	86	0.418605	0.0843925	-	-0.695615	0.439452	-0.477215	0.62 [0.19 - 2.08]
GENE	CES2	carboxylesterase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209668_x_at	104	0.153846	0.198727	-	-0.50633	0.765536	-0.263009	0.77 [0.14 - 4.33]
GENE	CES2	carboxylesterase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	213509_x_at	104	0.153846	0.00119842	0.0296517	-1.10165	0.0175039	-1.51389	0.22 [0.06 - 0.77]
GENE	CES2	carboxylesterase 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	209667_at	104	0.307692	0.000122485	0.00418622	-1.19462	0.0122813	-0.925433	0.40 [0.19 - 0.82]
GENE	CES2	carboxylesterase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P13790	117	0.119658	0.000101059	0.00353493	-1.25494	0.0255116	-0.533478	0.59 [0.37 - 0.94]
GENE	CES2	carboxylesterase 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P49192	117	0.649573	0.071411	-	-0.591252	0.438657	-0.145009	0.87 [0.60 - 1.25]
GENE	CES2	carboxylesterase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209668_x_at	204	0.161765	0.000209966	0.00670523	-1.08217	0.203015	-0.557902	0.57 [0.24 - 1.35]
GENE	CES2	carboxylesterase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209667_at	204	0.137255	0.0556824	-	-0.805573	0.713052	0.169277	1.18 [0.48 - 2.92]
GENE	CES2	carboxylesterase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	209667_at	204	0.137255	0.0545597	-	-0.639522	0.91484	0.0381385	1.04 [0.52 - 2.09]
GENE	CES2	carboxylesterase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	213509_x_at	204	0.25	0.0229021	0.294629	-0.825626	0.916924	-0.052023	0.95 [0.36 - 2.52]
GENE	CES2	carboxylesterase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	213509_x_at	204	0.20098	0.00381431	0.0763732	-0.826703	0.468075	-0.295053	0.74 [0.34 - 1.65]
GENE	CES2	carboxylesterase 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	209668_x_at	204	0.161765	0.000178806	0.00582953	-1.32604	0.598992	-0.28225	0.75 [0.26 - 2.16]
GENE	CES2	carboxylesterase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	213509_x_at	178	0.567416	0.0223933	0.290058	-0.477053	0.167475	-0.614772	0.54 [0.23 - 1.29]
GENE	CES2	carboxylesterase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209667_at	178	0.365169	0.142455	-	-0.293773	0.377973	-0.250894	0.78 [0.45 - 1.36]
GENE	CES2	carboxylesterase 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	209668_x_at	178	0.269663	0.0267128	0.327546	-0.461743	0.374307	-0.526042	0.59 [0.19 - 1.89]
GENE	CES2	carboxylesterase 2	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200017624	41	0.512195	0.104182	-	0.683733	0.805347	-0.098253	0.91 [0.41 - 1.98]
GENE	CES2	carboxylesterase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209667_at	111	0.144144	0.0322213	0.371531	-0.705145	0.656349	-0.152282	0.86 [0.44 - 1.68]
GENE	CES2	carboxylesterase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	213509_x_at	111	0.18018	0.0436507	0.451995	-0.630726	0.851432	-0.0862157	0.92 [0.37 - 2.26]
GENE	CES2	carboxylesterase 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	209668_x_at	111	0.315315	0.119203	-	-0.419951	0.790471	-0.103239	0.90 [0.42 - 1.93]
GENE	CES2	carboxylesterase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	213509_x_at	90	0.622222	0.018598	0.254489	-0.871274	0.156211	-0.758571	0.47 [0.16 - 1.34]
GENE	CES2	carboxylesterase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	213509_x_at	90	0.622222	0.00642421	0.115116	-1.25631	0.109472	-1.01129	0.36 [0.11 - 1.25]
GENE	CES2	carboxylesterase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209667_at	90	0.466667	0.0219244	0.285807	-0.74435	0.217371	-0.489753	0.61 [0.28 - 1.33]
GENE	CES2	carboxylesterase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209667_at	90	0.233333	0.00815747	0.138354	-0.976076	0.0653773	-0.888938	0.41 [0.16 - 1.06]
GENE	CES2	carboxylesterase 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	209668_x_at	90	0.666667	0.0280746	0.33879	-0.850499	0.304685	-0.444672	0.64 [0.27 - 1.50]
GENE	CES2	carboxylesterase 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	209668_x_at	90	0.777778	0.0207679	0.275154	-1.53919	0.164168	-0.703246	0.49 [0.18 - 1.33]
GENE	CES2	carboxylesterase 2	None	GSE4716-GPL3694	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF200	809	50	0.14	0.273541	-	1.07721	0.614641	0.172063	1.19 [0.61 - 2.32]
GENE	CES2	carboxylesterase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209667_at	138	0.15942	0.447587	-	-0.240437	0.805826	0.0317665	1.03 [0.80 - 1.33]
GENE	CES2	carboxylesterase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	213509_x_at	138	0.818841	0.335403	-	0.284178	0.990805	0.00183408	1.00 [0.73 - 1.37]
GENE	CES2	carboxylesterase 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	209668_x_at	138	0.333333	0.0599694	-	0.520459	0.882295	0.0195823	1.02 [0.79 - 1.32]
GENE	CES2	carboxylesterase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209668_x_at	129	0.496124	0.0553249	-	0.474911	0.606092	0.205084	1.23 [0.56 - 2.68]
GENE	CES2	carboxylesterase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	213509_x_at	129	0.395349	0.0602478	-	0.497799	0.573106	0.256734	1.29 [0.53 - 3.16]
GENE	CES2	carboxylesterase 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	209667_at	129	0.728682	0.31185	-	0.265614	0.962625	0.0175679	1.02 [0.49 - 2.12]
GENE	CES2	carboxylesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43381	56	0.232143	0.156432	-	-0.584435	0.913341	0.0344778	1.04 [0.56 - 1.93]
GENE	CES2	carboxylesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32978	56	0.375	0.168854	-	0.499821	0.773465	0.0783461	1.08 [0.63 - 1.84]
GENE	CES2	carboxylesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35263	56	0.160714	0.0245129	0.308818	-0.911787	0.969029	0.0139449	1.01 [0.50 - 2.05]
GENE	CES2	carboxylesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31888	56	0.25	0.124117	-	0.678646	0.727588	0.135265	1.14 [0.53 - 2.45]
GENE	CES2	carboxylesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	32978	56	0.375	0.27017	-	0.420133	0.735044	0.0992282	1.10 [0.62 - 1.96]
GENE	CES2	carboxylesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	43381	56	0.232143	0.169419	-	-0.537985	0.945419	0.0200564	1.02 [0.57 - 1.81]
GENE	CES2	carboxylesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	31888	56	0.357143	0.11503	-	0.635507	0.5362	0.257222	1.29 [0.57 - 2.92]
GENE	CES2	carboxylesterase 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35263	56	0.160714	0.00681519	0.120503	-1.03257	0.767641	-0.102443	0.90 [0.46 - 1.78]
GENE	CES2	carboxylesterase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	213509_x_at	278	0.438849	0.0208713	0.276117	-0.434501	0.140115	-0.329041	0.72 [0.46 - 1.11]
GENE	CES2	carboxylesterase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209668_x_at	278	0.517986	0.0279205	0.337531	-0.424217	0.205812	-0.262106	0.77 [0.51 - 1.15]
GENE	CES2	carboxylesterase 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	209667_at	278	0.280576	0.135393	-	0.328487	0.515529	-0.103531	0.90 [0.66 - 1.23]
GENE	CES2	carboxylesterase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209667_at	133	0.12782	0.0682435	-	-0.596638	0.99545	0.000900402	1.00 [0.73 - 1.36]
GENE	CES2	carboxylesterase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	209668_x_at	133	0.120301	0.102721	-	0.818632	0.814004	0.0331712	1.03 [0.78 - 1.36]
GENE	CES2	carboxylesterase 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	213509_x_at	133	0.451128	0.00212838	0.0476623	0.771876	0.352579	0.195946	1.22 [0.80 - 1.84]
GENE	CES2	carboxylesterase 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11908	81	0.209877	0.0283304	0.340874	-1.2089	0.204877	-0.425672	0.65 [0.34 - 1.26]
GENE	CES2	carboxylesterase 2	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15719	81	0.37037	0.0432593	0.449445	-1.06212	0.53733	-0.165336	0.85 [0.50 - 1.43]
GENE	CES2	carboxylesterase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209668_x_at	185	0.102703	0.104082	-	0.42303	0.801149	0.054266	1.06 [0.69 - 1.61]
GENE	CES2	carboxylesterase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213509_x_at	185	0.167568	0.173601	-	0.325279	0.508364	0.16103	1.17 [0.73 - 1.89]
GENE	CES2	carboxylesterase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209667_at	185	0.827027	0.289096	-	0.227354	0.938721	-0.0121483	0.99 [0.72 - 1.35]
GENE	CES2	carboxylesterase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209668_x_at	185	0.102703	0.0651002	-	0.559768	0.469578	0.173078	1.19 [0.74 - 1.90]
GENE	CES2	carboxylesterase 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	209667_at	185	0.827027	0.14282	-	0.330981	0.996915	-0.000665296	1.00 [0.71 - 1.40]
GENE	CES2	carboxylesterase 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	213509_x_at	185	0.216216	0.19938	-	0.252379	0.670735	0.0939259	1.10 [0.71 - 1.69]
GENE	CES2	carboxylesterase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P49192	110	0.509091	0.16002	-	0.325681	0.883973	-0.037921	0.96 [0.58 - 1.60]
GENE	CES2	carboxylesterase 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P13790	110	0.836364	0.156487	-	-0.495077	0.559351	-0.113697	0.89 [0.61 - 1.31]
GENE	CES2	carboxylesterase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P49192	110	0.109091	0.0901675	-	-0.647955	0.868911	-0.0591692	0.94 [0.47 - 1.90]
GENE	CES2	carboxylesterase 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P13790	110	0.154545	0.159345	-	0.610459	0.852916	0.046916	1.05 [0.64 - 1.72]
GENE	CES2	carboxylesterase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209668_x_at	80	0.8625	0.138736	-	0.742179	0.467667	0.346297	1.41 [0.56 - 3.60]
GENE	CES2	carboxylesterase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	213509_x_at	80	0.7125	0.178355	-	-0.734687	0.813145	0.120243	1.13 [0.42 - 3.06]
GENE	CES2	carboxylesterase 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	209667_at	80	0.875	0.0233837	0.298915	1.1126	0.316085	0.40304	1.50 [0.68 - 3.29]
GENE	CES2	carboxylesterase 2	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_0971	281	0.775801	0.097101	-	-0.28243	0.625331	-0.0448424	0.96 [0.80 - 1.14]
GENE	CES2	carboxylesterase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	213509_x_at	38	0.842105	0.232726	-	0.66621	0.933659	0.0633171	1.07 [0.24 - 4.73]
GENE	CES2	carboxylesterase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209668_x_at	38	0.157895	0.120751	-	1.46627	0.671949	0.359723	1.43 [0.27 - 7.57]
GENE	CES2	carboxylesterase 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	209667_at	38	0.236842	0.0814098	-	1.07703	0.801649	0.140217	1.15 [0.39 - 3.44]
GENE	CES2	carboxylesterase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	213509_x_at	140	0.464286	0.000750662	0.0200161	-1.02801	0.000446738	-1.48167	0.23 [0.10 - 0.52]
GENE	CES2	carboxylesterase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209667_at	140	0.542857	0.000206166	0.00659952	-1.28535	0.00242971	-0.856584	0.42 [0.24 - 0.74]
GENE	CES2	carboxylesterase 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	209668_x_at	140	0.514286	0.00193887	0.0441559	-0.995197	0.0101404	-1.19721	0.30 [0.12 - 0.75]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	206932_at	30	0.733333	0.111243	-	-0.78266	0.817279	-0.0762797	0.93 [0.49 - 1.77]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1741021	165	0.618182	0.101901	-	0.401572	0.355562	0.19898	1.22 [0.80 - 1.86]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1741021	165	0.545455	0.00544427	0.101183	0.997886	0.138851	0.384657	1.47 [0.88 - 2.44]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	206932_at	163	0.546012	0.304906	-	-0.205023	0.880019	0.0206707	1.02 [0.78 - 1.34]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	206932_at	79	0.873418	9.64207e-06	0.00043228	1.55312	9.79033e-05	0.414111	1.51 [1.23 - 1.86]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206932_at	58	0.344828	0.00415471	0.0817514	-0.83925	0.141797	-0.209076	0.81 [0.61 - 1.07]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	206932_at	34	0.117647	0.173889	-	0.841938	0.901714	0.022483	1.02 [0.72 - 1.46]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	206932_at	158	0.550633	0.00121697	0.030034	-0.777365	0.0457024	-1.12764	0.32 [0.11 - 0.98]
GENE	CH25H	cholesterol 25-hydroxylase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	206932_at	53	0.830189	0.198592	-	-0.672734	0.906072	0.0325189	1.03 [0.60 - 1.77]
GENE	CH25H	cholesterol 25-hydroxylase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	206932_at	53	0.811321	0.0934556	-	-0.982489	0.687439	-0.113976	0.89 [0.51 - 1.55]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	206932_at	180	0.388889	0.0656342	-	0.412666	0.433209	0.117774	1.12 [0.84 - 1.51]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	206932_at	559	0.883721	0.100702	-	0.416066	0.878921	0.0266985	1.03 [0.73 - 1.45]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	206932_at	77	0.415584	0.0652492	-	-0.472032	0.400495	-0.120787	0.89 [0.67 - 1.17]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	206932_at	70	0.171429	0.103174	-	-0.539076	0.498024	-0.0703621	0.93 [0.76 - 1.14]
GENE	CH25H	cholesterol 25-hydroxylase	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32363_at	50	0.22	0.0405586	0.431478	-0.83159	0.410253	-0.139327	0.87 [0.62 - 1.21]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	206932_at	74	0.702703	0.0413455	0.43678	-0.71154	0.0795533	-0.356032	0.70 [0.47 - 1.04]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	206932_at	67	0.104478	0.239022	-	15.268	0.677596	-0.16172	0.85 [0.40 - 1.82]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	206932_at	115	0.33913	0.00747424	0.129387	-1.38173	0.126212	-0.76796	0.46 [0.17 - 1.24]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32363_at	158	0.639241	0.0271833	0.331461	-0.737693	0.451589	-0.128836	0.88 [0.63 - 1.23]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32363_at	76	0.381579	0.0993542	-	-0.847316	0.613166	-0.19011	0.83 [0.40 - 1.73]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	206932_at	204	0.583333	0.173078	-	-0.194123	0.133723	-0.146783	0.86 [0.71 - 1.05]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	206932_at	87	0.103448	2.08722e-05	0.000867935	-1.7184	0.00219283	-0.704906	0.49 [0.31 - 0.78]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	206932_at	87	0.103448	2.08722e-05	0.000867935	-1.7184	0.00219283	-0.704906	0.49 [0.31 - 0.78]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	206932_at	77	0.142857	0.00122627	0.0302254	-1.84359	0.127916	-0.640266	0.53 [0.23 - 1.20]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	206932_at	77	0.142857	0.000660012	0.0179489	-1.73898	0.294551	-0.351156	0.70 [0.37 - 1.36]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	206932_at	136	0.742647	0.209782	-	-0.768473	0.508677	-0.20681	0.81 [0.44 - 1.50]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	206932_at	200	0.46	0.00149716	0.0356784	-0.941838	0.036908	-0.42188	0.66 [0.44 - 0.97]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21641	60	0.133333	0.00711939	0.124634	-1.19112	0.927226	0.0156477	1.02 [0.73 - 1.42]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21641	60	0.883333	0.443431	-	0.410943	0.932601	-0.0135615	0.99 [0.72 - 1.35]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	6749	155	0.741935	0.0473503	0.475473	0.550452	0.595805	0.156745	1.17 [0.66 - 2.09]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	206932_at	286	0.181818	0.00643824	0.11531	-0.598481	0.0348294	-0.284488	0.75 [0.58 - 0.98]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206932_at	159	0.188679	0.00100773	0.0256503	-1.04599	0.00440644	-0.621954	0.54 [0.35 - 0.82]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206932_at	159	0.761006	0.00468607	0.0899273	-2.32174	0.0148046	-0.669946	0.51 [0.30 - 0.88]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	206932_at	159	0.559748	0.00533485	0.0995864	-0.978802	0.000991358	-0.747535	0.47 [0.30 - 0.74]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	206932_at	54	0.203704	0.00159739	0.0376434	-1.98277	0.236536	-0.703777	0.49 [0.15 - 1.59]
GENE	CH25H	cholesterol 25-hydroxylase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206932_at	117	0.418803	0.0101094	0.162788	0.884664	0.743273	0.0653115	1.07 [0.72 - 1.58]
GENE	CH25H	cholesterol 25-hydroxylase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206932_at	117	0.418803	0.00684667	0.120933	1.17865	0.493046	0.155292	1.17 [0.75 - 1.82]
GENE	CH25H	cholesterol 25-hydroxylase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206932_at	117	0.418803	0.0101094	0.162788	0.884664	0.743273	0.0653115	1.07 [0.72 - 1.58]
GENE	CH25H	cholesterol 25-hydroxylase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	206932_at	117	0.418803	0.0450178	0.460802	0.864012	0.487696	0.163175	1.18 [0.74 - 1.87]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	206932_at	236	0.444915	1.68988e-05	0.000717709	-1.17231	0.000137794	-0.859296	0.42 [0.27 - 0.66]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	206932_at	249	0.421687	0.000376486	0.0111114	-0.742238	0.00245644	-0.547359	0.58 [0.41 - 0.82]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206932_at	62	0.225806	0.00556716	0.102966	-1.24366	0.240458	-0.23396	0.79 [0.54 - 1.17]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206932_at	125	0.104	0.000948902	0.0243875	-1.34664	0.166356	-0.618844	0.54 [0.22 - 1.29]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206932_at	125	0.104	0.0752993	-	-0.688238	0.586258	-0.171353	0.84 [0.45 - 1.56]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	206932_at	54	0.222222	0.00408109	0.080598	-1.52015	0.294605	-0.250822	0.78 [0.49 - 1.24]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206932_at	198	0.550505	0.311908	-	-0.26075	0.952895	0.00615367	1.01 [0.82 - 1.23]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206932_at	198	0.792929	0.247089	-	-0.402545	0.890231	0.0148678	1.01 [0.82 - 1.25]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	206932_at	198	0.237374	0.0788577	-	0.49268	0.450301	0.0679411	1.07 [0.90 - 1.28]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	206932_at	51	0.509804	0.171134	-	1.41045	0.964516	-0.0347093	0.97 [0.21 - 4.46]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	206932_at	62	0.354839	0.218386	-	-0.696767	0.650451	-0.2857	0.75 [0.22 - 2.59]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	206932_at	177	0.677966	0.0808269	-	0.418584	0.567171	0.0945628	1.10 [0.80 - 1.52]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	206932_at	145	0.137931	3.9248e-07	2.29149e-05	-1.61337	0.005248	-0.666883	0.51 [0.32 - 0.82]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	206932_at	177	0.638418	0.116065	-	0.42519	0.495306	0.130227	1.14 [0.78 - 1.66]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	206932_at	226	0.146018	5.59291e-05	0.00209458	-1.18382	0.00323266	-0.443155	0.64 [0.48 - 0.86]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	206932_at	55	0.854545	0.107574	-	0.849401	0.495248	0.222513	1.25 [0.66 - 2.37]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	206932_at	49	0.877551	0.024924	0.312373	1.2893	0.32233	0.381751	1.46 [0.69 - 3.12]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	206932_at	55	0.854545	0.00570222	0.104914	1.27042	0.0636974	0.549723	1.73 [0.97 - 3.10]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	206932_at	63	0.238095	0.0742702	-	-0.635184	0.320155	-0.216839	0.81 [0.53 - 1.23]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502498_3p_at	28	0.428571	0.00315751	0.0656415	-1.63411	0.169613	-1.07546	0.34 [0.07 - 1.58]
GENE	CH25H	cholesterol 25-hydroxylase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	206932_at	82	0.280488	0.0876885	-	-0.595502	0.196616	-0.28659	0.75 [0.49 - 1.16]
GENE	CH25H	cholesterol 25-hydroxylase	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32363_at	84	0.797619	0.0556759	-	-0.814333	0.412419	-0.124091	0.88 [0.66 - 1.19]
GENE	CH25H	cholesterol 25-hydroxylase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	206932_at	79	0.278481	0.0368081	0.405399	0.692842	0.309918	0.139784	1.15 [0.88 - 1.51]
GENE	CH25H	cholesterol 25-hydroxylase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	206932_at	104	0.298077	0.0367508	0.404989	-0.679181	0.583917	-0.0983551	0.91 [0.64 - 1.29]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P86470	117	0.316239	0.00211421	0.0474026	-0.858784	0.00439458	-0.221365	0.80 [0.69 - 0.93]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	206932_at	204	0.352941	0.0100077	0.161554	-0.91677	0.0675055	-0.352821	0.70 [0.48 - 1.03]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	206932_at	204	0.352941	0.00172326	0.0400753	-0.830101	0.0301789	-0.304922	0.74 [0.56 - 0.97]
GENE	CH25H	cholesterol 25-hydroxylase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	206932_at	178	0.308989	0.00780009	0.133693	-0.531359	0.097659	-0.174967	0.84 [0.68 - 1.03]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200014651	41	0.121951	2.40976e-05	0.000987514	-2.08908	0.0887825	-0.337093	0.71 [0.48 - 1.05]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	206932_at	111	0.666667	0.188074	-	0.352414	0.983421	-0.00341848	1.00 [0.72 - 1.38]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	206932_at	90	0.833333	0.194963	-	-0.673066	0.636702	-0.0817761	0.92 [0.66 - 1.29]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	206932_at	90	0.866667	0.0817294	-	-1.59692	0.311169	-0.216927	0.80 [0.53 - 1.22]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	206932_at	138	0.884058	0.305515	-	-0.434322	0.871986	-0.0101566	0.99 [0.87 - 1.12]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	206932_at	129	0.263566	0.0413949	0.437111	-0.531881	0.0866845	-0.369166	0.69 [0.45 - 1.05]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12973	56	0.892857	0.177159	-	0.64479	0.787309	-0.0349108	0.97 [0.75 - 1.24]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12973	56	0.892857	0.0684288	-	0.871466	0.968372	-0.00550597	0.99 [0.76 - 1.31]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	206932_at	278	0.823741	0.00529732	0.0990365	0.603228	0.104351	0.180599	1.20 [0.96 - 1.49]
GENE	CH25H	cholesterol 25-hydroxylase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	206932_at	133	0.593985	0.00340369	0.0697224	0.687213	0.133329	0.304498	1.36 [0.91 - 2.02]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206932_at	185	0.227027	0.0704828	-	0.383924	0.204679	0.26966	1.31 [0.86 - 1.99]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	206932_at	185	0.227027	0.0286285	0.343292	0.427614	0.0946277	0.322136	1.38 [0.95 - 2.01]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P86470	110	0.790909	0.0942057	-	0.459288	0.393285	0.0837989	1.09 [0.90 - 1.32]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P86470	110	0.7	0.286622	-	-0.377381	0.890679	0.0175214	1.02 [0.79 - 1.31]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	206932_at	80	0.8875	0.231236	-	-1.16884	0.880187	-0.0269474	0.97 [0.69 - 1.38]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP2_3222	281	0.519573	0.000399519	0.011693	0.497289	0.11083	0.109474	1.12 [0.98 - 1.28]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	206932_at	38	0.868421	0.178248	-	-1.29586	0.745883	-0.0899769	0.91 [0.53 - 1.57]
GENE	CH25H	cholesterol 25-hydroxylase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	206932_at	140	0.864286	0.00311352	0.0649043	0.957302	0.0169943	0.313562	1.37 [1.06 - 1.77]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHAT	choline O-acetyltransferase	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221197_s_at	30	0.2	0.000274027	0.00844811	-1.78687	0.675991	-0.432037	0.65 [0.09 - 4.92]
GENE	CHAT	choline O-acetyltransferase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1711347	165	0.339394	0.0636207	-	-0.449834	0.11407	-2.43364	0.09 [0.00 - 1.79]
GENE	CHAT	choline O-acetyltransferase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1711347	165	0.642424	0.138055	-	-0.597498	0.480728	-1.59267	0.20 [0.00 - 17.02]
GENE	CHAT	choline O-acetyltransferase	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221197_s_at	163	0.717791	0.228522	-	0.254398	0.886949	0.125589	1.13 [0.20 - 6.40]
GENE	CHAT	choline O-acetyltransferase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221197_s_at	79	0.670886	0.102245	-	-0.541082	0.467523	-0.700563	0.50 [0.07 - 3.29]
GENE	CHAT	choline O-acetyltransferase	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221197_s_at	58	0.896552	0.0639941	-	0.824487	0.902089	0.0178077	1.02 [0.77 - 1.35]
GENE	CHAT	choline O-acetyltransferase	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221197_s_at	34	0.147059	0.230807	-	-0.592643	0.53815	-0.17109	0.84 [0.49 - 1.45]
GENE	CHAT	choline O-acetyltransferase	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221197_s_at	158	0.765823	0.20177	-	-0.359688	0.464254	-0.696093	0.50 [0.08 - 3.22]
GENE	CHAT	choline O-acetyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221197_s_at	53	0.377358	0.174499	-	0.537622	0.455026	0.144354	1.16 [0.79 - 1.69]
GENE	CHAT	choline O-acetyltransferase	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221197_s_at	53	0.849057	0.28372	-	-0.56377	0.99828	-0.000381544	1.00 [0.71 - 1.41]
GENE	CHAT	choline O-acetyltransferase	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221197_s_at	180	0.811111	0.000274171	0.00845195	0.864933	0.0939018	0.214429	1.24 [0.96 - 1.59]
GENE	CHAT	choline O-acetyltransferase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221197_s_at	559	0.31127	0.0584388	-	0.489879	0.204977	0.161088	1.17 [0.92 - 1.51]
GENE	CHAT	choline O-acetyltransferase	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221197_s_at	77	0.337662	0.0127523	0.19355	0.706661	0.0675088	0.355889	1.43 [0.97 - 2.09]
GENE	CHAT	choline O-acetyltransferase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221197_s_at	70	0.128571	0.0867412	-	-0.612866	0.516548	-0.610437	0.54 [0.09 - 3.44]
GENE	CHAT	choline O-acetyltransferase	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221197_s_at	74	0.108108	0.0476958	0.477609	-0.797365	0.404757	-0.145706	0.86 [0.61 - 1.22]
GENE	CHAT	choline O-acetyltransferase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221197_s_at	67	0.19403	0.149985	-	15.3359	0.582436	1.20695	3.34 [0.05 - 247.00]
GENE	CHAT	choline O-acetyltransferase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221197_s_at	115	0.521739	0.0150789	0.218836	1.45471	0.499005	0.332362	1.39 [0.53 - 3.65]
GENE	CHAT	choline O-acetyltransferase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221197_s_at	204	0.446078	0.0426236	0.445273	-0.283459	0.267878	-0.0778067	0.93 [0.81 - 1.06]
GENE	CHAT	choline O-acetyltransferase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221197_s_at	87	0.206897	0.217414	-	-0.511407	0.885807	0.17927	1.20 [0.10 - 13.82]
GENE	CHAT	choline O-acetyltransferase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221197_s_at	87	0.206897	0.217414	-	-0.511407	0.885807	0.17927	1.20 [0.10 - 13.82]
GENE	CHAT	choline O-acetyltransferase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221197_s_at	77	0.818182	0.253858	-	0.768797	0.685121	0.747307	2.11 [0.06 - 78.22]
GENE	CHAT	choline O-acetyltransferase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221197_s_at	77	0.818182	0.0244954	0.308665	1.20887	0.0953873	2.78643	16.22 [0.61 - 428.96]
GENE	CHAT	choline O-acetyltransferase	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221197_s_at	136	0.852941	0.015512	0.223382	1.12574	0.738957	-0.0733452	0.93 [0.60 - 1.43]
GENE	CHAT	choline O-acetyltransferase	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221197_s_at	200	0.56	0.0482141	0.480797	-0.614297	0.452244	-0.119579	0.89 [0.65 - 1.21]
GENE	CHAT	choline O-acetyltransferase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6871	60	0.25	0.0673752	-	-0.730003	0.665369	-0.290477	0.75 [0.20 - 2.79]
GENE	CHAT	choline O-acetyltransferase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	6871	60	0.866667	0.00374548	0.0752712	1.2319	0.00340544	1.9896	7.31 [1.93 - 27.69]
GENE	CHAT	choline O-acetyltransferase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	3102	155	0.16129	0.00027439	0.00845779	-1.03965	0.093256	-0.182157	0.83 [0.67 - 1.03]
GENE	CHAT	choline O-acetyltransferase	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221197_s_at	286	0.118881	0.189203	-	-0.354936	0.52236	-0.0756409	0.93 [0.74 - 1.17]
GENE	CHAT	choline O-acetyltransferase	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221197_s_at	159	0.358491	0.232876	-	0.419496	0.629527	0.115263	1.12 [0.70 - 1.79]
GENE	CHAT	choline O-acetyltransferase	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221197_s_at	159	0.679245	0.00758062	0.130799	0.821734	0.178385	0.354131	1.42 [0.85 - 2.39]
GENE	CHAT	choline O-acetyltransferase	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221197_s_at	159	0.45283	0.230583	-	0.46434	0.684592	0.113691	1.12 [0.65 - 1.94]
GENE	CHAT	choline O-acetyltransferase	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221197_s_at	54	0.87037	0.204229	-	-15.3255	0.415636	-0.742495	0.48 [0.08 - 2.84]
GENE	CHAT	choline O-acetyltransferase	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221197_s_at	117	0.760684	0.0862659	-	-0.801016	0.963435	0.0220418	1.02 [0.40 - 2.62]
GENE	CHAT	choline O-acetyltransferase	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221197_s_at	117	0.598291	0.0893258	-	0.663105	0.426942	0.431688	1.54 [0.53 - 4.47]
GENE	CHAT	choline O-acetyltransferase	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221197_s_at	117	0.760684	0.0862659	-	-0.801016	0.963435	0.0220418	1.02 [0.40 - 2.62]
GENE	CHAT	choline O-acetyltransferase	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221197_s_at	117	0.589744	0.0186243	0.254745	0.881253	0.398343	0.420458	1.52 [0.57 - 4.04]
GENE	CHAT	choline O-acetyltransferase	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221197_s_at	236	0.165254	0.0306347	0.359258	1.0709	0.27906	0.219434	1.25 [0.84 - 1.85]
GENE	CHAT	choline O-acetyltransferase	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221197_s_at	249	0.702811	0.0109659	0.173024	-0.673302	0.60072	0.077934	1.08 [0.81 - 1.45]
GENE	CHAT	choline O-acetyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221197_s_at	125	0.368	0.269891	-	0.459562	0.913553	0.125963	1.13 [0.12 - 11.03]
GENE	CHAT	choline O-acetyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221197_s_at	125	0.472	0.0602887	-	0.566506	0.922727	0.0873525	1.09 [0.19 - 6.38]
GENE	CHAT	choline O-acetyltransferase	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221197_s_at	54	0.333333	0.111916	-	1.5189	0.750926	-0.078739	0.92 [0.57 - 1.50]
GENE	CHAT	choline O-acetyltransferase	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221197_s_at	62	0.709677	0.214699	-	-0.701578	0.631385	-0.0983924	0.91 [0.61 - 1.35]
GENE	CHAT	choline O-acetyltransferase	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221197_s_at	198	0.580808	0.0435579	0.451392	0.421005	0.402297	0.0688347	1.07 [0.91 - 1.26]
GENE	CHAT	choline O-acetyltransferase	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221197_s_at	198	0.767677	0.172137	-	-0.46848	0.766487	0.0295456	1.03 [0.85 - 1.25]
GENE	CHAT	choline O-acetyltransferase	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221197_s_at	198	0.767677	0.204976	-	-0.457818	0.755943	0.0325393	1.03 [0.84 - 1.27]
GENE	CHAT	choline O-acetyltransferase	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221197_s_at	51	0.294118	0.126374	-	15.6341	0.304625	2.2958	9.93 [0.12 - 795.62]
GENE	CHAT	choline O-acetyltransferase	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221197_s_at	62	0.145161	0.0491856	0.486716	-1.14247	0.847132	-0.282361	0.75 [0.04 - 13.31]
GENE	CHAT	choline O-acetyltransferase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221197_s_at	177	0.107345	0.0719084	-	-0.658606	0.517399	-0.647649	0.52 [0.07 - 3.72]
GENE	CHAT	choline O-acetyltransferase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221197_s_at	177	0.107345	0.00803013	0.136701	-0.803986	0.130613	-1.3538	0.26 [0.04 - 1.49]
GENE	CHAT	choline O-acetyltransferase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221197_s_at	145	0.613793	0.108034	-	-0.589916	0.336957	-1.17406	0.31 [0.03 - 3.40]
GENE	CHAT	choline O-acetyltransferase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221197_s_at	226	0.415929	0.212522	-	-0.355066	0.781051	-0.0383684	0.96 [0.73 - 1.26]
GENE	CHAT	choline O-acetyltransferase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221197_s_at	55	0.854545	0.0395408	0.424534	-15.3125	0.481714	-0.992743	0.37 [0.02 - 5.89]
GENE	CHAT	choline O-acetyltransferase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221197_s_at	55	0.854545	0.0602073	-	-15.2853	0.899431	0.19626	1.22 [0.06 - 25.53]
GENE	CHAT	choline O-acetyltransferase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221197_s_at	49	0.693878	0.103038	-	-1.54645	0.399596	-1.6675	0.19 [0.00 - 9.14]
GENE	CHAT	choline O-acetyltransferase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221197_s_at	63	0.714286	0.0122943	0.188387	-1.14686	0.0731375	-21.5259	0.00 [0.00 - 7.53]
GENE	CHAT	choline O-acetyltransferase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11038627_3p_a_at	28	0.678571	0.0780515	-	-1.30015	0.807014	0.595372	1.81 [0.02 - 215.38]
GENE	CHAT	choline O-acetyltransferase	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221197_s_at	82	0.170732	0.033189	0.37887	1.42782	0.89553	0.0361752	1.04 [0.60 - 1.78]
GENE	CHAT	choline O-acetyltransferase	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221197_s_at	79	0.455696	0.0281968	0.339787	-0.567789	0.979066	0.00607119	1.01 [0.64 - 1.58]
GENE	CHAT	choline O-acetyltransferase	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221197_s_at	104	0.211538	0.0205796	0.273398	-0.795335	0.0753287	-0.530744	0.59 [0.33 - 1.06]
GENE	CHAT	choline O-acetyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221197_s_at	204	0.887255	0.148178	-	-1.363	0.366493	-0.176121	0.84 [0.57 - 1.23]
GENE	CHAT	choline O-acetyltransferase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221197_s_at	204	0.348039	0.0539885	-	-0.52209	0.145071	-0.215529	0.81 [0.60 - 1.08]
GENE	CHAT	choline O-acetyltransferase	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221197_s_at	178	0.533708	0.00602409	0.109504	-0.553254	0.0697498	-0.244829	0.78 [0.60 - 1.02]
GENE	CHAT	choline O-acetyltransferase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221197_s_at	111	0.252252	0.341405	-	-0.272459	0.850989	-0.0257557	0.97 [0.74 - 1.28]
GENE	CHAT	choline O-acetyltransferase	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221197_s_at	90	0.288889	0.156482	-	0.64004	0.41	0.824387	2.28 [0.32 - 16.21]
GENE	CHAT	choline O-acetyltransferase	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221197_s_at	90	0.777778	0.0891253	-	-0.795366	0.985446	0.0155945	1.02 [0.19 - 5.43]
GENE	CHAT	choline O-acetyltransferase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221197_s_at	138	0.282609	0.00451752	0.0873613	-0.689099	0.250232	1.88904	6.61 [0.26 - 165.54]
GENE	CHAT	choline O-acetyltransferase	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221197_s_at	129	0.565891	0.0436529	0.452009	0.497321	0.976095	-0.00935635	0.99 [0.54 - 1.83]
GENE	CHAT	choline O-acetyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11658	56	0.142857	0.127849	-	-0.638132	0.95509	0.0310339	1.03 [0.35 - 3.04]
GENE	CHAT	choline O-acetyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1559	56	0.464286	0.107927	-	-0.545888	0.945571	0.0365805	1.04 [0.36 - 2.96]
GENE	CHAT	choline O-acetyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11658	56	0.125	0.198293	-	-0.578502	0.997399	0.00190296	1.00 [0.32 - 3.15]
GENE	CHAT	choline O-acetyltransferase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	1559	56	0.428571	0.185729	-	-0.467342	0.917373	0.0587435	1.06 [0.35 - 3.22]
GENE	CHAT	choline O-acetyltransferase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221197_s_at	278	0.122302	0.164374	-	0.445186	0.702537	0.202302	1.22 [0.43 - 3.46]
GENE	CHAT	choline O-acetyltransferase	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221197_s_at	133	0.849624	0.0011259	0.0281457	0.925155	0.00189578	6.83645	931.18 [12.46 - 69589.63]
GENE	CHAT	choline O-acetyltransferase	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221197_s_at	185	0.464865	0.0880075	-	0.30448	0.684656	0.1194	1.13 [0.63 - 2.01]
GENE	CHAT	choline O-acetyltransferase	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221197_s_at	185	0.464865	0.0562956	-	0.312662	0.821057	0.0602605	1.06 [0.63 - 1.79]
GENE	CHAT	choline O-acetyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P46894	110	0.809091	0.277788	-	-0.47207	0.820571	-0.0632972	0.94 [0.54 - 1.62]
GENE	CHAT	choline O-acetyltransferase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P128219	110	0.6	0.0462776	0.468781	0.587856	0.635365	0.161331	1.18 [0.60 - 2.29]
GENE	CHAT	choline O-acetyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P46894	110	0.254545	0.0969042	-	0.459673	0.758718	0.061329	1.06 [0.72 - 1.57]
GENE	CHAT	choline O-acetyltransferase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P128219	110	0.572727	0.060379	-	0.435153	0.390949	0.216127	1.24 [0.76 - 2.03]
GENE	CHAT	choline O-acetyltransferase	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221197_s_at	80	0.8875	0.150493	-	0.731061	0.920954	0.0214344	1.02 [0.67 - 1.56]
GENE	CHAT	choline O-acetyltransferase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221197_s_at	38	0.157895	0.157731	-	-0.806921	0.286442	-0.631215	0.53 [0.17 - 1.70]
GENE	CHAT	choline O-acetyltransferase	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221197_s_at	140	0.828571	0.0117411	0.182061	-1.3901	0.0847571	-1.76174	0.17 [0.02 - 1.27]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHDH	choline dehydrogenase	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1806681	165	0.848485	0.0378201	0.412571	0.638973	0.514373	0.248785	1.28 [0.61 - 2.71]
GENE	CHDH	choline dehydrogenase	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1806681	165	0.769697	0.00284809	0.060402	1.03169	0.109833	0.69488	2.00 [0.85 - 4.70]
GENE	CHDH	choline dehydrogenase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	229502_at	163	0.754601	0.00147015	0.0351441	-0.823166	0.0114649	-2.05431	0.13 [0.03 - 0.63]
GENE	CHDH	choline dehydrogenase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	230484_at	163	0.552147	0.0275485	0.334477	0.433044	0.32962	0.878211	2.41 [0.41 - 14.07]
GENE	CHDH	choline dehydrogenase	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	231994_at	163	0.116564	0.1836	-	0.458631	0.960622	0.0391513	1.04 [0.22 - 4.92]
GENE	CHDH	choline dehydrogenase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	230484_at	79	0.126582	0.00251026	0.0545264	-1.07798	0.141192	-1.49836	0.22 [0.03 - 1.64]
GENE	CHDH	choline dehydrogenase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	231994_at	79	0.506329	0.176872	-	-0.395955	0.63524	-0.436763	0.65 [0.11 - 3.93]
GENE	CHDH	choline dehydrogenase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1559591_s_at	79	0.379747	0.112242	-	0.492303	0.602	0.527292	1.69 [0.23 - 12.29]
GENE	CHDH	choline dehydrogenase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	229502_at	79	0.101266	0.03856	0.417751	-0.8285	0.243602	-1.03937	0.35 [0.06 - 2.03]
GENE	CHDH	choline dehydrogenase	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1559590_at	79	0.113924	0.123869	-	0.891103	0.977128	0.026884	1.03 [0.16 - 6.45]
GENE	CHDH	choline dehydrogenase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	230484_at	180	0.261111	0.287434	-	0.256582	0.80381	0.084621	1.09 [0.56 - 2.12]
GENE	CHDH	choline dehydrogenase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	231994_at	180	0.538889	0.009568	0.156173	-0.562055	0.238372	-0.0982663	0.91 [0.77 - 1.07]
GENE	CHDH	choline dehydrogenase	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	229502_at	180	0.2	0.0467055	0.471461	-0.469043	0.277635	-0.116374	0.89 [0.72 - 1.10]
GENE	CHDH	choline dehydrogenase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	231994_at	559	0.22898	0.0495393	0.488853	-0.421641	0.843738	-0.0258101	0.97 [0.75 - 1.26]
GENE	CHDH	choline dehydrogenase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	230484_at	559	0.686941	0.0713156	-	-0.394472	0.297714	-0.213288	0.81 [0.54 - 1.21]
GENE	CHDH	choline dehydrogenase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1559591_s_at	559	0.341682	0.0213805	0.280827	-0.463256	0.28779	-0.218126	0.80 [0.54 - 1.20]
GENE	CHDH	choline dehydrogenase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	229502_at	559	0.42576	0.0441953	0.455522	-0.400092	0.411411	-0.102341	0.90 [0.71 - 1.15]
GENE	CHDH	choline dehydrogenase	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1559590_at	559	0.400716	0.0857866	-	-0.343388	0.605122	-0.0511075	0.95 [0.78 - 1.15]
GENE	CHDH	choline dehydrogenase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	230484_at	77	0.883117	0.409993	-	0.311801	0.633706	0.221087	1.25 [0.50 - 3.10]
GENE	CHDH	choline dehydrogenase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	231994_at	77	0.363636	0.125771	-	-0.409278	0.627213	-0.0827359	0.92 [0.66 - 1.29]
GENE	CHDH	choline dehydrogenase	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	229502_at	77	0.792208	0.2563	-	0.345535	0.948701	-0.0118221	0.99 [0.69 - 1.42]
GENE	CHDH	choline dehydrogenase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	231994_at	70	0.585714	0.0530763	-	0.513267	0.21032	0.466394	1.59 [0.77 - 3.31]
GENE	CHDH	choline dehydrogenase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	230484_at	70	0.742857	0.143254	-	0.428532	0.628727	0.357623	1.43 [0.34 - 6.09]
GENE	CHDH	choline dehydrogenase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1559591_s_at	70	0.414286	0.0556985	-	0.521328	0.428409	0.356807	1.43 [0.59 - 3.46]
GENE	CHDH	choline dehydrogenase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	229502_at	70	0.542857	0.128942	-	0.400491	0.424087	0.694932	2.00 [0.36 - 11.01]
GENE	CHDH	choline dehydrogenase	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1559590_at	70	0.6	0.0326649	0.374909	0.567039	0.234564	1.18812	3.28 [0.46 - 23.27]
GENE	CHDH	choline dehydrogenase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	231994_at	74	0.135135	0.0141146	0.208538	-0.891662	0.674549	-0.0909828	0.91 [0.60 - 1.40]
GENE	CHDH	choline dehydrogenase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	229502_at	74	0.797297	0.00103969	0.0263305	1.03585	0.646749	0.160107	1.17 [0.59 - 2.33]
GENE	CHDH	choline dehydrogenase	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	230484_at	74	0.837838	0.004689	0.0899717	0.945253	0.383861	0.539976	1.72 [0.51 - 5.79]
GENE	CHDH	choline dehydrogenase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1559590_at	67	0.104478	0.0456796	0.465009	-1.338	0.150894	-4.90877	0.01 [0.00 - 5.99]
GENE	CHDH	choline dehydrogenase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1559591_s_at	67	0.179104	0.123328	-	15.4398	0.873076	0.274428	1.32 [0.05 - 38.14]
GENE	CHDH	choline dehydrogenase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	231994_at	67	0.358209	0.129005	-	1.47441	0.709043	0.70689	2.03 [0.05 - 83.09]
GENE	CHDH	choline dehydrogenase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	229502_at	67	0.447761	0.0528884	-	1.50452	0.578518	1.22415	3.40 [0.05 - 255.44]
GENE	CHDH	choline dehydrogenase	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	230484_at	67	0.865672	0.0338158	0.383567	1.4277	0.294978	2.47411	11.87 [0.12 - 1217.45]
GENE	CHDH	choline dehydrogenase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	231994_at	115	0.330435	0.14753	-	-0.751744	0.665821	-0.256836	0.77 [0.24 - 2.48]
GENE	CHDH	choline dehydrogenase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	230484_at	115	0.391304	0.00912863	0.150716	2.22127	0.0614468	2.46534	11.77 [0.89 - 155.86]
GENE	CHDH	choline dehydrogenase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1559591_s_at	115	0.321739	0.124927	-	-0.794479	0.652746	-0.273232	0.76 [0.23 - 2.50]
GENE	CHDH	choline dehydrogenase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	229502_at	115	0.286957	0.0603874	-	1.72336	0.384423	0.816916	2.26 [0.36 - 14.26]
GENE	CHDH	choline dehydrogenase	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1559590_at	115	0.321739	0.115879	-	-0.813332	0.639138	0.229624	1.26 [0.48 - 3.29]
GENE	CHDH	choline dehydrogenase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	231994_at	204	0.656863	0.0264236	0.325125	-0.325685	0.164738	-0.116774	0.89 [0.75 - 1.05]
GENE	CHDH	choline dehydrogenase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	229502_at	204	0.681373	0.0250238	0.313232	-0.332454	0.785	-0.0167861	0.98 [0.87 - 1.11]
GENE	CHDH	choline dehydrogenase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	230484_at	204	0.348039	0.110326	-	-0.236192	0.559491	-0.0809621	0.92 [0.70 - 1.21]
GENE	CHDH	choline dehydrogenase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1559591_s_at	204	0.563725	0.00464574	0.0893156	-0.405203	0.206427	-0.174066	0.84 [0.64 - 1.10]
GENE	CHDH	choline dehydrogenase	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1559590_at	204	0.656863	0.0296402	0.351407	-0.317786	0.208224	-0.0714888	0.93 [0.83 - 1.04]
GENE	CHDH	choline dehydrogenase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	231994_at	87	0.655172	0.131874	-	-0.681175	0.351507	-0.45343	0.64 [0.24 - 1.65]
GENE	CHDH	choline dehydrogenase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	230484_at	87	0.632184	0.275702	-	-0.453281	0.456055	-0.557454	0.57 [0.13 - 2.48]
GENE	CHDH	choline dehydrogenase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	230484_at	87	0.632184	0.275702	-	-0.453281	0.456055	-0.557454	0.57 [0.13 - 2.48]
GENE	CHDH	choline dehydrogenase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	231994_at	87	0.655172	0.131874	-	-0.681175	0.351507	-0.45343	0.64 [0.24 - 1.65]
GENE	CHDH	choline dehydrogenase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1559591_s_at	87	0.206897	0.0128379	0.194507	-0.974659	0.131073	-0.492442	0.61 [0.32 - 1.16]
GENE	CHDH	choline dehydrogenase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1559591_s_at	87	0.206897	0.0128379	0.194507	-0.974659	0.131073	-0.492442	0.61 [0.32 - 1.16]
GENE	CHDH	choline dehydrogenase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	229502_at	87	0.758621	0.0451159	0.461428	-1.15954	0.492182	-0.582316	0.56 [0.11 - 2.94]
GENE	CHDH	choline dehydrogenase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	229502_at	87	0.758621	0.0451159	0.461428	-1.15954	0.492182	-0.582316	0.56 [0.11 - 2.94]
GENE	CHDH	choline dehydrogenase	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1559590_at	87	0.54023	0.322847	-	-0.380363	0.494443	-0.342293	0.71 [0.27 - 1.90]
GENE	CHDH	choline dehydrogenase	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1559590_at	87	0.54023	0.322847	-	-0.380363	0.494443	-0.342293	0.71 [0.27 - 1.90]
GENE	CHDH	choline dehydrogenase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	231994_at	77	0.779221	0.126059	-	0.847218	0.595981	0.327093	1.39 [0.41 - 4.65]
GENE	CHDH	choline dehydrogenase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	230484_at	77	0.792208	0.0603059	-	-15.3884	0.300235	-1.67385	0.19 [0.01 - 4.45]
GENE	CHDH	choline dehydrogenase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	231994_at	77	0.779221	0.18294	-	0.835417	0.845639	0.13732	1.15 [0.29 - 4.57]
GENE	CHDH	choline dehydrogenase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1559591_s_at	77	0.194805	0.0601802	-	15.3898	0.26117	0.634584	1.89 [0.62 - 5.71]
GENE	CHDH	choline dehydrogenase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	229502_at	77	0.688312	0.0710972	-	0.96696	0.481608	0.95611	2.60 [0.18 - 37.30]
GENE	CHDH	choline dehydrogenase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	230484_at	77	0.415584	0.0126812	0.192753	-1.74236	0.112229	-2.8156	0.06 [0.00 - 1.93]
GENE	CHDH	choline dehydrogenase	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1559590_at	77	0.896104	0.00575816	0.105717	1.51365	0.354805	0.421946	1.52 [0.62 - 3.73]
GENE	CHDH	choline dehydrogenase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1559591_s_at	77	0.194805	0.10363	-	15.3803	0.448105	0.477487	1.61 [0.47 - 5.54]
GENE	CHDH	choline dehydrogenase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	229502_at	77	0.246753	0.160951	-	-0.877654	0.799858	-0.376139	0.69 [0.04 - 12.58]
GENE	CHDH	choline dehydrogenase	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1559590_at	77	0.896104	0.0496465	0.489499	1.2684	0.465244	0.375273	1.46 [0.53 - 3.98]
GENE	CHDH	choline dehydrogenase	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4753	60	0.233333	8.427e-05	0.00301158	-1.40193	0.00460648	-0.413047	0.66 [0.50 - 0.88]
GENE	CHDH	choline dehydrogenase	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4753	60	0.35	0.0019118	0.0436493	-1.12666	0.00437584	-0.409814	0.66 [0.50 - 0.88]
GENE	CHDH	choline dehydrogenase	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	18055	155	0.735484	0.00118931	0.0294635	0.884301	0.0174153	0.192405	1.21 [1.03 - 1.42]
GENE	CHDH	choline dehydrogenase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231994_at	159	0.207547	0.31789	-	0.438983	0.696062	0.0732683	1.08 [0.75 - 1.55]
GENE	CHDH	choline dehydrogenase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231994_at	159	0.207547	0.312607	-	0.537337	0.950314	0.0135451	1.01 [0.66 - 1.55]
GENE	CHDH	choline dehydrogenase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229502_at	159	0.893082	0.0944903	-	0.68344	0.828752	-0.0449334	0.96 [0.64 - 1.44]
GENE	CHDH	choline dehydrogenase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229502_at	159	0.641509	0.0129116	0.19533	0.769169	0.58959	0.11583	1.12 [0.74 - 1.71]
GENE	CHDH	choline dehydrogenase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	229502_at	159	0.641509	0.0512783	-	0.710144	0.676069	0.106544	1.11 [0.67 - 1.83]
GENE	CHDH	choline dehydrogenase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230484_at	159	0.433962	0.0844106	-	-0.541886	0.579652	-0.357622	0.70 [0.20 - 2.48]
GENE	CHDH	choline dehydrogenase	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230484_at	159	0.867925	0.155224	-	0.555298	0.976767	-0.020152	0.98 [0.25 - 3.80]
GENE	CHDH	choline dehydrogenase	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230484_at	159	0.867925	0.064011	-	0.783742	0.906722	0.093733	1.10 [0.23 - 5.27]
GENE	CHDH	choline dehydrogenase	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	231994_at	159	0.188679	0.229414	-	0.567031	0.530208	0.117424	1.12 [0.78 - 1.62]
GENE	CHDH	choline dehydrogenase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	230484_at	236	0.800847	0.02698	0.329773	0.646604	0.313972	0.575319	1.78 [0.58 - 5.45]
GENE	CHDH	choline dehydrogenase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	231994_at	236	0.364407	0.00852622	0.143099	-0.695921	0.591977	-0.0968919	0.91 [0.64 - 1.29]
GENE	CHDH	choline dehydrogenase	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	229502_at	236	0.148305	0.0335242	0.381387	1.19104	0.192435	0.413164	1.51 [0.81 - 2.81]
GENE	CHDH	choline dehydrogenase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	230484_at	249	0.811245	0.036964	0.40651	0.507628	0.170604	0.625034	1.87 [0.76 - 4.57]
GENE	CHDH	choline dehydrogenase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	231994_at	249	0.35743	0.00480405	0.091709	-0.592774	0.239868	-0.16058	0.85 [0.65 - 1.11]
GENE	CHDH	choline dehydrogenase	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	229502_at	249	0.156627	0.0936198	-	0.580176	0.664038	0.100241	1.11 [0.70 - 1.74]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	231994_at	177	0.282486	0.000174657	0.0057113	-0.990726	0.00214004	-0.972611	0.38 [0.20 - 0.70]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	230484_at	177	0.101695	0.00566158	0.104329	-0.825075	0.0155175	-1.77822	0.17 [0.04 - 0.71]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	230484_at	177	0.101695	0.00312852	0.065156	-0.962394	0.0935259	-1.38846	0.25 [0.05 - 1.26]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	231994_at	177	0.282486	0.00350724	0.0714175	-0.695765	0.0526937	-0.570546	0.57 [0.32 - 1.01]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1559591_s_at	177	0.146893	0.00853674	0.143233	-0.736573	0.0245305	-0.818097	0.44 [0.22 - 0.90]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1559591_s_at	177	0.480226	0.00288287	0.0609975	-0.823408	0.00322819	-1.21767	0.30 [0.13 - 0.67]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	229502_at	177	0.768362	0.00874353	0.145865	-0.904662	0.0347726	-1.0319	0.36 [0.14 - 0.93]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	230484_at	145	0.648276	0.007274	0.126713	-1.1395	0.0187111	-2.57785	0.08 [0.01 - 0.65]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1559590_at	177	0.627119	0.032883	0.376561	-0.555259	0.19453	-0.273979	0.76 [0.50 - 1.15]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	229502_at	177	0.689266	0.00410936	0.0810416	-1.05031	0.015601	-1.40755	0.24 [0.08 - 0.77]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	231994_at	145	0.262069	0.0893134	-	-0.588385	0.164646	-0.59914	0.55 [0.24 - 1.28]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1559590_at	177	0.627119	0.00690023	0.121663	-0.859349	0.0434513	-0.504301	0.60 [0.37 - 0.99]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1559591_s_at	145	0.103448	0.082021	-	-0.764181	0.134985	-0.817433	0.44 [0.15 - 1.29]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	229502_at	145	0.324138	0.0032925	0.0678884	-0.950406	0.0638398	-1.37069	0.25 [0.06 - 1.08]
GENE	CHDH	choline dehydrogenase	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1559590_at	145	0.531034	0.0669969	-	-0.651122	0.510309	-0.208117	0.81 [0.44 - 1.51]
GENE	CHDH	choline dehydrogenase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	230484_at	226	0.199115	0.0549168	-	-0.601733	0.911925	-0.0272702	0.97 [0.60 - 1.58]
GENE	CHDH	choline dehydrogenase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	231994_at	226	0.619469	0.0337755	0.383266	-0.673531	0.183676	-0.163408	0.85 [0.67 - 1.08]
GENE	CHDH	choline dehydrogenase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1559591_s_at	226	0.50885	0.0060842	0.110354	-0.803247	0.0423359	-0.486816	0.61 [0.38 - 0.98]
GENE	CHDH	choline dehydrogenase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	229502_at	226	0.411504	0.0381249	0.414711	-0.581619	0.115423	-0.191362	0.83 [0.65 - 1.05]
GENE	CHDH	choline dehydrogenase	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1559590_at	226	0.685841	0.00559631	0.103388	-1.07666	0.0824594	-0.210845	0.81 [0.64 - 1.03]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1559591_s_at	55	0.363636	0.0307171	0.359903	1.14939	0.228048	0.448908	1.57 [0.76 - 3.25]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	229502_at	55	0.854545	0.0427169	0.445888	-15.3036	0.278156	-0.931538	0.39 [0.07 - 2.12]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1559590_at	55	0.381818	0.0638622	-	0.927171	0.480177	0.194869	1.22 [0.71 - 2.09]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	231994_at	55	0.345455	0.00222095	0.0493497	2.43924	0.0424516	0.827925	2.29 [1.03 - 5.09]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	230484_at	55	0.4	0.13091	-	-0.7321	0.980661	-0.0399432	0.96 [0.04 - 24.28]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	231994_at	49	0.367347	0.0309639	0.361829	1.53281	0.442178	0.350491	1.42 [0.58 - 3.47]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	230484_at	49	0.77551	0.202771	-	-1.24898	0.699274	-0.75946	0.47 [0.01 - 22.06]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1559591_s_at	55	0.363636	0.00155743	0.0368631	2.49812	0.0255977	0.990911	2.69 [1.13 - 6.43]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	229502_at	55	0.581818	0.0210703	0.277963	1.10321	0.408786	0.659979	1.93 [0.40 - 9.26]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1559590_at	55	0.381818	0.00070459	0.0189714	2.62166	0.0645764	0.53068	1.70 [0.97 - 2.98]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1559591_s_at	49	0.387755	0.0456855	0.465046	1.4297	0.243893	0.546069	1.73 [0.69 - 4.33]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	229502_at	49	0.836735	0.0975067	-	-15.3358	0.330718	-1.05789	0.35 [0.04 - 2.93]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1559590_at	49	0.387755	0.0172862	0.241529	1.67043	0.463775	0.249885	1.28 [0.66 - 2.51]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	230484_at	55	0.163636	0.223834	-	-0.618592	0.562721	-0.877887	0.42 [0.02 - 8.12]
GENE	CHDH	choline dehydrogenase	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	231994_at	55	0.345455	0.0492375	0.48703	1.05424	0.572934	0.208174	1.23 [0.60 - 2.54]
GENE	CHDH	choline dehydrogenase	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	288703	34	0.294118	0.409918	-	-0.368654	0.586336	-0.335448	0.72 [0.21 - 2.39]
GENE	CHDH	choline dehydrogenase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1559591_s_at	63	0.15873	0.0161007	0.229487	-0.945918	0.434803	-0.464887	0.63 [0.20 - 2.02]
GENE	CHDH	choline dehydrogenase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	229502_at	63	0.126984	0.000304748	0.00926096	-1.39954	0.0133259	-37.8619	0.00 [0.00 - 0.00]
GENE	CHDH	choline dehydrogenase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1559590_at	63	0.190476	9.91082e-05	0.00347477	-1.37092	0.0452059	-13.3925	0.00 [0.00 - 0.75]
GENE	CHDH	choline dehydrogenase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	231994_at	63	0.396825	0.0772013	-	-0.591594	0.42214	-1.46911	0.23 [0.01 - 8.31]
GENE	CHDH	choline dehydrogenase	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	230484_at	63	0.190476	0.000858426	0.0224158	-1.17619	0.028941	-4.15946	0.02 [0.00 - 0.65]
GENE	CHDH	choline dehydrogenase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.131668.1.S1_3p_s_at	28	0.285714	0.0926434	-	-0.939914	0.680495	0.170366	1.19 [0.53 - 2.67]
GENE	CHDH	choline dehydrogenase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.146178.0.A1_3p_at	28	0.142857	0.0688832	-	-1.07386	0.626285	0.798306	2.22 [0.09 - 55.23]
GENE	CHDH	choline dehydrogenase	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.131668.0.A1_3p_at	28	0.357143	0.04462	0.458256	-1.1553	0.0770264	-21.2535	0.00 [0.00 - 10.03]
GENE	CHDH	choline dehydrogenase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P357185	117	0.358974	0.0104468	0.166853	-0.719451	0.0312808	-0.509253	0.60 [0.38 - 0.96]
GENE	CHDH	choline dehydrogenase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P69293	117	0.307692	0.00386996	0.0772605	-0.81343	0.0272493	-0.338824	0.71 [0.53 - 0.96]
GENE	CHDH	choline dehydrogenase	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P73507	117	0.188034	0.00534472	0.0997308	-0.876535	0.0228136	-0.381603	0.68 [0.49 - 0.95]
GENE	CHDH	choline dehydrogenase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1559591_s_at	204	0.75	0.138721	-	-0.513179	0.676407	-0.135335	0.87 [0.46 - 1.65]
GENE	CHDH	choline dehydrogenase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	229502_at	204	0.897059	0.00407624	0.0805219	0.938895	0.0598647	0.276044	1.32 [0.99 - 1.76]
GENE	CHDH	choline dehydrogenase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1559590_at	204	0.892157	0.35224	-	-0.478865	0.40281	0.172837	1.19 [0.79 - 1.78]
GENE	CHDH	choline dehydrogenase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	231994_at	204	0.872549	0.0476362	0.477242	0.832899	0.541429	0.210114	1.23 [0.63 - 2.42]
GENE	CHDH	choline dehydrogenase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	230484_at	204	0.176471	0.157386	-	-0.577868	0.884576	0.116962	1.12 [0.23 - 5.45]
GENE	CHDH	choline dehydrogenase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	231994_at	204	0.872549	0.0023915	0.0524186	0.934232	0.102456	0.435933	1.55 [0.92 - 2.61]
GENE	CHDH	choline dehydrogenase	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	230484_at	204	0.348039	0.0137491	0.20457	-0.660252	0.0633422	-1.04922	0.35 [0.12 - 1.06]
GENE	CHDH	choline dehydrogenase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1559591_s_at	204	0.745098	0.0359893	0.399519	-1.20281	0.510571	-0.289388	0.75 [0.32 - 1.77]
GENE	CHDH	choline dehydrogenase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	229502_at	204	0.897059	0.0548526	-	0.85104	0.624235	0.0980064	1.10 [0.75 - 1.63]
GENE	CHDH	choline dehydrogenase	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1559590_at	204	0.392157	0.00976764	0.158626	-0.929535	0.384948	-0.204631	0.81 [0.51 - 1.29]
GENE	CHDH	choline dehydrogenase	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300018430	41	0.317073	0.0441114	0.454981	1.06206	0.320266	0.170959	1.19 [0.85 - 1.66]
GENE	CHDH	choline dehydrogenase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1559591_s_at	111	0.882883	0.092752	-	-0.846179	0.594257	-0.141537	0.87 [0.52 - 1.46]
GENE	CHDH	choline dehydrogenase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	229502_at	111	0.792793	0.0679591	-	0.540816	0.259835	0.175308	1.19 [0.88 - 1.62]
GENE	CHDH	choline dehydrogenase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1559590_at	111	0.855856	0.0593691	-	0.606198	0.360609	0.110585	1.12 [0.88 - 1.42]
GENE	CHDH	choline dehydrogenase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	231994_at	111	0.108108	0.17542	-	0.784501	0.744654	0.0400252	1.04 [0.82 - 1.32]
GENE	CHDH	choline dehydrogenase	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	230484_at	111	0.225225	0.238888	-	-0.347414	0.808143	-0.104174	0.90 [0.39 - 2.09]
GENE	CHDH	choline dehydrogenase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	231994_at	138	0.434783	0.0326969	0.375152	-0.515639	0.269568	-0.680159	0.51 [0.15 - 1.69]
GENE	CHDH	choline dehydrogenase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	230484_at	138	0.181159	4.59305e-05	0.00175799	-1.02147	0.815128	-0.350492	0.70 [0.04 - 13.30]
GENE	CHDH	choline dehydrogenase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1559591_s_at	138	0.123188	0.0363275	0.401956	-0.656713	0.20586	-0.3613	0.70 [0.40 - 1.22]
GENE	CHDH	choline dehydrogenase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	229502_at	138	0.297101	0.00800802	0.136413	-0.637454	0.0816644	-13.5246	0.00 [0.00 - 5.48]
GENE	CHDH	choline dehydrogenase	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1559590_at	138	0.891304	0.048501	0.482552	-0.987727	0.0583199	-6.45228	0.00 [0.00 - 1.26]
GENE	CHDH	choline dehydrogenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37424	56	0.517857	0.0577847	-	0.640191	0.539971	0.208468	1.23 [0.63 - 2.40]
GENE	CHDH	choline dehydrogenase	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	37424	56	0.517857	0.0505288	-	0.688391	0.763774	0.111348	1.12 [0.54 - 2.31]
GENE	CHDH	choline dehydrogenase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	231994_at	278	0.863309	0.081089	-	-0.601023	0.116805	-0.704165	0.49 [0.21 - 1.19]
GENE	CHDH	choline dehydrogenase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	230484_at	278	0.428058	0.026388	0.324827	-0.416139	0.194233	-0.543777	0.58 [0.26 - 1.32]
GENE	CHDH	choline dehydrogenase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1559591_s_at	278	0.697842	0.0585042	-	-0.414216	0.292768	-0.34906	0.71 [0.37 - 1.35]
GENE	CHDH	choline dehydrogenase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	229502_at	278	0.460432	0.00417216	0.0820241	-0.541039	0.0112404	-1.0573	0.35 [0.15 - 0.79]
GENE	CHDH	choline dehydrogenase	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1559590_at	278	0.708633	0.00564098	0.104033	-0.683583	0.0120878	-1.75804	0.17 [0.04 - 0.68]
GENE	CHDH	choline dehydrogenase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P69293	110	0.109091	0.0289008	0.345489	-0.798526	0.255495	-0.225986	0.80 [0.54 - 1.18]
GENE	CHDH	choline dehydrogenase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P357185	110	0.127273	0.000283869	0.00871001	-1.12731	0.0782163	-0.359253	0.70 [0.47 - 1.04]
GENE	CHDH	choline dehydrogenase	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P69293	110	0.136364	0.010683	0.169673	-0.775634	0.077099	-0.284801	0.75 [0.55 - 1.03]
GENE	CHDH	choline dehydrogenase	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P357185	110	0.127273	0.000381957	0.01125	-1.18614	0.185598	-0.346465	0.71 [0.42 - 1.18]
GENE	CHDH	choline dehydrogenase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1559591_s_at	38	0.631579	0.0511541	-	-1.01559	0.586103	-0.186087	0.83 [0.42 - 1.62]
GENE	CHDH	choline dehydrogenase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	229502_at	38	0.236842	0.139508	-	-0.736461	0.211114	-0.373408	0.69 [0.38 - 1.24]
GENE	CHDH	choline dehydrogenase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1559590_at	38	0.289474	2.63139e-05	0.00106862	-2.18587	0.0203839	-1.29755	0.27 [0.09 - 0.82]
GENE	CHDH	choline dehydrogenase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	231994_at	38	0.473684	0.0650361	-	0.935286	0.345123	0.459662	1.58 [0.61 - 4.11]
GENE	CHDH	choline dehydrogenase	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	230484_at	38	0.605263	0.00692301	0.121973	1.25959	0.0199113	2.644	14.07 [1.52 - 130.32]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHIA	chitinase, acidic	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	220630_s_at	30	0.566667	0.269754	-	0.45213	0.438156	0.466563	1.59 [0.49 - 5.19]
GENE	CHIA	chitinase, acidic	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1679647	165	0.890909	0.00927561	0.152551	0.850136	0.14216	1.26824	3.55 [0.65 - 19.33]
GENE	CHIA	chitinase, acidic	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1679647	165	0.842424	0.0401939	0.429001	0.821141	0.627016	0.661322	1.94 [0.13 - 27.90]
GENE	CHIA	chitinase, acidic	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	220630_s_at	163	0.208589	0.0200867	0.268765	-0.523271	0.0585345	-1.45483	0.23 [0.05 - 1.05]
GENE	CHIA	chitinase, acidic	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	220630_s_at	79	0.898734	0.17621	-	-0.787843	0.983894	0.0161613	1.02 [0.21 - 4.88]
GENE	CHIA	chitinase, acidic	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	220630_s_at	58	0.327586	0.000876048	0.0228027	1.09037	0.00784417	0.51247	1.67 [1.14 - 2.44]
GENE	CHIA	chitinase, acidic	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	220630_s_at	34	0.764706	0.021982	0.286331	-1.12489	0.791845	-0.0627982	0.94 [0.59 - 1.50]
GENE	CHIA	chitinase, acidic	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	220630_s_at	158	0.101266	0.0137288	0.204348	-0.76009	0.732045	-0.320135	0.73 [0.12 - 4.54]
GENE	CHIA	chitinase, acidic	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	220630_s_at	53	0.45283	0.227995	-	0.446823	0.978009	0.00563547	1.01 [0.67 - 1.50]
GENE	CHIA	chitinase, acidic	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	220630_s_at	53	0.377358	0.397957	-	-0.291996	0.799589	-0.0483388	0.95 [0.66 - 1.38]
GENE	CHIA	chitinase, acidic	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	220630_s_at	180	0.783333	0.177472	-	-0.35529	0.376756	-0.122737	0.88 [0.67 - 1.16]
GENE	CHIA	chitinase, acidic	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	220630_s_at	559	0.402504	0.139793	-	-0.295343	0.720544	-0.0475436	0.95 [0.73 - 1.24]
GENE	CHIA	chitinase, acidic	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	220630_s_at	77	0.181818	0.099612	-	0.620534	0.395879	0.154258	1.17 [0.82 - 1.67]
GENE	CHIA	chitinase, acidic	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	220630_s_at	70	0.857143	0.0727464	-	0.622055	0.483993	0.442399	1.56 [0.45 - 5.37]
GENE	CHIA	chitinase, acidic	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	220630_s_at	74	0.824324	0.251868	-	-0.537054	0.665404	-0.104323	0.90 [0.56 - 1.45]
GENE	CHIA	chitinase, acidic	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	220630_s_at	67	0.850746	0.18989	-	-15.2852	0.746521	-0.667653	0.51 [0.01 - 29.40]
GENE	CHIA	chitinase, acidic	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	220630_s_at	115	0.808696	0.24317	-	-1.14769	0.872138	-0.073072	0.93 [0.38 - 2.26]
GENE	CHIA	chitinase, acidic	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	220630_s_at	204	0.892157	0.0339322	0.384434	0.481799	0.835706	-0.0166334	0.98 [0.84 - 1.15]
GENE	CHIA	chitinase, acidic	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	220630_s_at	87	0.367816	0.311775	-	0.420288	0.950217	0.0467841	1.05 [0.24 - 4.55]
GENE	CHIA	chitinase, acidic	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	220630_s_at	87	0.367816	0.311775	-	0.420288	0.950217	0.0467841	1.05 [0.24 - 4.55]
GENE	CHIA	chitinase, acidic	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	220630_s_at	77	0.584416	0.0288672	0.345219	-1.97007	0.383767	-1.31847	0.27 [0.01 - 5.20]
GENE	CHIA	chitinase, acidic	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	220630_s_at	77	0.649351	0.118415	-	-1.13821	0.678438	-0.541318	0.58 [0.05 - 7.52]
GENE	CHIA	chitinase, acidic	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	220630_s_at	136	0.536765	0.18361	-	0.600514	0.404815	0.206206	1.23 [0.76 - 2.00]
GENE	CHIA	chitinase, acidic	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	220630_s_at	200	0.125	0.0115273	0.179588	-0.881123	0.085762	-0.326783	0.72 [0.50 - 1.05]
GENE	CHIA	chitinase, acidic	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5669	60	0.5	0.411212	-	-0.321224	0.97436	0.00797588	1.01 [0.62 - 1.64]
GENE	CHIA	chitinase, acidic	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5669	60	0.883333	0.0402938	0.42968	0.999465	0.686866	0.117136	1.12 [0.64 - 1.99]
GENE	CHIA	chitinase, acidic	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	220630_s_at	286	0.104895	0.14331	-	-0.405215	0.749473	-0.0499066	0.95 [0.70 - 1.29]
GENE	CHIA	chitinase, acidic	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220630_s_at	159	0.591195	0.210264	-	0.394014	0.951784	0.0152674	1.02 [0.62 - 1.67]
GENE	CHIA	chitinase, acidic	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220630_s_at	159	0.119497	0.141614	-	1.02022	0.341426	0.247472	1.28 [0.77 - 2.13]
GENE	CHIA	chitinase, acidic	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	220630_s_at	159	0.207547	0.134218	-	-0.592862	0.675351	-0.122104	0.89 [0.50 - 1.57]
GENE	CHIA	chitinase, acidic	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	220630_s_at	54	0.333333	0.0333235	0.379881	-1.43296	0.232836	-2.17828	0.11 [0.00 - 4.06]
GENE	CHIA	chitinase, acidic	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220630_s_at	117	0.666667	0.022877	0.294404	-0.915853	0.963251	0.0429801	1.04 [0.17 - 6.50]
GENE	CHIA	chitinase, acidic	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220630_s_at	117	0.136752	0.127069	-	1.43068	0.936358	0.0883998	1.09 [0.12 - 9.57]
GENE	CHIA	chitinase, acidic	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220630_s_at	117	0.666667	0.022877	0.294404	-0.915853	0.963251	0.0429801	1.04 [0.17 - 6.50]
GENE	CHIA	chitinase, acidic	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	220630_s_at	117	0.717949	0.0596284	-	-0.978475	0.682654	-0.47234	0.62 [0.06 - 6.00]
GENE	CHIA	chitinase, acidic	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	220630_s_at	236	0.266949	0.0855206	-	-0.483366	0.220035	-0.305622	0.74 [0.45 - 1.20]
GENE	CHIA	chitinase, acidic	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	220630_s_at	249	0.26506	0.0188031	0.256483	-0.518622	0.298048	-0.204174	0.82 [0.56 - 1.20]
GENE	CHIA	chitinase, acidic	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220630_s_at	125	0.24	0.00309795	0.0646427	-1.07075	0.118613	-1.771	0.17 [0.02 - 1.57]
GENE	CHIA	chitinase, acidic	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220630_s_at	125	0.24	0.0019765	0.0448579	-0.880318	0.0632513	-1.59447	0.20 [0.04 - 1.09]
GENE	CHIA	chitinase, acidic	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220630_s_at	54	0.148148	0.169969	-	15.2393	0.705101	-0.0897439	0.91 [0.57 - 1.46]
GENE	CHIA	chitinase, acidic	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	220630_s_at	62	0.145161	0.0785176	-	15.2615	0.642656	-0.0909453	0.91 [0.62 - 1.34]
GENE	CHIA	chitinase, acidic	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220630_s_at	198	0.671717	0.159983	-	-0.333401	0.77459	0.0246435	1.02 [0.87 - 1.21]
GENE	CHIA	chitinase, acidic	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220630_s_at	198	0.338384	0.0312302	0.3639	0.646176	0.0953651	0.182962	1.20 [0.97 - 1.49]
GENE	CHIA	chitinase, acidic	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	220630_s_at	198	0.338384	0.0232074	0.29735	0.724857	0.116875	0.178809	1.20 [0.96 - 1.50]
GENE	CHIA	chitinase, acidic	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	220630_s_at	51	0.823529	0.180927	-	1.15667	0.937166	-0.062781	0.94 [0.20 - 4.47]
GENE	CHIA	chitinase, acidic	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	220630_s_at	62	0.483871	0.301736	-	0.622847	0.734598	-0.236016	0.79 [0.20 - 3.09]
GENE	CHIA	chitinase, acidic	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	220630_s_at	177	0.644068	0.0916009	-	-0.518215	0.232079	-1.0963	0.33 [0.06 - 2.02]
GENE	CHIA	chitinase, acidic	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	220630_s_at	177	0.491525	0.0692606	-	-0.431009	0.15885	-1.12329	0.33 [0.07 - 1.55]
GENE	CHIA	chitinase, acidic	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	220630_s_at	145	0.786207	0.128269	-	0.56411	0.947436	0.0699798	1.07 [0.13 - 8.59]
GENE	CHIA	chitinase, acidic	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	220630_s_at	226	0.327434	0.00100678	0.0256302	-0.901944	0.0140071	-0.332741	0.72 [0.55 - 0.93]
GENE	CHIA	chitinase, acidic	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	220630_s_at	55	0.454545	0.123926	-	-0.68922	0.821849	-0.310693	0.73 [0.05 - 10.95]
GENE	CHIA	chitinase, acidic	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	220630_s_at	55	0.454545	0.13744	-	-0.678627	0.617179	-0.742094	0.48 [0.03 - 8.74]
GENE	CHIA	chitinase, acidic	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	220630_s_at	49	0.469388	0.055972	-	-1.20446	0.76514	-0.50001	0.61 [0.02 - 16.13]
GENE	CHIA	chitinase, acidic	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	220630_s_at	63	0.206349	0.000174599	0.00570966	-1.29941	0.00656596	-42.0122	0.00 [0.00 - 0.00]
GENE	CHIA	chitinase, acidic	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g11141866_3p_a_at	28	0.214286	0.0458454	0.466058	-1.2349	0.398502	-4.01978	0.02 [0.00 - 202.75]
GENE	CHIA	chitinase, acidic	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	220630_s_at	82	0.121951	0.290294	-	0.752177	0.809605	0.0601595	1.06 [0.65 - 1.73]
GENE	CHIA	chitinase, acidic	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	220630_s_at	79	0.126582	0.0354326	0.395482	-0.733509	0.532073	0.108906	1.12 [0.79 - 1.57]
GENE	CHIA	chitinase, acidic	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	220630_s_at	104	0.769231	0.0181061	0.249673	-1.32112	0.0977774	-0.529458	0.59 [0.31 - 1.10]
GENE	CHIA	chitinase, acidic	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P34888	117	0.222222	3.80699e-05	0.00148706	-1.1487	0.000917637	-0.240445	0.79 [0.68 - 0.91]
GENE	CHIA	chitinase, acidic	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	220630_s_at	204	0.269608	0.000358699	0.0106583	-0.943192	0.0953159	-0.185204	0.83 [0.67 - 1.03]
GENE	CHIA	chitinase, acidic	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	220630_s_at	204	0.112745	0.00307981	0.0643377	-1.15745	0.213379	-0.18696	0.83 [0.62 - 1.11]
GENE	CHIA	chitinase, acidic	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	220630_s_at	178	0.730337	0.00302743	0.0634544	-0.752182	0.0374292	-0.275671	0.76 [0.59 - 0.98]
GENE	CHIA	chitinase, acidic	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	220630_s_at	111	0.216216	0.346388	-	-0.284467	0.8064	-0.0304071	0.97 [0.76 - 1.24]
GENE	CHIA	chitinase, acidic	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	220630_s_at	90	0.422222	0.0915185	-	0.666218	0.387422	0.268655	1.31 [0.71 - 2.41]
GENE	CHIA	chitinase, acidic	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	220630_s_at	90	0.866667	0.157779	-	0.583496	0.594372	0.158169	1.17 [0.65 - 2.10]
GENE	CHIA	chitinase, acidic	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	220630_s_at	138	0.15942	0.00764464	0.131646	-0.733311	0.662244	-0.0590195	0.94 [0.72 - 1.23]
GENE	CHIA	chitinase, acidic	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	220630_s_at	129	0.682171	0.0244944	0.308657	-0.666648	0.184038	-0.248138	0.78 [0.54 - 1.13]
GENE	CHIA	chitinase, acidic	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24220	56	0.339286	0.269402	-	-0.381056	0.915999	-0.013417	0.99 [0.77 - 1.27]
GENE	CHIA	chitinase, acidic	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	24220	56	0.321429	0.20421	-	-0.460774	0.817251	-0.0306217	0.97 [0.75 - 1.26]
GENE	CHIA	chitinase, acidic	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	220630_s_at	278	0.107914	0.0436155	0.451766	-0.537631	0.712343	-0.151219	0.86 [0.38 - 1.92]
GENE	CHIA	chitinase, acidic	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	220630_s_at	133	0.842105	0.00266824	0.0572954	0.900592	0.0841899	1.22891	3.42 [0.85 - 13.79]
GENE	CHIA	chitinase, acidic	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	220630_s_at	185	0.102703	0.170082	-	0.362204	0.840953	-0.0540924	0.95 [0.56 - 1.61]
GENE	CHIA	chitinase, acidic	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	220630_s_at	185	0.535135	0.235509	-	-0.214747	0.718132	-0.108619	0.90 [0.50 - 1.62]
GENE	CHIA	chitinase, acidic	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P34888	110	0.227273	6.16179e-05	0.00228267	-1.04929	0.138068	-0.468359	0.63 [0.34 - 1.16]
GENE	CHIA	chitinase, acidic	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P34888	110	0.109091	4.21746e-05	0.0016293	-1.55287	0.0461145	-0.971855	0.38 [0.15 - 0.98]
GENE	CHIA	chitinase, acidic	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	220630_s_at	80	0.4	0.0193399	0.26166	1.35476	0.183552	0.310295	1.36 [0.86 - 2.15]
GENE	CHIA	chitinase, acidic	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	220630_s_at	38	0.868421	0.326851	-	0.549266	0.695121	0.386841	1.47 [0.21 - 10.19]
GENE	CHIA	chitinase, acidic	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	220630_s_at	140	0.7	0.123125	-	-0.524268	0.395289	-0.73064	0.48 [0.09 - 2.60]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	208168_s_at	30	0.833333	0.0924491	-	-1.00716	0.438987	-0.1865	0.83 [0.52 - 1.33]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1770004	165	0.218182	0.0575107	-	-0.517488	0.832752	0.115906	1.12 [0.38 - 3.29]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1770004	165	0.218182	0.00665633	0.118325	-0.955454	0.696315	-0.336275	0.71 [0.13 - 3.87]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	208168_s_at	163	0.834356	0.293659	-	-0.285412	0.831375	-0.0716311	0.93 [0.48 - 1.80]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	208168_s_at	79	0.126582	0.117423	-	-0.63628	0.982219	-0.00323792	1.00 [0.75 - 1.33]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208168_s_at	58	0.568965	0.0397359	0.425873	0.565113	0.215221	0.211378	1.24 [0.88 - 1.73]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	208168_s_at	34	0.617647	0.0636698	-	-0.753776	0.288582	-0.28935	0.75 [0.44 - 1.28]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	208168_s_at	158	0.531646	0.00199184	0.0451432	-0.735591	0.100944	-0.24752	0.78 [0.58 - 1.05]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	208168_s_at	53	0.849057	0.0272674	0.332157	-1.47515	0.553431	-0.0592964	0.94 [0.77 - 1.15]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	208168_s_at	53	0.849057	0.0142221	0.209699	-2.09536	0.386559	-0.0930565	0.91 [0.74 - 1.12]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	208168_s_at	180	0.238889	0.0082083	0.139012	0.772595	0.1691	0.0696428	1.07 [0.97 - 1.18]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	208168_s_at	559	0.429338	0.0122608	0.188006	-0.498042	0.0644391	-0.256962	0.77 [0.59 - 1.02]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	208168_s_at	77	0.493506	0.212598	-	-0.319605	0.921549	-0.0154346	0.98 [0.72 - 1.34]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	208168_s_at	70	0.114286	0.280702	-	0.462417	0.205213	0.571449	1.77 [0.73 - 4.29]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	37061_at	50	0.26	0.0537898	-	0.910859	0.521722	0.403415	1.50 [0.44 - 5.14]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	208168_s_at	74	0.405405	0.0864655	-	0.521017	0.321748	0.217803	1.24 [0.81 - 1.91]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	208168_s_at	67	0.119403	0.288781	-	15.1956	0.0858145	0.92001	2.51 [0.88 - 7.17]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	208168_s_at	115	0.104348	0.0117226	0.181847	-1.38373	0.280226	-0.383758	0.68 [0.34 - 1.37]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	37061_at	158	0.664557	0.0765745	-	-0.563886	0.556867	-0.166637	0.85 [0.49 - 1.48]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	37061_at	76	0.578947	0.107467	-	0.825631	0.535141	-0.177607	0.84 [0.48 - 1.47]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	208168_s_at	204	0.387255	0.0881477	-	-0.249772	0.244687	-0.056169	0.95 [0.86 - 1.04]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	208168_s_at	87	0.62069	0.0799095	-	-0.748763	0.275918	-0.296497	0.74 [0.44 - 1.27]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	208168_s_at	87	0.62069	0.0799095	-	-0.748763	0.275918	-0.296497	0.74 [0.44 - 1.27]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	208168_s_at	77	0.844156	0.149196	-	0.959209	0.839806	0.0606517	1.06 [0.59 - 1.91]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	208168_s_at	77	0.194805	0.328934	-	-0.578685	0.970779	-0.0105343	0.99 [0.56 - 1.74]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	208168_s_at	136	0.279412	0.0406944	0.432397	-0.893882	0.297775	-0.265763	0.77 [0.46 - 1.26]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	208168_s_at	200	0.185	0.00780615	0.133773	-0.8571	0.0539844	-0.296837	0.74 [0.55 - 1.01]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5038	60	0.666667	0.00226695	0.0501825	1.1089	0.0216412	0.447948	1.57 [1.07 - 2.29]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	5038	60	0.383333	0.0751087	-	0.757004	0.12629	0.237548	1.27 [0.94 - 1.72]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	1165	155	0.574194	0.00454156	0.0877287	0.779743	0.0366453	0.414336	1.51 [1.03 - 2.23]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	208168_s_at	286	0.206294	0.000674788	0.0182892	-0.704784	0.00305405	-0.363771	0.70 [0.55 - 0.88]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208168_s_at	159	0.465409	0.322929	-	0.317738	0.790084	0.0435593	1.04 [0.76 - 1.44]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208168_s_at	159	0.352201	0.125151	-	0.654398	0.882868	0.0280819	1.03 [0.71 - 1.49]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	208168_s_at	159	0.352201	0.0440137	0.454349	0.745914	0.815049	0.0378156	1.04 [0.76 - 1.43]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	208168_s_at	54	0.333333	0.0070314	0.123444	-1.87997	0.0751996	-2.25396	0.10 [0.01 - 1.26]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208168_s_at	117	0.888889	0.0344531	0.388297	-1.863	0.242331	-0.243899	0.78 [0.52 - 1.18]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208168_s_at	117	0.74359	0.0101049	0.162734	-1.68417	0.0739184	-0.657398	0.52 [0.25 - 1.07]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208168_s_at	117	0.888889	0.0344531	0.388297	-1.863	0.242331	-0.243899	0.78 [0.52 - 1.18]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	208168_s_at	117	0.777778	0.0477652	0.478038	-1.35253	0.129549	-0.524271	0.59 [0.30 - 1.17]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	208168_s_at	236	0.457627	0.172231	-	0.380466	0.755404	0.0400688	1.04 [0.81 - 1.34]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	208168_s_at	249	0.46988	0.0036933	0.0744324	0.641071	0.0661603	0.180154	1.20 [0.99 - 1.45]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208168_s_at	62	0.290323	0.045569	0.464309	1.80622	0.984375	-0.00396182	1.00 [0.67 - 1.48]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208168_s_at	125	0.792	0.00849902	0.142751	-2.22174	0.0637827	-0.882151	0.41 [0.16 - 1.05]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208168_s_at	125	0.808	0.109993	-	-0.627578	0.142548	-0.403644	0.67 [0.39 - 1.15]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	208168_s_at	54	0.240741	0.0548355	-	15.4441	0.882946	0.035967	1.04 [0.64 - 1.67]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208168_s_at	198	0.833333	0.146279	-	0.440602	0.913869	-0.00891916	0.99 [0.84 - 1.16]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208168_s_at	198	0.358586	0.224071	-	-0.327222	0.743543	-0.0286225	0.97 [0.82 - 1.15]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	208168_s_at	198	0.712121	0.0229348	0.294921	0.492957	0.592907	0.0361601	1.04 [0.91 - 1.18]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	208168_s_at	51	0.490196	0.168585	-	1.41867	0.61802	0.807375	2.24 [0.09 - 53.56]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	208168_s_at	62	0.354839	0.0400113	0.427756	1.86446	0.400278	0.893577	2.44 [0.30 - 19.61]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	208168_s_at	177	0.666667	0.258303	-	-0.342327	0.72184	-0.107853	0.90 [0.50 - 1.63]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	208168_s_at	177	0.548023	0.175229	-	-0.325505	0.727108	-0.0911663	0.91 [0.55 - 1.52]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	208168_s_at	145	0.393103	0.00287473	0.0608582	1.25397	0.0208064	0.641801	1.90 [1.10 - 3.27]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	208168_s_at	226	0.831858	0.0137847	0.204958	0.743372	0.0697447	0.162711	1.18 [0.99 - 1.40]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	208168_s_at	55	0.363636	0.271818	-	-0.489589	0.406979	0.31498	1.37 [0.65 - 2.88]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	208168_s_at	55	0.381818	0.0254984	0.317296	-1.01827	0.108856	-1.90964	0.15 [0.01 - 1.53]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	208168_s_at	49	0.693878	0.0524858	-	-1.78321	0.103197	-2.147	0.12 [0.01 - 1.55]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	119384	34	0.852941	0.157537	-	-1.02	0.71226	0.243864	1.28 [0.35 - 4.66]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	1707107	34	0.882353	0.00441822	0.0858379	1.54133	0.0309755	4.23182	68.84 [1.47 - 3217.82]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	208168_s_at	63	0.142857	0.0150008	0.218011	-0.969393	0.634478	-0.0351273	0.97 [0.84 - 1.12]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502808_3p_a_at	28	0.642857	0.177522	-	-0.859788	0.899707	-0.115214	0.89 [0.15 - 5.35]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	208168_s_at	82	0.231707	5.54408e-05	0.00207833	-1.35859	0.0590433	-0.364153	0.69 [0.48 - 1.01]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	37061_at	84	0.869048	0.141134	-	0.565736	0.599736	0.100829	1.11 [0.76 - 1.61]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	208168_s_at	79	0.164557	9.13388e-05	0.00323349	-1.26468	0.0685452	-0.318748	0.73 [0.52 - 1.02]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	U29615_at	86	0.244186	0.0169694	0.238343	-0.965246	0.0506944	-0.670089	0.51 [0.26 - 1.00]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	208168_s_at	104	0.875	0.219788	-	-0.866607	0.862509	-0.0350071	0.97 [0.65 - 1.44]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P126278	117	0.794872	0.0238996	0.303464	-1.02208	0.217909	-0.09357	0.91 [0.78 - 1.06]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	208168_s_at	204	0.156863	0.0503066	-	1.75636	0.120206	0.158688	1.17 [0.96 - 1.43]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	208168_s_at	204	0.632353	0.0105215	0.167746	0.683835	0.0905696	0.126872	1.14 [0.98 - 1.31]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	208168_s_at	178	0.438202	0.158731	-	0.284351	0.727334	0.0370008	1.04 [0.84 - 1.28]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	208168_s_at	111	0.108108	0.000529845	0.0148891	-1.21547	0.0800141	-0.160792	0.85 [0.71 - 1.02]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	208168_s_at	90	0.766667	0.322542	-	-0.411885	0.851989	-0.0267524	0.97 [0.74 - 1.29]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	208168_s_at	90	0.766667	0.134338	-	-0.786725	0.676488	-0.0698531	0.93 [0.67 - 1.29]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	208168_s_at	138	0.101449	0.0207638	0.275116	-0.748187	0.615245	0.0317199	1.03 [0.91 - 1.17]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	208168_s_at	129	0.193798	0.0153782	0.221983	-0.693978	0.136002	-0.161908	0.85 [0.69 - 1.05]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26363	56	0.839286	0.112349	-	-1.11854	0.522158	-0.0799267	0.92 [0.72 - 1.18]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	26363	56	0.625	0.0533174	-	0.661568	0.759973	-0.0356078	0.97 [0.77 - 1.21]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	208168_s_at	278	0.115108	0.00108603	0.0273098	-0.752814	0.88444	-0.0169382	0.98 [0.78 - 1.24]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	208168_s_at	133	0.496241	0.0230872	0.296281	0.539425	0.254707	-1.03581	0.35 [0.06 - 2.11]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	11145	81	0.864198	0.112893	-	0.998929	0.955907	-0.0271401	0.97 [0.37 - 2.55]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	4066	81	0.135802	0.212727	-	1.2183	0.923609	0.0405692	1.04 [0.45 - 2.39]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208168_s_at	185	0.664865	0.0972936	-	-0.296095	0.996479	-0.000939967	1.00 [0.66 - 1.52]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	208168_s_at	185	0.664865	0.0443621	0.456597	-0.397347	0.591366	-0.127266	0.88 [0.55 - 1.40]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P126278	110	0.118182	0.00442259	0.085905	-1.04909	0.723278	-0.0638416	0.94 [0.66 - 1.34]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P126278	110	0.118182	0.00657128	0.117153	-0.90497	0.780797	0.0360663	1.04 [0.80 - 1.34]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	208168_s_at	80	0.6	0.0904494	-	0.735087	0.872309	0.0295953	1.03 [0.72 - 1.48]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_0944	281	0.786477	0.117372	-	-0.272085	0.667821	-0.0252826	0.98 [0.87 - 1.09]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	208168_s_at	38	0.157895	0.1554	-	1.0596	0.790666	0.0366679	1.04 [0.79 - 1.36]
GENE	CHIT1	chitinase 1 (chitotriosidase)	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	208168_s_at	140	0.378571	5.529e-05	0.00207331	-1.12498	0.0768353	-0.868671	0.42 [0.16 - 1.10]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHKA	choline kinase alpha	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204266_s_at	30	0.666667	0.115074	-	0.657856	0.410055	0.258798	1.30 [0.70 - 2.40]
GENE	CHKA	choline kinase alpha	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204233_s_at	30	0.833333	0.0496881	0.48975	0.994167	0.0996952	0.564124	1.76 [0.90 - 3.44]
GENE	CHKA	choline kinase alpha	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1658504	165	0.357576	0.203652	-	-0.309117	0.966446	0.00682754	1.01 [0.73 - 1.38]
GENE	CHKA	choline kinase alpha	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1658504	165	0.230303	0.152159	-	0.748125	0.770671	0.072107	1.07 [0.66 - 1.75]
GENE	CHKA	choline kinase alpha	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204233_s_at	163	0.730061	0.02321	0.297373	-0.559408	0.303195	-0.277786	0.76 [0.45 - 1.29]
GENE	CHKA	choline kinase alpha	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204266_s_at	163	0.754601	0.061621	-	-0.480748	0.489563	-0.17769	0.84 [0.51 - 1.39]
GENE	CHKA	choline kinase alpha	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204266_s_at	79	0.56962	0.00865199	0.144703	0.75619	0.0956531	0.515539	1.67 [0.91 - 3.07]
GENE	CHKA	choline kinase alpha	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204233_s_at	79	0.177215	0.0159849	0.228292	1.19306	0.0503557	0.463424	1.59 [1.00 - 2.53]
GENE	CHKA	choline kinase alpha	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204233_s_at	58	0.275862	0.000142504	0.00478055	1.30536	0.00397788	0.681212	1.98 [1.24 - 3.14]
GENE	CHKA	choline kinase alpha	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204266_s_at	58	0.551724	0.000167988	0.00552042	1.07267	0.0714323	0.277698	1.32 [0.98 - 1.79]
GENE	CHKA	choline kinase alpha	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204233_s_at	34	0.529412	0.0130982	0.197407	0.964976	0.174623	0.366867	1.44 [0.85 - 2.45]
GENE	CHKA	choline kinase alpha	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204266_s_at	34	0.411765	0.0488881	0.484911	0.783062	0.192262	0.334599	1.40 [0.85 - 2.31]
GENE	CHKA	choline kinase alpha	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204266_s_at	158	0.151899	0.0329873	0.377349	0.779352	0.854725	0.0659133	1.07 [0.53 - 2.16]
GENE	CHKA	choline kinase alpha	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204233_s_at	158	0.158228	0.0680034	-	0.638939	0.450065	0.28409	1.33 [0.64 - 2.78]
GENE	CHKA	choline kinase alpha	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204266_s_at	53	0.716981	0.0250275	0.313264	-0.978199	0.450666	-0.331966	0.72 [0.30 - 1.70]
GENE	CHKA	choline kinase alpha	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204233_s_at	53	0.716981	0.181843	-	0.512722	0.497131	0.27756	1.32 [0.59 - 2.94]
GENE	CHKA	choline kinase alpha	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204266_s_at	53	0.716981	0.024392	0.307767	-1.05881	0.35386	-0.453797	0.64 [0.24 - 1.66]
GENE	CHKA	choline kinase alpha	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204233_s_at	53	0.716981	0.20329	-	0.463126	0.412603	0.296794	1.35 [0.66 - 2.74]
GENE	CHKA	choline kinase alpha	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204266_s_at	180	0.122222	0.00158634	0.037428	-0.883845	0.35615	-0.195906	0.82 [0.54 - 1.25]
GENE	CHKA	choline kinase alpha	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204233_s_at	180	0.655556	0.301023	-	0.219862	0.920443	-0.010753	0.99 [0.80 - 1.22]
GENE	CHKA	choline kinase alpha	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204266_s_at	559	0.579606	0.0123	0.188451	0.498058	0.466731	0.0960586	1.10 [0.85 - 1.43]
GENE	CHKA	choline kinase alpha	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204233_s_at	559	0.250447	0.0327102	0.375252	0.549616	0.199988	0.169559	1.18 [0.91 - 1.54]
GENE	CHKA	choline kinase alpha	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204233_s_at	77	0.883117	0.0469365	0.472903	0.751795	0.655261	-0.0871494	0.92 [0.63 - 1.34]
GENE	CHKA	choline kinase alpha	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204266_s_at	77	0.428571	0.00454287	0.0877488	-0.73106	0.0994348	-0.364495	0.69 [0.45 - 1.07]
GENE	CHKA	choline kinase alpha	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204233_s_at	70	0.714286	0.0616608	-	0.52511	0.749639	0.154445	1.17 [0.45 - 3.01]
GENE	CHKA	choline kinase alpha	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204266_s_at	70	0.657143	0.0949588	-	0.452861	0.966203	0.0130773	1.01 [0.55 - 1.86]
GENE	CHKA	choline kinase alpha	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32567_at	50	0.2	0.000139635	0.00469612	-1.45209	0.0474311	-1.48641	0.23 [0.05 - 0.98]
GENE	CHKA	choline kinase alpha	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204266_s_at	74	0.148649	0.0309567	0.361774	-0.79781	0.813311	-0.0887873	0.92 [0.44 - 1.91]
GENE	CHKA	choline kinase alpha	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204233_s_at	74	0.189189	3.98881e-05	0.00155029	-1.33538	0.121036	-0.570876	0.57 [0.27 - 1.16]
GENE	CHKA	choline kinase alpha	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204266_s_at	67	0.149254	0.00325348	0.0672412	-1.76149	0.169221	-1.66897	0.19 [0.02 - 2.04]
GENE	CHKA	choline kinase alpha	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204233_s_at	67	0.58209	0.0116927	0.181502	-15.911	0.124744	-1.51537	0.22 [0.03 - 1.52]
GENE	CHKA	choline kinase alpha	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204233_s_at	115	0.634783	0.0223312	0.289497	1.20174	0.279298	0.529328	1.70 [0.65 - 4.43]
GENE	CHKA	choline kinase alpha	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204266_s_at	115	0.773913	0.0495739	0.489062	1.02026	0.951356	0.0385987	1.04 [0.30 - 3.59]
GENE	CHKA	choline kinase alpha	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32567_at	158	0.873418	0.00403684	0.0799022	0.960659	0.146926	0.235039	1.26 [0.92 - 1.74]
GENE	CHKA	choline kinase alpha	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32567_at	76	0.5	0.0232818	0.298011	-1.24946	0.138942	-0.653982	0.52 [0.22 - 1.24]
GENE	CHKA	choline kinase alpha	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204266_s_at	204	0.485294	0.124069	-	-0.221095	0.879734	-0.0188843	0.98 [0.77 - 1.25]
GENE	CHKA	choline kinase alpha	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204233_s_at	204	0.245098	0.0334748	0.381017	0.350266	0.492788	0.0836739	1.09 [0.86 - 1.38]
GENE	CHKA	choline kinase alpha	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204266_s_at	87	0.701149	0.273513	-	-0.499299	0.952101	0.0217457	1.02 [0.50 - 2.08]
GENE	CHKA	choline kinase alpha	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204233_s_at	87	0.287356	0.43852	-	0.337563	0.969535	-0.0125642	0.99 [0.52 - 1.88]
GENE	CHKA	choline kinase alpha	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204233_s_at	87	0.287356	0.43852	-	0.337563	0.969535	-0.0125642	0.99 [0.52 - 1.88]
GENE	CHKA	choline kinase alpha	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204266_s_at	87	0.701149	0.273513	-	-0.499299	0.952101	0.0217457	1.02 [0.50 - 2.08]
GENE	CHKA	choline kinase alpha	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204266_s_at	77	0.831169	0.0366189	0.404046	1.26833	0.0530736	0.803175	2.23 [0.99 - 5.04]
GENE	CHKA	choline kinase alpha	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204233_s_at	77	0.779221	0.0160825	0.229299	1.4092	0.13251	0.578314	1.78 [0.84 - 3.79]
GENE	CHKA	choline kinase alpha	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204266_s_at	77	0.467532	0.0158657	0.22706	1.6584	0.0493493	0.724589	2.06 [1.00 - 4.25]
GENE	CHKA	choline kinase alpha	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204233_s_at	77	0.74026	0.00657234	0.117168	1.39984	0.108165	0.53957	1.72 [0.89 - 3.31]
GENE	CHKA	choline kinase alpha	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204233_s_at	136	0.566176	0.0583694	-	-0.945021	0.859813	0.0676802	1.07 [0.50 - 2.27]
GENE	CHKA	choline kinase alpha	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204266_s_at	136	0.102941	0.00297751	0.0626091	-1.35485	0.146948	-0.420953	0.66 [0.37 - 1.16]
GENE	CHKA	choline kinase alpha	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204266_s_at	200	0.16	0.0111385	0.175053	-0.812058	0.0921183	-0.552224	0.58 [0.30 - 1.09]
GENE	CHKA	choline kinase alpha	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204233_s_at	200	0.14	0.00255066	0.0552382	-0.979663	0.0214101	-0.659725	0.52 [0.29 - 0.91]
GENE	CHKA	choline kinase alpha	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4115	60	0.183333	0.0345604	0.389089	1.42706	0.261296	-0.392621	0.68 [0.34 - 1.34]
GENE	CHKA	choline kinase alpha	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2024	60	0.566667	0.0725121	-	0.678963	0.207714	0.397965	1.49 [0.80 - 2.77]
GENE	CHKA	choline kinase alpha	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	4115	60	0.683333	0.0011617	0.0288916	1.17046	0.113178	0.632827	1.88 [0.86 - 4.12]
GENE	CHKA	choline kinase alpha	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	2024	60	0.85	0.00455668	0.0879597	1.13257	0.0868435	0.480823	1.62 [0.93 - 2.80]
GENE	CHKA	choline kinase alpha	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204266_s_at	286	0.272727	0.145791	-	-0.300608	0.204106	-0.276137	0.76 [0.50 - 1.16]
GENE	CHKA	choline kinase alpha	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204233_s_at	286	0.104895	0.148981	-	-0.39805	0.868019	-0.0244198	0.98 [0.73 - 1.30]
GENE	CHKA	choline kinase alpha	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204266_s_at	159	0.63522	0.00364123	0.0735926	0.896214	0.00620061	0.658019	1.93 [1.21 - 3.09]
GENE	CHKA	choline kinase alpha	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204266_s_at	159	0.874214	0.00239141	0.052417	1.19093	0.0104936	0.696447	2.01 [1.18 - 3.42]
GENE	CHKA	choline kinase alpha	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204233_s_at	159	0.893082	0.0626148	-	0.757667	0.397058	0.18597	1.20 [0.78 - 1.85]
GENE	CHKA	choline kinase alpha	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204233_s_at	159	0.893082	0.0166522	0.23513	0.918158	0.06144	0.41853	1.52 [0.98 - 2.36]
GENE	CHKA	choline kinase alpha	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204266_s_at	159	0.874214	0.0118691	0.183533	0.920579	0.154812	0.37818	1.46 [0.87 - 2.46]
GENE	CHKA	choline kinase alpha	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204233_s_at	159	0.893082	0.00469174	0.0900132	1.16259	0.0742056	0.465493	1.59 [0.96 - 2.66]
GENE	CHKA	choline kinase alpha	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204266_s_at	54	0.203704	7.16412e-05	0.00260885	-2.44198	0.153705	-0.986342	0.37 [0.10 - 1.45]
GENE	CHKA	choline kinase alpha	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204233_s_at	54	0.462963	0.0578402	-	-1.41259	0.480414	-0.478831	0.62 [0.16 - 2.34]
GENE	CHKA	choline kinase alpha	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204233_s_at	117	0.74359	0.0573876	-	-0.775212	0.28358	-0.20367	0.82 [0.56 - 1.18]
GENE	CHKA	choline kinase alpha	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204233_s_at	117	0.888889	0.142123	-	-1.38436	0.450169	-0.182026	0.83 [0.52 - 1.34]
GENE	CHKA	choline kinase alpha	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204266_s_at	117	0.897436	0.174766	-	-1.29082	0.157407	-0.4025	0.67 [0.38 - 1.17]
GENE	CHKA	choline kinase alpha	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204266_s_at	117	0.769231	0.239246	-	0.394179	0.543363	-0.145978	0.86 [0.54 - 1.38]
GENE	CHKA	choline kinase alpha	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204266_s_at	117	0.769231	0.239246	-	0.394179	0.543363	-0.145978	0.86 [0.54 - 1.38]
GENE	CHKA	choline kinase alpha	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204266_s_at	117	0.521368	0.23731	-	-0.471136	0.638745	-0.138341	0.87 [0.49 - 1.55]
GENE	CHKA	choline kinase alpha	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204233_s_at	117	0.74359	0.0573876	-	-0.775212	0.28358	-0.20367	0.82 [0.56 - 1.18]
GENE	CHKA	choline kinase alpha	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204233_s_at	117	0.888889	0.0313747	0.36502	-15.2523	0.110499	-0.371635	0.69 [0.44 - 1.09]
GENE	CHKA	choline kinase alpha	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204233_s_at	236	0.868644	0.045812	0.465847	0.662456	0.526529	-0.164717	0.85 [0.51 - 1.41]
GENE	CHKA	choline kinase alpha	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204266_s_at	236	0.898305	0.021688	0.283649	0.816796	0.740991	0.0945001	1.10 [0.63 - 1.92]
GENE	CHKA	choline kinase alpha	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204233_s_at	249	0.883534	0.03444	0.388201	0.607768	0.626577	-0.102456	0.90 [0.60 - 1.36]
GENE	CHKA	choline kinase alpha	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204266_s_at	249	0.831325	0.0131484	0.197964	0.620303	0.678411	0.0947602	1.10 [0.70 - 1.72]
GENE	CHKA	choline kinase alpha	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204233_s_at	62	0.790323	0.21481	-	-0.794682	0.813821	-0.0597226	0.94 [0.57 - 1.55]
GENE	CHKA	choline kinase alpha	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204233_s_at	125	0.296	0.0753352	-	0.928757	0.965369	-0.0186565	0.98 [0.42 - 2.28]
GENE	CHKA	choline kinase alpha	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204266_s_at	62	0.774194	0.150567	-	-0.910116	0.811604	-0.0442945	0.96 [0.66 - 1.38]
GENE	CHKA	choline kinase alpha	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204233_s_at	125	0.28	0.139707	-	0.539889	0.440869	-0.251103	0.78 [0.41 - 1.47]
GENE	CHKA	choline kinase alpha	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204233_s_at	54	0.777778	0.061673	-	-1.79482	0.480223	-0.223087	0.80 [0.43 - 1.49]
GENE	CHKA	choline kinase alpha	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204266_s_at	125	0.16	0.301333	-	0.742685	0.843698	0.066773	1.07 [0.55 - 2.08]
GENE	CHKA	choline kinase alpha	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204266_s_at	125	0.896	0.101839	-	-0.871347	0.349098	-0.247013	0.78 [0.47 - 1.31]
GENE	CHKA	choline kinase alpha	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204266_s_at	54	0.759259	0.0450227	0.460833	-1.88718	0.522569	-0.147602	0.86 [0.55 - 1.36]
GENE	CHKA	choline kinase alpha	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204233_s_at	198	0.70202	0.0169769	0.238418	0.631713	0.168308	0.22993	1.26 [0.91 - 1.75]
GENE	CHKA	choline kinase alpha	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204266_s_at	198	0.449495	0.218805	-	-0.311787	0.729693	-0.0490078	0.95 [0.72 - 1.26]
GENE	CHKA	choline kinase alpha	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204266_s_at	198	0.217172	0.123037	-	-0.452898	0.764884	-0.0443677	0.96 [0.72 - 1.28]
GENE	CHKA	choline kinase alpha	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204233_s_at	198	0.434343	0.0713225	-	0.390958	0.420329	0.103693	1.11 [0.86 - 1.43]
GENE	CHKA	choline kinase alpha	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204233_s_at	198	0.449495	0.0352203	0.393933	0.559237	0.276788	0.171122	1.19 [0.87 - 1.62]
GENE	CHKA	choline kinase alpha	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204266_s_at	198	0.111111	0.322318	-	0.365229	0.888202	0.0167894	1.02 [0.80 - 1.29]
GENE	CHKA	choline kinase alpha	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204233_s_at	51	0.156863	0.110446	-	-1.3531	0.670173	0.515343	1.67 [0.16 - 17.94]
GENE	CHKA	choline kinase alpha	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204233_s_at	62	0.322581	0.119033	-	-0.872817	0.999712	0.000292114	1.00 [0.20 - 4.89]
GENE	CHKA	choline kinase alpha	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204266_s_at	51	0.72549	0.150808	-	-15.5668	0.215462	-1.22481	0.29 [0.04 - 2.04]
GENE	CHKA	choline kinase alpha	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204266_s_at	62	0.822581	0.0731856	-	-15.3861	0.358457	-0.56325	0.57 [0.17 - 1.89]
GENE	CHKA	choline kinase alpha	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204266_s_at	177	0.79661	0.0310923	0.362829	-0.976486	0.718438	-0.134173	0.87 [0.42 - 1.81]
GENE	CHKA	choline kinase alpha	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204233_s_at	145	0.331034	0.00482504	0.0920248	-0.91132	0.476901	-0.277243	0.76 [0.35 - 1.63]
GENE	CHKA	choline kinase alpha	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204233_s_at	177	0.836158	0.032874	0.376493	-1.06408	0.290892	-0.321683	0.72 [0.40 - 1.32]
GENE	CHKA	choline kinase alpha	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204266_s_at	177	0.101695	0.0440532	0.454604	1.12699	0.904692	0.0381747	1.04 [0.56 - 1.94]
GENE	CHKA	choline kinase alpha	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204266_s_at	145	0.717241	0.02064	0.273962	-1.07603	0.385523	-0.427607	0.65 [0.25 - 1.71]
GENE	CHKA	choline kinase alpha	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204233_s_at	177	0.836158	0.0531899	-	-0.754518	0.639767	-0.121188	0.89 [0.53 - 1.47]
GENE	CHKA	choline kinase alpha	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204233_s_at	226	0.460177	0.0588982	-	-0.535988	0.819837	-0.0442008	0.96 [0.65 - 1.40]
GENE	CHKA	choline kinase alpha	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204266_s_at	226	0.123894	0.0472548	0.474881	-0.691499	0.49979	-0.13746	0.87 [0.58 - 1.30]
GENE	CHKA	choline kinase alpha	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204266_s_at	55	0.290909	0.110669	-	-0.703595	0.888826	-0.0680754	0.93 [0.36 - 2.43]
GENE	CHKA	choline kinase alpha	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204266_s_at	55	0.709091	0.0419818	0.441027	0.957633	0.112025	0.81479	2.26 [0.83 - 6.17]
GENE	CHKA	choline kinase alpha	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204266_s_at	49	0.836735	0.0217775	0.284467	1.34705	0.677202	-0.281133	0.75 [0.20 - 2.84]
GENE	CHKA	choline kinase alpha	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204233_s_at	55	0.418182	0.162739	-	0.73296	0.389822	0.539059	1.71 [0.50 - 5.86]
GENE	CHKA	choline kinase alpha	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204233_s_at	55	0.327273	0.0747108	-	-0.778445	0.309211	-0.587312	0.56 [0.18 - 1.72]
GENE	CHKA	choline kinase alpha	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204233_s_at	49	0.102041	0.0293782	0.349319	-1.36829	0.150147	-1.18452	0.31 [0.06 - 1.54]
GENE	CHKA	choline kinase alpha	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	46367	34	0.882353	0.0523767	-	1.0644	0.276087	0.261412	1.30 [0.81 - 2.08]
GENE	CHKA	choline kinase alpha	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204266_s_at	63	0.777778	0.0294585	0.34996	0.778184	0.335807	0.304668	1.36 [0.73 - 2.52]
GENE	CHKA	choline kinase alpha	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204233_s_at	63	0.619048	0.00918708	0.151447	0.861899	0.757009	0.0779191	1.08 [0.66 - 1.77]
GENE	CHKA	choline kinase alpha	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4557454_3p_a_at	28	0.178571	0.127884	-	-1.01767	0.37561	1.50667	4.51 [0.16 - 126.43]
GENE	CHKA	choline kinase alpha	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.77221.0.S1_3p_a_at	28	0.357143	0.0649301	-	-1.02053	0.306991	-3.27025	0.04 [0.00 - 20.17]
GENE	CHKA	choline kinase alpha	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204233_s_at	82	0.841463	0.000168481	0.00553459	1.31442	0.0259222	1.3031	3.68 [1.17 - 11.59]
GENE	CHKA	choline kinase alpha	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204266_s_at	82	0.780488	0.0067823	0.120054	0.927248	0.172979	0.477582	1.61 [0.81 - 3.20]
GENE	CHKA	choline kinase alpha	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204233_s_at	79	0.417722	0.0252281	0.314986	-0.584612	0.506937	-0.25021	0.78 [0.37 - 1.63]
GENE	CHKA	choline kinase alpha	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204266_s_at	79	0.797468	0.0285125	0.342352	-0.815167	0.141769	-0.424098	0.65 [0.37 - 1.15]
GENE	CHKA	choline kinase alpha	None	MICHIGAN-LC	Lung cancer	Adenocarcinoma	Overall Survival	Michigan (1994-2000)	Beer	HuGeneFL	D10704_at	86	0.697674	0.0232266	0.297521	-1.30709	0.128523	-0.590519	0.55 [0.26 - 1.19]
GENE	CHKA	choline kinase alpha	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204266_s_at	104	0.288462	0.000675096	0.0182962	-1.05914	0.00387452	-0.784782	0.46 [0.27 - 0.78]
GENE	CHKA	choline kinase alpha	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204233_s_at	104	0.278846	0.0025615	0.0554288	-0.952382	0.00824309	-1.02191	0.36 [0.17 - 0.77]
GENE	CHKA	choline kinase alpha	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P124742	117	0.136752	2.06267e-06	0.00010591	-1.44104	9.92593e-05	-0.874252	0.42 [0.27 - 0.65]
GENE	CHKA	choline kinase alpha	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P136135	117	0.102564	0.00827491	0.139872	-0.985009	0.229826	-0.250858	0.78 [0.52 - 1.17]
GENE	CHKA	choline kinase alpha	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204233_s_at	204	0.622549	0.286898	-	0.387412	0.913329	-0.0580611	0.94 [0.33 - 2.68]
GENE	CHKA	choline kinase alpha	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204233_s_at	204	0.691176	0.166655	-	0.383817	0.824399	0.088896	1.09 [0.50 - 2.40]
GENE	CHKA	choline kinase alpha	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204266_s_at	204	0.240196	0.0507871	-	-0.725638	0.0605478	-0.75844	0.47 [0.21 - 1.03]
GENE	CHKA	choline kinase alpha	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204266_s_at	204	0.20098	0.0043423	0.0846671	-0.815477	0.0431499	-0.61608	0.54 [0.30 - 0.98]
GENE	CHKA	choline kinase alpha	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204233_s_at	178	0.449438	0.138986	-	-0.29174	0.45074	-0.164192	0.85 [0.55 - 1.30]
GENE	CHKA	choline kinase alpha	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204266_s_at	178	0.275281	0.000278325	0.00856265	-0.731935	0.031078	-0.460984	0.63 [0.41 - 0.96]
GENE	CHKA	choline kinase alpha	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300020035	41	0.780488	0.0463258	0.469083	-1.36758	0.360258	-0.231755	0.79 [0.48 - 1.30]
GENE	CHKA	choline kinase alpha	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204266_s_at	111	0.378378	0.13045	-	0.427338	0.907663	0.0176654	1.02 [0.76 - 1.37]
GENE	CHKA	choline kinase alpha	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204233_s_at	111	0.666667	0.0482041	0.480736	0.51865	0.319638	0.159644	1.17 [0.86 - 1.61]
GENE	CHKA	choline kinase alpha	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204233_s_at	90	0.755556	0.0136766	0.203778	0.810758	0.552901	0.204992	1.23 [0.62 - 2.42]
GENE	CHKA	choline kinase alpha	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204233_s_at	90	0.755556	0.00803859	0.136811	0.9642	0.426999	0.308396	1.36 [0.64 - 2.91]
GENE	CHKA	choline kinase alpha	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204266_s_at	90	0.577778	0.0547214	-	0.615551	0.942555	0.0265882	1.03 [0.50 - 2.12]
GENE	CHKA	choline kinase alpha	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204266_s_at	90	0.577778	0.0550999	-	0.702234	0.571265	0.22576	1.25 [0.57 - 2.74]
GENE	CHKA	choline kinase alpha	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4735	50	0.88	0.343399	-	-0.943027	0.955984	0.0218667	1.02 [0.47 - 2.22]
GENE	CHKA	choline kinase alpha	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204233_s_at	138	0.891304	0.103062	-	-0.746947	0.963807	0.00551919	1.01 [0.79 - 1.28]
GENE	CHKA	choline kinase alpha	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204266_s_at	138	0.833333	0.165395	-	-0.49396	0.737413	-0.0490931	0.95 [0.71 - 1.27]
GENE	CHKA	choline kinase alpha	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204266_s_at	129	0.844961	1.06783e-05	0.000474145	1.24691	0.00734156	0.606883	1.83 [1.18 - 2.86]
GENE	CHKA	choline kinase alpha	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204233_s_at	129	0.75969	6.2568e-05	0.00231386	1.08853	0.0312978	0.413952	1.51 [1.04 - 2.21]
GENE	CHKA	choline kinase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23745	56	0.892857	0.0878454	-	0.75638	0.309371	0.233632	1.26 [0.81 - 1.98]
GENE	CHKA	choline kinase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39635	56	0.196429	0.049687	0.489743	-0.801684	0.825068	-0.0641288	0.94 [0.53 - 1.66]
GENE	CHKA	choline kinase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3294	56	0.892857	0.0312196	0.363818	1.01803	0.959997	-0.0133801	0.99 [0.58 - 1.66]
GENE	CHKA	choline kinase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	23745	56	0.892857	0.0288588	0.34515	0.968518	0.299802	0.255297	1.29 [0.80 - 2.09]
GENE	CHKA	choline kinase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3294	56	0.214286	0.0618677	-	-0.720711	0.805458	-0.0705736	0.93 [0.53 - 1.63]
GENE	CHKA	choline kinase alpha	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	39635	56	0.196429	0.0895845	-	-0.673943	0.954217	-0.0153958	0.98 [0.58 - 1.67]
GENE	CHKA	choline kinase alpha	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204266_s_at	278	0.899281	0.0176029	0.244692	0.621566	0.436314	0.123747	1.13 [0.83 - 1.55]
GENE	CHKA	choline kinase alpha	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204233_s_at	278	0.892086	0.234749	-	-0.392947	0.824715	-0.0300352	0.97 [0.74 - 1.27]
GENE	CHKA	choline kinase alpha	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204233_s_at	133	0.789474	0.0873695	-	-0.576495	0.943257	-0.00796956	0.99 [0.80 - 1.24]
GENE	CHKA	choline kinase alpha	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204266_s_at	133	0.360902	0.143404	-	0.37765	0.901279	0.0240672	1.02 [0.70 - 1.50]
GENE	CHKA	choline kinase alpha	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	14416	81	0.691358	0.12637	-	0.775439	0.44274	0.325123	1.38 [0.60 - 3.18]
GENE	CHKA	choline kinase alpha	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204266_s_at	185	0.145946	0.28838	-	0.252356	0.656206	-0.0631856	0.94 [0.71 - 1.24]
GENE	CHKA	choline kinase alpha	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204233_s_at	185	0.237838	0.107594	-	-0.292732	0.725041	-0.0656131	0.94 [0.65 - 1.35]
GENE	CHKA	choline kinase alpha	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204266_s_at	185	0.616216	0.202702	-	-0.231331	0.616502	-0.079692	0.92 [0.68 - 1.26]
GENE	CHKA	choline kinase alpha	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204233_s_at	185	0.108108	0.0533332	-	-0.488514	0.921569	-0.0199331	0.98 [0.66 - 1.46]
GENE	CHKA	choline kinase alpha	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P136135	110	0.472727	0.0451777	0.461822	0.463854	0.151489	0.216994	1.24 [0.92 - 1.67]
GENE	CHKA	choline kinase alpha	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P124742	110	0.290909	0.0216541	0.283338	0.625293	0.197906	0.221766	1.25 [0.89 - 1.75]
GENE	CHKA	choline kinase alpha	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P136135	110	0.8	0.00162617	0.038203	1.04683	0.0430768	0.411695	1.51 [1.01 - 2.25]
GENE	CHKA	choline kinase alpha	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P124742	110	0.6	0.0166703	0.235313	0.714202	0.0659597	0.419786	1.52 [0.97 - 2.38]
GENE	CHKA	choline kinase alpha	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204266_s_at	80	0.6875	0.0451719	0.461785	0.856523	0.211916	0.452573	1.57 [0.77 - 3.20]
GENE	CHKA	choline kinase alpha	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204233_s_at	80	0.7375	0.0314407	0.36553	0.925206	0.0859175	0.533753	1.71 [0.93 - 3.14]
GENE	CHKA	choline kinase alpha	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP4_5851	281	0.163701	0.0869868	-	0.337074	0.269862	0.125686	1.13 [0.91 - 1.42]
GENE	CHKA	choline kinase alpha	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204266_s_at	38	0.447368	0.000220417	0.00699449	2.17048	0.00279813	1.17311	3.23 [1.50 - 6.98]
GENE	CHKA	choline kinase alpha	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204233_s_at	38	0.394737	0.000511495	0.0144479	2.09795	0.00745581	0.907272	2.48 [1.27 - 4.82]
GENE	CHKA	choline kinase alpha	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204233_s_at	140	0.107143	3.66071e-05	0.00143594	-1.33498	0.0570532	-0.950654	0.39 [0.15 - 1.03]
GENE	CHKA	choline kinase alpha	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204266_s_at	140	0.25	0.000224729	0.00711326	-1.03863	0.14662	-0.589532	0.55 [0.25 - 1.23]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHKB	choline kinase beta	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	204193_at	30	0.433333	0.0129521	0.195782	-1.02142	0.874663	-0.124477	0.88 [0.19 - 4.15]
GENE	CHKB	choline kinase beta	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1681399	165	0.89697	0.236561	-	-0.544017	0.684552	-0.0673875	0.93 [0.68 - 1.29]
GENE	CHKB	choline kinase beta	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1681399	165	0.466667	0.195245	-	-0.457194	0.539439	-0.154391	0.86 [0.52 - 1.40]
GENE	CHKB	choline kinase beta	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	204193_at	163	0.110429	0.0866197	-	-0.488711	0.848616	0.0451554	1.05 [0.66 - 1.66]
GENE	CHKB	choline kinase beta	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	204193_at	79	0.443038	0.0261433	0.322766	0.668031	0.0920966	0.456079	1.58 [0.93 - 2.68]
GENE	CHKB	choline kinase beta	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204193_at	58	0.706897	0.0812769	-	-0.541362	0.137136	-0.240626	0.79 [0.57 - 1.08]
GENE	CHKB	choline kinase beta	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	204193_at	34	0.352941	0.0049745	0.0942628	-1.11749	0.0421793	-1.08196	0.34 [0.12 - 0.96]
GENE	CHKB	choline kinase beta	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	204193_at	158	0.778481	0.0750444	-	-0.537561	0.143953	-0.801351	0.45 [0.15 - 1.31]
GENE	CHKB	choline kinase beta	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	204193_at	53	0.830189	0.308562	-	0.429217	0.598159	0.272745	1.31 [0.48 - 3.62]
GENE	CHKB	choline kinase beta	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	204193_at	53	0.830189	0.0597333	-	0.795427	0.208706	0.706352	2.03 [0.67 - 6.10]
GENE	CHKB	choline kinase beta	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	204193_at	180	0.744444	0.00752201	0.130022	-0.694035	0.0849819	-0.393251	0.67 [0.43 - 1.06]
GENE	CHKB	choline kinase beta	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	204193_at	559	0.851521	0.079349	-	0.436386	0.31218	0.227635	1.26 [0.81 - 1.95]
GENE	CHKB	choline kinase beta	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	204193_at	77	0.415584	0.0175089	0.243755	-0.603763	0.0947213	-0.54473	0.58 [0.31 - 1.10]
GENE	CHKB	choline kinase beta	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	204193_at	70	0.885714	0.131466	-	-0.695522	0.484884	-0.294042	0.75 [0.33 - 1.70]
GENE	CHKB	choline kinase beta	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32033_at	50	0.26	0.10955	-	-0.630822	0.469289	-0.917328	0.40 [0.03 - 4.79]
GENE	CHKB	choline kinase beta	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	204193_at	74	0.581081	0.0888626	-	0.500439	0.379592	0.530076	1.70 [0.52 - 5.54]
GENE	CHKB	choline kinase beta	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	204193_at	67	0.567164	0.0285655	0.342781	-1.98367	0.0972884	-1.91277	0.15 [0.02 - 1.42]
GENE	CHKB	choline kinase beta	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	204193_at	115	0.434783	0.00500388	0.0947007	-1.64139	0.0353863	-1.7354	0.18 [0.04 - 0.89]
GENE	CHKB	choline kinase beta	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32033_at	158	0.392405	0.1678	-	0.428749	0.763798	-0.130451	0.88 [0.37 - 2.06]
GENE	CHKB	choline kinase beta	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32033_at	76	0.605263	0.201607	-	0.650004	0.739779	0.266973	1.31 [0.27 - 6.31]
GENE	CHKB	choline kinase beta	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	204193_at	204	0.382353	0.00207568	0.0466942	-0.446974	0.0156818	-0.47184	0.62 [0.43 - 0.91]
GENE	CHKB	choline kinase beta	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	204193_at	87	0.896552	0.0967242	-	0.799696	0.690445	0.20859	1.23 [0.44 - 3.44]
GENE	CHKB	choline kinase beta	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	204193_at	87	0.896552	0.0967242	-	0.799696	0.690445	0.20859	1.23 [0.44 - 3.44]
GENE	CHKB	choline kinase beta	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	204193_at	77	0.103896	0.264906	-	-0.86036	0.654468	0.349695	1.42 [0.31 - 6.56]
GENE	CHKB	choline kinase beta	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	204193_at	77	0.688312	0.0454283	0.463416	1.06308	0.206993	0.873708	2.40 [0.62 - 9.31]
GENE	CHKB	choline kinase beta	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	204193_at	136	0.102941	0.0336434	0.38228	-1.16102	0.0428401	-0.819909	0.44 [0.20 - 0.97]
GENE	CHKB	choline kinase beta	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	204193_at	200	0.41	0.0173396	0.242064	-0.694772	0.0404619	-0.88057	0.41 [0.18 - 0.96]
GENE	CHKB	choline kinase beta	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11383	60	0.166667	0.0127356	0.193362	-1.02619	0.223689	-0.316854	0.73 [0.44 - 1.21]
GENE	CHKB	choline kinase beta	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7577	60	0.283333	0.259598	-	-0.45683	0.691432	-0.113214	0.89 [0.51 - 1.56]
GENE	CHKB	choline kinase beta	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	11383	60	0.383333	0.126227	-	-0.584449	0.427103	-0.258146	0.77 [0.41 - 1.46]
GENE	CHKB	choline kinase beta	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	7577	60	0.866667	0.0523376	-	0.825878	0.892763	0.0543025	1.06 [0.48 - 2.33]
GENE	CHKB	choline kinase beta	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	204193_at	286	0.342657	0.201848	-	0.270316	0.977463	0.00872869	1.01 [0.55 - 1.85]
GENE	CHKB	choline kinase beta	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204193_at	159	0.245283	0.0776675	-	-0.577281	0.83114	-0.0926366	0.91 [0.39 - 2.14]
GENE	CHKB	choline kinase beta	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204193_at	159	0.201258	0.0952355	-	-0.6589	0.771467	-0.148217	0.86 [0.32 - 2.34]
GENE	CHKB	choline kinase beta	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	204193_at	159	0.207547	0.0308023	0.360569	-0.715152	0.553445	-0.250283	0.78 [0.34 - 1.78]
GENE	CHKB	choline kinase beta	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	204193_at	54	0.648148	0.168743	-	-1.07016	0.745622	-0.21705	0.80 [0.22 - 2.99]
GENE	CHKB	choline kinase beta	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204193_at	117	0.777778	0.0313611	0.364915	-0.9908	0.244906	-0.337753	0.71 [0.40 - 1.26]
GENE	CHKB	choline kinase beta	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204193_at	117	0.760684	0.0739914	-	-0.932302	0.268794	-0.385885	0.68 [0.34 - 1.35]
GENE	CHKB	choline kinase beta	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204193_at	117	0.777778	0.0313611	0.364915	-0.9908	0.244906	-0.337753	0.71 [0.40 - 1.26]
GENE	CHKB	choline kinase beta	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	204193_at	117	0.760684	0.159607	-	-0.747217	0.86966	-0.0606649	0.94 [0.46 - 1.94]
GENE	CHKB	choline kinase beta	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	204193_at	236	0.186441	0.000701676	0.018905	-0.940629	0.0399388	-0.928132	0.40 [0.16 - 0.96]
GENE	CHKB	choline kinase beta	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	204193_at	249	0.240964	0.0363508	0.402124	-0.477672	0.185851	-0.484283	0.62 [0.30 - 1.26]
GENE	CHKB	choline kinase beta	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204193_at	62	0.822581	0.0338727	0.383991	-1.91292	0.393492	-0.196636	0.82 [0.52 - 1.29]
GENE	CHKB	choline kinase beta	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204193_at	125	0.408	0.350871	-	0.393857	0.832916	-0.0986819	0.91 [0.36 - 2.27]
GENE	CHKB	choline kinase beta	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204193_at	125	0.896	0.173258	-	-0.792463	0.872713	-0.0580208	0.94 [0.46 - 1.92]
GENE	CHKB	choline kinase beta	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	204193_at	54	0.796296	0.096881	-	-1.58938	0.465804	-0.202145	0.82 [0.47 - 1.41]
GENE	CHKB	choline kinase beta	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204193_at	198	0.747475	0.0462435	0.468566	-0.675864	0.926594	-0.0190608	0.98 [0.65 - 1.47]
GENE	CHKB	choline kinase beta	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204193_at	198	0.747475	0.0602308	-	-0.671554	0.834461	-0.0445151	0.96 [0.63 - 1.45]
GENE	CHKB	choline kinase beta	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	204193_at	198	0.126263	0.0495425	0.488872	0.76063	0.536587	0.114811	1.12 [0.78 - 1.61]
GENE	CHKB	choline kinase beta	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	204193_at	51	0.509804	0.0232641	0.297854	-16.2337	0.303157	-1.11289	0.33 [0.04 - 2.73]
GENE	CHKB	choline kinase beta	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	204193_at	62	0.387097	0.0274607	0.333754	-1.26539	0.248058	-0.762387	0.47 [0.13 - 1.70]
GENE	CHKB	choline kinase beta	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	204193_at	177	0.180791	0.166266	-	0.513473	0.483528	0.263893	1.30 [0.62 - 2.72]
GENE	CHKB	choline kinase beta	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	204193_at	145	0.296552	0.0540179	-	0.898962	0.71393	0.20684	1.23 [0.41 - 3.72]
GENE	CHKB	choline kinase beta	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	204193_at	177	0.491525	0.109014	-	0.448156	0.36942	0.383691	1.47 [0.63 - 3.39]
GENE	CHKB	choline kinase beta	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	204193_at	226	0.185841	0.0206133	0.273713	1.28794	0.313756	0.313661	1.37 [0.74 - 2.52]
GENE	CHKB	choline kinase beta	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	204193_at	55	0.145455	0.204758	-	-0.78877	0.58962	-0.522561	0.59 [0.09 - 3.96]
GENE	CHKB	choline kinase beta	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	204193_at	49	0.857143	0.160673	-	-15.2621	0.568293	-0.667526	0.51 [0.05 - 5.08]
GENE	CHKB	choline kinase beta	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	204193_at	55	0.618182	0.140742	-	-0.743789	0.45271	-0.655866	0.52 [0.09 - 2.88]
GENE	CHKB	choline kinase beta	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	204193_at	63	0.285714	0.196269	-	0.51557	0.98364	-0.00532563	0.99 [0.60 - 1.65]
GENE	CHKB	choline kinase beta	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g6978648_3p_at	28	0.5	0.0178085	0.246733	1.28369	0.332281	0.579636	1.79 [0.55 - 5.76]
GENE	CHKB	choline kinase beta	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	204193_at	82	0.780488	0.0354663	0.395727	0.765025	0.360735	0.620395	1.86 [0.49 - 7.03]
GENE	CHKB	choline kinase beta	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32033_at	84	0.607143	0.00119954	0.0296749	-1.01564	0.0847466	-0.438979	0.64 [0.39 - 1.06]
GENE	CHKB	choline kinase beta	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	204193_at	79	0.886076	0.0520134	-	0.699333	0.657105	0.221393	1.25 [0.47 - 3.32]
GENE	CHKB	choline kinase beta	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	204193_at	104	0.365385	0.0129318	0.195556	-0.797782	0.203571	-0.629199	0.53 [0.20 - 1.41]
GENE	CHKB	choline kinase beta	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P314120	117	0.692308	0.0570168	-	-0.662698	0.243463	-0.279125	0.76 [0.47 - 1.21]
GENE	CHKB	choline kinase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	204193_at	204	0.593137	0.00173919	0.0403804	-1.41748	0.0108523	-1.40442	0.25 [0.08 - 0.72]
GENE	CHKB	choline kinase beta	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	204193_at	204	0.294118	0.000589283	0.0163009	-0.905694	0.001589	-1.2983	0.27 [0.12 - 0.61]
GENE	CHKB	choline kinase beta	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	204193_at	178	0.758427	0.00817138	0.138534	-0.724128	0.39799	-0.292017	0.75 [0.38 - 1.47]
GENE	CHKB	choline kinase beta	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	204193_at	111	0.558559	0.0648653	-	0.482888	0.702563	0.144065	1.15 [0.55 - 2.42]
GENE	CHKB	choline kinase beta	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	204193_at	90	0.6	0.00362985	0.0734086	-1.10223	0.113738	-0.858397	0.42 [0.15 - 1.23]
GENE	CHKB	choline kinase beta	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	204193_at	90	0.6	0.00310944	0.0648359	-1.35037	0.0980588	-1.0156	0.36 [0.11 - 1.21]
GENE	CHKB	choline kinase beta	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	204193_at	138	0.217391	0.0476395	0.477262	-0.528033	0.221994	-0.213552	0.81 [0.57 - 1.14]
GENE	CHKB	choline kinase beta	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	204193_at	129	0.178295	0.056716	-	-0.556598	0.886351	-0.0636836	0.94 [0.39 - 2.25]
GENE	CHKB	choline kinase beta	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	204193_at	278	0.471223	0.00344318	0.0703703	0.572565	0.137448	0.277252	1.32 [0.92 - 1.90]
GENE	CHKB	choline kinase beta	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	204193_at	133	0.496241	0.149778	-	0.344682	0.804356	0.0402727	1.04 [0.76 - 1.43]
GENE	CHKB	choline kinase beta	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	1283	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	CHKB	choline kinase beta	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204193_at	185	0.491892	0.179947	-	0.237725	0.753335	0.0739226	1.08 [0.68 - 1.71]
GENE	CHKB	choline kinase beta	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	204193_at	185	0.259459	0.180053	-	0.258479	0.866291	0.0364213	1.04 [0.68 - 1.58]
GENE	CHKB	choline kinase beta	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P314120	110	0.645455	0.0101511	0.163293	0.598028	0.383176	0.126651	1.14 [0.85 - 1.51]
GENE	CHKB	choline kinase beta	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P314120	110	0.881818	0.141311	-	-0.854261	0.91066	-0.0210847	0.98 [0.68 - 1.42]
GENE	CHKB	choline kinase beta	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	204193_at	80	0.325	0.0151556	0.219645	-1.08276	0.185513	-0.486975	0.61 [0.30 - 1.26]
GENE	CHKB	choline kinase beta	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	204193_at	38	0.210526	0.168512	-	0.863416	0.612764	0.334044	1.40 [0.38 - 5.09]
GENE	CHKB	choline kinase beta	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	204193_at	140	0.385714	7.57532e-05	0.00274092	-1.11542	0.00152542	-1.33766	0.26 [0.11 - 0.60]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHPF	chondroitin polymerizing factor	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	202175_at	30	0.533333	0.0349944	0.392281	0.84986	0.355293	0.579833	1.79 [0.52 - 6.11]
GENE	CHPF	chondroitin polymerizing factor	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1731353	165	0.890909	6.22281e-06	0.000290476	1.32324	0.0415827	0.366162	1.44 [1.01 - 2.05]
GENE	CHPF	chondroitin polymerizing factor	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1731353	165	0.890909	2.3988e-07	1.45076e-05	1.77081	0.0642104	0.495222	1.64 [0.97 - 2.77]
GENE	CHPF	chondroitin polymerizing factor	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	202175_at	163	0.141104	0.0699252	-	-0.469127	0.582246	-0.396374	0.67 [0.16 - 2.76]
GENE	CHPF	chondroitin polymerizing factor	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	202175_at	79	0.835443	0.0968834	-	0.586421	0.496645	0.602765	1.83 [0.32 - 10.39]
GENE	CHPF	chondroitin polymerizing factor	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202175_at	58	0.206897	0.124898	-	0.565691	0.749733	0.0868148	1.09 [0.64 - 1.86]
GENE	CHPF	chondroitin polymerizing factor	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	202175_at	34	0.117647	0.00370665	0.0746474	-1.53689	0.0532203	-1.06333	0.35 [0.12 - 1.01]
GENE	CHPF	chondroitin polymerizing factor	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	202175_at	158	0.78481	0.00923519	0.152047	0.649439	0.0468208	0.805425	2.24 [1.01 - 4.95]
GENE	CHPF	chondroitin polymerizing factor	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	202175_at	53	0.207547	0.0675055	-	0.94119	0.436593	0.329287	1.39 [0.61 - 3.19]
GENE	CHPF	chondroitin polymerizing factor	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	202175_at	53	0.320755	0.0617634	-	0.832714	0.307174	0.455567	1.58 [0.66 - 3.78]
GENE	CHPF	chondroitin polymerizing factor	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	202175_at	180	0.383333	0.0171604	0.240267	0.525764	0.464532	0.194532	1.21 [0.72 - 2.05]
GENE	CHPF	chondroitin polymerizing factor	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	202175_at	559	0.896243	0.165479	-	-0.62642	0.706082	-0.0880307	0.92 [0.58 - 1.45]
GENE	CHPF	chondroitin polymerizing factor	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	202175_at	77	0.194805	0.00276109	0.0589051	-0.91772	0.182476	-0.376298	0.69 [0.39 - 1.19]
GENE	CHPF	chondroitin polymerizing factor	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	202175_at	70	0.757143	0.074398	-	-0.594062	0.383508	-0.378204	0.69 [0.29 - 1.60]
GENE	CHPF	chondroitin polymerizing factor	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	32566_at	50	0.74	1.77307e-05	0.000749457	1.7025	0.0637643	0.292471	1.34 [0.98 - 1.83]
GENE	CHPF	chondroitin polymerizing factor	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	202175_at	74	0.594595	0.00900017	0.149105	0.755113	0.429026	0.335196	1.40 [0.61 - 3.21]
GENE	CHPF	chondroitin polymerizing factor	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	202175_at	67	0.179104	0.136675	-	15.3701	0.222438	0.778402	2.18 [0.62 - 7.61]
GENE	CHPF	chondroitin polymerizing factor	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	202175_at	115	0.382609	0.171082	-	0.866127	0.556031	0.416687	1.52 [0.38 - 6.07]
GENE	CHPF	chondroitin polymerizing factor	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	32566_at	158	0.265823	0.166699	-	0.505054	0.564633	0.195065	1.22 [0.63 - 2.36]
GENE	CHPF	chondroitin polymerizing factor	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	32566_at	76	0.605263	0.0187255	0.255729	1.21342	0.0942487	0.96825	2.63 [0.85 - 8.19]
GENE	CHPF	chondroitin polymerizing factor	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	202175_at	204	0.147059	0.0523487	-	-0.381609	0.33536	-0.147649	0.86 [0.64 - 1.17]
GENE	CHPF	chondroitin polymerizing factor	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	202175_at	87	0.16092	0.135226	-	-0.64896	0.888764	-0.0734843	0.93 [0.33 - 2.60]
GENE	CHPF	chondroitin polymerizing factor	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	202175_at	87	0.16092	0.135226	-	-0.64896	0.888764	-0.0734843	0.93 [0.33 - 2.60]
GENE	CHPF	chondroitin polymerizing factor	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	202175_at	77	0.883117	0.0304551	0.357849	1.38464	0.325262	0.814818	2.26 [0.45 - 11.45]
GENE	CHPF	chondroitin polymerizing factor	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	202175_at	77	0.883117	0.00375302	0.0753922	1.58469	0.109549	1.17326	3.23 [0.77 - 13.60]
GENE	CHPF	chondroitin polymerizing factor	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	202175_at	136	0.176471	0.19033	-	0.95515	0.704492	-0.239515	0.79 [0.23 - 2.71]
GENE	CHPF	chondroitin polymerizing factor	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	202175_at	200	0.14	0.00322867	0.0668288	-0.991234	0.00935979	-1.43139	0.24 [0.08 - 0.70]
GENE	CHPF	chondroitin polymerizing factor	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	202175_at	286	0.734266	0.00393625	0.0783132	-0.729245	0.0234537	-0.619364	0.54 [0.32 - 0.92]
GENE	CHPF	chondroitin polymerizing factor	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202175_at	159	0.314465	0.00316876	0.0658295	1.31502	0.0138395	1.18252	3.26 [1.27 - 8.37]
GENE	CHPF	chondroitin polymerizing factor	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202175_at	159	0.773585	0.00124354	0.0305797	1.14424	0.00319277	1.63647	5.14 [1.73 - 15.25]
GENE	CHPF	chondroitin polymerizing factor	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	202175_at	159	0.647799	0.000519744	0.0146466	1.06233	0.0180081	1.15032	3.16 [1.22 - 8.19]
GENE	CHPF	chondroitin polymerizing factor	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	202175_at	54	0.314815	0.151415	-	-0.952438	0.630467	-0.412592	0.66 [0.12 - 3.56]
GENE	CHPF	chondroitin polymerizing factor	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202175_at	117	0.871795	0.110558	-	0.657371	0.873558	0.0552905	1.06 [0.53 - 2.09]
GENE	CHPF	chondroitin polymerizing factor	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202175_at	117	0.871795	0.00933291	0.153263	1.08589	0.314696	0.423348	1.53 [0.67 - 3.49]
GENE	CHPF	chondroitin polymerizing factor	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202175_at	117	0.871795	0.110558	-	0.657371	0.873558	0.0552905	1.06 [0.53 - 2.09]
GENE	CHPF	chondroitin polymerizing factor	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	202175_at	117	0.871795	0.0565724	-	0.856518	0.793462	0.108567	1.11 [0.49 - 2.51]
GENE	CHPF	chondroitin polymerizing factor	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	202175_at	236	0.851695	0.0157889	0.226264	0.751071	0.35377	0.509708	1.66 [0.57 - 4.89]
GENE	CHPF	chondroitin polymerizing factor	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	202175_at	249	0.791165	0.0769553	-	0.426827	0.6079	0.219437	1.25 [0.54 - 2.88]
GENE	CHPF	chondroitin polymerizing factor	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202175_at	62	0.677419	0.151174	-	-0.772203	0.560275	-0.209177	0.81 [0.40 - 1.64]
GENE	CHPF	chondroitin polymerizing factor	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202175_at	125	0.216	0.199331	-	-0.539335	0.86343	-0.0659794	0.94 [0.44 - 1.99]
GENE	CHPF	chondroitin polymerizing factor	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202175_at	125	0.216	0.0868632	-	-0.563434	0.666872	-0.126346	0.88 [0.50 - 1.57]
GENE	CHPF	chondroitin polymerizing factor	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	202175_at	54	0.111111	0.121883	-	-1.16945	0.597993	-0.229751	0.79 [0.34 - 1.87]
GENE	CHPF	chondroitin polymerizing factor	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202175_at	198	0.126263	0.00130934	0.0319212	2.56871	0.0123564	0.568315	1.77 [1.13 - 2.76]
GENE	CHPF	chondroitin polymerizing factor	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202175_at	198	0.161616	0.00197381	0.044808	1.92391	0.0430231	0.483091	1.62 [1.02 - 2.59]
GENE	CHPF	chondroitin polymerizing factor	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	202175_at	198	0.10101	0.00894908	0.148463	1.42365	0.106325	0.318967	1.38 [0.93 - 2.03]
GENE	CHPF	chondroitin polymerizing factor	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	202175_at	51	0.45098	0.0897264	-	-1.6901	0.699696	-0.45165	0.64 [0.06 - 6.32]
GENE	CHPF	chondroitin polymerizing factor	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	202175_at	62	0.112903	0.17825	-	15.2264	0.860007	0.14101	1.15 [0.24 - 5.52]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	202175_at	177	0.870057	0.00014693	0.00491032	1.11214	0.0578737	0.939956	2.56 [0.97 - 6.76]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	202175_at	177	0.853107	0.00115641	0.0287817	0.867288	0.170113	0.619187	1.86 [0.77 - 4.50]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	202175_at	145	0.827586	0.000111747	0.00386195	1.26184	0.00195091	1.74426	5.72 [1.90 - 17.25]
GENE	CHPF	chondroitin polymerizing factor	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	202175_at	226	0.89823	0.000695533	0.0187646	1.09302	0.0607595	0.521002	1.68 [0.98 - 2.90]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	202175_at	55	0.418182	0.238024	-	-0.525124	0.605018	-0.329947	0.72 [0.21 - 2.51]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	202175_at	55	0.654545	0.126397	-	0.733295	0.691081	0.268974	1.31 [0.35 - 4.93]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	202175_at	49	0.510204	0.444607	-	-0.444744	0.890019	-0.112962	0.89 [0.18 - 4.43]
GENE	CHPF	chondroitin polymerizing factor	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	34847	34	0.382353	0.0501818	-	0.973283	0.36233	0.648763	1.91 [0.47 - 7.73]
GENE	CHPF	chondroitin polymerizing factor	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	202175_at	63	0.190476	0.158456	-	-0.562436	0.791596	-0.111251	0.89 [0.39 - 2.04]
GENE	CHPF	chondroitin polymerizing factor	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g13375692_3p_at	28	0.821429	0.0229761	0.29529	1.37487	0.175696	0.310362	1.36 [0.87 - 2.14]
GENE	CHPF	chondroitin polymerizing factor	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	202175_at	82	0.121951	0.00905461	0.149789	-1.08923	0.151341	-0.922591	0.40 [0.11 - 1.40]
GENE	CHPF	chondroitin polymerizing factor	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	32566_at	84	0.321429	0.0109516	0.172854	0.883093	0.0474872	0.501078	1.65 [1.01 - 2.71]
GENE	CHPF	chondroitin polymerizing factor	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	202175_at	79	0.531646	0.0382357	0.415487	0.538221	0.44998	0.368069	1.44 [0.56 - 3.75]
GENE	CHPF	chondroitin polymerizing factor	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	202175_at	104	0.5	0.0205797	0.273399	0.767956	0.525857	0.399692	1.49 [0.43 - 5.13]
GENE	CHPF	chondroitin polymerizing factor	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P131289	117	0.837607	0.146329	-	0.509964	0.916703	0.0209511	1.02 [0.69 - 1.51]
GENE	CHPF	chondroitin polymerizing factor	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	202175_at	204	0.573529	0.00820506	0.13897	0.966632	0.0822628	1.05786	2.88 [0.87 - 9.50]
GENE	CHPF	chondroitin polymerizing factor	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	202175_at	204	0.647059	5.61125e-06	0.000264378	1.19024	0.000311732	1.54438	4.69 [2.02 - 10.85]
GENE	CHPF	chondroitin polymerizing factor	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	202175_at	178	0.752809	0.00100362	0.0255626	0.688776	0.24582	0.423076	1.53 [0.75 - 3.12]
GENE	CHPF	chondroitin polymerizing factor	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200001473	41	0.829268	0.0618469	-	0.870556	0.18421	0.38317	1.47 [0.83 - 2.58]
GENE	CHPF	chondroitin polymerizing factor	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	202175_at	111	0.234234	0.00074354	0.0198554	1.35342	0.00697961	0.927709	2.53 [1.29 - 4.96]
GENE	CHPF	chondroitin polymerizing factor	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	202175_at	90	0.655556	0.158641	-	-0.51391	0.626551	0.218571	1.24 [0.52 - 3.00]
GENE	CHPF	chondroitin polymerizing factor	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	202175_at	90	0.5	0.238603	-	-0.44089	0.916508	0.0536729	1.06 [0.39 - 2.88]
GENE	CHPF	chondroitin polymerizing factor	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	202175_at	138	0.210145	0.0182912	0.251491	-0.62783	0.858659	0.0292628	1.03 [0.75 - 1.42]
GENE	CHPF	chondroitin polymerizing factor	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	202175_at	129	0.310078	0.0418205	0.439954	0.578884	0.885387	0.0683237	1.07 [0.42 - 2.71]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35171	56	0.375	0.000759698	0.0202197	-1.19474	0.532803	-0.213141	0.81 [0.41 - 1.58]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12993	56	0.303571	0.000586055	0.0162248	-1.24187	0.594561	-0.171209	0.84 [0.45 - 1.58]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	35171	56	0.375	0.000457153	0.0131251	-1.31356	0.584199	-0.18162	0.83 [0.44 - 1.60]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12993	56	0.303571	0.000810607	0.0213582	-1.24424	0.661197	-0.141209	0.87 [0.46 - 1.63]
GENE	CHPF	chondroitin polymerizing factor	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	202175_at	278	0.129496	0.18294	-	0.440527	0.820838	-0.0402586	0.96 [0.68 - 1.36]
GENE	CHPF	chondroitin polymerizing factor	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	202175_at	133	0.105263	0.0602524	-	0.849121	0.32143	0.189368	1.21 [0.83 - 1.76]
GENE	CHPF	chondroitin polymerizing factor	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202175_at	185	0.237838	0.204972	-	0.248246	0.79873	0.0421956	1.04 [0.75 - 1.44]
GENE	CHPF	chondroitin polymerizing factor	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	202175_at	185	0.886486	0.148376	-	0.35872	0.662876	0.0781823	1.08 [0.76 - 1.54]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P131289	110	0.127273	0.0196803	0.264911	-0.925471	0.339939	-0.220697	0.80 [0.51 - 1.26]
GENE	CHPF	chondroitin polymerizing factor	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P131289	110	0.127273	0.0868174	-	-0.537224	0.959014	0.00919138	1.01 [0.71 - 1.43]
GENE	CHPF	chondroitin polymerizing factor	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	202175_at	80	0.1375	0.22369	-	-0.671372	0.976263	0.0134964	1.01 [0.42 - 2.47]
GENE	CHPF	chondroitin polymerizing factor	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP3_2308	281	0.11032	0.0639813	-	-0.393279	0.526415	-0.129374	0.88 [0.59 - 1.31]
GENE	CHPF	chondroitin polymerizing factor	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	202175_at	38	0.605263	0.012461	0.190273	1.1533	0.158228	0.473416	1.61 [0.83 - 3.10]
GENE	CHPF	chondroitin polymerizing factor	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	202175_at	140	0.842857	0.0267432	0.3278	0.723381	0.121163	0.330398	1.39 [0.92 - 2.11]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	55093_at	30	0.866667	0.0756064	-	-1.23814	0.165954	-0.876658	0.42 [0.12 - 1.44]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221799_at	30	0.233333	0.0817649	-	-0.789589	0.177684	-0.939798	0.39 [0.10 - 1.53]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1772991	165	0.666667	0.0197727	0.265791	-0.643922	0.654959	-0.0825983	0.92 [0.64 - 1.32]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1772991	165	0.642424	0.120587	-	-0.625646	0.64602	0.13693	1.15 [0.64 - 2.06]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221799_at	163	0.625767	0.0122071	0.187396	0.493304	0.127576	0.363663	1.44 [0.90 - 2.30]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	55093_at	163	0.521472	0.0117837	0.182551	0.495113	0.115973	0.37167	1.45 [0.91 - 2.31]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	55093_at	79	0.367089	0.166832	-	0.437069	0.545349	0.210587	1.23 [0.62 - 2.44]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221799_at	79	0.797468	0.0346076	0.389438	0.681268	0.423561	0.299975	1.35 [0.65 - 2.81]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	55093_at	58	0.241379	0.171238	-	-0.422327	0.693456	-0.149564	0.86 [0.41 - 1.81]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221799_at	58	0.103448	0.110144	-	-0.688625	0.332872	-0.181559	0.83 [0.58 - 1.20]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221799_at	34	0.676471	0.00801712	0.136531	-1.20527	0.94149	0.0206914	1.02 [0.59 - 1.77]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	55093_at	34	0.117647	0.175872	-	0.962709	0.817654	0.0737082	1.08 [0.58 - 2.01]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	55093_at	158	0.841772	0.0193863	0.262104	0.636504	0.379671	0.547495	1.73 [0.51 - 5.86]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221799_at	158	0.405063	0.004104	0.0809575	0.733763	0.0357065	1.03706	2.82 [1.07 - 7.43]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221799_at	53	0.735849	0.0987249	-	0.621414	0.394128	0.387528	1.47 [0.60 - 3.59]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	55093_at	53	0.660377	0.0111427	0.175103	0.904681	0.292677	0.742618	2.10 [0.53 - 8.38]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221799_at	53	0.735849	0.0779682	-	0.630413	0.532506	0.269199	1.31 [0.56 - 3.05]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	55093_at	53	0.301887	0.0187169	0.255646	1.01763	0.295164	0.688122	1.99 [0.55 - 7.22]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	55093_at	180	0.483333	0.0404837	0.43097	0.432231	0.677458	0.174497	1.19 [0.52 - 2.71]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221799_at	180	0.205556	0.255391	-	-0.283503	0.746804	-0.0850217	0.92 [0.55 - 1.54]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	55093_at	559	0.325581	0.0992726	-	0.353074	0.424398	0.209347	1.23 [0.74 - 2.06]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221799_at	559	0.146691	0.251963	-	0.339478	0.615719	0.11077	1.12 [0.72 - 1.72]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221799_at	77	0.415584	0.00649569	0.116107	0.724503	0.0106713	0.493229	1.64 [1.12 - 2.39]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	55093_at	77	0.12987	0.0373029	0.408919	-0.720778	0.995725	0.00226405	1.00 [0.44 - 2.29]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	55093_at	70	0.2	0.032913	0.376788	-0.6535	0.365388	-0.283938	0.75 [0.41 - 1.39]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221799_at	70	0.371429	0.0202797	0.270584	-0.621062	0.533166	-0.202614	0.82 [0.43 - 1.54]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221799_at	74	0.891892	0.000436394	0.0126129	1.32624	0.00143611	0.907127	2.48 [1.42 - 4.33]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	55093_at	74	0.202703	0.0497867	0.490342	0.790125	0.0410919	0.914463	2.50 [1.04 - 6.00]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	55093_at	67	0.104478	0.162809	-	-1.07234	0.494223	-1.20196	0.30 [0.01 - 9.43]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221799_at	67	0.104478	0.0673286	-	-1.23199	0.507121	-1.0559	0.35 [0.02 - 7.88]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	55093_at	115	0.53913	0.154901	-	-0.815479	0.549118	-0.485537	0.62 [0.13 - 3.01]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221799_at	115	0.130435	0.0486755	0.483617	-1.10494	0.462139	-0.50412	0.60 [0.16 - 2.32]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	55093_at	204	0.186275	0.267175	-	-0.199716	0.841769	0.047608	1.05 [0.66 - 1.67]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221799_at	204	0.529412	0.0826554	-	0.250393	0.0541137	0.401252	1.49 [0.99 - 2.25]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221799_at	87	0.229885	2.23076e-05	0.000921394	-1.53852	0.0115311	-1.87043	0.15 [0.04 - 0.66]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	55093_at	87	0.103448	0.00578172	0.106054	-1.2268	0.166208	-0.789315	0.45 [0.15 - 1.39]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	55093_at	87	0.103448	0.00578172	0.106054	-1.2268	0.166208	-0.789315	0.45 [0.15 - 1.39]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221799_at	87	0.229885	2.23076e-05	0.000921394	-1.53852	0.0115311	-1.87043	0.15 [0.04 - 0.66]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	55093_at	77	0.350649	0.38566	-	0.563682	0.648917	0.383298	1.47 [0.28 - 7.64]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221799_at	77	0.688312	0.196167	-	0.705454	0.398226	0.752643	2.12 [0.37 - 12.17]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	55093_at	77	0.506494	0.0537143	-	-1.40717	0.544729	-0.577539	0.56 [0.09 - 3.64]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221799_at	77	0.87013	0.212726	-	-15.2318	0.966398	0.0414695	1.04 [0.15 - 7.18]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221799_at	136	0.470588	0.0787241	-	0.83553	0.825873	-0.0851671	0.92 [0.43 - 1.96]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	55093_at	136	0.272059	0.0125999	0.191839	-1.08806	0.177311	-0.986039	0.37 [0.09 - 1.56]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221799_at	200	0.76	0.00146914	0.0351242	0.921434	0.207178	0.574935	1.78 [0.73 - 4.34]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	55093_at	200	0.105	0.00937498	0.153786	-0.992144	0.420431	-0.522295	0.59 [0.17 - 2.11]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15962	60	0.716667	0.173115	-	0.530115	0.72311	0.140717	1.15 [0.53 - 2.51]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15962	60	0.533333	0.0836798	-	0.659703	0.260093	0.493005	1.64 [0.69 - 3.86]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221799_at	286	0.43007	0.0286563	0.343516	0.441165	0.118125	0.469994	1.60 [0.89 - 2.88]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	55093_at	286	0.867133	0.0222401	0.288673	0.561508	0.261567	0.459717	1.58 [0.71 - 3.53]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	55093_at	159	0.433962	0.0268665	0.328828	0.927279	0.249925	0.865272	2.38 [0.54 - 10.37]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221799_at	159	0.899371	0.043998	0.454247	0.817298	0.707636	0.138062	1.15 [0.56 - 2.36]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221799_at	159	0.578616	0.000626482	0.0171717	1.08279	0.0193748	1.02818	2.80 [1.18 - 6.62]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	55093_at	159	0.433962	0.225144	-	0.399556	0.81523	-0.148601	0.86 [0.25 - 3.00]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221799_at	159	0.899371	0.00300983	0.0631566	1.21518	0.181969	0.650821	1.92 [0.74 - 4.99]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	55093_at	159	0.660377	0.0012723	0.0311678	0.985338	0.027339	1.40068	4.06 [1.17 - 14.08]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221799_at	54	0.222222	0.0842429	-	15.4758	0.0809803	1.74765	5.74 [0.81 - 40.88]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	55093_at	54	0.888889	0.0165328	0.233913	1.58646	0.0939473	1.43495	4.20 [0.78 - 22.51]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221799_at	117	0.871795	0.0587293	-	-1.28275	0.637456	-0.154872	0.86 [0.45 - 1.63]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221799_at	117	0.65812	0.0649567	-	-0.890978	0.465133	-0.30438	0.74 [0.33 - 1.67]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	55093_at	117	0.461538	0.0922277	-	-0.639941	0.70151	-0.141952	0.87 [0.42 - 1.79]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	55093_at	117	0.461538	0.100192	-	-0.520656	0.612985	-0.157754	0.85 [0.46 - 1.57]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	55093_at	117	0.461538	0.0212275	0.279417	-0.919487	0.389035	-0.350398	0.70 [0.32 - 1.56]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	55093_at	117	0.461538	0.100192	-	-0.520656	0.612985	-0.157754	0.85 [0.46 - 1.57]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221799_at	117	0.871795	0.0587293	-	-1.28275	0.637456	-0.154872	0.86 [0.45 - 1.63]
GENE	CHPF2	chondroitin polymerizing factor 2	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221799_at	117	0.316239	0.165071	-	0.629915	0.591599	-0.211296	0.81 [0.37 - 1.75]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221799_at	236	0.707627	0.218116	-	-0.399386	0.537202	-0.171212	0.84 [0.49 - 1.45]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	55093_at	236	0.351695	0.0196154	0.264293	0.746123	0.333494	0.575012	1.78 [0.55 - 5.70]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	55093_at	249	0.349398	0.0303245	0.356822	0.513021	0.120641	0.761402	2.14 [0.82 - 5.60]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221799_at	249	0.26506	0.0182689	0.251272	0.640799	0.497056	0.174721	1.19 [0.72 - 1.97]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221799_at	125	0.544	0.0713491	-	0.691246	0.897206	0.0652197	1.07 [0.40 - 2.87]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	55093_at	62	0.112903	0.0279684	0.337923	-1.2104	0.411857	-0.15562	0.86 [0.59 - 1.24]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221799_at	125	0.544	0.13966	-	0.431761	0.556767	0.223211	1.25 [0.59 - 2.63]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221799_at	54	0.111111	0.0468739	0.472512	-1.30098	0.483536	-0.198793	0.82 [0.47 - 1.43]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	55093_at	125	0.184	0.226527	-	0.726122	0.810955	-0.146071	0.86 [0.26 - 2.86]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	55093_at	125	0.84	0.255133	-	0.382752	0.876132	0.0716734	1.07 [0.44 - 2.65]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	55093_at	54	0.111111	0.000350752	0.0104547	-2.00837	0.355489	-0.213996	0.81 [0.51 - 1.27]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221799_at	62	0.870968	0.200259	-	-1.2454	0.476452	-0.166222	0.85 [0.54 - 1.34]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	55093_at	198	0.10101	0.0828219	-	0.991354	0.322225	0.273111	1.31 [0.77 - 2.26]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	55093_at	198	0.10101	0.134311	-	0.863786	0.548555	0.175625	1.19 [0.67 - 2.12]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221799_at	198	0.752525	0.0296138	0.351197	0.487665	0.956764	-0.00900675	0.99 [0.72 - 1.37]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221799_at	198	0.712121	0.0593921	-	0.487542	0.996063	0.00100803	1.00 [0.67 - 1.49]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	55093_at	198	0.883838	0.244664	-	0.337407	0.727766	0.0807614	1.08 [0.69 - 1.71]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221799_at	198	0.207071	0.139283	-	-0.434484	0.65991	-0.0943966	0.91 [0.60 - 1.39]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221799_at	51	0.333333	0.189259	-	-1.13649	0.468342	-0.642797	0.53 [0.09 - 2.99]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221799_at	62	0.532258	0.163068	-	0.831165	0.436846	0.467679	1.60 [0.49 - 5.19]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	55093_at	51	0.411765	0.0759977	-	-1.75178	0.368862	-0.791349	0.45 [0.08 - 2.55]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	55093_at	62	0.870968	0.0105903	0.168569	1.44044	0.924871	0.0555322	1.06 [0.33 - 3.35]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	55093_at	145	0.675862	0.0302658	0.35636	0.709062	0.329023	0.658984	1.93 [0.51 - 7.26]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221799_at	177	0.124294	0.0816175	-	-0.568061	0.832554	0.111553	1.12 [0.40 - 3.14]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	55093_at	177	0.683616	0.0666853	-	0.497056	0.772666	0.159863	1.17 [0.40 - 3.47]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221799_at	145	0.358621	0.156752	-	0.539155	0.580666	0.414317	1.51 [0.35 - 6.58]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221799_at	177	0.118644	0.0213046	0.280128	-0.793127	0.920299	0.0604814	1.06 [0.32 - 3.47]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	55093_at	177	0.672316	0.115464	-	0.375147	0.730736	0.16543	1.18 [0.46 - 3.03]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221799_at	226	0.181416	0.0240183	0.304505	-0.716016	0.945338	-0.017459	0.98 [0.60 - 1.62]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	55093_at	226	0.89823	0.0792797	-	0.664915	0.355578	0.442342	1.56 [0.61 - 3.98]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221799_at	55	0.290909	0.00892561	0.148167	2.17331	0.119966	1.21748	3.38 [0.73 - 15.68]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221799_at	55	0.272727	0.254974	-	0.627425	0.985506	-0.0121872	0.99 [0.27 - 3.68]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221799_at	49	0.734694	0.233242	-	0.718688	0.905156	0.104078	1.11 [0.20 - 6.15]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	55093_at	55	0.563636	0.171977	-	-0.655765	0.796451	-0.158995	0.85 [0.25 - 2.86]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	55093_at	55	0.872727	0.00551538	0.102217	1.42582	0.160418	1.01813	2.77 [0.67 - 11.47]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	55093_at	49	0.244898	0.132587	-	1.44462	0.8924	-0.109271	0.90 [0.18 - 4.37]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	39955	34	0.264706	0.122182	-	0.935554	0.847984	-0.0929653	0.91 [0.35 - 2.36]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221799_at	63	0.761905	0.00291391	0.0615273	1.00627	0.0196718	0.384233	1.47 [1.06 - 2.03]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	55093_at	63	0.365079	0.000628295	0.0172139	1.4186	0.00855178	0.423039	1.53 [1.11 - 2.09]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.86392.0.S1_3p_at	28	0.607143	0.00469286	0.0900301	-1.92642	0.207562	-6.13344	0.00 [0.00 - 30.12]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.86392.0.S1_3p_x_at	28	0.892857	0.184323	-	1.01089	0.981936	-0.0264429	0.97 [0.10 - 9.61]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	221799_3p_at	28	0.535714	0.310728	-	-0.5644	0.747257	0.708901	2.03 [0.03 - 151.49]
GENE	CHPF2	chondroitin polymerizing factor 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221799_at	82	0.841463	0.239557	-	-0.695222	0.866868	0.0758826	1.08 [0.44 - 2.62]
GENE	CHPF2	chondroitin polymerizing factor 2	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	55093_at	82	0.280488	0.331986	-	0.373324	0.824163	0.148964	1.16 [0.31 - 4.32]
GENE	CHPF2	chondroitin polymerizing factor 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221799_at	79	0.860759	0.0530124	-	0.668226	0.747356	0.0960269	1.10 [0.61 - 1.97]
GENE	CHPF2	chondroitin polymerizing factor 2	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	55093_at	79	0.392405	0.0639546	-	-0.493872	0.880643	-0.0676149	0.93 [0.39 - 2.26]
GENE	CHPF2	chondroitin polymerizing factor 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	55093_at	104	0.653846	0.0144995	0.212678	0.777463	0.0258602	1.52523	4.60 [1.20 - 17.58]
GENE	CHPF2	chondroitin polymerizing factor 2	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221799_at	104	0.615385	0.0106019	0.168706	0.811274	0.0447051	0.881771	2.42 [1.02 - 5.71]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P397055	117	0.162393	0.090092	-	-0.573349	0.594579	-0.129604	0.88 [0.55 - 1.42]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_32_P54442	117	0.247863	0.0273329	0.332699	-0.652599	0.763084	-0.0807663	0.92 [0.55 - 1.56]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	55093_at	204	0.573529	0.00139857	0.0337188	1.19981	0.000691248	1.45133	4.27 [1.85 - 9.87]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	55093_at	204	0.47549	0.000159145	0.00526563	1.11518	0.000328493	1.20531	3.34 [1.73 - 6.44]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221799_at	204	0.357843	0.0105944	0.168618	1.28453	0.0151837	1.26291	3.54 [1.28 - 9.80]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221799_at	204	0.852941	0.00464117	0.0892462	0.85453	0.0828431	0.724708	2.06 [0.91 - 4.68]
GENE	CHPF2	chondroitin polymerizing factor 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221799_at	178	0.314607	0.00882068	0.146843	-0.537068	0.0673401	-0.569906	0.57 [0.31 - 1.04]
GENE	CHPF2	chondroitin polymerizing factor 2	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	55093_at	178	0.224719	0.0349898	0.392247	-0.471648	0.473132	-0.316065	0.73 [0.31 - 1.73]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200007194	41	0.756098	0.0232607	0.297824	-1.5329	0.430922	-0.19266	0.82 [0.51 - 1.33]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	55093_at	111	0.837838	0.0144487	0.212134	0.740233	0.251112	0.460032	1.58 [0.72 - 3.48]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221799_at	111	0.828829	0.00230977	0.0509543	0.893674	0.349861	0.307149	1.36 [0.71 - 2.59]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221799_at	90	0.611111	0.0215887	0.28274	0.836246	0.198062	0.633538	1.88 [0.72 - 4.94]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221799_at	90	0.388889	0.105033	-	0.561535	0.31018	0.436655	1.55 [0.67 - 3.60]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	55093_at	90	0.388889	0.217663	-	0.419877	0.928064	0.0454042	1.05 [0.39 - 2.80]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	55093_at	90	0.388889	0.183975	-	0.527985	0.869334	0.0955016	1.10 [0.35 - 3.43]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	3828	50	0.78	0.179889	-	-0.973965	0.532258	-0.193367	0.82 [0.45 - 1.51]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	55093_at	138	0.702899	0.0141159	0.208553	0.599359	0.278476	0.181536	1.20 [0.86 - 1.67]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221799_at	138	0.724638	0.0664725	-	0.464397	0.359226	0.170436	1.19 [0.82 - 1.71]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	55093_at	129	0.193798	0.139718	-	0.551307	0.563438	0.284266	1.33 [0.51 - 3.49]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221799_at	129	0.503876	0.0160899	0.229375	-0.606606	0.866083	0.0388506	1.04 [0.66 - 1.63]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11834	56	0.892857	0.0325406	0.373965	1.02071	0.278861	0.331347	1.39 [0.76 - 2.54]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28818	56	0.410714	0.190236	-	-0.456957	0.685251	0.103421	1.11 [0.67 - 1.83]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	11834	56	0.892857	0.0255964	0.318132	1.06179	0.304595	0.299496	1.35 [0.76 - 2.39]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	28818	56	0.875	0.119159	-	0.773571	0.664528	0.120058	1.13 [0.66 - 1.94]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	55093_at	278	0.125899	0.0155498	0.223777	0.865747	0.225712	0.225682	1.25 [0.87 - 1.81]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221799_at	278	0.115108	0.014601	0.213763	0.985663	0.137793	0.302215	1.35 [0.91 - 2.02]
GENE	CHPF2	chondroitin polymerizing factor 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	55093_at	133	0.894737	0.0653792	-	0.603735	0.292398	0.211935	1.24 [0.83 - 1.83]
GENE	CHPF2	chondroitin polymerizing factor 2	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221799_at	133	0.864662	0.0334633	0.380931	0.628447	0.04362	0.384299	1.47 [1.01 - 2.13]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221799_at	185	0.437838	0.0752389	-	-0.323547	0.280651	-0.198	0.82 [0.57 - 1.18]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	55093_at	185	0.389189	0.0235305	0.300214	-0.387833	0.355587	-0.23457	0.79 [0.48 - 1.30]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221799_at	185	0.702703	0.0408519	0.433461	-0.366895	0.238548	-0.196894	0.82 [0.59 - 1.14]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	55093_at	185	0.389189	0.0281233	0.339188	-0.403784	0.401231	-0.230198	0.79 [0.46 - 1.36]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P54442	110	0.227273	0.0690118	-	0.54619	0.454191	0.158558	1.17 [0.77 - 1.77]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P397055	110	0.372727	0.0988301	-	0.402143	0.581409	0.130656	1.14 [0.72 - 1.81]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_32_P54442	110	0.109091	0.0699918	-	-0.73382	0.762887	0.0844986	1.09 [0.63 - 1.88]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P397055	110	0.136364	0.0626447	-	-0.656595	0.546303	-0.183175	0.83 [0.46 - 1.51]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	55093_at	80	0.175	2.1499e-08	1.52137e-06	-2.78262	0.00121852	-2.34186	0.10 [0.02 - 0.40]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221799_at	80	0.8625	0.0891224	-	-1.58896	0.552693	-0.0963004	0.91 [0.66 - 1.25]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221799_at	38	0.184211	0.00250362	0.0544092	15.8036	0.00967899	1.32188	3.75 [1.38 - 10.21]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	55093_at	38	0.815789	0.0037851	0.0759061	1.44678	0.00543464	1.42316	4.15 [1.52 - 11.32]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221799_at	140	0.664286	0.00176417	0.0408576	0.882918	0.0109946	0.995274	2.71 [1.26 - 5.83]
GENE	CHPF2	chondroitin polymerizing factor 2	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	55093_at	140	0.692857	0.000201124	0.00645882	1.0339	0.00904268	0.953086	2.59 [1.27 - 5.31]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHPT1	choline phosphotransferase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	221675_s_at	30	0.233333	0.0170761	0.239419	-1.05971	0.164439	-0.505912	0.60 [0.30 - 1.23]
GENE	CHPT1	choline phosphotransferase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1729112	165	0.642424	0.1484	-	0.355514	0.454552	0.0815098	1.08 [0.88 - 1.34]
GENE	CHPT1	choline phosphotransferase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1729112	165	0.224242	0.158633	-	0.736402	0.699246	0.0600784	1.06 [0.78 - 1.44]
GENE	CHPT1	choline phosphotransferase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	221675_s_at	163	0.570552	0.222807	-	-0.245577	0.643985	-0.0924461	0.91 [0.62 - 1.35]
GENE	CHPT1	choline phosphotransferase 1	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	230364_at	163	0.570552	0.056972	-	0.374986	0.239551	0.357504	1.43 [0.79 - 2.59]
GENE	CHPT1	choline phosphotransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	230364_at	79	0.35443	0.00385335	0.076996	0.965782	0.0039395	0.822463	2.28 [1.30 - 3.98]
GENE	CHPT1	choline phosphotransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	1559739_at	79	0.898734	0.00190164	0.0434586	1.15837	0.357604	0.297591	1.35 [0.71 - 2.54]
GENE	CHPT1	choline phosphotransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	221675_s_at	79	0.367089	0.0692318	-	0.586686	0.212313	0.369683	1.45 [0.81 - 2.59]
GENE	CHPT1	choline phosphotransferase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221675_s_at	58	0.87931	0.0734514	-	-0.777524	0.843792	0.0680426	1.07 [0.54 - 2.11]
GENE	CHPT1	choline phosphotransferase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	221675_s_at	34	0.205882	0.0996192	-	0.830053	0.401167	0.265571	1.30 [0.70 - 2.42]
GENE	CHPT1	choline phosphotransferase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	221675_s_at	158	0.803797	0.0012145	0.0299833	0.83879	0.0977699	0.415543	1.52 [0.93 - 2.48]
GENE	CHPT1	choline phosphotransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	221675_s_at	53	0.169811	0.19367	-	0.772077	0.306615	0.623263	1.87 [0.56 - 6.16]
GENE	CHPT1	choline phosphotransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	221675_s_at	53	0.169811	0.280242	-	0.567908	0.49665	0.374702	1.45 [0.49 - 4.28]
GENE	CHPT1	choline phosphotransferase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	221675_s_at	180	0.872222	0.0147257	0.215093	0.650177	0.398581	0.229901	1.26 [0.74 - 2.15]
GENE	CHPT1	choline phosphotransferase 1	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	230364_at	180	0.85	0.0186223	0.254726	0.588844	0.243009	0.0975017	1.10 [0.94 - 1.30]
GENE	CHPT1	choline phosphotransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	230364_at	559	0.679785	0.100862	-	-0.376794	0.274979	-0.0928994	0.91 [0.77 - 1.08]
GENE	CHPT1	choline phosphotransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	1559739_at	559	0.275492	0.250339	-	-0.244077	0.654534	-0.0493985	0.95 [0.77 - 1.18]
GENE	CHPT1	choline phosphotransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	221675_s_at	559	0.128801	0.130588	-	-0.391077	0.638486	-0.0667531	0.94 [0.71 - 1.24]
GENE	CHPT1	choline phosphotransferase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	221675_s_at	77	0.116883	0.0115462	0.179807	-0.911185	0.37923	0.25195	1.29 [0.73 - 2.26]
GENE	CHPT1	choline phosphotransferase 1	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	230364_at	77	0.103896	0.057692	-	-0.757371	0.887456	0.0246002	1.02 [0.73 - 1.44]
GENE	CHPT1	choline phosphotransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	230364_at	70	0.342857	0.150473	-	0.410154	0.537827	0.0899	1.09 [0.82 - 1.46]
GENE	CHPT1	choline phosphotransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	1559739_at	70	0.314286	0.0451804	0.461839	0.586322	0.491364	0.114453	1.12 [0.81 - 1.55]
GENE	CHPT1	choline phosphotransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	221675_s_at	70	0.857143	0.127418	-	0.556931	0.706343	0.0786785	1.08 [0.72 - 1.63]
GENE	CHPT1	choline phosphotransferase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	221675_s_at	74	0.216216	0.337464	-	0.354461	0.982455	-0.012181	0.99 [0.33 - 2.93]
GENE	CHPT1	choline phosphotransferase 1	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	230364_at	74	0.810811	0.204346	-	0.433615	0.459728	0.211438	1.24 [0.71 - 2.16]
GENE	CHPT1	choline phosphotransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	1559739_at	67	0.791045	0.117885	-	-15.3908	0.394839	-0.564436	0.57 [0.15 - 2.09]
GENE	CHPT1	choline phosphotransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	230364_at	67	0.477612	0.283887	-	0.753184	0.664881	0.390512	1.48 [0.25 - 8.65]
GENE	CHPT1	choline phosphotransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	221675_s_at	67	0.432836	0.0339831	0.384813	1.94393	0.130907	1.29615	3.66 [0.68 - 19.65]
GENE	CHPT1	choline phosphotransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	1559739_at	115	0.513043	0.00630674	0.113479	-1.82194	0.385115	-0.297434	0.74 [0.38 - 1.45]
GENE	CHPT1	choline phosphotransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	221675_s_at	115	0.66087	0.0256386	0.318491	-1.97493	0.18668	-0.607229	0.54 [0.22 - 1.34]
GENE	CHPT1	choline phosphotransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	230364_at	115	0.869565	0.133281	-	-15.2391	0.643234	-0.15875	0.85 [0.44 - 1.67]
GENE	CHPT1	choline phosphotransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	221675_s_at	204	0.259804	0.00405032	0.0801144	-0.459848	0.0160948	-0.283293	0.75 [0.60 - 0.95]
GENE	CHPT1	choline phosphotransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	230364_at	204	0.338235	0.00217525	0.0485186	-0.461473	0.0121688	-0.283095	0.75 [0.60 - 0.94]
GENE	CHPT1	choline phosphotransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	1559739_at	204	0.289216	0.000117648	0.00404066	-0.602307	0.00444968	-0.223375	0.80 [0.69 - 0.93]
GENE	CHPT1	choline phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	230364_at	87	0.103448	0.00186941	0.0428524	-1.34427	0.0545156	-0.33896	0.71 [0.50 - 1.01]
GENE	CHPT1	choline phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	230364_at	87	0.103448	0.00186941	0.0428524	-1.34427	0.0545156	-0.33896	0.71 [0.50 - 1.01]
GENE	CHPT1	choline phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	1559739_at	87	0.896552	0.187976	-	-1.25687	0.530279	-0.096904	0.91 [0.67 - 1.23]
GENE	CHPT1	choline phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	1559739_at	87	0.896552	0.187976	-	-1.25687	0.530279	-0.096904	0.91 [0.67 - 1.23]
GENE	CHPT1	choline phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	221675_s_at	87	0.103448	0.000428342	0.0124132	-1.51066	0.074557	-0.390746	0.68 [0.44 - 1.04]
GENE	CHPT1	choline phosphotransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	221675_s_at	87	0.103448	0.000428342	0.0124132	-1.51066	0.074557	-0.390746	0.68 [0.44 - 1.04]
GENE	CHPT1	choline phosphotransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	221675_s_at	77	0.220779	0.00257111	0.0555975	-1.72562	0.0610934	-0.671693	0.51 [0.25 - 1.03]
GENE	CHPT1	choline phosphotransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	230364_at	77	0.116883	0.00196258	0.0445987	-1.76751	0.0488752	-0.556897	0.57 [0.33 - 1.00]
GENE	CHPT1	choline phosphotransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	1559739_at	77	0.207792	0.0983591	-	-0.911144	0.520194	-0.198152	0.82 [0.45 - 1.50]
GENE	CHPT1	choline phosphotransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	221675_s_at	77	0.220779	0.00154757	0.03667	-1.59274	0.0478156	-0.609848	0.54 [0.30 - 0.99]
GENE	CHPT1	choline phosphotransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	1559739_at	77	0.207792	0.110744	-	-0.989411	0.772099	-0.0994955	0.91 [0.46 - 1.78]
GENE	CHPT1	choline phosphotransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	230364_at	77	0.38961	0.0136711	0.203718	-1.3735	0.0331988	-0.518545	0.60 [0.37 - 0.96]
GENE	CHPT1	choline phosphotransferase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	221675_s_at	136	0.102941	0.00049836	0.0141305	-1.55132	0.0314635	-0.80707	0.45 [0.21 - 0.93]
GENE	CHPT1	choline phosphotransferase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	221675_s_at	200	0.57	0.0695248	-	-0.586705	0.390916	-0.232265	0.79 [0.47 - 1.35]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17844	60	0.333333	0.00631143	0.113544	-1.00043	0.0288075	-0.34458	0.71 [0.52 - 0.96]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13540	60	0.433333	0.0565226	-	-0.712094	0.17021	-0.242634	0.78 [0.55 - 1.11]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9020	60	0.2	0.00794908	0.135644	-1.06621	0.0191019	-0.421688	0.66 [0.46 - 0.93]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	9020	60	0.5	0.00849936	0.142755	-1.03534	0.0212677	-0.570117	0.57 [0.35 - 0.92]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	17844	60	0.583333	0.000662901	0.0180155	-1.53087	0.00328192	-0.65232	0.52 [0.34 - 0.80]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13540	60	0.55	0.0152004	0.220116	-0.98146	0.0358074	-0.430961	0.65 [0.43 - 0.97]
GENE	CHPT1	choline phosphotransferase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	7561	155	0.212903	0.0111843	0.17559	-0.736755	0.84657	0.0375911	1.04 [0.71 - 1.52]
GENE	CHPT1	choline phosphotransferase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	221675_s_at	286	0.202797	0.000219998	0.00698294	-0.759196	0.011597	-0.433061	0.65 [0.46 - 0.91]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221675_s_at	159	0.169811	0.0952915	-	-0.600548	0.53531	-0.185377	0.83 [0.46 - 1.49]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221675_s_at	159	0.238994	0.00427377	0.0836058	-0.89263	0.0476104	-0.626605	0.53 [0.29 - 0.99]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	221675_s_at	159	0.238994	0.00425804	0.0833616	-1.02279	0.0732324	-0.667214	0.51 [0.25 - 1.06]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230364_at	159	0.119497	0.0337982	0.383436	-0.816828	0.292369	-0.190617	0.83 [0.58 - 1.18]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230364_at	159	0.597484	0.000179996	0.00586335	-1.51245	0.011878	-0.42647	0.65 [0.47 - 0.91]
GENE	CHPT1	choline phosphotransferase 1	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	230364_at	159	0.119497	0.00134227	0.0325874	-1.25065	0.0182733	-0.467914	0.63 [0.42 - 0.92]
GENE	CHPT1	choline phosphotransferase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	221675_s_at	54	0.425926	0.0642769	-	-1.23467	0.269355	-0.280762	0.76 [0.46 - 1.24]
GENE	CHPT1	choline phosphotransferase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221675_s_at	117	0.786325	0.0699772	-	-0.860479	0.437323	-0.104353	0.90 [0.69 - 1.17]
GENE	CHPT1	choline phosphotransferase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221675_s_at	117	0.675214	0.0442226	0.455699	-1.04481	0.382328	-0.148427	0.86 [0.62 - 1.20]
GENE	CHPT1	choline phosphotransferase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221675_s_at	117	0.786325	0.0699772	-	-0.860479	0.437323	-0.104353	0.90 [0.69 - 1.17]
GENE	CHPT1	choline phosphotransferase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	221675_s_at	117	0.777778	0.102525	-	-0.960748	0.969138	-0.0063251	0.99 [0.72 - 1.37]
GENE	CHPT1	choline phosphotransferase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	221675_s_at	236	0.436441	0.000312544	0.00946516	-0.972578	0.0187673	-0.717151	0.49 [0.27 - 0.89]
GENE	CHPT1	choline phosphotransferase 1	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	230364_at	236	0.275424	0.000511255	0.0144421	-0.915358	0.00181633	-0.510526	0.60 [0.44 - 0.83]
GENE	CHPT1	choline phosphotransferase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	221675_s_at	249	0.445783	0.000144428	0.00483702	-0.799407	0.00706062	-0.629489	0.53 [0.34 - 0.84]
GENE	CHPT1	choline phosphotransferase 1	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	230364_at	249	0.578313	0.000174288	0.00570076	-0.861105	0.00289929	-0.383362	0.68 [0.53 - 0.88]
GENE	CHPT1	choline phosphotransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221675_s_at	125	0.192	0.184425	-	-0.575234	0.585467	-0.1098	0.90 [0.60 - 1.33]
GENE	CHPT1	choline phosphotransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221675_s_at	125	0.392	0.0939521	-	-0.490403	0.432314	-0.120659	0.89 [0.66 - 1.20]
GENE	CHPT1	choline phosphotransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221675_s_at	54	0.777778	0.146093	-	-1.40768	0.939866	-0.0195094	0.98 [0.59 - 1.63]
GENE	CHPT1	choline phosphotransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	221675_s_at	62	0.806452	0.225841	-	-0.890095	0.823133	0.0470912	1.05 [0.69 - 1.58]
GENE	CHPT1	choline phosphotransferase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221675_s_at	198	0.166667	0.00869614	0.145264	-0.656857	0.164703	-0.148073	0.86 [0.70 - 1.06]
GENE	CHPT1	choline phosphotransferase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221675_s_at	198	0.166667	0.000320566	0.00967444	-0.976382	0.022561	-0.294202	0.75 [0.58 - 0.96]
GENE	CHPT1	choline phosphotransferase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	221675_s_at	198	0.166667	2.14568e-05	0.000889755	-1.16132	0.0112017	-0.345812	0.71 [0.54 - 0.92]
GENE	CHPT1	choline phosphotransferase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	221675_s_at	51	0.705882	0.126374	-	-15.6341	0.317475	-0.947298	0.39 [0.06 - 2.48]
GENE	CHPT1	choline phosphotransferase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	221675_s_at	62	0.709677	0.0876805	-	-1.60613	0.710234	0.232331	1.26 [0.37 - 4.30]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	1559739_at	177	0.152542	0.0520544	-	-0.557943	0.664177	-0.166394	0.85 [0.40 - 1.79]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	1559739_at	177	0.118644	0.202298	-	-0.462148	0.825091	-0.0946091	0.91 [0.39 - 2.11]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	221675_s_at	177	0.248588	0.106995	-	-0.405776	0.316953	-0.268366	0.76 [0.45 - 1.29]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	1559739_at	145	0.124138	0.0175452	0.244117	-0.92451	0.305547	-0.640576	0.53 [0.15 - 1.79]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	221675_s_at	145	0.448276	0.00247613	0.0539229	-1.02504	0.0113852	-0.937698	0.39 [0.19 - 0.81]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	221675_s_at	177	0.881356	0.0132535	0.199128	-2.1122	0.0568745	-0.573142	0.56 [0.31 - 1.02]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	230364_at	177	0.225989	0.0514542	-	-0.501951	0.9984	-0.00045468	1.00 [0.64 - 1.56]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	230364_at	177	0.225989	0.0163396	0.231939	-0.683152	0.36753	-0.232424	0.79 [0.48 - 1.31]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	230364_at	145	0.124138	0.00224201	0.0497315	-1.12439	0.0684933	-0.566615	0.57 [0.31 - 1.04]
GENE	CHPT1	choline phosphotransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	1559739_at	226	0.836283	0.0281925	0.339752	-1.23076	0.474132	-0.0959837	0.91 [0.70 - 1.18]
GENE	CHPT1	choline phosphotransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	221675_s_at	226	0.309735	0.0016318	0.0383121	-0.86713	0.00377463	-0.756319	0.47 [0.28 - 0.78]
GENE	CHPT1	choline phosphotransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	230364_at	226	0.123894	3.79304e-07	2.22007e-05	-1.45244	0.00410279	-0.438909	0.64 [0.48 - 0.87]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	221675_s_at	49	0.102041	0.225043	-	15.1859	0.492494	0.463905	1.59 [0.42 - 5.98]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	230364_at	49	0.204082	0.0420712	0.44162	15.4904	0.106837	0.759672	2.14 [0.85 - 5.38]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	1559739_at	55	0.763636	0.178426	-	0.651943	0.939193	0.0651076	1.07 [0.20 - 5.69]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	230364_at	55	0.854545	0.106955	-	0.811822	0.224012	0.478921	1.61 [0.75 - 3.49]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	1559739_at	49	0.285714	0.0099079	0.16034	-1.39812	0.261496	-1.22033	0.30 [0.04 - 2.48]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	1559739_at	55	0.327273	0.00544701	0.101223	-1.19149	0.0871045	-1.49377	0.22 [0.04 - 1.24]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	221675_s_at	55	0.745455	9.72548e-05	0.00341745	1.74758	0.00115115	2.0745	7.96 [2.28 - 27.81]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	221675_s_at	55	0.745455	0.0592091	-	0.837971	0.273708	0.582768	1.79 [0.63 - 5.09]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	230364_at	55	0.672727	0.00577178	0.105912	1.26985	0.0125388	1.11631	3.05 [1.27 - 7.34]
GENE	CHPT1	choline phosphotransferase 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	24193	34	0.352941	0.15722	-	0.71211	0.497553	-0.196241	0.82 [0.47 - 1.45]
GENE	CHPT1	choline phosphotransferase 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	23980	34	0.794118	0.0794835	-	-1.23102	0.224929	-0.550335	0.58 [0.24 - 1.40]
GENE	CHPT1	choline phosphotransferase 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	151184	34	0.147059	0.12819	-	-0.835865	0.408924	-0.397038	0.67 [0.26 - 1.73]
GENE	CHPT1	choline phosphotransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	1559739_at	63	0.571429	9.36026e-05	0.00330406	1.28991	0.0442212	0.350141	1.42 [1.01 - 2.00]
GENE	CHPT1	choline phosphotransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	221675_s_at	63	0.428571	0.000183179	0.0059537	1.41116	0.00577161	0.794398	2.21 [1.26 - 3.89]
GENE	CHPT1	choline phosphotransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	230364_at	63	0.412698	0.0164095	0.232655	0.873597	0.130569	0.307511	1.36 [0.91 - 2.03]
GENE	CHPT1	choline phosphotransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs2.406852.1.S1_3p_at	28	0.892857	0.113218	-	1.20319	0.170489	0.232509	1.26 [0.90 - 1.76]
GENE	CHPT1	choline phosphotransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g9502012_3p_a_at	28	0.107143	0.334793	-	0.967246	0.825676	0.0456182	1.05 [0.70 - 1.57]
GENE	CHPT1	choline phosphotransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.313006.0.A1_3p_at	28	0.892857	0.0747667	-	1.14746	0.565778	1.12303	3.07 [0.07 - 142.01]
GENE	CHPT1	choline phosphotransferase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	221675_s_at	82	0.268293	0.163819	-	0.583979	0.746675	0.100116	1.11 [0.60 - 2.03]
GENE	CHPT1	choline phosphotransferase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	221675_s_at	79	0.708861	0.261278	-	0.318211	0.67207	-0.0971404	0.91 [0.58 - 1.42]
GENE	CHPT1	choline phosphotransferase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	221675_s_at	104	0.105769	0.275076	-	-0.484411	0.45118	-0.221093	0.80 [0.45 - 1.42]
GENE	CHPT1	choline phosphotransferase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P105571	117	0.880342	0.00214459	0.0479589	1.04776	0.158676	0.245064	1.28 [0.91 - 1.80]
GENE	CHPT1	choline phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	221675_s_at	204	0.171569	0.0162586	0.231109	-0.92792	0.944967	-0.0263974	0.97 [0.46 - 2.06]
GENE	CHPT1	choline phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	230364_at	204	0.102941	0.291303	-	1.02808	0.586586	0.219849	1.25 [0.56 - 2.75]
GENE	CHPT1	choline phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	221675_s_at	204	0.171569	0.00651222	0.116336	-0.824632	0.46987	-0.203125	0.82 [0.47 - 1.42]
GENE	CHPT1	choline phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	230364_at	204	0.230392	0.0347489	0.390478	-0.609854	0.498188	-0.193477	0.82 [0.47 - 1.44]
GENE	CHPT1	choline phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	1559739_at	204	0.161765	0.000287132	0.00879652	-1.28819	0.028292	-0.569497	0.57 [0.34 - 0.94]
GENE	CHPT1	choline phosphotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	1559739_at	204	0.156863	0.000419018	0.0121811	-1.00986	0.00278687	-0.627031	0.53 [0.35 - 0.81]
GENE	CHPT1	choline phosphotransferase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	221675_s_at	178	0.898876	0.0388122	0.419503	0.606656	0.950602	-0.0130303	0.99 [0.65 - 1.49]
GENE	CHPT1	choline phosphotransferase 1	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H300018851	41	0.585366	0.0873573	-	-0.763311	0.611201	-0.147166	0.86 [0.49 - 1.52]
GENE	CHPT1	choline phosphotransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	1559739_at	111	0.81982	0.0538221	-	-0.762611	0.230667	-0.160527	0.85 [0.66 - 1.11]
GENE	CHPT1	choline phosphotransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	221675_s_at	111	0.261261	0.179303	-	-0.376978	0.991779	0.00284157	1.00 [0.58 - 1.72]
GENE	CHPT1	choline phosphotransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	230364_at	111	0.36036	0.0452037	0.461987	-0.532448	0.475072	-0.0889218	0.91 [0.72 - 1.17]
GENE	CHPT1	choline phosphotransferase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	221675_s_at	90	0.888889	0.213444	-	0.60306	0.819233	-0.0744802	0.93 [0.49 - 1.76]
GENE	CHPT1	choline phosphotransferase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	221675_s_at	90	0.888889	0.0973006	-	0.681425	0.836123	0.0595594	1.06 [0.60 - 1.87]
GENE	CHPT1	choline phosphotransferase 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	5211	50	0.86	0.0428642	0.446856	1.13735	0.619342	0.200229	1.22 [0.55 - 2.69]
GENE	CHPT1	choline phosphotransferase 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	1656	50	0.58	0.140879	-	0.715673	0.683799	0.158171	1.17 [0.55 - 2.51]
GENE	CHPT1	choline phosphotransferase 1	None	GSE4716-GPL3696	Lung cancer	NSCLC	Overall Survival	Nagoya (1995-1996)	Tomida	GF201	4415	50	0.12	0.350706	-	0.929842	0.710412	0.16421	1.18 [0.50 - 2.80]
GENE	CHPT1	choline phosphotransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	1559739_at	138	0.137681	0.0142462	0.209959	-0.708159	0.697182	-0.0934072	0.91 [0.57 - 1.46]
GENE	CHPT1	choline phosphotransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	221675_s_at	138	0.268116	0.0502815	-	-0.499494	0.186448	-0.132113	0.88 [0.72 - 1.07]
GENE	CHPT1	choline phosphotransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	230364_at	138	0.565217	0.0218835	0.285434	-0.572663	0.41543	-0.106036	0.90 [0.70 - 1.16]
GENE	CHPT1	choline phosphotransferase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	221675_s_at	129	0.713178	0.139977	-	0.401457	0.950157	0.023781	1.02 [0.49 - 2.16]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12443	56	0.178571	0.000311381	0.00943475	-1.3876	0.568368	-0.144553	0.87 [0.53 - 1.42]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19288	56	0.125	0.0214328	0.281308	-1.02709	0.76878	-0.0734891	0.93 [0.57 - 1.52]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18695	56	0.125	0.104874	-	-0.724597	0.928979	0.0226874	1.02 [0.62 - 1.68]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	721	56	0.142857	0.00429234	0.0838939	-1.19501	0.276606	-0.268478	0.76 [0.47 - 1.24]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18957	56	0.232143	0.0042675	0.0835085	-1.03435	0.109757	-0.399395	0.67 [0.41 - 1.09]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16536	56	0.160714	0.033813	0.383546	-0.849598	0.958992	-0.0129044	0.99 [0.60 - 1.61]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21540	56	0.232143	0.0818632	-	-0.680776	0.930214	-0.0218148	0.98 [0.60 - 1.59]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18695	56	0.125	0.0214328	0.281308	-1.02709	0.32107	-0.252547	0.78 [0.47 - 1.28]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12443	56	0.160714	0.0074751	0.129398	-1.05397	0.626378	0.125496	1.13 [0.68 - 1.88]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	19288	56	0.785714	0.0600586	-	0.706312	0.421669	0.203648	1.23 [0.75 - 2.01]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	16536	56	0.160714	0.0025793	0.0557412	-1.21561	0.280837	-0.2711	0.76 [0.47 - 1.25]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	21540	56	0.232143	0.0104162	0.166485	-1.0185	0.252743	-0.28686	0.75 [0.46 - 1.23]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	721	56	0.142857	0.0347282	0.390325	-0.882292	0.963502	-0.0114403	0.99 [0.61 - 1.61]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	18957	56	0.232143	0.0479818	0.479371	-0.709107	0.5675	-0.143312	0.87 [0.53 - 1.42]
GENE	CHPT1	choline phosphotransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	1559739_at	278	0.726619	0.0305536	0.358623	-0.509682	0.409405	-0.0751019	0.93 [0.78 - 1.11]
GENE	CHPT1	choline phosphotransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	221675_s_at	278	0.820144	0.105845	-	-0.422803	0.760912	-0.0289884	0.97 [0.81 - 1.17]
GENE	CHPT1	choline phosphotransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	230364_at	278	0.100719	0.0685927	-	0.604106	0.894405	0.01383	1.01 [0.83 - 1.24]
GENE	CHPT1	choline phosphotransferase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	221675_s_at	133	0.646617	0.0025074	0.0544759	-0.819862	0.0115	-0.301706	0.74 [0.59 - 0.93]
GENE	CHPT1	choline phosphotransferase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221675_s_at	185	0.491892	0.0282811	0.340473	0.387504	0.262468	0.147194	1.16 [0.90 - 1.50]
GENE	CHPT1	choline phosphotransferase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	221675_s_at	185	0.259459	0.0353929	0.395193	0.39853	0.179182	0.161426	1.18 [0.93 - 1.49]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P105571	110	0.636364	0.138367	-	-0.366379	0.544629	-0.0765603	0.93 [0.72 - 1.19]
GENE	CHPT1	choline phosphotransferase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P105571	110	0.236364	0.0116409	0.180904	1.00998	0.180782	0.210801	1.23 [0.91 - 1.68]
GENE	CHPT1	choline phosphotransferase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	221675_s_at	80	0.1125	0.0455113	0.463943	-1.09954	0.318574	-0.344087	0.71 [0.36 - 1.39]
GENE	CHPT1	choline phosphotransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	221675_s_at	38	0.5	0.0676518	-	0.931743	0.254901	0.573679	1.77 [0.66 - 4.76]
GENE	CHPT1	choline phosphotransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	230364_at	38	0.236842	0.0118275	0.183055	1.73154	0.0940393	0.575595	1.78 [0.91 - 3.49]
GENE	CHPT1	choline phosphotransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	1559739_at	38	0.342105	0.166598	-	0.727105	0.113839	0.877599	2.41 [0.81 - 7.14]
GENE	CHPT1	choline phosphotransferase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	221675_s_at	140	0.871429	0.00609938	0.110568	-15.2428	0.0826121	-0.320312	0.73 [0.51 - 1.04]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	205567_at	30	0.133333	0.245468	-	0.834406	0.888675	0.0871156	1.09 [0.32 - 3.69]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1677719	165	0.139394	0.0417434	0.43944	-0.602103	0.646539	0.121992	1.13 [0.67 - 1.90]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1677719	165	0.49697	0.0175005	0.243671	0.878267	0.0779749	0.550415	1.73 [0.94 - 3.20]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	205567_at	163	0.177914	0.030758	0.360223	0.612896	0.580135	0.35641	1.43 [0.40 - 5.05]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	205567_at	79	0.518987	0.124328	-	-0.45261	0.69171	-0.384797	0.68 [0.10 - 4.56]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205567_at	58	0.293103	0.0932277	-	0.5147	0.514532	0.199473	1.22 [0.67 - 2.22]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	205567_at	34	0.764706	0.196986	-	-0.591968	0.648315	-0.269819	0.76 [0.24 - 2.43]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	205567_at	158	0.272152	0.000386734	0.0113709	-0.816139	0.00241071	-2.49967	0.08 [0.02 - 0.41]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	205567_at	53	0.716981	0.0307394	0.360077	0.770166	0.613145	-0.251226	0.78 [0.29 - 2.06]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	205567_at	53	0.773585	0.00276183	0.0589179	1.13803	0.817542	0.137322	1.15 [0.36 - 3.68]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	205567_at	180	0.188889	0.271868	-	-0.277498	0.668098	-0.126257	0.88 [0.49 - 1.57]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	205567_at	559	0.542039	0.0313586	0.364895	-0.440562	0.646159	-0.081781	0.92 [0.65 - 1.31]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	205567_at	77	0.831169	0.0178923	0.247563	-0.932783	0.0565942	-0.351492	0.70 [0.49 - 1.01]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	205567_at	70	0.857143	0.0834655	-	-0.688691	0.954383	-0.0106799	0.99 [0.69 - 1.43]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	MGH-glioma	Brain cancer	Glioma	Overall Survival	CBTTB, MGH, BWH, CH	Nutt	HG-U95A	41395_at	50	0.7	0.146573	-	-0.585028	0.550857	-0.0742375	0.93 [0.73 - 1.18]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	205567_at	74	0.108108	0.0092133	0.151774	2.17818	0.276823	0.20355	1.23 [0.85 - 1.77]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	205567_at	67	0.820895	0.114118	-	-15.4082	0.764439	-0.340868	0.71 [0.08 - 6.61]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	205567_at	115	0.617391	0.0303015	0.356642	1.14583	0.364444	0.44169	1.56 [0.60 - 4.04]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE3143	Breast cancer		Overall Survival	Duke	Bild	HG-U95A	41395_at	158	0.101266	0.0291007	0.347096	1.90522	0.78624	0.0430897	1.04 [0.76 - 1.43]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE7849	Breast cancer		Disease Free Survival	Duke (1990-2001)	Anders	HG-U95A	41395_at	76	0.342105	0.00848943	0.142628	-1.30034	0.998182	0.000782126	1.00 [0.51 - 1.96]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	205567_at	204	0.196078	0.0432355	0.449289	-0.356378	0.485385	-0.0465249	0.95 [0.84 - 1.09]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	205567_at	87	0.885057	0.0309124	0.361428	0.962757	0.28795	0.141647	1.15 [0.89 - 1.50]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	205567_at	87	0.885057	0.0309124	0.361428	0.962757	0.28795	0.141647	1.15 [0.89 - 1.50]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	205567_at	77	0.12987	0.152254	-	15.2363	0.712928	-0.0704228	0.93 [0.64 - 1.36]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	205567_at	77	0.571429	0.114734	-	-1.178	0.612652	-0.114094	0.89 [0.57 - 1.39]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	205567_at	136	0.132353	0.0644214	-	15.2715	0.681962	0.106567	1.11 [0.67 - 1.85]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	205567_at	200	0.89	0.0270953	0.33073	0.840623	0.527892	0.130813	1.14 [0.76 - 1.71]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13790	60	0.35	0.157136	-	0.606953	0.675158	0.0353712	1.04 [0.88 - 1.22]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	13790	60	0.683333	0.0788102	-	0.662324	0.499794	0.131723	1.14 [0.78 - 1.67]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE9893	Breast cancer		Overall Survival	Montpellier, Bordeaux, Turin (1989-2001)	Chanrion	MLRG Human 21K V12.0	17885	155	0.83871	0.0467856	0.471962	0.632001	0.150074	0.107232	1.11 [0.96 - 1.29]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	205567_at	286	0.143357	0.0059231	0.108071	1.02917	0.109842	0.230825	1.26 [0.95 - 1.67]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205567_at	159	0.138365	0.0450452	0.460977	-0.742853	0.309982	-0.257522	0.77 [0.47 - 1.27]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205567_at	159	0.138365	0.0858199	-	-0.729404	0.328637	-0.307883	0.74 [0.40 - 1.36]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	205567_at	159	0.899371	0.184047	-	0.580355	0.635391	0.0996367	1.10 [0.73 - 1.67]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	205567_at	54	0.240741	0.133926	-	15.4009	0.689411	0.0837635	1.09 [0.72 - 1.64]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205567_at	117	0.888889	0.0893771	-	0.742194	0.532628	0.0617996	1.06 [0.88 - 1.29]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205567_at	117	0.888889	0.0127618	0.193657	1.09522	0.225319	0.131683	1.14 [0.92 - 1.41]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205567_at	117	0.888889	0.0893771	-	0.742194	0.532628	0.0617996	1.06 [0.88 - 1.29]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	205567_at	117	0.888889	0.162673	-	0.745954	0.864124	0.0218749	1.02 [0.80 - 1.31]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	205567_at	236	0.169492	0.11565	-	-0.495773	0.577852	-0.104446	0.90 [0.62 - 1.30]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	205567_at	249	0.100402	0.026208	0.323312	-0.656681	0.923793	0.0134699	1.01 [0.77 - 1.34]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205567_at	62	0.290323	0.0753752	-	-0.87645	0.559432	-0.106484	0.90 [0.63 - 1.29]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205567_at	125	0.12	0.129295	-	1.42175	0.990678	-0.00228845	1.00 [0.68 - 1.46]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205567_at	125	0.232	0.0736742	-	0.715643	0.704902	0.0524469	1.05 [0.80 - 1.38]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	205567_at	54	0.462963	0.132733	-	-0.872353	0.569103	-0.126919	0.88 [0.57 - 1.36]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205567_at	198	0.883838	0.051209	-	0.640983	0.696084	0.0467102	1.05 [0.83 - 1.32]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205567_at	198	0.883838	0.0445177	0.457599	0.664631	0.748683	0.0389466	1.04 [0.82 - 1.32]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	205567_at	198	0.883838	0.101472	-	0.474083	0.718841	0.0353752	1.04 [0.85 - 1.26]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	205567_at	51	0.333333	0.502314	-	0.733588	0.997808	0.00681315	1.01 [0.01 - 130.00]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	205567_at	62	0.419355	0.140253	-	0.948265	0.688639	0.633565	1.88 [0.08 - 41.79]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	205567_at	145	0.558621	9.7681e-07	5.32493e-05	1.74433	1.46708e-06	2.26595	9.64 [3.83 - 24.24]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	205567_at	177	0.508475	0.00525609	0.0984312	0.773242	0.0230791	1.03855	2.83 [1.15 - 6.92]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	205567_at	177	0.502825	0.0051203	0.0964288	0.667574	0.0693836	0.74204	2.10 [0.94 - 4.68]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	205567_at	226	0.876106	4.30171e-06	0.000207505	1.29917	0.00041935	0.898028	2.45 [1.49 - 4.04]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	205567_at	49	0.77551	0.047604	0.477043	1.10764	0.846765	-0.188532	0.83 [0.12 - 5.60]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	205567_at	55	0.727273	0.0345421	0.388955	0.937282	0.888403	0.106886	1.11 [0.25 - 4.95]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	205567_at	55	0.709091	0.00449269	0.0869812	1.29868	0.420236	0.566674	1.76 [0.44 - 6.99]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	53039	34	0.735294	0.0154176	0.222395	1.0839	0.107331	1.17292	3.23 [0.78 - 13.47]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	205567_at	63	0.492063	0.0212522	0.279645	-0.787586	0.21141	1.37973	3.97 [0.46 - 34.59]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g4502840_3p_at	28	0.535714	0.237902	-	0.659434	0.84941	0.0448968	1.05 [0.66 - 1.66]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	205567_at	82	0.817073	0.06484	-	0.674978	0.423489	0.208315	1.23 [0.74 - 2.05]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	HARVARD-LC	Lung cancer	Adenocarcinoma	Overall Survival	Harvard	Beer	HG-U95A	41395_at	84	0.857143	0.0320164	0.369963	0.72612	0.0241159	0.660894	1.94 [1.09 - 3.44]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	205567_at	79	0.101266	0.144651	-	0.740676	0.476624	-0.166592	0.85 [0.54 - 1.34]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	205567_at	104	0.461538	0.0889886	-	-0.556544	0.52256	-0.268709	0.76 [0.34 - 1.74]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P98205	117	0.897436	0.105345	-	-1.11137	0.282572	-0.2141	0.81 [0.55 - 1.19]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	205567_at	204	0.857843	0.0215931	0.282779	0.916923	0.383691	0.274019	1.32 [0.71 - 2.44]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	205567_at	204	0.892157	0.0379058	0.413174	0.741767	0.294606	0.248368	1.28 [0.81 - 2.04]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	205567_at	178	0.668539	0.260304	-	0.230895	0.27719	-0.273811	0.76 [0.46 - 1.25]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	205567_at	111	0.873874	0.216766	-	-0.526869	0.722801	-0.0788312	0.92 [0.60 - 1.43]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	205567_at	90	0.344444	0.190205	-	-0.428003	0.312821	-0.350521	0.70 [0.36 - 1.39]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	205567_at	90	0.344444	0.0247927	0.31124	-0.813458	0.318816	-0.411799	0.66 [0.29 - 1.49]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	205567_at	138	0.108696	0.071597	-	0.899395	0.837243	-0.0207142	0.98 [0.80 - 1.19]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	205567_at	129	0.333333	0.0359989	0.399589	0.585744	0.965978	0.0109731	1.01 [0.61 - 1.67]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29399	56	0.821429	0.127171	-	-0.905309	0.321513	-0.351773	0.70 [0.35 - 1.41]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9993	56	0.142857	0.0494819	0.488507	-0.788747	0.221751	-0.28702	0.75 [0.47 - 1.19]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	29399	56	0.285714	0.115783	-	-0.549461	0.425522	-0.273587	0.76 [0.39 - 1.49]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	9993	56	0.214286	0.149596	-	-0.52458	0.411189	-0.188931	0.83 [0.53 - 1.30]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	205567_at	278	0.877698	0.00145779	0.0348991	-1.357	0.0353589	-0.176538	0.84 [0.71 - 0.99]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	205567_at	133	0.879699	0.219746	-	0.417156	0.775777	0.0183887	1.02 [0.90 - 1.16]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	9607	81	0	1	-	0	1	0	1.00 [1.00 - 1.00]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE8841	Ovarian cancer		Overall Survival	Milan (1992-2003)	Marchini	G4100A	15220	81	0.580247	0.0518059	-	-1.18591	0.125217	-0.644651	0.52 [0.23 - 1.20]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205567_at	185	0.556757	0.000185267	0.00601282	-0.639861	0.0170081	-0.286897	0.75 [0.59 - 0.95]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	205567_at	185	0.762162	3.8599e-05	0.0015055	-0.922827	0.00694314	-0.365663	0.69 [0.53 - 0.90]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P98205	110	0.163636	0.0581173	-	-0.54913	0.305018	-0.103378	0.90 [0.74 - 1.10]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P98205	110	0.663636	0.0038131	0.0763539	-1.00867	0.0469191	-0.241397	0.79 [0.62 - 1.00]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	205567_at	80	0.6125	0.0622857	-	-0.993683	0.675412	-0.116247	0.89 [0.52 - 1.53]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE16560	Prostate cancer		Overall Survival	Sweden (1977-1999)	Sboner	6K DASL	DAP1_1171	281	0.644128	0.036297	0.401736	-0.31113	0.177999	-0.0939169	0.91 [0.79 - 1.04]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	205567_at	38	0.421053	0.110162	-	0.772492	0.245391	0.324653	1.38 [0.80 - 2.39]
GENE	CHST1	carbohydrate (keratan sulfate Gal-6) sulfotransferase 1	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	205567_at	140	0.557143	0.0117211	0.18183	0.725306	0.31378	0.178763	1.20 [0.84 - 1.69]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	219634_at	30	0.133333	0.131795	-	1.06703	0.41038	0.291147	1.34 [0.67 - 2.68]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1655880	165	0.49697	0.0493356	0.487624	0.478964	0.820739	-0.0639709	0.94 [0.54 - 1.63]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1655880	165	0.89697	0.0539307	-	0.850907	0.88316	0.0635579	1.07 [0.46 - 2.49]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	219634_at	163	0.509202	0.00377851	0.0758006	0.571045	0.0553216	0.312328	1.37 [0.99 - 1.88]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226368_at	163	0.466258	0.00129553	0.0316407	0.647167	0.0129561	0.489999	1.63 [1.11 - 2.40]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226372_at	163	0.294479	0.00817842	0.138625	0.610345	0.0312263	0.29851	1.35 [1.03 - 1.77]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226372_at	79	0.848101	0.0547839	-	0.703432	0.681779	0.0853871	1.09 [0.72 - 1.64]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226368_at	79	0.683544	0.0393392	0.423147	0.606017	0.979487	-0.00621225	0.99 [0.62 - 1.60]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	219634_at	79	0.21519	0.190862	-	0.503404	0.96036	-0.0110946	0.99 [0.64 - 1.53]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219634_at	58	0.810345	0.130723	-	0.513257	0.876151	-0.0397651	0.96 [0.58 - 1.58]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	219634_at	34	0.529412	0.0533625	-	0.731244	0.364119	0.314882	1.37 [0.69 - 2.70]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	219634_at	158	0.689873	0.119479	-	-0.404386	0.793666	-0.0595198	0.94 [0.60 - 1.47]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	219634_at	53	0.113208	0.0645394	-	1.6784	0.435653	0.269616	1.31 [0.66 - 2.58]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	219634_at	53	0.113208	0.0336629	0.382425	1.87406	0.282114	0.358131	1.43 [0.74 - 2.75]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	219634_at	180	0.111111	0.0537039	-	-0.574104	0.655697	-0.0659758	0.94 [0.70 - 1.25]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226372_at	180	0.338889	0.0751679	-	0.41403	0.839908	0.0368949	1.04 [0.73 - 1.48]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226368_at	180	0.105556	0.0361787	0.400885	-0.623124	0.974005	0.00736747	1.01 [0.65 - 1.57]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226372_at	559	0.339893	0.0115041	0.179319	-0.502336	0.17071	-0.224199	0.80 [0.58 - 1.10]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226368_at	559	0.110912	0.0254772	0.317116	-0.57383	0.585771	-0.147187	0.86 [0.51 - 1.47]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	219634_at	559	0.683363	0.0428561	0.446803	0.420338	0.525685	0.107851	1.11 [0.80 - 1.55]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	219634_at	77	0.103896	0.227023	-	0.558388	0.667853	-0.0706442	0.93 [0.67 - 1.29]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226372_at	77	0.12987	5.61171e-06	0.000264398	-1.56634	0.0723346	-0.446585	0.64 [0.39 - 1.04]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226368_at	77	0.12987	0.000308969	0.00937164	-1.22082	0.0425974	-0.669644	0.51 [0.27 - 0.98]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226372_at	70	0.128571	0.0530139	-	-0.700475	0.402114	-0.176825	0.84 [0.55 - 1.27]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226368_at	70	0.185714	0.00806375	0.137138	-0.844354	0.486204	-0.184487	0.83 [0.49 - 1.40]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	219634_at	70	0.628571	0.0395221	0.424406	-0.573924	0.243004	-0.422096	0.66 [0.32 - 1.33]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	219634_at	74	0.810811	0.0603287	-	0.665088	0.271049	0.313993	1.37 [0.78 - 2.39]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226368_at	74	0.445946	0.0101772	0.163608	-0.739659	0.145286	-0.654064	0.52 [0.22 - 1.25]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226372_at	74	0.594595	0.0861845	-	-0.529566	0.837329	-0.056184	0.95 [0.55 - 1.62]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226372_at	67	0.835821	0.14249	-	0.999525	0.889422	-0.0931419	0.91 [0.25 - 3.39]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226368_at	67	0.820895	0.157025	-	-15.3318	0.985128	-0.014712	0.99 [0.21 - 4.63]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	219634_at	67	0.567164	0.322545	-	0.660001	0.931629	0.0644336	1.07 [0.24 - 4.65]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226368_at	115	0.843478	0.0315984	0.366749	1.1327	0.422157	0.546424	1.73 [0.45 - 6.56]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	219634_at	115	0.895652	0.0191124	0.259473	1.29048	0.090598	0.793544	2.21 [0.88 - 5.54]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226372_at	115	0.156522	0.376923	-	0.888288	0.943118	-0.0429886	0.96 [0.29 - 3.12]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226368_at	204	0.877451	0.160318	-	0.303006	0.612693	0.0718311	1.07 [0.81 - 1.42]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226372_at	204	0.583333	0.0616878	-	0.265373	0.225738	0.135777	1.15 [0.92 - 1.43]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	219634_at	204	0.588235	0.00084714	0.0221672	0.486994	0.0775274	0.195502	1.22 [0.98 - 1.51]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226372_at	87	0.528736	0.0734448	-	-0.698891	0.321494	-0.220311	0.80 [0.52 - 1.24]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226372_at	87	0.528736	0.0734448	-	-0.698891	0.321494	-0.220311	0.80 [0.52 - 1.24]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226368_at	87	0.103448	0.174286	-	-0.662702	0.423052	-0.297716	0.74 [0.36 - 1.54]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226368_at	87	0.103448	0.174286	-	-0.662702	0.423052	-0.297716	0.74 [0.36 - 1.54]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	219634_at	87	0.896552	0.153529	-	-1.35073	0.651295	-0.131931	0.88 [0.49 - 1.55]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	219634_at	87	0.896552	0.153529	-	-1.35073	0.651295	-0.131931	0.88 [0.49 - 1.55]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	219634_at	77	0.493506	0.0404767	0.430922	1.48154	0.101446	0.973775	2.65 [0.83 - 8.49]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226368_at	77	0.714286	0.0991411	-	0.88873	0.254121	0.600091	1.82 [0.65 - 5.11]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226372_at	77	0.87013	0.0467208	0.471557	1.28573	0.394945	0.548141	1.73 [0.49 - 6.12]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	219634_at	77	0.714286	0.0217842	0.284528	1.20386	0.0408197	1.05179	2.86 [1.04 - 7.84]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226368_at	77	0.714286	0.0123178	0.188653	1.47905	0.11393	0.959031	2.61 [0.79 - 8.57]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226372_at	77	0.844156	0.0443079	0.456248	1.14765	0.237642	0.676107	1.97 [0.64 - 6.04]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	219634_at	136	0.102941	0.0108432	0.171574	-1.19208	0.134344	-0.395038	0.67 [0.40 - 1.13]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	219634_at	200	0.115	0.0211576	0.278771	-0.836664	0.546489	-0.14005	0.87 [0.55 - 1.37]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21654	60	0.783333	0.00945547	0.154783	1.00207	0.0645217	0.289002	1.34 [0.98 - 1.81]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16707	60	0.433333	0.0114156	0.178291	1.05736	0.0949066	0.319193	1.38 [0.95 - 2.00]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	21654	60	0.483333	0.0108301	0.171419	1.02645	0.0507911	0.428105	1.53 [1.00 - 2.36]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	16707	60	0.2	0.0364095	0.402545	1.41523	0.0664619	0.495964	1.64 [0.97 - 2.79]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	219634_at	286	0.804196	0.146118	-	-0.401985	0.772894	-0.0414186	0.96 [0.72 - 1.27]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219634_at	159	0.36478	0.0805702	-	0.628055	0.200953	0.366651	1.44 [0.82 - 2.53]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219634_at	159	0.446541	0.0306335	0.359248	0.730235	0.0853266	0.505185	1.66 [0.93 - 2.95]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	219634_at	159	0.446541	0.0425309	0.444663	0.819795	0.158245	0.479401	1.62 [0.83 - 3.14]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226368_at	159	0.257862	0.063882	-	-0.596396	0.202852	-0.384441	0.68 [0.38 - 1.23]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226368_at	159	0.232704	0.0107284	0.170212	-0.811727	0.23058	-0.367111	0.69 [0.38 - 1.26]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226368_at	159	0.201258	0.0971755	-	-0.65417	0.280165	-0.382283	0.68 [0.34 - 1.37]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226372_at	159	0.415094	0.0419893	0.441077	-0.6358	0.518458	-0.229028	0.80 [0.40 - 1.59]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226372_at	159	0.377358	0.0304022	0.357434	-0.672899	0.950422	-0.0225782	0.98 [0.48 - 1.99]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226372_at	159	0.377358	0.0246928	0.310376	-0.816239	0.876213	-0.0665694	0.94 [0.40 - 2.16]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	219634_at	54	0.185185	0.14916	-	15.3805	0.960662	-0.0400909	0.96 [0.20 - 4.73]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219634_at	117	0.623932	0.0446196	0.458253	-0.700224	0.225486	-0.361813	0.70 [0.39 - 1.25]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219634_at	117	0.581197	0.306546	-	-0.420101	0.694201	-0.142198	0.87 [0.43 - 1.76]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219634_at	117	0.623932	0.0446196	0.458253	-0.700224	0.225486	-0.361813	0.70 [0.39 - 1.25]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	219634_at	117	0.581197	0.0143445	0.211016	-1.07511	0.0907466	-0.675029	0.51 [0.23 - 1.11]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	219634_at	236	0.559322	0.0235033	0.299973	0.610268	0.266791	0.321795	1.38 [0.78 - 2.43]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226372_at	236	0.29661	0.0229951	0.295459	-0.616939	0.271606	-0.30775	0.74 [0.42 - 1.27]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226368_at	236	0.457627	0.0541021	-	0.540046	0.645451	0.164794	1.18 [0.58 - 2.38]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	219634_at	249	0.437751	0.0105439	0.168014	0.571472	0.340409	0.209392	1.23 [0.80 - 1.90]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226372_at	249	0.285141	0.122387	-	-0.347855	0.652837	-0.099826	0.90 [0.59 - 1.40]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226368_at	249	0.526104	0.0486284	0.48333	0.418593	0.736298	0.0910845	1.10 [0.64 - 1.86]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219634_at	125	0.872	0.0440281	0.454442	-15.2333	0.230151	-0.416665	0.66 [0.33 - 1.30]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219634_at	125	0.112	0.0477334	0.477842	1.02328	0.697112	0.0961094	1.10 [0.68 - 1.79]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219634_at	54	0.759259	0.220781	-	-0.946276	0.792498	-0.0718778	0.93 [0.54 - 1.59]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	219634_at	62	0.806452	0.0780667	-	-1.27698	0.627344	-0.110759	0.90 [0.57 - 1.40]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219634_at	198	0.843434	0.0249098	0.31225	0.574458	0.305844	0.102187	1.11 [0.91 - 1.35]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219634_at	198	0.843434	0.0803999	-	0.527144	0.125979	0.200224	1.22 [0.95 - 1.58]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	219634_at	198	0.843434	0.101369	-	0.514423	0.175561	0.183669	1.20 [0.92 - 1.57]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	219634_at	51	0.45098	0.0944113	-	-1.66998	0.155469	-4.66893	0.01 [0.00 - 5.89]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	219634_at	62	0.209677	0.0513566	-	-1.08821	0.233867	-2.15523	0.12 [0.00 - 4.03]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	219634_at	177	0.423729	0.221043	-	0.299247	0.792491	-0.069136	0.93 [0.56 - 1.56]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226368_at	145	0.413793	0.00714814	0.125021	1.03315	0.010154	0.850616	2.34 [1.22 - 4.48]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	219634_at	145	0.365517	0.000482516	0.0137456	1.65737	0.0674566	0.554017	1.74 [0.96 - 3.15]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226368_at	177	0.79096	0.00367372	0.074117	0.817896	0.153933	0.416274	1.52 [0.86 - 2.69]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226372_at	177	0.60452	0.0267028	0.327463	0.517126	0.318516	0.277991	1.32 [0.76 - 2.28]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226372_at	177	0.451977	0.00641403	0.114974	0.790859	0.0995863	0.529288	1.70 [0.90 - 3.19]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	219634_at	177	0.367232	0.0903794	-	0.520382	0.711714	0.107221	1.11 [0.63 - 1.97]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226368_at	177	0.79096	0.00555335	0.102767	0.697208	0.284535	0.276648	1.32 [0.79 - 2.19]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226372_at	145	0.462069	2.29562e-05	0.00094542	1.69151	0.00289192	1.17503	3.24 [1.49 - 7.02]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226368_at	226	0.800885	0.0173144	0.241812	0.707534	0.147489	0.38141	1.46 [0.87 - 2.45]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	219634_at	226	0.340708	0.00642135	0.115076	1.00969	0.103476	0.314474	1.37 [0.94 - 2.00]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226372_at	226	0.880531	0.0165295	0.23388	0.797792	0.0596347	0.298904	1.35 [0.99 - 1.84]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226368_at	49	0.795918	0.202531	-	0.763084	0.72709	0.204656	1.23 [0.39 - 3.87]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226372_at	49	0.428571	0.34481	-	0.571678	0.914797	-0.0613344	0.94 [0.31 - 2.89]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	219634_at	55	0.236364	0.120117	-	1.14539	0.560144	0.223821	1.25 [0.59 - 2.66]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	219634_at	49	0.897959	0.244468	-	0.875005	0.787501	-0.145186	0.86 [0.30 - 2.49]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226372_at	55	0.727273	0.137629	-	0.666138	0.585362	0.234428	1.26 [0.54 - 2.93]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226368_at	55	0.727273	0.0352969	0.394493	0.92045	0.330683	0.441136	1.55 [0.64 - 3.78]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	219634_at	55	0.4	0.0536175	-	0.961426	0.464667	0.254375	1.29 [0.65 - 2.55]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226368_at	55	0.763636	0.107558	-	0.787784	0.251905	0.534523	1.71 [0.68 - 4.26]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226372_at	55	0.727273	0.245736	-	0.529792	0.913948	0.049932	1.05 [0.42 - 2.60]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	219634_at	63	0.492063	0.000697308	0.0188052	1.18107	0.00567323	0.555286	1.74 [1.18 - 2.58]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226372_at	63	0.666667	8.8302e-06	0.000399155	1.47546	0.00228347	0.668859	1.95 [1.27 - 3.00]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226368_at	63	0.460317	3.30111e-05	0.00130919	1.51558	0.00342883	0.590488	1.80 [1.22 - 2.68]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.64001.0.S2_3p_at	28	0.642857	0.218619	-	0.658786	0.822343	0.0649813	1.07 [0.61 - 1.88]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g8923757_3p_at	28	0.892857	0.126995	-	-15.2751	0.253191	-2.97536	0.05 [0.00 - 8.40]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.64001.0.S1_3p_at	28	0.642857	0.228045	-	0.653768	0.321422	0.334102	1.40 [0.72 - 2.70]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	219634_at	82	0.853659	0.0132125	0.198674	0.970684	0.132796	0.58335	1.79 [0.84 - 3.83]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	219634_at	79	0.151899	0.051838	-	0.818094	0.308628	0.285479	1.33 [0.77 - 2.30]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	219634_at	104	0.625	0.00937175	0.153746	0.823456	0.0338692	0.81702	2.26 [1.06 - 4.82]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P139919	117	0.136752	0.0939774	-	0.849862	0.482967	0.129424	1.14 [0.79 - 1.63]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226368_at	204	0.558824	0.000342079	0.0102317	1.37163	0.0090304	1.16583	3.21 [1.34 - 7.70]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226372_at	204	0.465686	0.00176877	0.0409454	1.32808	0.0152304	0.966735	2.63 [1.20 - 5.74]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226368_at	204	0.808824	0.000187432	0.00607404	1.02421	0.00369375	0.955184	2.60 [1.36 - 4.95]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226372_at	204	0.553922	8.64074e-05	0.00307893	1.08176	0.00318438	0.870446	2.39 [1.34 - 4.26]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	219634_at	204	0.647059	8.42844e-06	0.000382648	1.60097	0.00193328	1.06587	2.90 [1.48 - 5.70]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	219634_at	204	0.598039	1.31084e-08	9.55331e-07	1.54506	9.59938e-07	1.24712	3.48 [2.11 - 5.73]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	219634_at	178	0.404494	0.0664816	-	0.383617	0.115041	0.309276	1.36 [0.93 - 2.00]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200008923	41	0.317073	0.0547482	-	-0.795536	0.963747	0.00893909	1.01 [0.69 - 1.48]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	219634_at	111	0.792793	0.0171721	0.240384	0.711196	0.979872	0.00391436	1.00 [0.74 - 1.36]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226368_at	111	0.117117	0.0758762	-	-0.641666	0.608684	-0.125852	0.88 [0.54 - 1.43]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226372_at	111	0.135135	0.000530236	0.0148985	-1.0533	0.824451	0.0486302	1.05 [0.68 - 1.61]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	219634_at	90	0.633333	0.0129635	0.19591	-1.15686	0.33869	-0.319906	0.73 [0.38 - 1.40]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	219634_at	90	0.677778	0.0201242	0.269119	-0.939943	0.332538	-0.278619	0.76 [0.43 - 1.33]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	219634_at	138	0.847826	0.00442811	0.0859901	0.813015	0.263781	0.115019	1.12 [0.92 - 1.37]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226372_at	138	0.246377	0.0737732	-	0.545014	0.521442	0.0601779	1.06 [0.88 - 1.28]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226368_at	138	0.297101	0.00182005	0.0419199	0.934543	0.0774843	0.193705	1.21 [0.98 - 1.50]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	219634_at	129	0.782946	0.101544	-	-0.535738	0.872645	-0.0356912	0.96 [0.62 - 1.49]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25860	56	0.75	0.294721	-	-0.448223	0.956437	0.0098327	1.01 [0.71 - 1.44]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	25860	56	0.75	0.142599	-	-0.595341	0.651146	-0.0748562	0.93 [0.67 - 1.28]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	219634_at	278	0.42446	0.0351708	0.393571	0.410745	0.636144	0.0546342	1.06 [0.84 - 1.32]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226368_at	278	0.71223	0.0122703	0.188113	0.479796	0.274629	0.146371	1.16 [0.89 - 1.51]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226372_at	278	0.489209	0.0489974	0.485575	0.373196	0.240736	0.126619	1.13 [0.92 - 1.40]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	219634_at	133	0.406015	0.060415	-	0.471969	0.470672	-0.2018	0.82 [0.47 - 1.41]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219634_at	185	0.162162	0.250694	-	-0.248151	0.904254	0.0334671	1.03 [0.60 - 1.78]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	219634_at	185	0.897297	0.225876	-	0.322104	0.557368	0.148146	1.16 [0.71 - 1.90]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P139919	110	0.890909	0.156377	-	-0.590103	0.399944	-0.100656	0.90 [0.72 - 1.14]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P139919	110	0.118182	0.205393	-	-0.492389	0.73899	-0.0504325	0.95 [0.71 - 1.28]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	219634_at	80	0.375	0.218397	-	0.624503	0.627666	0.102119	1.11 [0.73 - 1.67]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	219634_at	38	0.710526	0.00595747	0.10856	1.26988	0.1123	0.397819	1.49 [0.91 - 2.43]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226372_at	38	0.710526	0.00595747	0.10856	1.26988	0.114872	0.537591	1.71 [0.88 - 3.34]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226368_at	38	0.710526	0.00126527	0.0310242	1.50085	0.0358709	0.759892	2.14 [1.05 - 4.35]
GENE	CHST11	carbohydrate (chondroitin 4) sulfotransferase 11	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	219634_at	140	0.521429	0.109478	-	0.462317	0.865813	0.0518832	1.05 [0.58 - 1.92]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE5287	Bladder cancer		Overall Survival	Aarhus (1995-2004)	Als	HG-U133A	218927_s_at	30	0.533333	0.220434	-	0.488152	0.50143	-0.364453	0.69 [0.24 - 2.01]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1735058	165	0.8	0.0387485	0.419061	0.551158	0.0477061	0.372036	1.45 [1.00 - 2.10]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1735058	165	0.206061	0.0332894	0.379626	1.42979	0.0460256	0.51084	1.67 [1.01 - 2.75]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE12417-GPL96	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133A	218927_s_at	163	0.815951	0.0860606	-	0.420093	0.80676	-0.0361202	0.96 [0.72 - 1.29]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	222786_at	163	0.343558	0.135151	-	0.315494	0.286007	0.217234	1.24 [0.83 - 1.85]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	222786_at	79	0.544304	0.00222729	0.0494649	0.884551	0.199107	0.282592	1.33 [0.86 - 2.04]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	218927_s_at	79	0.721519	0.0731687	-	0.557869	0.689596	0.0818961	1.09 [0.73 - 1.62]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE5122	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218927_s_at	58	0.137931	0.218333	-	0.500666	0.814023	0.0371564	1.04 [0.76 - 1.41]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE8970	Blood cancer	AML	Overall Survival	San Diego	Raponi	HG-U133A	218927_s_at	34	0.352941	0.182522	-	0.553082	0.42817	0.252104	1.29 [0.69 - 2.40]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE4475	Blood cancer	B-cell lymphoma	Overall Survival	Berlin (2003-2005)	Hummel	HG-U133A	218927_s_at	158	0.227848	0.0841576	-	0.523387	0.203327	0.396408	1.49 [0.81 - 2.74]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	E-TABM-346	Blood cancer	DLBCL	Overall Survival	GELA (1998-2000)	Jais	HG-U133A	218927_s_at	53	0.320755	0.15663	-	0.603581	0.629695	0.131201	1.14 [0.67 - 1.94]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	E-TABM-346	Blood cancer	DLBCL	Event Free Survival	GELA (1998-2000)	Jais	HG-U133A	218927_s_at	53	0.320755	0.0496411	0.489467	0.81559	0.310752	0.266937	1.31 [0.78 - 2.19]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE16131-GPL96	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133A	218927_s_at	180	0.472222	0.0796241	-	-0.370011	0.800047	0.0436697	1.04 [0.75 - 1.46]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	222786_at	180	0.816667	0.00271107	0.0580395	0.736272	0.070463	0.396027	1.49 [0.97 - 2.28]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	222786_at	559	0.146691	0.101615	-	-0.392839	0.419338	-0.246453	0.78 [0.43 - 1.42]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	218927_s_at	559	0.824687	0.314694	-	-0.288939	0.982752	-0.0061302	0.99 [0.57 - 1.73]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE4271-GPL96	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133A	218927_s_at	77	0.87013	0.0818859	-	0.663601	0.258307	0.381255	1.46 [0.76 - 2.84]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	222786_at	77	0.896104	0.015314	0.221309	0.904699	0.139857	0.568836	1.77 [0.83 - 3.76]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	222786_at	70	0.885714	0.00603258	0.109624	1.02964	0.410925	0.380396	1.46 [0.59 - 3.62]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	218927_s_at	70	0.142857	0.0363757	0.402302	-0.729994	0.525582	0.264188	1.30 [0.58 - 2.94]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE4412-GPL96	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133A	218927_s_at	74	0.418919	0.0715052	-	0.533877	0.951898	0.0287179	1.03 [0.40 - 2.62]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	222786_at	74	0.189189	0.0998705	-	-0.544748	0.626589	-0.238677	0.79 [0.30 - 2.06]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	218927_s_at	67	0.432836	0.00715224	0.125077	-1.8928	0.0125362	-3.56936	0.03 [0.00 - 0.46]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	222786_at	67	0.149254	0.000897405	0.0232698	-2.27753	0.189341	-2.38519	0.09 [0.00 - 3.24]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	218927_s_at	115	0.547826	0.0546176	-	-1.18099	0.389745	-0.678616	0.51 [0.11 - 2.38]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	222786_at	115	0.756522	0.0270553	0.330399	-15.4874	0.8688	-0.0962533	0.91 [0.29 - 2.85]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	218927_s_at	204	0.553922	0.00807003	0.13722	0.382399	0.16888	0.282417	1.33 [0.89 - 1.98]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	222786_at	204	0.833333	0.172656	-	-0.253705	0.466991	-0.119708	0.89 [0.64 - 1.22]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	222786_at	87	0.103448	0.389802	-	-0.461802	0.860388	0.0964748	1.10 [0.38 - 3.23]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	222786_at	87	0.103448	0.389802	-	-0.461802	0.860388	0.0964748	1.10 [0.38 - 3.23]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	218927_s_at	87	0.103448	0.0252911	0.315526	-1.06991	0.048887	-0.642234	0.53 [0.28 - 1.00]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	218927_s_at	87	0.103448	0.0252911	0.315526	-1.06991	0.048887	-0.642234	0.53 [0.28 - 1.00]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	222786_at	77	0.402597	0.0362528	0.401419	1.4744	0.0231373	1.45081	4.27 [1.22 - 14.92]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	218927_s_at	77	0.896104	0.00365057	0.0737435	1.58344	0.0508295	1.34859	3.85 [1.00 - 14.91]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	222786_at	77	0.402597	0.0322952	0.372095	1.93964	0.112577	1.00638	2.74 [0.79 - 9.48]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	218927_s_at	77	0.857143	0.0110778	0.174341	1.50138	0.165637	0.884683	2.42 [0.69 - 8.46]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE12093	Breast cancer		Distant Metastasis Free Survival	IO, NCI, TUM, CCF (1992-2000)	Zhang	HG-U133A	218927_s_at	136	0.551471	0.0142704	0.210219	-1.26983	0.535738	-0.205864	0.81 [0.42 - 1.56]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE11121	Breast cancer		Distant Metastasis Free Survival	Mainz (1988-1998)	Schmidt	HG-U133A	218927_s_at	200	0.725	0.232304	-	-0.424501	0.952074	-0.0271201	0.97 [0.40 - 2.36]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19813	60	0.116667	0.0120201	0.185263	-1.22456	0.418047	-0.165238	0.85 [0.57 - 1.26]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	19813	60	0.583333	0.0684242	-	0.679592	0.643307	0.1624	1.18 [0.59 - 2.34]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE2034	Breast cancer		Distant Metastasis Free Survival	Rotterdam (1980-1995)	Wang	HG-U133A	218927_s_at	286	0.43007	0.11497	-	-0.303478	0.721818	-0.0698845	0.93 [0.63 - 1.37]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE1456-GPL96	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218927_s_at	159	0.389937	0.10121	-	-0.512742	0.676496	-0.109698	0.90 [0.54 - 1.50]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE1456-GPL96	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218927_s_at	159	0.893082	0.0147173	0.215003	0.931114	0.163477	0.445604	1.56 [0.83 - 2.92]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE1456-GPL96	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133A	218927_s_at	159	0.672956	0.0604846	-	0.684787	0.326794	0.362317	1.44 [0.70 - 2.96]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222786_at	159	0.660377	0.00294918	0.0621279	0.910891	0.872576	0.0941471	1.10 [0.35 - 3.47]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222786_at	159	0.81761	0.00373669	0.0751301	0.944726	0.154866	0.858588	2.36 [0.72 - 7.70]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	222786_at	159	0.81761	0.00753672	0.130217	1.00216	0.330822	0.69713	2.01 [0.49 - 8.18]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE7378	Breast cancer		Disease Free Survival	UCSF	Zhou	U133AAofAv2	218927_s_at	54	0.203704	0.0504226	-	-1.29436	0.228381	-1.17164	0.31 [0.05 - 2.09]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	E-TABM-158	Breast cancer		Overall Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218927_s_at	117	0.188034	0.21809	-	0.581369	0.678838	0.162747	1.18 [0.54 - 2.54]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	E-TABM-158	Breast cancer		Distant Metastasis Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218927_s_at	117	0.863248	0.12937	-	0.685629	0.963787	0.0228676	1.02 [0.38 - 2.75]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	E-TABM-158	Breast cancer		Relapse Free Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218927_s_at	117	0.188034	0.21809	-	0.581369	0.678838	0.162747	1.18 [0.54 - 2.54]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	E-TABM-158	Breast cancer		Disease Specific Survival	UCSF, CPMC (1989-1997)	Chin	HG-U133A	218927_s_at	117	0.102564	0.124473	-	-0.740746	0.702088	-0.183741	0.83 [0.32 - 2.13]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE3494-GPL96	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133A	218927_s_at	236	0.20339	0.0102127	0.164037	-0.736943	0.356002	-0.261706	0.77 [0.44 - 1.34]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	222786_at	236	0.894068	0.000386663	0.0113691	1.10732	0.160273	0.70383	2.02 [0.76 - 5.40]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE4922-GPL96	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133A	218927_s_at	249	0.879518	0.0873328	-	0.49466	0.376183	-0.199794	0.82 [0.53 - 1.27]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	222786_at	249	0.859438	0.0441434	0.455187	0.539274	0.839723	0.0804925	1.08 [0.50 - 2.36]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218927_s_at	125	0.12	0.0386236	0.418194	15.2343	0.79775	-0.110188	0.90 [0.39 - 2.08]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218927_s_at	125	0.12	0.0256928	0.318953	1.93805	0.564604	-0.186659	0.83 [0.44 - 1.57]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE2990	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218927_s_at	54	0.666667	0.258675	-	-0.753148	0.645843	-0.121704	0.89 [0.53 - 1.49]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE2990	Breast cancer		Relapse Free Survival	Uppsala, Oxford	Sotiriou	HG-U133A	218927_s_at	62	0.709677	0.16917	-	-0.77765	0.708656	-0.0814446	0.92 [0.60 - 1.41]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE7390	Breast cancer		Relapse Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218927_s_at	198	0.79798	0.112708	-	-0.457463	0.901115	-0.0228639	0.98 [0.68 - 1.40]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE7390	Breast cancer		Distant Metastasis Free Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218927_s_at	198	0.828283	0.032273	0.371926	-0.962163	0.844618	0.0444931	1.05 [0.67 - 1.63]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE7390	Breast cancer		Overall Survival	Uppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)	Desmedt	HG-U133A	218927_s_at	198	0.828283	0.0261773	0.323053	-1.09812	0.930882	0.0199474	1.02 [0.65 - 1.60]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE12945	Colorectal cancer		Disease Free Survival	Berlin	Staub	HG-U133A	218927_s_at	51	0.156863	0.14446	-	-1.24966	0.526989	-0.912447	0.40 [0.02 - 6.78]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE12945	Colorectal cancer		Overall Survival	Berlin	Staub	HG-U133A	218927_s_at	62	0.66129	0.214181	-	0.702806	0.982763	-0.019096	0.98 [0.17 - 5.55]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	222786_at	145	0.806897	0.283109	-	-0.51702	0.902171	-0.0811103	0.92 [0.25 - 3.36]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	218927_s_at	177	0.146893	0.0652055	-	0.767527	0.440223	0.34853	1.42 [0.58 - 3.43]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	218927_s_at	145	0.627586	0.0317072	0.367587	0.702252	0.205262	0.837784	2.31 [0.63 - 8.45]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	218927_s_at	177	0.536723	0.0313131	0.364542	0.581236	0.3844	0.455031	1.58 [0.57 - 4.39]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	222786_at	177	0.519774	0.0509872	-	0.461356	0.923786	0.042222	1.04 [0.44 - 2.48]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	222786_at	177	0.542373	0.0760221	-	0.482102	0.996188	-0.00242829	1.00 [0.37 - 2.70]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	218927_s_at	226	0.39823	0.0839012	-	0.53817	0.392399	0.312474	1.37 [0.67 - 2.80]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	222786_at	226	0.575221	0.0118113	0.182869	0.709263	0.406353	0.224494	1.25 [0.74 - 2.13]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	218927_s_at	55	0.4	0.00990769	0.160337	1.48209	0.0352163	1.65169	5.22 [1.12 - 24.26]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	222786_at	55	0.181818	0.0266855	0.327319	15.3903	0.484462	0.706821	2.03 [0.28 - 14.71]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	218927_s_at	49	0.469388	0.053209	-	1.21572	0.308493	0.972732	2.65 [0.41 - 17.20]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	222786_at	49	0.877551	0.0512256	-	1.22799	0.386189	1.11614	3.05 [0.24 - 38.12]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	222786_at	55	0.854545	0.0115545	0.179904	1.17504	0.080056	1.78807	5.98 [0.81 - 44.27]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	218927_s_at	55	0.4	0.0165262	0.233847	1.26069	0.060093	1.40476	4.07 [0.94 - 17.62]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE11595	Esophagus cancer	Adenocarcinoma	Overall Survival	Sutton	Giddings	CRUKDMF_22K_v1.0.0	740441	34	0.794118	0.00284823	0.0604044	1.32429	0.00615025	4.42151	83.22 [3.52 - 1967.92]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	222786_at	63	0.142857	0.0637977	-	1.26496	0.335489	0.23668	1.27 [0.78 - 2.05]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	218927_s_at	63	0.380952	0.000240531	0.00754557	1.51995	0.0854376	0.370623	1.45 [0.95 - 2.21]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g8922111_3p_a_at	28	0.857143	0.0105027	0.167522	2.06425	0.850704	-1.76157	0.17 [0.00 - 15906003.90]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	g12804130_3p_at	28	0.142857	5.26336e-05	0.00198454	-2.2162	0.845308	0.0599878	1.06 [0.58 - 1.94]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	jacob-00182-CANDF	Lung cancer	Adenocarcinoma	Overall Survival	CAN/DF	Shedden	HG-U133A	218927_s_at	82	0.390244	0.232395	-	-0.403644	0.80607	-0.104778	0.90 [0.39 - 2.08]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	jacob-00182-HLM	Lung cancer	Adenocarcinoma	Overall Survival	HLM	Shedden	HG-U133A	218927_s_at	79	0.177215	0.0260959	0.322366	-0.693928	0.411252	-0.323106	0.72 [0.33 - 1.56]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	jacob-00182-MSK	Lung cancer	Adenocarcinoma	Overall Survival	MSK	Shedden	HG-U133A	218927_s_at	104	0.259615	0.11794	-	-0.528955	0.334896	-0.38089	0.68 [0.32 - 1.48]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P310421	117	0.504274	0.0116157	0.180613	0.730096	0.51413	0.186382	1.20 [0.69 - 2.11]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	218927_s_at	204	0.867647	0.055163	-	0.807168	0.522787	0.390479	1.48 [0.45 - 4.89]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	222786_at	204	0.485294	0.00019922	0.00640554	-1.54334	0.000220529	-2.47242	0.08 [0.02 - 0.31]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	218927_s_at	204	0.867647	0.0485197	0.482667	0.655369	0.147923	0.674284	1.96 [0.79 - 4.89]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	222786_at	204	0.504902	2.85365e-06	0.000142605	-1.41393	2.33149e-05	-2.08975	0.12 [0.05 - 0.33]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	jacob-00182-UM	Lung cancer	Adenocarcinoma	Overall Survival	UM	Shedden	HG-U133A	218927_s_at	178	0.157303	0.00376123	0.0755238	-0.687203	0.115502	-0.415855	0.66 [0.39 - 1.11]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE11117	Lung cancer	NSCLC	Overall Survival	Basel (2002-2005)	Baty	Novachip human 34.5k	H200003491	41	0.853659	0.0898483	-	-1.57216	0.372797	-0.362048	0.70 [0.31 - 1.54]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	218927_s_at	111	0.216216	0.0703771	-	-0.527727	0.279196	-0.323628	0.72 [0.40 - 1.30]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	222786_at	111	0.891892	0.0810099	-	-0.877796	0.401635	-0.224458	0.80 [0.47 - 1.35]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE14814	Lung cancer	NSCLC	Disease Specific Survival	JRB.10	Zhu	HG-U133A	218927_s_at	90	0.155556	0.0842681	-	-0.735475	0.879982	-0.0815449	0.92 [0.32 - 2.66]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE14814	Lung cancer	NSCLC	Overall Survival	JRB.10	Zhu	HG-U133A	218927_s_at	90	0.155556	0.137894	-	-0.58433	0.901441	-0.058471	0.94 [0.37 - 2.38]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	218927_s_at	138	0.282609	0.0891582	-	-0.426475	0.899727	-0.0255291	0.97 [0.66 - 1.45]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	222786_at	138	0.253623	0.0120512	0.185618	-0.63504	0.949382	0.0167761	1.02 [0.61 - 1.71]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE4573	Lung cancer	Squamous cell carcinoma	Overall Survival	Michigan (1991-2002)	Raponi	HG-U133A	218927_s_at	129	0.302326	0.000212662	0.00678005	-0.923064	0.0106588	-0.74137	0.48 [0.27 - 0.84]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40540	56	0.446429	0.104838	-	0.571505	0.628351	-0.142731	0.87 [0.49 - 1.55]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	40540	56	0.125	0.0796266	-	-0.784793	0.334911	-0.307538	0.74 [0.39 - 1.37]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	218927_s_at	278	0.690647	0.0261964	0.323214	0.426858	0.164881	0.281015	1.32 [0.89 - 1.97]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	222786_at	278	0.435252	0.0610297	-	0.359635	0.570626	0.11919	1.13 [0.75 - 1.70]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	DUKE-OC	Ovarian cancer		Overall Survival	Duke	Bild	HG-U133A	218927_s_at	133	0.676692	0.0518388	-	0.469643	0.111162	0.291255	1.34 [0.94 - 1.91]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE26712	Ovarian cancer		Overall Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218927_s_at	185	0.432432	0.0818492	-	0.311895	0.377156	0.176173	1.19 [0.81 - 1.76]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE26712	Ovarian cancer		Disease Free Survival	MSKCC (1990-2003)	Bonome	HG-U133_Plus_2	218927_s_at	185	0.421622	0.0169353	0.237999	0.396475	0.0614554	0.341168	1.41 [0.98 - 2.01]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P310421	110	0.109091	0.0105054	0.167554	-0.932452	0.946386	0.0171837	1.02 [0.62 - 1.68]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P310421	110	0.109091	0.0673661	-	-0.612472	0.940402	0.0143177	1.01 [0.70 - 1.48]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE14764	Ovarian cancer		Overall Survival	TOC	Denkert	HG-U133A	218927_s_at	80	0.275	0.170595	-	0.74716	0.860051	0.0417984	1.04 [0.66 - 1.66]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	218927_s_at	38	0.526316	0.176969	-	-0.656447	0.78662	-0.214562	0.81 [0.17 - 3.82]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	222786_at	38	0.447368	0.155269	-	-0.663554	0.673384	-0.237819	0.79 [0.26 - 2.38]
GENE	CHST12	carbohydrate (chondroitin 4) sulfotransferase 12	None	GSE30929	Soft tissue cancer	Liposarcoma	Distant Recurrence Free Survival	MSKCC (1993-2008)	Gobble	HG-U133A	218927_s_at	140	0.878571	0.00703635	0.123511	0.97591	0.101495	0.608035	1.84 [0.89 - 3.80]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE13507	Bladder cancer		Overall Survival	CNUH	Kim	Human-6 v2	ILMN_1734707	165	0.6	0.119306	-	-0.401675	0.283558	-0.380634	0.68 [0.34 - 1.37]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE13507	Bladder cancer	Transitional cell carcinoma 	Disease Specific Survival	CNUH	Kim	Human-6 v2	ILMN_1734707	165	0.70303	0.0178826	0.247468	0.816462	0.15472	0.533276	1.70 [0.82 - 3.55]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	239647_at	163	0.122699	0.173095	-	0.432704	0.955927	-0.00676115	0.99 [0.78 - 1.26]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	242503_at	163	0.613497	0.0797807	-	0.347055	0.959118	0.0326488	1.03 [0.30 - 3.60]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	239647_at	79	0.405063	0.0186841	0.255327	0.733748	0.0870715	0.216197	1.24 [0.97 - 1.59]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	242503_at	79	0.746835	0.0139096	0.206317	-1.02964	0.0346507	-1.88132	0.15 [0.03 - 0.87]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	239647_at	180	0.183333	0.115486	-	0.50179	0.798519	0.0372298	1.04 [0.78 - 1.38]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	242503_at	180	0.111111	0.0783675	-	0.680066	0.297271	0.116047	1.12 [0.90 - 1.40]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	239647_at	559	0.264758	0.0924668	-	-0.356995	0.210283	-0.182647	0.83 [0.63 - 1.11]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	242503_at	559	0.747764	0.00754301	0.1303	-0.752478	0.021747	-0.426342	0.65 [0.45 - 0.94]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	239647_at	77	0.558442	0.00416919	0.0819776	0.718318	0.0170108	0.579836	1.79 [1.11 - 2.87]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	242503_at	77	0.883117	0.0652314	-	0.70962	0.320768	0.193034	1.21 [0.83 - 1.78]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	239647_at	70	0.428571	0.0961377	-	0.446979	0.651508	0.212448	1.24 [0.49 - 3.11]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	242503_at	70	0.142857	0.00791084	0.135144	-0.947543	0.810494	-0.221414	0.80 [0.13 - 4.90]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	242503_at	74	0.851351	0.000187969	0.00608921	1.23193	0.00758154	1.02562	2.79 [1.31 - 5.92]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	239647_at	74	0.824324	1.88759e-07	1.16084e-05	1.70002	0.243296	0.319043	1.38 [0.81 - 2.35]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	242503_at	67	0.776119	0.079873	-	1.23779	0.230858	2.96983	19.49 [0.15 - 2510.01]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	239647_at	67	0.567164	0.00533182	0.099542	-16.0673	0.0495442	-4.04106	0.02 [0.00 - 0.99]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	239647_at	115	0.2	0.0518817	-	15.3863	0.0929276	1.48648	4.42 [0.78 - 25.04]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	242503_at	115	0.8	0.216023	-	-1.20932	0.752162	-0.110531	0.90 [0.45 - 1.78]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	242503_at	204	0.259804	0.0138438	0.205602	-0.400526	0.169994	-0.191236	0.83 [0.63 - 1.09]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	239647_at	204	0.348039	0.118088	-	0.227127	0.227376	0.124003	1.13 [0.93 - 1.38]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	239647_at	87	0.850575	0.137423	-	-1.04336	0.38714	-0.596788	0.55 [0.14 - 2.13]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	239647_at	87	0.850575	0.137423	-	-1.04336	0.38714	-0.596788	0.55 [0.14 - 2.13]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	242503_at	87	0.114943	0.372138	-	0.64397	0.530083	0.518139	1.68 [0.33 - 8.46]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	242503_at	87	0.114943	0.372138	-	0.64397	0.530083	0.518139	1.68 [0.33 - 8.46]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	239647_at	77	0.480519	0.140748	-	-0.977461	0.514035	-0.611041	0.54 [0.09 - 3.40]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	242503_at	77	0.272727	0.193959	-	1.28034	0.569815	0.755655	2.13 [0.16 - 28.84]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	239647_at	77	0.831169	0.156618	-	0.827708	0.449133	0.553317	1.74 [0.41 - 7.29]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	242503_at	77	0.272727	0.0892541	-	1.59506	0.338016	1.0958	2.99 [0.32 - 28.15]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	242503_at	159	0.742138	0.313785	-	0.391072	0.992909	0.00313816	1.00 [0.50 - 2.00]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239647_at	159	0.886792	0.0192802	0.261087	0.897928	0.452966	0.202711	1.22 [0.72 - 2.08]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239647_at	159	0.886792	0.0218785	0.285389	0.879712	0.376643	0.244806	1.28 [0.74 - 2.20]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	239647_at	159	0.886792	0.00511364	0.0963302	1.15535	0.526547	0.20043	1.22 [0.66 - 2.27]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	242503_at	159	0.45283	0.240481	-	-0.369629	0.431948	-0.243931	0.78 [0.43 - 1.44]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	242503_at	159	0.861635	0.116967	-	0.585297	0.557764	0.172801	1.19 [0.67 - 2.12]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	242503_at	236	0.855932	0.00324422	0.0670874	0.864131	0.0131027	0.555233	1.74 [1.12 - 2.70]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	239647_at	236	0.241525	0.0121204	0.186408	1.0366	0.412105	0.32464	1.38 [0.64 - 3.01]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	239647_at	249	0.192771	0.129282	-	0.466836	0.0961493	0.533998	1.71 [0.91 - 3.20]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	242503_at	249	0.851406	0.00243688	0.0532269	0.740668	0.0324149	0.409979	1.51 [1.03 - 2.19]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	242503_at	177	0.344633	0.00465852	0.0895096	-0.753348	0.0277791	-1.4274	0.24 [0.07 - 0.86]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	239647_at	177	0.135593	0.292211	-	-0.331984	0.665193	-0.128416	0.88 [0.49 - 1.57]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	239647_at	177	0.112994	0.0620863	-	-0.643418	0.0968932	-0.725466	0.48 [0.21 - 1.14]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	242503_at	177	0.870057	0.0148734	0.216662	-1.18287	0.0460793	-1.13537	0.32 [0.11 - 0.98]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	239647_at	145	0.524138	0.0301332	0.355314	-0.751685	0.265728	-0.598387	0.55 [0.19 - 1.58]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	242503_at	145	0.372414	0.0776894	-	-0.581933	0.327992	-0.81214	0.44 [0.09 - 2.26]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	239647_at	226	0.172566	1.57799e-05	0.000674733	-1.20756	3.63834e-05	-0.478228	0.62 [0.49 - 0.78]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	242503_at	226	0.482301	0.111274	-	-0.452523	0.607846	-0.0994842	0.91 [0.62 - 1.32]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	239647_at	55	0.745455	0.0275517	0.334504	0.970682	0.357234	0.287043	1.33 [0.72 - 2.46]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	242503_at	55	0.854545	0.0364352	0.402729	-15.3243	0.166316	-1.82245	0.16 [0.01 - 2.13]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	239647_at	55	0.763636	0.0301428	0.355391	1.0252	0.171837	0.3382	1.40 [0.86 - 2.28]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	242503_at	55	0.781818	0.0507481	-	-1.76612	0.302784	-1.37867	0.25 [0.02 - 3.47]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	242503_at	49	0.836735	0.0966663	-	-15.3353	0.517586	-1.02551	0.36 [0.02 - 8.01]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	239647_at	49	0.77551	0.0328497	0.376309	1.18582	0.799768	-0.1766	0.84 [0.21 - 3.28]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	239647_at	63	0.47619	0.0756239	-	-0.600551	0.522636	-0.244886	0.78 [0.37 - 1.66]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	242503_at	63	0.111111	3.30937e-06	0.000163305	-1.86419	0.0248841	-17.9103	0.00 [0.00 - 0.10]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.150905.0.A1_3p_at	28	0.178571	0.0985542	-	-0.986004	0.697243	-0.751724	0.47 [0.01 - 20.81]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.117048.0.A1_3p_at	28	0.357143	0.217816	-	-0.692907	0.499163	-2.24052	0.11 [0.00 - 70.64]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.117048.0.A1_3p_x_at	28	0.892857	0.126995	-	-15.2751	0.327036	-3.89179	0.02 [0.00 - 48.96]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P80473	117	0.111111	2.78608e-05	0.00112476	-1.34917	0.000578008	-1.06977	0.34 [0.19 - 0.63]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	242503_at	204	0.745098	0.0395471	0.424578	-1.18283	0.237958	-0.746641	0.47 [0.14 - 1.64]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	239647_at	204	0.867647	0.0666752	-	0.773231	0.539973	0.232458	1.26 [0.60 - 2.65]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	242503_at	204	0.47549	0.0112508	0.176369	-0.700335	0.290479	-0.490269	0.61 [0.25 - 1.52]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	239647_at	204	0.112745	0.0512017	-	-0.670997	0.741567	-0.0891568	0.91 [0.54 - 1.55]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	239647_at	111	0.207207	0.0272504	0.332016	-0.644334	0.0502807	-0.300406	0.74 [0.55 - 1.00]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	242503_at	111	0.648649	0.0880946	-	-0.49057	0.705519	-0.0943371	0.91 [0.56 - 1.48]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	239647_at	138	0.65942	0.0472319	0.474739	0.486432	0.687956	-0.0740816	0.93 [0.65 - 1.33]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	242503_at	138	0.181159	0.00942452	0.1544	-0.687997	0.331755	-3.51567	0.03 [0.00 - 36.01]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3494	56	0.696429	0.045281	0.46248	-1.02934	0.810236	0.0893313	1.09 [0.53 - 2.27]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	3494	56	0.321429	0.10529	-	0.58761	0.468599	0.24801	1.28 [0.66 - 2.51]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	242503_at	278	0.651079	0.0784009	-	-0.352416	0.353318	-0.350701	0.70 [0.34 - 1.48]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	239647_at	278	0.568345	0.0253344	0.315896	0.416663	0.211991	0.353816	1.42 [0.82 - 2.48]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P80473	110	0.627273	0.0954978	-	-0.552906	0.379584	-0.400882	0.67 [0.27 - 1.64]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P80473	110	0.627273	0.051684	-	-0.484221	0.445081	-0.258757	0.77 [0.40 - 1.50]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	239647_at	38	0.894737	0.0968887	-	-15.2345	0.513699	-0.281386	0.75 [0.32 - 1.76]
GENE	CHST13	carbohydrate (chondroitin 4) sulfotransferase 13	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	242503_at	38	0.315789	0.146961	-	-0.659489	0.619932	-0.157215	0.85 [0.46 - 1.59]

TYPE	ID_NAME	ID_DESCRIPTION	DATA_POSTPROCESSING	DATASET	CANCER TYPE	SUBTYPE	ENDPOINT	COHORT	CONTRIBUTOR	ARRAY TYPE	PROBE ID	N	CUTPOINT	MINIMUM P-VALUE	CORRECTED P-VALUE	ln(HR-high / HR-low)	COX P-VALUE	ln(HR)	HR [95% CI-low CI-upp]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE12417-GPL97	Blood cancer	AML	Overall Survival	AMLCG (1999-2003)	Metzeler	HG-U133B	226314_at	163	0.466258	0.0357615	0.397871	0.417639	0.0677338	0.398009	1.49 [0.97 - 2.28]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE12417-GPL570	Blood cancer	AML	Overall Survival	AMLCG (2004)	Metzeler	HG-U133_Plus_2	226314_at	79	0.898734	2.15897e-05	0.000894708	1.56713	0.00349231	0.686912	1.99 [1.25 - 3.15]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE16131-GPL97	Blood cancer	Follicular lymphoma	Overall Survival	NCI (1974-2001)	Dave	HG-U133B	226314_at	180	0.672222	0.0676253	-	-0.416879	0.661926	-0.181506	0.83 [0.37 - 1.88]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE2658	Blood cancer	Multiple myeloma	Disease Specific Survival	Arkansas	Zhan	HG-U133_Plus_2	226314_at	559	0.59034	0.0667816	-	0.366228	0.388448	0.213218	1.24 [0.76 - 2.01]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE4271-GPL97	Brain cancer	Astrocytoma	Overall Survival	MDA	Phillips	HG-U133B	226314_at	77	0.896104	0.000359633	0.0106822	1.36542	0.00520499	0.990952	2.69 [1.34 - 5.40]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE7696	Brain cancer	Glioblastoma	Overall Survival	Lausanne	Murat	HG-U133_Plus_2	226314_at	70	0.214286	0.0452506	0.462286	-0.60877	0.665049	-0.200134	0.82 [0.33 - 2.03]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE4412-GPL97	Brain cancer	Glioma	Overall Survival	UCLA (1996-2003)	Freije	HG-U133B	226314_at	74	0.864865	0.0104204	0.166536	0.960275	0.211285	0.577018	1.78 [0.72 - 4.40]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE16581	Brain cancer	Meningioma	Overall Survival	UCLA	Lee	HG-U133_Plus_2	226314_at	67	0.552239	0.0460032	0.467054	-1.85051	0.262344	-1.48978	0.23 [0.02 - 3.05]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE19615	Breast cancer		Distant Metastasis Free Survival	DF/HCC	Li	HG-U133_Plus_2	226314_at	115	0.895652	0.140703	-	0.937796	0.783047	0.31436	1.37 [0.15 - 12.83]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE12276	Breast cancer		Relapse Free Survival	EMC	Bos	HG-U133_Plus_2	226314_at	204	0.485294	9.89549e-05	0.00347004	-0.554481	0.00476348	-0.613227	0.54 [0.35 - 0.83]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE6532-GPL570	Breast cancer		Relapse Free Survival	GUYT	Loi	HG-U133_Plus_2	226314_at	87	0.482759	0.0353916	0.395183	-0.800198	0.230393	-0.585988	0.56 [0.21 - 1.45]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE6532-GPL570	Breast cancer		Distant Metastasis Free Survival	GUYT	Loi	HG-U133_Plus_2	226314_at	87	0.482759	0.0353916	0.395183	-0.800198	0.230393	-0.585988	0.56 [0.21 - 1.45]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE9195	Breast cancer		Distant Metastasis Free Survival	GUYT2	Loi	HG-U133_Plus_2	226314_at	77	0.519481	0.0405322	0.431299	1.48048	0.224931	1.08788	2.97 [0.51 - 17.20]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE9195	Breast cancer		Relapse Free Survival	GUYT2	Loi	HG-U133_Plus_2	226314_at	77	0.519481	0.0295534	0.350716	1.332	0.224017	0.945106	2.57 [0.56 - 11.81]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE1378	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15027	60	0.85	0.0155132	0.223394	1.01857	0.745399	0.148238	1.16 [0.47 - 2.84]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE1379	Breast cancer		Relapse Free Survival	MGH (1987-2000)	Ma	Arcturus 22k	15027	60	0.8	0.0128124	0.194223	0.980472	0.213448	0.516639	1.68 [0.74 - 3.78]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE1456-GPL97	Breast cancer		Overall Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226314_at	159	0.742138	0.173923	-	0.447086	0.943873	-0.0418145	0.96 [0.30 - 3.07]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE1456-GPL97	Breast cancer		Relapse Free Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226314_at	159	0.716981	0.0102092	0.163995	0.795313	0.525658	0.385989	1.47 [0.45 - 4.85]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE1456-GPL97	Breast cancer		Disease Specific Survival	Stockholm (1994-1996)	Pawitan	HG-U133B	226314_at	159	0.742138	0.0512131	-	0.71962	0.407527	0.591675	1.81 [0.45 - 7.33]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE3494-GPL97	Breast cancer		Disease Specific Survival	Uppsala (1987-1989)	Miller	HG-U133B	226314_at	236	0.322034	0.000100199	0.00350845	-1.00878	0.0291107	-1.30903	0.27 [0.08 - 0.88]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE4922-GPL97	Breast cancer		Disease Free Survival	Uppsala (1987-1989)	Ivshina	HG-U133B	226314_at	249	0.309237	0.000121971	0.00417077	-0.797667	0.0579574	-0.932469	0.39 [0.15 - 1.03]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17536	Colorectal cancer		Overall Survival	MCC	Smith	HG-U133_Plus_2	226314_at	177	0.254237	0.00340314	0.0697135	1.00242	0.120525	0.6865	1.99 [0.84 - 4.73]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17536	Colorectal cancer		Disease Specific Survival	MCC	Smith	HG-U133_Plus_2	226314_at	177	0.254237	0.0156904	0.225241	0.944385	0.0759967	0.897023	2.45 [0.91 - 6.61]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17536	Colorectal cancer		Disease Free Survival	MCC	Smith	HG-U133_Plus_2	226314_at	145	0.337931	0.00675406	0.119667	1.23097	0.00833105	1.53457	4.64 [1.48 - 14.51]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE14333	Colorectal cancer		Disease Free Survival	Melbourne	Jorissen	HG-U133_Plus_2	226314_at	226	0.845133	0.000308885	0.00936944	1.06828	0.0127167	0.758267	2.13 [1.18 - 3.88]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17537	Colorectal cancer		Overall Survival	VMC	Smith	HG-U133_Plus_2	226314_at	55	0.472727	0.00122765	0.0302536	1.63711	0.0541707	1.62143	5.06 [0.97 - 26.36]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17537	Colorectal cancer		Disease Free Survival	VMC	Smith	HG-U133_Plus_2	226314_at	55	0.472727	0.000162778	0.00537054	2.31244	0.00745833	2.29495	9.92 [1.85 - 53.31]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17537	Colorectal cancer		Disease Specific Survival	VMC	Smith	HG-U133_Plus_2	226314_at	49	0.530612	0.00157176	0.0371434	2.07441	0.104291	1.62555	5.08 [0.71 - 36.12]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE22138	Eye cancer	Uveal melanoma	Distant Metastasis Free Survival	BRCIC	Laurent	HG-U133_Plus_2	226314_at	63	0.444444	0.0589659	-	0.665761	0.232697	0.211827	1.24 [0.87 - 1.75]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE2837	Head and neck cancer	Squamous cell carcinoma	Relapse Free Survival	VUMC, VAMC, UTMDACC (1992-2005)	Chung	U133_X3P	Hs.24947.0.A1_3p_at	28	0.25	0.0110027	0.173457	-1.40734	0.116256	-6.42074	0.00 [0.00 - 4.91]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_23_P106532	117	0.119658	0.0113438	0.177455	-0.87312	0.467091	-0.29133	0.75 [0.34 - 1.64]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE13213	Lung cancer	Adenocarcinoma	Overall Survival	Nagoya (1995-1999, 2002-2004)	Tomida	G4112F	A_24_P210637	117	0.119658	0.144229	-	-0.558211	0.799721	-0.0493537	0.95 [0.65 - 1.39]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE31210	Lung cancer	Adenocarcinoma	Overall Survival	NCCRI	Okayama	HG-U133_Plus_2	226314_at	204	0.784314	0.030367	0.357157	0.800421	0.0772564	1.53651	4.65 [0.85 - 25.56]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE31210	Lung cancer	Adenocarcinoma	Relapse Free Survival	NCCRI	Okayama	HG-U133_Plus_2	226314_at	204	0.892157	0.0258995	0.320706	0.762567	0.166458	0.890657	2.44 [0.69 - 8.60]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE3141	Lung cancer	NSCLC	Overall Survival	Duke	Bild	HG-U133_Plus_2	226314_at	111	0.225225	0.128335	-	-0.446037	0.516041	-0.220308	0.80 [0.41 - 1.56]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE8894	Lung cancer	NSCLC	Relapse Free Survival	Seoul (1995-2005)	Lee	HG-U133_Plus_2	226314_at	138	0.855072	0.0914851	-	0.515842	0.78506	0.0467523	1.05 [0.75 - 1.47]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12477	56	0.892857	0.0271422	0.33112	1.04394	0.667783	0.198155	1.22 [0.49 - 3.01]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30674	56	0.732143	0.0017162	0.0399399	1.10958	0.242649	0.549071	1.73 [0.69 - 4.35]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17710	Lung cancer	Squamous cell carcinoma	Relapse Free Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	12477	56	0.892857	0.0122274	0.187627	1.17293	0.299189	0.481546	1.62 [0.65 - 4.02]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17710	Lung cancer	Squamous cell carcinoma	Overall Survival	UNC	Wilkerson	Agilent-UNC-custom-4X44K	30674	56	0.732143	0.110005	-	0.606155	0.870697	-0.0758558	0.93 [0.37 - 2.31]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE9891	Ovarian cancer		Overall Survival	AOCS, RBH, WH, NKI-AVL (1992-2006)	Tothill	HG-U133_Plus_2	226314_at	278	0.863309	0.0138967	0.206177	0.571495	0.86606	0.0358524	1.04 [0.68 - 1.57]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P106532	110	0.4	0.0485869	0.483077	-0.577316	0.581559	-0.136368	0.87 [0.54 - 1.42]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P210637	110	0.245455	0.00543283	0.101017	-0.69	0.860056	-0.0473519	0.95 [0.56 - 1.61]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17260	Ovarian cancer		Progression Free Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_23_P106532	110	0.736364	0.0169141	0.237784	0.604604	0.857451	-0.0356086	0.97 [0.65 - 1.42]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE17260	Ovarian cancer		Overall Survival	Niigata (1997-2008)	Yoshihara	G4112A	A_24_P210637	110	0.218182	0.000814818	0.0214518	-0.992835	0.189155	-0.461573	0.63 [0.32 - 1.26]
GENE	CHST14	carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14	None	GSE19234	Skin cancer	Melanoma	Overall Survival	NYU	Bogunovic	HG-U133_Plus_2	226314_at	38	0.289474	0.0144742	0.212408	1.46258	0.0344812	1.22767	3.41 [1.09 - 10.65]

